Citrus Sinensis ID: 046851
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 963 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S7I6 | 1151 | LRR receptor-like serine/ | yes | no | 0.992 | 0.830 | 0.689 | 0.0 | |
| Q9ZRF9 | 540 | Probable LRR receptor-lik | no | no | 0.454 | 0.811 | 0.603 | 1e-152 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.956 | 0.807 | 0.331 | 1e-122 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.916 | 0.740 | 0.317 | 1e-121 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.904 | 0.790 | 0.357 | 1e-119 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.919 | 0.803 | 0.323 | 1e-116 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.914 | 0.783 | 0.333 | 1e-114 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.953 | 0.734 | 0.323 | 1e-113 | |
| Q9ZVR7 | 1008 | Phytosulfokine receptor 1 | no | no | 0.929 | 0.887 | 0.323 | 1e-111 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.893 | 0.858 | 0.314 | 1e-111 |
| >sp|Q9S7I6|RPK2_ARATH LRR receptor-like serine/threonine-protein kinase RPK2 OS=Arabidopsis thaliana GN=RPK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1297 bits (3356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 684/992 (68%), Positives = 784/992 (79%), Gaps = 36/992 (3%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M LEVLDLEGNL+ G LPD L++LRV+NLGFNR++GEIP S + LE LNL GN
Sbjct: 167 MEKLEVLDLEGNLMTGSLPDQFTGLRNLRVMNLGFNRVSGEIPNSLQNLTKLEILNLGGN 226
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+NGTVP F+GR + ++L N L GS+P IG+ C LEHLDLSGN+L G IP SLG C
Sbjct: 227 KLNGTVPGFVGRFRVLHLPLNWLQGSLPKDIGDSCGKLEHLDLSGNFLTGRIPESLGKCA 286
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
+RSLLL+ N LEETIP E G LQ LEVLDVSRN+LSG +PV+LGNCS L++LVLSNL++
Sbjct: 287 GLRSLLLYMNTLEETIPLEFGSLQKLEVLDVSRNTLSGPLPVELGNCSSLSVLVLSNLYN 346
Query: 181 TYEDVRYSRGQSLVDQP-----SFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF 235
YED+ RG++ D P + M +DFNF++GGIPE ++ LP L+ILW PRATLEG F
Sbjct: 347 VYEDINSVRGEA--DLPPGADLTSMTEDFNFYQGGIPEEITRLPKLKILWVPRATLEGRF 404
Query: 236 PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMF 295
P +WG+C NLEM+NLG NFF G+ L CKNL LDLSSN+LTGEL +E+ VPCM++F
Sbjct: 405 PGDWGSCQNLEMVNLGQNFFKGEIPVGLSKCKNLRLLDLSSNRLTGELLKEISVPCMSVF 464
Query: 296 DVSGNALSGSIPTFSNMV---CPPVPYLSRNLFESY-NPSTAYLSLFAKKSQAGTPLPLR 351
DV GN+LSG IP F N CPPV Y R ESY +PS+ YLS F +K+Q GT L
Sbjct: 465 DVGGNSLSGVIPDFLNNTTSHCPPVVYFDRFSIESYSDPSSVYLSFFTEKAQVGTSLIDL 524
Query: 352 GRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNR 411
G DG A+FHNF NNF+G+L S+P+A ERLGK+ Y AG N+L G FPGN+F C+
Sbjct: 525 GSDGGPAVFHNFADNNFTGTLKSIPLAQERLGKRVSYIFSAGGNRLYGQFPGNLFDNCDE 584
Query: 412 LDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWN 471
L ++ VNVS N+++G++P + MC SLK LDAS NQI GPIP +G+L SLVALNLSWN
Sbjct: 585 LKAVYVNVSFNKLSGRIPQGLNNMCTSLKILDASVNQIFGPIPTSLGDLASLVALNLSWN 644
Query: 472 LMHDQIPTTLGQ-MKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLE 530
+ QIP +LG+ M L YLS+A NNLTG IP S GQL L+VLDLSSN LSG IP D
Sbjct: 645 QLQGQIPGSLGKKMAALTYLSIANNNLTGQIPQSFGQLHSLDVLDLSSNHLSGGIPHDFV 704
Query: 531 NLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPY 590
NL+NLTVLLLNNN LSG IPSG A T + FNVS NNLSGP+PS+ L KCS+V GNPY
Sbjct: 705 NLKNLTVLLLNNNNLSGPIPSGFA---TFAVFNVSSNNLSGPVPSTNGLTKCSTVSGNPY 761
Query: 591 LRPCRAFTLTEPS------------QDLHGPP-------SNGNRGFNSIEIASIASASAI 631
LRPC F+LT PS QD P S G GFNS+EIASIASASAI
Sbjct: 762 LRPCHVFSLTTPSSDSRDSTGDSITQDYASSPVENAPSQSPGKGGFNSLEIASIASASAI 821
Query: 632 VSVLLALIVLFVYTRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIG 691
VSVL+AL++LF YTRKW+P+SK+M +T++EVT+F +IGVP++F++VV+ATGNFNASN IG
Sbjct: 822 VSVLIALVILFFYTRKWHPKSKIMATTKREVTMFMDIGVPITFDNVVRATGNFNASNLIG 881
Query: 692 NGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET 751
NGGFGATYKAEIS V+VAIKRL++GRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET
Sbjct: 882 NGGFGATYKAEISQDVVVAIKRLSIGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET 941
Query: 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP 811
EMFL+YNYLPGGNLE FIQ+RSTR DWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP
Sbjct: 942 EMFLVYNYLPGGNLEKFIQERSTR--DWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP 999
Query: 812 SNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYG 871
SNILLDDD NAYLSDFGLARLLG SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYG
Sbjct: 1000 SNILLDDDCNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYG 1059
Query: 872 VVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVL 931
VVLLELLSDKKALDPSF SYGNGFNIV W CMLLRQGRAKEFFTAGLWDAGPHDDLVEVL
Sbjct: 1060 VVLLELLSDKKALDPSFVSYGNGFNIVQWACMLLRQGRAKEFFTAGLWDAGPHDDLVEVL 1119
Query: 932 HLAVVCTVDSLSTRPTMKQVVRRLKQLQPASC 963
HLAVVCTVDSLSTRPTMKQVVRRLKQLQP SC
Sbjct: 1120 HLAVVCTVDSLSTRPTMKQVVRRLKQLQPPSC 1151
|
Key regulator of anther development (e.g. lignification pattern), including tapetum degradation during pollen maturation (e.g. germination capacity). Together with RPK1, required for pattern formation along the radial axis (e.g. the apical embryonic domain cell types that generate cotyledon primordia), and the apical-basal axis (e.g. differentiation of the basal pole during early embryogenesis). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZRF9|RPK1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RPK1 OS=Arabidopsis thaliana GN=RPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 538 bits (1386), Expect = e-152, Method: Compositional matrix adjust.
Identities = 279/462 (60%), Positives = 347/462 (75%), Gaps = 24/462 (5%)
Query: 510 LLEVLDLSSNS-----LSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNV 564
+L + DLSS S L G+I + +L + VL L+ N L G+IP + + L ++
Sbjct: 91 VLHLPDLSSCSSSKRRLGGVISPVVGDLSEIRVLSLSFNDLRGEIPKEIWGLEKLEILDL 150
Query: 565 SFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAFTLTEPSQDLHGPPSN-----GNRGFNS 619
NN G + V+ N LR +F +D GP S G G
Sbjct: 151 KGNNFIGGI----------RVVDNVVLRKLMSF----EDEDEIGPSSADDDSPGKSGLYP 196
Query: 620 IEIASIASASAIVSVLLALIVLFVYTRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQ 679
IEIASI SAS IV VLL L++LF+YTRKW S+V KE+ +F +IG+PL++E +V+
Sbjct: 197 IEIASIVSASVIVFVLLVLVILFIYTRKWKRNSQVQVDEIKEIKVFVDIGIPLTYEIIVR 256
Query: 680 ATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPN 739
ATG F+ SNCIG+GGFG+TYKAE+SP + A+KRL+VGRFQG QQFHAEI L +RHPN
Sbjct: 257 ATGYFSNSNCIGHGGFGSTYKAEVSPTNVFAVKRLSVGRFQGDQQFHAEISALEMVRHPN 316
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
LV LIGYHASETEMFLIYNYL GGNL++FI++RS A++W+VLHKIALD+ARAL+YLH+Q
Sbjct: 317 LVMLIGYHASETEMFLIYNYLSGGNLQDFIKERSKAAIEWKVLHKIALDVARALSYLHEQ 376
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
C P+VLHRD+KPSNILLD+++NAYLSDFGL++LLG S++H TTGVAGTFGYVAPEYAMTC
Sbjct: 377 CSPKVLHRDIKPSNILLDNNYNAYLSDFGLSKLLGTSQSHVTTGVAGTFGYVAPEYAMTC 436
Query: 860 RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919
RVS+KADVYSYG+VLLEL+SDK+ALDPSFSS+ NGFNIV+W M+L QG+AKE FT GLW
Sbjct: 437 RVSEKADVYSYGIVLLELISDKRALDPSFSSHENGFNIVSWAHMMLSQGKAKEVFTTGLW 496
Query: 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961
+ GP DDLVEVLHLA+ CTVDSLS RPTMKQ VR LK++QP+
Sbjct: 497 ETGPPDDLVEVLHLALKCTVDSLSIRPTMKQAVRLLKRIQPS 538
|
Involved in the main abscisic acid-mediated (ABA) signaling pathway and in early ABA perception. Together with RPK2, required for pattern formation along the radial axis (e.g. the apical embryonic domain cell types that generate cotyledon primordia), and the apical-basal axis (e.g. differentiation of the basal pole during early embryogenesis). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1127), Expect = e-122, Method: Compositional matrix adjust.
Identities = 331/998 (33%), Positives = 510/998 (51%), Gaps = 77/998 (7%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+L+ L + G L G LP+S L+VL+L N + G+IP S S NLE L L N +
Sbjct: 106 SLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQL 165
Query: 63 NGTVPTFIGR---LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG-IPRSLGN 118
G +P I + LK + L N L GS+P+++G K + LE + + GN + G IP +G+
Sbjct: 166 TGKIPPDISKCSKLKSLILFDNLLTGSIPTELG-KLSGLEVIRIGGNKEISGQIPSEIGD 224
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178
C + L L + +P+ LG L+ LE L + +SG IP DLGNCS+L L L
Sbjct: 225 CSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFL--- 281
Query: 179 FDTYEDVRYSRGQSLVDQPSFMNDDF---NFFEGGIPEAVSSLPNLRILWAPRATLEGNF 235
YE+ + Q + + F N GGIPE + + NL+++ L G+
Sbjct: 282 ---YENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSI 338
Query: 236 PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTM 294
PS+ G LE + N FSG + C +L+ L L NQ++G + EL + +T+
Sbjct: 339 PSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTL 398
Query: 295 FDVSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGR 353
F N L GSIP ++ LSRN PS LF ++ L
Sbjct: 399 FFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPS----GLFMLRNLTKLLLISNSL 454
Query: 354 DGFLA---------IFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPG 403
GF+ + G N +G +PS +G + + + N+L G P
Sbjct: 455 SGFIPQEIGNCSSLVRLRLGFNRITGEIPS------GIGSLKKINFLDFSSNRLHGKVP- 507
Query: 404 NMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSL 463
+ G C+ L M+++SNN + G LP + + L+ LD S NQ G IP +G LVSL
Sbjct: 508 DEIGSCSELQ--MIDLSNNSLEGSLPNPVSSL-SGLQVLDVSANQFSGKIPASLGRLVSL 564
Query: 464 VALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEV-LDLSSNSLS 522
L LS NL IPT+LG GL+ L L N L+G IPS LG ++ LE+ L+LSSN L+
Sbjct: 565 NKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLT 624
Query: 523 GLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKC 582
G IP + +L L++L L++N L G + + LAN+ L + N+S+N+ SG LP +K +
Sbjct: 625 GKIPSKIASLNKLSILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQL 683
Query: 583 S--SVLGNPYLRPCRAFT----LTEPSQDLHGPPSNGNRGFNSIEIASIASASAIVSVLL 636
S + GN L C + LT + G + +R ++ +V ++L
Sbjct: 684 SPQDLEGNKKL--CSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMIL 741
Query: 637 ALIVLFVYTRKW-NPQSKVMGSTRK-EVTIFTEIGVPLSFESVVQATGNFNASNCIGNGG 694
+ + R N + +G T K + T F ++ SV Q N IG G
Sbjct: 742 GAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNF-----SVDQIIRCLVEPNVIGKGC 796
Query: 695 FGATYKAEISPGVLVAIKRLAVGRFQG---------VQQFHAEIKTLGRLRHPNLVTLIG 745
G Y+A++ G ++A+K+L G F AE+KTLG +RH N+V +G
Sbjct: 797 SGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLG 856
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ L+Y+Y+P G+L + + +R ++DW + ++I L A+ LAYLH C+P ++
Sbjct: 857 CCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIV 916
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDK 864
HRD+K +NIL+ DF Y++DFGLA+L+ + + VAG++GY+APEY + ++++K
Sbjct: 917 HRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEK 976
Query: 865 ADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK-EFFTAGLWD--A 921
+DVYSYGVV+LE+L+ K+ +DP+ G ++V W +RQ R E + L
Sbjct: 977 SDVYSYGVVVLEVLTGKQPIDPTVPE---GIHLVDW----VRQNRGSLEVLDSTLRSRTE 1029
Query: 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
D++++VL A++C S RPTMK V LK+++
Sbjct: 1030 AEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIK 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1124), Expect = e-121, Method: Compositional matrix adjust.
Identities = 327/1031 (31%), Positives = 503/1031 (48%), Gaps = 148/1031 (14%)
Query: 15 NGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGR-- 72
NG LP LK L L+L +N + IP SF + NL LNL + G +P +G
Sbjct: 223 NGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAELIGLIPPELGNCK 282
Query: 73 -LKRVYLSFNRLVGSVPSKIGE----------------------KCTNLEHLDLSGNYLV 109
LK + LSFN L G +P ++ E K L+ L L+ N
Sbjct: 283 SLKSLMLSFNSLSGPLPLELSEIPLLTFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFS 342
Query: 110 GGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSK 169
G IP + +C ++ L L SN+L +IP EL +LE +D+S N LSG+I CS
Sbjct: 343 GEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSS 402
Query: 170 LAILVLSNLFDTYEDVRYSRGQSLVDQPSFMND-DFNFFEGGIPEAVSSLPNLRILWAPR 228
L L+L+N + S + L P D D N F G IP+++ NL A
Sbjct: 403 LGELLLTN-----NQINGSIPEDLWKLPLMALDLDSNNFTGEIPKSLWKSTNLMEFTASY 457
Query: 229 ATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL- 287
LEG P+ G +L+ L L N +G+ +G +L L+L++N G++ EL
Sbjct: 458 NRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELG 517
Query: 288 PVPCMTMFDVSGNALSGSIP----TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQ 343
+T D+ N L G IP + + C + Y
Sbjct: 518 DCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSY------------------------ 553
Query: 344 AGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVA-------PERLGKQTVYAIVAGDNK 396
NN SGS+PS P A P+ Q N+
Sbjct: 554 ----------------------NNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNR 591
Query: 397 LSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRG 456
LSG P + G C L + +++SNN ++G++PA + R+ +L LD SGN + G IP+
Sbjct: 592 LSGPIPEEL-GEC--LVLVEISLSNNHLSGEIPASLSRLT-NLTILDLSGNALTGSIPKE 647
Query: 457 VGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516
+G + L LNL+ N ++ IP + G + L L+L N L G +P+SLG L+ L +DL
Sbjct: 648 MGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDL 707
Query: 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
S N+LSG + +L + L L + NK +G+IPS L N++ L +VS N LSG +P+
Sbjct: 708 SFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPT- 766
Query: 577 KNLMKCSSVLGNPYLRPCRAFTLTE-PSQDLHGPPS----NGNRGFN--------SIEIA 623
K + +L + E PS + PS +GN+ IE
Sbjct: 767 ----KICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGT 822
Query: 624 SIASASAIVSVLLAL-IVLFVYT---RKWNPQSKVM------------------------ 655
+ SA I ++L I++FV+ R+W +V
Sbjct: 823 KLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFL 882
Query: 656 -GSTRKE-----VTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLV 709
GS +E + +F + + + +V+AT +F+ N IG+GGFG YKA + V
Sbjct: 883 SGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTV 942
Query: 710 AIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFI 769
A+K+L+ + QG ++F AE++TLG+++HPNLV+L+GY + E L+Y Y+ G+L++++
Sbjct: 943 AVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWL 1002
Query: 770 QQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDF 827
+ ++ +DW KIA+ AR LA+LH +P ++HRD+K SNILLD DF ++DF
Sbjct: 1003 RNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADF 1062
Query: 828 GLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPS 887
GLARL+ E+H +T +AGTFGY+ PEY + R + K DVYS+GV+LLEL++ K+ P
Sbjct: 1063 GLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPD 1122
Query: 888 FSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT 947
F G N+V W + QG+A + L + + +L +A++C ++ + RP
Sbjct: 1123 FKE-SEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPN 1181
Query: 948 MKQVVRRLKQL 958
M V++ LK++
Sbjct: 1182 MLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 431 bits (1109), Expect = e-119, Method: Compositional matrix adjust.
Identities = 348/973 (35%), Positives = 492/973 (50%), Gaps = 102/973 (10%)
Query: 12 NLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG 71
N ++G LP S +LK L G N I+G +P+ +L L LA N ++G +P IG
Sbjct: 179 NNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIG 238
Query: 72 RLKR---VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLF 128
LK+ V L N G +P +I CT+LE L L N LVG IP+ LG+ + L L+
Sbjct: 239 MLKKLSQVILWENEFSGFIPREI-SNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLY 297
Query: 129 SNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYS 188
N L TIP E+G L +D S N+L+G IP++LGN L +L L F+
Sbjct: 298 RNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYL---FE-------- 346
Query: 189 RGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEML 248
N G IP +S+L NL L L G P + L ML
Sbjct: 347 ----------------NQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFML 390
Query: 249 NLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC-MTMFDVSGNALSGSIP 307
L N SG LG +L LD+S N L+G + L + M + ++ N LSG+IP
Sbjct: 391 QLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIP 450
Query: 308 TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGT-PLPLRGRDGFLAIFHNFGGN 366
T C + L A+ + G P L + AI G N
Sbjct: 451 T-GITTCKTLVQLR----------------LARNNLVGRFPSNLCKQVNVTAI--ELGQN 491
Query: 367 NFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAG 426
F GS+P E + + DN +G P + G+ ++L +L N+S+N++ G
Sbjct: 492 RFRGSIPR-----EVGNCSALQRLQLADNGFTGELPREI-GMLSQLGTL--NISSNKLTG 543
Query: 427 QLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKG 486
++P+EI CK L+ LD N G +P VG L L L LS N + IP LG +
Sbjct: 544 EVPSEIFN-CKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSR 602
Query: 487 LKYLSLAGNNLTGSIPSSLGQLQLLEV-LDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545
L L + GN GSIP LG L L++ L+LS N L+G IP +L NL L LLLNNN L
Sbjct: 603 LTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNL 662
Query: 546 SGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGN-----PYLRPCRAFTLT 600
SG+IPS AN+S+L +N S+N+L+GP+P +N+ SS +GN P L C
Sbjct: 663 SGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNI-SMSSFIGNEGLCGPPLNQCIQTQPF 721
Query: 601 EPSQDLHGPPSNGNRGFNSIEIASIASASAIVSVLLALIVLFVYTRKWNPQSKVMGSTRK 660
PSQ P G S +I +I +A+ I V L LI L VY + P V S +
Sbjct: 722 APSQSTGKP-----GGMRSSKIIAI-TAAVIGGVSLMLIALIVYLMR-RPVRTVASSAQD 774
Query: 661 ------EVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRL 714
+ I+ +F+ +V AT NF+ S +G G G YKA + G +A+K+L
Sbjct: 775 GQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKL 834
Query: 715 AVGRFQG-----VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFI 769
A G F AEI TLG +RH N+V L G+ + L+Y Y+P G+L +
Sbjct: 835 ASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEIL 894
Query: 770 QQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829
S +DW KIAL A+ LAYLH C PR+ HRD+K +NILLDD F A++ DFGL
Sbjct: 895 HDPSCN-LDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 953
Query: 830 ARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFS 889
A+++ + + + +AG++GY+APEYA T +V++K+D+YSYGVVLLELL+ K + P
Sbjct: 954 AKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP--- 1010
Query: 890 SYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA--GPHDD-----LVEVLHLAVVCTVDSL 942
G ++V W +R ++ ++G+ DA D+ ++ VL +A++CT S
Sbjct: 1011 -IDQGGDVVNW----VRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSP 1065
Query: 943 STRPTMKQVVRRL 955
RP+M+QVV L
Sbjct: 1066 VARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 420 bits (1080), Expect = e-116, Method: Compositional matrix adjust.
Identities = 319/985 (32%), Positives = 494/985 (50%), Gaps = 100/985 (10%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ +L+ L + N L G++P S L+ LR++ G N +G IP+ S +L+ L LA N
Sbjct: 162 LSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAEN 221
Query: 61 LVNGTVPTFIGRLKR---VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
L+ G++P + +L+ + L NRL G +P +G + LE L L NY G IPR +G
Sbjct: 222 LLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVG-NISRLEVLALHENYFTGSIPREIG 280
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+++ L L++N L IP E+G L + +D S N L+G IP + G+ L +L +
Sbjct: 281 KLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLL---H 337
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
LF+ R + ++ N G IP+ + LP L L LEG P
Sbjct: 338 LFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPP 397
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV-PCMTMFD 296
G N +L++ N SG + L+ L L SN+L+G + R+L +T
Sbjct: 398 LIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLM 457
Query: 297 VSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGF 356
+ N L+GS+P LF N +
Sbjct: 458 LGDNQLTGSLPI--------------ELFNLQNLTA------------------------ 479
Query: 357 LAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFP---GNMFGICNRLD 413
L + N+ N S L + + + + +N +G P GN+ I
Sbjct: 480 LELHQNWLSGNISADLGKL---------KNLERLRLANNNFTGEIPPEIGNLTKIVG--- 527
Query: 414 SLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLM 473
N+S+N++ G +P E+G C +++ LD SGN+ G I + +G+LV L L LS N +
Sbjct: 528 ---FNISSNQLTGHIPKELGS-CVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRL 583
Query: 474 HDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEV-LDLSSNSLSGLIPDDLENL 532
+IP + G + L L L GN L+ +IP LG+L L++ L++S N+LSG IPD L NL
Sbjct: 584 TGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNL 643
Query: 533 RNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSK--NLMKCSSVLGNPY 590
+ L +L LN+NKLSG+IP+ + N+ +L N+S NNL G +P + M S+ GN
Sbjct: 644 QMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHG 703
Query: 591 LRPCRAFTLTEPSQDLHGPP------SNGNRGFNSIEIASIASASAIV--SVLLALIVLF 642
L C SQ H P S N N + I + + IV SV L +
Sbjct: 704 L--CN-------SQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGL 754
Query: 643 VYTRKWNPQSKVMGSTRKEVTIFTEIGVP---LSFESVVQATGNFNASNCIGNGGFGATY 699
+T K + V + + + P +++ +V AT NF+ +G G G Y
Sbjct: 755 CWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVY 814
Query: 700 KAEISPGVLVAIKRLAVGRFQGV---QQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756
KAE+S G ++A+K+L R +G F AEI TLG++RH N+V L G+ + L+
Sbjct: 815 KAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLL 873
Query: 757 YNYLPGGNLENFIQQRSTRA-VDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNIL 815
Y Y+ G+L +Q+ +DW ++IAL A L YLH C P+++HRD+K +NIL
Sbjct: 874 YEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNIL 933
Query: 816 LDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLL 875
LD+ F A++ DFGLA+L+ S + + + VAG++GY+APEYA T +V++K D+YS+GVVLL
Sbjct: 934 LDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLL 993
Query: 876 ELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK-EFFTAGLW--DAGPHDDLVEVLH 932
EL++ K + P G ++V W +R E F A L D ++ VL
Sbjct: 994 ELITGKPPVQP----LEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLK 1049
Query: 933 LAVVCTVDSLSTRPTMKQVVRRLKQ 957
+A+ CT +S ++RPTM++VV + +
Sbjct: 1050 IALFCTSNSPASRPTMREVVAMITE 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1062), Expect = e-114, Method: Compositional matrix adjust.
Identities = 330/990 (33%), Positives = 476/990 (48%), Gaps = 109/990 (11%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
NLE L N L G LP S +L L G N +G IP +NL+ L LA N +
Sbjct: 182 NLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFI 241
Query: 63 NGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
+G +P IG +L+ V L N+ G +P IG T+LE L L GN LVG IP +GN
Sbjct: 242 SGELPKEIGMLVKLQEVILWQNKFSGFIPKDIG-NLTSLETLALYGNSLVGPIPSEIGNM 300
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLF 179
++ L L+ N L TIP ELG L + +D S N LSG IPV+L S+L +L L
Sbjct: 301 KSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYL---- 356
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNW 239
F N G IP +S L NL L +L G P +
Sbjct: 357 -------------------FQNK----LTGIIPNELSKLRNLAKLDLSINSLTGPIPPGF 393
Query: 240 GACDNLEMLNLGHNFFSG---KNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC----M 292
++ L L HN SG + LG+ P L +D S NQL+G++ P C +
Sbjct: 394 QNLTSMRQLQLFHNSLSGVIPQGLGLYSP---LWVVDFSENQLSGKIP---PFICQQSNL 447
Query: 293 TMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRG 352
+ ++ N + G+IP P ++L + L + + P L
Sbjct: 448 ILLNLGSNRIFGNIP--------PGVLRCKSLLQ--------LRVVGNRLTGQFPTELCK 491
Query: 353 RDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRL 412
AI N FSG LP PE Q + + N+ S + P + + N +
Sbjct: 492 LVNLSAI--ELDQNRFSGPLP-----PEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLV 544
Query: 413 DSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNL 472
NVS+N + G +P+EI CK L+ LD S N +G +P +G L L L LS N
Sbjct: 545 T---FNVSSNSLTGPIPSEIAN-CKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENR 600
Query: 473 MHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEV-LDLSSNSLSGLIPDDLEN 531
IP T+G + L L + GN +GSIP LG L L++ ++LS N SG IP ++ N
Sbjct: 601 FSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGN 660
Query: 532 LRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL--MKCSSVLGNP 589
L L L LNNN LSG+IP+ N+S+L N S+NNL+G LP ++ M +S LGN
Sbjct: 661 LHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNK 720
Query: 590 -----YLRPCRAFTLTEPSQDLHGPPSNGNRGFNSIEIASIASASAIVSVLLALIVLFVY 644
+LR C +PS S+ G I +S I + L LI + V+
Sbjct: 721 GLCGGHLRSC------DPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVH 774
Query: 645 TRKWNPQSKVMGSTRKEVTIFTEIGV------PLSFESVVQATGNFNASNCIGNGGFGAT 698
+ NP + F E + + + +++AT F+ S +G G G
Sbjct: 775 FLR-NPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTV 833
Query: 699 YKAEISPGVLVAIKRLAVGRFQGVQQ-------FHAEIKTLGRLRHPNLVTLIG--YHAS 749
YKA + G +A+K+L R F AEI TLG++RH N+V L YH
Sbjct: 834 YKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQG 893
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
L+Y Y+ G+L + + ++DW IAL A LAYLH C PR++HRD+
Sbjct: 894 SNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDI 953
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYS 869
K +NIL+D++F A++ DFGLA+++ + + + VAG++GY+APEYA T +V++K D+YS
Sbjct: 954 KSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYS 1013
Query: 870 YGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ----GRAKEFFTAGLWDAGPHD 925
+GVVLLELL+ K + P G ++ W +R + + + D +
Sbjct: 1014 FGVVLLELLTGKAPVQP----LEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILN 1069
Query: 926 DLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955
++ V +AV+CT S S RPTM++VV L
Sbjct: 1070 HMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1052), Expect = e-113, Method: Compositional matrix adjust.
Identities = 327/1011 (32%), Positives = 516/1011 (51%), Gaps = 93/1011 (9%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M L+ L L N L G++P S L +L+ L+L N +TGEIP F + L +L LA N
Sbjct: 262 MSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANN 321
Query: 61 LVNGTVPTFI----GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL 116
++G++P I L+++ LS +L G +P ++ KC +L+ LDLS N L G IP +L
Sbjct: 322 HLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELS-KCQSLKQLDLSNNSLAGSIPEAL 380
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS 176
++ L L +N LE T+ + L NL+ L + N+L G +P ++ KL +L L
Sbjct: 381 FELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFL- 439
Query: 177 NLFDTYEDVRYSRG--QSLVDQPSF-MNDDF-NFFEGGIPEAVSSLPNLRILWAPRATLE 232
YE+ R+S Q + + S M D F N FEG IP ++ L L +L + L
Sbjct: 440 -----YEN-RFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELV 493
Query: 233 GNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPC 291
G P++ G C L +L+L N SG G K L L L +N L G L L +
Sbjct: 494 GGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRN 553
Query: 292 MTMFDVSGNALSGSIPTFSNMVCPPVPYLS----RNLFESYNP-----STAYLSLFAKKS 342
+T ++S N L+G+I + +C YLS N FE P S L K+
Sbjct: 554 LTRINLSHNRLNGTI----HPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609
Query: 343 QAGTPLPLR-GRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSF 401
Q +P G+ L++ + N +G++P V ++L I +N LSG
Sbjct: 610 QLTGKIPWTLGKIRELSLL-DMSSNALTGTIPLQLVLCKKLTH-----IDLNNNFLSGPI 663
Query: 402 PGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV 461
P G ++L L +S+N+ LP E+ C L L GN + G IP+ +G L
Sbjct: 664 PP-WLGKLSQLGEL--KLSSNQFVESLPTELFN-CTKLLVLSLDGNSLNGSIPQEIGNLG 719
Query: 462 SLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE-VLDLSSNS 520
+L LNL N +P +G++ L L L+ N+LTG IP +GQLQ L+ LDLS N+
Sbjct: 720 ALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNN 779
Query: 521 LSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLM 580
+G IP + L L L L++N+L+G++P + ++ +L NVSFNNL G L +
Sbjct: 780 FTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRW 839
Query: 581 KCSSVLGN------PYLRPCRAFTLTEPSQDLHGPPSNGNRGFNSIEIASIASASAIVSV 634
S LGN P R R + +N +G ++ + I++ SA+ ++
Sbjct: 840 PADSFLGNTGLCGSPLSRCNRVRS------------NNKQQGLSARSVVIISAISALTAI 887
Query: 635 LLALIVLFVYTRKWNPQSKVMG--------------STRKEVTIFTEIGVPLSFESVVQA 680
L ++V+ ++ ++ + K +G +T K + + +E +++A
Sbjct: 888 GLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEA 947
Query: 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKR-LAVGRFQGVQQFHAEIKTLGRLRHPN 739
T N + IG+GG G YKAE+ G VA+K+ L + F E+KTLGR+RH +
Sbjct: 948 THNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRH 1007
Query: 740 LVTLIGYHASETE--MFLIYNYLPGGNLENFIQQ------RSTRAVDWRVLHKIALDIAR 791
LV L+GY +S++E LIY Y+ G++ +++ + + + +DW +IA+ +A+
Sbjct: 1008 LVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQ 1067
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP---SETHATTGVAGTF 848
+ YLH CVP ++HRD+K SN+LLD + A+L DFGLA++L + T + T A ++
Sbjct: 1068 GVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSY 1127
Query: 849 GYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAW-GCMLLRQ 907
GY+APEYA + + ++K+DVYS G+VL+E+++ K P+ S +G ++V W L
Sbjct: 1128 GYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKM---PTDSVFGAEMDMVRWVETHLEVA 1184
Query: 908 GRAKE-FFTAGLWDAGP--HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955
G A++ L P D +VL +A+ CT S RP+ +Q L
Sbjct: 1185 GSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 404 bits (1037), Expect = e-111, Method: Compositional matrix adjust.
Identities = 322/995 (32%), Positives = 495/995 (49%), Gaps = 100/995 (10%)
Query: 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
G + L+L L+G L +S L +RVLNL N I IP S + NL+ L+L+ N
Sbjct: 76 GRVIRLELGNKKLSGKLSESLGKLDEIRVLNLSRNFIKDSIPLSIFNLKNLQTLDLSSND 135
Query: 62 VNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
++G +PT I L+ LS N+ GS+PS I T + + L+ NY G G C
Sbjct: 136 LSGGIPTSINLPALQSFDLSSNKFNGSLPSHICHNSTQIRVVKLAVNYFAGNFTSGFGKC 195
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS--- 176
+ L L N L IP +L L+ L +L + N LSGS+ ++ N S L L +S
Sbjct: 196 VLLEHLCLGMNDLTGNIPEDLFHLKRLNLLGIQENRLSGSLSREIRNLSSLVRLDVSWNL 255
Query: 177 ------NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT 230
++FD +++ GQ+ N F GGIP+++++ P+L +L +
Sbjct: 256 FSGEIPDVFDELPQLKFFLGQT------------NGFIGGIPKSLANSPSLNLLNLRNNS 303
Query: 231 LEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP-V 289
L G N A L L+LG N F+G+ L CK L ++L+ N G++
Sbjct: 304 LSGRLMLNCTAMIALNSLDLGTNRFNGRLPENLPDCKRLKNVNLARNTFHGQVPESFKNF 363
Query: 290 PCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLP 349
++ F +S ++L+ N S+A L K+ L
Sbjct: 364 ESLSYFSLSNSSLA-------------------------NISSALGILQHCKNLTTLVLT 398
Query: 350 LRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGIC 409
L NF G +LP L + + +V + +L+GS P
Sbjct: 399 L-----------NFHGE----ALPD----DSSLHFEKLKVLVVANCRLTGSMP-RWLSSS 438
Query: 410 NRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLS 469
N L ++++S NR+ G +P+ IG K+L +LD S N G IP+ + +L SL + N+S
Sbjct: 439 NELQ--LLDLSWNRLTGAIPSWIGDF-KALFYLDLSNNSFTGEIPKSLTKLESLTSRNIS 495
Query: 470 WNLMHDQIPTTLGQ---MKGLKY---------LSLAGNNLTGSIPSSLGQLQLLEVLDLS 517
N P + + + L+Y + L NNL+G I G L+ L V DL
Sbjct: 496 VNEPSPDFPFFMKRNESARALQYNQIFGFPPTIELGHNNLSGPIWEEFGNLKKLHVFDLK 555
Query: 518 SNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSK 577
N+LSG IP L + +L L L+NN+LSG IP L +S LS F+V++NNLSG +PS
Sbjct: 556 WNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVIPSGG 615
Query: 578 NLMKC-SSVLGNPYLRPCRAFTLTEPSQDLHGPPSNGNRGFNSIEIASIASASAIVSVLL 636
+S + +L F +E ++ S +RG + IA S + LL
Sbjct: 616 QFQTFPNSSFESNHLCGEHRFPCSEGTESALIKRSRRSRGGDIGMAIGIAFGSVFLLTLL 675
Query: 637 ALIVLFVYTRKWNPQSKVMGS---TRKE--------VTIFTEIGVPLSFESVVQATGNFN 685
+LIVL R ++ S RKE V +F LS++ ++ +T +F+
Sbjct: 676 SLIVLRARRRSGEVDPEIEESESMNRKELGEIGSKLVVLFQSNDKELSYDDLLDSTNSFD 735
Query: 686 ASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+N IG GGFG YKA + G VAIK+L+ Q ++F AE++TL R +HPNLV L G
Sbjct: 736 QANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRG 795
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRST--RAVDWRVLHKIALDIARALAYLHDQCVPR 803
+ + + LIY+Y+ G+L+ ++ +R+ + W+ +IA A+ L YLH+ C P
Sbjct: 796 FCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPH 855
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
+LHRD+K SNILLD++FN++L+DFGLARL+ P ETH +T + GT GY+ PEY +
Sbjct: 856 ILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEYGQASVATY 915
Query: 864 KADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGP 923
K DVYS+GVVLLELL+DK+ +D ++++W + + RA E F ++
Sbjct: 916 KGDVYSFGVVLLELLTDKRPVD--MCKPKGCRDLISWVVKMKHESRASEVFDPLIYSKEN 973
Query: 924 HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
++ VL +A +C ++ RPT +Q+V L +
Sbjct: 974 DKEMFRVLEIACLCLSENPKQRPTTQQLVSWLDDV 1008
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 402 bits (1033), Expect = e-111, Method: Compositional matrix adjust.
Identities = 309/983 (31%), Positives = 467/983 (47%), Gaps = 123/983 (12%)
Query: 7 LDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTV 66
LDL G L+G L HL L+ L+L N+I+G IP S+ L LNL+ N+ NG
Sbjct: 74 LDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNG-- 131
Query: 67 PTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLL 126
S P ++ NL LDL N L G +P SL N Q+R L
Sbjct: 132 -------------------SFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLH 172
Query: 127 LFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVR 186
L N IPA G LE L VS N L+G IP ++GN + L L+ Y
Sbjct: 173 LGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLT-----TLRELYIGY---- 223
Query: 187 YSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLE 246
+N FE G+P + +L L A L G P G L+
Sbjct: 224 -----------------YNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLD 266
Query: 247 MLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP-VPCMTMFDVSGNALSGS 305
L L N F+G LG +L +DLS+N TGE+ + +T+ ++ N L G+
Sbjct: 267 TLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGA 326
Query: 306 IPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGG 365
IP F + P L L+ P L G +G L I +
Sbjct: 327 IPEFIGEM----------------PELEVLQLWENNFTGSIPQKL-GENGRLVIL-DLSS 368
Query: 366 NNFSGSLPSMPVA------------------PERLGK-QTVYAIVAGDNKLSGSFPGNMF 406
N +G+LP + P+ LGK +++ I G+N L+GS P +F
Sbjct: 369 NKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELF 428
Query: 407 GICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVAL 466
G+ +L V + +N + G+LP G + L + S NQ+ G +P +G L + L
Sbjct: 429 GL-PKLS--QVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKL 485
Query: 467 NLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIP 526
L N IP +G+++ L L + N +G I + + +LL +DLS N LSG IP
Sbjct: 486 LLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIP 545
Query: 527 DDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL--MKCSS 584
++L ++ L L L+ N L G IP +A++ +L++ + S+NNLSG +PS+ +S
Sbjct: 546 NELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTS 605
Query: 585 VLGN-----PYLRPCRAFTLTEPSQDLHGPPSNGNRGFNSIEIASIASASAIVSVLLALI 639
+GN PYL PC T H P ++ + S++ A I
Sbjct: 606 FVGNSHLCGPYLGPCGKGT-----HQSHVKP------LSATTKLLLVLGLLFCSMVFA-I 653
Query: 640 VLFVYTRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATY 699
V + R S+ + +T F + + + V+ + N IG GG G Y
Sbjct: 654 VAIIKARSLRNASE---AKAWRLTAFQRLD--FTCDDVLDS---LKEDNIIGKGGAGIVY 705
Query: 700 KAEISPGVLVAIKRLAVGRFQGVQQ--FHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757
K + G LVA+KRLA F+AEI+TLGR+RH ++V L+G+ ++ L+Y
Sbjct: 706 KGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 765
Query: 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817
Y+P G+L + + + W +KIAL+ A+ L YLH C P ++HRDVK +NILLD
Sbjct: 766 EYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLD 825
Query: 818 DDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLE 876
+F A+++DFGLA+ L S T + +AG++GY+APEYA T +V +K+DVYS+GVVLLE
Sbjct: 826 SNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 885
Query: 877 LLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL-WDAGPHDDLVEVLHLAV 935
L++ KK + +G+G +IV W + + L + P ++ V ++A+
Sbjct: 886 LITGKKPV----GEFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVAL 941
Query: 936 VCTVDSLSTRPTMKQVVRRLKQL 958
+C + RPTM++VV+ L ++
Sbjct: 942 LCVEEQAVERPTMREVVQILTEI 964
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 963 | ||||||
| 255573382 | 1141 | conserved hypothetical protein [Ricinus | 1.0 | 0.843 | 0.728 | 0.0 | |
| 224141079 | 1143 | predicted protein [Populus trichocarpa] | 1.0 | 0.842 | 0.734 | 0.0 | |
| 147803536 | 1136 | hypothetical protein VITISV_038106 [Viti | 1.0 | 0.847 | 0.734 | 0.0 | |
| 359488527 | 1139 | PREDICTED: LRR receptor-like serine/thre | 1.0 | 0.845 | 0.734 | 0.0 | |
| 356523630 | 1120 | PREDICTED: LRR receptor-like serine/thre | 0.997 | 0.858 | 0.710 | 0.0 | |
| 356567098 | 1136 | PREDICTED: LRR receptor-like serine/thre | 0.997 | 0.845 | 0.709 | 0.0 | |
| 224077678 | 1143 | predicted protein [Populus trichocarpa] | 1.0 | 0.842 | 0.720 | 0.0 | |
| 353677868 | 1137 | leucine-rich repeat receptor-like kinase | 0.997 | 0.845 | 0.696 | 0.0 | |
| 356551181 | 1140 | PREDICTED: LRR receptor-like serine/thre | 0.985 | 0.832 | 0.685 | 0.0 | |
| 356573540 | 1131 | PREDICTED: LRR receptor-like serine/thre | 0.993 | 0.846 | 0.695 | 0.0 |
| >gi|255573382|ref|XP_002527617.1| conserved hypothetical protein [Ricinus communis] gi|223532991|gb|EEF34756.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1395 bits (3611), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 712/977 (72%), Positives = 814/977 (83%), Gaps = 14/977 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M LEVLDLEGNL+ G LP S L++L+VLNLGFN+I GEIP+S + NLE LNLAGN
Sbjct: 165 MEKLEVLDLEGNLVTGSLPVSFSGLRNLQVLNLGFNKIEGEIPSSLVNCANLEILNLAGN 224
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+NGT+P F+G + V+LS N+L GSVP +IG KC LEHLDLSGN+ VG IP SLGNC
Sbjct: 225 RINGTIPAFVGGFRGVHLSLNQLAGSVPGEIGYKCEKLEHLDLSGNFFVGAIPTSLGNCG 284
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
+R+LLL+SN+ EE IP ELGML+ LEVLDVSRNSLSGSIP +LGNCS L++LVLSN+ D
Sbjct: 285 NLRTLLLYSNLFEEVIPPELGMLRKLEVLDVSRNSLSGSIPFELGNCSALSVLVLSNIID 344
Query: 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWG 240
Y+ V SRG L+DQ + N+DFNFF+GGIP + +LPNLR+LWAP ATLEG+ SN G
Sbjct: 345 PYQGVNSSRGDYLLDQLNSANEDFNFFQGGIPMEIMNLPNLRMLWAPSATLEGSLQSNHG 404
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGN 300
ACD LEM+NL HNFFSG C L +LDLS N+L GELA L VPCMT+FDVSGN
Sbjct: 405 ACDKLEMINLAHNFFSGGIPRNFRRCAKLWYLDLSYNRLKGELAEGLLVPCMTVFDVSGN 464
Query: 301 ALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIF 360
+LSG IP F C VP ++ + ++PS+AYLS FA+K+QAG+ + D I
Sbjct: 465 SLSGPIPNFYRNSCQWVPSINGHPSSIFDPSSAYLSFFARKAQAGSLVQSLAGDSESIIL 524
Query: 361 HNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVS 420
HNFG NNF+G+L SMP+A RLGKQT YA +AG+NKL+G F G +F C+ L +++NVS
Sbjct: 525 HNFGSNNFTGTLQSMPIANVRLGKQTAYAFLAGENKLTGPFLGVLFEKCDELSKMILNVS 584
Query: 421 NNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTT 480
NNRI+GQ+PA+IG++C+SLK LDAS NQI+GPIP GVG+LV+LV+LNLSWN++ QIPT+
Sbjct: 585 NNRISGQIPADIGKLCRSLKLLDASSNQIIGPIPPGVGKLVTLVSLNLSWNILQGQIPTS 644
Query: 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540
L Q+KGL+YLSLAGN + GSIP+SLG L LEVLDLSSN LSG IP++L NLRNLT LLL
Sbjct: 645 LSQIKGLRYLSLAGNEVNGSIPNSLGNLWSLEVLDLSSNMLSGEIPNNLVNLRNLTALLL 704
Query: 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAFTLT 600
N+NKLSG+IP GLANV+ LS FNVSFNNLSGPLP S NLMKCSSVLGNPYLRPC F+LT
Sbjct: 705 NDNKLSGQIPFGLANVTMLSVFNVSFNNLSGPLPLSNNLMKCSSVLGNPYLRPCHVFSLT 764
Query: 601 EP---------SQDLHGPPSNGNRG-----FNSIEIASIASASAIVSVLLALIVLFVYTR 646
P SQ P+N N+G FNSIEIASIASASAIVSVL+ALIVLF YTR
Sbjct: 765 VPTPDPGSATGSQSYAVSPANQNQGSGSNRFNSIEIASIASASAIVSVLVALIVLFFYTR 824
Query: 647 KWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPG 706
KW+P+SK+MG+T+KEVTIFT+IGVPL++E+VV+ATG+FNASNCIGNGGFGATYKAEISPG
Sbjct: 825 KWSPKSKIMGTTKKEVTIFTDIGVPLTYENVVRATGSFNASNCIGNGGFGATYKAEISPG 884
Query: 707 VLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLE 766
VLVAIKRLAVGRFQGVQQFHAEIKTLGRL HPNLVTLIGYHASETEMFLIYNYLP GNLE
Sbjct: 885 VLVAIKRLAVGRFQGVQQFHAEIKTLGRLHHPNLVTLIGYHASETEMFLIYNYLPDGNLE 944
Query: 767 NFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD 826
FIQ+RS+RAVDWR+LHKIALD+ARALAYLHDQCVPRVLHRDVKPSNILLD+DF AYLSD
Sbjct: 945 KFIQERSSRAVDWRILHKIALDVARALAYLHDQCVPRVLHRDVKPSNILLDNDFKAYLSD 1004
Query: 827 FGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP 886
FGLARLLG SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP
Sbjct: 1005 FGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP 1064
Query: 887 SFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP 946
SFSSYGNGFNIVAW CMLLRQGRAK+FFTAGLWD GPHDDLVEVLHLAVVCTVDSLSTRP
Sbjct: 1065 SFSSYGNGFNIVAWACMLLRQGRAKDFFTAGLWDGGPHDDLVEVLHLAVVCTVDSLSTRP 1124
Query: 947 TMKQVVRRLKQLQPASC 963
TMKQVVRRLKQLQP SC
Sbjct: 1125 TMKQVVRRLKQLQPPSC 1141
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141079|ref|XP_002323902.1| predicted protein [Populus trichocarpa] gi|222866904|gb|EEF04035.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1383 bits (3579), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 718/977 (73%), Positives = 809/977 (82%), Gaps = 14/977 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M LEVLDLEGNL++G LP S L++LRVLNLGFNRI GEIP S S LE LN+AGN
Sbjct: 167 MEKLEVLDLEGNLVSGSLPVSFSGLRNLRVLNLGFNRIEGEIPDSLSRCDGLEILNIAGN 226
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+NGT+P F GR K VYLS N+L GS+P G C LEHLDLSGN+LVGGIP +LGNC
Sbjct: 227 RINGTIPGFAGRFKGVYLSLNQLGGSLPEDFGYNCEKLEHLDLSGNFLVGGIPSNLGNCG 286
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
+R+LLL+SNM EE IP ELG L LEVLDVSRNSLSGS+P +LGNCS L++LVLSN+FD
Sbjct: 287 NLRTLLLYSNMFEEIIPRELGKLGKLEVLDVSRNSLSGSVPPELGNCSALSVLVLSNMFD 346
Query: 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWG 240
Y+DV +RG L+D S M++DFNFF+GGIP V +LP LR+LWAP ATL G SNW
Sbjct: 347 PYQDVNGTRGNGLLDHLSSMDEDFNFFQGGIPADVMTLPKLRMLWAPSATLGGMLLSNWD 406
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGN 300
+CD+LEM+NL HNFF G+ C L +LDLSSN L GEL E VPCMT+FDVSGN
Sbjct: 407 SCDSLEMINLSHNFFKGEIPHGFSRCNKLRYLDLSSNGLYGELLEEFRVPCMTVFDVSGN 466
Query: 301 ALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIF 360
ALSGSIP+F + CPPVP Y+PS+AY+S FA K++AG+P GR+G +++F
Sbjct: 467 ALSGSIPSFYSSSCPPVPSTIEYPLNIYDPSSAYISFFAYKAKAGSPTMSLGRNGEISVF 526
Query: 361 HNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVS 420
HNFG NNF+G+L S+P++P RLGKQT Y +AGDNKLSG FPG +F C+ L+ ++VNVS
Sbjct: 527 HNFGDNNFTGTLQSLPISPVRLGKQTAYTFLAGDNKLSGPFPGILFENCDGLNMMIVNVS 586
Query: 421 NNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTT 480
NNR++GQ+PA +G MC+SLK LDAS NQI G IP VGELVSLV L++SWNL+ QIP++
Sbjct: 587 NNRMSGQIPANMGPMCRSLKLLDASKNQIAGTIPPSVGELVSLVYLDMSWNLLQGQIPSS 646
Query: 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540
L Q+ GLKYLSL GN + GSIPSS+G+LQ LEVLDLSSN LSG IP+DL LRNLT LLL
Sbjct: 647 LSQISGLKYLSLTGNRIVGSIPSSIGKLQTLEVLDLSSNLLSGEIPNDLVRLRNLTALLL 706
Query: 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAFTLT 600
NNNKLSG+IPSGLANV+ LS FNVSFNNLSGPLPSS NLM CSSVLGNPYL PC F+L
Sbjct: 707 NNNKLSGQIPSGLANVTLLSIFNVSFNNLSGPLPSSNNLMNCSSVLGNPYLHPCHVFSLA 766
Query: 601 EPSQDLHGPPS--------------NGNRGFNSIEIASIASASAIVSVLLALIVLFVYTR 646
PS D G S N + GF SIEIASIASASAI SVLLALI LF+YTR
Sbjct: 767 SPSPDSPGRASEAQSYTSPSGQSQKNRSGGFTSIEIASIASASAIFSVLLALIFLFIYTR 826
Query: 647 KWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPG 706
KW+P+SK+MGS RKEVTIFT+IGVPL+FE+VV+ATG+FNASNCIGNGGFG+TYKAEISPG
Sbjct: 827 KWSPKSKIMGSARKEVTIFTDIGVPLTFENVVRATGSFNASNCIGNGGFGSTYKAEISPG 886
Query: 707 VLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLE 766
VLVAIK+LAVGRFQG+QQFHAEIKTLGRL HPNLVTLIGYHASETEMFL+YNYLPGGNLE
Sbjct: 887 VLVAIKKLAVGRFQGIQQFHAEIKTLGRLHHPNLVTLIGYHASETEMFLVYNYLPGGNLE 946
Query: 767 NFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD 826
FIQ+RSTRAVDWR+LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD
Sbjct: 947 KFIQERSTRAVDWRILHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD 1006
Query: 827 FGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP 886
FGLARLLG SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP
Sbjct: 1007 FGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP 1066
Query: 887 SFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP 946
SFSSYGNGFNIVAW CMLLRQGRAKEFFTAGLWDAGPHDDLVEVLH+AVVCTVDSLSTRP
Sbjct: 1067 SFSSYGNGFNIVAWACMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHMAVVCTVDSLSTRP 1126
Query: 947 TMKQVVRRLKQLQPASC 963
TMKQVVRRLKQLQP SC
Sbjct: 1127 TMKQVVRRLKQLQPPSC 1143
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147803536|emb|CAN77668.1| hypothetical protein VITISV_038106 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1381 bits (3574), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 721/981 (73%), Positives = 813/981 (82%), Gaps = 18/981 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M LEVLDLEGN ++G LP L++ RVLNLGFN+I G IP+S S+ ++LE LNLAGN
Sbjct: 156 MEKLEVLDLEGNSMSGSLPIRFGGLRNSRVLNLGFNKIAGVIPSSLSNLMSLEILNLAGN 215
Query: 61 LVNGTVPTFIGRLKR---VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
+VNGT+P FIG K VYLSFNRL GS+PS+IG C LE LDLSGN LVGGIP SLG
Sbjct: 216 MVNGTIPGFIGSFKELRGVYLSFNRLGGSIPSEIGSNCQKLEDLDLSGNLLVGGIPSSLG 275
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
NC Q+RS+LLFSN+LEE IPAELG L+NLEVLDVSRNSLSGSIP LGNCS+L+ LVLSN
Sbjct: 276 NCSQLRSILLFSNLLEEVIPAELGQLRNLEVLDVSRNSLSGSIPPALGNCSQLSALVLSN 335
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
LFD +++ +G S Q NDD+N+F+G IP +++LP LRI+WAPRATLEG FPS
Sbjct: 336 LFDPLLNIKNMKGDSNSGQLVSGNDDYNYFQGTIPVEITTLPKLRIIWAPRATLEGRFPS 395
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDV 297
NWGACD+LE++NL NFF+G+ CK L FLDLSSN+LTGEL +LPVPCMT+FDV
Sbjct: 396 NWGACDSLEVINLSQNFFTGEIPEGFSRCKKLHFLDLSSNKLTGELVEKLPVPCMTVFDV 455
Query: 298 SGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFL 357
S N LSG IP F C VP +R + ES + S+AY+S FA K PL D L
Sbjct: 456 SCNLLSGRIPRFYYGSCTRVPSNNRYVLESSSLSSAYVSFFANKGIVEAPLLFSKGDDSL 515
Query: 358 AIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMV 417
++FHNF NNF+G+ SMP+A +RLGKQTVY+ +AG+N L+G FP N+F C L+ ++V
Sbjct: 516 SVFHNFASNNFNGTFESMPIASDRLGKQTVYSFLAGENNLTGPFPRNLFDKCYGLNRVVV 575
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQI 477
NVSNNRI+GQLP EIG +CK+L LDASGNQI G IP +G LVSLVALNLS N + +I
Sbjct: 576 NVSNNRISGQLPTEIGALCKTLTLLDASGNQINGSIPHSIGNLVSLVALNLSSNHLQGEI 635
Query: 478 PTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTV 537
P++LG+++GLKYLSLAGN LTG IPSSLG LQ LEVL+LSSNSLSG IP DL NLR+LTV
Sbjct: 636 PSSLGKIEGLKYLSLAGNILTGPIPSSLGNLQSLEVLELSSNSLSGEIPRDLVNLRSLTV 695
Query: 538 LLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAF 597
LLLN+NKLSG+IPSGLANV+TLSAFNVSFNNLSGPLP + NLMKCSSVLGNP LR CR F
Sbjct: 696 LLLNDNKLSGQIPSGLANVTTLSAFNVSFNNLSGPLPLNDNLMKCSSVLGNPLLRSCRLF 755
Query: 598 TLTEPSQDLHG---------------PPSNGNRGFNSIEIASIASASAIVSVLLALIVLF 642
+LT PS D G P + + FNSIEIASI SASAIVSVLLAL+VLF
Sbjct: 756 SLTVPSSDQQGGVGDSQDYSASPSGSPTRSRSSSFNSIEIASITSASAIVSVLLALVVLF 815
Query: 643 VYTRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAE 702
+YTRK NP+S+++ S RKEVT+F +IGVPL+FE+VV+ATG+FNASNCIGNGGFGATYKAE
Sbjct: 816 IYTRKCNPKSRILRSARKEVTVFNDIGVPLTFENVVRATGSFNASNCIGNGGFGATYKAE 875
Query: 703 ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762
ISPGVLVAIKRLAVGRFQGVQQFHAE+KTLGRL HPNLVTLIGYHASETEMFLIYNYLPG
Sbjct: 876 ISPGVLVAIKRLAVGRFQGVQQFHAEVKTLGRLDHPNLVTLIGYHASETEMFLIYNYLPG 935
Query: 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822
GNLE FIQ+RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA
Sbjct: 936 GNLEKFIQERSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 995
Query: 823 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK 882
YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK
Sbjct: 996 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK 1055
Query: 883 ALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSL 942
ALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSL
Sbjct: 1056 ALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSL 1115
Query: 943 STRPTMKQVVRRLKQLQPASC 963
STRPTM+QVVRRLKQLQP SC
Sbjct: 1116 STRPTMRQVVRRLKQLQPPSC 1136
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488527|ref|XP_002279979.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1377 bits (3565), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 721/981 (73%), Positives = 813/981 (82%), Gaps = 18/981 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M LEVLDLEGN ++G LP L++ RVLNLGFN+I G IP+S S+ ++LE LNLAGN
Sbjct: 159 MEKLEVLDLEGNSMSGSLPIRFGGLRNSRVLNLGFNKIAGVIPSSLSNLMSLEILNLAGN 218
Query: 61 LVNGTVPTFIGRLKR---VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
+VNGT+P FIG K VYLSFNRL GS+PS+IG C LE LDLSGN LVGGIP SLG
Sbjct: 219 MVNGTIPGFIGSFKELRGVYLSFNRLGGSIPSEIGSNCQKLEDLDLSGNLLVGGIPSSLG 278
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
NC Q+RS+LLFSN+LEE IPAELG L+NLEVLDVSRNSLSGSIP LGNCS+L+ LVLSN
Sbjct: 279 NCSQLRSILLFSNLLEEVIPAELGQLRNLEVLDVSRNSLSGSIPPALGNCSQLSALVLSN 338
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
LFD +++ +G S Q NDD+N+F+G IP +++LP LRI+WAPRATLEG FPS
Sbjct: 339 LFDPLLNIKNMKGDSNSGQLVSGNDDYNYFQGTIPVEITTLPKLRIIWAPRATLEGRFPS 398
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDV 297
NWGACD+LE++NL NFF+G+ CK L FLDLSSN+LTGEL +LPVPCMT+FDV
Sbjct: 399 NWGACDSLEVINLSQNFFTGEIPEGFSRCKKLHFLDLSSNKLTGELVEKLPVPCMTVFDV 458
Query: 298 SGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFL 357
S N LSG IP F C VP +R + ES + S+AY+S FA K PL D L
Sbjct: 459 SCNLLSGRIPRFYYGSCTRVPSNNRYVLESSSLSSAYVSFFANKGIVEAPLLFSKGDDSL 518
Query: 358 AIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMV 417
++FHNF NNF+G+ SMP+A +RLGKQTVY+ +AG+N L+G FP N+F C L+ ++V
Sbjct: 519 SVFHNFASNNFNGTFESMPIASDRLGKQTVYSFLAGENNLTGPFPRNLFDKCYGLNRVVV 578
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQI 477
NVSNNRI+GQLP EIG +CK+L LDASGNQI G IP +G LVSLVALNLS N + +I
Sbjct: 579 NVSNNRISGQLPTEIGALCKTLTLLDASGNQINGSIPHSIGNLVSLVALNLSSNHLQGEI 638
Query: 478 PTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTV 537
P++LG+++GLKYLSLAGN LTG IPSSLG LQ LEVL+LSSNSLSG IP DL NLR+LTV
Sbjct: 639 PSSLGKIEGLKYLSLAGNILTGPIPSSLGNLQSLEVLELSSNSLSGEIPRDLVNLRSLTV 698
Query: 538 LLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAF 597
LLLN+NKLSG+IPSGLANV+TLSAFNVSFNNLSGPLP + NLMKCSSVLGNP LR CR F
Sbjct: 699 LLLNDNKLSGQIPSGLANVTTLSAFNVSFNNLSGPLPLNDNLMKCSSVLGNPLLRSCRLF 758
Query: 598 TLTEPSQDLHG---------------PPSNGNRGFNSIEIASIASASAIVSVLLALIVLF 642
+LT PS D G P + + FNSIEIASI SASAIVSVLLAL+VLF
Sbjct: 759 SLTVPSSDQQGGVGDSQDYSASPSGSPTRSRSSSFNSIEIASITSASAIVSVLLALVVLF 818
Query: 643 VYTRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAE 702
+YTRK NP+S+++ S RKEVT+F +IGVPL+FE+VV+ATG+FNASNCIGNGGFGATYKAE
Sbjct: 819 IYTRKCNPKSRILRSARKEVTVFNDIGVPLTFENVVRATGSFNASNCIGNGGFGATYKAE 878
Query: 703 ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762
ISPGVLVAIKRLAVGRFQGVQQFHAE+KTLGRL HPNLVTLIGYHASETEMFLIYNYLPG
Sbjct: 879 ISPGVLVAIKRLAVGRFQGVQQFHAEVKTLGRLDHPNLVTLIGYHASETEMFLIYNYLPG 938
Query: 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822
GNLE FIQ+RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA
Sbjct: 939 GNLEKFIQERSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 998
Query: 823 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK 882
YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK
Sbjct: 999 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK 1058
Query: 883 ALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSL 942
ALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSL
Sbjct: 1059 ALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSL 1118
Query: 943 STRPTMKQVVRRLKQLQPASC 963
STRPTM+QVVRRLKQLQP SC
Sbjct: 1119 STRPTMRQVVRRLKQLQPPSC 1139
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523630|ref|XP_003530440.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1369 bits (3544), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 695/978 (71%), Positives = 805/978 (82%), Gaps = 17/978 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M LEVLDLEGNL++G+LP LK+LRVLNLGFNR GEIP+S S+ +LE LNLAGN
Sbjct: 145 MEKLEVLDLEGNLISGVLPIRFNGLKNLRVLNLGFNRFVGEIPSSLSNVKSLEVLNLAGN 204
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+NG+V F+GRL+ VYLS+N L G++P +IGE C LEHLDLSGN L+ GIP SLGNC
Sbjct: 205 GINGSVSGFVGRLRGVYLSYNLLGGAIPEEIGEHCGQLEHLDLSGNLLMQGIPGSLGNCS 264
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
++R++LL SN+LE+ IPAELG L+ LEVLDVSRN+L G +P++LGNC++L++L+LSNLF
Sbjct: 265 ELRTVLLHSNILEDVIPAELGRLRKLEVLDVSRNTLGGQVPMELGNCTELSVLLLSNLFS 324
Query: 181 TYEDVRYSRGQSLVDQPSFMN-DDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNW 239
+ DV + G S V+Q MN D+FN+FEG +P + +LP LR+LWAPRA LEG+F S+W
Sbjct: 325 SVPDVNGTLGDSGVEQMVAMNIDEFNYFEGPVPVEIMNLPKLRLLWAPRANLEGSFMSSW 384
Query: 240 GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSG 299
G CD+LEMLNL N F+G LG CKNL FLDLS+N LTG LA ELPVPCMT+FDVSG
Sbjct: 385 GKCDSLEMLNLAQNDFTGDFPNQLGGCKNLHFLDLSANNLTGVLAEELPVPCMTVFDVSG 444
Query: 300 NALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAI 359
N LSG IP FS C VP S NLFE+ + + Y S FA K G L G G ++
Sbjct: 445 NVLSGPIPQFSVGKCASVPSWSGNLFETDDRALPYKSFFASKILGGPILASLGEVG-RSV 503
Query: 360 FHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNV 419
FHNFG NNF S+ S+P+A ++LGK VYAI+ G+NKL+G FP N+F C+ L++L++NV
Sbjct: 504 FHNFGQNNFV-SMESLPIARDKLGKGLVYAILVGENKLAGPFPTNLFEKCDGLNALLLNV 562
Query: 420 SNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPT 479
S N ++GQ+P++ GRMC+SLKFLDASGNQI GPIP G+G++VSLV+LNLS N + QI
Sbjct: 563 SYNMLSGQIPSKFGRMCRSLKFLDASGNQITGPIPVGLGDMVSLVSLNLSRNRLQGQILV 622
Query: 480 TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLL 539
++GQ+K LK+LSLA NN+ GSIP+SLG+L LEVLDLSSNSL+G IP +ENLRNLT +L
Sbjct: 623 SIGQLKHLKFLSLADNNIGGSIPTSLGRLYSLEVLDLSSNSLTGEIPKGIENLRNLTDVL 682
Query: 540 LNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAFTL 599
LNNNKLSG+IP+GLANVSTLSAFNVSFNNLSG PS+ N +KCS+ +GNP+LR C +L
Sbjct: 683 LNNNKLSGQIPAGLANVSTLSAFNVSFNNLSGSFPSNGNSIKCSNAVGNPFLRSCNEVSL 742
Query: 600 TEPSQD----------LHGPPS----NGNRGFNSIEIASIASASAIVSVLLALIVLFVYT 645
PS D PP G GFNSIEIASI SASAIVSVLLALIVLF+YT
Sbjct: 743 AVPSADQGQVDNSSSYTAAPPEVTGKKGGNGFNSIEIASITSASAIVSVLLALIVLFIYT 802
Query: 646 RKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISP 705
+KWNP+S+V+GS RKEVT+FT+IGVPL+FE+VV+ATGNFNASNCIGNGGFGATYKAEI P
Sbjct: 803 QKWNPRSRVVGSMRKEVTVFTDIGVPLTFENVVRATGNFNASNCIGNGGFGATYKAEIVP 862
Query: 706 GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765
G LVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL
Sbjct: 863 GNLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 922
Query: 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825
E FIQ+RSTRAVDWR+LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD+NAYLS
Sbjct: 923 EKFIQERSTRAVDWRILHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDYNAYLS 982
Query: 826 DFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885
DFGLARLLG SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD
Sbjct: 983 DFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 1042
Query: 886 PSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTR 945
PSFSSYGNGFNIVAW CMLLRQG+AKEFF AGLWDAGP DDLVEVLHLAVVCTVDSLSTR
Sbjct: 1043 PSFSSYGNGFNIVAWACMLLRQGQAKEFFAAGLWDAGPEDDLVEVLHLAVVCTVDSLSTR 1102
Query: 946 PTMKQVVRRLKQLQPASC 963
P+MK VVRRLKQLQP SC
Sbjct: 1103 PSMKHVVRRLKQLQPPSC 1120
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567098|ref|XP_003551760.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1367 bits (3538), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 694/978 (70%), Positives = 798/978 (81%), Gaps = 17/978 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M LEVLDLEGNL++G+LP LK+L+VLNLGFNRI GEIP+S S F +LE LNLAGN
Sbjct: 161 MEKLEVLDLEGNLISGVLPLRFNGLKNLKVLNLGFNRIVGEIPSSLSSFKSLEVLNLAGN 220
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+NG+VP+F+GRL+ VYLS+N L G++P +IGE C L+HLDLSGN L+ IP SLGNC
Sbjct: 221 GINGSVPSFVGRLRGVYLSYNLLGGAIPQEIGEHCGQLDHLDLSGNLLMQAIPGSLGNCS 280
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
++R +LL SN LE+ IPAELG L+ LEVLDVSRN+L G +P++LGNC++L++LVLSNLF
Sbjct: 281 ELRMILLHSNSLEDVIPAELGRLRKLEVLDVSRNTLGGQVPMELGNCTELSVLVLSNLFS 340
Query: 181 TYEDVRYSRGQSLVDQPSFMN-DDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNW 239
+ DV + V+Q MN D+FN+FEG +P + +LP LR+LWAPRA L G+FPS+W
Sbjct: 341 SVPDVNGTVRDLGVEQMVSMNIDEFNYFEGPVPVEIMNLPKLRVLWAPRANLAGSFPSSW 400
Query: 240 GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSG 299
G CD+LEMLNL N +G LG CKNL FLDLS+N TG LA ELPVPCMT+FDVSG
Sbjct: 401 GKCDSLEMLNLAQNDLTGDFPNQLGGCKNLHFLDLSANNFTGVLAEELPVPCMTVFDVSG 460
Query: 300 NALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAI 359
N LSG IP FS +C VP S NLFE+ + + Y S F K GT L G G ++
Sbjct: 461 NVLSGPIPQFSVGLCALVPSWSGNLFETDDRALPYKSFFVSKILGGTILSSLGEVG-RSV 519
Query: 360 FHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNV 419
FHNFG NNF S+ S+P+A +RLGK YAI+ G+NKL+G FP N+F C+ L++L++NV
Sbjct: 520 FHNFGQNNFV-SMESLPIARDRLGKGLAYAILVGENKLAGPFPTNLFEKCDGLNALLLNV 578
Query: 420 SNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPT 479
S I+GQ+P++ G MC+SLKFLDASGNQI GPIP G+G++VSLV+LNLS N + DQIP
Sbjct: 579 SYTMISGQIPSKFGGMCRSLKFLDASGNQITGPIPVGLGDMVSLVSLNLSKNRLQDQIPG 638
Query: 480 TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLL 539
LGQ+K LK+LSLA NNL+GSIP+SLGQL LEVLDLSSNSL+G IP +ENLRNLT +L
Sbjct: 639 NLGQLKDLKFLSLAENNLSGSIPTSLGQLYSLEVLDLSSNSLTGEIPKGIENLRNLTDVL 698
Query: 540 LNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAFTL 599
LNNNKLSG+IP+GLANVSTLSAFNVSFNNLSG LPS+ N +KCS+ +GNP+L C +L
Sbjct: 699 LNNNKLSGQIPAGLANVSTLSAFNVSFNNLSGSLPSNGNSIKCSNAVGNPFLHSCNEVSL 758
Query: 600 TEPSQD----------LHGPPS----NGNRGFNSIEIASIASASAIVSVLLALIVLFVYT 645
PS D PP G GFNSIEIASI SASAIVSVLLALIVLF+YT
Sbjct: 759 AVPSADQGQVDNSSSYTAAPPEVTGKKGGNGFNSIEIASITSASAIVSVLLALIVLFIYT 818
Query: 646 RKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISP 705
RKWNP+S+V+GSTRKEVT+FT+IGVPL+FE+VV+ATGNFNASNCIGNGGFGATYKAEI P
Sbjct: 819 RKWNPRSRVVGSTRKEVTVFTDIGVPLTFENVVRATGNFNASNCIGNGGFGATYKAEIVP 878
Query: 706 GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765
G LVAIKRLAVGRFQG QQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL
Sbjct: 879 GNLVAIKRLAVGRFQGAQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 938
Query: 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825
E FIQ+RSTRA DWR+LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD+NAYLS
Sbjct: 939 EKFIQERSTRAADWRILHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDYNAYLS 998
Query: 826 DFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885
DFGLARLLG SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD
Sbjct: 999 DFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 1058
Query: 886 PSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTR 945
PSFSSYGNGFNIVAW CMLLRQG+AKEFF GLWD GP DDLVEVLHLAVVCTVDSLSTR
Sbjct: 1059 PSFSSYGNGFNIVAWACMLLRQGQAKEFFATGLWDTGPEDDLVEVLHLAVVCTVDSLSTR 1118
Query: 946 PTMKQVVRRLKQLQPASC 963
P+MK VVRRLKQLQP SC
Sbjct: 1119 PSMKHVVRRLKQLQPPSC 1136
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224077678|ref|XP_002305358.1| predicted protein [Populus trichocarpa] gi|222848322|gb|EEE85869.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1363 bits (3527), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 704/977 (72%), Positives = 807/977 (82%), Gaps = 14/977 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M LEVLDLEGNL++G LP S L++LRVLN GFNRI GEIP S S LE LNLAGN
Sbjct: 167 MEKLEVLDLEGNLVSGSLPVSFSGLRNLRVLNFGFNRIEGEIPGSLSYCEGLEILNLAGN 226
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+NGT+P F+GRLK VYLS N+L GS+P + G+ C LEHLDLSGN++VGGIP +LG C
Sbjct: 227 RINGTIPGFVGRLKGVYLSLNQLGGSLPEEFGDNCEKLEHLDLSGNFVVGGIPSTLGKCG 286
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
+R+LLL+SN+ EE IP ELG L LEVLDVSRNSLSG +P +LGNCS L++LVLSN+FD
Sbjct: 287 NLRTLLLYSNLFEEIIPHELGKLGKLEVLDVSRNSLSGPVPPELGNCSALSVLVLSNMFD 346
Query: 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWG 240
Y+D +RG S +D +N+DFNFF+G +P V +LP LR+LWAP A LEG SNW
Sbjct: 347 PYQDFNGTRGDSSLDHSISVNEDFNFFQGDMPADVLTLPKLRMLWAPSAMLEGMLMSNWD 406
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGN 300
CD+LEM+NL HNF +G+ + C L +LDLS N+L GEL E PVPCMT+FDVS N
Sbjct: 407 PCDSLEMINLSHNFLTGEIPHGINHCNKLWYLDLSFNKLNGELLAEFPVPCMTVFDVSEN 466
Query: 301 ALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIF 360
ALSGSIP+F + CP VP ++ N +Y+PS+AY+S FA K+Q G+P G G + +F
Sbjct: 467 ALSGSIPSFYSSSCPRVPSVNDNPLNAYDPSSAYVSFFAYKAQTGSPAMSLGGSGGITVF 526
Query: 361 HNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVS 420
HNFG NNF+G+L S+P+AP R GKQT Y +AGDNKLSG FPG +F C+ L++++VNVS
Sbjct: 527 HNFGSNNFTGTLQSIPIAPVRSGKQTAYTFLAGDNKLSGPFPGILFEKCHGLNTMIVNVS 586
Query: 421 NNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTT 480
+NR++GQ+PA +G MC+SLK LDAS NQI+G IP VG+LVSLV+L++SWNL+H IP++
Sbjct: 587 SNRMSGQIPANMGPMCRSLKLLDASKNQIMGTIPPSVGDLVSLVSLDMSWNLLHGPIPSS 646
Query: 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540
L Q++GLKYLSLAGN + GSIPSSLG+LQ LEVLDLSSN LSG IP+DL LRNLT LLL
Sbjct: 647 LSQIRGLKYLSLAGNGINGSIPSSLGKLQTLEVLDLSSNLLSGEIPNDLVKLRNLTALLL 706
Query: 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAFTLT 600
NNNKLSG+IPSGLA+++ LS FNVSFNNLSGPLPSS +LM+CSSVLGNPYL PCR F+L
Sbjct: 707 NNNKLSGQIPSGLASMTLLSMFNVSFNNLSGPLPSSNSLMQCSSVLGNPYLHPCRVFSLA 766
Query: 601 EPSQDLHGPPSNGN--------------RGFNSIEIASIASASAIVSVLLALIVLFVYTR 646
PS D G S GF SIEIASIASASAI SVLLALI LF+YTR
Sbjct: 767 VPSPDSQGRASEAQGYASLSGQTQKRQGGGFTSIEIASIASASAIFSVLLALIFLFIYTR 826
Query: 647 KWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPG 706
KW+P+SK+MGS RKEVTIFT+IGV L+FE+VV+ATG+FNASNCIGNGGFGATYKAEISPG
Sbjct: 827 KWSPKSKIMGSARKEVTIFTDIGVTLTFENVVRATGSFNASNCIGNGGFGATYKAEISPG 886
Query: 707 VLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLE 766
VLVAIKRLAVGRFQG+QQFHAEIKTLGRL HPNLVTLIGYHASETEMFLIYNYLPGGNLE
Sbjct: 887 VLVAIKRLAVGRFQGIQQFHAEIKTLGRLHHPNLVTLIGYHASETEMFLIYNYLPGGNLE 946
Query: 767 NFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD 826
FIQ+RSTRAVDWR+LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD
Sbjct: 947 KFIQERSTRAVDWRILHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD 1006
Query: 827 FGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP 886
FGLARLLG SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP
Sbjct: 1007 FGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP 1066
Query: 887 SFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP 946
SFS YGNGFNIVAW CMLLRQGRAKEFFT GLWDAGPHDDLVE+LHLAVVCTVD+LSTRP
Sbjct: 1067 SFSPYGNGFNIVAWACMLLRQGRAKEFFTGGLWDAGPHDDLVEILHLAVVCTVDTLSTRP 1126
Query: 947 TMKQVVRRLKQLQPASC 963
TMKQVVRRLKQLQP SC
Sbjct: 1127 TMKQVVRRLKQLQPPSC 1143
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|353677868|dbj|BAL04590.1| leucine-rich repeat receptor-like kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 1334 bits (3452), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 681/978 (69%), Positives = 784/978 (80%), Gaps = 17/978 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M LEV+DLEGNL++G LP L+SLRVLNLGFNRI GE+P S S +LE LNLAGN
Sbjct: 162 MNKLEVIDLEGNLISGYLPSRFSGLRSLRVLNLGFNRIVGEVPNSLSSVASLEILNLAGN 221
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+NG+VP F+GRL+ VYLSFN L GS+P +IG+ C LEHLDLSGN+L IP SLGNC
Sbjct: 222 GINGSVPGFVGRLRGVYLSFNLLTGSIPQEIGDDCGRLEHLDLSGNFLTLEIPNSLGNCS 281
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
Q+R++ L SN+L++ IPAELG L+ LEVLDVSRN+L G +P +LG+C +L++LVLSNLF+
Sbjct: 282 QLRTISLHSNILQDVIPAELGKLRKLEVLDVSRNTLGGLVPPELGHCMELSVLVLSNLFN 341
Query: 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWG 240
DV SL DQ + D++N+FEG IP + +LP L+ILWAPRA LE +FP +W
Sbjct: 342 PLPDVSGMARDSLTDQLVSVIDEYNYFEGPIPVEIMNLPKLKILWAPRANLEDSFPRSWN 401
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGN 300
AC NLEMLNL N F+G L CK L FLDLS LTG+LA++LP PCMT+FDVSGN
Sbjct: 402 ACGNLEMLNLAQNDFTGDFPNQLSRCKKLHFLDLSFTNLTGKLAKDLPAPCMTVFDVSGN 461
Query: 301 ALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIF 360
LSGSIP FS CP P + NLFES N + Y FA K +PL G G ++
Sbjct: 462 VLSGSIPEFSGNACPSAPSWNGNLFESDNRALPYGFFFALKVLQRSPLSSLGDVG-RSVI 520
Query: 361 HNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVS 420
HNFG NNF S+ S+P+A RLGK YAI+ G+N L+G FP N+F C+ L++L++NVS
Sbjct: 521 HNFGQNNFI-SMDSLPIARYRLGKGFAYAILVGENNLTGPFPTNLFEKCDGLNALLLNVS 579
Query: 421 NNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTT 480
RI+GQ+ + GRMCKSLKFLDASGNQI G IP +G++VSLVALNLS N + QIPT+
Sbjct: 580 YTRISGQISSNFGRMCKSLKFLDASGNQITGTIPFDLGDMVSLVALNLSRNHLQGQIPTS 639
Query: 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540
LGQ+ LK+LSL NN +GSIP+SL QL LEVLDLSSNS G IP +ENLRNLTV+LL
Sbjct: 640 LGQLNDLKFLSLGNNNFSGSIPTSLDQLHSLEVLDLSSNSFIGEIPKGIENLRNLTVVLL 699
Query: 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAFTLT 600
NNNKLSG+IP+GLANVSTLSAFNVSFNNLSG LPS+ +L+KCSS +GNP+LR C +LT
Sbjct: 700 NNNKLSGQIPAGLANVSTLSAFNVSFNNLSGSLPSNSSLIKCSSAVGNPFLRSCIGVSLT 759
Query: 601 EPSQDLHG-----------PPSNGNR----GFNSIEIASIASASAIVSVLLALIVLFVYT 645
PS D HG PP + + GF SIEIA I SASAIVSVLLALIVLFV T
Sbjct: 760 VPSADQHGVADYPNSYTAAPPEDTGKTSGNGFTSIEIACITSASAIVSVLLALIVLFVCT 819
Query: 646 RKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISP 705
RKWNP+S+V+GSTRKEVT+FT++G PL+FESVV+ATG+FNA NCIGNGGFGATYKAEISP
Sbjct: 820 RKWNPRSRVVGSTRKEVTVFTDVGFPLTFESVVRATGSFNAGNCIGNGGFGATYKAEISP 879
Query: 706 GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765
G LVAIKRL+VGRFQG QQFHAEIKTLGRL HPNLVTLIGYHAS++EMFLIYNYL GGNL
Sbjct: 880 GNLVAIKRLSVGRFQGAQQFHAEIKTLGRLHHPNLVTLIGYHASDSEMFLIYNYLSGGNL 939
Query: 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825
E FIQ+RSTRAVDWR+LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD+NAYLS
Sbjct: 940 EKFIQERSTRAVDWRILHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDYNAYLS 999
Query: 826 DFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885
DFGLARLLG SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD
Sbjct: 1000 DFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 1059
Query: 886 PSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTR 945
PSFSSYGNGFNIVAW CMLLRQG+AK+FFTAGLWDA P DDLVEVLHLAVVCTV++LSTR
Sbjct: 1060 PSFSSYGNGFNIVAWACMLLRQGQAKDFFTAGLWDAAPADDLVEVLHLAVVCTVETLSTR 1119
Query: 946 PTMKQVVRRLKQLQPASC 963
PTMKQVVRRLKQLQP SC
Sbjct: 1120 PTMKQVVRRLKQLQPPSC 1137
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551181|ref|XP_003543956.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1325 bits (3428), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 675/985 (68%), Positives = 787/985 (79%), Gaps = 36/985 (3%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M NLEVLDLEGNL++G LP LK+LRVLNLGFNRI GEIP+S LE LNLAGN
Sbjct: 170 MENLEVLDLEGNLISGYLPLRVDGLKNLRVLNLGFNRIVGEIPSSIGSLERLEVLNLAGN 229
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+NG+VP F+GRL+ VYLSFN+L G +P +IGE C LEHLDLS N +VG IP SLGNC
Sbjct: 230 ELNGSVPGFVGRLRGVYLSFNQLSGVIPREIGENCEKLEHLDLSVNSMVGVIPGSLGNCG 289
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
++++LLL+SN+LEE IP ELG L++LEVLDVSRN LS S+P +LGNC +L +LVLSNLFD
Sbjct: 290 RLKTLLLYSNLLEEGIPGELGSLKSLEVLDVSRNILSSSVPRELGNCLELRVLVLSNLFD 349
Query: 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWG 240
DV S + + +++ N+FEG +P + LP LRILWAP LEG +WG
Sbjct: 350 PRGDV----ADSDLGKLGSVDNQLNYFEGAMPAEILLLPKLRILWAPMVNLEGGLQRSWG 405
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGN 300
C++LEM+NL NFFSGK LG CK L F+DLS+N LTGEL++EL VPCM++FDVSGN
Sbjct: 406 GCESLEMVNLAQNFFSGKFPNQLGVCKKLHFVDLSANNLTGELSQELRVPCMSVFDVSGN 465
Query: 301 ALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLA-- 358
LSGS+P FS+ CPPVP + LF + S Y S F K +R R F +
Sbjct: 466 MLSGSVPDFSDNACPPVPSWNGTLFADGDLSLPYASFFMSK--------VRERSLFTSME 517
Query: 359 -----IFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLD 413
+ HNFG N+F+G + S+P+A +RLGK++ Y + G+N L+G FP +F C+ L+
Sbjct: 518 GVGTSVVHNFGQNSFTG-IQSLPIARDRLGKKSGYTFLVGENNLTGPFPTFLFEKCDELE 576
Query: 414 SLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLM 473
+L++NVS NRI+GQ+P+ G +C+SLKFLDASGN++ GPIP +G LVSLV+LNLS N +
Sbjct: 577 ALLLNVSYNRISGQIPSNFGGICRSLKFLDASGNELAGPIPLDLGNLVSLVSLNLSRNQL 636
Query: 474 HDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLR 533
QIPT+LGQMK LK+LSLAGN L G IP+SLGQL L+VLDLSSNSL+G IP +EN+R
Sbjct: 637 QGQIPTSLGQMKNLKFLSLAGNRLNGLIPTSLGQLYSLKVLDLSSNSLTGEIPKAIENMR 696
Query: 534 NLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRP 593
NLT +LLNNN LSG IP+GLA+V+TLSAFNVSFNNLSG LPS+ L+KCSS +GNP+L P
Sbjct: 697 NLTDVLLNNNNLSGHIPNGLAHVATLSAFNVSFNNLSGSLPSNSGLIKCSSAVGNPFLSP 756
Query: 594 CRAFTLTEPSQDLHGPPSNGN---------------RGFNSIEIASIASASAIVSVLLAL 638
C +L+ PS + GPP +GN GF+SIEIASI SASAIVSVL+AL
Sbjct: 757 CHGVSLSVPSVNQPGPP-DGNSYNTATAQANDKKSGNGFSSIEIASITSASAIVSVLIAL 815
Query: 639 IVLFVYTRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGAT 698
IVLF YTRKW P+S+V+GS RKEVT+FT+IGVPL+FE+VVQATGNFNA NCIGNGGFGAT
Sbjct: 816 IVLFFYTRKWKPRSRVVGSIRKEVTVFTDIGVPLTFETVVQATGNFNAGNCIGNGGFGAT 875
Query: 699 YKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758
YKAEISPG+LVA+KRLAVGRFQGVQQFHAEIKTLGRL HPNLVTLIGYHA ETEMFLIYN
Sbjct: 876 YKAEISPGILVAVKRLAVGRFQGVQQFHAEIKTLGRLHHPNLVTLIGYHACETEMFLIYN 935
Query: 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD 818
YL GGNLE FIQ+RSTRAVDW++L+KIALDIARALAYLHD CVPRVLHRDVKPSNILLDD
Sbjct: 936 YLSGGNLEKFIQERSTRAVDWKILYKIALDIARALAYLHDTCVPRVLHRDVKPSNILLDD 995
Query: 819 DFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
DFNAYLSDFGLARLLG SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL
Sbjct: 996 DFNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 1055
Query: 879 SDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCT 938
SDKKALDPSFSSYGNGFNIVAW CMLL+QGRAKEFFTAGLW+AGP DDLVEVLHLAVVCT
Sbjct: 1056 SDKKALDPSFSSYGNGFNIVAWACMLLKQGRAKEFFTAGLWEAGPGDDLVEVLHLAVVCT 1115
Query: 939 VDSLSTRPTMKQVVRRLKQLQPASC 963
VDSLSTRPTMKQVVRRLKQLQP SC
Sbjct: 1116 VDSLSTRPTMKQVVRRLKQLQPPSC 1140
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573540|ref|XP_003554916.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1324 bits (3427), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 675/971 (69%), Positives = 776/971 (79%), Gaps = 14/971 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M NLEVLDLEGNL++G LP LK+LRVLNL FNRI G+IP+S LE LNLAGN
Sbjct: 167 MENLEVLDLEGNLISGCLPFRINGLKNLRVLNLAFNRIVGDIPSSIGSLERLEVLNLAGN 226
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+NG+VP F+GRL+ VYLSFN+L G +P +IGE C NLEHLDLS N +V IPRSLGNC
Sbjct: 227 ELNGSVPGFVGRLRGVYLSFNQLSGIIPREIGENCGNLEHLDLSANSIVRAIPRSLGNCG 286
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
++R+LLL+SN+L+E IP ELG L++LEVLDVSRN+LSGS+P +LGNC +L +LVLSNLFD
Sbjct: 287 RLRTLLLYSNLLKEGIPGELGRLKSLEVLDVSRNTLSGSVPRELGNCLELRVLVLSNLFD 346
Query: 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWG 240
DV + L +ND N+FEG +P V SLP LRILWAP LEG +WG
Sbjct: 347 PRGDVDAGDLEKL----GSVNDQLNYFEGAMPVEVLSLPKLRILWAPMVNLEGGLQGSWG 402
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGN 300
C++LEM+NL NFFSG+ LG CK L F+DLSSN LTGEL+ EL VPCM++FDVSGN
Sbjct: 403 GCESLEMVNLAQNFFSGEFPNQLGVCKKLHFVDLSSNNLTGELSEELRVPCMSVFDVSGN 462
Query: 301 ALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIF 360
LSGS+P FSN VCPPVP + NLF N S Y S F K + + G G ++
Sbjct: 463 MLSGSVPDFSNNVCPPVPSWNGNLFADGNASPRYASFFMSKVRERSLFTSMGGVG-TSVV 521
Query: 361 HNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVS 420
HNFG N+F+ + S+PVA +RLGK+ Y + G+N L+G FP +F C+ LD+L++NVS
Sbjct: 522 HNFGQNSFT-DIHSLPVAHDRLGKKCGYTFLVGENNLTGPFPTFLFEKCDELDALLLNVS 580
Query: 421 NNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTT 480
NRI+GQ+P+ G +C+SLKFLDASGN++ G IP VG LVSLV LNLS N + QIPT
Sbjct: 581 YNRISGQIPSNFGGICRSLKFLDASGNELAGTIPLDVGNLVSLVFLNLSRNQLQGQIPTN 640
Query: 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540
LGQMK LK+LSLAGN L GSIP SLGQL LEVLDLSSNSL+G IP +EN+RNLT +LL
Sbjct: 641 LGQMKNLKFLSLAGNKLNGSIPISLGQLYSLEVLDLSSNSLTGEIPKAIENMRNLTDVLL 700
Query: 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRAFTLT 600
NNN LSG IP+GLA+V+TLSAFNVSFNNLSG LPS+ L+KC S +GNP+L PCR +LT
Sbjct: 701 NNNNLSGHIPNGLAHVTTLSAFNVSFNNLSGSLPSNSGLIKCRSAVGNPFLSPCRGVSLT 760
Query: 601 EPSQ-----DLHGPPSNGNR---GFNSIEIASIASASAIVSVLLALIVLFVYTRKWNPQS 652
PS D P + G + GF+SIEIASI SASAIV VL+ALIVLF YTRKW P+S
Sbjct: 761 VPSGQLGPLDATAPATTGKKSGNGFSSIEIASITSASAIVLVLIALIVLFFYTRKWKPRS 820
Query: 653 KVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIK 712
+V+ S RKEVT+FT+IG PL+FE+VVQATGNFNA NCIGNGGFG TYKAEISPG+LVA+K
Sbjct: 821 RVISSIRKEVTVFTDIGFPLTFETVVQATGNFNAGNCIGNGGFGTTYKAEISPGILVAVK 880
Query: 713 RLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQR 772
RLAVGRFQGVQQFHAEIKTLGRL HPNLVTLIGYHA ETEMFLIYN+L GGNLE FIQ+R
Sbjct: 881 RLAVGRFQGVQQFHAEIKTLGRLHHPNLVTLIGYHACETEMFLIYNFLSGGNLEKFIQER 940
Query: 773 STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832
STR V+W++LHKIALDIARALAYLHD CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL
Sbjct: 941 STRDVEWKILHKIALDIARALAYLHDTCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 1000
Query: 833 LGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYG 892
LG SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSY
Sbjct: 1001 LGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYR 1060
Query: 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952
NGFNIVAW CMLL+QGRAKEFFTAGLW+AGP DDLVEVLHLAVVCTVD LSTRPTMKQVV
Sbjct: 1061 NGFNIVAWACMLLKQGRAKEFFTAGLWEAGPGDDLVEVLHLAVVCTVDILSTRPTMKQVV 1120
Query: 953 RRLKQLQPASC 963
RRLKQLQP +C
Sbjct: 1121 RRLKQLQPLTC 1131
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 963 | ||||||
| TAIR|locus:2026408 | 540 | RPK1 "receptor-like protein ki | 0.430 | 0.768 | 0.581 | 1.9e-136 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.951 | 0.831 | 0.323 | 3e-108 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.578 | 0.488 | 0.319 | 7.3e-108 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.307 | 0.248 | 0.387 | 4.8e-106 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.298 | 0.221 | 0.436 | 1.4e-103 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.955 | 0.818 | 0.308 | 6.9e-102 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.956 | 0.830 | 0.318 | 1.3e-98 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.584 | 0.501 | 0.289 | 8.7e-98 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.577 | 0.445 | 0.305 | 1e-97 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.901 | 0.693 | 0.299 | 3.9e-92 |
| TAIR|locus:2026408 RPK1 "receptor-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1272 (452.8 bits), Expect = 1.9e-136, Sum P(2) = 1.9e-136
Identities = 250/430 (58%), Positives = 314/430 (73%)
Query: 547 GKIPSGLANVSTLSAFNVSFNNLSGPLPSSK-NLMKCS--SVLGNPYLRPCRAFT----- 598
G I + ++S + ++SFN+L G +P L K + GN ++ R
Sbjct: 109 GVISPVVGDLSEIRVLSLSFNDLRGEIPKEIWGLEKLEILDLKGNNFIGGIRVVDNVVLR 168
Query: 599 --LTEPSQDLHGPPSN-----GNRGFNXXXXXXXXXXXXXXXXXXXXXXXFVYTRKWNPQ 651
++ +D GP S G G F+YTRKW
Sbjct: 169 KLMSFEDEDEIGPSSADDDSPGKSGLYPIEIASIVSASVIVFVLLVLVILFIYTRKWKRN 228
Query: 652 SKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAI 711
S+V KE+ +F +IG+PL++E +V+ATG F+ SNCIG+GGFG+TYKAE+SP + A+
Sbjct: 229 SQVQVDEIKEIKVFVDIGIPLTYEIIVRATGYFSNSNCIGHGGFGSTYKAEVSPTNVFAV 288
Query: 712 KRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQ 771
KRL+VGRFQG QQFHAEI L +RHPNLV LIGYHASETEMFLIYNYL GGNL++FI++
Sbjct: 289 KRLSVGRFQGDQQFHAEISALEMVRHPNLVMLIGYHASETEMFLIYNYLSGGNLQDFIKE 348
Query: 772 RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831
RS A++W+VLHKIALD+ARAL+YLH+QC P+VLHRD+KPSNILLD+++NAYLSDFGL++
Sbjct: 349 RSKAAIEWKVLHKIALDVARALSYLHEQCSPKVLHRDIKPSNILLDNNYNAYLSDFGLSK 408
Query: 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSY 891
LLG S++H TTGVAGTFGYVAPEYAMTCRVS+KADVYSYG+VLLEL+SDK+ALDPSFSS+
Sbjct: 409 LLGTSQSHVTTGVAGTFGYVAPEYAMTCRVSEKADVYSYGIVLLELISDKRALDPSFSSH 468
Query: 892 GNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQV 951
NGFNIV+W M+L QG+AKE FT GLW+ GP DDLVEVLHLA+ CTVDSLS RPTMKQ
Sbjct: 469 ENGFNIVSWAHMMLSQGKAKEVFTTGLWETGPPDDLVEVLHLALKCTVDSLSIRPTMKQA 528
Query: 952 VRRLKQLQPA 961
VR LK++QP+
Sbjct: 529 VRLLKRIQPS 538
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1070 (381.7 bits), Expect = 3.0e-108, P = 3.0e-108
Identities = 322/994 (32%), Positives = 478/994 (48%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+LE+L L N +G +P L SL L + NRI+G +P + ++L +L N +
Sbjct: 122 SLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNI 181
Query: 63 NGTVPTFIGRLKRVYLSF----NRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
+G +P IG LKR+ SF N + GS+PS+IG C +L L L+ N L G +P+ +G
Sbjct: 182 SGQLPRSIGNLKRL-TSFRAGQNMISGSLPSEIGG-CESLVMLGLAQNQLSGELPKEIGM 239
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVL--S 176
++ ++L+ N IP E+ +LE L + +N L G IP +LG+ L L L +
Sbjct: 240 LKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRN 299
Query: 177 NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFP 236
L T R S + F N G IP + ++ L +L+ L G P
Sbjct: 300 GLNGTIP--REIGNLSYAIEIDFSE---NALTGEIPLELGNIEGLELLYLFENQLTGTIP 354
Query: 237 SNWGACDNLEMLNLGHNFFSGK-NLGVLGPCKNLLFLDLSSNQLTGELARELP-VPCMTM 294
NL L+L N +G LG + L L L N L+G + +L + +
Sbjct: 355 VELSTLKNLSKLDLSINALTGPIPLG-FQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWV 413
Query: 295 FDVSGNALSGSIPTF----SNMVCPPVPY--LSRNLFESYNPSTAYLSL-FAKKSQAGT- 346
D+S N LSG IP++ SNM+ + LS N+ + L A+ + G
Sbjct: 414 LDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRF 473
Query: 347 PLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPGNM 405
P L + AI G N F GS+P +G + + DN +G P +
Sbjct: 474 PSNLCKQVNVTAI--ELGQNRFRGSIP------REVGNCSALQRLQLADNGFTGELPREI 525
Query: 406 FGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVA 465
G+ ++L +L N+S+N++ G++P+EI CK L+ LD N G +P VG L L
Sbjct: 526 -GMLSQLGTL--NISSNKLTGEVPSEIFN-CKMLQRLDMCCNNFSGTLPSEVGSLYQLEL 581
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPXXXXXXXXXXXXXXXX-NSLSGL 524
L LS N + IP LG + L L + GN GSIP N L+G
Sbjct: 582 LKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGE 641
Query: 525 IPDDXXXXXXXXXXXXXXXXXSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSS 584
IP + SG+IPS AN+S+L +N S+N+L+GP+P +N+ SS
Sbjct: 642 IPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNI-SMSS 700
Query: 585 VLGN-----PYLRPCRAFTLTEPSQDLHGPPSNGNRGFNXXXXXXXXXXXXXXXXXXXXX 639
+GN P L C PSQ S G G
Sbjct: 701 FIGNEGLCGPPLNQCIQTQPFAPSQ------STGKPGGMRSSKIIAITAAVIGGVSLMLI 754
Query: 640 XXFVYTRKWNPQSKVMGSTR--KEVTIFTEIGVP----LSFESVVQATGNFNASNCIGNG 693
VY + P V S + + + +I P +F+ +V AT NF+ S +G G
Sbjct: 755 ALIVYLMR-RPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRG 813
Query: 694 GFGATYKAEISPGVLVAIKRLAV----GRFQGVQQ-FHAEIKTLGRLRHPNLVTLIGYHA 748
G YKA + G +A+K+LA G V F AEI TLG +RH N+V L G+
Sbjct: 814 ACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCN 873
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+ L+Y Y+P G+L + S +DW KIAL A+ LAYLH C PR+ HRD
Sbjct: 874 HQGSNLLLYEYMPKGSLGEILHDPSCN-LDWSKRFKIALGAAQGLAYLHHDCKPRIFHRD 932
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K +NILLDD F A++ DFGLA+++ + + + +AG++GY+APEYA T +V++K+D+Y
Sbjct: 933 IKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIY 992
Query: 869 SYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGP--HDD 926
SYGVVLLELL+ K + P G ++V W +R ++ ++G+ DA D+
Sbjct: 993 SYGVVLLELLTGKAPVQP----IDQGGDVVNWVRSYIR----RDALSSGVLDARLTLEDE 1044
Query: 927 -----LVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955
++ VL +A++CT S RP+M+QVV L
Sbjct: 1045 RIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 628 (226.1 bits), Expect = 7.3e-108, Sum P(2) = 7.3e-108
Identities = 189/591 (31%), Positives = 276/591 (46%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+L+ L + G L G LP+S L+VL+L N + G+IP S S NLE L L N +
Sbjct: 106 SLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQL 165
Query: 63 NGTVPTFIGR---LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG-IPRSLGN 118
G +P I + LK + L N L GS+P+++G K + LE + + GN + G IP +G+
Sbjct: 166 TGKIPPDISKCSKLKSLILFDNLLTGSIPTELG-KLSGLEVIRIGGNKEISGQIPSEIGD 224
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVL-SN 177
C + L L + +P+ LG L+ LE L + +SG IP DLGNCS+L L L N
Sbjct: 225 CSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYEN 284
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
+ GQ + F+ N GGIPE + + NL+++ L G+ PS
Sbjct: 285 SLSG--SIPREIGQLTKLEQLFLWQ--NSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPS 340
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFD 296
+ G LE + N FSG + C +L+ L L NQ++G + EL + +T+F
Sbjct: 341 SIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFF 400
Query: 297 VSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNPSTAYLS------LFAKKSQAG-TPL 348
N L GSIP ++ LSRN PS ++ L S +G P
Sbjct: 401 AWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQ 460
Query: 349 PLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPGNMFG 407
+ + + G N +G +PS +G + + + N+L G P + G
Sbjct: 461 EIGNCSSLVRL--RLGFNRITGEIPS------GIGSLKKINFLDFSSNRLHGKVPDEI-G 511
Query: 408 ICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALN 467
C+ L M+++SNN + G LP + + L+ LD S NQ G IP +G LVSL L
Sbjct: 512 SCSELQ--MIDLSNNSLEGSLPNPVSSL-SGLQVLDVSANQFSGKIPASLGRLVSLNKLI 568
Query: 468 LSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPXXXXXXXXXXXXXX-XXNSLSGLIP 526
LS NL IPT+LG GL+ L L N L+G IP N L+G IP
Sbjct: 569 LSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIP 628
Query: 527 DDXXXXXXXXXXXXXXXXXSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSK 577
G + + LAN+ L + N+S+N+ SG LP +K
Sbjct: 629 SKIASLNKLSILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNK 678
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 4.8e-106, Sum P(2) = 4.8e-106
Identities = 116/299 (38%), Positives = 189/299 (63%)
Query: 662 VTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQG 721
+ +F + + + +V+AT +F+ N IG+GGFG YKA + VA+K+L+ + QG
Sbjct: 895 IAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQG 954
Query: 722 VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRS--TRAVDW 779
++F AE++TLG+++HPNLV+L+GY + E L+Y Y+ G+L+++++ ++ +DW
Sbjct: 955 NREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDW 1014
Query: 780 RVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839
KIA+ AR LA+LH +P ++HRD+K SNILLD DF ++DFGLARL+ E+H
Sbjct: 1015 SKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESH 1074
Query: 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899
+T +AGTFGY+ PEY + R + K DVYS+GV+LLEL++ K+ P F G N+V
Sbjct: 1075 VSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKE-SEGGNLVG 1133
Query: 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
W + QG+A + L + + +L +A++C ++ + RP M V++ LK++
Sbjct: 1134 WAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 607 (218.7 bits), Expect = 1.4e-103, Sum P(2) = 1.4e-103
Identities = 128/293 (43%), Positives = 183/293 (62%)
Query: 675 ESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVG-RFQGVQQFHAEIKTLG 733
+ +++AT NF+ + IG+GGFG YKA + G VAIKRL G +FQG ++F AE++T+G
Sbjct: 993 DDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMETIG 1052
Query: 734 RLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRST--RAVDWRVLHKIALDIAR 791
+++HPNLV L+GY E FLIY Y+ G+LE +++ R+ A+ W KI L AR
Sbjct: 1053 KVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDRLKICLGSAR 1112
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851
LA+LH VP ++HRD+K SNILLD++F +SDFGLAR++ ETH +T +AGTFGY+
Sbjct: 1113 GLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDIAGTFGYI 1172
Query: 852 APEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911
PEY +T + + K DVYS+GVV+LELL+ + G G N+V W ++ +G+
Sbjct: 1173 PPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQE-EVQGGG-NLVGWVRWMIARGKQN 1230
Query: 912 EFFTAGLWDAGP-HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPASC 963
E F L + + + VL +A CT D RPTM +VV+ LK C
Sbjct: 1231 ELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGLKMTHGMEC 1283
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1010 (360.6 bits), Expect = 6.9e-102, P = 6.9e-102
Identities = 308/997 (30%), Positives = 464/997 (46%)
Query: 4 LEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVN 63
LEV+ L N G +P L LR N+ N+++G +P D NLEEL N +
Sbjct: 135 LEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLT 194
Query: 64 GTVPTFIGRLKRVYLSF----NRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
G +P +G L ++ +F N G++P++IG KC NL+ L L+ N++ G +P+ +G
Sbjct: 195 GPLPRSLGNLNKL-TTFRAGQNDFSGNIPTEIG-KCLNLKLLGLAQNFISGELPKEIGML 252
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLF 179
+++ ++L+ N IP ++G L +LE L + NSL G IP ++GN L L L
Sbjct: 253 VKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQ-- 310
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDF--NFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
+ + + L M DF N G IP +S + LR+L+ + L G P+
Sbjct: 311 ---NQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPN 367
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC-MTMFD 296
NL L+L N +G ++ L L N L+G + + L + + + D
Sbjct: 368 ELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVD 427
Query: 297 VSGNALSGSIPTF----SNMVCPPVPYLSRNLFESYNP------STAYLSLFAKKSQAGT 346
S N LSG IP F SN++ + S +F + P S L + +
Sbjct: 428 FSENQLSGKIPPFICQQSNLILLNLG--SNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQF 485
Query: 347 PLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPGNM 405
P L AI N FSG LP PE +G Q + + N+ S + P +
Sbjct: 486 PTELCKLVNLSAI--ELDQNRFSGPLP-----PE-IGTCQKLQRLHLAANQFSSNLPNEI 537
Query: 406 FGICNRLDSLMV-NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLV 464
++L +L+ NVS+N + G +P+EI CK L+ LD S N +G +P +G L L
Sbjct: 538 ----SKLSNLVTFNVSSNSLTGPIPSEIAN-CKMLQRLDLSRNSFIGSLPPELGSLHQLE 592
Query: 465 ALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP-XXXXXXXXXXXXXXXXNSLSG 523
L LS N IP T+G + L L + GN +GSIP N SG
Sbjct: 593 ILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSG 652
Query: 524 LIPDDXXXXXXXXXXXXXXXXXSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL--MK 581
IP + SG+IP+ N+S+L N S+NNL+G LP ++ M
Sbjct: 653 EIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMT 712
Query: 582 CSSVLGNPYLRPCRAFTLT-EPSQDLHGPPSNGNRGFNXXXXXXXXXXXXXXXXXXXXXX 640
+S LGN L C + +PS S+ G
Sbjct: 713 LTSFLGNKGL--CGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIA 770
Query: 641 XFVYTRKWNPQSKVMGSTRKEVTIFTEIG---VP---LSFESVVQATGNFNASNCIGNGG 694
V+ + NP + F E VP + + +++AT F+ S +G G
Sbjct: 771 IVVHFLR-NPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGA 829
Query: 695 FGATYKAEISPGVLVAIKRLAVGRFQGVQQ--------FHAEIKTLGRLRHPNLVTLIG- 745
G YKA + G +A+K+L R +G F AEI TLG++RH N+V L
Sbjct: 830 CGTVYKAVMPSGKTIAVKKLESNR-EGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSF 888
Query: 746 -YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
YH L+Y Y+ G+L + + ++DW IAL A LAYLH C PR+
Sbjct: 889 CYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRI 948
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
+HRD+K +NIL+D++F A++ DFGLA+++ + + + VAG++GY+APEYA T +V++K
Sbjct: 949 IHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEK 1008
Query: 865 ADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ-GRAKEFFTAGLWDAGP 923
D+YS+GVVLLELL+ K + P G ++ W +R E L
Sbjct: 1009 CDIYSFGVVLLELLTGKAPVQP----LEQGGDLATWTRNHIRDHSLTSEILDPYLTKV-- 1062
Query: 924 HDD-----LVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955
DD ++ V +AV+CT S S RPTM++VV L
Sbjct: 1063 EDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
Identities = 313/984 (31%), Positives = 452/984 (45%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
NL L L N L G P+S + L + N + G IP++ + L L L N
Sbjct: 141 NLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQF 200
Query: 63 NGTVPTFIGR---LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
+G VP+ +G L+ +YL+ N LVG++P + NL +LD+ N LVG IP +C
Sbjct: 201 SGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNN-LENLVYLDVRNNSLVGAIPLDFVSC 259
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS-NL 178
Q+ ++ L +N +P LG +L +LSG IP G +KL L L+ N
Sbjct: 260 KQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNH 319
Query: 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSN 238
F + +S++D N EG IP + L L+ L L G P +
Sbjct: 320 FSGRIPPELGKCKSMIDLQLQQNQ----LEGEIPGELGMLSQLQYLHLYTNNLSGEVPLS 375
Query: 239 WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV-PCMTMFDV 297
+L+ L L N SG+ + K L+ L L N TG + ++L + + D+
Sbjct: 376 IWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDL 435
Query: 298 SGNALSGSIPTFSNMVCPPVPY----LSRNLFESYNPS-----TAYLSLFAKKSQAGTPL 348
+ N +G IP N+ C L N E PS + L +++ L
Sbjct: 436 TRNMFTGHIPP--NL-CSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGL 492
Query: 349 PLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGI 408
P L +F + GNNF+G P+ P + V AI N+LSGS P + G
Sbjct: 493 PDFVEKQNL-LFFDLSGNNFTG-----PIPPSLGNLKNVTAIYLSSNQLSGSIPPEL-GS 545
Query: 409 CNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNL 468
+L+ L N+S+N + G LP+E+ C L LDAS N + G IP +G L L L+L
Sbjct: 546 LVKLEHL--NLSHNILKGILPSELSN-CHKLSELDASHNLLNGSIPSTLGSLTELTKLSL 602
Query: 469 SWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPXXXXXXXXXXXXXXXXNSLSGLIPDD 528
N IPT+L Q L L L GN L G IP N L+G +P D
Sbjct: 603 GENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPPVGALQALRSLNLSS-NKLNGQLPID 661
Query: 529 XXXXXXXXXXXXXXXXXSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS-KNLMKCS--SV 585
SG + L+ + +L+ N+S N SGP+P S + S S
Sbjct: 662 LGKLKMLEELDVSHNNLSGTLRV-LSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSF 720
Query: 586 LGNPYLR-PCRAFTLTEPSQDLHGP---PSN-GNRGFNXXXXXXXXXXXXXXXXXXXXXX 640
GN L C A L P + P SN G G +
Sbjct: 721 SGNSDLCINCPADGLACPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICLFLFS 780
Query: 641 XFVYTRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYK 700
F++ + + V +E+ I + G V++AT N N IG G G YK
Sbjct: 781 AFLFL---HCKKSV-----QEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYK 832
Query: 701 AEISPGVLVAIKRLA-VGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759
A +SP + A+K+L G G EI+T+G++RH NL+ L + + ++Y Y
Sbjct: 833 ATLSPDKVYAVKKLVFTGIKNGSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTY 892
Query: 760 LPGGNLENFIQQRST-RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD 818
+ G+L + + + + + +DW H IA+ A LAYLH C P ++HRD+KP NILLD
Sbjct: 893 MENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDS 952
Query: 819 DFNAYLSDFGLARLLGPSETHATTG-VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLEL 877
D ++SDFG+A+LL S T + V GT GY+APE A T S ++DVYSYGVVLLEL
Sbjct: 953 DLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLEL 1012
Query: 878 LSDKKALDPSFSSYGNG-FNIVAWGCMLLRQ-GRAKEFFTAGLWD----AGPHDDLVEVL 931
++ KKALDPSF NG +IV W + Q G ++ L D + + + E L
Sbjct: 1013 ITRKKALDPSF----NGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEAL 1068
Query: 932 HLAVVCTVDSLSTRPTMKQVVRRL 955
LA+ C + RPTM+ VV++L
Sbjct: 1069 SLALRCAEKEVDKRPTMRDVVKQL 1092
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 8.7e-98, Sum P(2) = 8.7e-98
Identities = 171/591 (28%), Positives = 267/591 (45%)
Query: 3 NLEVLDLEGNLLNGIL-PDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
N+ L+ + ++G L P+ G LKSL++L+L N +G IP++ + L L+L+ N
Sbjct: 76 NVASLNFTRSRVSGQLGPEIG-ELKSLQILDLSTNNFSGTIPSTLGNCTKLATLDLSENG 134
Query: 62 VNGTVPTFIGRLKRV---YLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
+ +P + LKR+ YL N L G +P + + L+ L L N L G IP+S+G+
Sbjct: 135 FSDKIPDTLDSLKRLEVLYLYINFLTGELPESLF-RIPKLQVLYLDYNNLTGPIPQSIGD 193
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178
++ L +++N IP +G +L++L + RN L GS+P L L L + N
Sbjct: 194 AKELVELSMYANQFSGNIPESIGNSSSLQILYLHRNKLVGSLPESLNLLGNLTTLFVGNN 253
Query: 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSN 238
VR+ G ++ +N FEGG+P A+ + +L L L G PS+
Sbjct: 254 -SLQGPVRF--GSPNCKNLLTLDLSYNEFEGGVPPALGNCSSLDALVIVSGNLSGTIPSS 310
Query: 239 WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDV 297
G NL +LNL N SG LG C +L L L+ NQL G + L + + ++
Sbjct: 311 LGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLNDNQLVGGIPSALGKLRKLESLEL 370
Query: 298 SGNALSGSIPT--FSNMVCPPVPYLSRNL-----FESYNPSTAYLSLFAKKSQAGTPLPL 350
N SG IP + + + NL E ++ S G P
Sbjct: 371 FENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIATLFNNSFYGAIPPG 430
Query: 351 RGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICN 410
G + L +F GN +G +P P + + + G N L G+ P ++ G C
Sbjct: 431 LGVNSSLEEV-DFIGNKLTGEIP-----PNLCHGRKLRILNLGSNLLHGTIPASI-GHCK 483
Query: 411 RLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSW 470
+ ++ N ++G LP E + SL FLD + N GPIP +G +L ++NLS
Sbjct: 484 TIRRFILR--ENNLSGLLP-EFSQD-HSLSFLDFNSNNFEGPIPGSLGSCKNLSSINLSR 539
Query: 471 NLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPXXXXXXXXXXXXXXXXNSLSGLIPDDXX 530
N QIP LG ++ L Y++L+ N L GS+P NSL+G +P +
Sbjct: 540 NRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNSLNGSVPSNFS 599
Query: 531 XXXXXXXXXXXXXXXSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMK 581
SG IP L + LS ++ N G +PSS L++
Sbjct: 600 NWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIE 650
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 582 (209.9 bits), Expect = 1.0e-97, Sum P(2) = 1.0e-97
Identities = 180/590 (30%), Positives = 277/590 (46%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+L V N+LNG +P L++L +LNL N +TGEIP+ + L+ L+L N +
Sbjct: 216 DLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQL 275
Query: 63 NGTVPTFI---GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL-GN 118
G +P + G L+ + LS N L G +P + L+ L L+ N+L G +P+S+ N
Sbjct: 276 QGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLD-LVLANNHLSGSLPKSICSN 334
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178
+ L+L L IP EL Q+L+ LD+S NSL+GSIP L +L L L N
Sbjct: 335 NTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHN- 393
Query: 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSN 238
+T E S S + ++ N EG +P+ +S+L L +L+ G P
Sbjct: 394 -NTLEGT-LSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQE 451
Query: 239 WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC--MTMFD 296
G C +L+M+++ N F G+ +G K L L L N+L G L L C + + D
Sbjct: 452 IGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLG-NCHQLNILD 510
Query: 297 VSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNPSTAYLSL-------FAKKSQAGTPL 348
++ N LSGSIP+ F + L N + P + +SL + GT
Sbjct: 511 LADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSL-ISLRNLTRINLSHNRLNGTIH 569
Query: 349 PLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPGNMFG 407
PL G +L+ + N F +P LG Q + + G N+L+G P + G
Sbjct: 570 PLCGSSSYLSF--DVTNNGFEDEIPL------ELGNSQNLDRLRLGKNQLTGKIPWTL-G 620
Query: 408 ICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALN 467
L ++++S+N + G +P ++ +CK L +D + N + GPIP +G+L L L
Sbjct: 621 KIRELS--LLDMSSNALTGTIPLQLV-LCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELK 677
Query: 468 LSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPXXXXXXXXXXXXXXXXNSLSGLIPD 527
LS N + +PT L L LSL GN+L GSIP N SG +P
Sbjct: 678 LSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQ 737
Query: 528 DXXXXXXXXXXXXXXXXXSGKIPSGLANVSTL-SAFNVSFNNLSGPLPSS 576
+G+IP + + L SA ++S+NN +G +PS+
Sbjct: 738 AMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPST 787
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 918 (328.2 bits), Expect = 3.9e-92, P = 3.9e-92
Identities = 281/937 (29%), Positives = 452/937 (48%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+++ L+L GN L G++P L +L+ L+L N +TG I F LE L LA N +
Sbjct: 265 SIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRL 324
Query: 63 NGTVPTFI----GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
+G++P I LK+++LS +L G +P++I C +L+ LDLS N L G IP SL
Sbjct: 325 SGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISN-CQSLKLLDLSNNTLTGQIPDSLFQ 383
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVL-SN 177
++ +L L +N LE T+ + + L NL+ + N+L G +P ++G KL I+ L N
Sbjct: 384 LVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYEN 443
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
F V L + + N G IP ++ L +L L L GN P+
Sbjct: 444 RFSGEMPVEIGNCTRLQEIDWYGNR----LSGEIPSSIGRLKDLTRLHLRENELVGNIPA 499
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFD 296
+ G C + +++L N SG G L + +N L G L L + +T +
Sbjct: 500 SLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRIN 559
Query: 297 VSGNALSGSIPTFSNMVCPPVPYLS----RNLFESYNP-----STAYLSLFAKKSQAGTP 347
S N +GSI + +C YLS N FE P ST L K+Q
Sbjct: 560 FSSNKFNGSI----SPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGR 615
Query: 348 LPLR-GRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMF 406
+P G+ L++ + N+ SG +P + + L K+ + I +N LSG P
Sbjct: 616 IPRTFGKISELSLL-DISRNSLSGIIP-VELG---LCKKLTH-IDLNNNYLSGVIP-TWL 668
Query: 407 GICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLK-FLDASGNQIVGPIPRGVGELVSLVA 465
G L L +S+N+ G LP EI + L FLD GN + G IP+ +G L +L A
Sbjct: 669 GKLPLLGEL--KLSSNKFVGSLPTEIFSLTNILTLFLD--GNSLNGSIPQEIGNLQALNA 724
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPXXXXXXXXXXXXXXXX-NSLSGL 524
LNL N + +P+T+G++ L L L+ N LTG IP N+ +G
Sbjct: 725 LNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGR 784
Query: 525 IPDDXXXXXXXXXXXXXXXXXSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSS 584
IP G++P + ++ +L N+S+NNL G L + + +
Sbjct: 785 IPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADA 844
Query: 585 VLGNPYLRPCRAFTLTEPSQDLHGPPSNGNRGFNXXXXXXXXXXXXXXXXXXXXXXXFVY 644
+GN L C + P + S R + ++
Sbjct: 845 FVGNAGL--CGS-----PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILF 897
Query: 645 TRKWNPQ-SKVMG--------STRKEVTIFTEIGVP--LSFESVVQATGNFNASNCIGNG 693
++ + KV G S+ + +F+ G + ++ +++AT N IG+G
Sbjct: 898 FKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSG 957
Query: 694 GFGATYKAEISPGVLVAIKRLA-VGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752
G G YKAE+ G +A+K++ + F+ E+KTLG +RH +LV L+GY +S+ +
Sbjct: 958 GSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKAD 1017
Query: 753 --MFLIYNYLPGGNLENFIQ-QRSTR---AVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
LIY Y+ G++ +++ +T+ + W KIAL +A+ + YLH CVP ++H
Sbjct: 1018 GLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVH 1077
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLL-G--PSETHATTGVAGTFGYVAPEYAMTCRVSD 863
RD+K SN+LLD + A+L DFGLA++L G + T + T AG++GY+APEYA + + ++
Sbjct: 1078 RDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATE 1137
Query: 864 KADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAW 900
K+DVYS G+VL+E+++ K P+ + + ++V W
Sbjct: 1138 KSDVYSMGIVLMEIVTGKM---PTEAMFDEETDMVRW 1171
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9S7I6 | RPK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6895 | 0.9927 | 0.8305 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 963 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-94 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-32 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-26 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 6e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 320 bits (822), Expect = 1e-94
Identities = 300/990 (30%), Positives = 433/990 (43%), Gaps = 217/990 (21%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
NLE LDL N+L+G +P+ SL+VL+LG N + G+IP S ++ +LE L LA N +
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL 200
Query: 63 NGTVPTFIGR---LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
G +P +G+ LK +YL +N L G +P +IG T+L HLDL N L G IP SLGN
Sbjct: 201 VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG-LTSLNHLDLVYNNLTGPIPSSLGNL 259
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLF 179
++ L L+ N L IP + LQ L LD+S NSLSG IP + L IL L
Sbjct: 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL---- 315
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRIL--WAPRATLEGNFPS 237
F N+ F G IP A++SLP L++L W+ + G P
Sbjct: 316 -------------------FSNN----FTGKIPVALTSLPRLQVLQLWSNK--FSGEIPK 350
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC----MT 293
N LG NL LDLS+N LTGE+ L C +
Sbjct: 351 N------------------------LGKHNNLTVLDLSTNNLTGEIPEGL---CSSGNLF 383
Query: 294 MFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGR 353
+ N+L G IP SL A +S L
Sbjct: 384 KLILFSNSLEGEIPK---------------------------SLGACRSLRRVRLQ---- 412
Query: 354 DGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLD 413
N+FSG LPS E VY + +N L G + +
Sbjct: 413 -----------DNSFSGELPS-----EFTKLPLVYFLDISNNNLQGRINSRKW----DMP 452
Query: 414 SL-MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNL 472
SL M++++ N+ G LP G K L+ LD S NQ G +PR +G L L+ L LS N
Sbjct: 453 SLQMLSLARNKFFGGLPDSFG--SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 473 MHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENL 532
+ +IP L K L L L+ N L+G IP+S ++ +L LDLS N
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN------------- 557
Query: 533 RNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLM--KCSSVLGNPY 590
+LSG+IP L NV +L N+S N+L G LPS+ + S+V GN
Sbjct: 558 -----------QLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID 606
Query: 591 L---------RPCRAFTLTEPSQDLHGPPSNGNRGFNSIEIASIASASAIVSVLLALIVL 641
L PC+ T PS + I A +++ L+A +
Sbjct: 607 LCGGDTTSGLPPCKRVRKT-PSWWFY--------------ITCTLGAFLVLA-LVAFGFV 650
Query: 642 FVYTRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKA 701
F+ R +V F + V S ++ + N I G GA+YK
Sbjct: 651 FIRGRNNLELKRVENEDGTWELQFFDSKVSKSI-TINDILSSLKEENVISRGKKGASYKG 709
Query: 702 E-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760
+ I G+ +K + + +EI +G+L+HPN+V LIG SE +LI+ Y+
Sbjct: 710 KSIKNGMQFVVKE--INDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765
Query: 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF 820
G NL + R + W KIA+ IA+AL +LH +C P V+ ++ P I++D
Sbjct: 766 EGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820
Query: 821 NAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSD 880
+L RL P T + YVAPE T +++K+D+Y +G++L+ELL+
Sbjct: 821 EPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874
Query: 881 KKALDPSFSSYGNGFNIVAWG------CMLLRQGRAKEFFTAGLW-------DAGPH-DD 926
K D F +G +IV W C L +W D + ++
Sbjct: 875 KSPADAEFGVHG---SIVEWARYCYSDCHL------------DMWIDPSIRGDVSVNQNE 919
Query: 927 LVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956
+VEV++LA+ CT + RP V++ L+
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 5e-51
Identities = 70/192 (36%), Positives = 107/192 (55%), Gaps = 9/192 (4%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G GGFG Y A G VAIK + +++ EI+ L +L HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
E ++L+ Y GG+L++ +++ + + + +I L I L YLH ++HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 808 DVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR-VSDKA 865
D+KP NILLD D+ L+DFGL++LL ++ T V GT Y+APE + S+K+
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 866 DVYSYGVVLLEL 877
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-48
Identities = 71/192 (36%), Positives = 104/192 (54%), Gaps = 9/192 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G FG Y A + G LVAIK + + + ++ EIK L +L+HPN+V L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
E +++L+ Y GG+L + +++R + I AL YLH + ++HR
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSK---GIVHR 121
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
D+KP NILLD+D + L+DFGLAR L P E T GT Y+APE + D+
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 868 YSYGVVLLELLS 879
+S GV+L ELL+
Sbjct: 180 WSLGVILYELLT 191
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 5e-46
Identities = 76/197 (38%), Positives = 107/197 (54%), Gaps = 10/197 (5%)
Query: 689 CIGNGGFGATYKA-EISPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G+G FG YKA G +VA+K L + Q EI+ L RL HPN+V LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ ++L+ Y GG+L +++ + + KIAL I R L YLH ++
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD-K 864
HRD+KP NILLD++ ++DFGLA+ L S + TT V GT Y+APE + K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 865 ADVYSYGVVLLELLSDK 881
DV+S GV+L ELL+ K
Sbjct: 180 VDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 70/274 (25%), Positives = 126/274 (45%), Gaps = 31/274 (11%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG YK ++ V VA+K L Q +++F E + + +L HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+G E ++++ Y+ GG+L +++++ + L AL IAR + YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
+HRD+ N L+ ++ +SDFGL+R L + + G ++APE + +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 864 KADVYSYGVVLLELLSDKKALDPSFSSYGN--GFNIVAWGCMLLRQGRAKEFFTAGLWDA 921
K+DV+S+GV+L E+ + + Y ++ + L+ G
Sbjct: 183 KSDVWSFGVLLWEIFTLGE------QPYPGMSNEEVLEY----LKNGYRLPQ-------- 224
Query: 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955
P + E+ L + C + RPT ++V L
Sbjct: 225 -PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 690 IGNGGFGATYKAEISPG-----VLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG YK + V VA+K L Q +++F E + + +L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+G E + ++ Y+PGG+L +++++ + + L AL IAR + YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
+HRD+ N L+ ++ +SDFGL+R L + + G ++APE + +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 864 KADVYSYGVVLLELLSD 880
K+DV+S+GV+L E+ +
Sbjct: 184 KSDVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 690 IGNGGFGATYKAEI-----SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG YK + VA+K L G + ++F E + +L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+G ++++ Y+PGG+L +F+++ + + L ++AL IA+ + YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLESK---N 122
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG---YVAPEYAMTCR 860
+HRD+ N L+ ++ +SDFGL+R + + + G G ++APE +
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLKDGK 180
Query: 861 VSDKADVYSYGVVLLELLS 879
+ K+DV+S+GV+L E+ +
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 688 NCIGNGGFGATYKA-EISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G FG+ Y A + G L+A+K + + + ++ EI+ L L+HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 745 G-YHASETEMFLIY-NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
G E I+ Y+ GG+L + +++ + V+ K I LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN--- 120
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRV 861
++HRD+K +NIL+D D L+DFG A+ LG ET T V GT ++APE
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 862 SDKADVYSYGVVLLELLSDKKALDPSFSSYGN 893
AD++S G ++E+ + K P +S GN
Sbjct: 181 GRAADIWSLGCTVIEMATGK----PPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 688 NCIGNGGFGATYKAEISPG----VLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
+G G FG YK ++ VA+K L + + F E + + +L HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRA-------VDWRVLHKIALDIARALAY 795
L+G E ++L+ Y+ GG+L +++++ + + L A+ IA+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GYVAP 853
L + + +HRD+ N L+ +D +SDFGL+R + + + G ++AP
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKKTGGKLPIRWMAP 176
Query: 854 EYAMTCRVSDKADVYSYGVVLLELLS 879
E + K+DV+S+GV+L E+ +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 5e-35
Identities = 142/491 (28%), Positives = 203/491 (41%), Gaps = 109/491 (22%)
Query: 92 GEKCTNLEH---LDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEV 148
G C N +DLSG + G I S +F L ++
Sbjct: 62 GITCNNSSRVVSIDLSGKNISGKI-----------SSAIFR-------------LPYIQT 97
Query: 149 LDVSRNSLSGSIPVDL-GNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFF 207
+++S N LSG IP D+ S L L LSN N F
Sbjct: 98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSN---------------------------NNF 130
Query: 208 EGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCK 267
G IP S+PNL L L G P++ G+ +L++L+LG N GK L
Sbjct: 131 TGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT 188
Query: 268 NLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFE 326
+L FL L+SNQL G++ REL + + + N LSG IP
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY------------------ 230
Query: 327 SYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQT 386
+ G L D + +N N +G +PS + L
Sbjct: 231 ----------------EIGGLTSLNHLD----LVYN----NLTGPIPSSLGNLKNLQYLF 266
Query: 387 VYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASG 446
+Y NKLSG P ++F + L SL ++S+N ++G++P + ++ ++L+ L
Sbjct: 267 LY-----QNKLSGPIPPSIFSLQK-LISL--DLSDNSLSGEIPELVIQL-QNLEILHLFS 317
Query: 447 NQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLG 506
N G IP + L L L L N +IP LG+ L L L+ NNLTG IP L
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377
Query: 507 QLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSF 566
L L L SNSL G IP L R+L + L +N SG++PS + + ++S
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 567 NNLSGPLPSSK 577
NNL G + S K
Sbjct: 438 NNLQGRINSRK 448
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 9e-35
Identities = 122/382 (31%), Positives = 181/382 (47%), Gaps = 63/382 (16%)
Query: 209 GGIPEAVSSLPNLRILWAPRATLEGNFPSN-WGACDNLEMLNLGHNFFSGKNLGVLGPCK 267
G I A+ LP ++ + L G P + + +L LNL +N F+G G
Sbjct: 83 GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIP 140
Query: 268 NLLFLDLSSNQLTGELARELPV-PCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFE 326
NL LDLS+N L+GE+ ++ + + D+ GN L G IP L+ NL
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP----------NSLT-NL-- 187
Query: 327 SYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK-Q 385
S +L+L N G +P LG+ +
Sbjct: 188 ---TSLEFLTL--------------------------ASNQLVGQIPR------ELGQMK 212
Query: 386 TVYAIVAGDNKLSGSFPGNMFGIC--NRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLD 443
++ I G N LSG P + G+ N LD V NN + G +P+ +G + K+L++L
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL----VYNN-LTGPIPSSLGNL-KNLQYLF 266
Query: 444 ASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS 503
N++ GPIP + L L++L+LS N + +IP + Q++ L+ L L NN TG IP
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
Query: 504 SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFN 563
+L L L+VL L SN SG IP +L NLTVL L+ N L+G+IP GL + L
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386
Query: 564 VSFNNLSGPLPSSKNLMKCSSV 585
+ N+L G +P K+L C S+
Sbjct: 387 LFSNSLEGEIP--KSLGACRSL 406
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-34
Identities = 132/503 (26%), Positives = 208/503 (41%), Gaps = 113/503 (22%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M +L+ + L N L+G +P L SL L+L +N +TG IP+S + NL+ L L N
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270
Query: 61 LVNGTVPTFIGRLKRVY---LSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
++G +P I L+++ LS N L G +P + + NLE L L N G IP +L
Sbjct: 271 KLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI-QLQNLEILHLFSNNFTGKIPVALT 329
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+ +++ L L+SN IP LG NL VLD+S N+L+G IP L + L L+L
Sbjct: 330 SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLIL-- 387
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
F N +LEG P
Sbjct: 388 ---------------------FSN----------------------------SLEGEIPK 398
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGEL-ARELPVPCMTMFD 296
+ GAC +L + L N FSG+ + FLD+S+N L G + +R+ +P + M
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLS 458
Query: 297 VSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGF 356
++ N G +P LSRN F P L ++ Q
Sbjct: 459 LARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK--LGSLSELMQL------------ 504
Query: 357 LAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNM--FGICNRLDS 414
N SG +P + ++L ++ N+LSG P + + ++LD
Sbjct: 505 -----KLSENKLSGEIPDELSSCKKL-----VSLDLSHNQLSGQIPASFSEMPVLSQLD- 553
Query: 415 LMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMH 474
+S N+++G++P +G + SLV +N+S N +H
Sbjct: 554 ----LSQNQLSGEIPKNLGN-------------------------VESLVQVNISHNHLH 584
Query: 475 DQIPTTLGQMKGLKYLSLAGNNL 497
+P+T G + ++AGN
Sbjct: 585 GSLPST-GAFLAINASAVAGNID 606
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGY 746
IG G FG Y S G L +K + + + E+K L +L HPN++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAV---DWRVLHKIALDIARALAYLHDQCVPR 803
+ ++ ++ Y GG+L I+++ + ++L + + AL YLH + +
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD-WFVQLCLALKYLHSR---K 123
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE------YAM 857
+LHRD+KP NI L + L DFG++++L + A T V GT Y++PE Y
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQNKPY-- 180
Query: 858 TCRVSDKADVYSYGVVLLELLSDKKA 883
+ K+D++S G VL EL + K
Sbjct: 181 ----NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 688 NCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGV--QQFHAEIKTLGRLRHPNLVTLI 744
IG G FG K S G ++ K + G QQ +E+ L L+HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY- 64
Query: 745 GYH----ASETEMFLIYNYLPGGNLENFIQ--QRSTRAVDWRVLHKIALDIARALAYLHD 798
Y S ++++ Y GG+L IQ ++ + ++ + +I + AL H+
Sbjct: 65 -YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 799 QCVP--RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
+ P VLHRD+KP+NI LD + N L DFGLA++LG + A T V GT Y++PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQL 182
Query: 857 MTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN 893
+K+D++S G ++ EL AL P F++
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELC----ALSPPFTARNQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 79/280 (28%), Positives = 120/280 (42%), Gaps = 19/280 (6%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAV-GRFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG P G VA+K L G Q F EI+ L L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 744 IG--YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
G + LI YLP G+L +++Q+ + ++ + L + I + + YL Q
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGSQ-- 128
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG---TFGYVAPEYAMT 858
R +HRD+ NIL++ + +SDFGLA++L + + G F Y APE T
Sbjct: 129 -RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186
Query: 859 CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918
+ S +DV+S+GV L EL + DPS S ++ + R E G
Sbjct: 187 SKFSSASDVWSFGVTLYELFT---YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
P EV L +C RP+ ++ + +L
Sbjct: 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-32
Identities = 102/313 (32%), Positives = 161/313 (51%), Gaps = 35/313 (11%)
Query: 272 LDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNP 330
+DLS ++G+++ + +P + ++S N LSG IP ++F + +
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIP--------------DDIFTT-SS 118
Query: 331 STAYLSLFAKKSQAGTPLPLRGRDGFLAIFH--NFGGNNFSGSLPSMPVAPERLGKQTVY 388
S YL+L + +P G + + N SG +P+ + L
Sbjct: 119 SLRYLNL--SNNNFTGSIP----RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLK----- 167
Query: 389 AIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQ 448
+ G N L G P ++ + L+ L +++N++ GQ+P E+G+M KSLK++ N
Sbjct: 168 VLDLGGNVLVGKIPNSLTNL-TSLEFL--TLASNQLVGQIPRELGQM-KSLKWIYLGYNN 223
Query: 449 IVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQL 508
+ G IP +G L SL L+L +N + IP++LG +K L+YL L N L+G IP S+ L
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 509 QLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNN 568
Q L LDLS NSLSG IP+ + L+NL +L L +N +GKIP L ++ L + N
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 569 LSGPLPSSKNLMK 581
SG +P KNL K
Sbjct: 344 FSGEIP--KNLGK 354
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 17/196 (8%)
Query: 689 CIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH 747
IG GGFG YKA G VAIK + + + ++ EI+ L + +HPN+V G +
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHK-----IALDIARALAYLHDQCVP 802
+ E++++ + GG+L++ ++ + L + + ++ + L YLH
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKST------NQTLTESQIAYVCKELLKGLEYLHSN--- 117
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
++HRD+K +NILL D L DFGL+ L S+T A + GT ++APE
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 863 DKADVYSYGVVLLELL 878
KAD++S G+ +EL
Sbjct: 176 YKADIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 7e-31
Identities = 79/284 (27%), Positives = 120/284 (42%), Gaps = 25/284 (8%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHP- 738
++ +G G FG Y A LVA+K LA + V++F EI+ L L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAV-DWRVLHKIALDIARALAYLH 797
N+V L + E ++L+ Y+ GG+LE+ +++ + I I AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 798 DQCVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHA-----TTGVAGTFGYV 851
+ ++HRD+KP NILLD D L DFGLA+LL + + + GT GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 852 APEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908
APE + S +D++S G+ L ELL+ P F N ++L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL----PPFEGEKNSSATSQTLKIILELP 231
Query: 909 RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952
+ L + P L R + +
Sbjct: 232 T--PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLA---VGRFQGVQQFHAEIKTLGRL-RHPNLVTLI 744
IG G F A E AIK L + + + V+ E + L RL HP ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
E ++ + Y P G L +I++ + A +I AL YLH + +
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YAAEILLALEYLHSK---GI 123
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA------------------- 845
+HRD+KP NILLD D + ++DFG A++L P+ + +
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDK 881
GT YV+PE +D+++ G ++ ++L+ K
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 689 CIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G FG + G VA+K L Q F AE + LRHPNLV L+G
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
++++ Y+ G+L ++++ R + ALD+ + YL ++ +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+ N+L+ +D A +SDFGLA+ + + APE + S K+DV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 869 SYGVVLLELLS 879
S+G++L E+ S
Sbjct: 184 SFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G G FG + G L A+K L + + + V+ E L R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+E +++L+ Y PGG L + + + + + A +I AL YLH ++
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLHSL---GII 115
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
+RD+KP NILLD D + L+DFGLA+ SE T GT Y+APE +
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174
Query: 866 DVYSYGVVLLELLSDK 881
D +S GV+L E+L+ K
Sbjct: 175 DWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPN 739
N+ + IG G FG YK + G VAIK++++ + + ++ EI L L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+V IG + +++I Y G+L I ++ + V + + + LAYLH+Q
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVY-QVLQGLAYLHEQ 118
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
V+HRD+K +NIL D L+DFG+A L + V GT ++APE
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMS 174
Query: 860 RVSDKADVYSYGVVLLELL 878
S +D++S G ++ELL
Sbjct: 175 GASTASDIWSLGCTVIELL 193
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 70/218 (32%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIK--RLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY 746
IG G FG Y A + G L+A+K R+ + +++ E+K L L+HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
++++ Y GG LE + R +D V+ L + LAYLH ++H
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVH 122
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG---YVAPEYAMTCRVSD 863
RD+KP+NI LD + L DFG A L + T V G Y+APE +
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 864 K---ADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIV 898
AD++S G V+LE+ + K +S N F I+
Sbjct: 183 HGRAADIWSLGCVVLEMATGK----RPWSELDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 689 CIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQ-GVQQFHA--EIKTLGRLRHPNLVTLI 744
+G G +G YKA + G +VA+K++ + + G+ A EI L L+HPN+V L+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS-TALREISLLKELKHPNIVKLL 64
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+E +++L++ Y +L+ ++ +R + ++ I + R LAY H R+
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RI 119
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
LHRD+KP NIL++ D L+DFGLAR G T V T Y APE + +
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYST 178
Query: 865 A-DVYSYGVVLLELLSDKKAL 884
A D++S G + E+++ K L
Sbjct: 179 AVDIWSVGCIFAEMIT-GKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
IG G +G YKA + G +VAIK++ + A EIK L L HPN++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ +++L++ ++ +L I+ R R + ++ + + LA+ H +LH
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILH 121
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA- 865
RD+KP N+L++ + L+DFGLAR G T V T Y APE + +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTPV 180
Query: 866 DVYSYGVVLLELLS 879
D++S G + ELLS
Sbjct: 181 DIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 17/197 (8%)
Query: 689 CIGNGGFGATYKAEISP-GVLVAIKRLAV-GRFQGVQQFHAEIKTLGRLRHPNLVTLIGY 746
+G G G YK P G + A+K++ V G + +Q E+KTL P +V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
E E+ ++ Y+ GG+L + + + + VL IA I + L YLH + ++H
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIH 123
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV----- 861
RD+KPSN+L++ ++DFG++++L + T V GT Y++PE R+
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE-----RIQGESY 177
Query: 862 SDKADVYSYGVVLLELL 878
S AD++S G+ LLE
Sbjct: 178 SYAADIWSLGLTLLECA 194
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 21/199 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
IG G G +KA + G VA+K++A+ R +G A EIK L +HP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 747 HASETEMFLIYNYLPGG------NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
+ L+ Y+P + E + + + + + +AY+H
Sbjct: 68 FPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVK--------SYMRMLLKGVAYMHAN- 118
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
++HRD+KP+N+L+ D ++DFGLARL E + T Y APE R
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 861 VSDKA-DVYSYGVVLLELL 878
D D+++ G + ELL
Sbjct: 177 KYDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIK---RLAVGRFQGVQQFHAEIKTLGRLRHP 738
+F IG G FG + + A+K + V+ E + L L HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
LV L E M+L+ + L GG+L + Q+ + +I AL YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS 118
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+ ++HRD+KP NILLD+ + +++DF +A + P TT +GT GY+APE
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCR 173
Query: 859 CRVSDKADVYSYGVVLLELLSDKK 882
S D +S GV E L K+
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 57/190 (30%), Positives = 100/190 (52%), Gaps = 4/190 (2%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G G FG ++ + VA+K L G + F AE + + +LRHP L+ L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
E ++++ + G+L ++Q + RA+ L +A +A +AYL Q +HRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDL 129
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYS 869
N+L+ ++ ++DFGLAR++ A G + APE A+ R S K+DV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 870 YGVVLLELLS 879
+G++L E+++
Sbjct: 190 FGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 61/193 (31%), Positives = 99/193 (51%), Gaps = 13/193 (6%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G YKA + + G VAIK++ + + Q + EI + +HPN+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIA---LDIARALAYLHDQCVPRVL 805
E++++ Y+ GG+L + I Q R + +IA ++ + L YLH Q V+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNE----PQIAYVCREVLQGLEYLHSQ---NVI 138
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
HRD+K NILL D + L+DFG A L ++ + V GT ++APE K
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRKDYGPKV 197
Query: 866 DVYSYGVVLLELL 878
D++S G++ +E+
Sbjct: 198 DIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 66/198 (33%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 690 IGNGGFGAT----YKAEISPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLI 744
+G+G FG+ Y + V VA+K L G ++F E + +L HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAV-DWRVLHKIALDIARALAYLHDQCVPR 803
G E M L+ P G L ++++R V D + L A +A +AYL +
Sbjct: 63 GVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKEL---AHQVAMGMAYLESK---H 115
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH--ATTGVAGTFGYVAPEYAMTCRV 861
+HRD+ N+LL + A +SDFG++R LG + ATT + APE +
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 862 SDKADVYSYGVVLLELLS 879
S K+DV+SYGV L E S
Sbjct: 176 SSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 60/191 (31%), Positives = 99/191 (51%), Gaps = 10/191 (5%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA- 748
+G G FG + + VA+K L G + F E + + +LRH LV L +A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQL---YAV 69
Query: 749 -SETE-MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
SE E ++++ Y+ G+L +F++ + + L +A IA +AYL + +H
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
RD+ NIL+ ++ ++DFGLARL+ E A G + APE A R + K+D
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 867 VYSYGVVLLEL 877
V+S+G++L E+
Sbjct: 187 VWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 4/196 (2%)
Query: 684 FNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTL 743
F +G+G FG ++ V VAIK L Q F E++ L RLRH +L++L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+ +++I + G+L F++ + + L +A +A +AYL +Q
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
+HRD+ NIL+ +D ++DFGLARL+ + + ++ + + APE A S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 864 KADVYSYGVVLLELLS 879
K+DV+S+G++L E+ +
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQ---FHA--EIKTLGRLRHPNLVTL 743
+G G + YKA G +VAIK++ +G + + F A EIK L L+HPN++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHK-IALDIARALAYLHDQCVP 802
+ ++ + L++ ++ +LE I+ +S + K L R L YLH
Sbjct: 68 LDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADI--KSYMLMTLRGLEYLHSN--- 121
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV- 861
+LHRD+KP+N+L+ D L+DFGLAR G T V T Y APE R
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARHY 180
Query: 862 SDKADVYSYGVVLLELL 878
D++S G + ELL
Sbjct: 181 GVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 5/201 (2%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+GNG FG + + VA+K L G + F E + + +LRH LV L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAV-VS 71
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
E ++++ Y+ G+L +F++ RA+ L +A +A +AY+ +HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 128
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYS 869
+ +NIL+ D ++DFGLARL+ +E A G + APE A+ R + K+DV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 870 YGVVLLELLSDKKALDPSFSS 890
+G++L EL++ + P ++
Sbjct: 189 FGILLTELVTKGRVPYPGMNN 209
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 81/287 (28%), Positives = 131/287 (45%), Gaps = 31/287 (10%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G FG+ P G +VA+K+L + ++ F EI+ L L+H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 745 G--YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
G Y A + L+ YLP G+L +++Q+ R +D R L A I + + YL +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER-LDHRKLLLYASQICKGMEYLGSK--- 127
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT---GVAGTFGYVAPEYAMTC 859
R +HRD+ NIL++ + + DFGL ++L + + G + F Y APE
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTES 186
Query: 860 RVSDKADVYSYGVVLLELL--SDKKALDPS--FSSYGN---GFNIVAWGCMLLRQGRAKE 912
+ S +DV+S+GVVL EL SDK P+ GN G IV LL+
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL- 245
Query: 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
P E+ + C + S RP+ ++ +++ ++
Sbjct: 246 --------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 11/198 (5%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAV--GRFQGVQQFHAEIKTLGRLRHPNLVTLIGY 746
IG G +G YKA G LVA+K++ + + EIK L +LRHPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 747 HASE--TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
S+ +++++ Y+ +L + + + ++ + L YLH +
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC-YMKQLLEGLQYLHSN---GI 121
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
LHRD+K SNIL+++D L+DFGLAR + T T Y PE +
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGP 181
Query: 865 A-DVYSYGVVLLELLSDK 881
D++S G +L EL K
Sbjct: 182 EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 8/208 (3%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIGYH 747
+G G G K P G ++A+K + + + +Q Q E+ L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
+ ++ + Y+ GG+L+ +++ R + R+L KIA+ + + L YLH++ +++HR
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEKH--KIIHR 125
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
DVKPSNIL++ L DFG++ L + A T V GT Y+APE S K+D+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182
Query: 868 YSYGVVLLELLSDKKALDPSFSSYGNGF 895
+S G+ L+EL + + P F
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIF 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 7/201 (3%)
Query: 690 IGNGGFG-ATYKAEISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
+G G FG AT LV K + + R ++ A EI L L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ + + Y GG L + I ++ + + ++ I A++Y+H +LH
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILH 124
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
RD+K NI L L DFG++++LG + A T V GT Y++PE + + K+D
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKSD 183
Query: 867 VYSYGVVLLELLSDKKALDPS 887
+++ G VL ELL+ K+ D +
Sbjct: 184 IWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 7/201 (3%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G+G FG + + + VAIK + G F E K + +L HPNLV L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTR-AVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+ +F++ Y+ G L N++++R + +W L + D+ A+ YL +HRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNGF---IHRD 125
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+ N L+ +D +SDFGLAR + + ++ G + PE R S K+DV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 869 SYGVVLLELLSDKKALDPSFS 889
S+GV++ E+ S+ K FS
Sbjct: 186 SFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 54/190 (28%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 689 CIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G +G+ YKA G +VAIK + V + +Q+ EI L + P +V G +
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
T+++++ Y G++ + ++ + + + + I + L YLH + +HR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHR 123
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
D+K NILL+++ A L+DFG++ L + T V GT ++APE ++KAD+
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKADI 182
Query: 868 YSYGVVLLEL 877
+S G+ +E+
Sbjct: 183 WSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 9e-23
Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
IG G FGA + E + G VA+K + Q F E + +L H NLV L+G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGV-IL 69
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
++++ + GNL NF++ R V L + +LD+A + YL + +++HRD+
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDL 126
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYS 869
NIL+ +D A +SDFGLAR+ + + APE + S K+DV+S
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182
Query: 870 YGVVLLELLSDKKALDPSFS 889
YGV+L E+ S +A P S
Sbjct: 183 YGVLLWEVFSYGRAPYPKMS 202
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 26/228 (11%)
Query: 681 TGNFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGV-----QQFHAEIKTLGR 734
GNF IG G F YKA G +VA+K++ + F+ + Q EI L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQI--FEMMDAKARQDCLKEIDLLKQ 58
Query: 735 LRHPNLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQ--QRSTRAVDWRVLHKIALDI 789
L HPN+ I Y AS E+ ++ G+L I+ ++ R + R + K + +
Sbjct: 59 LDHPNV---IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 790 ARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG 849
AL ++H + R++HRD+KP+N+ + L D GL R S+T A + GT
Sbjct: 116 CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPY 171
Query: 850 YVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNI 897
Y++PE + K+D++S G +L E+ AL F YG+ N+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPF--YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 5/197 (2%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G G FG + + VAIK L G + F E + + +LRH LV L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 71
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
E ++++ Y+ G+L +F++ + + L +A IA +AY+ +HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 128
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYS 869
+ +NIL+ ++ ++DFGLARL+ +E A G + APE A+ R + K+DV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 870 YGVVLLELLSDKKALDP 886
+G++L EL + + P
Sbjct: 189 FGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 55/192 (28%), Positives = 98/192 (51%), Gaps = 6/192 (3%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGV-QQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G FG YK + VA+K + ++F E + L + HPN+V LIG
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+ ++++ +PGG+L F++++ R + + L +++LD A + YL + +HRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYVAPEYAMTCRVSDKADV 867
+ N L+ ++ +SDFG++R + G+ + APE R + ++DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 868 YSYGVVLLELLS 879
+SYG++L E S
Sbjct: 179 WSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 56/210 (26%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG----------VQQFHAEIKTLGRLRHP 738
IG G +G Y A ++ G ++A+K++ + V+ +EI+TL L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
N+V +G+ +E + + Y+PGG++ + + R+ + +++ + LAYLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE----THATTGVAGTFGYVAPE 854
+ +LHRD+K N+L+D D +SDFG+++ S+ + G+ ++APE
Sbjct: 127 K---GILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 855 YAMTCR--VSDKADVYSYGVVLLELLSDKK 882
+ S K D++S G V+LE+ + ++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 12/202 (5%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAV-GRFQGVQQFHA-EIKTLGRLRHPNLVTLIGY 746
IG G +G YKA + G +VA+K++ + +GV EI L L HPN+V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
SE +++L++ +L +L+ ++ +D ++ + + +AY H RVLH
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLH 122
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAMTCR-VSDK 864
RD+KP N+L+D + L+DFGLAR G P T+ V T Y APE + R S
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQYSTP 180
Query: 865 ADVYSYGVVLLELLSDKKALDP 886
D++S G + E+++ ++ L P
Sbjct: 181 VDIWSIGCIFAEMVN-RRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 70/220 (31%), Positives = 112/220 (50%), Gaps = 12/220 (5%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVG-RFQGVQQFHA-EIKTLGRLRHPN 739
NF IG G +G YKA G +VA+K++ + +GV EI L L HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+V L+ +E +++L++ +L +L+ F+ + ++ + + LA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAMT 858
RVLHRD+KP N+L++ + L+DFGLAR G P T+ V T Y APE +
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 174
Query: 859 CRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNI 897
C+ S D++S G + E+++ ++AL P S F I
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-22
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 9/207 (4%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPN 739
+ +G G FG + + LV IK++ V + ++ A E + L L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
++ + + ++ Y PGG L +IQ+R +D + + I AL ++H +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 800 CVPRVLHRDVKPSNILLDDDFNAY-LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+LHRD+K NILLD + DFG++++L S++ A T V GT Y++PE
Sbjct: 121 ---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT-VVGTPCYISPELCEG 175
Query: 859 CRVSDKADVYSYGVVLLELLSDKKALD 885
+ K+D+++ G VL EL S K+A +
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRF-----QGVQQFHAEIKTLGRLRHPNLVTL 743
+G+G FG+ Y+ + G A+K +++ + V+Q EI L +L+HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+G E +++ +PGG+L +++ + V+ I L YLHD+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---N 122
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
+HRD+K +NIL+D + L+DFG+A+ + E G+ ++APE
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 864 -KADVYSYGVVLLELLSDKKALDPSFSSY 891
AD++S G +LE+ + K P +S
Sbjct: 181 LAADIWSLGCTVLEMATGK----PPWSQL 205
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 690 IGNGGFGATYKAE-ISPG---VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTLI 744
+G+G FG + E + G + VA+K L + + F E + L H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G + M ++ P G+L + +++ + L A+ IA + YL + R
Sbjct: 63 GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RF 118
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT--FGYVAPEYAMTCRVS 862
+HRD+ NILL D + DFGL R L +E H F + APE T S
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 863 DKADVYSYGVVLLELLS 879
+DV+ +GV L E+ +
Sbjct: 179 HASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 690 IGNGGFGATYKAEIS----PGVLVAIKRLAVGRFQGVQQ--FHAEIKTLGRLRHPNLVTL 743
IG G FG + + + VAIK L G Q+ F E +G+ HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
G + +I Y+ G+L+ F+++ + L + IA + YL +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT-VGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE-THATTGVAGTFGYVAPEYAMTCRV- 861
+HRD+ NIL++ + +SDFGL+R L SE T+ T G + APE A+ R
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE-AIAYRKF 185
Query: 862 SDKADVYSYGVVLLELLS 879
+ +DV+S+G+V+ E++S
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 5/197 (2%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G G FG + + VAIK L G + F E + + +LRH LV L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAV-VS 71
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
E ++++ ++ G+L +F+++ + + L +A IA +AY+ +HRD+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDL 128
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYS 869
+ +NIL+ D+ ++DFGLARL+ +E A G + APE A+ R + K+DV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 870 YGVVLLELLSDKKALDP 886
+G++L EL++ + P
Sbjct: 189 FGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRF-----QGVQQFHAEIKTLGRLR 736
N+ +G G FG Y ++ G +A+K++ + V EI+ L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
H +V G + + + Y+PGG++++ ++ A+ V K I + YL
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYL 120
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT--TGVAGTFGYVAPE 854
H ++HRD+K +NIL D N L DFG ++ L + T V GT +++PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 855 YAMTCRVSDKADVYSYGVVLLELLSDK 881
KADV+S G ++E+L++K
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 59/192 (30%), Positives = 101/192 (52%), Gaps = 9/192 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG+G +G YKA +I+ G LVAIK + + + EI L RHPN+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+++++ Y GG+L++ I Q + + + + + + LAYLH+ +HRD
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRD 126
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA---MTCRVSDKA 865
+K +NILL +D + L+DFG++ L + + + GT ++APE A K
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGKC 185
Query: 866 DVYSYGVVLLEL 877
D+++ G+ +EL
Sbjct: 186 DIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 7/206 (3%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPN 739
+F N IG G FG +K + + A+K++ + + ++ A E + L +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
++ + ++ ++ Y G+L ++ + R + + + + I LA+LH +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
++LHRD+K N+ LD N + D G+A+LL + A T + GT Y++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDK 176
Query: 860 RVSDKADVYSYGVVLLELLSDKKALD 885
++K+DV++ GVVL E + K D
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
IG+G FG + VAIK + G + F E + + +L HP LV L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRA-VDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+ + L++ ++ G L +++ R+ R L + LD+ +AYL V +HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSNV---IHRD 125
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+ N L+ ++ +SDFG+ R + + ++TG + +PE + S K+DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 869 SYGVVLLELLSDKK 882
S+GV++ E+ S+ K
Sbjct: 186 SFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G+G FG YKA+ G+ A K + + + ++ F EI L +HPN+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E +++++ + GG L++ I R + + + + AL +LH +V+HRD
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 809 VKPSNILLDDDFNAYLSDFGL-ARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD---- 863
+K NILL D + L+DFG+ A+ + T GT ++APE D
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186
Query: 864 -KADVYSYGVVLLEL 877
KAD++S G+ L+EL
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 689 CIGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQGV-QQFHAEIKTLGRLRHPNLVTL 743
CIG G FG Y + + + VA+K V ++F E + + HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
IG +E ++++ P G L +++Q +D L + ++ ALAYL + R
Sbjct: 73 IGV-ITENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLESK---R 127
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
+HRD+ N+L+ L DFGL+R L + + ++APE R +
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 864 KADVYSYGVVLLELLS 879
+DV+ +GV + E+L
Sbjct: 188 ASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G G FG + VAIK + G +F E K + +L H LV L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
+ ++++ Y+ G L N++++ R ++L ++ D+ +AYL + + +HRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLESK---QFIHRDL 126
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYS 869
N L+DD +SDFGL+R + E ++ G + PE + + S K+DV++
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 870 YGVVLLELLS 879
+GV++ E+ S
Sbjct: 187 FGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 8e-21
Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 9/194 (4%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G GGFG ++ + G + A K+L R +G Q E K L ++ +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
++ ++ L+ + GG+L+ I A I L +LH + R++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
+RD+KP N+LLDD N +SD GLA L G AGT GY+APE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 866 DVYSYGVVLLELLS 879
D ++ G L E+++
Sbjct: 176 DWFALGCTLYEMIA 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
IG G FG + G VA+K + Q F AE + +LRH NLV L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 750 E-TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E ++++ Y+ G+L ++++ R + L K +LD+ A+ YL +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRD 127
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+ N+L+ +D A +SDFGL + ++ V T APE + S K+DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 869 SYGVVLLELLS 879
S+G++L E+ S
Sbjct: 184 SFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYH 747
IG G Y A P VAIKR+ + + Q V + E++ + + HPN+V Y+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---KYY 65
Query: 748 AS---ETEMFLIYNYLPGGNLENFIQQRSTRAV-DWRVLHKIALDIARALAYLHDQCVPR 803
S E++L+ YL GG+L + ++ R D ++ + ++ + L YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLL---GPSETHATTGVAGTFGYVAPEYAMTCR 860
+HRD+K NILL +D + ++DFG++ L G GT ++APE M
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQV 181
Query: 861 V--SDKADVYSYGVVLLEL 877
KAD++S+G+ +EL
Sbjct: 182 HGYDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 690 IGNGGFGATYKAE-ISPG----VLVAIKRL--AVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
+G+G FG YK I G + VAIK L + ++ E + + HP++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-KANKEILDEAYVMASVDHPHVVR 73
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L+G S LI +P G L ++++ + + L + IA+ ++YL ++
Sbjct: 74 LLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYLEEK--- 128
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET--HATTGVAGTFGYVAPEYAMTCR 860
R++HRD+ N+L+ + ++DFGLA+LL E HA G ++A E +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-PIKWMALESILHRI 187
Query: 861 VSDKADVYSYGVVLLELLS 879
+ K+DV+SYGV + EL++
Sbjct: 188 YTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHPNL 740
+G G FG YK E+ VAIK L A + Q Q+F E + + L+HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIA 786
V L+G E +++ YL G+L F+ + S ++D IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG 846
+ IA + YL +HRD+ N L+ + +SDFGL+R + ++ + +
Sbjct: 131 IQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 847 -TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
++ PE + + + ++D++S+GVVL E+ S
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 684 FNASNCIGNGGFGATYKA-EISPGVLVAIKRL----AVGRFQGVQQFHAEIKTLGRLRHP 738
F CIG G FG YKA + +VAIK + A + +QQ EI+ L + R P
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ---EIQFLSQCRSP 59
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
+ G +++++I Y GG+ + ++ +D + I ++ L YLH+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK---PGKLDETYIAFILREVLLGLEYLHE 116
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+ +HRD+K +NILL ++ + L+DFG++ L + + T V GT ++APE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQ 172
Query: 859 CRVSDKADVYSYGVVLLELL 878
+KAD++S G+ +EL
Sbjct: 173 SGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-20
Identities = 55/191 (28%), Positives = 101/191 (52%), Gaps = 5/191 (2%)
Query: 688 NCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY 746
+ +G G +G Y+ + VA+K L + V++F E + ++HPNLV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
E ++I ++ GNL +++++ + + V+ VL +A I+ A+ YL + +H
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
RD+ N L+ ++ ++DFGL+RL+ A G + APE + S K+D
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 867 VYSYGVVLLEL 877
V+++GV+L E+
Sbjct: 188 VWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 37/223 (16%)
Query: 690 IGNGGFGATYKAEI--SPGVLVAIKRLAV----------GRFQGVQQFHAEIKTLG-RLR 736
+G+G FG YK + L+A+K + V R + + +E+ + +LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 737 HPNLVTLIGYHASETE---MFLIYNYLPGGNL-ENFI-----QQRSTRAVDWRVLHKIAL 787
HPN+V Y+ + E ++++ + + G L E+F +QR T W I +
Sbjct: 68 HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW----NIFV 120
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT 847
+ AL YLH + R++HRD+ P+NI+L +D ++DFGLA+ P T V GT
Sbjct: 121 QMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGT 176
Query: 848 FGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS 890
Y PE +KADV+++G +L ++ L P F S
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMC----TLQPPFYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 690 IGNGGFG-ATYKAEISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
IG G FG A G IK + + + ++ + E+ L ++HPN+V Y
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ---Y 64
Query: 747 HASETE---MFLIYNYLPGGNLENFIQQR------STRAVDWRVLHKIALDIARALAYLH 797
S E ++++ +Y GG+L I + + +DW V I AL ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV------QICLALKHVH 118
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
D+ ++LHRD+K NI L D L DFG+AR+L + A T + GT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICE 174
Query: 858 TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIV 898
++K+D+++ G VL E+ + K A + GN N+V
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEA-----GNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-20
Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 22/225 (9%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRH 737
NF IG G F Y+A + GV VA+K++ + + EI L +L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 738 PNLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQ--QRSTRAVDWRVLHKIALDIARA 792
PN+ I Y+AS + E+ ++ G+L I+ ++ R + + + K + + A
Sbjct: 62 PNV---IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
L ++H + RV+HRD+KP+N+ + L D GL R S+T A + GT Y++
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174
Query: 853 PEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNI 897
PE + K+D++S G +L E+ AL F YG+ N+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM----AALQSPF--YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPN 739
+F +G G +G+ YK + +S A+K + +G ++ A EI+ L + HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 740 LVTLIGYHASETEMFLIYN-------YLPGGNLENFIQQRST--RAVDWRVLHKIALDIA 790
+ I Y E FL N Y P G+L I +R + + + + +I + +
Sbjct: 61 I---ISYK----EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY 850
R L LH+Q ++LHRD+K +NILL + + D G++++L + A T GT Y
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKT-QIGTPHY 167
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELLS 879
+APE S K+D++S G +L E+ +
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPN 739
F N IG G +G Y+A + + G +VA+K++ + + + EI L LRHPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 740 LVTL----IGYHASETEMFLIYNYLP---GGNLENFIQQRSTRAVDWRVLHKIALDIARA 792
+V L +G H +FL+ Y L+N S V + L + R
Sbjct: 68 IVELKEVVVGKHL--DSIFLVMEYCEQDLASLLDNMPTPFSESQVK-----CLMLQLLRG 120
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
L YLH+ + +HRD+K SN+LL D ++DFGLAR G T V T Y A
Sbjct: 121 LQYLHENFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRA 176
Query: 853 PEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
PE + C A D+++ G +L ELL+ K
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-20
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFH---AEIKTLGRLRHPNLVTLIG 745
IG+G FGA Y A ++ +VAIK+++ Q +++ E++ L +LRHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHK----------IALDIARALAY 795
+ E +L+ Y G A D +HK I + LAY
Sbjct: 83 CYLREHTAWLVMEYCLGS------------ASDILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE- 854
LH +HRD+K NILL + L+DFG A L+ P+ + GT ++APE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEV 182
Query: 855 -YAM-TCRVSDKADVYSYGVVLLELLSDKKAL 884
AM + K DV+S G+ +EL K L
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 9e-20
Identities = 55/190 (28%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G Y A +++ G VAIK++ + + + EI + +HPN+V + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E++++ YL GG+L + + + +D + + + +AL +LH +V+HRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 140
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K NILL D + L+DFG + P ++ +T V GT ++APE K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 869 SYGVVLLELL 878
S G++ +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA-------EIKTLGRLRHPNLV 741
+G G +G K + G +VAIK+ F+ + E+K L +LRH N+V
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKK-----FKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
L + ++L++ Y+ LE + S + + + +A+AY H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLELL--EASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLL-GPSETHATTGVAGTFGYVAPEYAMTCR 860
++HRD+KP NIL+ + L DFG AR L + T VA T Y APE +
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDT 177
Query: 861 VSDKA-DVYSYGVVLLELLS 879
K DV++ G ++ ELL
Sbjct: 178 NYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 65/198 (32%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
IG G +G +K G +VAIK+ V + A EI+ L +L+HPNLV LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ ++ L++ Y L +++ R V ++ KI +A+ + H +H
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIH 123
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA- 865
RDVKP NIL+ L DFG AR+L T VA T Y APE V D
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELL----VGDTQY 178
Query: 866 ----DVYSYGVVLLELLS 879
DV++ G V ELL+
Sbjct: 179 GPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 689 CIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--------EIKTLGRL-RHP 738
+G+G FG+ Y A G LVAIK++ ++F++ E+K+L +L HP
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
N+V L E++ ++ Y+ G NL ++ R + V+ I I + LA++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
HRD+KP N+L+ ++DFGLAR + + T V T Y APE +
Sbjct: 118 H---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLR 172
Query: 859 CRV-SDKADVYSYGVVLLELLS 879
S D+++ G ++ EL +
Sbjct: 173 STSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 6/201 (2%)
Query: 683 NFNASNCIGNGGFG-ATYKAEISPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNL 740
+N +G G FG A ++ A+K + + + V+ E L +++HPN+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
V ++ ++++ Y GG+L I+ + + + + + + + ++H++
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK- 119
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
RVLHRD+K NI L + L DFG ARLL +A T V GT YV PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 861 VSDKADVYSYGVVLLELLSDK 881
++K+D++S G +L EL + K
Sbjct: 177 YNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFH---AEIKTLGRLRHPNLVTLIG 745
I G +G + A+ S G + AIK + Q E L + + P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ ++L+ YLPGG+L + + + ++D V +I AL YLH ++
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSN---GII 115
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLAR-------LLGPSETHATTGVAGTFGYVAPEYAMT 858
HRD+KP NIL+D + + L+DFGL++ + + + GT Y+APE +
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 859 CRVSDKADVYSYGVVLLELLS 879
S D +S G +L E L
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 683 NFNASNCIGNGGFGATY----KAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHP 738
+ IG G FG Y K++ V+ I L + + E+ L +++HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEID-LTKMPVKEKEASKKEVILLAKMKHP 59
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQ-QRSTRAVDWRVLHKIALDIARALAYLH 797
N+VT +F++ Y GG+L I QR + ++L + I+ L ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF-VQISLGLKHIH 118
Query: 798 DQCVPRVLHRDVKPSNILLDDD-FNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
D+ ++LHRD+K NI L + A L DFG+AR L S A T GT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEIC 174
Query: 857 MTCRVSDKADVYSYGVVLLELLSDK 881
++K D++S G VL EL + K
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 690 IGNGGFGATYKAEIS-PG---VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTLI 744
IG G FG ++ + PG V VAIK L G + +Q F +E +G+ H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL--DIARALAYLHDQCVP 802
G +I Y+ G L+ +++ ++ + + IA + YL D
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDM--- 126
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLL--GPSETHATTGVAGTFGYVAPEYAMTCR 860
+HRD+ NIL++ + +SDFGL+R+L P T+ T+G + APE +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 861 VSDKADVYSYGVVLLELLS 879
+ +DV+S+G+V+ E++S
Sbjct: 187 FTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 4/201 (1%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G G FG + + VA+K L G VQ F E + L+H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
E +++I Y+ G+L +F++ V L + IA +AY+ + +HRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 129
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYS 869
+ +N+L+ + ++DFGLAR++ +E A G + APE + K+DV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 870 YGVVLLELLSDKKALDPSFSS 890
+G++L E+++ K P S+
Sbjct: 190 FGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-19
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 16/213 (7%)
Query: 674 FESVVQATGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG---VQQFHAEI 729
F +V + T + +G G FG A + G VAIK++ + F ++ + E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYREL 60
Query: 730 KTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDI 789
K L LRH N+++L S E L G +L + +R ++ + + I
Sbjct: 61 KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT---SRPLEKQFIQYFLYQI 117
Query: 790 ARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG 849
R L Y+H V+HRD+KPSNIL++++ + + DFGLAR+ + TG T
Sbjct: 118 LRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY 170
Query: 850 YVAPEYAMTCRVSD-KADVYSYGVVLLELLSDK 881
Y APE +T + D + D++S G + E+L K
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 15/202 (7%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLA---VGRFQGVQQFHAEIKTLGRLRHP 738
+ +G G FG + + A+K +A V R + Q H E + L + HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
++ L + ++++ Y+PGG L F R++ A +I AL YLH
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+ +++RD+KP NILLD + + L+DFG A+ L T + GT Y+APE +
Sbjct: 120 K---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAPE-VIQ 171
Query: 859 CRVSDKA-DVYSYGVVLLELLS 879
+ +KA D ++ G+++ E+L
Sbjct: 172 SKGHNKAVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 690 IGNGGFGATYKAEISPGVL-------VAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLV 741
IG G FG ++A +PG+L VA+K L +Q F E + HPN+V
Sbjct: 13 IGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAV------------------DWRVLH 783
L+G A M L++ Y+ G+L F++ RS RA
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 784 K--IALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-A 840
+ IA +A +AYL ++ + +HRD+ N L+ ++ ++DFGL+R + ++ + A
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFS 889
+ A ++ PE R + ++DV++YGVVL E+ S + P +
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--YGMQPYYG 235
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 28/209 (13%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG------VQQFHAEIKTLGRLRHPNLVT 742
+G G F + Y+A ++ G L+A+K++ R V+ EI+ + RL HP+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
++G ++ L ++ GG++ + + + A V+ + R L+YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN--- 122
Query: 803 RVLHRDVKPSNILLDDD-FNAYLSDFGLARLLGPSETHA---TTGVAGTFGYVAPE---- 854
+++HRDVK +N+L+D ++DFG A L T A + GT ++APE
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 855 --YAMTCRVSDKADVYSYGVVLLELLSDK 881
Y +C DV+S G V++E+ + K
Sbjct: 183 EQYGRSC------DVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 66/198 (33%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRF-QGVQQFHA-EIKTLGRLRHPNLVTLIGY 746
IG G +G YKA + +A+K++ + + +GV EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
SE ++L++ YL +L+ + A + R++ I R +AY H RVLH
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLH 125
Query: 807 RDVKPSNILLDDDFNAY-LSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAM-TCRVSD 863
RD+KP N+L+D NA L+DFGLAR G P T V T Y APE + + S
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGSRHYST 183
Query: 864 KADVYSYGVVLLELLSDK 881
D++S G + E+++ K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 690 IGNGGFGATYKAEIS-PG---VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTLI 744
IG G FG + PG + VAIK L G + ++ F +E +G+ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL--DIARALAYLHDQCVP 802
G + ++ Y+ G+L+ F+++ + + V+ + + IA + YL D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ---FTVIQLVGMLRGIASGMKYLSDM--- 125
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLL--GPSETHATTGVAGTFGYVAPEYAMTCR 860
+HRD+ NIL++ + +SDFGL+R+L P + T G + APE +
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 861 VSDKADVYSYGVVLLELLS 879
+ +DV+SYG+V+ E++S
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIGYHA 748
+G G FG +K + VA+K Q ++ +F +E + L + HPN+V LIG
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
++++ +PGG+ +F++++ + + L K ALD A +AYL + +HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESK---NCIHRD 118
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG-------YVAPEYAMTCRV 861
+ N L+ ++ +SDFG++R G+ + G + APE R
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 862 SDKADVYSYGVVLLELLS 879
S ++DV+SYG++L E S
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-18
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGR-FQGVQQFHA-----EIKTLGRLRHPNLVT 742
IG+G +G A G VAIK+ + F + A EIK L LRH N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKK--ISNVFDDL--IDAKRILREIKLLRHLRHENIIG 63
Query: 743 L---IGYHASET--EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH--KIALDIARALAY 795
L + + E +++++ + +L I+ D H I R L Y
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDD----HIQYFLYQILRGLKY 118
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA---TTGVAGTFGYVA 852
LH V+HRD+KPSNIL++ + + + DFGLAR + P E T V T Y A
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRA 174
Query: 853 PEYAMTCRVSDKA-DVYSYGVVLLELL 878
PE ++ KA D++S G + ELL
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 22/199 (11%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIG-- 745
+G G G+ K + G++ A+K + +Q Q E++ + P +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 746 YHASETEMFLIYNYLPGGNLENF---IQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
S + + + Y GG+L++ +++R R + +VL KIA + + L+YLH +
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHSR--- 124
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG----YVAPEYAMT 858
+++HRD+KPSNILL L DFG++ L S +AGTF Y+APE
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-------LAGTFTGTSFYMAPERIQG 177
Query: 859 CRVSDKADVYSYGVVLLEL 877
S +DV+S G+ LLE+
Sbjct: 178 KPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 76/280 (27%), Positives = 115/280 (41%), Gaps = 21/280 (7%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG P G +VA+K L Q + EI L L H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 744 IG--YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
G + LI Y+P G+L +++ + ++ L A I +AYLH Q
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQ-- 126
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH---ATTGVAGTFGYVAPEYAMT 858
+HRD+ N+LLD+D + DFGLA+ + + G + F Y A E
Sbjct: 127 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKE 184
Query: 859 CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918
+ S +DV+S+GV L ELL+ D S ++ + R E G+
Sbjct: 185 NKFSYASDVWSFGVTLYELLTH---CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
P + EV L C RPT + ++ LK++
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 684 FNASNCIGNGGFGATYKA---EISPGVLVAIKRL--AVGRFQGVQQFHA-EIKTLGRLRH 737
+ CIG G +G YKA G AIK+ ++ G+ Q EI L L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 738 PNLVTLIGYHASETEM--FLIYNY----LPGGNLENFIQQRSTRAVDWRVLHKIALDIAR 791
N+V+L+ + +L+++Y L + F +Q ++ ++ + I
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDL--WQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAY----LSDFGLARLL-GPSETHAT-TGVA 845
+ YLH V LHRD+KP+NIL+ + + D GLARL P + A V
Sbjct: 120 GVHYLHSNWV---LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 846 GTFGYVAPEYAMTCRVSDKA-DVYSYGVVLLELLSDKKALDPSF 888
T Y APE + R KA D+++ G + ELL+ L+P F
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT----LEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G+G FG + + + VAIK + G + F E K + +L HP LV L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
+ ++++ ++ G L N+++QR + + +L + D+ + YL +HRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SFIHRDL 126
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYS 869
N L+ +SDFG+ R + E +++G + PE + S K+DV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 870 YGVVLLELLSDKKALDPSFSSYGN 893
+GV++ E+ ++ K F N
Sbjct: 187 FGVLMWEVFTEGKM---PFEKKSN 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAV-GRFQGVQQFHA-EIKTLGRLRHPNLVTLIGY 746
IG G +G YK G +VA+K++ + +GV EI L L+HPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 747 HASETEMFLIYNYLPGGNLENFIQQ-RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
E+ ++LI+ +L +L+ ++ + +D ++ I + + + H + RVL
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVL 123
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLG-PSE--THATTGVAGTFGYVAPEYAM-TCRV 861
HRD+KP N+L+D+ L+DFGLAR G P TH T Y APE + + R
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAPEVLLGSPRY 179
Query: 862 SDKADVYSYGVVLLELLSDK 881
S D++S G + E+ + K
Sbjct: 180 STPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 57/192 (29%), Positives = 100/192 (52%), Gaps = 9/192 (4%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G G FG + + VAIK L G + F AE + +L+HP LV L +A
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRL---YAV 69
Query: 750 ETE--MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
T+ +++I Y+ G+L +F++ + L +A IA +A++ + +HR
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
D++ +NIL+ + ++DFGLARL+ +E A G + APE + K+DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 868 YSYGVVLLELLS 879
+S+G++L E+++
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLRHPNLVTLIG 745
+G GGFG ++ + G + A K+L R + G + E + L ++ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDW-RVLHKIALDIARALAYLHDQCVPRV 804
S+T + L+ + + GG+L+ I R ++ RV+H A I + +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA-QITCGILHLHSM---DI 116
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
++RD+KP N+LLDD N LSD GLA L + T AGT GY+APE S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVEL--KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 865 ADVYSYGVVLLELLSDK 881
D ++ G + E+++ +
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 6e-18
Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 15/194 (7%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLA---VGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G G FG G A+K L+ + + + V+ E + L +RHP LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
++ ++L+ Y+PGG L F R + V A + AL YLH ++
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIV 123
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
+RD+KP N+LLD D ++DFG A+ + + T + GT Y+APE + + KA
Sbjct: 124 YRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYLAPE-IILSKGYGKA 178
Query: 866 -DVYSYGVVLLELL 878
D ++ G+++ E+L
Sbjct: 179 VDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHA--------EIKTLGR 734
NF IG G F Y+A L+ K +A+ + Q + A EI L +
Sbjct: 3 NFQIEKKIGRGQFSEVYRAT----CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQ 58
Query: 735 LRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQ--QRSTRAVDWRVLHKIALDIARA 792
L HPN++ + + E+ ++ G+L I+ ++ R + R + K + + A
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
+ ++H + RV+HRD+KP+N+ + L D GL R S+T A + GT Y++
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174
Query: 853 PEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899
PE + K+D++S G +L E+ AL F YG+ N+ +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM----AALQSPF--YGDKMNLFS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-18
Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 15/196 (7%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G+G FG YKA+ G L A K + + ++ + EI+ L HP +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 749 SETEMFLIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ +++++ + PGG ++ + + R +V+ + L+ AL YLH +++H
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSM---KIIH 133
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD--- 863
RD+K N+LL D + L+DFG++ GT ++APE M + D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 864 --KADVYSYGVVLLEL 877
KAD++S G+ L+E+
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAV------GRFQGVQQFHAEIKTLGRLRHPNLV 741
+G G +G Y + G L+A+K++ + + ++ E+ L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
+G + + + ++PGG++ + + + + V K I +AYLH+ C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC- 122
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLL---GPSETHATT--GVAGTFGYVAPEYA 856
V+HRD+K +N++L + L DFG AR L G TH+ + GT ++APE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 857 MTCRVSDKADVYSYGVVLLELLSDKKAL 884
K+D++S G + E+ + K L
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G+G FG YKA+ GVL A K + + ++ + EI L HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 749 SETEMFLIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
E ++++ + GG ++ + + R RV+ K L+ AL YLH+ +++H
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHEN---KIIH 126
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD--- 863
RD+K NIL D + L+DFG++ GT ++APE M C S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVM-CETSKDRP 184
Query: 864 ---KADVYSYGVVLLEL 877
KADV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKR--LAVGRFQG-------VQQFHAEIKTLGRLRHPN 739
IG+G FG+ Y S G L+A+K+ L + EI L L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+V +G + + Y+PGG++ + A + ++ I + L YLH++
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR 125
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA-----GTFGYVAPE 854
++HRD+K +NIL+D+ +SDFG+++ L + T A G+ ++APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 855 YAMTCRVSDKADVYSYGVVLLELLSDK 881
+ KAD++S G +++E+L+ K
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 690 IGNGGFGATYKAEIS-PG---VLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLI 744
IG G FG + + PG + VAIK L G + + F +E +G+ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL--DIARALAYLHDQCVP 802
G + +I ++ G L++F++Q + + V+ + + IA + YL +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIAAGMKYLSEM--- 125
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLL--GPSETHATTGVAGTFG--YVAPEYAMT 858
+HRD+ NIL++ + +SDFGL+R L S+ T+ + G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 859 CRVSDKADVYSYGVVLLELLS 879
+ + +DV+SYG+V+ E++S
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 47/211 (22%)
Query: 690 IGNGGFGATYKAEISPG----VLVAIKRLAVGRFQGVQQFH--AEIKTLGRLRHPNLVTL 743
+G GGFG ++ L +K+ + + QQ H +E + L HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL---DIAR--------A 792
+ ++++ Y GG L W +L L AR A
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGEL-------------WTILRDRGLFDEYTARFYIACVVLA 105
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
YLH++ +++RD+KP N+LLD + L DFG A+ L + T GT YVA
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVA 160
Query: 853 PEYAMTCRVSDK-----ADVYSYGVVLLELL 878
PE + +K D +S G++L ELL
Sbjct: 161 PEI-----ILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 80/283 (28%), Positives = 130/283 (45%), Gaps = 36/283 (12%)
Query: 688 NCIGNGGFGATYKAEI----SPGVLVAIKRLA-VGRFQGVQQFHAEIKTLGRLRHPNLVT 742
IG G FG Y + + A+K L + + V+QF E + HPN+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 743 LIGYH-ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
L+G SE ++ Y+ G+L NFI+ T + L L +A+ + YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASK-- 117
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE---THATTGVAGTFGYVAPEYAMT 858
+ +HRD+ N +LD+ F ++DFGLAR + E H TG ++A E T
Sbjct: 118 -KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 859 CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR---AKEFFT 915
+ + K+DV+S+GV+L EL++ P + F+I + L QGR E+
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV----DSFDITVY----LLQGRRLLQPEYCP 228
Query: 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
D L EV+ + C RPT ++V R++Q+
Sbjct: 229 ---------DPLYEVM---LSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 54/190 (28%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G + A +++ G VAIK++ + + + EI + L++PN+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E+F++ YL GG+L + + + +D + + + +AL +LH +V+HRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K N+LL D + L+DFG + P ++ +T V GT ++APE K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 869 SYGVVLLELL 878
S G++ +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 690 IGNGGFGATYKAEISPGV------LVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVT 742
+G G FG + E LVA+K L ++ F E + L +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV------------LHKIALDIA 790
G +++ Y+ G+L F++ A + L +IA+ IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT--- 847
+ YL Q +HRD+ N L+ D + DFG++R + ++ + V G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR---VGGHTML 186
Query: 848 -FGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
++ PE M + + ++DV+S+GVVL E+ +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-17
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFH---AEIKTLGRLRHPNLVTLIG 745
IG+G FGA Y A ++ +VAIK+++ Q +++ E++ L +LRHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 746 YHASETEMFLIYNYLPGGNLENF-IQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ E +L+ Y G + + ++ + V+ + AL + LAYLH +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSH---NM 136
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC---RV 861
+HRDVK NILL + L DFG A ++ P+ GT ++APE + +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQY 191
Query: 862 SDKADVYSYGVVLLELLSDKKAL 884
K DV+S G+ +EL K L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 29/206 (14%)
Query: 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHA-----EIKTLGRLRHPNLVT 742
+G+G +G A + G VAIK+L+ R FQ HA E++ L + H N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS--RPFQSAI--HAKRTYRELRLLKHMDHENVIG 78
Query: 743 LIG-YHASETEM----FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
L+ + + + + +L G +L N + + + D + + I R L Y+H
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNNIV--KCQKLSDDHIQF-LVYQILRGLKYIH 135
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
++HRD+KPSNI +++D + DFGLAR TG T Y APE M
Sbjct: 136 SA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPE-IM 187
Query: 858 TCRV--SDKADVYSYGVVLLELLSDK 881
+ + D++S G ++ ELL+ K
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G G FG + A + VA+K + G V+ F AE + L+H LV L HA
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL---HAV 69
Query: 750 ETE--MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
T+ +++I ++ G+L +F++ L + IA +A++ + +HR
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 126
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
D++ +NIL+ ++DFGLAR++ +E A G + APE + K+DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 868 YSYGVVLLELLSDKKALDPSFSS 890
+S+G++L+E+++ + P S+
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSN 209
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 70/227 (30%), Positives = 102/227 (44%), Gaps = 49/227 (21%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G G +G Y A ++S V +AIK + + VQ H EI L+H N+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG-SD 74
Query: 749 SETEMFLIY-NYLPGGNLENFIQQRSTRAVDWRVLHK-------IALDIARALAYLHDQC 800
SE F I+ +PGG+L ++ + W L I L YLHD
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSK------WGPLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 801 VPRVLHRDVKPSNILLDDDFNAY-----LSDFGLA-RLLGPSETHATTGVAGTFGYVAPE 854
+++HRD+K N+L+ N Y +SDFG + RL G + T GT Y+APE
Sbjct: 128 --QIVHRDIKGDNVLV----NTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPE 179
Query: 855 YAMTCRVSDK--------ADVYSYGVVLLELLSDKKALDPSFSSYGN 893
V DK AD++S G ++E+ + K P F G
Sbjct: 180 ------VIDKGPRGYGAPADIWSLGCTIVEMATGK----PPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 5e-17
Identities = 55/190 (28%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G Y A +I+ G VAIK++ + + + EI + ++PN+V + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E++++ YL GG+L + + + +D + + + +AL +LH +V+HRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K NILL D + L+DFG + P ++ +T V GT ++APE K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 869 SYGVVLLELL 878
S G++ +E++
Sbjct: 200 SLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 25/201 (12%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-----H--PNLV 741
IG+G G YK G ++A+K++ R G ++ + I L L H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRI--LMDLDVVLKSHDCPYIV 77
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
GY +++++F I L L+ + +R + +L K+ + I +AL YL ++
Sbjct: 78 KCYGYFITDSDVF-ICMELMSTCLDK-LLKRIQGPIPEDILGKMTVAIVKALHYLKEK-- 133
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLA-RLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
V+HRDVKPSNILLD N L DFG++ RL+ ++ A T AG Y+APE
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPPD 190
Query: 861 VSDK----ADVYSYGVVLLEL 877
+ K ADV+S G+ L+EL
Sbjct: 191 PNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-17
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFH---AEIKTLGRLRHPNLVTLIG 745
IG+G FGA Y A S +VA+K+++ Q +++ E+K L +L+HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 746 YHASETEMFLIYNYLPGGNLENF-IQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ E +L+ Y G + + ++ + V+ + AL + LAYLH +
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSHNM--- 142
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC---RV 861
+HRD+K NILL + L+DFG A P+ + GT ++APE + +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTPYWMAPEVILAMDEGQY 197
Query: 862 SDKADVYSYGVVLLELLSDKKAL 884
K DV+S G+ +EL K L
Sbjct: 198 DGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFH---AEIKTLGRLRHPNLVTLIG 745
IG+G FGA Y A ++ +VAIK+++ Q +++ E+K L R++HPN + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 746 YHASETEMFLIYNYLPGGNLENF-IQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ E +L+ Y G + + ++ + V+ + AL + LAYLH +
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSH---NM 146
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC---RV 861
+HRD+K NILL + L+DFG A + P+ + GT ++APE + +
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMDEGQY 201
Query: 862 SDKADVYSYGVVLLELLSDKKAL 884
K DV+S G+ +EL K L
Sbjct: 202 DGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-17
Identities = 47/131 (35%), Positives = 70/131 (53%), Gaps = 16/131 (12%)
Query: 465 ALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGL 524
L L + IP + +++ L+ ++L+GN++ G+IP SLG + LEVLDLS NS +G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 525 IPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSA-FNVSFNNLSGPLPSSKNLMKCS 583
IP+ L L +L +L LN N LSG++P+ L A FN + N +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN---------------A 526
Query: 584 SVLGNPYLRPC 594
+ G P LR C
Sbjct: 527 GLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G GGFG ++ + G L A K+L R +G + E + L ++ +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 746 YHASETEMFLIYNYLPGGNLENFI---QQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
++T++ L+ + GG+L I + + + R A I L +LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA-QIISGLEHLHQR--- 116
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
R+++RD+KP N+LLD+D N +SD GLA L ++ T G AGT G++APE
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 863 DKADVYSYGVVLLELLSDK 881
D ++ GV L E+++ +
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-16
Identities = 59/192 (30%), Positives = 89/192 (46%), Gaps = 24/192 (12%)
Query: 709 VAIKRL---AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY-HASETEMFLIYNYLPGGN 764
VAIK L A +F E RL HPN+V L+ A +F ++ Y+PG
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 765 LENFIQ-QRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL---DDDF 820
L + + A + L LD ALA H+Q ++HRD+KP NI++
Sbjct: 66 LREVLAADGALPAGETGRLMLQVLD---ALACAHNQ---GIVHRDLKPQNIMVSQTGVRP 119
Query: 821 NAYLSDFGLARLLGPSETH--------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGV 872
+A + DFG+ LL TT V GT Y APE V+ +D+Y++G+
Sbjct: 120 HAKVLDFGIGTLL--PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 873 VLLELLSDKKAL 884
+ LE L+ ++ +
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHA-EIKTLGRLRHPNLVTLIGYH 747
+G G + YK + G +VA+K + + +G EI + L+H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTR-AVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+E ++ L++ Y+ +L+ ++ R A+D + + + +A+ H+ RVLH
Sbjct: 68 HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLH 123
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAMTCRV-SDK 864
RD+KP N+L++ L+DFGLAR G P T + V T Y AP+ + R S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYSTS 181
Query: 865 ADVYSYGVVLLELLSDK 881
D++S G ++ E+++ +
Sbjct: 182 IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 33/278 (11%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVGRFQGVQQFHA---EIKTLGRLRHPNLV 741
+G+G FG +K P + VAIK + G Q F + +G L H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIK--TIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
L+G + L+ P G+L + ++Q ++D + L + IA+ + YL + +
Sbjct: 73 RLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYVAPEYAMTCR 860
+HR++ NILL D ++DFG+A LL P + T ++A E + R
Sbjct: 131 ---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 861 VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920
+ ++DV+SYGV + E++ SYG A +R + G
Sbjct: 188 YTHQSDVWSYGVTVWEMM-----------SYG------AEPYAGMRPHEVPDLLEKGERL 230
Query: 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
A P ++V + V C + + RPT K++ ++
Sbjct: 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 53/190 (27%), Positives = 97/190 (51%), Gaps = 8/190 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G A + S G VA+K++ + + Q + E+ + +HPN+V + +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E++++ +L GG L + + TR ++ + + L + +AL++LH Q V+HRD
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTH--TR-MNEEQIATVCLAVLKALSFLHAQ---GVIHRD 140
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K +ILL D LSDFG + E + GT ++APE + D++
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIW 199
Query: 869 SYGVVLLELL 878
S G++++E++
Sbjct: 200 SLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 683 NFNASNCIGNGGFG----ATYKAEISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRL 735
+FN +G G FG ATYK E P V AIKR + + + V +E K L +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPV--AIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
HP V L G E+ ++L+ ++ GG F+++ D + A I Y
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY--AAQIVLIFEY 146
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
L +++RD+KP N+LLD D ++DFG A+++ +T T + GT Y+APE
Sbjct: 147 LQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEI 199
Query: 856 AMTCRVSDKADVYSYGVVLLELL 878
+ AD ++ G+ + E+L
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 687 SNCIGNGGFGATYKA-EISPGVLVAIKRLAV-GRFQGVQQFH----AEIKTLGRLRHPNL 740
IG G +G YKA +++ G VA+K++ V +G+ A +K L HPN+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 741 VTLI----GYHAS-ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
V L+ G E ++ L++ ++ +L ++ + + + + + R + +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE- 854
LH R++HRD+KP NIL+ D ++DFGLAR+ S A T V T Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRAPEV 177
Query: 855 -----YAMTCRVSDKADVYSYGVVLLEL 877
YA D++S G + EL
Sbjct: 178 LLQSSYATPV------DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRL--AVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIG 745
+G G +G +KA + +VA+K++ A Q+ EI L L HPN+V L+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 746 YHASE--TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHK--IALDIARALAYLHDQCV 801
+E +++L++ Y+ +L I RA +HK I + +AL Y+H
Sbjct: 75 VIKAENDKDIYLVFEYMET-DLHAVI-----RANILEDVHKRYIMYQLLKALKYIHSG-- 126
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-----VAGTFGYVAPEYA 856
V+HRD+KPSNILL+ D L+DFGLAR L E + VA T Y APE
Sbjct: 127 -NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA-TRWYRAPEIL 184
Query: 857 MTCRVSDKA-DVYSYGVVLLELLSDK 881
+ K D++S G +L E+L K
Sbjct: 185 LGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 690 IGNGGFGATYKAEIS-PGV----LVAIKRLA-VGRFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G FG YK + PG+ LVAIK L + Q +F E + L HPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTR---------------AVDWRVLHKIALD 788
+G E + +++ YL G+L F+ RS ++D IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 789 IARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGT 847
IA + YL +H+D+ NIL+ + + +SD GL+R + ++ +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 848 FGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
++ PE M + S +D++S+GVVL E+ S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 19/197 (9%)
Query: 688 NCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIG 745
N IG+G G YK P G L A+K + V+ Q EI+ L + HPN+V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
E+ ++ ++ GG+LE T D + L +A I +AYLH + ++
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEG------THIADEQFLADVARQILSGIAYLHRR---HIV 190
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
HRD+KPSN+L++ N ++DFG++R+L + + V GT Y++PE T ++ A
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINT-DLNHGA 248
Query: 866 ------DVYSYGVVLLE 876
D++S GV +LE
Sbjct: 249 YDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRH-PNLVTLI 744
IG G FG K P G ++A+KR+ + Q ++ ++ + R P +V
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ--KRLLMDLDVVMRSSDCPYIVKFY 69
Query: 745 GYHASETE----MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
G E + M L+ L ++ + + +L KIA+ +AL YL ++
Sbjct: 70 GALFREGDCWICMELMDISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
+++HRDVKPSNILLD + N L DFG++ L ++ A T AG Y+APE
Sbjct: 128 --KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 861 VSD---KADVYSYGVVLLEL 877
++DV+S G+ L E+
Sbjct: 184 RDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 32/228 (14%)
Query: 690 IGNGGFGATYKAEI---SPG---VLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHPNL 740
+G FG YK + +PG VAIK L A G + ++F E RL+HPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFKHEAMMRSRLQHPNI 70
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRA-----VDWRVLHK---------IA 786
V L+G E + +I++Y +L F+ RS + D + + I
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG 846
IA + +L V+H+D+ N+L+ D N +SD GL R + ++ + G +
Sbjct: 131 TQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 847 -TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN 893
+++PE M + S +D++SYGVVL E+ S L P + Y N
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQP-YCGYSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 54/199 (27%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGV--QQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G G K + P L+ ++L + Q E++ L P +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
S+ E+ + ++ GG+L+ +++ + + +L K+++ + R LAYL ++ +++HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHR 128
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
DVKPSNIL++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 185
Query: 868 YSYGVVLLELLSDKKALDP 886
+S G+ L+EL + + P
Sbjct: 186 WSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 15/193 (7%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRL----AVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
IG G FG YK + +VAIK + A + +QQ EI L + P +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G + T++++I YL GG+ + ++ ++ + I +I + L YLH + R
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE---RK 122
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
+HRD+K +N+LL + + L+DFG+A L ++ T V F ++APE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDFK 181
Query: 865 ADVYSYGVVLLEL 877
AD++S G+ +EL
Sbjct: 182 ADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 13/194 (6%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYH 747
IG G +GA Y+ + G +VA+K + + V E+ L +LR + Y+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 748 AS---ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
S +++I Y GG++ ++ + + + I ++ AL Y+H V
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMK---AGPIAEKYISVIIREVLVALKYIHKV---GV 122
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD- 863
+HRD+K +NIL+ + N L DFG+A LL + + +T GT ++APE + D
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKYYDT 181
Query: 864 KADVYSYGVVLLEL 877
KAD++S G+ + E+
Sbjct: 182 KADIWSLGITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 5e-16
Identities = 53/190 (27%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G Y A +++ G VAI+++ + + + EI + ++PN+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E++++ YL GG+L + + + +D + + + +AL +LH +V+HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K NILL D + L+DFG + P ++ +T V GT ++APE K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200
Query: 869 SYGVVLLELL 878
S G++ +E++
Sbjct: 201 SLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 690 IGNGGFGATYKAE--ISPGVLVAIKRLAV-----GRFQGVQQFHAEIKTLGRLRHPNLVT 742
IG G +G +KA + G VA+KR+ V G + A ++ L HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 743 L-----IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
L + ET++ L++ ++ +L ++ + V + + + R L +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
RV+HRD+KP NIL+ L+DFGLAR+ S A T V T Y APE +
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLL 182
Query: 858 TCRVSDKADVYSYGVVLLELLSDK 881
+ D++S G + E+ K
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 57/190 (30%), Positives = 96/190 (50%), Gaps = 14/190 (7%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIGYH 747
+G+G G YKA ++A+K + + +Q Q +E++ L + P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
E + + ++ GG+L+ + R + VL +IA+ + + L YL ++LHR
Sbjct: 69 FVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHR 119
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
DVKPSN+L++ L DFG++ L S A T V GT Y+APE + +DV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYV-GTNAYMAPERISGEQYGIHSDV 176
Query: 868 YSYGVVLLEL 877
+S G+ +EL
Sbjct: 177 WSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 34/216 (15%)
Query: 688 NCIGNGGFGATYKAEISPGVL---VAIKRLAVGRFQGVQQ-FHAEIKTLGRL-RHPNLVT 742
+ IG G FG KA I L AIKR+ + + F E++ L +L HPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQ--------------RSTRAVDWRVLHKIALD 788
L+G ++L Y P GNL +F+++ + + + L A D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 789 IARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF 848
+AR + YL + + +HRD+ NIL+ +++ A ++DFGL+R E + V T
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY----VKKTM 182
Query: 849 G-----YVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
G ++A E + +DV+SYGV+L E++S
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 690 IGNGGFGATYKAEISPGVLVA---IKRL-AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
IGNG FG E G+ A +K L A F E++ L HPN++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTR-----AVDWRVLHKIALDIARALAYLHDQC 800
L+ + P G+L+N++ RS R VL ++A ++A L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-VAGTFGYVAPEYA--- 856
+H D+ N L D + + D+GLA P + + T A ++APE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 857 ----MTCRVSDKADVYSYGVVLLEL 877
+ + K++++S GV + EL
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGV-QQFHAEIKTLGRLRHPNLVTLIGYH 747
IG G +G A P GV VAIK+++ Q Q+ EIK L R +H N++
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIG----- 67
Query: 748 ASETEMFLIYNYLPGGNLENF----IQQRSTRAVDWRVLHKIAL----------DIARAL 793
I + + + E+F I Q ++++ L I R L
Sbjct: 68 --------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGL 119
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA---TTGVAGTFGY 850
Y+H VLHRD+KPSN+LL+ + + + DFGLAR+ P H T VA T Y
Sbjct: 120 KYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-TRWY 175
Query: 851 VAPEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
APE + + KA D++S G +L E+LS++
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG------VQQFHAEIKTLGRLRHPNLVT 742
IG G +G YKA + G VA+K + V + V++ A +K L HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIVR 66
Query: 743 LIGYHAS-----ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
L+ A+ ET++ L++ ++ +L ++ + + + + R L +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
C+ +HRD+KP NIL+ L+DFGLAR+ S A T V T Y APE +
Sbjct: 126 ANCI---VHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVLL 180
Query: 858 TCRVSDKADVYSYGVVLLELLSDK 881
+ D++S G + E+ K
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 683 NFNASNCIGNGGFGATYKA-EIS---PGVLVAIKRLA----VGRFQGVQQFHAEIKTLGR 734
NF +G G +G + ++S G L A+K L V + + + E + L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 735 LRH-PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARAL 793
+R P LVTL ++T++ LI +Y+ GG L + QR R + V +I AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSG-EIVLAL 118
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853
+LH +++RD+K NILLD + + L+DFGL++ E GT Y+AP
Sbjct: 119 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 854 EYAMTCRVS-DKA-DVYSYGVVLLELLS 879
+ DKA D +S GV++ ELL+
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 45/236 (19%)
Query: 680 ATGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA----EIKTLGR 734
++ +G G FG YKA +I G +VA+K++ + + F EIK L +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 735 LRHPNLVTLI--------GYHASETEMFLIYNYLP---GGNLENFIQQRSTRAVDWRVLH 783
L+HPN+V LI ++++ Y+ G LEN ++
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN---------PSVKLTE 114
Query: 784 K----IALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL------ 833
L + + YLH+ +LHRD+K +NIL+D+ ++DFGLAR
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 834 ----GPSETHATTGVAGTFGYVAPEYAM-TCRVSDKADVYSYGVVLLELLSDKKAL 884
G T T + T Y PE + R + D++ G V E+ + + L
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 690 IGNGGFGATYKAE---ISP---GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG + AE + P +LVA+K L + FH E + L L+H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAV------------DWRVLHKIALDIAR 791
G + +++ Y+ G+L F++ AV ++LH IA IA
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH-IAQQIAA 131
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-VAGTFGY 850
+ YL Q +HRD+ N L+ ++ + DFG++R + ++ + G +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELLS 879
+ PE M + + ++DV+S GVVL E+ +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 9/190 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYH 747
IG G FG +K + +VAIK + + + ++ EI L + P + G +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
+T++++I YL GG+ + ++ +D + I +I + L YLH + + +HR
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE---KKIHR 125
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
D+K +N+LL + L+DFG+A L ++ T V F ++APE KAD+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKADI 184
Query: 868 YSYGVVLLEL 877
+S G+ +EL
Sbjct: 185 WSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 688 NCIGNGGFGATYKAEIS--PG----VLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRHPNL 740
+G+G FG Y+ G + VA+K L Q F E + + H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVD-----WRVLHKIALDIARALAY 795
V LIG F++ + GG+L++F+++ R + L A D+A+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 796 LHDQCVPRVLHRDVKPSNILLDD---DFNAYLSDFGLARLLGPSETHATTGVAG-TFGYV 851
L + +HRD+ N LL A ++DFG+AR + + + G A ++
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 852 APEYAMTCRVSDKADVYSYGVVLLELLS 879
PE + + K DV+S+GV+L E+ S
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 690 IGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLI 744
+G+G FG YK + VAIK L + V+ + E + + +L +P +V +I
Sbjct: 3 LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQ-QRSTRAVDWRV--LHKIALDIARALAYLHDQCV 801
G +E M L+ GG L F+ ++ V V +H++++ + YL +
Sbjct: 62 GVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM----GMKYLEGK-- 114
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GYVAPEYAMTC 859
+HRD+ N+LL + A +SDFGL++ LG +++ AG + + APE
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 860 RVSDKADVYSYGVVLLELLS 879
+ S ++DV+SYG+ + E S
Sbjct: 174 KFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 60/194 (30%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIGYH 747
+G G G+ K + I G ++A K + +G V+ Q E++ + R P +V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
+E + + ++ G+L+ ++ V+ +L KIA+ + L YL++ V R++HR
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVE--ILGKIAVAVVEGLTYLYN--VHRIMHR 128
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
D+KPSNIL++ L DFG++ L S A T V GT Y++PE + + K+DV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFV-GTSTYMSPERIQGGKYTVKSDV 185
Query: 868 YSYGVVLLELLSDK 881
+S G+ ++EL K
Sbjct: 186 WSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 683 NFNASNCIGNGGFGATYKAEI----SPGVLVAIKRL----AVGRFQGVQQFHAEIKTLGR 734
NF +G G +G + G L A+K L V + + + E + L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 735 LRH-PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARAL 793
+R P LVTL ++T++ LI +Y+ GG L + QR + V IA +I AL
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIA-EIVLAL 118
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853
+LH +++RD+K NILLD + + L+DFGL++ E GT Y+AP
Sbjct: 119 DHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 854 EYAMT-CRVSDKA-DVYSYGVVLLELLS 879
E DKA D +S GV+ ELL+
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRL--AVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
+G+G FG YK P + VAIK L G V+ F E + + HP+LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 73
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L+G S T + L+ +P G L +++ + + ++L + IA+ + YL ++
Sbjct: 74 LLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLL-GPSETHATTGVAGTFGYVAPEYAMTCRV 861
R++HRD+ N+L+ + ++DFGLARLL G + + G ++A E +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 862 SDKADVYSYGVVLLELLS 879
+ ++DV+SYGV + EL++
Sbjct: 189 THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 7e-15
Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTL-GRLRHPNLVTLI 744
IG G FG A+ + G A+K L A+ + + + AE L ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ +++ + +Y+ GG L F QR + R A +IA AL YLH +
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL-FFHLQRERSFPEPRA-RFYAAEIASALGYLHSL---NI 117
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
++RD+KP NILLD + L+DFGL + + S+T T+ GT Y+APE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPYDR 175
Query: 864 KADVYSYGVVLLELLSDKKALDPSFS 889
D + G VL E+L L P +S
Sbjct: 176 TVDWWCLGAVLYEMLY---GLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG P G VA+K L + EI+ L L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 744 IGYHASE--TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
G + + LI +LP G+L+ ++ R+ ++ + K A+ I + + YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGV---AGTFGYVAPEYAMT 858
+ +HRD+ N+L++ + + DFGL + + + + T + F Y APE +
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQ 186
Query: 859 CRVSDKADVYSYGVVLLELLS 879
+ +DV+S+GV L ELL+
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVG-----RFQGVQQFHAEIKTLGRLR 736
N+ +G G FG Y ++ G +A K++ + V EI+ L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 737 HPNLVTLIGY---HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARAL 793
H +V G A +T + + Y+PGG++++ Q ++ A+ V K I +
Sbjct: 63 HERIVQYYGCLRDRAEKT-LTIFMEYMPGGSVKD--QLKAYGALTESVTRKYTRQILEGM 119
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-----VAGTF 848
+YLH ++HRD+K +NIL D N L DFG ++ L +T +G V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICMSGTGIRSVTGTP 173
Query: 849 GYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSY 891
+++PE KADV+S G ++E+L++K P ++ Y
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK----PPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL------AVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
I G FG+ Y A+ S G AIK L A + V+ A + G P +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYVAK 61
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L S+ ++L+ YL GG+ + I+ DW + ++ + LH +
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW--AKQYIAEVVLGVEDLHQR--- 116
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLAR--LLGPSETHATTGVAGTFGYVAPEYAMTCR 860
++HRD+KP N+L+D + L+DFGL+R L GT Y+APE +
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-------FVGTPDYLAPETILGVG 169
Query: 861 VSDKADVYSYGVVLLELL 878
+D +S G V+ E L
Sbjct: 170 DDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 684 FNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLRHPN 739
F +G GGFG ++ + G + A K+L R + G E + L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+V+L + ++ + L+ + GG+L+ I + A +I L LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
R+++RD+KP NILLDD + +SD GLA + E G GT GY+APE
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNE 176
Query: 860 RVSDKADVYSYGVVLLELLS 879
R + D ++ G +L E+++
Sbjct: 177 RYTFSPDWWALGCLLYEMIA 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 15/193 (7%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRL----AVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
IG G FG +K + +VAIK + A + +QQ EI L + P +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G + T++++I YL GG+ + ++ D + + +I + L YLH + +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSE---KK 122
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
+HRD+K +N+LL + + L+DFG+A L ++ T V GT ++APE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 181
Query: 865 ADVYSYGVVLLEL 877
AD++S G+ +EL
Sbjct: 182 ADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 688 NCIGNGGFGATYKAEISPGVL---VAIKRLA-VGRFQGVQQFHAEIKTLGRL-RHPNLVT 742
+ IG G FG +A I L AIK L + F E++ L +L HPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVD--------------WRVLHKIALD 788
L+G + +++ Y P GNL +F+++ D + L + A D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 789 IARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF 848
+A + YL ++ + +HRD+ N+L+ ++ + ++DFGL+R E + V T
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY----VKKTM 177
Query: 849 G-----YVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
G ++A E + K+DV+S+GV+L E++S
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 51/185 (27%), Positives = 92/185 (49%), Gaps = 15/185 (8%)
Query: 707 VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765
VLVA+K L + + F EIK + RL++PN++ L+G S+ + +I Y+ G+L
Sbjct: 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 766 ENFIQQRSTRA----------VDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNIL 815
F+ QR + V L +A+ IA + YL +HRD+ N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161
Query: 816 LDDDFNAYLSDFGLARLLGPSETHATTGVAG-TFGYVAPEYAMTCRVSDKADVYSYGVVL 874
+ + + ++DFG++R L + + G A ++A E + + + +DV+++GV L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 875 LELLS 879
E+ +
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 680 ATGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RH 737
TG F IG G +G YKA G LVAIK + + ++ E L + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62
Query: 738 PNLVTLIG-YHAS-----ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV----LHKIAL 787
PN+ T G + + +++L+ GG++ + + + R R+ + I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILR 120
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT 847
+ R LAYLH+ +V+HRD+K NILL + L DFG++ L + T + GT
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GT 176
Query: 848 FGYVAPE-----YAMTCRVSDKADVYSYGVVLLEL 877
++APE ++DV+S G+ +EL
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAV-GRFQGVQQFHA-EIKTLGRLRHPNLVTLIGY 746
IG G +G +KA +VA+KR+ + +GV EI L L+H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRA-VDWRVLHKIALDIARALAYLHDQCVPRVL 805
S+ ++ L++ Y +L+ + S +D ++ + + LA+ H VL
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVL 121
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
HRD+KP N+L++ + L+DFGLAR G P ++ V T Y P+ ++
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYST 179
Query: 865 A-DVYSYGVVLLELLSDKKALDP 886
+ D++S G + EL + + L P
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
+G G +G K + G +VAIK+ + + A EI+ L +LRH NLV LI
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ ++L++ ++ L++ ++ +D + K I R + + H ++H
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIH 123
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLL-GPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
RD+KP NIL+ L DFG AR L P E + T VA T Y APE + +A
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYVA-TRWYRAPELLVGDTKYGRA 181
Query: 866 -DVYSYGVVLLELLS 879
D+++ G ++ E+L+
Sbjct: 182 VDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 732 LGRLRHPNLVTLIGYHASETEMFLIYNYLP--GGNLENFIQQRSTRAVDWRVLHKIALDI 789
L + HP+++ + S ++ LP +L ++ +RS + I I
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRP-LPIDQALIIEKQI 166
Query: 790 ARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG 849
L YLH Q R++HRDVK NI ++D + D G A+ P A G+AGT
Sbjct: 167 LEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVE 221
Query: 850 YVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKAL 884
APE + + KAD++S G+VL E+L+ +
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 57/296 (19%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLV 741
+G G FG KAE + VA+K L + + +E++ + + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQR--------------STRAVDWRVLHKIAL 787
L+G E ++++ Y GNL +F++ R + + L A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH------AT 841
+AR + +L + + +HRD+ N+L+ +D ++DFGLAR + H T
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDYYRKT 191
Query: 842 TGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAW 900
T ++APE A+ RV + ++DV+S+GV+L E+ + S Y I
Sbjct: 192 TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT------LGGSPYPG---IPVE 241
Query: 901 GCM-LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955
LL++G E P + E+ HL C + S RPT KQ+V L
Sbjct: 242 ELFKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 683 NFNASNCIGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHP 738
+F +G G FG A +K + +K+ + + + VQ E L L HP
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
+V ++ E ++ + ++ GG L F R V ++ A YLH
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+ +++RD+KP N+LLD+ + ++DFG A+ + T + GT Y+APE +
Sbjct: 137 K---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE-VIQ 188
Query: 859 CRVSDKA-DVYSYGVVLLELL 878
+ KA D ++ GV+L E +
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 8/190 (4%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G A + S G LVA+K++ + + Q + E+ + +H N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E++++ +L GG L + + TR + ++ + L + +AL+ LH Q V+HRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTH--TRMNEEQI-AAVCLAVLKALSVLHAQ---GVIHRD 141
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K +ILL D LSDFG + E + GT ++APE + D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 869 SYGVVLLELL 878
S G++++E++
Sbjct: 201 SLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G A E G VA+K++ + + Q + E+ + H N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E++++ +L GG L + + TR + ++ + L + RAL+YLH+Q V+HRD
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTH--TRMNEEQIA-TVCLSVLRALSYLHNQ---GVIHRD 143
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K +ILL D LSDFG + E + GT ++APE + D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 869 SYGVVLLELL 878
S G++++E++
Sbjct: 203 SLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVG-----RFQGVQQFHAEIKTLGRLR 736
N+ +G G FG Y + G +A+K++ + V EI+ L LR
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 737 HPNLVTLIG--YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALA 794
H +V G E ++ + Y+PGG++++ Q ++ A+ V + I + ++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD--QLKAYGALTENVTRRYTRQILQGVS 120
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT--TGVAGTFGYVA 852
YLH ++HRD+K +NIL D N L DFG ++ + T V GT +++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 853 PEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSY 891
PE KADV+S ++E+L++K P ++ Y
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK----PPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 690 IGNGGFGATYKAE---ISP---GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG + AE +SP +LVA+K L + F E + L L+H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRA---VDW------------RVLHKIALD 788
G + +++ Y+ G+L F++ A VD ++LH IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH-IASQ 131
Query: 789 IARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-VAGT 847
IA + YL Q +HRD+ N L+ + + DFG++R + ++ + G
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 848 FGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
++ PE M + + ++DV+S+GV+L E+ +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 7/193 (3%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIGYH 747
IG G FG + + + VA+K ++ +F E + L + HPN+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
+ ++++ + GG+ F++ R + + L ++ + A + YL + +HR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYVAPEYAMTCRVSDKAD 866
D+ N L+ + +SDFG++R +T G+ + APE R S ++D
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 867 VYSYGVVLLELLS 879
V+S+G++L E S
Sbjct: 179 VWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 42/101 (41%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 781 VLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840
+L KIA+ I +AL YLH + V+HRDVKPSN+L++ + L DFG++ L S A
Sbjct: 104 ILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VA 159
Query: 841 TTGVAGTFGYVAPEY---AMTCRVSD-KADVYSYGVVLLEL 877
T AG Y+APE + + D K+DV+S G+ ++EL
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 40/89 (44%), Positives = 56/89 (62%), Gaps = 3/89 (3%)
Query: 441 FLDASG--NQ-IVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNL 497
F+D G NQ + G IP + +L L ++NLS N + IP +LG + L+ L L+ N+
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 498 TGSIPSSLGQLQLLEVLDLSSNSLSGLIP 526
GSIP SLGQL L +L+L+ NSLSG +P
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 65/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLR-HPNLVTLIG 745
IG G F KA G AIK + F+ ++Q + EI+ L RL HPN++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 746 YHASETE--MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+ L++ L NL I+ R + RV + + ++L ++H
Sbjct: 66 VLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYM-YQLLKSLDHMHRN---G 120
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC-RVS 862
+ HRD+KP NIL+ DD L+DFG R G T T Y APE +T
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 863 DKADVYSYGVVLLELLSDKKALDPSF 888
K D+++ G V E+LS L P F
Sbjct: 178 PKMDIWAVGCVFFEILS----LFPLF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLI-- 744
IG G FG +KA +VA+K++ + + A EIK L L+H N+V LI
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 745 ------GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
Y+ + +L++ + +L + ++ + + K+ + L Y+H
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK-FTLSEIKKVMKMLLNGLYYIHR 137
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA----TTGVAGTFGYVAPE 854
++LHRD+K +NIL+ D L+DFGLAR S+ T V T Y PE
Sbjct: 138 N---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
Query: 855 YAMTCRVSDKA-DVYSYGVVLLEL 877
+ R D++ G ++ E+
Sbjct: 194 LLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVG-----RFQGVQQFHAEIKTLGRLR 736
N+ +G G FG Y + G +A+K++ + V EI+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 737 HPNLVTLIGY--HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALA 794
H +V G E + + ++PGG++++ Q +S A+ V K I ++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD--QLKSYGALTENVTRKYTRQILEGVS 120
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-----VAGTFG 849
YLH ++HRD+K +NIL D N L DFG ++ L +T +G V GT
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKSVTGTPY 174
Query: 850 YVAPEYAMTCRVSDKADVYSYGVVLLELLSDK 881
+++PE KAD++S G ++E+L++K
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIK--RLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIG 745
IG+G +G YKA ++ G L AIK +L G F VQQ EI + +H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFG 73
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ ++++ + GG+L++ T + + ++ + + L YLH + +
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSK---GKM 128
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR---VS 862
HRD+K +NILL D+ + L+DFG++ + + + + GT ++APE A R +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 863 DKADVYSYGVVLLEL 877
D+++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 51/175 (29%), Positives = 87/175 (49%), Gaps = 15/175 (8%)
Query: 723 QQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVL 782
Q E+K L P +V G S+ E+ + ++ GG+L+ + + + +L
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENIL 101
Query: 783 HKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842
KI++ + R L YL + +++HRDVKPSNIL++ L DFG++ L S A +
Sbjct: 102 GKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS 157
Query: 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL--------SDKKALDPSFS 889
V GT Y++PE + ++D++S G+ L+E+ D K L+ F
Sbjct: 158 FV-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFG 211
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-14
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 684 FNASNCIGNGGFGATYKAEISP-----GVLVAIKRLAVGRFQGV-QQFHAEIKTLGRLRH 737
F +G+G FG YK P + VAIK L ++ E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
P++ L+G + T + LI +P G L +++++ + + L + IA+ + YL
Sbjct: 69 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLE 126
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET--HATTGVAGTFGYVAPEY 855
++ R++HRD+ N+L+ + ++DFGLA+LLG E HA G ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-PIKWMALES 182
Query: 856 AMTCRVSDKADVYSYGVVLLELLS 879
+ + ++DV+SYGV + EL++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 52/206 (25%), Positives = 103/206 (50%), Gaps = 9/206 (4%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGV--QQFHAEIKTLGRLRHPNL 740
+F + +G G G +K P L+ ++L + Q E++ L P +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
V G S+ E+ + ++ GG+L+ +++ + ++L K+++ + + L YL ++
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK- 122
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
+++HRDVKPSNIL++ L DFG++ L S ++ GT Y++PE
Sbjct: 123 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 178
Query: 861 VSDKADVYSYGVVLLELLSDKKALDP 886
S ++D++S G+ L+E+ + + P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 688 NCIGNGGFGATY----KAEISPG---VLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPN 739
N +G+G FG Y + PG + VA+K L G Q ++F E + HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV-------LHKIALDIARA 792
+V L+G ++I + GG+L +++ R R + L I LD+A+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 793 LAYLHDQCVPRVLHRDVKPSNILL-----DDDFNAYLSDFGLARLLGPSETHATTGVAGT 847
YL +HRD+ N L+ D D + DFGLAR + S+ + G G
Sbjct: 119 CVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG-EGL 174
Query: 848 FG--YVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
++APE + + + ++DV+S+GV++ E+L+
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 39/223 (17%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G G G + G L A+K L + + V++ E + L L HP L TL
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL-- 66
Query: 746 YHASETEMFLIY--NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
Y + +TE +L +Y PGG L +Q++ + + V A ++ AL YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---G 123
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLG----------------------PSETHAT 841
+++RD+KP NILL + + LSDF L++ PSET +
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 842 TGVA------GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
GT Y+APE D ++ G++L E+L
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 690 IGNGGFGATYKA------EISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRL-RHPNLV 741
+G G FG +A + + VA+K L + +E+K + L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ-C 800
L+G + +I Y G+L NF++++ + L + +A+ +A+L + C
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG-TFGYVAPEYAMTC 859
+ HRD+ N+LL + DFGLAR + + G A ++APE C
Sbjct: 163 I----HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218
Query: 860 RVSDKADVYSYGVVLLELLS 879
+ ++DV+SYG++L E+ S
Sbjct: 219 VYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 683 NFNASNCIGNGGFGATYKAEISPG----VLVAIKRLA----VGRFQGVQQFHAEIKTLGR 734
NF +G G +G + G L A+K L V + + V+ E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 735 LRH-PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARAL 793
+R P LVTL +E ++ LI +Y+ GG + + QR + D + + +I AL
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED--EVRFYSGEIILAL 118
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853
+LH +++RD+K NILLD + + L+DFGL++ E T GT Y+AP
Sbjct: 119 EHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 854 EYAMTCRVSDKA-DVYSYGVVLLELLS 879
E KA D +S G+++ ELL+
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGR-LRHPNLVTLI 744
IG G FG A+ S G A+K L + + + AE L + L+HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ +++ + +Y+ GG L F QR ++ R A ++A A+ YLH +
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRA-RFYAAEVASAIGYLHSL---NI 117
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
++RD+KP NILLD + L+DFGL + G T+ GT Y+APE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 865 ADVYSYGVVLLELLSDKKALDPSFS 889
D + G VL E+L L P +S
Sbjct: 177 VDWWCLGAVLYEMLY---GLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 35/94 (37%), Positives = 60/94 (63%), Gaps = 1/94 (1%)
Query: 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQ 476
+ + N + G +P +I ++ + L+ ++ SGN I G IP +G + SL L+LS+N +
Sbjct: 423 LGLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL 510
IP +LGQ+ L+ L+L GN+L+G +P++LG L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLR 736
+ N I G +G Y+A + G +VA+K+L + + ++ EI L +L+
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQ 62
Query: 737 HPNLVTL--IGYHASETEMFLIYNYLP---GGNLENFIQQRSTRAVDWRVLHK-IALDIA 790
HPN+VT+ + ++ +++++ Y+ +E Q V K + L +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV------KCLMLQLL 116
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY 850
+A+LHD +LHRD+K SN+LL++ + DFGLAR G T V T Y
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 851 VAPEYAM-TCRVSDKADVYSYGVVLLELLSDKKAL 884
APE + S D++S G + ELL+ KK L
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G A E G VA+K + + + Q + E+ + +H N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E++++ +L GG L + + Q TR + ++ + + +AL YLH Q V+HRD
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIA-TVCESVLQALCYLHSQ---GVIHRD 142
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K +ILL D LSDFG + + + GT ++APE + D++
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 869 SYGVVLLELLSDKKALDPSFS 889
S G++++E++ + P FS
Sbjct: 202 SLGIMVIEMVDGEP---PYFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGV---QQFHAEIKTLGRLRHPNLVTLIG 745
+G+G +G+ A + G+ VA+K+L+ FQ + ++ + E++ L ++H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 746 YHASET------EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+++L+ +L G +L N + + + D V I I R L Y+H
Sbjct: 84 VFTPARSLEEFNDVYLV-THLMGADLNNIV--KCQKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT- 858
++HRD+KPSN+ +++D + DFGLAR TG T Y APE +
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNW 192
Query: 859 CRVSDKADVYSYGVVLLELLSDK 881
+ D++S G ++ ELL+ +
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 690 IGNGGFGATYKAEI----SPGVLVAIKRL---AVGRFQ-GVQQFHAEIKTLGRLRHPNLV 741
+G GG+G ++ G + A+K L + R Q AE L ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
LI + +++LI YL GG L +++ D + +I+ AL +LH Q
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY--LSEISLALEHLHQQ-- 119
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLAR--LLGPSETHATTGVAGTFGYVAPEYAMTC 859
+++RD+KP NILLD + L+DFGL + + + TH GT Y+APE M
Sbjct: 120 -GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEILMRS 175
Query: 860 RVSDKADVYSYGVVLLELLS 879
D +S G ++ ++L+
Sbjct: 176 GHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 684 FNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNL 740
F+ IG G +G YKA + G LVA+K++ + + A EIK L +L H N+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 741 VTL----------IGYHASETEMFLIYNYLPG---GNLENFIQQRSTRAVDWRVLHKIAL 787
V L + + + +L++ Y+ G LE+ + S + + K L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI--KSFMKQLL 126
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT 847
+ L Y H + LHRD+K SNILL++ L+DFGLARL E+ T T
Sbjct: 127 E---GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 848 FGYVAPEYAM-TCRVSDKADVYSYGVVLLELLSDK 881
Y PE + R DV+S G +L EL + K
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 62/235 (26%), Positives = 92/235 (39%), Gaps = 45/235 (19%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRL----AVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
IG G FG + + G + A+K L + R Q + AE L P +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKLY 67
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDW-RVLHKIALDIARALAYLHDQCVPR 803
E ++L+ Y+PGG+L N + ++ + R IA ++ AL +H
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY--IA-ELVLALDSVHKL---G 121
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLA-------------------------RLLGPSET 838
+HRD+KP NIL+D D + L+DFGL +
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 839 HATT---GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS 890
GT Y+APE + D +S GV+L E+L P F S
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG----FPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 48/206 (23%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 690 IGNGGFGATYK---AEISPGVL---VAIKRLAV-GRFQGVQQFHAEIKTLGRLRHPNLVT 742
+G G FG Y+ + G VAIK + + +F E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVL--------HKIALDIARALA 794
L+G ++ ++ + G+L+++++ R A + L ++A +IA +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG-TFGYVAP 853
YL + + +HRD+ N ++ +D + DFG+ R + ++ + G ++AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 854 EYAMTCRVSDKADVYSYGVVLLELLS 879
E + K+DV+S+GVVL E+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 690 IGNGGFGATYKAEISPG-----VLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTL 743
+G+G FG YK P + VAIK L + ++ E + + P + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+G + T + L+ +P G L +++++ R + + L + IA+ ++YL + R
Sbjct: 75 LGICLTST-VQLVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYLEEV---R 129
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET--HATTGVAGTFGYVAPEYAMTCRV 861
++HRD+ N+L+ + ++DFGLARLL ET HA G ++A E + R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALESILHRRF 188
Query: 862 SDKADVYSYGVVLLELLS 879
+ ++DV+SYGV + EL++
Sbjct: 189 THQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 9/199 (4%)
Query: 684 FNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLRHPN 739
F +G GGFG ++ + G + A KRL R + G E + L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+V L + ++ + L+ + GG+L+ I + A +I L LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
++RD+KP NILLDD + +SD GLA + E + G GT GY+APE
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 860 RVSDKADVYSYGVVLLELL 878
R + D + G ++ E++
Sbjct: 177 RYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 48/207 (23%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 690 IGNGGFGATYKAEISPG----VLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG+ + ++S + VA+K + + +++F +E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 744 IG--YHASETEMF----LIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARAL 793
IG + AS + +I ++ G+L +F+ + + L K +DIA +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYVA 852
YL ++ +HRD+ N +L +D ++DFGL++ + + + +A ++A
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 853 PEYAMTCRVSDKADVYSYGVVLLELLS 879
E + K+DV+++GV + E+ +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIK--RLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G+G +G YKA + G L A+K +L G F +QQ EI + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ S ++++ Y GG+L++ T + + + + + LAYLH + +
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR---VS 862
HRD+K +NILL D+ + L+DFG+A + + + + GT ++APE A + +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 863 DKADVYSYGVVLLEL 877
D+++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 690 IGNGGFGATYKAEIS-PGVLVAIKRL---AVGRFQGVQQFHAEIKTLG-RLRHPNLVTLI 744
+G G FG + AE+ AIK L V V+ E + L HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
++ +F + YL GG+L IQ S D A +I L +LH + +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSK---GI 117
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLAR--LLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
++RD+K NILLD D + ++DFG+ + +LG ++ T GT Y+APE + + +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPEILLGQKYN 174
Query: 863 DKADVYSYGVVLLELL 878
D +S+GV+L E+L
Sbjct: 175 TSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-13
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 690 IGNGGFGATYKAEISP--GVLVAIKRLAVGRFQGV---QQFHAEIKTLGRLRHPNLVTLI 744
IG G FG + + P G VA+K++ FQ + ++ E+K L +H N+++ +
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 745 GY----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH-KIAL-DIARALAYLHD 798
H E + L +L I + D H K+ L I R L YLH
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD----HVKVFLYQILRGLKYLHS 121
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+LHRD+KP N+L++ + + DFGLAR+ P E+ T T Y APE M
Sbjct: 122 A---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 859 CR-VSDKADVYSYGVVLLELLSDK 881
R + D++S G + ELL +
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 34/214 (15%)
Query: 690 IGNGGFGATYKAEISPGVL---VAIKRLA-VGRFQGVQQFHAEIKTLGRL-RHPNLVTLI 744
IG G FG KA I L AIKR+ + F E++ L +L HPN++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVD--------------WRVLHKIALDIA 790
G ++L Y P GNL +F+++ D + L A D+A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG- 849
R + YL + + +HRD+ NIL+ +++ A ++DFGL+R E + V T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY----VKKTMGR 172
Query: 850 ----YVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
++A E + +DV+SYGV+L E++S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 17/165 (10%)
Query: 728 EIKTLGRLRHPNLVTLI-GYHASETEMFLIYNYLPGGNLENFIQQR------STRAVDWR 780
E + L +L+HPN+V + + ++++ + GG+L + ++++ + V+W
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 781 VLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840
V IA AL YLH++ +LHRD+K N+ L + D G+AR+L A
Sbjct: 109 V------QIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159
Query: 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885
+T + GT Y++PE + K+DV++ G + E+ + K A +
Sbjct: 160 ST-LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 6e-13
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRL--AVGRFQGVQQFHAEIKTLGRLRHPN 739
+ IG+G +G A + G VAIK++ A ++ E+K L +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 740 LVTLIG-YHASETEMFLIYNY--LPGGNLENFIQQRST------RAVDWRVLHKIALDIA 790
++ + + +Y L +L + I R +++L
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLL-------- 117
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET----HATTGVAG 846
R L Y+H V +HRD+KPSN+L+++D + DFG+AR L S T T VA
Sbjct: 118 RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA- 173
Query: 847 TFGYVAPEYAMTC-RVSDKADVYSYGVVLLELL 878
T Y APE ++ + D++S G + E+L
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 31/204 (15%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEI---------------KTLGR 734
IG G FG VL+A KR G+ V+ +I L
Sbjct: 3 IGKGSFGK---------VLLA-KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 735 LRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALA 794
++HP LV L + +++ + +++ GG L F QR + R A +IA AL
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL-FFHLQRERSFPEPRARFYAA-EIASALG 110
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE 854
YLH +++RD+KP NILLD + L+DFGL + G +++ TT GT Y+APE
Sbjct: 111 YLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPE 166
Query: 855 YAMTCRVSDKADVYSYGVVLLELL 878
+ D + G VL E+L
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 684 FNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLG------RLR 736
F +G GGFG ++ + G + A K+L R +++ E L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR---IKKRKGEAMALNEKQILEKVN 58
Query: 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
+V+L + ++ + L+ + GG+L+ I D A +I L L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
H + R+++RD+KP NILLDD + +SD GLA + ET G GT GY+APE
Sbjct: 119 HRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVV 173
Query: 857 MTCRVSDKADVYSYGVVLLELLSDK 881
R + D + G ++ E++ K
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 9e-13
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGV---QQFHAEIKTLGRLRHPNLVTLIG 745
+G+G +G+ A + VA+K+L+ FQ + ++ + E++ L ++H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 746 YHASET------EMFLIYNYLPGGNLENFI--QQRSTRAVDWRVLHKIALDIARALAYLH 797
T E++L+ N L G +L N + Q+ S V + + + R L Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTN-LMGADLNNIVKCQKLSDEHVQFLIYQ-----LLRGLKYIH 135
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
++HRD+KPSN+ +++D + DFGLAR TG T Y APE +
Sbjct: 136 SA---GIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRAPEIML 188
Query: 858 T-CRVSDKADVYSYGVVLLELLSDKKALDP 886
+ D++S G ++ ELL KAL P
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKG-KALFP 217
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 20/200 (10%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIK--RLAV--GRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G +G+ YK P GV +A+K RL + +F + E+ L + P +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM---ELDILHKAVSPYIVDFY 65
Query: 745 GYHASETEMFLIYNYLPGGNLEN-FIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
G E +++ Y+ G+L+ + +T + VL +I + + L +L ++
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
++HRDVKP+N+L++ + L DFG++ L S A T + G Y+APE + +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNI-GCQSYMAPERIKSGGPNQ 180
Query: 864 ------KADVYSYGVVLLEL 877
++DV+S G+ +LE+
Sbjct: 181 NPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPN 739
G F +GNG +G YK + G L AIK + V + ++ EI L + H N
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRN 74
Query: 740 LVTLIGYHASET------EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARAL 793
+ T G ++ +++L+ + G++ + ++ A+ + I +I R L
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853
A+LH +V+HRD+K N+LL ++ L DFG++ L + T + GT ++AP
Sbjct: 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190
Query: 854 EYAMTCRVSD-----KADVYSYGVVLLEL 877
E D ++D++S G+ +E+
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 44/160 (27%), Positives = 83/160 (51%), Gaps = 25/160 (15%)
Query: 735 LRHPNLVTLIGYHASETEM-FLIYNYLPGGNLENFIQQ------RSTRAVDWRVLHKIAL 787
L H N++ ++ + E F++Y Y+ GNL+ F+QQ + +A+ + L +A+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT 847
IA ++YLH + V+H+D+ N ++D++ ++D L+R L P + H
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC------- 174
Query: 848 FG--------YVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
G ++A E + S +DV+S+GV+L EL++
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 31/205 (15%)
Query: 690 IGNGGFGATY----KAEISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTL 743
+G G FG Y K ++ L +K + VG + A E + L +L HP +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK- 66
Query: 744 IGYHAS--ETEMF-LIYNYLPGGNLENFIQQ--------RSTRAVDWRVLHKIALDIARA 792
+HAS E + F +I Y G +L+ +++ + +W + + +
Sbjct: 67 --FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH---- 120
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
Y+H + R+LHRD+K NI L ++ + DFG++RLL S ATT GT Y++
Sbjct: 121 --YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYMS 173
Query: 853 PEYAMTCRVSDKADVYSYGVVLLEL 877
PE K+D++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 44/147 (29%), Positives = 81/147 (55%), Gaps = 11/147 (7%)
Query: 743 LIGYHA---SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
L+G H+ + + +FL+ Y+ GG+L +Q++ R + A +I AL +LH++
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER 115
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGYVAPEYAMT 858
+++RD+K N+LLD D + L+D+G+ + LGP +T T+ GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRG 170
Query: 859 CRVSDKADVYSYGVVLLELLSDKKALD 885
D ++ GV++ E+++ + D
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 22/201 (10%)
Query: 690 IGNGGFGATY--KAEISP--GVLVAIKRL--AVGRFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG + + P G L A+K L A + + + E L + HP +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 744 IGYHASETE--MFLIYNYLPGGNLENFIQQRSTRAV---DWRVLHKIALDIARALAYLHD 798
++A +TE ++LI ++L GG+L R ++ V + V +A ++A AL +LH
Sbjct: 64 --HYAFQTEGKLYLILDFLRGGDLFT----RLSKEVMFTEEDVKFYLA-ELALALDHLHS 116
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+++RD+KP NILLD++ + L+DFGL++ E A + GT Y+APE
Sbjct: 117 L---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNR 172
Query: 859 CRVSDKADVYSYGVVLLELLS 879
+ AD +S+GV++ E+L+
Sbjct: 173 RGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-12
Identities = 46/142 (32%), Positives = 75/142 (52%), Gaps = 23/142 (16%)
Query: 463 LVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP-------SSL---------- 505
+V+++LS + +I + + ++ ++ ++L+ N L+G IP SSL
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 506 ------GQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTL 559
G + LE LDLS+N LSG IP+D+ + +L VL L N L GKIP+ L N+++L
Sbjct: 131 TGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSL 190
Query: 560 SAFNVSFNNLSGPLPSSKNLMK 581
++ N L G +P MK
Sbjct: 191 EFLTLASNQLVGQIPRELGQMK 212
|
Length = 968 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPN 739
G F +GNG +G YK + G L AIK + V + ++ EI L + H N
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRN 64
Query: 740 LVTLIGYHASET------EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARAL 793
+ T G + +++L+ + G++ + I+ + + I +I R L
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853
++LH +V+HRD+K N+LL ++ L DFG++ L + T + GT ++AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 180
Query: 854 EYAMTCRVSD-----KADVYSYGVVLLEL 877
E D K+D++S G+ +E+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 46/155 (29%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
HP LV L +E+ +F + Y+ GG+L +Q++ R + + +I+ AL YL
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYL 112
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGYVAPEY 855
H++ +++RD+K N+LLD + + L+D+G+ + L P +T T+ GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 167
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS 890
D ++ GV++ E+++ + D SS
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 29/193 (15%)
Query: 709 VAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA-------------SETEMFL 755
VA+K++ + Q V+ EIK + RL H N+V + Y S TE+
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--YEVLGPSGSDLTEDVGSLTELNS 90
Query: 756 IY--NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSN 813
+Y +L N ++Q R+ + R L Y+H VLHRD+KP+N
Sbjct: 91 VYIVQEYMETDLANVLEQGPLSEEHARLF---MYQLLRGLKYIHSA---NVLHRDLKPAN 144
Query: 814 ILLD-DDFNAYLSDFGLARLLGPSETHA---TTGVAGTFGYVAPEYAMTCRVSDKA-DVY 868
+ ++ +D + DFGLAR++ P +H + G+ + Y +P ++ KA D++
Sbjct: 145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMW 203
Query: 869 SYGVVLLELLSDK 881
+ G + E+L+ K
Sbjct: 204 AAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 24/189 (12%)
Query: 707 VLVAIKRLAVGRFQGV-QQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765
VLVA+K L + F E+K L RL PN+ L+G + + +I Y+ G+L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 766 ENFIQQR---------STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816
F+Q+ +++++ + L +A IA + YL +HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163
Query: 817 DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP------EYAMTCRVSDKADVYSY 870
++ ++DFG++R L S+ + G A P E + + + K+DV+++
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRA-----PLPIRWMAWESVLLGKFTTKSDVWAF 218
Query: 871 GVVLLELLS 879
GV L E+L+
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 690 IGNGGFGATYKAEISPG----VLVAIKRLAVGRFQGVQQFHAEIKTLG-RLRHPNLVTLI 744
+G G FG AE+ + A+K+ V V+ E + L HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
++ +F + YL GG+L IQ S R + R A +I L +LH + +
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARF-YAAEIICGLQFLHKK---GI 117
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
++RD+K N+LLD D + ++DFG+ + E A+T GT Y+APE + ++
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYNES 176
Query: 865 ADVYSYGVVLLELL 878
D +S+GV+L E+L
Sbjct: 177 VDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 672 LSFESVVQATGNFNASNCIGNGGFGATYK-AEISPGVLVAIKRLAVGRFQGVQQFHAEIK 730
L ES+ T + IG G +G YK G L A+K L ++ AE
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYN 70
Query: 731 TLGRL-RHPNLVTLIGY-----HASETEMFLIYNYLPGGNLENFIQ------QRSTRAVD 778
L L HPN+V G +++L+ GG++ ++ QR A+
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 779 WRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838
+L+ L L +LH+ R++HRDVK +NILL + L DFG++ L +
Sbjct: 131 SYILYGALL----GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 839 HATTGVAGTFGYVAPEYAMTCRVSD-----KADVYSYGVVLLEL 877
T V GT ++APE + D + DV+S G+ +EL
Sbjct: 184 RRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 684 FNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQG---VQQFHAE---IKTLGRLR 736
F +G G FG AE G L AIK L G V+ E +T R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIALDIARAL 793
HP LV L +E + + Y GG+L I RAV + A + L
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY------AACVVLGL 114
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGYVA 852
YLH+ ++++RD+K N+LLD + ++DFGL + +G + +T GT ++A
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFLA 169
Query: 853 PEYAMTCRVSDKADVYSYGVVLLELL 878
PE + D + GV++ E+L
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 45/135 (33%), Positives = 69/135 (51%), Gaps = 4/135 (2%)
Query: 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPS 812
+ L+ +Y G+L I+ R+ +R H+ L + L +H ++HRD+K +
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFRE-HEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 813 NILLDDDFNAYLSDFGLARLLGP--SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSY 870
NILL + L DFG +++ S+ T GT YVAPE S KAD++S
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 871 GVVLLELLSDKKALD 885
GV+L ELL+ K+ D
Sbjct: 232 GVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 690 IGNGGFGATYKAE---ISP---GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG + AE + P +LVA+K L Q F E + L L+H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRA-------------VDWRVLHKIALDIA 790
G + +++ Y+ G+L F++ A + + IA IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-VAGTFG 849
+ YL +HRD+ N L+ + DFG++R + ++ + G
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 850 YVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
++ PE + + + ++D++S+GVVL E+ +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 8e-12
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLR-HPNLVTLI 744
+G G FG A + G L A+K L + + V+ E + L R HP L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ +F + ++ GG+L IQ+ +R D A +I AL +LHD+ +
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK---GI 117
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
++RD+K N+LLD + + L+DFG+ + G T+ GT Y+APE
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 865 ADVYSYGVVLLELLS 879
D ++ GV+L E+L
Sbjct: 177 VDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 690 IGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGR-LRHPNLVTLI 744
IG G FG A +KAE + +++ A+ + + + +E L + ++HP LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ +++ + +Y+ GG L F + R A +IA AL YLH +
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSL---NI 117
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
++RD+KP NILLD + L+DFGL + + + T T+ GT Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDR 175
Query: 864 KADVYSYGVVLLELL 878
D + G VL E+L
Sbjct: 176 TVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 684 FNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLRHPN 739
F +G GGFG ++ + G + A K+L R + G E + L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+V+L + ++ + L+ + GG+L+ I D + A ++ L L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
R+++RD+KP NILLDD + +SD GLA + ET G GT GY+APE
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNE 176
Query: 860 RVSDKADVYSYGVVLLELL 878
+ + D + G ++ E++
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 690 IGNGGFGATYKAEI--------SPGVLVAIKRLAV-GRFQGVQQFHAEIKTLGRL-RHPN 739
+G G FG AE + V VA+K L + + +E++ + + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDW--------------RVLHKI 785
++ L+G + ++++ Y GNL +++ R +D+ + L
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-ATTGV 844
A +AR + YL Q + +HRD+ N+L+ +D ++DFGLAR + + + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 845 AGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLS 879
++APE A+ RV + ++DV+S+GV+L E+ +
Sbjct: 197 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 8/157 (5%)
Query: 727 AEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIA 786
+E+ L H +V S+ ++ LI Y GG+L I+QR + ++ +++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQE-YEVG 172
Query: 787 L---DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET-HATT 842
L I AL +H + + +HRD+K +NI L L DFG ++ S + +
Sbjct: 173 LLFYQIVLALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
GT Y+APE R S KAD++S GV+L ELL+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIGYH 747
+G G + YK LVA+K + + +G E+ L L+H N+VTL
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL---DIARALAYLHDQCVPRV 804
+E + L++ YL + ++Q + +H + L + R L Y H + +V
Sbjct: 74 HTEKSLTLVFEYL-----DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAM-TCRVS 862
LHRD+KP N+L+++ L+DFGLAR P++T++ V T Y P+ + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYS 183
Query: 863 DKADVYSYGVVLLELLSDK 881
+ D++ G + E+ + +
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIGYH 747
+G G + +K LVA+K + + +G E+ L L+H N+VTL
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL---DIARALAYLHDQCVPRV 804
++ + L++ YL + ++Q + +H + + I R LAY H + +V
Sbjct: 74 HTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KV 125
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAM-TCRVS 862
LHRD+KP N+L+++ L+DFGLAR P++T++ V T Y P+ + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183
Query: 863 DKADVYSYGVVLLELLSDK 881
+ D++ G + E+ S +
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 16/148 (10%)
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQ----RSTRAVDWRVLHKIALDIAR 791
+HP L L ++ +F + Y+ GG+L IQ+ RA + A +I
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVL 107
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGY 850
L +LH++ +++RD+K N+LLD + + ++DFG+ + + T T+ GT Y
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDY 162
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELL 878
+APE D ++ GV+L E+L
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 20/199 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQ--------QFHAEIKTLGRLRHPNL 740
IG GGFG Y + G + A+K L R + Q + + + G P +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC--PFI 59
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
V + + ++ I + + GG+L + Q + + A +I L ++H++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF 117
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
V ++RD+KP+NILLD+ + +SD GLA + HA+ GT GY+APE
Sbjct: 118 V---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 861 VSD-KADVYSYGVVLLELL 878
D AD +S G +L +LL
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIGYH 747
+G G + +K LVA+K + + +G E+ L L+H N+VTL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL---DIARALAYLHDQCVPRV 804
+E + L++ YL ++ ++Q + +H + + + R L+Y H + ++
Sbjct: 73 HTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAM-TCRVS 862
LHRD+KP N+L+++ L+DFGLAR P++T++ V T Y P+ + + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 863 DKADVYSYGVVLLELLSDK 881
D++ G +L E+ + +
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 690 IGNGGFGATYKAEIS--PGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIG 745
+G G + YK IS G LVA+K +++ +GV F A E L L+H N+V L
Sbjct: 13 LGEGSYATVYKG-ISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 746 Y-HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
H ET F ++ Y+ +L ++ Q + V + R LAY+H Q +
Sbjct: 71 IIHTKETLTF-VFEYMHT-DLAQYMIQHPGGLHPYNVR-LFMFQLLRGLAYIHGQ---HI 124
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAM-TCRVS 862
LHRD+KP N+L+ L+DFGLAR PS+T+++ V T Y P+ + S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182
Query: 863 DKADVYSYGVVLLELLSDKKALDPSFSSYGNGF 895
D++ G + +E+L + P+F + F
Sbjct: 183 SALDIWGAGCIFIEMLQGQ----PAFPGVSDVF 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 41/150 (27%), Positives = 81/150 (54%), Gaps = 8/150 (5%)
Query: 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
HP LV L +E+ +F + ++ GG+L +Q++ R + + +I+ AL +L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFL 112
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGYVAPEY 855
H++ +++RD+K N+LLD + + L+D+G+ + + P +T +T GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST--FCGTPNYIAPEI 167
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDKKALD 885
D ++ GV++ E+++ + D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 689 CIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGV---QQFHAEIKTLGRLRHPNLVTLI 744
IG G +G A+ S VAIK++A F ++ EIK L L H N++ +
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 745 G-----YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+ + +++++Y L +L I RS++ + + R L Y+H
Sbjct: 71 DIMPPPHREAFNDVYIVYE-LMDTDLHQII--RSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
VLHRD+KPSN+LL+ + + + DFGLAR T V T Y APE + C
Sbjct: 128 ---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNC 183
Query: 860 RVSDKA-DVYSYGVVLLELLSDKKALDP 886
A DV+S G + ELL +K L P
Sbjct: 184 SEYTTAIDVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 690 IGNGGFGATYKAEISPG------VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVT 742
+G G FG + A+ LV +K L + + +Q F E+ +L H N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWR-----VLHKIAL--DIARALAY 795
L+G ++I Y G+L+ F++ ++ + K+AL IA + +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
L + R +HRD+ N L+ +S L++ + SE + ++APE
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 856 AMTCRVSDKADVYSYGVVLLELLS 879
S K+DV+S+GV++ E+ +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 53/207 (25%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 690 IGNGGFGATYKAEISPG---VLVAIK--RLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G FG+ + +++ + VA+K ++A+ ++ F +E + HPN++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 745 G--YHASETEMF----LIYNYLPGGNLENFIQQRSTRAVDW------RVLHKIALDIARA 792
G E+E + +I ++ G+L +F+ +R D ++L K DIA
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLY--SRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYV 851
+ YL + +HRD+ N +L+++ N ++DFGL++ + + + +A ++
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 852 APEYAMTCRV-SDKADVYSYGVVLLEL 877
A E ++ RV + K+DV+S+GV + E+
Sbjct: 182 AIE-SLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 10/194 (5%)
Query: 690 IGNGGFGATYKAEISPG----VLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
IG G FG + L I++ + V AE L ++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
S +++L+ ++ GG L + +Q R R R A ++ AL LH V+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYTA-ELLCALENLHKF---NVI 115
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
+RD+KP NILLD + L DFGL + L + T GT Y+APE + +
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 866 DVYSYGVVLLELLS 879
D ++ GV+L E+L+
Sbjct: 175 DWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 690 IGNGGFG----ATYKAEISPGVLVAIKRL--AVGRFQGVQQFHAEIKTLGRLR-HPNLVT 742
+G G +G A AE S VAIK++ + ++ E+K L R H N+
Sbjct: 8 LGQGAYGIVCSARN-AETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 743 L----IGYHASETEMFLIYNYLPGGNLENFIQ--QRSTRAVDWRVLHKIALDIARALAYL 796
L I + + E++L Y L +L I+ Q T A +++I L Y+
Sbjct: 67 LYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIYQIL----CGLKYI 121
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT-----TGVAGTFGYV 851
H VLHRD+KP N+L++ D + DFGLAR G SE T T Y
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLAR--GFSENPGENAGFMTEYVATRWYR 176
Query: 852 APEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
APE ++ + KA DV+S G +L ELL K
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 6/144 (4%)
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
+HP L L ++ +F + Y+ GG+L IQ+ +R D A ++ AL +
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMF 111
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
LH V++RD+K NILLD + + L+DFG+ + G TT GT Y+APE
Sbjct: 112 LHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEI 167
Query: 856 AMTCRVSDKADVYSYGVVLLELLS 879
D ++ GV++ E+++
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMA 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
+FN +G G FG AE L AIK L V + V+ E + L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 739 NLVT-LIGYHASETEMFLIYNYLPGGNLENFIQQ----RSTRAVDWRVLHKIALDIARAL 793
+T L + ++ + Y+ GG+L IQQ + +AV + A +I+ L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGL 114
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA-----GTF 848
+LH + +++RD+K N++LD + + ++DFG+ + H GV GT
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK------EHMVDGVTTRTFCGTP 165
Query: 849 GYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885
Y+APE D ++YGV+L E+L+ + D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 64/299 (21%), Positives = 123/299 (41%), Gaps = 50/299 (16%)
Query: 690 IGNGGFGATYKA---EIS--PGVL-VAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVT 742
+G G FG KA + G VA+K L ++ +E L ++ HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQR----------------------STRAVDWR 780
L G + + + LI Y G+L +F+++ RA+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 781 VLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840
L A I+R + YL + +++HRD+ N+L+ + +SDFGL+R + +++
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 841 TTGVAGT-FGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899
++A E + ++DV+S+GV+L E+++ P + FN++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFNLLK 243
Query: 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
G + R E E+ +L + C RPT + + L+++
Sbjct: 244 TGYRMERPENCSE----------------EMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 690 IGNGGFGATYKAEISPGV---LVAIKRLAV-GRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
IGNG FG E++ G V +K L V Q +F E + L+H NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAV-----DWRVLHKIALDIARALAYLHDQC 800
T L+ + P G+L+ ++ RS R D L ++A +IA L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYVAPEYA--- 856
+H D+ N LL D + D+GL+ + + T ++APE
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 857 ----MTCRVSDKADVYSYGVVLLELL 878
+ + +++V+S GV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 3/110 (2%)
Query: 7 LDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTV 66
L L+ L G +P+ L+ L+ +NL N I G IP S +LE L+L+ N NG++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 67 PTFIGR---LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIP 113
P +G+ L+ + L+ N L G VP+ +G + + + + N + GIP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 67/206 (32%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA---EIKTLGRLRHPNLVTL-- 743
IG G +G A + G VAIK++ F+ V EIK L LRHP++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 744 IGYHASETEMFLIYNY--LPGGNLENFIQQRSTRAVDWRVLHKIAL-DIARALAYLHDQC 800
I S E IY L +L I+ + H+ L + RAL Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH---HQFFLYQLLRALKYIH--- 120
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL---GPSETHATTGVAGTFGYVAPEY-- 855
V HRD+KP NIL + D + DFGLAR+ P+ T VA T Y APE
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-TRWYRAPELCG 179
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDK 881
+ + + D++S G + E+L+ K
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 74/297 (24%), Positives = 134/297 (45%), Gaps = 51/297 (17%)
Query: 690 IGNGGFGATYKAE---ISPG-----VLVAIKRLA-VGRFQGVQQFHAEIKTLGRL-RHPN 739
+G G FG +AE I V VA+K L + + +E++ + + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVD--------------WRVLHKI 785
++ L+G E +++I Y GNL F++ R D ++ L
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-ATTGV 844
A +AR + YL + R +HRD+ N+L+ +D ++DFGLAR + + + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 845 AGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903
++APE A+ RV + ++DV+S+G+++ E+ F+ G+ + + +
Sbjct: 197 RLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEI----------FTLGGSPYPGIPVEEL 245
Query: 904 --LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
LLR+G + P + E+ L C + RPT KQ+V L ++
Sbjct: 246 FKLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 39/226 (17%)
Query: 690 IGNGGFGATYKAEI-SP----------------GVLVAIKRLAVGRFQGVQQ-FHAEIKT 731
+G G FG + E+ +P +LVA+K L + + F E+K
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 732 LGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTR---------------- 775
L RL+ PN++ L+G E + +I Y+ G+L F+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 776 -AVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834
A+ + L +AL IA + YL +HRD+ N L+ ++ ++DFG++R L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 835 PSETHATTGVAG-TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
+ + G A ++A E + + + +DV+++GV L E+L
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 20/166 (12%)
Query: 729 IKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDW--------- 779
+K +G+ H N++ L+G + +++I Y GNL +++ R +++
Sbjct: 77 MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 780 -----RVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834
+ L A +AR + YL + + +HRD+ N+L+ +D ++DFGLAR +
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 835 PSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
+ + TT ++APE + ++DV+S+GV+L E+ +
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 36/228 (15%)
Query: 688 NCIGNGGFGATYKAE-ISPGVLVAIKRL--------AVGRFQGVQQ----FHA--EIKTL 732
+G G +G KA G +VAIK++ Q V F E+K +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 733 GRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARA 792
++H N++ L+ + + L+ + + +L+ + ++ R + +V I L I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK-IRLTESQV-KCILLQILNG 131
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG-------------PSETH 839
L LH +HRD+ P+NI ++ ++DFGLAR G
Sbjct: 132 LNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 840 ATTGVAGTFGYVAPEYAM-TCRVSDKADVYSYGVVLLELLSDKKALDP 886
T T Y APE M + D++S G + ELL+ K L P
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKPLFP 235
|
Length = 335 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 9/217 (4%)
Query: 684 FNASNCIGNGGFGATYKAE-ISPGVLVAIKRL--AVGRFQGVQQFHAEIKTLGRLRHPNL 740
F +G G +G K +VAIK+ + + + E+K L L+ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
V L +++L++ Y+ LE +++ +V I + +A+ + H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN- 119
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
++HRD+KP N+L+ + L DFG AR L T T Y +PE +
Sbjct: 120 --DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 861 VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNI 897
D++S G +L E LSD + L P S F I
Sbjct: 178 YGKAVDMWSVGCILGE-LSDGQPLFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 684 FNASNC-IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGV---QQFHAEIKTLGRLRHPN 739
F C +G G +G YKA+ G K A+ + +G EI L L+HPN
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 740 LVTL--IGYHASETEMFLIYNYLPGGNLENFIQ-QRSTRA------VDWRVLHKIALDIA 790
++ L + S+ +++L+++Y +L + I+ R+++A + ++ + I
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILL----DDDFNAYLSDFGLARLL-GPSETHATTG-V 844
+ YLH V LHRD+KP+NIL+ + ++D G ARL P + A V
Sbjct: 119 DGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 845 AGTFGYVAPEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
TF Y APE + R KA D+++ G + ELL+ +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLA---VGRFQGVQQFHAEIKTLGR---LRHPNLVT 742
IG G FG Y+ + + A+K L+ + + V E L R P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L ++++++L+ +Y+ GG L +Q+ R + R IA ++ AL +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIA-ELVLALEHLHKY--- 115
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
+++RD+KP NILLD + L DFGL++ ++ T GT Y+APE + +
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 863 DK-ADVYSYGVVLLEL 877
K D +S GV++ E+
Sbjct: 175 TKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 690 IGNGGFGATYKAEIS-PGVLVAIKRL---AVGRFQGVQQFHAEIKTLG-RLRHPNLVTLI 744
+G G FG AE+ G A+K L V V+ E + L +P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQC 800
++ +F + +L GG+L IQ + RA + A +I L +LH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY------AAEIVCGLQFLHSK- 115
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
+++RD+K N++LD D + ++DFG+ + + A+T GT Y+APE +
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLK 172
Query: 861 VSDKADVYSYGVVLLELL 878
+ D +S+GV+L E+L
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 45/211 (21%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
+G G + YK G LVA+K + + +G F A E L L+H N+VTL
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHDI 71
Query: 747 HASETEMFLIYNYL-----------PGG----NLENFIQQRSTRAVDWRVLHKIALDIAR 791
++ + L++ YL GG N+ F+ Q + R
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ-----------------LLR 114
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGY 850
LAY H + RVLHRD+KP N+L+ + L+DFGLAR PS+T++ V T Y
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWY 169
Query: 851 VAPEYAM--TCRVSDKADVYSYGVVLLELLS 879
P+ + T S D++ G + E+ +
Sbjct: 170 RPPDVLLGSTE-YSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 727 AEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIA 786
E + +L +P +V +IG +E+ M L+ G L F+Q+ + V + + ++
Sbjct: 45 REANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQK--NKHVTEKNITELV 101
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG 846
++ + YL + +HRD+ N+LL A +SDFGL++ LG E + G
Sbjct: 102 HQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158
Query: 847 TF--GYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
+ + APE + S K+DV+S+GV++ E S
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 24/189 (12%)
Query: 707 VLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765
VLVA+K L F EIK + RL+ PN++ L+ + + +I Y+ G+L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 766 ENFI---------QQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816
F+ ++ + + L +A IA + YL +HRD+ N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163
Query: 817 DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP------EYAMTCRVSDKADVYSY 870
++ ++DFG++R L + + G A V P E + + + +DV+++
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRA-----VLPIRWMSWESILLGKFTTASDVWAF 218
Query: 871 GVVLLELLS 879
GV L E+L+
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLV 741
++ N IGNG FG Y+A I VAIK++ Q Q + E+ + L H N++
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINII 122
Query: 742 TLIGYHASET------EMFL--IYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIAR 791
L Y+ +E +FL + ++P + +++ R+ A+ ++ + + R
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAY-LSDFGLAR-LLGPSETHATTGVAGTFG 849
ALAY+H + + HRD+KP N+L+D + + L DFG A+ LL + + + F
Sbjct: 182 ALAYIHSKFI---CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRF- 235
Query: 850 YVAPEYAM-TCRVSDKADVYSYGVVLLELL 878
Y APE + + D++S G ++ E++
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 690 IGNGGFGATY---KAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTL--- 743
IG GGFG Y KA+ G + A+K L R + Q E L +LV+
Sbjct: 2 IGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQ---GETLALNERIMLSLVSTGDC 56
Query: 744 -------IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
+H + F I + + GG+L + Q + + A +I L ++
Sbjct: 57 PFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAEMRFY--AAEIILGLEHM 113
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
H++ V ++RD+KP+NILLD+ + +SD GLA + HA+ GT GY+APE
Sbjct: 114 HNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 857 MTCRVSD-KADVYSYGVVLLELL 878
D AD +S G +L +LL
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGV--LVAIKRL---AVGRFQGVQQFHAEIKTLGRLRH 737
+FN +G G FG AE G L AIK L + + V+ E + L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 738 PN-LVTLIGYHASETEMFLIYNYLPGGNLENFIQQ----RSTRAVDWRVLHKIALDIARA 792
P L L + ++ + Y+ GG+L IQQ + AV + A +IA
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AAEIAIG 113
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR--LLGPSETHATTGVAGTFGY 850
L +LH + +++RD+K N++LD + + ++DFG+ + + G T GT Y
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTPDY 167
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885
+APE D +++GV+L E+L+ + D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 690 IGNGGFGATYKAEI--------SPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRL-RHPN 739
+G G FG AE V VA+K L + + +E++ + + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRS----------TRAVD----WRVLHKI 785
++ L+G + +++I Y GNL +++ R R D ++ L
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-ATTGV 844
+AR + YL Q + +HRD+ N+L+ ++ ++DFGLAR + + + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 845 AGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLS 879
++APE A+ RV + ++DV+S+GV++ E+ +
Sbjct: 200 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 684 FNASNC-IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGV---QQFHAEIKTLGRLRHPN 739
F C +G G +G YKA+ G + A+ + +G EI L L+HPN
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 740 LVTL--IGYHASETEMFLIYNYLPGGNLENFIQ-QRSTRAVDWRV------LHKIALDIA 790
+++L + ++ +++L+++Y +L + I+ R+++A V + + I
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILL----DDDFNAYLSDFGLARLL-GPSETHATTG-V 844
+ YLH V LHRD+KP+NIL+ + ++D G ARL P + A V
Sbjct: 119 DGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 845 AGTFGYVAPEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
TF Y APE + R KA D+++ G + ELL+ +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 690 IGNGGFGAT-YKAEISPGVLVAIKRLAVGRFQG---VQQFHAEIKTLGRLRHPNLVTLIG 745
+G+G +G + G VAIK+L FQ ++ + E++ L ++H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 746 YHASE------TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+ + +L+ ++ G +L ++ + + R+ + + + L Y+H
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQF-LVYQMLKGLKYIH-- 135
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT- 858
++HRD+KP N+ +++D + DFGLAR TG T Y APE +
Sbjct: 136 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILNW 190
Query: 859 CRVSDKADVYSYGVVLLELLSDK 881
+ D++S G ++ E+L+ K
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 9e-10
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 43/209 (20%)
Query: 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
+G G + YK + G LVA+K + + +G F A E L L+H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 747 HASETEMFLIYNYL-----------PGG----NLENFIQQRSTRAVDWRVLHKIALDIAR 791
++ + L++ Y+ PGG N++ F+ Q + R
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQ-----------------LLR 114
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGY 850
L+Y+H + +LHRD+KP N+L+ D L+DFGLAR PS T++ V T Y
Sbjct: 115 GLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWY 169
Query: 851 VAPEYAM-TCRVSDKADVYSYGVVLLELL 878
P+ + + S D++ G + +E++
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 34/83 (40%), Positives = 50/83 (60%), Gaps = 1/83 (1%)
Query: 83 LVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGM 142
L G +P+ I K +L+ ++LSGN + G IP SLG+ + L L N +IP LG
Sbjct: 430 LRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 143 LQNLEVLDVSRNSLSGSIPVDLG 165
L +L +L+++ NSLSG +P LG
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-09
Identities = 23/60 (38%), Positives = 32/60 (53%)
Query: 486 GLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545
LK L L+ N LT + L L+VLDLS N+L+ + P+ L +L L L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 37/94 (39%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS-ETHATTGVAGTFGY 850
ALAYLH + ++HRDVK NI LD+ NA L DFG A L +T G +GT
Sbjct: 197 ALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELLSDKKAL 884
+PE K D++S G+VL E+ L
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIK--RLAVGRFQGVQQFH-AEIKTLGRLRH-PNLVTLI 744
IG G +G YKA + + G LVA+K RL + +G+ EI L L +V L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLL 67
Query: 745 GYHASETE-----MFLIYNYLPGGNLENFI---QQRSTRAVDWRVLHKIALDIARALAYL 796
E + ++L++ YL +L+ F+ + R + + + + + +A+
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAY-LSDFGLARLLG---PSETHATTGVAGTFGYVA 852
H V+HRD+KP N+L+D ++D GL R S TH T Y A
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLWYRA 179
Query: 853 PEYAMTCR-VSDKADVYSYGVVLLELLSDKKALDP 886
PE + S D++S G + E+ K+ L P
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFP 213
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
+F+ + +G G FG E + G + A+K + + + V F E L P
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
+ L + ++L+ Y PGG+L + + R D + ++ A+ +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+HRD+KP N+L+D + L+DFG A L ++ + GT Y+APE T
Sbjct: 121 M---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 859 CRVSDKA------DVYSYGVVLLELL 878
K D +S GV+ E++
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 48/187 (25%), Positives = 77/187 (41%), Gaps = 20/187 (10%)
Query: 706 GVLVAIKRLAVGRFQGVQQFHAEI--------------KTLGRLRHPNLVTLIGYHASET 751
G ++ ++ A GR+ ++ E+ + L RHP L L +
Sbjct: 9 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 68
Query: 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP 811
+ + Y GG L F R +I AL YLH + V++RD+K
Sbjct: 69 RLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKL 123
Query: 812 SNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYG 871
N++LD D + ++DFGL + G S+ GT Y+APE D + G
Sbjct: 124 ENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 872 VVLLELL 878
VV+ E++
Sbjct: 183 VVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 6/151 (3%)
Query: 728 EIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL 787
E + L RHP L +L ++ + + Y+ GG L F R
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA 102
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT 847
+I AL YLH ++++RD+K N++LD D + ++DFGL + G ++ GT
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGT 158
Query: 848 FGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
Y+APE D + GVV+ E++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 690 IGNGGFGATYKAEISPGVLVA---IKRL-AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
IGNG FG +EI VA +K L A + +F + L+HPN++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 746 YHASETEMFLIYNYLPGGNLENFI--QQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
L++ Y G+L++++ +Q R +L ++A +IA + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS---ETHATT--GVAGTFGYVAPEYA-- 856
LH D+ N L D + D+G +GPS E + T ++APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYG----IGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 857 -----MTCRVSDKADVYSYGVVLLELLSDKKALDPSFS 889
+T + ++V++ GV L EL + S
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 737 HPNLVTLIGYHASET--EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALA 794
+PN + L Y++ T LI +Y+ G+L + +++ + + KI + AL
Sbjct: 68 NPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALN 123
Query: 795 YLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853
LH ++H D+K N+L D YL D+GL +++G + GT Y +P
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 854 EYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
E + D + D ++ GV+ ELL+ K
Sbjct: 176 E-KIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 53/214 (24%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRLA---VGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G GG+G + A+ G +VA+KR+ + + V+ E L + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 746 YHASETEMFLIYNYLPGGNLENFI------QQRSTR--------AVDWRVLHKIALDIAR 791
+ ++L Y+PGG+ + + R AVD LH+
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD--ALHE------- 119
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851
L Y+H RD+KP N L+D + L+DFGL++ + ++ V G+ Y+
Sbjct: 120 -LGYIH---------RDLKPENFLIDASGHIKLTDFGLSK-GIVTYANS---VVGSPDYM 165
Query: 852 APE------YAMTCRVSDKADVYSYGVVLLELLS 879
APE Y T D +S G +L E L
Sbjct: 166 APEVLRGKGYDFTV------DYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQ-----FHAEIKTLGRLRH 737
+++ IG G FG V +L + +F+ +++ F E +
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
P +V L + ++++ Y+PGG+L N + W + ++ AL +H
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFY--TAEVVLALDAIH 159
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA-RLLGPSETHATTGVAGTFGYVAPE-- 854
++HRDVKP N+LLD + L+DFG ++ T V GT Y++PE
Sbjct: 160 SM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVL 215
Query: 855 --------YAMTCRVSDKADVYSYGVVLLELL 878
Y C D +S GV L E+L
Sbjct: 216 KSQGGDGYYGREC------DWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-09
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 50/231 (21%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRL-------AVGRFQGVQ-----QFHAEIKTLGRLRH 737
IGNG FG + LV KR A+ ++G++ Q E+ + L+H
Sbjct: 21 IGNGRFGEVF--------LVKHKRTQEFFCWKAIS-YRGLKEREKSQLVIEVNVMRELKH 71
Query: 738 PNLVTLIG--YHASETEMFLIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARAL 793
N+V I + + +++++ + G+L IQ+ + ++ + I + AL
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 794 AYLHD-QCVP---RVLHRDVKPSNILLD-------------DDFN----AYLSDFGLARL 832
AY H+ + P RVLHRD+KP NI L ++ N A + DFGL++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 833 LGPSETHATTGVAGTFGYVAPEYAM--TCRVSDKADVYSYGVVLLELLSDK 881
+G E+ A + V GT Y +PE + T DK+D+++ G ++ EL S K
Sbjct: 192 IG-IESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 9/144 (6%)
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
PN+V L Y SE +FL+ + GG L + I + + + + A ++ AL LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALH 102
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
+ ++ RD+ P+NILLDD + L+ F + S G A Y APE
Sbjct: 103 RE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGG 155
Query: 858 TCRVSDKADVYSYGVVLLELLSDK 881
++ D +S G +L ELL+ K
Sbjct: 156 ISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQ-----FHAEIKTLGRLR 736
+F+ IG G FG S + A+K L+ +F+ +++ F E +
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHAN 101
Query: 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
+V L + ++++ Y+PGG+L N + W + ++ AL +
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFY--TAEVVLALDAI 158
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA-RLLGPSETHATTGVAGTFGYVAPEY 855
H +HRDVKP N+LLD + L+DFG ++ T V GT Y++PE
Sbjct: 159 HSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEV 214
Query: 856 AMTCRVSD----KADVYSYGVVLLELL 878
+ + D +S GV L E+L
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 34/142 (23%), Positives = 64/142 (45%), Gaps = 8/142 (5%)
Query: 689 CIGNGGFGATYKAEISPGVLVAIKR--LAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY 746
C + K + + LVA+K+ L + ++ EI T +L+HPN++ +
Sbjct: 9 CFEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH-DQCVPRVL 805
++E++++ + G+ E+ ++ + + I D+ AL Y+H +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI---- 123
Query: 806 HRDVKPSNILLDDDFNAYLSDF 827
HR VK S+ILL D LS
Sbjct: 124 HRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 1e-08
Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
NL+ LDL N L I + L +L+VL+L N +T P +FS +L L+L+GN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 684 FNASNCIGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRH 737
F +G G FG A K+E VA+K L F +++F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 738 PNLVTLIGYHA-SETEMFL-----IYNYLPGGNLENFIQQ----RSTRAVDWRVLHKIAL 787
PN++ LIG S + L I ++ G+L F+ + + L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT 847
DIA + YL + +HRD+ N +L+++ ++DFGL++ + S + G A
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKI-YSGDYYRQGCASK 176
Query: 848 F--GYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
++A E + +DV+++GV + E+++
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 19/187 (10%)
Query: 706 GVLVAIKRLAVGRFQGVQQFHAEI--------------KTLGRLRHPNLVTLIGYHASET 751
G ++ +K A GR+ ++ E+ + L RHP L L +
Sbjct: 9 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 68
Query: 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP 811
+ + Y GG L F R +I AL YLH + V++RD+K
Sbjct: 69 RLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKL 124
Query: 812 SNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYG 871
N++LD D + ++DFGL + G + GT Y+APE D + G
Sbjct: 125 ENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 872 VVLLELL 878
VV+ E++
Sbjct: 184 VVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 44/151 (29%), Positives = 64/151 (42%), Gaps = 6/151 (3%)
Query: 728 EIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL 787
E + L RHP L L + + + Y GG L F R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT 847
+I AL YLH V++RD+K N++LD D + ++DFGL + G S+ GT
Sbjct: 103 EIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGT 158
Query: 848 FGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
Y+APE D + GVV+ E++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-08
Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 17/164 (10%)
Query: 724 QFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI--------YNYLPGGNLENFIQQRSTR 775
Q EI LGRL H N++ + SE ++I Y+++ R
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----DWKDR 263
Query: 776 AVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835
+ + I + A+ Y+HD+ +++HRD+K NI L+ D L DFG A
Sbjct: 264 PLLKQT-RAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
Query: 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
G GT +PE + D++S G++LL++LS
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG---VQQFHAEIKTLGRLRHPNLVTLIG 745
+G+G +G+ A + G VAIK+L+ FQ ++ + E+ L ++H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 746 YHASETEMFLIYN-YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
S + YL ++ +Q+ + + + + L Y+H +
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GI 138
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA---TTGVAGTFGYVAPEYAMT-CR 860
+HRD+KP N+ +++D + DFGLAR HA TG T Y APE +
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 861 VSDKADVYSYGVVLLELLSDK 881
+ D++S G ++ E+L+ K
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 47/195 (24%), Positives = 88/195 (45%), Gaps = 9/195 (4%)
Query: 690 IGNGGFGATYKAEIS-PG---VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTLI 744
+G G FG + + P + VAI L G ++ F AE TLG+ H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G M ++ Y+ G L++F+++ + V +++ + +A + YL +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP-GLASGMKYLSEM---GY 128
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
+H+ + +L++ D +S F + + T + APE S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188
Query: 865 ADVYSYGVVLLELLS 879
+DV+S+G+V+ E++S
Sbjct: 189 SDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-08
Identities = 50/173 (28%), Positives = 68/173 (39%), Gaps = 36/173 (20%)
Query: 101 LDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSI 160
L L L G IP + ++S+ L N + IP LG + +LEVLD+S NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 161 PVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPN 220
P LG + L IL L+ N G +P A+
Sbjct: 483 PESLGQLTSLRILNLNG---------------------------NSLSGRVPAALGGRL- 514
Query: 221 LRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGV-LGPCKNLLFL 272
L RA+ NF N G C + G + G +G+ G LFL
Sbjct: 515 LH-----RASF--NFTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSVAFLFL 560
|
Length = 623 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 690 IGNGGFG---ATYKAEISPGVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLV 741
IG+G G A Y A + V AIK+L+ FQ Q HA E+ + + H N++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQ--NQTHAKRAYRELVLMKCVNHKNII 79
Query: 742 TLIGYHASET------EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
+L+ + +++L+ L NL IQ +D + + + + +
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKH 134
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
LH ++HRD+KPSNI++ D + DFGLAR G S T T Y APE
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEV 189
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDK 881
+ + D++S G ++ E++ K
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845
+ +AR + +L + + +HRD+ NILL ++ + DFGLAR + + G A
Sbjct: 179 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 846 G-TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904
++APE + ++DV+S+GV+L E+ S + P G I C
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-------GVQIDEEFCRR 288
Query: 905 LRQG---RAKEFFTA-------GLWDAGPHD-----DLVEVL 931
L++G RA E+ T W P D +LVE+L
Sbjct: 289 LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 30/78 (38%), Positives = 42/78 (53%)
Query: 4 LEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVN 63
L+ ++L GN + G +P S + SL VL+L +N G IP S +L LNL GN ++
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503
Query: 64 GTVPTFIGRLKRVYLSFN 81
G VP +G SFN
Sbjct: 504 GRVPAALGGRLLHRASFN 521
|
Length = 623 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 31/233 (13%)
Query: 665 FTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRL-AVGRFQGV 722
F G + F+S + + IG G +G +K G A+K L +
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-- 58
Query: 723 QQFHAEIKTLGRLR-HPNLVTLIGYHASET-----EMFLIYNYLPGGNLENFIQ------ 770
++ AE L L HPN+V G + + +++L+ GG++ + ++
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118
Query: 771 QRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830
+R + +LH+ + L +LH + +HRDVK +NILL + L DFG++
Sbjct: 119 ERMEEPIIAYILHEALM----GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
Query: 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCR------VSDKADVYSYGVVLLEL 877
L + T V GT ++APE + C + DV+S G+ +EL
Sbjct: 172 AQLTSTRLRRNTSV-GTPFWMAPE-VIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 54/152 (35%), Positives = 78/152 (51%), Gaps = 6/152 (3%)
Query: 431 EIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMK-GLKY 489
E L LD + N++ I + EL +L +L+L N + IP +G +K LK
Sbjct: 87 ENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNI-TDIPPLIGLLKSNLKE 144
Query: 490 LSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKI 549
L L+ N + S+PS L L L+ LDLS N LS +P L NL NL L L+ NK+S +
Sbjct: 145 LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DL 201
Query: 550 PSGLANVSTLSAFNVSFNNLSGPLPSSKNLMK 581
P + +S L ++S N++ L S NL
Sbjct: 202 PPEIELLSALEELDLSNNSIIELLSSLSNLKN 233
|
Length = 394 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 25/201 (12%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
IG+G G A + G+ VA+K+L+ FQ Q HA E+ L + H N+++L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQ--NQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 744 IGYHASET------EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
+ + +++L+ L NL I +D + + + + +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME----LDHERMSYLLYQMLCGIKHLH 140
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
++HRD+KPSNI++ D + DFGLAR T T Y APE +
Sbjct: 141 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVIL 195
Query: 858 TCRVSDKADVYSYGVVLLELL 878
+ D++S G ++ EL+
Sbjct: 196 GMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGV--LVAIKRL---AVGRFQGVQQFHAEIKTLGRLRH 737
+FN +G G FG AE G L AIK L V + V+ E + L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 738 PNLVT-LIGYHASETEMFLIYNYLPGGNLENFIQQ----RSTRAVDWRVLHKIALDIARA 792
P +T L + ++ + Y+ GG+L IQQ + AV + A +IA
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAEIAIG 113
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
L +LH + +++RD+K N++LD + + ++DFG+ + + T GT Y+A
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIA 169
Query: 853 PEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885
PE D +++GV+L E+L+ + +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 26/181 (14%)
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845
+ +A+ + +L + + +HRD+ NILL ++ + DFGLAR + + G A
Sbjct: 185 SFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 846 G-TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904
++APE + ++DV+S+GV+L E+ S + P G I C
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRR 294
Query: 905 LRQG---RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961
L++G RA ++ T E+ + C S RPT ++V L L A
Sbjct: 295 LKEGTRMRAPDYTTP------------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342
Query: 962 S 962
+
Sbjct: 343 N 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 682 GNFNASNCIGNGGFGATY----KAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRH 737
+F I NG +GA Y K + I + + +QQ E L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
P +V++ ++ + ++ Y+ GG+ ++ VD ++ + AL YLH
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY--FAETVLALEYLH 118
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTG------------- 843
+ ++HRD+KP N+L+ + L+DFGL+++ L T+ G
Sbjct: 119 NY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 844 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
V GT Y+APE + D ++ G++L E L
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 30/145 (20%), Positives = 52/145 (35%), Gaps = 14/145 (9%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLV-TLIGYH 747
+ G Y V ++ R +G E+ L L V ++
Sbjct: 6 LKGGLTNRVYLLGTKDEDYVL--KINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
S+ +L+ ++ G L+ ++ IA +A LA LH + + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKE---------DIAEQLAELLAKLHQLPLLVLCHG 113
Query: 808 DVKPSNILLDDDFNAYLSDFGLARL 832
D+ P NIL+DD + D+ A
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 56/240 (23%), Positives = 90/240 (37%), Gaps = 55/240 (22%)
Query: 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHP 738
+F + IG G FG + G + A+K L + V AE L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH----KIALDIARALA 794
+V + + ++LI +LPGG++ + ++ T + + + +A+D L
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT------------ 842
++H RD+KP N+LLD + LSDFGL G + H T
Sbjct: 122 FIH---------RDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEFYRNLTHNPPSD 170
Query: 843 ------------------------GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
GT Y+APE M + D +S GV++ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 56/240 (23%), Positives = 89/240 (37%), Gaps = 55/240 (22%)
Query: 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHP 738
+F + IG G FG + G + A+K L + V AE L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRST---RAVDWRVLHKI-ALDIARALA 794
+V + + ++LI +LPGG++ + ++ T + + + A+D L
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT------------ 842
++H RD+KP N+LLD + LSDFGL G + H T
Sbjct: 122 FIH---------RDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNLNHSLPSD 170
Query: 843 ------------------------GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
GT Y+APE M + D +S GV++ E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 6/157 (3%)
Query: 728 EIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL 787
E L + HP+++ L G LI LP + + + R + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT 847
+ RA+ YLH+ R++HRD+K NI ++ + L DFG A + G AGT
Sbjct: 190 SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 848 FGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKAL 884
APE D++S G+VL E+ + +L
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQ-----FHAEIKTLGRLR 736
++ IG G FG S + A+K L+ +F+ +++ F E +
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFAN 101
Query: 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHK----IALDIARA 792
P +V L + ++++ Y+PGG+L N + W + +ALD +
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHS 160
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
+ ++H RDVKP N+LLD + L+DFG + GT Y++
Sbjct: 161 MGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 853 PE----------YAMTCRVSDKADVYSYGVVLLELL 878
PE Y C D +S GV L E+L
Sbjct: 212 PEVLKSQGGDGYYGREC------DWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 35/108 (32%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 782 LHKIALDIARALAYLHDQ-CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840
L + + +A+ + +L + C+ HRDV N+LL D A + DFGLAR + +
Sbjct: 214 LLRFSSQVAQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269
Query: 841 TTGVAG-TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPS 887
G A ++APE C + ++DV+SYG++L E+ S K+ P
Sbjct: 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 9/134 (6%)
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
E ++L+ +Y GG+L + + R + IA ++ A+ +H +HRD+
Sbjct: 73 ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIHQL---HYVHRDI 128
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY--AM---TCRVSDK 864
KP N+LLD + + L+DFG + T ++ GT Y++PE AM + +
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188
Query: 865 ADVYSYGVVLLELL 878
D +S GV + E+L
Sbjct: 189 CDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 690 IGNGGFG---ATYKAEISPGVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLV 741
IG+G G A Y A + V AIK+L+ FQ Q HA E+ + + H N++
Sbjct: 32 IGSGAQGIVCAAYDAILERNV--AIKKLS-RPFQ--NQTHAKRAYRELVLMKCVNHKNII 86
Query: 742 TLIGYHASETEM-----FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
L+ + + I L NL IQ +D + + + + +L
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 142
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
H ++HRD+KPSNI++ D + DFGLAR G S T T Y APE
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 857 MTCRVSDKADVYSYGVVLLELLSDK 881
+ + D++S G ++ E++
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 46/152 (30%), Positives = 69/152 (45%), Gaps = 9/152 (5%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGR-FQGVQQFH--AEIKTLGRLRHP 738
+F+ IG G FG + G + A+K L F+ Q H AE L P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
+V+L ++LI +LPGG+L + + T + D V + A+ +H
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED--VTRFYMAECVLAIEAVHK 119
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830
+HRD+KP NIL+D + LSDFGL+
Sbjct: 120 L---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-07
Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 28/194 (14%)
Query: 769 IQQRSTRAVDWRVLHKIALDIARALAYLHDQ-CVPRVLHRDVKPSNILLDDDFNAYLSDF 827
I + A+D L + +A+ +++L + C+ HRD+ NILL + DF
Sbjct: 203 ILEEDELALDTEDLLSFSYQVAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDF 258
Query: 828 GLARLLGPSETHATTGVAG-TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP 886
GLAR + + G A ++APE C + ++DV+SYG++L E+ S + P
Sbjct: 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318
Query: 887 SFSSYGNGFNIVAWGC-MLLRQGRAKEFF--TAGLWDAGPHDDLVEVLHLAVVCTVDSLS 943
+ ++ G ML + E + WDA P
Sbjct: 319 GMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADP-------------------L 359
Query: 944 TRPTMKQVVRRLKQ 957
RPT KQ+V+ ++Q
Sbjct: 360 KRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 56/180 (31%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQ 476
+++S N+I+ LP EI + +L+ LD S N I+ + + L +L L LS N + D
Sbjct: 191 LDLSGNKIS-DLPPEIELLS-ALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED- 246
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
+P ++G + L+ L L+ N + S SSLG L L LDLS NSLS +P L L
Sbjct: 247 LPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIAL-LLLLL 303
Query: 537 VLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRA 596
LLLN + L ++ ++ N LS SS + L N +
Sbjct: 304 ELLLNLLLTLKALELKLNSI------LLNNNILSNGETSSPEALSILESLNNLWTLDNAL 357
|
Length = 394 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 26/182 (14%)
Query: 709 VAIKRLAVGR-FQGVQQFHA-----EIKTLGRLRHPNLVTLIGYHASET------EMFLI 756
VAIK+L+ R FQ V HA E+ + + H N++ L+ + +++L+
Sbjct: 44 VAIKKLS--RPFQNVT--HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99
Query: 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816
L NL IQ +D + + + + +LH ++HRD+KPSNI++
Sbjct: 100 ME-LMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 151
Query: 817 DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLE 876
D + DFGLAR G + T V T Y APE + + D++S G ++ E
Sbjct: 152 KSDCTLKILDFGLARTAG-TSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGE 209
Query: 877 LL 878
++
Sbjct: 210 MI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 39/139 (28%), Positives = 63/139 (45%), Gaps = 19/139 (13%)
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTR-----AVDWRVLHKIALDIARALAYLHDQCVPRV 804
E ++L+ +Y GG+L + + R A + IA+D L Y+H
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH------- 125
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC----- 859
RD+KP NIL+D + + L+DFG L T ++ GT Y++PE
Sbjct: 126 --RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 860 RVSDKADVYSYGVVLLELL 878
+ + D +S GV + E+L
Sbjct: 184 KYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 690 IGNGGFGATYKAEISPGVL-------VAIKRL-AVGRFQGVQQFHAEIKTLGRLRHPNLV 741
+G G FG Y+ I+ GV+ VAIK + + +F E + ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVD----------WRVLHKIALDIAR 791
L+G + +I + G+L++++ RS R + + ++A +IA
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG-- 849
+AYL+ + +HRD+ N ++ +DF + DFG+ R + ++ + G G
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG-KGLLPVR 186
Query: 850 YVAPEYAMTCRVSDKADVYSYGVVLLEL 877
+++PE + +DV+S+GVVL E+
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-07
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 728 EIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG--GNLENFIQQRSTRAVDWRVLHKI 785
E + L RL HP ++ L+ L+ LP +L ++ R R + + +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARL-RPLGLAQVTAV 265
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL-GPSETHATTGV 844
A + A+ Y+H + ++HRD+K N+L++ + L DFG A G T G+
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 845 AGTFGYVAPEYAMTCRVSDKADVYSYGVVLLE 876
AGT APE + D++S G+V+ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-06
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 45/226 (19%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLA--VGRFQGVQ-QFHAEIKTLGRLRHPNLVTLIG 745
IG GG G Y A + VA+K++ + ++ +F E K L HP +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVD---------------WRVLHKIALDIA 790
+ ++ Y+ G L++ + +S + + HKI I
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLL--KSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET------------ 838
Y+H + VLHRD+KP NILL + D+G A E
Sbjct: 128 ----YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 839 --HATT---GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
+ T + GT Y+APE + S+ D+Y+ GV+L ++L+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 26/162 (16%)
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845
+ +AR + +L + + +HRD+ NILL ++ + DFGLAR + + G A
Sbjct: 180 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 846 G-TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904
++APE + ++DV+S+GV+L E+ S + P G I C
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-------GVQINEEFCQR 289
Query: 905 LRQG---RAKEFFTAGL-------WDAGPHD-----DLVEVL 931
L+ G RA E T + W P + LVE+L
Sbjct: 290 LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-06
Identities = 60/241 (24%), Positives = 90/241 (37%), Gaps = 68/241 (28%)
Query: 690 IGNGGFGAT-YKAEISPGVLVAIKRL----AVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
IG G FG + G + A+K+L + + Q V AE L +P +V L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKLY 67
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH----KIALDIARALAYLHDQC 800
E ++LI YLPGG++ + ++ T + + +A+D L Y
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY----- 122
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGL------------------ARLLGPSETHATT 842
+HRD+KP N+LLD + LSDFGL A + +
Sbjct: 123 ----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 843 -------------------GVAGTFGYVAPE------YAMTCRVSDKADVYSYGVVLLEL 877
GT Y+APE Y C D +S GV++ E+
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC------DWWSLGVIMYEM 232
Query: 878 L 878
L
Sbjct: 233 L 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-06
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 9/147 (6%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIG 745
I G FG Y + + L A+K + V Q AE L + P +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
S ++L+ YL GG++++ + D + K ++A AL YLH ++
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRH---GII 126
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARL 832
HRD+KP N+L+ ++ + L+DFGL+++
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 25/142 (17%)
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR--------ALAYLHDQCV 801
E ++L+ +Y GG+L + ++ D ++ D+AR A+ +H
Sbjct: 73 ENNLYLVMDYYVGGDLLTLL----SKFED-----RLPEDMARFYLAEMVLAIDSVHQL-- 121
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY--AM-- 857
+HRD+KP N+LLD + + L+DFG L T + GT Y++PE AM
Sbjct: 122 -GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 858 -TCRVSDKADVYSYGVVLLELL 878
R + D +S GV + E+L
Sbjct: 181 GKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 4e-06
Identities = 21/59 (35%), Positives = 34/59 (57%)
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL 569
L+ LDLS+N L+ + + L NL VL L+ N L+ P + + +L + ++S NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 56/235 (23%), Positives = 90/235 (38%), Gaps = 51/235 (21%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLA---VGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
IG G FG ++ L A+K L V AE L + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ ++ + +Y+PGG++ + + + D + IA ++ A+ +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFY-IA-ELTCAIESVHKM---GFI 123
Query: 806 HRDVKPSNILLDDDFNAYLSDFGL------------------ARL--LGPSETHATTGVA 845
HRD+KP NIL+D D + L+DFGL R + PSE +
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 846 ----------------------GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
GT Y+APE + + D +S GV+L E+L
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-06
Identities = 22/45 (48%), Positives = 31/45 (68%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS 45
+ +LEVLDL N NG +P+S L SLR+LNL N ++G +PA+
Sbjct: 465 ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 47/209 (22%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 690 IGNGGFGATYKA------EISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
+G G FG Y+ + VA+K + + +F E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTR----------AVDWRVLHKIALDIARA 792
L+G + ++ + G+L++++ RS R + + ++A +IA
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GY 850
+AYL+ + + +HRD+ N ++ DF + DFG+ R + ++ + G G +
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG-KGLLPVRW 187
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELLS 879
+APE + +D++S+GVVL E+ S
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 23/60 (38%), Positives = 31/60 (51%)
Query: 462 SLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSL 521
+L +L+LS N + + LK L L+GNNLT P + L L LDLS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 56/240 (23%), Positives = 91/240 (37%), Gaps = 57/240 (23%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRL----AVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G FG A ++ L A+K L + R Q V AE L + +V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ-VAHVKAERDILAEADNEWVVRLY 67
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ ++ + +Y+PGG++ + + + D + ++ A+ +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED--LARFYIAELTCAVESVHKM---GF 122
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGL----------------------------------- 829
+HRD+KP NIL+D D + L+DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 830 ---ARLLGPSETHATT--------GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
L P E A + GT Y+APE + + D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 34/127 (26%), Positives = 57/127 (44%), Gaps = 10/127 (7%)
Query: 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ-CVPRVLHRDVKPSNIL 815
Y ++N + + + L +AR + +L + CV HRD+ N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV----HRDLAARNVL 269
Query: 816 LDDDFNAYLSDFGLARLLGPSETHATTGVAGTF---GYVAPEYAMTCRVSDKADVYSYGV 872
L + DFGLAR + + + G TF ++APE + +DV+SYG+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 873 VLLELLS 879
+L E+ S
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 8e-05
Identities = 24/61 (39%), Positives = 30/61 (49%), Gaps = 1/61 (1%)
Query: 72 RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNM 131
LK + LS NRL +P + NL+ LDLSGN L P + +RSL L N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 132 L 132
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 59/241 (24%), Positives = 96/241 (39%), Gaps = 59/241 (24%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRL----AVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G FG A ++ L A+K L + R Q V AE L + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-VAHVKAERDILAEADNEWVVKLY 67
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIAL-DIARALAYLHDQCVPR 803
+ ++ + +Y+PGG++ + + + V VL + + ++ A+ +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---G 121
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLAR--------------------LLGPS------- 836
+HRD+KP NIL+D D + L+DFGL + PS
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 837 -----------ETHATT--------GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLEL 877
E AT + GT Y+APE + + D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 878 L 878
L
Sbjct: 242 L 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 71/300 (23%), Positives = 111/300 (37%), Gaps = 39/300 (13%)
Query: 12 NLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG 71
N L +L + +H + NL F E A +NL L + + +
Sbjct: 15 NTLREVLSSNTYHTTPQSI-NLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLD 73
Query: 72 RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNM 131
L +S ++ + L LDL+ N L I L + SL L +N
Sbjct: 74 LLSPSGISSLDGSENLLN-----LLPLPSLDLNLNRLRSNISELLELT-NLTSLDLDNNN 127
Query: 132 LEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQ 191
+ + P + NL+ LD+S N + S+P L N L L LS
Sbjct: 128 ITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN------------- 173
Query: 192 SLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLG 251
L D +P+ +S+L NL L + + P LE L+L
Sbjct: 174 DLSD---------------LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217
Query: 252 HNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSN 311
+N + L L KNL L+LS+N+L + + D+S N +S SI + +
Sbjct: 218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISSLGS 275
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 18/38 (47%), Positives = 24/38 (63%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRI 38
+ NL+VLDL GN L I P++ L SLR L+L N +
Sbjct: 23 LPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 58/180 (32%), Positives = 82/180 (45%), Gaps = 18/180 (10%)
Query: 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
+ LD NLLN L L L+L NR+ I + NL L+L N
Sbjct: 78 SGISSLDGSENLLN---------LLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNN 127
Query: 62 VNGTVPT---FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
+ P LK + LS N++ S+PS + NL++LDLS N L +P+ L N
Sbjct: 128 ITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRN-LPNLKNLDLSFNDLSD-LPKLLSN 184
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178
+ +L L S +P E+ +L LE LD+S NS+ + L N L+ L LSN
Sbjct: 185 LSNLNNLDL-SGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 38/118 (32%), Positives = 58/118 (49%), Gaps = 3/118 (2%)
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+P + L+SL L+ S L + L L L N L +I S L +L L
Sbjct: 62 LPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLT 119
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
LDL +N+++ + P NL L L++NK+ +PS L N+ L ++SFN+LS
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS 176
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-04
Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 1/78 (1%)
Query: 231 LEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PV 289
L G P++ +L+ +NL N G LG +L LDLS N G + L +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 290 PCMTMFDVSGNALSGSIP 307
+ + +++GN+LSG +P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 27/185 (14%)
Query: 734 RLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRST-RAVDWRVLHKIALDIARA 792
++ H ++V L G + E ++ ++ G L+ F+ ++S W+ K+A +A A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASA 117
Query: 793 LAYLHDQCVPRVLHRDVKPSNILL-----DDDFNAY--LSDFGLARLLGPSETHATTGVA 845
L+YL D+ ++H +V NILL D + + LSD G+ P +
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI-----PITVLSRQECV 169
Query: 846 GTFGYVAPEYAMTCRV-SDKADVYSYGVVLLEL-------LSDKKALDPSFSSYGNGFNI 897
++APE + S AD +S+G L E+ L DK L Y +
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEKERFYEGQCML 228
Query: 898 VAWGC 902
V C
Sbjct: 229 VTPSC 233
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 25/75 (33%), Positives = 43/75 (57%)
Query: 209 GGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKN 268
G IP +S L +L+ + ++ GN P + G+ +LE+L+L +N F+G LG +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 269 LLFLDLSSNQLTGEL 283
L L+L+ N L+G +
Sbjct: 492 LRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 6e-04
Identities = 17/36 (47%), Positives = 23/36 (63%), Gaps = 2/36 (5%)
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546
LE LDLS+N ++ L L NL NL L L+ NK++
Sbjct: 3 LETLDLSNNQITDL--PPLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 71/300 (23%), Positives = 101/300 (33%), Gaps = 79/300 (26%)
Query: 51 NLEELNLAGNLVNGTVPTFIG-------RLKRVYLSFNRL------VGSVPSKIGEKCTN 97
L+ L L GN + + LK + LS N + S+ + K
Sbjct: 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLT-KGCG 82
Query: 98 LEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFS---NMLEET----IPAELGMLQ-NLEVL 149
L+ LDLS N L L + + SL N L + + L L LE L
Sbjct: 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142
Query: 150 DVSRNSLSGSIPVDLGN----CSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFN 205
+ RN L G+ L L L L+N + D
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLAN-------------NGIGDA--------- 180
Query: 206 FFEGGIP---EAVSSLPNLRILWAPRATLEGNFPSNWGACD---------NLEMLNLGHN 253
GI E + + NL +L L N ++ GA +LE+LNLG N
Sbjct: 181 ----GIRALAEGLKANCNLEVLD-----LNNNGLTDEGASALAETLASLKSLEVLNLGDN 231
Query: 254 FFSGKNL-----GVLGPCKNLLFLDLSSNQLTGE----LARELP-VPCMTMFDVSGNALS 303
+ +L P +LL L LS N +T + LA L + D+ GN
Sbjct: 232 NLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.7 bits (86), Expect = 0.002
Identities = 19/50 (38%), Positives = 25/50 (50%), Gaps = 7/50 (14%)
Query: 485 KGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRN 534
L+ L L+ N +T +P L L LE LDLS N ++ DL L N
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT-----DLSPLSN 43
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 20/80 (25%), Positives = 35/80 (43%), Gaps = 10/80 (12%)
Query: 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP 811
++ Y+ G L++ I +++ +I R + LH ++H D+
Sbjct: 73 NFIIVMEYIEGEPLKDLINSNGME------ELELSREIGRLVGKLHSA---GIIHGDLTT 123
Query: 812 SNILLDDDFNAYLSDFGLAR 831
SN++L YL DFGLA
Sbjct: 124 SNMILSGG-KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.004
Identities = 17/80 (21%), Positives = 31/80 (38%), Gaps = 13/80 (16%)
Query: 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP 811
++ Y+ G L++ + + ++ R + LH ++H D+
Sbjct: 73 NGLIVMEYIEGELLKDAL---------EEARPDLLREVGRLVGKLHKA---GIVHGDLTT 120
Query: 812 SNILLDDDFNAYLSDFGLAR 831
SNI+L Y DFGL
Sbjct: 121 SNIILSGG-RIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 32/120 (26%), Positives = 48/120 (40%), Gaps = 18/120 (15%)
Query: 780 RVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS--- 836
R L +I AL Y H + ++H D+KP NIL++ D R L P
Sbjct: 231 RHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVV--DPVTNRALPPDPCR 286
Query: 837 -----------ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885
E H+ T + T Y +PE + D++S G ++ EL + K D
Sbjct: 287 VRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 963 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.68 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.27 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.26 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.24 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.17 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.15 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.15 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.93 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.74 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.59 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.45 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-98 Score=943.57 Aligned_cols=872 Identities=31% Similarity=0.474 Sum_probs=673.8
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCcc-ccCcccccceeccccccccCCCc-ccccccceeec
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAGNLVNGTVPT-FIGRLKRVYLS 79 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~-~~~~L~~L~L~ 79 (963)
++++.|||++|++++..+..|..+++|++|+|++|++.+.+|.. +..+++|++|+|++|.+++.+|. .+.+|++|+|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls 148 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLS 148 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECc
Confidence 46899999999999999999999999999999999998777765 45999999999999999987775 56789999999
Q ss_pred cccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccC
Q 046851 80 FNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGS 159 (963)
Q Consensus 80 ~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 159 (963)
+|.+++.+|..+. ++++|++|+|++|.+.+..|..|+++++|++|+|++|++.+..|..|.++++|++|+|++|.+++.
T Consensus 149 ~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 227 (968)
T PLN00113 149 NNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227 (968)
T ss_pred CCcccccCChHHh-cCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCc
Confidence 9999877887764 799999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccc
Q 046851 160 IPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNW 239 (963)
Q Consensus 160 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 239 (963)
+|..++++++|+.|++++ |.+.+.+|..+..+++|+.|++++|++.+..|..+
T Consensus 228 ~p~~l~~l~~L~~L~L~~---------------------------n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 280 (968)
T PLN00113 228 IPYEIGGLTSLNHLDLVY---------------------------NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280 (968)
T ss_pred CChhHhcCCCCCEEECcC---------------------------ceeccccChhHhCCCCCCEEECcCCeeeccCchhH
Confidence 999999999999999998 55556667777777777777777777777777777
Q ss_pred cccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCccCCCC-CCCCCCCCc
Q 046851 240 GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPT-FSNMVCPPV 317 (963)
Q Consensus 240 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~~~-~~~l~~l~~ 317 (963)
.++++|++|+|++|.+....+..+..+++|+.|++++|.+++..+..+ .+++|+.|++++|.+.+..|. +..+.+|+.
T Consensus 281 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~ 360 (968)
T PLN00113 281 FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360 (968)
T ss_pred hhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcE
Confidence 777777777777777776666667777777777777777766555443 567777777777777765443 666777777
Q ss_pred ccccccccccCCCCch-hhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCc
Q 046851 318 PYLSRNLFESYNPSTA-YLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNK 396 (963)
Q Consensus 318 l~l~~n~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~ 396 (963)
+++++|.+....|... .+. .....++.+|++.+.+|.... ....++.+.+++|.
T Consensus 361 L~Ls~n~l~~~~p~~~~~~~--------------------~L~~L~l~~n~l~~~~p~~~~-----~~~~L~~L~L~~n~ 415 (968)
T PLN00113 361 LDLSTNNLTGEIPEGLCSSG--------------------NLFKLILFSNSLEGEIPKSLG-----ACRSLRRVRLQDNS 415 (968)
T ss_pred EECCCCeeEeeCChhHhCcC--------------------CCCEEECcCCEecccCCHHHh-----CCCCCCEEECcCCE
Confidence 7777776654322110 000 001123445555554443211 23457788999999
Q ss_pred ccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCc
Q 046851 397 LSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQ 476 (963)
Q Consensus 397 ~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~ 476 (963)
++|.+|.. |..++.+. .|++++|.+++.+|..+..+ ++|+.|++++|++.+.+|..+ ..++|+.|++++|++++.
T Consensus 416 l~~~~p~~-~~~l~~L~--~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~ 490 (968)
T PLN00113 416 FSGELPSE-FTKLPLVY--FLDISNNNLQGRINSRKWDM-PSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGA 490 (968)
T ss_pred eeeECChh-HhcCCCCC--EEECcCCcccCccChhhccC-CCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCc
Confidence 99999876 47778887 89999999999888877765 889999999999998888766 458999999999999999
Q ss_pred cchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCcccc
Q 046851 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANV 556 (963)
Q Consensus 477 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 556 (963)
.|..+..+++|+.|+|++|++++.+|..+.++++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 491 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 570 (968)
T PLN00113 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570 (968)
T ss_pred cChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceEeeccccCccCCCCCCCc--ccccccCCCCCCCCCCCccCCCCCCCCCCCCCCCCCCCcchhhHHHHHHHHHHHH
Q 046851 557 STLSAFNVSFNNLSGPLPSSKNL--MKCSSVLGNPYLRPCRAFTLTEPSQDLHGPPSNGNRGFNSIEIASIASASAIVSV 634 (963)
Q Consensus 557 ~~L~~l~l~~N~l~~~~p~~~~~--~~~~~~~~np~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~v 634 (963)
++|++|++++|+++|.+|+.... ....++.|||..|.-...... +++...++.....+++++++++++++
T Consensus 571 ~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~--------~~c~~~~~~~~~~~~~~~~~~~~~~~ 642 (968)
T PLN00113 571 ESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL--------PPCKRVRKTPSWWFYITCTLGAFLVL 642 (968)
T ss_pred cccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCC--------CCCccccccceeeeehhHHHHHHHHH
Confidence 99999999999999999986442 334567899977631110000 01111111111111111122222222
Q ss_pred HHHHHhheeeccccCCCCccccCCcc--ceeeee-cCCCCCChHHHHHHcCCCCCccccccCCCccEEEEEE-CCCcEEE
Q 046851 635 LLALIVLFVYTRKWNPQSKVMGSTRK--EVTIFT-EIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEI-SPGVLVA 710 (963)
Q Consensus 635 ll~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~va 710 (963)
+++++++++++++++...+....... +...+. .....++++++. ..|...+.||+|+||.||+|.. .+|..||
T Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~va 719 (968)
T PLN00113 643 ALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFV 719 (968)
T ss_pred HHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEE
Confidence 22222233333222111111111111 000111 111223444433 4577888999999999999976 5789999
Q ss_pred EEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHH
Q 046851 711 IKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIA 790 (963)
Q Consensus 711 vK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~ 790 (963)
||++...... ...|++.+++++||||++++|+|.+.+..++||||+++|+|.++++. ++|.++.+|+.|+|
T Consensus 720 vK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia 790 (968)
T PLN00113 720 VKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIA 790 (968)
T ss_pred EEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHH
Confidence 9988643321 23568889999999999999999999999999999999999999963 89999999999999
Q ss_pred HHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHH
Q 046851 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSY 870 (963)
Q Consensus 791 ~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 870 (963)
+|++|||..+.++|+||||||+||+++.++.+++. ||.+..... .....+++.|+|||++.+..++.++|||||
T Consensus 791 ~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~ 864 (968)
T PLN00113 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGF 864 (968)
T ss_pred HHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhH
Confidence 99999997666799999999999999999988875 665543221 122367899999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC--CChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 871 GVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA--GPHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 871 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
||++|||+||+.||+.... ......+|++..........++|+..... .+.++..++.+++.+||+.||++||+|
T Consensus 865 Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~ 941 (968)
T PLN00113 865 GLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA 941 (968)
T ss_pred HHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH
Confidence 9999999999999964432 34557777776665555566666655433 344566788999999999999999999
Q ss_pred HHHHHHHhccCC
Q 046851 949 KQVVRRLKQLQP 960 (963)
Q Consensus 949 ~evl~~L~~l~~ 960 (963)
+||++.|+++.+
T Consensus 942 ~evl~~L~~~~~ 953 (968)
T PLN00113 942 NDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHhhc
Confidence 999999999865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-52 Score=526.56 Aligned_cols=508 Identities=36% Similarity=0.487 Sum_probs=391.0
Q ss_pred CCCceEEEccCCcccccCCCcc-ccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccce
Q 046851 1 MGNLEVLDLEGNLLNGILPDSG-FHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRV 76 (963)
Q Consensus 1 l~~l~~L~ls~n~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L 76 (963)
+.+|++|+|++|++++.+|..+ ..+++|++|+|++|++.+.+|. ..+++|++|+|++|.+++.+|..++ +|++|
T Consensus 92 l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L 169 (968)
T PLN00113 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVL 169 (968)
T ss_pred CCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEE
Confidence 4689999999999997777765 4999999999999999987775 5689999999999999988887654 79999
Q ss_pred eeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCcc
Q 046851 77 YLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSL 156 (963)
Q Consensus 77 ~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 156 (963)
+|++|.+.+.+|..+. ++++|++|+|++|++++..|..++++++|+.|+|++|++++..|..|.++++|++|+|++|.+
T Consensus 170 ~L~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 248 (968)
T PLN00113 170 DLGGNVLVGKIPNSLT-NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248 (968)
T ss_pred ECccCcccccCChhhh-hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCcee
Confidence 9999999878888765 799999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCC
Q 046851 157 SGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFP 236 (963)
Q Consensus 157 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~ 236 (963)
++.+|..++++++|+.|++++|.+...... ....+..+..++++.|.+.+.+|..+.++++|+.|++++|.+.+..|
T Consensus 249 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~---~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~ 325 (968)
T PLN00113 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPP---SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325 (968)
T ss_pred ccccChhHhCCCCCCEEECcCCeeeccCch---hHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC
Confidence 999999999999999999998554321100 01112333444445555555555555555555555555555555555
Q ss_pred ccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCccCCCC-CCCCCC
Q 046851 237 SNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPT-FSNMVC 314 (963)
Q Consensus 237 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~~~-~~~l~~ 314 (963)
..+..+++|+.|++++|.+.+..+..++.+++|+.|++++|++++..+..+ .++.|+.|++++|++.+..|. +..+.+
T Consensus 326 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~ 405 (968)
T PLN00113 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405 (968)
T ss_pred hhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCC
Confidence 555555555555555555554444455555555555555555554433332 344555555555555544333 444555
Q ss_pred CCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCC
Q 046851 315 PPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGD 394 (963)
Q Consensus 315 l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 394 (963)
|+.+++++|.+ ++.+|... .....+..+++++
T Consensus 406 L~~L~L~~n~l-------------------------------------------~~~~p~~~-----~~l~~L~~L~Ls~ 437 (968)
T PLN00113 406 LRRVRLQDNSF-------------------------------------------SGELPSEF-----TKLPLVYFLDISN 437 (968)
T ss_pred CCEEECcCCEe-------------------------------------------eeECChhH-----hcCCCCCEEECcC
Confidence 55555555544 33333211 1123466789999
Q ss_pred CcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCC
Q 046851 395 NKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMH 474 (963)
Q Consensus 395 n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~ 474 (963)
|.++|.+|..+ ..+..|+ .|++++|++.+.+|..+. .++|+.|++++|++++.+|..+..+++|+.|++++|.+.
T Consensus 438 N~l~~~~~~~~-~~l~~L~--~L~L~~n~~~~~~p~~~~--~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 512 (968)
T PLN00113 438 NNLQGRINSRK-WDMPSLQ--MLSLARNKFFGGLPDSFG--SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512 (968)
T ss_pred CcccCccChhh-ccCCCCc--EEECcCceeeeecCcccc--cccceEEECcCCccCCccChhhhhhhccCEEECcCCcce
Confidence 99999998765 4567777 899999999999998764 378999999999999999999999999999999999999
Q ss_pred CccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCcc
Q 046851 475 DQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLA 554 (963)
Q Consensus 475 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 554 (963)
+.+|..+..+++|++|+|++|.+++.+|..|..+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.+|.. +
T Consensus 513 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~ 591 (968)
T PLN00113 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-G 591 (968)
T ss_pred eeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-c
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999999964 3
Q ss_pred ccccCceEeecccc
Q 046851 555 NVSTLSAFNVSFNN 568 (963)
Q Consensus 555 ~l~~L~~l~l~~N~ 568 (963)
.+..+....+.+|+
T Consensus 592 ~~~~~~~~~~~~n~ 605 (968)
T PLN00113 592 AFLAINASAVAGNI 605 (968)
T ss_pred hhcccChhhhcCCc
Confidence 34444444445554
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-51 Score=447.09 Aligned_cols=289 Identities=45% Similarity=0.782 Sum_probs=254.3
Q ss_pred CCCCChHHHHHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeee
Q 046851 669 GVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748 (963)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 748 (963)
...|+++++..||++|...+.||+|+||.||+|.+.+|+.||||++.....+...+|..|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34589999999999999999999999999999999999999999887655431455999999999999999999999999
Q ss_pred CCC-eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeec
Q 046851 749 SET-EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 749 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 827 (963)
+.+ +.++|||||++|+|.++++......++|.++.+||.++|+||+|||+.+.|.|+||||||+|||+|+++++||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 988 5999999999999999998765437899999999999999999999999899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 828 GLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 828 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
|+|+..............||.+|+|||+...+..+.|+|||||||+++|++||+++.+...+. ....+++|++..+..
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~--~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR--GELSLVEWAKPLLEE 299 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc--ccccHHHHHHHHHHC
Confidence 999654331111111117999999999999999999999999999999999999988865522 344599999999999
Q ss_pred CcccceeccccC-CCCCh-hHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 908 GRAKEFFTAGLW-DAGPH-DDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 908 ~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
+...+++|+.+. ..++. .+..++..++.+|++.+|++||+|.||+++|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999987 55554 68888999999999999999999999999997765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=399.04 Aligned_cols=256 Identities=33% Similarity=0.558 Sum_probs=214.8
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccchh--HHHHHHHHHHHhccCCCCeeEEEEeeeCCC-eEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGYHASET-EMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 759 (963)
++...+.||+|+||+||+|.++....||||++....... .++|.+|+.++.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 345556699999999999999944449999997654332 568999999999999999999999999887 79999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecccCCCCeEECCCC-cEEEeecccccccCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR-VLHRDVKPSNILLDDDF-NAYLSDFGLARLLGPSE 837 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 837 (963)
+++|+|.++++......+++..+.+||.+||+||+|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999885456799999999999999999999999 7 99999999999999997 99999999998765332
Q ss_pred CcccccccccccccCccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 838 THATTGVAGTFGYVAPEYAM--TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.......||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .+.+.....
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~--------- 260 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVV--------- 260 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh---------
Confidence 2333368999999999999 56999999999999999999999999984422 222222222
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
...+...+..++..+..++.+||+.||++||++.+++..|+.+.
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 22333445557889999999999999999999999999998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=395.77 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=224.5
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
.++..+.||+|.||+||.|.+.....||+|.++... ...+.|.+|+++|++++|++||+++|+|..++.+++|||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 456788999999999999999977899999998764 3347889999999999999999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+|++...+..+...+...++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...++......
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 9999999987778899999999999999999999999 9999999999999999999999999999966555555555
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
+..-+..|.|||.+....++.|||||||||+||||+| |+.|+... +..+ +.+.++.+.+-.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--------sn~e----------v~~~le~GyRlp 424 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--------SNEE----------VLELLERGYRLP 424 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--------CHHH----------HHHHHhccCcCC
Confidence 5566779999999999999999999999999999999 55565422 2222 333455566667
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.|..|+..+.++|..||+.+|++|||++.+...|+++..
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 788999999999999999999999999999999988654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=374.86 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=211.8
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC-eEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET-EMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 759 (963)
+++..+.||+|..|+|||+.++ +++.+|+|++.... ....+++.+|++++++.+||+||++||+|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4555778999999999999887 58889999995443 344678999999999999999999999999888 59999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++|||++++... +.+++....+|+.+|++||.|||+ + +||||||||+|||++..|.|||||||.+..+...
T Consensus 160 MDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999999875 459999999999999999999996 6 9999999999999999999999999999887544
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
...+.+||..|||||.+.+..|+.++||||||+.++||.+|+.|+.+..+.+.....+..+ +..+. .
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~---Iv~~p-p-------- 299 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA---IVDEP-P-------- 299 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH---HhcCC-C--------
Confidence 4566789999999999999999999999999999999999999998763332222222222 22111 1
Q ss_pred CCCCCh-hHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPH-DDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...|. ..+.++..++..|+++||.+||++.|++++
T Consensus 300 -P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 -PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11233 367789999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=363.85 Aligned_cols=200 Identities=34% Similarity=0.591 Sum_probs=181.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
-++|.+.+.||.|+||+||+|+++ ++..||||.+... .....+-...|+.+++.++|||||++++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357999999999999999999776 5899999999776 4445566789999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC------CcEEEeeccccc
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD------FNAYLSDFGLAR 831 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgla~ 831 (963)
|||+||+|.+|+++++ .+++..++.++.|+|.|+++||++ +||||||||+|||++.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999864 599999999999999999999999 99999999999999864 458999999999
Q ss_pred ccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPS 887 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 887 (963)
.+.+ .......+|++-|||||++...+|+.|+|+||+|+|+|||++|+.||+..
T Consensus 164 ~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9863 34445679999999999999999999999999999999999999999844
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=379.08 Aligned_cols=248 Identities=23% Similarity=0.398 Sum_probs=213.5
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
..|...+.||+|||+.+|+++. ..|+.||+|++.+.. ....+.+.+||++.++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999977 789999999997642 334577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
|+|+.++|.+++++ ++.+++.+++.+++||+.|+.|||++ +|+|||||..|++++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 99999999999985 45799999999999999999999999 9999999999999999999999999999988644
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....+.+|||.|.|||++....++..+||||+|||+|-|+.|++||+...- .+.... +... ++
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~-Ik~~---~Y---- 235 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNK-IKLN---EY---- 235 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHH-HHhc---Cc----
Confidence 3445568999999999999999999999999999999999999999984311 111111 1111 11
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..|.....+..+||.++|+.+|.+|||+++|+.+
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1234556678899999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=400.60 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=221.5
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
.+....+.||+|+||+||+|+.. +...||||.++..... ..++|++|++.+..++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 45677889999999999999654 3567999999877655 6789999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhc--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 755 LIYNYLPGGNLENFIQQRS--------TRA----VDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~--------~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
+|+|||..|+|.+|+..++ +.. ++..+.+.||.|||.||+||.++ .+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 9999999999999997654 223 78889999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccc-cccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhH
Q 046851 823 YLSDFGLARLLGPSETHATT-GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAW 900 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 900 (963)
||+|||+++..-..+.+... ...-..+|||||.+..++++.+||||||||+|||+++ |+-||.....+ +
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--------E- 713 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--------E- 713 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--------H-
Confidence 99999999987666655544 3345679999999999999999999999999999998 67777633221 1
Q ss_pred HHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCCC
Q 046851 901 GCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPAS 962 (963)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~~ 962 (963)
+....+++ -....|+.++.+++.||..||+..|++||+++||-..|+...+++
T Consensus 714 VIe~i~~g---------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIECIRAG---------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHcC---------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 22223333 335678899999999999999999999999999999999866554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=385.56 Aligned_cols=490 Identities=27% Similarity=0.375 Sum_probs=390.8
Q ss_pred CCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeeccccccccCCccccccCCCCCeE
Q 046851 25 LKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHL 101 (963)
Q Consensus 25 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L 101 (963)
-..|+.|.+++|.+. .+-+.+.++..|+.|++++|+++ ..|.+++ .++.|+.+.|+++ .+|..+.+ +.+|..|
T Consensus 44 qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s-~~~l~~l 119 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGS-LISLVKL 119 (565)
T ss_pred hcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhh-hhhhhhh
Confidence 356778888888877 44445777888888888888887 5555554 4667788888887 88888874 7788888
Q ss_pred eCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCc
Q 046851 102 DLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDT 181 (963)
Q Consensus 102 ~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~ 181 (963)
+++.|.+. ..++.++.+..|..|+..+|+++ ..|+.+..+.+|..|++.+|+++. +|...-+++.|++|+.-+|.
T Consensus 120 ~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~-- 194 (565)
T KOG0472|consen 120 DCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNL-- 194 (565)
T ss_pred hcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhh--
Confidence 88888887 67788888888888888888887 467777888888888888888884 44444448888888876532
Q ss_pred ccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCcc
Q 046851 182 YEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLG 261 (963)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 261 (963)
.+.+|..++++.+|..|+|..|+|. ..| .|.++..|.+|+++.|+|+.++.+
T Consensus 195 --------------------------L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae 246 (565)
T KOG0472|consen 195 --------------------------LETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAE 246 (565)
T ss_pred --------------------------hhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHH
Confidence 3367888899999999999999998 455 899999999999999999999999
Q ss_pred ccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCc------hhh
Q 046851 262 VLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPST------AYL 335 (963)
Q Consensus 262 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~------~~~ 335 (963)
....+++|..|||++|++++.+...+-+.+|+.||+|+|.+++.++.+++| +|+.|-+.+|++..+..+. ..+
T Consensus 247 ~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vL 325 (565)
T KOG0472|consen 247 HLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVL 325 (565)
T ss_pred HhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHH
Confidence 988999999999999999999999999999999999999999999999999 9999999999988765422 112
Q ss_pred hhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceE
Q 046851 336 SLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSL 415 (963)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~ 415 (963)
..+..+..+....... ++..-.+..|+ ...+..-...+.+++++++-+++ .+|.++|.....--+-
T Consensus 326 KyLrs~~~~dglS~se------------~~~e~~~t~~~-~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt 391 (565)
T KOG0472|consen 326 KYLRSKIKDDGLSQSE------------GGTETAMTLPS-ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVT 391 (565)
T ss_pred HHHHHhhccCCCCCCc------------ccccccCCCCC-Ccccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceE
Confidence 2222211111100000 00001111111 12223333456778888888887 7899998877655555
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
.++++.|++. ++|..+..+-..++.+++++|.+. -+|..++.+++|..|+|++|.+ ..+|..++.+..|+.||++.|
T Consensus 392 ~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~L-n~LP~e~~~lv~Lq~LnlS~N 468 (565)
T KOG0472|consen 392 SVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLL-NDLPEEMGSLVRLQTLNLSFN 468 (565)
T ss_pred EEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchh-hhcchhhhhhhhhheeccccc
Confidence 8999999998 999998887555667888888887 8999999999999999999999 578999999999999999999
Q ss_pred cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCcc
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~ 571 (963)
++. .+|.++..+..|+.+-.++|++....|..+.+|.+|.+|||.+|.+. .+|..++++.+|++|.+++|+|..
T Consensus 469 rFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 469 RFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred ccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCC
Confidence 999 89999999999999999999999776677999999999999999999 999999999999999999999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=360.91 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=206.4
Q ss_pred cCCCCCccccccCCCccEEEE-EECCCcEEEEEEeecccch-------hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe
Q 046851 681 TGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQ-------GVQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (963)
.+.|.+.+.+|+|+||.|-+| ..++|+.||||++.+.... ....+.+|+++|++++||+||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 346888999999999999999 4567999999999754221 22345799999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC---CcEEEeeccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD---FNAYLSDFGL 829 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl 829 (963)
.|+||||++||.|.+.+-.. ..+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999764 4477888899999999999999999 99999999999999866 6799999999
Q ss_pred ccccCCCCCcccccccccccccCccccccCCC---CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMTCRV---SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
|+..+. .....+.+|||.|.|||++.+..+ ..++|+||+||++|-+++|.+||.+...+ .+ ...+..
T Consensus 326 AK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~s----l~eQI~ 395 (475)
T KOG0615|consen 326 AKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PS----LKEQIL 395 (475)
T ss_pred hhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----cc----HHHHHh
Confidence 998763 344556799999999999986543 34789999999999999999999854332 11 222233
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+.... ......+..++..++|.+||..||++|||+.|++++
T Consensus 396 ~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 KGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 332221 111223567789999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=344.47 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=208.9
Q ss_pred CCCCccccccCCCccEEEE-EECCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEE-eeeCCCe-EEEEE
Q 046851 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIG-YHASETE-MFLIY 757 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~ 757 (963)
+|++.++||+|.||+|||+ ...+|..||.|.+..+.. ...++...|+.++++++|||||++++ .+.++.+ .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 6888999999999999999 456899999999975543 34567899999999999999999998 4555555 89999
Q ss_pred eccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 758 NYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPR--VLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
||+..|+|...++..+ .+.+++.++++++.|+++||.++|++. |. |+||||||.||+++.+|.||++|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999997543 567999999999999999999999942 24 999999999999999999999999999998
Q ss_pred CCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
..... ...+.+|||.||+||.+.+.+|+.|+||||+||++|||+.-++||... ++... ...+.+++...
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L-~~KI~qgd~~~- 247 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSL-CKKIEQGDYPP- 247 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHH-HHHHHcCCCCC-
Confidence 65443 445678999999999999999999999999999999999999999843 33332 22333332221
Q ss_pred eccccCCCCC-hhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 914 FTAGLWDAGP-HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 914 ~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
.| ...+.++..++..|+..||+.||+.-.+++.+
T Consensus 248 --------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 248 --------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred --------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 23 45678899999999999999999854444433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=386.24 Aligned_cols=267 Identities=27% Similarity=0.462 Sum_probs=230.5
Q ss_pred CCCChHHHHHHcCC---------CCCccccccCCCccEEEEEECC----CcEEEEEEeecccch-hHHHHHHHHHHHhcc
Q 046851 670 VPLSFESVVQATGN---------FNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRL 735 (963)
Q Consensus 670 ~~~~~~~~~~~~~~---------~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l 735 (963)
.|++|||.-+|-.+ ..+.++||.|.||+||+|+++. ...||||.++....+ ...+|..|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 46778876666543 4678899999999999998763 467999999987554 456899999999999
Q ss_pred CCCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeE
Q 046851 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNIL 815 (963)
Q Consensus 736 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 815 (963)
+||||+++.|+......+++|.|||++|+|+.|++.+.+ .+++.+...+.++||.||.||.++ ++|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence 999999999999999999999999999999999998865 499999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecccccccCCCCCcccccccc--cccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 046851 816 LDDDFNAYLSDFGLARLLGPSETHATTGVAG--TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYG 892 (963)
Q Consensus 816 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~ 892 (963)
++.+..+|++|||+++.+.++.........| +.+|.|||.+..++++.++||||||+++||.++ |.+||.+....
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-- 841 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-- 841 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--
Confidence 9999999999999999876544333332223 469999999999999999999999999999775 88888744221
Q ss_pred CCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
++...++++++...|.+|+..+.+||..||++|-.+||.+.+++..|+++
T Consensus 842 ----------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 842 ----------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ----------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 24445667788889999999999999999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.54 Aligned_cols=242 Identities=28% Similarity=0.404 Sum_probs=206.4
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
.++|++.++||+|+||.||.++.. +++.+|+|++++... .+.+..++|..++.+++||.||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357999999999999999999654 689999999976532 3456789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
+||+.||.|...+++. ..+++..++-++.+|+.||.|||++ +|||||+||+|||+|.+|+++|+|||+++... .
T Consensus 104 ld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~-~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL-K 177 (357)
T ss_pred EeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc-c
Confidence 9999999999999874 4599999999999999999999999 99999999999999999999999999998643 2
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
....+.+.+||+.|||||++.+..|+.++|.||+|+++|||++|.+||... +...+...+....
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGK-------- 241 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCc--------
Confidence 334555689999999999999999999999999999999999999999743 3334443333332
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCC
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRP 946 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 946 (963)
....+.....+..+++...+..||++|-
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1122333456788999999999999995
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=351.16 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=209.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC--eEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET--EMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 758 (963)
.+|...+.||+|+||+||.+... +|+..|||.+........+.+.+|+.++++++|||||+.+|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35778899999999999999765 48999999887664444677899999999999999999999855544 6899999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEeecccccccCC--
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFGLARLLGP-- 835 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~-- 835 (963)
|+++|+|.+++...++ .+++..+..+++||++||+|||++ ||+||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998766 799999999999999999999999 9999999999999999 79999999999987763
Q ss_pred CCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
..........||+.|||||++..+ ....++||||+||++.||+||++||... ....++.-........
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~---- 241 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSL---- 241 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCC----
Confidence 222334457899999999999963 3335899999999999999999999742 1112222222222211
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
...|...+.+..+++.+|+..+|+.||||.+++++-.
T Consensus 242 -----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 -----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1345556778899999999999999999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=331.78 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=204.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hh-HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QG-VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+.|+...++|+|+||+||+++.+ +|+.||||++..... +. .+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788889999999999999876 599999999965443 22 3456899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++. ++.+.+.+.+ ..++...+.+++.|+++|+.|+|++ +++||||||+|||++.+|.+|+||||+|+.+.. ..
T Consensus 82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 9987 7777777665 3488899999999999999999999 999999999999999999999999999999873 23
Q ss_pred cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhH----------HHHHHhc
Q 046851 839 HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAW----------GCMLLRQ 907 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~ 907 (963)
...+..+.|.+|+|||.+.+ .+|...+||||+||++.||++|.+-|....+- ..+... -...+..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi----DQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI----DQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH----HHHHHHHHHHcccCHHHHHHhcc
Confidence 33445678999999999988 68999999999999999999999877533211 111110 0111111
Q ss_pred C-cccceeccccCCCCC-----hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 G-RAKEFFTAGLWDAGP-----HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ~-~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .+..+.-+......+ .....-+.+++..|++.||++|++-++++.+
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1 111111111111111 1223467899999999999999999998753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.77 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=212.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
..|++.+.||.|..++||+|+.. .++.||||++..+.- .+.+.+.+|+..++.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 47999999999999999999654 589999999976533 3468899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
|.+||+.+.++..-...+++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999987767799999999999999999999999 9999999999999999999999999988766543322
Q ss_pred cc---ccccccccccCccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 840 AT---TGVAGTFGYVAPEYAM--TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 840 ~~---~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
.. ...+||++|||||++. ...|+.|+||||||+...|+.+|..||....+- +..-..+. +..+...
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--------kvLl~tLq-n~pp~~~ 253 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--------KVLLLTLQ-NDPPTLL 253 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------HHHHHHhc-CCCCCcc
Confidence 11 4568999999999954 347999999999999999999999999855432 11112222 2222211
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......+........+.+++..|++.||++|||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111111222334578999999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=344.79 Aligned_cols=326 Identities=26% Similarity=0.417 Sum_probs=227.8
Q ss_pred CcchhhHHHHHHHHHHHHHHHHHhheeeccccCCCCccccCCccceeeeecCCCCCChHHHHHHcCCCCCccccccCCCc
Q 046851 617 FNSIEIASIASASAIVSVLLALIVLFVYTRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFG 696 (963)
Q Consensus 617 ~~~~~i~~~~~~~~~~~vll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g 696 (963)
...++++.+....+.+.+++++.+++.|+.++..+.....-. . .....+...+- -...-...++.++||+|.||
T Consensus 151 ~~~~~~al~~~~~v~~l~~lvi~~~~~~r~~k~~~~~~e~~~---~-p~~d~~~~~ss--pl~~l~pl~l~eli~~Grfg 224 (534)
T KOG3653|consen 151 GEVLIYALIPLLLVSLLAALVILAFLGYRQRKNAREEIEPVL---I-PLEDSGPAPSS--PLLELDPLQLLELIGRGRFG 224 (534)
T ss_pred CceehhhHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCc---c-cCCCCCCCCCc--ccccCCchhhHHHhhcCccc
Confidence 444555555555555555555556666665544443221000 0 00111111110 01113467788899999999
Q ss_pred cEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHh--ccCCCCeeEEEEeeeCCC----eEEEEEeccCCCChHHHHh
Q 046851 697 ATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLG--RLRHPNLVTLIGYHASET----EMFLIYNYLPGGNLENFIQ 770 (963)
Q Consensus 697 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~ 770 (963)
.||||.+. ++.||||++.... .+.|..|-++.+ .++|+||++++++-...+ ++++|+||.+.|+|.+|+.
T Consensus 225 ~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~ 300 (534)
T KOG3653|consen 225 CVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK 300 (534)
T ss_pred eeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH
Confidence 99999998 6899999997544 456666666654 558999999999876554 8999999999999999998
Q ss_pred hhcCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc-cccc
Q 046851 771 QRSTRAVDWRVLHKIALDIARALAYLHDQ------CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-ATTG 843 (963)
Q Consensus 771 ~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~ 843 (963)
. ..++|.+..+|+..+++||+|||+. .+|+|+|||||++||||..|+++.|+|||+|..+.+.... ...+
T Consensus 301 ~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~ 377 (534)
T KOG3653|consen 301 A---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHG 377 (534)
T ss_pred h---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhh
Confidence 6 4599999999999999999999974 5789999999999999999999999999999988754432 3345
Q ss_pred ccccccccCccccccCC-CC-----cchhhHHHHHHHHHHHcCCCCCCCC-CCC--------CCCCcchhhHHHHHHhcC
Q 046851 844 VAGTFGYVAPEYAMTCR-VS-----DKADVYSYGVVLLELLSDKKALDPS-FSS--------YGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 844 ~~gt~~y~aPE~~~~~~-~~-----~~~Dv~slG~il~elltg~~p~~~~-~~~--------~~~~~~~~~~~~~~~~~~ 908 (963)
.+||.+|||||++.+.. .. .+.||||+|.++|||+++...+++. .++ .+...++.++.....++.
T Consensus 378 qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK 457 (534)
T KOG3653|consen 378 QVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKK 457 (534)
T ss_pred hhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhc
Confidence 78999999999998752 22 2589999999999999987666421 111 111222223222233333
Q ss_pred cccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 909 RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
..+.+-+.-. ......-+.+.+..||.+||+.|-|+.=|-+.+.++.
T Consensus 458 ~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 458 QRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred cCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 2222222111 1144667889999999999999999999988887754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=358.22 Aligned_cols=250 Identities=24% Similarity=0.411 Sum_probs=215.3
Q ss_pred CCCCCccccccCCCccEEEE-EECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
..|+...+||+|+.|.||.| +..+++.||||++........+-+..|+.+|+..+|+|||.+++.|...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46888899999999999999 55678999999998877777778899999999999999999999999889999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
+||+|.+.+.. ..+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999999975 3489999999999999999999999 999999999999999999999999999988765544 4
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
...++|||.|||||+.....|.+|+||||||++++||+-|++||-...+- .+. +.+...+ . ...
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------rAl-yLIa~ng-~-------P~l 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RAL-YLIATNG-T-------PKL 489 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-------HHH-HHHhhcC-C-------CCc
Confidence 55678999999999999999999999999999999999999999743221 111 1111111 1 112
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..++.....+.+++.+||+.|+++||++.|++++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2345567789999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=350.36 Aligned_cols=260 Identities=26% Similarity=0.387 Sum_probs=207.3
Q ss_pred cCCCCCccccccCCCccEEEEE-ECCCcEEEEEEeecccchhHHH--HHHHHHHHhccC-CCCeeEEEEeeeCCC-eEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQ--FHAEIKTLGRLR-HPNLVTLIGYHASET-EMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 755 (963)
.++|.+.++||.|.||.||+|+ ..+|..||||+++..-.. +++ =.+|+..++++. ||||+++.+++.+.+ ..++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3579999999999999999995 457999999999765443 333 268999999998 999999999998887 8999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
|||||+. +|+++++.+ ++.+++.++..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+....
T Consensus 88 VfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 9999976 999999988 78899999999999999999999999 999999999999999988999999999998765
Q ss_pred CCCcccccccccccccCccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC------
Q 046851 836 SETHATTGVAGTFGYVAPEYAM-TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG------ 908 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 908 (963)
...+ +..+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++-|.+..+- +..-.+...+..-
T Consensus 163 kpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-----Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 163 KPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-----DQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred CCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-----HHHHHHHHHhCCCccccch
Confidence 5443 3457899999999976 567999999999999999999998877644321 0011111111110
Q ss_pred -----------cccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 -----------RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 -----------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+....+..-.+ .+..+..+++.+|+++||++||||.+++++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 011111111111112 267789999999999999999999999875
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.33 Aligned_cols=386 Identities=25% Similarity=0.243 Sum_probs=264.9
Q ss_pred ceEEEccCCcccccCCCccccC--CCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcc---cccccceee
Q 046851 4 LEVLDLEGNLLNGILPDSGFHL--KSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTF---IGRLKRVYL 78 (963)
Q Consensus 4 l~~L~ls~n~i~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~L~~L~L 78 (963)
.+.||.+++++..+....+.++ ..-+.|++++|+++.+.+..|.++++|+++++..|.++ .+|.. .++|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 4678888888886655555443 44567999999999888888999999999999999888 66644 346888888
Q ss_pred ccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCcccc
Q 046851 79 SFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSG 158 (963)
Q Consensus 79 ~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 158 (963)
.+|.|+ ++...-.+.++.|+.||||.|.|+.+.-.+|..-.++++|+|++|+|+.+....|.++.+|..|.|++|+|+.
T Consensus 133 ~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt 211 (873)
T KOG4194|consen 133 RHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT 211 (873)
T ss_pred eccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc
Confidence 888887 7777666677888888888888876555677777788888888888887777788888888888888888885
Q ss_pred CCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcc
Q 046851 159 SIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSN 238 (963)
Q Consensus 159 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 238 (963)
..+..|+++++|+.|+|..|.|.. ..--.|.+|++|+.|.|.+|.+.......
T Consensus 212 Lp~r~Fk~L~~L~~LdLnrN~iri---------------------------ve~ltFqgL~Sl~nlklqrN~I~kL~DG~ 264 (873)
T KOG4194|consen 212 LPQRSFKRLPKLESLDLNRNRIRI---------------------------VEGLTFQGLPSLQNLKLQRNDISKLDDGA 264 (873)
T ss_pred cCHHHhhhcchhhhhhccccceee---------------------------ehhhhhcCchhhhhhhhhhcCcccccCcc
Confidence 555666667777777666543332 22234555666666666666665555555
Q ss_pred ccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcc
Q 046851 239 WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVP 318 (963)
Q Consensus 239 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l 318 (963)
|..|.++++|+|+.|+++.+..+.+.+++.|+.|+||+|.|..+.++.+
T Consensus 265 Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~W------------------------------- 313 (873)
T KOG4194|consen 265 FYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSW------------------------------- 313 (873)
T ss_pred eeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchh-------------------------------
Confidence 5556666666666666665555555555555555555555542211111
Q ss_pred cccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCccc
Q 046851 319 YLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLS 398 (963)
Q Consensus 319 ~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~ 398 (963)
T Consensus 314 -------------------------------------------------------------------------------- 313 (873)
T KOG4194|consen 314 -------------------------------------------------------------------------------- 313 (873)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccc
Q 046851 399 GSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIP 478 (963)
Q Consensus 399 ~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~ 478 (963)
..+++|++|+|+.|+|+...+..|..+..|++|+|++|.|+....
T Consensus 314 -----------------------------------sftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e 358 (873)
T KOG4194|consen 314 -----------------------------------SFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAE 358 (873)
T ss_pred -----------------------------------hhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHh
Confidence 113567777777777775555667777777777777777766666
Q ss_pred hhhccCcccceeccccccccccCCc---ccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccc
Q 046851 479 TTLGQMKGLKYLSLAGNNLTGSIPS---SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN 555 (963)
Q Consensus 479 ~~~~~l~~L~~L~l~~N~l~~~~p~---~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~ 555 (963)
..|..+++|+.|||++|.|++.+.+ .|..|++|+.|+|.+|+|..+....|.++++|+.|||.+|.|...-|.+|..
T Consensus 359 ~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~ 438 (873)
T KOG4194|consen 359 GAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEP 438 (873)
T ss_pred hHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccccccc
Confidence 6677777777777777777654432 4566777777777777777444456777777777777777776666777777
Q ss_pred cccCceEeec
Q 046851 556 VSTLSAFNVS 565 (963)
Q Consensus 556 l~~L~~l~l~ 565 (963)
+ .|+.|.+.
T Consensus 439 m-~Lk~Lv~n 447 (873)
T KOG4194|consen 439 M-ELKELVMN 447 (873)
T ss_pred c-hhhhhhhc
Confidence 6 66666554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=347.93 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=210.2
Q ss_pred HcCCCCCccccccCCCccEEEEE-ECCCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 754 (963)
...+|..++.||+|+|++||+|+ ..+++.||||++.+.- ....+-+..|-++|.++ .||+|++++..|+++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34579999999999999999994 4579999999986542 22334567888899999 7999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+|+||+++|+|.+++++.+ .+++..++.++.+|+.||+|||++ |||||||||+|||+|+||+++|+|||-|+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999999864 599999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCc------------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHH
Q 046851 835 PSETH------------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGC 902 (963)
Q Consensus 835 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 902 (963)
+.... .....+||..|.+||++.....+..+|+|+||||+|+|+.|++||....+. .-+.+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------liFqk 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LIFQK 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------HHHHH
Confidence 42211 124589999999999999999999999999999999999999999855332 11111
Q ss_pred HHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 903 MLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+..+. ..+...++.+.+|+.+.|..||.+|++..++.++
T Consensus 299 I~~l~y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 IQALDY------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHhcc------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111111 2344445688899999999999999999998775
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=347.88 Aligned_cols=263 Identities=25% Similarity=0.328 Sum_probs=207.8
Q ss_pred CCCCCccccccCCCccEEEE-EECCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 756 (963)
+.|+..++||+|.||.||+| +..+|+.||+|++.... +.......+||.+++++.||||+++.+...+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45778889999999999999 45679999999998765 34455668999999999999999999987665 789999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
+|||+. +|.-++... +-.+++.++..++.|++.||+|||++ ||+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999988 999888753 45699999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH-------HhcC
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML-------LRQG 908 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~ 908 (963)
.....+..+-|.+|+|||.+.|. .|+.++|+||.|||+.||++|++.+....+- ..+....+.+ |...
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv----eQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV----EQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH----HHHHHHHHHhCCCChhccccc
Confidence 76666777889999999999875 6999999999999999999999988754321 0111111110 1100
Q ss_pred cccceeccccCCCCC-------hhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 909 RAKEFFTAGLWDAGP-------HDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 909 ~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
....+.--.....+. ...+....+|+..+|..||++|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011000000000111 122456789999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=380.60 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=216.2
Q ss_pred cCCCCCccccccCCCccEEEEEECC--C----cEEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISP--G----VLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
..+.+..+.||+|+||.||+|...+ | ..||||.+... ..+...+|.+|+.+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456778899999999999997653 3 34999988655 456678999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecc
Q 046851 754 FLIYNYLPGGNLENFIQQRS-----TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
++++|||++|+|..|+++.. ...++..+...++.+||+|+.||+++ ++|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998752 34688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccc-cccccccCccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 829 LARLLGPSETHATTGV-AGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSD-KKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 829 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
+|+.....+.+...+. .-...|||||.++.+.++.|+|||||||++||++|. ..||. +... .+......+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~-~~~n-------~~v~~~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP-SRSN-------FEVLLDVLE 919 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC-Ccch-------HHHHHHHHh
Confidence 9996655555544443 445699999999999999999999999999999995 45554 2211 111111112
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
+ .+...|..|+..++++|..||+.+|++||++..+++.+.++.+
T Consensus 920 g----------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 G----------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred C----------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 2 2556788999999999999999999999999999998887654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.89 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=208.9
Q ss_pred CccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 686 ASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
..+.+|.|+.|.||.|+++ ++.||||+++.- -+.+|+-+++++||||+.+.|+|.....+|+|||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3567999999999999998 788999987532 25678889999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccccc
Q 046851 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845 (963)
Q Consensus 766 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (963)
++.++. ++.++......|..+||.||.|||.+ +|||||||.-||||..+..|||+|||-++..... .....++
T Consensus 200 ~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 200 YEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 999987 45689999999999999999999999 9999999999999999999999999999887544 2334578
Q ss_pred ccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChh
Q 046851 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHD 925 (963)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (963)
||..|||||++...+.++|+|||||||+||||+||..||.+-+.. ..++.-+ ...+....|..
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----------AIIwGVG------sNsL~LpvPst 335 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----------AIIWGVG------SNSLHLPVPST 335 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----------eeEEecc------CCcccccCccc
Confidence 999999999999999999999999999999999999999743322 1111111 22344556788
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 926 DLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 926 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
+++-+.-|++.||+..|..||++++++.+|+-..
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 9999999999999999999999999999997543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=353.50 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=211.0
Q ss_pred HHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
...+++.+.+.||+|.||+||+|.|. | .||||++..... +..+.|+.|+.++++-+|.||+-+.|||..... .+|
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred cCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 33456778899999999999999998 3 499999976643 456889999999999999999999999998876 999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
..+|+|.+|+.+++... ..++..+...||+|||+|+.|||.+ +|||||||..||+++++++|||+|||++.....-
T Consensus 466 TqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred ehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 99999999999999765 4589999999999999999999999 9999999999999999999999999998654321
Q ss_pred -CCcccccccccccccCcccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 837 -ETHATTGVAGTFGYVAPEYAMT---CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 837 -~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.........|...|||||++.. .+|++.+||||||+++|||+||..||.....+ +.+++.-+..-..+
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--------qIifmVGrG~l~pd 613 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--------QIIFMVGRGYLMPD 613 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--------heEEEecccccCcc
Confidence 1111222357889999999974 47899999999999999999999999833222 00111111100011
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
. ......+++++.+|+..||..++++||.+.+++..|+++.+
T Consensus 614 ~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 614 L------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred c------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1 11234678899999999999999999999999999988765
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.46 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=205.8
Q ss_pred CCCCCccccccCCCccEEEEE-ECCCcEEEEEEeecccchh--HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.+|...+++|+|.||.||+|+ ..+|+.||||+++..+..+ .....+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 367788899999999999994 5679999999998765432 2456899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
||+. +|+..++.. ...++..++..++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 82 fm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9987 999999875 45689999999999999999999999 999999999999999999999999999999986655
Q ss_pred cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh---c---Ccc-
Q 046851 839 HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR---Q---GRA- 910 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---~~~- 910 (963)
..+.. +-|..|+|||.+.|. .|+..+|+||.|||+.||+-|.+-|... .+ .+.....++ . ..+
T Consensus 157 ~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sD-------idQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 157 IQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SD-------IDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred ccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-ch-------HHHHHHHHHHcCCCCcccCc
Confidence 54443 679999999999875 6899999999999999999987555422 11 111111111 0 001
Q ss_pred -----cceec-----cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 -----KEFFT-----AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 -----~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+++++ .......-..+..+..+++..|+..+|.+|.++.|++++
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11110 000111112345567999999999999999999999865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.99 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=213.1
Q ss_pred CCCCCccccccCCCccEEEEE-ECCCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
..|+..+.||+|.||.||+|. ...++.||+|++..+.. ...+++.+|+.++.+.+++||.++||.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 357778999999999999994 45789999999986644 3467889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+.||++.+.++.. ..+++.++..|++++..|+.|+|++ +.+|||||+.||++..+|.+|++|||.+.........
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999863 3458888899999999999999999 9999999999999999999999999999887644433
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
. ...+|||.|||||++....|+.|+||||+|++.+||.+|.+|+....+. ++.-.+.+...
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------------rvlflIpk~~P 228 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------------RVLFLIPKSAP 228 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------------eEEEeccCCCC
Confidence 3 6789999999999999889999999999999999999999999755442 22222222222
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+....+.+++..|+..+|+.||+|.+++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 23333566779999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=356.04 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=206.5
Q ss_pred cCCCCCccccccCCCccEEEEEE------CCCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCC-C
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASE-T 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 751 (963)
.++|++.++||+|+||.||+|.+ .+++.||||++..... ...+.+.+|++++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35799999999999999999964 2356899999875432 3346789999999999 899999999988764 4
Q ss_pred eEEEEEeccCCCChHHHHhhhc----------------------------------------------------------
Q 046851 752 EMFLIYNYLPGGNLENFIQQRS---------------------------------------------------------- 773 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 773 (963)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999997532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc-ccccccccccc
Q 046851 774 --TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGY 850 (963)
Q Consensus 774 --~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y 850 (963)
...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12477889999999999999999999 9999999999999999999999999999865433222 22233466789
Q ss_pred cCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHH
Q 046851 851 VAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVE 929 (963)
Q Consensus 851 ~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (963)
+|||++.+..++.++|||||||++|||++ |..||...... .. .......+.. ...+...+..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~-~~~~~~~~~~---------~~~~~~~~~~ 305 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EE-FCQRLKDGTR---------MRAPENATPE 305 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HH-HHHHHhcCCC---------CCCCCCCCHH
Confidence 99999999999999999999999999997 99998643221 01 1111111111 1112344567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 930 VLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 930 l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=350.82 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=209.8
Q ss_pred CCCCCccccccCCCccEEEEEECC--C---cEEEEEEeecc---cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP--G---VLVAIKRLAVG---RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
++..+.++||+|+||.||+|.+.. + ..||||..+.. ......+|.+|++++++++|||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455667999999999999997653 2 23899988753 245678899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++|||+|+||+|.+++++.+. .++..+..+++.+.|+||+|||++ +++||||.++|+|++.++.+||+|||+++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999998654 589999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.. .........-+..|+|||.+....++.++|||||||++||+++ |..||.+... .+.......
T Consensus 313 ~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--------~~v~~kI~~------ 377 (474)
T KOG0194|consen 313 SQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--------YEVKAKIVK------ 377 (474)
T ss_pred cc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------HHHHHHHHh------
Confidence 31 1111111124579999999999999999999999999999999 7778764322 111111112
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
...+...+...+.++..++.+||..+|++||+|.++.+.++.+.
T Consensus 378 ---~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 378 ---NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred ---cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 22333445577888999999999999999999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.87 Aligned_cols=249 Identities=31% Similarity=0.436 Sum_probs=207.1
Q ss_pred HcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc----cc-hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG----RF-QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETE 752 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 752 (963)
..+.|.+.+.||+|.||+|+.|.+ .+|+.||||++... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456899999999999999999955 46899999977553 11 23456678999999999 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC-CcEEEeeccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD-FNAYLSDFGLAR 831 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~ 831 (963)
.++||||+.||+|.+++.. ..++.+.++.+++.|++.|++|||++ ||+||||||+||+++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999998 34588899999999999999999999 99999999999999999 999999999999
Q ss_pred ccCCCCCcccccccccccccCccccccCC-CC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCR-VS-DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.. ....... ...+.
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~k-i~~~~ 239 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRK-IRKGE 239 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHH-HhcCC
Confidence 874 2233445568999999999999877 76 67999999999999999999998522 1121111 11111
Q ss_pred ccceeccccCCCCChhH-HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 910 AKEFFTAGLWDAGPHDD-LVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
. ..|... ..++..++.+|+..+|.+|+++.++++
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 123333 678899999999999999999999983
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=324.98 Aligned_cols=262 Identities=25% Similarity=0.337 Sum_probs=202.6
Q ss_pred HHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHH--HhccCCCCeeEEEEeeeC----CCe
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKT--LGRLRHPNLVTLIGYHAS----ETE 752 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~----~~~ 752 (963)
....+..+.+.||+|.||+||+|+|+ |+.||||+|....+. .+.+|.++ -..++|+||+.++++... ..+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 44568899999999999999999999 999999999765544 34445555 455699999999998643 357
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCceecccCCCCeEECCCCcEEEeec
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-----QCVPRVLHRDVKPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Df 827 (963)
.|+|.+|.+.|||+||+.+ ..++.....+++..+|.||+|||- +.+|.|.|||||++|||+..++.+.|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 8999999999999999986 458999999999999999999995 47899999999999999999999999999
Q ss_pred ccccccCCCCCc---ccccccccccccCccccccCC-----CC-cchhhHHHHHHHHHHHcCC----------CCCCCCC
Q 046851 828 GLARLLGPSETH---ATTGVAGTFGYVAPEYAMTCR-----VS-DKADVYSYGVVLLELLSDK----------KALDPSF 888 (963)
Q Consensus 828 gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~-~~~Dv~slG~il~elltg~----------~p~~~~~ 888 (963)
|+|......... .....+||.+|||||++...- -+ ..+||||||.++||+.-+. .||.+-.
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999887655322 334568999999999986421 12 3589999999999997532 4554332
Q ss_pred CCCCCCcchhhHHHHHHhcCcccceeccccCCC-----CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 889 SSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA-----GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
+.+ .++.++ +. .+-.+.++.. ...++...+.++|..||..+|..|-|+--+-+.|.++.
T Consensus 441 p~D---Ps~eeM-rk--------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 441 PSD---PSFEEM-RK--------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCC---CCHHHH-hc--------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 221 111111 11 1112222222 24567788999999999999999999999999888775
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=340.24 Aligned_cols=247 Identities=27% Similarity=0.442 Sum_probs=213.2
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|.+.+.||+|.||.||||+- .+.+.||+|.+.+... .+.+.+.+|++++++++||||+.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4788999999999999999954 4688999998865433 345678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+.| +|..++.. +..++++.+..|+.++..||.|||+. +|.|||+||+|||++..|.+|+||||+|+..... .
T Consensus 82 ~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 9987 99999987 45699999999999999999999999 9999999999999999999999999999987543 3
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.....+.|||.|||||...+..|+..+|.||+|||+|||++|++||... ++.+.++.+..+..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~v--------- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDPV--------- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCCC---------
Confidence 4445678999999999999999999999999999999999999999732 34444444443331
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..|......+..++...+.+||..|.+-.+++.+
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1344677789999999999999999999888754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.58 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=218.4
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
....++++||+|.||+|..+....+..||||+++.... ....+|.+|+++|.+++||||++++|+|..++.+++++|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 34678899999999999999999889999999986644 34589999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+|+.++...........+|+.|||.|++||.+. .+||||+.++|+|++.++++||+|||+++.+-..+.+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999887544445566678999999999999999 99999999999999999999999999999776666554
Q ss_pred cc-cccccccccCccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 841 TT-GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS--DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 841 ~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.. ..+-+.+|||||.+.-++++.++|||+||+++||+++ ...||.....+ ..++-.....+.+....
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~~~~~~~~~~----- 764 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGEFFRDQGRQV----- 764 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhhhcCCCCcce-----
Confidence 44 3455679999999999999999999999999999865 56777643222 23333333333332221
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
....|.-++..+++++.+||..|.++||+++++...|.+.
T Consensus 765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1234667888999999999999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=311.35 Aligned_cols=235 Identities=26% Similarity=0.392 Sum_probs=201.3
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch---hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+|+..+.+|.|+||+|..++.+ +|..+|+|++.+...- ..+....|.++++.+.||.++++++.+.+.+..++|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 6888999999999999999765 5899999999766443 34556789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++||-|.+++++. +++++..++.+|.||+.|++|||+. +|++||+||+|||+|++|.+||+|||+|+...
T Consensus 125 yv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---- 195 (355)
T KOG0616|consen 125 YVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---- 195 (355)
T ss_pred ccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec----
Confidence 99999999999874 4599999999999999999999999 99999999999999999999999999999864
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
..+.+.+|||.|+|||.+....+..++|.|||||++|||+.|.+||....+. .-+-+....+-
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~v---------- 258 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGKV---------- 258 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCcc----------
Confidence 2356689999999999999999999999999999999999999999855331 11111111111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCC
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTR 945 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~R 945 (963)
.+|.....++.+|+...++.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2344555678889999999998888
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.74 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=213.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++++.+|+|.||.||.|+.+ ++..||+|++.+... +...++.+|+++-+.++||||++++++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 47999999999999999999654 678899999976543 33468899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||.++|++...+.......+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..||+|||.+....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 999999999999977778899999999999999999999999 99999999999999999999999999997532
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||+..... +..+.+.. .+.
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--------etYkrI~k----~~~---- 239 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--------ETYKRIRK----VDL---- 239 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--------HHHHHHHH----ccc----
Confidence 44556689999999999999999999999999999999999999999854321 11111111 111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..|...+..+.++|.+|+..+|.+|.+..||+++
T Consensus 240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2344566788999999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=339.19 Aligned_cols=247 Identities=18% Similarity=0.273 Sum_probs=202.4
Q ss_pred cccccCCCccEEEEEECCCcEEEEEEeecccchh---HHHHHHHHHHHhccCCCCeeEEEEeeeC----CCeEEEEEecc
Q 046851 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQG---VQQFHAEIKTLGRLRHPNLVTLIGYHAS----ETEMFLIYNYL 760 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 760 (963)
..||+|++|.||+|.+. |+.||||++....... .+.+.+|++++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 67999999999999885 8999999987553332 4678899999999999999999999866 45789999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+++... ..+++....+++.+++.|++|+|+.. +++||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 999999999864 45899999999999999999999732 78899999999999999999999999998654322
Q ss_pred cccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 841 TTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
....|++.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+........+ .
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~~~i~~~~---------~ 239 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIYDLIINKN---------N 239 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcC---------C
Confidence 22457899999999976 6789999999999999999999999974321 11211111111 1
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
....+..++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111233456789999999999999999999999999998763
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=348.28 Aligned_cols=254 Identities=23% Similarity=0.192 Sum_probs=229.6
Q ss_pred CceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCC---cccccccceeec
Q 046851 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVP---TFIGRLKRVYLS 79 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~L~~L~L~ 79 (963)
..+.||+++|++..+.+..|.++++|++++|..|.++ .+|...+...+|+.|+|.+|.|+..-. ..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 4678999999999999999999999999999999999 888777777889999999999885443 445689999999
Q ss_pred cccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccC
Q 046851 80 FNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGS 159 (963)
Q Consensus 80 ~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 159 (963)
.|.|+ ++|...|..-.++++|+|++|+|+....+.|.++.+|..|.|++|+|+...+..|.+|++|+.|+|..|+|...
T Consensus 158 rN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 158 RNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence 99999 99999998888999999999999999999999999999999999999999999999999999999999999844
Q ss_pred CCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccc
Q 046851 160 IPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNW 239 (963)
Q Consensus 160 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 239 (963)
--..|.++++|+.|.|..|. +...-..+|..+.++++|+|+.|++...-..++
T Consensus 237 e~ltFqgL~Sl~nlklqrN~---------------------------I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~l 289 (873)
T KOG4194|consen 237 EGLTFQGLPSLQNLKLQRND---------------------------ISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWL 289 (873)
T ss_pred hhhhhcCchhhhhhhhhhcC---------------------------cccccCcceeeecccceeecccchhhhhhcccc
Confidence 35679999999999999844 444455678999999999999999999999999
Q ss_pred cccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCC
Q 046851 240 GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAR 285 (963)
Q Consensus 240 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 285 (963)
.+++.|+.|+||+|.|..+.......+++|+.|+|++|+|+...+.
T Consensus 290 fgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~ 335 (873)
T KOG4194|consen 290 FGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEG 335 (873)
T ss_pred cccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChh
Confidence 9999999999999999999999999999999999999999854443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.63 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=209.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
+-|++++.+|+|+.|.|-.|++. +|+.+|||++.+... .....+.+|+-+|+-+.||||+++++++....++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 46889999999999999999664 799999999976521 22456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|-|.+++-++ +.+++.++.+++.||+.|+.|||.. +|+|||+||+|+|+|..+++||+|||+|..-.++
T Consensus 92 Eyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 999999999999875 4589999999999999999999999 9999999999999999999999999999864332
Q ss_pred CcccccccccccccCccccccCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVS-DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
..-.+-+|+|.|.|||++.|.+|. .++||||+|||||.++||+.||+++ + +.. .-..++.|.+
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----N---ir~-LLlKV~~G~f------ 229 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----N---IRV-LLLKVQRGVF------ 229 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----c---HHH-HHHHHHcCcc------
Confidence 233445899999999999998875 6899999999999999999999833 1 111 1122233322
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+.|...+.++.+|+.+|+..||++|.|++||.+|
T Consensus 230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2356677889999999999999999999999986
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.95 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=228.1
Q ss_pred HHcCCCCCccccccCCCccEEEEEECC-CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
....++.+.+++|.|.||.||.|.|+. .-.||||.++... ...++|.+|+.+|+.++|||+|+++|+|..+..+|+|.
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 334467888999999999999998875 5679999887554 45789999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
|||.+|+|.+|+++.....++....+.+|.||+.||+||..+ .+|||||.++|+|+.++..|||+|||+++....+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 999999999999998878888889999999999999999999 99999999999999999999999999999987777
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.....+....+.|.|||-+....++.|+|||+|||+|||+.| |..||..- ++.+ +..+++.
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--------dlSq----------VY~LLEk 481 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQ----------VYGLLEK 481 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--------cHHH----------HHHHHhc
Confidence 666666677889999999999999999999999999999987 55665422 2222 2344555
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
.++-+.|..|+..+++||+.||++.|.+||+++|+-+.++.+-..
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 666677889999999999999999999999999999999886543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.06 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=222.4
Q ss_pred HcCCCCCccccccCCCccEEEEEECC---C--cEEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEISP---G--VLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
+.+.....++||+|.||.||+|...+ | -.||||..+.. ..++.+.|..|+.+++.++||||++++|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 33456678899999999999996542 3 35889988774 44567889999999999999999999999976 478
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
|+|||.++-|-|++|++.++ ..++......++.|++.||+|||+. .+|||||.++|||+.....||++|||+++..
T Consensus 466 WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999999999875 4588899999999999999999999 9999999999999999999999999999999
Q ss_pred CCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
..+..+......-+..|||||.+.-.+++.++|||.|||++||+++ |..||..-. ..++.-
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------------NsDVI~ 603 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------------NSDVIG 603 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc------------------ccceEE
Confidence 8777666655555679999999999999999999999999999875 788987332 223444
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.++.+-+...|..|+..++.++.+||+.||.+||++.++...|+++.+
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 456667778899999999999999999999999999999999987644
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.82 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=203.7
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch---hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
.++|++.++||+|+||.||.|+.+ +|..+|+|++++.... ..+.++.|-.+|....+|.||+++..|++.+..|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 468999999999999999999654 6999999999877543 345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC-
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP- 835 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~- 835 (963)
|||++||++..++... ..+++..++.++.+++.|++-+|.. |+|||||||+|+|||..|++||+|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999874 4599999999999999999999999 999999999999999999999999999853311
Q ss_pred ---------------------CCCc------------------------ccccccccccccCccccccCCCCcchhhHHH
Q 046851 836 ---------------------SETH------------------------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSY 870 (963)
Q Consensus 836 ---------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 870 (963)
.+.. .....+|||.|||||++.+..|...+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0112579999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCC---
Q 046851 871 GVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT--- 947 (963)
Q Consensus 871 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs--- 947 (963)
|||+|||+.|.+||..+.+. ..|.+........ ..........+..+||.+|+. ||++|--
T Consensus 375 G~ImyEmLvGyPPF~s~tp~-------~T~rkI~nwr~~l--------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQ-------ETYRKIVNWRETL--------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhhhc--------cCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 99999999999999866543 1222222211111 111122334678899999999 9999985
Q ss_pred HHHHH
Q 046851 948 MKQVV 952 (963)
Q Consensus 948 ~~evl 952 (963)
+.||.
T Consensus 439 ~~EIK 443 (550)
T KOG0605|consen 439 AEEIK 443 (550)
T ss_pred HHHHh
Confidence 44544
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.79 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=206.9
Q ss_pred CCCCCccccccCCCccEEEEEEC----CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
.+|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+..+++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999653 367899999876533 3345789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999997643 4589999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.........++..|+|||.+.+..++.++|||||||++||+++ |+.||..... .+..... ..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~-~~~------- 224 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKAV-EDG------- 224 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHH-HCC-------
Confidence 2222222345678999999999999999999999999999775 9999864321 1111111 111
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.....+..++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122345667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.01 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=210.8
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4789999999999999999998888899999876543 235788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.......+++.++..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999876666789999999999999999999999 999999999999999999999999999987654332222
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....++..|+|||+..+..++.++||||||+++|||++ |+.||...... ..... ..... ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~-~~~~~---------~~ 223 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSA-LQRGY---------RM 223 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHH-HHcCC---------CC
Confidence 33346678999999998889999999999999999998 88888633111 11111 11110 01
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
......+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=336.19 Aligned_cols=262 Identities=23% Similarity=0.404 Sum_probs=205.3
Q ss_pred CCCCCccccccCCCccEEEEEECC-----------------CcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP-----------------GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTL 743 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 743 (963)
++|++.+.||+|+||.||+|.+.+ +..||+|.+..... ....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 34699998875432 335678999999999999999999
Q ss_pred EEeeeCCCeEEEEEeccCCCChHHHHhhhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 046851 744 IGYHASETEMFLIYNYLPGGNLENFIQQRS-----------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806 (963)
Q Consensus 744 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 806 (963)
++++.+.+..++||||+++|+|.+++.... ...+++.++.+++.|++.|++|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999986532 12467889999999999999999999 9999
Q ss_pred cccCCCCeEECCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcC--CCC
Q 046851 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSD--KKA 883 (963)
Q Consensus 807 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg--~~p 883 (963)
|||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433222 22233457899999999988899999999999999999874 556
Q ss_pred CCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 884 LDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
|..... ......+....+...... ....+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 242 ~~~~~~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD-----EQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH-----HHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 653211 112222222222111111 011233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.74 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=211.0
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35689999999999999999988778899999986543 23567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.......+++.++..++.|++.|+.|||+. +++||||||+||++++++.++|+|||++..........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999999876556789999999999999999999999 99999999999999999999999999998775332222
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
..+...+..|+|||++.+..++.++||||||+++|||++ |+.||..... ...... .... ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~-~~~~---------~~ 222 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQ-VDQG---------YR 222 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH-HHcC---------CC
Confidence 222334468999999999899999999999999999999 8888863311 111111 1111 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
...+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 112334557899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=349.07 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=205.4
Q ss_pred cCCCCCccccccCCCccEEEEEE------CCCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (963)
.++|++.+.||+|+||.||+|.+ .++..||||+++... ....+.+.+|++++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34799999999999999999964 235689999986433 33456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhc-----------------------------------------------------------
Q 046851 753 MFLIYNYLPGGNLENFIQQRS----------------------------------------------------------- 773 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 773 (963)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999996532
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 774 --------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 774 --------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
...+++..+.+++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478889999999999999999999 9999999999999999999999999999866433222
Q ss_pred c-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 840 A-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 840 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
. .....++..|+|||++.+..++.++||||||+++|||++ |..||...... .....+ ...+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~~----~~~~--------- 333 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYKM----IKEG--------- 333 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHHH----HHhC---------
Confidence 1 122345668999999999999999999999999999998 78887643211 111111 1111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.....+...+.++.+++.+||+.||++||++.||++.|++.
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11111223356789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.17 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=215.7
Q ss_pred HcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+..+|++.+.||.|+||.||+|...++..||+|++.........++..|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34579999999999999999999888999999999876665667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.......+++.++..++.|+++|++|||+. +++||||+|+||+++.++.+||+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999876666789999999999999999999999 9999999999999999999999999999876433222
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+....... ..
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~----------~~ 221 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQITA----------GY 221 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHHh----------CC
Confidence 223446778999999998889999999999999999998 7888864321 111111111 11
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
....+..++..+.+++.+|++.+|++|||++++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1122345567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=329.50 Aligned_cols=251 Identities=24% Similarity=0.413 Sum_probs=205.7
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+|++.+.||+|+||.||+|++.++..+|+|.+.... ...+++..|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 588889999999999999999888899999876443 2346788999999999999999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.++++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.++...........
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 84 GCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999997643 3589999999999999999999999 9999999999999999999999999999865433332233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
...++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.......... ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~----------~~ 221 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFR----------LY 221 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCC----------CC
Confidence 3345678999999998889999999999999999999 8888863321 111211111111 01
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
.+...+..+.+++.+||+.+|++||+++++++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12223457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=302.12 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=213.5
Q ss_pred cCCCCCccccccCCCccEEEEE-ECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-----CeEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-----TEMF 754 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 754 (963)
..+|++.+.+|+|||+.||.++ ..++..||+|++.....++.+..++|++..++++|||+++++++...+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3579999999999999999995 567899999999888878888899999999999999999999886433 3589
Q ss_pred EEEeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 755 LIYNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
++++|+..|||.+.+.... +..+++.++++|+.++++||++||+. .|+++||||||.||++++++.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999997654 45689999999999999999999998 45699999999999999999999999999876
Q ss_pred cCCCCCc--------ccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHH
Q 046851 833 LGPSETH--------ATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWG 901 (963)
Q Consensus 833 ~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 901 (963)
..-.... .......|..|+|||.+. +...++++|||||||++|+|+.|..||+.....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------- 247 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------- 247 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence 5321111 112234688999999885 556789999999999999999999999844331
Q ss_pred HHHHhcCccc-ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 902 CMLLRQGRAK-EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 902 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.+... ......+.-......++.+.+++.+|++.||.+||++.+++..++.+.+
T Consensus 248 -----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li~ 302 (302)
T KOG2345|consen 248 -----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLIA 302 (302)
T ss_pred -----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhcC
Confidence 11111 1111112112223367889999999999999999999999999988754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.44 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=204.6
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++.+++|++++++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999965 5789999999865432 233467889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999988765555689999999999999999999999 99999999999999999999999999998753322
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...... .............
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~---------- 220 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKED---------- 220 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhcc----------
Confidence 223457899999999999999999999999999999999999999754321 0011111111110
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
....+......+.+++.+||+.||++||+ +++++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11123344567889999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=330.38 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=210.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.+|.+.+.||+|+||.||+|... .++.||+|++... .....++.+|++++++++|+|++++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35788899999999999999664 5889999988654 334567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.......+++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999876556689999999999999999999999 99999999999999999999999999998765433322
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....++..|+|||++.+..++.++||||||+++|||++ |..||.... ..+..... ... ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~-~~~---------~~ 223 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELL-EKG---------YR 223 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHH-HCC---------CC
Confidence 223344678999999999899999999999999999998 888876321 11111111 111 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
...+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.03 Aligned_cols=241 Identities=23% Similarity=0.326 Sum_probs=204.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 756 (963)
++|.+.+++|+|.||+|+.|..+ +++.+|||++++.. .++.+..+.|.+++.... ||.++.++.+|++.+++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 47999999999999999999765 58899999998764 355677788888887775 99999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+.||++..+.+ ...+++..+..+|..|+.||.|||++ +||+||||.+|||+|.+|.+||+|||+++.-. .
T Consensus 448 mey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~ 520 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-G 520 (694)
T ss_pred EEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC-C
Confidence 99999999444433 45699999999999999999999999 99999999999999999999999999998643 2
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
....+.+.+|||.|||||++.+..|+.++|.|||||++|||+.|..||..+.+++ ....+..++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------~FdsI~~d~-------- 584 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------VFDSIVNDE-------- 584 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHhcCC--------
Confidence 3346677899999999999999999999999999999999999999998665441 111111111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
..+|...+.+...++.+++..+|++|--+
T Consensus 585 ---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12567778899999999999999999866
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=334.27 Aligned_cols=249 Identities=31% Similarity=0.544 Sum_probs=198.2
Q ss_pred CccccccCCCccEEEEEEC-----CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 686 ASNCIGNGGFGATYKAEIS-----PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+.+.||.|.||.||+|.+. .+..|+||.+..... +..+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999877 367899999965433 3468899999999999999999999999988889999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC-
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET- 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 838 (963)
+++|+|.+++.......+++.++..|+.|+++||+|||+. +++||||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987556799999999999999999999999 999999999999999999999999999987632222
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......+...|+|||.+.+..++.++||||||+++|||++ |+.|+... ...+..... ..+..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~-~~~~~------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKL-KQGQR------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHH-HTTEE-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccc-ccccc-------
Confidence 22333456789999999999889999999999999999999 67776532 122222222 22211
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
...+..++..+.+++.+||+.+|++||++.++++.|
T Consensus 224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 122334567899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=346.95 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=205.4
Q ss_pred cCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (963)
.++|++.+.||+|+||.||+|... ++..||||++.... ......+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 347999999999999999998642 24579999997543 33346788999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhc-----------------------------------------------------------
Q 046851 753 MFLIYNYLPGGNLENFIQQRS----------------------------------------------------------- 773 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 773 (963)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986431
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc-cccc
Q 046851 774 ---------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-ATTG 843 (963)
Q Consensus 774 ---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~ 843 (963)
...+++.++.+++.|+++|++|||++ +|+||||||+||++++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 12478889999999999999999999 9999999999999999999999999999765432221 1122
Q ss_pred ccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 844 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||...... . .+. .....+ .....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----~---~~~-~~~~~~---------~~~~~ 336 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----S---KFY-KMVKRG---------YQMSR 336 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----H---HHH-HHHHcc---------cCccC
Confidence 335678999999998899999999999999999997 99998643221 0 111 111111 11111
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
+...+.++.+++.+||+.||++||++.+|++.|+++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 223356889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=348.94 Aligned_cols=261 Identities=26% Similarity=0.333 Sum_probs=218.5
Q ss_pred cCCCCCccccccCCCccEEEEEECCC-cEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeee----C---CC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPG-VLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHA----S---ET 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~----~---~~ 751 (963)
..++++.++|.+|||+.||.|....+ ..||+|++...+.+..+.+++|+++|+.++ |+|||.+++... . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34678889999999999999977765 999999999888888899999999999997 999999999321 1 24
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
++++.||||+||+|-+++..+-...+++.++++|+.++++|+++||.. .|+|||||||.+|||++.+|..||||||-|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 789999999999999999987767799999999999999999999988 7789999999999999999999999999986
Q ss_pred ccCCCCC-cc-------cccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhH
Q 046851 832 LLGPSET-HA-------TTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAW 900 (963)
Q Consensus 832 ~~~~~~~-~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~ 900 (963)
....... .. .-...-|+.|+|||++. +...++|+|||++||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 5432221 10 01134689999999874 67899999999999999999999999984411
Q ss_pred HHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCCCC
Q 046851 901 GCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPASC 963 (963)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~~~ 963 (963)
-.+++..+.-.........+..||..||+++|++||++.+|+..+.+++...|
T Consensus 264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 12223333222334678899999999999999999999999999999887765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.53 Aligned_cols=257 Identities=24% Similarity=0.320 Sum_probs=204.0
Q ss_pred HHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--------------hhHHHHHHHHHHHhccCCCCeeEE
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--------------QGVQQFHAEIKTLGRLRHPNLVTL 743 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 743 (963)
..-++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...++..+||.++++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34468999999999999999999654 689999999965321 123578999999999999999999
Q ss_pred EEeeeC--CCeEEEEEeccCCCChHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC
Q 046851 744 IGYHAS--ETEMFLIYNYLPGGNLENFIQQRSTRA-VDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF 820 (963)
Q Consensus 744 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 820 (963)
+++..+ .+.+|+|+|||..|.+...- ...+ ++..+++++++++..||+|||.+ |||||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 999876 56899999999888765432 2333 88999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCC----cccccccccccccCccccccCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 046851 821 NAYLSDFGLARLLGPSET----HATTGVAGTFGYVAPEYAMTCR----VSDKADVYSYGVVLLELLSDKKALDPSFSSYG 892 (963)
Q Consensus 821 ~~kl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~~~~~~ 892 (963)
+|||+|||.+..+..... ..-...+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||..++.-
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-- 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-- 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence 999999999987632211 1122368999999999987632 346789999999999999999999855322
Q ss_pred CCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
+. ...++...+.-....+..+++.+|+.++|++||+.|.+..+|..+..-.
T Consensus 326 ------~l---------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 326 ------EL---------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred ------HH---------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 11 1122233333333335667899999999999999999999998876543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.75 Aligned_cols=247 Identities=23% Similarity=0.401 Sum_probs=209.7
Q ss_pred CCCCCccccccCCCccEEEEE-ECCCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.+|++.+.+|+|.||.|-+|. +..|+.||||.+++... ++.-.+++|+++|+.++||||+.++++|...+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 478899999999999999994 46799999999876543 44556789999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||..+|.|++|+.+++ .+++.++.++++||..|+.|+|.+ +++|||+|.+|||+|+++++||+|||++..+....
T Consensus 133 EYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999864 599999999999999999999999 99999999999999999999999999999886443
Q ss_pred CcccccccccccccCccccccCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVS-DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.-..++|+|-|.+||.+.+.+|. +.+|-||+||+||-++.|..||+.. +.-..++++ ..+ .+.+
T Consensus 208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQI-s~G---aYrE- 272 (668)
T KOG0611|consen 208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQI-SRG---AYRE- 272 (668)
T ss_pred --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHh-hcc---cccC-
Confidence 34567999999999999998875 5799999999999999999999843 222222222 112 1211
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
...+....-||.+|+-.+|++|.|..+|..+-
T Consensus 273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 -------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 23345677899999999999999999998764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=331.11 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=208.7
Q ss_pred CCCCCccccccCCCccEEEEEECC------CcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP------GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|++.+.||+|+||.||+|.... ...||+|.+..... ....++.+|++.+.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 368899999999999999997642 25799998865433 33467899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC
Q 046851 755 LIYNYLPGGNLENFIQQRST--------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF 820 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 820 (963)
++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999976421 4578899999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchh
Q 046851 821 NAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIV 898 (963)
Q Consensus 821 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~ 898 (963)
.++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999986543322 22233456789999999998889999999999999999998 99898643211
Q ss_pred hHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 899 AWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
+.. .....+. ....+..++.++.+++.+||+.+|++||++.||+++|+.+
T Consensus 234 ~~~-~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 EVI-EMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH-HHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111 1111111 1123445677899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=326.01 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=205.5
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+|++.+.||+|+||.||+|++.++..||||.+..... ..+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 5788899999999999999888777899998875432 346789999999999999999999999998999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++..... .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.++...........
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 999999976433 689999999999999999999999 9999999999999999999999999998866443322223
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
...++..|+|||+..+..++.++||||||+++|||++ |+.||...... +..... ..+.. ..
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~-~~~~~---------~~ 221 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKV-SQGLR---------LY 221 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHH-hcCCC---------CC
Confidence 3345678999999998889999999999999999998 88888633211 111111 11111 11
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
.+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12223568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=308.83 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=203.9
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchh--HHHHHHHHHHHhccCCCCeeEEEEeee--CCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGYHA--SETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv 756 (963)
++|+..+.|++|.||.||+|+. ++++.||+|+++...... .-...+||.++.+++|||||.+..+.. .-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3688899999999999999954 578999999997654321 224589999999999999999998764 45679999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||++. +|..+++..+ +++...++..++.|+++|++|||.. .|+|||+|++|+|+...|.+||+|||+|+.++..
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999988 9999999875 5789999999999999999999999 9999999999999999999999999999998755
Q ss_pred CCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh---cCcccc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR---QGRAKE 912 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 912 (963)
. ...+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++-|....+- +..+.+-.... +..++.
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-----dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-----DQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-----HHHHHHHHHhCCCccccCCC
Confidence 3 334456789999999999875 5899999999999999999999888654322 11111111110 011111
Q ss_pred eecc--------------ccCCCCChh-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 FFTA--------------GLWDAGPHD-DLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~--------------~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+.+. .++..++.. ..+.-++|+...+..||++|.|+.|.+++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111 111112211 23567789999999999999999998864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=302.81 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=207.3
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
+++|++.+.||+|.|+.||+..+ .+|+.+|+|++... ...+.+++.+|+++-+.++||||+++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 35788999999999999999954 46999999988543 2345688899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~ 834 (963)
|+|+|++|..-+-.+ ..+++..+...++||++|+.|+|.. +|||||+||+|+++.. ...+|++|||+|....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999998877654 3478888999999999999999999 9999999999999953 3459999999999887
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
......+.+|||+|||||+.+..+|+..+|||+.|||||-++.|++||.+.... .+.+ .+..+.. -+
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----rlye----~I~~g~y--d~ 231 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYE----QIKAGAY--DY 231 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----HHHH----HHhcccc--CC
Confidence 555667789999999999999999999999999999999999999999853222 1111 1111111 11
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+.+. -....++..+|+.+|+..||++|.|+.|.+.+
T Consensus 232 ~~~~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 PSPE----WDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCcc----cCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 2212 22345678899999999999999999998764
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.11 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=208.1
Q ss_pred CCCCCccccccCCCccEEEEEECC----CcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|.+.. ...||||.+..... ....+|.+|+..+++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 478999999999999999997742 45799998875433 3346789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999997653 3689999999999999999999999 9999999999999999999999999999887522
Q ss_pred C-CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 837 E-THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 837 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
. ........+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ... ......
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~-~~~~~~------ 224 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVI-KAVEDG------ 224 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHH-HHHHcC------
Confidence 2 222222345678999999998899999999999999999998 88888633211 111 111111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.....+...+..+.+++.+|++.+|++||++.||+++|+++
T Consensus 225 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 ---YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112334566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=339.77 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=205.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... .....+..|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999776 589999999975432 33466889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999764 4588999999999999999999999 999999999999999999999999999986543
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +......... ..+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~---~~~~~~ 220 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--------ETWENLKYWK---ETLQRP 220 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--------HHHHHHHhcc---ccccCC
Confidence 233457899999999999999999999999999999999999999743211 1111111100 001111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...........++.+++.+|+..+|++||++++++++
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1110012345678899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.85 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=216.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe-EEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE-MFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 757 (963)
++|...+++|+|+||.++..+++ ++..|++|.+..... ...+....|+.++++++|||||.+.+.|..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999665 578899999976543 233457899999999999999999999998888 99999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
+|++||++.+.+.+..+..++++.+.+|+.|++.|+.|||+. .|+|||||+.||+++.++.|+|+|||+|+...+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999988878899999999999999999999999 99999999999999999999999999999987655
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
. ....++||+.||.||.+.+.+|..|+|+||+||++|||++-+++|.... ....+....+..
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~~~--------- 222 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINRGL--------- 222 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhhcc---------
Confidence 3 3455789999999999999999999999999999999999999998442 223332222221
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+.....++..++..|+..+|+.||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233456677789999999999999999999999876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=332.35 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=203.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999765 689999999865432 33456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999999764 3589999999999999999999999 9999999999999999999999999999865422
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......... +.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~-~~-------- 214 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILA-GK-------- 214 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CC--------
Confidence 2235689999999999998899999999999999999999999974321 111111111 11
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
...+......+.+++.+|++.||.+||+ ++|++++
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1122233557889999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.37 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=207.9
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++++++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 46889999999999999999888888999999875433 34678999999999999999999998854 56889999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.......+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999876556689999999999999999999999 999999999999999999999999999987654332333
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....++..|+|||+..+..++.++||||||+++|||++ |..||.... ..+........ ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~----------~~~ 222 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NREVLEQVERG----------YRM 222 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcC----------CCC
Confidence 33345678999999998889999999999999999999 788886321 11111111111 111
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
..+...+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2233456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.52 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=207.2
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.++||+|+||.||+|...++..||+|++..... ..+++.+|++++++++||||+++++++.. ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 46999999999999999999887777899999875332 34678999999999999999999998754 56799999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+|+|.+++.+.....+++..+..++.|+++||+|+|+. +++||||||+||++++++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999875555689999999999999999999999 999999999999999999999999999987654433333
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....++..|+|||+..+..++.++||||||+++|||++ |..||...... ....... .+ ...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~-~~---------~~~ 222 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVE-RG---------YRM 222 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHh-cC---------CCC
Confidence 33456778999999998889999999999999999999 77777533211 1111111 11 011
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
..+...+..+.+++.+|++.+|++||+++++++.|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 12234566889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.05 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=208.4
Q ss_pred cCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccc-hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 752 (963)
.++|.+.++||+|+||.||+|... .+..||||++..... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 468999999999999999999753 234799999965432 33467899999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhc-----------------------------------------------------------
Q 046851 753 MFLIYNYLPGGNLENFIQQRS----------------------------------------------------------- 773 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 773 (963)
.++||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999986531
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC
Q 046851 774 -----------------------------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD 818 (963)
Q Consensus 774 -----------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 818 (963)
...+++.++..++.|+++|++|||+. +|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12477888899999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcc
Q 046851 819 DFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFN 896 (963)
Q Consensus 819 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~ 896 (963)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------ 346 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------ 346 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------
Confidence 999999999999865432221 2223456788999999999899999999999999999997 88888643211
Q ss_pred hhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 897 IVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.........+ .....+...+..+.+++.+||+.+|++||++.+|.+.|+++.+
T Consensus 347 --~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 --STFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0111111111 1111233456688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=313.53 Aligned_cols=269 Identities=23% Similarity=0.324 Sum_probs=205.7
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccch--hHHHHHHHHHHHhccCCCC-eeEEEEeeeCCC------
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPN-LVTLIGYHASET------ 751 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 751 (963)
..|...++||+|+||+||+|+. .+|+.||+|++.....+ ......+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3577778899999999999955 46899999999766442 2345689999999999999 999999998876
Q ss_pred eEEEEEeccCCCChHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRST--RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 829 (963)
..++|+||++. +|.++++..+. ..++...++.++.|+++|++|||++ +|+||||||+||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999976 99999988653 3577789999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc-
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ- 907 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 907 (963)
|+.+.-.... ....++|..|+|||++.+. .|+...||||+|||++||+++++-|..+.+. .....+......
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-----~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-----DQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-----HHHHHHHHHcCCC
Confidence 9977533222 3345789999999999987 7899999999999999999998887754331 111111111110
Q ss_pred --Cccccee---cc--ccCCCC-Ch----hH---HHHHHHHHHHcccCCCCCCCCHHHHHHH--HhccCC
Q 046851 908 --GRAKEFF---TA--GLWDAG-PH----DD---LVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQLQP 960 (963)
Q Consensus 908 --~~~~~~~---~~--~~~~~~-~~----~~---~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l~~ 960 (963)
..++... +- ...... +. .. .....+++.+|++.+|.+|.|++.++++ +.++..
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0111110 00 000000 10 11 1367899999999999999999999987 665543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.44 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=204.5
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+|++.+.||+|+||.||+|.+.++..+|+|++..... ....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 5888999999999999999888778899998864432 335688899999999999999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999997654 3689999999999999999999999 9999999999999999999999999999765433222222
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +..... ..+ ....
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~-~~~---------~~~~ 221 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESV-SAG---------YRLY 221 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHH-HcC---------CcCC
Confidence 2234568999999998899999999999999999999 78888633211 111111 111 1111
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
.+...+.++.+++.+||+.+|++|||+.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 22345668999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.94 Aligned_cols=261 Identities=21% Similarity=0.259 Sum_probs=199.8
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|.. .+++.||+|+.. ...+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5799999999999999999965 468999999643 245678999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
. ++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 166 ~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 166 K-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred C-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 5 6899988764 3588999999999999999999999 99999999999999999999999999997643333333
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc-c-------
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK-E------- 912 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~------- 912 (963)
.....||+.|+|||++.+..++.++||||+||++|||++|+.|+.......................+... +
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 34567999999999999989999999999999999999999887643322111111000000000000000 0
Q ss_pred ----e---------eccccCCC--CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 ----F---------FTAGLWDA--GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 ----~---------~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ..+..+.. .....+.++.+++.+||+.||++|||++|++++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00000000 001235578899999999999999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=341.48 Aligned_cols=488 Identities=27% Similarity=0.359 Sum_probs=399.6
Q ss_pred cccccceeccccccccCCCc--ccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEE
Q 046851 49 FVNLEELNLAGNLVNGTVPT--FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLL 126 (963)
Q Consensus 49 l~~L~~L~Ls~N~l~~~~~~--~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 126 (963)
-..|+.|.+++|.+....+. .+..+..|.+++|++. ++|..+. .+..++.|+.++|++. .+|..++.+.+|..|+
T Consensus 44 qv~l~~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig-~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLEVLREDLKNLACLTVLNVHDNKLS-QLPAAIG-ELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred hcchhhhhhccCchhhccHhhhcccceeEEEeccchhh-hCCHHHH-HHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 45689999999998854443 3557889999999999 9999998 4889999999999998 8999999999999999
Q ss_pred cccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCc
Q 046851 127 LFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNF 206 (963)
Q Consensus 127 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~ 206 (963)
.++|.+.+ .++.++.+.+|..|+..+|+++ ..|..+.++.+|..+++.+ |+
T Consensus 121 ~s~n~~~e-l~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~---------------------------n~ 171 (565)
T KOG0472|consen 121 CSSNELKE-LPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEG---------------------------NK 171 (565)
T ss_pred ccccceee-cCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccc---------------------------cc
Confidence 99999994 6777888999999999999999 8899999999999999887 56
Q ss_pred cccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCC
Q 046851 207 FEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARE 286 (963)
Q Consensus 207 ~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 286 (963)
+....|+.+. ++.|++|+...|-++ .+|..++++.+|+-|+|..|+|..+| .|..+..|++|+++.|+|...+...
T Consensus 172 l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~ 247 (565)
T KOG0472|consen 172 LKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEH 247 (565)
T ss_pred hhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHH
Confidence 6656666666 999999999999988 67889999999999999999999998 7899999999999999999888877
Q ss_pred C-CCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccc---cchhhhhc
Q 046851 287 L-PVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRD---GFLAIFHN 362 (963)
Q Consensus 287 ~-~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 362 (963)
+ .++++..||+++|+++..|.++.-+++|+.||+++|-+.++++++..+ .+......|+|++.+.++ +.+...+.
T Consensus 248 ~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLK 326 (565)
T KOG0472|consen 248 LKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLK 326 (565)
T ss_pred hcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHH
Confidence 7 799999999999999999999999999999999999999999999998 778888999998877665 22222223
Q ss_pred cccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCccccccc-CCcceEEEEccCCeeeecCchhHhhccCC--c
Q 046851 363 FGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGIC-NRLDSLMVNVSNNRIAGQLPAEIGRMCKS--L 439 (963)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~-~~l~~~~L~l~~n~l~~~~p~~~~~~~~~--L 439 (963)
+.+..+...-++.+.. ...-.+..|.+.|..- .......|++++-+++ .+|.++|+..++ .
T Consensus 327 yLrs~~~~dglS~se~---------------~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~V 390 (565)
T KOG0472|consen 327 YLRSKIKDDGLSQSEG---------------GTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIV 390 (565)
T ss_pred HHHHhhccCCCCCCcc---------------cccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcce
Confidence 3333222222221100 0011122222222221 1223337889999998 999999987432 7
Q ss_pred cEEECcCCcCCCCCccccccCCCCC-EEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccc
Q 046851 440 KFLDASGNQIVGPIPRGVGELVSLV-ALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSS 518 (963)
Q Consensus 440 ~~L~ls~n~l~~~~p~~~~~l~~L~-~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~ 518 (963)
+..+++.|++. ++|..+..+..+. .+.+++|.+ +-+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|+
T Consensus 391 t~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~ 467 (565)
T KOG0472|consen 391 TSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSF 467 (565)
T ss_pred EEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccc
Confidence 88999999999 8999998888765 556677766 789999999999999999999998 8999999999999999999
Q ss_pred cccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCCCCCCc--ccccccCCCCCCCC
Q 046851 519 NSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL--MKCSSVLGNPYLRP 593 (963)
Q Consensus 519 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~--~~~~~~~~np~~~~ 593 (963)
|++. ..|..+..+..|+.+-.++|++...-|+.+.++.+|.+||+.+|.+...+|..++- .......||||.-|
T Consensus 468 NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr~P 543 (565)
T KOG0472|consen 468 NRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFRQP 543 (565)
T ss_pred cccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccCCC
Confidence 9998 78999888889999989999999555556999999999999999999876665543 33345679998643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.09 Aligned_cols=242 Identities=23% Similarity=0.272 Sum_probs=198.7
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999664 68999999987542 233456788999999999999999999999999999999999999
Q ss_pred ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccc
Q 046851 764 NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG 843 (963)
Q Consensus 764 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (963)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence 999999763 4589999999999999999999999 9999999999999999999999999998753222 222334
Q ss_pred ccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCC
Q 046851 844 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGP 923 (963)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (963)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ ... ...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~-~~~----------~~~p 215 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELIL-MEE----------IRFP 215 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHH-cCC----------CCCC
Confidence 5799999999999999999999999999999999999999964321 11111111 111 1123
Q ss_pred hhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 924 HDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 924 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
.....++.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 34556788999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.53 Aligned_cols=268 Identities=20% Similarity=0.241 Sum_probs=203.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999775 58899999987542 2334677899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9998777655433 34589999999999999999999999 999999999999999999999999999987654333
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC-------CcchhhHHHHHHhcCccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN-------GFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 911 (963)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||......... +.....+...........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 3334457899999999999988999999999999999999999999743211000 000000000000000000
Q ss_pred ceeccccCC------CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWD------AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+.... ......+..+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0111234578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=312.02 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=204.3
Q ss_pred HcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEee--cccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC-----CC
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLA--VGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS-----ET 751 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 751 (963)
....|...+.||+|+||.|+.|.. .+|+.||||++. .......++..+|++.++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345677788999999999999955 479999999997 4555667888999999999999999999998755 46
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
.+|+|+|+|+. +|.+.++.. +.++...+..++.|+++|+.|+|+. +|+|||+||+|++++.+...||+|||+|+
T Consensus 100 DvYiV~elMet-DL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 78999999954 999999874 4489999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCC-CcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHH-------
Q 046851 832 LLGPSE-THATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGC------- 902 (963)
Q Consensus 832 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------- 902 (963)
...... ....+..+.|.+|+|||.+.. ..|+.+.||||.|||+.||++|++-|.+...- .....+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-----~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-----HQLQLILELLGTPS 248 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-----HHHHHHHHhcCCCC
Confidence 875431 122355678999999999864 57999999999999999999999988754321 0000000
Q ss_pred ----HHHhcCcccceecccc-------CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 903 ----MLLRQGRAKEFFTAGL-------WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 903 ----~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.......+..++.... ...++ .......+|+.+|+..||.+|+|++|++++
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0001001111111100 00112 334567899999999999999999999875
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.16 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=210.0
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++|++.++||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 357899999999999999999988899999999875443 3467899999999999999999999874 45689999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++....+..+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999999876666789999999999999999999999 99999999999999999999999999998765333333
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+..... ..+ ..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~-~~~---------~~ 221 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNL-ERG---------YR 221 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHH-HcC---------CC
Confidence 333456778999999998889999999999999999999 9999863321 1111111 111 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
...+...+.++.+++.+|++.+|++||+++++.+.|+.+
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 112233456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=334.33 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=215.7
Q ss_pred CCCCCccccccCCCccEEEEEECC--C--cEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP--G--VLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++..+.+.||+|.||.|++|.|.. | ..||||.+...... ...+|.+|+.+|.+++|+|++++||+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 356678899999999999998763 3 46899999876544 67899999999999999999999999987 678899
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
||.++.|||.+.+++.....+-....+.++.|||.||.||.++ ++||||+.++|+++-....|||+|||+++.++..
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999999987677888999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCcccc--cccccccccCccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 837 ETHATT--GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSD-KKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 837 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
+.+... ...-...|+|||.+....++.++|||+|||++|||+|+ ..||-..... .+.+.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------------qIL~~ 327 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------------QILKN 327 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------------------HHHHh
Confidence 544322 12235689999999999999999999999999999985 5676533211 12334
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
+|++-+...+..|++++++++..||.+.|++|||+.++.+.+-.
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 55666667788999999999999999999999999999855533
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.91 Aligned_cols=245 Identities=24% Similarity=0.335 Sum_probs=203.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 47899999999999999999775 58999999987542 233467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999999999999864 4588999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ...+..
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~-i~~~~~------- 232 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEK-ILAGRL------- 232 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHH-HhcCCc-------
Confidence 2235789999999999999999999999999999999999999964321 111111 111111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
..+.....++.+++.+||+.||++||+ +++++++
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 122234457889999999999999997 6777654
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.81 Aligned_cols=258 Identities=23% Similarity=0.401 Sum_probs=210.4
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|.+.+.||+|+||.||+|... ++..|++|.+........+.+.+|++.+++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35888899999999999999642 356699998876666666789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc
Q 046851 756 IYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN 821 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 821 (963)
||||+++++|.+++.... ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999997642 23478999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhh
Q 046851 822 AYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 822 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 899 (963)
++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... +
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~ 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------E 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------H
Confidence 99999999976543221 11223456789999999999899999999999999999999 99998643221 1
Q ss_pred HHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.. .....+... ..+...+..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 234 ~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 VI-ECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HH-HHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11 111122111 1122345678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.36 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=207.5
Q ss_pred CCCCCccccccCCCccEEEEEECC------CcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP------GVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|.+.+.||+|+||.||+|...+ +..||||++...... ..+.+.+|++++++++|+|++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468889999999999999997643 478999998765443 4578999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 755 LIYNYLPGGNLENFIQQRS------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
+||||+++++|.+++...+ ...+++.++..++.|++.|++|+|+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997643 23478899999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhH
Q 046851 823 YLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAW 900 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 900 (963)
+|+|||++........ .......+++.|+|||++.+..++.++||||+|+++|||++ |..||...... ...+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-----~~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----EVIEC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHH
Confidence 9999999976533221 11223345788999999999999999999999999999998 99998633211 11111
Q ss_pred HHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 901 GCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
...+.. ...+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 237 ----~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ----ITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111 11223455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=313.29 Aligned_cols=258 Identities=26% Similarity=0.353 Sum_probs=197.6
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC-----eEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET-----EMFLI 756 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 756 (963)
.|...+++|.|+||.||+|... +++.||||+....... --+|+++|+.++|||||++..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5777899999999999999765 5799999988654321 257999999999999999999875422 34689
Q ss_pred EeccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC-CcEEEeeccccccc
Q 046851 757 YNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD-FNAYLSDFGLARLL 833 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~ 833 (963)
|||||. +|+++++.. .+..++...+.-+..|+++|++|||+. +|+||||||+|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999988 999999852 245688888999999999999999999 99999999999999976 89999999999998
Q ss_pred CCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC----
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG---- 908 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 908 (963)
.+.... .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+... ...+...++..-...
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~----~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS----VDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH----HHHHHHHHHHhCCCCHHHH
Confidence 766554 334678899999999975 699999999999999999999988875322 112222221111000
Q ss_pred -----cccceeccccCC-----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 -----RAKEFFTAGLWD-----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 -----~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+.-.+.... -.......+..+++.+++..+|.+|.++.|++++
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 000111111111 1233456788999999999999999999999754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.88 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=209.8
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|.+.+.||+|+||.||++... ++..||+|.+........+.+.+|++++++++|||++++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 47889999999999999999642 356699998876655556789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 756 IYNYLPGGNLENFIQQRS-----------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
||||+++++|.+++.... ...+++.++..++.|++.|++|||++ +++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999997542 13489999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHH
Q 046851 825 SDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGC 902 (963)
Q Consensus 825 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 902 (963)
+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||...... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~~~ 233 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EVIE 233 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHH
Confidence 999999865432211 1222345778999999998899999999999999999998 88887633211 1111
Q ss_pred HHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 903 MLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
....+... ..+...+.++.+++.+||+.+|.+|||+.+|.+.|+++..+
T Consensus 234 -~i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 -CITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11121111 11223456789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=332.29 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=205.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||++... +|..||+|.+..... ...+++.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 58999999999999999999765 688999998876532 3346789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++|+|.+++... ..+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 85 MDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 9999999999764 35889999999999999999999852 6999999999999999999999999998765322
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC---cc------
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG---RA------ 910 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~------ 910 (963)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+..........+ ..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhcccccccccCCccccCcc
Confidence 223456899999999999999999999999999999999999999643211 0000000000000 00
Q ss_pred ------------------------cceeccccCCC-CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 911 ------------------------KEFFTAGLWDA-GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 911 ------------------------~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
.+.+....... .......++.+++.+||+.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000000 0112456789999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.11 Aligned_cols=257 Identities=21% Similarity=0.358 Sum_probs=204.7
Q ss_pred HcCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (963)
++++|++.+.||+|+||.||+|.+. ++..||||++.... .....++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999653 35679999886432 2344578899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 753 MFLIYNYLPGGNLENFIQQRS--------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
.++||||+++|+|.+++.... ....++..+..++.|+++|++|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999997532 12357888999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHH
Q 046851 825 SDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGC 902 (963)
Q Consensus 825 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 902 (963)
+|||++.......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||..... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLR 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 9999987654332221 112345778999999998889999999999999999999 6778753311 11111
Q ss_pred HHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 903 MLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
.. ..+.. ...+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 233 ~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FV-MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HH-HcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 11111 11223445678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=349.50 Aligned_cols=251 Identities=24% Similarity=0.279 Sum_probs=205.7
Q ss_pred CCCCccccccCCCccEEEEEEC-C-CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-P-GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.|.+.+.||+|++|.||+|... + ++.||+|.+..........+..|+++++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999544 3 6789999876555555567888999999999999999999999999999999999
Q ss_pred CCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 761 PGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 761 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
++|+|.+++... ....+++.++..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988653 234588999999999999999999999 999999999999999999999999999987653322
Q ss_pred -cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 839 -HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 839 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+......... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~-~------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGK-Y------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C-------
Confidence 12344579999999999999999999999999999999999999986321 112222211111 1
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+||+.+|++||++++++++
T Consensus 289 --~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 --DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11223345678999999999999999999998753
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=319.91 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=206.2
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|.+.+.||+|++|.||+|....+..||+|++.... ...+.+.+|++++++++|+|++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4688899999999999999988877789999876543 234678899999999999999999998754 56789999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.......+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999876555689999999999999999999999 999999999999999999999999999977643332222
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....++..|+|||+..+..++.++||||||+++|||++ |+.||...... +......... ..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~----------~~ 222 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERGY----------RM 222 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCC----------CC
Confidence 33446778999999998889999999999999999999 88888643211 1111111111 01
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
..+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223456688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=324.43 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=205.0
Q ss_pred CCCCCccccccCCCccEEEEEE-----CCCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-----SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.+|++.+.||+|+||.||+|.+ ..+..||+|.+.... .+...++.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3578889999999999999974 246789999987433 3344678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC
Q 046851 756 IYNYLPGGNLENFIQQRS---------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF 820 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 820 (963)
||||+++++|.+++.... ...+++.++..++.|++.|++|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999986432 12478889999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchh
Q 046851 821 NAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIV 898 (963)
Q Consensus 821 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~ 898 (963)
.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999986543321 12233445678999999998889999999999999999998 8888753211 1
Q ss_pred hHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 899 AWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
. +........ ....+...+.++.+++.+||+.+|++||++.++.++|+.
T Consensus 234 ~-~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 E-VIEMVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H-HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 111111111 111233455688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=329.63 Aligned_cols=239 Identities=24% Similarity=0.320 Sum_probs=195.6
Q ss_pred cccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
||+|+||.||+|... +++.||+|++.... ......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999765 58899999986532 23446678899999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccccc
Q 046851 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845 (963)
Q Consensus 766 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (963)
.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.++|+|||+++...... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 9999763 4589999999999999999999999 99999999999999999999999999987543222 2233457
Q ss_pred ccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChh
Q 046851 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHD 925 (963)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (963)
||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+......... ...+..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~-----------~~~~~~ 215 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEP-----------LRFPDG 215 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC-----------CCCCCc
Confidence 9999999999999999999999999999999999999997431 122222221111 112334
Q ss_pred HHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 046851 926 DLVEVLHLAVVCTVDSLSTRPT---MKQVVR 953 (963)
Q Consensus 926 ~~~~l~~l~~~cl~~dP~~RPs---~~evl~ 953 (963)
....+.+++.+||+.||++||+ +.|++.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 4567889999999999999986 455544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=324.35 Aligned_cols=267 Identities=26% Similarity=0.379 Sum_probs=205.6
Q ss_pred CCCccccccCCCccEEEEEE-----CCCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeEEE
Q 046851 684 FNASNCIGNGGFGATYKAEI-----SPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEMFL 755 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 755 (963)
|+..+.||+|+||+||.+.. .++..||+|.+..... .....+.+|++++++++||||+++++++.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988642 3578899999876533 345678899999999999999999998765 346899
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++++|.+++... .+++.++..++.|+++|++|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999753 489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcc--cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETHA--TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh---hhcccccccchhhhhhh
Confidence 32211 11223566799999999888999999999999999999999998643321100 00000000000011111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.+.......+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2222222234456678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=320.60 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=210.8
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++|++.+.||+|+||.||+|...++..||||.+.... ...+++.+|+.++++++|+|++++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 35799999999999999999988888899999887543 33567899999999999999999999999989999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.......+++.++..++.+++.|++|||+. +++|+||||+||++++++.++++|||.+..........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999876656789999999999999999999999 99999999999999999999999999998765432222
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....++..|+|||.+.+..++.++||||+|+++|||++ |+.||..... .......... ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~----------~~ 222 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERG----------YR 222 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC----------CC
Confidence 223345678999999998889999999999999999998 8888853211 1111111111 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
...+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11223345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=325.24 Aligned_cols=262 Identities=25% Similarity=0.337 Sum_probs=197.7
Q ss_pred CCCCCccccccCCCccEEEEEEC--CCcEEEEEEeecccc--hhHHHHHHHHHHHhcc---CCCCeeEEEEeee-----C
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS--PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRL---RHPNLVTLIGYHA-----S 749 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 749 (963)
.+|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999763 468899998865432 2234556677776665 6999999999875 3
Q ss_pred CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccc
Q 046851 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829 (963)
Q Consensus 750 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 829 (963)
....++||||++ ++|.+++.......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 5999999876666689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC-
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG- 908 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 908 (963)
+...... .......|++.|+|||++.+..++.++||||+||++|||++|++||...... .....+.......
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-----~~~~~i~~~~~~~~ 229 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGLPG 229 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHHhCCCC
Confidence 9865433 2333456899999999999888999999999999999999999999754221 1111111110000
Q ss_pred --ccc-------ceeccccCC---CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 --RAK-------EFFTAGLWD---AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 --~~~-------~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... ..+...... .........+.+++.+|++.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 000000000 0011234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=333.57 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=205.4
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC-CCe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS-ETE 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 752 (963)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 47999999999999999999532 357899999875432 2345678899999999 79999999998764 457
Q ss_pred EEEEEeccCCCChHHHHhhhcC----------------------------------------------------------
Q 046851 753 MFLIYNYLPGGNLENFIQQRST---------------------------------------------------------- 774 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 774 (963)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 8899999999999999865321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc-cccccccccccC
Q 046851 775 -RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA-TTGVAGTFGYVA 852 (963)
Q Consensus 775 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~a 852 (963)
..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||++.......... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578999999999999999999999 99999999999999999999999999998764332222 223456678999
Q ss_pred ccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHH
Q 046851 853 PEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVL 931 (963)
Q Consensus 853 PE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 931 (963)
||++.+..++.++||||+||++|||++ |..||...... +........+.. ...+.....++.
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~---------~~~~~~~~~~~~ 306 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTR---------MRAPEYATPEIY 306 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCC---------CCCCccCCHHHH
Confidence 999999999999999999999999998 99888643211 111111111111 111233456789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 932 HLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 932 ~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
+++.+||+.+|++||++.|++++|+++.+
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=333.19 Aligned_cols=245 Identities=26% Similarity=0.352 Sum_probs=202.1
Q ss_pred CCCCCccccccCCCccEEEEEECC--CcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP--GVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 369999999999999999997543 3689999986532 23346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999864 3589999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... ..+..
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i-~~~~~------ 245 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKI-LEGII------ 245 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHH-hcCCC------
Confidence 23457899999999999988999999999999999999999999743211 111111 11110
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
..+......+.+++.+|++.||++|+ ++++++++
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 12233445678999999999999995 89888775
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=330.88 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=204.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCc----EEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGV----LVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.+|+..+.||+|+||.||+|.+. +|. .||||++.... ....+++..|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 36999999999999999999764 333 48999986543 33456789999999999999999999998764 5779
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
|+||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999998643 3588999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||+.... .++. .....+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~~-~~~~~~----- 227 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEIS-SILEKG----- 227 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHH-HHHhCC-----
Confidence 32221 222334678999999999999999999999999999998 8998863211 1111 111111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.....+..+...+.+++.+||+.+|++||++.++++.+.++..
T Consensus 228 ----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 228 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1111223345678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=320.32 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=210.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +++.||||.+.... .....++.+|++++++++|||++++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47899999999999999999764 68999999876432 233457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 758 NYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||+++|+|.+++.... ...+++..+..++.|+++|++|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 34578899999999999999999999 999999999999999999999999999887643
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
... ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ...+.... ......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~-~~~~~~---- 226 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKI-EQCDYP---- 226 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHH-hcCCCC----
Confidence 222 222346888999999999888999999999999999999999998643221 12222211 111111
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.......+..+.+++.+||+.+|++||++.+|++.+++++
T Consensus 227 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 ----PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1112234567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=331.71 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=201.9
Q ss_pred CCCCccccccCCCccEEEEEE----CCCcEEEEEEeeccc----chhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeE
Q 046851 683 NFNASNCIGNGGFGATYKAEI----SPGVLVAIKRLAVGR----FQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEM 753 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 753 (963)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|++++..++ |++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999965 358899999986532 223456788999999994 99999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++|+|.+++..+ ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999999764 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............ .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~-~---- 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRRILK-C---- 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHHHhc-C----
Confidence 44433344456799999999999865 4788999999999999999999999743221 111111111111 1
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
+ ...+......+.+++.+|++.||++|| ++++++++
T Consensus 227 --~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --D----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --C----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1 112233456788999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.51 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=210.4
Q ss_pred CCCCccccccCCCccEEEEEECC-CcEEEEEEeecccch---hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.|++.+.||+|.-|+||.++.++ +..+|+|++.+.... ...+...|-++++.++||.++.+|+.++.++..|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 57788999999999999998874 589999999766443 34567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC--
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS-- 836 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~-- 836 (963)
||+||+|..+.+++++..+++..++.+|.+|+-||+|||-. |||+|||||+||||.++|++.|+||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999999999999999999999999999999999999 9999999999999999999999999988654210
Q ss_pred --------------------------------C---------------------CcccccccccccccCccccccCCCCc
Q 046851 837 --------------------------------E---------------------THATTGVAGTFGYVAPEYAMTCRVSD 863 (963)
Q Consensus 837 --------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 863 (963)
. .......+||-.|.|||++.|...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 01122357999999999999999999
Q ss_pred chhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCC
Q 046851 864 KADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLS 943 (963)
Q Consensus 864 ~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 943 (963)
++|.|+|||++|||+.|..||...... . ...+.+ -+.+.-......+..+.+||.+.|.+||.
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~----~----Tl~NIv---------~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNK----E----TLRNIV---------GQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCch----h----hHHHHh---------cCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999855332 1 112222 12222222235667899999999999999
Q ss_pred CCCC----HHHHHHH
Q 046851 944 TRPT----MKQVVRR 954 (963)
Q Consensus 944 ~RPs----~~evl~~ 954 (963)
+|-. ++||-++
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9998 7777653
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=324.20 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=207.0
Q ss_pred CCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
+|++.+.||+|+||.||+|... ....||+|.+..... ....++.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999653 235788888865433 335678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCC
Q 046851 756 IYNYLPGGNLENFIQQRS----------------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSN 813 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 813 (963)
|+||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986531 13478899999999999999999999 99999999999
Q ss_pred eEECCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 046851 814 ILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSY 891 (963)
Q Consensus 814 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~ 891 (963)
|++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999865433222 1222345678999999998889999999999999999998 88888633211
Q ss_pred CCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 892 GNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
.. ....... .....+...+.++.+++.+|++.+|++||+++++++.|+++-..
T Consensus 237 -------~~-~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 -------RL-FNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -------HH-HHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11 1111111 11122334556889999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=329.54 Aligned_cols=242 Identities=24% Similarity=0.282 Sum_probs=197.8
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
+.||+|+||.||++... +|..||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 68999999997542 233456788999999999999999999999999999999999999
Q ss_pred ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccc
Q 046851 764 NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG 843 (963)
Q Consensus 764 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (963)
+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccc
Confidence 999988763 4589999999999999999999999 9999999999999999999999999998754222 122234
Q ss_pred ccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCC
Q 046851 844 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGP 923 (963)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (963)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~~~~-----------~~~p 215 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEE-----------IRFP 215 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCC-----------CCCC
Confidence 57899999999999999999999999999999999999999643211 1111111110 0123
Q ss_pred hhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 924 HDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 924 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
......+.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 34456788999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=323.93 Aligned_cols=262 Identities=20% Similarity=0.330 Sum_probs=200.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46899999999999999999765 689999999865432 2345678999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 975 9999987643 4578999999999999999999999 99999999999999999999999999997653222 1
Q ss_pred ccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh--------c---
Q 046851 840 ATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR--------Q--- 907 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~--- 907 (963)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ........... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-----EELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhcccc
Confidence 2233468999999999875 56889999999999999999999999643211 00111100000 0
Q ss_pred -CcccceeccccCCC----CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 -GRAKEFFTAGLWDA----GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 -~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........+..... .......+..+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000010100000 011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.37 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=202.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCc----EEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGV----LVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|++.+.||+|+||.||+|.+. +|+ .|++|.+..... ....++..|+..++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46888999999999999999764 344 477887754322 234567888889999999999999998864 45788
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
++||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997643 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ........+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---------~~~~~~~~~~~~-- 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---------EVPDLLEKGERL-- 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---------HHHHHHHCCCcC--
Confidence 3221 2233456779999999998899999999999999999998 99888643221 111111221111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
..+..+...+.+++.+||..+|++|||+.|+++.|..+..
T Consensus 231 -------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 -------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1122244567889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.17 Aligned_cols=200 Identities=26% Similarity=0.459 Sum_probs=175.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||.||+|... +|..||+|++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999776 688899998875432 334678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++|+|.+++... ..+++..+..++.++++|++|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999999764 35889999999999999999999742 7999999999999999999999999998765322
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPS 887 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 887 (963)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 223346899999999999988999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=322.70 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=206.4
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.+|...++||+|+||.||+|... ++..||+|.+..........+.+|++.+++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 36788899999999999999542 366899998876666666789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 756 IYNYLPGGNLENFIQQRST-------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
+|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999976431 3478999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhH
Q 046851 823 YLSDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAW 900 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 900 (963)
+|+|||++.......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... +.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~ 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--------EA 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------HH
Confidence 999999997654322211 122345678999999999999999999999999999998 88888633211 11
Q ss_pred HHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 901 GCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
.... ..+. ....+..++..+.+++.+||+.||.+||++.||++.|++
T Consensus 234 ~~~~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 IECI-TQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHH-HcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111 1110 111223445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.76 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=208.6
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+|++++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 47889999999999999999876 88999999976544 46788999999999999999999999998999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.......+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 99999999876655789999999999999999999999 999999999999999999999999999987632221
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
...++..|+|||++.+..++.++||||||+++|||++ |..||...... . .......+ ...
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~-~~~~~~~~---------~~~ 218 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------D-VVPHVEKG---------YRM 218 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------H-HHHHHhcC---------CCC
Confidence 2334668999999998889999999999999999997 88888633111 1 11111111 011
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
..+...+..+.+++.+|+..+|++||++.|++++|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 12234457889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.52 Aligned_cols=265 Identities=26% Similarity=0.407 Sum_probs=206.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-----CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-----PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 754 (963)
..|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999643 578999999877666666789999999999999999999998743 35689
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++++|.+++.... ..+++..+..++.|+++|++|||+. +++||||||+||++++++.++|+|||++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999997643 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcc--cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC-------CcchhhHHHHHH
Q 046851 835 PSETHA--TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN-------GFNIVAWGCMLL 905 (963)
Q Consensus 835 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~ 905 (963)
...... .....++..|+|||+..+..++.++||||||+++|||++|..++......... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL- 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH-
Confidence 332211 11122345699999999888999999999999999999988765432211000 00000000011
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
+........+...+..+.+++.+||+.+|++|||+.||++.|+.++
T Consensus 239 --------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 239 --------LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred --------HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 1111111223345668999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.39 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=204.4
Q ss_pred cCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
+++|++.+.||+|++|.||+|.+. .+..||+|.+..... .....|..|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 457999999999999999999765 357899998865432 3345689999999999999999999999988899
Q ss_pred EEEEeccCCCChHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC---cEEEe
Q 046851 754 FLIYNYLPGGNLENFIQQRST-----RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF---NAYLS 825 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 825 (963)
++||||+++++|.+++..... ..+++..+.+++.|++.|++|||+. +++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999976532 2589999999999999999999999 999999999999998754 59999
Q ss_pred ecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHH
Q 046851 826 DFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 826 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~~~~ 233 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EVMEF 233 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHH
Confidence 999998763222111 112234568999999999999999999999999999997 88888643211 11111
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
..... ....+...+..+.+++.+|++.+|++||++.+|+++|.+
T Consensus 234 ~~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 234 VTGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11111 112233456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=329.32 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=198.5
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
+.||+|+||.||++... +|+.||||++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999654 68999999997542 234567788999999999999999999999999999999999999
Q ss_pred ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccc
Q 046851 764 NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG 843 (963)
Q Consensus 764 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (963)
+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccc
Confidence 999998763 4589999999999999999999999 9999999999999999999999999998754322 122234
Q ss_pred ccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCC
Q 046851 844 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGP 923 (963)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (963)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... ...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~~~-----------~~~p 215 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMED-----------IKFP 215 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhccCC-----------ccCC
Confidence 5799999999999998999999999999999999999999964321 11111111110 0123
Q ss_pred hhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 924 HDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 924 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
.....++.+++.+|++.||++|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 34456788999999999999997 88998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.90 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=198.6
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 57899999997542 23345677888888776 799999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|..++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 9999988763 4589999999999999999999999 99999999999999999999999999987543221 2223
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...............+.......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CC
Confidence 45789999999999999999999999999999999999999964322211112222232222222111 12
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPT------MKQVVRR 954 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~ 954 (963)
+......+.+++.+|++.||++||+ +.+++++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 3344567889999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.64 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=198.5
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
+.||+|+||.||+|... +++.||+|.+..... +....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999764 689999998764432 3346789999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc-cc
Q 046851 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT-GV 844 (963)
Q Consensus 766 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~-~~ 844 (963)
.+++... ...+++.++..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++............ ..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999754 34589999999999999999999999 9999999999999999999999999998764322111111 11
Q ss_pred cccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCC
Q 046851 845 AGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGP 923 (963)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (963)
.++..|+|||.+.+..++.++||||+|+++|||++ |..||...... . ........ .....+
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~-~~~~~~~~---------~~~~~~ 218 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------Q-TREAIEQG---------VRLPCP 218 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------H-HHHHHHcC---------CCCCCc
Confidence 23457999999998889999999999999999998 88887632111 1 11111111 111223
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 924 HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 924 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
...+..+.+++.+|++.+|++||++.++.+.|++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 3446688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.52 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=201.0
Q ss_pred cccccCCCccEEEEEECCCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCChH
Q 046851 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLE 766 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 766 (963)
++||+|+||.||+|...++..||+|++...... ....+.+|++.+++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888999999988755432 3356889999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccccccc
Q 046851 767 NFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG 846 (963)
Q Consensus 767 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 846 (963)
+++.... ..+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.++++|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9987643 4578999999999999999999999 99999999999999999999999999987643322222222244
Q ss_pred cccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChh
Q 046851 847 TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHD 925 (963)
Q Consensus 847 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (963)
+..|+|||++.+..++.++||||||+++||+++ |..||...... ... .....+ .....+..
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~-~~~~~~---------~~~~~~~~ 218 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAR-EQVEKG---------YRMSCPQK 218 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHH-HHHHcC---------CCCCCCCC
Confidence 678999999998889999999999999999998 88888633211 111 111111 11122334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 926 DLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 926 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
.+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 5678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.36 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=208.6
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|+|++++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35789999999999999999988878889999886543 235678999999999999999999999887 7789999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.+.....+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999876566689999999999999999999999 99999999999999999999999999997664333323
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....++..|+|||++.+..++.++|+||||+++|++++ |+.||...... .... ....+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~----~~~~~~~--------- 221 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIR----ALERGYR--------- 221 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----HHHH----HHhCCCC---------
Confidence 333445678999999998889999999999999999999 88888633111 1111 1111111
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
...+...+..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 111233456788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=346.94 Aligned_cols=256 Identities=24% Similarity=0.299 Sum_probs=206.6
Q ss_pred HHHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC---
Q 046851 678 VQATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET--- 751 (963)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 751 (963)
....++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+..+..++|+|++++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34456999999999999999999965 479999999986543 334567889999999999999999988764322
Q ss_pred -----eEEEEEeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 752 -----EMFLIYNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 752 -----~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
..++||||+++|+|.+++..+. ...+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 3689999999999999997543 34688999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCC-CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 825 SDFGLARLLGPSE-THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 825 ~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVMHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHH
Confidence 9999998764322 122334579999999999999999999999999999999999999996331 1222222
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... ....+...+.++.+++.+||+.||++||++.+++++
T Consensus 257 ~~~~~----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGR----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 21111 111233456689999999999999999999999864
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=325.85 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=208.1
Q ss_pred HcCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCC
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASET 751 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (963)
..++|++.+.||+|+||.||+|... ....||+|++.... .....++.+|++++.++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3457889999999999999999764 23679999887542 23446788999999999 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 752 EMFLIYNYLPGGNLENFIQQR--------------STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
..+++|||+++|+|.++++.+ ....+++..+..++.|++.|++|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999999753 235688999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCc
Q 046851 818 DDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGF 895 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~ 895 (963)
.++.+||+|||+++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 240 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 240 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH------
Confidence 9999999999999876533221 1222335678999999998899999999999999999997 8888753211
Q ss_pred chhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 896 NIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.+.. .....+. ....+......+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 241 --~~~~-~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 --EELF-KLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHH-HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111 1111111 11223345668899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.73 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=212.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||+|.++... ....+++.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999776 79999999886432 233567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 758 NYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 758 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||+++++|.+++... ....+++.++..++.++++|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998653 234588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... ..+
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~------- 223 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKI-EKC------- 223 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhh-hcC-------
Confidence 222 22334688899999999988899999999999999999999999864321 122221111 111
Q ss_pred cccCCCCCh-hHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 916 AGLWDAGPH-DDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 916 ~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.....+. .....+.+++.+||+.+|++||++.+|++.|+++.+
T Consensus 224 --~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 224 --DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred --CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 1111122 445678899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.23 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=199.8
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999765 68899999997542 23345678899999888 699999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence 9999998753 4589999999999999999999999 9999999999999999999999999998753221 12233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+.............++.......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------CC
Confidence 45789999999999999999999999999999999999999974322211122222333222222211 12
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPT------MKQVVRR 954 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~ 954 (963)
+......+.+++.+|++.||++||+ +++++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 2334567889999999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.76 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=207.4
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (963)
++|.+.+.||+|+||.||+|... ++..||||++.... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46899999999999999999642 35579999887543 23346789999999999 799999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++|+|.++++......+++.++..++.|++.|++|||++ +++|+||||+||+++.++.++++|||++...
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999999865545589999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 834 GPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 834 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
...... ......++..|+|||.+.+..++.++||||+|+++|||++ |..||...... +........+
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--------~~~~~~~~~~--- 260 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--------SKFYKLIKEG--- 260 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--------HHHHHHHHcC---
Confidence 433221 1222345778999999999889999999999999999998 88888643221 1111111111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.....+...+.++.+++.+|++.+|++||++.|+++.|+++
T Consensus 261 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.16 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=210.8
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|++|.||+|.. .++..||||.+.... ....+++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999975 478999999886532 233467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 758 NYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||+++++|.+++.... ...+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987422 34589999999999999999999999 999999999999999999999999999876643
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||...... ......... ...
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~------ 224 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIE-QCD------ 224 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhh-cCC------
Confidence 322 223346889999999999888999999999999999999999998643211 111111111 100
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.....+......+.+++.+||+.+|++||||.+|++.++++.+
T Consensus 225 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 267 (267)
T cd08229 225 --YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267 (267)
T ss_pred --CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhcC
Confidence 0111123456689999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=326.86 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=206.7
Q ss_pred CCCCCccccccCCCccEEEEEEC--------CCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCC
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS--------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASET 751 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (963)
++|.+.+.||+|+||.||+|... ++..||+|.+.... .....++..|++++..+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57999999999999999999653 23579999987543 33456788899999999 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 752 EMFLIYNYLPGGNLENFIQQRST--------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
..++||||+++|+|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999976431 3478999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCc
Q 046851 818 DDFNAYLSDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGF 895 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~ 895 (963)
+++.++|+|||.+.......... .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------- 247 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 247 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-------
Confidence 99999999999987654322111 112234568999999998889999999999999999998 778875321
Q ss_pred chhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 896 NIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
..+.... ..... ....+.....++.+++.+|++.+|++||++.+|++.|+++.+
T Consensus 248 -~~~~~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 248 -VEELFKL-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred -HHHHHHH-HHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1111111 11111 112233456688899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=338.62 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=205.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ......+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36899999999999999999765 68999999997542 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999875 4589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ----------------------------CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 046851 838 ----------------------------THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFS 889 (963)
Q Consensus 838 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~ 889 (963)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345689999999999999999999999999999999999999974421
Q ss_pred CCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 046851 890 SYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-MKQVVRR 954 (963)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~ 954 (963)
. .......... ...........+..+.+++.+|+. ||++||+ +++++++
T Consensus 236 ~--------~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 Q--------ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H--------HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1111111100 001111111245678899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.49 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=204.2
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+|++.+.||+|+||.||++... +++.||||++..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999764 689999999865432 223457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++|+|.+++.......+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999998765555689999999999999999999999 99999999999999999999999999998654222
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~---------- 220 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKED---------- 220 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhhc----------
Confidence 223346899999999999888999999999999999999999999743221 1111111111111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
....+...+..+.+++.+||+.||++|| ++++++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1112334556788999999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.33 Aligned_cols=254 Identities=22% Similarity=0.403 Sum_probs=202.8
Q ss_pred CCCccccccCCCccEEEEEECC----CcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe-----
Q 046851 684 FNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE----- 752 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 752 (963)
|++.+.||+|+||.||+|.... +..||||+++... ......+..|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5778999999999999997642 3679999987543 2335678999999999999999999998866544
Q ss_pred -EEEEEeccCCCChHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeec
Q 046851 753 -MFLIYNYLPGGNLENFIQQRS----TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 753 -~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 827 (963)
.+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999986532 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 828 GLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 828 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
|+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||..... .+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 9998765433222 112234678999999998889999999999999999999 7888753221 11111111
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.+. ....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 230 -~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 -HGN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -cCC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 1112334566899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.60 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=203.1
Q ss_pred CCCCCccccccCCCccEEEEEECC-C--cEEEEEEeecc-cchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP-G--VLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999997653 3 34788887643 233456789999999999 799999999999999999999
Q ss_pred EeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 757 YNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
+||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999997632 13478899999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHH
Q 046851 823 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWG 901 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 901 (963)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |+.||..... ....
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AELY 228 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence 99999998643211 11111123457999999998889999999999999999997 9999864321 1111
Q ss_pred HHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 902 CMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
... ..+ .....+...+..+.+++.+||+.+|.+||+++++++.|+++..
T Consensus 229 ~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 229 EKL-PQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHH-hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 111 1111233455678999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=326.43 Aligned_cols=242 Identities=26% Similarity=0.354 Sum_probs=197.3
Q ss_pred cccccCCCccEEEEEE----CCCcEEEEEEeeccc----chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 688 NCIGNGGFGATYKAEI----SPGVLVAIKRLAVGR----FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+.||+|+||.||++.. .+++.||||++.... ......+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999965 357899999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 9999999999764 4578899999999999999999999 99999999999999999999999999987543222 2
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......... +.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~-~~---------- 216 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILK-GK---------- 216 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CC----------
Confidence 23345789999999999998899999999999999999999999974321 111111111 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+......+.+++.+|++.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 112333456788999999999999999 78887664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.97 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=207.6
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|++.+.||+|++|.||+|... +++.|++|.+... .....+.+.+|++++++++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999765 6899999988653 234457789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.......+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999876556789999999999999999999999 9999999999999999999999999998876543222
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....|++.|+|||+..+..++.++||||||+++|||++|+.||..... ....... ..+..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~--------- 218 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKI-IRGVF--------- 218 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HcCCC---------
Confidence 2334688999999999998899999999999999999999999874321 1111111 11111
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+......+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11222445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.44 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=199.7
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999775 689999999875432 223467889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++ +++.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 58888887643 4588999999999999999999999 99999999999999999999999999987543222
Q ss_pred cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC---------
Q 046851 839 HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG--------- 908 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 908 (963)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..............
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI----QDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhCCCChhhccchh
Confidence 22234568999999999875 45788999999999999999999999743211 00011110000000
Q ss_pred cccceeccccCCCCC---------hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 RAKEFFTAGLWDAGP---------HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 ~~~~~~~~~~~~~~~---------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..............+ ......+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000000000 0123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.96 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=198.2
Q ss_pred ccccCCCccEEEEEEC---CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 689 CIGNGGFGATYKAEIS---PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 689 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
.||+|+||.||+|.++ ++..||+|++..... ...+++..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 578899998864432 33567899999999999999999999885 45678999999999
Q ss_pred ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc--c
Q 046851 764 NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA--T 841 (963)
Q Consensus 764 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~ 841 (963)
+|.+++... ..+++..+..++.|++.|++|+|++ +++||||||+||+++.++.+||+|||++.......... .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999999764 3589999999999999999999999 99999999999999999999999999998765433221 1
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .++... ...+. ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~-i~~~~---------~~ 217 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQM-IESGE---------RM 217 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH-HHCCC---------CC
Confidence 22234579999999988888999999999999999998 8999864321 112211 12211 11
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
..+...+.++.+++.+||+.||++||++.+|++.|++.
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 22334567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.19 Aligned_cols=259 Identities=22% Similarity=0.365 Sum_probs=206.8
Q ss_pred cCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccc-hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 752 (963)
.++|.+.+.||+|+||.||+|.+. .+..||||++..... ...+.+.+|++++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346888999999999999999764 246899999975432 33457889999999997 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcC----------------------------------------------------------
Q 046851 753 MFLIYNYLPGGNLENFIQQRST---------------------------------------------------------- 774 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 774 (963)
.++||||+++|+|.+++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 775 --------------------------------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 775 --------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
..+++..+..++.|++.|++|||+. +++||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 2367778899999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q 046851 817 DDDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNG 894 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~ 894 (963)
+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---- 348 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---- 348 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch----
Confidence 9999999999999986533221 12223456789999999998889999999999999999998 88887633111
Q ss_pred cchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
+........+ .....+.....++.+++.+||+.+|.+||+++|+++.|+++.
T Consensus 349 ----~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 ----EQFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----HHHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111 111223345678999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.39 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=203.8
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEee-eCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH-ASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~ 760 (963)
.+|++.+.||+|+||.||+|... |..||+|.+.... ..+.+.+|+.++++++|++++++++++ ......++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 36888999999999999999776 8889999886433 346789999999999999999999975 4556789999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.......+++..+..++.|++.|++|||++ +++||||||+||+++.++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999999876655689999999999999999999999 99999999999999999999999999987643222
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
....++..|+|||+..+..++.++||||||+++|||++ |+.||.... ........ ..+. .
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~---------~ 217 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRV-EKGY---------K 217 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-hcCC---------C
Confidence 22334678999999998889999999999999999997 888875321 11111111 1111 1
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
...+...+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 112234566889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=334.60 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=195.7
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+|+..+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 5677889999999999999765 689999999865433 33467899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+. ...++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 155 ~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 155 DGGSLEGT------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred CCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 99998653 2356778889999999999999999 99999999999999999999999999998764322 12
Q ss_pred cccccccccccCcccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 841 TTGVAGTFGYVAPEYAMT-----CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||...... .............
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~------- 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCAICMSQ------- 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhccC-------
Confidence 234578999999998743 23456899999999999999999999732211 1111111110000
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+.....++.+++.+||+.||++||++.|++++
T Consensus 293 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223455678999999999999999999999986
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.61 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=198.0
Q ss_pred ccccCCCccEEEEEEC---CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCC
Q 046851 689 CIGNGGFGATYKAEIS---PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGN 764 (963)
Q Consensus 689 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 764 (963)
.||+|+||.||+|.+. ++..||+|++..... ...+++.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999764 356799998875533 334678999999999999999999998864 57899999999999
Q ss_pred hHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc--c
Q 046851 765 LENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT--T 842 (963)
Q Consensus 765 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~--~ 842 (963)
|.+++... ...+++..+.+++.|+++|++|||++ +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999754 34589999999999999999999999 999999999999999999999999999986543322211 1
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
...+++.|+|||++.+..++.++||||||+++||+++ |+.||..... .+.. .....+. ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~-~~~~~~~---------~~~ 218 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVM-SFIEQGK---------RLD 218 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHH-HHHHCCC---------CCC
Confidence 1223578999999988889999999999999999996 9999864321 1111 1111211 112
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.+..++.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.51 Aligned_cols=254 Identities=27% Similarity=0.367 Sum_probs=204.4
Q ss_pred CCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
+|++.+.||+|+||.||+|... ++..||+|++...... ..+.+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4778889999999999999753 2578999998754432 34668899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc
Q 046851 756 IYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN 821 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 821 (963)
++||+++++|.+++..+. ...+++..+.+++.|++.|++|+|++ +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999986321 23478889999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhh
Q 046851 822 AYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 822 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 899 (963)
+||+|||+++........ ......+++.|+|||++.+..++.++||||+|+++|||++ |..||.... ..+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 999999998865433221 1223346789999999988889999999999999999998 777775321 112
Q ss_pred HHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
+........ . ...+..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 235 ~~~~i~~~~-~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQ-V---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222211111 1 12234566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.65 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=204.9
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc-----hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF-----QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|++.+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4789999999999999999965 4689999998865422 223568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
|+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999999764 3588999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCccc--ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETHAT--TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||...... .. ........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~-~~~~~~~~----- 223 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AA-IFKIATQP----- 223 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------HH-HHHHhccC-----
Confidence 222111 3346788999999999988999999999999999999999998632111 11 11111111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+......+.+++.+||..+|++||++.+++++
T Consensus 224 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112233456678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=290.66 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=204.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc----hh----HHHHHHHHHHHhccC-CCCeeEEEEeeeCCC
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF----QG----VQQFHAEIKTLGRLR-HPNLVTLIGYHASET 751 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 751 (963)
.+|...+.+|+|..++|.++.++ +|..+|+|++..... +. .+.-.+|+.+++++. ||+|+++.++++++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 46888899999999999998554 688899999864322 11 234567999999985 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
.+++|+|.|+.|-|.+++.+ .-.+++.+..+|++|+.+|++|||.. .|||||+||+|||++++.++||+|||+|+
T Consensus 97 F~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred hhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999987 34589999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccc------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMT------CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
.+.++. .-...+|||+|.|||.+.- ..|+..+|.|++|||+|-++.|.+||.... .. .+-+++
T Consensus 172 ~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------Qm-lMLR~I 240 (411)
T KOG0599|consen 172 QLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QM-LMLRMI 240 (411)
T ss_pred ccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HH-HHHHHH
Confidence 886543 4456799999999999863 357888999999999999999999996221 01 111222
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
-++... .....-.+......+|+.+|++.||.+|.|++|++++
T Consensus 241 meGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 241 MEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred Hhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 222211 1122223456678899999999999999999999875
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=326.43 Aligned_cols=244 Identities=25% Similarity=0.426 Sum_probs=207.1
Q ss_pred ccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCChHH
Q 046851 689 CIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLEN 767 (963)
Q Consensus 689 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 767 (963)
++|+|.||+||.|+.. +..++|||.+.....+..+.+.+|+...++++|.|||+++|.+.+++.+-+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999654 567899999988887888899999999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC-CCCcEEEeecccccccCCCCCcccccc
Q 046851 768 FIQQRSTRAV--DWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTGV 844 (963)
Q Consensus 768 ~l~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~ 844 (963)
+++..= +++ .+.+...+.+||++||.|||+. .|||||||-+|||++ -.|.+||+|||-++.+..-. ..+...
T Consensus 662 LLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETF 736 (1226)
T KOG4279|consen 662 LLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETF 736 (1226)
T ss_pred HHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccccc
Confidence 998643 334 6778888999999999999999 999999999999996 68899999999998875433 344557
Q ss_pred cccccccCccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 845 AGTFGYVAPEYAMTC--RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 845 ~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
.||..|||||++..+ .|..++|||||||.+.||.||++||.+.... ...+++-+... .....
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----------qAAMFkVGmyK------vHP~i 800 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----------QAAMFKVGMYK------VHPPI 800 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----------hHhhhhhccee------cCCCC
Confidence 899999999999754 5888999999999999999999999754333 11222222111 23446
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
|.+...+...++.+|+.+||.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7788899999999999999999999999875
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.74 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=197.9
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.|+..+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999965 468899999997543 2334678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC-
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE- 837 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 837 (963)
|+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999764 3588999999999999999999999 99999999999999999999999999976432100
Q ss_pred ---------------------------------------------CcccccccccccccCccccccCCCCcchhhHHHHH
Q 046851 838 ---------------------------------------------THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGV 872 (963)
Q Consensus 838 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 872 (963)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00112357999999999999988999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHH--cccCCCCCCCCHHH
Q 046851 873 VLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVV--CTVDSLSTRPTMKQ 950 (963)
Q Consensus 873 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~e 950 (963)
++|||++|+.||...... ........... ............++.+++.+ |+..+|..||+++|
T Consensus 237 il~elltG~~Pf~~~~~~--------~~~~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPT--------ETQLKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHHhCCCCCcCCCHH--------HHHHHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999743221 11111110000 00011111234566777776 55667777999999
Q ss_pred HHHH
Q 046851 951 VVRR 954 (963)
Q Consensus 951 vl~~ 954 (963)
++++
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=334.12 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=203.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 357999999999999999999765 68899999986432 22345578899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999753 478889999999999999999999 9999999999999999999999999999876443
Q ss_pred CCcccccccccccccCccccccC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTC----RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.........||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .............
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~-- 265 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKNS-- 265 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCCc--
Confidence 33233446799999999998753 478899999999999999999999974321 1111111111100
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLST--RPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 954 (963)
.........+..+.+++.+|+..+|++ ||++.|++++
T Consensus 266 -----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 -----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000111234567889999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=315.82 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=203.7
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4799999999999999999976 468899999987665555567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.++++.. ..+++..+..++.|+++|++|||+. +|+|||++|+||+++.++.++|+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 999999999764 3589999999999999999999999 99999999999999999999999999998664322 12
Q ss_pred cccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 841 TTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....|++.|+|||.+. ...++.++||||+||++|||++|+.||......... ..+ ... ....+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~----~~~-----~~~---~~~~~~ 230 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----FLM-----SKS---NFQPPK 230 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh----eee-----ecC---CCCCCC
Confidence 23346889999999885 345778999999999999999999998643221000 000 000 000000
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
. ......+..+.+++.+||+.+|++||+++++++++
T Consensus 231 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 01123356789999999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=330.92 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=204.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||+||+|... +|+.||+|++..... +..+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36889999999999999999664 689999999975432 34466889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++.+.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999998752 4589999999999999999999999 99999999999999999999999999998765443
Q ss_pred CcccccccccccccCccccc------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 838 THATTGVAGTFGYVAPEYAM------TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
........||+.|+|||++. +..++.++|||||||++|||++|+.||..... ..............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~ 228 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQRFL 228 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCCcc
Confidence 33334457899999999987 45677899999999999999999999974321 11122221111111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+ ......+..+.+++..|++ +|++||++.+++++
T Consensus 229 ~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 10 1112345678899999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=315.88 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=206.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CC---cEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PG---VLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|+..+.||+|+||.||+|... ++ ..||+|.+.... ....+++..|++++++++|+|++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46888899999999999999764 23 379999886543 33456789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999997643 4589999999999999999999999 9999999999999999999999999999766432
Q ss_pred CCccc--ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 837 ETHAT--TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 837 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
..... .....++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~----- 227 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGF----- 227 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCC-----
Confidence 22111 11223457999999998889999999999999999997 9999863321 12222221111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
....+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112234566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.70 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=208.6
Q ss_pred cCCCCCccccccCCCccEEEEEECC-----CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeC-CCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISP-----GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS-ETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 753 (963)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++|+|++++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578899999999999999998765 6889999886442 2345678899999999999999999998765 5778
Q ss_pred EEEEeccCCCChHHHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeec
Q 046851 754 FLIYNYLPGGNLENFIQQRST------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 827 (963)
++++||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999976432 4589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 828 GLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 828 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... .++... .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~-~ 232 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAY-L 232 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHH-H
Confidence 9998664433221 122345678999999998889999999999999999999 9999864321 111111 1
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
..+ .....+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 233 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111 0111122345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.69 Aligned_cols=259 Identities=24% Similarity=0.418 Sum_probs=208.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC--------CCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS--------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASE 750 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (963)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 357889999999999999999642 24579999886442 34456789999999999 799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
...++||||+++|+|.+++.... ...+++.++..++.|+++|++|||++ +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999997642 23478889999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q 046851 817 DDDFNAYLSDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNG 894 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~ 894 (963)
++++.+||+|||.++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------- 243 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------- 243 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-------
Confidence 999999999999998765332221 222345678999999998889999999999999999998 67776532
Q ss_pred cchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
...++.... ..+. ....+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 244 -~~~~~~~~~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 244 -PVEELFKLL-KEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -CHHHHHHHH-HcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 122222222 1111 111233456788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.55 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=196.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||+||+|... +++.||||++.... ......+..|+.++.+++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999654 58999999997542 223456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++.+. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999864 4589999999999999999999999 99999999999999999999999999987543211
Q ss_pred C----------------------------------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCC
Q 046851 838 T----------------------------------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKA 883 (963)
Q Consensus 838 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 883 (963)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001235799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 046851 884 LDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTV--DSLSTRPTMKQVVRR 954 (963)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~RPs~~evl~~ 954 (963)
|...... +............ .+.+ ......++.+++.+++. .++..||+++|++++
T Consensus 236 f~~~~~~--------~~~~~i~~~~~~~-~~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQ--------ETYKKVMNWKETL-IFPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHH--------HHHHHHHcCcCcc-cCCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9743211 1111111110000 0000 11123455666665433 344567999999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=316.32 Aligned_cols=254 Identities=22% Similarity=0.382 Sum_probs=199.0
Q ss_pred CCCccccccCCCccEEEEEECCC-c--EEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeC------CCe
Q 046851 684 FNASNCIGNGGFGATYKAEISPG-V--LVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS------ETE 752 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 752 (963)
|.+.+.||+|+||.||+|.+.+. . .||+|.++.. .....+.+..|+++++.++|+||+++++++.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 45678999999999999977543 2 6899988654 23445778999999999999999999998643 224
Q ss_pred EEEEEeccCCCChHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecc
Q 046851 753 MFLIYNYLPGGNLENFIQQRS----TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
.+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885322 23478999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 829 LARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 829 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
+++......... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||..... .+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~-~~~~ 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIY-DYLR 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH-HHHH
Confidence 998764332211 122345678999999999999999999999999999999 7788753211 1111 1122
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.+... ..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 229 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22111 11223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.55 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=204.6
Q ss_pred HcCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (963)
.+++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3468999999999999999999653 24589999876443 2334567889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 753 MFLIYNYLPGGNLENFIQQRS--------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
.++||||+++|+|.+++.... ....++..+..++.|++.|++|||++ +|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 23456778899999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHH
Q 046851 825 SDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGC 902 (963)
Q Consensus 825 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 902 (963)
+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~~~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLK 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 9999987654322211 112235678999999998889999999999999999998 6778763211 11221
Q ss_pred HHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 903 MLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
...... . ...+...+..+.+++.+|++.+|++|||+.++++.|++.
T Consensus 233 ~~~~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVMDGG-Y---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCC-C---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111 1 111233456899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.72 Aligned_cols=241 Identities=25% Similarity=0.321 Sum_probs=193.2
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 57899999997542 22344556677776644 799999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 9999999764 3589999999999999999999999 99999999999999999999999999997653322 2334
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+...... .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~-~~----------~~~~ 215 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSIL-ND----------RPHF 215 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-cC----------CCCC
Confidence 45799999999999998999999999999999999999999974321 11111111 11 1112
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMK-QVVR 953 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 953 (963)
+.....++.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 333456788999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.23 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=196.0
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHH---hccCCCCeeEEEEeeeCCCeEEEE
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTL---GRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
|++.+.||+|+||.||+|... +|+.||||++.... ....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667889999999999999765 68999999997542 22334566666554 567899999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|..++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988864 3589999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.........
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~-------- 217 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVNDE-------- 217 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC--------
Confidence 2223346799999999999999999999999999999999999999974321 11111111111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+...+..+.+++.+|++.||++|| ++.+++++
T Consensus 218 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 ---VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 012333456788999999999999999 46666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=332.92 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=200.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36899999999999999999765 68999999997542 233456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999764 3589999999999999999999999 99999999999999999999999999987543211
Q ss_pred Cc-------------------------------------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcC
Q 046851 838 TH-------------------------------------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSD 880 (963)
Q Consensus 838 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg 880 (963)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 11124699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 046851 881 KKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT---MKQVVRR 954 (963)
Q Consensus 881 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 954 (963)
+.||..... .+.......... .............+.+++.+|+. +|.+|++ ++|++++
T Consensus 236 ~~Pf~~~~~--------~~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNP--------QETYRKIINWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCH--------HHHHHHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999974321 111111111100 00001111234577888999986 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.74 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=196.2
Q ss_pred cccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
||+|+||.||++... +|+.||+|++..... .....+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999764 589999999864322 2234556799999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccccc
Q 046851 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845 (963)
Q Consensus 766 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (963)
.+++.......+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9998766656689999999999999999999999 99999999999999999999999999987664322 223346
Q ss_pred ccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChh
Q 046851 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHD 925 (963)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (963)
|++.|+|||++.+..++.++||||+||++|||++|+.||...... .............. . . .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~-~----~-----~~~~~ 221 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK----VAKEELKRRTLEDE-V----K-----FEHQN 221 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch----hhHHHHHHHhhccc-c----c-----ccccc
Confidence 899999999999888999999999999999999999998643221 11111111111110 0 0 00112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 926 DLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 926 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...++.+++.+||+.||++||+++|+++.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 35578899999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=315.56 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=205.8
Q ss_pred CCCCCccccccCCCccEEEEEEC----CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|.+. .+..||+|.+..... ...+.+..|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 47889999999999999999763 234799998865432 3346789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997653 4589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccc--ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 837 ETHAT--TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 837 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
..... ....++..|+|||++.+..++.++||||||+++||+++ |..||...... +..... ..+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~-~~~----- 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKAI-EEG----- 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--------HHHHHH-hCC-----
Confidence 32221 12233568999999998889999999999999999886 99998643211 111111 111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.....+...+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01111233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=324.32 Aligned_cols=236 Identities=25% Similarity=0.343 Sum_probs=192.6
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +++.||||++.... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 58899999987542 23345677888888776 699999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 9999998764 4589999999999999999999999 99999999999999999999999999987543222 2233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....... +.. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~-~~~----------~~ 215 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILN-DEV----------VY 215 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhc-CCC----------CC
Confidence 45799999999999998999999999999999999999999974321 122222111 110 11
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
+.....++.+++.+|++.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 22345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.43 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=201.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999775 58899999986432 22345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999999753 478899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccCccccccCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCR----VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.........||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ...............
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~ 267 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHKNSLN 267 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCcccC
Confidence 333334567999999999987643 77899999999999999999999974321 111112111111000
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLST--RPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 954 (963)
..........+.+++..|+..+|.+ ||++.|++++
T Consensus 268 -------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 -------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111233556788889999865544 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=312.78 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=200.3
Q ss_pred cccccCCCccEEEEEECC----CcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEISP----GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|.+.. +..||+|.+..... ...+++.+|+++++++.|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999996532 26899999875544 34567899999999999999999999876 4568999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998743 589999999999999999999999 9999999999999999999999999999876543322211
Q ss_pred --cccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 843 --GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 843 --~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .....++ .... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~~----~~~~---------~ 216 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAML----ESGE---------R 216 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHH----HcCC---------c
Confidence 1223468999999999899999999999999999998 8999864321 1111211 1111 1
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
...+...+..+.+++.+|++.+|++||++.++++.|+++.+
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 257 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhccC
Confidence 11233455688999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.18 Aligned_cols=252 Identities=24% Similarity=0.419 Sum_probs=205.4
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ...++.+|++++++++||+++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 36888899999999999999887788999998865432 34678999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.... ..++++.+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+...........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999997643 3578999999999999999999999 999999999999999999999999999876543322222
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....++.+|+|||++.+..++.++||||+|+++|||++ |+.||..... ....... ..+ ...
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~-~~~---------~~~ 220 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETI-NAG---------FRL 220 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHH-hCC---------CCC
Confidence 33345678999999998889999999999999999998 8888863321 1111111 111 011
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
..+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112224567999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=346.90 Aligned_cols=258 Identities=22% Similarity=0.314 Sum_probs=203.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.++||+|+||.||+|... +|+.||||++..... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999765 589999999865322 23467899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecc
Q 046851 758 NYLPGGNLENFIQQRS---------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
||++||+|.+++.... ....++..+.+++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 22356778899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 046851 829 LARLLGPSET-----------------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSY 891 (963)
Q Consensus 829 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~ 891 (963)
+++....... .......||+.|+|||++.+..++.++||||+||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986621110 1112356999999999999999999999999999999999999999742211
Q ss_pred CCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhcc
Q 046851 892 GNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-TMKQVVRRLKQL 958 (963)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~l 958 (963)
.. .+ . .. ..++... ......+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus 238 ----ki-~~-----~-~~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 ----KI-SY-----R-DV---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ----hh-hh-----h-hh---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00 0 00 0000000 01123456788999999999999996 677777777664
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.63 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=197.1
Q ss_pred cccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
||+|+||+||++... +|+.||+|++..... ...+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999654 689999999865432 2335678899999999999999999999999999999999999999
Q ss_pred HHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccc
Q 046851 766 ENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG 843 (963)
Q Consensus 766 ~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (963)
.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9888542 234689999999999999999999999 999999999999999999999999999976543322 2334
Q ss_pred ccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCC
Q 046851 844 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGP 923 (963)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (963)
..|++.|+|||++.+..++.++||||+|+++|||++|+.||...... ........... .. ....+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~---------~~--~~~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRIL---------ND--SVTYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhhc---------cc--CCCCc
Confidence 57899999999999999999999999999999999999999743221 00001110000 00 01123
Q ss_pred hhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 924 HDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 924 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+..+.+++.+|++.||++|| ++++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 34566788999999999999999 67777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.51 Aligned_cols=255 Identities=28% Similarity=0.428 Sum_probs=201.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCc--EEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGV--LVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|.+. +|. .+|+|.+.... ......+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 47889999999999999999764 454 45777765432 23446788999999999 899999999999999999999
Q ss_pred EeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 757 YNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
|||+++++|.++++... ...+++.++..++.|+++|++|||+. +++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999997542 23578999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHH
Q 046851 823 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWG 901 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 901 (963)
||+|||++...... .......++..|+|||++.+..++.++||||||+++|||+| |..||..... .+..
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY 233 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHHH
Confidence 99999998643211 11111234568999999988889999999999999999998 9999863321 1111
Q ss_pred HHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 902 CMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
... ... .....+...+..+.+++.+||+.+|++||++.++++.++++.
T Consensus 234 ~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 234 EKL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHH-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 111 111122234567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.25 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=206.1
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+|++.+.||+|+||.||++... ++..||+|.+.... ....+.+..|+.+++.++|+|++++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999765 68999999886432 334567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.......+++..+..++.|++.|+.|||++ +++|+||||+||++++++.++++|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999999765566689999999999999999999999 999999999999999999999999999976643222 2
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
.....|++.|+|||+..+..++.++||||+|+++|+|++|+.||..... ...... ...+...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~~--------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILK-VCQGSYK--------- 218 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHH-HhcCCCC---------
Confidence 2335688999999999998899999999999999999999999974311 111111 1111111
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+......+.+++.+||+.||++||++.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1123344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=318.18 Aligned_cols=263 Identities=24% Similarity=0.424 Sum_probs=206.8
Q ss_pred cCCCCCccccccCCCccEEEEEECC-----------------CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISP-----------------GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVT 742 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 742 (963)
.++|++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3579999999999999999996542 2468999887543 234567899999999999999999
Q ss_pred EEEeeeCCCeEEEEEeccCCCChHHHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCC
Q 046851 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRS---------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSN 813 (963)
Q Consensus 743 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 813 (963)
+++++..++..++||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999997643 12589999999999999999999999 99999999999
Q ss_pred eEECCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCC
Q 046851 814 ILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS--DKKALDPSFSS 890 (963)
Q Consensus 814 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~ 890 (963)
|+++.++.++|+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 99999999999999999765433221 2233456789999999998889999999999999999998 5666653211
Q ss_pred CCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 891 YGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
...........+...... ....+...+.++.+++.+|++.||++|||+.|+++.|++
T Consensus 240 ----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 ----QQVIENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ----HHHHHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111122211111111111 111223345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=317.93 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=205.8
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 47889999999999999999664 24689999986543 234567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEee
Q 046851 755 LIYNYLPGGNLENFIQQRS--------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD 826 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 826 (963)
+||||+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 9999999999999997532 22468889999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 827 FGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 827 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
||+++........ ......++..|+|||.+.+..++.++||||||+++||+++ |..||...... .....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~~~- 233 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVLKF- 233 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHHHH-
Confidence 9999765433321 2223356789999999998889999999999999999998 88888632211 11111
Q ss_pred HhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 905 LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
...+. ....+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 234 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111 111233446789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.29 Aligned_cols=242 Identities=23% Similarity=0.276 Sum_probs=197.2
Q ss_pred cccccCCCccEEEEEE-CCCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 688 NCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
+.||+|+||.||+|.. .+|+.||+|++.... .....++..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 468999999997542 233456788999999999999999999999999999999999999
Q ss_pred ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 764 NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 764 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
+|.+++... ..+++.++..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMK 154 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccc
Confidence 999998763 458999999999999999999997 7 99999999999999999999999999987543222 2223
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~-~~~----------~~~ 215 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELIL-MEE----------IRF 215 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHh-cCC----------CCC
Confidence 45699999999999999999999999999999999999999964321 11111111 110 012
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
+.....++.+++.+|++.||++|+ ++.+++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 233456788999999999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=324.02 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=196.4
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +++.||||++.... ....+.+..|.+++... +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 57899999987542 23345677888888766 799999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 9999998764 4589999999999999999999999 99999999999999999999999999987543222 2233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~-----------~~~ 215 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDD-----------VLY 215 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC-----------CCC
Confidence 45789999999999998999999999999999999999999974322 11121211111 011
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRP-------TMKQVVRR 954 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~ 954 (963)
+.....++.+++.+|++.||++|| ++.+++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 223456788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=331.15 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=214.5
Q ss_pred CCCCccccccCCCccEEEEEEC-C----CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-P----GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
..+..++||.|+||+||+|.|- + .-+||+|++.... .+...++.+|+..|.+++|||+++++|+|.... ..+|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3566789999999999999653 2 3468999886543 345678999999999999999999999998765 8899
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
++||+.|+|.+|++.++ ..+-....+.|..|||+||.|||++ .+|||||.++||||..-..+||.|||+++....+
T Consensus 776 tq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999999864 4578888999999999999999999 9999999999999999999999999999988755
Q ss_pred CCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 837 ETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 837 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
... ...+..-.+.|||-|.+....++.++|||||||.+||++| |..|++.... .++++++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------------------~eI~dll 913 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------------------EEIPDLL 913 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------------------HHhhHHH
Confidence 433 2333334569999999999999999999999999999987 7778764322 2355566
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
+...+...|..+..++..++.+||..|++.||+++++...+.++
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 66666778889999999999999999999999999999998764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=319.27 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=206.4
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4789999999999999999975 468999999998766666678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++........ .
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 99999999865 3478999999999999999999999 999999999999999999999999999876543322 1
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+. ....... . ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~-~~~~~~~-~-------~~ 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALY-LIATNGT-P-------EL 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHH-HHhcCCC-C-------CC
Confidence 22346889999999999888899999999999999999999999643221 0111 1111110 0 01
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+......+.+++.+||..+|++||++.|++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1123345678899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=326.71 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=196.7
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-----CeEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-----TEMF 754 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 754 (963)
+|++.+.||+|+||.||+|... +|..||||++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999754 6899999988643 223445788999999999999999999987542 3579
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+. ++|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 5999998764 3589999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCC--cccccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH------
Q 046851 835 PSET--HATTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML------ 904 (963)
Q Consensus 835 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 904 (963)
.... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~ 229 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLITDLLGTPSP 229 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCCH
Confidence 2221 12234578999999999876 57889999999999999999999999643211 000000000
Q ss_pred -----HhcCcccceec---cccCC---CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 -----LRQGRAKEFFT---AGLWD---AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 -----~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+. ..... .........+.+++.+||+.||++||+++|++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 00000 0001234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.40 Aligned_cols=251 Identities=27% Similarity=0.352 Sum_probs=212.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch---hHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 755 (963)
...|++.+.||+|.||.||++... +|+.+|+|.+.+.... +...+.+|+++++++. |||||.+++++.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 457999999999999999999766 4999999999766543 3468899999999998 9999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC----CCcEEEeeccccc
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD----DFNAYLSDFGLAR 831 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfgla~ 831 (963)
|||++.||.|.+.+... .+++..+..++.|++.|+.|||+. ||+|||+||+|+|+.. ++.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999876 399999999999999999999999 9999999999999963 3579999999999
Q ss_pred ccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...... .... ....+..
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----~~~~-----~i~~~~~- 255 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF----EIFL-----AILRGDF- 255 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh----HHHH-----HHHcCCC-
Confidence 8765 45566789999999999999999999999999999999999999999855432 0001 1122211
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
-++ ...-......+.+++..|+..||.+|+|+.+++++
T Consensus 256 -~f~----~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFT----SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCC----CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111 12223346678899999999999999999999987
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.81 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=203.7
Q ss_pred CCCCCccccccCCCccEEEEEE------CCCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC-CCe
Q 046851 682 GNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS-ETE 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 752 (963)
++|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999963 3478899999875432 3346788999999999 68999999998765 456
Q ss_pred EEEEEeccCCCChHHHHhhhc-----------------------------------------------------------
Q 046851 753 MFLIYNYLPGGNLENFIQQRS----------------------------------------------------------- 773 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 773 (963)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999987532
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc-ccccccc
Q 046851 774 ------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAG 846 (963)
Q Consensus 774 ------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g 846 (963)
...+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||++......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367888899999999999999999 9999999999999999999999999999865332221 1222345
Q ss_pred cccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChh
Q 046851 847 TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHD 925 (963)
Q Consensus 847 t~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (963)
++.|+|||++.+..++.++||||||+++|||++ |..||...... ... ......+.. ...+..
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~-~~~~~~~~~---------~~~~~~ 306 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEF-CRRLKEGTR---------MRAPDY 306 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHH-HHHHhccCC---------CCCCCC
Confidence 678999999998899999999999999999997 88887633211 011 111111111 111222
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 926 DLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 926 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
...++.+++..||+.+|++||++.|++++|+.+.++
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 345788999999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.51 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=204.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCc----EEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGV----LVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.+|+..+.||+|+||+||+|.+. +|. .||+|++..... ....++.+|+..+..++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 46888999999999999999753 444 489998865433 3356788999999999999999999998754 5779
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
++||+++|+|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999997643 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... ......+++.|+|||...+..++.++||||||+++|||++ |..||+..... .... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~----~~~~~~---- 228 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----EIPD----LLEKGE---- 228 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH----HHHCCC----
Confidence 3221 1122235678999999998899999999999999999998 88888633211 1111 111111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
....+...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 229 -----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred -----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1111233456788999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=323.10 Aligned_cols=241 Identities=24% Similarity=0.291 Sum_probs=195.5
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCC-CeeEEEEeeeCCCeEEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHP-NLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 757 (963)
+|++.+.||+|+||.||+|... +++.||||++.... ....+.+..|++++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999765 57899999987542 23456678899999999764 5888999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999999764 3588999999999999999999999 99999999999999999999999999987532221
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+...... ..
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~-~~--------- 216 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIM-EH--------- 216 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-cC---------
Confidence 223345689999999999999999999999999999999999999974321 11111111 11
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
....+......+.+++.+|++.||++|++.
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011233345678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=318.97 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=202.8
Q ss_pred CCCCCccccccCCCccEEEEEECC---------------CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP---------------GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIG 745 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 745 (963)
++|++.+.||+|+||.||++...+ ...||+|.+.... .....++.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 479999999999999999986532 2358999886543 233467899999999999999999999
Q ss_pred eeeCCCeEEEEEeccCCCChHHHHhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeE
Q 046851 746 YHASETEMFLIYNYLPGGNLENFIQQRS----------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNIL 815 (963)
Q Consensus 746 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 815 (963)
++...+..++||||+++++|.+++.... ...+++..++.++.|+++|++|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999996532 12468899999999999999999999 9999999999999
Q ss_pred ECCCCcEEEeecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCCC
Q 046851 816 LDDDFNAYLSDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS--DKKALDPSFSSYG 892 (963)
Q Consensus 816 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~~~ 892 (963)
++.++.+||+|||++.......... .....++..|+|||+..+..++.++||||||+++|||++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 9999999999999997654332211 222345678999999998889999999999999999998 45566532111
Q ss_pred CCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
................ .....+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ---QVIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111111110 0111122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=315.78 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=206.8
Q ss_pred CCCCCccccccCCCccEEEEEECC----CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
.+|++.+.||+|+||.||+|...+ ...||||...... ....+.+..|++++++++|||++++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 358888999999999999997643 3468999887654 3445688999999999999999999999875 457899
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++.... ..+++..+..++.+++.|++|+|+. +++||||||+||+++.++.++++|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999997643 3589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.........++..|+|||.+....++.++||||||+++||+++ |..||...... +..... ..+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~-~~~~------ 225 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------DVIGRI-ENGE------ 225 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHH-HcCC------
Confidence 3322233345568999999988889999999999999999986 99998644221 111111 1111
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
....+...+..+.+++.+|+..+|++|||+.++++.|+++...
T Consensus 226 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 ---RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1112334556899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.53 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=202.5
Q ss_pred HHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC------C
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS------E 750 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~ 750 (963)
.+++.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+|++++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999764 58899999986543 3346788999999998 69999999999864 2
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
...++||||+++++|.+++.......+++..+..++.|++.|++|||++ +|+||||+|+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999999875556689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
....... .......|++.|+|||++. +..++.++||||+||++|||++|+.||...... .... ..
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~~--~~ 228 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALF--LI 228 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHH--HH
Confidence 7654322 2233456899999999986 345788999999999999999999998643211 1111 01
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... ....+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 PRNPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred hcCCC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11100 011122344578899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.52 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=204.1
Q ss_pred CCCCccccccCCCccEEEEEECC-C---cEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEISP-G---VLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
+|++.+.||+|+||.||+|.+.. + ..||||++.... .....+|..|+..+++++||||+++++++......++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 57889999999999999997653 3 369999987542 334568999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+||+++.++.++++|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999997643 4589999999999999999999999 99999999999999999999999999987654322
Q ss_pred Cccc--cccc--ccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 838 THAT--TGVA--GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 838 ~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.... .... .+..|+|||++.+..++.++||||+|+++|||++ |..||...... ....++ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i----~~~---- 227 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAI----EQD---- 227 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHH----HcC----
Confidence 2111 1111 2457999999999899999999999999999886 99998643211 111111 111
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.....+.+.+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01112234556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=318.50 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=205.7
Q ss_pred cCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
.++|+..+.||+|+||.||+|... ++..||+|++..... ...+++.+|+.++++++|||++++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357899999999999999999753 467899998875432 3346789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCC
Q 046851 754 FLIYNYLPGGNLENFIQQRS--------------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSN 813 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 813 (963)
++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999997532 12467889999999999999999999 99999999999
Q ss_pred eEECCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 046851 814 ILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSY 891 (963)
Q Consensus 814 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~ 891 (963)
|+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999998765433221 1222345678999999998899999999999999999997 7778753211
Q ss_pred CCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 892 GNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
.+.... ...+... ..+...+.++.+++.+|++.+|++||++.|+++.|++
T Consensus 239 ------~~~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ------EEVIYY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122211 1111111 1223445689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=328.89 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=204.4
Q ss_pred HHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC
Q 046851 676 SVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET 751 (963)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (963)
+.....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445578999999999999999999765 58899999986432 223456788999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999999753 478899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccccCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCR----VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
..............||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ..........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~ 262 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNH 262 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC
Confidence 76543333334567999999999987543 78899999999999999999999974321 1122222211
Q ss_pred CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 046851 908 GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLST--RPTMKQVVRRL 955 (963)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 955 (963)
.....+ .........+.+++..|+..++.+ ||++.|+.++.
T Consensus 263 ~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111 111234567888999999844433 78999988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=317.79 Aligned_cols=262 Identities=21% Similarity=0.388 Sum_probs=204.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-----------------CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-----------------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTL 743 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 743 (963)
++|++.+.||+|+||.||++... ++..||+|++.... .....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46999999999999999998543 23468999887543 3345678999999999999999999
Q ss_pred EEeeeCCCeEEEEEeccCCCChHHHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCe
Q 046851 744 IGYHASETEMFLIYNYLPGGNLENFIQQRST---------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNI 814 (963)
Q Consensus 744 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 814 (963)
++++...+..++||||+++|+|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999976431 2467889999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCC
Q 046851 815 LLDDDFNAYLSDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS--DKKALDPSFSSY 891 (963)
Q Consensus 815 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~~ 891 (963)
+++.++.++|+|||++..+....... .....+++.|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 99999999999999998654332211 122344678999999988889999999999999999998 66777532211
Q ss_pred CCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 892 GNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
................. ....+..++..+.+++.+||+.||++||++.||++.|++
T Consensus 241 ----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 ----QVIENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ----HHHHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111110000 111223355789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=336.00 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=194.4
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--------C
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--------T 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 751 (963)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999764 68999999885432 2345799999999999999999876321 2
Q ss_pred eEEEEEeccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeecc
Q 046851 752 EMFLIYNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFG 828 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg 828 (963)
..++||||+++ ++.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999975 888877542 245689999999999999999999999 999999999999999765 69999999
Q ss_pred cccccCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
+|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|.+||...... ..+..... ....
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~~-~~~~ 289 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRIIQ-VLGT 289 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHH-HhCC
Confidence 998764322 22345689999999998764 6899999999999999999999999743221 01111110 0000
Q ss_pred ---------------CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 ---------------GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ---------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..........+....+...+.++.+++.+||..||.+|||+.|++++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000000111111233345688999999999999999999999854
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.74 Aligned_cols=238 Identities=26% Similarity=0.352 Sum_probs=195.0
Q ss_pred cccccCCCccEEEEEE----CCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 688 NCIGNGGFGATYKAEI----SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 3589999999975432 234567789999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+|+|.+++.+. ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 99999999763 4589999999999999999999999 99999999999999999999999999987654322 223
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... .. ..
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~-~~----------~~ 216 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILK-AK----------LG 216 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHc-CC----------CC
Confidence 346789999999999988899999999999999999999999974321 111111111 10 11
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHH
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQ 950 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 950 (963)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23334567889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.01 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=202.6
Q ss_pred cccccCCCccEEEEEECC--C--cEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEISP--G--VLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+++.+|++.+++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 3 3699999987665 556789999999999999999999999888 889999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc--c
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH--A 840 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~ 840 (963)
++|.+++.......+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999875435689999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.......... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~---------~ 219 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEGE---------R 219 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcCC---------c
Confidence 122456789999999998899999999999999999998 9999863311 112211111110 0
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
...+...+..+.+++.+|++.+|++||++.++++.|.+
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 11223345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=321.62 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=205.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC--------CCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS--------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASE 750 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (963)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .....++..|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999642 24579999887543 33456788999999999 599999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
+..++||||+++|+|.+++.... ...+++.++.+++.|++.|++|||++ +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999997642 23588999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q 046851 817 DDDFNAYLSDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNG 894 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~ 894 (963)
+.++.+||+|||.++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 999999999999998664322211 111234468999999998889999999999999999999 7888753211
Q ss_pred cchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.+... ....+.. ...+..++.++.+++.+|++.+|++||++.|+++.|+++.
T Consensus 243 ---~~~~~-~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 ---EELFK-LLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHH-HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111 1111111 1123345567889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=317.76 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=202.3
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
|+..+.||+|+||.||+|... +++.||||.+..... .....+..|+.++++++|++++++++++.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999664 689999998865432 2234577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.......+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999999765555689999999999999999999999 99999999999999999999999999987653222
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||...... .. ........... .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~-~~~~~~~~~~~----------~ 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IK-REEVERLVKEV----------Q 221 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----ch-HHHHHhhhhhh----------h
Confidence 122347899999999999989999999999999999999999999754221 00 00011110000 0
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
...+......+.+++.+||+.||++||| +.|++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1122334557889999999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=317.86 Aligned_cols=262 Identities=23% Similarity=0.397 Sum_probs=205.6
Q ss_pred CCCCccccccCCCccEEEEEE-----CCCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeEE
Q 046851 683 NFNASNCIGNGGFGATYKAEI-----SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEMF 754 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 754 (963)
.|++.+.||+|+||.||.|.. .++..||+|.+.... ......+.+|++++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478889999999999999964 357889999986543 33456789999999999999999999998765 5689
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++++|.+++.+.. ..+++.++..++.|++.|++|+|+. +++||||||+||+++.++.++|+|||++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999997643 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC-------CCCcchhhHHHHHH
Q 046851 835 PSETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSY-------GNGFNIVAWGCMLL 905 (963)
Q Consensus 835 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~-------~~~~~~~~~~~~~~ 905 (963)
..... ......++..|+|||++.+..++.++||||||+++|||++++.|........ .......... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHH
Confidence 33221 1223456778999999998889999999999999999999887654221110 0000111111 111
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
..+ .....+...+..+.+++.+|++.+|++||++.++++.++++
T Consensus 240 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111 11122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=320.04 Aligned_cols=241 Identities=27% Similarity=0.356 Sum_probs=193.4
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhc-cCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGR-LRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +++.||||++.... ....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 57899999987542 2334556778888776 4899999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 9999999763 4588999999999999999999999 99999999999999999999999999987542221 2233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+..... .... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i-~~~~----------~~~ 215 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSI-RMDN----------PCY 215 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HhCC----------CCC
Confidence 45789999999999998999999999999999999999999974321 1111111 1110 011
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMK-QVVR 953 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 953 (963)
+.....++.+++.+|++.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 223445788999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=318.74 Aligned_cols=245 Identities=27% Similarity=0.413 Sum_probs=203.4
Q ss_pred CCCccccccCCCccEEEEE-ECCCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 684 FNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
|.-.+.||.|+||.||-|+ ..+.+.||||++.... .+.++++.+|++++.+++|||++.+.|+|..+.+.|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5556779999999999995 4578899999996543 35678999999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
|-| |-.|++.-.. .++.+.++..|+.+.+.||+|||++ +.||||||+.|||+++.|.||++|||.|....+.
T Consensus 108 ClG-SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred Hhc-cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 965 8888887653 5688999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 840 ATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
..++|||.|||||++. .+.|+-|+||||+|++..|+.-.++|+..... . -+-..+.+.+.+.+-
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--------M-SALYHIAQNesPtLq-- 246 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------M-SALYHIAQNESPTLQ-- 246 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--------H-HHHHHHHhcCCCCCC--
Confidence 4468999999999986 46799999999999999999999999763311 0 112223333333221
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
..+-...++.++..|++.-|.+|||.++++++-
T Consensus 247 ------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 247 ------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 223456788999999999999999999998763
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=320.50 Aligned_cols=240 Identities=23% Similarity=0.311 Sum_probs=193.3
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +|+.||+|+++... ....+.+..|.+++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999765 68899999997542 23345567788877654 899999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.++|+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 9999998764 4588999999999999999999999 99999999999999999999999999987532221 2233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+..... .... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~-~~~~----------~~~ 215 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESI-RVDT----------PHY 215 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HhCC----------CCC
Confidence 45789999999999999999999999999999999999999974321 1111111 1110 112
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMK-QVV 952 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 952 (963)
+.....++.+++.+|++.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223456788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=335.06 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=197.8
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999654 589999999865322 234567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC--
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS-- 836 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~-- 836 (963)
|+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|..+...
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999764 3588899999999999999999999 9999999999999999999999999997533100
Q ss_pred ----------------------------------------CCcccccccccccccCccccccCCCCcchhhHHHHHHHHH
Q 046851 837 ----------------------------------------ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLE 876 (963)
Q Consensus 837 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~e 876 (963)
.........||+.|+|||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0001123579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCC---CHHHHHH
Q 046851 877 LLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP---TMKQVVR 953 (963)
Q Consensus 877 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~evl~ 953 (963)
|++|+.||...... +.......... .............+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 237 ll~G~~Pf~~~~~~--------~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADTPA--------ETQLKVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCCHH--------HHHHHHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999744221 11111111000 0000111223456677777765 5999999 8888886
Q ss_pred H
Q 046851 954 R 954 (963)
Q Consensus 954 ~ 954 (963)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=333.52 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=198.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36889999999999999999654 68999999986532 233467888999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999764 4588999999999999999999999 99999999999999999999999999996432110
Q ss_pred Cc----------------------------------------------ccccccccccccCccccccCCCCcchhhHHHH
Q 046851 838 TH----------------------------------------------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYG 871 (963)
Q Consensus 838 ~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 871 (963)
.. ......||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124699999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCC---CCH
Q 046851 872 VVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTR---PTM 948 (963)
Q Consensus 872 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~ 948 (963)
|++|||++|+.||...... +........... ...........++.+++.+|+. +|.+| +++
T Consensus 236 vil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~-------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 236 AIMFECLIGWPPFCSENSH--------ETYRKIINWRET-------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCc-------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 9999999999999643211 111111110000 0001111234578899999997 66665 699
Q ss_pred HHHHHH
Q 046851 949 KQVVRR 954 (963)
Q Consensus 949 ~evl~~ 954 (963)
.|++++
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=320.57 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=196.7
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +++.||||++.... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 57899999997542 23345677888888877 699999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|..++... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 9999998764 3589999999999999999999999 99999999999999999999999999987532221 2223
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......... .. ...
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~-~~----------~~~ 215 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILE-DE----------VRY 215 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHc-CC----------CCC
Confidence 45689999999999999999999999999999999999999964321 111111111 10 012
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTM-----KQVVRR 954 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 954 (963)
+...+..+.+++.+||+.||++||++ .+++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 23345678999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.50 Aligned_cols=249 Identities=29% Similarity=0.432 Sum_probs=196.4
Q ss_pred cccccCCCccEEEEEECC-Cc--EEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEISP-GV--LVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|...+ +. .+|+|.+.... ....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999997753 43 46888876432 33456788999999999 799999999999999999999999999
Q ss_pred CChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecc
Q 046851 763 GNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 763 gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
|+|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 12478999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||..... .+.......
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~~- 226 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKLPQ- 226 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHHhC-
Confidence 98632211 11111223567999999988889999999999999999997 9999863211 111111111
Q ss_pred CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 908 GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
+ .....+.....++.+++.+||+.+|.+||++.++++.|+++-
T Consensus 227 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1 111122234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=321.46 Aligned_cols=241 Identities=24% Similarity=0.300 Sum_probs=195.6
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 757 (963)
+|++.+.||+|+||.||+|... +++.||||++.... ......+..|.+++... +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999765 57899999987542 22334567788887777 5899999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999999764 3589999999999999999999999 99999999999999999999999999987543222
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~~--------- 217 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHN--------- 217 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC---------
Confidence 2233457899999999999999999999999999999999999999743211 1111111111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
...+.....++.+++.+|++.||++|++.
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11233455678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.96 Aligned_cols=248 Identities=28% Similarity=0.480 Sum_probs=204.9
Q ss_pred cccccCCCccEEEEEECC----CcEEEEEEeecccchh-HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEISP----GVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997754 7889999987654433 67889999999999999999999999999999999999999
Q ss_pred CChHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 763 GNLENFIQQRS-------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 763 gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
++|.+++.... ...+++.++..++.|+++|++|||++ +++||||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998752 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
... .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||..... ...... ...+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~-~~~~----- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEY-LRKG----- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH-HHcC-----
Confidence 321 22334457889999999998889999999999999999999 5888874411 111111 1111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
.....+...+.++.+++.+|++.+|++||++.|++++|+
T Consensus 224 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111223344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.45 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=207.8
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|+..+.||+|+||.||.++. .++..|++|++.... ....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999999965 458899999886543 34456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.......+++.++..++.|+++|++|||+. +++||||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999876556689999999999999999999999 999999999999999999999999999987644332
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......+++.|+|||+..+..++.++||||+|+++|||++|+.||..... .+....... +..
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~-~~~--------- 218 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQ-GNY--------- 218 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHc-CCC---------
Confidence 23345689999999999988889999999999999999999999864321 122222211 111
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
...+...+.++.+++.+||+.+|++||++.++++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111233456788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.38 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=205.7
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5799999999999999999975 479999999997666555677899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.+ ..+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 99999999865 3478999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
.....+++.|+|||...+..++.++||||+|+++|+|++|+.||........ .......+ ....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--------~~~~~~~~--------~~~~ 235 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATNG--------TPEL 235 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--------eeeeccCC--------CCCC
Confidence 2334688999999999998899999999999999999999999964322100 00000000 0001
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
..+...+..+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122334566889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=327.86 Aligned_cols=259 Identities=23% Similarity=0.349 Sum_probs=200.3
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC-----eEE
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET-----EMF 754 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 754 (963)
+|++.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999975 47899999988643 2234567889999999999999999999998766 789
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 588888865 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH---------
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML--------- 904 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 904 (963)
...........+++.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-----QQLDLITDLLGTPSLEAM 229 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcCCCCHHHH
Confidence 4433333445688999999999874 4788999999999999999999999754321 001111000
Q ss_pred ----------H-hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 ----------L-RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 ----------~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .......... . ..........++.+++.+|++.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLP-V-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchH-H-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000000000 0 001112235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.49 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=206.2
Q ss_pred cCCCCCccccccCCCccEEEEEECC-CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.++|+..+.||+|+||.||+|...+ +..||+|.+..... .+++.+|++++++++|||++++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3579999999999999999998764 78999999875433 57899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++... ...+++..+..++.|+++|+.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 80 CGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999999754 34689999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......++..|+|||++.+..++.++||||||+++|||++|+.||...... ... ........ ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-------~~~--~~~~~~~~-------~~ 218 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-------RAI--FMIPNKPP-------PT 218 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-------hhh--hhhccCCC-------CC
Confidence 223345788999999999989999999999999999999999998743221 000 00000000 00
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+......+.+++.+|++.+|++||++.||+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11122344678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=314.48 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=200.1
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|.. .++..||+|++.... ....+++..|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3688889999999999999965 568999999986542 33346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
++++++..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997652 367888999999999999999999 9999999999999999999999999999765432
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||.......... .......... ..... .
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~-~~~~~-----~-- 219 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIV-DEDPP-----V-- 219 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHh-ccCCC-----C--
Confidence 2233578999999999999899999999999999999999999997543221111 0111111111 11000 0
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........++.+++.+|++.+|++||+++|++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 -LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111234578899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=332.60 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=195.6
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999965 468899999987543 2334578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC-
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE- 837 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 837 (963)
|+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999764 3588999999999999999999999 99999999999999999999999999975332100
Q ss_pred ---------------------------------------------CcccccccccccccCccccccCCCCcchhhHHHHH
Q 046851 838 ---------------------------------------------THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGV 872 (963)
Q Consensus 838 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 872 (963)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00112346899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCC---HH
Q 046851 873 VLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT---MK 949 (963)
Q Consensus 873 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ 949 (963)
++|||++|+.||....+. +.......... ............++.+++.+|+ .+|++|++ +.
T Consensus 237 il~elltG~~Pf~~~~~~--------~~~~~i~~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPL--------ETQMKVINWQT-------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHHhCCCCCCCCCHH--------HHHHHHHccCC-------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 999999999999743221 11111111000 0000111123445667776665 59999997 77
Q ss_pred HHHHH
Q 046851 950 QVVRR 954 (963)
Q Consensus 950 evl~~ 954 (963)
+++++
T Consensus 301 ei~~h 305 (382)
T cd05625 301 EIKAH 305 (382)
T ss_pred HHhcC
Confidence 77654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.31 Aligned_cols=243 Identities=21% Similarity=0.299 Sum_probs=194.6
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 57899999997543 23345678899998888 599999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCcee
Confidence 9999988763 4589999999999999999999999 9999999999999999999999999998753221 12233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....++......... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~----------~~~ 222 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--DMNTEDYLFQVILEKP----------IRI 222 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--ccccHHHHHHHHHhCC----------CCC
Confidence 4579999999999999999999999999999999999999996432221 1111222222222111 012
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
+...+..+.+++.+|++.||++|+++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 33345678899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.80 Aligned_cols=250 Identities=23% Similarity=0.383 Sum_probs=204.1
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC-CCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS-ETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 758 (963)
+|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999654 57899999986543 2345678899999999999999999998764 446799999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++++|.+++.......+++.++..++.+++.|++|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999999876556689999999999999999999999 99999999999999999999999999998664322
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.......+++.|+|||+..+..++.++||||+|+++|||++|+.||.... ......... .+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~-~~~~-------- 219 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRII-EGKL-------- 219 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHH-hcCC--------
Confidence 22334568899999999999999999999999999999999999986321 111111111 1111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+......+.+++.+|++.+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11233455688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.39 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=200.7
Q ss_pred cccccCCCccEEEEEECCCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCChH
Q 046851 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLE 766 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 766 (963)
++||+|+||.||+|...+++.||+|++...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998777999999988765443 4568899999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc-cccc
Q 046851 767 NFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT-TGVA 845 (963)
Q Consensus 767 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~ 845 (963)
+++.... ..+++..+..++.+++.|++|||++ +++||||+|+||+++.++.++|+|||++........... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9997643 3578999999999999999999999 999999999999999999999999999976542221111 1123
Q ss_pred ccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCCh
Q 046851 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPH 924 (963)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (963)
++..|+|||.+.+..++.++||||||+++|||++ |..||...... .... ..... .....+.
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~-~~~~~---------~~~~~~~ 218 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRE-RIESG---------YRMPAPQ 218 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHH-HHhcC---------CCCCCCc
Confidence 4567999999998889999999999999999999 77777533211 1111 11111 1111233
Q ss_pred hHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 925 DDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 925 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
..+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 456689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.97 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=198.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999765 58999999986432 223456888999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999763 34588999999999999999999999 99999999999999999999999999987665433
Q ss_pred CcccccccccccccCcccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 838 THATTGVAGTFGYVAPEYAMT-----CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKEHFQ 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCccc
Confidence 333333568999999999873 457789999999999999999999996431 1122222211111000
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCC--CCCCCHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSL--STRPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP--~~RPs~~evl~~ 954 (963)
+ .......+..+.+++.+|+..++ ..||++.+++++
T Consensus 229 ~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 F------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 01111245567788888775533 348899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.43 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=204.7
Q ss_pred HHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 677 VVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 677 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445667777789999999999999754 578899999887766667789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEeecccccc
Q 046851 756 IYNYLPGGNLENFIQQRSTRAV--DWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFGLARL 832 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~ 832 (963)
|+||+++++|.+++.... ..+ ++..+..++.|+++|++|||+. +|+||||||+||+++. ++.++|+|||.+..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999998642 234 7888999999999999999999 9999999999999986 67999999999876
Q ss_pred cCCCCCcccccccccccccCccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTCR--VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
...... ......|++.|+|||++.+.. ++.++||||+|+++|+|++|+.||...... ....+.....
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~----- 227 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMF----- 227 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhh-----
Confidence 543222 222345789999999986543 788999999999999999999998643211 0001100000
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......+.....++.+++.+||+.+|++|||+.|++++
T Consensus 228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111233455678899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.57 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=205.9
Q ss_pred CCCCCccccccCCCccEEEEEEC--------CCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCC
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS--------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASET 751 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (963)
.+|++.+.||+|+||.||+|... .+..||+|.+.... ....+++.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 36889999999999999999642 12468999887543 23457889999999999 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 752 EMFLIYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
..+++|||+++|+|.+++.+.. ...+++.++..++.|+++|++|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999997642 23478899999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCc
Q 046851 818 DDFNAYLSDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGF 895 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~ 895 (963)
.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------- 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------- 241 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-------
Confidence 99999999999998664332211 122234568999999999999999999999999999998 778775321
Q ss_pred chhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 896 NIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
..++..... ... ....+...+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 242 -~~~~~~~~~-~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 242 -VEELFKLLK-EGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -HHHHHHHHH-cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 222222221 111 11123344568889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=305.68 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=211.3
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchh--HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.+-|++.+.||+|.|+.|-.|++ -+|..||||++.+..... ...+.+|+++|+-++|||||++|++.......|+|.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45688999999999999999954 479999999997765443 456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC-CCCcEEEeecccccccCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~ 836 (963)
|.-++|+|++|+-++. ..+.+..+.+++.||+.|+.|+|.. .+||||+||+||.+- +-|-||++|||++..+.++
T Consensus 97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999998764 4589999999999999999999999 999999999999875 5789999999999988765
Q ss_pred CCcccccccccccccCccccccCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVS-DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
... ...+|+..|-|||.+.|..|. +++||||+|||||-+++|++||+.....+ ....++|
T Consensus 173 ~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------------TLTmImD 233 (864)
T KOG4717|consen 173 KKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------------TLTMIMD 233 (864)
T ss_pred chh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------------hhhhhhc
Confidence 443 345899999999999998876 46899999999999999999998654331 1112222
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
- .-..|.....++.+||..|+..||++|.+.+||+..
T Consensus 234 C--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 234 C--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred c--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1 123466778899999999999999999999998753
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.25 Aligned_cols=247 Identities=29% Similarity=0.453 Sum_probs=201.1
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.+|++.+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3588999999999999999975 47889999886543 236788999999999999999999998664 4789999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.......+++.++..++.|++.|+.|+|+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999876655689999999999999999999999 99999999999999999999999999987643221
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
.....+..|+|||++.+..++.++||||+|+++|||++ |+.||..... ....... ..+. ..
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~-~~~~---------~~ 216 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVKECV-EKGY---------RM 216 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHH-hCCC---------CC
Confidence 12234568999999998889999999999999999997 8888863321 1111111 1111 11
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
..+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1123445678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.75 Aligned_cols=237 Identities=27% Similarity=0.336 Sum_probs=190.2
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHH-HHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIK-TLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||+||+|... +|+.||||++..... ....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999765 689999999875422 22344555554 46788999999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++...... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence 9999999763 4588999999999999999999999 9999999999999999999999999998754222 22233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-----------~~~ 215 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKP-----------LRL 215 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCC-----------CCC
Confidence 4578999999999999999999999999999999999999997431 112222211111 011
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMK 949 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ 949 (963)
+...+..+.+++.+|++.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 223356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.32 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=192.4
Q ss_pred cccccCCCccEEEEEECC---CcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 688 NCIGNGGFGATYKAEISP---GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
+.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 359999999999997653 45799998865443 33457889999999999999999999999999999999999999
Q ss_pred ChHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc-
Q 046851 764 NLENFIQQRS---TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH- 839 (963)
Q Consensus 764 sL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 839 (963)
+|.+++.... ....++..+..++.|+++|++|||+. +++||||||+||+++.++.++++|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997543 22456778889999999999999999 9999999999999999999999999998754332221
Q ss_pred ccccccccccccCccccccC-------CCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 840 ATTGVAGTFGYVAPEYAMTC-------RVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||...... ....+ ... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-----~~~~~---~~~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-----QVLTY---TVR-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-----HHHHH---Hhh-cccC
Confidence 12234577899999998642 35789999999999999996 99998643211 11111 111 1111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
...++.. .......+.+++..|+ .+|++|||++||++.|+
T Consensus 229 ~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 1223456788999999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=296.73 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=210.2
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
-|++++++|+|+||.||+|.++ .|..||||.+... .+.+++.+|+.++++.+.|+||++||.+-.....|+|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3778889999999999999655 6999999998765 456889999999999999999999999988999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
-|++.+.++.+ +.++++.++..+++..++||+|||.. .-+|||||+.|||++-+|.+|++|||.|..+.+. -...
T Consensus 112 AGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKR 186 (502)
T ss_pred CCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhh
Confidence 99999999876 46799999999999999999999999 8999999999999999999999999999766422 2234
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
..+.|||.|||||++..-.|..++||||+|+...||..|++||.+-.+-. +..+......+.+ .
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AIFMIPT~PPPTF-------~ 250 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AIFMIPTKPPPTF-------K 250 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------eeEeccCCCCCCC-------C
Confidence 56789999999999999999999999999999999999999997443320 0001111111111 2
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
.|+.-..++-++++.|+-..|++|-|+.++.++-
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 3445567899999999999999999999988763
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.49 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=195.5
Q ss_pred cccccCCCccEEEEEEC----CCcEEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeee-CCCeEEEEEeccC
Q 046851 688 NCIGNGGFGATYKAEIS----PGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA-SETEMFLIYNYLP 761 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 761 (963)
+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++.++|||++++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2457999988543 2344578889999999999999999999775 4556899999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC---
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET--- 838 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--- 838 (963)
+|+|.+++.... ...++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997643 3467888899999999999999999 999999999999999999999999999976533211
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.......++..|+|||+..+..++.++||||||+++|||++|+.|+.... .............
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-------~~~~~~~~~~~~~---------- 219 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------DSFDITVYLLQGR---------- 219 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHhcCC----------
Confidence 11123345778999999998889999999999999999999655433221 1112222111111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
....+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 011122345678899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.26 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=201.6
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
|+..+.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999664 688999999865432 2234578899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.......+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999998765555799999999999999999999999 99999999999999999999999999987653222
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......|+..|+|||++.+..++.++|+||+|+++|||++|+.||...... .....+........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-----~~~~~~~~~~~~~~---------- 221 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-----VKREEVDRRVLETE---------- 221 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhhhccc----------
Confidence 123356899999999999889999999999999999999999999743221 00011111111110
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
...+......+.+++..|++.||++||+ +.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0112234457789999999999999999 6676654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.31 Aligned_cols=261 Identities=24% Similarity=0.314 Sum_probs=196.0
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--hHHHHHHHHHHHhcc---CCCCeeEEEEeeeC-----CC
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRL---RHPNLVTLIGYHAS-----ET 751 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 751 (963)
+|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999665 6899999988754221 223456677776655 69999999998754 34
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
..++||||+++ +|.+++.......+++.++..++.|++.|++|+|+. +++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57999999975 999999876556689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc---C
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ---G 908 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 908 (963)
...... ......|+..|+|||++.+..++.++||||+||++|||++|++||...... ....... ..... .
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~~~-~~~~~~~~~ 229 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGKIF-DLIGLPPED 229 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHHHH-HHhCCCChh
Confidence 764322 223356889999999999989999999999999999999999998643221 0011110 00000 0
Q ss_pred ccc-------ceeccccC---CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 RAK-------EFFTAGLW---DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 ~~~-------~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... ..+.+... ..........+.+++.+|++.||++|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00000000 00111234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.34 Aligned_cols=251 Identities=27% Similarity=0.487 Sum_probs=204.2
Q ss_pred CCCccccccCCCccEEEEEECC-----CcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 684 FNASNCIGNGGFGATYKAEISP-----GVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
|++.+.||+|+||.||+|...+ +..||+|++...... ..+.+..|++++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567889999999999997763 388999999765433 5678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++.......+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999875443389999999999999999999999 99999999999999999999999999998765443
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
........+++.|+|||.+.+..++.++||||+|+++|||++ |..||.... ........ ..+..
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~~------ 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--------NEEVLEYL-KKGYR------ 222 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-hcCCC------
Confidence 332222336789999999988889999999999999999998 677776321 11111111 11111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
...+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112223566889999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.96 Aligned_cols=265 Identities=27% Similarity=0.410 Sum_probs=208.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-----CCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-----PGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 753 (963)
+.|++.+.||+|+||.||+|.+. ++..||||++...... ..+.+.+|++.+++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35778899999999999999754 3688999998765443 45789999999999999999999999877 5678
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999998653 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcc--cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC------CcchhhHHHHHH
Q 046851 834 GPSETHA--TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN------GFNIVAWGCMLL 905 (963)
Q Consensus 834 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~------~~~~~~~~~~~~ 905 (963)
....... .....++..|+|||...+..++.++||||||+++|||++|+.|+......... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 5332211 11234556799999999888999999999999999999999987643322100 000011111111
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
... .....+..++.++.+++.+||+.+|++||+|.||+++|+++.
T Consensus 240 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 240 KEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 111 111223344578999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=327.34 Aligned_cols=261 Identities=21% Similarity=0.254 Sum_probs=198.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
..|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46999999999999999999765 478899996432 34578999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc-
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH- 839 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 839 (963)
. ++|.+++.... ..+++.++..|+.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 243 ~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 243 R-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 5 69999987643 3689999999999999999999999 9999999999999999999999999999865432221
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc--ce---e
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK--EF---F 914 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---~ 914 (963)
......||+.|+|||++.+..++.++|||||||++|||++|..|+..............+ +.......... ++ .
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~-l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ-ILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHH-HHHHHHhhccccccCCCCc
Confidence 223457999999999999999999999999999999999988766433221111111111 11111111100 00 0
Q ss_pred cc------------ccCCCCC-------hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TA------------GLWDAGP-------HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~------------~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.. ....... ......+.+++.+||+.||++|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0000000 0122367889999999999999999999975
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.15 Aligned_cols=240 Identities=22% Similarity=0.311 Sum_probs=190.6
Q ss_pred cccccCCCccEEEEEECC-------------CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 688 NCIGNGGFGATYKAEISP-------------GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
+.||+|+||.||+|.+.+ ...||+|.+..........+.+|+..++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997542 2358999887655555667889999999999999999999999988999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc-------EEEeec
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN-------AYLSDF 827 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~Df 827 (963)
+||||+++|+|..++.... ..+++..+.+++.|+++|++|||+. +|+||||||+||+++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999987543 4589999999999999999999999 9999999999999987664 899999
Q ss_pred ccccccCCCCCcccccccccccccCccccc-cCCCCcchhhHHHHHHHHHHH-cCCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 828 GLARLLGPSETHATTGVAGTFGYVAPEYAM-TCRVSDKADVYSYGVVLLELL-SDKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 828 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+...... +.. ...
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~-~~~ 222 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--------EKE-RFY 222 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--------HHH-HHH
Confidence 998754322 2245788999999887 466888999999999999998 577776532111 100 111
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
.... .........+.+++.+||+.||++||++.++++.+.
T Consensus 223 -~~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 -EGQC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -hcCc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1100 011123457889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.39 Aligned_cols=256 Identities=22% Similarity=0.334 Sum_probs=206.5
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
.+|+..+.||+|+||.||+|... +...||+|.+...... ..+++.+|++++++++|+|++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888999999999999999764 2467999988654443 4567899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeec
Q 046851 755 LIYNYLPGGNLENFIQQRST-------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 827 (963)
+||||+++|+|.+++..... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976541 1589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 828 GLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 828 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
|++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~-~~ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNR-LQ 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHH-HH
Confidence 9987654333333344456788999999988888999999999999999998 6778753211 111111 11
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
.+... ...+...+..+.+++.+|++.+|++||++.|+++.|.+
T Consensus 233 ~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11111 11123445689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.99 Aligned_cols=248 Identities=25% Similarity=0.425 Sum_probs=204.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||.|++|.||+|... +++.||+|++.... ......+.+|+++++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999765 68999999987553 34456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999999864 589999999999999999999999 99999999999999999999999999998765432 2
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......+++.|+|||++.+..++.++||||||+++|||++|+.||....+. ... ...........
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~-~~~~~~~~~~~------ 218 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVL-FLIPKNNPPSL------ 218 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHH-HHhhhcCCCCC------
Confidence 223346888999999999988999999999999999999999999643211 111 11111111111
Q ss_pred CCCChh-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHD-DLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+.. .+..+.+++.+|++.+|++||++++++++
T Consensus 219 ---~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 ---EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111 45578899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.63 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=202.7
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccc------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
+|+..+.||+|+||.||+|...+|+.||||.+..... ...+.+.+|++.+++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999888899999998864321 2235688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999764 3578999999999999999999999 9999999999999999999999999998765321
Q ss_pred C-----CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 837 E-----THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 837 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
. ........|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-------AAMFYIGAHRGL-- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-------HHHHHhhhccCC--
Confidence 1 11223356889999999999988999999999999999999999999643211 111000000010
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
....+.....++.+++.+||+.+|++||++.++++
T Consensus 227 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01122334567899999999999999999999976
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.38 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=195.2
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 757 (963)
+|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999764 68999999987542 233456778888888875 577888999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999999764 4589999999999999999999999 99999999999999999999999999987543222
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...........
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~--------- 217 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHN--------- 217 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC---------
Confidence 223345689999999999998999999999999999999999999974321 11111111111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
...+.....++.+++.+|++.+|++|++.
T Consensus 218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11223345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=314.39 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=202.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|... ++..||+|.+..... ....++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36899999999999999999765 578899998865432 3345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.++++.. ..+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999864 45889999999999999999999732 8999999999999999999999999998755322
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc--------
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK-------- 911 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 911 (963)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ....+...........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCccccccccCCcccccC
Confidence 223356889999999998888999999999999999999999998643211 0011000000000000
Q ss_pred ------------ceecc---ccCCCCC-hhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 912 ------------EFFTA---GLWDAGP-HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 912 ------------~~~~~---~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
+..+. ......+ .....++.+++.+|++.+|++||++++++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000 0000001 12345688999999999999999999998873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.64 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=205.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
..|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++++.|||++++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35778889999999999999764 58899999887543 34457789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.. ..+++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999999875 3478899999999999999999999 999999999999999999999999999976643322
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......++..|+|||++.+..++.++||||||+++|||++|+.||...... ..... ... ...
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~-~~~---------~~~ 218 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFL-IPK---------NNP 218 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhh-hhc---------CCC
Confidence 223346788999999999888999999999999999999999998744221 00000 001 111
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12334567789999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.82 Aligned_cols=250 Identities=23% Similarity=0.400 Sum_probs=206.2
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.+|+..+.||.|++|.||+|.. .+|+.||+|.+........+.+.+|+..++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3689999999999999999964 568999999997666556678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999998753 489999999999999999999999 999999999999999999999999999876543322 2
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .......... ... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------~~~~~~~~~~-~~~-------~ 235 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNG-TPE-------L 235 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcC-Ccc-------c
Confidence 23346889999999999888999999999999999999999999743221 1111111111 000 1
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+..+.+++.+||..||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1223345578899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.98 Aligned_cols=249 Identities=24% Similarity=0.416 Sum_probs=201.8
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch---------hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ---------GVQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (963)
+|.+...||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778889999999999999654 5889999988654321 12567899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999764 4588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-----cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 833 LGPSET-----HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 833 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
...... .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .-+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~ 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKIG-E 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHHh-c
Confidence 642211 1112345788999999999888999999999999999999999999743111 1011100 0
Q ss_pred CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .....+...+..+.+++.+||+.||.+||++.|++++
T Consensus 227 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 N---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred c---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 1112233456688999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.54 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=202.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 47888899999999999999654 68999999987665555567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++... ..+++.++..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 999999999764 3589999999999999999999999 99999999999999999999999999987654322 22
Q ss_pred cccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 841 TTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....|++.|+|||++. ...++.++||||+||++|||++|+.||....+. ............. +.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--------~~~~~~~~~~~~~----~~ 230 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMTKSNFQP----PK 230 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--------hhHHhhhccCCCC----Cc
Confidence 23456899999999974 455788999999999999999999998643221 0000000010000 00
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ......+..+.+++.+|++.+|++||++++++++
T Consensus 231 ~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 L--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 0011234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.09 Aligned_cols=240 Identities=26% Similarity=0.307 Sum_probs=190.6
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHH-HHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIK-TLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +++.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 578899999875422 22234444444 46788999999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+.+..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 9999999763 4578889999999999999999999 99999999999999999999999999987543222 2233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+......... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~-----------~~~ 215 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKP-----------LQL 215 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC-----------cCC
Confidence 45799999999999999999999999999999999999999974321 11111111110 011
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 952 (963)
+......+.+++.+|++.||.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 223456788999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.75 Aligned_cols=196 Identities=27% Similarity=0.443 Sum_probs=162.0
Q ss_pred ccccccCCCccEEEEEEC---CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeEEEEEeccC
Q 046851 687 SNCIGNGGFGATYKAEIS---PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEMFLIYNYLP 761 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 761 (963)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999764 467899998865432 2456889999999999999999998854 456899999996
Q ss_pred CCChHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE----CCCCcEEEeecccc
Q 046851 762 GGNLENFIQQRS-------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL----DDDFNAYLSDFGLA 830 (963)
Q Consensus 762 ~gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla 830 (963)
+ ++.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 8988876422 23588999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCC--cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 046851 831 RLLGPSET--HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSF 888 (963)
Q Consensus 831 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~ 888 (963)
+....... .......||+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643221 122345789999999999874 58889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.80 Aligned_cols=239 Identities=26% Similarity=0.309 Sum_probs=190.5
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHH-HHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIK-TLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999664 68999999987542 223345555655 46778999999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|..++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 9999998753 4589999999999999999999999 9999999999999999999999999998753222 12233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... .+......... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~~~-~----------~~ 215 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILHKP-L----------VL 215 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHcCC-c----------cC
Confidence 45799999999999999999999999999999999999999974321 11111111111 0 01
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQV 951 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 951 (963)
+......+.+++.+|++.+|.+||++++.
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 12344577899999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.47 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=201.9
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|||++++++++......++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3677889999999999999765 478889998876655566788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|..++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++....... ...
T Consensus 86 ~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 86 GGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 99999988653 34689999999999999999999999 99999999999999999999999999987653222 222
Q ss_pred ccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 842 TGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
....+++.|+|||++. +..++.++||||+||++|||++|+.||..... .+......... ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~-~~~---- 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSE-PPT---- 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcC-CCC----
Confidence 3356889999999984 44577899999999999999999999863211 11111111111 000
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 ---LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122345678999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.17 Aligned_cols=260 Identities=23% Similarity=0.397 Sum_probs=205.7
Q ss_pred ChHHHHHHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeee--
Q 046851 673 SFESVVQATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHA-- 748 (963)
Q Consensus 673 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 748 (963)
++.+...+.+.|++.+.||+|+||.||+|.. .+++.||+|++..... ...++..|+.++.++ +|+|++++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4556666778999999999999999999976 4688999998865432 345678899999998 6999999999984
Q ss_pred ----CCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 749 ----SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 749 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
.....+++|||+++|+|.+++.......+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 346789999999999999999876666688999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhh
Q 046851 825 SDFGLARLLGPSETHATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~ 899 (963)
+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||....+. ..
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~~ 234 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RA 234 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------hh
Confidence 99999876532221 223356889999999876 346788999999999999999999999643221 00
Q ss_pred HHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+.. .........+..+.+++.+||+.||.+||++.|++++
T Consensus 235 -~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 235 -LFLIPRNP---------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -hhhHhhCC---------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00000000 0011122345679999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=317.48 Aligned_cols=255 Identities=20% Similarity=0.273 Sum_probs=199.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||++... +++.||+|++.... ......+..|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 37889999999999999999765 47889999986432 222345788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++.+.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999998643 3589999999999999999999999 99999999999999999999999999987654333
Q ss_pred CcccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 838 THATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
........||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKERFQ 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCcccc
Confidence 33333457999999999986 3457889999999999999999999997432 1222222221110000
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLST--RPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 954 (963)
........+..+.+++.+|+..++++ |+++.|++++
T Consensus 229 ------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01111234567888888888654444 7899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.95 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=206.0
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|++.+.||+|+||.||++... +|+.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888999999999999999654 68999999986542 23446789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.......+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999999875555688999999999999999999999 999999999999999999999999999976543222
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......|++.|+|||+..+..++.++||||||+++|+|++|+.||..... .+......... .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~-~--------- 218 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGS-Y--------- 218 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCC-C---------
Confidence 12234578899999999988899999999999999999999999863311 11222221111 1
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+.....++.+++.+||+.+|++||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11233445678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.22 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=202.1
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+..|++.+++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667788999999999999654 57899999886443 334567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.. ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||++........ .
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 99999999864 3588999999999999999999999 999999999999999999999999999976543221 2
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
.....|+..|+|||++.+..++.++||||||+++|||++|+.|+....+. .... ..... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~-~~~~~---------~~~ 219 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLF-LIPKN---------SPP 219 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHh-hhhcC---------CCC
Confidence 22345788999999999988999999999999999999999998643221 0000 11111 111
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1223445678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.93 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=205.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCc----EEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGV----LVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|++.+.||+|+||.||+|.+. +|. .||+|....... ....++.+|+..+++++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46888999999999999999764 233 589998865543 345678899999999999999999999887 78899
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999998653 3489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
..... .....++..|+|||.+....++.++||||||+++||+++ |+.||..... .++.. ....+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~-~~~~~~---- 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPD-LLEKGE---- 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHH-HHhCCC----
Confidence 32221 122234568999999988889999999999999999998 9999864321 11111 111111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
....+..+...+.+++.+||..+|.+||++.++++.|+++.
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 229 -----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11122334457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.59 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=203.7
Q ss_pred ChHHHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeee--
Q 046851 673 SFESVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHA-- 748 (963)
Q Consensus 673 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 748 (963)
.++++..++++|++.+.||+|+||.||+|... +++.||+|++..... ....+..|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34555667889999999999999999999664 588999998764322 235678899999999 6999999999873
Q ss_pred ---CCCeEEEEEeccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEE
Q 046851 749 ---SETEMFLIYNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAY 823 (963)
Q Consensus 749 ---~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 823 (963)
.++..++||||+++++|.+++... ....+++..+..++.|+++|+.|||+. +++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 456789999999999999988642 234588999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccccccccCcccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchh
Q 046851 824 LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT-----CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIV 898 (963)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~ 898 (963)
|+|||++....... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||...... .
T Consensus 165 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------~ 236 (286)
T cd06638 165 LVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------R 236 (286)
T ss_pred EccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-------H
Confidence 99999987654322 22233468999999998753 45788999999999999999999998743221 0
Q ss_pred hHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 899 AWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
... . ......... ..+......+.+++.+||+.+|++||++.|++++.
T Consensus 237 ~~~-~-~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ALF-K-IPRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHh-h-ccccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 0 001100011 11222345788999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.82 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=198.7
Q ss_pred cccccCCCccEEEEEECC-------CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 688 NCIGNGGFGATYKAEISP-------GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+.||+|+||.||+|...+ +..||||.+.... .....++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999997642 3579999876543 23456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-----cEEEeeccc
Q 046851 760 LPGGNLENFIQQRS-----TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-----NAYLSDFGL 829 (963)
Q Consensus 760 ~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgl 829 (963)
+++++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 23478899999999999999999999 999999999999999887 899999999
Q ss_pred ccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 830 ARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 830 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
+......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~~-~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQHV-TA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHHH-hc
Confidence 9765433221 1122345678999999999999999999999999999998 8988863211 1111111 11
Q ss_pred CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 908 GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
+ .....+...+..+.+++.+||..+|++||++.++.+.|++
T Consensus 229 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 G---------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C---------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111233456788999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=319.25 Aligned_cols=196 Identities=27% Similarity=0.432 Sum_probs=171.4
Q ss_pred CCCCccccccCCCccEEEE-EECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-C-----CCeeEEEEeeeCCCeEEE
Q 046851 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-H-----PNLVTLIGYHASETEMFL 755 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 755 (963)
+|.+.+.||+|.||.|.+| +..+++.||||+++.... -..+-..|+.++..++ | -|+|++++||...++.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999 556799999999975533 2355678999999986 4 379999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC--cEEEeeccccccc
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF--NAYLSDFGLARLL 833 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgla~~~ 833 (963)
|+|.+.. +|+++++......++...++.|+.||+.||..||+. +|||+||||+|||+.+-+ .+||+|||.|+..
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999955 999999999888899999999999999999999999 999999999999997544 6999999999875
Q ss_pred CCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPS 887 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 887 (963)
...-. ...-+..|+|||++.|.+|+.+.||||||||++||++|.+-|..+
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 43222 345577999999999999999999999999999999997666544
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=321.69 Aligned_cols=265 Identities=20% Similarity=0.288 Sum_probs=197.8
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC------
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE------ 750 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 750 (963)
..++|++.+.||+|+||.||+|... +|..||||++... ......++.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3468999999999999999999664 5899999998643 223456778999999999999999999988643
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 357999999976 67776643 378899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCC----------CCcchh--
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYG----------NGFNIV-- 898 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~----------~~~~~~-- 898 (963)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ......
T Consensus 171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 764322 222345689999999999999999999999999999999999999974421100 000000
Q ss_pred --hHHHHHHhcC-cc-----cceeccccC---CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 899 --AWGCMLLRQG-RA-----KEFFTAGLW---DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 899 --~~~~~~~~~~-~~-----~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.......... .. .+.+..... ..........+.+++.+|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 00 000000000 00111224568899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=307.14 Aligned_cols=253 Identities=23% Similarity=0.425 Sum_probs=202.8
Q ss_pred CCCCccccccCCCccEEEEEECC--CcEEEEEEeeccc----------chhHHHHHHHHHHHhc-cCCCCeeEEEEeeeC
Q 046851 683 NFNASNCIGNGGFGATYKAEISP--GVLVAIKRLAVGR----------FQGVQQFHAEIKTLGR-LRHPNLVTLIGYHAS 749 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 749 (963)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++|||++++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998764 7889999885432 2234557788888765 789999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEee
Q 046851 750 ETEMFLIYNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSD 826 (963)
Q Consensus 750 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~D 826 (963)
.+..++||||+++++|.+++... ....+++..++.++.|++.|+.|||+ . +++||||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999998542 24568899999999999999999996 5 899999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 827 FGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 827 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
||.+....... ......|+..|+|||...+..++.++||||||+++|||++|+.||..... ....... .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~-~ 226 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSLATKI-V 226 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHHHHHH-h
Confidence 99998754432 33445688999999999988899999999999999999999999863311 1111111 1
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
..... ..........+.+++.+||+.||++||++.||.+++++
T Consensus 227 ~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 227 EAVYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred hccCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11111 11111334678899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.91 Aligned_cols=237 Identities=28% Similarity=0.349 Sum_probs=189.7
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHH-HHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIK-TLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
++||+|+||.||+|... +|+.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 688999999875432 22334555554 57889999999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|..++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 9999988753 4588899999999999999999999 99999999999999999999999999987532222 2233
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......... .. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~-~~----------~~~ 215 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILH-KP----------LQL 215 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhc-CC----------CCC
Confidence 4578999999999999899999999999999999999999997432 1111111111 10 112
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMK 949 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ 949 (963)
+......+.+++.+|++.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 233456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=315.35 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=195.5
Q ss_pred CccccccC--CCccEEEEEE-CCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 686 ASNCIGNG--GFGATYKAEI-SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 686 ~~~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+.++||+| +|++||++.. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6789999965 4689999999875432 23456778999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC-c
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET-H 839 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~ 839 (963)
++|+|.+++.......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+........ .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999765555689999999999999999999999 999999999999999999999999986544321111 0
Q ss_pred -----ccccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 840 -----ATTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 840 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... .+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~-~~~~~~ 229 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--------MLLEKL-NGTVPC 229 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--------HHHHHh-cCCccc
Confidence 1112346778999999976 458899999999999999999999997432110 000000 000000
Q ss_pred ee-------------------ccc-----------------cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 FF-------------------TAG-----------------LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 ~~-------------------~~~-----------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.. +.. ............+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 000 0001112234578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.16 Aligned_cols=239 Identities=22% Similarity=0.296 Sum_probs=188.8
Q ss_pred ccccCCCccEEEEEECC-------------------------CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEE
Q 046851 689 CIGNGGFGATYKAEISP-------------------------GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTL 743 (963)
Q Consensus 689 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 743 (963)
.||+|+||.||+|.+.. ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999996421 24589998876555555678899999999999999999
Q ss_pred EEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC---
Q 046851 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF--- 820 (963)
Q Consensus 744 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--- 820 (963)
++++......++||||+++|+|..++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998753 34588999999999999999999999 999999999999997644
Q ss_pred ----cEEEeecccccccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHH-cCCCCCCCCCCCCCCC
Q 046851 821 ----NAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELL-SDKKALDPSFSSYGNG 894 (963)
Q Consensus 821 ----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell-tg~~p~~~~~~~~~~~ 894 (963)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---- 228 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS---- 228 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH----
Confidence 3899999988654221 12356788999998875 56889999999999999994 788888643221
Q ss_pred cchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
....+ .... . ..+......+.+++.+||+.+|++||++.++++.|+
T Consensus 229 -~~~~~----~~~~---------~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 -EKERF----YEKK---------H--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHH----HHhc---------c--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 01111 1110 0 011112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.37 Aligned_cols=251 Identities=22% Similarity=0.398 Sum_probs=203.6
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeec--ccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAV--GRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 758 (963)
..|++.++||+||.+.||++...+.+.||+|++.. ...+..+-|..|+..+.+++ |.+||++++|-..++..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 46999999999999999999988888899987753 34456788999999999996 9999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|=+. +|.+++.++......| .++.+..|++.|+.++|.+ ||||.||||.|+|+-. |.+||+|||.|.....+..
T Consensus 441 ~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 9754 9999999876655556 7788999999999999999 9999999999999875 5999999999988776543
Q ss_pred c-ccccccccccccCccccccC-----------CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 839 H-ATTGVAGTFGYVAPEYAMTC-----------RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 839 ~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
. .....+||+.||+||.+... +.++++||||+|||||+|+.|++||.... + .|.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n--~~a----- 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------N--QIA----- 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------H--HHH-----
Confidence 3 34456899999999998643 25678999999999999999999997221 1 111
Q ss_pred cCcccceeccccCCCCCh-hHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 QGRAKEFFTAGLWDAGPH-DDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+.|+...-+++. ....++.+++..||+.||++||+..|++++
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1233334433222222 122238999999999999999999999875
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=317.45 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=199.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999765 57889999986532 223455788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++.... ..+++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999998643 3588999999999999999999999 99999999999999999999999999998765443
Q ss_pred CcccccccccccccCcccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 838 THATTGVAGTFGYVAPEYAMT-----CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
........|++.|+|||++.+ ..++.++||||+|+++|||++|+.||..... .+.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHEERFQ 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcCCCccc
Confidence 333334579999999999875 4578899999999999999999999974321 111111111110000
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLST--RPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 954 (963)
+ .......+.++.+++.+|+..++++ |++++++.++
T Consensus 229 -~-----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 -F-----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -C-----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0111234567888999998866544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.74 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=199.5
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|++.+.||+|++|.||+|... ++..||||++..... .....+.+|+.++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999765 689999998865432 2346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
++ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 58999987643 35689999999999999999999999 99999999999999999999999999997654332
Q ss_pred cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH-------h----
Q 046851 839 HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL-------R---- 906 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~---- 906 (963)
.......+++.|+|||++.+. .++.++||||+|+++|||++|+.||...... ........... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhcchh
Confidence 122233578899999988754 4788999999999999999999999744221 00000000000 0
Q ss_pred ----cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 ----QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.......... ...........++.+++.+|++.||++|||+.+|+++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKG-SLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcc-hhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 0000111245577899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.40 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=203.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+.|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 57999999999999999999775 48899999998776666778899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
+++++..++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++...... ...
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence 9999998886543 4589999999999999999999999 9999999999999999999999999998754322 122
Q ss_pred cccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 841 TTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.....+++.|+|||++. ...++.++|||||||++|||++|+.||..... ........ .......
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~-~~~~~~~-- 235 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIA-KSEPPTL-- 235 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHh-cCCCccC--
Confidence 23346788999999985 34567899999999999999999999864321 11111111 1111100
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+.....++.+++.+||+.+|++||++.+++++
T Consensus 236 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 -----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1122344578899999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=314.10 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=202.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCc----EEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGV----LVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|+..+.||+|+||.||+|.+. +|. .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46888899999999999999753 444 578888765433 2334688999999999999999999998754 4678
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
++||+++|+|.+++.... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999997643 3578999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .... ....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----~~~~----~~~~~~~--- 229 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----EIPD----LLEKGER--- 229 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH----HHHCCCC---
Confidence 3221 1223345678999999999899999999999999999997 88888633111 1111 1111110
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
...+..+...+.+++.+||..+|++||+++++++.|+++..
T Consensus 230 ------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 230 ------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11122344578899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.31 Aligned_cols=240 Identities=23% Similarity=0.319 Sum_probs=191.3
Q ss_pred cccccCCCccEEEEEECC--------CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 688 NCIGNGGFGATYKAEISP--------GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999996542 234888887655545557789999999999999999999999998899999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc--------EEEeeccccc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN--------AYLSDFGLAR 831 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfgla~ 831 (963)
+++|+|.++++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++. ++++|||.+.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999998653 3589999999999999999999999 9999999999999987765 6999999886
Q ss_pred ccCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCC-CCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDK-KALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
.... .....+++.|+|||++.+. .++.++||||||+++|||++|. .|+..... ..... ... .
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~~-~~~-~- 220 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQ-FYE-D- 220 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHHH-HHH-c-
Confidence 5432 1224578899999999874 5788999999999999999995 44432111 11110 000 0
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122334467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=310.98 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=206.0
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.++|++.+.||+|+||.||+|... ++..||+|++........+.+..|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457999999999999999999764 6899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.... ..+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999987643 4589999999999999999999999 999999999999999999999999999876543222
Q ss_pred ccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 840 ATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
......+++.|+|||.+. +..++.++||||+|+++|||++|+.||...... ...... .......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~-~~~~~~~-- 227 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKI-LKSEPPT-- 227 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHH-hcCCCCC--
Confidence 223356889999999975 345677899999999999999999998743211 111111 1111110
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+||+.+|++||++.+++++
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 -----LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01122345578899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=325.97 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=197.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|+..+.||+|+||.||+|... +++.||+|++.... ......+..|+.++.+++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999765 68999999987532 233467788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999764 4589999999999999999999999 99999999999999999999999999987543211
Q ss_pred C----------------------------------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCC
Q 046851 838 T----------------------------------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKA 883 (963)
Q Consensus 838 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 883 (963)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 011235799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 046851 884 LDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT---MKQVVRR 954 (963)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 954 (963)
|...... ............. .+. .......++.+++.+|+ .+|++|++ +.|+.++
T Consensus 236 f~~~~~~--------~~~~~i~~~~~~~-~~p------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETPQ--------ETYRKVMNWKETL-VFP------PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCHH--------HHHHHHHcCCCce-ecC------CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9743221 1111111100000 000 01123456777777766 49999995 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=305.74 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=207.4
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.++|++.+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++|||++++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357899999999999999999764 5788999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+....... .
T Consensus 82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 9999999998764 24589999999999999999999999 99999999999999999999999999987654322 1
Q ss_pred ccccccccccccCccccccC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 840 ATTGVAGTFGYVAPEYAMTC---RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
......++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... .-... ....... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--------~~~~~-~~~~~~~---~~ 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--------RALFL-ISKSNFP---PP 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HHhccCC---Cc
Confidence 22335688899999999876 7889999999999999999999998743211 00111 1111000 00
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+...+.++.+++.+||+.+|.+||++.+|+.+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 --KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011223345678999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.37 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=204.4
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|+..+.||+|++|.||+|.. .+++.||||++.... ....+.+..|++++++++|||++++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999965 468899999986543 23456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~ 838 (963)
+++++|.+++.......+++..+..++.++++|++|||++ +++||||+|+||++++++ .++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999876666689999999999999999999999 999999999999998654 58999999998764332
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...........
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~---------- 217 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGT---------- 217 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcC----------
Confidence 22234688899999999988889999999999999999999999864321 11111111111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+...+..+.+++.+||+.+|++|||+.|++++
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011122345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=323.48 Aligned_cols=261 Identities=21% Similarity=0.250 Sum_probs=199.8
Q ss_pred cCCCCCccccccCCCccEEEEEEC---CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS---PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
..+|.+.+.||+|+||.||+|... .+..||||.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999653 3578999987643 23468999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
|++. ++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++......
T Consensus 166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 589999854 35689999999999999999999999 99999999999999999999999999997665432
Q ss_pred C-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc--cc--
Q 046851 838 T-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA--KE-- 912 (963)
Q Consensus 838 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-- 912 (963)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+....+ ....... ..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~-~~~~~~~~~~~~~ 317 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIR-CMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHH-HhccCccccCCcc
Confidence 2 22335679999999999999999999999999999999999999997543321 0001111000 0000000 00
Q ss_pred ---------eeccccCCCC-------ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 ---------FFTAGLWDAG-------PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 ---------~~~~~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......+... ......++.+++.+|+..||++||++.|++.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 01224567889999999999999999999875
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=305.86 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=197.2
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc-----chhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR-----FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 753 (963)
.+|+..+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3788999999999999999965 468999999886432 1234568899999999999999999998865 4678
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++++||+++++|.+++... ..+++.....++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 8999999999999999764 3488999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCC--CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 834 GPSE--THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 834 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
.... ........++..|+|||++.+..++.++||||+|+++|||++|+.||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~~--- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQP--- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcCC---
Confidence 3221 11122345888999999999988999999999999999999999998743111 1111111111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+......+..++ .||..+|++||+++||+++
T Consensus 226 ------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 ------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 01112333445566666 6888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=314.18 Aligned_cols=262 Identities=22% Similarity=0.327 Sum_probs=199.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46899999999999999999765 678899999875432 2234678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++ ++.+++.... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 976 8988887643 4578999999999999999999999 999999999999999999999999999976533222
Q ss_pred ccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC---------c
Q 046851 840 ATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG---------R 909 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 909 (963)
......+++.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ............. .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhhcc
Confidence 2223467899999999865 45788999999999999999999999644221 0000000000000 0
Q ss_pred ccceeccccCC-------CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEFFTAGLWD-------AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+..... ........++.+++.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000 0011234567899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=309.83 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=206.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||+||+|... +|..||+|++.... ....+++.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888999999999999999765 58899999886543 33457789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
+++++|.+++... ..+++..+..++.+++.|+.|||+ + +++||||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 9999999998763 458999999999999999999997 5 8999999999999999999999999998654221
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC---CcchhhHHHHHHhcCcccceec
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN---GFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ......+.........
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 230 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------ 230 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------
Confidence 122356899999999998888999999999999999999999999854432111 1111222222221110
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
........+..+.+++.+|++.||++||++.|++++.
T Consensus 231 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0001112456789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=315.31 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=204.5
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch---hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+|+..+.||+|++|.||+|... +++.||+|.+...... ..+.+..|+++++.++|+||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888999999999999999765 4899999999765332 45678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+.+++|.+++.......+++..+..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999876566789999999999999999999999 999999999999999999999999999876532211
Q ss_pred c----------------------------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 046851 839 H----------------------------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS 890 (963)
Q Consensus 839 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~ 890 (963)
. ......|+..|+|||+..+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 1 112346788999999999988999999999999999999999998643221
Q ss_pred CCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCC----HHHHHHH
Q 046851 891 YGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT----MKQVVRR 954 (963)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~~ 954 (963)
..+. .... ...........+..+.+++.+|++.+|++||+ ++|++++
T Consensus 239 -------~~~~-~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 -------ETFS-NILK---------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred -------HHHH-HHhc---------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1111 1111 11111111125678999999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.59 Aligned_cols=253 Identities=30% Similarity=0.511 Sum_probs=201.8
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHH--HHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQ--QFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
|++.+.||+|+||+||+|... +++.||+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999776 4678999999876544332 3456999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++... ..+++.++..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 999999999843 4589999999999999999999999 99999999999999999999999999997642 22233
Q ss_pred cccccccccccCccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAM-TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....++..|+|||++. +..++.++||||+|+++|+|++|+.||..... .............. . ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-----~~~~~~~~~~~~~~-~----~~~~- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-----DDQLEIIEKILKRP-L----PSSS- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-----HHHHHHHHHHHHTH-H----HHHT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-----hhhhhhhhhccccc-c----cccc-
Confidence 44567899999999998 88899999999999999999999999984410 01111111111100 0 0000
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+.+++.+||+.||++||++.+++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011123789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=320.30 Aligned_cols=265 Identities=21% Similarity=0.272 Sum_probs=198.5
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC------
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE------ 750 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 750 (963)
..++|++.+.||+|+||.||+|... .++.||||++.... .....++.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999654 68899999986532 23346778899999999999999999987543
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
...++||||+++ ++.+++.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999976 77777753 378899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCC----------CCcc----
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYG----------NGFN---- 896 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~----------~~~~---- 896 (963)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 865432 222345789999999999999999999999999999999999999974321100 0000
Q ss_pred hhhHHHHHHhcC-cc-----cceeccccC---CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 897 IVAWGCMLLRQG-RA-----KEFFTAGLW---DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 897 ~~~~~~~~~~~~-~~-----~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
............ .. ......... ...+......+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 00 000000000 00111234578899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.02 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=203.3
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-----chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-----FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
+|+..+.||+|++|.||+|... ++..||+|.+.... .+..+.+..|++++++++|+|++++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999776 78999999886543 22456789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999764 3588999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCcccccccccccccCccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCR-VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
. ......|+..|+|||.+.... ++.++|+||+|+++|+|++|+.||..... .............
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~----- 220 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKEL----- 220 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhcccC-----
Confidence 2 233456889999999988766 88999999999999999999999874321 1111111111111
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+......+.+++.+||+.+|++||++.+++++
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11223345678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.71 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=206.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||.|+||+||+|... ++..||+|++.... ....+.+.+|++.++.++|+|++++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36899999999999999999754 68899999986543 23557889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRST-RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976432 5689999999999999999999999 999999999999999999999999999977654332
Q ss_pred c---ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 839 H---ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 839 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
. ......|+..|+|||++... .++.++||||||+++|||++|+.||...... . ......... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~----~~~~~~~~~-~~--- 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----K----VLMLTLQND-PP--- 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----h----hHHHHhcCC-CC---
Confidence 2 22344688999999998876 7889999999999999999999999744221 0 111111111 00
Q ss_pred ccccCCC-CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDA-GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... .....+..+.+++.+|++.||++||++++++++
T Consensus 226 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 --SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01000 012345678899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=337.54 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=199.1
Q ss_pred HHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeE
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEM 753 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 753 (963)
...++|++.+.||+|+||+||+|... ++..||+|++.... ......+..|+.++.+++||||++++++|.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44568999999999999999999765 57789999886542 2345678999999999999999999998754 4578
Q ss_pred EEEEeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCceecccCCCCeEECCC--------
Q 046851 754 FLIYNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCV----PRVLHRDVKPSNILLDDD-------- 819 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~dlk~~Nill~~~-------- 819 (963)
|+||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+... .+|+||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997632 3468999999999999999999998521 259999999999999642
Q ss_pred ---------CcEEEeecccccccCCCCCcccccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 046851 820 ---------FNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKALDPSF 888 (963)
Q Consensus 820 ---------~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~ 888 (963)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998654322 2234578999999999864 457889999999999999999999996331
Q ss_pred CCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 889 SSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
.....+.. ..... . . .....+.++.+|+..||+.+|++||++.|+++
T Consensus 248 -------~~~qli~~-lk~~p--~-----l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 -------NFSQLISE-LKRGP--D-----L---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred -------cHHHHHHH-HhcCC--C-----C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11222211 11110 0 0 01123467889999999999999999999984
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.81 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=189.5
Q ss_pred ccccccCCCccEEEEEEC---CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeee--CCCeEEEEEeccC
Q 046851 687 SNCIGNGGFGATYKAEIS---PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA--SETEMFLIYNYLP 761 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~ 761 (963)
..+||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++. .....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999765 357899998865432 245788999999999999999999884 3567899999996
Q ss_pred CCChHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE----CCCCcEEEeecccc
Q 046851 762 GGNLENFIQQRS-------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL----DDDFNAYLSDFGLA 830 (963)
Q Consensus 762 ~gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla 830 (963)
+ ++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 8888875321 23478899999999999999999999 99999999999999 56678999999999
Q ss_pred cccCCCCC--cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcch-hhHHHHHHh
Q 046851 831 RLLGPSET--HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNI-VAWGCMLLR 906 (963)
Q Consensus 831 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~ 906 (963)
+....... .......||+.|+|||++.+. .++.++||||+||++|||+||++||.....+....... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 87653322 122345689999999998764 57899999999999999999999997543321111100 000000000
Q ss_pred c---------------Ccccceecc---------cc---CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 Q---------------GRAKEFFTA---------GL---WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~---------------~~~~~~~~~---------~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ......... .. ...........+.+++.+|++.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 000000000 00 000011123467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=305.59 Aligned_cols=255 Identities=22% Similarity=0.411 Sum_probs=199.4
Q ss_pred CCCccccccCCCccEEEEEEC----CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC------
Q 046851 684 FNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET------ 751 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 751 (963)
|++.+.||+|+||.||+|.+. ++..||||++.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999653 36889999886542 234567889999999999999999999875432
Q ss_pred eEEEEEeccCCCChHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeec
Q 046851 752 EMFLIYNYLPGGNLENFIQQRS----TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 827 (963)
..++++||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999999875322 22478899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 828 GLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 828 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
|.++........ ......+++.|++||...+..++.++||||||+++|||++ |+.||..... .....+ ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~~~~---~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEIYNY---LI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHHHHH---HH
Confidence 999876433221 1122345678999999998889999999999999999999 7788763311 111111 11
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.... ...+...+..+.+++.+|++.+|++||++.++++.|+++.
T Consensus 230 -~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 230 -KGNR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred -cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 1110 0112234568999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.21 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=190.1
Q ss_pred cccccCCCccEEEEEECC---CcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 688 NCIGNGGFGATYKAEISP---GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
+.||+|+||.||+|...+ ...+|+|.+..... .....+.+|++.++.++|+||+++++++......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999996543 35788887754432 33456889999999999999999999999999999999999999
Q ss_pred ChHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc-
Q 046851 764 NLENFIQQRST---RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH- 839 (963)
Q Consensus 764 sL~~~l~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 839 (963)
+|.+++..... ...++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 2346788899999999999999999 9999999999999999999999999998754322211
Q ss_pred ccccccccccccCcccccc-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 840 ATTGVAGTFGYVAPEYAMT-------CRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
......+++.|+|||+... ..++.++||||+|+++|||++ |..||...... +.......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~-~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQD-I 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhccC-c
Confidence 1223345678999998753 356789999999999999999 67777533111 11111111111 1
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
...++ ..+...+..+.+++..|+ .||++||+++||++.|.
T Consensus 229 ~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 112234566778888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=318.17 Aligned_cols=265 Identities=21% Similarity=0.273 Sum_probs=198.0
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC------
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE------ 750 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 750 (963)
..++|++.+.||+|+||.||+|... .++.||||++.... ....+++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999654 58899999986532 23446778999999999999999999987543
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
...++||||+++ ++.+++.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999975 78887753 378899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC-------CcchhhH---
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN-------GFNIVAW--- 900 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~-------~~~~~~~--- 900 (963)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......... +....++
T Consensus 174 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 865432 2223456899999999999999999999999999999999999999743211000 0000000
Q ss_pred ----HHHHHhcCc-cc-----ceeccccC---CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 901 ----GCMLLRQGR-AK-----EFFTAGLW---DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 901 ----~~~~~~~~~-~~-----~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......... .. ........ ..........+.+++.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00 00000000 00111124578899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.44 Aligned_cols=238 Identities=26% Similarity=0.356 Sum_probs=190.2
Q ss_pred cccccCCCccEEEEEECCCc-----------EEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 688 NCIGNGGFGATYKAEISPGV-----------LVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999776432 5788877654433 5788999999999999999999999887 778999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-------cEEEeeccc
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-------NAYLSDFGL 829 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfgl 829 (963)
|||+++|+|.+++..... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++ .++|+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999987542 689999999999999999999999 999999999999999887 799999999
Q ss_pred ccccCCCCCcccccccccccccCccccccC--CCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMTC--RVSDKADVYSYGVVLLELLSD-KKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
+..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+...... .+......
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~~~~~~~~ 221 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------EKERFYQD 221 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------hHHHHHhc
Confidence 986543 2223467789999999876 788999999999999999995 6666533211 11111110
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
.. ..+......+.+++.+||..+|++||++.++++.|+
T Consensus 222 ~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 001111268889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=317.26 Aligned_cols=193 Identities=26% Similarity=0.365 Sum_probs=166.5
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999765 5778999975432 23568999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+. ++|.+++... ...+++.++..|+.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 138 HYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred ccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 995 5999998764 34689999999999999999999999 9999999999999999999999999999753222
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~ 885 (963)
.......||+.|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 22234568999999999999999999999999999999999766654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.37 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=198.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-----chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-----FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 753 (963)
.+|++.+.||+|+||.||+|... +|..||||++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999764 58999999885322 12346788999999999999999999988663 567
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++++|.+++... ..+++..+.+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999999764 3478899999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCC--cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 834 GPSET--HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 834 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
..... .......|+..|+|||++.+..++.++||||||+++|||++|+.||...... .. ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~-~~~~~~~~--- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AA-IFKIATQP--- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HH-HHHHhcCC---
Confidence 42211 1223346888999999999888999999999999999999999998632111 11 11111111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+......+.+++.+|+. +|++||+++|++++
T Consensus 226 ------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 ------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1112234455678889999985 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=310.48 Aligned_cols=262 Identities=20% Similarity=0.317 Sum_probs=200.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++.+++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46889999999999999999765 588999999865432 2335678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
++ ++|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 49999987643 4588999999999999999999999 999999999999999999999999999976533221
Q ss_pred ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh------------
Q 046851 840 ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR------------ 906 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 906 (963)
......+++.|+|||++.+. .++.++||||+|+++|||++|+.||...... .....+.....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-----EQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCChhhchhhhc
Confidence 22234578899999998754 5788999999999999999999999743211 01111111000
Q ss_pred cCcccceeccccCC----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 QGRAKEFFTAGLWD----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.......-.+.... .........+.+++.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000000000 0112235578899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.43 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=205.3
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.|.....||+|+||.||++... ++..||||++........+.+.+|+..++.++|+|++++++++..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 4445577999999999999764 688999999876655556778999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.. ..+++.++..++.|++.|++|||++ +++||||||+||+++.++.++|+|||++........ ..
T Consensus 103 ~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 103 GGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 9999998864 3488999999999999999999999 999999999999999999999999999876543222 22
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
....|+..|+|||...+..++.++||||||+++|||++|+.||...... ..... .... +.....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~-~~~~-----~~~~~~-- 239 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAMRR-IRDN-----LPPRVK-- 239 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HHhc-----CCCccc--
Confidence 3356889999999999888999999999999999999999998633211 11111 1110 111111
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhccCCCCC
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQLQPASC 963 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l~~~~~ 963 (963)
........+.+++.+|+..||.+|||++|++++ ++...+.+|
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 111234568899999999999999999999976 444444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=312.78 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=208.1
Q ss_pred CCCCccccccCCCccEEEEEECC-CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 683 NFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
-|.++..+|.|+||.||+|..++ +...|.|++.....+..++|.-||+++...+||+||++++.|.-++..|+..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 46677789999999999997663 55567788888888889999999999999999999999999988999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
||.+...+-.- ++.+++.++..+++|++.||.|||++ .|||||+|+.|||++-+|.++++|||.+.... ......
T Consensus 113 GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKR 187 (1187)
T ss_pred CchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHhhh
Confidence 99999988765 46799999999999999999999999 99999999999999999999999999986542 223345
Q ss_pred ccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 842 TGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
..+.|||.|||||+.. ..+|..++||||||+.|.||..+.+|-..-.+ .. +-..+...+.+.++.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MR-VllKiaKSePPTLlq- 257 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MR-VLLKIAKSEPPTLLQ- 257 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HH-HHHHHhhcCCCcccC-
Confidence 6689999999999875 56899999999999999999999988652211 11 112222333333333
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
|..-...+.+++.+|+..+|+.||++++++++
T Consensus 258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 33445678899999999999999999999875
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.77 Aligned_cols=246 Identities=24% Similarity=0.405 Sum_probs=197.0
Q ss_pred CCccccccCCCccEEEEEE-CCCcEEEEEEeec----ccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC--eEEEEE
Q 046851 685 NASNCIGNGGFGATYKAEI-SPGVLVAIKRLAV----GRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET--EMFLIY 757 (963)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 757 (963)
+...+||+|+|-+||||-. .+|..||.-.++. ..+...++|..|+.+++.++||||++++.++.+.. ...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4567899999999999944 4577787654432 23345689999999999999999999999997754 488999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEeecccccccCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~ 836 (963)
|.+..|+|+.|.++.+ .++...+..|++||++||.|||++ .|+|+|||||-+||+|+. -|.|||+|.|+|......
T Consensus 123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999999864 488899999999999999999999 889999999999999985 589999999999987543
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
. . ..+.|||.|||||+.. ..|.+.+||||||++++||+|+..||...... .+.. ..+-.|.-+..+.
T Consensus 200 ~--a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------AQIY-KKV~SGiKP~sl~- 266 (632)
T KOG0584|consen 200 H--A-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------AQIY-KKVTSGIKPAALS- 266 (632)
T ss_pred c--c-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------HHHH-HHHHcCCCHHHhh-
Confidence 2 2 2378999999999988 68999999999999999999999999755332 2211 1222222211111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.-...++.++|.+|+.. .++|||+.|++++
T Consensus 267 -------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 -------KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -------ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 01123688999999999 9999999999863
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.20 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=203.4
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeEEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEMFLIY 757 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 757 (963)
+|++.+.||.|+||.||+|.. .+|..||+|++.... ....+++..|++++++++|||++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999965 468899999886543 2345678899999999999999999997753 45689999
Q ss_pred eccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 758 NYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLH-----DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
||+++++|.+++.... ...+++..+..++.|++.|++|+| +. +++||||+|+||+++.++.+|++|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999997642 356899999999999999999999 77 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
......... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ..+.. ....+.
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~-~~~~~~- 226 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLAS-KIKEGK- 226 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHH-HHhcCC-
Confidence 876543321 2334689999999999998899999999999999999999999874321 11111 111111
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+...+.++.+++.+|++.+|++||++.+|+++
T Consensus 227 --------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 --------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112333456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.91 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=203.3
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+..|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999764 6899999998765443 567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++... ..+++..+..++.++++|++|||+. +++|+||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999864 3478999999999999999999999 9999999999999999999999999999876543332
Q ss_pred cc---ccccccccccCccccccCC---CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 840 AT---TGVAGTFGYVAPEYAMTCR---VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 840 ~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.. ....+++.|+|||++.+.. ++.++||||||+++||+++|+.||...... ...... ...+....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~-~~~~~~~~- 226 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFH-VGAGHKPP- 226 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHH-HhcCCCCC-
Confidence 21 2356788999999998766 888999999999999999999999743211 111100 01110000
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
..........+.+++.+|++.+|++||++.|++.
T Consensus 227 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 ------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011123567789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.52 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=206.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|+..+.||+|++|.||+|... +++.||+|++..... ...+++.+|++.+++++||||+++++++......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999776 689999999876533 3456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
+++++|.+++.... ..+++..+.+++.|+++|++|+|+ . +++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999998753 568999999999999999999999 8 999999999999999999999999999876532221
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
. ...++..|+|||+..+..++.++||||+|+++|+|++|+.||...... ............... .
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~-------- 221 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEP-P-------- 221 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCC-C--------
Confidence 1 156888999999999989999999999999999999999999754321 111222222222111 0
Q ss_pred CCCCChh-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHD-DLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+.. ....+.+++.+||..+|++|||+.+++++
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 -PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011111 45678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.71 Aligned_cols=254 Identities=24% Similarity=0.425 Sum_probs=200.1
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc----------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF----------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET 751 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (963)
+|...+.||+|+||.||+|.. .+|+.||+|.+..... ...+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999965 4689999998864211 11346788999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
..++||||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999865 4589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCC-cccccccccccccCccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 832 LLGPSET-HATTGVAGTFGYVAPEYAMTCR--VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 832 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
....... .......|+..|+|||.+.... ++.++||||+|+++||+++|..||..... ... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~-~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAA-MFKLGNKR 228 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHH-HHHhhccc
Confidence 6542211 1223456888999999987654 78899999999999999999999863211 111 11111111
Q ss_pred cccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+... .....+..+.+++.+|++.+|++||++++|+++
T Consensus 229 -~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 -SAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -cCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111111 112345688899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.22 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=189.2
Q ss_pred cccccCCCccEEEEEECCC---cEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 688 NCIGNGGFGATYKAEISPG---VLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+..++.++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3599999999999965443 345666665433 234568899999999999999999999999999999999999999
Q ss_pred ChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC-Ccc
Q 046851 764 NLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE-THA 840 (963)
Q Consensus 764 sL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-~~~ 840 (963)
+|.+++.+.. ....++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997643 23456777889999999999999999 99999999999999999999999999986432211 112
Q ss_pred cccccccccccCcccccc-------CCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 841 TTGVAGTFGYVAPEYAMT-------CRVSDKADVYSYGVVLLELLSD-KKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.....++..|+|||+... ..++.++||||||+++|||+++ ..||..... .+......... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~-~~~ 228 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKDQ-QVK 228 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhhc-ccc
Confidence 234567889999998753 2457789999999999999975 556642211 12222222221 122
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
..++... .....++.+++..|| .+|++||++++|++.|.
T Consensus 229 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222222 223456788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=304.11 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=202.7
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|++.+.||+|++|.||+|... +|+.||||++..... .....+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999764 689999999876542 3346789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+ +++|.+++.... ..+++.++..++.|+++|++|||+. +++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999997643 5689999999999999999999999 9999999999999999999999999999876544332
Q ss_pred ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC---------c
Q 046851 840 ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG---------R 909 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 909 (963)
......|+..|+|||++.+. .++.++||||+|+++|||++|.++|...... ............. .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-----EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-----HHHHHHHHHcCCCChHHHhhccC
Confidence 23345688999999998754 4688999999999999999998777533211 1111111100000 0
Q ss_pred c---cce-ecccc---CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 A---KEF-FTAGL---WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~---~~~-~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ... ..... ......+....+.+++.+|++.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000 00000 000011234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.03 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=205.4
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|.. .++..||+|.+........+.+..|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5899999999999999999965 468899999987655555677899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.+. .+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999999753 478999999999999999999999 999999999999999999999999999876644332 2
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
.....+++.|+|||.+.+..++.++||||||+++||+++|+.||....... ........+ ....
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--------~~~~~~~~~--------~~~~ 235 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG--------TPEL 235 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--------heeehhcCC--------CCCC
Confidence 233468889999999988889999999999999999999999997442210 000000000 0001
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+......+.+++.+||..+|++||++.+++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122345578899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=308.24 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=201.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|... +|..||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999776 68999999887542 33356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ +++||||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999999987632 236899999999999999999999632 8999999999999999999999999998765322
Q ss_pred cccccccccccccCccccccCC------CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCR------VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||...... ......... ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~--- 226 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSAI-VDGD--- 226 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHHH-hhcC---
Confidence 122345788999999986543 478999999999999999999999643111 111111111 1111
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+.....++.+++.+|++.+|++||++.+++.+
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 ------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111233456778899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=327.89 Aligned_cols=263 Identities=21% Similarity=0.232 Sum_probs=192.5
Q ss_pred HHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccC------CCCeeEEEEeee
Q 046851 676 SVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR------HPNLVTLIGYHA 748 (963)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~ 748 (963)
++...+++|++.+.||+|+||+||+|... .++.||||+++... .....+..|++++..++ |.+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999664 57889999986432 22234556777666664 456899999887
Q ss_pred CC-CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCC------
Q 046851 749 SE-TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDF------ 820 (963)
Q Consensus 749 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~------ 820 (963)
.. ...++|||++ +++|.+++.+. ..+++.++..|+.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccc
Confidence 64 5788999988 77999998764 458999999999999999999997 6 999999999999998765
Q ss_pred ----------cEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 046851 821 ----------NAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS 890 (963)
Q Consensus 821 ----------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~ 890 (963)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999876432 2233467999999999999999999999999999999999999999743211
Q ss_pred CCCCcchhhHHHHHHh---------------------cCcccceecccc----CCCC---ChhHHHHHHHHHHHcccCCC
Q 046851 891 YGNGFNIVAWGCMLLR---------------------QGRAKEFFTAGL----WDAG---PHDDLVEVLHLAVVCTVDSL 942 (963)
Q Consensus 891 ~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~----~~~~---~~~~~~~l~~l~~~cl~~dP 942 (963)
.....+..... .+......++.. .... .......+.+|+.+||+.||
T Consensus 352 -----~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 352 -----EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred -----HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 10000000000 000000000000 0000 00113457799999999999
Q ss_pred CCCCCHHHHHHH
Q 046851 943 STRPTMKQVVRR 954 (963)
Q Consensus 943 ~~RPs~~evl~~ 954 (963)
++|||++|++++
T Consensus 427 ~~R~ta~e~L~H 438 (467)
T PTZ00284 427 QKRLNARQMTTH 438 (467)
T ss_pred hhCCCHHHHhcC
Confidence 999999999873
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.29 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=200.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|+..+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999776 589999998864432 233567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++++++..+.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888877543 3589999999999999999999999 999999999999999999999999999987644322
Q ss_pred cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH----------HHhc
Q 046851 839 HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM----------LLRQ 907 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~ 907 (963)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... ......... ....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV----DQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCChHHhhhccc
Confidence 2223457889999999876 45788999999999999999999999743221 000000000 0000
Q ss_pred Ccc-cceeccccCCCCC-----hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 GRA-KEFFTAGLWDAGP-----HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ~~~-~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... .....+......+ ...+..+.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 0000000000001 1234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.96 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=204.5
Q ss_pred CChHHHHHHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC
Q 046851 672 LSFESVVQATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS 749 (963)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 749 (963)
++.+++..++++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34456666788999999999999999999976 4688999998865432 235678899999998 79999999999864
Q ss_pred C-----CeEEEEEeccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 750 E-----TEMFLIYNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 750 ~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
. +..++||||+++++|.++++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 4689999999999999998642 234689999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccccccC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcch
Q 046851 823 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC-----RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNI 897 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~ 897 (963)
+|+|||++........ ......|+..|+|||++... .++.++||||+||++|||++|+.||......
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------- 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------- 239 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------
Confidence 9999999886543222 22234688999999997643 3678999999999999999999998643211
Q ss_pred hhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 898 VAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...... ......... .+......+.+++.+|++.+|++||++.|++++
T Consensus 240 -~~~~~~-~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 -KTLFKI-PRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HHHHHH-hcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111 111111111 122334578999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=308.39 Aligned_cols=266 Identities=23% Similarity=0.360 Sum_probs=200.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999875 589999998864332 234568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++++++.++.... ..+++.++..++.|+++|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998877643 3489999999999999999999999 99999999999999999999999999988654332
Q ss_pred cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhh-------HHHHHHhcCcc
Q 046851 839 HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA-------WGCMLLRQGRA 910 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 910 (963)
.......++..|+|||+..+ ..++.++||||||+++|||++|++||...... ........ ...........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233467889999999875 34778999999999999999999888633211 00000000 00000000000
Q ss_pred c-ceeccccCC-----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 K-EFFTAGLWD-----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~-~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ....+.... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 000000000 0011335678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=318.29 Aligned_cols=240 Identities=23% Similarity=0.294 Sum_probs=187.2
Q ss_pred cccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhcc---CCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRL---RHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
||+|+||+||+|... +|+.||||++..... .....+..|..++... .||+|+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999765 589999999865422 2233445566666555 699999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.+++... ..+++..+..++.|+++|++|||++ +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 9999998763 4589999999999999999999999 99999999999999999999999999987543222 2233
Q ss_pred cccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 843 GVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
...||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .+..... ..+... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i-~~~~~~------~--- 216 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNI-AFGKVR------F--- 216 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHH-HcCCCC------C---
Confidence 45799999999998764 478999999999999999999999964321 1111111 111110 0
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPT----MKQVVR 953 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~ 953 (963)
........+.+++.+||+.||++||+ +.++++
T Consensus 217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01123457789999999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.38 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=198.1
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|||++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999765 689999999865432 2235678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++ +|.+++.... ..+++..+..++.|+++|+.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 975 8888887543 4589999999999999999999999 999999999999999999999999999986543222
Q ss_pred ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc------ccc
Q 046851 840 ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR------AKE 912 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 912 (963)
......+++.|+|||++.+. .++.++||||+||++|||++|+.|+...... ............... ...
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH----HHHHHHHHHHhCCCChHHhHHhhh
Confidence 12234578899999998764 4688999999999999999999987543221 000000000000000 000
Q ss_pred eeccccC---------CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 FFTAGLW---------DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~---------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+.... .........++.+++.+|++.||.+|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 01112235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.37 Aligned_cols=253 Identities=24% Similarity=0.427 Sum_probs=203.1
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
+|+..+.||+|++|.||+|.. .+++.||+|++..... ...+++..|++++++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999965 5689999999865331 134678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeecccccccC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGLARLLG 834 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~ 834 (963)
||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .++|+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999763 3588999999999999999999999 999999999999998876 59999999997765
Q ss_pred CCCCc---ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 835 PSETH---ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 835 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
..... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~--- 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIASAT--- 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhccC---
Confidence 33211 122346788999999998888999999999999999999999998633211 1111111111111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+.....++.+++.+|+..+|++||++.+++++
T Consensus 228 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 ------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1112333455688899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=301.94 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=203.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 757 (963)
++|+..+.||.|++|.||+|... +++.||+|.+..... ....++.+|++++++++||||+++++++.+ ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999764 588999998875433 345678999999999999999999998865 34789999
Q ss_pred eccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 758 NYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 758 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||+++++|.+++... ....+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987642 234578899999999999999999999 999999999999999999999999999875532
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.. .....++..|+|||.+.+..++.++||||+|+++|||++|+.||+..............+. .. ...... .
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-~~~~~~-~ 229 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI---VN-MPNPEL-K 229 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH---hc-CCchhh-c
Confidence 21 1234578899999999998999999999999999999999999985533211111222221 11 111111 1
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... .........+.+++.+||+.+|++|||+.|++++
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 0011235678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=302.06 Aligned_cols=248 Identities=23% Similarity=0.409 Sum_probs=200.4
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc-chhHHHHHHHHHHHhccC---CCCeeEEEEeeeCCCeEEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLR---HPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 757 (963)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999976 468999999886542 344567889999999986 999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++... .+++..+..++.|+++|+.|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998653 589999999999999999999999 99999999999999999999999999998765443
Q ss_pred CcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .... ....... +
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~-~~~~~~~-----~ 220 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMM-LIPKSKP-----P 220 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhh-ccccCCC-----C
Confidence 2 2233468899999999875 45688999999999999999999999743221 1110 0000100 0
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... ....+.++.+++.+||+.||++||++.|++++
T Consensus 221 ~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 110 11245678899999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=297.49 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=209.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|++|.||+|... +++.||||++..... ...+.+..|++.+.+++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999776 499999999876644 4457889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
+++++|.+++... ..+++..+..++.|+++|++|+|+ . +++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999864 458999999999999999999999 8 999999999999999999999999999987653332
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+......... .
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~-~-------- 220 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAICDGP-P-------- 220 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHhcCC-C--------
Confidence 2 22346788999999999988999999999999999999999998754321 1122222222111 1
Q ss_pred CCCCChh-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHD-DLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+.. .+..+.+++.+|++.+|++||++.+++++
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111222 56789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.93 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=202.4
Q ss_pred HHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCC------
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASE------ 750 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 750 (963)
.++++|++.+.||+|++|.||+|... +++.||+|++..... ..+++.+|+++++++ .|+||+++++++...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35679999999999999999999775 578999998875543 346789999999999 699999999998654
Q ss_pred CeEEEEEeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
...++||||+++++|.+++.... ...+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 35899999999999999987643 45689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCcccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMT-----CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
.+....... .......|+..|+|||++.. ..++.++||||+|+++|||++|+.||...... .....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~ 229 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RALFK 229 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HHHHH
Confidence 987654322 22233568899999998753 34677899999999999999999999633111 11111
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... ..... ...+.....++.+++.+||..||++|||+.+++++
T Consensus 230 ~~~-~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 IPR-NPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhc-cCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 11110 11122345678899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.89 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=202.3
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
-|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+..+++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 477888999999999999965 468899999876443 233467889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 99999999874 3488999999999999999999999 999999999999999999999999999876543222 2
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
.....++..|+|||.+.+..++.++||||+||++|+|++|..||...... ..... ..... ..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~-~~~~~---------~~ 219 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFL-IPKNN---------PP 219 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHH-HhcCC---------CC
Confidence 23346788999999999888899999999999999999999998632211 11111 11111 11
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+..+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1223345678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=308.26 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=203.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|++|.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999775 58899999886542 2334678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++++.+..+... ...+++.++..++.|+++|++|||+. +++|||++|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9998777665544 24489999999999999999999999 999999999999999999999999999987654443
Q ss_pred cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh-----------
Q 046851 839 HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR----------- 906 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 906 (963)
.......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...... ...........
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-----DQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHHHhhhcc
Confidence 233345678899999999888 7889999999999999999999998643211 00000000000
Q ss_pred -cCc-----ccceeccc-cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 -QGR-----AKEFFTAG-LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 -~~~-----~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... .....+.. .....+...+.++.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 00000000 0001122336789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=313.63 Aligned_cols=258 Identities=22% Similarity=0.359 Sum_probs=195.7
Q ss_pred HHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-----
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASE----- 750 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 750 (963)
...++|++.+.||+|+||.||+|.. .++..||||++..... ...+++.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3456899999999999999999965 4688999999865422 2345678899999999999999999887532
Q ss_pred -CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccc
Q 046851 751 -TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829 (963)
Q Consensus 751 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 829 (963)
...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 4578999998 7799988864 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .............
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~ 235 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-----DQLKRIMEVVGTP 235 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHHhCCC
Confidence 9865432 234568999999999877 56889999999999999999999998643211 0000000000000
Q ss_pred -----------cccceeccccCCCCC--------hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 -----------RAKEFFTAGLWDAGP--------HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 -----------~~~~~~~~~~~~~~~--------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....... .. ...+ ......+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQ-SL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhh-cc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00 0000 0123357899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.25 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=201.6
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.|+....||+|+||.||+|... +++.||+|++........+.+.+|+..++.++|||++++++++..++..++||||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445567999999999999664 689999999876555556778899999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++....... ...
T Consensus 102 ~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 102 GGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 9999998864 3489999999999999999999999 99999999999999999999999999987654322 222
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
....|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ...... ....... ..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~-~~~~~~~-------~~ 238 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRL-RDSPPPK-------LK 238 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH-hccCCCC-------cc
Confidence 3456899999999999888999999999999999999999998733211 111111 1110000 01
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........+.+++.+|++.+|++||++++++++
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 112234568899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.87 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=204.4
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+++++.++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999765 58899999986542 23446788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~ 838 (963)
+++++|.+++.......+++..+..++.|+++|++|||+. +++|+||+|+||++++++ .++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999876555689999999999999999999999 999999999999999886 469999999987653322
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..++....... ..
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~-------- 219 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQG-YF-------- 219 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcc-cC--------
Confidence 2223458899999999998889999999999999999999999986331 22222222111 11
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+|++.+|++|||+.|++++
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122344678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.67 Aligned_cols=245 Identities=25% Similarity=0.400 Sum_probs=202.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999765 589999999865432 33467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999874 4589999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....+++.|+|||.+.+...+.++||||+|+++|+|++|+.||..... ........ .+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~-------- 214 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKIL-EGK-------- 214 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-cCC--------
Confidence 2345688999999999888889999999999999999999999864321 11111111 111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+......+.+++.+||..+|.+|| +++|++++
T Consensus 215 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 --VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 112223356788999999999999999 67776643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.55 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=201.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... .++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999765 578999998875432 23457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++... ..+++..+..++.|++.|++|+|+. +++||||||+||+++.++.++++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999764 3589999999999999999999999 99999999999999999999999999986421110
Q ss_pred --------------CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 838 --------------THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 838 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
........++..|+|||++.+..++.++|+||||+++|||++|+.||..... .++...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~~~ 227 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFGQ 227 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 0011124578899999999988899999999999999999999999863311 112211
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
..... .. .+ ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ~~~~~-~~---~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDD-IE---WP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcc-cC---CC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111 00 00 0111345678999999999999999997666665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=302.86 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=207.1
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+++.|+..+.||+|++|.||+|... ++..||+|++..... ..+.+..|++.+++++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888999999999999999776 688999999976544 45678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999998754 3689999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
......++..|+|||++.+..++.++||||||+++|+|++|+.||...... .......... ...
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~~~------ 235 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITTKG-IPP------ 235 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcC-CCC------
Confidence 223345788999999999888999999999999999999999998633211 1111111111 111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+|++.+|.+||++.+++++
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 -LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01122245678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.36 Aligned_cols=361 Identities=27% Similarity=0.323 Sum_probs=282.5
Q ss_pred CceEEEccCCccc-ccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcc---cccccceee
Q 046851 3 NLEVLDLEGNLLN-GILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTF---IGRLKRVYL 78 (963)
Q Consensus 3 ~l~~L~ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~L~~L~L 78 (963)
=++-.|+++|.++ +..|.....|++++.|-|...++. .+|+.++.+.+|+.|.+++|++. .+... ++.|+.+.+
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3677899999998 678889999999999999999999 89999999999999999999987 44443 457888999
Q ss_pred ccccccc-cCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccc
Q 046851 79 SFNRLVG-SVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLS 157 (963)
Q Consensus 79 ~~n~l~~-~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 157 (963)
..|+++. .||..+| ++..|+.||||+|+++ ..|..+...+++-.|+|++|+|..++...|.+|+.|-.||||+|++.
T Consensus 86 R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 9999964 5999999 5999999999999999 89999999999999999999999877778899999999999999999
Q ss_pred cCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccccc-CCC
Q 046851 158 GSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEG-NFP 236 (963)
Q Consensus 158 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~ 236 (963)
.+|..+..+..|+.|.|++|.+.. .--..+..+++|+.|.+++.+=+- .+|
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~h---------------------------fQLrQLPsmtsL~vLhms~TqRTl~N~P 215 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNH---------------------------FQLRQLPSMTSLSVLHMSNTQRTLDNIP 215 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhH---------------------------HHHhcCccchhhhhhhcccccchhhcCC
Confidence 788889999999999999865442 122334455666666776654332 466
Q ss_pred ccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCC
Q 046851 237 SNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPP 316 (963)
Q Consensus 237 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~ 316 (963)
.++.++.+|..+|||.|.+..+| +.+-++++|+.|+||+|+|+...
T Consensus 216 tsld~l~NL~dvDlS~N~Lp~vP-ecly~l~~LrrLNLS~N~iteL~--------------------------------- 261 (1255)
T KOG0444|consen 216 TSLDDLHNLRDVDLSENNLPIVP-ECLYKLRNLRRLNLSGNKITELN--------------------------------- 261 (1255)
T ss_pred CchhhhhhhhhccccccCCCcch-HHHhhhhhhheeccCcCceeeee---------------------------------
Confidence 66666666666666666666544 34455666666666666655210
Q ss_pred cccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCc
Q 046851 317 VPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNK 396 (963)
Q Consensus 317 ~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~ 396 (963)
T Consensus 262 -------------------------------------------------------------------------------- 261 (1255)
T KOG0444|consen 262 -------------------------------------------------------------------------------- 261 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCC-C
Q 046851 397 LSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMH-D 475 (963)
Q Consensus 397 ~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~-~ 475 (963)
...... .+|++|+||+|+++ .+|+.++++++|+.|.+.+|+++ .
T Consensus 262 ---------------------------------~~~~~W-~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~Fe 306 (1255)
T KOG0444|consen 262 ---------------------------------MTEGEW-ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFE 306 (1255)
T ss_pred ---------------------------------ccHHHH-hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccccc
Confidence 001111 45778888888887 78888888888888888888875 4
Q ss_pred ccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCC
Q 046851 476 QIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 476 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 546 (963)
-+|..++++.+|+.+..++|.+. .+|+.++.+.+|+.|.|++|++- .+|..+.-++.|+.|||..|+=-
T Consensus 307 GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 307 GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 56778888888888888888887 77888888888888888888876 56788888888888888887654
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=303.08 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=199.8
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch-----hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ-----GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
+|++.+.||+|++|.||+|... +|+.||||++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999764 6899999999755332 234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+ +|+|.+++.... ..+++.++..++.|+++||+|||++ +++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 889999997643 3689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc--------
Q 046851 837 ETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ-------- 907 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 907 (963)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|.++|...... ............
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-----DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-----HHHHHHHHHcCCCchhhhhh
Confidence 22 2222356788999998865 45788999999999999999997776533211 001111000000
Q ss_pred -CcccceeccccCCCC-----ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 -GRAKEFFTAGLWDAG-----PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 -~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
............... .......+.+++.+||+.+|++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000001000000011 12235678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=295.52 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=206.7
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
+|+..+.||+|++|.||+|... ++..|++|++........+.+.+|++.+++++|++++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999775 688999999977655566789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.... ..+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999998753 4689999999999999999999999 999999999999999999999999999987654432 3
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... .......
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~~~------- 218 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--------MKALFKIAT-NGPPGLR------- 218 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--------HHHHHHHHh-cCCCCcC-------
Confidence 345688999999999988889999999999999999999999874321 111111111 1111110
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+...+..+.+++.+|++.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111125678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=303.10 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=197.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|+..+.||+|++|.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 47889999999999999999765 6899999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++ +|.+++.... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 975 9999987643 3689999999999999999999999 999999999999999999999999999875432211
Q ss_pred ccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC---c------
Q 046851 840 ATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG---R------ 909 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~------ 909 (963)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... .............. .
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV----EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHhcCCCChhhhhhhhh
Confidence 1122346789999999875 45788999999999999999999998643211 00000000000000 0
Q ss_pred ccceec--------cccCCCC-ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEFFT--------AGLWDAG-PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~~~--------~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...... ....... .......+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 0000000 01112567899999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=302.05 Aligned_cols=248 Identities=22% Similarity=0.358 Sum_probs=202.3
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.|...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567899999999999975 4688999998876555555678899999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.. ..+++.++..++.|++.|++|||++ +++||||+|+||+++.++.++++|||.+........ ..
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 9999999976 3488999999999999999999999 999999999999999999999999998876543222 22
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
....|++.|+|||...+..++.++||||+|+++|||++|+.||..... ....... ........ .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~-~~~~~~~~-------~ 236 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRI-RDNLPPKL-------K 236 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHH-HhcCCCCC-------c
Confidence 335688999999999988899999999999999999999999864321 1111111 11111110 0
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
.+...+..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11224567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.03 Aligned_cols=265 Identities=21% Similarity=0.295 Sum_probs=198.2
Q ss_pred HcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++++|.+.+.||+|+||.||+|.. .+|..||+|++...... ....+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 456899999999999999999965 46899999998654332 2346788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||++ +++.+++.... ..+++.++..++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 68888776533 4578889999999999999999999 99999999999999999999999999987643222
Q ss_pred CcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc---------
Q 046851 838 THATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ--------- 907 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 907 (963)
. ......+++.|+|||++.+. .++.++||||+|+++|||++|+.||+..... .......+.....
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV----FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH----HHHHHHHHHHcCCCChhhhhhh
Confidence 1 12334578899999998764 5788999999999999999999999743221 0000000000000
Q ss_pred CcccceeccccCCC---------CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 GRAKEFFTAGLWDA---------GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ~~~~~~~~~~~~~~---------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.............. ........+.+++.+|+..||++|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000 001124577899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=302.44 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=199.9
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|+..+.||.|++|.||+|... +|+.||||++..... .....+..|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999764 689999998865432 2345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+. ++|.+++.......+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 5899999876666789999999999999999999999 999999999999999999999999999876543222
Q ss_pred ccccccccccccCccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc-----------
Q 046851 840 ATTGVAGTFGYVAPEYAMTCR-VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ----------- 907 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 907 (963)
......+++.|+|||+..+.. ++.++||||||+++|||+||+.||...... ....+........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhhhhHH
Confidence 122235688999999887654 588899999999999999999998643211 0111111000000
Q ss_pred ----CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 ----GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
............ .........+.+++.+|++.||++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 0011223567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=302.42 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=195.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHH-HhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKT-LGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||.||+|... +|+.||+|++..... ....++..|+.. ++..+|||++++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999765 699999999875432 233455566665 566789999999999999999999999
Q ss_pred ccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 759 YLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 759 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|++ |+|.+++... ....+++..+..++.|++.|++|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 5898888653 2346899999999999999999999853 8999999999999999999999999999865322
Q ss_pred CCcccccccccccccCcccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMT----CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.......++..|+|||.+.+ ..++.++|+||+|+++|||++|+.||...... .+......... ...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~ 227 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQLKQVVEEP-SPQ 227 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHHHHHHHhcC-CCC
Confidence 12223467889999998865 45688999999999999999999998632211 11111111111 010
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
. .....+.++.+++.+||..+|++||++.++++
T Consensus 228 ~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 L--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred C--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01123567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.00 Aligned_cols=247 Identities=27% Similarity=0.337 Sum_probs=204.2
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+|++.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999765 589999999975432 345788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++++|.+++... ..+++.++..++.|+++|+.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999864 4689999999999999999999999 99999999999999999999999999988764332
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ...+....... .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~----------~ 217 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET----------A 217 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc----------c
Confidence 223456888999999999888999999999999999999999998754321 11111111111 1
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTM--KQVV 952 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl 952 (963)
....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 112233445788999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=296.57 Aligned_cols=250 Identities=25% Similarity=0.445 Sum_probs=207.9
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|++.+.||+|+||.||++... ++..||+|++..... ...+++.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999765 689999999976543 4567789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 760 LPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 760 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
+++++|.+++.... ...+++.++..++.++++|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998753 35689999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... .+........ .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~-------- 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKILKG-Q-------- 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHhcC-C--------
Confidence 223335688999999999988899999999999999999999999863321 1111111111 1
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+......+.+++.+||..+|++||++.|++++
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 -YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111233455688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.09 Aligned_cols=267 Identities=23% Similarity=0.315 Sum_probs=199.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--hHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 756 (963)
++|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|+..+.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999775 5889999998754322 234567899999999999999999998776 889999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++ +|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999975 9999987643 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCC--------cchhhHHHHH--H
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG--------FNIVAWGCML--L 905 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~--~ 905 (963)
.. ......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||.......... .....|.... .
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 21 22234578899999998764 46889999999999999999999987432110000 0000000000 0
Q ss_pred --hcCcccceeccccCCCCChh-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 906 --RQGRAKEFFTAGLWDAGPHD-DLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 906 --~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.................+.. ....+.+++.+|++.+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000011111112222 35678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=303.06 Aligned_cols=246 Identities=27% Similarity=0.394 Sum_probs=197.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
..|+..+.||+|+||.||+|... +|+.||+|++.... .+..+++.+|+++++.++|||++++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888999999999999999765 68999999886432 233467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||++ |++.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 48888776433 4589999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 838 THATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
....+++.|+|||++. ...++.++||||||+++|||++|+.||...... ..... .......
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~-~~~~~~~--- 232 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYH-IAQNDSP--- 232 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHH-HhcCCCC---
Confidence 2346788999999874 356788999999999999999999998633211 11111 1111110
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+......+.+++.+||+.+|++||++.+++++
T Consensus 233 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 -----TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01122345678999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.74 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=207.8
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeEEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEMFLIY 757 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 757 (963)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.+++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999776 689999999876543 4467889999999999999999999999888 8899999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++.... .+++.++..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998753 689999999999999999999999 99999999999999999999999999998775443
Q ss_pred Cc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 TH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.. ......++..|+|||...+...+.++||||+|+++|+|++|+.||..... .......... .
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~---------~ 219 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGS---------S 219 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccc---------c
Confidence 21 12335688899999999988899999999999999999999999975431 1111111110 1
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......+...+..+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11122333446789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=300.38 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=199.1
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
|++.+.||.|++|.||+|... +|..||+|++..... .....+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999764 799999999875432 22356888999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
+ ++|.+++.......+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 6999999876545689999999999999999999999 9999999999999999999999999999765432211
Q ss_pred cccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC--------ccc
Q 046851 841 TTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG--------RAK 911 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 911 (963)
.....+++.|+|||++.+. .++.++||||+|+++|||++|+.||...... .............. ...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhhhhhch
Confidence 1223568899999988764 5688999999999999999999998643211 00111000000000 000
Q ss_pred ce---ec---cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EF---FT---AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~---~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
++ +. ...........+..+.+++.+|++.+|++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00 000001122334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=335.80 Aligned_cols=483 Identities=26% Similarity=0.265 Sum_probs=251.5
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCccc---ccccceeeccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFI---GRLKRVYLSFN 81 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~L~~L~L~~n 81 (963)
+.|.++.|-+-.-.-+.+....+|+.|+|++|++. ..|..+..+.+|+.|+++.|.|. .+|... .+|++|.|.+|
T Consensus 24 ~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n 101 (1081)
T KOG0618|consen 24 QILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNN 101 (1081)
T ss_pred HhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccc
Confidence 34445555443222222333334666666666665 55555666666666666666555 333222 24556666666
Q ss_pred cccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCC
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIP 161 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 161 (963)
.+. .+|.++. .+++|++|++|.|++. .+|..+..++.+..+..++|......+. .. ++.++|..|.+.+.++
T Consensus 102 ~l~-~lP~~~~-~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~----~~-ik~~~l~~n~l~~~~~ 173 (1081)
T KOG0618|consen 102 RLQ-SLPASIS-ELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ----TS-IKKLDLRLNVLGGSFL 173 (1081)
T ss_pred hhh-cCchhHH-hhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc----cc-chhhhhhhhhcccchh
Confidence 665 5665553 4666666666666665 5666666666666666666622111111 11 5555555555555555
Q ss_pred cCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccc
Q 046851 162 VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGA 241 (963)
Q Consensus 162 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 241 (963)
..+..+.. .|+|..|.++..+..-. ..+..+..+.|++.. ---..++|+.|+.+.|.+....+.. .
T Consensus 174 ~~i~~l~~--~ldLr~N~~~~~dls~~------~~l~~l~c~rn~ls~----l~~~g~~l~~L~a~~n~l~~~~~~p--~ 239 (1081)
T KOG0618|consen 174 IDIYNLTH--QLDLRYNEMEVLDLSNL------ANLEVLHCERNQLSE----LEISGPSLTALYADHNPLTTLDVHP--V 239 (1081)
T ss_pred cchhhhhe--eeecccchhhhhhhhhc------cchhhhhhhhcccce----EEecCcchheeeeccCcceeecccc--c
Confidence 55555444 45555444331111110 001111111122211 1113466777777777776433221 2
Q ss_pred cccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCccccc
Q 046851 242 CDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLS 321 (963)
Q Consensus 242 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~ 321 (963)
-.+|+++++++|+++.++ ++++.+.+|+.|+..+|+++..+.......+|+.|++..|.+.-.++....+.+|+.|+|.
T Consensus 240 p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cccceeeecchhhhhcch-HHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeeh
Confidence 246777888888887777 7777777888888888887766666667777777888888877777777777777777777
Q ss_pred ccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCC
Q 046851 322 RNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSF 401 (963)
Q Consensus 322 ~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~ 401 (963)
.|.+..+++.. +...... ++.. |..+..++..
T Consensus 319 ~N~L~~lp~~~--l~v~~~~-------------------l~~l-n~s~n~l~~l-------------------------- 350 (1081)
T KOG0618|consen 319 SNNLPSLPDNF--LAVLNAS-------------------LNTL-NVSSNKLSTL-------------------------- 350 (1081)
T ss_pred hccccccchHH--HhhhhHH-------------------HHHH-hhhhcccccc--------------------------
Confidence 77777766521 1100000 0000 0000000000
Q ss_pred CcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCcc-ccccCCCCCEEeccCCcCCCccchh
Q 046851 402 PGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPR-GVGELVSLVALNLSWNLMHDQIPTT 480 (963)
Q Consensus 402 p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~L~ls~N~i~~~~~~~ 480 (963)
| -++....-.+..|.+.+|.++...-+-+-. +++|+.|+|++|++. .+|+ .+.++..|+.|+||+|++ ..+|..
T Consensus 351 p--~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~-~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL-~~Lp~t 425 (1081)
T KOG0618|consen 351 P--SYEENNHAALQELYLANNHLTDSCFPVLVN-FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKL-TTLPDT 425 (1081)
T ss_pred c--cccchhhHHHHHHHHhcCcccccchhhhcc-ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchh-hhhhHH
Confidence 0 001111111114555666665433222222 255666666666665 3443 355566666666666666 345566
Q ss_pred hccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCc
Q 046851 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLS 560 (963)
Q Consensus 481 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~ 560 (963)
+..++.|++|...+|++. .+| .+..+++|+.+|+|.|+|+...-..-..-++|++|||+||.-...--..|..++++.
T Consensus 426 va~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~ 503 (1081)
T KOG0618|consen 426 VANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLS 503 (1081)
T ss_pred HHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhh
Confidence 666666666666666666 555 566666666666666666533222222225666666666653223334444555555
Q ss_pred eEeeccc
Q 046851 561 AFNVSFN 567 (963)
Q Consensus 561 ~l~l~~N 567 (963)
.++++-|
T Consensus 504 ~~~i~~~ 510 (1081)
T KOG0618|consen 504 QMDITLN 510 (1081)
T ss_pred heecccC
Confidence 5555544
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=302.31 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=196.9
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|+..+.||+|+||.||++... +|+.||+|++..... .....+.+|+..+.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4666788999999999999664 589999999875432 34567889999999996 99999999999998999999999
Q ss_pred cCCCChHHHH---hhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 760 LPGGNLENFI---QQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 760 ~~~gsL~~~l---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
++. ++.++. .......+++..+..++.+++.|++|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 665543 3333456899999999999999999999742 8999999999999999999999999999765432
Q ss_pred CCcccccccccccccCccccccC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTC---RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.. .....|++.|+|||++.+. .++.++||||+|+++|||++|+.||.... ............. .
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~-~--- 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGD-P--- 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCC-C---
Confidence 22 2233578899999999876 68899999999999999999999986332 1111111111111 1
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+......+...+..+.+++.+||+.+|++|||+.+|+++
T Consensus 229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112223456688999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.99 Aligned_cols=244 Identities=25% Similarity=0.322 Sum_probs=195.6
Q ss_pred cccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
||+|+||+||+|... +|+.||+|.+..... .....+..|++++++++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999654 689999999865322 2345667899999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccccc
Q 046851 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845 (963)
Q Consensus 766 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (963)
.+++.......+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 9999876555689999999999999999999999 9999999999999999999999999998765432 2223345
Q ss_pred ccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChh
Q 046851 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHD 925 (963)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (963)
++..|+|||+..+..++.++||||+|+++|+|++|+.||....... . ...+. ..... .....+..
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~-~~~~~----~~~~~------~~~~~~~~ 220 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----E-KEELK----RRTLE------MAVEYPDK 220 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----c-HHHHH----hcccc------ccccCCcc
Confidence 7889999999988889999999999999999999999997443210 0 01110 00000 01112233
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 046851 926 DLVEVLHLAVVCTVDSLSTRP-----TMKQVVR 953 (963)
Q Consensus 926 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 953 (963)
....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 456788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.25 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=198.0
Q ss_pred cccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
||+|++|.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999765 489999999865432 3346789999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccccc
Q 046851 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845 (963)
Q Consensus 766 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (963)
.+++.+. ..+++..+..++.|+++|++|+|+. +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999864 3488999999999999999999999 99999999999999999999999999998764332 223346
Q ss_pred ccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChh
Q 046851 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHD 925 (963)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (963)
+++.|+|||.+.+..++.++|+||+|+++|||++|+.||.....+ ........... ......+..
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~ 218 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDILKG---------NGKLEFPNY 218 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHHhcc---------CCCCCCCcc
Confidence 888999999998888999999999999999999999999754321 11111111110 111123333
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046851 926 DLVEVLHLAVVCTVDSLSTRPT-----MKQVVR 953 (963)
Q Consensus 926 ~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 953 (963)
....+.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 4668999999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=295.24 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=204.7
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|++.+.||+|+||.||++... +++.+|+|++.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999654 68899999987543 23356778899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 760 LPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 760 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
+++++|.+++.... ...+++..+..++.|+++|++|||+. +++||||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987632 35689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......+++.|+|||...+..++.++|+||+|+++|||++|+.||..... .... .......
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~-~~~~~~~-------- 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLR-YKVQRGK-------- 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHhcCC--------
Confidence 22234578899999999998899999999999999999999999864321 1111 1111111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+.....++.+++.+|++.+|++||++.+++++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 -YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112233456779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.30 Aligned_cols=261 Identities=26% Similarity=0.332 Sum_probs=200.5
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeEEEEEe
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEMFLIYN 758 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 758 (963)
|++.+.||+|++|.||+|... +|+.||+|++.... ......+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999776 48999999997653 33346788999999999999999999999887 88999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++ +|.+++.... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 9999887643 4689999999999999999999999 999999999999999999999999999987755433
Q ss_pred cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc---Ccccce-
Q 046851 839 HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ---GRAKEF- 913 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 913 (963)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............ ......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-----EQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchhhccccc
Confidence 23334457889999998765 45788999999999999999999998744321 011111000000 000000
Q ss_pred -------------eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 914 -------------FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 914 -------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
............++..+.+++.+|++.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.88 Aligned_cols=268 Identities=23% Similarity=0.315 Sum_probs=199.0
Q ss_pred CCCCccccccCCCccEEEEEEC---CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS---PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEMF 754 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 754 (963)
+|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999764 47899999987633 23346678899999999999999999999887 8899
Q ss_pred EEEeccCCCChHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC----CCcEEEeec
Q 046851 755 LIYNYLPGGNLENFIQQRS---TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD----DFNAYLSDF 827 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 827 (963)
+||||+++ ++.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 7777775432 23578999999999999999999999 9999999999999999 999999999
Q ss_pred ccccccCCCCC--cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCc-----chhh
Q 046851 828 GLARLLGPSET--HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGF-----NIVA 899 (963)
Q Consensus 828 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~-----~~~~ 899 (963)
|++........ .......+++.|+|||++.+. .++.++||||||+++|||++|+.||........... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 122345678899999988764 578899999999999999999999975543321000 0000
Q ss_pred HHHHHH-----------hcCcccceeccccCCCCC-----------hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 900 WGCMLL-----------RQGRAKEFFTAGLWDAGP-----------HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 900 ~~~~~~-----------~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+.... .........+.......+ .....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 000000000000000111 0234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.33 Aligned_cols=371 Identities=27% Similarity=0.388 Sum_probs=271.1
Q ss_pred CCCCcEEEccCCccc-ccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeC
Q 046851 25 LKSLRVLNLGFNRIT-GEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDL 103 (963)
Q Consensus 25 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L 103 (963)
|+-.+-.|+++|.++ +..|.....++.++.|.|...++. .+|..+. .+.+|++|.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~----------------------~vPeEL~-~lqkLEHLs~ 62 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE----------------------QVPEELS-RLQKLEHLSM 62 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh----------------------hChHHHH-HHhhhhhhhh
Confidence 344455555555555 445555555555555555555444 7888776 5888999999
Q ss_pred CCCccccCcCccccCcccccEEEcccCcccc-cCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcc
Q 046851 104 SGNYLVGGIPRSLGNCFQVRSLLLFSNMLEE-TIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTY 182 (963)
Q Consensus 104 s~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~ 182 (963)
++|++. .+-+.+..++.|+.+.+.+|++.. -+|..+-.+..|+.||||+|+++ ..|..+...+++-.|+||+
T Consensus 63 ~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~----- 135 (1255)
T KOG0444|consen 63 AHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSY----- 135 (1255)
T ss_pred hhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEccc-----
Confidence 999888 677888888888888888888873 35666777888899999999888 6777777777777777766
Q ss_pred cccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccc
Q 046851 183 EDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGV 262 (963)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 262 (963)
|++..+...-|-+|..|-.|+|++|++. .+|..+..+..|++|.|++|.+.......
T Consensus 136 ----------------------N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQ 192 (1255)
T KOG0444|consen 136 ----------------------NNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQ 192 (1255)
T ss_pred ----------------------CccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhc
Confidence 3333333333445555555555555555 34444555555555555555554444444
Q ss_pred cCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhccc
Q 046851 263 LGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKS 342 (963)
Q Consensus 263 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~ 342 (963)
+-.|++|+.|.+++.+=+- .
T Consensus 193 LPsmtsL~vLhms~TqRTl---------------------~--------------------------------------- 212 (1255)
T KOG0444|consen 193 LPSMTSLSVLHMSNTQRTL---------------------D--------------------------------------- 212 (1255)
T ss_pred Cccchhhhhhhcccccchh---------------------h---------------------------------------
Confidence 4444555555555443220 0
Q ss_pred ccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCC
Q 046851 343 QAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNN 422 (963)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n 422 (963)
.+|.++ ..+.+|. .+|+|.|
T Consensus 213 ---------------------------------------------------------N~Ptsl-d~l~NL~--dvDlS~N 232 (1255)
T KOG0444|consen 213 ---------------------------------------------------------NIPTSL-DDLHNLR--DVDLSEN 232 (1255)
T ss_pred ---------------------------------------------------------cCCCch-hhhhhhh--hcccccc
Confidence 011111 1222333 5677778
Q ss_pred eeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceecccccccc-ccC
Q 046851 423 RIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLT-GSI 501 (963)
Q Consensus 423 ~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~~~ 501 (963)
.+. .+|+.+..+ .+|+.|+||+|+|+ .+.-..+...+|++|+||.|++ ..+|+.+.++++|+.|.+.+|+++ .-+
T Consensus 233 ~Lp-~vPecly~l-~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQL-t~LP~avcKL~kL~kLy~n~NkL~FeGi 308 (1255)
T KOG0444|consen 233 NLP-IVPECLYKL-RNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQL-TVLPDAVCKLTKLTKLYANNNKLTFEGI 308 (1255)
T ss_pred CCC-cchHHHhhh-hhhheeccCcCcee-eeeccHHHHhhhhhhccccchh-ccchHHHhhhHHHHHHHhccCcccccCC
Confidence 777 889999887 88999999999999 7877888889999999999999 589999999999999999999987 347
Q ss_pred CcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCC
Q 046851 502 PSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLP 574 (963)
Q Consensus 502 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p 574 (963)
|..++.+.+|+.+..++|.+. .+|.+++.+.+|+.|.|+.|+|- .+|+.+.-++.|+.||+..|+=..-+|
T Consensus 309 PSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 309 PSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred ccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 999999999999999999998 88999999999999999999998 899999999999999999998655333
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=323.11 Aligned_cols=266 Identities=20% Similarity=0.244 Sum_probs=189.9
Q ss_pred cCCCCCccccccCCCccEEEEEECC--CcEEEEEEe--------------ec---ccchhHHHHHHHHHHHhccCCCCee
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISP--GVLVAIKRL--------------AV---GRFQGVQQFHAEIKTLGRLRHPNLV 741 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~niv 741 (963)
.++|++.+.||+|+||+||++.++. +..+++|.+ .. ........+.+|++++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999986542 222222211 00 1112345678999999999999999
Q ss_pred EEEEeeeCCCeEEEEEeccCCCChHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC
Q 046851 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRS---TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD 818 (963)
Q Consensus 742 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 818 (963)
++++++...+..++|+|++. +++.+++.... .......++..|+.|++.||+|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999995 48888875432 11234567788999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchh
Q 046851 819 DFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIV 898 (963)
Q Consensus 819 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~ 898 (963)
++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|+.++...... ....
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~----~~~~ 378 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG----KPGK 378 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC----CHHH
Confidence 999999999999877544444444567999999999999999999999999999999999987544322111 0001
Q ss_pred hHHHHHHhcC----ccc-------ceeccccCCCC---------ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 899 AWGCMLLRQG----RAK-------EFFTAGLWDAG---------PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 899 ~~~~~~~~~~----~~~-------~~~~~~~~~~~---------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.......... ... .+++....... ......++.+++.+|++.||.+|||+.|++++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000000 000 00000000000 01123456778999999999999999999874
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.13 Aligned_cols=247 Identities=29% Similarity=0.473 Sum_probs=205.0
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999665 578999999976654 4567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999764 4589999999999999999999999 9999999999999999999999999999876543332
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ..... ... ... .
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~-~~~-~~~---------~ 216 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALF-RIV-QDD---------H 216 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHH-HHh-ccC---------C
Confidence 2335688899999999888888999999999999999999999863321 11111 111 110 1
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
...+......+.+++.+|++.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1123344568889999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=296.29 Aligned_cols=242 Identities=26% Similarity=0.324 Sum_probs=188.6
Q ss_pred ccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHh---ccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 689 CIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLG---RLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 689 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.||+|+||.||+|... +++.||+|.+..... .....+..|..+++ ..+||+++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 589999998865422 11223344444333 3479999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 99999998764 3589999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred ccccccccccCccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAM-TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....|++.|+|||.+. +..++.++||||+||++|||++|+.||...... . .......... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~-~~~~~~~~~~----------~~~ 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----D-KHEIDRMTLT----------VNV 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----C-HHHHHHHhhc----------CCc
Confidence 2346899999999986 456889999999999999999999999744322 0 1111111100 011
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
..+...+.++.+++.+|++.||++|| +++|++++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12334456888999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=276.34 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=208.7
Q ss_pred ChHHHHHHcCCCCCccccccCCCccEEEE-EECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCC
Q 046851 673 SFESVVQATGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASE 750 (963)
Q Consensus 673 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 750 (963)
.++|+.+.++ +.+|+|+||.|-.+ .+.+|..||||++.+.......++.+|++++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4677777775 56999999999988 56789999999998887778889999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC---cEEEeec
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF---NAYLSDF 827 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Df 827 (963)
+.+|+|||.|.||+|...++++ ..+++.++.++.++|+.||.+||.+ ||.|||+||+|||-..-. -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999999885 4599999999999999999999999 999999999999986543 4899999
Q ss_pred ccccccCCCC------CcccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCC---CCCCC
Q 046851 828 GLARLLGPSE------THATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSF---SSYGN 893 (963)
Q Consensus 828 gla~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~---~~~~~ 893 (963)
.++.-..... ...-.+.+|+..|||||+.. ...|..+.|.||+|||+|-|++|.+||...= -.++.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 8875432111 11223457899999999864 3457889999999999999999999997432 23444
Q ss_pred CcchhhHHHHH---HhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 894 GFNIVAWGCML---LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 894 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
+..-....... +.++. .++-|... ...+.+..+++...+..||.+|-++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGk-YeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGK-YEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccC-CcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 44433332222 22221 12222111 233556778888889999999999999886
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=301.48 Aligned_cols=260 Identities=18% Similarity=0.282 Sum_probs=194.7
Q ss_pred cccccC--CCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNG--GFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
..||+| +||+||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 88999999764 79999999986543 23346788999999999999999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc--
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA-- 840 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-- 840 (963)
+++.+++.......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999876555689999999999999999999999 99999999999999999999999998654332211110
Q ss_pred ----cccccccccccCccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHH-------------
Q 046851 841 ----TTGVAGTFGYVAPEYAMTC--RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWG------------- 901 (963)
Q Consensus 841 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~------------- 901 (963)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||....... ......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH----HHHHHhcCCCCCCcccccc
Confidence 0112345679999999763 47889999999999999999999997442110 000000
Q ss_pred ---HHHH----------------hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 902 ---CMLL----------------RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 902 ---~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... .........+.......+......+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 0000000111111112233456788999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.37 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=204.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
+.|..-++||+|+||.||-++.+ +|+-||.|++.+... ........|-.++.+++.+.||.+-.+|.+.+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 46788899999999999999665 699999998865432 33455688999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
..|.||+|.-++...+.+.+++..+..+|.+|+.||++||.. +||.||+||+|||+|+.|+++|+|.|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999999888878899999999999999999999999 99999999999999999999999999999876444
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
. ..+.+||.+|||||++.+..|+...|.||+||++|||+.|+.||....+. +.| +-+|.+
T Consensus 342 ~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-------vk~-----------eEvdrr 401 (591)
T KOG0986|consen 342 P--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-------VKR-----------EEVDRR 401 (591)
T ss_pred c--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------hhH-----------HHHHHH
Confidence 3 34458999999999999999999999999999999999999999744322 111 011111
Q ss_pred cC---CCCChhHHHHHHHHHHHcccCCCCCCCC
Q 046851 918 LW---DAGPHDDLVEVLHLAVVCTVDSLSTRPT 947 (963)
Q Consensus 918 ~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs 947 (963)
.. ..++...+++...+....++.||++|--
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 11 1234555677888888899999999964
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=333.14 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=207.8
Q ss_pred cCCCCCccccccCCCccEEEE-EECCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
+-+++....||.|.||.||.| ...+|+-.|+|.++.... ...+.+.+|..++..++|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 346778889999999999999 556799999998865432 33456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
|||++|+|.+.+.. ++..++.....+..|++.|++|||++ |||||||||.||+++.+|.+|.+|||.|.......
T Consensus 1314 EyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 99999999999986 34467777788999999999999999 99999999999999999999999999998876543
Q ss_pred ---CcccccccccccccCccccccC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH-hcCcc
Q 046851 838 ---THATTGVAGTFGYVAPEYAMTC---RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL-RQGRA 910 (963)
Q Consensus 838 ---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 910 (963)
.......+||+.|||||++.+. ....++||||+||++.||+||++||...+.. |+.++. ..+
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~aIMy~V~~g-- 1457 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WAIMYHVAAG-- 1457 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hHHHhHHhcc--
Confidence 2233457899999999999864 3556899999999999999999999855433 332221 122
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
-..+.|.....+-.+++..|+..||++|-++.|++++
T Consensus 1458 -------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 -------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2234566677788899999999999999888887764
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=297.01 Aligned_cols=262 Identities=21% Similarity=0.340 Sum_probs=199.4
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+|+..+.||+|++|.||+|... +|..||||++..... ...+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999775 689999999876533 23456788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 761 PGGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 761 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
++ +|.+++.... ...+++..+..++.|+++|++|||+. +++||||+|+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8999887643 24589999999999999999999999 999999999999999999999999999976543221
Q ss_pred ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC---------c
Q 046851 840 ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG---------R 909 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 909 (963)
......+++.|++||++.+. .++.++||||+|+++|||++|+.||...... ....... ...... .
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIF-RIMGTPTESTWPGISQ 230 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHH-HHhCCCChhhHHHHhc
Confidence 12234578899999998664 5688999999999999999999998744221 0000000 000000 0
Q ss_pred ccceecccc------CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEFFTAGL------WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......... ........+..+.+++.+|++.||++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 000111234578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=320.94 Aligned_cols=252 Identities=30% Similarity=0.409 Sum_probs=191.1
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--------
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-------- 750 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 750 (963)
..+|+..+.+|+||||.||+++.+ ||+.||||++.... ......+.+|+.++.+++|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 347888899999999999999876 89999999997653 23346688999999999999999987422000
Q ss_pred --------------------------------------------------------------------------------
Q 046851 751 -------------------------------------------------------------------------------- 750 (963)
Q Consensus 751 -------------------------------------------------------------------------------- 750 (963)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 046851 751 -------------------------------TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799 (963)
Q Consensus 751 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 799 (963)
...|+-||||+..++++++++.... -.....++++++|++|++|+|++
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhC
Confidence 0158889999997777777764321 14678899999999999999999
Q ss_pred CCCCceecccCCCCeEECCCCcEEEeecccccccC------C-----------CCCcccccccccccccCccccccC---
Q 046851 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG------P-----------SETHATTGVAGTFGYVAPEYAMTC--- 859 (963)
Q Consensus 800 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~--- 859 (963)
|||||||||.||+++++..|||+|||+|.... . ......++.+||.-|+|||++.+.
T Consensus 717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999998721 0 111133457899999999999865
Q ss_pred CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHccc
Q 046851 860 RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTV 939 (963)
Q Consensus 860 ~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 939 (963)
.|+.|+|+||+|||++||+. ||....+. ..+-..++.+..+.- ..........=.++|.+|++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--------a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMER--------ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHH--------HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 49999999999999999997 56533221 111222333333322 11122233345688999999
Q ss_pred CCCCCCCCHHHHHH
Q 046851 940 DSLSTRPTMKQVVR 953 (963)
Q Consensus 940 ~dP~~RPs~~evl~ 953 (963)
+||.+||||.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=295.94 Aligned_cols=246 Identities=23% Similarity=0.355 Sum_probs=199.0
Q ss_pred CccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCC
Q 046851 686 ASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGN 764 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 764 (963)
....||+|+||.||+|... +|..||||++..........+..|+.+++.++|+|++++++++..++..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3467999999999999764 689999999866555556778999999999999999999999999999999999999999
Q ss_pred hHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccccc
Q 046851 765 LENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGV 844 (963)
Q Consensus 765 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 844 (963)
|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++....... ......
T Consensus 104 L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 104 LTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 9998864 3478999999999999999999999 99999999999999999999999999987654322 122335
Q ss_pred cccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCCh
Q 046851 845 AGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPH 924 (963)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (963)
.|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ...... ..... ..... ...
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~-~~~~~-----~~~~~--~~~ 240 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKM-IRDNL-----PPKLK--NLH 240 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHhhC-----CcccC--Ccc
Confidence 688999999999888889999999999999999999999863211 111111 11110 00000 112
Q ss_pred hHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 925 DDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 925 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+..+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 234568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=292.52 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=199.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc-----cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG-----RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 753 (963)
.+|++.+.||+|+||.||+|... ++..||+|++... ..+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999754 6899999987532 123456788999999999999999999998653 568
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++|+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999999764 3478999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC--CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 834 GPSE--THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 834 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
.... ........++..|+|||++.+..++.++||||||+++|||++|+.||...... .-+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~--- 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIATQP--- 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHHcCC---
Confidence 3211 11122356889999999999888999999999999999999999998633111 1111111111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+......+.+++.+|+. +|.+||++.+++.+
T Consensus 226 ------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 ------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1112344556789999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=296.66 Aligned_cols=262 Identities=25% Similarity=0.334 Sum_probs=197.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++|||++++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999765 688999998865432 234568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEeecccccccCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~ 837 (963)
|++ +++.+++........++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5898888765555568889999999999999999999 9999999999999985 5579999999997654322
Q ss_pred CcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee--
Q 046851 838 THATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF-- 914 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 914 (963)
. ......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||...... ....... ...... .....
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~-~~~~~~-~~~~~~~ 230 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIF-RILGTP-NEETWPG 230 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-HHhCCC-Chhhccc
Confidence 1 12233578899999998764 5788999999999999999999998643211 0000000 000000 00000
Q ss_pred -----c-----cccCC----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 -----T-----AGLWD----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 -----~-----~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+ +.... ........++.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000 0112234568899999999999999999999864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=295.90 Aligned_cols=258 Identities=18% Similarity=0.256 Sum_probs=186.8
Q ss_pred CCCCCccccccCCCccEEEEEECC----CcEEEEEEeecccchhH-----------HHHHHHHHHHhccCCCCeeEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVGRFQGV-----------QQFHAEIKTLGRLRHPNLVTLIGY 746 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~~ 746 (963)
++|++.+.||+|+||.||+|.+.+ +..+|+|+......... .....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999997764 34566665433222110 112233445667789999999987
Q ss_pred eeCCC----eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 747 HASET----EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 747 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
+.... ..++++|++.. ++.+.+... ...++..+..++.|+++|++|||+. +|+||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 65433 34778888744 777776643 2357888999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCc------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcc
Q 046851 823 YLSDFGLARLLGPSETH------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFN 896 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~ 896 (963)
+|+|||+|+.+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~----~~ 241 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN----GN 241 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc----hH
Confidence 99999999876432211 112346999999999999999999999999999999999999999754221 11
Q ss_pred hhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 897 IVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
............ ...... ....++..+.+++..|+..+|++||++.++.+.++
T Consensus 242 ~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKR----LHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHH----hhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111111000000 000000 11234567899999999999999999999998764
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=299.05 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=198.1
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.|+..+.||+|+||.||+|... ++..||+|++..... .....+..|++++++++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999764 688999998864322 334578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++ ++.+++... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 9975 888877654 34589999999999999999999999 9999999999999999999999999998754322
Q ss_pred cccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 839 HATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
....|++.|+|||++. +..++.++|||||||++|||++|+.||..... ........... .
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~-~----- 241 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNE-S----- 241 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhcc-C-----
Confidence 2346788999999974 45688899999999999999999999864311 11111111111 0
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
...........+.+++.+|++.+|.+||++.+++++...
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 011122345578899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=295.93 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=203.2
Q ss_pred CCCCccccccCCCccEEEEEE----CCCcEEEEEEeecccc----hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeE
Q 046851 683 NFNASNCIGNGGFGATYKAEI----SPGVLVAIKRLAVGRF----QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEM 753 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (963)
+|++.+.||+|++|.||+|.. .+++.||||++..... ...+.+..|++++.++ +||+|+++++++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999964 3578899998874322 2345678999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999999763 3588999999999999999999999 9999999999999999999999999998876
Q ss_pred CCCCCcccccccccccccCccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTCR--VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
............|+..|+|||...+.. .+.++||||+|+++|||++|..||...... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~--- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKSK--- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHccC---
Confidence 544333334456889999999987655 778999999999999999999998633211 11112221111110
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
...+......+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 229 --------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 --------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11223344578899999999999999999988877754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=303.68 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=199.3
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC------
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE------ 750 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 750 (963)
..++|+..+.||+|+||.||+|... +|+.||||++... ......++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4568999999999999999999654 6899999988643 233445678899999999999999999987543
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
...++||||+++ +|.+++... +++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999965 888888642 88899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCC-------CCcchhhH---
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYG-------NGFNIVAW--- 900 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~-------~~~~~~~~--- 900 (963)
....... ......+++.|+|||.+.+..++.++||||+||++|+|++|+.||........ .+....++
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8754322 22334678899999999999999999999999999999999999864321100 00000000
Q ss_pred ----HHHHHhcCc------ccceeccccCC----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 901 ----GCMLLRQGR------AKEFFTAGLWD----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 901 ----~~~~~~~~~------~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......... ....+...... ..+......+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00011110000 0122345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=298.54 Aligned_cols=261 Identities=18% Similarity=0.258 Sum_probs=193.9
Q ss_pred CccccccCCCccEEEEEECCCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 686 ASNCIGNGGFGATYKAEISPGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
+.+.+|.|+++.||++.. +|+.||||++... .....+.+.+|++.+++++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455555555555544 5899999998754 3345678999999999999999999999999999999999999999
Q ss_pred ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC-----
Q 046851 764 NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET----- 838 (963)
Q Consensus 764 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~----- 838 (963)
++.+++.......+++..+..++.|+++||+|||++ +|+||||||+||+++.++.++++|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999876556689999999999999999999999 999999999999999999999999998875532211
Q ss_pred -cccccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH----hcC---
Q 046851 839 -HATTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL----RQG--- 908 (963)
Q Consensus 839 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~--- 908 (963)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... ....+...... ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCccccccCchh
Confidence 11223457789999999876 35788999999999999999999999743221 00000000000 000
Q ss_pred ----cccc----eeccc----cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 ----RAKE----FFTAG----LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 ----~~~~----~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... ..+.. ...........++.+++.+||+.||++|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 0011122334678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=288.90 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=194.6
Q ss_pred HHHHHHcCCCCCcccc--ccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCC
Q 046851 675 ESVVQATGNFNASNCI--GNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASE 750 (963)
Q Consensus 675 ~~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (963)
.+.....++|++.+.+ |+|+||.||++... ++..+|+|.+........ |+.....+ +|||++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 4444555678887877 99999999999654 688899998865432211 22222222 699999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeeccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGL 829 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl 829 (963)
+..++||||+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||+|+||+++.++ .++|+|||.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999998643 689999999999999999999999 999999999999999998 999999999
Q ss_pred ccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
+...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||...... ......+.... ..
T Consensus 157 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~- 225 (267)
T PHA03390 157 CKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE---ELDLESLLKRQ--QK- 225 (267)
T ss_pred ceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc---hhhHHHHHHhh--cc-
Confidence 8765422 1235789999999999989999999999999999999999999743222 11112221111 00
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-MKQVVRR 954 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~ 954 (963)
. ...+......+.+++.+|++.+|.+||+ ++|++++
T Consensus 226 ~---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 K---------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred c---------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 0112245567899999999999999996 6888753
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=268.67 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=199.2
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeec-ccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAV-GRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+.+...-+|.|.-|.|++++.+ .|..+|||.+.. .+.++.+++...++++..-. +|.||+.+|||..+..+++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3445667999999999999776 589999998864 35566778888888876664 99999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
|.- -...++++ ..+++++..+-++...+.+||.||-+++ +|+|||+||+|||+|+.|++|+||||.+-++.+ +.
T Consensus 173 Ms~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--Sk 246 (391)
T KOG0983|consen 173 MST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SK 246 (391)
T ss_pred HHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--cc
Confidence 943 45555544 4566899999999999999999999875 999999999999999999999999999987643 34
Q ss_pred ccccccccccccCcccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 840 ATTGVAGTFGYVAPEYAMT---CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
......|.+.|||||.+.- ..|.-++||||||+.++|+.||+.||.....+ .+......... .+ .
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~ltkvln~e-PP-~--- 314 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEVLTKVLNEE-PP-L--- 314 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHHHHHHHhcC-CC-C---
Confidence 4445579999999999864 36788999999999999999999999865443 12222222211 11 1
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+ .+.......+.+++..|+..|+.+||...+++++
T Consensus 315 -L--~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 -L--PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -C--CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 1122256789999999999999999999998875
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.23 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=207.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.+.|.+.+.||+|.|+.|..|++. +|..||||.+.+..- ...+.+.+|++++..++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457999999999999999999654 699999999976543 33456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+.+|.+++|+.+.+. ..+.++..++.|+.+|++|||++ .|||||||++||+++.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--
Confidence 99999999999998643 55688999999999999999999 999999999999999999999999999998863
Q ss_pred CcccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.......+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||+...-.... +.++..
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~rvl~g 270 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PRVLRG 270 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------chheee
Confidence 334556799999999999998765 47899999999999999999999844222100 011111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
.++ .+.....++.+++++++-.+|.+|++++++.++-
T Consensus 271 k~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 271 KYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eec--ccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 111 2333455778999999999999999999998753
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=293.68 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=199.7
Q ss_pred CCCCccccccCCCccEEEEEE----CCCcEEEEEEeecccc----hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeE
Q 046851 683 NFNASNCIGNGGFGATYKAEI----SPGVLVAIKRLAVGRF----QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEM 753 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (963)
+|++.+.||+|+||.||+|.. .+|..||+|++..... ...+.+..|++++.++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999975 3689999999875422 2345678899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++++|.+++... ..+++.++..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999764 4588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTC--RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
............|+..|+|||...+. .++.++||||+|+++|+|++|+.||..... ......+........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~--- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE--- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccC---
Confidence 44333333345688999999998753 467889999999999999999999863211 111222222211111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+......+.+++.+|++.+|++|| ++.++..+
T Consensus 229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 112333456788999999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=296.83 Aligned_cols=266 Identities=25% Similarity=0.318 Sum_probs=200.6
Q ss_pred HHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC----
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET---- 751 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 751 (963)
...++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34568999999999999999999775 589999999875432 23356788999999999999999999887654
Q ss_pred ------eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEe
Q 046851 752 ------EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825 (963)
Q Consensus 752 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 825 (963)
..++|+||+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 787877654 34689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 826 DFGLARLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 826 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
|||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|++||..... ......+...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~~~~ 233 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELISRL 233 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHH
Confidence 999998765433222233356788999998865 3578899999999999999999999874321 1111111111
Q ss_pred HhcCc---cccee--------cccc-----CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 LRQGR---AKEFF--------TAGL-----WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 ~~~~~---~~~~~--------~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... ..... +... ........+..+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10000 00000 0000 000111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=295.17 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=195.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCe-----
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETE----- 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 752 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999765 689999998765432 22356788999999995 6999999999877655
Q ss_pred EEEEEeccCCCChHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEeecc
Q 046851 753 MFLIYNYLPGGNLENFIQQRS---TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFG 828 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 828 (963)
.++||||+++ ++.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 8999887543 23579999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
++..+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|..||...... .........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~ 227 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--------QQLLHIFKL 227 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHH
Confidence 98865432211 122356889999998865 45788999999999999999999998643211 111111000
Q ss_pred -Cccc-----ceeccc------c-C----CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 -GRAK-----EFFTAG------L-W----DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 -~~~~-----~~~~~~------~-~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+... ...+.. . . ..........+.+++.+|++.+|++||++.|++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000000 0 0 00011245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.42 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=197.4
Q ss_pred cccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
||+|+||.||+|... +|+.||+|++..... ...+.+.+|++.+++++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 499999999865543 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC-------
Q 046851 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET------- 838 (963)
Q Consensus 766 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~------- 838 (963)
.+++.+.. .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998743 589999999999999999999999 999999999999999999999999999876543211
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.......++..|+|||...+...+.++||||||+++||+++|+.||..... .+....... +...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~------- 219 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILN-GKIE------- 219 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-CCcC-------
Confidence 122335678899999999988889999999999999999999999874321 111111111 1100
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
.......+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 -WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0001112567889999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=275.01 Aligned_cols=269 Identities=24% Similarity=0.311 Sum_probs=200.1
Q ss_pred CCCCCccccccCCCccEEEEEEC---C--CcEEEEEEeecccch--hHHHHHHHHHHHhccCCCCeeEEEEeeeC-CCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS---P--GVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVTLIGYHAS-ETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 753 (963)
..|+....||+|.||.||+|.-. + ...+|+|+++.+... -.....+|+..++.++|||++.+..++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46999999999999999999332 2 236999999765332 12456899999999999999999998877 7889
Q ss_pred EEEEeccCCCChHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC----CcEEEee
Q 046851 754 FLIYNYLPGGNLENFIQQRS---TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD----FNAYLSD 826 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~D 826 (963)
++++||.+. +|.+.++-.+ .+.++...+..|+.||+.|+.|||+. =|+|||+||.||++..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 9999986543 35688889999999999999999999 89999999999999888 8999999
Q ss_pred cccccccCCCCC--cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCC-cchhhHHH
Q 046851 827 FGLARLLGPSET--HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG-FNIVAWGC 902 (963)
Q Consensus 827 fgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~ 902 (963)
||+++.+...-. .....++-|..|+|||.+.|. .|+.+.|||+.|||+.||+|-++-|.......... ....+.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999999864422 234557789999999999876 58889999999999999999888876544331111 11111111
Q ss_pred HHHh-cC-----cccce------------eccccCCCCCh--------hHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 903 MLLR-QG-----RAKEF------------FTAGLWDAGPH--------DDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 903 ~~~~-~~-----~~~~~------------~~~~~~~~~~~--------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+++. -+ .++.+ +.......... .-....++|+.+++..||.+|.|+++++++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1111 00 00000 00000000000 001136789999999999999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=291.67 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=196.2
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--hHHHHHHHHHHHhcc---CCCCeeEEEEeeeCCCe-----
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRL---RHPNLVTLIGYHASETE----- 752 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 752 (963)
|++.+.||+|+||.||+|... ++..||+|++...... ....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999876 4899999999754322 234456777776655 59999999999987766
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.+++|||+++ +|.+++.......+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 899999875555689999999999999999999999 999999999999999999999999999977
Q ss_pred cCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc--
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA-- 910 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 910 (963)
...... .....++..|+|||++.+..++.++||||||+++|||++|++||...... .....+..........
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA----DQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH----HHHHHHHHHcCCCChHhc
Confidence 643322 12335788999999999989999999999999999999999888743221 1111111100000000
Q ss_pred -------cceeccccC---CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 -------KEFFTAGLW---DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 -------~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......... ..........+.+++.+||+.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 00011234677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=272.23 Aligned_cols=254 Identities=24% Similarity=0.272 Sum_probs=201.5
Q ss_pred HcCCCCCc-cccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC----CCe
Q 046851 680 ATGNFNAS-NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS----ETE 752 (963)
Q Consensus 680 ~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 752 (963)
.+++|.+. ++||-|-.|.|..+.++ +|+++|+|++... ...++|++..-.. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34566654 47999999999999654 7999999987533 3457888875444 59999999998753 566
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC---CCCcEEEeeccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD---DDFNAYLSDFGL 829 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl 829 (963)
..+|||.|+||.|.+.++.++...+++.++..|+.||+.|+.|||+. .|.||||||+|+|.. .|..+|++|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 78999999999999999999988999999999999999999999999 999999999999996 455799999999
Q ss_pred ccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
|+..... ..-.+.+-||.|.|||++...+|....|+||+||++|-|++|.+||...... .+..-++..++.+.
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-----aispgMk~rI~~gq 283 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKRRIRTGQ 283 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-----cCChhHHhHhhccC
Confidence 9875432 3334457899999999999999999999999999999999999999865432 22222333333331
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ++-+ ..-...+++..++|+.++..+|.+|-|+.+++.+
T Consensus 284 y-~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y-EFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-cCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1 1111 1112346678889999999999999999999764
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=293.14 Aligned_cols=258 Identities=26% Similarity=0.296 Sum_probs=194.1
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCC--CeEEEEEe
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASE--TEMFLIYN 758 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 758 (963)
|++.+.||+|+||.||+|... ++..||+|++..... .......+|+..+.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 667889999999999999654 689999998865422 22234457888888885 99999999999887 88999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++ ++.+++.... ..+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||++........
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9974 8888887543 4689999999999999999999999 9999999999999999 9999999999987643322
Q ss_pred cccccccccccccCccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH-----------Hh
Q 046851 839 HATTGVAGTFGYVAPEYAM-TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML-----------LR 906 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~ 906 (963)
. ....++..|+|||+.. +..++.++||||+||++|||++|+.||...... ....+.... ..
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-----DQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-----HHHHHHHHHcCCCCHHHHHhhc
Confidence 2 2345788999999765 455788999999999999999999999643221 111111110 00
Q ss_pred cCcccceeccccCC----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 QGRAKEFFTAGLWD----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+.... ......+..+.+++.+|++.+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0012346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=296.31 Aligned_cols=263 Identities=27% Similarity=0.345 Sum_probs=197.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--hHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 755 (963)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+|++++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357999999999999999999764 6899999998754322 123457899999999999999999998654 56899
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++ +|.+++.... ..+++.++..++.|+++|++|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999965 8999887643 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc-----
Q 046851 836 SETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR----- 909 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 909 (963)
.... .....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .....+........
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 161 PAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-----EQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred ccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCChhhch
Confidence 3221 222345788999999875 45788999999999999999999998743211 11111111100000
Q ss_pred ------ccceecc--ccCCC---CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 ------AKEFFTA--GLWDA---GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ------~~~~~~~--~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+.. ..... ........+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 00000 001124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=293.65 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=196.2
Q ss_pred CCCCCccccccCCCccEEEEEECC-CcEEEEEEeecccc-hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|++|.||+|.+.+ ++.||||++..... ....++..|+..+.+.. ||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 478899999999999999998764 89999999875432 23455667777766665 9999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
|+++ ++.++..... ..+++..+..++.|+++|++|||+ . +|+||||+|+||++++++.++|+|||++.......
T Consensus 95 ~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9854 7887776543 468999999999999999999997 5 99999999999999999999999999987654322
Q ss_pred CcccccccccccccCccccccCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 838 THATTGVAGTFGYVAPEYAMTCR----VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.. ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+......... ....
T Consensus 170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~ 239 (296)
T cd06618 170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEE-PPSL 239 (296)
T ss_pred cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCC-CCCC
Confidence 21 2235788999999987553 788999999999999999999998642111 11111111111 0000
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
........++.+++.+||+.||++||++.+++++-
T Consensus 240 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 -------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 01112456789999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=302.86 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=196.5
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-----CeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-----TEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 753 (963)
+++|++.+.||+|+||.||+|.. .+|+.||||++.... .....++.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999965 468999999986432 23346678899999999999999999886543 357
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++|+||+++ ++.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999965 88888764 3589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCc--ccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc-
Q 046851 834 GPSETH--ATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR- 909 (963)
Q Consensus 834 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 909 (963)
...... ......|++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .....+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-----~~~~~~~~~~~~~~~ 231 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-----HQLNLILGVLGTPSQ 231 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCCH
Confidence 432221 1233568899999998765 46888999999999999999999999643210 00111100000000
Q ss_pred ----------ccceecc-ccCCCC-----ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 ----------AKEFFTA-GLWDAG-----PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ----------~~~~~~~-~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....... ...... ......++.+++.+||+.+|++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000000 01234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=320.14 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=211.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC--------CCcEEEEEEeecccc-hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS--------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASE 750 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 750 (963)
.++..+.+.+|+|+||.|++|... ....||||..+.... .+.+.+..|+++++.+. |+||+.++|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 345567779999999999999543 145799999875433 45678999999999994 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhhc------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRS------------T--RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
+..++|+||+..|+|.++++..+ . ..++..+...++.|||.|++||++. +++|||+.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 99999999999999999998765 0 2388899999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCcccccccc--cccccCccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCCC
Q 046851 817 DDDFNAYLSDFGLARLLGPSETHATTGVAG--TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSD-KKALDPSFSSYGN 893 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~ 893 (963)
+++..+||+|||+|+.......+....-.| ...|||||.+....++.++|||||||++|||+|. ..||.. ...
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~~~--- 527 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-IPP--- 527 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-CCc---
Confidence 999999999999999766555554333233 4479999999999999999999999999999995 455542 110
Q ss_pred CcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 894 GFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
..+. ....+. +.+...|..+..+++++|..||+.+|++||++.++++.++..
T Consensus 528 ---~~~l-~~~l~~---------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 ---TEEL-LEFLKE---------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---HHHH-HHHHhc---------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1111 112333 344456778889999999999999999999999999999873
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=291.82 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=200.8
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
|+..+.||+|++|.||+|... +|+.+|+|++...... ....+.+|++++++++|++++++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999764 6899999988654332 4567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++ ++.+++.... ..+++.++..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 76 8988887643 4689999999999999999999999 99999999999999999999999999998775443 12
Q ss_pred cccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC---ccccee--
Q 046851 841 TTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG---RAKEFF-- 914 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 914 (963)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ............. ......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-----DQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCchHhcccchhh
Confidence 2234578899999998876 7889999999999999999999998643211 0000000000000 000000
Q ss_pred ---------ccccC--CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 ---------TAGLW--DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ---------~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+.... .........++.+++.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 00112345688999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=303.10 Aligned_cols=267 Identities=22% Similarity=0.337 Sum_probs=203.9
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeC------CCeEE
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS------ETEMF 754 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~ 754 (963)
.|...+.+|+|+||.||+|++ .+|+.||||.+... .....++..+|++++++++|+|||+++++-.+ .....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 456778899999999999985 47999999998753 34456788999999999999999999987544 34568
Q ss_pred EEEeccCCCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC--CCCc--EEEeeccc
Q 046851 755 LIYNYLPGGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD--DDFN--AYLSDFGL 829 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~--~kl~Dfgl 829 (963)
+|||||.||||+.++.+-. ...+++.+.+.++..++.||.|||++ +||||||||.||++- .+|. -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999998644 35699999999999999999999999 999999999999984 4443 79999999
Q ss_pred ccccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
|+...+.. ...+++||..|.+||.... +.|+..+|.|||||++|++.||..||.+...+... .+.++......
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~----~~~~~~~~tkk 244 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN----KEIMWHIITKK 244 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc----chhhhhhhccC
Confidence 99886443 5667899999999999995 78888999999999999999999999866544211 11222221111
Q ss_pred --cccceeccccCC--------CCC----hhHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHhcc
Q 046851 909 --RAKEFFTAGLWD--------AGP----HDDLVEVLHLAVVCTVDSLSTRP--TMKQVVRRLKQL 958 (963)
Q Consensus 909 --~~~~~~~~~~~~--------~~~----~~~~~~l~~l~~~cl~~dP~~RP--s~~evl~~L~~l 958 (963)
.+.....+...+ +.+ .....++...+..++..+|++|- .+.++...+.+|
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 111111111111 112 22345667788888899999998 666666655543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=289.61 Aligned_cols=242 Identities=24% Similarity=0.308 Sum_probs=188.2
Q ss_pred ccccCCCccEEEEEE-CCCcEEEEEEeecccch---hHHHHHHHHH---HHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 689 CIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQ---GVQQFHAEIK---TLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 689 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.||+|+||.||+|.. .+|+.||+|.+...... ....+..|.. .++...||+++++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 45889999988654321 1122333433 3444579999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++... ..+++.++..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999998753 4589999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred ccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....|+..|+|||++.+. .++.++||||+|+++|||++|+.||....... .... ...... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~----------~~~ 216 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEI-DRMTLT----------MAV 216 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHHH-HHHhhc----------cCC
Confidence 234689999999998754 68899999999999999999999997542210 0000 000000 001
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
..+...+..+.+++.+|+..+|++|| ++.+++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 12223456889999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=288.37 Aligned_cols=243 Identities=23% Similarity=0.273 Sum_probs=189.5
Q ss_pred cccccCCCccEEEEEEC-CCcEEEEEEeecccch---hHHHHHHHHHH-HhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ---GVQQFHAEIKT-LGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|... +|+.||||++...... ....+..|... ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999664 5899999998654321 22334455444 4455899999999999999999999999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||++++++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 9999999764 3588999999999999999999999 999999999999999999999999999875432 22
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...+++.|+|||.+.+..++.++||||+|+++|||++|..||..... ........ ..... .....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~------~~~~~ 216 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNIL-SRRIN------WPEEV 216 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-hcccC------CCCcc
Confidence 34678899999999988889999999999999999999999964321 11111111 11100 00011
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
....+..+.+++.+||+.+|++||++.++.+.+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 123456789999999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=298.56 Aligned_cols=263 Identities=27% Similarity=0.367 Sum_probs=198.1
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC--CCeE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS--ETEM 753 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~ 753 (963)
..++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++ +||||+++++++.. ....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3457999999999999999999765 5889999988542 233445678899999999 99999999998864 3468
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++ +|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~~-~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEeccccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 999999975 999998753 588999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC----cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH----
Q 046851 834 GPSET----HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML---- 904 (963)
Q Consensus 834 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 904 (963)
..... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~ 232 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-----NQLEKIIEVIGPP 232 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCC
Confidence 43322 12233568899999998765 45788999999999999999999998643211 000000000
Q ss_pred -------HhcCcccceec----cccC--CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 -------LRQGRAKEFFT----AGLW--DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 -------~~~~~~~~~~~----~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........+++ .... .......+..+.+++.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000 0000 00011145678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=291.81 Aligned_cols=265 Identities=25% Similarity=0.349 Sum_probs=198.4
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEecc
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
|++.+.||+|++|+||+|... +++.||||++..... .......+|+..+.+++ |+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999875 478899998865432 22234567999999999 999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
+|++.+++.......+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 77999999876545689999999999999999999999 999999999999999999999999999986543222
Q ss_pred cccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCC--------CCcchhhHHHHHHhcCccc
Q 046851 841 TTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYG--------NGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 911 (963)
.....++..|+|||++.+ ..++.++|+||||+++|||++|++||........ .......|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 223467889999998754 4578899999999999999999999864321100 0000001111111111111
Q ss_pred ceeccccC---CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLW---DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+..... .........++.+++.+||+.+|++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00011224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=291.91 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=204.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 756 (963)
++|.+.+.||+|+||.||+|... +|..||+|++.... ....+.+..|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36889999999999999999765 68999999886532 233466788999999998 99999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999874 3599999999999999999999999 9999999999999999999999999999876533
Q ss_pred CC-------------------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcch
Q 046851 837 ET-------------------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNI 897 (963)
Q Consensus 837 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~ 897 (963)
.. .......++..|+|||...+..++.++||||+|++++++++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------- 227 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------- 227 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--------
Confidence 21 222334678899999999988899999999999999999999999874321
Q ss_pred hhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCH----HHHHHH
Q 046851 898 VAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM----KQVVRR 954 (963)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~~ 954 (963)
......... .....+...+..+.+++.+||+.+|++||++ ++++++
T Consensus 228 ~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111111111 1111233346678999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=277.43 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=215.5
Q ss_pred HHHHHcCCCCCccccccCCCccEEEEEECC------CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeee
Q 046851 676 SVVQATGNFNASNCIGNGGFGATYKAEISP------GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748 (963)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 748 (963)
++.....+++....+-+|.||.||+|.|.+ .+.|-||.++... .-....+..|.-.+..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 444445678888899999999999996653 3456777665432 234567889999999999999999999875
Q ss_pred C-CCeEEEEEeccCCCChHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc
Q 046851 749 S-ETEMFLIYNYLPGGNLENFIQQRS------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN 821 (963)
Q Consensus 749 ~-~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 821 (963)
+ .+..+++|.++.-|+|..|+...+ .+.++..+...++.|++.|++|||++ ++||.||.++|.++|+...
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhee
Confidence 5 566789999999999999998432 34566778889999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCccc-ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhh
Q 046851 822 AYLSDFGLARLLGPSETHAT-TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 822 ~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 899 (963)
+||+|=.+++.+.+.+.+.- .....+..||+||.+....|+.++|||||||++|||+| |+.|+.+-++.
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--------- 505 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--------- 505 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---------
Confidence 99999999998877765542 33446679999999999999999999999999999998 67787644332
Q ss_pred HHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
++..++.++.+...|..|+.+++.+|.-||..+|++||++++++..|.++
T Consensus 506 ---------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 506 ---------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ---------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 12333445566677889999999999999999999999999999999875
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=294.64 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=195.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC-------
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET------- 751 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 751 (963)
++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47999999999999999999765 689999998865432 22345678999999999999999999886543
Q ss_pred -eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 752 -EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 752 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
..++||||+.+ ++.+++.... ..+++.++..++.|+++|++|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 8888887543 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 831 RLLGPSETH---ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 831 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
......... ......++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... .....+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-----~~~~~~~~~~~ 241 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-----HQLTLISQLCG 241 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhC
Confidence 866433221 12234578899999988764 4688999999999999999999998644221 11111111110
Q ss_pred c--------CcccceeccccCCC----------CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 Q--------GRAKEFFTAGLWDA----------GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~--------~~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .......+...... .+......+.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 00000000000000 000123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=300.50 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=198.8
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC----CCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS----ETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 753 (963)
.++|++.+.||+|++|.||+|... +|..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999654 69999999987542 2335677889999999999999999987753 3568
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+. ++|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 5999998753 3489999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCc---ccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh---
Q 046851 834 GPSETH---ATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR--- 906 (963)
Q Consensus 834 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 906 (963)
...... ......|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~g~~~ 232 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVLGSPS 232 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHhCCCh
Confidence 432211 1223468899999999865 45788999999999999999999999643211 00011000000
Q ss_pred --------cCcccceeccc-cCCCC-----ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 --------QGRAKEFFTAG-LWDAG-----PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 --------~~~~~~~~~~~-~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........+.. ..... ....+.++.+++.+|++.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 00001 12235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=300.15 Aligned_cols=265 Identities=25% Similarity=0.341 Sum_probs=200.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-----Ce
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-----TE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 752 (963)
.++|.+.+.||+|+||+||+|... ++..||||.+... ......++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999654 6899999988643 223345678899999999999999999987643 35
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||+. ++|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 6999998753 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh-----
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR----- 906 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 906 (963)
..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ...........
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-----HQLKLITELLGSPSEE 231 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCChH
Confidence 64332 22233457889999998865 46889999999999999999999998643110 00000000000
Q ss_pred ------cCccccee-------ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 046851 907 ------QGRAKEFF-------TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQL 958 (963)
Q Consensus 907 ------~~~~~~~~-------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l 958 (963)
.......+ +.... ........++.+++.+|++.+|++|||++|++++ ++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000 00000 0112345678899999999999999999999987 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=273.50 Aligned_cols=240 Identities=25% Similarity=0.310 Sum_probs=199.4
Q ss_pred CCCCCccccccCCCccEEEEE-ECCCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|+..+++|+|.||.|..++ ..+|+.||+|+++++-. .....-..|-++++..+||.+..+...|+..++.|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 579999999999999999995 45799999999986643 23344577999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+.||.|.-++.+. +.+++...+.+-.+|..||.|||++ +||.||+|.+|.++|.||++||+|||+++.-. ..
T Consensus 248 eyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KY 321 (516)
T ss_pred EEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-cc
Confidence 999999999888763 5589999999999999999999999 99999999999999999999999999998643 22
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
...+...+|||.|.|||++....|..++|.|.+||++|||++|+.||...+.+ .+.+.+ ...+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----kLFeLI--l~ed---------- 384 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----KLFELI--LMED---------- 384 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----HHHHHH--Hhhh----------
Confidence 34456789999999999999999999999999999999999999999744322 111111 0000
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCC
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRP 946 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 946 (963)
..+|.....+...|+.-.+..||.+|-
T Consensus 385 --~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 --LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 113444555777888899999999996
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=293.04 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=196.8
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc---cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG---RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.|+..+.||+|+||.||+|... ++..||+|.+... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4777788999999999999764 5788999988642 22334578889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+. |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 58888876543 4589999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 839 HATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||...... ..... ........
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~-~~~~~~~~--- 233 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYH-IAQNESPA--- 233 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHH-HhhcCCCC---
Confidence 2345788999999975 346788999999999999999999998632111 11111 11111110
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
.........+.+++.+||+.+|++||++.+++++-.
T Consensus 234 -----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 -----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -----cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 112234567889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=297.86 Aligned_cols=265 Identities=26% Similarity=0.371 Sum_probs=203.7
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC-----eEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET-----EMF 754 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 754 (963)
+|++.+.||+|++|.||+|... +|..||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788999999999999999765 48999999887543 334567899999999999999999999987765 789
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++ +|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 81 lv~e~~~~-~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMET-DLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhh-hHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99999975 899998764 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH------
Q 046851 835 PSET--HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL------ 905 (963)
Q Consensus 835 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 905 (963)
.... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...... .....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLIVEVLGTPSEE 229 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHhcCCCChh
Confidence 4321 122334678899999999887 7899999999999999999999998644211 0000000000
Q ss_pred -----hcCcccceecccc------CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 046851 906 -----RQGRAKEFFTAGL------WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQL 958 (963)
Q Consensus 906 -----~~~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l 958 (963)
........+.... ........+..+.+++.+||+.+|++||++.+++++ ++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000000000000 000111245678899999999999999999999985 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=291.84 Aligned_cols=244 Identities=26% Similarity=0.399 Sum_probs=194.3
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
|...+.||+|+||+||+|... +|+.||+|++..... ...+.+..|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999764 688999999865432 3345688899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+. |++.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 58888876543 4589999999999999999999999 999999999999999999999999999864321
Q ss_pred ccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 840 ATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.....|+..|+|||++. +..++.++||||||+++|||++|..||..... ........... ....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~-~~~~--- 240 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQND-SPTL--- 240 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcC-CCCC---
Confidence 22346888999999984 45678899999999999999999999864321 11111111111 1111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........+.+++.+|++.+|.+||++.+++++
T Consensus 241 -----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233468899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=296.85 Aligned_cols=260 Identities=21% Similarity=0.331 Sum_probs=196.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC------Ce
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE------TE 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 752 (963)
++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 68999999999999999999754 68999999886532 22235678999999999999999999988643 35
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++|+||+.. ++.++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 6999999965 7777653 3489999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC--c
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG--R 909 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~ 909 (963)
... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......... .
T Consensus 167 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~ 234 (342)
T cd07879 167 ADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--------DQLTQILKVTGVP 234 (342)
T ss_pred CCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhcCCC
Confidence 432 2223467889999999876 46888999999999999999999999743211 0011100000 0
Q ss_pred ------------ccceecc--ccCC----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhccCCC
Q 046851 910 ------------AKEFFTA--GLWD----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQLQPA 961 (963)
Q Consensus 910 ------------~~~~~~~--~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l~~~ 961 (963)
....... .... .........+.+++.+||+.||++||++++++++ ++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000000 0000 0001234568899999999999999999999966 6665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=315.17 Aligned_cols=258 Identities=22% Similarity=0.284 Sum_probs=208.9
Q ss_pred HHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc---cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC
Q 046851 676 SVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG---RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET 751 (963)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (963)
++....++|.+.++||+|+||.|..++.+ +++.||+|++.+- ...+..-|..|-.+|..-..+-|+.++.+|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44444578999999999999999999775 6889999998762 2334567899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
+.|+|||||+||+|-.++.+.. .+++..+..++..|.-||.-+|+. |+|||||||+|||+|..|++|++|||-+.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999999998864 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccc----c-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAM----T-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
....+..-.....+|||-|.+||++. + +.|.+.+|.||+||++|||+.|..||..+ ++++....+..
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------slveTY~KIm~ 295 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------SLVETYGKIMN 295 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------HHHHHHHHHhc
Confidence 88766655666678999999999986 2 56889999999999999999999999844 23333222222
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT---MKQVVRR 954 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 954 (963)
..+.-.+. ...+.++...+||.+.+. +|+.|-. +.++-.|
T Consensus 296 hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 296 HKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 21111111 113356677777777665 6777776 7776554
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=287.29 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=196.5
Q ss_pred CCCCccccccCCCccEEEEEECC-CcEEEEEEeecc-----cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVG-----RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999996653 445666655431 122334567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 757 YNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
|||+++++|.+++... ....+++.++..++.|+++|+.|||+. +++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998752 245689999999999999999999999 9999999999999975 569999999987764
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
.... ......|++.|+|||...+..++.++|+||+|+++|+|++|..||.... ......... .+.
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~-~~~----- 221 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIV-EGP----- 221 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHH-cCC-----
Confidence 3322 2233467889999999988888999999999999999999999986321 111111111 111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+...+.++.+++.+|++.+|++||++.|++++
T Consensus 222 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 ----TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ----CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111233455688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=271.30 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=197.7
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.+-...||.|+||+|+|-.++ .|+..|||++..... .+.+++..|.++..+- ++|+||+++|++-.++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 334456999999999999776 589999999987655 4457888888875554 6999999999999999999999999
Q ss_pred CCCChHHHH---hhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 761 PGGNLENFI---QQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 761 ~~gsL~~~l---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
+- |+..+- ..-....+++.-+-+|+....+||.||-+.. .|+|||+||+|||++..|.+|+||||.+-.+..
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-- 220 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-- 220 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence 55 766543 3333456888888899999999999998875 999999999999999999999999999977643
Q ss_pred CcccccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 838 THATTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
+...+.-+|...|||||.+.. ..|.-++||||+|+++||+.||+.|+... .+..+.+.+..... .+.+..
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-------~svfeql~~Vv~gd-pp~l~~ 292 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-------DSVFEQLCQVVIGD-PPILLF 292 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-------HHHHHHHHHHHcCC-CCeecC
Confidence 333444578999999999974 35888999999999999999999998733 22333344433333 222211
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
+ ....+....+..++..|+-+|-+.||...++.+
T Consensus 293 ~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 D----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred c----ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1 112345667899999999999999999998865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=293.86 Aligned_cols=266 Identities=25% Similarity=0.362 Sum_probs=198.7
Q ss_pred HHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC-CCe
Q 046851 677 VVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS-ETE 752 (963)
Q Consensus 677 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 752 (963)
+...+++|++.+.||+|+||.||+|... +|..||||++.... ....+.+..|++++++++|||++++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999654 78999999885432 2334677899999999999999999998865 567
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 89999999 5699988864 3478888999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC-------CcchhhHHHHH
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN-------GFNIVAWGCML 904 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~ 904 (963)
... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......... +....++....
T Consensus 158 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 432 1223457889999998766 56889999999999999999999998643210000 00000011000
Q ss_pred HhcCcccceecc-ccCCCCC-----hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 LRQGRAKEFFTA-GLWDAGP-----HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 ~~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... ..+++.. ......+ ......+.+++.+|++.+|++||++.+++.+
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000 0001111 1234678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=287.01 Aligned_cols=259 Identities=26% Similarity=0.400 Sum_probs=199.1
Q ss_pred CCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 684 FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
|+..+.||+|++|.||+|... +++.||+|++.... ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999776 48999999987653 233467788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
+ ++|.+++.... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 49999998753 3589999999999999999999999 999999999999999999999999999987643322 2
Q ss_pred cccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh-------------
Q 046851 841 TTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR------------- 906 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 906 (963)
.....++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... .....+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-----DQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHHHhCCCcHHHHHhhccc
Confidence 2233467789999998776 7889999999999999999999988643211 00000100000
Q ss_pred ---cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 ---QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
............ ..........+.+++.+|+..+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000000 00011125678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=298.35 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=194.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC----------
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE---------- 750 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 750 (963)
++|.+.+.||+|+||.||+|... +|..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 58999999999999999999664 6899999999776666667789999999999999999999776543
Q ss_pred ----CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEe
Q 046851 751 ----TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLS 825 (963)
Q Consensus 751 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~ 825 (963)
...++||||++ ++|.+++.. ..+++..+..++.|+++|++|||+. +++||||||+||+++. ++.++++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 499988864 3488999999999999999999999 9999999999999984 5678999
Q ss_pred ecccccccCCCCCcc--cccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHH
Q 046851 826 DFGLARLLGPSETHA--TTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGC 902 (963)
Q Consensus 826 Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 902 (963)
|||.+.......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+.. .......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~~~~ 233 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE----QMQLILE 233 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH
Confidence 999997654322111 122357889999998754 567889999999999999999999996442210 0000000
Q ss_pred H----------HHhcCcccceeccccCCCC-----ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 903 M----------LLRQGRAKEFFTAGLWDAG-----PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 903 ~----------~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ................... ......++.+++.+|++.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 0000000000000000000 11234578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=294.25 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=195.8
Q ss_pred CCCC-CccccccCCCccEEEEEEC-CCcEEEEEEeecccchh--------------HHHHHHHHHHHhccCCCCeeEEEE
Q 046851 682 GNFN-ASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQG--------------VQQFHAEIKTLGRLRHPNLVTLIG 745 (963)
Q Consensus 682 ~~~~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 745 (963)
++|. +.+.||+|+||.||+|... +++.||||++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999754 68999999886542211 125778999999999999999999
Q ss_pred eeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEe
Q 046851 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825 (963)
Q Consensus 746 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 825 (963)
++..++..++||||++ |+|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999997 5999998753 3589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCC-------------CcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 046851 826 DFGLARLLGPSE-------------THATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSY 891 (963)
Q Consensus 826 Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~ 891 (963)
|||++....... ........+++.|+|||.+.+. .++.++||||+|+++|||++|+.||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 999997664111 1111223467899999998764 4688999999999999999999998744321
Q ss_pred CCCcchhhHHHHHHhcCc---cccee--------cccc---CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 892 GNGFNIVAWGCMLLRQGR---AKEFF--------TAGL---WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~---~~~~~--------~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+........ ..... .... ...........+.+++.+|++.+|++||+++|++.+
T Consensus 241 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 ----DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ----HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111111111000 00000 0000 000011234678899999999999999999999864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=293.02 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=194.7
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--hHHHHHHHHHHHhccCCCCeeEEEEeeeCC-------
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVTLIGYHASE------- 750 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 750 (963)
.++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999765 6899999988654322 234568899999999999999999876443
Q ss_pred -CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccc
Q 046851 751 -TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829 (963)
Q Consensus 751 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 829 (963)
...++||||+.+ ++.+.+... ...+++.++..++.|+++||+|||+. +++||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 356999999965 787777653 34689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc----------ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchh
Q 046851 830 ARLLGPSETH----------ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIV 898 (963)
Q Consensus 830 a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~ 898 (963)
+......... ......+++.|+|||.+.+. .++.++||||+|+++|||++|++||...... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----~~~ 236 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----DQL 236 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence 9765432211 11234568889999988654 5788999999999999999999998643221 000
Q ss_pred hHHHHHHhcC---------cccceeccccCCCCC-------hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 899 AWGCMLLRQG---------RAKEFFTAGLWDAGP-------HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 899 ~~~~~~~~~~---------~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+......... ......+.......+ ......+.+++.+|++.+|++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000000000 000000000000000 1123568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=294.42 Aligned_cols=262 Identities=21% Similarity=0.332 Sum_probs=195.4
Q ss_pred HcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC-----
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET----- 751 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 751 (963)
..++|++.+.||+|+||.||+|.. .+|..||||++.... ......+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456899999999999999999964 478999999885432 223456789999999999999999999886543
Q ss_pred -eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 752 -EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 752 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999 6799988864 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC-------CcchhhHHH
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN-------GFNIVAWGC 902 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~ 902 (963)
...... .....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||......... ......+..
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 765322 223457889999999876 45788999999999999999999999743211000 000000000
Q ss_pred HHHhcCcccceecc--ccC----CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 903 MLLRQGRAKEFFTA--GLW----DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 903 ~~~~~~~~~~~~~~--~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
.. ........... ... ..........+.+++.+|++.||++|||+.++++
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 242 KL-QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hh-cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000000000 000 0011233456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=293.80 Aligned_cols=266 Identities=21% Similarity=0.346 Sum_probs=198.7
Q ss_pred hHHHHHHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC
Q 046851 674 FESVVQATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE 750 (963)
Q Consensus 674 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 750 (963)
.+++...+++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345667788999999999999999999964 468999999986532 22345678899999999999999999987542
Q ss_pred ------CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 751 ------TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 751 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
...+++++++ +++|.+++.. ..+++..+..++.|+++|++|||+. +++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 3467888887 7799988864 3489999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 825 SDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
+|||++..... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .........
T Consensus 162 ~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~ 233 (345)
T cd07877 162 LDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQLKLILRL 233 (345)
T ss_pred ecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHH
Confidence 99999876432 2233467889999999876 46788999999999999999999998633211 000000000
Q ss_pred H----------HhcCcccce---ec---cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 904 L----------LRQGRAKEF---FT---AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 904 ~----------~~~~~~~~~---~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ........+ ++ +.............+.+++.+|++.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 000000000 00 000000001234568899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=295.79 Aligned_cols=262 Identities=23% Similarity=0.388 Sum_probs=213.9
Q ss_pred CChHHHHHHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeee-
Q 046851 672 LSFESVVQATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHA- 748 (963)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 748 (963)
..++.+...++.|++.+.||+|.+|.||+++. ++|+.+|||+.......+ ++++.|+++++.. .|||++.++|++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34455556778899999999999999999954 468899999876554433 5678899999888 4999999999874
Q ss_pred ----CCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 749 ----SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 749 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
.+++.|+|||||.+||..|+++.-.+..+.|+.+..|+++++.|+.+||.. .++|||||-.|||++.++.||+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 367899999999999999999887788899999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccCcccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhh
Q 046851 825 SDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT-----CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~ 899 (963)
+|||.+..... .........|||.|||||++.. ..|+.++|+||+|++..||--|.+|+-+..+.
T Consensus 165 vDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------- 234 (953)
T KOG0587|consen 165 VDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------- 234 (953)
T ss_pred eeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------
Confidence 99999987653 3344455689999999999964 34667899999999999999999998755443
Q ss_pred HHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+..+... -.+......+..-.+++-++|..|+..|-++||++.+++++
T Consensus 235 --raLF~Ip-----RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 --RALFLIP-----RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --hhhccCC-----CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111111 11222223345557789999999999999999999998764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=310.62 Aligned_cols=145 Identities=30% Similarity=0.484 Sum_probs=131.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +++.||||++..... .....+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999766 689999999875432 23467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
||+++++|.+++... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999764 3588999999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=278.10 Aligned_cols=236 Identities=29% Similarity=0.364 Sum_probs=194.3
Q ss_pred cccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 690 IGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
||+|+||.||++... +++.||+|++..... .....+..|++++++++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999765 589999999875533 2456789999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccccc
Q 046851 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845 (963)
Q Consensus 766 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 845 (963)
.+++... ..+++..+..++.|+++|+.|+|+. +++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 9999864 3589999999999999999999999 99999999999999999999999999998764332 1233456
Q ss_pred ccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChh
Q 046851 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHD 925 (963)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (963)
++..|+|||...+...+.++|+||||+++||+++|+.||..... ......... . ....+..
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~----------~~~~~~~ 215 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-D----------PLRFPEF 215 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-C----------CCCCCCC
Confidence 78899999999988889999999999999999999999863321 111111111 1 1112333
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHH
Q 046851 926 DLVEVLHLAVVCTVDSLSTRPTMKQ 950 (963)
Q Consensus 926 ~~~~l~~l~~~cl~~dP~~RPs~~e 950 (963)
.+..+.+++.+||..||++||++++
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3567889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=293.33 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=196.6
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe----
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE---- 752 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 752 (963)
..++|++.+.||+|++|.||+|... ++..||||++.... ....+.+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4568999999999999999999775 58899999886432 2334567789999999999999999988766554
Q ss_pred --EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 753 --MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 753 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||+|+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 6699999875 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh---
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR--- 906 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 906 (963)
...... .....++..|+|||...+ ..++.++||||+|+++|||++|+.||...... ...........
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-----~~~~~i~~~~~~~~ 236 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-----DQLKRIMNLVGTPD 236 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHhcCCCC
Confidence 865432 233467889999999865 36788999999999999999999998643211 00000000000
Q ss_pred --------cCcccceeccccCC---C---CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 --------QGRAKEFFTAGLWD---A---GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 --------~~~~~~~~~~~~~~---~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......++...... . .......++.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000 0 001235678899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=276.28 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=199.3
Q ss_pred cCCCCCccccccCCCccEEEE-EECCCcEEEEEEeecccc--hh-----HHHHHHHHHHHhccCCCCeeEEEEeee-CCC
Q 046851 681 TGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRF--QG-----VQQFHAEIKTLGRLRHPNLVTLIGYHA-SET 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~--~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~ 751 (963)
.++|-+...+|+|||+.||+| ++...+.||||+-..... +. .+...+|.++.+.+.||.||++|+|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 346888899999999999999 667788999997654321 11 234578999999999999999999986 467
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC---CCCcEEEeecc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD---DDFNAYLSDFG 828 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg 828 (963)
.+|-|.||++|-+|.-|++.. +.+++.++..|+.||+.||.||.+. +|+|||-|+||.|||+- .-|.+||+|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999999875 4589999999999999999999998 78999999999999995 45789999999
Q ss_pred cccccCCCCCc------ccccccccccccCccccccC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchh
Q 046851 829 LARLLGPSETH------ATTGVAGTFGYVAPEYAMTC----RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIV 898 (963)
Q Consensus 829 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~ 898 (963)
+++....+... -+....||.+|++||.+.-+ +.+.|+||||.|||+|+++.|+.||..+...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-------- 690 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-------- 690 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--------
Confidence 99987644322 23345799999999988633 5678999999999999999999999855332
Q ss_pred hHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 899 AWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
..++....+....+-.+ ........+...+|.+|+++--++|.+..++..
T Consensus 691 ---QdILqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 ---QDILQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ---HHHHhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11122221111111111 111234557788999999999999988777653
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=286.98 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=192.3
Q ss_pred CCCCccccccCCCccEEEEEEC-C--CcEEEEEEeeccc--chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC----CCe
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-P--GVLVAIKRLAVGR--FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS----ETE 752 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 752 (963)
+|++.+.||+|+||.||+|... . +..||+|++.... ....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999765 3 6789999886432 22346778899999999 59999999987532 345
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++++||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999986 599999875 34589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc---ccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC-------CcchhhHH
Q 046851 833 LGPSETH---ATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN-------GFNIVAWG 901 (963)
Q Consensus 833 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~ 901 (963)
....... ......|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||......... +....++.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6432211 1233568999999998765 46889999999999999999999998643210000 00000000
Q ss_pred HHHHhcCcccce---ecc---ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 902 CMLLRQGRAKEF---FTA---GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 902 ~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....... .... ... .............+.+++.+|++.+|++|||+.+++++
T Consensus 235 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPK-AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred Hhhhhhh-HHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000 000 00000011224578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=273.26 Aligned_cols=260 Identities=20% Similarity=0.290 Sum_probs=201.7
Q ss_pred cCCCCCccccccCCCccEEEEE-ECCCcEEEEEEeecccchhHHHHHHHHHHHhccC--CCC----eeEEEEeeeCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR--HPN----LVTLIGYHASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~l~~~~~~~~~~ 753 (963)
+++|.+...+|+|.||.|-++. ...+..||||+++.-... .+..+-|++++.++. -|+ ++.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6789999999999999999994 445899999988643221 244577999999993 222 78888899999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC----------------
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD---------------- 817 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---------------- 817 (963)
++|+|.+ |.|+.+++..+.-.+++...+..|+.|+++++++||+. +++|.|+||+||++.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999 66999999998888899999999999999999999999 999999999999992
Q ss_pred ----CCCcEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 046851 818 ----DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN 893 (963)
Q Consensus 818 ----~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~ 893 (963)
.+..++|+|||-|.+..... ..++.|..|+|||++.+-.++.++||||+||||+|+.+|..-|+....
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen---- 314 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN---- 314 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc----
Confidence 13458999999998754332 456789999999999999999999999999999999999998875431
Q ss_pred CcchhhHHHHHHhcCc--------ccceeccc-------------------cC-----CCCChhHHHHHHHHHHHcccCC
Q 046851 894 GFNIVAWGCMLLRQGR--------AKEFFTAG-------------------LW-----DAGPHDDLVEVLHLAVVCTVDS 941 (963)
Q Consensus 894 ~~~~~~~~~~~~~~~~--------~~~~~~~~-------------------~~-----~~~~~~~~~~l~~l~~~cl~~d 941 (963)
.+.+ +++..+..... ..+++... .. -.....+..++.+|+..|+..|
T Consensus 315 ~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 315 LEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 1111 22222222110 00000000 00 0112334567999999999999
Q ss_pred CCCCCCHHHHHHH
Q 046851 942 LSTRPTMKQVVRR 954 (963)
Q Consensus 942 P~~RPs~~evl~~ 954 (963)
|.+|+|+.|++++
T Consensus 394 P~~RiTl~EAL~H 406 (415)
T KOG0671|consen 394 PARRITLREALSH 406 (415)
T ss_pred ccccccHHHHhcC
Confidence 9999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-33 Score=265.13 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=195.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeC--------C
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--------E 750 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 750 (963)
+.|.-..+||+|.||+||+|+.+ +|+.||+|++..++. .-.....+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45777788999999999999765 578899987654322 112455889999999999999999987743 3
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
..+++||++++. +|.-.+... ...++..++.+++.++.+||.|+|+. .|+|||+||.|||++.+|.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 458999999987 999888764 35689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 831 RLLGPSETH---ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 831 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
+.+...... ..+..+-|..|++||.+.|. .|+++.|||..|||+.||+||.+-+..+.+. ....+.........
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql~~Is~LcGs~t 249 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQLHLISQLCGSIT 249 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHHHHHHHHhccCC
Confidence 876533222 12334568999999999874 6899999999999999999999888755432 00011111110111
Q ss_pred cCcccceeccccCC----------CC--------ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 QGRAKEFFTAGLWD----------AG--------PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~~~~~~~~~~~~----------~~--------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+.++.+..-.+.. .+ |-....+..+|+..++..||.+|+++.+++.+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111111100000 00 00012257789999999999999999999865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=273.30 Aligned_cols=220 Identities=25% Similarity=0.230 Sum_probs=177.2
Q ss_pred CCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhh
Q 046851 693 GGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQ 771 (963)
Q Consensus 693 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 771 (963)
|.+|.||++.. .+++.||+|++.... .+..|...+....|||++++++++...+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999965 468999999987543 233455555566799999999999999999999999999999999976
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccccccccccc
Q 046851 772 RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851 (963)
Q Consensus 772 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ 851 (963)
.. .+++..+..++.|+++|++|+|+. +++||||||+||+++.++.++++|||.+...... .....++..|+
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 43 489999999999999999999999 9999999999999999999999999988665432 12234577899
Q ss_pred CccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHH
Q 046851 852 APEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVL 931 (963)
Q Consensus 852 aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 931 (963)
|||...+..++.++||||+|+++|||++|+.|+....... ... .....+......+.
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~----~~~~~~~~~~~~~~ 206 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTH----TTLNIPEWVSEEAR 206 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------ccc----cccCCcccCCHHHH
Confidence 9999988888999999999999999999998865321110 000 00011223456788
Q ss_pred HHHHHcccCCCCCCCCHH
Q 046851 932 HLAVVCTVDSLSTRPTMK 949 (963)
Q Consensus 932 ~l~~~cl~~dP~~RPs~~ 949 (963)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=315.51 Aligned_cols=480 Identities=25% Similarity=0.293 Sum_probs=298.3
Q ss_pred EEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeeccccc
Q 046851 7 LDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSFNRL 83 (963)
Q Consensus 7 L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~n~l 83 (963)
+|++.+.+. .+|..+..-..++.|+++.|-+-...-+...+--.|+.|||++|+++ ..|..+. +|+.|.++.|-+
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 455555555 44444433333566666665544221222233333555555555555 3333322 344555555555
Q ss_pred cccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcC
Q 046851 84 VGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD 163 (963)
Q Consensus 84 ~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 163 (963)
. .+|.... ++.+|++|.|.+|++. ..|..+..+++|++|+++.|++. ..|..+..+..+..+..++|.....++..
T Consensus 81 ~-~vp~s~~-~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~ 156 (1081)
T KOG0618|consen 81 R-SVPSSCS-NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQT 156 (1081)
T ss_pred h-hCchhhh-hhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccc
Confidence 4 4443332 3455555555555544 44555555555555555555554 34444455555555555555111111111
Q ss_pred ccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccc
Q 046851 164 LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACD 243 (963)
Q Consensus 164 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 243 (963)
. ++.++ +..|.+.+.++..+..+.. .|+|.+|++. -..+.++.
T Consensus 157 ~-----ik~~~---------------------------l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~ 199 (1081)
T KOG0618|consen 157 S-----IKKLD---------------------------LRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLA 199 (1081)
T ss_pred c-----chhhh---------------------------hhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhcc
Confidence 1 23333 3335555555555555555 5777777765 22355666
Q ss_pred cCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCccccccc
Q 046851 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRN 323 (963)
Q Consensus 244 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n 323 (963)
+|+.|....|++..+... -++|+.|+.++|.++... .......|+.+|++.|++.+.+..+..+.+|+.+...+|
T Consensus 200 ~l~~l~c~rn~ls~l~~~----g~~l~~L~a~~n~l~~~~-~~p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N 274 (1081)
T KOG0618|consen 200 NLEVLHCERNQLSELEIS----GPSLTALYADHNPLTTLD-VHPVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHN 274 (1081)
T ss_pred chhhhhhhhcccceEEec----CcchheeeeccCcceeec-cccccccceeeecchhhhhcchHHHHhcccceEecccch
Confidence 677777777776665432 256677777777766221 122334566777777777766655666667777777777
Q ss_pred ccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCC-cceEEEEEcCCCcccCCCC
Q 046851 324 LFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLG-KQTVYAIVAGDNKLSGSFP 402 (963)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~l~~~~n~~~~~~p 402 (963)
.+..++......+.+.+.... .|.+. .+| ..+. ...+..|++..|++. .+|
T Consensus 275 ~l~~lp~ri~~~~~L~~l~~~--------------------~nel~-yip------~~le~~~sL~tLdL~~N~L~-~lp 326 (1081)
T KOG0618|consen 275 RLVALPLRISRITSLVSLSAA--------------------YNELE-YIP------PFLEGLKSLRTLDLQSNNLP-SLP 326 (1081)
T ss_pred hHHhhHHHHhhhhhHHHHHhh--------------------hhhhh-hCC------Ccccccceeeeeeehhcccc-ccc
Confidence 666555444333332222111 11111 011 1112 346788999999996 677
Q ss_pred cccccccCC-cceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhh
Q 046851 403 GNMFGICNR-LDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTL 481 (963)
Q Consensus 403 ~~~~~~~~~-l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~ 481 (963)
+.+|..... ++ .|+.+.|.+. ..|..-......|+.|.+.+|.++...-..+.++.+|+.|+|++|++.......+
T Consensus 327 ~~~l~v~~~~l~--~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~ 403 (1081)
T KOG0618|consen 327 DNFLAVLNASLN--TLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKL 403 (1081)
T ss_pred hHHHhhhhHHHH--HHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHH
Confidence 777776655 55 6788888887 6664444445679999999999998888889999999999999999965556678
Q ss_pred ccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCC-cCCCCccccccCc
Q 046851 482 GQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG-KIPSGLANVSTLS 560 (963)
Q Consensus 482 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~ 560 (963)
.++..|++|+||+|+++ .+|..+.+++.|++|...+|+|. ..| .+..++.|+.+|+|.|+|+. .+|... ..++|+
T Consensus 404 ~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~-p~p~Lk 479 (1081)
T KOG0618|consen 404 RKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL-PSPNLK 479 (1081)
T ss_pred hchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC-CCcccc
Confidence 99999999999999999 89999999999999999999998 667 89999999999999999983 334333 338999
Q ss_pred eEeeccccC
Q 046851 561 AFNVSFNNL 569 (963)
Q Consensus 561 ~l~l~~N~l 569 (963)
+||+++|..
T Consensus 480 yLdlSGN~~ 488 (1081)
T KOG0618|consen 480 YLDLSGNTR 488 (1081)
T ss_pred eeeccCCcc
Confidence 999999984
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=239.37 Aligned_cols=259 Identities=22% Similarity=0.337 Sum_probs=198.6
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|+..++||+|.||+||+|+.. +++.||+|+++..... -.....+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5677789999999999999654 6899999998765432 235678999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
++. +|..|..... ..++.+.+..++.|+++|+.++|++ .+.|||+||+|.+++.+|+.|++|||+++.++-....
T Consensus 83 cdq-dlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hhH-HHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 965 9999998764 4689999999999999999999999 9999999999999999999999999999988644332
Q ss_pred ccccccccccccCccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc------Cccc-
Q 046851 840 ATTGVAGTFGYVAPEYAMTCR-VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ------GRAK- 911 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~- 911 (963)
....+-|..|++|+++.+.+ |+...|+||.|||+.|+.....|..+... ..+..+.+++. +.++
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-------vddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-------VDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-------HHHHHHHHHHHhCCCccccCCc
Confidence 33345789999999999865 78889999999999999987666553322 12222222221 1111
Q ss_pred --ceeccccCCCCChh-HH--------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 --EFFTAGLWDAGPHD-DL--------VEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 --~~~~~~~~~~~~~~-~~--------~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+-|-.....++.. .+ ..=.+++...+.-+|..|.++++.+++
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11121112222211 11 123466777777799999999998874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=287.66 Aligned_cols=240 Identities=25% Similarity=0.270 Sum_probs=193.3
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++.|.....+|.|+|+.|-++.. .+++..+||++..... +-.+|+.++... +|||++++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45788888899999999999855 4688899999976522 234566665555 69999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE-CCCCcEEEeecccccccCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL-DDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgla~~~~~~~ 837 (963)
.+.|+-+.+.+...+ .+. .++..|+.+++.|+.|||++ |+||||+||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999998877776533 233 77888999999999999999 99999999999999 68999999999999887544
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
....+-|..|.|||+.....|++++|+||+|++||+|++|+.||.....+ .-+......+
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~~--------- 529 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQMP--------- 529 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcCC---------
Confidence 22335688999999999999999999999999999999999999854322 1111111111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+....+....+|+.+||+.||.+||+|.++..+
T Consensus 530 ---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 ---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1124456678899999999999999999998754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=270.00 Aligned_cols=241 Identities=25% Similarity=0.311 Sum_probs=197.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (963)
.+|....+||+|+||.|..|.-+ +.+.||||++++.- ..+.+--+.|-+++.-. +-|.+++++.+|+.-++.|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 36889999999999999999544 57789999987652 23334445677777665 467899999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+.||+|--.+++.+ .+.+..+..+|.+||-||-+||++ ||+.||+|.+||+++.+|++||+|||+++.-..
T Consensus 429 MEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred EEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 99999999998888754 488899999999999999999999 999999999999999999999999999976432
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
....+...+|||.|+|||.+...+|...+|.|||||+||||+.|++||+..+++ +....+. +.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--------elF~aI~---------eh 565 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQAIM---------EH 565 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHH---------Hc
Confidence 233456689999999999999999999999999999999999999999866544 1111111 11
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCC
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT 947 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 947 (963)
.-.+|...+.+...+....+...|.+|-.
T Consensus 566 --nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 --NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 12356666778888888888999998853
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=276.91 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=195.6
Q ss_pred CccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 686 ASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
..+++|.|.||+||-|.++ +|+.||||++.+.+. ....+++.|+.++++++||.||.+-..|+..+.+++|||.+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 3578999999999999665 699999999976543 2346789999999999999999999999999999999999955
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC---CcEEEeecccccccCCCCCc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD---FNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~~~~~~~~ 839 (963)
+..+.+-.....++++.....++.||+.||.|||.+ +|+|+|+||+|||+... ..+||||||+|+..+...
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 666666555556789888899999999999999999 99999999999999644 469999999999986543
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
....++|||.|.|||++....|...-|+||.|||+|-=++|..||+++.+- -+.+ +. ..-+..+..+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-------ndQI----QN--AaFMyPp~PW 788 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-------NDQI----QN--AAFMYPPNPW 788 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-------hHHh----hc--cccccCCCch
Confidence 345679999999999999999999999999999999999999999854321 1111 11 1111122222
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. +......++|...++..-++|-+..+.+.+
T Consensus 789 ~----eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 789 S----EISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred h----hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 2 233456677777788877888887766543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=297.10 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=172.0
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-C----CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEe------ee
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-P----GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY------HA 748 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 748 (963)
..++|.+.+.||+|+||.||+|.+. + +..||||++...... +.+..| .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999775 4 689999987543221 111111 1111112222211111 24
Q ss_pred CCCeEEEEEeccCCCChHHHHhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccC
Q 046851 749 SETEMFLIYNYLPGGNLENFIQQRSTR------------------AVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVK 810 (963)
Q Consensus 749 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 810 (963)
.....++||||+++++|.+++...... ......+..++.|+++||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567899999999999999998753210 112334667999999999999999 99999999
Q ss_pred CCCeEECC-CCcEEEeecccccccCCCCCcccccccccccccCccccccC----------------------CCCcchhh
Q 046851 811 PSNILLDD-DFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC----------------------RVSDKADV 867 (963)
Q Consensus 811 ~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 867 (963)
|+|||++. ++.+||+|||+|+..............+++.|+|||.+... .+..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987654444445566889999999965422 23346799
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCC-----CCCCcchhhHHHHHHhcCcccceeccccCC--CCChhHHHHHHHHHHHcccC
Q 046851 868 YSYGVVLLELLSDKKALDPSFSS-----YGNGFNIVAWGCMLLRQGRAKEFFTAGLWD--AGPHDDLVEVLHLAVVCTVD 940 (963)
Q Consensus 868 ~slG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~ 940 (963)
||+||++|||+++..+++..... ...+.....|....... ..+.... ...........+|+.+|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999977654422100 00011112221111000 0000000 00011123456899999999
Q ss_pred CCCCCCCHHHHHHH
Q 046851 941 SLSTRPTMKQVVRR 954 (963)
Q Consensus 941 dP~~RPs~~evl~~ 954 (963)
||++|||++|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=239.73 Aligned_cols=207 Identities=28% Similarity=0.407 Sum_probs=170.6
Q ss_pred HHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhc-cCCCCeeEEEEeeeCCCeEEE
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGR-LRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~l 755 (963)
.+.+...-...||+|++|.|-+.++. +|...|+|+++..- .+..++...|+.+..+ ..+|.+|.++|....+..+|+
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 33445556678999999999888664 69999999997653 3445667788887544 479999999999999999999
Q ss_pred EEeccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 756 IYNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
.||.|+- ||..+-.+. .+..+++..+-+||..+.+||.|||++. .++|||+||+|||++.+|++|+||||.+-.+
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999966 888775442 2567899999999999999999999986 9999999999999999999999999999877
Q ss_pred CCCCCcccccccccccccCcccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMT----CRVSDKADVYSYGVVLLELLSDKKALDPSFSS 890 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~ 890 (963)
.++ -..+-..|...|||||.+.. ..|+-|+||||+|+.+.||.+++.||+....+
T Consensus 200 ~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 200 VDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 433 22333468899999999863 36889999999999999999999999855443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=285.13 Aligned_cols=262 Identities=18% Similarity=0.247 Sum_probs=182.0
Q ss_pred HcCCCCCccccccCCCccEEEEEE-----------------CCCcEEEEEEeecccchhHHH--------------HHHH
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI-----------------SPGVLVAIKRLAVGRFQGVQQ--------------FHAE 728 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 728 (963)
..++|++.++||+|+||+||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999953 235689999986543322222 3447
Q ss_pred HHHHhccCCCCe-----eEEEEeeeC--------CCeEEEEEeccCCCChHHHHhhhc----------------------
Q 046851 729 IKTLGRLRHPNL-----VTLIGYHAS--------ETEMFLIYNYLPGGNLENFIQQRS---------------------- 773 (963)
Q Consensus 729 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------- 773 (963)
+.++.+++|.++ +++++||.. .+..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 667777643 356899999999999999987431
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccccccccccccCc
Q 046851 774 TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853 (963)
Q Consensus 774 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP 853 (963)
....++..+..++.|+++|++|+|+. +|+||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12346778899999999999999999 999999999999999999999999999976543322222223457899999
Q ss_pred cccccCC----------------------CCcchhhHHHHHHHHHHHcCCC-CCCCCCCC----CCCCcchhhHHHHHHh
Q 046851 854 EYAMTCR----------------------VSDKADVYSYGVVLLELLSDKK-ALDPSFSS----YGNGFNIVAWGCMLLR 906 (963)
Q Consensus 854 E~~~~~~----------------------~~~~~Dv~slG~il~elltg~~-p~~~~~~~----~~~~~~~~~~~~~~~~ 906 (963)
|.+.... ...+.||||+||+++||++|.. |+.....- .........|.. ..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hc
Confidence 9875422 1134699999999999999875 55421100 000111111111 11
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSL---STRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~ 954 (963)
.... +- ...........+++.+|+..+| .+|+|++|+++|
T Consensus 458 ~~~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQKY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccCC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1110 00 0112234567788889998765 789999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=266.82 Aligned_cols=238 Identities=32% Similarity=0.450 Sum_probs=194.6
Q ss_pred CCccEEEEEEC-CCcEEEEEEeecccchh-HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhh
Q 046851 694 GFGATYKAEIS-PGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQ 771 (963)
Q Consensus 694 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 771 (963)
+||.||+|... +|+.||+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999886 48999999997765544 67899999999999999999999999999999999999999999999976
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccccccccccc
Q 046851 772 RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851 (963)
Q Consensus 772 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ 851 (963)
... +++..+..++.++++++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 432 88999999999999999999999 99999999999999999999999999998765432 233456788999
Q ss_pred CccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHH
Q 046851 852 APEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVL 931 (963)
Q Consensus 852 aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 931 (963)
+||...+..++.++||||+|+++|++++|..||...... .... .......... .......+.++.
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~-~~~~~~~~~~-------~~~~~~~~~~~~ 218 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELF-KKIGKPKPPF-------PPPEWKISPEAK 218 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHH-HHHhccCCCC-------ccccccCCHHHH
Confidence 999999888899999999999999999999998642111 1111 1111111100 000001456889
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 046851 932 HLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 932 ~l~~~cl~~dP~~RPs~~evl~ 953 (963)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=252.99 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=199.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc---cchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG---RFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (963)
.+|++.++||+|+|+.|..+++. +.+.||+|+++++ ..++.+....|-.+..+. +||.+|.++.+|..+.+.++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57999999999999999999765 6788999998765 334556677788887776 599999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
.||++||+|--.+++. +.++++.+..+..+|.-||.|||+. ||+.||+|.+|||+|..|.+|++|+|+++.-- .
T Consensus 330 ieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-G 403 (593)
T ss_pred EEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-C
Confidence 9999999998888764 4599999999999999999999999 99999999999999999999999999997633 2
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
....+...+|||.|.|||.+.+..|...+|.|++||+++||+.|+.||+--..+ ....+..++.-+.+-+..
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~-n~d~ntedylfqvilekq------- 475 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD-NPDMNTEDYLFQVILEKQ------- 475 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC-CcccchhHHHHHHHhhhc-------
Confidence 334456789999999999999999999999999999999999999999843211 112222333322221111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCC
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRP 946 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 946 (963)
.+ .|...+.+...+++.-+.+||.+|-
T Consensus 476 -ir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 -IR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -cc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 11 1223334566788888999999885
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=259.73 Aligned_cols=266 Identities=23% Similarity=0.356 Sum_probs=202.2
Q ss_pred cCCCCCccccccCCCccEEEE-EECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-----C---CCeeEEEEeeeC--
Q 046851 681 TGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-----H---PNLVTLIGYHAS-- 749 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 749 (963)
.++|.+.++||-|.|++||.| +....+.||+|+.+...- -.+....||+++++++ | ..||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368999999999999999999 455688999999876532 2355688999999984 3 359999998854
Q ss_pred --CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC--------
Q 046851 750 --ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD-------- 819 (963)
Q Consensus 750 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------- 819 (963)
+.++++|+|++ |.+|..++....-+.++...+.+|++||+.||.|||+.| ||||.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 56899999999 679999999887778999999999999999999999999 99999999999999100
Q ss_pred --------------------------------------------------------------------------------
Q 046851 820 -------------------------------------------------------------------------------- 819 (963)
Q Consensus 820 -------------------------------------------------------------------------------- 819 (963)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 046851 820 ------------------------------------------------------------------------------FN 821 (963)
Q Consensus 820 ------------------------------------------------------------------------------~~ 821 (963)
-+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred EEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC-CCCCcchhhH
Q 046851 822 AYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS-YGNGFNIVAW 900 (963)
Q Consensus 822 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~-~~~~~~~~~~ 900 (963)
|||+|||-|+.+..... .-.-|..|+|||++.+..|++.+|+||++|+++||.||...|++.... |+.+.+..+.
T Consensus 393 vKIaDlGNACW~~khFT----~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 393 VKIADLGNACWVHKHFT----EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEEeeccchhhhhhhhc----hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 33444444333221111 112478999999999999999999999999999999999999876543 5555554444
Q ss_pred HHHHH--------hc-Ccccceecccc----------C---------CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046851 901 GCMLL--------RQ-GRAKEFFTAGL----------W---------DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952 (963)
Q Consensus 901 ~~~~~--------~~-~~~~~~~~~~~----------~---------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 952 (963)
+.... .. ....++++.+. + -..+.++..++.+++.-||+.+|++||||++.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 33222 11 12223333221 1 134677788999999999999999999999998
Q ss_pred HH
Q 046851 953 RR 954 (963)
Q Consensus 953 ~~ 954 (963)
++
T Consensus 549 ~h 550 (590)
T KOG1290|consen 549 KH 550 (590)
T ss_pred cC
Confidence 64
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=287.05 Aligned_cols=245 Identities=25% Similarity=0.383 Sum_probs=189.6
Q ss_pred CCCccccccCCCcc-EEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 684 FNASNCIGNGGFGA-TYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 684 ~~~~~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
|.-.+++|.|+.|+ ||+|... |+.||||++-.+. .....+|+..++.-+ |||||++++.-.++...|++.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456789999885 7999888 8999999886443 245578999999885 9999999999999999999999996
Q ss_pred CCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---C--CcEEEeecccccccC
Q 046851 762 GGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---D--FNAYLSDFGLARLLG 834 (963)
Q Consensus 762 ~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgla~~~~ 834 (963)
. +|.+++... ............+..|+++|+++||+. +||||||||+||||+. + .+++|+|||+++...
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 999999874 111111134577899999999999998 9999999999999975 3 469999999999987
Q ss_pred CCCCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 835 PSETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSD-KKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 835 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
.+... ...+..||-+|+|||++....-+.++|+||+||++|+.++| .+||.+..... .++.....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------~NIl~~~~-- 730 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------ANILTGNY-- 730 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------hhhhcCcc--
Confidence 54432 34567899999999999998888899999999999999987 88998543221 11111110
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.++ .-.+.... +..+||.+|++++|..||++.+|+.+
T Consensus 731 ~L~-----~L~~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 731 TLV-----HLEPLPDC-EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cee-----eeccCchH-HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 010 00111111 78899999999999999999999854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=268.44 Aligned_cols=203 Identities=25% Similarity=0.409 Sum_probs=174.4
Q ss_pred CCCCccccccCCCccEEEEE-ECCCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
-|...+.||-|+||+|..++ .++...||.|.+.+... .....++.|-.++...+.+-||++|..|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 36778899999999999994 45577899998876543 334557889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC----
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG---- 834 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~---- 834 (963)
|++||++-.++.+. ..+.+..++.++.++..|+++.|.. |+|||||||+|||||.+|++||+|||++.-+.
T Consensus 710 YIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999874 4588899999999999999999999 99999999999999999999999999985432
Q ss_pred -----CCCC--------------------------------cccccccccccccCccccccCCCCcchhhHHHHHHHHHH
Q 046851 835 -----PSET--------------------------------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLEL 877 (963)
Q Consensus 835 -----~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el 877 (963)
..+. ......+||+.|+|||++....++.-+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 1100 011235799999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCC
Q 046851 878 LSDKKALDPSFSS 890 (963)
Q Consensus 878 ltg~~p~~~~~~~ 890 (963)
+.|+.||-.+.+.
T Consensus 865 ~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 865 LVGQPPFLADTPG 877 (1034)
T ss_pred hhCCCCccCCCCC
Confidence 9999999876655
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=239.18 Aligned_cols=256 Identities=20% Similarity=0.286 Sum_probs=196.5
Q ss_pred CCCCCccccccCCCccEEEEE-ECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCC--CeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASE--TEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 757 (963)
++|++.+++|+|.|++||.|. ..+.++++||+++.- ..+.+.+|+.++..++ ||||+++++...+. ....+|+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 479999999999999999994 566889999998743 3467899999999997 99999999988664 5678999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEeecccccccCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~ 836 (963)
||+.+-+...+-. .++...+..++.+++.||.|||++ ||.|||+||.||++|. ....+++|||+|.++.+.
T Consensus 115 E~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999987776654 377788999999999999999999 9999999999999996 456999999999999876
Q ss_pred CCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc-----
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA----- 910 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 910 (963)
..+... +.+..|..||.+... .|...-|+|||||++..|+..+.||...... ...++..++-. ...+.
T Consensus 187 ~eYnVR--VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN---~DQLVkIakVL-Gt~el~~Yl~ 260 (338)
T KOG0668|consen 187 KEYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVKIAKVL-GTDELYAYLN 260 (338)
T ss_pred ceeeee--eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC---HHHHHHHHHHh-ChHHHHHHHH
Confidence 655433 567789999998764 4677789999999999999999999755433 22222222111 00000
Q ss_pred --cceeccccC----------------CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 --KEFFTAGLW----------------DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 --~~~~~~~~~----------------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.-.+|+... .+...-...+..+++.+.+..|..+|||++|++++
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000111110 01111123578899999999999999999998764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-31 Score=269.51 Aligned_cols=278 Identities=20% Similarity=0.187 Sum_probs=203.1
Q ss_pred CceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccc-cccccCCCcccccccceeeccc
Q 046851 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG-NLVNGTVPTFIGRLKRVYLSFN 81 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~L~~L~L~~n 81 (963)
...+++|..|.|+.+.+++|+.+++|+.|||++|.|+.+-|++|.++++|..|-+-+ |+|+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~------------------ 129 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT------------------ 129 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh------------------
Confidence 345667777777777667777777777777777777777777777777666655544 5555
Q ss_pred cccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCc------
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNS------ 155 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~------ 155 (963)
.+|...|.+|..|+.|.+.-|++..+..++|..+++|..|.+.+|.+..+...+|..+.+++.+.+..|.
T Consensus 130 ----~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 130 ----DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred ----hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence 7788888888888888888888877777788888888888888888775555577888888888888777
Q ss_pred ------cccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCc
Q 046851 156 ------LSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRA 229 (963)
Q Consensus 156 ------l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n 229 (963)
+....|..++...-..-..+...++...++..+... ..+.+.......+.........|.+|++|+.|+|++|
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~-~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN 284 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS-LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNN 284 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh-HHhHHHhhccccCcCCcChHHHHhhcccceEeccCCC
Confidence 222444555555555555566666665555544332 1111112222223333344567899999999999999
Q ss_pred ccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCc
Q 046851 230 TLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALS 303 (963)
Q Consensus 230 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~ 303 (963)
+|+.+-+.+|.++.++++|.|..|+|..+....|.++..|+.|+|.+|+|+.+.+..+ .+..|..|+|-.|.+.
T Consensus 285 ~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 285 KITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred ccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 9999999999999999999999999999999999999999999999999998887777 5778888888888775
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-30 Score=249.51 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=197.4
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-----CeEE
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-----TEMF 754 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 754 (963)
+.+-.+.||-|+||.||..+. ++|+.||.|++..- +....+++.+|+.++..++|.|++..++..... .+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345568899999999999954 57999999988643 334567899999999999999999888765432 3567
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
++.|.|.. +|.+.+-. .+.++.+.+.-+.+||++|+.|||+. +|.||||||.|.|++.+-..||||||+++...
T Consensus 134 V~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 88888855 88887764 45688899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh-------
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR------- 906 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 906 (963)
.++....+..+-|..|+|||.++|. .|+.+.||||.|||+.|++.++.-|....+- ...+.+...+.
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-----qQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-----EQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-----HHHHHHHHHhCCCcHHHH
Confidence 6655555555678899999999975 6899999999999999999988877644321 11111111110
Q ss_pred ----cCcccceeccc---------cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 907 ----QGRAKEFFTAG---------LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 907 ----~~~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
++--..++... .....+.....+...+...++..||++|.+.++.++++
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 01000000000 01112223344567788899999999999999998765
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=264.92 Aligned_cols=241 Identities=22% Similarity=0.296 Sum_probs=198.3
Q ss_pred CCCCccccccCCCccEEEEEECCCc-EEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGV-LVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+++....+|-|+||.|-.+...... .+|+|++++... ...+.+..|-++|...+.|.||++|-.|.+.+.+|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 5666778999999999998766333 388888865432 334557789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
-|-||.+...++.+ ..++..++..++..+.+|++|||++ +||.||+||+|.+++.+|-+||.|||+|+..+..
T Consensus 501 aClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-- 573 (732)
T KOG0614|consen 501 ACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-- 573 (732)
T ss_pred hhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence 99999999999875 4589999999999999999999999 9999999999999999999999999999998644
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
..+-+.+|||.|.|||.+.+.....++|.||+|+++||+++|.+||...++- .....++...+..
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--------ktYn~ILkGid~i------- 638 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--------KTYNLILKGIDKI------- 638 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--------HHHHHHHhhhhhh-------
Confidence 3455679999999999999999999999999999999999999999854332 1111122222111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCC
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPT 947 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 947 (963)
..|....+...+++++....+|.+|-.
T Consensus 639 --~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 --EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 134455667788888888999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=237.58 Aligned_cols=211 Identities=35% Similarity=0.598 Sum_probs=185.7
Q ss_pred cccCCCccEEEEEECC-CcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCChHH
Q 046851 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLEN 767 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 767 (963)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998764 899999998766543 35678999999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEeecccccccCCCCCcccccccc
Q 046851 768 FIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFGLARLLGPSETHATTGVAG 846 (963)
Q Consensus 768 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g 846 (963)
++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 998642 3588999999999999999999999 9999999999999999 89999999999987654322 2233457
Q ss_pred cccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChh
Q 046851 847 TFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHD 925 (963)
Q Consensus 847 t~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (963)
...|++||..... .++.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999887 788899999999999998
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 926 DLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 926 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
..+.+++.+|++.+|++||++.++++.+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4688999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=238.74 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=197.1
Q ss_pred CCCCCccccccCCCccEEEE-EECCCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC------Ce
Q 046851 682 GNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE------TE 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 752 (963)
.+|.....+|.|+. .|..| +.-.+++||+|+.... ..+.+++..+|..++..+.|+|+++++.++... .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 36777888999998 66666 3335899999987543 334567788999999999999999999998643 45
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
+|+|||+|.. +|...+.. .++-.++..|..|++.|+.|+|+. +|+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 7999999955 99999874 267789999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC--------------CCCCcchh
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS--------------YGNGFNIV 898 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~--------------~~~~~~~~ 898 (963)
.+.. ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+...- ......+.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 5443 4455677899999999999999999999999999999999999877633210 00001111
Q ss_pred hHHHHHHhcC------cccceeccccCC---CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 899 AWGCMLLRQG------RAKEFFTAGLWD---AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 899 ~~~~~~~~~~------~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+.++...+.. ...+.+.+.... +.+.-....+.+++.+|+..+|++|-++++++++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1112221110 111111111111 1122234567889999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=231.38 Aligned_cols=252 Identities=19% Similarity=0.295 Sum_probs=190.5
Q ss_pred CCCCCccccccCCCccEEEEEECC-CcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEE-eeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIG-YHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~~~~~lv~e 758 (963)
+.|.+.+.+|+|.||.+-.++++. .+.+++|-++.... ..++|.+|..---.+. |.||+..|+ .|+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 479999999999999999998874 67899998765433 3578888888755554 999998877 4777888999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC--CCCcEEEeecccccccCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD--DDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~ 836 (963)
|+|.|+|.+-+... .+.+....+++.|++.|+.|+|++ .+||||||.+|||+- +..++|+||||..+..+..
T Consensus 103 ~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred cCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999988753 377888899999999999999999 999999999999993 3458999999998865422
Q ss_pred CCcccccccccccccCccccccC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTC-----RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
- .....+..|.+||..... ...+.+|||.||++++.++||+.||+..... +..+..|.+..-+.. +
T Consensus 177 V----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~w~~rk~--~ 247 (378)
T KOG1345|consen 177 V----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQWLKRKN--P 247 (378)
T ss_pred e----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHHHhcccC--c
Confidence 2 122345689999987532 3456789999999999999999999955433 444555543332222 2
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
.. .... ....+.+.++..+-+.++|++|-...++.++-
T Consensus 248 ~~-P~~F-----~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 AL-PKKF-----NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cC-chhh-----cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11 1111 12345677888899999999996666655544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=234.93 Aligned_cols=199 Identities=33% Similarity=0.527 Sum_probs=174.6
Q ss_pred CCCccccccCCCccEEEEEECC-CcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 684 FNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
|++.+.||.|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999998875 899999999876554 56789999999999999999999999999899999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++..... .+++..+..++.++++++.|+|+. +++|+|++|+||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999986432 178999999999999999999999 999999999999999999999999999987754431122
Q ss_pred ccccccccccCcccc-ccCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 046851 842 TGVAGTFGYVAPEYA-MTCRVSDKADVYSYGVVLLELLSDKKALDP 886 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~p~~~ 886 (963)
....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 344678899999998 666778899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=258.65 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=204.5
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.++|....++|.|.||.||||+. ..++..|||+++.....+.+-..+|+-+++..+||||+.++|.+...+..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35799999999999999999954 56899999999988777788889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+.+|+|.+.-+. ..++++.++..++++..+|++|||++ +=+|||||-.||++++.|.+|++|||.+..+... -.
T Consensus 94 cgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IA 167 (829)
T ss_pred cCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hh
Confidence 999999997664 56789999999999999999999999 9999999999999999999999999998776432 23
Q ss_pred ccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 840 ATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
......||+.|||||+.. .+.|..++|||+.|+...|+---++|...-.+. ....-+--........-|
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTkS~~qpp~lkD- 239 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTKSGFQPPTLKD- 239 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhccCCCCCcccC-
Confidence 345678999999999864 567889999999999999998777775422211 110000000111111111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
...-.+.+-++++.|+..+|++||+++.+++
T Consensus 240 ------k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 ------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2223446778999999999999999998765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-27 Score=249.94 Aligned_cols=196 Identities=23% Similarity=0.370 Sum_probs=168.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--------hhHHHHHHHHHHHhccC---CCCeeEEEEeeeC
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--------QGVQQFHAEIKTLGRLR---HPNLVTLIGYHAS 749 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 749 (963)
.+|...+.+|.|+||.|+.|.++ +...|+||.+.+++. ...-.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999766 456789998876532 11223456999999997 9999999999999
Q ss_pred CCeEEEEEecc-CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecc
Q 046851 750 ETEMFLIYNYL-PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 750 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
++.+|++||.. ++.+|.+++...+ .+++.++..|++||+.|+++||++ +|||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 99999999986 4569999998754 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccccccCCCCc-chhhHHHHHHHHHHHcCCCCCC
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD-KADVYSYGVVLLELLSDKKALD 885 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~elltg~~p~~ 885 (963)
.|.+...+ .....+||..|.|||++.|.+|-- .-|||++|+++|-++....||.
T Consensus 716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99875433 334568999999999999988754 4799999999999999988875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=238.94 Aligned_cols=266 Identities=24% Similarity=0.358 Sum_probs=200.2
Q ss_pred HHHHHcCCCCCccccccCCCccEEEEEEC----CCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCC
Q 046851 676 SVVQATGNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASE 750 (963)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 750 (963)
++......|..+++||+|.|++||+|... .++.||+|.+..... ..++..|++++..+. +.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455678999999999999999999443 478899998865443 367899999999995 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEeeccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFGL 829 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl 829 (963)
+.+.+|+||++.....++... ++..++..++..+..||+++|.. |||||||||+|++.+. -+.-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 999999999999999988865 67899999999999999999999 9999999999999985 56789999999
Q ss_pred ccccCCC---------------------------------C----------CcccccccccccccCccccccC-CCCcch
Q 046851 830 ARLLGPS---------------------------------E----------THATTGVAGTFGYVAPEYAMTC-RVSDKA 865 (963)
Q Consensus 830 a~~~~~~---------------------------------~----------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 865 (963)
|...... . ........||+||+|||++... .-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 9732100 0 0011225699999999999865 467789
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHH---------HHHhcCc--------ccce---------ec-ccc
Q 046851 866 DVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGC---------MLLRQGR--------AKEF---------FT-AGL 918 (963)
Q Consensus 866 Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~~~~~~--------~~~~---------~~-~~~ 918 (963)
||||.|||+.-+++++.||.....+.+. +.+.+. ...-.+. .... ++ ...
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~a---l~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADA---LAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred ceeeccceeehhhccccccccCccccch---HHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 9999999999999999999755443221 111110 0001111 0000 00 000
Q ss_pred --------C-CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 --------W-DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 --------~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .......+..+++++.+|++.+|.+|.|++|.+++
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 00111223468899999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-26 Score=239.97 Aligned_cols=201 Identities=23% Similarity=0.297 Sum_probs=167.5
Q ss_pred HHHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccC------CCCeeEEEEeeeCC
Q 046851 678 VQATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR------HPNLVTLIGYHASE 750 (963)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~ 750 (963)
+.....|.+....|+|-|++|.+|.. ..|..||||+|....... +.=.+|+++++++. --|.++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 34557899999999999999999954 458899999997654332 33478999999995 34788888888889
Q ss_pred CeEEEEEeccCCCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeecc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFG 828 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg 828 (963)
.++|+|+|.+.- +|.+++++.+ ...+....+..++.|+.-||..|-.. +|+|.||||.||||++.. .+||||||
T Consensus 507 nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence 999999999854 9999998865 34577788999999999999999998 999999999999999765 58999999
Q ss_pred cccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP 886 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~ 886 (963)
.|.......-. .+.-+..|.|||.+.|..|+...|+||.||+|||+.||+..|..
T Consensus 583 SA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 583 SASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 99876543322 22345689999999999999999999999999999999988763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=215.61 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=200.5
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+..+..+|.+...|+.|+|+|+ |..+++|++....- ...++|..|.-.++-+.||||.+++|.|.......++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3455667899999999999999 66778888765432 23467899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEe--ecccccccCCCCC
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS--DFGLARLLGPSET 838 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~--Dfgla~~~~~~~~ 838 (963)
+.|||+..++....-..+..++.+++.++|+|++|||+. .|-|----+.++.|++|++.+++|+ |--++
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs-------- 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS-------- 340 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee--------
Confidence 999999999988777788899999999999999999997 4444455689999999999988875 32222
Q ss_pred cccccccccccccCccccccCCCC---cchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVS---DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
....+..-.|.||+||.++..+.. .++|+|||++++||+.|...||.+-.+- +. .+++.-
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm--------ec---------gmkial 403 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM--------EC---------GMKIAL 403 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch--------hh---------hhhhhh
Confidence 122233457899999999876543 4689999999999999999999744322 00 122223
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
+.++...|.....-+.+++.-|+..||.+||.+..|+-.|++++
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34555667777888999999999999999999999999999864
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=264.63 Aligned_cols=126 Identities=22% Similarity=0.311 Sum_probs=72.7
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|+|++|.....+|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 446666666665554566666666666666666654334455444 4566666666665433344432 245666666
Q ss_pred cccccCCCCChhhhccccCCeEEecc-ccCCCcCCCCccccccCceEeecccc
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNN-NKLSGKIPSGLANVSTLSAFNVSFNN 568 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~l~l~~N~ 568 (963)
++|.|+ .+|..+..+++|+.|+|++ |+|. .+|..+..+++|+.++++++.
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 666665 4566666666666666666 3444 456566666666666666553
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-26 Score=231.20 Aligned_cols=291 Identities=19% Similarity=0.154 Sum_probs=213.7
Q ss_pred CCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCC-
Q 046851 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSG- 105 (963)
Q Consensus 27 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~- 105 (963)
.-..++|..|+|+.+.+.+|+.+++|+.||||+|+|+ .|.+..|.++.+|..|-+.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is----------------------~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS----------------------FIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchh----------------------hcChHhhhhhHhhhHHHhhcC
Confidence 4567778888888777778888888888888888777 77788888898887776666
Q ss_pred CccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCc-CccCCCCCceEeecCcCCcccc
Q 046851 106 NYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV-DLGNCSKLAILVLSNLFDTYED 184 (963)
Q Consensus 106 N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~n~~~~~~ 184 (963)
|+|+....+.|++|..|+.|.+.-|++.-+..++|..|++|..|.+..|.+. .+++ .|..+..++.+.+..|....+-
T Consensus 126 NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 126 NKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred CchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccccc
Confidence 9999888899999999999999999999999999999999999999999999 4555 8999999999999876522111
Q ss_pred cccccCCcccCC---------CcccCCCCCccccCCcccccC-CCCCceEecCCcccccC-CCccccccccCceeecCcc
Q 046851 185 VRYSRGQSLVDQ---------PSFMNDDFNFFEGGIPEAVSS-LPNLRILWAPRATLEGN-FPSNWGACDNLEMLNLGHN 253 (963)
Q Consensus 185 ~~~~~~~~~~~~---------~~~~~~~~n~~~~~~~~~l~~-l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~N 253 (963)
--.+........ +.-..+..+.+...-+..|.. +..+..=..+.+....+ ....|..+++|+.|+|++|
T Consensus 205 nL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN 284 (498)
T KOG4237|consen 205 NLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNN 284 (498)
T ss_pred ccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCC
Confidence 000000000000 000000111111111222211 11221112223333333 3356899999999999999
Q ss_pred cccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCccCCCC-CCCCCCCCcccccccccccCCCC
Q 046851 254 FFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNPS 331 (963)
Q Consensus 254 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~~~-~~~l~~l~~l~l~~n~~~~~~~~ 331 (963)
+|+.|...+|.....++.|.|..|+|..+....+ ++..|+.|+|.+|+|+...|. |..+.+|..++|-.|+|-+ +..
T Consensus 285 ~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C-nC~ 363 (498)
T KOG4237|consen 285 KITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC-NCR 363 (498)
T ss_pred ccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC-ccc
Confidence 9999999999999999999999999997776666 789999999999999987665 9999999999999999987 456
Q ss_pred chhhhhhhcc
Q 046851 332 TAYLSLFAKK 341 (963)
Q Consensus 332 ~~~~~~~~~~ 341 (963)
+.|+.-|...
T Consensus 364 l~wl~~Wlr~ 373 (498)
T KOG4237|consen 364 LAWLGEWLRK 373 (498)
T ss_pred hHHHHHHHhh
Confidence 6666655544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=268.18 Aligned_cols=196 Identities=17% Similarity=0.198 Sum_probs=139.2
Q ss_pred ccCC-CCeeEEEEee-------eCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 046851 734 RLRH-PNLVTLIGYH-------ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805 (963)
Q Consensus 734 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 805 (963)
..+| +||++++++| ...+.++.++||+ +++|.+++... ...+++.++..++.||++||+|||++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 3445 5777777776 2234678889988 55999999753 35589999999999999999999999 999
Q ss_pred ecccCCCCeEECCC-------------------CcEEEeecccccccCCCC---------------Cccccccccccccc
Q 046851 806 HRDVKPSNILLDDD-------------------FNAYLSDFGLARLLGPSE---------------THATTGVAGTFGYV 851 (963)
Q Consensus 806 H~dlk~~Nill~~~-------------------~~~kl~Dfgla~~~~~~~---------------~~~~~~~~gt~~y~ 851 (963)
||||||+|||++.. +.+|++|||+++...... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999653 455666666665321100 00011235888999
Q ss_pred CccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHH
Q 046851 852 APEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVL 931 (963)
Q Consensus 852 aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 931 (963)
|||++.+..++.++|||||||++|||++|.+|+.... ...... ... ...+ ..........
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~-~~~----~~~~-----~~~~~~~~~~ 242 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSL-RHR----VLPP-----QILLNWPKEA 242 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHH-HHh----hcCh-----hhhhcCHHHH
Confidence 9999999999999999999999999999887754211 011111 100 0010 0011223456
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 046851 932 HLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 932 ~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.++.+||+++|.+||+|.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 78889999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-24 Score=211.19 Aligned_cols=170 Identities=22% Similarity=0.218 Sum_probs=129.2
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|+|.++++.+ +..+++.++..|+.|+++||+|||++ + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6899999864 34699999999999999999999999 6 999999999999999 99988754322
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .. ++. ....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~-~~--~~~-~~~~ 131 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-------SAILEILLNGMP-AD--DPR-DRSN 131 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-------cHHHHHHHHHhc-cC--Ccc-cccc
Confidence 25889999999999999999999999999999999999998643221 111111111110 00 000 0011
Q ss_pred ChhHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 923 PHDDLV--EVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 923 ~~~~~~--~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
+..... .+.+++.+||+.+|++||++.|+++++..+.+.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 122222 689999999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=203.90 Aligned_cols=201 Identities=21% Similarity=0.319 Sum_probs=174.6
Q ss_pred CCCCCccccccCCCccEEEE-EECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
-.|+++++||+|.||+++.| .+-+++.||||.-+.... ..+++.|++..+.+. .++|..++.|...+..-.+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 37999999999999999999 455799999996654332 356788999988885 89999999998888889999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-----cEEEeecccccccC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-----NAYLSDFGLARLLG 834 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgla~~~~ 834 (963)
+ |.||+|+++-.+ +.++..++..||.|++.-++|+|++ .+|.|||||+|+||..-+ .+.|+|||+|+.+.
T Consensus 106 L-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9 779999988764 5699999999999999999999999 999999999999997433 48999999999987
Q ss_pred CCCCc------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 046851 835 PSETH------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFS 889 (963)
Q Consensus 835 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~ 889 (963)
+.... ......||.+||+-..+.+.+-+.+.|.-|+|-+++.++-|..||..-..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 65433 34567899999999999999999999999999999999999999986543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-22 Score=217.73 Aligned_cols=259 Identities=22% Similarity=0.248 Sum_probs=195.6
Q ss_pred CCCCccccccCCCccEEEEEECCC--cEEEEEEeecccchhHHHHHHHHHHHhccCC----CCeeEEEEee-eCCCeEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEISPG--VLVAIKRLAVGRFQGVQQFHAEIKTLGRLRH----PNLVTLIGYH-ASETEMFL 755 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 755 (963)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999976543 5789998766533322367788888888863 6899999998 57788899
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC-----CcEEEeecccc
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD-----FNAYLSDFGLA 830 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfgla 830 (963)
||+.+ |.+|.++......+.++..++.+|+.|++.+|+++|+. |++||||||.|+.++.. ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 77999998776667899999999999999999999999 99999999999999865 35999999999
Q ss_pred cccC--CCCC-----c-c-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHH
Q 046851 831 RLLG--PSET-----H-A-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWG 901 (963)
Q Consensus 831 ~~~~--~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 901 (963)
+.+. .... . . .....||..|+++..+.+...+++.|+||+++++.|+..|..||........ ... .
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~~~-~ 249 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----KSK-F 249 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----HHH-H
Confidence 8332 1111 1 1 2345699999999999999999999999999999999999999964432210 111 1
Q ss_pred HHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 902 CMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
...... ..... .....+..+.++...+-..+...+|....+...+++..
T Consensus 250 ~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 250 EKDPRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHhhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 111111 11110 11223344555555555688899999999998887643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=220.14 Aligned_cols=166 Identities=20% Similarity=0.214 Sum_probs=131.0
Q ss_pred HHHHcCCCCCccccccCCCccEEEEEEC--CCcEEEEEEeecc-----cchhHHHHHHHHHHHhccCCCCeeE-EEEeee
Q 046851 677 VVQATGNFNASNCIGNGGFGATYKAEIS--PGVLVAIKRLAVG-----RFQGVQQFHAEIKTLGRLRHPNLVT-LIGYHA 748 (963)
Q Consensus 677 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~ 748 (963)
.....++|.+.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|++++++++|+|+++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3445678999999999999999999764 5788899987532 1223466899999999999999985 4432
Q ss_pred CCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccc-CCCCeEECCCCcEEEeec
Q 046851 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV-KPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 749 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Df 827 (963)
+..++||||++|++|.. ... .. ...++.++++|++|||++ ||+|||| ||+||+++.++.+||+||
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45799999999999963 211 11 146788999999999999 9999999 999999999999999999
Q ss_pred ccccccCCCCCcc-------cccccccccccCcccccc
Q 046851 828 GLARLLGPSETHA-------TTGVAGTFGYVAPEYAMT 858 (963)
Q Consensus 828 gla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 858 (963)
|+|+.+....... .....+++.|+|||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999775433111 134678889999999864
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-21 Score=246.37 Aligned_cols=348 Identities=21% Similarity=0.237 Sum_probs=232.0
Q ss_pred cCCCccccCCCCcEEEccCCcc------cccCCccccCcc-cccceeccccccccCCCcccccccceeeccccccccCCc
Q 046851 17 ILPDSGFHLKSLRVLNLGFNRI------TGEIPASFSDFV-NLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPS 89 (963)
Q Consensus 17 ~~~~~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~ 89 (963)
+.+.+|.+|++|+.|.+..+.. ...+|..|..++ +|+.|.+.+|.+. .+|.
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~----------------------~lP~ 606 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR----------------------CMPS 606 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC----------------------CCCC
Confidence 5667899999999999976643 334666677664 5888888888776 4444
Q ss_pred cccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCC
Q 046851 90 KIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSK 169 (963)
Q Consensus 90 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 169 (963)
.+ ...+|+.|+|++|++. .++..+..+++|+.|+|++|.....+| .+..+++|+.|+|++|.....+|..+.++++
T Consensus 607 ~f--~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~ 682 (1153)
T PLN03210 607 NF--RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNK 682 (1153)
T ss_pred cC--CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCC
Confidence 43 2456666666666665 455556666666666666554332334 3566666777777666544466666666677
Q ss_pred CceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceee
Q 046851 170 LAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLN 249 (963)
Q Consensus 170 L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 249 (963)
|+.|++++| ...+.+|..+ ++++|+.|++++|.....+|.. ..+|++|+
T Consensus 683 L~~L~L~~c---------------------------~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~ 731 (1153)
T PLN03210 683 LEDLDMSRC---------------------------ENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLD 731 (1153)
T ss_pred CCEEeCCCC---------------------------CCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeee
Confidence 777766652 1122333333 5677777777777554444432 35788999
Q ss_pred cCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCC
Q 046851 250 LGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYN 329 (963)
Q Consensus 250 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~ 329 (963)
|++|.+..++... .+++|+.|++.++....... .+....+
T Consensus 732 L~~n~i~~lP~~~--~l~~L~~L~l~~~~~~~l~~----------------~~~~l~~---------------------- 771 (1153)
T PLN03210 732 LDETAIEEFPSNL--RLENLDELILCEMKSEKLWE----------------RVQPLTP---------------------- 771 (1153)
T ss_pred cCCCccccccccc--cccccccccccccchhhccc----------------cccccch----------------------
Confidence 9999988876532 57888888887654321100 0000000
Q ss_pred CCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCccccccc
Q 046851 330 PSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGIC 409 (963)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~ 409 (963)
..+..+
T Consensus 772 --------------------------------------------------------------------------~~~~~~ 777 (1153)
T PLN03210 772 --------------------------------------------------------------------------LMTMLS 777 (1153)
T ss_pred --------------------------------------------------------------------------hhhhcc
Confidence 000111
Q ss_pred CCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccce
Q 046851 410 NRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKY 489 (963)
Q Consensus 410 ~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~ 489 (963)
..|+ .|++++|...+.+|..+..+ ++|+.|++++|..-+.+|..+ ++++|+.|++++|.....+|.. .++|+.
T Consensus 778 ~sL~--~L~Ls~n~~l~~lP~si~~L-~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~ 850 (1153)
T PLN03210 778 PSLT--RLFLSDIPSLVELPSSIQNL-HKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISD 850 (1153)
T ss_pred ccch--heeCCCCCCccccChhhhCC-CCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCE
Confidence 2233 56777776666788887765 789999999875444778776 6889999999988654555543 367899
Q ss_pred eccccccccccCCcccccCCccceecccc-cccCCCCChhhhccccCCeEEecccc
Q 046851 490 LSLAGNNLTGSIPSSLGQLQLLEVLDLSS-NSLSGLIPDDLENLRNLTVLLLNNNK 544 (963)
Q Consensus 490 L~l~~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~ 544 (963)
|+|++|.++ .+|.++..+++|+.|+|++ |+++ .+|..+..+++|+.|++++|.
T Consensus 851 L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 851 LNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred eECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 999999998 7899999999999999988 5566 577788889999999998874
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=232.84 Aligned_cols=105 Identities=30% Similarity=0.328 Sum_probs=65.8
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
.+|+.|++++|+|+ .+|... .+|+.|++++|.|++ +|.. .++|+.|++++|+|+ .+|..+ .+|+.|++
T Consensus 362 ~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~L 429 (788)
T PRK15387 362 SELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSV 429 (788)
T ss_pred cccceehhhccccc-cCcccc---cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhh
Confidence 34555666666666 345422 356666666666643 3432 245677777777776 455432 35667777
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCCcCCCCcc
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLA 554 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 554 (963)
++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+.
T Consensus 430 s~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~ 466 (788)
T PRK15387 430 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 466 (788)
T ss_pred ccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHH
Confidence 777777 5677777777777777777777766665553
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=232.69 Aligned_cols=64 Identities=27% Similarity=0.389 Sum_probs=43.0
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCccc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSL 505 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 505 (963)
++|+.|++++|+|+ .+|... .+|+.|++++|+|+ .+|..+..+++|+.|+|++|.|++..|..+
T Consensus 402 s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 402 SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 44677777777776 455432 35666777777774 567777777777777777777776665554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=190.50 Aligned_cols=258 Identities=22% Similarity=0.291 Sum_probs=196.4
Q ss_pred cCCCCCccccccCCCccEEEE-EECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|.++++||.|+||.+|.| ...+|+.||||+-...... .++..|.++.+.++ ...|..+..|+.+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 468999999999999999999 5667999999977544332 45678888888887 5788888889999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC---cEEEeecccccccCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF---NAYLSDFGLARLLGP 835 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~~~ 835 (963)
.. |.||++++.-.. +.++..+++-.|-|++.-++|+|.+ +++||||||+|+|+.-+. .+.++|||+|+.+.+
T Consensus 92 LL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 99 779999887653 4589999999999999999999999 999999999999997543 589999999998864
Q ss_pred CCC------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 836 SET------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 836 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
... .......||.+|.+-..+.+...+.+.|+-|+|+++..+--|..||+.-.... ....+. .+.+..
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t----k~QKyE--kI~EkK 240 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT----KKQKYE--KISEKK 240 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh----HHHHHH--HHHHhh
Confidence 332 23345789999999998888888999999999999999999999998654330 011111 111111
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
....+. .+... .+.++...+.-|-..--++-|+..-+-+.+.
T Consensus 241 ~s~~ie-~LC~G----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 241 MSTPIE-VLCKG----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred cCCCHH-HHhCC----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 111111 11222 2446667777787777778887766655543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.4e-22 Score=228.76 Aligned_cols=254 Identities=17% Similarity=0.184 Sum_probs=189.3
Q ss_pred CCccccccCCCccEEEEEEC-CCcEEEEEEeec----c-cchh-HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 685 NASNCIGNGGFGATYKAEIS-PGVLVAIKRLAV----G-RFQG-VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~----~-~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
...+++|.|++|.|+.+... +...++.|.+.. . .... ...+..|+-+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988887433 344455554431 1 1111 122566788888889999988887777766666669
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++ +|..++... ..++..++..++.|+..|+.|+|+. |+.|||+|++|++++.+|.+||+|||.+..+.-+.
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999999864 3588899999999999999999999 99999999999999999999999999997765433
Q ss_pred C---cccccccccccccCccccccCCCCcc-hhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 838 T---HATTGVAGTFGYVAPEYAMTCRVSDK-ADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 838 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
. ....+.+|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||.......... ......+...
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~~-- 545 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQRN-- 545 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccccc--
Confidence 2 45677899999999999999988875 799999999999999999998654432111 0000000000
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+.. .........+.+...++.+|++.||.+|.|+++|++.
T Consensus 546 ~~~-~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 546 IFE-GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccc-ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000 0001122345677889999999999999999999763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-19 Score=198.49 Aligned_cols=260 Identities=29% Similarity=0.428 Sum_probs=198.9
Q ss_pred CCCccccccCCCccEEEEEECCCcEEEEEEeecccch---hHHHHHHHHHHHhccCCC-CeeEEEEeeeCCCeEEEEEec
Q 046851 684 FNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ---GVQQFHAEIKTLGRLRHP-NLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 759 (963)
|.+.+.+|.|+||.||++... ..+|+|.+...... ....+.+|+..+..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677888999999999999877 78999988765432 367889999999999988 799999999877778999999
Q ss_pred cCCCChHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeecccccccCCCC
Q 046851 760 LPGGNLENFIQQRST-RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGLARLLGPSE 837 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 837 (963)
+.++++.+++..... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765432 2588899999999999999999999 999999999999999988 79999999998655433
Q ss_pred Cc-----ccccccccccccCcccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 838 TH-----ATTGVAGTFGYVAPEYAMT---CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 838 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
.. ......|+..|+|||...+ ..+....|+||+|++++++++|..|+...... ..............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~ 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILELP 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhcC
Confidence 22 2356689999999999988 57888999999999999999999996533221 00111111111111
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.. .................+.+++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 000000000002223578889999999999999999887654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-20 Score=218.68 Aligned_cols=93 Identities=28% Similarity=0.389 Sum_probs=62.5
Q ss_pred cccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEc
Q 046851 72 RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDV 151 (963)
Q Consensus 72 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 151 (963)
+...|++++++++ ++|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+++. +|..+. ++|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip---~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP---EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc---cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEEC
Confidence 4567777777777 7777654 46788888888887 4555443 478888888888874 454443 46888888
Q ss_pred cCCccccCCCcCccCCCCCceEeecC
Q 046851 152 SRNSLSGSIPVDLGNCSKLAILVLSN 177 (963)
Q Consensus 152 ~~N~l~~~~p~~~~~l~~L~~L~l~~ 177 (963)
++|.+. .+|..+. ++|+.|++++
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~ 271 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFH 271 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcC
Confidence 888887 5565442 3455555554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=187.94 Aligned_cols=170 Identities=14% Similarity=0.153 Sum_probs=132.8
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHH---H------HHHHHHHHhccCCCCeeEEEEeeeCC-
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQ---Q------FHAEIKTLGRLRHPNLVTLIGYHASE- 750 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~~- 750 (963)
.++|+..+++|.|+||.||.++. ++..+|||++......... . +.+|++.+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999866 4778999999755433222 2 68999999999999999998886532
Q ss_pred -------CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEE
Q 046851 751 -------TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAY 823 (963)
Q Consensus 751 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 823 (963)
...++||||++|.+|.++.. .+. ....+++.++..+|+. |++|||++|+||+++++| ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988732 222 2456999999999999 999999999999999998 99
Q ss_pred EeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHH
Q 046851 824 LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878 (963)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 878 (963)
++|||........... . .+.....+..++|+||||+.+....
T Consensus 175 liDfg~~~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 9999988755221111 0 1233334557899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.5e-20 Score=182.50 Aligned_cols=139 Identities=18% Similarity=0.228 Sum_probs=108.7
Q ss_pred ccccccCCCccEEEEEECCCcEEEEEEeecccch--h-------HHH-----------------HHHHHHHHhccCCCCe
Q 046851 687 SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ--G-------VQQ-----------------FHAEIKTLGRLRHPNL 740 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 740 (963)
...||+|+||.||+|...+|+.||||+++..... . ..+ ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998878999999999754321 0 112 2349999999987776
Q ss_pred eEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecccCCCCeEECCC
Q 046851 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL-HDQCVPRVLHRDVKPSNILLDDD 819 (963)
Q Consensus 741 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlk~~Nill~~~ 819 (963)
.....+.. ...++||||++++++...... ...+++.++..++.|++.++.|+ |+. +|+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 43332222 223899999998877655332 24588999999999999999999 688 999999999999998 4
Q ss_pred CcEEEeeccccccc
Q 046851 820 FNAYLSDFGLARLL 833 (963)
Q Consensus 820 ~~~kl~Dfgla~~~ 833 (963)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.4e-20 Score=216.39 Aligned_cols=180 Identities=26% Similarity=0.364 Sum_probs=110.9
Q ss_pred cccceeccccccccCCCc-ccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEccc
Q 046851 51 NLEELNLAGNLVNGTVPT-FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFS 129 (963)
Q Consensus 51 ~L~~L~Ls~N~l~~~~~~-~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~ 129 (963)
+.+.|+++++.++ .+|. ....|+.|+|++|+++ .+|..++ ++|++|+|++|+++ .+|..+. .+|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIPEQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcC-cCCcccccCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 3455666666665 3343 2235666666666666 6666554 36777777777766 4454442 3567777777
Q ss_pred CcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCcccc
Q 046851 130 NMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEG 209 (963)
Q Consensus 130 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~ 209 (963)
|+++. +|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|.++ +
T Consensus 251 N~L~~-LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt---------------------------~ 297 (754)
T PRK15370 251 NRITE-LPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR---------------------------T 297 (754)
T ss_pred CccCc-CChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc---------------------------c
Confidence 77763 444443 46777777777777 4565543 46777777764333 1
Q ss_pred CCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccc
Q 046851 210 GIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 210 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 280 (963)
+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.++.++... .++|+.|++++|+|+
T Consensus 298 -LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l---~~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 298 -LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSLPASL---PPELQVLDVSKNQIT 359 (754)
T ss_pred -Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccCChhh---cCcccEEECCCCCCC
Confidence 222221 367778888888874 344332 57899999999988876432 257777777777765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=215.56 Aligned_cols=250 Identities=18% Similarity=0.243 Sum_probs=182.3
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccc-hhHHHHHHHHHH--HhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF-QGVQQFHAEIKT--LGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+|...+.+|.+.|=+|.+|++++|. |+||++.+..+ -..+.|.++++- ...++|||.+++.-+-...+..|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6888999999999999999999887 89999976553 234444443333 5556899999988777777778889999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC--CCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG--PSE 837 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~--~~~ 837 (963)
+.+ +|+|.+..++ .+...+.++|+.|++.|+..+|.. ||+|||||.+|||++.-.-+.|+||.--+..- .++
T Consensus 103 vkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 966 9999998754 478889999999999999999999 99999999999999999999999997654321 111
Q ss_pred Cc----ccccccccccccCccccccC----------C-CCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCCCCcchhhHH
Q 046851 838 TH----ATTGVAGTFGYVAPEYAMTC----------R-VSDKADVYSYGVVLLELLSD-KKALDPSFSSYGNGFNIVAWG 901 (963)
Q Consensus 838 ~~----~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~ 901 (963)
+. ...+.....+|.|||.+... . .+++.||||+||+++|+++. +++|. +.+..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----------LSQL~ 245 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----------LSQLL 245 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----------HHHHH
Confidence 11 11222344599999987541 1 56788999999999999986 55554 12221
Q ss_pred HHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 902 CMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
+.. .+. ......-+... +...+++++..|++.||++|-+++++++.-..
T Consensus 246 aYr--~~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 246 AYR--SGN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hHh--ccC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 111 110 00000001000 11267899999999999999999999987443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=171.03 Aligned_cols=187 Identities=18% Similarity=0.117 Sum_probs=142.4
Q ss_pred CCccccccCCCccEEEEEECCCcEEEEEEeecccc----hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEec
Q 046851 685 NASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF----QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.....+++|+||+||.+.- ++.+++.+.+..... .....+.+|+++++++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998765 588888777754432 11236889999999995 5889999886 346999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccc-CCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV-KPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
++|.+|.+.... ....++.|++++++++|++ ||+|||| ||+||+++.++.++|+|||+|....+...
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754321 1135778999999999999 9999999 79999999999999999999986554321
Q ss_pred c----c--------cccccccccccCccccccC-CCC-cchhhHHHHHHHHHHHcCCCCCCCCC
Q 046851 839 H----A--------TTGVAGTFGYVAPEYAMTC-RVS-DKADVYSYGVVLLELLSDKKALDPSF 888 (963)
Q Consensus 839 ~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slG~il~elltg~~p~~~~~ 888 (963)
. . ..-...++.|++|+...-- ..+ .+.+.++-|.-+|.++|++.+...+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 0112357788888865432 223 56799999999999999998876443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.2e-19 Score=182.59 Aligned_cols=232 Identities=19% Similarity=0.277 Sum_probs=150.8
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCC----------CCeeEEEEee-
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRH----------PNLVTLIGYH- 747 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~- 747 (963)
.+..++.||.|+++.||.++.. +|+.+|||++..... ...+.+++|.-....+.+ -.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556788999999999999775 589999998865432 345677777766655432 1222222211
Q ss_pred -----------eCCC-----eEEEEEeccCCCChHHHHhh---hcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 046851 748 -----------ASET-----EMFLIYNYLPGGNLENFIQQ---RSTR--AVDWRVLHKIALDIARALAYLHDQCVPRVLH 806 (963)
Q Consensus 748 -----------~~~~-----~~~lv~e~~~~gsL~~~l~~---~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 806 (963)
.+.. ..+++|+-+.+ +|.+++.. .... ......+..+..|+.+.+++||+. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 1111 23678888854 88888643 2211 122344566778999999999999 9999
Q ss_pred cccCCCCeEECCCCcEEEeecccccccCCCCCcccccccccccccCcccccc--------CCCCcchhhHHHHHHHHHHH
Q 046851 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT--------CRVSDKADVYSYGVVLLELL 878 (963)
Q Consensus 807 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ell 878 (963)
+||+|+|++++++|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999988765432221 234578999997754 24788899999999999999
Q ss_pred cCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCC
Q 046851 879 SDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTR 945 (963)
Q Consensus 879 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 945 (963)
+|+.||+...+...... ...... +.++.+..||..+++.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999985543311110 112233 678899999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.5e-19 Score=181.52 Aligned_cols=196 Identities=21% Similarity=0.278 Sum_probs=142.2
Q ss_pred CCCCeeEEEEeeeC---------------------------CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHH
Q 046851 736 RHPNLVTLIGYHAS---------------------------ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALD 788 (963)
Q Consensus 736 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ 788 (963)
+|||||++.++|.+ +...|+||..++. +|++|+..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999987632 2457999999976 9999998643 566677789999
Q ss_pred HHHHHHHHHhCCCCCceecccCCCCeEEC--CCC--cEEEeecccccccCCC-----CCcccccccccccccCccccccC
Q 046851 789 IARALAYLHDQCVPRVLHRDVKPSNILLD--DDF--NAYLSDFGLARLLGPS-----ETHATTGVAGTFGYVAPEYAMTC 859 (963)
Q Consensus 789 i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~ 859 (963)
+++|+.|||.+ ||.|||+|++|||+. +|+ ...|+|||.+-..... .........|.-.-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 999999999999984 444 4789999987543211 11122334677889999998754
Q ss_pred C------CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHH
Q 046851 860 R------VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHL 933 (963)
Q Consensus 860 ~------~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 933 (963)
+ --.|+|.|+.|.+.||+++...||...-+- ..+... .++. -....+..++..+.++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem------~L~~r~--Yqe~---------qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM------LLDTRT--YQES---------QLPALPSRVPPVARQL 489 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh------eechhh--hhhh---------hCCCCcccCChHHHHH
Confidence 2 124899999999999999999999752111 000000 1111 1123456677788999
Q ss_pred HHHcccCCCCCCCCHHHHHHHH
Q 046851 934 AVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 934 ~~~cl~~dP~~RPs~~evl~~L 955 (963)
+...++.||++||+..-....|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 9999999999999876554443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=174.61 Aligned_cols=139 Identities=17% Similarity=0.239 Sum_probs=110.9
Q ss_pred ccccccCCCccEEEEEECCCcEEEEEEeecccch---------------------h-----HHHHHHHHHHHhccCCCCe
Q 046851 687 SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ---------------------G-----VQQFHAEIKTLGRLRHPNL 740 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 740 (963)
.+.||+|++|.||+|...+|+.||||++...... . ...+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999998778999999998754211 0 1224678999999999987
Q ss_pred eEEEEeeeCCCeEEEEEeccCCCChHHH-HhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECC
Q 046851 741 VTLIGYHASETEMFLIYNYLPGGNLENF-IQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDD 818 (963)
Q Consensus 741 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~ 818 (963)
.....+... ..++||||++|+++... +.. ..++..++.+++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 544443332 24899999998865443 332 347788999999999999999999 8 999999999999999
Q ss_pred CCcEEEeecccccccC
Q 046851 819 DFNAYLSDFGLARLLG 834 (963)
Q Consensus 819 ~~~~kl~Dfgla~~~~ 834 (963)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=188.66 Aligned_cols=217 Identities=27% Similarity=0.424 Sum_probs=164.5
Q ss_pred HhccCCCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-eecccC
Q 046851 732 LGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV-LHRDVK 810 (963)
Q Consensus 732 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~dlk 810 (963)
++.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.-...++++++.|++|+|.. .| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 35678999999999999999999999999999999999874 35688889999999999999999998 55 999999
Q ss_pred CCCeEECCCCcEEEeecccccccCCC-CCcccccccccccccCccccccCC-------CCcchhhHHHHHHHHHHHcCCC
Q 046851 811 PSNILLDDDFNAYLSDFGLARLLGPS-ETHATTGVAGTFGYVAPEYAMTCR-------VSDKADVYSYGVVLLELLSDKK 882 (963)
Q Consensus 811 ~~Nill~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~il~elltg~~ 882 (963)
+.|.+++....+|++|||+....... .........-..-|.|||.+.+.. .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998766421 111111122445899999987631 4667999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 883 ALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 883 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
||+.....+.. .....+++. + ....+.+...... +...++..++..||..+|++||++++|-..++.+-.
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~----~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKK----G-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCCh-HHHHHHHHh----c-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99865544322 112222211 1 1111222221111 334478899999999999999999999988876543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-20 Score=168.52 Aligned_cols=172 Identities=29% Similarity=0.510 Sum_probs=154.2
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
.|.+|+|.++ .+|+.+..+ .+|+.|++++|+|+ .+|..++.+++|+.|+++-|++ ...|..|+.++.|+.|||++|
T Consensus 37 rLtLSHNKl~-~vppnia~l-~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl-~~lprgfgs~p~levldltyn 112 (264)
T KOG0617|consen 37 RLTLSHNKLT-VVPPNIAEL-KNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRL-NILPRGFGSFPALEVLDLTYN 112 (264)
T ss_pred hhhcccCcee-ecCCcHHHh-hhhhhhhcccchhh-hcChhhhhchhhhheecchhhh-hcCccccCCCchhhhhhcccc
Confidence 5678999998 899999987 88999999999999 8999999999999999999999 689999999999999999999
Q ss_pred ccc-ccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCC
Q 046851 496 NLT-GSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLP 574 (963)
Q Consensus 496 ~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p 574 (963)
++. ..+|..|..|+.|+.|+|++|.+. .+|++++.+++|+.|.+..|.+- .+|.+++.+.+|+.|.+.+|+++..+|
T Consensus 113 nl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlpp 190 (264)
T KOG0617|consen 113 NLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPP 190 (264)
T ss_pred ccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecCh
Confidence 996 468999999999999999999998 78999999999999999999998 899999999999999999999998888
Q ss_pred CCCCccccc-----ccCCCCCCCC
Q 046851 575 SSKNLMKCS-----SVLGNPYLRP 593 (963)
Q Consensus 575 ~~~~~~~~~-----~~~~np~~~~ 593 (963)
+..+....+ ....|||..+
T Consensus 191 el~~l~l~~~k~v~r~E~NPwv~p 214 (264)
T KOG0617|consen 191 ELANLDLVGNKQVMRMEENPWVNP 214 (264)
T ss_pred hhhhhhhhhhHHHHhhhhCCCCCh
Confidence 766653332 2346888654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-18 Score=200.46 Aligned_cols=198 Identities=24% Similarity=0.321 Sum_probs=159.1
Q ss_pred HHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccC---CCCeeEEEEeeeCCCeEE
Q 046851 678 VQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR---HPNLVTLIGYHASETEMF 754 (963)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 754 (963)
+.....|.+.+.||+|+||.||+|...+|+.||+|+-+....- +|.-=.+++.+++ -+.|..+..++.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445678999999999999999999888999999987655432 2222223333443 234455555555567789
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC-------CCCcEEEeec
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD-------DDFNAYLSDF 827 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-------~~~~~kl~Df 827 (963)
+|+||.+.|+|.+++.. .+.++|...+.++.|+++.+++||.. +||||||||+|.++. ....++|+||
T Consensus 771 lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999999999999984 56699999999999999999999999 999999999999994 3346999999
Q ss_pred ccccccCC-CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCC
Q 046851 828 GLARLLGP-SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKA 883 (963)
Q Consensus 828 gla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 883 (963)
|.+..+.. .+.....+.++|-.+-.+|+..|+.++..+|-|.++.+++-|+.|+..
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99976542 223355667889999999999999999999999999999999999854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7e-19 Score=193.19 Aligned_cols=225 Identities=25% Similarity=0.292 Sum_probs=181.3
Q ss_pred ccccCCCccEEEEE----ECCCcEEEEEEeecccch--hHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 689 CIGNGGFGATYKAE----ISPGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 689 ~ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|+|.||.|+.++ .+.|.-+|.|+.+..... .......|..++...+ ||.++++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999873 344778899987654321 1124566777888887 9999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+|.+...+... ..++......+...++-|++++|+. +++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99998888764 4477788888899999999999999 9999999999999999999999999999876433222
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
+||..|||||++. ....++|.||||++.+||+||..||.. +...++... ...
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~-----------~~~ 205 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKA-----------ELE 205 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhh-----------ccC
Confidence 8999999999998 456789999999999999999999974 122222221 123
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
.|.+....+.+++..+...+|..|--.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 466667778888889999999988755
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-17 Score=164.15 Aligned_cols=137 Identities=19% Similarity=0.237 Sum_probs=107.1
Q ss_pred CCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhcc-----CCCCeeEEEEeeeCCC---e-EE
Q 046851 684 FNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-----RHPNLVTLIGYHASET---E-MF 754 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 754 (963)
+.-.+.||+|+||.||. .-.++.. +||++........+.+.+|+..++.+ .||||++++|++.++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 3233444 79988765455567889999999999 5799999999998763 3 34
Q ss_pred EEEec--cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceecccCCCCeEECC----CCcEEEeec
Q 046851 755 LIYNY--LPGGNLENFIQQRSTRAVDWRVLHKIALDIARAL-AYLHDQCVPRVLHRDVKPSNILLDD----DFNAYLSDF 827 (963)
Q Consensus 755 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 827 (963)
+|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5579999999652 25554 35677888777 999999 9999999999999974 337999995
Q ss_pred ccc
Q 046851 828 GLA 830 (963)
Q Consensus 828 gla 830 (963)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-19 Score=162.87 Aligned_cols=152 Identities=30% Similarity=0.566 Sum_probs=130.6
Q ss_pred EEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCC-ccchhhccCcccceeccccc
Q 046851 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHD-QIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 417 L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~-~~~~~~~~l~~L~~L~l~~N 495 (963)
|++++|+|. .+|..+..+ ++|+.|+++-|++. .+|..|+.++.|+.|||++|.+.+ .+|..|-.|+.|+.|+|+.|
T Consensus 61 ln~~nnqie-~lp~~issl-~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dn 137 (264)
T KOG0617|consen 61 LNLSNNQIE-ELPTSISSL-PKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDN 137 (264)
T ss_pred hhcccchhh-hcChhhhhc-hhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCC
Confidence 344444444 566666665 77999999999998 899999999999999999999974 68999999999999999999
Q ss_pred cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccC---ceEeeccccCccC
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTL---SAFNVSFNNLSGP 572 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L---~~l~l~~N~l~~~ 572 (963)
.+. .+|..++++++|+.|.+.+|.+- .+|..++.++.|++|.+.+|+++ .+|.+++++.-+ +.+.+.+|++..+
T Consensus 138 dfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~p 214 (264)
T KOG0617|consen 138 DFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNP 214 (264)
T ss_pred Ccc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence 999 99999999999999999999998 67999999999999999999999 889888877543 5567788888754
Q ss_pred CC
Q 046851 573 LP 574 (963)
Q Consensus 573 ~p 574 (963)
+-
T Consensus 215 Ia 216 (264)
T KOG0617|consen 215 IA 216 (264)
T ss_pred HH
Confidence 43
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.4e-17 Score=166.48 Aligned_cols=142 Identities=20% Similarity=0.216 Sum_probs=112.8
Q ss_pred CCCCccccccCCCccEEEEE--ECCCcEEEEEEeecccch------------------------hHHHHHHHHHHHhccC
Q 046851 683 NFNASNCIGNGGFGATYKAE--ISPGVLVAIKRLAVGRFQ------------------------GVQQFHAEIKTLGRLR 736 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 736 (963)
-|.+.+.||+|++|.||+|. ..+|+.||||++...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999997 568999999998754211 0123568999999997
Q ss_pred CC--CeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecccCCCC
Q 046851 737 HP--NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR-VLHRDVKPSN 813 (963)
Q Consensus 737 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlk~~N 813 (963)
+. .+.+++++ ...++||||++++++..+... .......++..++.|++.+++++|+. + ++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 53 34555543 235899999999888776532 22355667789999999999999999 9 9999999999
Q ss_pred eEECCCCcEEEeecccccccC
Q 046851 814 ILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 814 ill~~~~~~kl~Dfgla~~~~ 834 (963)
|+++ ++.++++|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.8e-19 Score=193.54 Aligned_cols=173 Identities=24% Similarity=0.221 Sum_probs=98.0
Q ss_pred EEEccCCccc-ccCCCccccCCCCcEEEccCCcccc----cCCccccCcccccceecccccccc------CCCcccc---
Q 046851 6 VLDLEGNLLN-GILPDSGFHLKSLRVLNLGFNRITG----EIPASFSDFVNLEELNLAGNLVNG------TVPTFIG--- 71 (963)
Q Consensus 6 ~L~ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~------~~~~~~~--- 71 (963)
.|+|+++.++ .-....|..+.+|++|++++|.++. .++..+...++|++|+++++.+.. .++..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788888887 3444556778889999999999852 345567778889999999987762 1112222
Q ss_pred cccceeeccccccccCCccccccCCC---CCeEeCCCCcccc----CcCccccCc-ccccEEEcccCcccc----cCccc
Q 046851 72 RLKRVYLSFNRLVGSVPSKIGEKCTN---LEHLDLSGNYLVG----GIPRSLGNC-FQVRSLLLFSNMLEE----TIPAE 139 (963)
Q Consensus 72 ~L~~L~L~~n~l~~~~p~~~~~~l~~---L~~L~Ls~N~i~~----~~~~~~~~l-~~L~~L~L~~n~l~~----~~~~~ 139 (963)
+|+.|++++|.+.+..+.. +..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++ ..+..
T Consensus 82 ~L~~L~l~~~~~~~~~~~~-~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 82 GLQELDLSDNALGPDGCGV-LESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred ceeEEEccCCCCChhHHHH-HHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 5666666666665222222 222333 6666666666542 222334444 556666666666552 12334
Q ss_pred ccCCCCCCEEEccCCccccC----CCcCccCCCCCceEeecCcC
Q 046851 140 LGMLQNLEVLDVSRNSLSGS----IPVDLGNCSKLAILVLSNLF 179 (963)
Q Consensus 140 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~n~ 179 (963)
+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~ 204 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG 204 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCc
Confidence 44555566666666655521 12223344455555555543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-18 Score=189.54 Aligned_cols=67 Identities=19% Similarity=0.055 Sum_probs=34.5
Q ss_pred cccCCCCCceEecCCcccccCCCcccccccc---CceeecCcccccCcC----ccccCCC-CCCcEEeccCcccc
Q 046851 214 AVSSLPNLRILWAPRATLEGNFPSNWGACDN---LEMLNLGHNFFSGKN----LGVLGPC-KNLLFLDLSSNQLT 280 (963)
Q Consensus 214 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~----~~~~~~l-~~L~~L~L~~N~l~ 280 (963)
.+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|+++... ...+..+ ++|+.|++++|.++
T Consensus 76 ~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~ 150 (319)
T cd00116 76 GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLE 150 (319)
T ss_pred HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCC
Confidence 3444445555555555554333333333333 666666666655311 1223344 67777777777765
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=159.73 Aligned_cols=144 Identities=22% Similarity=0.225 Sum_probs=113.3
Q ss_pred HHHHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccch----------------------hHHHHHHHHHHHh
Q 046851 676 SVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ----------------------GVQQFHAEIKTLG 733 (963)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 733 (963)
++......|.+.+.||+|+||.||+|...+|+.||||++...... ....+..|+..+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444458889999999999999998888999999987643210 1123567888888
Q ss_pred ccCCC--CeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCC
Q 046851 734 RLRHP--NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP 811 (963)
Q Consensus 734 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 811 (963)
.+.|+ .+++.++. ...++||||++|++|.+.... .....++.++++++.++|+. +++||||+|
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 88777 44444442 345899999999998765431 34567889999999999999 999999999
Q ss_pred CCeEECCCCcEEEeecccccccC
Q 046851 812 SNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 812 ~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.3e-16 Score=161.52 Aligned_cols=134 Identities=23% Similarity=0.422 Sum_probs=113.6
Q ss_pred cccccCCCccEEEEEECCCcEEEEEEeecccch--------hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ--------GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+.||+|++|.||+|.+ +|..|+||+....... ...++.+|++.+..+.|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 4788999976543221 124578899999999999988777777677788999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
++|++|.+++... .+ ++..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998652 12 7889999999999999999 999999999999999 78999999998865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.4e-17 Score=176.66 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=159.6
Q ss_pred CCCCccccccCCCccEEEEEECCC----cEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEE-------ee---
Q 046851 683 NFNASNCIGNGGFGATYKAEISPG----VLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIG-------YH--- 747 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-------~~--- 747 (963)
...+.+..++.+++.++.+....+ +.++.+..............+++-.+.... |+..+. .+ ..
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~-~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSIL-EDLRPSLFESSKRN 323 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccc-cCCCCchhhhcccc
Confidence 345556667777777766643322 333333333333122222233444443333 444332 21 11
Q ss_pred --eCCCeEEEEEeccCCCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 748 --ASETEMFLIYNYLPGGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 748 --~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
......++.|+++...+|.+|+..+. ....++.....++.|++.|++| + +.+|+|+||.||+...+..+||
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhh
Confidence 11235789999999999999997443 4557888999999999999999 7 9999999999999999999999
Q ss_pred eecccccccCCCC-----CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhh
Q 046851 825 SDFGLARLLGPSE-----THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 825 ~Dfgla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~ 899 (963)
.|||+........ ........||..||+||.+.+..|+.|+||||+|++++|++. +|...++. .
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er-------~- 466 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFER-------I- 466 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHH-------H-
Confidence 9999987765443 233455689999999999999999999999999999999997 22211100 0
Q ss_pred HHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
-....++.+.++ +.....+| .=+.++.++++..|.+||++.++..
T Consensus 467 ~t~~d~r~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 467 ATLTDIRDGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred HhhhhhhcCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHhh
Confidence 001112222222 11112222 2347888999999999996665543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.9e-16 Score=157.99 Aligned_cols=131 Identities=24% Similarity=0.429 Sum_probs=106.9
Q ss_pred ccccCCCccEEEEEECCCcEEEEEEeecccc--------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 689 CIGNGGFGATYKAEISPGVLVAIKRLAVGRF--------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 689 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.||+|++|.||+|.+. |..|++|+...... ....++.+|++.+..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999865 78899998653221 11356778999999999887655555555566678999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
+|++|.+++.... . .++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~------~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH------H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999876421 0 7899999999999999 999999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=178.28 Aligned_cols=138 Identities=22% Similarity=0.323 Sum_probs=113.2
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeeccc--c------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR--F------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (963)
...|...+.||+|+||+||+|.+... .+++|+..... . ...+++.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34567789999999999999987643 44555432111 1 123568899999999999999888888777778
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 3467899999999999999 99999999999999 677999999999975
Q ss_pred c
Q 046851 833 L 833 (963)
Q Consensus 833 ~ 833 (963)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-16 Score=181.08 Aligned_cols=210 Identities=23% Similarity=0.288 Sum_probs=145.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.+|+.++.|-.|+||.||..+++ ..+++|+| +.+...- .+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee-------------------
Confidence 47999999999999999999876 36778884 4322211 110 22222333333
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC---
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE--- 837 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~--- 837 (963)
|+-...++..+. ++. +.+.+++|+|+. +|+|||+||+|.+|+.-|++|++|||+++.-....
T Consensus 136 --gDc~tllk~~g~--lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP--LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCCC--Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 344444443222 222 127889999999 99999999999999999999999999987543211
Q ss_pred -----------CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 838 -----------THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 838 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
......++||+.|+|||++....|...+|.|++|+|+||.+.|+.||+.+.+++-. ...+.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf--------g~vis 272 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF--------GQVIS 272 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH--------hhhhh
Confidence 11234578999999999999999999999999999999999999999877444111 11111
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHH
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMK 949 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 949 (963)
+. -.+.+.....+.+..+++.+.++.+|..|--..
T Consensus 273 d~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 273 DD--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hh--------ccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 11 111112233455788889999999999997433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.9e-14 Score=145.20 Aligned_cols=136 Identities=22% Similarity=0.269 Sum_probs=98.9
Q ss_pred ccccccCCCccEEEEEECCCcEEEEEEeecccch--hHHH----------------------HHHHHHHHhccCCC--Ce
Q 046851 687 SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ--GVQQ----------------------FHAEIKTLGRLRHP--NL 740 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni 740 (963)
.+.||+|+||.||+|...+|+.||||++...... .... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998888999999988653221 1111 13456666665433 24
Q ss_pred eEEEEeeeCCCeEEEEEeccCCCChHH-HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECC
Q 046851 741 VTLIGYHASETEMFLIYNYLPGGNLEN-FIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDD 818 (963)
Q Consensus 741 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~ 818 (963)
.+.+++ ...++||||++++++.. .+.... .. .++..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 445443 23589999999954321 111110 11 5678899999999999999 8 999999999999999
Q ss_pred CCcEEEeecccccccC
Q 046851 819 DFNAYLSDFGLARLLG 834 (963)
Q Consensus 819 ~~~~kl~Dfgla~~~~ 834 (963)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.8e-14 Score=137.02 Aligned_cols=135 Identities=20% Similarity=0.197 Sum_probs=114.8
Q ss_pred CccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCC--CCeeEEEEeeeCCCeEEEEEeccCCC
Q 046851 686 ASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRH--PNLVTLIGYHASETEMFLIYNYLPGG 763 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 763 (963)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| ..+++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999998864 7899998865443 4678899999999976 58999999988888899999999987
Q ss_pred ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 764 NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 764 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.+..+ +......++.+++++++++|....++++|||++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77544 4566778899999999999986444799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.5e-14 Score=144.43 Aligned_cols=136 Identities=24% Similarity=0.321 Sum_probs=106.5
Q ss_pred ccccc-cCCCccEEEEEECCCcEEEEEEeeccc-------------chhHHHHHHHHHHHhccCCCCe--eEEEEeeeCC
Q 046851 687 SNCIG-NGGFGATYKAEISPGVLVAIKRLAVGR-------------FQGVQQFHAEIKTLGRLRHPNL--VTLIGYHASE 750 (963)
Q Consensus 687 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 750 (963)
...|| .|+.|+||++... +..++||++.... .....++.+|++++.++.|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999886 7789999885321 1223567889999999998774 6777764332
Q ss_pred -C---eEEEEEeccCC-CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEe
Q 046851 751 -T---EMFLIYNYLPG-GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825 (963)
Q Consensus 751 -~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 825 (963)
. ..++||||++| .+|.+++... .++.. .+.+++.++.++|+. ||+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6999988642 24443 357899999999999 99999999999999999999999
Q ss_pred eccccccc
Q 046851 826 DFGLARLL 833 (963)
Q Consensus 826 Dfgla~~~ 833 (963)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2e-15 Score=175.85 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=190.1
Q ss_pred cCCCCCccccccCCCccEEEEEECC--CcEEEEEEeeccc--chhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISP--GVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 755 (963)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|...-.... |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3468888899999999999886543 4556666554332 222344455777777776 9999999999999999999
Q ss_pred EEeccCCCChHHHH-hhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecccCCCCeEECCCC-cEEEeecccccc
Q 046851 756 IYNYLPGGNLENFI-QQRSTRAVDWRVLHKIALDIARALAYLH-DQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGLARL 832 (963)
Q Consensus 756 v~e~~~~gsL~~~l-~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~ 832 (963)
+.+|.+++++.+-+ +.. ....+...+..+..|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999999888 432 224666778889999999999999 77 999999999999999999 999999999988
Q ss_pred cCC--CCCcccccccc-cccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 833 LGP--SETHATTGVAG-TFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 833 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
+.. +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+...... .....|.
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~------- 244 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWK------- 244 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeec-------
Confidence 876 33344455678 9999999999884 45567899999999999999999998554432 1111121
Q ss_pred cccceeccccC--CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046851 909 RAKEFFTAGLW--DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952 (963)
Q Consensus 909 ~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 952 (963)
+.... ............++..+++..+|..|.+.+++.
T Consensus 245 ------~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 245 ------SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ------ccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 11110 001122334566788888889999999988764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.8e-15 Score=158.14 Aligned_cols=143 Identities=30% Similarity=0.527 Sum_probs=119.1
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
++|++.|+++ .+|..++.+ + |+.|.+++|+++ .+|..++.+..|..||.+.|.| ..+|..++++.+|+.|++..|
T Consensus 125 ~l~ls~NqlS-~lp~~lC~l-p-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei-~slpsql~~l~slr~l~vrRn 199 (722)
T KOG0532|consen 125 FLDLSSNQLS-HLPDGLCDL-P-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI-QSLPSQLGYLTSLRDLNVRRN 199 (722)
T ss_pred Hhhhccchhh-cCChhhhcC-c-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhh-hhchHHhhhHHHHHHHHHhhh
Confidence 6788888887 888888876 4 999999999998 8999999888999999999999 468888999999999999999
Q ss_pred cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCcccccc---CceEeeccc
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVST---LSAFNVSFN 567 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~---L~~l~l~~N 567 (963)
++. .+|+.+..|+ |..||+|.|+++ .+|-.|.+|+.|++|-|.+|+|. ..|..+...-+ +++|+..-.
T Consensus 200 ~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 200 HLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred hhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 998 7888888666 889999999998 67999999999999999999998 66655543333 456665544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.6e-13 Score=158.79 Aligned_cols=106 Identities=39% Similarity=0.641 Sum_probs=62.8
Q ss_pred CCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEecc
Q 046851 463 LVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNN 542 (963)
Q Consensus 463 L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 542 (963)
++.|+|++|.+.+.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 45556666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred ccCCCcCCCCcccc-ccCceEeecccc
Q 046851 543 NKLSGKIPSGLANV-STLSAFNVSFNN 568 (963)
Q Consensus 543 N~l~~~~p~~l~~l-~~L~~l~l~~N~ 568 (963)
|+++|.+|..+..+ .++..+++.+|+
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCc
Confidence 66666666555442 234445555443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-12 Score=147.58 Aligned_cols=141 Identities=21% Similarity=0.271 Sum_probs=102.1
Q ss_pred ccccccCCCccEEEEEECCCcEEEEEEeecccchh----------------------------------------HHHHH
Q 046851 687 SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQG----------------------------------------VQQFH 726 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 726 (963)
.+.||.|++|.||+|++.+|+.||||+.+...... .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542110 00245
Q ss_pred HHHHHHhccC-----CCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 046851 727 AEIKTLGRLR-----HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR-ALAYLHDQC 800 (963)
Q Consensus 727 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~ 800 (963)
.|++.+.++. ++++.-..-|....+..++||||++|+++.++...... .. ...+++..+++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 5666666652 34432222222234557999999999999988754221 12 23456666666 47888998
Q ss_pred CCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 801 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
|++|+|++|.||++++++.++++|||++..+.
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.4e-14 Score=154.49 Aligned_cols=177 Identities=33% Similarity=0.424 Sum_probs=160.9
Q ss_pred CceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc--cccceeecc
Q 046851 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG--RLKRVYLSF 80 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~L~~L~L~~ 80 (963)
.....||+.|++. .+|..+..+..|..|.|..|.+. .+|.++.++..|++|||+.|+++ ..|..+. -|+.|-+++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sN 152 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSN 152 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEec
Confidence 4567899999998 77999999999999999999999 89999999999999999999999 6666665 489999999
Q ss_pred ccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCC
Q 046851 81 NRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSI 160 (963)
Q Consensus 81 n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (963)
|+++ .+|..+. .++.|.+||.+.|.|. .+|..++++.+|+.|.+..|++.. +|..+..| .|..||++.|+++ .+
T Consensus 153 Nkl~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~L-pLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 153 NKLT-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCSL-PLIRLDFSCNKIS-YL 226 (722)
T ss_pred Cccc-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCC-ceeeeecccCcee-ec
Confidence 9999 9999998 7999999999999998 789999999999999999999984 66677755 6899999999999 89
Q ss_pred CcCccCCCCCceEeecCcCCcccccccc
Q 046851 161 PVDLGNCSKLAILVLSNLFDTYEDVRYS 188 (963)
Q Consensus 161 p~~~~~l~~L~~L~l~~n~~~~~~~~~~ 188 (963)
|-.|.+++.|++|-|.+|.+..++++..
T Consensus 227 Pv~fr~m~~Lq~l~LenNPLqSPPAqIC 254 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNPLQSPPAQIC 254 (722)
T ss_pred chhhhhhhhheeeeeccCCCCCChHHHH
Confidence 9999999999999999998888776654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.9e-13 Score=134.59 Aligned_cols=203 Identities=22% Similarity=0.307 Sum_probs=140.8
Q ss_pred HHHhccCCCCeeEEEEeeeCC-----CeEEEEEeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 046851 730 KTLGRLRHPNLVTLIGYHASE-----TEMFLIYNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVP 802 (963)
Q Consensus 730 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 802 (963)
.-+-++.|.|+++++.|+.+. .+..++.|||..|++..++++-. ...+......+|+-||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 335556799999999988653 45789999999999999998643 34466677789999999999999987 88
Q ss_pred CceecccCCCCeEECCCCcEEEeecccccccCCCC----CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHH
Q 046851 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE----THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878 (963)
Q Consensus 803 ~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 878 (963)
.|+|+++.-+-|++..+|-+|+.--- -....... ......-.+-++|.+||+-.....+.++|||+||+...||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999999874221 11111110 11111123568999999988878888999999999999998
Q ss_pred cCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 879 SDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 879 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
.+..-.............. ..........+ =+.++..|++..|..||+|++.+.+.
T Consensus 277 ilEiq~tnseS~~~~ee~i----------a~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENI----------ANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceeehhhhh----------hhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 8764322111110000000 00000111111 12467789999999999999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.3e-12 Score=141.49 Aligned_cols=247 Identities=20% Similarity=0.246 Sum_probs=182.9
Q ss_pred CCCCcccccc--CCCccEEEEEE---CCCcEEEEEEeec--ccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEE
Q 046851 683 NFNASNCIGN--GGFGATYKAEI---SPGVLVAIKRLAV--GRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMF 754 (963)
Q Consensus 683 ~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 754 (963)
.|.....+|. |.+|.||.+.. .++..+|+|+-+. ..+....+-.+|+....+++ |++.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999976 3688899997433 22233344466777777775 999999888899999999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceecccCCCCeEECCC-CcEEEeeccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR----ALAYLHDQCVPRVLHRDVKPSNILLDDD-FNAYLSDFGL 829 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl 829 (963)
+-.|++. .++.++.+... ..++...++.+..+..+ |+.++|+. .++|-|+||.||+...+ ..++++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 9999995 69999887643 34677788888888888 99999999 99999999999999999 8899999999
Q ss_pred ccccCCCCCc----ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 830 ARLLGPSETH----ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 830 a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
...++..... ......|...|++||...+ -++.++|+|++|.+..+-.++..+.....-. .| ..+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W--~~~ 338 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--------SW--SQL 338 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cc--ccc
Confidence 9888765422 1223367889999999876 4578899999999999999887655422111 11 111
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
++.. +.. ++-..-..++...+..|++.+|..|++.+.+..
T Consensus 339 r~~~----ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY----IPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc----Cch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111 000 111112234555888999999999999988764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.4e-11 Score=130.87 Aligned_cols=168 Identities=17% Similarity=0.254 Sum_probs=132.5
Q ss_pred EECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHH
Q 046851 702 EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV 781 (963)
Q Consensus 702 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 781 (963)
+..++.+|.|...+...........+-++.++.++||+|++++..+...+..|+|+|.+ ..|..++++. ....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----GKEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----HHHH
Confidence 44568889988887665544556778889999999999999999999999999999998 4688888764 3577
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccccccccccccCccccccCCC
Q 046851 782 LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861 (963)
Q Consensus 782 ~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 861 (963)
....+.||+.||.+||..| +++|+++....|++++.|..||++|.++........ ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 7888999999999999776 999999999999999999999999998865432221 111122223566777654433
Q ss_pred CcchhhHHHHHHHHHHHcCC
Q 046851 862 SDKADVYSYGVVLLELLSDK 881 (963)
Q Consensus 862 ~~~~Dv~slG~il~elltg~ 881 (963)
-..|.|.||+++||++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 2369999999999999993
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.3e-12 Score=144.24 Aligned_cols=198 Identities=34% Similarity=0.411 Sum_probs=137.7
Q ss_pred ceeccccccccCCCccc--ccccceeeccccccccCCccccccCC-CCCeEeCCCCccccCcCccccCcccccEEEcccC
Q 046851 54 ELNLAGNLVNGTVPTFI--GRLKRVYLSFNRLVGSVPSKIGEKCT-NLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN 130 (963)
Q Consensus 54 ~L~Ls~N~l~~~~~~~~--~~L~~L~L~~n~l~~~~p~~~~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n 130 (963)
.|+++.|.+...+.... ..++.|++.+|.++ .+|.... .+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~-~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIG-LLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccc-cchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 46666666633333222 35777777777777 6776654 343 7888888888877 56667777888888888888
Q ss_pred cccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccC
Q 046851 131 MLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGG 210 (963)
Q Consensus 131 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~ 210 (963)
+++. ++.....+++|+.|++++|++. .+|.....+..|++|.+++|.+. .
T Consensus 174 ~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~----------------------------~ 223 (394)
T COG4886 174 DLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII----------------------------E 223 (394)
T ss_pred hhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce----------------------------e
Confidence 8874 4444446777888888888887 56666666667777777764211 2
Q ss_pred CcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC
Q 046851 211 IPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL 287 (963)
Q Consensus 211 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 287 (963)
.+..+..+.++..|.+.+|++.. .+..++.+++|++|++++|+++.++. ++.+.+++.|++++|.+...++...
T Consensus 224 ~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 224 LLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred cchhhhhcccccccccCCceeee-ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 45567777777777777787763 36667778888888888888888876 7778888888888888876655444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.4e-12 Score=130.00 Aligned_cols=132 Identities=28% Similarity=0.322 Sum_probs=115.2
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
+.|+++|||+|.|+ .+-....-++.++.|++|+|.|... +.++.+++|+.||||+|.++ .+..+-..+.+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 45999999999999 7888888899999999999999643 44899999999999999999 78888888999999999
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCC-cCCCCccccccCceEeeccccCccCCCC
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSG-KIPSGLANVSTLSAFNVSFNNLSGPLPS 575 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~l~l~~N~l~~~~p~ 575 (963)
++|.|... ..+..+-+|..||+++|+|.. .-...++++|-|+++.|.+|++.+ +|+
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~-~vd 416 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG-SVD 416 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc-cch
Confidence 99999844 678899999999999999972 224678999999999999999987 444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.1e-12 Score=142.51 Aligned_cols=199 Identities=31% Similarity=0.396 Sum_probs=156.5
Q ss_pred EEEccCCcccccCCccccCcccccceeccccccccCCCcc--cc-cccceeeccccccccCCccccccCCCCCeEeCCCC
Q 046851 30 VLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTF--IG-RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106 (963)
Q Consensus 30 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~-~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N 106 (963)
.|+++.|.+. .....+..++.++.|++.+|.++...+.. +. +|+.|++++|++. .+|..+. .+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~-~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLR-NLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhh-ccccccccccCCc
Confidence 6888888875 34445666788899999999888544422 32 6889999999988 7765554 6899999999999
Q ss_pred ccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccc
Q 046851 107 YLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVR 186 (963)
Q Consensus 107 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~ 186 (963)
+++ .++...+.+++|+.|++++|+++. +|........|++|++++|++. ..+..+.++.++..+.+.+|++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~----- 245 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE----- 245 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-----
Confidence 998 677777788999999999999984 5655566677999999999755 56778888999988888775443
Q ss_pred cccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccC
Q 046851 187 YSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLG 264 (963)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 264 (963)
.++..++.+++++.|++++|.++.... ++.+.+|+.|++++|.+..+++....
T Consensus 246 -----------------------~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 246 -----------------------DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred -----------------------eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 125778888999999999999986544 88999999999999999887765443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.7e-11 Score=110.55 Aligned_cols=144 Identities=23% Similarity=0.305 Sum_probs=111.7
Q ss_pred CccccccCCCccEEEEEECCCcEEEEEEeecccch--------hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 686 ASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ--------GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
....+-||+-+.|+++.+. |+...||.-...... ..++..+|++.+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999988 888888855443221 2356788999999987656655555666667778999
Q ss_pred eccCC-CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc---EEEeeccccccc
Q 046851 758 NYLPG-GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN---AYLSDFGLARLL 833 (963)
Q Consensus 758 e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla~~~ 833 (963)
||++| .++.+++...-...........++..|-+.+.-||.. +++||||..+||++.+++. +.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 4888888765443333344478899999999999999 9999999999999976653 689999998654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.7e-12 Score=150.21 Aligned_cols=109 Identities=31% Similarity=0.457 Sum_probs=98.8
Q ss_pred ccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeec
Q 046851 486 GLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVS 565 (963)
Q Consensus 486 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~ 565 (963)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCccCCCCCCCcc----cccccCCCCCCCCC
Q 046851 566 FNNLSGPLPSSKNLM----KCSSVLGNPYLRPC 594 (963)
Q Consensus 566 ~N~l~~~~p~~~~~~----~~~~~~~np~~~~c 594 (963)
+|+++|.+|...... ....+.+|+..|.+
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC
Confidence 999999999864321 23456789988864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.1e-11 Score=118.85 Aligned_cols=131 Identities=20% Similarity=0.182 Sum_probs=97.2
Q ss_pred ccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCe-eEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 687 SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNL-VTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
.+.++.|.++.||+++.. |..|++|....... ....+..|+.++..+.+.++ .+++.+.. +..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356899999999999876 78899998754432 12346789999988865554 44555443 335799999999887
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 766 ENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC--VPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 766 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.+.- .....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 111345679999999999982 12359999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-10 Score=110.61 Aligned_cols=131 Identities=21% Similarity=0.416 Sum_probs=104.2
Q ss_pred cccccCCCccEEEEEECCCcEEEEEEeecccch--------hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ--------GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
..+++|+-+.+|.+.+. |..+++|.-..+... ...+-.+|++++.+++--.|....-|..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45899999999999886 555777744333221 124567899999999766666656666777788999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
++|..|.+++... ...++..+-+-+.-||.. ||+|||++++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999898763 246778888889999999 999999999999998875 99999999975
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.7e-11 Score=135.16 Aligned_cols=145 Identities=17% Similarity=0.228 Sum_probs=95.6
Q ss_pred CCCCccccccCCCccEEEEEECC-CcEEEEEEeecccchh----------------------------------H-----
Q 046851 683 NFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQG----------------------------------V----- 722 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~----- 722 (963)
.|+. +.||.|++|.||+|++++ |+.||||+.+....+. .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4666 789999999999999987 9999999997542100 0
Q ss_pred -HHHHHHHHHHhccC----CCCeeEEEEeeeC-CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHH-HHHH
Q 046851 723 -QQFHAEIKTLGRLR----HPNLVTLIGYHAS-ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR-ALAY 795 (963)
Q Consensus 723 -~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~-~l~~ 795 (963)
-+|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++-.-.. ...+... ++...++ -+..
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~---la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKL---LAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHH---HHHHHHHHHHHH
Confidence 12445555555552 4433433333322 456799999999999987532111 1122221 2221111 1233
Q ss_pred HHhCCCCCceecccCCCCeEECCCC----cEEEeecccccccCC
Q 046851 796 LHDQCVPRVLHRDVKPSNILLDDDF----NAYLSDFGLARLLGP 835 (963)
Q Consensus 796 LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla~~~~~ 835 (963)
+... |++|+|+||.||+++.++ .++++|||++..+.+
T Consensus 276 if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3456 999999999999999988 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.6e-10 Score=112.87 Aligned_cols=137 Identities=13% Similarity=0.192 Sum_probs=100.4
Q ss_pred ccccccCCCccEEEEEECC-------CcEEEEEEeecccc----------------------hhHHHH----HHHHHHHh
Q 046851 687 SNCIGNGGFGATYKAEISP-------GVLVAIKRLAVGRF----------------------QGVQQF----HAEIKTLG 733 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~ 733 (963)
...||.|.-+.||.|.-.+ +..+|||+.+.... ...+.+ ++|++.+.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999996543 57999998764211 001223 37999999
Q ss_pred ccCC--CCeeEEEEeeeCCCeEEEEEeccCCCChHH-HHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceeccc
Q 046851 734 RLRH--PNLVTLIGYHASETEMFLIYNYLPGGNLEN-FIQQRSTRAVDWRVLHKIALDIARALAYL-HDQCVPRVLHRDV 809 (963)
Q Consensus 734 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dl 809 (963)
++.. -++.+++++ ...++||||+.+..+.. .++. ..++..+...+..+++.++.++ |.. ++||||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9853 456667765 46689999997643322 2221 2245566778889999999999 888 9999999
Q ss_pred CCCCeEECCCCcEEEeecccccccC
Q 046851 810 KPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 810 k~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
++.||+++ ++.++++|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.5e-11 Score=119.23 Aligned_cols=121 Identities=32% Similarity=0.413 Sum_probs=47.2
Q ss_pred CCccEEECcCCcCCCCCccccc-cCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCccc-ccCCcccee
Q 046851 437 KSLKFLDASGNQIVGPIPRGVG-ELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSL-GQLQLLEVL 514 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L 514 (963)
..+++|+|++|+|+ .+ +.++ .+.+|+.|++++|.|+.. +.+..+++|++|++++|+|+ .+.+.+ ..+++|+.|
T Consensus 19 ~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-cc-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 35788888888887 44 3455 577888888888888643 35777888888888888888 555545 368888888
Q ss_pred cccccccCCCCC-hhhhccccCCeEEeccccCCCcCCC----CccccccCceEe
Q 046851 515 DLSSNSLSGLIP-DDLENLRNLTVLLLNNNKLSGKIPS----GLANVSTLSAFN 563 (963)
Q Consensus 515 ~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~L~~l~ 563 (963)
+|++|+|...-. ..+..+++|+.|+|.+|+++ ..+. .+..+|+|+.||
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SEET
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhheeC
Confidence 888888875322 45677888888888888887 3343 256678887766
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.5e-12 Score=124.78 Aligned_cols=59 Identities=36% Similarity=0.495 Sum_probs=37.7
Q ss_pred CCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccc
Q 046851 96 TNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLS 157 (963)
Q Consensus 96 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 157 (963)
+-|++||||+|.|+ .+.++..-++.++.|++++|.|..+ +.+..|++|+.||||+|.++
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls 342 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA 342 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH
Confidence 45666777777766 5556666666666666666666643 22666666666666666665
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5e-12 Score=132.97 Aligned_cols=213 Identities=26% Similarity=0.170 Sum_probs=134.6
Q ss_pred ccCCCCcEEEccCCcccccCC-ccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeE
Q 046851 23 FHLKSLRVLNLGFNRITGEIP-ASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHL 101 (963)
Q Consensus 23 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L 101 (963)
.++.+|++..|.++.+..... .....+++++.||||.|-+... ..-..+.+.|++|+.|
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw--------------------~~v~~i~eqLp~Le~L 177 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNW--------------------FPVLKIAEQLPSLENL 177 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhH--------------------HHHHHHHHhcccchhc
Confidence 367888888898888872221 3567788888888888877621 1112334567777777
Q ss_pred eCCCCccccCcC-ccccCcccccEEEcccCccccc-CcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcC
Q 046851 102 DLSGNYLVGGIP-RSLGNCFQVRSLLLFSNMLEET-IPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLF 179 (963)
Q Consensus 102 ~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 179 (963)
+|+.|++..-.. ..-..++.|+.|.|+.|.++.. +......+|+|..|+|..|.....-......+..|+.|+|++|.
T Consensus 178 Nls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~ 257 (505)
T KOG3207|consen 178 NLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNN 257 (505)
T ss_pred ccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCc
Confidence 777777652111 1112456777888888877722 22234567888888888885332444445667778888887754
Q ss_pred CcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccC-CCcc-----ccccccCceeecCcc
Q 046851 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN-FPSN-----WGACDNLEMLNLGHN 253 (963)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~-~~~~-----~~~l~~L~~L~Ls~N 253 (963)
+-..++ -.....++.|+.|+++.+.+..+ .|+. ...+++|++|+++.|
T Consensus 258 li~~~~--------------------------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N 311 (505)
T KOG3207|consen 258 LIDFDQ--------------------------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISEN 311 (505)
T ss_pred cccccc--------------------------ccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccC
Confidence 433221 13456677888888888877763 2322 245677888888888
Q ss_pred cccCcCc-cccCCCCCCcEEeccCccccc
Q 046851 254 FFSGKNL-GVLGPCKNLLFLDLSSNQLTG 281 (963)
Q Consensus 254 ~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 281 (963)
+|.+... ..+..+++|+.|.+..|.++.
T Consensus 312 ~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 312 NIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ccccccccchhhccchhhhhhcccccccc
Confidence 8865432 344556677777777777763
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.2e-12 Score=132.13 Aligned_cols=243 Identities=25% Similarity=0.293 Sum_probs=118.1
Q ss_pred CCceEEEccCCcccc----cCCCccccCCCCcEEEccCC---cccccCCc-------cccCcccccceeccccccccCCC
Q 046851 2 GNLEVLDLEGNLLNG----ILPDSGFHLKSLRVLNLGFN---RITGEIPA-------SFSDFVNLEELNLAGNLVNGTVP 67 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~----~~~~~~~~l~~L~~L~L~~n---~l~~~~~~-------~~~~l~~L~~L~Ls~N~l~~~~~ 67 (963)
..++.|+||+|.+.. .+...+...++|+..++++= ++...+|. ++...+.|++||||+|-+....+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 345666666666653 22223344556666666642 22223332 23445566666666666654444
Q ss_pred cccc-------cccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCccccc----C
Q 046851 68 TFIG-------RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET----I 136 (963)
Q Consensus 68 ~~~~-------~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~----~ 136 (963)
..+. +|++|+|.+|.+...-...+. ..|.+|. .......-++|+.+..++|++..- .
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~---~al~~l~---------~~kk~~~~~~Lrv~i~~rNrlen~ga~~~ 177 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLG---RALFELA---------VNKKAASKPKLRVFICGRNRLENGGATAL 177 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHH---HHHHHHH---------HHhccCCCcceEEEEeeccccccccHHHH
Confidence 3332 344555555554311111111 1111111 112233446778888888877632 2
Q ss_pred cccccCCCCCCEEEccCCccccC----CCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCc
Q 046851 137 PAELGMLQNLEVLDVSRNSLSGS----IPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIP 212 (963)
Q Consensus 137 ~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~ 212 (963)
...|...+.|+.+.++.|.|... +...|..+++|++|||..|-++...... +.
T Consensus 178 A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~-----------------------La 234 (382)
T KOG1909|consen 178 AEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVA-----------------------LA 234 (382)
T ss_pred HHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHH-----------------------HH
Confidence 34566677888888888887521 1223556666666666654443322221 23
Q ss_pred ccccCCCCCceEecCCcccccCCCcccc-----ccccCceeecCcccccCc----CccccCCCCCCcEEeccCccc
Q 046851 213 EAVSSLPNLRILWAPRATLEGNFPSNWG-----ACDNLEMLNLGHNFFSGK----NLGVLGPCKNLLFLDLSSNQL 279 (963)
Q Consensus 213 ~~l~~l~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l 279 (963)
..++.+++|+.|++++|.+...-..+|. ..++|+.|.|.+|.|+.- ....+...+.|..|+|++|++
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 4455555666666666655543332221 234455555555554431 112222344455555555544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.3e-11 Score=116.00 Aligned_cols=138 Identities=25% Similarity=0.269 Sum_probs=42.6
Q ss_pred ccCCcccccCCCccccCCCCcEEEccCCcccccCCcccc-CcccccceeccccccccCCCcccccccceeeccccccccC
Q 046851 9 LEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFS-DFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSV 87 (963)
Q Consensus 9 ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~ 87 (963)
|+.+.|..+ ..+.+...+++|+|++|+|+.+. .++ .+.+|+.|+|++|.|+ .+
T Consensus 4 lt~~~i~~~--~~~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~----------------------~l 57 (175)
T PF14580_consen 4 LTANMIEQI--AQYNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQIT----------------------KL 57 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S------------------------
T ss_pred ccccccccc--ccccccccccccccccccccccc--chhhhhcCCCEEECCCCCCc----------------------cc
Confidence 444445422 22445556777888888777332 344 4667777777777776 33
Q ss_pred CccccccCCCCCeEeCCCCccccCcCccc-cCcccccEEEcccCcccccC-cccccCCCCCCEEEccCCccccCCCc---
Q 046851 88 PSKIGEKCTNLEHLDLSGNYLVGGIPRSL-GNCFQVRSLLLFSNMLEETI-PAELGMLQNLEVLDVSRNSLSGSIPV--- 162 (963)
Q Consensus 88 p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~--- 162 (963)
+. +..+++|+.|++++|+|+. +.+.+ ..+++|+.|+|++|+|.... -..+..+++|+.|+|.+|+++.. +.
T Consensus 58 ~~--l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~ 133 (175)
T PF14580_consen 58 EG--LPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRL 133 (175)
T ss_dssp TT------TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHH
T ss_pred cC--ccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHH
Confidence 32 2345666666666666663 32223 34666666666666665422 14566788888888888888733 33
Q ss_pred -CccCCCCCceEeec
Q 046851 163 -DLGNCSKLAILVLS 176 (963)
Q Consensus 163 -~~~~l~~L~~L~l~ 176 (963)
.+..+++|+.||-.
T Consensus 134 ~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 134 FVIYKLPSLKVLDGQ 148 (175)
T ss_dssp HHHHH-TT-SEETTE
T ss_pred HHHHHcChhheeCCE
Confidence 26678888888654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.2e-11 Score=130.54 Aligned_cols=249 Identities=20% Similarity=0.196 Sum_probs=177.9
Q ss_pred HcCCCCCccccccCCCccEEEEEEC--CCcEEEEEEeecccchhHHHH--HHHHHHHhcc-CCCCeeEEEEeeeCCCeEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS--PGVLVAIKRLAVGRFQGVQQF--HAEIKTLGRL-RHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 754 (963)
...+|..+..||.|.|+.|++...+ ++..|++|...........+. ..|+.+...+ .|.++++.+..+...+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457999999999999999998544 688899998766544433332 3455555555 4888898888887778888
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC-CcEEEeeccccccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD-FNAYLSDFGLARLL 833 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~ 833 (963)
+--||+++++....... ...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..+
T Consensus 343 ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred CchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence 99999999988776632 23477888999999999999999999 99999999999999886 78899999988643
Q ss_pred CCCCCcccccccccccc-cCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 834 GPSETHATTGVAGTFGY-VAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
... .......+..| .+|+......+..+.|+||||.-+.|..++..--... +.|. .
T Consensus 418 ~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----------~~~~----------~ 474 (524)
T KOG0601|consen 418 AFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----------VQSL----------T 474 (524)
T ss_pred cee---cccccccccccccchhhccccccccccccccccccccccccCcccCccc----------ccce----------e
Confidence 211 11111122233 3566666778888999999999999999876432211 1111 1
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
...... ...+ .....+..+...+...++..||.+.+...+.+..
T Consensus 475 i~~~~~-p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 IRSGDT-PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred eecccc-cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111001 0111 2225677788889999999999999987766544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-11 Score=129.49 Aligned_cols=132 Identities=23% Similarity=0.264 Sum_probs=66.9
Q ss_pred CCccEEECcCCcCCCC-CccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCC--cccccCCccce
Q 046851 437 KSLKFLDASGNQIVGP-IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP--SSLGQLQLLEV 513 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~-~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~ 513 (963)
++|+.|.|+.|.++-. +-.....+|+|+.|+|..|...........-+..|++|||++|.+- ..+ ...+.++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 4455666666655511 1222334556666666666322232333334556666666666665 333 34455666666
Q ss_pred ecccccccCCCC-Chh-----hhccccCCeEEeccccCCCcCC--CCccccccCceEeeccccCc
Q 046851 514 LDLSSNSLSGLI-PDD-----LENLRNLTVLLLNNNKLSGKIP--SGLANVSTLSAFNVSFNNLS 570 (963)
Q Consensus 514 L~ls~N~l~~~~-p~~-----~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~L~~l~l~~N~l~ 570 (963)
|+++.+.|..+- |+. ...+++|++|+++.|++. ..+ ..+..+++|+.|....|.|+
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhccccccc
Confidence 666666665321 111 234566666666666664 222 23344455555555555444
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.8e-10 Score=114.27 Aligned_cols=142 Identities=19% Similarity=0.258 Sum_probs=109.8
Q ss_pred cccccCCCccEEEEEECCCcEEEEEEeecccc-hhHHHHHHHHHHHhccCC--CCeeEEEEeeeCC---CeEEEEEeccC
Q 046851 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRH--PNLVTLIGYHASE---TEMFLIYNYLP 761 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~ 761 (963)
+.++.|..+.||++...+|+.+++|....... ....++..|++++..+.+ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999998765432 134577899999999975 3457777776654 36689999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ------------------------------------------ 799 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 799 (963)
|+++.+.+.. ..++..+...++.++++++.+||+.
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888775532 2366677777888888888888842
Q ss_pred -----------CCCCceecccCCCCeEECC--CCcEEEeecccccc
Q 046851 800 -----------CVPRVLHRDVKPSNILLDD--DFNAYLSDFGLARL 832 (963)
Q Consensus 800 -----------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~ 832 (963)
....++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.8e-12 Score=128.17 Aligned_cols=243 Identities=23% Similarity=0.266 Sum_probs=148.4
Q ss_pred cccCCCCcEEEccCCccc----ccCCccccCcccccceecccccc---ccCCCcccccccceeeccccccccCCcccccc
Q 046851 22 GFHLKSLRVLNLGFNRIT----GEIPASFSDFVNLEELNLAGNLV---NGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEK 94 (963)
Q Consensus 22 ~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~Ls~N~l---~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~ 94 (963)
...+..+++++|++|.+. ..+...+...++|+.-++|+--. ...+|..+. .+...+ ..
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~--------------~l~~aL-~~ 90 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALK--------------MLSKAL-LG 90 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHH--------------HHHHHH-hc
Confidence 345678899999999887 34445566777888888875421 122232221 011111 13
Q ss_pred CCCCCeEeCCCCccccCc----CccccCcccccEEEcccCcccccCcc-------------cccCCCCCCEEEccCCccc
Q 046851 95 CTNLEHLDLSGNYLVGGI----PRSLGNCFQVRSLLLFSNMLEETIPA-------------ELGMLQNLEVLDVSRNSLS 157 (963)
Q Consensus 95 l~~L~~L~Ls~N~i~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~L~L~~N~l~ 157 (963)
+++|+.||||+|-+.-.. .+.+.+++.|+.|.|.+|.+...-.. ....-+.|+++...+|++.
T Consensus 91 ~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 91 CPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE 170 (382)
T ss_pred CCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc
Confidence 456777777777664222 22345566777777777776632222 2233467888888888886
Q ss_pred cCCC----cCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccccc
Q 046851 158 GSIP----VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEG 233 (963)
Q Consensus 158 ~~~p----~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~ 233 (963)
+... ..|...+.|+.+.++.|.|...+. ..+..+|..++.|+.|+|..|-++.
T Consensus 171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~-----------------------~al~eal~~~~~LevLdl~DNtft~ 227 (382)
T KOG1909|consen 171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGV-----------------------TALAEALEHCPHLEVLDLRDNTFTL 227 (382)
T ss_pred cccHHHHHHHHHhccccceEEEecccccCchh-----------------------HHHHHHHHhCCcceeeecccchhhh
Confidence 3322 346667788888887766653322 1345677788888888888887654
Q ss_pred C----CCccccccccCceeecCcccccCcCcccc-----CCCCCCcEEeccCcccccccCCCC-----CCCceeEEEecc
Q 046851 234 N----FPSNWGACDNLEMLNLGHNFFSGKNLGVL-----GPCKNLLFLDLSSNQLTGELAREL-----PVPCMTMFDVSG 299 (963)
Q Consensus 234 ~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~-----~~~~L~~L~l~~ 299 (963)
. +...++.+++|+.|++++|.++.-....| ...++|+.|.+.+|.|+......+ ..+.|..|+|++
T Consensus 228 egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLng 307 (382)
T KOG1909|consen 228 EGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNG 307 (382)
T ss_pred HHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCc
Confidence 2 44556677778888888887776544222 235778888888888774332221 246677777777
Q ss_pred CcC
Q 046851 300 NAL 302 (963)
Q Consensus 300 N~l 302 (963)
|++
T Consensus 308 N~l 310 (382)
T KOG1909|consen 308 NRL 310 (382)
T ss_pred ccc
Confidence 776
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.1e-08 Score=104.37 Aligned_cols=265 Identities=17% Similarity=0.164 Sum_probs=165.4
Q ss_pred CCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEE------eeeCC-CeEEE
Q 046851 684 FNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIG------YHASE-TEMFL 755 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~------~~~~~-~~~~l 755 (963)
...++.+|+|+.+.+|-.--- ...+.|+..........+ .+..+... .||-+-.=+. +...+ ....+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 345678999999999976221 123456665544332222 22233333 4665433111 11222 23678
Q ss_pred EEeccCCC-ChHHHHh----hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 756 IYNYLPGG-NLENFIQ----QRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 756 v~e~~~~g-sL~~~l~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
.|..+++. .+..+.. +++-...+|.-..++++.+|.+.+.||.+ |.+-||+.++|+|+++++.+.+.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 88888764 2333332 22345678999999999999999999999 9999999999999999999999986544
Q ss_pred cccCCCCCcccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCCCCcchhhHHHHH
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSD-KKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
... .........+|...|.+||... +..-+...|-|.+|+++++++.| ++||..-........... ..
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~ 238 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TD 238 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hh
Confidence 333 2333344557899999999765 34556678999999999999887 889864332111110000 01
Q ss_pred HhcCcccceecccc-CC----CCChh-HHHHHHHHHHHcccC--CCCCCCCHHHHHHHHhccCCCC
Q 046851 905 LRQGRAKEFFTAGL-WD----AGPHD-DLVEVLHLAVVCTVD--SLSTRPTMKQVVRRLKQLQPAS 962 (963)
Q Consensus 905 ~~~~~~~~~~~~~~-~~----~~~~~-~~~~l~~l~~~cl~~--dP~~RPs~~evl~~L~~l~~~~ 962 (963)
+..+.+...-+.+. .. ..|-. .+..+..+..+|+.. .+.-||+++..+..|.++++..
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11111111111111 00 11211 245677788888865 3678999999999998877653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.3e-11 Score=133.35 Aligned_cols=57 Identities=28% Similarity=0.300 Sum_probs=27.8
Q ss_pred CceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccc
Q 046851 221 LRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 221 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 280 (963)
|+.++++.|.+... +..+..+..+..|++.+|++..+.. +.....+..+..+.|++.
T Consensus 234 L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 234 LRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNKLA 290 (414)
T ss_pred HHHHhcccCccccc-cccccccccccccchhhcccccccc--ccccchHHHhccCcchhc
Confidence 55555555555421 1334455555555555555554422 233344555555555544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.5e-08 Score=108.05 Aligned_cols=168 Identities=21% Similarity=0.284 Sum_probs=130.1
Q ss_pred CCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC----CCeEEEEEeccCC-CChHH
Q 046851 694 GFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS----ETEMFLIYNYLPG-GNLEN 767 (963)
Q Consensus 694 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~ 767 (963)
-..+.||+.. .||..|++|+++..+.+....-..-++.++++.|+|+|++.+++.. +...++||+|+|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457899944 5799999999965554444344566888999999999999998763 4567999999986 47777
Q ss_pred HHhhh-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 768 FIQQR-------------STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 768 ~l~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+--.. .+...++..+|.++.|+..||.++|+. |..-+-+.+++|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 64221 134467889999999999999999999 99999999999999999999999888876654
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCC
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK 882 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~ 882 (963)
.+.. |.+. -..+-|.-.+|.+++.+.||..
T Consensus 445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 3320 1111 1235799999999999999963
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2e-10 Score=130.70 Aligned_cols=240 Identities=27% Similarity=0.251 Sum_probs=157.0
Q ss_pred CceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCC-cccccccceeeccc
Q 046851 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVP-TFIGRLKRVYLSFN 81 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~L~~L~L~~n 81 (963)
.++.+.+..|.|.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|+|+...+ ..+..|+.|++++|
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N 150 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGN 150 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccchhhccchhhheeccC
Confidence 45556667777763 33446677888888888888883 33336777888888888888775433 33456778888888
Q ss_pred cccccCCccccccCCCCCeEeCCCCccccCcC-ccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCC
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIP-RSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSI 160 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (963)
.++ .+... ..+++|+.+++++|+++...+ . ...+.+++.+++.+|.+..+ ..+..+..+..+++..|.++..-
T Consensus 151 ~i~-~~~~~--~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~ 224 (414)
T KOG0531|consen 151 LIS-DISGL--ESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLE 224 (414)
T ss_pred cch-hccCC--ccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceecc
Confidence 877 55443 236778888888888774333 2 46777778888888877643 34455556666677777776322
Q ss_pred CcCccCCC--CCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcc
Q 046851 161 PVDLGNCS--KLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSN 238 (963)
Q Consensus 161 p~~~~~l~--~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 238 (963)
.+..+. .|+.+++++|.+.. .+..+..+.++..|++..|++... ..
T Consensus 225 --~l~~~~~~~L~~l~l~~n~i~~----------------------------~~~~~~~~~~l~~l~~~~n~~~~~--~~ 272 (414)
T KOG0531|consen 225 --GLNELVMLHLRELYLSGNRISR----------------------------SPEGLENLKNLPVLDLSSNRISNL--EG 272 (414)
T ss_pred --CcccchhHHHHHHhcccCcccc----------------------------ccccccccccccccchhhcccccc--cc
Confidence 222222 26777777755442 115677788889999999988753 23
Q ss_pred ccccccCceeecCcccccCcC---c-cccCCCCCCcEEeccCcccccc
Q 046851 239 WGACDNLEMLNLGHNFFSGKN---L-GVLGPCKNLLFLDLSSNQLTGE 282 (963)
Q Consensus 239 ~~~l~~L~~L~Ls~N~l~~~~---~-~~~~~l~~L~~L~L~~N~l~~~ 282 (963)
+.....+..+.+..|.+.... . ......+.++.+.+..|.+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 273 LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKI 320 (414)
T ss_pred ccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccc
Confidence 555677888888888876331 1 1145567788888888877643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=2e-08 Score=105.50 Aligned_cols=141 Identities=19% Similarity=0.207 Sum_probs=102.4
Q ss_pred cccccCCCccEEEEEECCCcEEEEEEeecccch-----------hHHHHHHHHHHHhccCCCC--eeEEEEeeeC-----
Q 046851 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ-----------GVQQFHAEIKTLGRLRHPN--LVTLIGYHAS----- 749 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 749 (963)
+.+-......|++..+. |+.|.||+....... ....+.+|.+.+.++...+ +++++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44554445557788775 789999977433211 1113678999888885333 3344445432
Q ss_pred CCeEEEEEeccCCC-ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-------CCc
Q 046851 750 ETEMFLIYNYLPGG-NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-------DFN 821 (963)
Q Consensus 750 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~ 821 (963)
....++|+|++++. +|.+++........+......++.+++..+.-||.. ||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 34578999999886 899998643333456677789999999999999999 9999999999999975 467
Q ss_pred EEEeecccccc
Q 046851 822 AYLSDFGLARL 832 (963)
Q Consensus 822 ~kl~Dfgla~~ 832 (963)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=9.9e-10 Score=127.94 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=172.5
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc---cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG---RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
..+.+.+.+.+-.|.++.++-+.-. .|...++|+.... .....+....+-.+.-..++|.+++...-+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456777888999999999988433 2433344433221 11112222333333333445777766555566778899
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
+++|+.++++...++..+ ..+.+-+......+..+.+|||+. .+.|+|++|.|.+...++..+++|||.....+.
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999998754 355556666777888999999999 899999999999999999999999984332210
Q ss_pred ---------------------CC---------CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046851 836 ---------------------SE---------THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885 (963)
Q Consensus 836 ---------------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~ 885 (963)
.. ........||+.|.+||...+......+|.|+.|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 011334578999999999999999999999999999999999999998
Q ss_pred CCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHH
Q 046851 886 PSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMK 949 (963)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 949 (963)
...+... ...+... ...+...+........+++...+..+|.+|-.|.
T Consensus 1037 a~tpq~~--------f~ni~~~--------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI--------FENILNR--------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhh--------hhccccC--------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 6654411 0111100 0112233445556777888888888999998776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.8e-08 Score=99.64 Aligned_cols=126 Identities=25% Similarity=0.334 Sum_probs=85.1
Q ss_pred cEEEEEECCCcEEEEEEeecccc-------------h-------------hHHHHHHHHHHHhccCCC--CeeEEEEeee
Q 046851 697 ATYKAEISPGVLVAIKRLAVGRF-------------Q-------------GVQQFHAEIKTLGRLRHP--NLVTLIGYHA 748 (963)
Q Consensus 697 ~Vy~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 748 (963)
.||.|...+|..+|||+.+.... . ......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999988899999998764311 0 023457899999999765 466776553
Q ss_pred CCCeEEEEEeccC--CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceecccCCCCeEECCCCcEEEe
Q 046851 749 SETEMFLIYNYLP--GGNLENFIQQRSTRAVDWRVLHKIALDIARALAY-LHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825 (963)
Q Consensus 749 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 825 (963)
..++||||++ |..+..+.... ++......++.+++..+.. +|.. |++|||+++.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3479999998 65555544322 1134556677888886666 4688 99999999999999988 99999
Q ss_pred ecccccccC
Q 046851 826 DFGLARLLG 834 (963)
Q Consensus 826 Dfgla~~~~ 834 (963)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.2e-09 Score=83.84 Aligned_cols=61 Identities=43% Similarity=0.533 Sum_probs=57.7
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceecccccc
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 62 (963)
++|++|++++|+|+.+.++.|.++++|++|++++|+++.+.+++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999988889999999999999999999999999999999999999999975
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.4e-09 Score=83.22 Aligned_cols=61 Identities=33% Similarity=0.414 Sum_probs=45.7
Q ss_pred CCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCccc
Q 046851 219 PNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQL 279 (963)
Q Consensus 219 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 279 (963)
|+|+.|++++|+++...+..|.++++|++|++++|+++.+++..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4577777777777777667777777777777777777777777777777777777777764
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.9e-08 Score=99.07 Aligned_cols=136 Identities=22% Similarity=0.221 Sum_probs=99.9
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccch----------------------hHHHHHHHHHHHhccCCC--
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ----------------------GVQQFHAEIKTLGRLRHP-- 738 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~-- 738 (963)
-..+++.||-|.-+.||.|....|.++|||.-+.+.+. .....++|.++|.++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35577899999999999999989999999954432210 122357789999988644
Q ss_pred CeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC
Q 046851 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD 818 (963)
Q Consensus 739 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 818 (963)
.|.+.+++ +...+||||++|-.|...- ++......++..|++-+.-+-.. |+||||+++-||++++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 56665544 5779999999996665432 12334445555566655555567 9999999999999999
Q ss_pred CCcEEEeecccccc
Q 046851 819 DFNAYLSDFGLARL 832 (963)
Q Consensus 819 ~~~~kl~Dfgla~~ 832 (963)
||.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-09 Score=125.43 Aligned_cols=125 Identities=26% Similarity=0.345 Sum_probs=96.2
Q ss_pred ccccceeccccccccCCCccc--ccccceeecccc--ccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEE
Q 046851 50 VNLEELNLAGNLVNGTVPTFI--GRLKRVYLSFNR--LVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSL 125 (963)
Q Consensus 50 ~~L~~L~Ls~N~l~~~~~~~~--~~L~~L~L~~n~--l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 125 (963)
...+...+-+|.+. .++... ++|+.|-+.+|. +. .++..+|..++.|+.|||++|.=-+.+|..++.+.+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCCCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 44445555555443 222111 146666666665 55 8888889999999999999887666899999999999999
Q ss_pred EcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecC
Q 046851 126 LLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177 (963)
Q Consensus 126 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 177 (963)
+|++..++ .+|..+.+|..|.+|++..+.-...+|.....+.+|++|.+..
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeec
Confidence 99999998 6788999999999999998887656677788899999998865
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.1e-08 Score=121.71 Aligned_cols=103 Identities=27% Similarity=0.319 Sum_probs=68.5
Q ss_pred ccccceeeccccccccCCccccccCCCCCeEeCCCCc--cccCcCccccCcccccEEEcccCcccccCcccccCCCCCCE
Q 046851 71 GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNY--LVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEV 148 (963)
Q Consensus 71 ~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~--i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 148 (963)
...+...+.+|.+. .++... ..++|+.|-+.+|. +.....+.|..++.|+.|+|++|.-.+.+|..++.|-+|++
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~--~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSS--ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchh-hccCCC--CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 35666777777766 555543 34567777777774 44344455666777777777776555567777777777777
Q ss_pred EEccCCccccCCCcCccCCCCCceEeecC
Q 046851 149 LDVSRNSLSGSIPVDLGNCSKLAILVLSN 177 (963)
Q Consensus 149 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 177 (963)
|+|++..++ .+|..+.+++.|.+|++..
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~ 627 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEV 627 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheecccc
Confidence 777777777 6777777777777777764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.8e-07 Score=89.67 Aligned_cols=138 Identities=15% Similarity=0.171 Sum_probs=105.4
Q ss_pred cccCCCccEEEEEECCCcEEEEEEeeccc------chhHHHHHHHHHHHhccCCC--CeeEEEEeee---C--CCeEEEE
Q 046851 690 IGNGGFGATYKAEISPGVLVAIKRLAVGR------FQGVQQFHAEIKTLGRLRHP--NLVTLIGYHA---S--ETEMFLI 756 (963)
Q Consensus 690 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~---~--~~~~~lv 756 (963)
-|+||-+-|++-... |..+-+|+-.... +-....|.+|+..+.++..- .+.++. ++. . ....++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888889998877 5578888764211 23457899999999998532 244444 332 1 2346899
Q ss_pred EeccCC-CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc--EEEeecccccc
Q 046851 757 YNYLPG-GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN--AYLSDFGLARL 832 (963)
Q Consensus 757 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~ 832 (963)
+|-++| .+|.+++......+.+......+..++++++.-||+. |+.|+|+.++||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998864 4899998765444567788889999999999999999 9999999999999986667 99999987654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.5e-09 Score=120.81 Aligned_cols=124 Identities=30% Similarity=0.377 Sum_probs=79.2
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
+.+.+.|++. .+-..+ ++++.|+.|||++|+++ .. +.+..++.|+.|||++|.++...--....+. |+.|++.||
T Consensus 168 ~a~fsyN~L~-~mD~SL-qll~ale~LnLshNk~~-~v-~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN 242 (1096)
T KOG1859|consen 168 TASFSYNRLV-LMDESL-QLLPALESLNLSHNKFT-KV-DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNN 242 (1096)
T ss_pred hhhcchhhHH-hHHHHH-HHHHHhhhhccchhhhh-hh-HHHHhcccccccccccchhccccccchhhhh-heeeeeccc
Confidence 4566666665 333333 34467788888888877 22 3777777888888888877532222222233 777888888
Q ss_pred cccccCCcccccCCccceecccccccCCCCC-hhhhccccCCeEEeccccCC
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIP-DDLENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 546 (963)
.++ .+ ..+.++++|+.||++.|-|.+.-- .-++.|..|+.|+|.||++.
T Consensus 243 ~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 243 ALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 777 33 346677778888888887765321 23466677777888888776
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.8e-09 Score=93.86 Aligned_cols=111 Identities=26% Similarity=0.265 Sum_probs=70.7
Q ss_pred CccEEECcCCcCCCCCcccccc---CCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCcccee
Q 046851 438 SLKFLDASGNQIVGPIPRGVGE---LVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVL 514 (963)
Q Consensus 438 ~L~~L~ls~n~l~~~~p~~~~~---l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 514 (963)
.+..+||+.+++. .+++.... ...|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|..+..|+.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 4566677777665 45554333 334555577777774333333344456777777777777 677777777777777
Q ss_pred cccccccCCCCChhhhccccCCeEEeccccCCCcCCCC
Q 046851 515 DLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG 552 (963)
Q Consensus 515 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 552 (963)
+++.|.+. ..|..+..+.+|..|+..+|.+. .+|..
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d 141 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD 141 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence 77777776 45666666777777777777776 55544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.4e-08 Score=112.49 Aligned_cols=150 Identities=17% Similarity=0.230 Sum_probs=105.7
Q ss_pred HHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccc--------cccccccccCcccccc
Q 046851 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT--------GVAGTFGYVAPEYAMT 858 (963)
Q Consensus 787 ~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~ 858 (963)
.+++.|+.|+|.. +++||++|.|++|.++.++.+||+.|+.+........+... -......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4455999999987 49999999999999999999999999988765442222111 1234568999999999
Q ss_pred CCCCcchhhHHHHHHHHHHHcCCCC-CCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHc
Q 046851 859 CRVSDKADVYSYGVVLLELLSDKKA-LDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVC 937 (963)
Q Consensus 859 ~~~~~~~Dv~slG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 937 (963)
...+.++|+||+|+++|.+..|+.+ +...... .... .....+..-...+....+.++.+=+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~----------~~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYS----------FSRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhh----------hhhcccccccccccccCcHHHHHHHHHH
Confidence 8888999999999999999954444 3322111 0000 0011111122233456677888888999
Q ss_pred ccCCCCCCCCHHHHHH
Q 046851 938 TVDSLSTRPTMKQVVR 953 (963)
Q Consensus 938 l~~dP~~RPs~~evl~ 953 (963)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999997776643
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.7e-09 Score=91.94 Aligned_cols=136 Identities=22% Similarity=0.293 Sum_probs=107.3
Q ss_pred EEEccCCeeeecCchhHhhcc--CCccEEECcCCcCCCCCccccc-cCCCCCEEeccCCcCCCccchhhccCcccceecc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMC--KSLKFLDASGNQIVGPIPRGVG-ELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSL 492 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~--~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l 492 (963)
.++|+.|++. .+++....+. .+|+.++|++|.+. .+|..|. .++.++.|+|++|.|+ .+|..+..++.|+.|++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 6788888886 6777665443 45777899999999 6777665 4569999999999994 68888999999999999
Q ss_pred ccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCcccc
Q 046851 493 AGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANV 556 (963)
Q Consensus 493 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 556 (963)
+.|.+. ..|..+..+.+|-.||..+|.+. .+|..+-.-+..-..++.++++.+.-+..+..+
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence 999999 88999989999999999999998 566554333344445667888887666544433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.1e-07 Score=91.45 Aligned_cols=106 Identities=32% Similarity=0.478 Sum_probs=83.9
Q ss_pred HHHHHHHHHHhccCCC--CeeEEEEeeeCC----CeEEEEEeccCCC-ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 046851 723 QQFHAEIKTLGRLRHP--NLVTLIGYHASE----TEMFLIYNYLPGG-NLENFIQQRSTRAVDWRVLHKIALDIARALAY 795 (963)
Q Consensus 723 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~ 795 (963)
.+..+|.+.+.++... .+++.+++.... ...++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 4677888887777533 345555655432 3458999999884 89999976332 5667788999999999999
Q ss_pred HHhCCCCCceecccCCCCeEECCCC---cEEEeeccccccc
Q 046851 796 LHDQCVPRVLHRDVKPSNILLDDDF---NAYLSDFGLARLL 833 (963)
Q Consensus 796 LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~ 833 (963)
||+. ||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 999999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=8.1e-07 Score=101.19 Aligned_cols=141 Identities=25% Similarity=0.347 Sum_probs=97.0
Q ss_pred cccccCCCccEEEEEECCCcEEEEEEeecccchh----------------------------------------HHHHHH
Q 046851 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQG----------------------------------------VQQFHA 727 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 727 (963)
+.|+.++-|-||+|++++|+.||||+.+.+-.+. .=++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999886532110 012445
Q ss_pred HHHHHhccC-----CCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHH-HHHHHhCCC
Q 046851 728 EIKTLGRLR-----HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARA-LAYLHDQCV 801 (963)
Q Consensus 728 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~-l~~LH~~~~ 801 (963)
|+..+.+++ .+.+.-..=|..-.+...++|||++|-.+.+...-.. ...+... ++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhc--
Confidence 666665552 3443322223333567799999999999988853322 3355333 33333332 2333335
Q ss_pred CCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 802 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
|++|+|.+|.||+++.+|.+.+.|||+.....+
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999987754
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-08 Score=100.96 Aligned_cols=104 Identities=23% Similarity=0.256 Sum_probs=62.3
Q ss_pred ceEEEccCCcccccCCCc-c-ccCCCCcEEEccCCccc--ccCCccccCcccccceeccccccccCC---Ccccccccce
Q 046851 4 LEVLDLEGNLLNGILPDS-G-FHLKSLRVLNLGFNRIT--GEIPASFSDFVNLEELNLAGNLVNGTV---PTFIGRLKRV 76 (963)
Q Consensus 4 l~~L~ls~n~i~~~~~~~-~-~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~L~~L 76 (963)
++.|.+.++.|..+.... | ...++++.|||.+|.|+ ..+...+.++|.|+.|+|+.|++...+ |....+|+.|
T Consensus 47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~l 126 (418)
T KOG2982|consen 47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVL 126 (418)
T ss_pred hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEE
Confidence 345666666666443221 2 23467788888888877 233344667788888888888776432 3334466666
Q ss_pred eeccccccccCCccccccCCCCCeEeCCCCc
Q 046851 77 YLSFNRLVGSVPSKIGEKCTNLEHLDLSGNY 107 (963)
Q Consensus 77 ~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~ 107 (963)
-|.+..+.-+-..+....+|.+++|.+|.|.
T Consensus 127 VLNgT~L~w~~~~s~l~~lP~vtelHmS~N~ 157 (418)
T KOG2982|consen 127 VLNGTGLSWTQSTSSLDDLPKVTELHMSDNS 157 (418)
T ss_pred EEcCCCCChhhhhhhhhcchhhhhhhhccch
Confidence 6666666544444444556666666666664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 963 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-30 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-30 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-18 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-30 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-20 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-08 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 8e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-117
Identities = 162/607 (26%), Positives = 245/607 (40%), Gaps = 104/607 (17%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
L+ LD+ GN L+G + L++LN+ N+ G IP +L+ L+LA N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAEN 279
Query: 61 LVNGTVPTFIG----RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR-S 115
G +P F+ L + LS N G+VP G C+ LE L LS N G +P +
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDT 338
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELG-MLQNLEVLDVSRNSLSGSIPVDLGNCSK--LAI 172
L ++ L L N +P L + +L LD+S N+ SG I +L K L
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398
Query: 173 LVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLE 232
L L N N F G IP +S+ L L L
Sbjct: 399 LYLQN---------------------------NGFTGKIPPTLSNCSELVSLHLSFNYLS 431
Query: 233 GNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC- 291
G PS+ G+ L L L N G+ L K L L L N LTGE+ L C
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL-SNCT 490
Query: 292 -MTMFDVSGNALSGSIP-TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLP 349
+ +S N L+G IP + + A L L
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRL-----------------ENLAILKL------------ 521
Query: 350 LRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPGNMFGI 408
N+FSG++P+ LG +++ + N +G+ P MF
Sbjct: 522 --------------SNNSFSGNIPA------ELGDCRSLIWLDLNTNLFNGTIPAAMF-- 559
Query: 409 CNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGN--QIVGPIPRGVGELVSLVAL 466
++ N IAG+ I K +GN + G + L +
Sbjct: 560 -----KQSGKIAANFIAGKRYVYIKN-DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613
Query: 467 NLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIP 526
N++ + T + +L ++ N L+G IP +G + L +L+L N +SG IP
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP 673
Query: 527 DDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL--MKCSS 584
D++ +LR L +L L++NKL G+IP ++ ++ L+ ++S NNLSGP+P +
Sbjct: 674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAK 733
Query: 585 VLGNPYL 591
L NP L
Sbjct: 734 FLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-113
Identities = 158/608 (25%), Positives = 235/608 (38%), Gaps = 105/608 (17%)
Query: 2 GNLEVLDLEGNLLNGI---LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLA 58
+ +DL LN + S L L L L + I G + F +L L+L+
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 59 GNLVNGTVPTF--IGRLKR---VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIP 113
N ++G V T +G + +S N L G K +LE LDLS N + G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 114 RSL---GNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKL 170
C +++ L + N + + + NLE LDVS N+ S IP LG+CS L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSAL 225
Query: 171 AILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT 230
L +S N G A+S+ L++L
Sbjct: 226 QHLDISG---------------------------NKLSGDFSRAISTCTELKLLNISSNQ 258
Query: 231 LEGNFPSNWGACDNLEMLNLGHNFFSGK-NLGVLGPCKNLLFLDLSSNQLTGELAREL-P 288
G P +L+ L+L N F+G+ + G C L LDLS N G +
Sbjct: 259 FVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316
Query: 289 VPCMTMFDVSGNALSGSIP--TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGT 346
+ +S N SG +P T M L L
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKM-----------------RGLKVLDL--------- 350
Query: 347 PLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK--QTVYAIVAGDNKLSGSFPGN 404
N FSG LP L ++ + N SG N
Sbjct: 351 -----------------SFNEFSGELPE------SLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 405 MFGICNRLDSLMV-NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSL 463
+ N ++L + NN G++P + C L L S N + G IP +G L L
Sbjct: 388 LCQ--NPKNTLQELYLQNNGFTGKIPPTLSN-CSELVSLHLSFNYLSGTIPSSLGSLSKL 444
Query: 464 VALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSG 523
L L N++ +IP L +K L+ L L N+LTG IPS L L + LS+N L+G
Sbjct: 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG 504
Query: 524 LIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCS 583
IP + L NL +L L+NN SG IP+ L + +L +++ N +G +P++ + K S
Sbjct: 505 EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA--MFKQS 562
Query: 584 SVLGNPYL 591
+ ++
Sbjct: 563 GKIAANFI 570
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-108
Identities = 161/601 (26%), Positives = 245/601 (40%), Gaps = 94/601 (15%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA--SFSDFVNLEELNLAGN 60
LE L L + +NG + SL L+L N ++G + S L+ LN++ N
Sbjct: 78 GLESLFLSNSHINGSVSGFK-CSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSN 136
Query: 61 LVNGTVPTFIG----RLKRVYLSFNRLVGSVPSKIGE--KCTNLEHLDLSGNYLVGGIPR 114
++ G L+ + LS N + G+ C L+HL +SGN + G +
Sbjct: 137 TLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD- 195
Query: 115 SLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILV 174
+ C + L + SN IP LG L+ LD+S N LSG + C++L +L
Sbjct: 196 -VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLN 253
Query: 175 LSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN 234
+S+ N F G IP L +L+ L G
Sbjct: 254 ISS---------------------------NQFVGPIPP--LPLKSLQYLSLAENKFTGE 284
Query: 235 FPSN-WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL--PVPC 291
P GACD L L+L N F G G C L L LSSN +GEL + +
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 292 MTMFDVSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPL 350
+ + D+S N SG +P +N LS +L L L
Sbjct: 345 LKVLDLSFNEFSGELPESLTN--------LSASLL--------TLDL------------- 375
Query: 351 RGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICN 410
NNFSG + + K T+ + +N +G P C+
Sbjct: 376 -------------SSNNFSGPILP---NLCQNPKNTLQELYLQNNGFTGKIP-PTLSNCS 418
Query: 411 RLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSW 470
L SL ++S N ++G +P+ +G L+ L N + G IP+ + + +L L L +
Sbjct: 419 ELVSL--HLSFNYLSGTIPSSLGS-LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 471 NLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLE 530
N + +IP+ L L ++SL+ N LTG IP +G+L+ L +L LS+NS SG IP +L
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 531 NLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPY 590
+ R+L L LN N +G IP+ + S A N + + +C
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595
Query: 591 L 591
Sbjct: 596 F 596
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-107
Identities = 147/592 (24%), Positives = 234/592 (39%), Gaps = 103/592 (17%)
Query: 1 MGNLEVLDLEGNLLNGILPDSG--FHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNL 57
+L LDL N L+G + L+ LN+ N + S +LE L+L
Sbjct: 99 SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 58 AGNLVNGTVPTFIG------RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG 111
+ N ++G LK + +S N++ G V + +C NLE LD+S N G
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VS-RCVNLEFLDVSSNNFSTG 215
Query: 112 IPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLA 171
IP LG+C ++ L + N L + L++L++S N G IP L
Sbjct: 216 IP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQ 272
Query: 172 ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVS-SLPNLRILWAPRAT 230
L L+ N F G IP+ +S + L L
Sbjct: 273 YLSLAE---------------------------NKFTGEIPDFLSGACDTLTGLDLSGNH 305
Query: 231 LEGNFPSNWGACDNLEMLNLGHNFFSGK-NLGVLGPCKNLLFLDLSSNQLTGELAREL-- 287
G P +G+C LE L L N FSG+ + L + L LDLS N+ +GEL L
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
Query: 288 PVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTP 347
+ D+S N SG I NL ++ + L L
Sbjct: 366 LSASLLTLDLSSNNFSGPIL--------------PNLCQNPKNTLQELYL---------- 401
Query: 348 LPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQT-VYAIVAGDNKLSGSFPGNMF 406
N F+G +P L + + ++ N LSG+ P +
Sbjct: 402 ----------------QNNGFTGKIPP------TLSNCSELVSLHLSFNYLSGTIPSS-L 438
Query: 407 GICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVAL 466
G ++L L + N + G++P E+ K+L+ L N + G IP G+ +L +
Sbjct: 439 GSLSKLRDL--KLWLNMLEGEIPQELMY-VKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 467 NLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIP 526
+LS N + +IP +G+++ L L L+ N+ +G+IP+ LG + L LDL++N +G IP
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 527 DDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFN--NLSGPLPSS 576
+ + N ++GK + N + + N G
Sbjct: 556 AAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-48
Identities = 77/342 (22%), Positives = 131/342 (38%), Gaps = 58/342 (16%)
Query: 242 CDN--LEMLNLGHNFFSGKNLGV---LGPCKNLLFLDLSSNQLTGELARELPVPCMTMFD 296
C + + ++L + V L L L LS++ + G ++ +T D
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLD 106
Query: 297 VSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGF 356
+S N+LSG + T +++ + +L++
Sbjct: 107 LSRNSLSGPVTTLTSL---------GSC-----SGLKFLNV------------------- 133
Query: 357 LAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLM 416
N +L V + N +SG+ + + + L
Sbjct: 134 -------SSNTLDFPGKVSGGL--KLNSLEV--LDLSANSISGANVVG-WVLSDGCGELK 181
Query: 417 V-NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHD 475
+S N+I+G + + R C +L+FLD S N IP +G+ +L L++S N +
Sbjct: 182 HLAISGNKISGDVD--VSR-CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSG 237
Query: 476 QIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLE-NLRN 534
+ LK L+++ N G IP L+ L+ L L+ N +G IPD L
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDT 295
Query: 535 LTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
LT L L+ N G +P + S L + +S NN SG LP
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-116
Identities = 111/287 (38%), Positives = 174/287 (60%), Gaps = 3/287 (1%)
Query: 673 SFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQ-QFHAEIKT 731
S + A+ NF+ N +G GGFG YK ++ G LVA+KRL R QG + QF E++
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 732 LGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFI--QQRSTRAVDWRVLHKIALDI 789
+ H NL+ L G+ + TE L+Y Y+ G++ + + + S +DW +IAL
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 790 ARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG 849
AR LAYLHD C P+++HRDVK +NILLD++F A + DFGLA+L+ +TH TT V GT G
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 850 YVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909
++APEY T + S+K DV+ YGV+LLEL++ ++A D + + + ++ W LL++ +
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956
+ L +++ +++ +A++CT S RP M +VVR L+
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 334 bits (860), Expect = e-107
Identities = 106/294 (36%), Positives = 159/294 (54%), Gaps = 13/294 (4%)
Query: 673 SFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTL 732
+ +AT NF+ IG+G FG YK + G VA+KR QG+++F EI+TL
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 733 GRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLEN--FIQQRSTRAVDWRVLHKIALDIA 790
RHP+LV+LIG+ EM LIY Y+ GNL+ + T ++ W +I + A
Sbjct: 90 SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS--ETHATTGVAGTF 848
R L YLH + ++HRDVK NILLD++F ++DFG+++ G +TH +T V GT
Sbjct: 150 RGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLSTVVKGTL 205
Query: 849 GYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908
GY+ PEY + R+++K+DVYS+GVVL E+L + A+ S N+ W G
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNG 263
Query: 909 RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK---QLQ 959
+ ++ L D + L + AV C S RP+M V+ +L+ +LQ
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = 1e-98
Identities = 89/300 (29%), Positives = 149/300 (49%), Gaps = 23/300 (7%)
Query: 673 SFESVVQATGNFN------ASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR----FQGV 722
SF + T NF+ N +G GGFG YK + VA+K+LA +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 723 QQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAV-DWRV 781
QQF EIK + + +H NLV L+G+ + ++ L+Y Y+P G+L + + W +
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 782 LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE--TH 839
KIA A + +LH+ +HRD+K +NILLD+ F A +SDFGLAR T
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTV 190
Query: 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899
T+ + GT Y+APE + ++ K+D+YS+GVVLLE+++ A+D ++
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP----QLLLD 245
Query: 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
+ + + E + + + + +A C + + RP +K+V + L+++
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 7e-76
Identities = 81/314 (25%), Positives = 126/314 (40%), Gaps = 30/314 (9%)
Query: 669 GVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAE 728
GV L E++ + G FG +KA++ VA+K + Q Q E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYE 68
Query: 729 IKTLGRLRHPNLVTLIGY----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHK 784
+ +L ++H N++ IG + + +++LI + G+L +F++ V W L
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCH 125
Query: 785 IALDIARALAYLH-------DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837
IA +AR LAYLH D P + HRD+K N+LL ++ A ++DFGLA +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 838 THA-TTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSY 891
+ T G GT Y+APE + D+Y+ G+VL EL S A D Y
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 892 GNGFNIVAWGCMLLRQGRAKEFFTAG------LWDAGPHDDLVEVLHLAVVCTVDSLSTR 945
F L + W H + + C R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ--KHAGMAMLCETIEECWDHDAEAR 303
Query: 946 PTMKQVVRRLKQLQ 959
+ V R+ Q+Q
Sbjct: 304 LSAGCVGERITQMQ 317
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 2e-75
Identities = 108/613 (17%), Positives = 195/613 (31%), Gaps = 87/613 (14%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ L+VL+L+ N L+ + + +L L+L N I F NL L+L+ N
Sbjct: 72 LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN 131
Query: 61 LVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGE-KCTNLEHLDLSGNYLVGGIPRSL 116
++ T L+ + LS N++ ++ ++L+ L+LS N + P
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGM---LQNLEVLDVSRNSLSGSIPVDLGNC--SKLA 171
++ L L + L ++ +L + ++ L +S + LS + + L
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT 251
Query: 172 ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL 231
+L LS N ++ + LP L + +
Sbjct: 252 MLDLSY---------------------------NNLNVVGNDSFAWLPQLEYFFLEYNNI 284
Query: 232 EGNFPSNWGACDNLEMLNLGHNFFSGK---------NLGVLGPCKNLLFLDLSSNQLTGE 282
+ F + N+ LNL +F + K L L++ N + G
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344
Query: 283 LAREL-PVPCMTMFDVSGNALSGSIP---TFSNMVCPP--VPYLSRNLFESYNPSTAYLS 336
+ + + +S + S TF ++ P + L++N
Sbjct: 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA---- 400
Query: 337 LFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNK 396
F+ L L + G N L G + ++ I NK
Sbjct: 401 -FSWLGH------LE----VL----DLGLNEIGQELTGQEWR----GLENIFEIYLSYNK 441
Query: 397 LSGSFPGNMFGICNRLDSLMVNVSNNRIAG-QLPAEIGRMCKSLKFLDASGNQIVGPIPR 455
N F + L L + + + ++L LD S N I
Sbjct: 442 YLQLTR-NSFALVPSLQRL--MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 456 GVGELVSLVALNLSWN--------LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQ 507
+ L L L+L N L + L L+L N
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558
Query: 508 LQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANV-STLSAFNVSF 566
L L+++DL N+L+ L N +L L L N ++ L+ ++ F
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 567 NNLSGPLPSSKNL 579
N S
Sbjct: 619 NPFDCTCESIAWF 631
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 1e-68
Identities = 116/601 (19%), Positives = 206/601 (34%), Gaps = 86/601 (14%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+ EV D L + D ++ VLNL N++ A+F+ + L L++ N +
Sbjct: 5 SHEVADCSHLKLTQVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 63 NGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQV 122
+ P +L L+ L+L N L ++ C +
Sbjct: 62 SKLEPELCQKL----------------------PMLKVLNLQHNELSQLSDKTFAFCTNL 99
Query: 123 RSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTY 182
L L SN +++ +NL LD+S N LS + L L+LSN
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN----- 154
Query: 183 EDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPN--LRILWAPRATLEGNFPSNWG 240
N + E + N L+ L ++ P +
Sbjct: 155 ----------------------NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192
Query: 241 ACDNLEMLNLGHNFFSG---KNLGVLGPCKNLLFLDLSSNQLTGELA---RELPVPCMTM 294
A L L L + + L + ++ L LS++QL+ L +TM
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM 252
Query: 295 FDVSGNALSGSIP-TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGR 353
D+S N L+ +F+ + +L N + + +R
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS-----LHGLFN------VR-- 299
Query: 354 DGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLD 413
+L + +F + S + + + + DN + G NMF L
Sbjct: 300 --YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLK 356
Query: 414 SLMVNVSNNRIAGQ-LPAEI--GRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSW 470
L ++SN+ + + L E L L+ + N+I L L L+L
Sbjct: 357 YL--SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL 414
Query: 471 NLMHDQIP-TTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGL--IPD 527
N + ++ ++ + + L+ N +S + L+ L L +L + P
Sbjct: 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474
Query: 528 DLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLG 587
+ LRNLT+L L+NN ++ L + L ++ NNL+ L N L
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR-LWKHANPGGPIYFLK 533
Query: 588 N 588
Sbjct: 534 G 534
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-50
Identities = 92/501 (18%), Positives = 155/501 (30%), Gaps = 95/501 (18%)
Query: 94 KCT-NLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVS 152
KCT + E D S L +P L + L L N L A L LDV
Sbjct: 1 KCTVSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57
Query: 153 RNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIP 212
N++S P L +L L + N
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQH---------------------------NELSQLSD 90
Query: 213 EAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272
+ + NL L +++ + + NL L+L HN S LG +NL L
Sbjct: 91 KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQEL 150
Query: 273 DLSSNQLTGELARELPVPCMT---MFDVSGNALSGSIP-TFSNMVCPPVPYLSRNLFESY 328
LS+N++ + EL + + ++S N + P F + LF
Sbjct: 151 LLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI---------GRLFG-- 199
Query: 329 NPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVY 388
L L SL
Sbjct: 200 ------LFL--------------------------NNVQLGPSLTEKLCLELANTSIRN- 226
Query: 389 AIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQ 448
+ +++LS F + M+++S N + L++ N
Sbjct: 227 -LSLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAW-LPQLEYFFLEYNN 283
Query: 449 IVGPIPRGVGELVSLVALNLSWNLMHDQI---------PTTLGQMKGLKYLSLAGNNLTG 499
I + L ++ LNL + I + +K L++L++ N++ G
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
Query: 500 SIPSSLGQLQLLEVLDLSSN--SLSGLIPDDLENLRN--LTVLLLNNNKLSGKIPSGLAN 555
+ L L+ L LS++ SL L + +L + L +L L NK+S +
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403
Query: 556 VSTLSAFNVSFNNLSGPLPSS 576
+ L ++ N + L
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQ 424
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 1e-73
Identities = 87/608 (14%), Positives = 186/608 (30%), Gaps = 101/608 (16%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITG----EIPASFSDFVNLEELN 56
G + L LEG +G +PD+ L L VL LG + P S ++ E+
Sbjct: 80 NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139
Query: 57 LAGNLVNGTVPTFIGR-----LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG 111
T + R L + ++ + S+ + N +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR-ITLKDTQIGQLSNNI-TF 197
Query: 112 IPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLA 171
+ +++ ++R + ++ E +N E + + N L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLT 252
Query: 172 ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILW------ 225
+ + N +P + +LP ++++
Sbjct: 253 DVEVYN---------------------------CPNLTKLPTFLKALPEMQLINVACNRG 285
Query: 226 --APRATLEGNFPSNWGACDNLEMLNLGHN-FFSGKNLGVLGPCKNLLFLDLSSNQLTG- 281
+ + ++ + ++++ +G+N + L K L L+ NQL G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 282 --ELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFE---SYNPSTAYLS 336
E + +++ N ++ F + + ++N L
Sbjct: 346 LPAFGSE---IKLASLNLAYNQITEIPANFCG--------FTEQVENLSFAHN----KLK 390
Query: 337 LFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNK 396
A + + + +N G+ + + P + V +I +N+
Sbjct: 391 YIPNIFDAKSVSVMS----AIDFSYNEIGSVDGKNFDPLDPTPFKGIN--VSSINLSNNQ 444
Query: 397 LSGSFPGNMFGICNRLDSLMVNVSNNRIAG-------QLPAEIGRMCKSLKFLDASGNQI 449
+S FP +F + L S+ N+ N + L +D N++
Sbjct: 445 ISK-FPKELFSTGSPLSSI--NLMGNMLTEIPKNSLKDENENFKN-TYLLTSIDLRFNKL 500
Query: 450 VG-PIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSL------AGNNLTGSIP 502
L LV ++LS+N + PT LK + GN P
Sbjct: 501 TKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 503 SSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAF 562
+ L L + SN + + + N++VL + +N S + +
Sbjct: 560 EGITLCPSLTQLQIGSNDIRKVNE---KITPNISVLDIKDNPNISIDLSYVCPYIEAGMY 616
Query: 563 NVSFNNLS 570
+ ++
Sbjct: 617 MLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 8e-63
Identities = 86/591 (14%), Positives = 169/591 (28%), Gaps = 115/591 (19%)
Query: 32 NLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGR---LKRVYLSFNRLVG--- 85
N + + S + + L+L G +G VP IG+ L+ + L +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 86 -SVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG--NCFQVRSLLLFSNMLEETIPAELGM 142
P I + E + + + + S+ +++I +
Sbjct: 123 LFGPKGISA-NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181
Query: 143 LQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMND 202
+ N+++ + + +KL + N +++ + N
Sbjct: 182 TLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFV--------AENICEAWENENS 232
Query: 203 DFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFF------- 255
++ +L +L + P+ A ++++N+ N
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292
Query: 256 -SGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC-------MTMFDVSGNALSGSIP 307
+ L + + + + N L PV + M + N L G +P
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLK-----TFPVETSLQKMKKLGMLECLYNQLEGKLP 347
Query: 308 TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNN 367
F + + L+ N +P N
Sbjct: 348 AFGSEIKLASLNLAYNQITE--------------------IP----------------AN 371
Query: 368 FSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSL-MVNVSNNRIAG 426
F G + E L NKL P N+F + + + ++ S N I
Sbjct: 372 FCGFTEQV----ENLS--------FAHNKLK-YIP-NIFDAKS-VSVMSAIDFSYNEIGS 416
Query: 427 -------QLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHD---- 475
L + ++ ++ S NQI L ++NL N++ +
Sbjct: 417 VDGKNFDPLDPTPFK-GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475
Query: 476 ---QIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLLEVLDLSSNSLSGLIPDDLEN 531
L + L N LT L L +DLS NS S P N
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
Query: 532 LRNLTVL------LLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
L N+ + P G+ +L+ + N++ +
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEK 584
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-33
Identities = 39/350 (11%), Positives = 84/350 (24%), Gaps = 85/350 (24%)
Query: 240 GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSG 299
+ + L+L SG+ +G L L L S+
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV------------------ 119
Query: 300 NALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAI 359
N S + R ++ T + R+ F +
Sbjct: 120 NERLFGPKGISANMSDEQKQKMRMHYQ------------------KTFVDYDPREDFSDL 161
Query: 360 FHN-FGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVN 418
+ + S+ L +
Sbjct: 162 IKDCINSDPQQKSIKKS--------------------------------SRITLKDTQIG 189
Query: 419 VSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIP 478
+N I + + R L+ + V E +
Sbjct: 190 QLSNNITF-VSKAVMR-LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----ED 242
Query: 479 TTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGL--------IPDDLE 530
+K L + + +P+ L L +++++++ N D
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 531 NLRNLTVLLLNNNKL-SGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
+ ++ + N L + + + L + L +N L G LP+ +
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSE 352
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 18/202 (8%), Positives = 50/202 (24%), Gaps = 8/202 (3%)
Query: 393 GDNKLSGSFPGNMFG-ICNRLDSLMVNVSNNRIAGQLPAEIGRM-CKSLKFLDASGNQIV 450
G + + I + R L + +
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
Query: 451 GPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL 510
I + + + N + + + ++ L+ + + +
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-- 229
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+ +NL++LT + + N K+P+ L + + NV+ N
Sbjct: 230 ---ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286
Query: 571 GPLPSSKNLMKCSSVLGNPYLR 592
+ + ++
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQ 308
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-17
Identities = 22/120 (18%), Positives = 39/120 (32%), Gaps = 6/120 (5%)
Query: 467 NLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSG--- 523
N ++ Q +L + LSL G +G +P ++GQL LEVL L S+
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 524 -LIPDDLENLRNLTVLLLNNNKLSGKIPSGLA--NVSTLSAFNVSFNNLSGPLPSSKNLM 580
P + + + S L ++ + + S +
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-15
Identities = 22/140 (15%), Positives = 43/140 (30%), Gaps = 32/140 (22%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLG------FNRITGEIPASFSDFVNLEE 54
+ L +DL N + P + +L+ + NR E P + +L +
Sbjct: 512 LPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ 570
Query: 55 LNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR 114
L + N + V KI N+ LD+ N +
Sbjct: 571 LQ---------------------IGSNDIR-KVNEKI---TPNISVLDIKDNPNISIDLS 605
Query: 115 SLGNCFQVRSLLLFSNMLEE 134
+ + +LF + ++
Sbjct: 606 YVCPYIEAGMYMLFYDKTQD 625
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 3e-73
Identities = 102/595 (17%), Positives = 188/595 (31%), Gaps = 82/595 (13%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+ + LDL N L + S F L+VL+L I ++ +L L L GN +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 63 NGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG-IPRSLGN 118
L+++ L IG L+ L+++ N + +P N
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEV----LDVSRNSLSGSIPVDLGNCSKLAILV 174
+ L L SN ++ +L +L + + LD+S N ++ P +L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKEIRLHKLT 206
Query: 175 LSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE-AVSSLPNLRILW------AP 227
L N NF + + + L L +
Sbjct: 207 LRN---------------------------NFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 228 RATLEGNFPSNWGACDNLEMLNLGHN---FFSGKNLGVLGPCKNLLFLDLSSNQLTGELA 284
LE S NL + ++ + + N+ L S +
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 285 RELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQA 344
++ F + + L+ + N +
Sbjct: 300 FSYN-FGWQHLELVNCKFGQ----FPTLKLKSLKRLTFTSNKGGNAFS------------ 342
Query: 345 GTPLP-LRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPG 403
LP L FL + N G +F G L + N +
Sbjct: 343 EVDLPSLE----FLDLSRN--GLSFKGCCSQSDFGTTSL-----KYLDLSFNGVITMSSN 391
Query: 404 NMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSL 463
F +L+ L + ++ + + ++L +LD S L SL
Sbjct: 392 --FLGLEQLEHL--DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 464 VALNLSWNLMHDQI-PTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLS 522
L ++ N + P +++ L +L L+ L P++ L L+VL++S N+
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 523 GLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANV-STLSAFNVSFNNLSGPLPSS 576
L + L +L VL + N + L + S+L+ N++ N+ +
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-65
Identities = 110/606 (18%), Positives = 189/606 (31%), Gaps = 101/606 (16%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
L+VLDL + I + L L L L N I +FS +L++L +
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 63 NGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
IG LK + ++ N + + TNLEHLDLS N + L
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172
Query: 120 FQVR----SLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILV 174
Q+ SL L N + P + L L + N S ++ + + L +
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231
Query: 175 LS----NLFDTYEDVRYSRGQSLVDQPSFMNDD--FNFFEGGIPEAVSSLPNLRILWAPR 228
L E S + L + +++ I + + L N+
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF---- 287
Query: 229 ATLEGN---FPSNWGACDNLEMLNLGHNFFS-------------------GKNLGVLGPC 266
+L ++ + L L + F G N
Sbjct: 288 -SLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
Query: 267 KNLLFLDLSSNQLT--GELAREL-PVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRN 323
+L FLDLS N L+ G ++ + D+S N + F +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGL----------- 395
Query: 324 LFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLG 383
+L +F +N
Sbjct: 396 ------EQLEHL--------------------------DFQHSNLKQMSE-----FSVFL 418
Query: 384 K-QTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFL 442
+ + + +F G +F + L+ L ++ N +I ++L FL
Sbjct: 419 SLRNLIYLDISHTHTRVAFNG-IFNGLSSLEVL--KMAGNSFQENFLPDIFTELRNLTFL 475
Query: 443 DASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP 502
D S Q+ P L SL LN+S N + L+ L + N++ S
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
Query: 503 SSLGQL-QLLEVLDLSSNSLSGLIP--DDLENLRNLTVLLLNNNKLSGKIPSGLANVSTL 559
L L L+L+ N + L+ +++ LL+ ++ PS + L
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVL 595
Query: 560 SAFNVS 565
S N++
Sbjct: 596 S-LNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-32
Identities = 67/516 (12%), Positives = 124/516 (24%), Gaps = 140/516 (27%)
Query: 76 VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET 135
+P + + ++LDLS N L S + +++ L L ++
Sbjct: 12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 136 IPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVD 195
L +L L ++ N + S L LV
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE------------------ 109
Query: 196 QPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFF 255
+ L L+ L N+ HN
Sbjct: 110 ---------TNLASLENFPIGHLKTLKEL------------------------NVAHNLI 136
Query: 256 SGKNLG-VLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIP-TFSNMV 313
L NL LDL S N + +
Sbjct: 137 QSFKLPEYFSNLTNLEHLDL-----------------------SSNKIQSIYCTDLRVL- 172
Query: 314 CPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLP 373
+ LSL + N + P
Sbjct: 173 --------HQM------PLLNLSL------------------------DLSLNPMNFIQP 194
Query: 374 SMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIG 433
+ ++ + +N S + L+ + + R G L
Sbjct: 195 GA------FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 434 RMCKSLKFLDASGNQI------VGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGL 487
+ L L ++ + I L ++ + +L + + G
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGW 306
Query: 488 KYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS- 546
++L L L L+ L + + +L +L L L+ N LS
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV-----DLPSLEFLDLSRNGLSF 361
Query: 547 -GKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMK 581
G ++L ++SFN + + L +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 397
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 40/179 (22%), Positives = 65/179 (36%), Gaps = 23/179 (12%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFH-LKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG 59
+ LE LD + + L + S F L++L L++ F+ +LE L
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK--- 451
Query: 60 NLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
++ N + I + NL LDLS L P + +
Sbjct: 452 ------------------MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNC-SKLAILVLSN 177
++ L + N L +L+VLD S N + S +L + S LA L L+
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-29
Identities = 32/166 (19%), Positives = 61/166 (36%), Gaps = 5/166 (3%)
Query: 412 LDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWN 471
+ ++ ++P + S K LD S N + L L+LS
Sbjct: 7 VPNITYQCMELNFY-KIPDNLPF---STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 472 LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLEN 531
+ + L L L GN + + L L+ L +L+ L + +
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 532 LRNLTVLLLNNNKL-SGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
L+ L L + +N + S K+P +N++ L ++S N + +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 36/175 (20%), Positives = 61/175 (34%), Gaps = 8/175 (4%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEI-PASFSDFVNLEELNLAG 59
+ NL LD+ L SL VL + N P F++ NL L+L+
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 60 NLVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL 116
+ PT L+ + +S N +L+ LD S N+++ + L
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK-CLNSLQVLDYSLNHIMTSKKQEL 538
Query: 117 GNCF-QVRSLLLFSNMLEETIPAE--LGMLQNLEVLDVSRNSLSGSIPVDLGNCS 168
+ + L L N T + L +++ L V + + P D
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-11
Identities = 23/110 (20%), Positives = 43/110 (39%), Gaps = 8/110 (7%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFV-NLEELNLAG 59
+ +L+VL++ N + L SL+VL+ N I F +L LNL
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
Query: 60 NLVNGTVP-----TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLS 104
N T +I +++ + R+ + PS + L+++
Sbjct: 553 NDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM--PVLSLNIT 600
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 6e-62
Identities = 96/578 (16%), Positives = 193/578 (33%), Gaps = 59/578 (10%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+ E L+ N+L I + L +L L+L +I +F L+ L L N +
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 63 NGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
T + LK ++ + + LE L L N++
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLH-NQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEV--LDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+++ L +N + ++ LQ L+++ N ++ I + + L
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGG 211
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
+ F+G + SL +
Sbjct: 212 TQNLLV----------------------IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDV 297
++E +NL ++F + L LDL++ L+ + + + + +
Sbjct: 250 GLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVL 308
Query: 298 SGNALSGSIP-TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGF 356
S N + SN + N + +L LR
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN----------LR----E 354
Query: 357 LAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLM 416
L + ++ + + L + ++ N+ S F C +L+ L
Sbjct: 355 L----DLSHDDIE-TSDCCNLQLRNLSH--LQSLNLSYNEPL-SLKTEAFKECPQLELL- 405
Query: 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNL---M 473
+++ R+ + + LK L+ S + + + L +L LNL N
Sbjct: 406 -DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 474 HDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLR 533
+ Q +L + L+ L L+ +L+ + L+++ +DLS N L+ + L +L+
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
Query: 534 NLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571
+ L L +N +S +PS L +S N+ N L
Sbjct: 525 GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-52
Identities = 105/587 (17%), Positives = 169/587 (28%), Gaps = 59/587 (10%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
NL LDL + I D+ L L L N + + S L+ L +
Sbjct: 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117
Query: 63 NGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
+ + L+ +YL N + S+ G L+ LD N + + +
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSL 176
Query: 120 F--QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCS--KLAILVL 175
SL L N + I + L+ I L N + L +
Sbjct: 177 QQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 176 SNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN- 234
++ D G + S N ++F L+ L L
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESI-NLQKHYFFNISSNTFHCFSGLQELD-----LTATH 289
Query: 235 ---FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL--PV 289
PS L+ L L N F +L L + N EL +
Sbjct: 290 LSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349
Query: 290 PCMTMFDVSGNALSGSIP---TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGT 346
+ D+S + + S N+ LS N S F + Q
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA-----FKECPQ--- 401
Query: 347 PLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPGNM 405
L L + + L + + + L +
Sbjct: 402 ---LE----LL----DLAFTRLKVKDA--QSPFQNLHLLKVLN---LSHSLLD-ISSEQL 444
Query: 406 FGICNRLDSLMVNVSNNRIAGQLPAEIG--RMCKSLKFLDASGNQIVGPIPRGVGELVSL 463
F L L N+ N + + L+ L S + L +
Sbjct: 445 FDGLPALQHL--NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
Query: 464 VALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSG 523
++LS N + L +KG+ YL+LA N+++ +PS L L ++L N L
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
Query: 524 LIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
N+ L N KL + N L +S LS
Sbjct: 562 ----TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-49
Identities = 94/590 (15%), Positives = 157/590 (26%), Gaps = 103/590 (17%)
Query: 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNG 64
+ + E LN I P + + S L FN + +FS +NL L+L +
Sbjct: 15 KTYNCENLGLNEI-PGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 65 TVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRS 124
L+ L L+ N L+ +L ++
Sbjct: 72 IHEDTFQSQ----------------------HRLDTLVLTANPLIFMAETALSGPKALKH 109
Query: 125 LLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYED 184
L + L + LE L + N +S KL +L N
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN------- 162
Query: 185 VRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF----PSNWG 240
N E +SSL L L GN
Sbjct: 163 --------------------NAIHYLSKEDMSSLQQATNL---SLNLNGNDIAGIEPGAF 199
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCK--NLLFLDLSSNQLTGELARELPVPC---MTMF 295
+ LN G L +L C +
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259
Query: 296 DVSGNAL----SGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLR 351
++ + S + FS + L+ LS L+
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQEL---DLTATHLSELPSGLVGLST------------LK 304
Query: 352 GRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNR 411
L N F L + N
Sbjct: 305 ----KL----VLSANKFENLCQISASNFPSL-----THLSIKGNTKRLELGTGCLENLEN 351
Query: 412 LDSLMVNVSNNRIAG-QLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSW 470
L L ++S++ I R L+ L+ S N+ + E L L+L++
Sbjct: 352 LREL--DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 471 N-LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLI---P 526
L + + LK L+L+ + L S L L+ L+L N
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 527 DDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
+ L+ L L +L+L+ LS ++ ++ ++S N L+ +
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 64/317 (20%), Positives = 114/317 (35%), Gaps = 43/317 (13%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
L+ LDL L+ + P L +L+ L L N+ S S+F +L L++ GN
Sbjct: 277 FSGLQELDLTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 61 LVNGTVPTFI----GRLKRVYLSFNRLVGSVPSKIG-EKCTNLEHLDLSGNYLVGGIPRS 115
+ T L+ + LS + + S + ++L+ L+LS N + +
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 116 LGNCFQVRSLLLFSNMLEETIP-AELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILV 174
C Q+ L L L+ + L L+VL++S + L S L L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455
Query: 175 LSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN 234
L N F ++ +L L IL L
Sbjct: 456 LQG-----------------------N-HFPKGNIQKTNSLQTLGRLEILV-----LSFC 486
Query: 235 F-----PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV 289
+ + + ++L HN + ++ L K ++L+L+SN ++ L LP+
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG-IYLNLASNHISIILPSLLPI 545
Query: 290 -PCMTMFDVSGNALSGS 305
++ N L +
Sbjct: 546 LSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-30
Identities = 68/456 (14%), Positives = 113/456 (24%), Gaps = 110/456 (24%)
Query: 135 TIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLV 194
IP L + E L+ S N L L L L+
Sbjct: 26 EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTR----------------- 66
Query: 195 DQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNF 254
+ S L L L N
Sbjct: 67 ----------CQIYWIHEDTFQSQHRLDTL------------------------VLTANP 92
Query: 255 FSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP-VPCMTMFDVSGNALSG-SIPTFSNM 312
L K L L ++ L + + N +S +P
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 313 VCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSL 372
L N
Sbjct: 153 -----------------EKLKVLDF--------------------------QNNAIHYLS 169
Query: 373 PSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEI 432
L + T ++ N ++G PG + +N + + +
Sbjct: 170 KE---DMSSLQQATNLSLNLNGNDIAGIEPG----AFDSAVFQSLNFGGTQNLLVIFKGL 222
Query: 433 -GRMCKSLKFLDASGNQIVGPIPRGVGEL--VSLVALNLSWNLMHDQIPTTLGQMKGLKY 489
+SL P L +S+ ++NL + + T GL+
Sbjct: 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQE 282
Query: 490 LSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKI 549
L L +L+ +PS L L L+ L LS+N L N +LT L + N ++
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 550 PSG-LANVSTLSAFNVSFNNLSGPLPSSKNLMKCSS 584
+G L N+ L ++S +++ + L S
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSH 377
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-24
Identities = 30/166 (18%), Positives = 56/166 (33%), Gaps = 4/166 (2%)
Query: 411 RLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSW 470
+ + N N + ++P + S + L+ S N + L++L L+L+
Sbjct: 11 KEVNKTYNCENLGLN-EIPGTLPN---STECLEFSFNVLPTIQNTTFSRLINLTFLDLTR 66
Query: 471 NLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLE 530
++ T L L L N L ++L + L+ L +S + L
Sbjct: 67 CQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH 126
Query: 531 NLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
N + L L L +N +S L + N +
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-22
Identities = 35/198 (17%), Positives = 63/198 (31%), Gaps = 9/198 (4%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
++ + F +RLD+L ++ N + + K+LK L I
Sbjct: 65 TRCQIY-WIHEDTFQSQHRLDTL--VLTANPLIF-MAETALSGPKALKHLFFIQTGISSI 120
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+ +L +L L N + + LK L N + + LQ
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180
Query: 513 V--LDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN--VSTLSAFNVSFNN 568
L+L+ N ++G I + L + I GL N + +L +
Sbjct: 181 NLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 569 LSGPLPSSKNLMKCSSVL 586
P+ + SV
Sbjct: 240 DEDISPAVFEGLCEMSVE 257
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 10/74 (13%), Positives = 27/74 (36%), Gaps = 3/74 (4%)
Query: 498 TGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVS 557
T S + ++ + + + L+ IP L + L + N L + + +
Sbjct: 1 TTSSDQKCIEKEVNKTYNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLI 57
Query: 558 TLSAFNVSFNNLSG 571
L+ +++ +
Sbjct: 58 NLTFLDLTRCQIYW 71
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-61
Identities = 79/640 (12%), Positives = 167/640 (26%), Gaps = 116/640 (18%)
Query: 7 LDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTV 66
+ E ++ + + L+L G +P + L+ L+ + +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 67 PTFIGR---LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL-----VGGIPRSLGN 118
F +R+ + L DL + + + I +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178
+ + +N + I + L L+++ + + + +
Sbjct: 424 SLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-------- 474
Query: 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSN 238
D+ + S+L +L + P
Sbjct: 475 ------------------------DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510
Query: 239 WGACDNLEMLNLGHNFFSGKNLGV---------LGPCKNLLFLDLSSNQLTGELARELPV 289
L+ LN+ N + + N L E P
Sbjct: 511 LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-----EFPA 565
Query: 290 PC-------MTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKS 342
+ + D N + + F V L N E A
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIEEIPE-----DFCAFTD 619
Query: 343 QAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFP 402
Q + L HN L +P + ++ NK+ S
Sbjct: 620 Q------VE----GLGFSHN--------KLKYIPNIFNAKSVYVMGSVDFSYNKIG-SEG 660
Query: 403 GNMFGICNRLDSL---MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQI-------VGP 452
N+ + + V +S N I P E+ + + S N + + P
Sbjct: 661 RNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTL--GQMKGLKYLSLAGNNLTGSIPSSLGQLQL 510
L ++L +N + + + L + ++ N + S P+
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQ 777
Query: 511 LEVLDL------SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNV 564
L+ + N + P + +L L + +N + K+ L L ++
Sbjct: 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDI 834
Query: 565 SFNNL-SGPLPSSKNLMKCSSVL----GNPYLRPCRAFTL 599
+ N S + S ++ + +R C A +
Sbjct: 835 ADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGI 874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-58
Identities = 76/605 (12%), Positives = 166/605 (27%), Gaps = 125/605 (20%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFV-NLEELNLAGNL 61
L+VL + G + + +RI F D+ L +L +
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 62 VNGTVPTFIG---------RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGI 112
+N P + ++ NR+ + I + T L+ + + +
Sbjct: 408 INR-NPEMKPIKKDSRISLKDTQIGNLTNRI-TFISKAIQ-RLTKLQIIYFANSPFTYDN 464
Query: 113 PRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAI 172
E L++L +++ +P L + +L
Sbjct: 465 IAVDWE-----DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519
Query: 173 LVLS-NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL 231
L ++ N + ++ + + + + P ++I + +
Sbjct: 520 LNIACNRGISAAQLKADWTR-------------------LADDEDTGPKIQIFY-----M 555
Query: 232 EGN----FPSNW--GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT----- 280
N FP++ L +L+ HN +L G L L L NQ+
Sbjct: 556 GYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIPED 613
Query: 281 -GELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFA 339
++ S N L F+ + +
Sbjct: 614 FCAFTDQV-----EGLGFSHNKLKYIPNIFNAKSVYVMGSV------------------- 649
Query: 340 KKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSG 399
+F N ++ + + + N++
Sbjct: 650 ----------------------DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK 687
Query: 400 SFPGNMFGICNRLDSLMVNVSNNRI-------AGQLPAEIGRMCKSLKFLDASGNQIVG- 451
FP +F + + ++ +SNN + L +D N++
Sbjct: 688 -FPTELFATGSPISTI--ILSNNLMTSIPENSLKPKDGNYKN-TYLLTTIDLRFNKLTSL 743
Query: 452 PIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSL------AGNNLTGSIPSSL 505
L L +++S+N PT LK + GN + P+ +
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
Query: 506 GQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVS 565
L L + SN + + + L L +L + +N + + + +
Sbjct: 803 TTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLL 859
Query: 566 FNNLS 570
++
Sbjct: 860 YDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-33
Identities = 51/354 (14%), Positives = 95/354 (26%), Gaps = 80/354 (22%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITG---------EIPASFSDFVN 51
+ +L ++L LPD + L L+ LN+ NR +
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 52 LEELNLAGN-LVNGTVPTFIGRLKR---VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNY 107
++ + N L + ++ + + N++ G L L L N
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFG-TNVKLTDLKLDYNQ 606
Query: 108 LVGGIPRSLGNCF-QVRSLLLFSNMLEETIPAELGM--LQNLEVLDVSRNSLSG-----S 159
+ IP QV L N L + IP + + +D S N + S
Sbjct: 607 IE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS 664
Query: 160 IPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLP 219
+D + + LS N + E ++
Sbjct: 665 CSMDDYKGINASTVTLSY---------------------------NEIQKFPTELFATGS 697
Query: 220 NLRILWAPRATLEGN------------FPSNWGACDNLEMLNLGHNFFSG--KNLGVLGP 265
+ + L N N+ L ++L N + +
Sbjct: 698 PISTII-----LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFR-ATT 751
Query: 266 CKNLLFLDLSSNQLT------GELARELPVPCMTMFDVSGNALSGSIP-TFSNM 312
L +D+S N + ++ D GN + P +
Sbjct: 752 LPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 5e-14
Identities = 25/144 (17%), Positives = 48/144 (33%), Gaps = 7/144 (4%)
Query: 442 LDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSI 501
LD + ++ N ++ DQ L + LSLAG G +
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 502 PSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLA------N 555
P ++GQL L+VL ++S + + + +++ N
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399
Query: 556 VSTLSAFNVSFNNLSGPLPSSKNL 579
+S L ++ N P+ +
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRI 423
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-59
Identities = 93/586 (15%), Positives = 174/586 (29%), Gaps = 78/586 (13%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+ + +DL N L + S + L+ L+L I ++ +L L L GN +
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 63 NGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVG-GIPRSLGN 118
P L+ + +L IG + L+ L+++ N++ +P N
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIG-QLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNL----EVLDVSRNSLSGSIPVDLGNCSKLAILV 174
+ + L N ++ +L L+ LD+S N + I KL L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210
Query: 175 LSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE-AVSSLPNLRILWAPRATLEG 233
L NF I + + +L L + +
Sbjct: 211 LRG---------------------------NFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243
Query: 234 NFPSNWGACDNLE--------MLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAR 285
+E L + ++ N+ + L+ + L
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLED 302
Query: 286 ELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAG 345
+ L P ++ L+ N A SL
Sbjct: 303 VPKHFKWQSLSIIRCQLK-QFP-TLDLPFLKSLTLTMNKGSISFKKVALPSLS------- 353
Query: 346 TPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNM 405
+L + N S S + LG ++ + N
Sbjct: 354 ----------YL----DLSRNALSF---SGCCSYSDLGTNSLRHLDLSFNGAII--MSAN 394
Query: 406 FGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVA 465
F L L + ++ + + L +LD S L SL
Sbjct: 395 FMGLEELQHL--DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT 452
Query: 466 LNLSWNLMHDQIPT-TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGL 524
L ++ N D + L +L L+ L L L++L++S N+L L
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 525 IPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
L +L+ L + N++ +L+ FN++ N+++
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-51
Identities = 96/561 (17%), Positives = 171/561 (30%), Gaps = 96/561 (17%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ +L L L GN + P S L SL L ++ + L++LN+A N
Sbjct: 79 LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN 138
Query: 61 -LVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIG---EKCTNLEHLDLSGNYLVGGIP 113
+ + +P + L V LS+N + + + E LD+S N + I
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQ 197
Query: 114 RSLGNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAI 172
++ L L N I L L L V + +++ S +
Sbjct: 198 DQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEG 257
Query: 173 LVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLE 232
L + + + L N+ + +L
Sbjct: 258 LCDVTIDE-------------------FRLTYTNDFSDDIVKFHCLANVSAM-----SLA 293
Query: 233 GN---FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV 289
G + + + L++ L L L L+ N+ + ++ +
Sbjct: 294 GVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSISFK-KVAL 349
Query: 290 PCMTMFDVSGNALSGSIP-TFSNMVCPPVPYL--SRNLFESYNPSTAYLSLFAKKSQAGT 346
P ++ D+S NALS S ++S++ + +L S N + + L
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEE--------- 400
Query: 347 PLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMF 406
L+ L +F + + F
Sbjct: 401 ---LQ----HL----DFQHSTLKRVTEF-----------------------------SAF 420
Query: 407 GICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVA 465
+L L ++S I SL L +GN V +L
Sbjct: 421 LSLEKLLYL--DISYTNTKI-DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLI 525
L+LS + + L+ L+++ NNL S QL L LD S N +
Sbjct: 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537
Query: 526 PDDLENLRNLTVLLLNNNKLS 546
++L L NN ++
Sbjct: 538 GILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-39
Identities = 85/538 (15%), Positives = 160/538 (29%), Gaps = 97/538 (18%)
Query: 50 VNLEELNLAGNLVNGTVPTFIGR-LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL 108
+ L+ VP I K + LSFN L + S + L+ LDLS +
Sbjct: 16 YQCMDQKLS------KVPDDIPSSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEI 68
Query: 109 VGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCS 168
++ + +L+L N ++ P L +LE L L+ +G
Sbjct: 69 ETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLI 128
Query: 169 KLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEG-GIPEAVSSLPNLRILWAP 227
L L +++ NF +P S+L NL
Sbjct: 129 TLKKLNVAH---------------------------NFIHSCKLPAYFSNLTNLVH---- 157
Query: 228 RATLEGNFPSNWGACDNLEMLNLGHNFFSG---KNLGVLGPCKNLLF-LDLSSNQLTGEL 283
++L +N+ +L L + LD+S N +
Sbjct: 158 --------------------VDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQ 197
Query: 284 ARELPVPCMTMFDVSGNALSGSIP--TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKK 341
+ + + GN S +I N+ V L F+ +
Sbjct: 198 DQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF------- 250
Query: 342 SQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSF 401
P + G N + A+ +
Sbjct: 251 ----EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV-----SAMSLAGVSIK-YL 300
Query: 402 PGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV 461
+ SL ++ ++ Q P LK L + N+ + L
Sbjct: 301 EDVPK--HFKWQSL--SIIRCQLK-QFPTL---DLPFLKSLTLTMNKGSISFKK--VALP 350
Query: 462 SLVALNLSWNLMHDQIPTTLGQMKG--LKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSN 519
SL L+LS N + + + L++L L+ N + ++ L+ L+ LD +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409
Query: 520 SLSGLIP-DDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
+L + +L L L ++ +++L+ ++ N+ S+
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 34/161 (21%), Positives = 64/161 (39%), Gaps = 5/161 (3%)
Query: 412 LDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWN 471
+ ++ + +++ ++P +I S K +D S N + L L+LS
Sbjct: 11 VPNITYQCMDQKLS-KVPDDIPS---STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRC 66
Query: 472 LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLEN 531
+ + L L L GN + P S L LE L L+ L +
Sbjct: 67 EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126
Query: 532 LRNLTVLLLNNNKLSG-KIPSGLANVSTLSAFNVSFNNLSG 571
L L L + +N + K+P+ +N++ L ++S+N +
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 7e-58
Identities = 68/284 (23%), Positives = 105/284 (36%), Gaps = 38/284 (13%)
Query: 1 MGNLEVLDLEGNLLNG--ILPDSGFHLKSLRVLNL-GFNRITGEIPASFSDFVNLEELNL 57
+ LDL G L +P S +L L L + G N + G IP + + L L +
Sbjct: 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108
Query: 58 AGNLVNGTVPTFIGRLKR---VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR 114
V+G +P F+ ++K + S+N L G++P I NL + GN + G IP
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIPD 167
Query: 115 SLGNCFQ-VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAIL 173
S G+ + S+ + N L IP L NL +D+SRN L G V G+ +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 174 VLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEG 233
L+ N + + V NL L + G
Sbjct: 227 HLAK---------------------------NSLAFDLGK-VGLSKNLNGLDLRNNRIYG 258
Query: 234 NFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSN 277
P L LN+ N G+ + G + ++N
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGE-IPQGGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-57
Identities = 80/310 (25%), Positives = 124/310 (40%), Gaps = 54/310 (17%)
Query: 7 LDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGE--IPASFSDFVNLEELNLAGNLVNG 64
D G+L D+ + L+L + IP+S ++ L L + G
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI---- 86
Query: 65 TVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRS 124
N LVG +P I K T L +L ++ + G IP L + +
Sbjct: 87 ----------------NNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129
Query: 125 LLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLA-ILVLSNLFDTYE 183
L N L T+P + L NL + N +SG+IP G+ SKL + +S
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR------ 183
Query: 184 DVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACD 243
N G IP ++L NL + R LEG+ +G+
Sbjct: 184 ---------------------NRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDK 221
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP-VPCMTMFDVSGNAL 302
N + ++L N + +LG +G KNL LDL +N++ G L + L + + +VS N L
Sbjct: 222 NTQKIHLAKNSLAF-DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 303 SGSIPTFSNM 312
G IP N+
Sbjct: 281 CGEIPQGGNL 290
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-55
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 16/240 (6%)
Query: 356 FLAIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPGNMFGICNRLDS 414
+L + G NN G +P + K ++ + +SG+ P L +
Sbjct: 77 YLNFLYIGGINNLVGPIPP------AIAKLTQLHYLYITHTNVSGAIPDF-LSQIKTLVT 129
Query: 415 LMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLV-ALNLSWNLM 473
L + S N ++G LP I +L + GN+I G IP G L ++ +S N +
Sbjct: 130 L--DFSYNALSGTLPPSISS-LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 474 HDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLR 533
+IP T + L ++ L+ N L G G + + + L+ NSL+ + + +
Sbjct: 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSK 244
Query: 534 NLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMK--CSSVLGNPYL 591
NL L L NN++ G +P GL + L + NVSFNNL G +P NL + S+ N L
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-47
Identities = 69/325 (21%), Positives = 113/325 (34%), Gaps = 62/325 (19%)
Query: 230 TLEGNFPSNWGACDNLEMLNLGHNFFSGKNL--GVLGPCKNLLFLDLSS-NQLTGELARE 286
T G + L+L L L FL + N L G +
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 287 L-PVPCMTMFDVSGNALSGSIP-TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQA 344
+ + + ++ +SG+IP S + + L L
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQI---------KTLV--------TLDF------- 132
Query: 345 GTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPG 403
N SG+LP + + I N++SG+ P
Sbjct: 133 -------------------SYNALSGTLPP------SISSLPNLVGITFDGNRISGAIPD 167
Query: 404 NMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSL 463
+ S+ +S NR+ G++P + +L F+D S N + G G +
Sbjct: 168 SYGSFSKLFTSM--TISRNRLTGKIPPTFANL--NLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 464 VALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSG 523
++L+ N + + +G K L L L N + G++P L QL+ L L++S N+L G
Sbjct: 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 524 LIPDDLENLRNLTVL-LLNNNKLSG 547
IP NL+ V NN L G
Sbjct: 283 EIPQGG-NLQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 9/187 (4%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQ--LPAEIGRMCKSLKFLD-ASGNQIV 450
+ G R+++L ++S + +P+ + L FL N +V
Sbjct: 35 NRTWLGVLCDTD-TQTYRVNNL--DLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLV 90
Query: 451 GPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL 510
GPIP + +L L L ++ + IP L Q+K L L + N L+G++P S+ L
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNL-TVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL 569
L + N +SG IPD + L T + ++ N+L+GKIP AN++ L+ ++S N L
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209
Query: 570 SGPLPSS 576
G
Sbjct: 210 EGDASVL 216
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 26/98 (26%), Positives = 40/98 (40%), Gaps = 5/98 (5%)
Query: 490 LSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSG--LIPDDLENLRNLTVL-LLNNNKLS 546
G + + Q + LDLS +L IP L NL L L + N L
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 547 GKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSS 584
G IP +A ++ L ++ N+SG +P L + +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDF--LSQIKT 126
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-57
Identities = 67/316 (21%), Positives = 108/316 (34%), Gaps = 45/316 (14%)
Query: 680 ATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPN 739
N IG G +GA YK + VA+K + Q I + + H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINE-KNIYRVPLMEHDN 68
Query: 740 LVTLIGY-----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALA 794
+ I E L+ Y P G+L ++ + DW ++A + R LA
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLA 125
Query: 795 YLH------DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS-------ETHAT 841
YLH D P + HRD+ N+L+ +D +SDFGL+ L + E +A
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 842 TGVAGTFGYVAPEYAMTC-------RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG 894
GT Y+APE + D+Y+ G++ E+ L P S
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE-- 243
Query: 895 FNIVAWGCMLLRQGRAKEFFTA-----------GLWDAGPHDDLVEVLHLAVVCTVDSLS 943
+A+ + ++ W + + C
Sbjct: 244 -YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVRSLKETIEDCWDQDAE 301
Query: 944 TRPTMKQVVRRLKQLQ 959
R T + R+ +L
Sbjct: 302 ARLTAQXAEERMAELM 317
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-57
Identities = 73/284 (25%), Positives = 129/284 (45%), Gaps = 38/284 (13%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG-------VQQFHAEIKTLGRLRHPNLV 741
IG GGFG +K + +VAIK L +G +G Q+F E+ + L HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
L G ++ ++P G+L + + ++ + W V ++ LDIA + Y+
Sbjct: 87 KLYG--LMHNPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 802 PRVLHRDVKPSNILLD-----DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE-- 854
P ++HRD++ NI L A ++DFGL++ H+ +G+ G F ++APE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETI 198
Query: 855 YAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914
A ++KAD YS+ ++L +L+ + P F + + + M+ +G
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEG---P-FD--EYSYGKIKFINMIREEGLRPTI- 251
Query: 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
P D + ++ +C RP +V+ L +L
Sbjct: 252 --------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-56
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 23/273 (8%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGYH 747
IG G FG ++AE G VA+K L F V +F E+ + RLRHPN+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTR-AVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ ++ YL G+L + + R +D R +A D+A+ + YLH P ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
R++K N+L+D + + DFGL+RL S ++ AGT ++APE ++K+D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 867 VYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDD 926
VYS+GV+L EL + ++ P + N + + + E P +
Sbjct: 222 VYSFGVILWELATLQQ---P----W-GNLNPAQVVAAVGFKCKRLEI---------PRNL 264
Query: 927 LVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
+V + C + RP+ ++ L+ L
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-55
Identities = 71/272 (26%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G G FG KA+ VAIK++ + + F E++ L R+ HPN+V L G A
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG--AC 70
Query: 750 ETEMFLIYNYLPGGNLENFIQ-QRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+ L+ Y GG+L N + L ++ +AYLH ++HRD
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 809 VKPSNILLDDDFNAY-LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
+KP N+LL + DFG A + T G+ ++APE S+K DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 868 YSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDL 927
+S+G++L E+++ +K P F G + W G +
Sbjct: 187 FSWGIILWEVITRRK---P-FDEIGGPAFRIMWAV---HNGTRPPL---------IKNLP 230
Query: 928 VEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
+ L C S RP+M+++V+ + L
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 6e-54
Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 48/285 (16%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGY- 746
+ G +K G + +K L V + + F+ E L HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 747 -HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
LI +++P G+L N + + + VD K ALD+AR +A+LH P +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE---YAMTCRVS 862
+ ++++D+D A +S + + G +VAPE
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 863 DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR----QGRAKEFFTAGL 918
AD++S+ V+L EL++ + P F+ N + LR G + + L
Sbjct: 190 RSADMWSFAVLLWELVTRE---VP-FADLSNMEIGMKVALEGLRPTIPPGISPHV--SKL 243
Query: 919 ----WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
+ P RP +V L+++Q
Sbjct: 244 MKICMNEDPAK-------------------RPKFDMIVPILEKMQ 269
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-53
Identities = 76/293 (25%), Positives = 121/293 (41%), Gaps = 60/293 (20%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQ----GVQQFHAEIKTLGRLRHPNLVTLIG 745
IG GGFG Y+A G VA+K + ++ E K L+HPN++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
E + L+ + GG L + + + +L A+ IAR + YLHD+ + ++
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 806 HRDVKPSNILLDDDFNAY--------LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
HRD+K SNIL+ ++DFGLAR + AG + ++APE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIR 187
Query: 858 TCRVSDKADVYSYGVVLLELLSDK---KALDPSFSSYGNGFN----IVAWGC-----MLL 905
S +DV+SYGV+L ELL+ + + +D +YG N + C L+
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM 247
Query: 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
W+ PH RP+ ++ +L +
Sbjct: 248 EDC----------WNPDPHS-------------------RPSFTNILDQLTTI 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-51
Identities = 61/297 (20%), Positives = 111/297 (37%), Gaps = 34/297 (11%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY- 746
IG G +G + + G VA+K EI +RH N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEAS-WFRETEIYQTVLMRHENILGFIAAD 100
Query: 747 ---HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH-----D 798
S T+++LI +Y G+L ++++ + +D + + K+A L +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH---ATTGVAGTFGYVAPE- 854
Q P + HRD+K NIL+ + ++D GLA GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 855 -----YAMTCRVSDKADVYSYGVVLLELLSDKKALD-------PSFSSYGNGFNIVAWGC 902
+ AD+YS+G++L E+ + P + +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 903 MLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
++ + F D ++ L C + ++R T +V + L ++
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLR----QMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-50
Identities = 65/300 (21%), Positives = 117/300 (39%), Gaps = 42/300 (14%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAE--IKTLGRLRHPNLVTLIG 745
C+G G +G ++ G VA+K + + + E + LRH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 746 Y----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH---- 797
S T+++LI +Y G+L +++Q + +D +I L IA LA+LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 798 -DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH---ATTGVAGTFGYVAP 853
Q P + HRD+K NIL+ + ++D GLA + S GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 854 E------YAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907
E + D++++G+VL E+ + + Y + ++
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDY-----KPPFYDVVPND 240
Query: 908 GRAKEFFTAGLWD---------AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
++ D L + L C + S R T ++ + L ++
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-50
Identities = 72/279 (25%), Positives = 131/279 (46%), Gaps = 32/279 (11%)
Query: 690 IGNGGFGATYKAEISPGVL---VAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLI 744
IG+G FG YK G VA+K L V +Q F E+ L + RH N++ +
Sbjct: 32 IGSGSFGTVYK-----GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
GY ++ ++ ++ + G +L + + T+ + + L IA AR + YLH + +
Sbjct: 87 GY-STAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGP-SETHATTGVAGTFGYVAPE---YAMTCR 860
+HRD+K +NI L +D + DFGLA S +H ++G+ ++APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 861 VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920
S ++DVY++G+VL EL++ + P +S+ N I+ M+ R + +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQL---P-YSNINNRDQIIE---MVGRGSLSPDLSKV---- 250
Query: 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
+ + L C RP+ +++ +++L
Sbjct: 251 --RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-50
Identities = 70/287 (24%), Positives = 114/287 (39%), Gaps = 40/287 (13%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G G FG K G ++ +K L + + F E+K + L HPN++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+ + I Y+ GG L I+ ++ W A DIA +AYLH ++HRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSM---NIIHRD 133
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHAT-------------TGVAGTFGYVAPEY 855
+ N L+ ++ N ++DFGLARL+ +T V G ++APE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDKKA---LDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912
+K DV+S+G+VL E++ A P +G R +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV----------RGFLDRY 243
Query: 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
P + + V C RP+ ++ L+ L+
Sbjct: 244 C---------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-49
Identities = 66/303 (21%), Positives = 120/303 (39%), Gaps = 46/303 (15%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAE--IKTLGRLRHPNLVTLIG 745
IG G FG ++ + G VA+K + + + E I LRH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 746 ----YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH---- 797
+ + T+++L+ +Y G+L +++ + + V + K+AL A LA+LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIV 160
Query: 798 -DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH---ATTGVAGTFGYVAP 853
Q P + HRD+K NIL+ + ++D GLA + A GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 854 E------YAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907
E +AD+Y+ G+V E+ + ++ Y + + ++
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDY-----QLPYYDLVPSD 274
Query: 908 GRAKEFFTA-----------GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956
+E W + L + + C + + R T ++ + L
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 957 QLQ 959
QL
Sbjct: 333 QLS 335
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-48
Identities = 57/299 (19%), Positives = 106/299 (35%), Gaps = 67/299 (22%)
Query: 690 IGNGGFGATYKA----EISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTL 743
IG G FG Y E VAI+ + + R ++ F E+ + RH N+V
Sbjct: 41 IGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+G S + +I + G L + ++ +D +IA +I + + YLH +
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHAK---G 150
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARL----LGPSETHATTGVAGTFGYVAPE----- 854
+LH+D+K N+ D+ ++DFGL + G ++APE
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 855 ----YAMTCRVSDKADVYSYGVVLLELLSDK---KALDPSFSSYGNGFNIVAWGCMLLRQ 907
S +DV++ G + EL + + K + G ++
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG--------MKP 261
Query: 908 GRAKEFFTAGL-------WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
++ + W + RPT +++ L++L
Sbjct: 262 NLSQIGMGKEISDILLFCWAFEQEE-------------------RPTFTKLMDMLEKLP 301
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-45
Identities = 110/583 (18%), Positives = 191/583 (32%), Gaps = 95/583 (16%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN-L 61
+ + LDL N L + S F L+VL+L I ++ +L L L GN +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 62 VNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL-VGGIPRSLGN 118
+ + F G L+++ L S+ + L+ L+++ N + +P N
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEV----LDVSRNSLSGSIPVDLGNCSKLAILV 174
+ L L SN ++ +L +L + + LD+S N ++ I +L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206
Query: 175 LSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE-AVSSLPNLRILWAPRATLEG 233
L N NF + + + L L + L
Sbjct: 207 LRN---------------------------NFDSLNVMKTCIQGLAGLEVHR-----LVL 234
Query: 234 NFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL--PVPC 291
N NLE + NL + L+ + +L +
Sbjct: 235 GEFRN---EGNLEKFDKSA-LEGLCNL-------TIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 292 MTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLR 351
++ F + + + FS L F + P+ SL
Sbjct: 284 VSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQF-PTLKLKSLK------------- 328
Query: 352 GRDGFLAIFHNFGGNNFSGS-LPSMPVAPERLGKQTVYAIVAGDNKLSG-SFPGNMFGIC 409
L N GGN FS LPS + + N LS
Sbjct: 329 ----RLTFTSNKGGNAFSEVDLPS------------LEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 410 NRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNL 468
L L ++S N + + + + L+ LD + + V L +L+ L++
Sbjct: 373 TSLKYL--DLSFNGVI-TMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 469 SWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLLEVLDLSSNSLSGLIPD 527
S + L+ L +AGN+ + +L+ L LDLS L L P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 528 DLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+L +L VL + +N+L +++L + N
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-40
Identities = 84/521 (16%), Positives = 151/521 (28%), Gaps = 75/521 (14%)
Query: 76 VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET 135
+P + + ++LDLS N L S + +++ L L ++
Sbjct: 12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 136 IPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVD 195
L +L L ++ N + S L LV
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE------------------ 109
Query: 196 QPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN------FPSNWGACDNLEMLN 249
+ L L+ L + N P + NLE L+
Sbjct: 110 ---------TNLASLENFPIGHLKTLKELN-----VAHNLIQSFKLPEYFSNLTNLEHLD 155
Query: 250 LGHNFFSGKNLGVLGPCKNL----LFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGS 305
L N L + L LDLS N + + + N S +
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLN 215
Query: 306 IP--TFSNMVCPPVPYLSRNLFESYNPSTA----------YLSLFAKKSQAGTPLPLRGR 353
+ + V L F + L++ +
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275
Query: 354 DGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLD 413
D F + + + S ++ + G Q + + + + L
Sbjct: 276 DLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS-------LK 328
Query: 414 SLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQI--VGPIPRGVGELVSLVALNLSWN 471
L ++N+ G +E+ SL+FLD S N + G + SL L+LS+N
Sbjct: 329 RL--TFTSNKG-GNAFSEVD--LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 472 LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSS-LGQLQLLEVLDLSSNSLSGLIPDDLE 530
+ + + ++ L++L +NL S L+ L LD+S
Sbjct: 384 GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 531 NLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
L +L VL + N + L+ ++S L
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-22
Identities = 40/182 (21%), Positives = 71/182 (39%), Gaps = 7/182 (3%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRIT--GEIPASFSDFVNLEELNLA 58
+ +L+ L N S L SL L+L N ++ G S +L+ L+L+
Sbjct: 324 LKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 59 GNLVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL 116
N V F+G +L+ + + L + NL +LD+S +
Sbjct: 382 FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441
Query: 117 GNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVL 175
+ L + N +E + L+NL LD+S+ L P + S L +L +
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501
Query: 176 SN 177
++
Sbjct: 502 AS 503
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-20
Identities = 93/498 (18%), Positives = 162/498 (32%), Gaps = 95/498 (19%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRIT-GEIPASFSDFVNLEELNLAG 59
+ +L+ L L + HLK+L+ LN+ N I ++P FS+ NLE L+L+
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 60 NLVNGTVPTFIGRLK-------RVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGI 112
N + T + L + LS N + + ++ L L L N+ +
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKE-IRLHKLTLRNNFDSLNV 216
Query: 113 PRSLGN---CFQVRSLLLFSNMLEETIPA-ELGMLQNLEVLDVSRNSLSGSIPVDLGNCS 168
++ +V L+L E + + L+ L L + L+ L
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY-----LDYYL 271
Query: 169 KLAILVLSNLFD-TYEDVRYSRGQSLVDQPSFMN----DDFNFFEGGIPEAVSSLPNLRI 223
I + + L + + + + + D + N G P L +L+
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT--LKLKSLKR 329
Query: 224 LWAPRATLEGNFPSNWGA---CDNLEMLNLGHNFFSGKNL--GVLGPCKNLLFLDLSSNQ 278
L T N N + +LE L+L N S K +L +LDLS N
Sbjct: 330 L-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 279 LTGELARELP-VPCMTMFDVSGNALSGSIPTFSNMVCPP---VPYLSRNLFESYNPSTAY 334
+ ++ + + D + L + FS + +S
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGI-- 440
Query: 335 LSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGD 394
F S L L GN+F +
Sbjct: 441 ---FNGLSS------LE----VL----KMAGNSFQENFLP-------------------- 463
Query: 395 NKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIP 454
++F L L ++S ++ QL SL+ L+ + NQ+ +P
Sbjct: 464 ---------DIFTELRNLTFL--DLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKS-VP 510
Query: 455 RGV-GELVSLVALNLSWN 471
G+ L SL + L N
Sbjct: 511 DGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-20
Identities = 32/163 (19%), Positives = 59/163 (36%), Gaps = 5/163 (3%)
Query: 415 LMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMH 474
+ ++P + S K LD S N + L L+LS +
Sbjct: 10 ITYQCMELNFY-KIPDNLPF---STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 475 DQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRN 534
+ L L L GN + + L L+ L +L+ L + +L+
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 535 LTVLLLNNNKL-SGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
L L + +N + S K+P +N++ L ++S N + +
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-20
Identities = 63/334 (18%), Positives = 109/334 (32%), Gaps = 61/334 (18%)
Query: 3 NLEVLDLEGNLLNGI---LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG 59
NL + + L+ + D L ++ +L I S+ + L L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVN 313
Query: 60 NLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL--VGGIPRSLG 117
+ LKR+ + N+ G+ S++ +LE LDLS N L G +S
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKG-GNAFSEVD--LPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLS 176
++ L L N + T+ + L+ LE LD ++L + L L +S
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 177 NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN-- 234
+ + L +L +L + GN
Sbjct: 430 H---------------------------THTRVAFNGIFNGLSSLEVLK-----MAGNSF 457
Query: 235 ----FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL--P 288
P + NL L+L + +L L+++SNQL + +
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDR 516
Query: 289 VPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSR 322
+ + + N S CP + YLSR
Sbjct: 517 LTSLQKIWLHTNPWDCS--------CPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-18
Identities = 35/185 (18%), Positives = 70/185 (37%), Gaps = 11/185 (5%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
++ + + + L +L ++ N I L SL+ L A +
Sbjct: 60 SRCEIQ-TIEDGAYQSLSHLSTL--ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASL 115
Query: 453 IPRGVGELVSLVALNLSWN-LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLL 511
+G L +L LN++ N + ++P + L++L L+ N + + L L +
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 512 EV----LDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSF 566
+ LDLS N ++ + P + + L L L NN S + + ++ L +
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 567 NNLSG 571
Sbjct: 235 GEFRN 239
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 1e-44
Identities = 128/673 (19%), Positives = 226/673 (33%), Gaps = 80/673 (11%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEI-PASFSDFVNLEELNLAGN- 60
E L L N + + S L+ L++L LG I +F + NL L+L +
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 61 --LVNGTVPTFIGRLKRVYLSFNRL-VGSVPSKIGEKCTNLEHLDLSGNYLVG-GIPRSL 116
++ + L + L F L + L LDLS N + + S
Sbjct: 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSF 144
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGMLQ--NLEVLDVSRNSLSGSIPVDLGNC-SKLAIL 173
G ++S+ SN + EL LQ L ++ NSL + VD G C + +
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
Query: 174 VLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEG 233
VL L DV + + + N ++ ++ ++
Sbjct: 205 VLEIL-----DVSGNGWTVDI-----TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 234 NFPSNWG--ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL--PV 289
+ + A ++ L+L H F N V K+L L+L+ N++ ++A E +
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGL 313
Query: 290 PCMTMFDVSGNALSGSIP--TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTP 347
+ + ++S N L + F + L +N T F +
Sbjct: 314 DNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQT-----FKFLEK---- 363
Query: 348 LPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFG 407
L+ L + N + ++ +P P+ I NKL N+
Sbjct: 364 --LQ----TL----DLRDNALT-TIHFIPSIPD---------IFLSGNKLVTLPKINLTA 403
Query: 408 ICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVAL 466
N + +S NR+ L+ L + N+ E SL L
Sbjct: 404 --NLIH-----LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456
Query: 467 NLSWNLMHDQIPT-----TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSL 521
L N++ T + L+ L L N L P L L L L+SN L
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
Query: 522 SGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG--PLPSSKNL 579
+ L +DL NL +L ++ N+L P + LS +++ N L + N
Sbjct: 517 TVLSHNDL--PANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECELSTFINW 571
Query: 580 MKCSSVLGNPYLRPCRAFTLTE----PSQDLHGPPSNGNRGFNSIEIASIASASAIVSVL 635
+ ++V L + S++ + + +++
Sbjct: 572 LNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLF 631
Query: 636 LALIVLFVYTRKW 648
L I+ R +
Sbjct: 632 LMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-25
Identities = 86/594 (14%), Positives = 169/594 (28%), Gaps = 140/594 (23%)
Query: 1 MGNLEVLDLEGNLLNGILPDS--GFHLKSLRVLNLGFNRITGEIPASFSDFVN------L 52
+ +L+ +D N + + K+L +L N + + + +N L
Sbjct: 147 LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206
Query: 53 EELNLAGNLVNGTVP---------------TFIGRLKRVYLSFNRLVGSVPSKI--GEKC 95
E L+++GN + + F+ + G
Sbjct: 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLAR 265
Query: 96 TNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNS 155
+++ HLDLS ++ R ++ L L N + + L NL+VL++S N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 156 LSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAV 215
L + K+A + L + F
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQK----------------NHIAIIQDQTF----------- 358
Query: 216 SSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLS 275
L L+ L L N + ++ + L N L + NL + LS
Sbjct: 359 KFLEKLQTL-----DLRDNALTTIHFIPSIPDIFLSGNKLV--TLPKINLTANL--IHLS 409
Query: 276 SNQLTG--ELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTA 333
N+L L L VP + + ++ N S S + S NPS
Sbjct: 410 ENRLENLDILYFLLRVPHLQILILNQNRFS---------------SCSGDQTPSENPSLE 454
Query: 334 YLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAG 393
L L G N + +
Sbjct: 455 QLFL--------------------------GENMLQLAWET------------------- 469
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
++F + L L +++N + LP + +L+ L + N++ +
Sbjct: 470 ------ELCWDVFEGLSHLQVL--YLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTV-L 519
Query: 454 PRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP-SSLGQLQLLE 512
+L L++S N + P L L + N S+
Sbjct: 520 SHNDL-PANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINWLNHT 575
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSF 566
+ ++ + + ++ +++ L+ + S V+
Sbjct: 576 NVTIAGPP-ADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTL 628
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-24
Identities = 79/442 (17%), Positives = 124/442 (28%), Gaps = 103/442 (23%)
Query: 143 LQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMND 202
L E L +S N + +L +L L +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGS------------------------- 57
Query: 203 DFNFFEGGI-PEAVSSLPNLRILWAPRATLEGN----FPSNW-GACDNLEMLNLGHNFFS 256
+ I EA +LPNLRIL L + + +L L L S
Sbjct: 58 --QYTPLTIDKEAFRNLPNLRILD-----LGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 257 GKNL--GVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMF---DVSGNALSGSIPTFSN 311
L G K L LDLS NQ+ L + D S N +
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIR-SLYLHPSFGKLNSLKSIDFSSNQIF-------- 161
Query: 312 MVCPPVPYLSRNLFES-YNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSG 370
+ + E + ++ SL A L R + + F
Sbjct: 162 -------LVCEHELEPLQGKTLSFFSL------AANSLYSRVSVDWGKCMNPFRNMVLE- 207
Query: 371 SLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPA 430
+SG N + +N I+ A
Sbjct: 208 -----------------------ILDVSG----------NGWTVDITGNFSNAISK-SQA 233
Query: 431 EIGRMCKSLKFLDASGNQIVGPIPRGVGELV--SLVALNLSWNLMHDQIPTTLGQMKGLK 488
+ + + I P L S+ L+LS + +K LK
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293
Query: 489 YLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGK 548
L+LA N + + L L+VL+LS N L L + L + + L N ++
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 549 IPSGLANVSTLSAFNVSFNNLS 570
+ L ++ N L+
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-15
Identities = 32/135 (23%), Positives = 57/135 (42%), Gaps = 7/135 (5%)
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSI-PSSLGQLQLL 511
+P+ L + L LS+N + ++ ++ L+ L L +I + L L
Sbjct: 19 VPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75
Query: 512 EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKI--PSGLANVSTLSAFNVSFNNL 569
+LDL S+ + L PD + L +L L L LS + N+ L+ ++S N +
Sbjct: 76 RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
Query: 570 SGPLPSSKNLMKCSS 584
L + K +S
Sbjct: 136 RS-LYLHPSFGKLNS 149
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-40
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 11/209 (5%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPN 739
+ IG G FG + G IK + + R + ++ E+ L ++HPN
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+V ++++ +Y GG+L I + + + I AL ++HD+
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
++LHRD+K NI L D L DFG+AR+L + A + GT Y++PE
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENK 200
Query: 860 RVSDKADVYSYGVVLLELLSDKKALDPSF 888
++K+D+++ G VL EL L +F
Sbjct: 201 PYNNKSDIWALGCVLYELC----TLKHAF 225
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-39
Identities = 101/554 (18%), Positives = 166/554 (29%), Gaps = 122/554 (22%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
L+ + L +P ++KS ++ P + + L L
Sbjct: 12 FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD 70
Query: 63 NGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQV 122
+ + L+ L S+P +LE L S N L +P + +
Sbjct: 71 R--------QAHELELNNLGLS-SLPELPP----HLESLVASCNSLT-ELPELPQSLKSL 116
Query: 123 RSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS-NLFDT 181
L + P LE L VS N L +P +L N S L I+ + N
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL-- 165
Query: 182 YEDVRYSRGQSLVDQPS---FMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN---- 234
+ L D P F+ N E +PE + +LP L ++ + N
Sbjct: 166 ---------KKLPDLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIY-----ADNNSLKK 209
Query: 235 FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP--VPCM 292
P +LE + G+N L L L + +N L LP P +
Sbjct: 210 LPDL---PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-----TLPDLPPSL 259
Query: 293 TMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRG 352
+V N L+ ++ L S N + L L
Sbjct: 260 EALNVRDNYLTDLPELPQSL---------TFLDVSENIFSGLSELPPN---------LY- 300
Query: 353 RDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRL 412
+L N + S+ P L + + +NKL P L
Sbjct: 301 ---YLNASSN--------EIRSLCDLPPSLEE-----LNVSNNKLI-ELPAL---PPR-L 339
Query: 413 DSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNL 472
+ L S N +A ++P +LK L N + P + L +
Sbjct: 340 ERL--IASFNHLA-EVPELPQ----NLKQLHVEYNPLRE-FPDIPESVEDLRMNSHL--- 388
Query: 473 MHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENL 532
++P LK L + N L P +E L ++S + E
Sbjct: 389 --AEVPELPQN---LKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETT 439
Query: 533 RNLTVLLLNNNKLS 546
L + ++
Sbjct: 440 DKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 89/466 (19%), Positives = 148/466 (31%), Gaps = 108/466 (23%)
Query: 113 PRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAI 172
PR++ N F ++ L S+ L E +P E +++ + + + P G ++A+
Sbjct: 5 PRNVSNTF-LQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 173 LVLSNLFDTYEDVRYSRGQSLVDQPSFMND------DFNFFEGGIPEAVSSLPNLRILWA 226
L + D L P N +PE SL +L +
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 227 PRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARE 286
L P LE L + +N L L L +D+ +N L +
Sbjct: 122 NLKALSDLPP-------LLEYLGVSNNQLE--KLPELQNSSFLKIIDVDNNSLK-----K 167
Query: 287 LP--VPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQA 344
LP P + N L +P N+ L +
Sbjct: 168 LPDLPPSLEFIAAGNNQLE-ELPELQNL---------PFLTA--------IYA------- 202
Query: 345 GTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGN 404
N+ LP +P++ E + VAG+N L P
Sbjct: 203 -------------------DNNSLK-KLPDLPLSLESI--------VAGNNILE-ELPE- 232
Query: 405 MFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLV 464
L ++ NN + LP SL+ L+ N + +P L L
Sbjct: 233 -LQNLPFLTTI--YADNNLLK-TLPDLPP----SLEALNVRDNYLTD-LPELPQSLTFLD 283
Query: 465 ALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGL 524
++ + L YL+ + N + S+ LE L++S+N L L
Sbjct: 284 VSENIFS----GLSELPPN---LYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIEL 332
Query: 525 IPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
P L L + N L+ ++P N+ L +V +N L
Sbjct: 333 -PALPPRLERLI---ASFNHLA-EVPELPQNLKQL---HVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 67/328 (20%), Positives = 107/328 (32%), Gaps = 65/328 (19%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA---------------S 45
+LE L N L LP+ LKSL V N ++ P
Sbjct: 90 PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE 148
Query: 46 FSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSG 105
+ L+ +++ N + +P L+ + N+L ++ L +
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQL--EELPELQ-NLPFLTAIYADN 204
Query: 106 NYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLG 165
N L +P + S++ +N+L EL L L + N L ++P
Sbjct: 205 NSLK-KLPDLPLSL---ESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP 257
Query: 166 NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPS---FMNDDFNFFEGGIPEAVSSLPNLR 222
+ L +VR + L + P F++ N F G+ E PNL
Sbjct: 258 SLEAL-------------NVRDNYLTDLPELPQSLTFLDVSENIFS-GLSE---LPPNLY 300
Query: 223 ILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGP-CKNLLFLDLSSNQLTG 281
L A + + +LE LN+ +N L L L L S N L
Sbjct: 301 YLNASSNEIR-SLCDLPP---SLEELNVSNN-----KLIELPALPPRLERLIASFNHLA- 350
Query: 282 ELARELP--VPCMTMFDVSGNALSGSIP 307
E+P + V N L P
Sbjct: 351 ----EVPELPQNLKQLHVEYNPLR-EFP 373
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-18
Identities = 51/302 (16%), Positives = 98/302 (32%), Gaps = 66/302 (21%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITG------------------EI 42
+LE + N L LP+ +L L + N + E
Sbjct: 172 PPSLEFIAAGNNQLE-ELPELQ-NLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEE 229
Query: 43 PASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLD 102
+ L + NL+ T+P L+ + + N L +P +L LD
Sbjct: 230 LPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLT-DLPELPQ----SLTFLD 283
Query: 103 LSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV 162
+S N G+ N + L SN + + +LE L+VS N L +P
Sbjct: 284 VSENIF-SGLSELPPN---LYYLNASSNEIRS-LCDLPP---SLEELNVSNNKLI-ELPA 334
Query: 163 DLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPS---FMNDDFNFFEGGIPEAVSSLP 219
+L ++ + + P ++ ++N P+ S+
Sbjct: 335 LPPRLERL-------------IASFNHLAEVPELPQNLKQLHVEYNPLR-EFPDIPESVE 380
Query: 220 NLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPC-KNLLFLDLSSNQ 278
+LR+ + NL+ L++ N L +++ L ++S +
Sbjct: 381 DLRMN--------SHLAEVPELPQNLKQLHVETN-----PLREFPDIPESVEDLRMNSER 427
Query: 279 LT 280
+
Sbjct: 428 VV 429
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-17
Identities = 39/176 (22%), Positives = 68/176 (38%), Gaps = 23/176 (13%)
Query: 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
NL L+ N + L D SL LN+ N++ E+PA LE L + N
Sbjct: 297 PNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNH 348
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
+ VP LK++++ +N L P ++E L ++ + + +P N
Sbjct: 349 LA-EVPELPQNLKQLHVEYNPLR-EFPDIPE----SVEDLRMNSH--LAEVPELPQNL-- 398
Query: 122 VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+ L + +N L E P ++E L ++ + KL V +
Sbjct: 399 -KQLHVETNPLRE-FPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEH 449
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 24/132 (18%), Positives = 52/132 (39%), Gaps = 15/132 (11%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
LE L N L +P+ ++L+ L++ +N + E P ++E+L + +
Sbjct: 336 PPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRMNSH 387
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
L VP LK++++ N L P ++E L ++ +V +
Sbjct: 388 L--AEVPELPQNLKQLHVETNPLR-EFPDIPE----SVEDLRMNSERVVDPYEFAHETTD 440
Query: 121 QVRSLLLFSNML 132
++ + +
Sbjct: 441 KLEDDVFEHHHH 452
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLV 741
+F IG+GGFG +KA+ G IKR+ ++ E+K L +L H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 742 TLIGY----------------HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKI 785
G + +F+ + G LE +I++R +D + ++
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845
I + + Y+H + ++++RD+KPSNI L D + DFGL L +
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--K 182
Query: 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
GT Y++PE + + D+Y+ G++L ELL
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 29/211 (13%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G GGF E + G A+KR+ Q ++ E HPN++ L+ Y
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 749 SET----EMFLIYNYLPGGNLENFIQQRSTRAVDW---RVLHKIALDIARALAYLHDQCV 801
E E +L+ + G L N I++ + ++L + L I R L +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAIHA--- 152
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA--------GTFGYVAP 853
HRD+KP+NILL D+ L D G + + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 854 E------YAMTCRVSDKADVYSYGVVLLELL 878
E + C + ++ DV+S G VL ++
Sbjct: 213 ELFSVQSH---CVIDERTDVWSLGCVLYAMM 240
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIG- 745
IG G +G K S G ++ K L G Q +E+ L L+HPN+V
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 746 -YHASETEMFLIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
+ T ++++ Y GG+L + I + + + +D + ++ + AL H +
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 803 --RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
VLHRD+KP+N+ LD N L DFGLAR+L + A T V GT Y++PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMS 192
Query: 861 VSDKADVYSYGVVLLELLSDKKALDPSF 888
++K+D++S G +L EL AL P F
Sbjct: 193 YNEKSDIWSLGCLLYELC----ALMPPF 216
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-37
Identities = 82/557 (14%), Positives = 165/557 (29%), Gaps = 88/557 (15%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL- 61
++ LDL N + I +L+VL L +RI +F +LE L+L+ N
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 62 --VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR-SLGN 118
++ + + LK + L N + + TNL+ L + I R
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178
+ L + + L L ++++ L + + + + + S + L L +
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSN 238
+ F E P + + L
Sbjct: 207 ----------------NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI 250
Query: 239 WGACDNLEMLNLGHNFFSGKNLGVLG--------PCKNLLFLDLSSNQLTGELAREL-PV 289
+E + N N + L + L +L+ +
Sbjct: 251 LE-LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309
Query: 290 PCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLP 349
+ V + + + + + S +L
Sbjct: 310 EKVKRITVENSKVF---------------LVPCSFSQH-LKSLEFL-------------- 339
Query: 350 LRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSG-SFPGNMFGI 408
+ N ++ +V N L G +
Sbjct: 340 ------------DLSENLMVEEYLKNSACKGAW--PSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 409 CNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNL 468
L SL ++S N +P + ++FL+ S I + + +L L++
Sbjct: 386 LKNLTSL--DISRNTF-HPMPDSCQWP-EKMRFLNLSSTGIRV-VKTCI--PQTLEVLDV 438
Query: 469 SWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDD 528
S N + D L + L+ L ++ N L ++P + +L V+ +S N L +
Sbjct: 439 SNNNL-DSFSLFLPR---LQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGI 492
Query: 529 LENLRNLTVLLLNNNKL 545
+ L +L + L+ N
Sbjct: 493 FDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-34
Identities = 94/513 (18%), Positives = 167/513 (32%), Gaps = 59/513 (11%)
Query: 76 VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET 135
S+PS + ++ LDLS N + L C ++ L+L S+ + T
Sbjct: 10 CDGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NT 64
Query: 136 IPAE-LGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSNLFDTYEDVRYSRGQSL 193
I + L +LE LD+S N LS S+ G S L L L
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMG---------------- 107
Query: 194 VDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNW-GACDNLEMLNLGH 252
N + G+ +L NL+ L +L L +
Sbjct: 108 -------N---PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 253 NFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPTFSN 311
L +++ L L ++ L + + ++ L+
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPL 216
Query: 312 MVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGS 371
PV +S + + + + L + G +F+ S
Sbjct: 217 ----PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272
Query: 372 LPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAE 431
+ ++ T+ + L ++ + ++ + V N+++ +P
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLST-VYSLLEKVKRI--TVENSKV-FLVPCS 328
Query: 432 IGRMCKSLKFLDASGNQI---VGPIPRGVGELVSLVALNLSWNLMHD--QIPTTLGQMKG 486
+ KSL+FLD S N + G SL L LS N + + L +K
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 487 LKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546
L L ++ N +P S + + L+LSS + + + L VL ++NN L
Sbjct: 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV---KTCIPQTLEVLDVSNNNLD 444
Query: 547 GKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
L + L +S N L LP +
Sbjct: 445 -SFSLFLPRLQEL---YISRNKLKT-LPDASLF 472
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-20
Identities = 40/204 (19%), Positives = 76/204 (37%), Gaps = 8/204 (3%)
Query: 395 NKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIP 454
NK++ C L L + ++RI + + SL+ LD S N + +
Sbjct: 36 NKIT-YIGHGDLRACANLQVL--ILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSS-LS 90
Query: 455 RGV-GELVSLVALNLSWN-LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP-SSLGQLQLL 511
G L SL LNL N + + + L+ L + I L L
Sbjct: 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150
Query: 512 EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571
L++ + SL L+++R++ L L+ ++ + + +S++ + NL+
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 572 PLPSSKNLMKCSSVLGNPYLRPCR 595
S + + SS + R
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSV 234
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-18
Identities = 52/282 (18%), Positives = 90/282 (31%), Gaps = 84/282 (29%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEI---PASFSDFVNLEELNL 57
+ ++ + +E + + + HLKSL L+L N + E A + +L+ L L
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 58 AGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
+ N + +++ L NL LD+S N +P S
Sbjct: 369 SQNH--------LRSMQKTGEILLTL------------KNLTSLDISRNTF-HPMPDSCQ 407
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
++R L L S + + + Q LEVLDVS N+L S + L L L +S
Sbjct: 408 WPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISR 460
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
N +LP + +
Sbjct: 461 ---------------------------NKL--------KTLP------------DASLFP 473
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQL 279
L ++ + N G+ +L + L +N
Sbjct: 474 ------VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-18
Identities = 51/337 (15%), Positives = 105/337 (31%), Gaps = 62/337 (18%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ +L L+++ L S ++ + L L + + ++ L L
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 61 LVNG------TVPTFIGRLKRVYLSFNRLVGSVPSKIGE------KCTNLEHLDLSGNYL 108
+ V +K++ + L +++ + + + +E D + N L
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 109 VGGIPRSLG--------NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSI 160
P +R L + L + +L+ ++ + V + + +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LV 325
Query: 161 PVDLG-NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLP 219
P + L L LS +V++ + + P
Sbjct: 326 PCSFSQHLKSLEFLDLSE-------------NLMVEEYLKNSACKG-----------AWP 361
Query: 220 NLRILWAPRATLEGN----FPSNWGACD---NLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272
+L+ L L N NL L++ N F P + + FL
Sbjct: 362 SLQTLV-----LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWP-EKMRFL 415
Query: 273 DLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTF 309
+LSS + + +P + + DVS N L S F
Sbjct: 416 NLSSTGIR-VVKTCIP-QTLEVLDVSNNNLD-SFSLF 449
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-15
Identities = 32/142 (22%), Positives = 50/142 (35%), Gaps = 4/142 (2%)
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
C + D IP G+ ++ +L+LS+N + L L+ L L +
Sbjct: 4 CDASGVCDGRSRSFTS-IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG-KIPSGLA 554
+ + L LE LDLS N LS L L +L L L N + S
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 555 NVSTLSAFNVSFNNLSGPLPSS 576
N++ L + +
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-14
Identities = 35/210 (16%), Positives = 71/210 (33%), Gaps = 14/210 (6%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
DN LS S + FG + L L N+ N + +L+ L + I
Sbjct: 83 DNHLS-SLSSSWFGPLSSLKYL--NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEI 139
Query: 454 PRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
R L SL L + + + +L ++ + +L+L + + L +
Sbjct: 140 RRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVR 199
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG----------KIPSGLANVSTLSAF 562
L+L +L+ L + + + S K+ + +S +
Sbjct: 200 YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFD 259
Query: 563 NVSFNNLSGPLPSSKNLMKCSSVLGNPYLR 592
+ + N L PS +++ + +R
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIR 289
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-13
Identities = 60/443 (13%), Positives = 130/443 (29%), Gaps = 97/443 (21%)
Query: 148 VLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFF 207
V D S + SIP L + + L LS N
Sbjct: 9 VCDGRSRSFT-SIPSGL--TAAMKSLDLSF---------------------------NKI 38
Query: 208 EGGIPEAVSSLPNLRILWAPRATLEGNFPSN--WGACD---NLEMLNLGHNFFSGKNLGV 262
+ + NL++L L+ + + A +LE L+L N S +
Sbjct: 39 TYIGHGDLRACANLQVLI-----LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSW 93
Query: 263 LGPCKNLLFLDLSSNQLTGELAREL--PVPCMTMFDVSGNALSGSIP--TFSNMVCPPVP 318
GP +L +L+L N L + + + I F+ +
Sbjct: 94 FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153
Query: 319 YLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVA 378
+ +Y + +R L + + +
Sbjct: 154 EIKALSLRNYQS--------------QSLKSIR-DIHHLTLHLSESAFLLEIFADILS-- 196
Query: 379 PERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKS 438
+V + D L+ F + + + R
Sbjct: 197 -------SVRYLELRDTNLA-RFQFSPLPVDEVSSPM--KKLAFRG-------------- 232
Query: 439 LKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKG--------LKYL 490
D S N+++ + R + EL + + + N + D P+ + ++ L
Sbjct: 233 SVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291
Query: 491 SLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKI- 549
+ L + + L+ ++ + + ++ + + ++L++L L L+ N + +
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 550 --PSGLANVSTLSAFNVSFNNLS 570
+ +L +S N+L
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLR 374
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 682 GNFNASNCIGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRH 737
+F +G G FG Y A E ++A+K L + + Q E++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
PN++ L GY T ++LI Y P G + + Q+ ++ + R I +A AL+Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITE-LANALSYCH 126
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
+ RV+HRD+KP N+LL ++DFG + PS GT Y+ PE
Sbjct: 127 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDL--CGTLDYLPPEMIE 180
Query: 858 TCRVSDKADVYSYGVVLLELL 878
+K D++S GV+ E L
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFL 201
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-37
Identities = 96/569 (16%), Positives = 171/569 (30%), Gaps = 119/569 (20%)
Query: 9 LEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPT 68
+ +N I D+ L LG +T + +D + L
Sbjct: 9 TQDTPINQIFTDTA--LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSID 62
Query: 69 FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLF 128
+ L NL ++ S N L P L N ++ +L+
Sbjct: 63 GVEYL----------------------NNLTQINFSNNQLTDITP--LKNLTKLVDILMN 98
Query: 129 SNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYS 188
+N + + P L L NL L + N ++ P L N + L L LS+
Sbjct: 99 NNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSS----------- 143
Query: 189 RGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF--PSNWGACDNLE 246
N A+S L +L+ L LE
Sbjct: 144 ----------------NTISD--ISALSGLTSLQQLS-----FGNQVTDLKPLANLTTLE 180
Query: 247 MLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSI 306
L++ N S ++ VL NL L ++NQ++ + + + ++GN L I
Sbjct: 181 RLDISSNKVS--DISVLAKLTNLESLIATNNQISDITPLGI-LTNLDELSLNGNQLK-DI 236
Query: 307 PTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGN 366
T +++ L+ N + P + L T L G N
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAPLSGLTKL--------TEL-------------KLGAN 275
Query: 367 NFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIA 425
S P L + + +N+L P L L + N I+
Sbjct: 276 QISNISP--------LAGLTALTNLELNENQLEDISP---ISNLKNLTYL--TLYFNNIS 322
Query: 426 GQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMK 485
P + + L+ L N++ + L ++ L+ N + D P L +
Sbjct: 323 DISP--VSSL-TKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLT 375
Query: 486 GLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545
+ L L T + + + + + + +L + P + + + T + N
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLP 433
Query: 546 SGKIPSGLANVSTLSAFNVSFNNLSGPLP 574
S S SG +
Sbjct: 434 S-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 90/528 (17%), Positives = 163/528 (30%), Gaps = 95/528 (17%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
L + + + L + L I NL ++N + N +
Sbjct: 25 EKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQL 80
Query: 63 NGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
P + +L + ++ N++ P TNL L L N + P L N
Sbjct: 81 TDITPLKNLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 122 VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDT 181
+ L L SN + + + L L +L+ L N ++ P L N + L L +S+
Sbjct: 136 LNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISS---- 186
Query: 182 YEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGA 241
N ++ L NL L A + + G
Sbjct: 187 -----------------------NKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGI 219
Query: 242 CDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELA-RELPVPCMTMFDVSGN 300
NL+ L+L N ++G L NL LDL++NQ++ L +T + N
Sbjct: 220 LTNLDELSLNGNQLK--DIGTLASLTNLTDLDLANNQISNLAPLSGL--TKLTELKLGAN 275
Query: 301 ALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIF 360
+S +I + + L+ N E +P + +L T L
Sbjct: 276 QIS-NISPLAGLTALTNLELNENQLEDISPISNLKNL--------TYL------------ 314
Query: 361 HNFGGNNFSGSLPSMPVAPERLGKQT-VYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNV 419
NN S P + T + + +NK+S + ++ L +
Sbjct: 315 -TLYFNNISDISP--------VSSLTKLQRLFFYNNKVSDV---SSLANLTNINWL--SA 360
Query: 420 SNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQI-P 478
+N+I+ P + L + ++ N N+ I P
Sbjct: 361 GHNQISDLTPLA---NLTRITQLGLNDQAWTNAPV---NYKANVSIPNTVKNVTGALIAP 414
Query: 479 TTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIP 526
T+ + N + + + + SG +
Sbjct: 415 ATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 95/513 (18%), Positives = 163/513 (31%), Gaps = 101/513 (19%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG 59
+ + L + + I G +L +L +N N++T P + L ++ +
Sbjct: 45 LDQVTTLQADRLGIKSI---DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 99
Query: 60 NLVNGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
N + P + L + L N++ P + TNL L+LS N + +L
Sbjct: 100 NQIADITPLANLTNLTGLTLFNNQITDIDPL---KNLTNLNRLELSSNTISD--ISALSG 154
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178
++ L N + + P L L LE LD+S N +S L + L L+ +N
Sbjct: 155 LTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATN- 208
Query: 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF--- 235
N + L NL L +L GN
Sbjct: 209 --------------------------NQISD--ITPLGILTNLDEL-----SLNGNQLKD 235
Query: 236 PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG--ELARELPVPCMT 293
+ NL L+L +N S NL L L L L +NQ++ LA + +T
Sbjct: 236 IGTLASLTNLTDLDLANNQIS--NLAPLSGLTKLTELKLGANQISNISPLAG---LTALT 290
Query: 294 MFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGR 353
+++ N L I SN+ L N +P ++ L L
Sbjct: 291 NLELNENQLE-DISPISNLKNLTYLTLYFNNISDISPVSSLTKL--------QRL----- 336
Query: 354 DGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQT-VYAIVAGDNKLSGSFPGNMFGICNRL 412
F N S L T + + AG N++S P R+
Sbjct: 337 --------FFYNNKVSD--------VSSLANLTNINWLSAGHNQISDLTP---LANLTRI 377
Query: 413 DSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNL 472
L +++ P + ++ P + + S +++WNL
Sbjct: 378 TQL--GLNDQAWTN-APVNYKANVSIPNTVKNVTGALIAPAT--ISDGGSYTEPDITWNL 432
Query: 473 MHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSL 505
+ +G++ L
Sbjct: 433 P-SYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 79/371 (21%), Positives = 138/371 (37%), Gaps = 59/371 (15%)
Query: 213 EAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272
++L + + + D + L K++ + NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQI 73
Query: 273 DLSSNQLTG--ELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNP 330
+ S+NQLT L + + ++ N ++ I +N+ L N +P
Sbjct: 74 NFSNNQLTDITPLKN---LTKLVDILMNNNQIA-DITPLANLTNLTGLTLFNNQITDIDP 129
Query: 331 STAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAI 390
+L L N S A L +
Sbjct: 130 LKNLTNL--------NRL-------------ELSSNTISD-----ISALSGLTSLQQLSF 163
Query: 391 VAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIV 450
N+++ P L+ L ++S+N+++ + + ++ +L+ L A+ NQI
Sbjct: 164 ---GNQVTDLKP---LANLTTLERL--DISSNKVSD--ISVLAKL-TNLESLIATNNQIS 212
Query: 451 GPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL 510
P +G L +L L+L+ N + D TL + L L LA N ++ P L L
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 266
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
L L L +N +S + P L L LT L LN N+L S ++N+ L+ + FNN+S
Sbjct: 267 LTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNIS 322
Query: 571 G--PLPSSKNL 579
P+ S L
Sbjct: 323 DISPVSSLTKL 333
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-20
Identities = 46/186 (24%), Positives = 74/186 (39%), Gaps = 16/186 (8%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
+N++S P +L L + N+I+ + G +L L+ + NQ+
Sbjct: 251 ANNQISNLAP---LSGLTKLTEL--KLGANQISN-ISPLAG--LTALTNLELNENQLEDI 302
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
P + L +L L L +N + D P + + L+ L N ++ SSL L +
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNIN 356
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGP 572
L N +S L P L NL +T L LN+ + + ANVS + L P
Sbjct: 357 WLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP 414
Query: 573 LPSSKN 578
S
Sbjct: 415 ATISDG 420
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-18
Identities = 40/186 (21%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 389 AIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQ 448
A + D ++ +F + + + + + + L A
Sbjct: 6 ATITQDTPIN-----QIFTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLG 57
Query: 449 IVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQL 508
I GV L +L +N S N + D P L + L + + N + P L L
Sbjct: 58 I--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANL 111
Query: 509 QLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNN 568
L L L +N ++ + P L+NL NL L L++N +S S L+ +++L + N
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQ 166
Query: 569 LSGPLP 574
++ P
Sbjct: 167 VTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 27/120 (22%), Positives = 51/120 (42%), Gaps = 9/120 (7%)
Query: 462 SLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSL 521
L + ++ + +QI T + L N+T ++ L + L +
Sbjct: 2 PLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 522 SGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG--PLPSSKNL 579
+ D +E L NLT + +NN+L+ P L N++ L ++ N ++ PL + NL
Sbjct: 59 KSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNL 114
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 19/198 (9%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG----VQQFHAEIKTLGRLRHPNLVTLI 744
+G GG G Y+AE +VA+K ++ + E +T GRL+ P++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRS----TRAVDWRVLHKIALDIARALAYLHDQC 800
+ + ++++ + G +L ++++ RAV I I AL H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA------IVRQIGSALDAAHAA- 153
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
HRDVKP NIL+ D AYL DFG+A + GT Y+APE
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 861 VSDKADVYSYGVVLLELL 878
+ +AD+Y+ VL E L
Sbjct: 212 ATYRADIYALTCVLYECL 229
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 16/224 (7%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRH 737
NF IG G F Y+A + GV VA+K++ + + EI L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQ--QRSTRAVDWRVLHKIALDIARALAY 795
PN++ + E+ ++ G+L I+ ++ R + R + K + + AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
+H + RV+HRD+KP+N+ + L D GL R T A + V GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899
+ K+D++S G +L E+ AL F YG+ N+ +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMA----ALQSPF--YGDKMNLYS 245
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 689 CIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGY 746
C+G GGFG ++A+ AIKR+ + + ++ E+K L +L HP +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 747 HASETEM------------FLIYNYLPGGNLENFIQQRSTRA-VDWRVLHKIALDIARAL 793
+ ++ NL++++ R T + V I L IA A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA-------- 845
+LH + ++HRD+KPSNI D + DFGL + E T
Sbjct: 132 EFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 846 ---GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
GT Y++PE S K D++S G++L ELL
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 53/234 (22%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLV 741
+F +G G FG KA AIK++ + + +E+ L L H +V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVV 65
Query: 742 TLIG-------------YHASETEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKI 785
++ +F+ Y G L + I R WR+ +I
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL------------ 833
AL+Y+H Q ++HRD+KP NI +D+ N + DFGLA+ +
Sbjct: 126 LE----ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 834 --GPSETHATTGVAGTFGYVAPE-------YAMTCRVSDKADVYSYGVVLLELL 878
S + T+ + GT YVA E Y ++K D+YS G++ E++
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHY------NEKIDMYSLGIIFFEMI 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 682 GNFNASNCIGNGGFGATYKA-EISPGVLVAIK---RLAVGRFQGVQQFHAEIKTLGRLRH 737
+F N +G G F Y+A I G+ VAIK + A+ + VQ+ E+K +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
P+++ L Y ++L+ G + +++ R + H + I + YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH 129
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA-RLLGPSETHATTGVAGTFGYVAPEYA 856
+LHRD+ SN+LL + N ++DFGLA +L P E H T GT Y++PE A
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIA 184
Query: 857 MTCRVSDKADVYSYGVVLLELL 878
++DV+S G + LL
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLL 206
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-35
Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 27/213 (12%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLV 741
+F + +G+G G + VA+KR+ F + E++ L HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 742 TLIGYHASETEMFLIYNYLP----GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
+ + F Y+ L+ +++Q+ + + LA+LH
Sbjct: 82 RY--FCTEKDRQFQ---YIAIELCAATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLH 135
Query: 798 DQCVPRVLHRDVKPSNILL-----DDDFNAYLSDFGLARLL--GPSETHATTGVAGTFGY 850
++HRD+KP NIL+ A +SDFGL + L G +GV GT G+
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 851 VAPEY---AMTCRVSDKADVYSYGVVLLELLSD 880
+APE + D++S G V ++S+
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 682 GNFNASNCIGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRH 737
+F+ +G G FG Y A E ++A+K L + + Q EI+ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
PN++ + Y ++L+ + P G L + Q+ R + R + ++A AL Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFME-ELADALHYCH 131
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
++ +V+HRD+KP N+L+ ++DFG + + PS T GT Y+ PE
Sbjct: 132 ER---KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTM--CGTLDYLPPEMIE 185
Query: 858 TCRVSDKADVYSYGVVLLELL 878
+K D++ GV+ E L
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFL 206
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 47/224 (20%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 671 PLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAE 728
L F+S+ ++ IG+GG ++ + AIK + + Q + + E
Sbjct: 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 729 IKTLGRLRHPNL--VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIA 786
I L +L+ + + L Y ++ ++++ +L ++++++ +++D
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYW 133
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT-TGVA 845
++ A+ +H ++H D+KP+N L+ D L DFG+A + P T
Sbjct: 134 KNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 846 GTFGYVAPE-----------YAMTCRVSDKADVYSYGVVLLELL 878
GT Y+ PE ++S K+DV+S G +L +
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-35
Identities = 59/192 (30%), Positives = 101/192 (52%), Gaps = 5/192 (2%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G FG + + VAIK L G + F E + + +LRH LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAV- 247
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
SE ++++ Y+ G+L +F++ + + + L +A IA +AY+ +HR
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
D++ +NIL+ ++ ++DFGLARL+ +E A G + APE A+ R + K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 868 YSYGVVLLELLS 879
+S+G++L EL +
Sbjct: 365 WSFGILLTELTT 376
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-35
Identities = 54/193 (27%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 688 NCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY 746
+ +G G +G Y+ + VA+K L + V++F E + ++HPNLV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
E ++I ++ GNL +++++ + + V VL +A I+ A+ YL + +H
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
R++ N L+ ++ ++DFGL+RL+ A G + APE + S K+D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 867 VYSYGVVLLELLS 879
V+++GV+L E+ +
Sbjct: 402 VWAFGVLLWEIAT 414
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 56/194 (28%), Positives = 91/194 (46%), Gaps = 11/194 (5%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG----VQQFHAEIKTLGRLRHPNLVTLI 744
+G GG Y AE + VAIK + + +++F E+ +L H N+V++I
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ +L+ Y+ G L +I+ + I + + HD R+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
+HRD+KP NIL+D + + DFG+A+ L + T V GT Y +PE A +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 865 ADVYSYGVVLLELL 878
D+YS G+VL E+L
Sbjct: 193 TDIYSIGIVLYEML 206
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 13/227 (5%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G FG+ P G +VA+K+L + ++ F EI+ L L+H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 745 G--YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
G Y A + LI YLP G+L +++Q+ R +D L + I + + YL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GYVAPEYAMTCR 860
R +HRD+ NIL++++ + DFGL ++L + G + APE +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 861 VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907
S +DV+S+GVVL EL + + + + G M++
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 51/192 (26%), Positives = 96/192 (50%), Gaps = 5/192 (2%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G FG + A + VA+K + G V+ F AE + L+H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAV- 251
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
++ +++I ++ G+L +F++ L + IA +A++ + +HR
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
D++ +NIL+ ++DFGLAR++ +E A G + APE + K+DV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 868 YSYGVVLLELLS 879
+S+G++L+E+++
Sbjct: 369 WSFGILLMEIVT 380
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 13/227 (5%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G FG+ P G +VA+K+L + ++ F EI+ L L+H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 745 G--YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
G Y A + LI YLP G+L +++Q+ R +D L + I + + YL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GYVAPEYAMTCR 860
R +HRD+ NIL++++ + DFGL ++L + + G + APE +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 861 VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907
S +DV+S+GVVL EL + + + + G M++
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-34
Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 9/195 (4%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYH 747
IG G FG + + + LVA+K +F E + L + HPN+V LIG
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
+ ++++ + GG+ F++ + + L ++ D A + YL + +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVSDKA 865
D+ N L+ + +SDFG++R A+ G APE R S ++
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG-LRQVPVKWTAPEALNYGRYSSES 296
Query: 866 DVYSYGVVLLELLSD 880
DV+S+G++L E S
Sbjct: 297 DVWSFGILLWETFSL 311
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 689 CIGNGGFGATYKA-EISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIG 745
IG G F YK + V VA L + Q+F E + L L+HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 746 Y----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
+ + L+ + G L+ ++++ + + +VL I + L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT-RT 149
Query: 802 PRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
P ++HRD+K NI + + + D GLA L + A V GT ++APE +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA-VIGTPEFMAPEM-YEEK 205
Query: 861 VSDKADVYSYGVVLLELL 878
+ DVY++G+ +LE+
Sbjct: 206 YDESVDVYAFGMCMLEMA 223
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-34
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 44/224 (19%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHA 748
+G G G G VA+KR+ + EIK L HPN++ Y +
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRY--YCS 77
Query: 749 SETEMFLIYNYLP----GGNLENFIQQRSTRAVDWRVLH-----KIALDIARALAYLHDQ 799
T+ FL Y+ NL++ ++ ++ + ++ + IA +A+LH
Sbjct: 78 ETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 800 CVPRVLHRDVKPSNILLD-------------DDFNAYLSDFGLARLLGPSETHATT---G 843
+++HRD+KP NIL+ ++ +SDFGL + L ++ T
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 844 VAGTFGYVAPE-------YAMTCRVSDKADVYSYGVVLLELLSD 880
+GT G+ APE R++ D++S G V +LS
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 12/202 (5%)
Query: 682 GNFNASNCIGNGGFGATYKA-EISPGVLVAIK---RLAVGRFQGVQQFHAEIKTLGRLRH 737
+ +G GGF ++ + + A K + + + ++ EI L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
++V G+ +F++ +L ++R +A+ I YLH
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH 132
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYA 856
RV+HRD+K N+ L++D + DFGLA + E GT Y+APE
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVL 187
Query: 857 MTCRVSDKADVYSYGVVLLELL 878
S + DV+S G ++ LL
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLL 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-34
Identities = 59/192 (30%), Positives = 101/192 (52%), Gaps = 5/192 (2%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G FG + + VAIK L G + F E + + +LRH LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAV- 330
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
SE ++++ Y+ G+L +F++ + + + L +A IA +AY+ +HR
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADV 867
D++ +NIL+ ++ ++DFGLARL+ +E A G + APE A+ R + K+DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 868 YSYGVVLLELLS 879
+S+G++L EL +
Sbjct: 448 WSFGILLTELTT 459
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-34
Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 19/198 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G+G FG ++ E + G + K + EI + +L HP L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTR-----AVDWRVLHKIALDIARALAYLHDQCVPR 803
+ EM LI +L GG L + I + ++ L ++H+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN------YMRQACEGLKHMHEH---S 169
Query: 804 VLHRDVKPSNILLDDDFNAYL--SDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
++H D+KP NI+ + + + DFGLA L P E T + APE V
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPV 227
Query: 862 SDKADVYSYGVVLLELLS 879
D+++ GV+ LLS
Sbjct: 228 GFYTDMWAIGVLGYVLLS 245
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-34
Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G+G F + + G L A+K + EI L +++H N+VTL +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 749 SETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVPRV 804
S T +L+ + GG L + I +R A + + A+ YLH+ +
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQVLSAVKYLHEN---GI 127
Query: 805 LHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
+HRD+KP N+L +++ ++DFGL+++ + GT GYVAPE
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVLAQKPY 184
Query: 862 SDKADVYSYGVVLLELLS 879
S D +S GV+ LL
Sbjct: 185 SKAVDCWSIGVITYILLC 202
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 12/202 (5%)
Query: 682 GNFNASNCIGNGGFGATYKA-EISPGVLVAIK---RLAVGRFQGVQQFHAEIKTLGRLRH 737
+ +G GGF ++ + + A K + + + ++ EI L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
++V G+ +F++ +L ++R +A+ I YLH
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH 158
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYA 856
RV+HRD+K N+ L++D + DFGLA + E GT Y+APE
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVL 213
Query: 857 MTCRVSDKADVYSYGVVLLELL 878
S + DV+S G ++ LL
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLL 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 44/207 (21%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNL--VTL 743
IG+GG ++ + AIK + + Q + + EI L +L+ + + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
Y ++ ++++ +L ++++++ +++D ++ A+ +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT-TGVAGTFGYVAPE-------- 854
++H D+KP+N L+ D L DFG+A + P T GT Y+ PE
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 855 ---YAMTCRVSDKADVYSYGVVLLELL 878
++S K+DV+S G +L +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMT 214
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-33
Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 26/203 (12%)
Query: 689 CIGNGGFGATYKAE--ISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
CI +GG G Y A G V +K L G + AE + L + HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 746 Y-----HASETEMFLIYNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHD 798
+ + +++ Y+ G +L+ Q+ A+ L+I AL+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA------YLLEILPALSYLHS 200
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+++ D+KP NI+L ++ L D G + + + GT G+ APE T
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPEIVRT 251
Query: 859 CRVSDKADVYSYGVVLLELLSDK 881
+ D+Y+ G L L D
Sbjct: 252 -GPTVATDIYTVGRTLAALTLDL 273
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G FG+ P G LVA+K+L + F EI+ L L +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 745 G--YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
G Y + L+ YLP G L +F+Q+ R +D L + I + + YL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSR--- 146
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GYVAPEYAMTCR 860
R +HRD+ NIL++ + + ++DFGLA+LL + + G + APE
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 861 VSDKADVYSYGVVLLELLS 879
S ++DV+S+GVVL EL +
Sbjct: 207 FSRQSDVWSFGVVLYELFT 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-33
Identities = 53/289 (18%), Positives = 99/289 (34%), Gaps = 30/289 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G ++ G L AIK F V E + L +L H N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 748 ASET--EMFLIYNYLPGGNLENFIQQR-STRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
T LI + P G+L +++ + + + D+ + +L + +
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GI 133
Query: 805 LHRDVKPSNILL----DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE------ 854
+HR++KP NI+ D L+DFG AR L E + + GT Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAV 191
Query: 855 --YAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912
+ D++S GV + F + ++ + K
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGS----LPFRPFEGPRRNKE---VMYKIITGKP 244
Query: 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961
+ + + V C++ S + + V+ + +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSL-SRGLQVLLTPVLANILEADQE 292
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G FG + + VA+K L G F AE + +L+H LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807
++ +++I Y+ G+L +F++ S + L +A IA +A++ ++ +HR
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVSDKA 865
D++ +NIL+ D + ++DFGLARL+ +E A G F APE + K+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG--AKFPIKWTAPEAINYGTFTIKS 191
Query: 866 DVYSYGVVLLELLS 879
DV+S+G++L E+++
Sbjct: 192 DVWSFGILLTEIVT 205
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 30/203 (14%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G +G A + + A K++ + V +F EI+ + L HPN++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 749 SETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVPRV 804
T+++L+ GG L + + A I D+ A+AY H V
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAAR------IMKDVLSAVAYCHKL---NV 127
Query: 805 LHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE-----YA 856
HRD+KP N L D L DFGLA P + T GT YV+P+ Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLEGLY- 184
Query: 857 MTCRVSDKADVYSYGVVLLELLS 879
+ D +S GV++ LL
Sbjct: 185 -----GPECDEWSAGVMMYVLLC 202
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYH 747
+ GGF Y+A+ + G A+KRL + + E+ + +L HPN+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 748 ASETEM-------FLIYNYLPGGNLENFIQQRSTRAV--DWRVLHKIALDIARALAYLHD 798
+ E FL+ L G L F+++ +R VL KI RA+ ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCRAVQHMHR 154
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL--GPSETHATTGVA---------GT 847
Q P ++HRD+K N+LL + L DFG A + P + + A T
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 848 FGYVAPE---YAMTCRVSDKADVYSYGVVLLELL 878
Y PE + +K D+++ G +L L
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-33
Identities = 45/251 (17%), Positives = 99/251 (39%), Gaps = 25/251 (9%)
Query: 645 TRKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEIS 704
+ + T + + E + ++ IG+GG ++
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE 78
Query: 705 PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNL--VTLIGYHASETEMFLIYNYL 760
+ AIK + + Q + + EI L +L+ + + L Y ++ ++++
Sbjct: 79 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137
Query: 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF 820
+L ++++++ +++D ++ A+ +H ++H D+KP+N L+ D
Sbjct: 138 GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG- 191
Query: 821 NAYLSDFGLARLLGPSET--HATTGVAGTFGYVAPE-----------YAMTCRVSDKADV 867
L DFG+A + P T + G Y+ PE ++S K+DV
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250
Query: 868 YSYGVVLLELL 878
+S G +L +
Sbjct: 251 WSLGCILYYMT 261
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG P G VA+K L + EI+ L L H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 744 IG--YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
G + LI +LP G+L+ ++ + + ++ + K A+ I + + YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSR-- 145
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GYVAPEYAMTC 859
+ +HRD+ N+L++ + + DFGL + + + + T + APE M
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 860 RVSDKADVYSYGVVLLELLS 879
+ +DV+S+GV L ELL+
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 73/544 (13%), Positives = 154/544 (28%), Gaps = 81/544 (14%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
++ + + L L +++ L+L N ++ A + F LE LNL+ N++
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 63 NGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
L+ + L+ N + ++ ++E L + N + + S G
Sbjct: 71 Y-ETLDLESLSTLRTLDLNNNYV-----QELLV-GPSIETLHAANNNI-SRVSCSRGQ-- 120
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSG-SIPVDLGNCSKLAILVLSNLF 179
+++ L +N + + G ++ LD+ N + + + L L L
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY-- 178
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----F 235
NF + V L+ L L N
Sbjct: 179 -------------------------NFIY-DVKGQV-VFAKLKTLD-----LSSNKLAFM 206
Query: 236 PSNWGACDNLEMLNLGHNFFSGKNL-GVLGPCKNLLFLDLSSNQLTGELARELPVPCMTM 294
+ + + ++L +N + L +NL DL N R+ +
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV--LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 295 FDVSGNALSG-SIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGR 353
V+ + + P + + E P P R
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED------------------LPAPFADR 306
Query: 354 DGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLD 413
L + + + ER + I A + + +
Sbjct: 307 LIALKRKEHALLSGQGSETERLE--CERENQARQREIDALKEQYR-TVIDQVTLRKQAKI 363
Query: 414 SLMVNVSNNRIAGQLPAEIGRMCKSLK-FLDASGNQIVGPIPRGVGELVSLVALNLSWNL 472
+L + Q+ + A G + L L A+ +
Sbjct: 364 TL--EQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEE 421
Query: 473 MHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENL 532
M + Q ++ + + T + +L DL+ S + + + +
Sbjct: 422 M--YVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVRE 479
Query: 533 RNLT 536
+NL
Sbjct: 480 QNLA 483
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 69/541 (12%), Positives = 163/541 (30%), Gaps = 83/541 (15%)
Query: 18 LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLK 74
+ + + ++ + + + + + N++EL+L+GN ++ + +L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 75 RVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEE 134
+ LS N L ++ E + L LDL+ NY+ + L + +L +N +
Sbjct: 62 LLNLSSNVLYETLDL---ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 135 TIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLV 194
+ Q + + ++ N ++ +D G S++ L L
Sbjct: 114 -VSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL----------------- 153
Query: 195 DQPSFMNDDFNFFEG-GIPEAVSSLPNLRILWAPRATLEGN----FPSNWGACDNLEMLN 249
N + E +S L L L+ N L+ L+
Sbjct: 154 ----------NEIDTVNFAELAASSDTLEHLN-----LQYNFIYDVKGQVV-FAKLKTLD 197
Query: 250 LGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPT 308
L N + + ++ L +N+L + + L + FD+ GN
Sbjct: 198 LSSNKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 309 FSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNF 368
V +++ + L + + G
Sbjct: 256 DFFSKNQRVQTVAKQTVKK--------------------LTGQNEEECTVPTLGHYGAYC 295
Query: 369 SGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQL 428
LP+ K+ +A+++G + R + + + +
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN-QARQREI--DALKEQYR-TV 351
Query: 429 PAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLK 488
++ ++ L+ + + G L L + ++ + L+
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG-TLQQAVGQIELQHATEEQSPLQ 410
Query: 489 YLSLAGNNLT-GSIPSSLGQLQLLEVLDLSSNSLSGLIPDD--LENLRNLTVLLLNNNKL 545
L + Q + D+ + + L ++ L+ L L L +
Sbjct: 411 LLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANA 470
Query: 546 S 546
+
Sbjct: 471 T 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 33/161 (20%), Positives = 64/161 (39%), Gaps = 13/161 (8%)
Query: 410 NRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLS 469
NR V+++ + Q A + + ++K LD SGN + + L LNLS
Sbjct: 10 NRYKIE--KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 470 WNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDL 529
N++++ L + L+ L L N + L +E L ++N++S +
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV---SC 116
Query: 530 ENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+ + L NNK++ S + ++ N +
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 37/196 (18%), Positives = 74/196 (37%), Gaps = 29/196 (14%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
D+ L ++ + L ++S N ++ A++ L+ L+ S N + +
Sbjct: 19 DSSLK-QALASLRQSAWNVKEL--DLSGNPLSQISAADLAP-FTKLELLNLSSNVLYETL 74
Query: 454 PRGVGELVSLVALNLSWNLMHD------------------QIPTTLGQMKGLKYLSLAGN 495
+ L +L L+L+ N + + ++ + GQ G K + LA N
Sbjct: 75 D--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQ--GKKNIYLANN 130
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDL-ENLRNLTVLLLNNNKLSGKIPSGLA 554
+T G ++ LDL N + + +L + L L L N + +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-V 188
Query: 555 NVSTLSAFNVSFNNLS 570
+ L ++S N L+
Sbjct: 189 VFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-17
Identities = 50/380 (13%), Positives = 119/380 (31%), Gaps = 50/380 (13%)
Query: 210 GIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNL 269
I E + +I ++L+ S + N++ L+L N S + L P L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 270 LFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYN 329
L+LSSN L E + + D++ N + + ++ + + N +
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIE---TLHAANNNISRVS 115
Query: 330 PSTA------YLS---LFAKKSQAGTPLP-LRGRDGFLAIFHN----FGGNNFSGSLPSM 375
S YL+ + + ++ +L + N + S ++
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQ----YLDLKLNEIDTVNFAELAASSDTL 171
Query: 376 PVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRM 435
E L N + G + +L +L ++S+N++A + E
Sbjct: 172 ----EHL--------NLQYNFIY-DVKGQVV--FAKLKTL--DLSSNKLA-FMGPEFQS- 212
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWN-LMHDQIPTTLGQMKGLKYLSLAG 494
+ ++ N++V I + + +L +L N + + + ++ ++
Sbjct: 213 AAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK-- 269
Query: 495 NNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG----KIP 550
+ + + + + + L + L L G ++
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329
Query: 551 SGLANVSTLSAFNVSFNNLS 570
N + +
Sbjct: 330 CERENQARQREIDALKEQYR 349
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 24/103 (23%), Positives = 43/103 (41%), Gaps = 3/103 (2%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
I K + ++L ++ S ++ LDLS N LS + DL L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 537 VLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
+L L++N L L ++STL +++ N + L ++
Sbjct: 62 LLNLSSNVLYE-TLD-LESLSTLRTLDLNNNYVQE-LLVGPSI 101
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 17/80 (21%), Positives = 33/80 (41%), Gaps = 1/80 (1%)
Query: 500 SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTL 559
+I ++ ++ +SL + ++ N+ L L+ N LS + LA + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 560 SAFNVSFNNLSGPLPSSKNL 579
N+S N L ++L
Sbjct: 61 ELLNLSSNVLYE-TLDLESL 79
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 23/213 (10%), Positives = 50/213 (23%), Gaps = 33/213 (15%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
NKL+ F + + ++ NN++ + + ++L+ D GN
Sbjct: 200 SNKLA-FMGPE-FQSAAGVTWI--SLRNNKLV-LIEKALRFS-QNLEHFDLRGNGFHCGT 253
Query: 454 PRGV-----------------------GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYL 490
R E + D ++ LK
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRK 313
Query: 491 SLA----GNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546
A + T + +D +I + L L
Sbjct: 314 EHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
Query: 547 GKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
++ +G + L +++
Sbjct: 374 EQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRL-RHP 738
+F + +G+G +G +K G L A+KR + + AE+ + ++ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
V L ++L G +L+ + + +V D ALA+LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLHS 175
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE---- 854
Q ++H DVKP+NI L L DFGL LG + G Y+APE
Sbjct: 176 Q---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQG 230
Query: 855 -YAMTCRVSDKADVYSYGVVLLELLSDKK 882
Y ADV+S G+ +LE+ + +
Sbjct: 231 SY------GTAADVFSLGLTILEVACNME 253
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 17/218 (7%)
Query: 689 CIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G +G Y ++S V +AIK + + Q H EI L+H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDW-RVLHKIALDIARALAYLHDQCVPRVLH 806
+ + + +PGG+L ++ + D + + I L YLHD +++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 807 RDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV--SD 863
RD+K N+L++ +SDFG ++ L T GT Y+APE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204
Query: 864 KADVYSYGVVLLELLSDKKALDPSFSSYGNG----FNI 897
AD++S G ++E+ + K P F G F +
Sbjct: 205 AADIWSLGCTIIEMATGK----PPFYELGEPQAAMFKV 238
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 9/192 (4%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
IG+G FG + VAIK + G + F E + + +L HP LV L G
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
+ + L+ ++ G L ++++ + L + LD+ +AYL + V+HRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEA---CVIHRDL 130
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVSDKADV 867
N L+ ++ +SDFG+ R + + ++TG F +PE R S K+DV
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG--TKFPVKWASPEVFSFSRYSSKSDV 188
Query: 868 YSYGVVLLELLS 879
+S+GV++ E+ S
Sbjct: 189 WSFGVLMWEVFS 200
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG----VQQFHAEIKTLGRLRHPNLVTLI 744
+G GG + A + VA+K L +F E + L HP +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAV- 77
Query: 745 GYHASETEM------FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
Y E E +++ Y+ G L + + + + ++ D +AL + H
Sbjct: 78 -YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ 134
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT-TG-VAGTFGYVAPEYA 856
++HRDVKP+NI++ + DFG+AR + S T T V GT Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 857 MTCRVSDKADVYSYGVVLLELL 878
V ++DVYS G VL E+L
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVL 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 5e-32
Identities = 50/192 (26%), Positives = 95/192 (49%), Gaps = 9/192 (4%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G+G FG + VA+K + G +F E +T+ +L HP LV G +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
E ++++ Y+ G L N+++ + ++ L ++ D+ +A+L + +HRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVSDKADV 867
N L+D D +SDFG+ R + + ++ G F APE + S K+DV
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG--TKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 868 YSYGVVLLELLS 879
+++G+++ E+ S
Sbjct: 189 WAFGILMWEVFS 200
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-32
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 671 PLSFESVVQATGNFNA------SNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQ 723
P V G N+ + +G G FG +K E + G+ +A K + + +
Sbjct: 72 PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 724 QFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTR-----AVD 778
+ EI + +L H NL+ L S+ ++ L+ Y+ GG L + I S +
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL 191
Query: 779 WRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL--SDFGLARLLGPS 836
I + ++H +LH D+KP NIL + + DFGLAR P
Sbjct: 192 ------FMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
E GT ++APE VS D++S GV+ LLS
Sbjct: 243 EKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 690 IGNGGFGATYKAEISP-----GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG P G +VA+K L Q + EI L L H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 744 IG--YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
G A + L+ Y+P G+L +++ + S + L A I +AYLH Q
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GYVAPEYAMTC 859
+HRD+ N+LLD+D + DFGLA+ + + G + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 860 RVSDKADVYSYGVVLLELLS 879
+ +DV+S+GV L ELL+
Sbjct: 213 KFYYASDVWSFGVTLYELLT 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 8e-32
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 33/206 (16%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGY 746
+G G F + + G+ A K + + Q+ E + +L+HPN+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVP 802
E+ +L+++ + GG L I R A I ++AY H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH------CIQQILESIAYCHSN--- 124
Query: 803 RVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE----- 854
++HR++KP N+LL L+DFGLA + SE A G AGT GY++PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKD 182
Query: 855 -YAMTCRVSDKADVYSYGVVLLELLS 879
Y S D+++ GV+L LL
Sbjct: 183 PY------SKPVDIWACGVILYILLV 202
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 14/199 (7%)
Query: 690 IGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQGVQQ---FHAEIKTLGRLRHPNLVT 742
+G+G FG + A V VA+K L + F E+ + L H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L G + M ++ P G+L + +++ L + A+ +A + YL +
Sbjct: 86 LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCR 860
R +HRD+ N+LL + DFGL R L ++ H + APE T
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 861 VSDKADVYSYGVVLLELLS 879
S +D + +GV L E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 20/198 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G G FG ++ E S K + V + EI L RH N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTR-----AVDWRVLHKIALDIARALAYLHDQCVPR 803
S E+ +I+ ++ G ++ I + V + AL +LH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVS------YVHQVCEALQFLHSH---N 122
Query: 804 VLHRDVKPSNILLDDDFNAYL--SDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
+ H D++P NI+ ++ + +FG AR L P + + Y APE V
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVV 180
Query: 862 SDKADVYSYGVVLLELLS 879
S D++S G ++ LLS
Sbjct: 181 STATDMWSLGTLVYVLLS 198
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 32/205 (15%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGY 746
+G G FG K + A+K + + E++ L +L HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVP 802
+ +++ GG L + I +R A I + + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMHKH--- 140
Query: 803 RVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE----- 854
++HRD+KP NILL + D + + DFGL+ + GT Y+APE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLRGT 198
Query: 855 YAMTCRVSDKADVYSYGVVLLELLS 879
Y +K DV+S GV+L LLS
Sbjct: 199 Y------DEKCDVWSAGVILYILLS 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 21/200 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGY 746
+G G F + + G+ A K + + Q+ E + +L+HPN+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVP 802
E+ +L+++ + GG L I R A I ++AY H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH------CIQQILESIAYCHSN--- 147
Query: 803 RVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
++HR++KP N+LL L+DFGLA + SE A G AGT GY++PE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKD 205
Query: 860 RVSDKADVYSYGVVLLELLS 879
S D+++ GV+L LL
Sbjct: 206 PYSKPVDIWACGVILYILLV 225
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/202 (30%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G+G FG + E S G+ IK + R Q ++Q AEI+ L L HPN++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDW--RVLHKIALDIARALAYLHDQCVPRVL 805
M+++ GG L I R + ++ + ALAY H Q V+
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVV 146
Query: 806 HRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE-----YAM 857
H+D+KP NIL + DFGLA L E AGT Y+APE
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFKRDV-- 202
Query: 858 TCRVSDKADVYSYGVVLLELLS 879
+ K D++S GVV+ LL+
Sbjct: 203 ----TFKCDIWSAGVVMYFLLT 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 690 IGNGGFGATYKAEISPG---VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTLIG 745
+G G FG+ + + VAIK L G + + E + + +L +P +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+E + L+ GG L F+ + + + ++ ++ + YL ++ +
Sbjct: 78 VCQAEA-LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFV 132
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GYVAPEYAMTCRVSD 863
HRD+ N+LL + A +SDFGL++ LG +++ T AG + + APE + S
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 864 KADVYSYGVVLLELLS 879
++DV+SYGV + E LS
Sbjct: 193 RSDVWSYGVTMWEALS 208
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 52/197 (26%), Positives = 81/197 (41%), Gaps = 16/197 (8%)
Query: 688 NCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY 746
+G G FG ++ + G A+K++ + F+ + E+ L P +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--VE---ELVACAGLSSPRIVPLYGA 118
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ + L GG+L I + + L YLH + R+LH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTR---RILH 173
Query: 807 RDVKPSNILLDDD-FNAYLSDFGLARLLGPSETHATTG----VAGTFGYVAPEYAMTCRV 861
DVK N+LL D A L DFG A L P + + GT ++APE M
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 862 SDKADVYSYGVVLLELL 878
K D++S ++L +L
Sbjct: 234 DAKVDIWSSCCMMLHML 250
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG------VQQFHAEIKTLGRLRHPNLVT 742
+G+G F K + G A K + R ++ E+ L +RHPN++T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIALDIARALAYLHDQ 799
L ++T++ LI + GG L +F+ ++ + + I + YLH +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA-----TQFLKQILDGVHYLHSK 127
Query: 800 CVPRVLHRDVKPSNILL----DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
R+ H D+KP NI+L + L DFG+A + + GT +VAPE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 856 AMTCRVSDKADVYSYGVVLLELLS 879
+ +AD++S GV+ LLS
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLS 206
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 54/302 (17%), Positives = 90/302 (29%), Gaps = 72/302 (23%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
L+L L PD F L L+ + + + E+P + F LE L LA N
Sbjct: 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARN 137
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
L+ ++P+ I L L + + +P L +
Sbjct: 138 -----------PLR-----------ALPASIA-SLNRLRELSIRACPELTELPEPLASTD 174
Query: 121 ---------QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLA 171
++SL L + +PA + LQNL+ L + + LS ++ + + KL
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232
Query: 172 ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL 231
L L P L+ L +
Sbjct: 233 ELDLRG--------------------------CTALRN-YPPIFGGRAPLKRLILKDCSN 265
Query: 232 EGNFPSNWGACDNLEMLNLGHNFFSGKNLGVL----GPCKNLLFLDLSSNQLTGELAREL 287
P + LE L+L NL L + + + +L +
Sbjct: 266 LLTLPLDIHRLTQLEKLDLRGC----VNLSRLPSLIAQLPANCIILVPPHLQA-QLDQHR 320
Query: 288 PV 289
PV
Sbjct: 321 PV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 38/194 (19%), Positives = 67/194 (34%), Gaps = 17/194 (8%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRM--------CKSLKFLDAS 445
N L + P + NRL L ++ +LP + +L+ L
Sbjct: 136 RNPLR-ALPAS-IASLNRLREL--SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191
Query: 446 GNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSL 505
I +P + L +L +L + + + + + + L+ L L G + P
Sbjct: 192 WTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
Query: 506 GQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVS 565
G L+ L L S +P D+ L L L L ++PS +A + V
Sbjct: 250 GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309
Query: 566 FN---NLSGPLPSS 576
+ L P +
Sbjct: 310 PHLQAQLDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 45/318 (14%), Positives = 89/318 (27%), Gaps = 51/318 (16%)
Query: 16 GILPDSGFHLKSLRVLNL-GFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLK 74
G H L G + S + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALR-PYHDVLSQWQRHYNADRNRWHSAWRQAN-SNNPQ 59
Query: 75 RVYLSFNRLVGSVPSKIGE-KCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLE 133
+ L + + + L+L L P ++ + + + L
Sbjct: 60 IETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 134 ETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS----------NLFDTYE 183
E +P + LE L ++RN L ++P + + ++L L + L T
Sbjct: 118 E-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175
Query: 184 DVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FPSNW 239
+ +L + ++ +P ++++L NL+ L + +
Sbjct: 176 SGEHQGLVNLQS----LRLEWTGIR-SLPASIANLQNLKSLK-----IRNSPLSALGPAI 225
Query: 240 GACDNLEMLNLGHNFFSGKNLGVL----GPCKNLLFLDLSS-NQLTGELARELPV----- 289
LE L+L L G L L L + L LP+
Sbjct: 226 HHLPKLEELDLRGC----TALRNYPPIFGGRAPLKRLILKDCSNLL-----TLPLDIHRL 276
Query: 290 PCMTMFDVSGNALSGSIP 307
+ D+ G +P
Sbjct: 277 TQLEKLDLRGCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 33/185 (17%), Positives = 62/185 (33%), Gaps = 22/185 (11%)
Query: 409 CNRLDSLMVNVSN----NRIAGQLPAEIGRMCKS--LKFLDASGNQIVGPIPRGVGELVS 462
L +S R S + +G + + +
Sbjct: 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA-TADLLEDATQ 80
Query: 463 --LVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNS 520
VAL L + Q P ++ L+++++ L +P ++ Q LE L L+ N
Sbjct: 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNP 138
Query: 521 LSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVST---------LSAFNVSFNNLSG 571
L L P + +L L L + ++P LA+ L + + + +
Sbjct: 139 LRAL-PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS 197
Query: 572 PLPSS 576
LP+S
Sbjct: 198 -LPAS 201
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 54/330 (16%), Positives = 96/330 (29%), Gaps = 48/330 (14%)
Query: 216 SSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNL----GVLGPCK--NL 269
L + + + N + N + +G+ L +L
Sbjct: 30 DVLSQWQRHY----NADRNRWHSAWRQANSNNPQIETR--TGRALKATADLLEDATQPGR 83
Query: 270 LFLDLSSNQLTGELARELPV-----PCMTMFDVSGNALSGSIP-TFSNMVCPPVPYLSRN 323
+ L+L S L + P + + L +P T L+RN
Sbjct: 84 VALELRSVPLP-----QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARN 137
Query: 324 LFESYNPSTAYL-SLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERL 382
+ S A L L L +R + + SG + L
Sbjct: 138 PLRALPASIASLNRL--------RELSIRACPELTELPEPLASTDASGEHQGL----VNL 185
Query: 383 GKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFL 442
Q++ + S P + L SL + N+ ++ L I L+ L
Sbjct: 186 --QSLRL---EWTGIR-SLPAS-IANLQNLKSL--KIRNSPLS-ALGPAIHH-LPKLEEL 234
Query: 443 DASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP 502
D G + P G L L L +P + ++ L+ L L G +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 503 SSLGQLQLLEVLDLSSNSLSGLIPDDLENL 532
S + QL ++ + + + L
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 27/176 (15%), Positives = 50/176 (28%), Gaps = 24/176 (13%)
Query: 434 RMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLS-----WNLMHDQ------------ 476
+ L G+ + P + + + + W +
Sbjct: 9 HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRAL 68
Query: 477 --IPTTLGQ--MKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENL 532
L G L L L P +L L+ + + + L L PD ++
Sbjct: 69 KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL-PDTMQQF 126
Query: 533 RNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGN 588
L L L N L +P+ +A+++ L ++ LP S
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 23/149 (15%), Positives = 41/149 (27%), Gaps = 26/149 (17%)
Query: 450 VGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMK--------------------GLKY 489
+G L + L Q + +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 490 LSLAGNNLTGSIPSSLGQLQL--LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547
+ G L + L L+L S L PD L +L + ++ L
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM- 117
Query: 548 KIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
++P + + L ++ N L LP+S
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-LPAS 145
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 46/396 (11%), Positives = 89/396 (22%), Gaps = 134/396 (33%)
Query: 95 CTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLF----------SNMLEE---------T 135
+ E+L G+ + L + + SN +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 136 IPAELGMLQ--NLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSL 193
L L++ L P S L + +
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA---------------- 113
Query: 194 VDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FPSNWGACDNLEMLN 249
+P+ + L L L N P++ + + L L+
Sbjct: 114 -----------AGLM-ELPDTMQQFAGLETLT-----LARNPLRALPASIASLNRLRELS 156
Query: 250 LGHN---------FFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV-----PCMTMF 295
+ S G NL L L + LP +
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-----SLPASIANLQNLKSL 211
Query: 296 DVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDG 355
+ + LS P ++ L E L L
Sbjct: 212 KIRNSPLSALGPAIHHL---------PKLEE--------LDL------------------ 236
Query: 356 FLAIFHNFGGNNFSGSLPSMPVAPERLGKQT--VYAIVAGDNKLSGSFPGNMFGICNRLD 413
G + P G + I+ + L + P + +L+
Sbjct: 237 --------RGCTALRNY------PPIFGGRAPLKRLILKDCSNLL-TLPLD-IHRLTQLE 280
Query: 414 SLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQI 449
L ++ +LP+ I ++ + + +
Sbjct: 281 KL--DLRGCVNLSRLPSLIAQL-PANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 52/379 (13%), Positives = 92/379 (24%), Gaps = 95/379 (25%)
Query: 139 ELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYE-------DVRYSRGQ 191
E L ++ L + + + + G+
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGR 66
Query: 192 SLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLG 251
+L + D ++ P L L FP +L+ + +
Sbjct: 67 ALKATADLLED-------------ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTID 112
Query: 252 HNFFSGKNLGVL----GPCKNLLFLDLSSNQLTGELARELPV-----PCMTMFDVSGNAL 302
L L L L L+ N L LP + +
Sbjct: 113 AA-----GLMELPDTMQQFAGLETLTLARNPLR-----ALPASIASLNRLRELSIRACPE 162
Query: 303 SGSIP-TFSNMVCPPVP---------YLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRG 352
+P ++ L S S A L
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQN--------------- 207
Query: 353 RDGFLAIFHNFGGNNFS------GSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMF 406
L + S LP + E L + G L ++P F
Sbjct: 208 ----LKSL-KIRNSPLSALGPAIHHLPKL----EEL-------DLRGCTALR-NYPPI-F 249
Query: 407 GICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVAL 466
G L L++ + + LP +I R L+ LD G + +P + +L + +
Sbjct: 250 GGRAPLKRLILK-DCSNLL-TLPLDIHR-LTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306
Query: 467 NLSWNLMH---DQIPTTLG 482
+ +L P
Sbjct: 307 LVPPHLQAQLDQHRPVARP 325
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG-----VQQFHAEIKTLGRLRHPNLVTL 743
IG G F + G A+K + V +F + E L+HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDW--RVLHKIALDIARALAYLHDQCV 801
+ ++S+ +++++ ++ G +L I +R+ + V I AL Y HD
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-- 149
Query: 802 PRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
++HRDVKP +LL ++ L FG+A LG G GT ++APE
Sbjct: 150 -NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTPHFMAPEVVKR 207
Query: 859 CRVSDKADVYSYGVVLLELLS 879
DV+ GV+L LLS
Sbjct: 208 EPYGKPVDVWGCGVILFILLS 228
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY- 746
IG G FG + G VA+K + Q F AE + +LRH NLV L+G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ ++++ Y+ G+L ++++ R + L K +LD+ A+ YL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 312
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVSDK 864
RD+ N+L+ +D A +SDFGL + + G APE + S K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT--GKLPVKWTAPEALREKKFSTK 366
Query: 865 ADVYSYGVVLLELLS 879
+DV+S+G++L E+ S
Sbjct: 367 SDVWSFGILLWEIYS 381
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 54/291 (18%), Positives = 100/291 (34%), Gaps = 30/291 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G ++ G L AIK F V E + L +L H N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 748 ASET--EMFLIYNYLPGGNLENFIQQR-STRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
T LI + P G+L +++ + + + D+ + +L + +
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GI 133
Query: 805 LHRDVKPSNILL----DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE------ 854
+HR++KP NI+ D L+DFG AR L E + + GT Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAV 191
Query: 855 --YAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912
+ D++S GV + F + ++ + K
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGS----LPFRPFEGPRRNKE---VMYKIITGKP 244
Query: 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPASC 963
+ + + V C++ S + + V+ + + C
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSL-SRGLQVLLTPVLANILEADQEKC 294
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 690 IGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G G +G Y+ + VA+K L + V++F E + ++HPNLV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E ++I ++ GNL +++++ + + V VL +A I+ A+ YL + +HRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVSDKAD 866
+ N L+ ++ ++DFGL+RL+ A G F APE + S K+D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKWTAPESLAYNKFSIKSD 194
Query: 867 VYSYGVVLLELLS 879
V+++GV+L E+ +
Sbjct: 195 VWAFGVLLWEIAT 207
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 13/197 (6%)
Query: 690 IGNGGFGATYKAEISPG---VLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLI 744
+G+G FG K VA+K L + AE + +L +P +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G +E+ L+ G L ++QQ R V + + ++ ++ + YL +
Sbjct: 85 GICEAES-WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NF 138
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF--GYVAPEYAMTCRVS 862
+HRD+ N+LL A +SDFGL++ L E + G + + APE + S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 863 DKADVYSYGVVLLELLS 879
K+DV+S+GV++ E S
Sbjct: 199 SKSDVWSFGVLMWEAFS 215
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G G Y+ + A+K L + + EI L RL HPN++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 749 SETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVPRV 804
+ TE+ L+ + GG L + I ++ A D I A+AYLH+ +
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAAD------AVKQILEAVAYLHEN---GI 169
Query: 805 LHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
+HRD+KP N+L D ++DFGL++++ T V GT GY APE C
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPEILRGCAY 227
Query: 862 SDKADVYSYGVVLLELLS 879
+ D++S G++ LL
Sbjct: 228 GPEVDMWSVGIITYILLC 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-31
Identities = 56/198 (28%), Positives = 86/198 (43%), Gaps = 19/198 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G G FG ++ E + G A K + + EI+T+ LRHP LV L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTR-----AVDWRVLHKIALDIARALAYLHDQCVPR 803
+ EM +IY ++ GG L + + AV+ + + L ++H+
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE------YMRQVCKGLCHMHEN---N 275
Query: 804 VLHRDVKPSNILLDDDFNAYL--SDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
+H D+KP NI+ + L DFGL L P ++ GT + APE A V
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKPV 333
Query: 862 SDKADVYSYGVVLLELLS 879
D++S GV+ LLS
Sbjct: 334 GYYTDMWSVGVLSYILLS 351
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-31
Identities = 55/200 (27%), Positives = 84/200 (42%), Gaps = 20/200 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGY 746
+G G F + ++ G A + + Q+ E + L+HPN+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVP 802
+ E +LI++ + GG L I R A I A+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH------CIQQILEAVLHCHQM--- 129
Query: 803 RVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
V+HR++KP N+LL L+DFGLA + E A G AGT GY++PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 860 RVSDKADVYSYGVVLLELLS 879
D+++ GV+L LL
Sbjct: 189 PYGKPVDLWACGVILYILLV 208
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-31
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 679 QATGNFNASNCIGNGGFGATYKA-EISPGVLVAIK----RLAVGRFQGVQQFHAEIKTLG 733
Q G + +G GGFG + G VAIK L+ + EI+ +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL---EIQIMK 67
Query: 734 RLRHPNLVTLI------GYHASETEMFLIYNYLPGGNLENFIQQR-STRAVDWRVLHKIA 786
+L HPN+V+ A L Y GG+L ++ Q + + + +
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAY---LSDFGLARLLGPSETHATTG 843
DI+ AL YLH+ R++HRD+KP NI+L + D G A+ L E
Sbjct: 128 SDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-- 182
Query: 844 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
GT Y+APE + + D +S+G + E ++
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 20/199 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGY 746
+G+G +G + V AIK + + E+ L L HPN++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 747 HASETEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+ +L+ GG L + I R + I + + YLH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-----AVIIKQVLSGVTYLHKH---N 156
Query: 804 VLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
++HRD+KP N+LL + D + DFGL+ + + GT Y+APE + +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VLRKK 213
Query: 861 VSDKADVYSYGVVLLELLS 879
+K DV+S GV+L LL+
Sbjct: 214 YDEKCDVWSIGVILFILLA 232
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 5e-31
Identities = 30/247 (12%), Positives = 65/247 (26%), Gaps = 44/247 (17%)
Query: 669 GVPLSFESVV-QATGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG---VQ 723
+ +S++ Q + G + ++ A+K +G ++
Sbjct: 48 NAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE 107
Query: 724 QFHAEIKTLGRLRHPNLVTLIGYH--------------------ASETEMFLIYNY---- 759
+ H RL + + + + + NY
Sbjct: 108 RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLM 167
Query: 760 -LPGGNLENFIQQRSTRAV-----DWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSN 813
+LE V LH + + R A L + ++H P N
Sbjct: 168 PAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDN 224
Query: 814 ILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM--TCRVSDKADVYSYG 871
+ + D L D +G + Y E+ T + + + G
Sbjct: 225 LFIMPDGRLMLGDVSALWKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 872 VVLLELL 878
+ + +
Sbjct: 281 LSIYRVW 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-31
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG---VQQFHAEIKTLGRLRHPNLVTLIG 745
+G G FG + G A+K ++ + + + E++ L +L HPN++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIALDIARALAYLHDQCVP 802
+ + +L+ GG L + I R S +I + + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-----ARIIRQVLSGITYMHKN--- 145
Query: 803 RVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
+++HRD+KP N+LL D N + DFGL+ S+ GT Y+APE +
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHG 202
Query: 860 RVSDKADVYSYGVVLLELLS 879
+K DV+S GV+L LLS
Sbjct: 203 TYDEKCDVWSTGVILYILLS 222
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG------VQQFHAEIKTLGRLRHPNLVT 742
+G+G F K E S G+ A K + + + ++ E+ L ++ H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIALDIARALAYLHDQ 799
L + + T++ LI + GG L +F+ Q+ S I + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFIKQILDGVNYLHTK 134
Query: 800 CVPRVLHRDVKPSNILL----DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
++ H D+KP NI+L + L DFGLA + + GT +VAPE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEI 189
Query: 856 AMTCRVSDKADVYSYGVVLLELLS 879
+ +AD++S GV+ LLS
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLS 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-31
Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 9/192 (4%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749
+G G FG + VAIK + G +F E K + L H LV L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDV 809
+ +F+I Y+ G L N++++ R + L ++ D+ A+ YL + + LHRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 146
Query: 810 KPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVSDKADV 867
N L++D +SDFGL+R + E ++ G F PE M + S K+D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG--SKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 868 YSYGVVLLELLS 879
+++GV++ E+ S
Sbjct: 205 WAFGVLMWEIYS 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-31
Identities = 68/287 (23%), Positives = 116/287 (40%), Gaps = 32/287 (11%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ NLE L+L GN + I P S +L L L +G N+IT ++ + NL EL L +
Sbjct: 65 LTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNED 120
Query: 61 LVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
++ + ++ + L N + S S + T L +L ++ + + P + N
Sbjct: 121 NISD-ISPLANLTKMYSLNLGANHNL-SDLSPLS-NMTGLNYLTVTESKVKDVTP--IAN 175
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS-N 177
+ SL L N +E+ P L L +L N ++ P + N ++L L + N
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF-- 235
+ + L +++ N AV L L++L + N
Sbjct: 232 KITDLSPL--ANLSQL----TWLEIGTNQISD--INAVKDLTKLKMLN-----VGSNQIS 278
Query: 236 -PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG 281
S L L L +N +++ V+G NL L LS N +T
Sbjct: 279 DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 58/321 (18%), Positives = 112/321 (34%), Gaps = 66/321 (20%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
++ L + G + I +L +L LNL N+IT P S+ V L L + N +
Sbjct: 45 SITKLVVAGEKVASIQGIE--YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI 100
Query: 63 NGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
T + + L+ +YL+ + + S S + T + L+L N+ + + L N
Sbjct: 101 --TDISALQNLTNLRELYLNEDNI--SDISPLA-NLTKMYSLNLGANHNLSDLS-PLSNM 154
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLF 179
+ L + + +++ P + L +L L ++ N + P L + + L
Sbjct: 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV-- 208
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF---P 236
N P V+++ L L + N
Sbjct: 209 -------------------------NQITDITP--VANMTRLNSLK-----IGNNKITDL 236
Query: 237 SNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV----PCM 292
S L L +G N S ++ + L L++ SNQ++ ++ V +
Sbjct: 237 SPLANLSQLTWLEIGTNQIS--DINAVKDLTKLKMLNVGSNQIS-----DISVLNNLSQL 289
Query: 293 TMFDVSGNALSGSIP-TFSNM 312
++ N L +
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGL 310
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-28
Identities = 64/338 (18%), Positives = 125/338 (36%), Gaps = 58/338 (17%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ L+ + ++ L+S+ L + ++ I NLE LNL GN
Sbjct: 21 LAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGN 76
Query: 61 LVNGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
+ P + + +L +Y+ N++ + S + TNL L L+ + + P L N
Sbjct: 77 QITDISPLSNLVKLTNLYIGTNKI--TDISALQ-NLTNLRELYLNEDNISDISP--LANL 131
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLF 179
++ SL L +N + + L + L L V+ + + P + N + L L L+
Sbjct: 132 TKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY-- 186
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNW 239
N E ++SL +L A + +
Sbjct: 187 -------------------------NQIED--ISPLASLTSLHYFTAYVNQITD--ITPV 217
Query: 240 GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT-----GELARELPVPCMTM 294
L L +G+N + +L L L +L++ +NQ++ +L + + M
Sbjct: 218 ANMTRLNSLKIGNNKIT--DLSPLANLSQLTWLEIGTNQISDINAVKDLTK------LKM 269
Query: 295 FDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPST 332
+V N +S I +N+ +L+ N + +
Sbjct: 270 LNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 51/316 (16%), Positives = 105/316 (33%), Gaps = 60/316 (18%)
Query: 4 LEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVN 63
L +N I PD+ L L +T + + ++ +L +AG V
Sbjct: 2 AATLATLPAPINQIFPDAD--LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 64 GTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
++ L+ + L+ N++ P L +L + N + +L N
Sbjct: 58 -SIQGIEYLTNLEYLNLNGNQITDISPL---SNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 122 VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDT 181
+R L L + + + P L L + L++ N + L N + L L ++
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTE---- 164
Query: 182 YEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN---FPSN 238
+ + +++L +L L L N S
Sbjct: 165 -----------------------SKVKD--VTPIANLTDLYSLS-----LNYNQIEDISP 194
Query: 239 WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG--ELARELPVPCMTMFD 296
+ +L N + ++ + L L + +N++T LA + +T +
Sbjct: 195 LASLTSLHYFTAYVNQIT--DITPVANMTRLNSLKIGNNKITDLSPLAN---LSQLTWLE 249
Query: 297 VSGNALSGSIPTFSNM 312
+ N +S I ++
Sbjct: 250 IGTNQIS-DINAVKDL 264
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 72/457 (15%), Positives = 138/457 (30%), Gaps = 124/457 (27%)
Query: 124 SLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYE 183
+L + + P L + + S++ + + LV++
Sbjct: 4 TLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAG------ 53
Query: 184 DVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACD 243
V+S+ +
Sbjct: 54 -----------------EK------------VASIQGI------------------EYLT 66
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT-----GELARELPVPCMTMFDVS 298
NLE LNL N + ++ L L L + +N++T L + ++
Sbjct: 67 NLEYLNLNGNQIT--DISPLSNLVKLTNLYIGTNKITDISALQNLTN------LRELYLN 118
Query: 299 GNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLA 358
+ +S I +N+ + +L N + + LS + + L +L
Sbjct: 119 EDNIS-DISPLANL-----TKM-YSLNLGANHNLSDLSPLSNMTG------LN----YL- 160
Query: 359 IFHNFGGNNFS-----GSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLD 413
+ +L + L N++ P L
Sbjct: 161 ---TVTESKVKDVTPIANLTDL----YSLS--------LNYNQIEDISP---LASLTSLH 202
Query: 414 SLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLM 473
N+I P + M L L N+I P + L L L + N +
Sbjct: 203 YF--TAYVNQITDITP--VANM-TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
Query: 474 HDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLR 533
D + + LK L++ N ++ S L L L L L++N L + + L
Sbjct: 256 SD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
Query: 534 NLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
NLT L L+ N ++ P LA++S + + + + +
Sbjct: 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 70/372 (18%), Positives = 140/372 (37%), Gaps = 57/372 (15%)
Query: 213 EAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272
+ L +A++ +++ L + + ++ + NL +L
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA--SIQGIEYLTNLEYL 71
Query: 273 DLSSNQLTG--ELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNP 330
+L+ NQ+T L+ + +T + N ++ I N+ YL+ + +P
Sbjct: 72 NLNGNQITDISPLSN---LVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP 127
Query: 331 STAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYA 389
+ L N G N+ L + + +
Sbjct: 128 LANLTKM--------YSL-------------NLGANHNLSDLSPL----SNMTGLNYLTV 162
Query: 390 IVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQI 449
++K+ P L SL +++ N+I P + + SL + A NQI
Sbjct: 163 ---TESKVKDVTP---IANLTDLYSL--SLNYNQIEDISP--LASL-TSLHYFTAYVNQI 211
Query: 450 VGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQ 509
P V + L +L + N + D P L + L +L + N ++ +++ L
Sbjct: 212 TDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLT 265
Query: 510 LLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL 569
L++L++ SN +S + L NL L L LNNN+L + + ++ L+ +S N++
Sbjct: 266 KLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
Query: 570 SG--PLPSSKNL 579
+ PL S +
Sbjct: 324 TDIRPLASLSKM 335
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 12/178 (6%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ +L L L N + I P + L SL N+IT P ++ L L + N
Sbjct: 176 LTDLYSLSLNYNQIEDISPLAS--LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231
Query: 61 LVNGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
+ P + +L + + N++ S + + T L+ L++ N + L N
Sbjct: 232 KITDLSPLANLSQLTWLEIGTNQI--SDINAVK-DLTKLKMLNVGSNQISD--ISVLNNL 286
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
Q+ SL L +N L +G L NL L +S+N ++ P L + SK+ +N
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-18
Identities = 32/159 (20%), Positives = 62/159 (38%), Gaps = 12/159 (7%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ +L N + I P + + L L +G N+IT P ++ L L + N
Sbjct: 198 LTSLHYFTAYVNQITDITPVAN--MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253
Query: 61 LVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
++ + +LK + + N++ S S + + L L L+ N L +G
Sbjct: 254 QIS-DINAVKDLTKLKMLNVGSNQI--SDISVLN-NLSQLNSLFLNNNQLGNEDMEVIGG 309
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLS 157
+ +L L N + + P L L ++ D + +
Sbjct: 310 LTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 35/143 (24%), Positives = 61/143 (42%), Gaps = 12/143 (8%)
Query: 439 LKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLT 498
L I P +L + L + D T +++ + L +AG +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 499 GSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVST 558
SI + L LE L+L+ N ++ + P L NL LT L + NK++ S L N++
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 559 LSAFNVSFNNLSG--PLPSSKNL 579
L ++ +N+S PL + +
Sbjct: 112 LRELYLNEDNISDISPLANLTKM 134
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-07
Identities = 18/96 (18%), Positives = 38/96 (39%), Gaps = 8/96 (8%)
Query: 486 GLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545
G L+ + P L L S++ ++ E L ++T L++ K+
Sbjct: 1 GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 546 SGKIPSGLANVSTLSAFNVSFNNLSG--PLPSSKNL 579
+ G+ ++ L N++ N ++ PL + L
Sbjct: 57 AS--IQGIEYLTNLEYLNLNGNQITDISPLSNLVKL 90
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG------VQQFHAEIKTLGRLRHPNLVT 742
+G+G F K E S G+ A K + R + + E+ L ++HPN++T
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHD 798
L + ++T++ LI + GG L +F+ ++ + A + I + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYLHS 132
Query: 799 QCVPRVLHRDVKPSNILL----DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE 854
++ H D+KP NI+L + DFGLA + + GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPE 187
Query: 855 YAMTCRVSDKADVYSYGVVLLELLS 879
+ +AD++S GV+ LLS
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 48/341 (14%), Positives = 104/341 (30%), Gaps = 55/341 (16%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
++ + + L L +++ L+L N ++ A + F LE LNL+ N++
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 63 NGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
L+ + L+ N + ++ ++E L + N + + S G
Sbjct: 71 Y-ETLDLESLSTLRTLDLNNNYV-----QELLV-GPSIETLHAANNNI-SRVSCSRGQ-- 120
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSG-SIPVDLGNCSKLAILVLSNLF 179
+++ L +N + + G ++ LD+ N + + + L L L
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY-- 178
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----F 235
NF + V L+ L L N
Sbjct: 179 -------------------------NFIY-DVKGQV-VFAKLKTLD-----LSSNKLAFM 206
Query: 236 PSNWGACDNLEMLNLGHNFFSGKNL-GVLGPCKNLLFLDLSSNQLTGELARELPVPCMTM 294
+ + + ++L +N + L +NL DL N R+ +
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV--LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 295 FDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYL 335
V+ + + + C + + +
Sbjct: 265 QTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 36/169 (21%), Positives = 66/169 (39%), Gaps = 16/169 (9%)
Query: 410 NRLDSL-------MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVS 462
N + L ++ +NN I+ ++ G+ K + + N+I G
Sbjct: 90 NYVQELLVGPSIETLHAANNNIS-RVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSR 145
Query: 463 LVALNLSWN-LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSL 521
+ L+L N + L++L+L N + + + L+ LDLSSN L
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203
Query: 522 SGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+ + + ++ +T + L NNKL I L L F++ N
Sbjct: 204 AF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 36/180 (20%), Positives = 66/180 (36%), Gaps = 15/180 (8%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ L LDL N + +L S+ L+ N I+ + S + + LA N
Sbjct: 79 LSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANN 130
Query: 61 LVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
+ G R++ + L N + +++ LEHL+L N++ + +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV- 188
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
++++L L SN L + E + + + N L I L L L
Sbjct: 189 VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 36/178 (20%), Positives = 70/178 (39%), Gaps = 17/178 (9%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N LS +L+ L N+S+N + ++ + +L+ LD + N +
Sbjct: 43 GNPLS-QISAADLAPFTKLELL--NLSSNVLYE--TLDLESL-STLRTLDLNNNYV---- 92
Query: 454 PRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEV 513
+ + S+ L+ + N + + + GQ G K + LA N +T G ++
Sbjct: 93 -QELLVGPSIETLHAANNNISR-VSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 514 LDLSSNSLSGL-IPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
LDL N + + + + L L L N + + + L ++S N L+
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 33/161 (20%), Positives = 64/161 (39%), Gaps = 13/161 (8%)
Query: 410 NRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLS 469
NR V+++ + Q A + + ++K LD SGN + + L LNLS
Sbjct: 10 NRYKIE--KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 470 WNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDL 529
N++++ L + L+ L L N + L +E L ++N++S +
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV---SC 116
Query: 530 ENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+ + L NNK++ S + ++ N +
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 37/172 (21%), Positives = 60/172 (34%), Gaps = 8/172 (4%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
+NK++ G +R+ L ++ N I AE+ +L+ L+ N I
Sbjct: 128 ANNKIT-MLRDLDEGCRSRVQYL--DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD- 183
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+ V L L+LS N + + G+ ++SL N L I +L Q LE
Sbjct: 184 VKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 513 VLDLSSNSLSGLIPDDL-ENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFN 563
DL N D + + + K V TL +
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 27/140 (19%), Positives = 51/140 (36%), Gaps = 10/140 (7%)
Query: 431 EIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYL 490
EI + K + + + + ++ L+LS N + L L+ L
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 491 SLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP 550
+L+ N L L L L LDL++N + +L ++ L NN +S
Sbjct: 64 NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSC 116
Query: 551 SGLANVSTLSAFNVSFNNLS 570
S + ++ N ++
Sbjct: 117 SRGQGKKNI---YLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 42/224 (18%), Positives = 79/224 (35%), Gaps = 27/224 (12%)
Query: 96 TNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNS 155
+ ++ + L + + + V+ L L N L + A+L LE+L++S N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 156 LSGSIPVDLGNCSKLAILVLS-NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEA 214
L DL + S L L L+ N G S+ ++ N +
Sbjct: 70 LY-ETL-DLESLSTLRTLDLNNNYVQE-----LLVGPSIET----LHAANNNIS-RVSC- 116
Query: 215 VSSLPNLRILWAPRATLEGNF-----PSNWGACDNLEMLNLGHNFFSGKNLG-VLGPCKN 268
S + ++ L N + G ++ L+L N N +
Sbjct: 117 -SRGQGKKNIY-----LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 269 LLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNM 312
L L+L N + ++ ++ + D+S N L+ P F +
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAFMGPEFQSA 213
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 53/342 (15%), Positives = 112/342 (32%), Gaps = 45/342 (13%)
Query: 210 GIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNL 269
I E + +I ++L+ S + N++ L+L N S + L P L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 270 LFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYN 329
L+LSSN L E + + D++ N + + ++ + + N +
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIE---TLHAANNNISRVS 115
Query: 330 PSTA------YLS---LFAKKSQAGTPLP-LRGRDGFLAIFHN----FGGNNFSGSLPSM 375
S YL+ + + ++ +L + N + S ++
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQ----YLDLKLNEIDTVNFAELAASSDTL 171
Query: 376 PVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRM 435
E L N + G + +L +L ++S+N++A + E
Sbjct: 172 ----EHL--------NLQYNFIY-DVKGQVV--FAKLKTL--DLSSNKLA-FMGPEFQS- 212
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWN-LMHDQIPTTLGQMKGLKYLSLAG 494
+ ++ N++V I + + +L +L N + + + ++ ++
Sbjct: 213 AAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 495 N-NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNL 535
LTG L L D L L +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHH 313
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 3/103 (2%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
I K + ++L ++ S ++ LDLS N LS + DL L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 537 VLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
+L L++N L + L ++STL +++ N + L ++
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQE-LLVGPSI 101
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 22/160 (13%), Positives = 49/160 (30%), Gaps = 14/160 (8%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
LE L+L+ N + + L+ L+L N++ + F + ++L N
Sbjct: 168 SDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 61 LVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
+ + + L+ L N K ++ + + G
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLS 157
V +L + E +PA ++ + +
Sbjct: 284 T---VPTLGHYGAYCCEDLPAPFA----DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 17/80 (21%), Positives = 33/80 (41%), Gaps = 1/80 (1%)
Query: 500 SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTL 559
+I ++ ++ +SL + ++ N+ L L+ N LS + LA + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 560 SAFNVSFNNLSGPLPSSKNL 579
N+S N L ++L
Sbjct: 61 ELLNLSSNVLYE-TLDLESL 79
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 31/170 (18%), Positives = 59/170 (34%), Gaps = 37/170 (21%)
Query: 111 GIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKL 170
I N + + + + L++ + + N++ LD+S N LS DL +KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 171 AILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT 230
+L LS+ L + + L LR L
Sbjct: 61 ELLNLSS-------------NVLYETLDLES----------------LSTLRTLD----- 86
Query: 231 LEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
L N+ ++E L+ +N S + + + L++N++T
Sbjct: 87 LNNNYVQELLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKIT 133
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 690 IGNGGFGATYKAEISPG-----VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTL 743
+G+G FG YK P + VAIK L + E + + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+G + T + LI +P G L +++++ + + L + IA+ + YL D+ R
Sbjct: 83 LGICLTST-VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYVAPEYAMTCRVS 862
++HRD+ N+L+ + ++DFGLA+LLG E ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 863 DKADVYSYGVVLLELLS 879
++DV+SYGV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIK--------RLAVGRFQGVQQ-FHAEIKTLGRL-RHP 738
+G G + A+K + Q +++ E+ L ++ HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALA 794
N++ L + + T FL+++ + G L +++ ++ T I + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK------IMRALLEVIC 138
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE 854
LH ++HRD+KP NILLDDD N L+DFG + L P E V GT Y+APE
Sbjct: 139 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPE 193
Query: 855 ------YAMTCRVSDKADVYSYGVVLLELLS 879
+ D++S GV++ LL+
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG------VQQFHAEIKTLGRLRHPNLVT 742
+G+G F K E S G+ A K + + + ++ E+ L ++ HPN++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIALDIARALAYLHDQ 799
L + + T++ LI + GG L +F+ Q+ S I + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFIKQILDGVNYLHTK 134
Query: 800 CVPRVLHRDVKPSNILL----DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
++ H D+KP NI+L + L DFGLA + + GT +VAPE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEI 189
Query: 856 AMTCRVSDKADVYSYGVVLLELLS 879
+ +AD++S GV+ LLS
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLS 213
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--------EIKTLGRLR-HPN 739
IG G + + G A+K + V + + E L ++ HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRS------TRAVDWRVLHKIALDIARAL 793
++TLI + S + MFL+++ + G L +++ ++ TR I + A+
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR--------SIMRSLLEAV 213
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853
++LH ++HRD+KP NILLDD+ LSDFG + L P E + GT GY+AP
Sbjct: 214 SFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAP 268
Query: 854 E------YAMTCRVSDKADVYSYGVVLLELLS 879
E + D+++ GV+L LL+
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 688 NCIGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVT 742
IG+G G + V VAIK L G + ++ F +E +G+ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L G ++ Y+ G+L+ F++ + L + + + YL D
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDL--- 170
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCR 860
+HRD+ N+L+D + +SDFGL+R+L A T G APE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 861 VSDKADVYSYGVVLLELLS 879
S +DV+S+GVV+ E+L+
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 20/199 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLIGY 746
+G G FG K + A+K + + E++ L +L HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 747 HASETEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+ +++ GG L + I +R S +I + + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-----ARIIKQVFSGITYMHKH---N 141
Query: 804 VLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
++HRD+KP NILL + D + + DFGL+ + GT Y+APE +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGT 198
Query: 861 VSDKADVYSYGVVLLELLS 879
+K DV+S GV+L LLS
Sbjct: 199 YDEKCDVWSAGVILYILLS 217
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 32/215 (14%), Positives = 62/215 (28%), Gaps = 24/215 (11%)
Query: 688 NCIGNGGFGATYKAE------ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLV 741
+ +G G F Y+A +K ++ L +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIALDIARALAYLHD 798
H + L+ G L N I + + ++ A+ + + +HD
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 799 QCVPRVLHRDVKPSNILL-----------DDDFNAYLSDFGLARLLGP-SETHATTGVAG 846
++H D+KP N +L D L D G + + + T
Sbjct: 191 C---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 847 TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDK 881
T G+ E + + D + + +L
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 31/210 (14%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLA-------------VGRFQGVQQFHAEIKTLGRL 735
+G+G +G E + AIK + + ++ + EI L L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRST---RAVDWRVLHKIALDIARA 792
HPN++ L + +L+ + GG L I R I I
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-----ANIMKQILSG 158
Query: 793 LAYLHDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFG 849
+ YLH ++HRD+KP NILL + N + DFGL+ GT
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAY 213
Query: 850 YVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
Y+APE + + ++K DV+S GV++ LL
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLC 242
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 44/222 (19%), Positives = 89/222 (40%), Gaps = 31/222 (13%)
Query: 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIK-----------------RLAVGRFQGVQQ 724
++ + G F E A+K +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 725 FHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQR------STRAVD 778
F E++ + +++ +T G + E+++IY Y+ ++ F + T +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 779 WRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838
+V+ I + + +Y+H++ + HRDVKPSNIL+D + LSDFG + + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 839 HATTGVAGTFGYVAPEYAMTCRVSD--KADVYSYGVVLLELL 878
+ GT+ ++ PE+ + K D++S G+ L +
Sbjct: 208 K-GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRH-PNLVTLIG 745
+G G F + S G A K L R + EI L + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ + +E+ LI Y GG + + V + ++ I + YLH ++
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIV 153
Query: 806 HRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
H D+KP NILL + + DFG++R +G + + GT Y+APE ++
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNYDPIT 211
Query: 863 DKADVYSYGVVLLELLS 879
D+++ G++ LL+
Sbjct: 212 TATDMWNIGIIAYMLLT 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-30
Identities = 57/241 (23%), Positives = 89/241 (36%), Gaps = 54/241 (22%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIK-----RLAVGRFQGVQQFHAEIKTLGRLRHPNLVTL 743
IG G +G A E + AIK ++ + V++ E++ + +L HPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH-------------------- 783
+ E + L+ GG+L + + + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 784 ------------------KIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL- 824
I I AL YLH+Q + HRD+KP N L + + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 825 -SDFGLARLLG---PSETHATTGVAGTFGYVAPE--YAMTCRVSDKADVYSYGVVLLELL 878
DFGL++ E + T AGT +VAPE K D +S GV+L LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 879 S 879
Sbjct: 271 M 271
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-30
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 690 IGNGGFGATYKAEISPG---VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTLIG 745
+G G FG+ + + VAIK L G + + E + + +L +P +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+E + L+ GG L F+ + + + ++ ++ + YL ++ +
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVSD 863
HR++ N+LL + A +SDFGL++ LG +++ T AG + APE + S
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 864 KADVYSYGVVLLELLS 879
++DV+SYGV + E LS
Sbjct: 519 RSDVWSYGVTMWEALS 534
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH-A 748
IG G FG + G VA+K + Q F AE + +LRH NLV L+G
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+ ++++ Y+ G+L ++++ R + L K +LD+ A+ YL +HRD
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 142
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVSDKAD 866
+ N+L+ +D A +SDFGL + + G APE + S K+D
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK----EASSTQDT--GKLPVKWTAPEALREKKFSTKSD 196
Query: 867 VYSYGVVLLELLS 879
V+S+G++L E+ S
Sbjct: 197 VWSFGILLWEIYS 209
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 18/199 (9%)
Query: 690 IGNGGFG----ATYKAEISPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLI 744
+G G FG Y + VA+K ++F +E + L HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G E ++I P G L +++++ + L +L I +A+AYL
Sbjct: 80 GI-IEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESI---NC 134
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG----VAGTFGYVAPEYAMTCR 860
+HRD+ NIL+ L DFGL+R + + + + + +PE R
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESINFRR 190
Query: 861 VSDKADVYSYGVVLLELLS 879
+ +DV+ + V + E+LS
Sbjct: 191 FTTASDVWMFAVCMWEILS 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLA--------VGRFQGVQQFHAEIKTLGRLRHPNL 740
+G+G G A E VAI+ ++ EI+ L +L HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRS------TRAVDWRVLHKIALDIARALA 794
+ + + + +++ + GG L + + + + A+
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--------LYFYQMLLAVQ 253
Query: 795 YLHDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851
YLH+ ++HRD+KP N+LL ++D ++DFG +++LG ET + GT Y+
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYL 308
Query: 852 APE---YAMTCRVSDKADVYSYGVVLLELLS 879
APE T + D +S GV+L LS
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLS 339
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG--------VQQFHAEIKTLGRLRHPNL 740
+G+G G A E VAIK ++ +F EI+ L +L HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRS------TRAVDWRVLHKIALDIARALA 794
+ + + +E + +++ + GG L + + + + A+
Sbjct: 78 IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCK--------LYFYQMLLAVQ 128
Query: 795 YLHDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851
YLH+ ++HRD+KP N+LL ++D ++DFG +++LG ET + GT Y+
Sbjct: 129 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYL 183
Query: 852 APE---YAMTCRVSDKADVYSYGVVLLELLS 879
APE T + D +S GV+L LS
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLS 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 690 IGNGGFGATYKAEISPG-----VLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTL 743
+G+G FG YK P + VAIK L + E + + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+G + T + LI +P G L +++++ + + L + IA+ + YL D+ R
Sbjct: 83 LGICLTST-VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYVAPEYAMTCRVS 862
++HRD+ N+L+ + ++DFGLA+LLG E ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 863 DKADVYSYGVVLLELLS 879
++DV+SYGV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 9e-29
Identities = 51/192 (26%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 688 NCIGNGGFGATYKAEISP-GVLVAIKRLAV-GRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+ +G G G +K P G+++A K + + + Q E++ L P +V G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
S+ E+ + ++ GG+L+ +++ + ++L K+++ + + L YL ++ +++
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH--KIM 154
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
HRDVKPSNIL++ L DFG++ L ++ A + GT Y++PE S ++
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTHYSVQS 211
Query: 866 DVYSYGVVLLEL 877
D++S G+ L+E+
Sbjct: 212 DIWSMGLSLVEM 223
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 690 IGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTLI 744
+G G FG K + VAIK L VG + ++ F E +G+ HPN++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G + ++ Y+ G+L++F+++ + L + IA + YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GY 168
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRVS 862
+HRD+ NIL++ + +SDFGL R+L A T G +PE + +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 863 DKADVYSYGVVLLELLS 879
+DV+SYG+VL E++S
Sbjct: 229 SASDVWSYGIVLWEVMS 245
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 1e-28
Identities = 38/251 (15%), Positives = 76/251 (30%), Gaps = 44/251 (17%)
Query: 669 GVPLSFESVV-QATGNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG---VQ 723
G P ES + + +G A +A G + ++
Sbjct: 64 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123
Query: 724 QFHAEIKTLGRLR----------------------HPNLVTLIGYHASETEMFLIYNYL- 760
Q E+ L LR P +I E +M+++ +
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 761 ---PGGNLENFIQQ-----RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPS 812
NL+ F + + +++ ++ L + R LA LH ++H ++P
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPV 240
Query: 813 NILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE-----YAMTCRVSDKADV 867
+I+LD +L+ F G S A ++ D
Sbjct: 241 DIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDT 300
Query: 868 YSYGVVLLELL 878
++ G+ + +
Sbjct: 301 WTLGLAIYWIW 311
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 690 IGNGGFGATYKAEISPG-----VLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTL 743
+G+G FG +K P + V IK + Q Q + +G L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+G + + L+ YLP G+L + ++Q + ++L + IA+ + YL +
Sbjct: 81 LGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEH---G 135
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYVAPEYAMTCRVS 862
++HR++ N+LL ++DFG+A LL P + A T ++A E + +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 863 DKADVYSYGVVLLELLS 879
++DV+SYGV + EL++
Sbjct: 196 HQSDVWSYGVTVWELMT 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 690 IGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLVTLI 744
IG G FG Y + +P + VAIK V++ F E T+ + HP++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G +++I G L +F+Q R +D L A ++ ALAYL + R
Sbjct: 83 GVITENP-VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESK---RF 137
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
+HRD+ N+L+ + L DFGL+R + S + + ++APE R +
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 865 ADVYSYGVVLLELLS 879
+DV+ +GV + E+L
Sbjct: 198 SDVWMFGVCMWEILM 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 28/227 (12%)
Query: 667 EIGVPLSFESVVQATGNFNA----SNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG 721
+GV + + + + F IG G + + + + A+K + +
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP 62
Query: 722 VQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRST----RA 776
+ EI+ L R +HPN++TL + ++++ + GG L + I ++ A
Sbjct: 63 TE----EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118
Query: 777 VDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL-DDDFNAY---LSDFGLARL 832
+ I + + YLH Q V+HRD+KPSNIL D+ N + DFG A+
Sbjct: 119 SA------VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 833 LGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
L T T +VAPE D++S GV+L +L+
Sbjct: 170 LRAENGLLMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 34/210 (16%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQ----GVQQFHAEIKTLGRLRHPNLVTL- 743
+G G +G + A+K L + + G EI+ L RLRH N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 744 -IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR--------ALA 794
+ Y+ + +M+++ Y G E D + + A L
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEML---------DSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL---GPSETHATTGVAGTFGYV 851
YLH Q ++H+D+KP N+LL +S G+A L +T T+ G+ +
Sbjct: 124 YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQ 178
Query: 852 APEYAMTCRVSD--KADVYSYGVVLLELLS 879
PE A K D++S GV L + +
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 38/259 (14%), Positives = 79/259 (30%), Gaps = 57/259 (22%)
Query: 669 GVPLSFESVV-QATGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG---VQ 723
G P ES + + +G A +A + G + ++
Sbjct: 59 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 724 QFHAEIKTLGRLR-------------------------HPNLVTLIGYHASETEM--FLI 756
Q E+ L LR ++ + + F +
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 757 YNYLPGGNLENFIQ-----QRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP 811
Y NL+ F + + +++ ++ L + R LA LH ++H ++P
Sbjct: 179 Y-PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRP 234
Query: 812 SNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT-----------CR 860
+I+LD +L+ F G + + G+ PE
Sbjct: 235 VDIVLDQRGGVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTL 289
Query: 861 VSDKADVYSYGVVLLELLS 879
++ D ++ G+V+ +
Sbjct: 290 MTFSFDAWALGLVIYWIWC 308
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 34/205 (16%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYH 747
+G G F K A+K ++ Q+ EI L HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVPR 803
+ FL+ L GG L I+++ A I + A++++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY------IMRKLVSAVSHMHDV---G 126
Query: 804 VLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE------ 854
V+HRD+KP N+L +D+ + DFG ARL P + T Y APE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLHYAAPELLNQNG 185
Query: 855 YAMTCRVSDKADVYSYGVVLLELLS 879
Y +C D++S GV+L +LS
Sbjct: 186 YDESC------DLWSLGVILYTMLS 204
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 52/195 (26%), Positives = 100/195 (51%), Gaps = 8/195 (4%)
Query: 684 FNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
+ IG G G Y A +++ G VAI+++ + + + EI + ++PN+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
+ + E++++ YL GG+L + + + +D + + + +AL +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN--- 135
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
+V+HRD+K NILL D + L+DFG + P ++ +T + GT ++APE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 194
Query: 863 DKADVYSYGVVLLEL 877
K D++S G++ +E+
Sbjct: 195 PKVDIWSLGIMAIEM 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 690 IGNGGFGATYKAEISPG----VLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLI 744
IG G FG Y + + A+K L V QF E + HPN+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 745 GY-HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ-CVP 802
G SE ++ Y+ G+L NFI+ + + L L +A+ + YL + V
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFV- 150
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV---APEYAMTC 859
HRD+ N +LD+ F ++DFGLAR + E ++ G V A E T
Sbjct: 151 ---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 860 RVSDKADVYSYGVVLLELLS 879
+ + K+DV+S+GV+L EL++
Sbjct: 208 KFTTKSDVWSFGVLLWELMT 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 681 TGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAV-GRFQGVQQFHAEIKTLGRLRHP 738
F+ +G G +G+ YKA G +VAIK++ V Q + + EI + + P
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK---EISIMQQCDSP 84
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTR------AVDWRVLHKIALDIARA 792
++V G + T+++++ Y G++ + I+ R+ A I +
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-------ILQSTLKG 137
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
L YLH R +HRD+K NILL+ + +A L+DFG+A L + T + GT ++A
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMA 193
Query: 853 PEYAMTCRVSDKADVYSYGVVLLEL 877
PE + AD++S G+ +E+
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEM 218
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 41/213 (19%), Positives = 79/213 (37%), Gaps = 38/213 (17%)
Query: 690 IGNGGFGATYKAE--------ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLV 741
+G G F +K V +K L + F + +L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
G E L+ ++ G+L+ ++++ ++ ++A +A A+ +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEEN-- 132
Query: 802 PRVLHRDVKPSNILLDDDFNAY--------LSDFGLARLLGPSETHATTGVAGTFGY--- 850
++H +V NILL + + LSD G++ + P +
Sbjct: 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQER 180
Query: 851 ---VAPEYAMTCRV-SDKADVYSYGVVLLELLS 879
V PE + + D +S+G L E+ S
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 45/219 (20%), Positives = 78/219 (35%), Gaps = 34/219 (15%)
Query: 689 CIGNGGFGATYKA-EISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRL-RHPNLVTLI 744
IG+G FG+ +K + G + AIKR Q E+ L +H ++V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
A + M + Y GG+L + I + R L + L + R L Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--- 134
Query: 803 RVLHRDVKPSNILLDDDFNAY-------------------LSDFGLARLLGPSETHATTG 843
++H D+KPSNI + + D G + +
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV----- 189
Query: 844 VAGTFGYVAPE-YAMTCRVSDKADVYSYGVVLLELLSDK 881
G ++A E KAD+++ + ++ +
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 689 CIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGY 746
IG G FG +K + +VAIK + + + ++ EI L + P + G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ +T++++I YL GG+ + ++ +D + I +I + L YLH + + +H
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE---KKIH 142
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
RD+K +N+LL + L+DFG+A L ++ T GT ++APE KAD
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKAD 201
Query: 867 VYSYGVVLLEL 877
++S G+ +EL
Sbjct: 202 IWSLGITAIEL 212
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 42/204 (20%), Positives = 76/204 (37%), Gaps = 18/204 (8%)
Query: 688 NCIGNG--GFGATYKA-EISPGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVT 742
IG G A G V ++R+ + V E+ HPN+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
++ E++++ +++ G+ ++ I ++ + I + +AL Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM--- 147
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV------APEYA 856
+HR VK S+IL+ D YLS + V +PE
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE-V 206
Query: 857 MTCRVS---DKADVYSYGVVLLEL 877
+ + K+D+YS G+ EL
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACEL 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-27
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 690 IGNGGFG----ATYKAEISPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLI 744
IG G FG Y + +P + VAIK ++F E T+ + HP++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G +E +++I G L +F+Q R +D L A ++ ALAYL + R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESK---RF 512
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDK 864
+HRD+ N+L+ + L DFGL+R + S + + ++APE R +
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 865 ADVYSYGVVLLELLS 879
+DV+ +GV + E+L
Sbjct: 573 SDVWMFGVCMWEILM 587
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYH 747
+G G + A+K + + E++ L + + H N++ LI +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVPR 803
E +L++ + GG++ + I +R A + D+A AL +LH++
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV------VVQDVASALDFLHNK---G 131
Query: 804 VLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHAT------TGVAGTFGYVAPE 854
+ HRD+KP NIL + + DF L + + + G+ Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 855 ----YAMTCRVSDKA-DVYSYGVVLLELLS 879
++ + DK D++S GV+L LLS
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLS 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 690 IGNGGFGATYKA-----EISPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTL 743
IG G FG YK V VAIK L G + F E +G+ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
G + M +I Y+ G L+ F++++ L + IA + YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANM---N 167
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY--VAPEYAMTCRV 861
+HRD+ NIL++ + +SDFGL+R+L T G APE +
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 862 SDKADVYSYGVVLLELLS 879
+ +DV+S+G+V+ E+++
Sbjct: 228 TSASDVWSFGIVMWEVMT 245
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 54/236 (22%), Positives = 102/236 (43%), Gaps = 11/236 (4%)
Query: 646 RKWNPQSKVMGSTRKEVTIFTEIGVPLSFESVVQA---TGNFNASNCIGNGGFGATYKA- 701
+ + + + T + VV ++ IG G G A
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 702 EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761
E G VA+K + + + Q + E+ + +H N+V + + E++++ +L
Sbjct: 66 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125
Query: 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN 821
GG L + + Q ++ + + + +ALAYLH Q V+HRD+K +ILL D
Sbjct: 126 GGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGR 179
Query: 822 AYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLEL 877
LSDFG + + + GT ++APE + + D++S G++++E+
Sbjct: 180 VKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 684 FNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
+ +G+G FG YKA G L A K + + ++ + EI+ L HP +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L+G + + +++++ + PGG ++ + + R + + + + AL +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
R++HRD+K N+L+ + + L+DFG++ + + + GT ++APE M +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195
Query: 863 D-----KADVYSYGVVLLEL 877
D KAD++S G+ L+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 15/168 (8%)
Query: 723 QQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAV-DWRV 781
+I+ + N V + + + +++ NL++++ +R + + V
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165
Query: 782 LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841
I + IA A+ +LH + ++HRD+KPSNI D + DFGL + E T
Sbjct: 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 842 -----------TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELL 878
TG GT Y++PE S K D++S G++L ELL
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 18/59 (30%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 689 CIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGV-QQFHAEIKTLGRLRHPNLVTLIG 745
C+G GGFG ++A+ AIKR+ + + ++ E+K L +L HP +V
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 45/211 (21%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 690 IGNGGFGATYKAEI----SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG+ +A++ V VA+K L +++F E + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 744 IG------YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV----LHKIALDIARAL 793
+G +I ++ G+L F+ + + L + +DIA +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV-- 851
YL + +HRD+ N +L +D ++DFGL+R + + + G +
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKLPV 203
Query: 852 ---APEYAMTCRVSDKADVYSYGVVLLELLS 879
A E + +DV+++GV + E+++
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 689 CIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGY 746
IG+G A VAIKR+ + + Q + + EI+ + + HPN+V+
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVL---HKIAL---DIARALAYLHDQC 800
+ E++L+ L GG++ + I+ + + IA ++ L YLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF-G---YVAPEYA 856
+HRDVK NILL +D + ++DFG++ L V TF G ++APE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 857 MTCRVSD-KADVYSYGVVLLEL 877
R D KAD++S+G+ +EL
Sbjct: 199 EQVRGYDFKADIWSFGITAIEL 220
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 690 IGNGGFG----ATYKAEISPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLI 744
IG G FG Y + + AIK L+ Q V+ F E + L HPN++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 745 GY-HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ-CVP 802
G E ++ Y+ G+L FI+ R + L L +AR + YL +Q V
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFV- 146
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV---APEYAMTC 859
HRD+ N +LD+ F ++DFGLAR + E ++ V A E T
Sbjct: 147 ---HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 860 RVSDKADVYSYGVVLLELLS 879
R + K+DV+S+GV+L ELL+
Sbjct: 204 RFTTKSDVWSFGVLLWELLT 223
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 690 IGNGGFGATYKAEI----SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLI 744
IG G FG Y + + A+K L V QF E + HPN+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 745 GY-HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ-CVP 802
G SE ++ Y+ G+L NFI+ + + L L +A+ + +L + V
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFV- 214
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV---APEYAMTC 859
HRD+ N +LD+ F ++DFGLAR + E + G V A E T
Sbjct: 215 ---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 860 RVSDKADVYSYGVVLLELLS 879
+ + K+DV+S+GV+L EL++
Sbjct: 272 KFTTKSDVWSFGVLLWELMT 291
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 62/201 (30%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
IG G +G +K G +VAIK+ V + A EI+ L +L+HPNLV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ + L++ Y + + + + R V ++ I +A+ + H +H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKH---NCIH 125
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA- 865
RDVKP NIL+ L DFG ARLL + VA T Y +PE +
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYGPPV 184
Query: 866 DVYSYGVVLLELLSDKKALDP 886
DV++ G V ELLS L P
Sbjct: 185 DVWAIGCVFAELLS-GVPLWP 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 672 LSFESVVQATGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIK 730
+ ++ G F +GNG +G YK + G L AIK + V ++ EI
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEIN 72
Query: 731 TLGRL-RHPNLVTLIG------YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH 783
L + H N+ T G + +++L+ + G++ + I+ + +
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 784 KIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG 843
I +I R L++LH +V+HRD+K N+LL ++ L DFG++ L + T
Sbjct: 133 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT- 188
Query: 844 VAGTFGYVAPEYAMTCRVSD-----KADVYSYGVVLLEL 877
GT ++APE D K+D++S G+ +E+
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 45/210 (21%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 690 IGNGGFGATYKAEI----SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG+ + + + VA+K + + + +++F +E + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 744 IG-----YHASETEMFLIYNYLPGGNLENFIQQR----STRAVDWRVLHKIALDIARALA 794
+G + +I ++ G+L ++ + + + L K +DIA +
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV--- 851
YL ++ LHRD+ N +L DD ++DFGL++ + + + G +
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVK 214
Query: 852 --APEYAMTCRVSDKADVYSYGVVLLELLS 879
A E + K+DV+++GV + E+ +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 28/203 (13%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLA----VGRFQGVQQFHAEIKTLGRL-RHPNLVTL 743
+G G G + G A+K L + E+ + P++V +
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---------EVDHHWQASGGPHIVCI 87
Query: 744 IGY----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+ H + + +I + GG L + IQ+R +A R +I DI A+ +LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 800 CVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
+ HRDVKP N+L + D L+DFG A+ + T YVAPE
Sbjct: 148 ---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVL 201
Query: 857 MTCRVSDKADVYSYGVVLLELLS 879
+ D++S GV++ LL
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLC 224
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAV-GRFQGVQQFHAEIKTLGRL-RHPNLVTLIGY 746
+G G +G K P G ++A+KR+ Q ++ ++ R P VT G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 747 HASETEMFLIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
E ++++ + +L+ F +Q + + +L KIA+ I +AL +LH + V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD- 863
+HRDVKPSN+L++ + DFG++ L + A AG Y+APE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 864 ---KADVYSYGVVLLEL 877
K+D++S G+ ++EL
Sbjct: 190 YSVKSDIWSLGITMIEL 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 28/214 (13%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIK--------RLAVGRFQGVQQFHAEIKTL 732
++ + +G+G FG + A V +K + + EI L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 733 GRLRHPNLVTLIGYHASETEMFLIY-NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR 791
R+ H N++ ++ ++ L+ + G +L FI + +D + I +
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVS 141
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851
A+ YL + ++HRD+K NI++ +DF L DFG A L + T GT Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYC 196
Query: 852 APE------YAMTCRVSDKADVYSYGVVLLELLS 879
APE Y + +++S GV L L+
Sbjct: 197 APEVLMGNPYR-----GPELEMWSLGVTLYTLVF 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 34/216 (15%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG + AE +LVA+K L + F E + L L+H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV--------------LHKIALDI 789
G + +++ Y+ G+L F++ A+ + IA I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 790 ARALAYLHDQ-CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG-- 846
A + YL Q V HRD+ N L+ + + DFG++R + ++ + G
Sbjct: 143 ASGMVYLASQHFV----HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 847 ---TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
PE M + + ++DV+S+GV+L E+ +
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAV-GRFQGVQQFHAEIKTLGRL-RHPNLVTLIGY 746
IG G +G+ K P G ++A+KR+ + +Q ++ + R P +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 747 HASETEMFLIYNYLPGG--NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
E + ++ + ++ + +L KI L +AL +L + ++
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD- 863
+HRD+KPSNILLD N L DFG++ L ++ A T AG Y+APE
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 864 ---KADVYSYGVVLLEL 877
++DV+S G+ L EL
Sbjct: 206 YDVRSDVWSLGITLYEL 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIK---RLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G G FG E G VA+K R + V + EI+ L RHP+++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR--------ALAYLH 797
++ T+ F++ Y+ GG L ++I + ++ AR A+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEMEARRLFQQILSAVDYCH 128
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE--- 854
V+HRD+KP N+LLD NA ++DFGL+ ++ E T+ G+ Y APE
Sbjct: 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS 183
Query: 855 ---YAMTCRVSDKADVYSYGVVLLELLS 879
YA + D++S GV+L LL
Sbjct: 184 GRLYA-----GPEVDIWSCGVILYALLC 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 27/203 (13%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIK----RLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTL 743
+G G G + A+K R E++ R + P++V +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR---------EVELHWRASQCPHIVRI 120
Query: 744 IGYH----ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+ + A + ++ L GG L + IQ R +A R +I I A+ YLH
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180
Query: 800 CVPRVLHRDVKPSNILL-DDDFNAYL--SDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
+ HRDVKP N+L NA L +DFG A+ + T T YVAPE
Sbjct: 181 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 235
Query: 857 MTCRVSDKADVYSYGVVLLELLS 879
+ D++S GV++ LL
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLC 258
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 91/578 (15%), Positives = 168/578 (29%), Gaps = 90/578 (15%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+E+L+L + I + + +++ L +GFN I P F + L L L N
Sbjct: 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133
Query: 61 LVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL----VGGI 112
++ ++P F +L + +S N L + + T+L++L LS N L + I
Sbjct: 134 DLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLI 191
Query: 113 PR------------SLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSI 160
P +L V L N + + + L +L + N+L+
Sbjct: 192 PSLFHANVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNLT-DT 247
Query: 161 PVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPN 220
L N L + LS N E + +
Sbjct: 248 AW-LLNYPGLVEVDLSY---------------------------NELEKIMYHPFVKMQR 279
Query: 221 LRILWAPRATLEGN----FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSS 276
L L+ + N L++L+L HN L L L
Sbjct: 280 LERLY-----ISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVERN-QPQFDRLENLYLDH 333
Query: 277 NQLTGELARELPV---PCMTMFDVSGNALSGS--IPTFSNMVCPPVPYLSRNLFESYNPS 331
N + L + + +S N + F N+ P V ++ Y
Sbjct: 334 NSIV-----TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLE 388
Query: 332 TAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIV 391
+ K L + G + + + Q +
Sbjct: 389 HGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPL 448
Query: 392 AGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQ-----LPAEIGRMCKSLKFLDASG 446
G+ +L N L + + ++N +I + L AEI + +
Sbjct: 449 QGNEQLEAEV--------NELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGL 500
Query: 447 NQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLG 506
+ + + L A L + K + L L + +
Sbjct: 501 ARSSDNLNKVFTHLKERQAFKLRETQAR--RTEADAKQKETEDLEQENIALEKQLDNKRA 558
Query: 507 -QLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543
Q +L + L + L N V +++
Sbjct: 559 KQAELRQETSLKRQKVKQLEAKKNRNPDTRRVSHHHHH 596
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 61/312 (19%), Positives = 109/312 (34%), Gaps = 56/312 (17%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAG 59
+ N +++ + + + + + + +LNL +I EI +F+ +++L +
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 60 NLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
N + +P F L + L N L S+P I L L +S N L +
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVL 175
+++L L SN L + L ++ +L +VS N LS L + L
Sbjct: 167 FQATTSLQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 218
Query: 176 SNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF 235
S+ N + V L IL L+ N
Sbjct: 219 SH---------------------------NSIN-VVRGPV--NVELTILK-----LQHNN 243
Query: 236 ---PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPC 291
+ L ++L +N + L L +S+N+L L P+P
Sbjct: 244 LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302
Query: 292 MTMFDVSGNALS 303
+ + D+S N L
Sbjct: 303 LKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 45/216 (20%), Positives = 83/216 (38%), Gaps = 11/216 (5%)
Query: 366 NNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIA 425
N P L V+ V D + + G N + N+ +
Sbjct: 7 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIV--TFKNSTMR 64
Query: 426 GQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQM 484
+LPA + + ++ L+ + QI I ++ L + +N + P +
Sbjct: 65 -KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122
Query: 485 KGLKYLSLAGNNLTGSIPSSL-GQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543
L L L N+L+ S+P + L L +S+N+L + D + +L L L++N
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181
Query: 544 KLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
+L+ S + ++ NVS+N LS L +
Sbjct: 182 RLTHVDLSLIPSLFHA---NVSYNLLST-LAIPIAV 213
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 41/260 (15%), Positives = 82/260 (31%), Gaps = 26/260 (10%)
Query: 28 LRVLNLGFNRITGEIPASFSD--FVNLEELNLAGNL---VNGTVPTFIGRLKRVYLSFNR 82
++ + T ++ F D N + + + + + +++ + L+ +
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86
Query: 83 LVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGM 142
+ + + ++ L + N + P N + L+L N L
Sbjct: 87 IE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 145
Query: 143 LQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLS-NLFDTYEDVRYSRGQSLVDQPSFM 200
L L +S N+L I D + L L LS N +
Sbjct: 146 TPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHA------- 197
Query: 201 NDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNL 260
N +N ++ + L A ++ L +L L HN + +
Sbjct: 198 NVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT--DT 247
Query: 261 GVLGPCKNLLFLDLSSNQLT 280
L L+ +DLS N+L
Sbjct: 248 AWLLNYPGLVEVDLSYNELE 267
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 4e-17
Identities = 43/178 (24%), Positives = 78/178 (43%), Gaps = 19/178 (10%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N LS S P +F +L +L ++SNN + ++ + + SL+ L S N++ +
Sbjct: 132 RNDLS-SLPRGIFHNTPKLTTL--SMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-V 186
Query: 454 PRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEV 513
+ + SL N+S+NL+ +TL ++ L + N++ + + L +
Sbjct: 187 DLSL--IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTI 236
Query: 514 LDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
L L N+L+ L N L + L+ N+L KI + L +S N L
Sbjct: 237 LKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 6e-17
Identities = 46/190 (24%), Positives = 74/190 (38%), Gaps = 23/190 (12%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N+L+ ++ L NVS N ++ L I +++ LDAS N I +
Sbjct: 180 SNRLT-HVDLSLI---PSLFHA--NVSYNLLS-TLAIPI-----AVEELDASHNSINV-V 226
Query: 454 PRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEV 513
V V L L L N + D L GL + L+ N L + ++Q LE
Sbjct: 227 RGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282
Query: 514 LDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS--- 570
L +S+N L + + + L VL L++N L + L + N++
Sbjct: 283 LYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 340
Query: 571 -GPLPSSKNL 579
+ KNL
Sbjct: 341 LSTHHTLKNL 350
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 3e-16
Identities = 59/334 (17%), Positives = 110/334 (32%), Gaps = 53/334 (15%)
Query: 242 CDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL--PVPCMTMFDVSG 299
++ + + + G L N + ++ + +L L + + +++
Sbjct: 29 FYDVHIDMQTQDVYFGFEDITL---NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLND 84
Query: 300 NALSGSIP--TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFL 357
+ I F+ Y+ N P F L L
Sbjct: 85 LQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-----FQNVPL------LT----VL 128
Query: 358 AIFHNFGGNNFSGSLPSMPVAPERLGK-QTVYAIVAGDNKLSGSFPGNMFGICNRLDSLM 416
N+ S SLP K T+ +N L + F L +L
Sbjct: 129 ----VLERNDLS-SLP--RGIFHNTPKLTTLS---MSNNNLE-RIEDDTFQATTSLQNL- 176
Query: 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQ 476
+S+NR+ + + SL + S N + + +++ L+ S N ++
Sbjct: 177 -QLSSNRLT-HVDL---SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-V 225
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
+ L L L NNLT L L +DLS N L ++ ++ L
Sbjct: 226 VRG--PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281
Query: 537 VLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
L ++NN+L + + TL ++S N+L
Sbjct: 282 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 56/208 (26%), Positives = 83/208 (39%), Gaps = 37/208 (17%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G +G A VA+K + + R + EI L H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR--------ALAYLHDQ 799
+L Y GG L + I+ + A+ + YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL--LGPSETHATTGVAGTFGYVAPE--- 854
+ HRD+KP N+LLD+ N +SDFGLA + E GT YVAPE
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 855 ---YAMTCRVSDKADVYSYGVVLLELLS 879
+ ++ DV+S G+VL +L+
Sbjct: 181 RREFH-----AEPVDVWSCGIVLTAMLA 203
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVT 742
+G G FG Y+ P VAIK + + +F E + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV--------LHKIALDIARALA 794
L+G + +I + G+L+++++ + V + ++A +IA +A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 795 YLHDQ-CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV-- 851
YL+ V HRD+ N ++ +DF + DFG+ R + ++ + G G +
Sbjct: 153 YLNANKFV----HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPV 204
Query: 852 ---APEYAMTCRVSDKADVYSYGVVLLELLS 879
+PE + +DV+S+GVVL E+ +
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 61/284 (21%), Positives = 91/284 (32%), Gaps = 55/284 (19%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAGNL 61
L VL LE N L+ + + L L++ N + I F +L+ L L+ N
Sbjct: 118 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
+ + I L +S+N L ++ +E LD S N + + + +
Sbjct: 177 LTHVDLSLIPSLFHANVSYNLL-STLA-----IPIAVEELDASHNSINV-VRGPV--NVE 227
Query: 122 VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSNLFD 180
+ L L N L + L L +D+S N L I +L L +SN
Sbjct: 228 LTILKLQHNNLTD-TAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISN--- 281
Query: 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FP 236
N + +P L++L L N
Sbjct: 282 ------------------------NRLVA-LNLYGQPIPTLKVLD-----LSHNHLLHVE 311
Query: 237 SNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
N D LE L L HN L L L LS N
Sbjct: 312 RNQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 67/341 (19%), Positives = 118/341 (34%), Gaps = 69/341 (20%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+E+L+L + I + + +++ L +GFN I P F + L L L N
Sbjct: 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
Query: 61 L---VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
+ + +L + +S N L + + T+L++L LS N L +
Sbjct: 128 DLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP 186
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+ + + N+L L + +E LD S NS++ + + +L IL L +
Sbjct: 187 S---LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 235
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN--- 234
+L D +N P L + L N
Sbjct: 236 N-------------NLTDTAWLLN----------------YPGLVEVD-----LSYNELE 261
Query: 235 -FPSN-WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP-VPC 291
+ + LE L + +N N P L LDLS N L + R P
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLVALN-LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
Query: 292 MTMFDVSGNALSGSIP--TFSNMVCPPVPYLSRNLFESYNP 330
+ + N++ ++ T + +NL S+N
Sbjct: 320 LENLYLDHNSIV-TLKLSTHHTL---------KNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 61/316 (19%), Positives = 110/316 (34%), Gaps = 57/316 (18%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAG 59
+ N +++ + + + + + + +LNL +I EI +F+ +++L +
Sbjct: 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 60 NLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
N + +P F L + L N L S+P I L L +S N L +
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVL 175
+++L L SN L + L ++ +L +VS N LS L + L
Sbjct: 161 FQATTSLQNLQLSSNRL-THVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 212
Query: 176 SNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF 235
S+ N + V L IL L+ N
Sbjct: 213 SH---------------------------NSIN-VVRGPV--NVELTILK-----LQHNN 237
Query: 236 ---PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPC 291
+ L ++L +N + L L +S+N+L L P+P
Sbjct: 238 LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296
Query: 292 MTMFDVSGNALSGSIP 307
+ + D+S N L +
Sbjct: 297 LKVLDLSHNHLL-HVE 311
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 66/345 (19%), Positives = 106/345 (30%), Gaps = 64/345 (18%)
Query: 212 PEAVSSLPNLRILWAPRATLEGNF-----PSNWGACDNLEMLNLGHNFFSGKNLGVLGPC 266
+ S + +L L + ++ L +G N V
Sbjct: 62 AALLDSFRQVELL-----NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 116
Query: 267 KNLLFLDLSSNQLTGELAREL--PVPCMTMFDVSGNALSGSIP--TFSNMVCPPVPYLSR 322
L L L N L+ L R + P +T +S N L I TF LS
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSS 174
Query: 323 NLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERL 382
N + S ++FH N +L
Sbjct: 175 NRLTHVDLSL-----------------------IPSLFHANVSYNLLSTLAIPI------ 205
Query: 383 GKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFL 442
V + A N ++ G + L L + +N + + L +
Sbjct: 206 ---AVEELDASHNSIN-VVRGPVN---VELTIL--KLQHNNLT-DTAWLLN--YPGLVEV 253
Query: 443 DASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSI 501
D S N++ I ++ L L +S N + + + LK L L+ N+L +
Sbjct: 254 DLSYNELEK-IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HV 310
Query: 502 PSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546
+ Q LE L L NS+ L L+NLT L++N
Sbjct: 311 ERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT---LSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-20
Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 26/193 (13%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N LS S P +F +L +L ++SNN + ++ + + SL+ L S N++ +
Sbjct: 126 RNDLS-SLPRGIFHNTPKLTTL--SMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-V 180
Query: 454 PRGVGELVSLVALNLSWNLMHD-QIPTTL---------------GQMKGLKYLSLAGNNL 497
+ + SL N+S+NL+ IP + L L L NNL
Sbjct: 181 DLSL--IPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL 238
Query: 498 TGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVS 557
T + L L +DLS N L ++ ++ L L ++NN+L + +
Sbjct: 239 TD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 558 TLSAFNVSFNNLS 570
TL ++S N+L
Sbjct: 296 TLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-19
Identities = 36/171 (21%), Positives = 71/171 (41%), Gaps = 8/171 (4%)
Query: 411 RLDSLMV-NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNL 468
L++ + N+ + +LPA + + ++ L+ + QI I ++ L +
Sbjct: 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYM 100
Query: 469 SWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDD 528
+N + P + L L L N+L+ L L +S+N+L + D
Sbjct: 101 GFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 529 LENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
+ +L L L++N+L+ S + ++ NVS+N LS L +
Sbjct: 161 FQATTSLQNLQLSSNRLTHVDLSLIPSLFHA---NVSYNLLST-LAIPIAV 207
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 39/273 (14%), Positives = 81/273 (29%), Gaps = 34/273 (12%)
Query: 18 LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL---VNGTVPTFIGRLK 74
+ + + +++ N + + + + + +++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 75 RVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEE 134
+ L+ ++ + + ++ L + N + P N + L+L N L
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 135 TIPAEL-GMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLS-NLFDTYEDVRYSRGQ 191
+P + L L +S N+L I D + L L LS N +
Sbjct: 132 -LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 189
Query: 192 SLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FPSNWGACDNLEM 247
N +N ++ + L N L +
Sbjct: 190 HA-------NVSYNLL-----STLAIPIAVEELD-----ASHNSINVVRG--PVNVELTI 230
Query: 248 LNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
L L HN + + L L+ +DLS N+L
Sbjct: 231 LKLQHNNLT--DTAWLLNYPGLVEVDLSYNELE 261
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 43/177 (24%), Positives = 70/177 (39%), Gaps = 19/177 (10%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N+L+ ++ L NVS N ++ L I +++ LDAS N I +
Sbjct: 174 SNRLT-HVDLSLI---PSLFHA--NVSYNLLS-TLAIPI-----AVEELDASHNSINV-V 220
Query: 454 PRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEV 513
V V L L L N + D L GL + L+ N L + ++Q LE
Sbjct: 221 RGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276
Query: 514 LDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
L +S+N L + + + L VL L++N L + L + N++
Sbjct: 277 LYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 9/111 (8%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
L +DL N L I+ ++ L L + NR+ + L+ L+L+ N
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305
Query: 61 LVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL 108
+ V RL+ +YL N +V ++ L++L LS N
Sbjct: 306 HLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST---HHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 15/114 (13%), Positives = 40/114 (35%), Gaps = 4/114 (3%)
Query: 460 LVSLVALNLSWNLMHDQIPTTLGQ--MKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLS 517
V ++ ++ + + K ++ + + + L + +E+L+L+
Sbjct: 18 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77
Query: 518 SNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
+ + + L + N + +P NV L+ + N+LS
Sbjct: 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 14/95 (14%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
I + L + + L +++ ++++ L L++ R +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 537 VLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
+L LN+ ++ +I + A T+ + FN +
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 45/224 (20%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHA--------------------- 727
IG G +G A + A+K L+ + F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 728 -----EIKTLGRLRHPNLVTL--IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWR 780
EI L +L HPN+V L + +E +++++ + G + + R
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 781 VLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840
D+ + + YLH Q +++HRD+KPSN+L+ +D + ++DFG++ S+
Sbjct: 141 ---FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194
Query: 841 TTGVAGTFGYVAPEYAMTCRVSDK------ADVYSYGVVLLELL 878
+ GT ++APE + + K DV++ GV L +
Sbjct: 195 SN-TVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFV 234
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 33/215 (15%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTL 743
+G G FG + AE +LVA+K L Q F E + L L+H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV-------------LHKIALDIA 790
G + +++ Y+ G+L F++ A L +A +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 791 RALAYLHDQ-CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG 849
+ YL V HRD+ N L+ + DFG++R + ++ + G
Sbjct: 169 AGMVYLAGLHFV----HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VGGRT 220
Query: 850 YV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
+ PE + + + ++DV+S+GVVL E+ +
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 684 FNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG---VQQFHAEIKTLGRLRHPN 739
F+ IG+G FGA Y A ++ +VAIK+++ Q Q E++ L +LRHPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+ G + E +L+ Y G + + + + + + + + LAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
++HRDVK NILL + L DFG A ++ P+ + GT ++APE +
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAM 225
Query: 860 RVSD---KADVYSYGVVLLEL 877
K DV+S G+ +EL
Sbjct: 226 DEGQYDGKVDVWSLGITCIEL 246
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 690 IGNGGFGATYKAEISPG---VLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPNLVTLI 744
IG G FG KA I + AIKR+ + F E++ L +L HPN++ L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV--------------LHKIALDIA 790
G ++L Y P GNL +F+++ D L A D+A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY 850
R + YL + + +HRD+ NIL+ +++ A ++DFGL+R G T G
Sbjct: 153 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM-----GR 202
Query: 851 V-----APEYAMTCRV-SDKADVYSYGVVLLELLS 879
+ A E ++ V + +DV+SYGV+L E++S
Sbjct: 203 LPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 690 IGNGGFGATYKAE---ISPG---VLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVT 742
+G FG YK +PG VAIK L ++F E RL+HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV--------------LHKIALD 788
L+G + + +I++Y G+L F+ RS + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 789 IARALAYLHDQ-CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG- 846
IA + YL V H+D+ N+L+ D N +SD GL R + ++ + G +
Sbjct: 137 IAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 847 ----TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879
APE M + S +D++SYGVVL E+ S
Sbjct: 193 PIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAV-GRFQGVQQFHAEIKTLGRL-RHPNLVTLIGY 746
+G+G G +K G ++A+K++ G + ++ ++ + + P +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ T++F+ + + +++R + R+L K+ + I +AL YL ++ V+H
Sbjct: 93 FITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIH 148
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD--- 863
RDVKPSNILLD+ L DFG++ L + A AG Y+APE +
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 864 --KADVYSYGVVLLEL 877
+ADV+S G+ L+EL
Sbjct: 207 DIRADVWSLGISLVEL 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQ-GVQQFHA--EIKTLGRLRHPNLVTLIG 745
IG G +G +KA +VA+KR+ + GV A EI L L+H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP-SSALREICLLKELKHKNIVRLHD 68
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
S+ ++ L++ + +L+ + + +D ++ + + L + H + VL
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR---NVL 123
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV-SDK 864
HRD+KP N+L++ + L++FGLAR G + V T Y P+ ++ S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 182
Query: 865 ADVYSYGVVLLELLSDKKAL 884
D++S G + EL + + L
Sbjct: 183 IDMWSAGCIFAELANAGRPL 202
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 56/208 (26%), Positives = 83/208 (39%), Gaps = 37/208 (17%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYH 747
+G G +G A VA+K + + R + EI L H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 748 ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR--------ALAYLHDQ 799
+L Y GG L + I+ + A+ + YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL--LGPSETHATTGVAGTFGYVAPE--- 854
+ HRD+KP N+LLD+ N +SDFGLA + E GT YVAPE
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 855 ---YAMTCRVSDKADVYSYGVVLLELLS 879
+ ++ DV+S G+VL +L+
Sbjct: 181 RREFH-----AEPVDVWSCGIVLTAMLA 203
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-25
Identities = 99/554 (17%), Positives = 183/554 (33%), Gaps = 110/554 (19%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+L++ N ++ + L LR+L + NRI + F LE L+L+ N
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN-- 79
Query: 63 NGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQV 122
+L + +S + NL+HLDLS N +L C
Sbjct: 80 ---------KLVK--ISCHPT------------VNLKHLDLSFNAF-----DALPIC--- 108
Query: 123 RSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTY 182
E G + L+ L +S L S + + + + +L++
Sbjct: 109 ---------------KEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE 153
Query: 183 EDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGAC 242
+ E L + +L FP+N
Sbjct: 154 K-----------------------------EDPEGLQDFNTE-----SLHIVFPTNKEFH 179
Query: 243 DNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNAL 302
L++ N+ + + S + +L + + + N+
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYF--LSILAKLQTNPKLSNLTLNNIETTWNSF 237
Query: 303 SGSIPTFSNMVCPPVPYLS-RNLFESYNPSTAYLSLFAKKSQAGTPLPLRGR------DG 355
+ + V Y S N+ +A + +
Sbjct: 238 IRILQLVWHT---TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY 294
Query: 356 FLAIFHNFGGNNFSGS---LPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRL 412
IF N NF+ S + M P ++ + +N L+ G L
Sbjct: 295 IYEIFSNMNIKNFTVSGTRMVHMLC-PSKISPFLH--LDFSNNLLT-DTVFENCGHLTEL 350
Query: 413 DSLMVNVSNNRIAGQLPAEIGRMCK--SLKFLDASGNQIVGPIPRGV-GELVSLVALNLS 469
++L + N++ +L + SL+ LD S N + +G SL++LN+S
Sbjct: 351 ETL--ILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 470 WNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDL 529
N++ D I L +K L L N + SIP + +L+ L+ L+++SN L +
Sbjct: 408 SNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIF 464
Query: 530 ENLRNLTVLLLNNN 543
+ L +L + L+ N
Sbjct: 465 DRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 87/503 (17%), Positives = 164/503 (32%), Gaps = 58/503 (11%)
Query: 76 VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET 135
V S N L+ VP + L++S NY+ + + ++R L++ N ++
Sbjct: 5 VDRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 136 IPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS-NLFDTYEDVRYSRGQSLV 194
+ Q LE LD+S N L I L L LS N F +L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAF-----------DALP 106
Query: 195 DQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL-EGNFPSNWGACDNLEMLNLGHN 253
F ++ L+ L L + + + +L LG
Sbjct: 107 ICKEF----------------GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 254 FFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCM-TMFDVSGNALSGSIPTFSNM 312
+ ++ L ++ L T + + + T+ ++ + + +
Sbjct: 151 YGEKEDPEGL---QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 313 VCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHN-FGGNNFSGS 371
+ + + N + + L + +I + G
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267
Query: 372 LPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAE 431
+ + L V + + G ++ I + ++ VS R +
Sbjct: 268 FDYSGTSLKALSIHQVV------SDVFGFPQSYIYEIFSNMNIKNFTVSGTR---MVHML 318
Query: 432 IGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLG---QMKGLK 488
LD S N + + G L L L L N + ++ QMK L+
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQ 377
Query: 489 YLSLAGNNLTGSIPSSL-GQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547
L ++ N+++ + L L++SSN L+ I L + VL L++NK+
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK- 434
Query: 548 KIPSGLANVSTLSAFNVSFNNLS 570
IP + + L NV+ N L
Sbjct: 435 SIPKQVVKLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 38/186 (20%), Positives = 74/186 (39%), Gaps = 13/186 (6%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
N+ + + + + + L+ N +T + + LE L L N +
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 63 NGTVPTFIG------RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL 116
+ L+++ +S N + +L L++S N L I R L
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVL 175
+++ L L SN + ++IP ++ L+ L+ L+V+ N L S+P + L + L
Sbjct: 420 PP--RIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWL 475
Query: 176 S-NLFD 180
N +D
Sbjct: 476 HTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 7e-14
Identities = 60/438 (13%), Positives = 125/438 (28%), Gaps = 74/438 (16%)
Query: 145 NLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDF 204
+L++S+N +S D+ + SKL IL++S+
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISH--------------------------- 54
Query: 205 NFFEGGIPEAVSSLPNLRILWAPRATLEGN----FPSNWGACDNLEMLNLGHNFF-SGKN 259
N + L L L N + NL+ L+L N F +
Sbjct: 55 NRIQYLDISVFKFNQELEYLD-----LSHNKLVKISCHP--TVNLKHLDLSFNAFDALPI 107
Query: 260 LGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPY 319
G L FL LS+ L + A +
Sbjct: 108 CKEFGNMSQLKFLGLSTTHLEKSSVLPI-------------AHLNISKVLLVLGETYGEK 154
Query: 320 LSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAP 379
+ +N + ++ K L + + + + +
Sbjct: 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA 214
Query: 380 ERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSL 439
+ + + + + + + + + ++SN ++ GQL
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD---------F 265
Query: 440 KFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTG 499
+ D SG L +L + ++ + + +
Sbjct: 266 RDFDYSGTS-----------LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 500 SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS--GKIPSGLANVS 557
++ LD S+N L+ + ++ +L L L+L N+L KI +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 558 TLSAFNVSFNNLSGPLPS 575
+L ++S N++S
Sbjct: 375 SLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 7e-12
Identities = 51/289 (17%), Positives = 90/289 (31%), Gaps = 68/289 (23%)
Query: 3 NLEVLDLEGNLLNGILPDSGFH-----LKSLRVLNLGFNRITGEIPASFSDFVNLEELNL 57
+ + L G L F LK+L + + + + F N+ N
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 58 AGN---LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR 114
+ +V+ P+ I + S N L + T LE L L N L +
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQL-----K 361
Query: 115 SLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILV 174
L ++ + +++L+ LD+S+NS+S G+CS L+
Sbjct: 362 ELSKIAEM-----TTQ------------MKSLQQLDISQNSVSYDEKK--GDCSWTKSLL 402
Query: 175 LSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN 234
N+ N I + P +++L L N
Sbjct: 403 SLNM------------------------SSNILTDTIFRCL--PPRIKVLD-----LHSN 431
Query: 235 ----FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQL 279
P + L+ LN+ N G+ +L + L +N
Sbjct: 432 KIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 9e-11
Identities = 28/110 (25%), Positives = 52/110 (47%), Gaps = 8/110 (7%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG 59
M +L+ LD+ N ++ KSL LN+ N +T I ++ L+L
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHS 430
Query: 60 NLVNGTVPTFI---GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
N + ++P + L+ + ++ N+L SVP I ++ T+L+ + L N
Sbjct: 431 NKIK-SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 32/135 (23%), Positives = 62/135 (45%), Gaps = 8/135 (5%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF--HLKSLRVLNLGFNRIT-GEIPASFSDFVNLEELNL 57
+ LE L L+ N L + + +KSL+ L++ N ++ E S +L LN+
Sbjct: 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 58 AGN-LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR-S 115
+ N L + R+K + L N++ S+P ++ K L+ L+++ N L +P
Sbjct: 407 SSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVV-KLEALQELNVASNQL-KSVPDGI 463
Query: 116 LGNCFQVRSLLLFSN 130
++ + L +N
Sbjct: 464 FDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 26/144 (18%), Positives = 46/144 (31%), Gaps = 24/144 (16%)
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+P+ + LN+S N + + + + + L+ L ++ N + S Q LE
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 513 VLDLSSNSLSGLIPDDLENLR----------------------NLTVLLLNNNKLSGKIP 550
LDLS N L + NL+ L L L+ L
Sbjct: 73 YLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSV 132
Query: 551 SGLANVSTLSAFNVSFNNLSGPLP 574
+A+++ V
Sbjct: 133 LPIAHLNISKVLLVLGETYGEKED 156
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 37/206 (17%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVTLIGY 746
IG G F A I G VAIK + + +Q+ E++ + L HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR--------ALAYLHD 798
+E ++LI Y GG + +++ ++ AR A+ Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH----------GRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE---- 854
+ + +HRD+K N+LLD D N ++DFG + G Y APE
Sbjct: 133 KRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQG 187
Query: 855 --YAMTCRVSDKADVYSYGVVLLELL 878
Y + DV+S GV+L L+
Sbjct: 188 KKYD-----GPEVDVWSLGVILYTLV 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
+G G +G K G +VAIK+ + + A EIK L +LRH NLV L+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
+ +L++ ++ + + ++ +D++V+ K I + + H ++H
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSH---NIIH 147
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
RD+KP NIL+ L DFG AR L P E + VA T Y APE + KA
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-DDEVA-TRWYRAPELLVGDVKYGKA 205
Query: 866 -DVYSYGVVLLELLSDKKALDP 886
DV++ G ++ E+ + L P
Sbjct: 206 VDVWAIGCLVTEMFM-GEPLFP 226
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 67/396 (16%), Positives = 115/396 (29%), Gaps = 88/396 (22%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKS-----------------LRVLNLGFNRITGEIPAS 45
VL++ + L + H+ + LR L + N++T +P
Sbjct: 41 GNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT-SLPVL 99
Query: 46 FSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSG 105
+ L + +P L ++++ N+L S+P L+ L +S
Sbjct: 100 PPGLLELSIFSNPLT----HLPALPSGLCKLWIFGNQL-TSLPVLPP----GLQELSVSD 150
Query: 106 NYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLG 165
N L +P + L ++N L +P L+ L VS N L+ S+P
Sbjct: 151 NQL-ASLPALPSE---LCKLWAYNNQLTS-LPMLPS---GLQELSVSDNQLA-SLPTLPS 201
Query: 166 NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILW 225
KL +N + +P L+ L
Sbjct: 202 ELYKLWA--YNNRLTS-----------------------------LPA---LPSGLKELI 227
Query: 226 APRATLEGNFPSNWGACDNLEMLNLGHNFFSG--KNLGVLGPCKNLLFLDLSSNQLTGEL 283
L + P L+ L + N + LL L + NQLT L
Sbjct: 228 VSGNRLT-SLPVLPS---ELKELMVSGNRLTSLPMLPS------GLLSLSVYRNQLT-RL 276
Query: 284 ARELP-VPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKS 342
L + T ++ GN LS + P S + +
Sbjct: 277 PESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH 335
Query: 343 QAGTPL---PLRGRDGFLAIFHNFGGNNFSGSLPSM 375
A G +H FG + + +
Sbjct: 336 LAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLF 371
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 52/289 (17%), Positives = 90/289 (31%), Gaps = 61/289 (21%)
Query: 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
L L++ GN L LP L L + + + L +L + GN
Sbjct: 81 PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQ 132
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
+ ++P L+ + +S N+L S+P+ L L N L +P
Sbjct: 133 LT-SLPVLPPGLQELSVSDNQL-ASLPALPS----ELCKLWAYNNQLT-SLPMLPSG--- 182
Query: 122 VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDT 181
++ L + N L ++P L L + N L+ S+P L L++S
Sbjct: 183 LQELSVSDNQL-ASLPTLPSELYKLWAYN---NRLT-SLPALPSG---LKELIVSGN--- 231
Query: 182 YEDVRYSRGQSLVDQPSFMND------DFNFFEGGIPEAVSSLPNLRILWAPRATLEGN- 234
L P ++ N +P L L + N
Sbjct: 232 ----------RLTSLPVLPSELKELMVSGNRLT-SLPM---LPSGLLSLS-----VYRNQ 272
Query: 235 ---FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
P + + +NL N S + L + + S +
Sbjct: 273 LTRLPESLIHLSSETTVNLEGNPLSERTLQA---LREITSAPGYSGPII 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
L+ L + N L LP L L N N++T +P S L+EL+++ N
Sbjct: 140 PPGLQELSVSDNQLAS-LPALPSELCKLWAYN---NQLT-SLPMLPS---GLQELSVSDN 191
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
+ ++PT L +++ NRL S+P+ L+ L +SGN L +P
Sbjct: 192 QLA-SLPTLPSELYKLWAYNNRLT-SLPALPS----GLKELIVSGNRL-TSLPVLPSE-- 242
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
++ L++ N L +P L L V RN L+ +P L + S + L
Sbjct: 243 -LKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-23
Identities = 80/401 (19%), Positives = 131/401 (32%), Gaps = 90/401 (22%)
Query: 242 CDNLEMLNLGHNFFSGKNLGVLGPC--KNLLFLDLSSNQLTGELARELPV--PCMTMFDV 297
+ +LN+G + L L C ++ L + N LT LP P + +V
Sbjct: 39 NNGNAVLNVGES-----GLTTLPDCLPAHITTLVIPDNNLT-----SLPALPPELRTLEV 88
Query: 298 SGNALSGSIP-TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGF 356
SGN L+ S+P ++ + + L +
Sbjct: 89 SGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWI------------------- 128
Query: 357 LAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLM 416
GN + SLP +P + L DN+L+ S P L L
Sbjct: 129 -------FGNQLT-SLPVLPPGLQEL--------SVSDNQLA-SLPA---LPSE-LCKL- 166
Query: 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQ 476
NN++ LP L+ L S NQ+ +P EL L A N
Sbjct: 167 -WAYNNQLT-SLPMLPS----GLQELSVSDNQLAS-LPTLPSELYKLWAYNNR----LTS 215
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLL-----------------EVLDLSSN 519
+P LK L ++GN LT S+P +L+ L L + N
Sbjct: 216 LPALPSG---LKELIVSGNRLT-SLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRN 271
Query: 520 SLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
L+ L P+ L +L + T + L N LS + L +++ ++ S+
Sbjct: 272 QLTRL-PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 580 MKCSSVLGNPYLRPCRAFTLTEPSQDLHGPPSNGNRGFNSI 620
+ + +L P R + + F+
Sbjct: 331 TRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLF 371
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-20
Identities = 60/287 (20%), Positives = 95/287 (33%), Gaps = 52/287 (18%)
Query: 25 LKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLV 84
VLN+G + +T +P ++ L + N + ++P L+ + +S N+L
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLEVSGNQLT 94
Query: 85 GSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQ 144
S+P L +L +P L L +F N L +P
Sbjct: 95 -SLPVLPP-GLLELSIFSNPLTHLP-ALPSGL------CKLWIFGNQLTS-LPVLPP--- 141
Query: 145 NLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMND-- 202
L+ L VS N L+ S+P KL ++ SL PS + +
Sbjct: 142 GLQELSVSDNQLA-SLPALPSELCKL-------------WAYNNQLTSLPMLPSGLQELS 187
Query: 203 -DFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLG 261
N +P S L L +L L+ L + N L
Sbjct: 188 VSDNQLA-SLPTLPSELYKLWAYNNRLTSLPAL-------PSGLKELIVSGN-----RLT 234
Query: 262 VLGP-CKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIP 307
L L L +S N+LT L + V N L+ +P
Sbjct: 235 SLPVLPSELKELMVSGNRLT-SLPMLP--SGLLSLSVYRNQLT-RLP 277
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 87/453 (19%), Positives = 130/453 (28%), Gaps = 135/453 (29%)
Query: 142 MLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMN 201
+ VL+V + L+ ++P L + LV+ + T
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS------------------- 75
Query: 202 DDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FPSNWGACDNLEMLNLGHNFFSG 257
+P P LR L + GN P L + +
Sbjct: 76 ---------LPA---LPPELRTL-----EVSGNQLTSLPVLPPGLLELSIFSNPLT---- 114
Query: 258 KNLGVLGPCKNLLFLDLSSNQLTGELARELPV--PCMTMFDVSGNALSGSIPTFSNMVCP 315
+L L L L + NQLT LPV P + VS N L+ S +
Sbjct: 115 -HLPAL--PSGLCKLWIFGNQLT-----SLPVLPPGLQELSVSDNQLASLPALPSEL--- 163
Query: 316 PVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSM 375
L+ N L S+
Sbjct: 164 ------CKLWAYNN-----------------------------------------QLTSL 176
Query: 376 PVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRM 435
P+ P L + + DN+L+ S P + L L NNR+ LPA
Sbjct: 177 PMLPSGLQE-----LSVSDNQLA-SLPTLP----SELYKL--WAYNNRLT-SLPALPS-- 221
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
LK L SGN++ +P EL L +S N + +P L LS+ N
Sbjct: 222 --GLKELIVSGNRLTS-LPVLPSELKEL---MVSGNRL-TSLPMLPSG---LLSLSVYRN 271
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN 555
LT +P SL L ++L N LS L + + + S
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 556 VSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGN 588
L + + L + G
Sbjct: 331 TRALH--LAAADWLVPAREGEPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 9e-19
Identities = 82/435 (18%), Positives = 137/435 (31%), Gaps = 117/435 (26%)
Query: 95 CTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRN 154
L++ + L +P L + +L++ N L +PA L L+VS N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLTS-LPALPP---ELRTLEVSGN 91
Query: 155 SLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEA 214
L+ S+PV +L+I L PS
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPL-------------THLPALPS---------------- 121
Query: 215 VSSLPNLRILWAPRATLEGN----FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPC-KNL 269
L LW + GN P L+ L++ N L L L
Sbjct: 122 -----GLCKLW-----IFGNQLTSLPVLPP---GLQELSVSDN-----QLASLPALPSEL 163
Query: 270 LFLDLSSNQLTGELARELPV--PCMTMFDVSGNALSGSIP-TFSNMVCPPVPYLSRNLFE 326
L +NQLT LP+ + VS N L+ S+P S + L+
Sbjct: 164 CKLWAYNNQLT-----SLPMLPSGLQELSVSDNQLA-SLPTLPSEL---------YKLWA 208
Query: 327 SYNPSTAYLSLFAKKSQAGTPLP-LRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQ 385
N T+ LP L L + N L S+PV P L +
Sbjct: 209 YNNRLTS--------------LPALPSGLKELIVSGN--------RLTSLPVLPSELKE- 245
Query: 386 TVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDAS 445
++ N+L+ S P + L SL +V N++ +LP + + S ++
Sbjct: 246 ----LMVSGNRLT-SLPML----PSGLLSL--SVYRNQLT-RLPESLIHL-SSETTVNLE 292
Query: 446 GNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSL 505
GN + + + E+ S + + + + L + + L +
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA--DWLVPAREGEP 350
Query: 506 GQLQLLEVLDLSSNS 520
+ N+
Sbjct: 351 APADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-18
Identities = 44/182 (24%), Positives = 66/182 (36%), Gaps = 15/182 (8%)
Query: 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
L+ L + N L LP L L N NR+T +PA S L+EL ++GN
Sbjct: 181 SGLQELSVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPALPS---GLKELIVSGNR 232
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
+ ++P LK + +S NRL S+P L L + N L +P SL +
Sbjct: 233 LT-SLPVLPSELKELMVSGNRLT-SLPMLPS----GLLSLSVYRNQLTR-LPESLIHLSS 285
Query: 122 VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDT 181
++ L N L E L + + + L + L
Sbjct: 286 ETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPA 345
Query: 182 YE 183
E
Sbjct: 346 RE 347
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 33/169 (19%), Positives = 55/169 (32%), Gaps = 20/169 (11%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
L+ L + GN L LP L+ L + NR+T +P S L L++ N
Sbjct: 220 PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLPS---GLLSLSVYRN 271
Query: 61 LVNGTVPTFIGR---LKRVYLSFNRLVGSVPSKIGEKCTNLEHLD---LSGNYLVGGIPR 114
+ +P + V L N L + + T+ + + PR
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 115 SLGNCFQVRSLLLFSNMLEETIPAE----LGMLQNLEVLDVSRNSLSGS 159
+ L E PA+ G N + + + LS +
Sbjct: 330 ETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 30/196 (15%), Positives = 55/196 (28%), Gaps = 23/196 (11%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
L+ L + GN L LP L L++ N++T +P S + +NL GN
Sbjct: 240 PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVG---------G 111
++ + + ++ + + ++LV
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD 354
Query: 112 IPRSLGNCFQVRSLLLFSNMLEETIPAE---------LGMLQNLEVLDVSRNSLSGSIPV 162
G + LF + L ET L L + R +
Sbjct: 355 RWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDEALRANTFAMATE 414
Query: 163 DLGNCSKLAILVLSNL 178
+C L +
Sbjct: 415 ATSSCEDRVTFFLHQM 430
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 38/207 (18%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIK---RLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G G FG + G VA+K R + V + EI+ L RHP+++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR--------ALAYLH 797
++ +++F++ Y+ GG L ++I + ++ +R + Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEKESRRLFQQILSGVDYCH 133
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE--- 854
V+HRD+KP N+LLD NA ++DFGL+ ++ E T+ G+ Y APE
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS 188
Query: 855 ---YAMTCRVSDKADVYSYGVVLLELL 878
YA + D++S GV+L LL
Sbjct: 189 GRLYA-----GPEVDIWSSGVILYALL 210
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 36/219 (16%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPNLV 741
+G G FG +A + VA+K L + +E+K L L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV----------------LHKI 785
L+G +I Y G+L NF++++ + + L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845
+ +A+ +A+L + +HRD+ NILL + DFGLAR + + V
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY----VV 203
Query: 846 GTFGYV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
+ APE C + ++DV+SYG+ L EL S
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPNLV 741
+G G FG +A + VA+K L + +E+K + L +H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRST------------RAVDWRVLHKIALDI 789
L+G + +I Y G+L NF++++S R L + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 790 ARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG 849
A+ +A+L + +HRDV N+LL + A + DFGLAR + + +
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKGNA 226
Query: 850 YV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
+ APE C + ++DV+SYG++L E+ S
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 27/226 (11%)
Query: 673 SFESVVQATGNFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQF----HA 727
+ E + F G G FG + G+ VAIK++ Q +F
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQ-DPRFRNRELQ 68
Query: 728 EIKTLGRLRHPNLVTLIGYHASETE-------MFLIYNYLPGGNLENFIQQRSTRAVDWR 780
++ L L HPN+V L Y + E + ++ Y+P L + R V
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP 127
Query: 781 VLHK--IALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS--DFGLARLLGPS 836
+ + R++ LH V V HRD+KP N+L+++ + L DFG A+ L PS
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPS 185
Query: 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
E + + + Y APE + A D++S G + E++ +
Sbjct: 186 EPN-VAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 50/219 (22%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 690 IGNGGFGATYKAEI--------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPN 739
+G G FG AE V VA+K L + + +E++ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDW--------------RVLHKI 785
++ L+G + +++I Y GNL +++ R +++ + L
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845
+AR + YL Q + +HRD+ N+L+ ++ ++DFGLAR + + +
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 215
Query: 846 GTFGYV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
T G + APE + ++DV+S+GV++ E+ +
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQ-GVQQFHA----EIKTLGRLR---HPNL 740
IG G +G YKA + G VA+K + V G E+ L RL HPN+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 741 VTLI-----GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
V L+ E ++ L++ ++ +L ++ + + + + R L +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
LH ++HRD+KP NIL+ L+DFGLAR+ T V T Y APE
Sbjct: 136 LHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TLWYRAPEV 190
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDKKAL 884
+ + D++S G + E+ +K L
Sbjct: 191 LLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 66/242 (27%), Positives = 107/242 (44%), Gaps = 21/242 (8%)
Query: 649 NPQSKVMGSTRKEVTIFTEIGVPLSFESVVQATGNFNASNCIGNGGFGATYKAEISP-GV 707
+ + S K+ + T + ++ + IGNG FG Y+A++ G
Sbjct: 21 SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 708 LVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF------LIYNYLP 761
LVAIK++ Q + + E++ + +L H N+V L + S E L+ +Y+P
Sbjct: 81 LVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 136
Query: 762 GGNLENFIQQRSTRAVDWRVLHK--IALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD 819
+ + S V++ + R+LAY+H + HRD+KP N+LLD D
Sbjct: 137 E-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPD 192
Query: 820 FNAY-LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA-DVYSYGVVLLEL 877
L DFG A+ L E + + + + Y APE + DV+S G VL EL
Sbjct: 193 TAVLKLCDFGSAKQLVRGEPN-VSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 250
Query: 878 LS 879
L
Sbjct: 251 LL 252
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 32/209 (15%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL------AVGRFQGVQQFHAEIKTLGRLR----HP 738
+G GGFG + ++ + VAIK + E+ L ++ HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 739 NLVTLIGYHASETEMFLIYNY-LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
++ L+ + ++ L+ LP +L ++I ++ + + A+ + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCH 156
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAY-LSDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
+ V+HRD+K NIL+D L DFG LL GT Y PE+
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPPEW- 209
Query: 857 MTCRVSDK------ADVYSYGVVLLELLS 879
+S A V+S G++L +++
Sbjct: 210 ----ISRHQYHALPATVWSLGILLYDMVC 234
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-24
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 30/204 (14%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAV-----GRFQGVQQFHAEIKTLGRLRHPNLVTLI 744
IGNG FG ++A++ VAIK++ R E++ + ++HPN+V L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR---------ELQIMRIVKHPNVVDLK 98
Query: 745 ------GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH--KIALDIARALAYL 796
G E + L+ Y+P + + + +L + R+LAY+
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAY-LSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
H + HRD+KP N+LLD L DFG A++L E + + + + Y APE
Sbjct: 158 HSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYIC-SRYYRAPEL 212
Query: 856 AMTCRVSDKA-DVYSYGVVLLELL 878
D++S G V+ EL+
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELM 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 51/219 (23%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 690 IGNGGFGATYKAE---ISPG-----VLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPN 739
+G G FG AE I V VA+K L + + +E++ + + +H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDW--------------RVLHKI 785
++ L+G + +++I Y GNL +++ R +++ + L
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845
+AR + YL Q + +HRD+ N+L+ ++ ++DFGLAR + + +
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 261
Query: 846 GTFGYV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
T G + APE + ++DV+S+GV++ E+ +
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-24
Identities = 67/315 (21%), Positives = 113/315 (35%), Gaps = 28/315 (8%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGN- 60
+LDL N + + D L L L N ++ + +F++ NL L L N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNR 91
Query: 61 LVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
L + F G L ++ +S N++V + + + NL+ L++ N LV R+
Sbjct: 92 LKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 119 CFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS- 176
+ L L L +IP E L L L VL + +++ +L +L +S
Sbjct: 151 LNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 177 NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE-AVSSLPNLRILWAPRATLEGN- 234
+ G +L ++ +P AV L LR L L N
Sbjct: 210 WPYLDTMTPNCLYGLNLTS----LSITHCNLT-AVPYLAVRHLVYLRFLN-----LSYNP 259
Query: 235 ---FPSNW-GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL--P 288
+ L+ + L + L L++S NQLT L +
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 289 VPCMTMFDVSGNALS 303
V + + N L+
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 60/288 (20%), Positives = 99/288 (34%), Gaps = 43/288 (14%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ NL L L N L I L +L L++ N+I + F D NL+ L + N
Sbjct: 79 LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138
Query: 61 -LVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
LV + F G L+++ L L S+P++ L L L + S
Sbjct: 139 DLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLS 176
++++ L + +T+ NL L ++ +L+ ++P + + L L LS
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS 256
Query: 177 NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF- 235
N + L L+ + L G
Sbjct: 257 Y---------------------------NPISTIEGSMLHELLRLQEIQ-----LVGGQL 284
Query: 236 ----PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQL 279
P + + L +LN+ N + V NL L L SN L
Sbjct: 285 AVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 34/179 (18%), Positives = 64/179 (35%), Gaps = 8/179 (4%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
+NK+ MF L SL V +N + + SL+ L + I
Sbjct: 113 ENKIV-ILLDYMFQDLYNLKSL--EVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-I 167
Query: 454 PRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
P L L+ L L ++ + ++ LK L ++ ++ + L
Sbjct: 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
L ++ +L+ + + +L L L L+ N +S I L + L + L+
Sbjct: 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 38/186 (20%), Positives = 73/186 (39%), Gaps = 10/186 (5%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N++ + + F L+ L ++ N ++ + +L+ L N++ I
Sbjct: 41 KNRIK-TLNQDEFASFPHLEEL--ELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL-I 95
Query: 454 PRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLL 511
P GV L +L L++S N + + + LK L + N+L I + L L
Sbjct: 96 PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSL 154
Query: 512 EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
E L L +L+ + + L +L L VL L + ++ I + L +S
Sbjct: 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYL 213
Query: 571 GPLPSS 576
+ +
Sbjct: 214 DTMTPN 219
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 31/155 (20%), Positives = 59/155 (38%), Gaps = 5/155 (3%)
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQ 476
++ NRI L + L+ L+ + N + + G L +L L L N +
Sbjct: 38 DLGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLKLI 95
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
+ L L ++ N + + L L+ L++ N L + L +L
Sbjct: 96 PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLE 155
Query: 537 VLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
L L L+ IP+ L+++ L + N++
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 36/154 (23%), Positives = 63/154 (40%), Gaps = 6/154 (3%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
++ + F RL L +S+ + +L L + + +
Sbjct: 185 HLNIN-AIRDYSFKRLYRLKVL--EISHWPYLDTMTPNCLYGL-NLTSLSITHCNLTA-V 239
Query: 454 PRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
P LV L LNLS+N + + L ++ L+ + L G L P + L L
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546
VL++S N L+ L ++ NL L+L++N L+
Sbjct: 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 28/119 (23%), Positives = 46/119 (38%), Gaps = 4/119 (3%)
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+P G+ L+L N + L+ L L N ++ P + L L
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLR 83
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGL-ANVSTLSAFNVSFNNLS 570
L L SN L + L NLT L ++ NK+ + + ++ L + V N+L
Sbjct: 84 TLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV 141
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 50/252 (19%), Positives = 79/252 (31%), Gaps = 25/252 (9%)
Query: 71 GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN 130
+ + V R V +VP I T LDL N + + + L L N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 131 MLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLS-NLFDTYEDVRYS 188
++ P L NL L + N L IP+ S L L +S N D +
Sbjct: 67 IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 189 RGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FPSNW-GACD 243
+L + N A S L +L L TLE P+
Sbjct: 126 DLYNLKS----LEVGDNDLVYISHRAFSGLNSLEQL-----TLEKCNLTSIPTEALSHLH 176
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC-MTMFDVSGNAL 302
L +L L H + L L++S + +T ++ L
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236
Query: 303 SGSIP--TFSNM 312
+ ++P ++
Sbjct: 237 T-AVPYLAVRHL 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 690 IGNGGFGATYKAEI--------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPN 739
+G G FG AE + VA+K L + + +E++ + + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDW--------------RVLHKI 785
++ L+G + +++I Y GNL ++Q R +++ + L
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVA 845
A +AR + YL + + +HRD+ N+L+ +D ++DFGLAR + + +
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KK 249
Query: 846 GTFGYV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
T G + APE + ++DV+S+GV+L E+ +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQ-GVQQFHA--EIKTLGRLRHPNLVTLIGY 746
+G G +G YKA+ S G +VA+KR+ + G+ A EI L L HPN+V+LI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP-STAIREISLLKELHHPNIVSLIDV 87
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
SE + L++ ++ +L+ + + T + + + R +A+ H R+LH
Sbjct: 88 IHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQH---RILH 142
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV-SDKA 865
RD+KP N+L++ D L+DFGLAR G T V T Y AP+ M + S
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSV 201
Query: 866 DVYSYGVVLLELLSDKKALDP 886
D++S G + E+++ K L P
Sbjct: 202 DIWSIGCIFAEMIT-GKPLFP 221
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 41/224 (18%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPNLV 741
+G+G FG A + VA+K L + +E+K + +L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV-------------------- 781
L+G ++LI+ Y G+L N+++ + + + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 782 -LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840
L A +A+ + +L + +HRD+ N+L+ + DFGLAR + +
Sbjct: 173 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY- 228
Query: 841 TTGVAGTFGYV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
V + APE + K+DV+SYG++L E+ S
Sbjct: 229 ---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 41/224 (18%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVT 742
+G G FG KA + VA+K L ++ +E L ++ HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV--------------------- 781
L G + + + LI Y G+L F+++ +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 782 -LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840
L A I++ + YL + +++HRD+ NIL+ + +SDFGL+R + +++
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 841 TTGVAGTFGYV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
V + G + A E + ++DV+S+GV+L E+++
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-23
Identities = 60/337 (17%), Positives = 110/337 (32%), Gaps = 49/337 (14%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
L L L+ LPD+ + VL + N + +P + +LE L+ N +
Sbjct: 60 QFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPA---SLEYLDACDNRL 112
Query: 63 NGTVPTFIGRLKRVYLSFNRLVGSVPSKIG----------------EKCTNLEHLDLSGN 106
+ T+P LK + + N+L +P E T+LE L + N
Sbjct: 113 S-TLPELPASLKHLDVDNNQLT-MLPELPALLEYINADNNQLTMLPELPTSLEVLSVRNN 170
Query: 107 YLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLE----VLDVSRNSLSGSIPV 162
L +P + +L + +N+L E++PA + E N ++ IP
Sbjct: 171 QL-TFLPELPESL---EALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPE 224
Query: 163 DLGNCSKLAILVLS-NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNL 221
++ + ++L N + S+ + D F+ +G L +
Sbjct: 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY-HGPRIYFSMSDGQQNTLHRPLADA 283
Query: 222 RILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG 281
W P W E + F + L L + Q+
Sbjct: 284 VTAWFPENKQSD-VSQIW---HAFEHEEHANTFSA--FLDRLSDTVSARNTSGFREQVAA 337
Query: 282 ELAR--ELPVPCMTMFDVSGNALS----GSIPTFSNM 312
L + F V+ +A T++N+
Sbjct: 338 WLEKLSASAELRQQSFAVAADATESCEDRVALTWNNL 374
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 42/194 (21%), Positives = 74/194 (38%), Gaps = 20/194 (10%)
Query: 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
+LE LD N L+ LP+ SL+ L++ N++T +P + LE +N N
Sbjct: 100 ASLEYLDACDNRLS-TLPEL---PASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQ 151
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
+ +P L+ + + N+L +P +LE LD+S N L +P
Sbjct: 152 LT-MLPELPTSLEVLSVRNNQL-TFLPELPE----SLEALDVSTNLLES-LPAVPVRNHH 204
Query: 122 VRSLLLF----SNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+F N + IP + L + + N LS I L +
Sbjct: 205 SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPR 263
Query: 178 LFDTYEDVRYSRGQ 191
++ + D + +
Sbjct: 264 IYFSMSDGQQNTLH 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 5e-21
Identities = 48/312 (15%), Positives = 87/312 (27%), Gaps = 60/312 (19%)
Query: 3 NLEVLDLEGNLLN---GILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG 59
E L G N +L + + L L ++ +P + + L +
Sbjct: 35 KWEKQALPGENRNEAVSLLKEC--LINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQ 89
Query: 60 NLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
N + ++P L+ + NRL ++P +L+HLD+ N L +P
Sbjct: 90 NAL-ISLPELPASLEYLDACDNRLS-TLPELPA----SLKHLDVDNNQLT-MLPELPAL- 141
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLF 179
+ + +N L +P +LEVL V N L+ +P + L L +S
Sbjct: 142 --LEYINADNNQL-TMLPELPT---SLEVLSVRNNQLT-FLPELPES---LEALDVST-- 189
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----F 235
N E +P + N
Sbjct: 190 -------------------------NLLE-SLPAVPVRNHHSEETEI-FFRCRENRITHI 222
Query: 236 PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMF 295
P N + D + L N S + + + + +
Sbjct: 223 PENILSLDPTCTIILEDNPLSSR-IRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA 281
Query: 296 DVSGNALSGSIP 307
D +
Sbjct: 282 DAVTAWFPENKQ 293
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 3e-18
Identities = 48/292 (16%), Positives = 94/292 (32%), Gaps = 26/292 (8%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+L+ LD++ N L +LP+ L +N N++T +P + +LE L++ N
Sbjct: 119 PASLKHLDVDNNQLT-MLPEL---PALLEYINADNNQLT-MLPELPT---SLEVLSVRNN 170
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLE----HLDLSGNYLVGGIPRSL 116
+ +P L+ + +S N L S+P+ + + E N + IP ++
Sbjct: 171 QLT-FLPELPESLEALDVSTNLLE-SLPAVPV-RNHHSEETEIFFRCRENRIT-HIPENI 226
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS 176
+ +++L N L I L R S S LA V +
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286
Query: 177 NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFP 236
+ + + + + F+ F + +S + R R +
Sbjct: 287 WFPENKQSDVSQIWHAFEHEEH--ANTFSAF----LDRLSDTVSARNTSGFREQVAAWLE 340
Query: 237 SNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP 288
L + L + +L L + + L
Sbjct: 341 ----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLF 388
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 6e-18
Identities = 45/218 (20%), Positives = 78/218 (35%), Gaps = 43/218 (19%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
LS S P N + ++ L ++ N + LP SL++LDA N++
Sbjct: 67 NRLNLS-SLPDN---LPPQITVL--EITQNAL-ISLPELPA----SLEYLDACDNRLST- 114
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLL- 511
+P SL L++ N + +P L+Y++ N LT +P L++L
Sbjct: 115 LP---ELPASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTSLEVLS 166
Query: 512 ----------------EVLDLSSNSLSGLIPDDLENLRNLTVLL----LNNNKLSGKIPS 551
E LD+S+N L L P + N+++ IP
Sbjct: 167 VRNNQLTFLPELPESLEALDVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRIT-HIPE 224
Query: 552 GLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNP 589
+ ++ + N LS + S + P
Sbjct: 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 7e-17
Identities = 58/350 (16%), Positives = 100/350 (28%), Gaps = 76/350 (21%)
Query: 31 LNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPT----FIGRLKRVYLSFNRLVGS 86
N +N I+G FS + E+ L G N V I + + L+ L S
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-S 73
Query: 87 VPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNL 146
+P + + L+++ N L+ +P + + L N L +P L++
Sbjct: 74 LPDNLP---PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLST-LPELPASLKH- 124
Query: 147 EVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNF 206
LDV N L+ +P L + N N
Sbjct: 125 --LDVDNNQLT-MLPELPAL---LEYINADN---------------------------NQ 151
Query: 207 FEGGIPEAVSSLPNLRILWAPRATLEGN----FPSNWGACDNLEMLNLGHNFFSG--KNL 260
+PE +L +L + N P ++LE L++ N
Sbjct: 152 LT-MLPE---LPTSLEVLS-----VRNNQLTFLPE---LPESLEALDVSTNLLESLPAVP 199
Query: 261 GVLGPCKNLL-FLDLSSNQLTGELARELPV-----PCMTMFDVSGNALSGSIPTFSNMVC 314
+ F N++T +P + N LS I +
Sbjct: 200 VRNHHSEETEIFFRCRENRIT-----HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254
Query: 315 PPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFG 364
Y ++ S + P + I+H F
Sbjct: 255 AQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFE 304
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 4e-15
Identities = 34/163 (20%), Positives = 53/163 (32%), Gaps = 17/163 (10%)
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQI 477
N NN++ LP SL+ L NQ+ +P SL AL++S NL+ +
Sbjct: 146 NADNNQL-TMLPELPT----SLEVLSVRNNQLTF-LP---ELPESLEALDVSTNLLE-SL 195
Query: 478 PTTLGQMKGLK----YLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLR 533
P + + + N +T IP ++ L + L N LS I + L
Sbjct: 196 PAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254
Query: 534 NLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
S + G N + S
Sbjct: 255 AQPDYHGPRIYFS--MSDGQQNTLHRPLADAVTAWFPENKQSD 295
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 62/438 (14%), Positives = 114/438 (26%), Gaps = 122/438 (27%)
Query: 124 SLLLFSNMLEET---IPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
S F N + T + + + +RN + ++ + L L+ L
Sbjct: 14 SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFSELQLNRL-- 69
Query: 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FP 236
+L +P+ + P + +L + N P
Sbjct: 70 -----------NLSS---------------LPDNL--PPQITVLE-----ITQNALISLP 96
Query: 237 SNWGACDNLEMLNLGHNFFSGKNLGVLGP-CKNLLFLDLSSNQLTGELARELP--VPCMT 293
+LE L+ N L L +L LD+ +NQLT LP +
Sbjct: 97 ELPA---SLEYLDACDN-----RLSTLPELPASLKHLDVDNNQLT-----MLPELPALLE 143
Query: 294 MFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGR 353
+ N L+ +P L +L LS+
Sbjct: 144 YINADNNQLTM------------LPELPTSL--------EVLSV---------------- 167
Query: 354 DGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICN-RL 412
NN LP +P + E L N L S P +
Sbjct: 168 -----------RNNQLTFLPELPESLEALD--------VSTNLLE-SLPAVPVRNHHSEE 207
Query: 413 DSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNL 472
+ NRI +P I + N + I + + + +
Sbjct: 208 TEIFFRCRENRIT-HIPENILS-LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265
Query: 473 MHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENL 532
+ L + S + Q+ + +N+ S D L +
Sbjct: 266 FSMSDGQQNTLHRPLADAVT--AWFPENKQSDVSQIWHAFEHEEHANTFSA-FLDRLSDT 322
Query: 533 RNLTVLLLNNNKLSGKIP 550
+ +++ +
Sbjct: 323 VSARNTSGFREQVAAWLE 340
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 7e-09
Identities = 28/118 (23%), Positives = 44/118 (37%), Gaps = 17/118 (14%)
Query: 466 LNLSWNLMHDQIPTT-------LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSS 518
+LS N ++ I T + + N + L + L L+
Sbjct: 11 FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNR 68
Query: 519 NSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
+LS L PD+L +TVL + N L +P A++ L + N LS LP
Sbjct: 69 LNLSSL-PDNL--PPQITVLEITQNALI-SLPELPASLEYL---DACDNRLST-LPEL 118
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRFQ-GVQQFHA--EIKTLGRLRHPNLVTLIGY 746
IG G +G YKA+ + G A+K++ + + G+ EI L L+H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP-STTIREISILKELKHSNIVKLYDV 68
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
++ + L++ +L +L+ + ++ L + +AY HD+ RVLH
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV-SDKA 865
RD+KP N+L++ + ++DFGLAR G T + T Y AP+ M + S
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTI 182
Query: 866 DVYSYGVVLLELLSDKKAL 884
D++S G + E+++ L
Sbjct: 183 DIWSVGCIFAEMVN-GTPL 200
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
+F IG G FG + + A+K + V+ E++ + L HP
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
LV L E +MF++ + L GG+L +Q ++ + V I ++ AL YL +
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFIC-ELVMALDYLQN 133
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
Q R++HRD+KP NILLD+ + +++DF +A +L T +AGT Y+APE +
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSS 188
Query: 859 CRVS--DKA-DVYSYGVVLLELL 878
+ + A D +S GV ELL
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELL 211
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPNLV 741
+G G FG +A+ + VA+K L G + +E+K L + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 742 TLIGY-HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV--------------LHKIA 786
L+G + +I + GNL +++ + V ++V L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAG 846
+A+ + +L + + +HRD+ NILL + + DFGLAR + + V
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRK 207
Query: 847 TFGYV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
+ APE + ++DV+S+GV+L E+ S
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 29/206 (14%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
IG+G G A + VAIK+L+ FQ Q HA E+ + + H N++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS-RPFQ--NQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 744 IGYHASET------EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHK--IALDIARALAY 795
+ + +++++ + NL IQ + + + +
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHE------RMSYLLYQMLCGIKH 142
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
LH ++HRD+KPSNI++ D + DFGLAR G S T T Y APE
Sbjct: 143 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEV 197
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDK 881
+ + D++S G ++ E++
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPNLVTLIGY 746
+GNG + YK + GV VA+K + + +G A EI + L+H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP-STAIREISLMKELKHENIVRLYDV 71
Query: 747 HASETEMFLIYNYLP---GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+E ++ L++ ++ +++ + R ++ ++ + + LA+ H+ +
Sbjct: 72 IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---K 128
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV-S 862
+LHRD+KP N+L++ L DFGLAR G ++ V T Y AP+ M R S
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYS 187
Query: 863 DKADVYSYGVVLLELLSDKKALDP 886
D++S G +L E+++ K L P
Sbjct: 188 TSIDIWSCGCILAEMIT-GKPLFP 210
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 39/208 (18%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIK---RLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G G FG A VA+K R + + + EI L LRHP+++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR--------ALAYLH 797
+ T++ ++ Y GG L ++I ++ ++ D R A+ Y H
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKK----------RMTEDEGRRFFQQIICAIEYCH 125
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE--- 854
+++HRD+KP N+LLDD+ N ++DFGL+ ++ T+ G+ Y APE
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN 180
Query: 855 ---YAMTCRVSDKADVYSYGVVLLELLS 879
YA + DV+S G+VL +L
Sbjct: 181 GKLYA-----GPEVDVWSCGIVLYVMLV 203
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 29/211 (13%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVT 742
+G+G FG Y+ ++ + VA+K L Q F E + + H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH-----KIALDIARALAYLH 797
IG F++ + GG+L++F+++ R L +A DIA YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 798 DQ-CVPRVLHRDVKPSNILLD---DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV-- 851
+ + HRD+ N LL A + DFG+AR + + + G +
Sbjct: 158 ENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC----AMLPV 209
Query: 852 ---APEYAMTCRVSDKADVYSYGVVLLELLS 879
PE M + K D +S+GV+L E+ S
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 690 IGNGGFGATYKA---EISPGVLVAIKRLAVGRFQGVQQFHA-EIKTLGRLRHPNLVTLIG 745
+G G +G YKA + A+K++ G+ EI L L+HPN+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACREIALLRELKHPNVISLQK 85
Query: 746 --YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH-------KIALDIARALAYL 796
++ +++L+++Y +L + I+ + + + + I + YL
Sbjct: 86 VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAY----LSDFGLARLLGP---SETHATTGVAGTFG 849
H VLHRD+KP+NIL+ + ++D G ARL V TF
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 850 YVAPEYAMTCRVSDKA-DVYSYGVVLLELLSDKKAL 884
Y APE + R KA D+++ G + ELL+ + +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 30/206 (14%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL------AVGRFQGVQQFHAEIKTLGRLRH--PNL 740
+G+GGFG+ Y +S + VAIK + G + E+ L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 741 VTLIGYHASETEMFLIYNY-LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+ L+ + LI P +L +FI +R A+ + + A+ + H+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC 168
Query: 800 CVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
VLHRD+K NIL+D + L DFG LL + GT Y PE+
Sbjct: 169 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEW--- 219
Query: 859 CRVSDK------ADVYSYGVVLLELL 878
+ A V+S G++L +++
Sbjct: 220 --IRYHRYHGRSAAVWSLGILLYDMV 243
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 9e-23
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--------EIKTLGRLRHPNL 740
+G G F YKA + + +VAIK++ + + EIK L L HPN+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
+ L+ ++ + L+++++ +LE I+ S + + L + L YLH
Sbjct: 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEYLHQH- 131
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAMTC 859
+LHRD+KP+N+LLD++ L+DFGLA+ G P+ + T V T Y APE
Sbjct: 132 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVV-TRWYRAPELLFGA 187
Query: 860 RVSDKA-DVYSYGVVLLELLSDKKALDP 886
R+ D+++ G +L ELL + P
Sbjct: 188 RMYGVGVDMWAVGCILAELLL-RVPFLP 214
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 43/225 (19%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVT 742
IG G FG ++A P +VA+K L F E + +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV--------------------- 781
L+G A M L++ Y+ G+L F++ S V
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 782 -LHKIALDIARALAYLHDQ-CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839
IA +A +AYL ++ V HRD+ N L+ ++ ++DFGL+R + ++ +
Sbjct: 175 EQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 840 ATTGVAGTFGYV-----APEYAMTCRVSDKADVYSYGVVLLELLS 879
A + PE R + ++DV++YGVVL E+ S
Sbjct: 231 ----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-23
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
F +G GGFG ++ + G + A K+L + + +G E + L ++
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVD-WRVLHKIALDIARALAYLH 797
+V+L + ++ + L+ + GG+L+ I R + A +I L LH
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLH 303
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
+ R+++RD+KP NILLDD + +SD GLA + +T G GT GY+APE
Sbjct: 304 RE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVK 358
Query: 858 TCRVSDKADVYSYGVVLLELL 878
R + D ++ G +L E++
Sbjct: 359 NERYTFSPDWWALGCLLYEMI 379
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
+F +G G F A E++ AIK L + + V E + RL HP
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
V L + +++ +Y G L +I+ + + A +I AL YLH
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALEYLHG 148
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-VAGTFGYVAPEYAM 857
+ ++HRD+KP NILL++D + ++DFG A++L P A GT YV+PE
Sbjct: 149 K---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 858 TCRVSDKADVYSYGVVLLELLS 879
+D+++ G ++ +L++
Sbjct: 206 EKSACKSSDLWALGCIIYQLVA 227
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLRHPN 739
+ + +G G + YK LVA+K + + +G A E+ L L+H N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-CTAIREVSLLKDLKHAN 61
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+VTL +E + L++ YL +L+ ++ ++ + + R LAY H Q
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLLRGLAYCHRQ 119
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAMT 858
+VLHRD+KP N+L+++ L+DFGLAR P++T+ V T Y P+ +
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYRPPDILLG 174
Query: 859 CRV-SDKADVYSYGVVLLELLSDKKALDP 886
S + D++ G + E+ + + L P
Sbjct: 175 STDYSTQIDMWGVGCIFYEMAT-GRPLFP 202
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 29/211 (13%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVT 742
+G+G FG Y+ ++ + VA+K L Q F E + + H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLH-----KIALDIARALAYLH 797
IG F++ + GG+L++F+++ R L +A DIA YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 798 DQ-CVPRVLHRDVKPSNILLD---DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV-- 851
+ + HRD+ N LL A + DFG+AR + + + G +
Sbjct: 199 ENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGCAMLPV 250
Query: 852 ---APEYAMTCRVSDKADVYSYGVVLLELLS 879
PE M + K D +S+GV+L E+ S
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 6e-22
Identities = 57/206 (27%), Positives = 79/206 (38%), Gaps = 38/206 (18%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG+G FG LVA+K + G + EI LRHPN+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR--------ALAYLHDQC 800
+ T + +I Y GG L I + + D AR ++Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAG----------RFSEDEARFFFQQLLSGVSYCHSM- 135
Query: 801 VPRVLHRDVKPSNILLDDDF--NAYLSDFGLARLLGPSETHATTGVAGTFGYVAPE---- 854
++ HRD+K N LLD + DFG ++ +T GT Y+APE
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 191
Query: 855 --YAMTCRVSDKADVYSYGVVLLELL 878
Y ADV+S GV L +L
Sbjct: 192 QEYD-----GKIADVWSCGVTLYVML 212
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQ-GVQQFHA--EIKTLGRLRHPNLVTLIG 745
+G G +G YKA + VAIKR+ + + GV A E+ L L+H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP-GTAIREVSLLKELQHRNIIELKS 100
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ LI+ Y +L+ ++ V RV+ + + + H + R L
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSR---RCL 154
Query: 806 HRDVKPSNILLDDDFNAY-----LSDFGLARLLG-PSETHATTGVAGTFGYVAPEYAMTC 859
HRD+KP N+LL + + DFGLAR G P T + T Y PE +
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TLWYRPPEILLGS 212
Query: 860 RV-SDKADVYSYGVVLLELLSDKKAL 884
R S D++S + E+L K L
Sbjct: 213 RHYSTSVDIWSIACIWAEMLM-KTPL 237
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-21
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 29/206 (14%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
IG+G G A + VAIK+L+ FQ Q HA E+ + + H N+++L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQ--NQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 744 --IGYHASETEMF----LIYNYLPGGNLENFIQQRSTRAVDWRVLHK--IALDIARALAY 795
+ E F L+ + NL IQ + + + +
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE------RMSYLLYQMLCGIKH 179
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
LH + +HRD+KPSNI++ D + DFGLAR G S T T Y APE
Sbjct: 180 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEV 234
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDK 881
+ + D++S G ++ E++ K
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 44/213 (20%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
+G+G +G+ A G VAIK+L+ FQ + A E+ L ++H N++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQ--SEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 744 --IGYHASETEMF----LIYNYLPGGNLENFIQQRSTRAVDWRVLHK--IALDIARALAY 795
+ AS F L+ ++ +L+ + + + + + + L Y
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEE------KIQYLVYQMLKGLKY 141
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV---- 851
+H V+HRD+KP N+ +++D + DFGLAR T GYV
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTRW 188
Query: 852 --APEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
APE ++ ++ D++S G ++ E+L+ K
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-21
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
F +G GGFG + ++ + G L A K+L + + +G Q E K L ++
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDW---RVLHKIALDIARALAY 795
+V+L ++T++ L+ + GG++ I + R + A I L +
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEH 304
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
LH + +++RD+KP N+LLDDD N +SD GLA + T G AGT G++APE
Sbjct: 305 LHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAPEL 360
Query: 856 AMTCRVSDKADVYSYGVVLLELL 878
+ D ++ GV L E++
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMI 383
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 59/291 (20%), Positives = 106/291 (36%), Gaps = 51/291 (17%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN-L 61
+ +LDL+ N ++ + D L+ L L L N+I+ +FS L++L ++ N L
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL-VGGIPRSLGNCF 120
V L + + NR+ VP + N+ +++ GN L G +
Sbjct: 115 VEIPPNLPSS-LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV-DLGNCSKLAILVLSNLF 179
++ L + L IP + + L L + N + +I + DL SKL L L +
Sbjct: 173 KLNYLRISEAKLTG-IPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH-- 226
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----F 235
+Q + ++S LP LR L L+ N
Sbjct: 227 ---------------NQIRMIE----------NGSLSFLPTLRELH-----LDNNKLSRV 256
Query: 236 PSNWGACDNLEMLNLGHNFFSG------KNLGVLGPCKNLLFLDLSSNQLT 280
P+ L+++ L N + +G + L +N +
Sbjct: 257 PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 54/300 (18%), Positives = 92/300 (30%), Gaps = 67/300 (22%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ +L L L N ++ I + L+ L+ L + N + EIP + +L EL + N
Sbjct: 77 LQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDN 133
Query: 61 LVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVG---GIP 113
+ VP F G + + + N L S L +L +S L G +P
Sbjct: 134 RIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP 192
Query: 114 RSLGNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLA 171
+L L L N ++ I E L L L + N + I L L
Sbjct: 193 ETL------NELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLR 244
Query: 172 ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL 231
L L N N +P + L L++++ L
Sbjct: 245 ELHLDN---------------------------NKLS-RVPAGLPDLKLLQVVY-----L 271
Query: 232 EGNF-----------PSNWGACDNLEMLNLGHNFFSGKNL--GVLGPCKNLLFLDLSSNQ 278
N ++L +N + + L + + +
Sbjct: 272 HTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 32/200 (16%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
+NK+S F +L L +S N + ++P + SL L N+I +
Sbjct: 87 NNKIS-KIHEKAFSPLRKLQKL--YISKNHLV-EIPPN---LPSSLVELRIHDNRIRK-V 138
Query: 454 PRGV-GELVSLVALNLSWN-LMHDQIPTTLGQMKGLKYLSLAGNNLTG---SIPSSLGQL 508
P+GV L ++ + + N L + L YL ++ LTG +P +L +L
Sbjct: 139 PKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNEL 198
Query: 509 QL------------------LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP 550
L L L L N + + L L L L L+NNKLS ++P
Sbjct: 199 HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257
Query: 551 SGLANVSTLSAFNVSFNNLS 570
+GL ++ L + NN++
Sbjct: 258 AGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 57/313 (18%), Positives = 103/313 (32%), Gaps = 72/313 (23%)
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALS 303
+L L L +N S + P + L L +S N L E+ LP + + N +
Sbjct: 79 HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP-SSLVELRIHDNRIR 136
Query: 304 GSIP--TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFH 361
+P FS + RN+ + +
Sbjct: 137 -KVPKGVFSGL---------RNMNC--------IEM------------------------ 154
Query: 362 NFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSN 421
G N L + P + + + KL+ P ++ L+ L ++ +
Sbjct: 155 ---GGN---PLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE---TLNEL--HLDH 202
Query: 422 NRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTT 480
N+I + E L L NQI I G L +L L+L N + ++P
Sbjct: 203 NKIQ-AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAG 259
Query: 481 LGQMKGLKYLSLAGNNLTGSIPSS-------LGQLQLLEVLDLSSNSLS--GLIPDDLEN 531
L +K L+ + L NN+T + + + + L +N + + P
Sbjct: 260 LPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
Query: 532 LRNLTVLLLNNNK 544
+ + + N K
Sbjct: 319 VTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 44/201 (21%), Positives = 77/201 (38%), Gaps = 33/201 (16%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
+N +S + F L +L + NN+I+ ++ + + L+ L S N +V I
Sbjct: 63 NNDIS-ELRKDDFKGLQHLYAL--VLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLVE-I 117
Query: 454 PRGV----------------------GELVSLVALNLSWN-LMHDQIPTTLGQMKGLKYL 490
P + L ++ + + N L + L YL
Sbjct: 118 PPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL 177
Query: 491 SLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP 550
++ LT IP L + L L L N + + +DL L L L +N++ I
Sbjct: 178 RISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIE 233
Query: 551 SG-LANVSTLSAFNVSFNNLS 570
+G L+ + TL ++ N LS
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 36/181 (19%), Positives = 71/181 (39%), Gaps = 22/181 (12%)
Query: 393 GDNKL-SGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVG 451
G N L + F F L+ L +S ++ +P + + ++L L N+I
Sbjct: 155 GGNPLENSGFEPGAFDGLK-LNYL--RISEAKLT-GIPKD---LPETLNELHLDHNKIQA 207
Query: 452 PIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL 510
I L L L N + +L + L+ L L N L+ +P+ L L+L
Sbjct: 208 -IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265
Query: 511 LEVLDLSSNSLSGLIPDDLENLR------NLTVLLLNNNKLS-GKIP----SGLANVSTL 559
L+V+ L +N+++ + +D + + L NN + ++ + + +
Sbjct: 266 LQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325
Query: 560 S 560
Sbjct: 326 Q 326
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 20/77 (25%), Positives = 31/77 (40%), Gaps = 3/77 (3%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
+P + L L N+++ LQ L L L +N +S + LR L
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105
Query: 537 VLLLNNNKLSGKIPSGL 553
L ++ N L +IP L
Sbjct: 106 KLYISKNHLV-EIPPNL 121
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 690 IGNGGFGATYKA--EISPGVLVAIKRLAVGRFQ-GVQQFHA--EIKTLGRLR---HPNLV 741
IG G +G +KA + G VA+KR+ V + G+ E+ L L HPN+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRHLETFEHPNVV 77
Query: 742 TLI-----GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
L ET++ L++ ++ +L ++ + V + + + R L +L
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
H RV+HRD+KP NIL+ L+DFGLAR+ T+ V T Y APE
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLWYRAPEVL 191
Query: 857 MTCRVSDKADVYSYGVVLLELLSDKKAL 884
+ + D++S G + E+ +K L
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 57/292 (19%), Positives = 102/292 (34%), Gaps = 52/292 (17%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN-L 61
+ +LDL+ N + I +LK+L L L N+I+ P +F+ V LE L L+ N L
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL-VGGIP-RSLGNC 119
L+ + + N + V + + ++L N L GI +
Sbjct: 113 KELPEKMPKT-LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSNL 178
++ + + + TIP G+ +L L + N ++ + L + LA L LS
Sbjct: 171 KKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSF- 225
Query: 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN---- 234
N ++++ P+LR L L N
Sbjct: 226 --------------------------NSISAVDNGSLANTPHLREL-----HLNNNKLVK 254
Query: 235 FPSNWGACDNLEMLNLGHNFFSGKNLGVLGP------CKNLLFLDLSSNQLT 280
P ++++ L +N S P + + L SN +
Sbjct: 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 57/300 (19%), Positives = 100/300 (33%), Gaps = 68/300 (22%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ NL L L N ++ I P + L L L L N++ E+P L+EL + N
Sbjct: 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHEN 131
Query: 61 LVNGTVP--TFIG--RLKRVYLSFNRL-VGSVPSKIGEKCTNLEHLDLSGNYLVG---GI 112
+ V F G ++ V L N L + + + L ++ ++ + G+
Sbjct: 132 EIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL 190
Query: 113 PRSLGNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKL 170
P SL L L N + + + A L L NL L +S NS+S ++ L N L
Sbjct: 191 PPSL------TELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHL 242
Query: 171 AILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT 230
L L+N N +P ++ +++++
Sbjct: 243 RELHLNN---------------------------NKLV-KVPGGLADHKYIQVVY----- 269
Query: 231 LEGN-----------FPSNWGACDNLEMLNLGHNFFSGKNL--GVLGPCKNLLFLDLSSN 277
L N P + ++L N + + L +
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 16/181 (8%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
+NK+S F +L+ L +S N++ +LP + M K+L+ L N+I +
Sbjct: 85 NNKIS-KISPGAFAPLVKLERL--YLSKNQLK-ELPEK---MPKTLQELRVHENEITK-V 136
Query: 454 PRGV-GELVSLVALNLSWN-LMHDQIP-TTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL 510
+ V L ++ + L N L I MK L Y+ +A N+T +IP L
Sbjct: 137 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPS 193
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNL 569
L L L N ++ + L+ L NL L L+ N +S + +G LAN L +++ N L
Sbjct: 194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL 252
Query: 570 S 570
Sbjct: 253 V 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 38/185 (20%), Positives = 69/185 (37%), Gaps = 18/185 (9%)
Query: 393 GDNKL-SGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVG 451
G N L S F +L + +++ I +P + SL L GN+I
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYI--RIADTNIT-TIPQG---LPPSLTELHLDGNKITK 206
Query: 452 PIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL 510
+ L +L L LS+N + +L L+ L L N L +P L +
Sbjct: 207 -VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 264
Query: 511 LEVLDLSSNSLSGL------IPDDLENLRNLTVLLLNNNKLS-GKIPSGL-ANVSTLSAF 562
++V+ L +N++S + P + + + L +N + +I V +A
Sbjct: 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 563 NVSFN 567
+
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 420 SNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGE-LVSLVALNLSWNLMHDQIP 478
NN+I ++ + K+L L N+I I G LV L L LS N + ++P
Sbjct: 60 QNNKIT-EIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQLK-ELP 116
Query: 479 TTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLLEVLDLSSNSL--SGLIPDDLENLRNL 535
+ K L+ L + N +T + L + V++L +N L SG+ + ++ L
Sbjct: 117 EKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 173
Query: 536 TVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+ + + + ++ IP GL +L+ ++ N ++
Sbjct: 174 SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 205
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 32/162 (19%), Positives = 62/162 (38%), Gaps = 20/162 (12%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
D ++ + P + L L ++ N+I ++ A + +L L S N I
Sbjct: 179 ADTNIT-TIPQGLPP---SLTEL--HLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA- 230
Query: 453 IPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSS------- 504
+ G L L+L+ N + ++P L K ++ + L NN++ +I S+
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGY 288
Query: 505 LGQLQLLEVLDLSSNSL--SGLIPDDLENLRNLTVLLLNNNK 544
+ + L SN + + P + + L N K
Sbjct: 289 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
+P L L L N +T L+ L L L +N +S + P L L
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 537 VLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
L L+ N+L ++P + TL V N ++
Sbjct: 104 RLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT 134
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 34/215 (15%), Positives = 61/215 (28%), Gaps = 70/215 (32%)
Query: 73 LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNML 132
L+ V S L VP + + LDL N + N + +L+L +N +
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 133 EETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQS 192
+ P L LE L +S+N L +P +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM---------------------------- 119
Query: 193 LVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN-----FPSNWGACDNLEM 247
L+ L + N S + + + +
Sbjct: 120 -------------------------PKTLQELR-----VHENEITKVRKSVFNGLNQMIV 149
Query: 248 LNLGHNFFSGKNL--GVLGPCKNLLFLDLSSNQLT 280
+ LG N + G K L ++ ++ +T
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 41/186 (22%), Positives = 70/186 (37%), Gaps = 13/186 (6%)
Query: 1 MGNLEVLDLEGNLLN--GILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLA 58
+ L L L N L+ G S F SL+ L+L FN + + ++F LE L+
Sbjct: 51 LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 109
Query: 59 GNLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR 114
+ + F+ L + +S + I ++LE L ++GN
Sbjct: 110 HSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 115 -SLGNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLA 171
+ L L L E + L +L+VL++S N+ S+ + L
Sbjct: 169 DIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQ 226
Query: 172 ILVLSN 177
+L S
Sbjct: 227 VLDYSL 232
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 52/288 (18%), Positives = 94/288 (32%), Gaps = 67/288 (23%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRIT-GEIPA-SFSDFVNLEELNLAGN 60
+ L+LE N L + L L L+L N ++ + S +L+ L+L+ N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 61 LVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
V F+G +L+ + + L + NL +LD+S +
Sbjct: 89 GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 119 CFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+ L + N +E + L+NL LD+S+ L +
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS---------------- 191
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN--- 234
P A +SL +L++L + N
Sbjct: 192 ----------------------------------PTAFNSLSSLQVLN-----MSHNNFF 212
Query: 235 -FPSNWGAC-DNLEMLNLGHNFFSGKNLGVLGP-CKNLLFLDLSSNQL 279
+ C ++L++L+ N L +L FL+L+ N
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 32/162 (19%), Positives = 60/162 (37%), Gaps = 9/162 (5%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
LE LD + + L + S F L++L L++ F+ +LE L +AGN
Sbjct: 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161
Query: 62 VNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
F L + LS +L + ++L+ L++S N
Sbjct: 162 FQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 118 NCFQVRSLLLFSNMLEETIPAEL--GMLQNLEVLDVSRNSLS 157
++ L N + T + +L L++++N +
Sbjct: 221 CLNSLQVLDYSLNHI-MTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 37/181 (20%), Positives = 71/181 (39%), Gaps = 9/181 (4%)
Query: 394 DNKLS-GSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
N LS L L ++S N + + + + + L+ LD + +
Sbjct: 61 SNGLSFKGCCSQSDFGTTSLKYL--DLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNLKQM 116
Query: 453 IPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQL 510
V L +L+ L++S + L+ L +AGN+ + +L+
Sbjct: 117 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNL 569
L LDLS L L P +L +L VL +++N + + +++L + S N++
Sbjct: 177 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI 235
Query: 570 S 570
Sbjct: 236 M 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 54/265 (20%), Positives = 85/265 (32%), Gaps = 68/265 (25%)
Query: 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN---LVNGTVPTFIG--RLKRVYLSFN 81
S L L N++ F L +L+L+ N + G LK + LSFN
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELG 141
++ ++ S LEHLD + L Q+ +F +
Sbjct: 89 GVI-TMSSNF-LGLEQLEHLDFQHSNLK-----------QMSEFSVFLS----------- 124
Query: 142 MLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFM 200
L+NL LD+S S L +L ++
Sbjct: 125 -LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAG----------------------- 159
Query: 201 NDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FPSNWGAC-DNLEMLNLGHNFF 255
N +F E +P+ + L NL L L +L++LN+ HN F
Sbjct: 160 N---SFQENFLPDIFTELRNLTFLD-----LSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211
Query: 256 SGKNLGVLGPCKNLLFLDLSSNQLT 280
+ +L LD S N +
Sbjct: 212 FSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 35/156 (22%), Positives = 59/156 (37%), Gaps = 5/156 (3%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
+ L ++F L L ++S+ I SL+ L +GN
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYL--DISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQEN 165
Query: 453 IPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLL 511
+ EL +L L+LS + PT + L+ L+++ NN L L
Sbjct: 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 225
Query: 512 EVLDLSSNSLSGLIPDDLENL-RNLTVLLLNNNKLS 546
+VLD S N + +L++ +L L L N +
Sbjct: 226 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 35/144 (24%), Positives = 61/144 (42%), Gaps = 10/144 (6%)
Query: 438 SLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKG---LKYLSLA 493
S L+ N++ +P GV +L L L+LS N G LKYL L+
Sbjct: 29 SATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSN-GLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 494 GNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDL-ENLRNLTVLLLNNNKLSGKIPSG 552
N + ++ S+ L+ LE LD ++L + + +LRNL L +++ +G
Sbjct: 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 553 -LANVSTLSAFNVSFNNLSGPLPS 575
+S+L ++ N+
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLP 168
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 23/113 (20%), Positives = 53/113 (46%), Gaps = 10/113 (8%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLA 58
+ +LEVL + GN F L++L L+L ++ ++ +F+ +L+ LN++
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMS 207
Query: 59 GNLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEK-CTNLEHLDLSGN 106
N ++ + L+ + S N ++ + + + ++L L+L+ N
Sbjct: 208 HNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 24/97 (24%), Positives = 34/97 (35%), Gaps = 5/97 (5%)
Query: 476 QIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLS--GLIPDDLENLR 533
+PT + L L N L +L L L LSSN LS G
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 534 NLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+L L L+ N + + S + L + +NL
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 114
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 21/87 (24%), Positives = 34/87 (39%), Gaps = 4/87 (4%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ NL LDL L + P + L SL+VLN+ N + +L+ L+ + N
Sbjct: 174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 61 ----LVNGTVPTFIGRLKRVYLSFNRL 83
+ F L + L+ N
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 38/245 (15%), Positives = 72/245 (29%), Gaps = 62/245 (25%)
Query: 74 KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLE 133
+ + L SVP+ I ++ L+L N L Q+ L L SN L
Sbjct: 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 134 --ETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQ 191
+L+ LD+S N + ++ + +L L + S +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH----------SNLK 114
Query: 192 SLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLG 251
+ + F++ L NL L +
Sbjct: 115 QMSEFSVFLS----------------LRNLIYLD------------------------IS 134
Query: 252 HNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC--MTMFDVSGNALSGSIP-- 307
H G+ +L L ++ N ++ +T D+S L +
Sbjct: 135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 193
Query: 308 TFSNM 312
F+++
Sbjct: 194 AFNSL 198
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 5/85 (5%)
Query: 488 KYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547
+ LT S+P+ + L+L SN L L + L LT L L++N LS
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 548 KIPSGLA--NVSTLSAFNVSFNNLS 570
K + ++L ++SFN +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI 91
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 53/263 (20%), Positives = 83/263 (31%), Gaps = 40/263 (15%)
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARE---LPVPCMTMFDVSGN 300
+ L L N GV L L LSSN L+ + + D+S N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 301 ALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIF 360
+ F + + + + + +LSL L +L I
Sbjct: 89 GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN----------LI----YLDIS 134
Query: 361 HN----FGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLM 416
H F+G L S+ E L N +F ++F L L
Sbjct: 135 HTHTRVAFNGIFNG-LSSL----EVL--------KMAGNSFQENFLPDIFTELRNLTFL- 180
Query: 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHD 475
++S ++ QL SL+ L+ S N + L SL L+ S N +
Sbjct: 181 -DLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMT 237
Query: 476 QIPTTLGQM-KGLKYLSLAGNNL 497
L L +L+L N+
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDF 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 61/210 (29%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRL--AVGRFQGVQQF----HA-----EIKTLGRLRHP 738
I +G +GA S G+ VAIKR+ V + V EI+ L HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 739 NLVTL--IGYHASETEMFLIYNY--LPGGNLENFIQQRSTRAVDWRVLHK--IALDIARA 792
N++ L I H E M +Y L +L I + H I
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP---QHIQYFMYHILLG 146
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
L LH+ V+HRD+ P NILL D+ + + DF LAR + T Y A
Sbjct: 147 LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRWYRA 201
Query: 853 PEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
PE M + K D++S G V+ E+ + K
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-20
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRL--- 735
+F+ IG GGFG Y G + A+K L + QG E L +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
P +V + + ++ I + + GG+L + Q + + A +I L +
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAA-EIILGLEH 307
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
+H++ V++RD+KP+NILLD+ + +SD GLA + H GT GY+APE
Sbjct: 308 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEV 361
Query: 856 AMTCRVSDKA-DVYSYGVVLLELL 878
D + D +S G +L +LL
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 26/196 (13%), Positives = 54/196 (27%), Gaps = 43/196 (21%)
Query: 689 CIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLI 744
G ++A + VA+ + +Q+ + L R+ P + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRST--RAVDWRVLHKIALDIARALAYLHDQCVP 802
+ ++ ++ GG+L+ + A+ +A A H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAHRA--- 148
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
V PS + + D G L + +
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPD-------AN 180
Query: 863 DKADVYSYGVVLLELL 878
+ D+ G L LL
Sbjct: 181 PQDDIRGIGASLYALL 196
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 29/206 (14%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLR-HPNLVT 742
+G G + ++A I+ V +K L + EIK L LR PN++T
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKKKIKREIKILENLRGGPNIIT 95
Query: 743 L--IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
L I L++ ++ + + Q + + +I +AL Y H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-----RFYMYEILKALDYCHSM- 149
Query: 801 VPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
++HRDVKP N+++D + L D+GLA P + + VA + + PE +
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPELLVDY 205
Query: 860 RVSDKA-DVYSYGVVLLELLSDKKAL 884
++ D + D++S G +L ++ K+
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 52/238 (21%), Positives = 83/238 (34%), Gaps = 59/238 (24%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA----EIKTLGRLRHPNLVTLI 744
+G G FG + G A+K+ V Q E+ + L H N++ L+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRV--------------------LHK 784
Y + + P + + + V LHK
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 785 IALD-------------------IARALAYLHDQCVPRVLHRDVKPSNILLD-DDFNAYL 824
+ + RA+ ++H + HRD+KP N+L++ D L
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKL 183
Query: 825 SDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
DFG A+ L PSE + F Y APE + + D++S G V EL+ K
Sbjct: 184 CDFGSAKKLIPSEPS-VAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-20
Identities = 63/318 (19%), Positives = 112/318 (35%), Gaps = 48/318 (15%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLA 58
+ +L+ L +E ++ ++ F L SL +L L +N+ ++ F+ NLE L L
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLT 111
Query: 59 GN-LVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLV---G 110
L + F L+ + L N + P+ LDL+ N +
Sbjct: 112 QCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE 171
Query: 111 GIPRSLGNCFQVRSLLLFSNMLEETIPAELGM--------LQNLEVLDVSRNSLSGSIP- 161
+ L L S L++ LG ++ LD+S N S+
Sbjct: 172 EDLLNFQGK-HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 162 --VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFE---------GG 210
D +K+ L+LSN ++ ++ + + +F + + +
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF-TFKGLEASGVKTCDLSKSKIFA 289
Query: 211 IPEAV-SSLPNLRILWAPRATLEGN----FPSNWGACD---NLEMLNLGHNFFSGKNLGV 262
+ ++V S +L L L N A +L LNL NF + +
Sbjct: 290 LLKSVFSHFTDLEQLT-----LAQNEINKIDD--NAFWGLTHLLKLNLSQNFLGSIDSRM 342
Query: 263 LGPCKNLLFLDLSSNQLT 280
L LDLS N +
Sbjct: 343 FENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 74/465 (15%), Positives = 136/465 (29%), Gaps = 106/465 (22%)
Query: 96 TNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAEL-GMLQNLEVLDVSRN 154
++ ++DLS N + S ++ L + I L +L +L + N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 155 SLSGSIPVD-LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE 213
+ + L +L L+ N +
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQ-----------------------C---NLDGAVLSG 122
Query: 214 AV-SSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272
L +L +L L N N++ + F + + VL
Sbjct: 123 NFFKPLTSLEMLV-----LRDN---------NIKKIQPASFFLNMRRFHVL--------- 159
Query: 273 DLSSNQ-----------LTGELARELPVPCMTMFDVSGNALSGSIP-TFSNMVCPPVPYL 320
DL+ N+ G+ L + +T+ D++ L L
Sbjct: 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDL 219
Query: 321 SRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPE 380
S N F+ + ++ AGT + + +FG NF
Sbjct: 220 SGNGFKESMAKRFFDAI------AGTKIQSLILSNSYNMGSSFGHTNFK----------- 262
Query: 381 RLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLK 440
F ++S ++I L + L+
Sbjct: 263 -------------------DPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLE 302
Query: 441 FLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTG 499
L + N+I I L L+ LNLS N + + L+ L L+ N++
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR- 360
Query: 500 SIPS-SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543
++ S L L+ L L +N L + + L +L + L+ N
Sbjct: 361 ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 63/370 (17%), Positives = 106/370 (28%), Gaps = 43/370 (11%)
Query: 212 PEAVSSLPNLRILWAPRATLEGNFPSNWGACD---NLEMLNLGHNFFSGKNLGVLGPCKN 268
+ S L +L+ L + T + +L +L L +N F G N
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRN--NTFRGLSSLIILKLDYNQFLQLETGAFNGLAN 104
Query: 269 LLFLDLSSNQLTGELARE---LPVPCMTMFDVSGNALSGSIP--TFSNMVCPPVPYLSRN 323
L L L+ L G + P+ + M + N + P F NM V L+ N
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
Query: 324 LFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLG 383
+S L+ + P +
Sbjct: 165 KVKS-ICEEDLLNF--------QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
Query: 384 KQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQ-LPAEIGRMCKSLKFL 442
+ N S F + +SN+ G + + F
Sbjct: 216 TLDLS-----GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 443 DASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP 502
+ + +LS + + + + L+ L+LA N + I
Sbjct: 271 GLEAS--------------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KID 315
Query: 503 S-SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGL-ANVSTLS 560
+ L L L+LS N L + ENL L VL L+ N + + + L
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLK 374
Query: 561 AFNVSFNNLS 570
+ N L
Sbjct: 375 ELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 35/159 (22%), Positives = 59/159 (37%), Gaps = 10/159 (6%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N ++ F L L V + R SL L NQ + +
Sbjct: 39 LNSIA-ELNETSFSRLQDLQFL--KVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-L 94
Query: 454 PRGV-GELVSLVALNLSWNLMHDQI--PTTLGQMKGLKYLSLAGNNLTGSIPSSL-GQLQ 509
G L +L L L+ + + + L+ L L NN+ P+S ++
Sbjct: 95 ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR 154
Query: 510 LLEVLDLSSNSLSGLIPDDLENL--RNLTVLLLNNNKLS 546
VLDL+ N + + +DL N ++ T+L L++ L
Sbjct: 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ 193
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 8/109 (7%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGNL 61
+LE L L N +N I ++ + L L LNL N + I + F + LE L+L+ N
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNH 358
Query: 62 VNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
+ + +F+G LK + L N+L SVP I ++ T+L+ + L N
Sbjct: 359 I-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 23/113 (20%), Positives = 44/113 (38%), Gaps = 3/113 (2%)
Query: 461 VSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLLEVLDLSSN 519
+ ++LS N + + T+ +++ L++L + I + + L L +L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 520 SLSGLIPDDLENLRNLTVLLLNNNKL-SGKIPSGL-ANVSTLSAFNVSFNNLS 570
L L NL VL L L + +++L + NN+
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 43/230 (18%), Positives = 70/230 (30%), Gaps = 55/230 (23%)
Query: 1 MGNLEVLDLEGNLLNGILPDS--GFHLKSLRVLNLGFN--------RITGEIPASFSDFV 50
M VLDL N + I + F K +L L + E +
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
Query: 51 NLEELNLAGNLVNGTVP--------------------------------------TFIG- 71
++ L+L+GN ++ TF G
Sbjct: 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGL 272
Query: 72 ---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLF 128
+K LS +++ ++ + T+LE L L+ N + + + L L
Sbjct: 273 EASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLS 331
Query: 129 SNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDL-GNCSKLAILVLSN 177
N L L LEVLD+S N + ++ L L L
Sbjct: 332 QNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDT 380
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 31/193 (16%), Positives = 54/193 (27%), Gaps = 17/193 (8%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRI-AGQLPAEIGRMCKSLKFLDASGNQIVG 451
N+ F L+ L ++ + L + SL+ L N I
Sbjct: 87 DYNQFL-QLETGAFNGLANLEVL--TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK 143
Query: 452 PIPRGV-GELVSLVALNLSWNLMHDQIPTTL---GQMKGLKYLSLAGNNLT--------G 499
P + L+L++N + I Q K L L+ L
Sbjct: 144 IQPASFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202
Query: 500 SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTL 559
+ + + LDLS N + + T + S + S + +
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
Query: 560 SAFNVSFNNLSGP 572
N +F L
Sbjct: 263 DPDNFTFKGLEAS 275
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 15/80 (18%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 494 GNNLTG--SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPS 551
L +P+ + +DLS NS++ L L++L L + I +
Sbjct: 19 NRGLHQVPELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN 72
Query: 552 GL-ANVSTLSAFNVSFNNLS 570
+S+L + +N
Sbjct: 73 NTFRGLSSLIILKLDYNQFL 92
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 33/210 (15%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
IG G +G A + V VAIK+++ F+ Q + EIK L R RH N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISP--FE--HQTYCQRTLREIKILLRFRHENIIGI 90
Query: 744 IG-YHASETEMF----LIYNYLPGGNLENFIQ-QRSTRAVDWRVLHK--IALDIARALAY 795
A E ++ + + +L ++ Q + H I R L Y
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSND------HICYFLYQILRGLKY 143
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA---TTGVAGTFGYVA 852
+H VLHRD+KPSN+LL+ + + DFGLAR+ P H T VA T Y A
Sbjct: 144 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRA 199
Query: 853 PEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
PE + + K+ D++S G +L E+LS++
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-20
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 688 NCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQ---FHA--EIKTLGRLRHPNLV 741
IG G FG +KA G VA+K++ + ++ A EIK L L+H N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVV 79
Query: 742 TLIG--------YHASETEMFLIYNYLP---GGNLENFIQQRSTRAVDWRVLHKIALDIA 790
LI Y+ + ++L++++ G L N + + + + ++ +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI-----KRVMQMLL 134
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA----TTGVAG 846
L Y+H ++LHRD+K +N+L+ D L+DFGLAR ++ T V
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190
Query: 847 TFGYVAPEYAMTCRVSDKA-DVYSYGVVLLELLSDKKAL 884
T Y PE + R D++ G ++ E+ + + +
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 38/180 (21%), Positives = 72/180 (40%), Gaps = 7/180 (3%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+ + L GN ++ + S ++L +L L N + A+F+ LE+L+L+ N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 63 NGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
+V TF G RL ++L L + + L++L L N L + +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSN 177
+ L L N + L +L+ L + +N ++ + + +L L L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFA 210
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 47/184 (25%), Positives = 72/184 (39%), Gaps = 11/184 (5%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAG 59
NL +L L N+L I + L L L+L N + + F L L+L
Sbjct: 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114
Query: 60 NLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
+ + F G L+ +YL N L ++P NL HL L GN + R+
Sbjct: 115 CGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 116 LGNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAIL 173
+ LLL N + + L L L + N+LS ++P + L L L
Sbjct: 173 FRGLHSLDRLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYL 230
Query: 174 VLSN 177
L++
Sbjct: 231 RLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 11/163 (6%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLA 58
+ LE LDL N + + F L L L+L + E+ F L+ L L
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQ 137
Query: 59 GNLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR 114
N + +P TF L ++L NR+ SVP + +L+ L L N + P
Sbjct: 138 DNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 115 SLGNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSL 156
+ + ++ +L LF+N L +P E L L+ L+ L ++ N
Sbjct: 196 AFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 9/180 (5%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N++S P F C L L + +N +A ++ A L+ LD S N + +
Sbjct: 41 GNRIS-HVPAASFRACRNLTIL--WLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 454 PRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLL 511
L L L+L + + P + L+YL L N L ++P + L L
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNL 155
Query: 512 EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
L L N +S + L +L LLL+ N+++ + ++ L + NNLS
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 7/178 (3%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N L+ F L+ L ++ N ++ + L L + +
Sbjct: 65 SNVLA-RIDAAAFTGLALLEQLDLS-DNAQLR-SVDPATFHGLGRLHTLHLDRCGLQE-L 120
Query: 454 PRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
G+ L +L L L N + T + L +L L GN ++ + L L+
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNL 569
L L N ++ + P +L L L L N LS +P+ LA + L ++ N
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 5/120 (4%)
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+P G+ + + L N + + + L L L N L ++ L LLE
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 513 VLDLSSNS-LSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
LDLS N+ L + P L L L L+ L ++ G ++ L + N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 52/258 (20%), Positives = 79/258 (30%), Gaps = 48/258 (18%)
Query: 76 VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET 135
L +VP I + + L GN + S C + L L SN+L
Sbjct: 16 TSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 136 IPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSNLFDTYEDVRYSRGQSLV 194
A L LE LD+S N+ S+ +L L L Q L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR----------CGLQEL- 120
Query: 195 DQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FPSN-WGACDNLEMLN 249
F G L L+ L+ L+ N P + + NL L
Sbjct: 121 --------GPGLFRG--------LAALQYLY-----LQDNALQALPDDTFRDLGNLTHLF 159
Query: 250 LGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL--PVPCMTMFDVSGNALSGSIP 307
L N S +L L L N++ + + + + N LS ++P
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALP 217
Query: 308 --TFSNMVCPPVPYLSRN 323
+ + L+ N
Sbjct: 218 TEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 17/84 (20%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 494 GNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG- 552
L ++P + + + L N +S + RNLT+L L++N L+ +I +
Sbjct: 20 QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAA 75
Query: 553 LANVSTLSAFNVSFNNLSGPLPSS 576
++ L ++S N + +
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPA 99
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-20
Identities = 24/134 (17%), Positives = 55/134 (41%), Gaps = 5/134 (3%)
Query: 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNN 496
SL ++ + + + G+ ++ L ++ + P + + L+ L + G +
Sbjct: 44 NSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 497 LTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANV 556
+T +L L L +LD+S ++ I + L + + L+ N I L +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158
Query: 557 STLSAFNVSFNNLS 570
L + N+ F+ +
Sbjct: 159 PELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 24/136 (17%), Positives = 47/136 (34%), Gaps = 5/136 (3%)
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
++K L + P + L +L L + + L + L L ++ +
Sbjct: 65 AHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN 555
SI + + L + +DLS N I L+ L L L + + + G+ +
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DY-RGIED 179
Query: 556 VSTLSAFNVSFNNLSG 571
L+ + G
Sbjct: 180 FPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 34/181 (18%), Positives = 65/181 (35%), Gaps = 18/181 (9%)
Query: 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
G E L+ + N +PDS K+ LG + + + +L + LA
Sbjct: 1 GAAEQTGLKASQDNVNIPDST--FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN 55
Query: 62 VNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSL 116
V T T I +K + ++ + +NLE L + G + +L
Sbjct: 56 V--TDLTGIEYAHNIKDLTINNIHA-----TNYNPISGLSNLERLRIMGKDVTSDKIPNL 108
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS 176
+ L + + +++I ++ L + +D+S N I L +L L +
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQ 167
Query: 177 N 177
Sbjct: 168 F 168
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 23/159 (14%), Positives = 53/159 (33%), Gaps = 33/159 (20%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
N++ L + P SG L +L L + +T + + S +L L+++ +
Sbjct: 67 NIKDLTINNIHATNYNPISG--LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 63 NGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
+ ++ T I ++ + LS+N + + + L+ L++ +
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFD------------- 169
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSG 158
V + L L ++ G
Sbjct: 170 -GVHDYRGIED------------FPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 19/118 (16%), Positives = 49/118 (41%), Gaps = 7/118 (5%)
Query: 459 ELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSS 518
+ + L + + T QM L Y++LA N+T + + + ++ L +++
Sbjct: 21 TFKAYLNGLLGQSSTAN---ITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 519 NSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
+ P + L NL L + ++ L+ +++L+ ++S + + +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 19/109 (17%), Positives = 38/109 (34%), Gaps = 8/109 (7%)
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQI 477
+ + + + SL LD S + I + L + +++LS+N I
Sbjct: 94 RIMGKDVTSDKIPNLSGL-TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN---GAI 149
Query: 478 --PTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGL 524
L + LK L++ + + + L L S ++ G
Sbjct: 150 TDIMPLKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 16/102 (15%), Positives = 36/102 (35%), Gaps = 5/102 (4%)
Query: 213 EAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272
+S L NL L + + N +L +L++ H+ L + + +
Sbjct: 82 NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141
Query: 273 DLSSNQLTGELA--RELPVPCMTMFDVSGNALSGSIPTFSNM 312
DLS N ++ + LP + ++ + + +
Sbjct: 142 DLSYNGAITDIMPLKTLPE--LKSLNIQFDGVH-DYRGIEDF 180
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 50/217 (23%), Positives = 78/217 (35%), Gaps = 35/217 (16%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
+F IG G F G + A+K + + + V F E L
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 739 NLVTLIGYHA--SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR----- 791
+ L + A E ++L+ Y GG+L + + +I ++AR
Sbjct: 122 WITQL--HFAFQDENYLYLVMEYYVGGDLLTLLS---------KFGERIPAEMARFYLAE 170
Query: 792 ---ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF 848
A+ +H +HRD+KP NILLD + L+DFG L T + GT
Sbjct: 171 IVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 849 GYVAPEYAMTCRVSDKADVY-------SYGVVLLELL 878
Y++PE Y + GV E+
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 11/181 (6%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGNL 61
N L+L N + I D+ HL L VL LG N I +I +F+ +L L L N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134
Query: 62 VNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR-SL 116
+ +P F +L+ ++L N + S+PS + +L LDL + I +
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS 176
F ++ L L +++ +P L L LE L++S N P S L L +
Sbjct: 193 EGLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250
Query: 177 N 177
N
Sbjct: 251 N 251
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 46/183 (25%), Positives = 77/183 (42%), Gaps = 11/183 (6%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAG 59
+ +L L+L N L I + +L LR L L N I IP+ +F+ +L L+L
Sbjct: 122 LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGE 180
Query: 60 NLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
+ F G LK + L + +P+ LE L++SGN+ P S
Sbjct: 181 LKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN--LTPLVGLEELEMSGNHFPEIRPGS 237
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILV 174
++ L + ++ + L +L L+++ N+LS S+P D L L
Sbjct: 238 FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELH 296
Query: 175 LSN 177
L +
Sbjct: 297 LHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-18
Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 13/184 (7%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAG 59
+ +LEVL L N + I + L SL L L N +T IP+ +F L EL L
Sbjct: 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRN 156
Query: 60 NLVNGTVP--TFIG--RLKRVYLS-FNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR 114
N + ++P F L R+ L +L + E NL++L+L + +P
Sbjct: 157 NPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP- 212
Query: 115 SLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAIL 173
+L + L + N E P L +L+ L V + +S I + + L L
Sbjct: 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVEL 271
Query: 174 VLSN 177
L++
Sbjct: 272 NLAH 275
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 31/160 (19%), Positives = 59/160 (36%), Gaps = 7/160 (4%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLG-FNRITGEIPASFSDFVNLEELNLAG 59
+ L L L N + I + + SL L+LG ++ +F NL+ LNL
Sbjct: 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 60 NLVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
+ +P L+ + +S N + ++L+ L + + + +
Sbjct: 206 CNIK-DMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD 263
Query: 118 NCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSL 156
+ L L N L ++P + L+ L L + N
Sbjct: 264 GLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 11/180 (6%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N + F L++L + +N + +P+ L+ L N I I
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTL--ELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-I 162
Query: 454 PRGV-GELVSLVALNLS-WNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLL 511
P + SL+ L+L + + LKYL+L N+ +P+ L L L
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGL 220
Query: 512 EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
E L++S N + P L +L L + N+++S I +++L N++ NNLS
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 8e-16
Identities = 36/151 (23%), Positives = 61/151 (40%), Gaps = 5/151 (3%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
+N + S P F L L + ++ + +LK+L+ I
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLG-ELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD- 210
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+P LV L L +S N + P + + LK L + + ++ ++ L L
Sbjct: 211 MPNLTP-LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543
L+L+ N+LS L D LR L L L++N
Sbjct: 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 11/179 (6%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLD-ASGNQIVGP 452
DN L+ P F ++L L + NN I +P+ SL LD ++
Sbjct: 132 DNWLT-VIPSGAFEYLSKLREL--WLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEY- 186
Query: 453 IPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLL 511
I G L +L LNL + D +P L + GL+ L ++GN+ P S L L
Sbjct: 187 ISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 512 EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNL 569
+ L + ++ +S + + + L +L L L +N LS +P + L ++ N
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 3/101 (2%)
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+P+G+ + LNL N + T + L+ L L N++ + L L
Sbjct: 69 VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLN 126
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGL 553
L+L N L+ + E L L L L NN + IPS
Sbjct: 127 TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 45/220 (20%), Positives = 69/220 (31%), Gaps = 52/220 (23%)
Query: 71 GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN 130
+ +V + L VP I +N +L+L N + + + + L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 131 MLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSNLFDTYEDVRYSR 189
+ + L +L L++ N L+ IP SKL L L N
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRN------------ 156
Query: 190 GQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILW---------APRATLEGNFPSNWG 240
N E A + +P+L L EG
Sbjct: 157 ---------------NPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG------- 194
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
NL+ LNLG ++ L P L L++S N
Sbjct: 195 -LFNLKYLNLGMCNIK--DMPNLTPLVGLEELEMSGNHFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 17/85 (20%), Positives = 35/85 (41%), Gaps = 5/85 (5%)
Query: 487 LKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546
+ L+ +P + L+L N++ + D +L +L VL L N +
Sbjct: 56 FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 547 GKIPSG-LANVSTLSAFNVSFNNLS 570
+I G +++L+ + N L+
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNWLT 136
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 53/180 (29%), Positives = 77/180 (42%), Gaps = 9/180 (5%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
N +L+L N + I +S HL+ L +L L N I +F+ NL L L N +
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 63 NGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR-SLG 117
T+P F+ +LK ++L N + S+PS + +L LDL + I +
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+R L L L E IP L L L+ LD+S N LS P L L +
Sbjct: 183 GLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 9/182 (4%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAG 59
+ +LE+L L N + I + L +L L L NR+T IP +F L+EL L
Sbjct: 87 LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRN 145
Query: 60 NL---VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL 116
N + I L+R+ L + + + E +NL +L+L+ L IP +L
Sbjct: 146 NPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NL 203
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVL 175
++ L L N L P L +L+ L + ++ + I + N L + L
Sbjct: 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINL 262
Query: 176 SN 177
++
Sbjct: 263 AH 264
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 11/183 (6%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAG 59
+ NL L+L N L I + +L L+ L L N I IP+ +F+ +L L+L
Sbjct: 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGE 169
Query: 60 NLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
+ F G L+ + L+ L +P+ L+ LDLSGN+L P S
Sbjct: 170 LKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPGS 226
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILV 174
++ L + + ++ LQ+L ++++ N+L+ +P D L +
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIH 285
Query: 175 LSN 177
L +
Sbjct: 286 LHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 9/161 (5%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLG-FNRITGEIPA-SFSDFVNLEELNLA 58
+ L+ L L N + I + + SLR L+LG R++ I +F NL LNLA
Sbjct: 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLA 193
Query: 59 GNLVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL 116
+ +P +L + LS N L ++ + +L+ L + + + +
Sbjct: 194 MCNLR-EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251
Query: 117 GNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSL 156
N + + L N L +P + L +LE + + N
Sbjct: 252 DNLQSLVEINLAHNNL-TLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 11/180 (6%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N + + F L++L + +NR+ +P LK L N I I
Sbjct: 97 RNHIR-TIEIGAFNGLANLNTL--ELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-I 151
Query: 454 PRGV-GELVSLVALNLS-WNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLL 511
P + SL L+L + + L+YL+LA NL IP+ L L L
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKL 209
Query: 512 EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
+ LDLS N LS + P + L +L L + +++ I N+ +L N++ NNL+
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 11/179 (6%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLD-ASGNQIVGP 452
DN+L+ + P F ++L L + NN I +P+ SL+ LD ++
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKEL--WLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSY- 175
Query: 453 IPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLL 511
I G L +L LNL+ + + IP L + L L L+GN+L+ P S L L
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233
Query: 512 EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNL 569
+ L + + + + + +NL++L + L +N L+ +P + L ++ N
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 35/136 (25%), Positives = 53/136 (38%), Gaps = 5/136 (3%)
Query: 438 SLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNL 497
+ + L+ NQI L L L LS N + + L L L N L
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 498 TGSIPS-SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVL-LLNNNKLSGKIPSG-LA 554
T +IP+ + L L+ L L +N + + + +L L L +LS I G
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFE 182
Query: 555 NVSTLSAFNVSFNNLS 570
+S L N++ NL
Sbjct: 183 GLSNLRYLNLAMCNLR 198
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 26/117 (22%), Positives = 46/117 (39%), Gaps = 4/117 (3%)
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+P G+ + LNL N + + ++ L+ L L+ N++ + L L
Sbjct: 58 VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGL-ANVSTLSAFNVSFNN 568
L+L N L+ + L L L L NN + IPS + +L ++
Sbjct: 116 TLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 52/304 (17%), Positives = 93/304 (30%), Gaps = 83/304 (27%)
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL--PVPCMTMFDVSGNA 301
N +LNL N + ++L L LS N + + + + ++ N
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNR 123
Query: 302 LSGSIP--TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAI 359
L+ +IP F + L L
Sbjct: 124 LT-TIPNGAFVYL-----------------SKLKELWL---------------------- 143
Query: 360 FHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNV 419
N S+PS A R+ + +LS F + L L N+
Sbjct: 144 ----RNNPIE-SIPSY--AFNRIPSLRRLDL-GELKRLS-YISEGAFEGLSNLRYL--NL 192
Query: 420 SNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPT 479
+ + ++P L LD SGN + I G
Sbjct: 193 AMCNLR-EIPN--LTPLIKLDELDLSGNHLSA-IRPG----------------------- 225
Query: 480 TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLL 539
+ + L+ L + + + ++ LQ L ++L+ N+L+ L D L +L +
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIH 285
Query: 540 LNNN 543
L++N
Sbjct: 286 LHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 51/220 (23%), Positives = 67/220 (30%), Gaps = 52/220 (23%)
Query: 71 GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN 130
+ +V L VP I TN L+L N + S + + L L N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 131 MLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSNLFDTYEDVRYSR 189
+ L NL L++ N L+ +IP SKL L L N
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRN------------ 145
Query: 190 GQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILW---------APRATLEGNFPSNWG 240
N E A + +P+LR L EG
Sbjct: 146 ---------------NPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG------- 183
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
NL LNL + L P L LDLS N L+
Sbjct: 184 -LSNLRYLNLAMCNLR--EIPNLTPLIKLDELDLSGNHLS 220
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 13/205 (6%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
+F IG G FG + + A+K L + + F E L
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
+ TL + ++L+ +Y GG+L + + R + +A ++ A+ +H
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQ 193
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+HRD+KP NIL+D + + L+DFG L T ++ GT Y++PE
Sbjct: 194 L---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 859 CRVSDK-----ADVYSYGVVLLELL 878
D +S GV + E+L
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEML 275
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
+G G +G A P G +VAIK++ F + A EIK L +H N++T+
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEP--FD--KPLFALRTLREIKILKHFKHENIITI 74
Query: 744 IG-YHASETEMF----LIYNYLPGGNLENFIQ-QRSTRAVDWRVLHK--IALDIARALAY 795
E F +I + +L I Q + H RA+
Sbjct: 75 FNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDD------HIQYFIYQTLRAVKV 127
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF---GYV- 851
LH V+HRD+KPSN+L++ + + + DFGLAR++ S + +V
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 852 -----APEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
APE +T +A DV+S G +L EL +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 52/217 (23%), Positives = 79/217 (36%), Gaps = 42/217 (19%)
Query: 684 FNASNCIGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHPN 739
+ IG G FG S + A+K L + + F E + P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR-------- 791
+V L + ++++ Y+PGG+L + + + AR
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDL--VNLMSN---------YDVPEKWARFYTAEVVL 179
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851
AL +H +HRDVKP N+LLD + L+DFG + GT Y+
Sbjct: 180 ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 852 APE----------YAMTCRVSDKADVYSYGVVLLELL 878
+PE Y C D +S GV L E+L
Sbjct: 237 SPEVLKSQGGDGYYGREC------DWWSVGVFLYEML 267
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 688 NCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLV 741
+ +G+G +G+ A + G+ VA+K+L+ FQ HA E++ L ++H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQ--SIIHAKRTYRELRLLKHMKHENVI 91
Query: 742 TLI------GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
L+ +++L+ + + G +L N + + + D V + I R L Y
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQKLTDDHVQF-LIYQILRGLKY 147
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
+H ++HRD+KPSN+ +++D + DFGLAR + T VA T Y APE
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVA-TRWYRAPEI 200
Query: 856 AMTCRVSDKA-DVYSYGVVLLELLSDK 881
+ ++ D++S G ++ ELL+ +
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 7e-19
Identities = 88/549 (16%), Positives = 161/549 (29%), Gaps = 107/549 (19%)
Query: 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGS 86
+ L+L N I+ S L L L S NR+ S
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRL---------------------SHNRI-RS 90
Query: 87 VPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNL 146
+ + +LE+LD+S N L + I + +L
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRL-------------------------QNISC--CPMASL 123
Query: 147 EVLDVSRNSLSGSIPV--DLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDF 204
LD+S N +PV + GN +KL L LS F D
Sbjct: 124 RHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSA-------------------AKFRQLDL 163
Query: 205 NFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLG 264
L +L E N L ++ ++ FS + +
Sbjct: 164 LPVAHL--HLSCILLDLVSYHIKGGETESLQIPN---TTVLHLVFHPNSLFSVQVNMSVN 218
Query: 265 PCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNL 324
+L ++ N + + L T+ V + R +
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278
Query: 325 --FESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERL 382
YN + + + + T L + + F S ++
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKS-------LMIEHVKNQVFLFSKEALY---SVF 328
Query: 383 GKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFL 442
+ + + + + L N + N + K L+ L
Sbjct: 329 AEMNIKML--SISDTP-FIHMVCPPSPSSFTFL--NFTQNVF-TDSVFQGCSTLKRLQTL 382
Query: 443 DASGNQIVGPIPRGVGELVSLVALNLSWN----LMHDQIPTTLGQMKGLKYLSLAGNNLT 498
N + + ++ +L L T + + L+L+ N LT
Sbjct: 383 ILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
Query: 499 GSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG----LA 554
GS+ L ++VLDL +N + + P D+ +L+ L L + +N+L +P G L
Sbjct: 442 GSVFRCL--PPKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLK-SVPDGVFDRLT 497
Query: 555 NVSTLSAFN 563
++ + +
Sbjct: 498 SLQYIWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 9e-18
Identities = 82/510 (16%), Positives = 155/510 (30%), Gaps = 70/510 (13%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAGNL 61
+ L L N ++ + L LRVL L NRI + F +LE L+++ N
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
+ + L+ + LSFN K T L L LS + +
Sbjct: 112 LQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHL 171
Query: 122 VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDT 181
LL + + E + N VL + + S + + L L LSN+
Sbjct: 172 SCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231
Query: 182 YEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT----------- 230
E+ + + S+ + W
Sbjct: 232 DENCQRLMTFLSELTRGPTLLNVTLQHIETTWK-CSVKLFQFFWPRPVEYLNIYNLTITE 290
Query: 231 --LEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP 288
F + A +L + ++ + F + + LS + +
Sbjct: 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-----FIH 345
Query: 289 VPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPL 348
+ C S +F+ + ++N+F
Sbjct: 346 MVC-----------PPSPSSFTFL------NFTQNVFTD--------------------S 368
Query: 349 PLRGRDGFLAI-FHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFG 407
+G + N + + + + + D L+
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL-----DVSLNSLNSHAYDR 422
Query: 408 ICNRLDSLMV-NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVAL 466
C +S++V N+S+N + G + + +K LD N+I+ IP+ V L +L L
Sbjct: 423 TCAWAESILVLNLSSNMLTGSVFRCLPP---KVKVLDLHNNRIMS-IPKDVTHLQALQEL 478
Query: 467 NLSWNLMHDQIPTTLGQMKGLKYLSLAGNN 496
N++ N + ++ L+Y+ L N
Sbjct: 479 NVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 92/506 (18%), Positives = 166/506 (32%), Gaps = 68/506 (13%)
Query: 76 VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET 135
V S L VP + + L LS N + + ++R L L N + +
Sbjct: 36 VDYSNRNLT-HVPKDL---PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RS 90
Query: 136 IPAEL-GMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS-NLFDTYEDVRYSRGQSL 193
+ + Q+LE LDVS N L +I + L L LS N FD
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVL----------- 136
Query: 194 VDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL-EGNFPSNWGACDNLEMLNLGH 252
+ + +L L L A + + + +L+L
Sbjct: 137 ----------------PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVS 180
Query: 253 NFFSGKNLGVLGPCK-NLLFLDLSSNQLTGELAREL--PVPCMTMFDVSGNALS-GSIPT 308
G L +L L N L + + + ++ N + + T
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 309 FSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHN-FGGNN 367
F + + L+ L + LF + P+ +L I++
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLF--QFFWPRPV------EYLNIYNLTITERI 292
Query: 368 FSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQ 427
A + L + V + S ++ + ++ M+++S+
Sbjct: 293 DREEFTYSETALKSLMIEHVK-----NQVFLFSKEA-LYSVFAEMNIKMLSISDTPF--- 343
Query: 428 LPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGL 487
+ S FL+ + N + +G L L L L N + + K +
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNM 402
Query: 488 KYLSLAGNNLT----GSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543
L +L + + + + VL+LSSN L+G + L + VL L+NN
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNN 460
Query: 544 KLSGKIPSGLANVSTLSAFNVSFNNL 569
++ IP + ++ L NV+ N L
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 48/197 (24%), Positives = 78/197 (39%), Gaps = 12/197 (6%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ + L + I S LN N T + S L+ L L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 61 -LVN----GTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
L N + + L+ + +S N L + ++ L+LS N L G + R
Sbjct: 388 GLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILV 174
L +V+ L L +N + +IP ++ LQ L+ L+V+ N L S+P + L +
Sbjct: 448 LPP--KVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIW 503
Query: 175 LS-NLFD-TYEDVRYSR 189
L N +D T +RY
Sbjct: 504 LHDNPWDCTCPGIRYLS 520
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 58/390 (14%), Positives = 104/390 (26%), Gaps = 51/390 (13%)
Query: 212 PEAVSSLPNLRILWAPRATLEGN----FPSNWGACD---NLEMLNLGHNFFSGKNLGVLG 264
+S L LR+L L N +LE L++ HN + +
Sbjct: 69 MPDISFLSELRVLR-----LSHNRIRSLDF--HVFLFNQDLEYLDVSHNRLQNISCCPM- 120
Query: 265 PCKNLLFLDLSSNQLTGELARELPVPCMTMFD---------VSGNALSGS---------- 305
+L LDLS N +P F +S
Sbjct: 121 --ASLRHLDLSFNDFDV-------LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHL 171
Query: 306 IPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGG 365
++V + + N + +L + G L + +
Sbjct: 172 SCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231
Query: 366 NNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIA 425
+ L + R + + S F ++ L N+ N I
Sbjct: 232 DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL--NIYNLTIT 289
Query: 426 GQLPAEIGRMC----KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTL 481
++ E KSL + + LS +
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 482 GQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLN 541
+L+ N T S+ L+ L+ L L N L +N++ L
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF-FKVALMTKNMSSLETL 408
Query: 542 NNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571
+ L+ + S + + A ++ NLS
Sbjct: 409 DVSLN-SLNSHAYDRTCAWAESILVLNLSS 437
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 49/349 (14%), Positives = 100/349 (28%), Gaps = 25/349 (7%)
Query: 240 GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV------PCMT 293
+ L+L N S + + L L LS N++ L +
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-----SLDFHVFLFNQDLE 103
Query: 294 MFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTA--------YLSLFAKKSQAG 345
DVS N L +I M LS N F+ +L L A K +
Sbjct: 104 YLDVSHNRLQ-NIS-CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 346 TPLP---LRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAI-VAGDNKLSGSF 401
LP L L + + SL L V + ++
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 402 PGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV 461
+ I ++ ++ + P + + ++ ++ E +
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 462 SLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSL 521
++ L ++ + ++ + +K L + S + + + LS +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 522 SGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+ + + T L N + + G + + L + N L
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 65/337 (19%), Positives = 112/337 (33%), Gaps = 43/337 (12%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLK-SLRVLNLGFNRITGEIPASFSDFVNLEELNLAG 59
+ L L L + HL S +L+L I G S N L+L
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI-PNTTVLHLVF 203
Query: 60 N---LVNGTVPTFIGRLKRVYLSFNRL----VGSVPSKIGEKCTNLEHLDLSGNYLVGGI 112
+ L + V + L + LS +L + + + E L+++ ++
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 113 PRSLGN----------CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV 162
S+ + +L + + E L++L + V S
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323
Query: 163 DLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDF-------NFFEGGIPEAV 215
+++ I +LS S + F N F + +
Sbjct: 324 LYSVFAEMNIKMLSI----------SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGC 373
Query: 216 SSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGV----LGPCKNLLF 271
S+L L+ L R L+ NF N+ L + N +++L
Sbjct: 374 STLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 272 LDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPT 308
L+LSSN LTG + R LP P + + D+ N + SIP
Sbjct: 433 LNLSSNMLTGSVFRCLP-PKVKVLDLHNNRIM-SIPK 467
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
+G GG G + A + VAIK++ EIK + RL H N+V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIV---LT--DPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 744 I--------------GYHASETEMFLIYNYLPGGNLENFI-QQRSTRAVDWRVLHK--IA 786
G ++++ Y+ +L N + Q H
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEE------HARLFM 126
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHA---TT 842
+ R L Y+H VLHRD+KP+N+ ++ +D + DFGLAR++ P +H +
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 843 GVAGTFGYVAPEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
G+ T Y +P ++ KA D+++ G + E+L+ K
Sbjct: 184 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 45/214 (21%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
+G+G +GA A G VAIK+L FQ + A E++ L +RH N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQ--SELFAKRAYRELRLLKHMRHENVIGL 89
Query: 744 --IGYHASETEMF----LIYNYLPGGNLENFIQ-QRSTRAVDWRVLHK--IALDIARALA 794
+ + F L+ ++ G +L ++ ++ + + + L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGED------RIQFLVYQMLKGLR 142
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV--- 851
Y+H ++HRD+KP N+ +++D + DFGLAR T GYV
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT----------GYVVTR 189
Query: 852 ---APEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
APE + + D++S G ++ E+++ K
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 13/201 (6%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
F+ +G G FG G A+K L V + + ++ E + L + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
LV L + ++++ Y+ GG + F R A I YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+++RD+KP N+L+D ++DFG A+ + T + GT +APE ++
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILS 212
Query: 859 CRVSDKADVYSYGVVLLELLS 879
+ D ++ GV++ E+ +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAA 233
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 48/203 (23%), Positives = 75/203 (36%), Gaps = 48/203 (23%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIK----RLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTL 743
+G G G + A+K R E++ R + P++V +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR---------EVELHWRASQCPHIVRI 76
Query: 744 IGYH----ASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+ + A + ++ L GG L + IQ R +A R +I I A+ YLH
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 800 CVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA 856
+ HRDVKP N+L + L+DFG A+ ET Y
Sbjct: 137 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTGE-------KY------ 175
Query: 857 MTCRVSDKADVYSYGVVLLELLS 879
D++S GV++ LL
Sbjct: 176 -----DKSCDMWSLGVIMYILLC 193
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 47/293 (16%), Positives = 85/293 (29%), Gaps = 41/293 (13%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
NL L + N L + L L LN N++T ++ S L LN A N +
Sbjct: 86 NLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTL 139
Query: 63 NGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQV 122
+ +L + N+ + + T L LD S N + + +
Sbjct: 140 TEIDVSHNTQLTELDCHLNKKITKLDV---TPQTQLTTLDCSFNKITEL---DVSQNKLL 193
Query: 123 RSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN----- 177
L +N + + +L L LD S N L+ +D+ ++L S
Sbjct: 194 NRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLTE 247
Query: 178 ----LFDTYEDVRYSRGQ----SLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRA 229
+ + L + V+ L +L
Sbjct: 248 LDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLD---- 303
Query: 230 TLEGNFPS--NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
+ + + L L L + + L + L L + +
Sbjct: 304 -CQAAGITELDLSQNPKLVYLYLNNTELT--ELD-VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 67/371 (18%), Positives = 110/371 (29%), Gaps = 57/371 (15%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
L L+ + N L + L LN N +T EI S L EL+ N
Sbjct: 107 KLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNK- 159
Query: 63 NGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
T +L + SFN++ S+ L L+ N + + L
Sbjct: 160 KITKLDVTPQTQLTTLDCSFNKITELDVSQ----NKLLNRLNCDTNNITK-LD--LNQNI 212
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180
Q+ L SN L I + L L D S N L+ +D+ SKL L
Sbjct: 213 QLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDL 266
Query: 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLE----GNFP 236
D+ + L+ F + + V+ L +L A + P
Sbjct: 267 LEIDL--THNTQLI---YFQAEGCRKIK---ELDVTHNTQLYLLDCQAAGITELDLSQNP 318
Query: 237 S--------------NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGE 282
+ L+ L+ + + +G L + Q
Sbjct: 319 KLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQ--DFSSVGKIPALNNNFEAEGQTITM 376
Query: 283 LARELPVPCMT------MFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLS 336
L +T + D GN ++ P + ++ + NP+ Y
Sbjct: 377 PKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTITWENLSTDNPAVTYTF 435
Query: 337 LFAKKSQAGTP 347
+ GT
Sbjct: 436 TSENGAIVGTV 446
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 80/551 (14%), Positives = 148/551 (26%), Gaps = 156/551 (28%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
N + S L +L L+ + IT ++ L +L N
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSN-- 74
Query: 63 NGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQV 122
+ + LS + TNL +L N L + + ++
Sbjct: 75 ---------NITTLDLS--------------QNTNLTYLACDSNKLTN-LD--VTPLTKL 108
Query: 123 RSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTY 182
L +N L + ++ L L+ +RN+L+ +D+ + ++L L
Sbjct: 109 TYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKI- 161
Query: 183 EDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGAC 242
V+ L L + S
Sbjct: 162 ----------------------------TKLDVTPQTQLTTLDCSFNKITELDVSQ---N 190
Query: 243 DNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV---PCMTMFDVSG 299
L LN N + +L L FLD SSN+LT E+ V +T FD S
Sbjct: 191 KLLNRLNCDTNNITKLDLN---QNIQLTFLDCSSNKLT-----EIDVTPLTQLTYFDCSV 242
Query: 300 NALSGSIPTFSNMVCPPVPYLSRNLFESYNPS--TAYLSLFAKKSQAGTPLPLRGRDGFL 357
N L+ + + + + + + + T + A+ + L +
Sbjct: 243 NPLT-ELDVSTLSKLTTL-HCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDV------- 293
Query: 358 AIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMV 417
+ Y + ++ +L L
Sbjct: 294 ------------THNTQL------------YLLDCQAAGIT-ELD---LSQNPKLVYL-- 323
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQI 477
++N + +L LK L I + S
Sbjct: 324 YLNNTELT-ELDV---SHNTKLKSLSCVNAHI----------------QDFS-------- 355
Query: 478 PTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL-----LEVLDLSSNSLSGLIPDDLENL 532
++G++ L A +L L ++LD N ++ + P D
Sbjct: 356 --SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVY 412
Query: 533 RNLTVLLLNNN 543
T + N
Sbjct: 413 DQATNTITWEN 423
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 68/441 (15%), Positives = 130/441 (29%), Gaps = 103/441 (23%)
Query: 144 QNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDD 203
N + + + + + L L N S+ D
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHN-------------SSITDMTGI---- 60
Query: 204 FNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS--NWGACDNLEMLNLGHNFFSGKNLG 261
L L L N + + NL L N + ++
Sbjct: 61 ------------EKLTGLTKLI-----CTSNNITTLDLSQNTNLTYLACDSNKLTNLDVT 103
Query: 262 VLGPCKNLLFLDLSSNQLTGELARELPV---PCMTMFDVSGNALSGSIPTFSNMVCPPVP 318
P L +L+ +N+LT +L V P +T + + N L+ I N
Sbjct: 104 ---PLTKLTYLNCDTNKLT-----KLDVSQNPLLTYLNCARNTLT-EIDVSHN------T 148
Query: 319 YLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVA 378
L L N L + + L L N + + V+
Sbjct: 149 QL-TELDCHLNKKITKLDVTPQTQ-------LT----TLDCSFN--------KITELDVS 188
Query: 379 PERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKS 438
+ + + N ++ +L L + S+N++ ++
Sbjct: 189 ----QNKLLNRLNCDTNNIT-KLD---LNQNIQLTFL--DCSSNKLT-EIDV---TPLTQ 234
Query: 439 LKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLT 498
L + D S N + + V L L L+ + + I L L Y G
Sbjct: 235 LTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDLLE-ID--LTHNTQLIYFQAEGCRKI 288
Query: 499 GSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVST 558
+ + L +LD + ++ L DL L L LNN +L+ ++ +++ +
Sbjct: 289 KELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTK 340
Query: 559 LSAFNVSFNNLSGPLPSSKNL 579
L + + ++ S +
Sbjct: 341 LKSLSCVNAHIQD-FSSVGKI 360
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 25/143 (17%), Positives = 48/143 (33%), Gaps = 11/143 (7%)
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
L LD I + + + LV L L+ + + + + LK LS
Sbjct: 296 NTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNA 349
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG---KIPSG 552
++ S +G++ L + + + L N + + G I G
Sbjct: 350 HIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPG 407
Query: 553 LANVSTLSAFNVSFNNLSGPLPS 575
V + +++ NLS P+
Sbjct: 408 DGGVYDQATNTITWENLSTDNPA 430
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 48/282 (17%), Positives = 84/282 (29%), Gaps = 30/282 (10%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGNL 61
++ LDL N + I +L+ L L N I I SFS +LE L+L+ N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 62 VNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIP-RSL 116
+ + F L + L N + + T L+ L + I +
Sbjct: 112 L-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDL-GNCSKLAILVL 175
+ L + ++ L+ P L +QN+ L + + S + L L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLEL 229
Query: 176 SNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF 235
+ F+ G ++ R + +L
Sbjct: 230 RDT-------------------DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QV 269
Query: 236 PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSN 277
L L N G+ +L + L +N
Sbjct: 270 MKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 53/265 (20%), Positives = 98/265 (36%), Gaps = 40/265 (15%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAG 59
NL+ L L N +N I DS L SL L+L +N ++ + +S F +L LNL G
Sbjct: 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133
Query: 60 N----LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
N L ++ + + +L+ + + + K T LE L++ + L P+S
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVL 175
L + V L+L + + + ++E L++ L +L
Sbjct: 194 LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL----------S 243
Query: 176 SNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN- 234
+ ++ R + D+ F + + ++ + L L N
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLFQ----------VMKLLNQISGLLELE-----FSRNQ 288
Query: 235 ---FPSNWGACD---NLEMLNLGHN 253
P G D +L+ + L N
Sbjct: 289 LKSVPD--GIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 49/261 (18%), Positives = 95/261 (36%), Gaps = 28/261 (10%)
Query: 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL---VNGTVPTFIGRLKRVYLSFNRL 83
+++ L+L NRIT + VNL+ L L N + + +G L+ + LS+N L
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 84 VGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL-GNCFQVRSLLLFSNMLEETIPAE-LG 141
++ S + ++L L+L GN SL + +++ L + + I +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 142 MLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFM 200
L LE L++ + L S L + ++ L+L Q +
Sbjct: 172 GLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMK-----------------QHILL 213
Query: 201 NDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNL 260
+ F + L + + + L ++ + + + +
Sbjct: 214 LE--IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270
Query: 261 GVLGPCKNLLFLDLSSNQLTG 281
+L LL L+ S NQL
Sbjct: 271 KLLNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 35/198 (17%), Positives = 71/198 (35%), Gaps = 16/198 (8%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMV-NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVG 451
N ++ + + F + L SL ++S N ++ L + + SL FL+ GN
Sbjct: 84 TSNGIN-TIEEDSF---SSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT 138
Query: 452 PIPRGV-GELVSLVALNLSWNLMHDQIPT-TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQ 509
+ L L L + +I + L+ L + ++L P SL +Q
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQ 198
Query: 510 LLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG----KIPSG----LANVSTLSA 561
+ L L L+ ++ ++ L L + L ++ +G L T
Sbjct: 199 NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258
Query: 562 FNVSFNNLSGPLPSSKNL 579
++ +L + +
Sbjct: 259 VKITDESLFQVMKLLNQI 276
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 37/169 (21%), Positives = 70/169 (41%), Gaps = 11/169 (6%)
Query: 407 GICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVA 465
G+ + SL ++SNNRI + + C +L+ L + N I I L SL
Sbjct: 49 GLTEAVKSL--DLSNNRIT-YISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEH 104
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP--SSLGQLQLLEVLDLSSN-SLS 522
L+LS+N + + + + L +L+L GN ++ S L L++L + + + +
Sbjct: 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFT 163
Query: 523 GLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS 570
+ D L L L ++ + L L ++ +S +
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 23/162 (14%), Positives = 53/162 (32%), Gaps = 14/162 (8%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
G+ F L+ L + + + + + +++ L Q +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEEL--EIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHIL- 212
Query: 453 IPRGV-GELVSLVALNLSWNLMHD----QIPT----TLGQMKGLKYLSLAGNNLTGSIPS 503
+ S+ L L + ++ T +L + + + + +L +
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMK 271
Query: 504 SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545
L Q+ L L+ S N L + + L +L + L+ N
Sbjct: 272 LLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 26/187 (13%), Positives = 59/187 (31%), Gaps = 15/187 (8%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
N ++F +L L V N ++ + L+ L+ + +
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRV--GNMDTFTKIQRKDFAGLTFLEELEIDASDLQS- 188
Query: 453 IPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTG----SIPS---- 503
+ ++ L L + + ++ L L +L + +
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
Query: 504 SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAF 562
SL + + ++ SL + L + L L + N+L +P G +++L
Sbjct: 249 SLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKI 306
Query: 563 NVSFNNL 569
+ N
Sbjct: 307 WLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 49/218 (22%), Positives = 78/218 (35%), Gaps = 13/218 (5%)
Query: 75 RVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEE 134
S L S+PS + ++ LDLS N + L C +++L+L SN +
Sbjct: 35 ICKGSSGSL-NSIPSGL---TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN- 89
Query: 135 TIPAEL-GMLQNLEVLDVSRNSLSGSIPVDL-GNCSKLAILVLS-NLFDTYEDVRYSRGQ 191
TI + L +LE LD+S N LS ++ S L L L N + T +
Sbjct: 90 TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL 148
Query: 192 -SLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNL 250
L D F + + + L L L + L+ P + + N+ L L
Sbjct: 149 TKLQILRVGNMDTFTKIQ---RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 251 GHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP 288
+ ++ L+L L EL
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 49/237 (20%), Positives = 87/237 (36%), Gaps = 50/237 (21%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
IG G +G Y A VAIK++ F+ EI L RL+ ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFE--DLIDCKRILREITILNRLKSDYIIRL 90
Query: 744 IGYHASET-----EMFLIYNYLPGGNLENFI--QQRSTRAVDWRVLHK--IALDIARALA 794
+ E++++ +L+ T H I ++
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEE------HIKTILYNLLLGEN 143
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF------ 848
++H+ ++HRD+KP+N LL+ D + + DFGLAR + +
Sbjct: 144 FIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 849 ---------GYV------APEYAMTCRVSDKA-DVYSYGVVLLELLSDKKALDPSFS 889
+V APE + K+ D++S G + ELL+ ++ +
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-17
Identities = 52/241 (21%), Positives = 89/241 (36%), Gaps = 51/241 (21%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLRHPNLVTL 743
IG G +G +A +VAIK++ F+ EI L RL H ++V +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFE--DLIDCKRILREIAILNRLNHDHVVKV 117
Query: 744 IG-YHASETEMF----LIYNYLPGGNLENFIQQRSTRAVDWRVLHK--IALDIARALAYL 796
+ + E F ++ + + + H + ++ + Y+
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTEL----HIKTLLYNLLVGVKYV 172
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF-------- 848
H +LHRD+KP+N L++ D + + DFGLAR + E +
Sbjct: 173 HSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 849 ------------GYV------APEYAMTCRVSDKA-DVYSYGVVLLELLSDKKALDPSFS 889
G+V APE + +A DV+S G + ELL+ K +
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289
Query: 890 S 890
Sbjct: 290 D 290
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
+F +G G FG + G A+K L V R + V+ + E L + HP
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQ-QRSTRAVDWRVLHKIALDIARALAYLH 797
++ + G ++F+I +Y+ GG L F ++S R + A ++ AL YLH
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAA-EVCLALEYLH 123
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
+ +++RD+KP NILLD + + ++DFG A+ + T + GT Y+APE
Sbjct: 124 SK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVS 176
Query: 858 TCRVSDKADVYSYGVVLLELLS 879
T + D +S+G+++ E+L+
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLA 198
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 7e-17
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 683 NFNASNCIGNGGFG----ATYKAEISPGVLVAIKRLA----VGRFQGVQQFHAEIKTLGR 734
F +G GG+G + G + A+K L V + AE L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 735 LRHPNLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQ-QRSTRAVDWRVLHKIALDIA 790
++HP +V L + +++LI YL GG L F+Q +R ++ +A +I+
Sbjct: 78 VKHPFIVDL---IYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EIS 131
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY 850
AL +LH + +++RD+KP NI+L+ + L+DFGL + + T GT Y
Sbjct: 132 MALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEY 187
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELL 878
+APE M + D +S G ++ ++L
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 7e-17
Identities = 38/178 (21%), Positives = 68/178 (38%), Gaps = 18/178 (10%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+L+ + + + L S+ + + I + N+ +L L GN +
Sbjct: 22 ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKL 77
Query: 63 NGTVP-TFIGRLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSLGNC 119
P T + L ++L N++ + + L+ L L N + I L +
Sbjct: 78 TDIKPLTNLKNLGWLFLDENKI-----KDLSSLKDLKKLKSLSLEHNGIS-DIN-GLVHL 130
Query: 120 FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
Q+ SL L +N + + L L L+ L + N +S I L +KL L LS
Sbjct: 131 PQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 184
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.5 bits (203), Expect = 3e-16
Identities = 57/332 (17%), Positives = 100/332 (30%), Gaps = 73/332 (21%)
Query: 4 LEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVN 63
+ + I PD NL +T + ++ +++++ +
Sbjct: 1 MGETITVSTPIKQIFPDDA--FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD-- 54
Query: 64 GTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVR 123
I ++ + + N+ L L+GN L I L N +
Sbjct: 55 ------IKSVQGI----------------QYLPNVTKLFLNGNKLT-DIK-PLTNLKNLG 90
Query: 124 SLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYE 183
L L N +++ L L+ L+ L + N +S I L + +L L L N
Sbjct: 91 WLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGN------ 140
Query: 184 DVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF---PSNWG 240
+ D +S L L L LE N
Sbjct: 141 -------NKITD----------------ITVLSRLTKLDTLS-----LEDNQISDIVPLA 172
Query: 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGN 300
L+ L L N S +L L KNL L+L S + + + + +
Sbjct: 173 GLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 230
Query: 301 ALSGSIPTFSNMVCPPVPYLSRNLFESYNPST 332
+ S+ P + +L E N +
Sbjct: 231 GSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS 262
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 5e-16
Identities = 42/176 (23%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
N+ L L GN L I P + +LK+L L L N+I ++ S D L+ L+L N +
Sbjct: 66 NVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGI 121
Query: 63 NGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
+ + +L+ +YL N++ + + + + T L+ L L N + I L +
Sbjct: 122 SDINGLVHLPQLESLYLGNNKI--TDITVL-SRLTKLDTLSLEDNQIS-DIV-PLAGLTK 176
Query: 122 VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+++L L N + + L L+NL+VL++ N + ++
Sbjct: 177 LQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 230
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 9e-16
Identities = 49/274 (17%), Positives = 94/274 (34%), Gaps = 28/274 (10%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
+++ + + + + G +L ++ L L N++T +I ++ NL L L N
Sbjct: 44 SIDQIIANNSDIKSV---QGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENK 98
Query: 62 VNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSLG 117
+ + + +LK + L N + S I LE L L N + L
Sbjct: 99 IK-DLSSLKDLKKLKSLSLEHNGI-----SDINGLVHLPQLESLYLGNNKIT--DITVLS 150
Query: 118 NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
++ +L L N + + +P L L L+ L +S+N +S + L L +L L +
Sbjct: 151 RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 206
Query: 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPS 237
+ + +LV + N D + I + W L
Sbjct: 207 --QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKW----HLPEFTNE 260
Query: 238 NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLF 271
+ F G+ L + +
Sbjct: 261 VSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSY 294
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 2e-15
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 15/166 (9%)
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQI 477
N+ + + S+ + A+ + I + G+ L ++ L L+ N + D
Sbjct: 27 NLKKKSVTDAVTQN---ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK 81
Query: 478 PTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTV 537
P L +K L +L L N + + SSL L+ L+ L L N +S + L +L L
Sbjct: 82 P--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISDING--LVHLPQLES 135
Query: 538 LLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS--GPLPSSKNLMK 581
L L NNK++ I + L+ ++ L ++ N +S PL L
Sbjct: 136 LYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 179
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.5 bits (185), Expect = 4e-14
Identities = 29/145 (20%), Positives = 56/145 (38%), Gaps = 16/145 (11%)
Query: 439 LKFLDASGNQI--VGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNN 496
+ I + P + NL + D T ++ + + ++
Sbjct: 1 MGETITVSTPIKQIFPDDA----FAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD 54
Query: 497 LTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANV 556
+ S+ + L + L L+ N L+ + P L NL+NL L L+ NK+ + S L ++
Sbjct: 55 IK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDL 108
Query: 557 STLSAFNVSFNNLS--GPLPSSKNL 579
L + ++ N +S L L
Sbjct: 109 KKLKSLSLEHNGISDINGLVHLPQL 133
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 9e-11
Identities = 46/284 (16%), Positives = 95/284 (33%), Gaps = 27/284 (9%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSL-MVNVSNNRIAGQLPAEIG--RMCKSLKFLDASGNQI 449
+NK+ ++ + + L L +++ +N I+ +I L+ L N+I
Sbjct: 95 DENKIK-----DLSSLKD-LKKLKSLSLEHNGIS-----DINGLVHLPQLESLYLGNNKI 143
Query: 450 VGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQ 509
+ L L L+L N + D +P L + L+ L L+ N+++ + +L L+
Sbjct: 144 TDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLK 197
Query: 510 LLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL 569
L+VL+L S + NL + + L P +++ NV ++
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLP 255
Query: 570 SGPLPSSKNLMKCSSVLGNPYLRPCRAFT----LTEPSQDLHGPPSNGNRGFNSIEIASI 625
S + ++ R + S D+ G + I +
Sbjct: 256 EFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGT-RITAP 314
Query: 626 ASASAIVSVLLALIVLFVYTRKWNPQSKVMGSTRKEVTIFTEIG 669
+ V +WN + M + +
Sbjct: 315 KPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTLYAVFKAE 358
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 24/134 (17%), Positives = 46/134 (34%), Gaps = 8/134 (5%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ LE L L N + I S L L L+L N+I+ +I + L+ L L+ N
Sbjct: 130 LPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKN 185
Query: 61 LVNGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC 119
++ + L + L + + + + LV P + +
Sbjct: 186 HISDLRALAGLKNLDVLELFSQECLNKPINHQ-SNLVVPNTVKNTDGSLV--TPEIISDD 242
Query: 120 FQVRSLLLFSNMLE 133
+ ++ E
Sbjct: 243 GDYEKPNVKWHLPE 256
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 53/276 (19%), Positives = 104/276 (37%), Gaps = 53/276 (19%)
Query: 9 LEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVP- 67
+ +N I PD L + + G + +T + +D + L+ G V
Sbjct: 4 TQPTAINVIFPDPA--LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGV 59
Query: 68 TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLL 127
++ L + L N++ + + + + T + L+LSGN L ++ +++L L
Sbjct: 60 QYLNNLIGLELKDNQI--TDLAPL-KNLTKITELELSGNPLK--NVSAIAGLQSIKTLDL 114
Query: 128 FSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRY 187
S + + P L L NL+VL + N ++ +I L + L L + N
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGN---------- 160
Query: 188 SRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF---PSNWGACDN 244
++ L +++L L L + N S + N
Sbjct: 161 AQVSDL-------------------TPLANLSKLTTLK-----ADDNKISDISPLASLPN 196
Query: 245 LEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
L ++L +N S ++ L NL + L++ +T
Sbjct: 197 LIEVHLKNNQIS--DVSPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQI 477
+ + + + L A G + I GV L +L+ L L N + D
Sbjct: 25 AAGKSNVTDTVTQA---DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA 79
Query: 478 PTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTV 537
P L + + L L+GN L ++ S++ LQ ++ LDL+S ++ + P L L NL V
Sbjct: 80 P--LKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQV 133
Query: 538 LLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG--PLPSSKNL 579
L L+ N+++ I S LA ++ L ++ +S PL + L
Sbjct: 134 LYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTPLANLSKL 175
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 10/154 (6%)
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
+S+K LD + QI P + L +L L L N + + P L + L+YLS+
Sbjct: 106 LQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNA 161
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN 555
++ + + L L L L N +S + P L +L NL + L NN++S S LAN
Sbjct: 162 QVS-DL-TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLAN 215
Query: 556 VSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNP 589
S L ++ ++ N + +V+ P
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGP 249
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 20/179 (11%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
NL L+L+ N + + P +L + L L N + + A + +++ L+L +
Sbjct: 64 NLIGLELKDNQITDLAPLK--NLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQI 119
Query: 63 NGTVPTFIG--RLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSLGN 118
V G L+ +YL N++ + I TNL++L + + P L N
Sbjct: 120 T-DVTPLAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVSDLTP--LAN 171
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
++ +L N + + P L L NL + + N +S P L N S L I+ L+N
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 12/146 (8%)
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
+L L+ NQI P + L + L LS N + + + + ++ +K L L
Sbjct: 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTST 117
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN 555
+T P L L L+VL L N ++ + P L L NL L + N ++S + + LAN
Sbjct: 118 QITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL-TPLAN 171
Query: 556 VSTLSAFNVSFNNLSG--PLPSSKNL 579
+S L+ N +S PL S NL
Sbjct: 172 LSKLTTLKADDNKISDISPLASLPNL 197
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 49/282 (17%), Positives = 89/282 (31%), Gaps = 60/282 (21%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
N + + + + + L + L+ +T I NL L L N +
Sbjct: 20 NAIKIAAGKSNVTDTVTQAD--LDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQI 75
Query: 63 NGTVPTFIG--RLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSLGN 118
+ ++ + LS N L + +++ LDL+ + + L
Sbjct: 76 T-DLAPLKNLTKITELELSGNPL-----KNVSAIAGLQSIKTLDLTSTQI-TDVT-PLAG 127
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178
++ L L N + P L L NL+ L + +S P L N SKL L +
Sbjct: 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD- 182
Query: 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF--- 235
N ++SLPNL + L+ N
Sbjct: 183 --------------------------NKISD--ISPLASLPNLIEVH-----LKNNQISD 209
Query: 236 PSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSN 277
S NL ++ L + + + + NL+ ++
Sbjct: 210 VSPLANTSNLFIVTLTNQTITNQPVFYN---NNLVVPNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 36/162 (22%), Positives = 62/162 (38%), Gaps = 11/162 (6%)
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQI 477
++++ +I P +L+ L NQI I + L +L L++ + D
Sbjct: 113 DLTSTQITDVTPLA---GLSNLQVLYLDLNQITN-IS-PLAGLTNLQYLSIGNAQVSDLT 167
Query: 478 PTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTV 537
P L + L L N ++ I S L L L + L +N +S + P L N NL +
Sbjct: 168 P--LANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 538 LLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
+ L N ++ + N+ + P S N
Sbjct: 222 VTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNG 263
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 31/123 (25%), Positives = 56/123 (45%), Gaps = 10/123 (8%)
Query: 459 ELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSS 518
L + + + + + D T + G+ LS G +T +I + L L L+L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72
Query: 519 NSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG--PLPSS 576
N ++ L P L+NL +T L L+ N L K S +A + ++ +++ ++ PL
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 577 KNL 579
NL
Sbjct: 129 SNL 131
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 25/137 (18%), Positives = 55/137 (40%), Gaps = 8/137 (5%)
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
+L++L Q+ + + L L L N + D P L + L + L N
Sbjct: 150 LTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNN 205
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN 555
++ + S L L ++ L++ +++ NL V+ + P+ +++
Sbjct: 206 QIS-DV-SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISD 261
Query: 556 VSTLSAFNVSFNNLSGP 572
T ++ N+++N S
Sbjct: 262 NGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 41/240 (17%), Positives = 82/240 (34%), Gaps = 51/240 (21%)
Query: 96 TNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNS 155
N + + + + + + +L F + TI + L NL L++ N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 156 LSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAV 215
++ + L N +K+ L LS N + A+
Sbjct: 75 IT-DLA-PLKNLTKITELELSG---------------------------NPLK--NVSAI 103
Query: 216 SSLPNLRILWAPRATLEGNFPSNW---GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272
+ L +++ L L ++ NL++L L N + N+ L NL +L
Sbjct: 104 AGLQSIKTLD-----LTSTQITDVTPLAGLSNLQVLYLDLNQIT--NISPLAGLTNLQYL 156
Query: 273 DLSSNQLTG--ELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNP 330
+ + Q++ LA + +T N +S I +++ +L N +P
Sbjct: 157 SIGNAQVSDLTPLAN---LSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQISDVSP 212
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 30/159 (18%), Positives = 62/159 (38%), Gaps = 12/159 (7%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ NL+VL L+ N + I P +G L +L+ L++G +++ ++ ++ L L N
Sbjct: 128 LSNLQVLYLDLNQITNISPLAG--LTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDN 183
Query: 61 LVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
++ + L V+L N++ P +NL + L+ + N
Sbjct: 184 KIS-DISPLASLPNLIEVHLKNNQISDVSPL---ANTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLS 157
V ++ PA + +++ N S
Sbjct: 240 --LVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 15/101 (14%), Positives = 43/101 (42%), Gaps = 8/101 (7%)
Query: 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540
+ ++ +N+T + L + L ++ + + ++ L NL L L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLS--GPLPSSKNL 579
+N+++ + + L N++ ++ +S N L + +++
Sbjct: 71 KDNQIT-DL-APLKNLTKITELELSGNPLKNVSAIAGLQSI 109
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 40/189 (21%), Positives = 64/189 (33%), Gaps = 19/189 (10%)
Query: 3 NLEVLDLEGNLLNGILPD----SGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLA 58
+L +L+L + L+VL++ F L L+L+
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 59 GN-------LVNGTVPTFIGRLKRVYLSFNRL--VGSVPSKIGEKCTNLEHLDLSGNYLV 109
N L++ P L+ + L + V S + L+ LDLS N L
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241
Query: 110 GGIPRSLGNCFQ-VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCS 168
+ + SL L L++ +P L L VLD+S N L P
Sbjct: 242 DAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLD-RNP-SPDELP 296
Query: 169 KLAILVLSN 177
++ L L
Sbjct: 297 QVGNLSLKG 305
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 44/198 (22%), Positives = 73/198 (36%), Gaps = 18/198 (9%)
Query: 394 DNKLSGSFPGNMFGICNR-LDSLMVNVSNNRIAGQ---LPAEIGRMCKSLKFLDASGNQI 449
+ +++G+ P + L+ L N+ N A + L + LK L +
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNIL--NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 450 VGPIPRGVGELVSLVALNLSWNLMHDQIP----TTLGQMKGLKYLSLAGNNLT---GSIP 502
+ V +L L+LS N + + L+ L+L + G
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 503 SSLGQLQLLEVLDLSSNSLSGLIPDDL-ENLRNLTVLLLNNNKLSGKIPSGLANVSTLSA 561
+ L+ LDLS NSL + L L L+ L ++P GL + LS
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSV 278
Query: 562 FNVSFNNLSGPLPSSKNL 579
++S+N L PS L
Sbjct: 279 LDLSYNRLDR-NPSPDEL 295
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 36/170 (21%), Positives = 57/170 (33%), Gaps = 21/170 (12%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFS----DFVNLEELNLA 58
L+VL + + +L L+L N GE + F L+ L L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 59 GNL---VNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLV--- 109
+G +L+ + LS N L + + + + L L+LS L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 110 GGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGS 159
G+P L L L N L+ P+ L + L + N S
Sbjct: 270 KGLPAKL------SVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 36/157 (22%), Positives = 52/157 (33%), Gaps = 14/157 (8%)
Query: 398 SGSFPGNMFGICNRLDSLMVNVSNNRIAGQLP---AEIGRMCKSLKFLDASGNQ---IVG 451
S +F + L +L ++S+N G+ A +L+ L G
Sbjct: 161 SLNFSCEQVRVFPALSTL--DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 452 PIPRGVGELVSLVALNLSWNLMHDQIPTTLGQ-MKGLKYLSLAGNNLTGSIPSSLGQLQL 510
V L L+LS N + D L L+L+ L +P L
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAK 275
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547
L VLDLS N L + L + L L N
Sbjct: 276 LSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 47/293 (16%), Positives = 79/293 (26%), Gaps = 65/293 (22%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKS---LRVLNLGFNRITGEIPASFSDFV--NLEELNL 57
+L+ L + + + + L+ L L +TG P + +L LNL
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 58 AGNLVNGTVPTFIGR--------LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLV 109
N+ T ++ LK + ++ + + L LDLS N +
Sbjct: 129 R-NVSWATRDAWLAELQQWLKPGLKVLSIAQAHS-LNFSCEQVRVFPALSTLDLSDNPEL 186
Query: 110 GGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSK 169
G ++ P + LQ L + + + SG +
Sbjct: 187 GERG-----------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ 229
Query: 170 LAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLP-NLRILWAPR 228
L L LS+ N P L L
Sbjct: 230 LQGLDLSH---------------------------NSLRDAAGAPSCDWPSQLNSLNLSF 262
Query: 229 ATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG 281
L+ P A L +L+L +N + L L N
Sbjct: 263 TGLKQ-VPKGLPA--KLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 37/187 (19%), Positives = 58/187 (31%), Gaps = 28/187 (14%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF--HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLA 58
+ L+ L LE + G P L +LNL A ++ +
Sbjct: 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPG-- 150
Query: 59 GNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
LK + ++ + + L LDLS N +G
Sbjct: 151 --------------LKVLSIAQAHS-LNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 119 CF----QVRSLLLFSNMLEE---TIPAELGMLQNLEVLDVSRNSLSGSIPVDL-GNCSKL 170
C ++ L L + +E A L+ LD+S NSL + S+L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 171 AILVLSN 177
L LS
Sbjct: 256 NSLNLSF 262
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 55/321 (17%), Positives = 89/321 (27%), Gaps = 80/321 (24%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGF--NRITGEIPASFSDFVN---LEELNL 57
+LE L + + + +KSL + L RI I + L+EL L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102
Query: 58 AGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
V GT P + +L L+L L
Sbjct: 103 ENLEVTGTAPPPLLEA--------------------TGPDLNILNLRNVSWA-TRDAWLA 141
Query: 118 NCFQ-----VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAI 172
Q ++ L + ++ + L LD+S N G + C
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC----- 196
Query: 173 LVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLE 232
P +L L + A T
Sbjct: 197 ---------------------------------------PLKFPTLQVLALRNAGMETPS 217
Query: 233 GNFPSNWGACDNLEMLNLGHNFFSGK-NLGVLGPCKNLLFLDLSSNQLTGELARELPVPC 291
G + A L+ L+L HN L L+LS L ++ + LP
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AK 275
Query: 292 MTMFDVSGNALSGSIPTFSNM 312
+++ D+S N L P+ +
Sbjct: 276 LSVLDLSYNRLD-RNPSPDEL 295
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 30/135 (22%), Positives = 45/135 (33%), Gaps = 11/135 (8%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMV-NVSNNRIAGQLPAEIGRM---CKSLKFLDASGNQI 449
DN G + +L V + N + + L+ LD S N +
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGME-TPSGVCSALAAARVQLQGLDLSHNSL 240
Query: 450 VGPIPRGVGE-LVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQL 508
+ L +LNLS+ + Q+P L L L L+ N L PS +L
Sbjct: 241 RDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPSPD-EL 295
Query: 509 QLLEVLDLSSNSLSG 523
+ L L N
Sbjct: 296 PQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 21/88 (23%), Positives = 32/88 (36%), Gaps = 5/88 (5%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG 59
L+ LDL N L L LNL F + ++P L L+L+
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSY 283
Query: 60 N-LVNGTVPTFIGRLKRVYLSFNRLVGS 86
N L P + ++ + L N + S
Sbjct: 284 NRLDRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 34/176 (19%), Positives = 60/176 (34%), Gaps = 10/176 (5%)
Query: 409 CNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIP-RGVGELVSLVALN 467
CN D S G E+ +SL++L + + + +SL L
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLT 74
Query: 468 LSWNLMHDQIPTTLGQ---MKGLKYLSLAGNNLTGSIPSSLGQLQL--LEVLDLSSNSLS 522
+ + +I + + GL+ L+L +TG+ P L + L +L+L + S +
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 523 GLIPDDLE----NLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLP 574
E L VL + + LS ++S N G
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 683 NFNASNCIGNGGFG----ATYKAEISPGVLVAIKRLAVGRFQGVQQFH--AEIKTLGRLR 736
F +G G FG + L A+K L + + E L +
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 737 HPNLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQ-QRSTRAVDWRVLHKIALDIARA 792
HP +V L H + E +++LI ++L GG+L F + + + V +A ++A A
Sbjct: 85 HPFIVKL---HYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA-ELALA 138
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVA 852
L +LH +++RD+KP NILLD++ + L+DFGL++ GT Y+A
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 194
Query: 853 PEYAMTCRVSDKADVYSYGVVLLELL 878
PE + AD +S+GV++ E+L
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 54/207 (26%), Positives = 82/207 (39%), Gaps = 23/207 (11%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
F +G G FG + + G A+K L + V E + L RHP
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 739 NLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIAR 791
L L S + + Y GG L + + RA + +I
Sbjct: 209 FLTAL---KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVS 259
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851
AL YLH + V++RD+K N++LD D + ++DFGL + G + GT Y+
Sbjct: 260 ALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 316
Query: 852 APEYAMTCRVSDKADVYSYGVVLLELL 878
APE D + GVV+ E++
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 12/146 (8%)
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
++ L +GN++ I + L +L L L N + D + ++L +K LK LSL N
Sbjct: 67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEHN 122
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN 555
++ I + L L LE L L +N ++ + L L L L L +N++S I LA
Sbjct: 123 GIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAG 176
Query: 556 VSTLSAFNVSFNNLS--GPLPSSKNL 579
++ L +S N++S L KNL
Sbjct: 177 LTKLQNLYLSKNHISDLRALAGLKNL 202
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 22/189 (11%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMV-NVSNNRIAGQLPAEIG--RMCKSLKFLDASGNQI 449
NKL+ ++ + N L +L + N++ ++ + K LK L N I
Sbjct: 76 NGNKLT-----DIKPLAN-LKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGI 124
Query: 450 VGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQ 509
I G+ L L +L L N + D T L ++ L LSL N ++ I L L
Sbjct: 125 SD-IN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLT 178
Query: 510 LLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL 569
L+ L LS N +S L L L+NL VL L + + K + +N+ + + +L
Sbjct: 179 KLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
Query: 570 SGPLPSSKN 578
P S +
Sbjct: 237 VTPEIISDD 245
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 42/179 (23%), Positives = 78/179 (43%), Gaps = 18/179 (10%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
N+ L L GN L I P + +LK+L L L N++ ++ S D L+ L+L N +
Sbjct: 69 NVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI 124
Query: 63 NGTVPTFIG--RLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSLGN 118
+ + + +L+ +YL N++ + I + T L+ L L N + I L
Sbjct: 125 S-DINGLVHLPQLESLYLGNNKI-----TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAG 176
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
++++L L N + + L L+NL+VL++ N + ++
Sbjct: 177 LTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 51/275 (18%), Positives = 84/275 (30%), Gaps = 73/275 (26%)
Query: 9 LEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPT 68
+ I D NL +T + ++ +++++ +
Sbjct: 9 TVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS-------- 56
Query: 69 FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLF 128
I ++ + + N+ L L+GN L P L N + L L
Sbjct: 57 DIKSVQGI----------------QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98
Query: 129 SNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYS 188
N +++ L L+ L+ L + N +S I L + +L L L N
Sbjct: 99 ENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGN----------- 143
Query: 189 RGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF---PSNWGACDNL 245
+ D +S L L L LE N L
Sbjct: 144 --NKITD----------------ITVLSRLTKLDTLS-----LEDNQISDIVPLAGLTKL 180
Query: 246 EMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
+ L L N S +L L KNL L+L S +
Sbjct: 181 QNLYLSKNHIS--DLRALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 25/111 (22%), Positives = 50/111 (45%), Gaps = 8/111 (7%)
Query: 460 LVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSN 519
+ NL + D T ++ + + +++ S+ + L + L L+ N
Sbjct: 23 FAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 78
Query: 520 SLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
L+ + P L NL+NL L L+ NK+ + S L ++ L + ++ N +S
Sbjct: 79 KLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 37/152 (24%), Positives = 64/152 (42%), Gaps = 17/152 (11%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
L+ L LE N ++ I +G HL L L LG N+IT +I S L+ L+L N
Sbjct: 113 KLKSLSLEHNGISDI---NGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQ 167
Query: 62 VNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSLG 117
++ + G +L+ +YLS N + S + NL+ L+L +
Sbjct: 168 IS-DIVPLAGLTKLQNLYLSKNHI-----SDLRALAGLKNLDVLELFSQECLNKPINHQS 221
Query: 118 NCFQVRSL-LLFSNMLEETIPAELGMLQNLEV 148
N ++ +++ I ++ G + V
Sbjct: 222 NLVVPNTVKNTDGSLVTPEIISDDGDYEKPNV 253
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 18/90 (20%), Positives = 38/90 (42%), Gaps = 6/90 (6%)
Query: 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540
+L ++T + +L ++ + +++ + + ++ L N+T L L
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
N NKL+ I LAN+ L + N +
Sbjct: 76 NGNKLT-DI-KPLANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 14/79 (17%), Positives = 33/79 (41%), Gaps = 6/79 (7%)
Query: 503 SSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAF 562
S +L S++ + L ++ ++ NN+ + + G+ + ++
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 563 NVSFNNLS--GPLPSSKNL 579
++ N L+ PL + KNL
Sbjct: 74 FLNGNKLTDIKPLANLKNL 92
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-16
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 44/224 (19%)
Query: 690 IGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHA-----EIKTLGRLR-HPNLVT 742
+G G +G +K+ G +VA+K++ FQ A EI L L H N+V
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQ--NSTDAQRTFREIMILTELSGHENIVN 73
Query: 743 LIGYHASET--EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHK--IALDIARALAYLHD 798
L+ ++ +++L+++Y+ +L I R+ +HK + + + + YLH
Sbjct: 74 LLNVLRADNDRDVYLVFDYM-ETDLHAVI--RANILEP---VHKQYVVYQLIKVIKYLHS 127
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTF---------- 848
+LHRD+KPSNILL+ + + ++DFGL+R
Sbjct: 128 G---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 849 ----GYV------APEYAMTCRVSDKA-DVYSYGVVLLELLSDK 881
YV APE + K D++S G +L E+L K
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 24/207 (11%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
+F+ +G G FG + G A+K L + V E + L RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 739 NLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIAR 791
L L + + + Y GG L + + RA + +I
Sbjct: 66 FLTAL---KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY------GAEIVS 116
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851
AL YLH + V++RD+K N++LD D + ++DFGL + G S+ GT Y+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 172
Query: 852 APEYAMTCRVSDKADVYSYGVVLLELL 878
APE D + GVV+ E++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 683 NFNASNCIGNGGFGATYKAEISP----GVLVAIKRLA----VGRFQGVQQFHAEIKTLGR 734
NF +G G +G + G L A+K L V + + + E + L
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 735 LRH-PNLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQ-QRSTRAVDWRVLHKIALDI 789
+R P LVTL H + ET++ LI +Y+ GG L F + R + V + +I
Sbjct: 115 IRQSPFLVTL---HYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVG-EI 168
Query: 790 ARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFG 849
AL +LH +++RD+K NILLD + + L+DFGL++ ET GT
Sbjct: 169 VLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 850 YVAPEYAMTCRVS-DKA-DVYSYGVVLLELL 878
Y+AP+ DKA D +S GV++ ELL
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 42/180 (23%), Positives = 63/180 (35%), Gaps = 30/180 (16%)
Query: 3 NLEVLDLEGNLLNGILPDSGFH-LKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGN 60
+LDL N L+ + + L +L L L N + I + +F NL L+L+ N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 61 LVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL 116
++ T+ F L+ + L N +V V E L+ L LS N + P
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVE- 154
Query: 117 GNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS 176
L + L L +LD+S N L DL L
Sbjct: 155 ----------LIKD---------GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 16/143 (11%)
Query: 438 SLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQI----PTTLGQMKGLKYLSL 492
LD S N + L +L +L LS N + + L+YL L
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN----HLNFISSEAFVPVPNLRYLDL 95
Query: 493 AGNNLTGSIPS-SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPS 551
+ N+L ++ LQ LEVL L +N + + + E++ L L L+ N++S + P
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 552 G----LANVSTLSAFNVSFNNLS 570
+ L ++S N L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 42/158 (26%), Positives = 64/158 (40%), Gaps = 12/158 (7%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
N LS L SL +S+N + + +E +L++LD S N +
Sbjct: 47 SHNNLSRLRAEWTPTRLTNLHSL--LLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT- 102
Query: 453 IPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP----SSLGQ 507
+ + +L +L L L N + M L+ L L+ N ++ P +
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK 161
Query: 508 LQLLEVLDLSSNSLSGLIPDDLENLRNLTV--LLLNNN 543
L L +LDLSSN L L DL+ L L L+NN
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 38/116 (32%), Positives = 55/116 (47%), Gaps = 11/116 (9%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAG 59
+ NL L L N LN I ++ + +LR L+L N + + FSD LE L L
Sbjct: 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYN 121
Query: 60 NLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKI---GEKCTNLEHLDLSGNYL 108
N + V F +L+++YLS N++ P ++ G K L LDLS N L
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL 175
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 44/181 (24%), Positives = 71/181 (39%), Gaps = 27/181 (14%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGN 60
NL LDL N L+ L + F L++L VL L N I + +F D L++L L+ N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 61 LVNGTVP--TFIG-----RLKRVYLSFNRLVGSVPSKIGEKCTNLEH--LDLSGNYLVGG 111
++ P +L + LS N+L +P +K L L N L
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKL-KKLPLTDLQKLPAWVKNGLYLHNNPLE-- 202
Query: 112 IPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLA 171
+C + LFS+ + + + ++L + L +D NCS+
Sbjct: 203 -----CDC---KLYQLFSHWQYRQLSSVMDFQEDLYC--MHSKKLHNIFSLDFFNCSEYK 252
Query: 172 I 172
Sbjct: 253 E 253
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 49/224 (21%), Positives = 71/224 (31%), Gaps = 59/224 (26%)
Query: 74 KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLV----GGIPRSLGNCFQVRSLLLFS 129
+ S +L +VP + + LDLS N L P L N + SLLL
Sbjct: 21 NILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTN---LHSLLLSH 73
Query: 130 NMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLAILVLSNLFDTYEDVRY 187
N L I +E + NL LD+S N L ++ + L +L+L N
Sbjct: 74 NHL-NFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYN---------- 121
Query: 188 SRGQSLVDQPSFMNDDFNFFEGGIPEAV-SSLPNLRILWAPRATLEGN----FP----SN 238
N + + L+ L+ L N FP +
Sbjct: 122 -----------------NHIV-VVDRNAFEDMAQLQKLY-----LSQNQISRFPVELIKD 158
Query: 239 WGACDNLEMLNLGHNFFSGKNLGVLGPCKNL--LFLDLSSNQLT 280
L +L+L N L L L L +N L
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 3e-15
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGR-LRH 737
+FN +G G FG +E L A+K L V + V+ E + L +
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARAL 793
P L L + ++ + Y+ GG+L IQQ AV + A +IA L
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------AAEIAIGL 455
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGYVA 852
+L + +++RD+K N++LD + + ++DFG+ + + T T GT Y+A
Sbjct: 456 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIA 510
Query: 853 PEYAMTCRVSDKADVYSYGVVLLELL 878
PE D +++GV+L E+L
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 47/181 (25%), Positives = 70/181 (38%), Gaps = 14/181 (7%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+ +L L NLL + L LNL +T ++ L L+L+ N +
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQL 89
Query: 63 NG--TVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN---YLVGGIPRSLG 117
+ + L + +SFNRL S+P L+ L L GN L G+
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 118 NCFQVRSLLLFSNMLEETIPAEL-GMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS 176
+ L L +N L +PA L L+NL+ L + NSL +IP L L
Sbjct: 149 K---LEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 177 N 177
Sbjct: 204 G 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 13/157 (8%)
Query: 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQ 476
VN + LP ++ + L S N + + L LNL +
Sbjct: 15 VNCDKRNLT-ALPPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA----E 66
Query: 477 IPT--TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRN 534
+ G + L L L+ N L S+P L L VLD+S N L+ L L L
Sbjct: 67 LTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 535 LTVLLLNNNKLSGKIPSGL-ANVSTLSAFNVSFNNLS 570
L L L N+L +P GL L +++ NNL+
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 48/165 (29%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
+N L +F RL L N+ + +L + L LD S NQ+ +
Sbjct: 40 ENLLY-TFSLATLMPYTRLTQL--NLDRAELT-KLQVDGT--LPVLGTLDLSHNQLQS-L 92
Query: 454 PRGVGELVSLVALNLSWNLMHDQI----PTTLGQMKGLKYLSLAGNNLTGSIPSSL-GQL 508
P L +L L++S+N ++ L + L+ L L GN L ++P L
Sbjct: 93 PLLGQTLPALTVLDVSFN----RLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 509 QLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGL 553
LE L L++N+L+ L L L NL LLL N L IP G
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGF 191
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 43/137 (31%), Positives = 61/137 (44%), Gaps = 8/137 (5%)
Query: 410 NRLDSL-MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALN 467
L L +++S+N++ LP + +L LD S N++ +P G L L L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTL-PALTVLDVSFNRLTS-LPLGALRGLGELQELY 130
Query: 468 LSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSL-GQLQLLEVLDLSSNSLSGLIP 526
L N + P L L+ LSLA NNLT +P+ L L+ L+ L L NSL IP
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP 188
Query: 527 DDLENLRNLTVLLLNNN 543
L L+ N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 49/216 (22%), Positives = 72/216 (33%), Gaps = 50/216 (23%)
Query: 73 LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNML 132
V L ++P + + L LS N L +L ++ L L L
Sbjct: 12 HLEVNCDKRNL-TALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 133 EETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQS 192
+ + L L LD+S N L S+P+ L +L +S +R S
Sbjct: 68 -TKLQVDGT-LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF----------NRLTS 114
Query: 193 LVDQPSFMNDDFNFFEGGIPEAV-SSLPNLRILWAPRATLEGN----FPSNWGACD---N 244
L P L L+ L+ L+GN P G
Sbjct: 115 L------------------PLGALRGLGELQELY-----LKGNELKTLPP--GLLTPTPK 149
Query: 245 LEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
LE L+L +N + G+L +NL L L N L
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGR-LRHPNLVTLI 744
IG G + + A+K + V + + E + HP LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL- 75
Query: 745 GYHAS---ETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLH 797
H+ E+ +F + Y+ GG+L +Q++ A + + +I+ AL YLH
Sbjct: 76 --HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY------SAEISLALNYLH 127
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGYVAPEYA 856
++ +++RD+K N+LLD + + L+D+G+ + L P +T T+ GT Y+APE
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 182
Query: 857 MTCRVSDKADVYSYGVVLLELLS 879
D ++ GV++ E+++
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMA 205
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGR-LRHPNLVTLI 744
IG G + + A++ + V + + E + HP LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL- 118
Query: 745 GYHAS---ETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLH 797
H+ E+ +F + Y+ GG+L +Q++ A + + +I+ AL YLH
Sbjct: 119 --HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY------SAEISLALNYLH 170
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFGYVAPEYA 856
++ +++RD+K N+LLD + + L+D+G+ + L P +T T+ GT Y+APE
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 225
Query: 857 MTCRVSDKADVYSYGVVLLELLS 879
D ++ GV++ E+++
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMA 248
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 42/208 (20%), Positives = 67/208 (32%), Gaps = 34/208 (16%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAG-- 59
N L L I + L + + N + I A FS+ L E+ +
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 60 NLVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL- 116
NL+ F L+ + +S + +P LD+ N + I R+
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 117 -GNCFQVRSLLLFSNMLEE-----------------------TIPAE-LGMLQNLEVLDV 151
G F+ L L N ++E +P + +LD+
Sbjct: 150 VGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 152 SRNSLSGSIPVD-LGNCSKLAILVLSNL 178
SR + S+P L N KL NL
Sbjct: 210 SRTRIH-SLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 40/202 (19%), Positives = 73/202 (36%), Gaps = 12/202 (5%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N + ++F +L + + N + + E + +L++L S I +
Sbjct: 63 QNDVLEVIEADVFSNLPKLHEIRIE-KANNLL-YINPEAFQNLPNLQYLLISNTGIKH-L 119
Query: 454 PRGV-GELVSLVALNLSWNLMHDQIPTTL--GQMKGLKYLSLAGNNLTGSIPSSLGQLQL 510
P + V L++ N+ I G L L N + S+ QL
Sbjct: 120 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQL 179
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNL 569
E+ +N+L L D +L ++ ++ +PS L N+ L A + NL
Sbjct: 180 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNL 236
Query: 570 SGPLPSSKNLMKCSSV-LGNPY 590
LP+ + L+ L P
Sbjct: 237 KK-LPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 29/159 (18%), Positives = 63/159 (39%), Gaps = 9/159 (5%)
Query: 26 KSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGNLVNGTVP--TFIG--RLKRVYLSF 80
++ L ++ I +FS F +LE++ ++ N V + F +L + +
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 81 NRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAEL 140
+ + + + NL++L +S + + Q L + N+ TI
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 141 --GMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
G+ +L +++N + I N ++L L LS+
Sbjct: 149 FVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSD 186
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 24/183 (13%), Positives = 55/183 (30%), Gaps = 33/183 (18%)
Query: 418 NVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNLS-WNLMHD 475
++ + L+ ++ S N ++ I V L L + + N +
Sbjct: 36 RFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 94
Query: 476 QIPTTLGQMKGLKYLSLAGNNLTGSIPS-------SLGQLQL------------------ 510
P + L+YL ++ + +P L +
Sbjct: 95 INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153
Query: 511 --LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFN 567
+L L+ N + + + + L +NN L ++P+ S ++S
Sbjct: 154 FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRT 212
Query: 568 NLS 570
+
Sbjct: 213 RIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 30/160 (18%), Positives = 58/160 (36%), Gaps = 10/160 (6%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDF-VNLEELNLA 58
+ NL+ L + + + H +L++ N I SF L L
Sbjct: 103 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162
Query: 59 GNLVNGTVP--TFIG-RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
N + + F G +L + LS N + +P+ + + LD+S +
Sbjct: 163 KNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 221
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNS 155
L N ++R+ ++ + +P L L L ++ S
Sbjct: 222 LENLKKLRARSTYNL---KKLPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 27/146 (18%), Positives = 45/146 (30%), Gaps = 22/146 (15%)
Query: 476 QIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLLEVLDLSSNSLSGLIPDD-LENLR 533
+IP+ L + L L I + LE +++S N + +I D NL
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79
Query: 534 NLTVL-LLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLS-------GPLPSSKNLMKCSS 584
L + + N L I N+ L +S + L
Sbjct: 80 KLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL----D 134
Query: 585 VLGNPYLR--PCRAFT-LTEPSQDLH 607
+ N + +F L+ S L
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILW 160
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 15/85 (17%), Positives = 26/85 (30%), Gaps = 9/85 (10%)
Query: 490 LSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKI 549
+ +T IPS L + L L + +L + ++ N + I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 550 P----SGLANVSTLSAFNVSFNNLS 570
S L + + NNL
Sbjct: 71 EADVFSNLPKLHEIRIEK--ANNLL 93
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGR-LRH 737
+F +G G FG + AE AIK L V V+ E + L H
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 738 PNLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIA 790
P L + + + +F + YL GG+L IQ RA + A +I
Sbjct: 78 PFLTHM---FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY------AAEII 128
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY 850
L +LH + +++RD+K NILLD D + ++DFG+ + T GT Y
Sbjct: 129 LGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDY 184
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELL 878
+APE + + + D +S+GV+L E+L
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGR-LRH 737
+FN +G G FG +E L A+K L V + V+ E + L +
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 738 PNLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIA 790
P L L H+ ++ + Y+ GG+L IQQ AV + A +IA
Sbjct: 81 PFLTQL---HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------AAEIA 131
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGY 850
L +L + +++RD+K N++LD + + ++DFG+ + + T GT Y
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDY 187
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELL 878
+APE D +++GV+L E+L
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 41/185 (22%), Positives = 73/185 (39%), Gaps = 14/185 (7%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAGNL 61
+ + LDL N L + S F L+VL+L I I + +L L L GN
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 62 ---VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL-VGGIPRSLG 117
+ + + L+++ L S+ + L+ L+++ N + +P
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 118 NCFQVRSLLLFSNMLEETIPAE-LGMLQNLEV----LDVSRNSLSGSIPVDLGNCSKLAI 172
N + L L SN + ++I L +L + + LD+S N ++ I +L
Sbjct: 147 NLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204
Query: 173 LVLSN 177
L L
Sbjct: 205 LALDT 209
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 15/168 (8%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGP 452
++ + + + L +L ++ N I L SL+ L A +
Sbjct: 60 SRCEIQ-TIEDGAYQSLSHLSTL--ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS- 114
Query: 453 IPRGV-GELVSLVALNLSWNLMHD-QIPTTLGQMKGLKYLSLAGNNLTGSIP----SSLG 506
+ G L +L LN++ NL+ ++P + L++L L+ N + SI L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLH 173
Query: 507 QLQLLEV-LDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGL 553
Q+ LL + LDLS N ++ + P + + L L L+ N+L +P G+
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLK-SVPDGI 219
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 36/162 (22%), Positives = 66/162 (40%), Gaps = 14/162 (8%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGN- 60
+L L L GN + + + L SL+ L + + L+ELN+A N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 61 LVNGTVP-TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLE----HLDLSGNYLVGGIP 113
+ + +P F L+ + LS N++ S+ + LDLS N + I
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQ 193
Query: 114 RSLGNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSRN 154
+++ L L +N L +++P L +L+ + + N
Sbjct: 194 PGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 46/186 (24%), Positives = 69/186 (37%), Gaps = 16/186 (8%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGNL 61
L+VLDL + I + L L L L N I + +FS +L++L
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETN 111
Query: 62 VNGTVPTFI----GRLKRVYLSFNRLVGSVPS-KIGEKCTNLEHLDLSGNYLV---GGIP 113
+ ++ F LK + ++ N + S + TNLEHLDLS N +
Sbjct: 112 LA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
Query: 114 RSLGN-CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD-LGNCSKLA 171
R L SL L N + I L+ L + N L S+P + L
Sbjct: 170 RVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQ 227
Query: 172 ILVLSN 177
+ L
Sbjct: 228 KIWLHT 233
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 31/140 (22%), Positives = 51/140 (36%), Gaps = 13/140 (9%)
Query: 438 SLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNN 496
S K LD S N + + L L+LS + + L L L GN
Sbjct: 29 STKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 497 LTGSIPSSL-GQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP----- 550
+ S+ L L+ L +L+ L + +L+ L L + +N +
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYF 145
Query: 551 SGLANVSTLSAFNVSFNNLS 570
S L N+ L ++S N +
Sbjct: 146 SNLTNLEHL---DLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 8/95 (8%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
+P + K L L+ N L S L+VLDLS + + ++L +L+
Sbjct: 26 LPFST------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 537 VLLLNNNKLSGKIPSGL-ANVSTLSAFNVSFNNLS 570
L+L N + + G + +S+L NL+
Sbjct: 80 TLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 42/220 (19%), Positives = 67/220 (30%), Gaps = 52/220 (23%)
Query: 74 KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLE 133
+P + + ++LDLS N L S + +++ L L +
Sbjct: 10 ITYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI- 64
Query: 134 ETIPAEL-GMLQNLEVLDVSRNSLSGSIPVDL-GNCSKLAILVLSNLFDTYEDVRYSRGQ 191
+TI L +L L ++ N + S+ + S L LV +
Sbjct: 65 QTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVE----------TNLA 113
Query: 192 SLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN----FPSNWGACD---N 244
SL +F + L L+ L + N F N
Sbjct: 114 SL---ENF--------------PIGHLKTLKELN-----VAHNLIQSFKLP-EYFSNLTN 150
Query: 245 LEMLNLGHNFFSGKNLGVLGPCKNL----LFLDLSSNQLT 280
LE L+L N L + L LDLS N +
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.2 bits (184), Expect = 5e-14
Identities = 34/126 (26%), Positives = 53/126 (42%), Gaps = 11/126 (8%)
Query: 469 SWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDD 528
+ + + ++ L LA +LT + L QL L+ LDLS N L +P
Sbjct: 425 LRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPA 481
Query: 529 LENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSS---- 584
L LR L VL ++N L + G+AN+ L + N L + + L+ C
Sbjct: 482 LAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLL 538
Query: 585 -VLGNP 589
+ GN
Sbjct: 539 NLQGNS 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 6e-13
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 6/106 (5%)
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLI 525
L+L+ + L Q+ + +L L+ N L ++P +L L+ LEVL S N+L +
Sbjct: 446 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV- 501
Query: 526 PDDLENLRNLTVLLLNNNKLSG-KIPSGLANVSTLSAFNVSFNNLS 570
D + NL L LLL NN+L L + L N+ N+L
Sbjct: 502 -DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 5e-10
Identities = 24/125 (19%), Positives = 50/125 (40%), Gaps = 12/125 (9%)
Query: 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQ 476
+++++ + + + + + LD S N++ +P + L L L S N + +
Sbjct: 446 LHLAHKDL--TVLCHLEQ-LLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL-EN 500
Query: 477 IPTTLGQMKGLKYLSLAGNNLTG-SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNL 535
+ + + L+ L L N L + L L +L+L NSL E ++
Sbjct: 501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-----QEEGIQER 554
Query: 536 TVLLL 540
+L
Sbjct: 555 LAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.5 bits (138), Expect = 2e-08
Identities = 42/235 (17%), Positives = 69/235 (29%), Gaps = 62/235 (26%)
Query: 24 HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYL----- 78
+ L L + T + + L+EL T+ + L +
Sbjct: 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETL 405
Query: 79 -SFNRLVGSVPSKIGEK-----------------CTNLEHLDLSGNYLVGGIPRSLGNCF 120
F+ L P + ++ L L+ L + L
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLL 463
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS-NLF 179
V L L N L +P L L+ LEVL S N+L ++ + N +L L+L N
Sbjct: 464 LVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 520
Query: 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN 234
+ + + S P L +L L+GN
Sbjct: 521 QQSAAI---------------------------QPLVSCPRLVLLN-----LQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 33/213 (15%), Positives = 70/213 (32%), Gaps = 20/213 (9%)
Query: 96 TNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNS 155
L +LS + L +C +++ L + TI + +++ L+ L + +
Sbjct: 349 EQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKET 404
Query: 156 LSGSIPVDLGNCSKLAILVLSNL-FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGI--P 212
L S L + + ++ S++ + +
Sbjct: 405 LQ--------YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL 456
Query: 213 EAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272
+ L + L L P A LE+L N +N+ + L L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQEL 513
Query: 273 DLSSNQLTG--ELARELPVPCMTMFDVSGNALS 303
L +N+L + + P + + ++ GN+L
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 24/106 (22%), Positives = 35/106 (33%), Gaps = 24/106 (22%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ + LDL N L + P L+ L VL N + + ++ L+EL L N
Sbjct: 462 LLLVTHLDLSHNRLRALPPALA-ALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 518
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
+ I L C L L+L GN
Sbjct: 519 RLQ-QSAA-IQPLV-------------------SCPRLVLLNLQGN 543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 30/188 (15%), Positives = 65/188 (34%), Gaps = 13/188 (6%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFH-LKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLA 58
+ N+ + + ++ L F+ L + + + R I + L+ L +
Sbjct: 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113
Query: 59 GN----LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTN-LEHLDLSGNYLVGGIP 113
+ T + ++ N + S+P + N L L N +
Sbjct: 114 NTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQ 172
Query: 114 RSLGNCFQVRSLLLFSNMLEETIPAEL--GMLQNLEVLDVSRNSLSGSIPVDLGNCSKLA 171
N ++ ++ L N I + G+ +LDVS+ S++ ++P L
Sbjct: 173 GYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLK 229
Query: 172 ILVLSNLF 179
L+ N +
Sbjct: 230 ELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 34/186 (18%), Positives = 62/186 (33%), Gaps = 16/186 (8%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
+ L + P + F + + V+ + + QL + + ++ + + I
Sbjct: 40 ETHLR-TIPSHAFSNLPNISRIYVS-IDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYI 96
Query: 454 PRGV-GELVSLVALNLSWNLMHDQIP--TTLGQMKGLKYLSLAGNNLTGSIPSSL--GQL 508
EL L L + + P T + L + N SIP + G
Sbjct: 97 DPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155
Query: 509 QLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP----SGLANVSTLSAFNV 564
L L +N + + N L + LN NK I G+ S S +V
Sbjct: 156 NETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV--YSGPSLLDV 212
Query: 565 SFNNLS 570
S +++
Sbjct: 213 SQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 27/155 (17%), Positives = 44/155 (28%), Gaps = 11/155 (7%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIG-RMCKSLKFLDASGNQIVG 451
+ + + L L + N + P L+ + N +
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFL--GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMT 144
Query: 452 PIPRGV--GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSL--GQ 507
IP G + L L N + L + L N I G
Sbjct: 145 SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203
Query: 508 LQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNN 542
+LD+S S++ L LE+L+ L N
Sbjct: 204 YSGPSLLDVSQTSVTALPSKGLEHLKELI--ARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 40/230 (17%), Positives = 67/230 (29%), Gaps = 50/230 (21%)
Query: 65 TVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR-SLGNCFQVR 123
+P+ + + L L ++PS N+ + +S + + + S N +V
Sbjct: 25 RIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVT 83
Query: 124 SLLLFSNMLEETIPAE-LGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTY 182
+ + + I + L L L+ L + L P DL I + + D
Sbjct: 84 HIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP-DLTKVYSTDIFFILEITD-- 139
Query: 183 EDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE-AVSSLPN-LRILWAPRATLEGN----FP 236
N + IP A L N L L N
Sbjct: 140 ----------------------NPYMTSIPVNAFQGLCNETLTLK-----LYNNGFTSVQ 172
Query: 237 SNWGACDNLEMLNLGHNFFSGKNLGVLGP------CKNLLFLDLSSNQLT 280
L+ + L N K L V+ LD+S +T
Sbjct: 173 GYAFNGTKLDAVYLNKN----KYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGR-LRH 737
NF +G G FG A G L A+K L + + V+ E + L H
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 738 PNLVTLIGYHAS---ETEMFLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIA 790
P L L +F + ++ GG+L IQ+ RA + A +I
Sbjct: 84 PFLTQL---FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY------AAEII 134
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL-LGPSETHATTGVAGTFG 849
AL +LHD+ +++RD+K N+LLD + + L+DFG+ + + T T GT
Sbjct: 135 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPD 189
Query: 850 YVAPEYAMTCRVSDKADVYSYGVVLLELL 878
Y+APE D ++ GV+L E+L
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 63/198 (31%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGR-LRHPNLVTLI 744
IG G FG A + V A+K L A+ + + + +E L + ++HP LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 104
Query: 745 GYHAS---ETEMFLIYNYLPGGNLENFIQ-QRSTRAVDWRVLHKIALDIARALAYLHDQC 800
H S +++ + +Y+ GG L F QR ++ R A +IA AL YLH
Sbjct: 105 --HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAA-EIASALGYLHSL- 158
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
+++RD+KP NILLD + L+DFGL + T+ GT Y+APE
Sbjct: 159 --NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 861 VSDKADVYSYGVVLLELL 878
D + G VL E+L
Sbjct: 216 YDRTVDWWCLGAVLYEML 233
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 34/145 (23%), Positives = 63/145 (43%), Gaps = 4/145 (2%)
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
L ++ +S + F+ L E + + L + +A+ + +
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT-FGYVAPE 854
L + + +HRD+ NILL + + DFGLAR + + G A ++APE
Sbjct: 209 LASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 855 YAMTCRVSDKADVYSYGVVLLELLS 879
+ ++DV+S+GV+L E+ S
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 23/98 (23%), Positives = 41/98 (41%), Gaps = 9/98 (9%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPNLV 741
+G G FG +A+ + VA+K L G + +E+K L + H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 742 TLIGYH-ASETEMFLIYNYLPGGNLENFIQQRSTRAVD 778
L+G + +I + GNL +++ + V
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 33/135 (24%), Positives = 57/135 (42%), Gaps = 11/135 (8%)
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
+LK L S NQI + + +L L L+++ N + + L L L N
Sbjct: 62 FTNLKELHLSHNQISD-LS-PLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNN 116
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN 555
L SL L+ LE+L + +N L + L L L VL L+ N+++ GL
Sbjct: 117 ELRD--TDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNT--GGLTR 170
Query: 556 VSTLSAFNVSFNNLS 570
+ ++ +++
Sbjct: 171 LKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 32/157 (20%), Positives = 60/157 (38%), Gaps = 15/157 (9%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
++ + + + + + +L+ L+L N+I+ ++ D LEEL++ N +
Sbjct: 42 GVQNFNGDNSNIQSLAGMQ--FFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRL 97
Query: 63 NGTVPTFIGRLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
L R++L N L NLE L + N L I LG
Sbjct: 98 KNLNGIPSACLSRLFLDNNEL-----RDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLS 150
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLS 157
++ L L N + T L L+ + +D++
Sbjct: 151 KLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 11/122 (9%)
Query: 460 LVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSN 519
L + V NL + D + ++ G++ + +N+ S+ + + L+ L LS N
Sbjct: 18 LANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHN 73
Query: 520 SLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG--PLPSSK 577
+S L P L++L L L +N N+L + +G+ + + LS + N L L K
Sbjct: 74 QISDLSP--LKDLTKLEELSVNRNRLK-NL-NGIPS-ACLSRLFLDNNELRDTDSLIHLK 128
Query: 578 NL 579
NL
Sbjct: 129 NL 130
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 28/162 (17%), Positives = 57/162 (35%), Gaps = 14/162 (8%)
Query: 409 CNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNL 468
+L+ L +V+ NR+ L L N++ + L +L L++
Sbjct: 84 LTKLEEL--SVNRNRLKNLNGIP----SACLSRLFLDNNELRDT--DSLIHLKNLEILSI 135
Query: 469 SWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDD 528
N + + LG + L+ L L GN +T + L +L+ + +DL+
Sbjct: 136 RNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKY 191
Query: 529 LENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
L + + + P ++N + V +
Sbjct: 192 QPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 49/274 (17%), Positives = 82/274 (29%), Gaps = 94/274 (34%)
Query: 9 LEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPT 68
+N + PD G L + NLG +T D V+ +EL+
Sbjct: 4 QRPTPINQVFPDPG--LANAVKQNLGKQSVT--------DLVSQKELS------------ 41
Query: 69 FIGRLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLL 126
++ + + + + TNL+ L LS N + P L + ++ L
Sbjct: 42 ---GVQNFNGDNSNI-----QSLAGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91
Query: 127 LFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVR 186
+ N L+ L L + N L L + L IL + N
Sbjct: 92 VNRNRLKNLNGIP---SACLSRLFLDNNELR-DTD-SLIHLKNLEILSIRN--------- 137
Query: 187 YSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLE 246
N + S+ L L LE
Sbjct: 138 --------------N------------KLKSIVMLGFL------------------SKLE 153
Query: 247 MLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280
+L+L N + N G L K + ++DL+ +
Sbjct: 154 VLDLHGNEIT--NTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 37/193 (19%), Positives = 65/193 (33%), Gaps = 24/193 (12%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
NL+ L L N ++ + P L L L++ NR+ + + L L L N +
Sbjct: 64 NLKELHLSHNQISDLSPLK--DLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNEL 118
Query: 63 NGTVPTFIG--RLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYLVGGIPRSLGN 118
+ I L+ + + N+L I + LE LDL GN + L
Sbjct: 119 R-DTDSLIHLKNLEILSIRNNKL-----KSIVMLGFLSKLEVLDLHGNEITN--TGGLTR 170
Query: 119 CFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSI--PVDLGNCSKLAILVLS 176
+V + L + L + + ++ G P + N +
Sbjct: 171 LKKVNWIDLTGQKCVNE---PVKYQPELYITNTVKD-PDGRWISPYYISNGGSYVDGCVL 226
Query: 177 NLFDTY-EDVRYS 188
Y ++V Y
Sbjct: 227 WELPVYTDEVSYK 239
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 17/90 (18%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540
+ +L ++T + S +L ++ + ++++ L ++ NL L L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
++N++S + S L +++ L +V+ N L
Sbjct: 71 SHNQIS-DL-SPLKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 30/220 (13%), Positives = 65/220 (29%), Gaps = 64/220 (29%)
Query: 93 EKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVS 152
N +L + S V++ ++ ++ + NL+ L +S
Sbjct: 16 PGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLS 71
Query: 153 RNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIP 212
N +S + L + +KL L + + N
Sbjct: 72 HNQIS-DLS-PLKDLTKLEELSV---------------------------NRN------- 95
Query: 213 EAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272
+ +L + L L L +N + L KNL L
Sbjct: 96 -RLKNLNGIPSA-------------------CLSRLFLDNNELR--DTDSLIHLKNLEIL 133
Query: 273 DLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNM 312
+ +N+L + + + + D+ GN ++ + + +
Sbjct: 134 SIRNNKLK-SIVMLGFLSKLEVLDLHGNEIT-NTGGLTRL 171
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 16/184 (8%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAGNL 61
+ + LDL+ N L+ + + L LR+L L N++ +PA F + NLE L + N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 62 ---VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLV---GGIPRS 115
+ V + L + L N+L S+P ++ + T L +L L N L G+
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155
Query: 116 LGNCFQVRSLLLFSNMLEETIPAEL-GMLQNLEVLDVSRNSLSGSIPVDL-GNCSKLAIL 173
L + ++ L L++N L + +P L L+ L + N L +P + KL +L
Sbjct: 156 LTS---LKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKML 210
Query: 174 VLSN 177
L
Sbjct: 211 QLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 12/155 (7%)
Query: 393 GDNKLSGSFPGNMFGICNRLDSL-MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVG 451
DNKL + P +F L +L + V++N++ LP + +L L NQ+
Sbjct: 69 NDNKLQ-TLPAGIF---KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS 123
Query: 452 PIPRGV-GELVSLVALNLSWNLMHDQIPTTL-GQMKGLKYLSLAGNNLTGSIPSSL-GQL 508
+P V L L L+L +N + +P + ++ LK L L N L +P +L
Sbjct: 124 -LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKL 180
Query: 509 QLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543
L+ L L +N L + ++L L +L L N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 36/129 (27%), Positives = 54/129 (41%), Gaps = 9/129 (6%)
Query: 438 SLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNN 496
K LD N++ +P L L L L+ N + ++K L+ L + N
Sbjct: 38 DTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 497 LTGSIPSSL-GQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG--- 552
L ++P + QL L L L N L L P ++L LT L L N+L +P G
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 553 -LANVSTLS 560
L ++ L
Sbjct: 155 KLTSLKELR 163
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 23/168 (13%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
NKLS S P F +L L +++N++ LPA I + K+L+ L + N++ +
Sbjct: 46 SNKLS-SLPSKAFHRLTKLRLL--YLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-L 100
Query: 454 PRGV-GELVSLVALNLSWNLMHDQI----PTTLGQMKGLKYLSLAGNNLTGSIPS----S 504
P GV +LV+L L L N Q+ P + L YLSL N L S+P
Sbjct: 101 PIGVFDQLVNLAELRLDRN----QLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 505 LGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG 552
L L+ L L +N L + + L L L L+NN+L ++P G
Sbjct: 156 LTSLK---ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 35/135 (25%), Positives = 56/135 (41%), Gaps = 8/135 (5%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAG 59
+ NLE L + N L + L +L L L N++ +P F L L+L
Sbjct: 84 LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY 142
Query: 60 NLVNGTVPTFI----GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
N + ++P + LK + L N+L VP +K T L+ L L N L +
Sbjct: 143 NELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 116 LGNCFQVRSLLLFSN 130
+ +++ L L N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 8/95 (8%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
IP K L L N L+ + +L L +L L+ N L L + L+NL
Sbjct: 35 IPADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 537 VLLLNNNKLSGKIPSGL-ANVSTLSAFNVSFNNLS 570
L + +NKL +P G+ + L+ + N L
Sbjct: 89 TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 54/261 (20%), Positives = 102/261 (39%), Gaps = 46/261 (17%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRLR----------- 736
+G G F + A+ + VA+K + + + EIK L R+
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 737 HPNLVTLIG--YHASETE--MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARA 792
+++ L+ H + +++ L G NL I++ R + + +I+ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAY------LSDFGLARLLGPSETHATTGVAG 846
L Y+H +C ++H D+KP N+L++ + ++D G A T
Sbjct: 144 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYTNSIQ 197
Query: 847 TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP-SFSSYGNGFNIVAWGCM-- 903
T Y +PE + AD++S ++ EL++ +P SY + +A +
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA--QIIE 255
Query: 904 --------LLRQG-RAKEFFT 915
LLR G + FF
Sbjct: 256 LLGELPSYLLRNGKYTRTFFN 276
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 3e-12
Identities = 99/729 (13%), Positives = 195/729 (26%), Gaps = 236/729 (32%)
Query: 179 FDTYEDVRYSRGQSL-VDQPSFMND-DFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFP 236
F+T E +Y L V + +F+++ D + +S I+ + A + G
Sbjct: 9 FETGE-HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA-VSGTLR 66
Query: 237 SNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFD 296
W E + F VL N FL + + E R+ P M+
Sbjct: 67 LFWTLLSKQE--EMVQKFVEE----VLRI--NYKFL---MSPIKTE-QRQ-PSMMTRMYI 113
Query: 297 VSGNALSGSIPTFSNM-VCPPVPYLS-RNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRD 354
+ L F+ V PYL R P+ + + G
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK-NVLID-------------GVL 159
Query: 355 GFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMF----GICN 410
G GK V V K+ +F CN
Sbjct: 160 GS--------------------------GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 411 RLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSW 470
++++ + + + S + I + + + L
Sbjct: 194 SPETVLEMLQK-------------LLYQIDPNWTSRSDHSSNIKLRIHSIQA--ELR--- 235
Query: 471 NLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLE 530
L+ + Y + L L+ +++
Sbjct: 236 RLLKSK-----------PY------------ENCL------------------LVLLNVQ 254
Query: 531 NLRNL-------TVLLLNNNKLSGKIPSGLAN-VSTLSAFNVSFNNLSGPLPSSKNLMKC 582
N + +LL K + + +S + ++S ++ S L +
Sbjct: 255 NAKAWNAFNLSCKILLTTRFK-------QVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 583 SSVLGNPYLRPCRAFTLTEPSQDLHGPPSNGNRGFNSIEIASIASASAIVSVLLALIVLF 642
L CR L P + L P ++ IA + LA +
Sbjct: 308 LKYLD------CRPQDL--PREVLTTNP---------RRLSIIA---ESIRDGLATWDNW 347
Query: 643 VYTRKWNPQSKVMGST---------RK---EVTIFTE-IGVP----------LSFESVVQ 679
+ + ++ S+ RK +++F +P + V+
Sbjct: 348 KHVNCDK-LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 680 ATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEI----KTLGRL 735
+ + + +T I P + + +K H I
Sbjct: 407 VVNKLHKYSLVEKQPKESTI--SI-PSIYLELKVKLENE----YALHRSIVDHYNIPKTF 459
Query: 736 RHPNLVTL---------IGYH---ASETEMFLIYN--YLPGGNLENFIQQRSTRAVD--W 779
+L+ IG+H E ++ +L + F++Q+ R W
Sbjct: 460 DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL---DF-RFLEQK-IRHDSTAW 514
Query: 780 RVLHKIA---LDIARALAYLHDQC-------------VPRV---LHRDVKPSNIL---LD 817
I + Y+ D +P++ L K +++L L
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS-KYTDLLRIALM 573
Query: 818 DDFNAYLSD 826
+ A +
Sbjct: 574 AEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 5e-05
Identities = 70/467 (14%), Positives = 131/467 (28%), Gaps = 140/467 (29%)
Query: 31 LNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRL---KRVYLSFN----RL 83
LNL + LE L L+ P + R + L + L
Sbjct: 187 LNLKNCNSPETV---------LEMLQ---KLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 84 VGSVPSKIGEKC----------TNLEHLDLSGNYLV----GGIPRSLGNCFQVR-SLLLF 128
+ SK E C +LS L+ + L SL
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294
Query: 129 SNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS-------NLFDT 181
S L +L L+ LD L P ++ + + +++ +D
Sbjct: 295 SMTLTP--DEVKSLL--LKYLDCRPQDL----PREVLTTNPRRLSIIAESIRDGLATWDN 346
Query: 182 YEDVRYSRGQSLVD------QPSFMN---DDFNFFEGG--IPEAVSSLPNLRILWAPRAT 230
++ V + ++++ +P+ D + F IP + L ++W
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL-----LSLIW----- 396
Query: 231 LEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVP 290
+ + D + ++N H +L P ++ + + + EL V
Sbjct: 397 --FDVIKS----DVMVVVNKLHK----YSLVEKQPKESTISIP--------SIYLELKVK 438
Query: 291 CMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPL 350
L R++ + YN + S P L
Sbjct: 439 LENE-----------------------YALHRSIVDHYNIPKTF------DSDDLIPPYL 469
Query: 351 RGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGD-----NKL--SGSFPG 403
D + F++ G++ E + T++ +V D K+ +
Sbjct: 470 ---DQY---FYSHIGHHLKNI--------EHPERMTLFRMVFLDFRFLEQKIRHDSTAWN 515
Query: 404 NMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIV 450
I N L L I P + L FL ++
Sbjct: 516 ASGSILNTLQQL--KFYKPYICDNDPKYERLVNAILDFLPKIEENLI 560
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-11
Identities = 62/355 (17%), Positives = 115/355 (32%), Gaps = 86/355 (24%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-----HLKSLRVLNLGFNRITGE----IPASFSDFVNLE 53
+++ LD++ L+ D+ + L+ +V+ L +T I ++ L
Sbjct: 4 DIQSLDIQCEELS----DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59
Query: 54 ELNLAGNLVNGTVPTFIG--------RLKRVYLSFNRLVGSVPSKIGE---KCTNLEHLD 102
ELNL N + + +++++ L L G+ + L+ L
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 103 LSGNYLVGGIPRSLG-----NCFQVRSLLLFSNMLEET----IPAELGMLQNLEVLDVSR 153
LS N L + L ++ L L L + + L + + L VS
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 154 NSLSGSIPVDLG-----NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFE 208
N ++ + L + +L L L + T ++ R
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRD--------------------- 218
Query: 209 GGIPEAVSSLPNLRILWAPRATLEGNFPSNWGA----------CDNLEMLNLGHNFFS-- 256
+ V+S +LR L L N + G L L + +
Sbjct: 219 --LCGIVASKASLRELA-----LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK 271
Query: 257 -GKNLG-VLGPCKNLLFLDLSSNQLTGE----LARELPVPC--MTMFDVSGNALS 303
+L VL ++L L L+ N+L E L L P + V + +
Sbjct: 272 GCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 64/359 (17%), Positives = 119/359 (33%), Gaps = 90/359 (25%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHL---------KSLRVLNLGFNRITGE----IPASFSDF 49
L L+L N L D G H ++ L+L +TG + ++
Sbjct: 57 ALAELNLRSNELG----DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL 112
Query: 50 VNLEELNLAGNLVNGTVPTFIG--------RLKRVYLSFNRLVGSVPSKIGE---KCTNL 98
L+EL+L+ NL+ + RL+++ L + L + + +
Sbjct: 113 PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDF 172
Query: 99 EHLDLSGNYL----VGGIPRSLG-NCFQVRSLLLFSNMLEET----IPAELGMLQNLEVL 149
+ L +S N + V + + L + Q+ +L L S + + + +L L
Sbjct: 173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL 232
Query: 150 DVSRNSLSGS-----IPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDF 204
+ N L P L S+L L + T +
Sbjct: 233 ALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD----------------- 275
Query: 205 NFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGA----------CDNLEMLNLGHNF 254
+ + + +L+ L L GN + GA LE L +
Sbjct: 276 ------LCRVLRAKESLKELS-----LAGNELGDEGARLLCETLLEPGCQLESLWVKSCS 324
Query: 255 FS---GKNLG-VLGPCKNLLFLDLSSNQLTGE----LARELPVPC--MTMFDVSGNALS 303
F+ + VL + LL L +S+N+L L + L P + + ++ +S
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 54/359 (15%), Positives = 104/359 (28%), Gaps = 90/359 (25%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHL---------KSLRVLNLGFNRITGEIPASFSDFV--- 50
L+ L L NLL D+G L L L L + ++ + +
Sbjct: 114 TLQELHLSDNLLG----DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAK 169
Query: 51 -NLEELNLAGNLVNGTVPTFIG--------RLKRVYLSFNRLVGSVPSKIGE---KCTNL 98
+ +EL ++ N +N + +L+ + L + + +L
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229
Query: 99 EHLDLSGNYL----VGGIPRSLGNC-FQVRSLLLFSNMLEET----IPAELGMLQNLEVL 149
L L N L + + L + ++R+L ++ + + L ++L+ L
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289
Query: 150 DVSRNSLSGSIPVDLG-----NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDF 204
++ N L L +L L + + T +
Sbjct: 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH----------------- 332
Query: 205 NFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACD----------NLEMLNLGHNF 254
++ L L + N + G + L +L L
Sbjct: 333 ------FSSVLAQNRFLLELQ-----ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381
Query: 255 FSGKNLG----VLGPCKNLLFLDLSSNQLTGE----LARELPVPC--MTMFDVSGNALS 303
S + L +L LDLS+N L L + P + + S
Sbjct: 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 39/181 (21%), Positives = 64/181 (35%), Gaps = 24/181 (13%)
Query: 412 LDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQI----VGPIPRGVGELVSLVALN 467
+ SL ++ ++ AE+ + + + + + I + +L LN
Sbjct: 5 IQSL--DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 468 LSWNLMHDQIPTTLGQM-----KGLKYLSLAGNNLT----GSIPSSLGQLQLLEVLDLSS 518
L N + D + Q ++ LSL LT G + S+L L L+ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 519 NSLSG-----LIPDDLENLRNLTVLLLNNNKLSGK----IPSGLANVSTLSAFNVSFNNL 569
N L L L+ L L L LS + S L VS N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 570 S 570
+
Sbjct: 183 N 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 30/179 (16%), Positives = 66/179 (36%), Gaps = 26/179 (14%)
Query: 418 NVSNNRI----AGQLPAEIGRMCKSLKFLDASGNQI----VGPIPRGVGELVSLVALNLS 469
N+ +N + + + ++ L + G + + L +L L+LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 470 WNLMHDQIPTTLGQM-----KGLKYLSLAGNNLT----GSIPSSLGQLQLLEVLDLSSNS 520
NL+ D L + L+ L L +L+ + S L + L +S+N
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 521 LSG----LIPDDLE-NLRNLTVLLLNNNKLSGK----IPSGLANVSTLSAFNVSFNNLS 570
++ ++ L+ + L L L + ++ + +A+ ++L + N L
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 51/323 (15%), Positives = 94/323 (29%), Gaps = 84/323 (26%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHL---------KSLRVLNLGFNRITGEIPASFSDFV--- 50
+ + L + N +N ++G + L L L +T + V
Sbjct: 171 DFKELTVSNNDIN----EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226
Query: 51 -NLEELNLAGNLVNGTVPTFIG--------RLKRVYLSFNRLVGSVPSKIGE---KCTNL 98
+L EL L N + + RL+ +++ + + +L
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286
Query: 99 EHLDLSGNYL----VGGIPRSLGNC-FQVRSLLLFSNMLEET----IPAELGMLQNLEVL 149
+ L L+GN L + +L Q+ SL + S + L + L L
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346
Query: 150 DVSRNSLSGSIPVDLG-----NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDF 204
+S N L + +L S L +L L++ +
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSS----------------- 389
Query: 205 NFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLG 264
+ + + +LR L L N + G +E +
Sbjct: 390 ------LAATLLANHSLRELD-----LSNNCLGDAGILQLVESVRQ-------------- 424
Query: 265 PCKNLLFLDLSSNQLTGELAREL 287
P L L L + E+ L
Sbjct: 425 PGCLLEQLVLYDIYWSEEMEDRL 447
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 42/190 (22%), Positives = 68/190 (35%), Gaps = 36/190 (18%)
Query: 411 RLDSLMVNVSNNRI----AGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV----- 461
+L++L + + + L I SL+ L N++ G+ EL
Sbjct: 200 QLEAL--KLESCGVTSDNCRDL-CGIVASKASLRELALGSNKL---GDVGMAELCPGLLH 253
Query: 462 ---SLVALNLSWNLMHDQ----IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL---- 510
L L + + + + L + LK LSLAGN L L + L
Sbjct: 254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGC 313
Query: 511 -LEVLDLSSNSLSGL----IPDDLENLRNLTVLLLNNNKLSGK----IPSGLANV-STLS 560
LE L + S S + L R L L ++NN+L + GL S L
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373
Query: 561 AFNVSFNNLS 570
++ ++S
Sbjct: 374 VLWLADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 30/156 (19%), Positives = 55/156 (35%), Gaps = 25/156 (16%)
Query: 437 KSLKFLDASGNQIVGPIPRGVGELVSLVA----LNLSWNLMHDQ----IPTTLGQMKGLK 488
++ LD ++ EL+ L+ + L + + I + L L
Sbjct: 3 LDIQSLDIQCEELS---DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59
Query: 489 YLSLAGNNLTGSIPSSLGQL-----QLLEVLDLSSNSLS----GLIPDDLENLRNLTVLL 539
L+L N L + Q ++ L L + L+ G++ L L L L
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 540 LNNNKLSGK----IPSGLANV-STLSAFNVSFNNLS 570
L++N L + GL + L + + +LS
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 39/238 (16%), Positives = 67/238 (28%), Gaps = 58/238 (24%)
Query: 96 TNLEHLDLSGNYL-VGGIPRSLGNCFQVRSLLLFSNMLEET----IPAELGMLQNLEVLD 150
+++ LD+ L L Q + + L L E I + L + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 151 VSRNSLSGSIPVDLGNC-----SKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFN 205
+ N L + K+ L L N T
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV------------------ 104
Query: 206 FFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGA----------CDNLEMLNLGHNFF 255
+ + +LP L+ L L N + G LE L L +
Sbjct: 105 -----LSSTLRTLPTLQEL-----HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL 154
Query: 256 S---GKNLG-VLGPCKNLLFLDLSSNQLTGE----LARELPVPCMTM--FDVSGNALS 303
S + L VL + L +S+N + L + L + + ++
Sbjct: 155 SAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 40/189 (21%), Positives = 64/189 (33%), Gaps = 30/189 (15%)
Query: 409 CNRLDSLMVNVSNNRI----AGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV--- 461
+RL +L + I G L + R +SLK L +GN++ R + E +
Sbjct: 255 SSRLRTL--WIWECGITAKGCGDL-CRVLRAKESLKELSLAGNELGDEGARLLCETLLEP 311
Query: 462 --SLVALNLSWNLMHDQ----IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQL-----QL 510
L +L + + L Q + L L ++ N L + L Q +
Sbjct: 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 371
Query: 511 LEVLDLSSNSLS----GLIPDDLENLRNLTVLLLNNNKLSGKIPSGLA-----NVSTLSA 561
L VL L+ +S + L +L L L+NN L L L
Sbjct: 372 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 431
Query: 562 FNVSFNNLS 570
+ S
Sbjct: 432 LVLYDIYWS 440
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 37/175 (21%), Positives = 65/175 (37%), Gaps = 35/175 (20%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLI---- 744
IG+GGFG Y A + A + V Q +E+K R+ + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 745 -------------GYHASETEM--FLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIA 786
G + F++ L G +L+ Q V ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV-----LQLG 157
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLD--DDFNAYLSDFGLARLLGPSETH 839
+ + L Y+H+ +H D+K +N+LL + YL+D+GL+ P+ H
Sbjct: 158 IRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 31/137 (22%), Positives = 51/137 (37%), Gaps = 15/137 (10%)
Query: 3 NLEVLDLEGNLLNGILPDSGFH-LKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
L L N + F L LR +N N+IT +F + E+ L N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 62 VNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR--- 114
+ V F G LK + L NR+ V + +++ L L N + +
Sbjct: 93 LE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAF 149
Query: 115 -SLGNCFQVRSLLLFSN 130
+L + + +L L +N
Sbjct: 150 DTLHS---LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 28/126 (22%), Positives = 52/126 (41%), Gaps = 4/126 (3%)
Query: 420 SNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIP 478
+NN I + L+ ++ S N+I I G + + L+ N + +
Sbjct: 40 NNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLENVQH 98
Query: 479 TTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTV 537
++ LK L L N +T + + S L + +L L N ++ + P + L +L+
Sbjct: 99 KMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST 157
Query: 538 LLLNNN 543
L L N
Sbjct: 158 LNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 20/100 (20%), Positives = 44/100 (44%), Gaps = 6/100 (6%)
Query: 466 LNLSWNLMHDQIPT-TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGL 524
L L+ N T ++ L+ ++ + N +T + + + L+SN L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV 96
Query: 525 IPDDLENLRNLTVLLLNNNKLSGKIPSG----LANVSTLS 560
+ L +L L+L +N+++ + + L++V LS
Sbjct: 97 QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLS 135
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 31/126 (24%), Positives = 47/126 (37%), Gaps = 5/126 (3%)
Query: 420 SNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIP 478
N I +P K L+ +D S NQI + L SL +L L N + +
Sbjct: 40 EQNTIK-VIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKITELPK 97
Query: 479 TTLGQMKGLKYLSLAGNNLTGSIPSSLGQ-LQLLEVLDLSSNSLSGLIPDDLENLRNLTV 537
+ + L+ L L N + + Q L L +L L N L + LR +
Sbjct: 98 SLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156
Query: 538 LLLNNN 543
+ L N
Sbjct: 157 MHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 30/133 (22%), Positives = 56/133 (42%), Gaps = 8/133 (6%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA-SFSDFVNLEELNLAGNL 61
+ + LE N + I P + K LR ++L N+I+ E+ +F +L L L GN
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 62 VNGTVPTFI----GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG 117
+ +P + L+ + L+ N++ + + NL L L N L +
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 118 NCFQVRSLLLFSN 130
++++ L N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 10/110 (9%)
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLLEVLDLSSNSLSGL 524
+ L N + P K L+ + L+ N ++ + + L+ L L L N ++ L
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 525 IPDDLENLRNLTVLLLNNNKLSGKIPSG----LANVSTLSAFNVSFNNLS 570
E L +L +LLLN NK++ + L N++ LS ++ N L
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYD---NKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 23/77 (29%), Positives = 39/77 (50%), Gaps = 7/77 (9%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
+P T+ + L N + P + + L +DLS+N +S L PD + LR+L
Sbjct: 30 LPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 537 VLLLNNNKLSGKIPSGL 553
L+L NK++ ++P L
Sbjct: 84 SLVLYGNKIT-ELPKSL 99
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 54/209 (25%), Positives = 83/209 (39%), Gaps = 42/209 (20%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRH------PNLV 741
IG G FG KA VA+K + RF +Q EI+ L LR N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH--RQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 742 TLIGY-----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
++ H + + + L NL I++ + ++ K A I + L L
Sbjct: 163 HMLENFTFRNH-----ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAY--LSDFGLARLLGPSETHATTGVAGTFGYV--- 851
H R++H D+KP NILL + + DFG + + T Y+
Sbjct: 217 HKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYT--------YIQSR 263
Query: 852 ---APEYAMTCRVSDKADVYSYGVVLLEL 877
APE + R D++S G +L EL
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 54/212 (25%), Positives = 82/212 (38%), Gaps = 26/212 (12%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNL 740
+ IG+G FG Y I+ G VAIK Q H E K ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVG 66
Query: 741 VTLIGYHASETEMFLIYNYLP----GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
+ I + +E + YN + G +LE+ S R + + +A + + Y+
Sbjct: 67 IPTIRWCGAEGD----YNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYI 121
Query: 797 HDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSETH------ATTGVAGT 847
H + +HRDVKP N L+ Y+ DFGLA+ + TH + GT
Sbjct: 122 HSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 848 FGYVAPEYAMTCRV-SDKADVYSYGVVLLELL 878
Y A S + D+ S G VL+
Sbjct: 179 ARY-ASINTHLGIEQSRRDDLESLGYVLMYFN 209
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 18/198 (9%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRHP------NLV 741
IG G FG KA VAIK + F Q E++ L + +V
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL--NQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
L + + L++ L NL + ++ + R V + K A + AL +L +
Sbjct: 120 HLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 802 PRVLHRDVKPSNILLDDDFNAY--LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
++H D+KP NILL + + + DFG + LG + + F Y +PE +
Sbjct: 179 -SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRI-YQYIQSRF-YRSPEVLLGM 233
Query: 860 RVSDKADVYSYGVVLLEL 877
D++S G +L+E+
Sbjct: 234 PYDLAIDMWSLGCILVEM 251
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 10/107 (9%)
Query: 442 LDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPT--TLGQMKGLKYLSLAGNNLTG 499
L I + + L + L LS N I +L M+ L+ LSL N +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTN----NIEKISSLSGMENLRILSLGRNLIK- 83
Query: 500 SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546
I + LE L +S N ++ L +E L NL VL ++NNK++
Sbjct: 84 KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 6/116 (5%)
Query: 436 CKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495
K+ K L S N I I + + +L L+L NL+ I L+ L ++ N
Sbjct: 47 LKACKHLALSTNNIEK-I-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYN 103
Query: 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIP-DDLENLRNLTVLLLNNNKLSGKIP 550
+ S+ S + +L L VL +S+N ++ D L L L LLL N L
Sbjct: 104 QIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 29/167 (17%)
Query: 3 NLEVLDLEGNLLNGI--LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
E ++L ++ I + + LK+ + L L N I +I +S S NL L+L N
Sbjct: 24 EAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRN 80
Query: 61 L---VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIG--EKCTNLEHLDLSGNYL--VGGIP 113
L + + L+ +++S+N++ + + EK NL L +S N + G I
Sbjct: 81 LIKKIEN-LDAVADTLEELWISYNQI-----ASLSGIEKLVNLRVLYMSNNKITNWGEI- 133
Query: 114 RSLGNCFQVRSLLLFSNMLEETIPAE----------LGMLQNLEVLD 150
L ++ LLL N L + L NL+ LD
Sbjct: 134 DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 29/145 (20%), Positives = 51/145 (35%), Gaps = 42/145 (28%)
Query: 93 EKCTNLEHLDLSGNYLVGGIPR--SLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLD 150
+HL LS N I + SL +R L L N++++ I + LE L
Sbjct: 45 STLKACKHLALSTN----NIEKISSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELW 99
Query: 151 VSRNSLSGSIPVDLGNCSKLAILVLS-NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEG 209
+S N ++ S+ + L +L +S N + ++
Sbjct: 100 ISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEI------------------------ 133
Query: 210 GIPEAVSSLPNLRILWAPRATLEGN 234
+ +++L L L L GN
Sbjct: 134 ---DKLAALDKLEDLL-----LAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 7/63 (11%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRIT--GEIPASFSDFVNLEELNL 57
LE L + N + + SG L +LRVL + N+IT GEI + LE+L L
Sbjct: 92 ADTLEELWISYNQIASL---SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLL 147
Query: 58 AGN 60
AGN
Sbjct: 148 AGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 30/161 (18%), Positives = 46/161 (28%), Gaps = 39/161 (24%)
Query: 134 ETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSL 193
E + A L L+ + L +S N++ I L L IL L
Sbjct: 38 EKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGR---------------- 79
Query: 194 VDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF---PSNWGACDNLEMLNL 250
N + I + L LW + N S NL +L +
Sbjct: 80 -----------NLIKK-IENLDAVADTLEELW-----ISYNQIASLSGIEKLVNLRVLYM 122
Query: 251 GHNFFSG-KNLGVLGPCKNLLFLDLSSNQLTGELARELPVP 290
+N + + L L L L+ N L +
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 40/201 (19%), Positives = 63/201 (31%), Gaps = 54/201 (26%)
Query: 90 KIGEKCTNLEHLDLSGNY-LVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEV 148
+ T E ++L G + + +L + L L +N +E+ + L ++NL +
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRI 74
Query: 149 LDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFE 208
L + RN + I L L +S N
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISY---------------------------NQIA 106
Query: 209 GGIPEAVSSLPNLRILWAPRATLEGNFPSNW------GACDNLEMLNLGHNFFSGKNLG- 261
+ L NLR+L+ + N +NW A D LE L L N
Sbjct: 107 --SLSGIEKLVNLRVLY-----MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159
Query: 262 ---------VLGPCKNLLFLD 273
V+ NL LD
Sbjct: 160 NATSEYRIEVVKRLPNLKKLD 180
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 40/172 (23%), Positives = 63/172 (36%), Gaps = 26/172 (15%)
Query: 690 IGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIG-- 745
IG GGFG Y A+++ V V + E+K R P +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 746 ------------YHASETEMFLIYNY----LPGGNLENFIQQRSTRAVDWRVLHKIALDI 789
+ Y + G +L+ + + R VL +++L I
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL-QLSLRI 161
Query: 790 ARALAYLHDQCVPRVLHRDVKPSNILLD--DDFNAYLSDFGLARLLGPSETH 839
L Y+H+ +H D+K SN+LL+ + YL D+GLA P H
Sbjct: 162 LDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 33/172 (19%), Positives = 61/172 (35%), Gaps = 26/172 (15%)
Query: 690 IGNGGFGATYKAE---------ISPGVLVAIK------RLAV-GRFQGVQQFHAEI---K 730
G Y+A ++K RL F ++ K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 731 TLGRLRHPNLVTLIGYHASETEM-FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDI 789
L + T +G+ + + FL+ L G +L++ + + R + ++A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL 168
Query: 790 ARALAYLHDQCVPRVLHRDVKPSNILL--DDDFNAYLSDFGLARLLGPSETH 839
AL +LH+ +H +V NI + +D L+ +G A PS H
Sbjct: 169 LDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 8e-11
Identities = 37/209 (17%), Positives = 61/209 (29%), Gaps = 56/209 (26%)
Query: 671 PLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVG--------RFQGV 722
P+ F + T IG G FG ++ I+ VAIK +A+ +
Sbjct: 10 PVPFSHCL-PTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 723 QQFHAEIKTLGRL---------RHPNLVTLIGYH-------------------------- 747
++ EI L R + L H
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 748 ----ASETEMFLIYNYLPGGN-LENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
+ ++F++ + GG LE + S+ I + +LA
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSS----LATAKSILHQLTASLAVAEASL-- 181
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLAR 831
R HRD+ N+LL L +
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 20/160 (12%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNL 740
NF IG G FG + + VAIK Q H E + +L +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP--MKSRAPQLHLEYRFYKQLGSGDG 66
Query: 741 VTLIGYHASETEMFLIYNYLP----GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
+ + Y + YN + G +LE+ R + + IA+ + + Y+
Sbjct: 67 IPQVYYFGPCGK----YNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYV 121
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNA-----YLSDFGLAR 831
H + + ++RDVKP N L+ N ++ DF LA+
Sbjct: 122 HSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 58/346 (16%), Positives = 102/346 (29%), Gaps = 101/346 (29%)
Query: 26 KSLRVLNLGFNRITGE----IPASFSDFVNLEELNLAGNLVNGTVPTFIGR-------LK 74
S+ +L + IT E + A + +++E+ L+GN + ++ L+
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 75 RVYLSFNRLVGSVPSKIGE----------KCTNLEHLDLSGNYL----VGGIPRSLGNCF 120
S G V +I E KC L + LS N + L
Sbjct: 64 IAEFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122
Query: 121 QVRSLLLFSNML-------------EETIPAELGMLQNLEVLDVSRNSLSG----SIPVD 163
+ L L +N L E + + L + RN L
Sbjct: 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182
Query: 164 LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFF--EGG---IPEAVSSL 218
+ L + + N EG + E ++
Sbjct: 183 FQSHRLLHTVKMVQ---------------------------NGIRPEGIEHLLLEGLAYC 215
Query: 219 PNLRILWAPRATLEGNFPSNWGA---------CDNLEMLNLGHNFFS---GKNLG-VLGP 265
L++L L+ N ++ G+ NL L L S +
Sbjct: 216 QELKVLD-----LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK 270
Query: 266 CKN--LLFLDLSSNQLTGELAREL------PVPCMTMFDVSGNALS 303
+N L L L N++ + R L +P + +++GN S
Sbjct: 271 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 61/329 (18%), Positives = 101/329 (30%), Gaps = 65/329 (19%)
Query: 241 ACDNLEMLNLGHNFFS---GKNLG-VLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFD 296
D+++ + L N + L + K+L + S TG + E+P +
Sbjct: 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF-TGRVKDEIPEALRLL-- 86
Query: 297 VSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGF 356
AL P + LS N F + L F K L L
Sbjct: 87 --LQALLKC-PKLHTV------RLSDNAFG--PTAQEPLIDFLSKHTPLEHLYLHNNG-- 133
Query: 357 LAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKL---SGSFPGNMFGICNRLD 413
G + +L + V + + +I+ G N+L S F L
Sbjct: 134 ---LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 190
Query: 414 SLMVNVSNNRI----AGQLPAEIGRMCKSLKFLDASGNQI----VGPIPRGVGELVSLVA 465
++ + N I L E C+ LK LD N + + +L
Sbjct: 191 TV--KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 248
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLA---GNNLTGSIPSSLGQLQLLEVLDLSSNSLS 522
L L+ L+ +G + A N+ L+ L L N +
Sbjct: 249 LGLNDCLLSA---------RGAAAVVDAFSKLENIG------------LQTLRLQYNEIE 287
Query: 523 G----LIPDDL-ENLRNLTVLLLNNNKLS 546
+ + E + +L L LN N+ S
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 32/203 (15%), Positives = 65/203 (32%), Gaps = 37/203 (18%)
Query: 403 GNMFGICNRLDSLMVNVSNNRI--AGQLP-AEIGRMCKSLKFLDASGNQI---------- 449
C +L ++ +S+N Q P + L+ L N +
Sbjct: 87 LQALLKCPKLHTV--RLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144
Query: 450 ---VGPIPRGVGELVSLVALNLSWNLMHDQ----IPTTLGQMKGLKYLSLAGNNLT---- 498
+ + L ++ N + + T + L + + N +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 499 -GSIPSSLGQLQLLEVLDLSSNSLSG----LIPDDLENLRNLTVLLLNNNKLSGK----I 549
+ L Q L+VLDL N+ + + L++ NL L LN+ LS + +
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264
Query: 550 PSGLANVS--TLSAFNVSFNNLS 570
+ + L + +N +
Sbjct: 265 VDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 32/193 (16%), Positives = 58/193 (30%), Gaps = 39/193 (20%)
Query: 417 VNVSNNRI---AGQLPAEIGRMCKSLKFLDASGNQI---VGPIPRGVGELV-------SL 463
+ +S N I A + +E K L+ + S IP + L+ L
Sbjct: 37 IVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 96
Query: 464 VALNLSWNLMHDQ----IPTTLGQMKGLKYLSLAGNNLT-------------GSIPSSLG 506
+ LS N + L + L++L L N L ++
Sbjct: 97 HTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAK 156
Query: 507 QLQLLEVLDLSSNSLSG----LIPDDLENLRNLTVLLLNNNKLSGK-----IPSGLANVS 557
L + N L ++ R L + + N + + + GLA
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216
Query: 558 TLSAFNVSFNNLS 570
L ++ N +
Sbjct: 217 ELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 32/197 (16%), Positives = 54/197 (27%), Gaps = 42/197 (21%)
Query: 3 NLEVLDLEGNLLNGI---LPDSGFHL-------KSLRVLNLGFNRITGEIPASFSDF--- 49
+LE+ + + +P++ L L + L N DF
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 50 -VNLEELNLAGN----------------LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIG 92
LE L L N L L+ + NRL +
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180
Query: 93 E---KCTNLEHLDLSGNYL-----VGGIPRSLGNCFQVRSLLLFSNMLEET----IPAEL 140
+ L + + N + + L C +++ L L N + L
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240
Query: 141 GMLQNLEVLDVSRNSLS 157
NL L ++ LS
Sbjct: 241 KSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 26/168 (15%), Positives = 48/168 (28%), Gaps = 35/168 (20%)
Query: 437 KSLKFLDASGNQI----VGPIPRGVGELVSLVALNLSWNLMHDQ----IPTTLGQMKGLK 488
S++ + I + + E S+ + LS N + + + + K L+
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 489 YLSLAGNNL----------TGSIPSSLGQLQLLEVLDLSSNSLSG----LIPDDLENLRN 534
+ + +L + L + LS N+ + D L
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 535 LTVLLLNNNKLS-------------GKIPSGLANVSTLSAFNVSFNNL 569
L L L+NN L + N L + N L
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 26/132 (19%), Positives = 48/132 (36%), Gaps = 30/132 (22%)
Query: 3 NLEVLDLEGNLLN-----GILPDSGFHLKSLRVLNLGFNRITGE----IPASFSDFVNLE 53
L + + N + +L + + + L+VL+L N T + + + NL
Sbjct: 188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 247
Query: 54 ELNLAGN-------------LVNGTVPTFIGRLKRVYLSFNRL----VGSVPSKIGEKCT 96
EL L L+ + L +N + V ++ + I EK
Sbjct: 248 ELGLNDCLLSARGAAAVVDAFSKLENIG----LQTLRLQYNEIELDAVRTLKTVIDEKMP 303
Query: 97 NLEHLDLSGNYL 108
+L L+L+GN
Sbjct: 304 DLLFLELNGNRF 315
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 54/204 (26%), Positives = 80/204 (39%), Gaps = 26/204 (12%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG+G FG Y I VAIK Q E K L+ + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLEN--VKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 749 SETEMFLIYNYLP----GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
E + YN L G +LE+ S R + + + +A + + ++H +
Sbjct: 73 VEGD----YNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSF--- 124
Query: 805 LHRDVKPSNILLDDDFNA---YLSDFGLARLLGPSETH------ATTGVAGTFGYVAPEY 855
LHRD+KP N L+ A Y+ DFGLA+ + TH + GT Y A
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVN 183
Query: 856 AMTCRV-SDKADVYSYGVVLLELL 878
S + D+ S G VL+ L
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFL 207
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 8e-10
Identities = 51/309 (16%), Positives = 95/309 (30%), Gaps = 43/309 (13%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-----HLKSLRVLNL-GFNRITGE-IPASFSDFVNLEEL 55
LE + L+ ++ D K+ +VL L + + + A + NL+EL
Sbjct: 106 WLEEIRLKRMVVT----DDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKEL 161
Query: 56 NLAGNLVNGTVPTFIGRLKR-----VYLSFNRLVGSVP----SKIGEKCTNLEHLDLSGN 106
+L + V+ ++ V L+ + L V ++ +C NL+ L L+
Sbjct: 162 DLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221
Query: 107 YLVGGIPRSLGNCFQVRSLLLFS------NMLEETIPAELGMLQNLEVLDVSRNSLSGSI 160
+ + L Q+ L + + L + L L +++ +
Sbjct: 222 VPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYL 281
Query: 161 PVDLGNCSKLAILVLSNLFDTYEDVRY-----SRGQSLVDQPSFMNDDFNFFEGGIPEAV 215
P CS+L L LS D+ + Q L +
Sbjct: 282 PAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCK--- 338
Query: 216 SSLPNLRILWAPRATLEGNFPSNWGA-------CDNLEMLNLGHNFFSGKNLGVLGP-CK 267
L LR+ + +E N C LE + + L +
Sbjct: 339 -DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRP 397
Query: 268 NLLFLDLSS 276
N+ L
Sbjct: 398 NMTRFRLCI 406
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 49/333 (14%), Positives = 101/333 (30%), Gaps = 38/333 (11%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-----HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNL 57
+L L++ L + S +L+ L L ++ LEEL
Sbjct: 185 SLVSLNISC--LASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGT 242
Query: 58 AG-------NLVNGTVPTFIGRLKRVYLSFNRLVGSVP-SKIGEKCTNLEHLDLSGNYLV 109
G ++ +G G + LS + C+ L L+LS +
Sbjct: 243 GGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
Query: 110 G-GIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRN---SLSGSIPV-DL 164
+ + L C +++ L + + + + ++L L V + + ++ + +
Sbjct: 303 SYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362
Query: 165 G------NCSKLAILVLSNLFDTYEDVRY---------SRGQSLVDQPSFMNDDFNFFEG 209
G C KL ++ T + +++ + +
Sbjct: 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI 422
Query: 210 GIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLG-VLGPCKN 268
G V +LR L + F +EML++ S + VL C +
Sbjct: 423 GFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDS 482
Query: 269 LLFLDLSSNQLTGELARELPVPC--MTMFDVSG 299
L L++ + M +S
Sbjct: 483 LRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 47/321 (14%), Positives = 95/321 (29%), Gaps = 36/321 (11%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLG-FNRITGE-----IPASFSDFVNLEELN 56
NL+ L L + L L L G + + + S L L+
Sbjct: 212 NLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLS 271
Query: 57 LAGNLVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIP 113
+ V +P RL + LS+ + K+ +C L+ L + G+
Sbjct: 272 GFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE 331
Query: 114 RSLGNCFQVRSLLLF----------SNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD 163
C +R L +F + E+ + + LE + ++ + +
Sbjct: 332 VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALIT 391
Query: 164 LG-NCSKLAILVLSNLFDTYEDVRYSRG-----QSLVDQ-PSFMNDDFNFFEG--GIPEA 214
+ N + L + D ++V+ +
Sbjct: 392 IARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYI 451
Query: 215 VSSLPNLRIL--WAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNL-GVLGPCKNLLF 271
+ + +L + G CD+L L + F K L + +
Sbjct: 452 GTYAKKMEMLSVAFAGDSDLG-MHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510
Query: 272 LDLSSNQLTGE----LARELP 288
L +SS ++ L +++P
Sbjct: 511 LWMSSCSVSFGACKLLGQKMP 531
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 43/294 (14%), Positives = 80/294 (27%), Gaps = 46/294 (15%)
Query: 23 FHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFN 81
+ ++ + PA+ F + + L G V +
Sbjct: 38 YEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGK-------PHFADFNLVPDGWG 90
Query: 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG-NCFQVRSLLL--FSNMLEETIPA 138
V + T LE + L + + + + L+L + + A
Sbjct: 91 GYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA 150
Query: 139 ELGMLQNLEVLDVSRNSLSGSIPVDLG----NCSKLAILVLSNLFDTYED------VRYS 188
+NL+ LD+ + + L + L L +S L V
Sbjct: 151 IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRC 210
Query: 189 RG-QSL-----------------------VDQPSFMNDDFNFFEGGIPEAVSSLPNLRIL 224
+SL + + + G+ A+S LR L
Sbjct: 211 PNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCL 270
Query: 225 WAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNL-GVLGPCKNLLFLDLSSN 277
+ P+ + C L LNL + +L +L C L L +
Sbjct: 271 SGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 31/175 (17%), Positives = 61/175 (34%), Gaps = 14/175 (8%)
Query: 409 CNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV----SLV 464
L+++ S + A I C++LK LD + + + SLV
Sbjct: 129 FKNFKVLVLS-SCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187
Query: 465 ALNLSW---NLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSL 521
+LN+S + + + + LK L L + + L + LE L +
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA 247
Query: 522 SG------LIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+ L + L L + + +P+ + S L+ N+S+ +
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 35/168 (20%), Positives = 63/168 (37%), Gaps = 20/168 (11%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNL 740
++ IG G FG ++ + VAIK R Q E +T L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTG 67
Query: 741 VTLIGYHASETEMFLIYNYLP----GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
+ + Y E +N L G +LE+ + R + + A + + +
Sbjct: 68 IPNVYYFGQEGL----HNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 122
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNA-----YLSDFGLARLLGPSETH 839
H++ + ++RD+KP N L+ + Y+ DFG+ + T
Sbjct: 123 HEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 26/152 (17%), Positives = 56/152 (36%), Gaps = 13/152 (8%)
Query: 6 VLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVN-- 63
++ L L+ + R L+L +I I + + ++ + N +
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL 57
Query: 64 GTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL--VGGIPRSLGNCFQ 121
P RLK + ++ NR+ + + + +L L L+ N L +G + L +
Sbjct: 58 DGFPLLR-RLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKS 114
Query: 122 VRSLLLFSN---MLEETIPAELGMLQNLEVLD 150
+ L + N + + + + VLD
Sbjct: 115 LTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 3/91 (3%)
Query: 456 GVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLD 515
V L+L I + + + N + + L+ L+ L
Sbjct: 14 QYTNAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70
Query: 516 LSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546
+++N + + + L +LT L+L NN L
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 20/106 (18%), Positives = 34/106 (32%), Gaps = 27/106 (25%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
+ +D N + + GF L+ L+ L + NRI +L EL L N
Sbjct: 43 QFDAIDFSDNEIRKL---DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN- 98
Query: 62 VNGTVPTFIGRLKRV-YLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
+ L + L+ +L +L + N
Sbjct: 99 -------SLVELGDLDPLA--------------SLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 23/159 (14%), Positives = 45/159 (28%), Gaps = 52/159 (32%)
Query: 30 VLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPS 89
++ L I + +++ V EL+L G ++ +
Sbjct: 1 MVKLTAELIE-QAA-QYTNAVRDRELDLRGY-----------KIPVI------------E 35
Query: 90 KIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVL 149
+G + +D S N + R L +L+ L+ L
Sbjct: 36 NLGATLDQFDAIDFSDNEI-----RKLDG---------------------FPLLRRLKTL 69
Query: 150 DVSRNSLSGSIPVDLGNCSKLAILVLS-NLFDTYEDVRY 187
V+ N + L L+L+ N D+
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP 108
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 13/62 (20%), Positives = 23/62 (37%), Gaps = 3/62 (4%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRIT--GEIPASFSDFVNLEELNLA 58
+ L+ L + N + I L L L L N + G++ + +L L +
Sbjct: 63 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCIL 121
Query: 59 GN 60
N
Sbjct: 122 RN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 9/113 (7%)
Query: 409 CNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNL 468
R L ++ +I + +G +D S N+I + G L L L +
Sbjct: 18 AVRDREL--DLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLV 71
Query: 469 SWNLMHDQIPTTLGQMKGLKYLSLAGNNLT--GSIPSSLGQLQLLEVLDLSSN 519
+ N + + L L L N+L G + L L+ L L + N
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 10/98 (10%)
Query: 404 NMFGICNRLDSLMVNVSNNRIA--GQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV 461
N+ ++ D++ + S+N I P + + LK L + N+I L
Sbjct: 36 NLGATLDQFDAI--DFSDNEIRKLDGFP-----LLRRLKTLLVNNNRICRIGEGLDQALP 88
Query: 462 SLVALNLSWNLMHD-QIPTTLGQMKGLKYLSLAGNNLT 498
L L L+ N + + L +K L YL + N +T
Sbjct: 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 60.0 bits (144), Expect = 1e-09
Identities = 26/196 (13%), Positives = 67/196 (34%), Gaps = 23/196 (11%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASF--SDFVNLEELNLA 58
+ + +L+ L +L+ L + + + SD NLE+L L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 59 GNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGN 118
+ + Y + P ++ NL+ L + +
Sbjct: 228 VGVED-------------YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLE 274
Query: 119 CF---QVRSLLLFSNMLE----ETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLA 171
Q+ ++ + + +L + + +++L+ +++ N LS + +L +
Sbjct: 275 SDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPM- 333
Query: 172 ILVLSNLFDTYEDVRY 187
+ +S+ + +D Y
Sbjct: 334 KIDVSDSQEYDDDYSY 349
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 5e-06
Identities = 26/195 (13%), Positives = 64/195 (32%), Gaps = 21/195 (10%)
Query: 380 ERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSL 439
I + ++S ++ + + + L + + +L
Sbjct: 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGK---KPRPNL 195
Query: 440 KFLDASGNQIVGPIPRGVG--ELVSLVALNLSWNLMHDQIPTTL---------GQMKGLK 488
K L+ + + + +L +L L L + + + LK
Sbjct: 196 KSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255
Query: 489 YLSLAGNNLTGSIPSSLGQ---LQLLEVLDLSSNSLSG----LIPDDLENLRNLTVLLLN 541
+L + + + L LE +D+S+ L+ L+ D ++ +++L + +
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 542 NNKLSGKIPSGLANV 556
N LS ++ L
Sbjct: 316 YNYLSDEMKKELQKS 330
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 6e-04
Identities = 30/191 (15%), Positives = 63/191 (32%), Gaps = 28/191 (14%)
Query: 128 FSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRY 187
S + + + L + L L + + ++ + L L + + V
Sbjct: 156 ISWIEQVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVED 212
Query: 188 ---SRGQSLVDQPSFMNDDFNFFEGGIPE-----AVSSLPNLRILWAPRATLEGNFPSNW 239
S +L ++ + F+G + + PNL+ L + N
Sbjct: 213 ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLG-----IVDAEEQNV 267
Query: 240 GA--------CDNLEMLNLGHNFFSGKN----LGVLGPCKNLLFLDLSSNQLTGELAREL 287
LE +++ + + L + K+L F+++ N L+ E+ +EL
Sbjct: 268 VVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
Query: 288 PVPCMTMFDVS 298
DVS
Sbjct: 328 QKSLPMKIDVS 338
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 30/106 (28%), Positives = 45/106 (42%), Gaps = 8/106 (7%)
Query: 441 FLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGS 500
LD + G I E V+L L+L + + + L ++ LK L L+ N + G
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLIS-V-SNLPKLPKLKKLELSENRIFGG 86
Query: 501 IPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLR---NLTVLLLNNN 543
+ +L L L+LS N L + LE L+ L L L N
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 28/86 (32%), Positives = 42/86 (48%), Gaps = 3/86 (3%)
Query: 462 SLVALNLSWN-LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNS 520
++ L L +I + L++LSL L S+ S+L +L L+ L+LS N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENR 82
Query: 521 LSGLIPDDLENLRNLTVLLLNNNKLS 546
+ G + E L NLT L L+ NKL
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 28/106 (26%), Positives = 36/106 (33%), Gaps = 27/106 (25%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
NLE L L L + S L L+ L L NRI G + NL LNL+GN
Sbjct: 50 NLEFLSLINVGLISV---SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN- 105
Query: 62 VNGTVPTFIGRLKRV-YLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
+ + + L K L+ LDL
Sbjct: 106 -------KLKDISTLEPLK--------------KLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 25/110 (22%), Positives = 40/110 (36%), Gaps = 9/110 (8%)
Query: 486 GLKYLSLAGNNLT-GSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNK 544
++ L L G I + LE L L + L + +L L L L L+ N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENR 82
Query: 545 LSGKIPSGLANVSTLSAFNVSFNNLS-----GPLPSSKNLMKCSSVLGNP 589
+ G + + L+ N+S N L PL + L K +
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECL-KSLDLFNCE 131
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 36/154 (23%), Positives = 57/154 (37%), Gaps = 31/154 (20%)
Query: 3 NLEVLDLEGNLLNGI-LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
+ L L+ N + +L L+L + NL +L
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------SVSNLPKLP----- 71
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL--VGGIPRSLGNC 119
+LK++ LS NR+ + EK NL HL+LSGN L + + L
Sbjct: 72 ----------KLKKLELSENRIF-GGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKL 119
Query: 120 FQVRSLLLFSN---MLEETIPAELGMLQNLEVLD 150
++SL LF+ L + + +L L LD
Sbjct: 120 ECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 29/135 (21%), Positives = 52/135 (38%), Gaps = 26/135 (19%)
Query: 25 LKSLRVLNLGFNRIT-GEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRL 83
++R L L + G+I ++FVNLE L+L + + +
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG--------LISVSNL------- 67
Query: 84 VGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEE-TIPAELGM 142
K L+ L+LS N + GG+ + L L N L++ + L
Sbjct: 68 ---------PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKK 118
Query: 143 LQNLEVLDVSRNSLS 157
L+ L+ LD+ ++
Sbjct: 119 LECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 15/62 (24%), Positives = 25/62 (40%), Gaps = 3/62 (4%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRIT--GEIPASFSDFVNLEELNLA 58
+ L+ L+L N + G L L +L LNL N++ + L+ L+L
Sbjct: 70 LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLF 128
Query: 59 GN 60
Sbjct: 129 NC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 21/116 (18%), Positives = 35/116 (30%), Gaps = 27/116 (23%)
Query: 73 LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNML 132
++ + L + + + NLE L L L S+ N
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSN-------------- 66
Query: 133 EETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS-NLFDTYEDVRY 187
L L L+ L++S N + G + + L L LS N +
Sbjct: 67 -------LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP 115
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 32/118 (27%), Positives = 46/118 (38%), Gaps = 13/118 (11%)
Query: 404 NMFGICNRLDSLMVNVSNNRIA--GQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV 461
+ L+ L ++ N + LP LK L+ S N+I G + +L
Sbjct: 43 GLTAEFVNLEFL--SLINVGLISVSNLP-----KLPKLKKLELSENRIFGGLDMLAEKLP 95
Query: 462 SLVALNLSWNLMHD-QIPTTLGQMKGLKYLSLAGN---NLTGSIPSSLGQLQLLEVLD 515
+L LNLS N + D L +++ LK L L NL S L L LD
Sbjct: 96 NLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 68/331 (20%), Positives = 112/331 (33%), Gaps = 102/331 (30%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHA--EIKTLGRLR-----HPN-- 739
+G G F + + I VA+K V + A EI+ L +R PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 740 -LVTLI---------GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDI 789
+V L+ G H + +++ L G +L +I + + + + + KI +
Sbjct: 102 MVVQLLDDFKISGVNGTH-----ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 790 ARALAYLHDQCVPRVLHRDVKPSNILL--------------------------------- 816
+ L YLH +C R++H D+KP NILL
Sbjct: 156 LQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 817 ----------------DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
+ ++D G A + T T Y + E +
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHF--TEDIQTRQYRSLEVLIGSG 269
Query: 861 VSDKADVYSYGVVLLELLSDKKALDP-SFSSYGNGFNIVA-----WGCM---LLRQG-RA 910
+ AD++S + EL + +P S Y + +A G + L+ G +
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 911 KEFFT--------AGLWDAGPHDDLVEVLHL 933
KEFFT L G + LVE
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEW 360
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 19/94 (20%), Positives = 30/94 (31%), Gaps = 2/94 (2%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNL 535
L + L L + + L L L L + + L + PD L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 536 TVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL 569
+ L L+ N L + +L +S N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 9e-08
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 2/94 (2%)
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPT-TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLL 511
+ +L L + + L + L+ L++ + L P + L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 512 EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545
L+LS N+L L ++ L +L L+L+ N L
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 24/100 (24%), Positives = 33/100 (33%), Gaps = 5/100 (5%)
Query: 500 SIPSSLGQLQLLEVLDLSSN-SLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVST 558
L + L L + + L L DL L L L + + L P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 559 LSAFNVSFNNLS---GPLPSSKNLMKCSSVLGNPYLRPCR 595
LS N+SFN L +L + + GNP C
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQEL-VLSGNPLHCSCA 120
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 14/77 (18%), Positives = 22/77 (28%), Gaps = 5/77 (6%)
Query: 36 NRITGEIPASFSDFVNLEELNLAGNLVNGTVP--TFIG--RLKRVYLSFNRLVGSVPSKI 91
+ NL EL + + G L+ + + + L V
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 92 GEKCTNLEHLDLSGNYL 108
L L+LS N L
Sbjct: 76 FHFTPRLSRLNLSFNAL 92
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 5/88 (5%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG 59
NL L +E L L LR L + + + P +F L LNL+
Sbjct: 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89
Query: 60 NLVNGTVP--TFIG-RLKRVYLSFNRLV 84
N + ++ T G L+ + LS N L
Sbjct: 90 NALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 96 TNLEHLDLSGNYLVGGIPR-SLGNCFQVRSLLLFSNMLEETIPAE-LGMLQNLEVLDVSR 153
NL L + + + L ++R+L + + L + + L L++S
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTPRLSRLNLSF 89
Query: 154 NSLSGSIPVDLGNCSKLAILVLSN 177
N+L S+ L LVLS
Sbjct: 90 NALE-SLSWKTVQGLSLQELVLSG 112
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 36/133 (27%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 24 HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVN--GTVPTFIGRLKRVYLSFN 81
+K L + N N ++ +F LE L+ + +P +LK++ LS N
Sbjct: 18 DVKELVLDNSRSNEG--KLEGLTDEFEELEFLSTINVGLTSIANLPKLN-KLKKLELSDN 74
Query: 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVG-GIPRSLGNCFQVRSLLLFSN---MLEETIP 137
R+ + EKC NL HL+LSGN + L ++SL LF+ L +
Sbjct: 75 RVS-GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRE 133
Query: 138 AELGMLQNLEVLD 150
+L L LD
Sbjct: 134 NVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 25/109 (22%), Positives = 44/109 (40%), Gaps = 9/109 (8%)
Query: 487 LKYLSLAGNNLT-GSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545
+K L L + G + + + LE L + L+ + +L L L L L++N++
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRV 76
Query: 546 SGKIPSGLANVSTLSAFNVSFNNLSG-----PLPSSKNLMKCSSVLGNP 589
SG + L+ N+S N + PL +NL K +
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENL-KSLDLFNCE 124
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 24/71 (33%), Positives = 39/71 (54%), Gaps = 2/71 (2%)
Query: 476 QIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNL 535
++ + + L++LS LT SI ++L +L L+ L+LS N +SG + E NL
Sbjct: 33 KLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL 90
Query: 536 TVLLLNNNKLS 546
T L L+ NK+
Sbjct: 91 THLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 28/105 (26%), Positives = 37/105 (35%), Gaps = 25/105 (23%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
LE L L I + L L+ L L NR++G + NL LNL+GN
Sbjct: 43 ELEFLSTINVGLTSI---ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK 99
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
+ + I LK K NL+ LDL
Sbjct: 100 IKD--LSTIEPLK-------------------KLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-07
Identities = 16/61 (26%), Positives = 25/61 (40%), Gaps = 1/61 (1%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITG-EIPASFSDFVNLEELNLAG 59
+ L+ L+L N ++G L +L LNL N+I NL+ L+L
Sbjct: 63 LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122
Query: 60 N 60
Sbjct: 123 C 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 21/99 (21%), Positives = 36/99 (36%), Gaps = 4/99 (4%)
Query: 91 IGEKCTNLEHLDLSGN-YLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVL 149
++++ L L + G + ++ L + L A L L L+ L
Sbjct: 12 RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKL 69
Query: 150 DVSRNSLSGSIPVDLGNCSKLAILVLS-NLFDTYEDVRY 187
++S N +SG + V C L L LS N +
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 28/118 (23%), Positives = 44/118 (37%), Gaps = 13/118 (11%)
Query: 404 NMFGICNRLDSLMVNVSNNRIA--GQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV 461
+ L+ L + N + LP LK L+ S N++ G + +
Sbjct: 36 GLTDEFEELEFL--STINVGLTSIANLPK-----LNKLKKLELSDNRVSGGLEVLAEKCP 88
Query: 462 SLVALNLSWNLMHD-QIPTTLGQMKGLKYLSLAGNNLTGSI---PSSLGQLQLLEVLD 515
+L LNLS N + D L +++ LK L L +T + L L LD
Sbjct: 89 NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 8/109 (7%)
Query: 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPAS-FSDFVNLEELNLAGN--- 60
E LDL+ L + + L L LNL +N++ + A F D L L LA N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 61 -LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL 108
L G V + +L ++YL N+L S+PS + ++ T L+ L L+ N L
Sbjct: 97 SLPLG-VFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 46/156 (29%), Positives = 60/156 (38%), Gaps = 13/156 (8%)
Query: 442 LDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSI 501
LD + L L LNL +N + + L L LA N L S+
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98
Query: 502 PSSL-GQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG----LANV 556
P + L L+ L L N L L + L L L LN N+L IP+G L N+
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 557 STLSAFNVSFNNL-SGPLPSSKNLMKCSSV--LGNP 589
TLS N L S P + L K ++ GN
Sbjct: 158 QTLSLST---NQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN- 60
L L+L+ N L L F L L L L N++ F L++L L GN
Sbjct: 60 KLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQ 118
Query: 61 ---LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPR-SL 116
L +G V + +LK + L+ N+L S+P+ +K TNL+ L LS N L +P +
Sbjct: 119 LKSLPSG-VFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQL-QSVPHGAF 175
Query: 117 GNCFQVRSLLLFSN 130
+++++ LF N
Sbjct: 176 DRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 21/77 (27%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
IP + L L L ++ L L L+L N L L ++L L
Sbjct: 33 IPADT------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86
Query: 537 VLLLNNNKLSGKIPSGL 553
L L NN+L+ +P G+
Sbjct: 87 TLGLANNQLA-SLPLGV 102
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 39/189 (20%), Positives = 68/189 (35%), Gaps = 13/189 (6%)
Query: 3 NLEVLDLEG-NLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG-- 59
++ +DL + L L+ L+L R++ I + + NL LNL+G
Sbjct: 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153
Query: 60 NLVNGTVP---TFIGRLKRVYLSFNRLVG--SVPSKIGEKCTNLEHLDLSGNYLV---GG 111
+ + RL + LS+ V + + L+LSG
Sbjct: 154 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 213
Query: 112 IPRSLGNCFQVRSL-LLFSNMLEETIPAELGMLQNLEVLDVSR-NSLSGSIPVDLGNCSK 169
+ + C + L L S ML+ E L L+ L +SR + ++LG
Sbjct: 214 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 273
Query: 170 LAILVLSNL 178
L L + +
Sbjct: 274 LKTLQVFGI 282
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 39/183 (21%), Positives = 72/183 (39%), Gaps = 14/183 (7%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNL-GFNRITGEIPASFSDF-VNLEELNLAG- 59
L+ L LEG L+ + ++ +L LNL G + + + L+ELNL+
Sbjct: 119 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178
Query: 60 -NLVNGTVPTFIGR----LKRVYLS-FNRLVGSVP-SKIGEKCTNLEHLDLSGNYLVG-- 110
+ V + + ++ LS + + + S + +C NL HLDLS + ++
Sbjct: 179 FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND 238
Query: 111 GIPRSLGNCFQVRSLLL-FSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSK 169
+ ++ L L + ELG + L+ L V G++ +
Sbjct: 239 CF-QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH 297
Query: 170 LAI 172
L I
Sbjct: 298 LQI 300
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 48/261 (18%), Positives = 76/261 (29%), Gaps = 56/261 (21%)
Query: 47 SDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
SD + L+L G ++ V + + R P ++H+DLS
Sbjct: 44 SDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSN- 102
Query: 107 YLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGN 166
S + T+ L L+ L + LS I L
Sbjct: 103 ----------------------SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK 140
Query: 167 CSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRIL-- 224
S L L LS S ++ + +SS L L
Sbjct: 141 NSNLVRLNLSGC-------------------SGFSEF------ALQTLLSSCSRLDELNL 175
Query: 225 -WAPRATLEGNFPSNWGACDNLEMLNLG--HNFFSGKNLGVLGP-CKNLLFLDLSS-NQL 279
W T + + + + LNL +L L C NL+ LDLS L
Sbjct: 176 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 235
Query: 280 TGELAREL-PVPCMTMFDVSG 299
+ +E + + +S
Sbjct: 236 KNDCFQEFFQLNYLQHLSLSR 256
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 36/233 (15%), Positives = 67/233 (28%), Gaps = 37/233 (15%)
Query: 55 LNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPS--KIGEKCTNLEHLDLSGNYLVGGI 112
+ ++ + + ++ + V V + I +C+ L++L L G L I
Sbjct: 75 FRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPI 134
Query: 113 PRSLGNCFQVRSLLLF--SNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDL---GNC 167
+L + L L S E + L L+ L++S V +
Sbjct: 135 VNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 194
Query: 168 SKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRIL--- 224
+ L LS + + V PNL L
Sbjct: 195 ETITQLNLSGY------------------RKNLQKS------DLSTLVRRCPNLVHLDLS 230
Query: 225 WAPRATLEGNFPSNWGACDNLEMLNLGH-NFFSGKNLGVLGPCKNLLFLDLSS 276
+ + + + L+ L+L + L LG L L +
Sbjct: 231 DSVMLKNDC--FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 30/161 (18%), Positives = 64/161 (39%), Gaps = 20/161 (12%)
Query: 409 CNRLDSL----MVNVSNNRIAGQLPAEIGRMCKSLKFLDASG-NQIVGPIPRGVGELV-- 461
C+RLD L + + + + + +++ L+ SG + + + LV
Sbjct: 167 CSRLDELNLSWCFDFTEKHVQ----VAVAHVSETITQLNLSGYRKNLQK--SDLSTLVRR 220
Query: 462 --SLVALNLSW-NLMHDQIPTTLGQMKGLKYLSLAG-NNLTGSIPSSLGQLQLLEVLDLS 517
+LV L+LS ++ + Q+ L++LSL+ ++ LG++ L+ L +
Sbjct: 221 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 280
Query: 518 SNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVST 558
G + E L +L +N + + + N
Sbjct: 281 GIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKN 318
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 52/303 (17%), Positives = 96/303 (31%), Gaps = 47/303 (15%)
Query: 3 NLEVLDLEGNLLNGILPDSGF--HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG- 59
+L + + IL GF +L G +P + + V +L G
Sbjct: 221 SLVSVKVGDF---EILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL 277
Query: 60 -NLVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS 115
+ +P +++++ L + L + +KC NLE L+ G+
Sbjct: 278 SYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVL 337
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGML------------QNLEVLDVSRNSLSGSIPVD 163
C Q++ L + E+ + E G++ Q LE + V + ++
Sbjct: 338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES 397
Query: 164 LG-NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLR 222
+G L L L R + + D P + G+ + LR
Sbjct: 398 IGTYLKNLCDFRLVLL---------DREERITDLP---------LDNGVRSLLIGCKKLR 439
Query: 223 ILWA----PRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGP-CKNLLFLDLSSN 277
T G N+ + LG+ S + L C NL L++
Sbjct: 440 RFAFYLRQGGLTDLG-LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC 498
Query: 278 QLT 280
+
Sbjct: 499 CFS 501
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 42/294 (14%), Positives = 83/294 (28%), Gaps = 36/294 (12%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
NL L L+G + +L N G + ++ L+ ++ +V
Sbjct: 74 NLRSLKLKG--------KPRAAMFNLIPENWGGYVTPW-VTEISNNLRQLKSVHFRRMIV 124
Query: 63 NGT-----VPTFIGRLKRVYLSFNRLVGSV-PSKIGEKCTNLEHLDLSGNYLVGGIPRSL 116
+ L+ + L + I C ++ L + + + L
Sbjct: 125 SDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWL 184
Query: 117 G----NCFQVRSLLL----FSNMLEETIPAELGMLQNLEVLDVSRNSLS--GSIPVDLGN 166
+ + L F+ + + + ++L + V + N
Sbjct: 185 HELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAAN 244
Query: 167 CSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRIL-- 224
+ L+ E + + N +P +R L
Sbjct: 245 LEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN----EMPILFPFAAQIRKLDL 300
Query: 225 -WAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGP-CKNLLFLDLSS 276
+A T + + C NLE+L N + L VL CK L L +
Sbjct: 301 LYALLETEDH--CTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIER 351
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 51/230 (22%), Positives = 83/230 (36%), Gaps = 62/230 (26%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIK--RLAVGRFQGVQQFHAEIKTLGRLRH-----PNLV 741
+G+G FG + I A+K R + ++ + E L ++++ N+V
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYT--RSAKIEADILKKIQNDDINNNNIV 99
Query: 742 TLIGY-----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
G H M LI+ L G +L I + + + ++I +AL YL
Sbjct: 100 KYHGKFMYYDH-----MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL 153
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGT------FG- 849
+ H D+KP NILLDD + R + + T FG
Sbjct: 154 RKM---SLTHTDLKPENILLDD--PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 850 ----------------YVAPE------YAMTCRVSDKADVYSYGVVLLEL 877
Y APE + ++ D++S+G VL EL
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGWDVSS------DMWSFGCVLAEL 252
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 39/119 (32%), Positives = 51/119 (42%), Gaps = 24/119 (20%)
Query: 3 NLEVLDLEGNLLNGILPDSGFH-LKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN- 60
NL L L GN L LP+ F L +L+ L L N++ F NL LNLA N
Sbjct: 86 NLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ 144
Query: 61 -----------LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL 108
L N L + LS+N+L S+P + +K T L+ L L N L
Sbjct: 145 LQSLPKGVFDKLTN---------LTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 39/176 (22%), Positives = 61/176 (34%), Gaps = 44/176 (25%)
Query: 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQ 476
N+ + + + S + V I L ++ L L N +
Sbjct: 24 ANLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGN----K 74
Query: 477 IPTTLG---QMKGLKYLSLAGNNLTGSIPSSL-GQLQLLEVLDLSSNSLSGL---IPDDL 529
+ + ++ L YL L GN L S+P+ + +L L+ L L N L L + D L
Sbjct: 75 L-HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL 132
Query: 530 ENLR---------------------NLTVLLLNNNKLSGKIPSG----LANVSTLS 560
NL NLT L L+ N+L +P G L + L
Sbjct: 133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLR 187
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN- 60
+++ + + + + G +L ++R L LG N++ +I A + NL L L GN
Sbjct: 42 SIDQIIANNSDIKSV---QGIQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQ 96
Query: 61 --LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVG---GIPRS 115
+ V + LK + L N+L S+P + +K TNL +L+L+ N L G+
Sbjct: 97 LQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDK 155
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGM---LQNLEVLDVSRNSLSGSIP 161
L N + L L N L+ +P G+ L L+ L + +N L S+P
Sbjct: 156 LTN---LTELDLSYNQLQS-LPE--GVFDKLTQLKDLRLYQNQLK-SVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 41/151 (27%), Positives = 65/151 (43%), Gaps = 28/151 (18%)
Query: 407 GICNRLDSL-MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLV 464
L +L + ++ N++ LP + +LK L NQ+ +P GV +L +L
Sbjct: 79 SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLT 136
Query: 465 ALNLSWNLMHDQIPT-------TLGQMKGLKYLSLAGNNLTGSIPS----SLGQLQLLEV 513
LNL+ N Q+ + L L L L+ N L S+P L QL+ L
Sbjct: 137 YLNLAHN----QLQSLPKGVFDKLTN---LTELDLSYNQLQ-SLPEGVFDKLTQLKDL-- 186
Query: 514 LDLSSNSLSGLIPDD-LENLRNLTVLLLNNN 543
L N L +PD + L +L + L++N
Sbjct: 187 -RLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 41/125 (32%), Positives = 57/125 (45%), Gaps = 21/125 (16%)
Query: 438 SLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTTL-----GQMKGLKYLS 491
+L +L +GNQ+ +P GV +L +L L L N Q+ +L ++ L YL+
Sbjct: 86 NLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVEN----QL-QSLPDGVFDKLTNLTYLN 139
Query: 492 LAGNNLTGSIPS----SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547
LA N L S+P L L L DLS N L L + L L L L N+L
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTEL---DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195
Query: 548 KIPSG 552
+P G
Sbjct: 196 -VPDG 199
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN- 60
NL+ L L N L LPD F L +L LNL N++ F NL EL+L+ N
Sbjct: 110 NLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQ 168
Query: 61 ---LVNGTVPTF--IGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
L G F + +LK + L N+L SVP + ++ T+L+++ L N
Sbjct: 169 LQSLPEG---VFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 215
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 35/122 (28%), Positives = 49/122 (40%), Gaps = 23/122 (18%)
Query: 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN---- 60
LDLE N L + L SL L LG N++ F+ +L LNL+ N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 61 --------LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGI 112
L LK + L+ N+L S+P + +K T L+ L L N L +
Sbjct: 91 LPNGVFDKLTQ---------LKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL-KSV 139
Query: 113 PR 114
P
Sbjct: 140 PD 141
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 7/103 (6%)
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSL-GQLQLLEVLDLSSNSLSGL 524
L+L N + ++ L L L GN L S+P+ + +L L L+LS+N L L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 525 IPDDLENLRNLTVLLLNNNKLSGKIPSG----LANVSTLSAFN 563
+ L L L LN N+L +P G L + L +
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 35/122 (28%), Positives = 52/122 (42%), Gaps = 19/122 (15%)
Query: 440 KFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTL-----GQMKGLKYLSLAG 494
+LD N + EL SL L L N ++ +L ++ L YL+L+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGN----KL-QSLPNGVFNKLTSLTYLNLST 85
Query: 495 NNLTGSIPS----SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP 550
N L S+P+ L QL+ L L++N L L + L L L L N+L +P
Sbjct: 86 NQLQ-SLPNGVFDKLTQLKEL---ALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VP 140
Query: 551 SG 552
G
Sbjct: 141 DG 142
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 39/123 (31%), Positives = 56/123 (45%), Gaps = 12/123 (9%)
Query: 427 QLPAEIGRMCKSLKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQMK 485
LP + SL L GN++ +P GV +L SL LNLS N + ++
Sbjct: 42 SLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLT 100
Query: 486 GLKYLSLAGNNLTGSIPS----SLGQLQLLEVLDLSSNSLSGLIPDD-LENLRNLTVLLL 540
LK L+L N L S+P L QL+ L L N L +PD + L +L + L
Sbjct: 101 QLKELALNTNQLQ-SLPDGVFDKLTQLKDL---RLYQNQLKS-VPDGVFDRLTSLQYIWL 155
Query: 541 NNN 543
++N
Sbjct: 156 HDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 23/76 (30%), Positives = 30/76 (39%), Gaps = 7/76 (9%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
IP YL L N+L +L L L L N L L L +LT
Sbjct: 26 IPAQT------TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79
Query: 537 VLLLNNNKLSGKIPSG 552
L L+ N+L +P+G
Sbjct: 80 YLNLSTNQLQ-SLPNG 94
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 27/88 (30%), Positives = 40/88 (45%), Gaps = 12/88 (13%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
IP + L L GN T +P L + L ++DLS+N +S L N+ L
Sbjct: 29 IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 537 VLLLNNNKLSGKIPSG----LANVSTLS 560
L+L+ N+L IP L ++ LS
Sbjct: 82 TLILSYNRLRC-IPPRTFDGLKSLRLLS 108
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 29/108 (26%), Positives = 46/108 (42%), Gaps = 11/108 (10%)
Query: 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN---- 60
L L+GN ++P + K L +++L NRI+ SFS+ L L L+ N
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 61 LVNGTVPTF--IGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
+ TF + L+ + L N + VP + L HL + N
Sbjct: 93 IPPR---TFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 22/109 (20%)
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP----SSLGQLQLLEVLDLSSNSL 521
L L N +P L K L + L+ N ++ ++ S++ QL L LS N L
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLL---TLILSYNRL 90
Query: 522 SGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
+ P + L++L +L L+ N +S +P G +FN+LS
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEG------------AFNDLS 126
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 47/227 (20%), Positives = 82/227 (36%), Gaps = 60/227 (26%)
Query: 690 IGNGGFGATYKA--EISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRHP------NL 740
+G G FG + VA+K + VG+++ + EI L +++
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR--EAARLEINVLKKIKEKDKENKFLC 84
Query: 741 VTLIGY-----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
V + + H M + + L G N F+++ + + + +A + AL +
Sbjct: 85 VLMSDWFNFHGH-----MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAY-------------------LSDFGLARLLGPS 836
LH+ ++ H D+KP NIL + ++DFG A
Sbjct: 139 LHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD--H 193
Query: 837 ETHATTGVAGTFGYV------APEYAMTCRVSDKADVYSYGVVLLEL 877
E H T V PE + + DV+S G +L E
Sbjct: 194 EHHTT--------IVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 11/109 (10%)
Query: 5 EVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN--- 60
L L N L I D F L L L L N++TG P +F +++EL L N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 61 -LVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
+ N F+G +LK + L N++ V E +L L+L+ N
Sbjct: 92 EISNK---MFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 14/90 (15%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSS--LGQLQLLEVLDLSSNSLSGLIPDDLENLRN 534
IP L L N L I S G+L L L+L N L+G+ P+ E +
Sbjct: 27 IPLHT------TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 535 LTVLLLNNNKLSGKIPSG----LANVSTLS 560
+ L L NK+ +I + L + TL+
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLN 108
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 31/111 (27%), Positives = 48/111 (43%), Gaps = 17/111 (15%)
Query: 442 LDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQI----PTTLGQMKGLKYLSLAGNN 496
L + N++ G+ G L LV L L N Q+ P ++ L L N
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRN----QLTGIEPNAFEGASHIQELQLGENK 89
Query: 497 LTGSIPS----SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543
+ I + L QL+ L +L N +S ++P E+L +LT L L +N
Sbjct: 90 IK-EISNKMFLGLHQLKTL---NLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 20/89 (22%), Positives = 35/89 (39%), Gaps = 13/89 (14%)
Query: 483 QMKGLKYLSLAGNNLTGSIPS----SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVL 538
++ L L L N LT I +Q L L N + + L L L
Sbjct: 52 RLPHLVKLELKRNQLT-GIEPNAFEGASHIQ---ELQLGENKIKEISNKMFLGLHQLKTL 107
Query: 539 LLNNNKLSGKIPSG----LANVSTLSAFN 563
L +N++S + G L ++++L+ +
Sbjct: 108 NLYDNQISC-VMPGSFEHLNSLTSLNLAS 135
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 3/105 (2%)
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSL-GQLQLLEVLDLSSNSLSGL 524
L L N + P + LK L L N L ++P + L L VLDL +N L+ L
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 525 IPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL 569
+ L +L L + NKL+ ++P G+ ++ L+ + N L
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 29 RVLNLGFNRITGEIPASFSDFVNLEELNLAGN----LVNGTVPTFIGRLKRVYLSFNRLV 84
++L L N+IT P F +NL+EL L N L G V + +L + L N+L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQLTVLDLGTNQLT 101
Query: 85 GSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNML 132
+PS + ++ +L+ L + N L +PR + + L L N L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 37/120 (30%), Positives = 50/120 (41%), Gaps = 20/120 (16%)
Query: 442 LDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTL-----GQMKGLKYLSLAGNN 496
L NQI P L++L L L N Q+ L + L L L N
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSN----QL-GALPVGVFDSLTQLTVLDLGTNQ 99
Query: 497 LTGSIPS----SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG 552
LT +PS L L+ L + N L+ +P +E L +LT L L+ N+L IP G
Sbjct: 100 LT-VLPSAVFDRLVHLKE---LFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHG 153
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 38/108 (35%), Positives = 54/108 (50%), Gaps = 7/108 (6%)
Query: 3 NLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
NL+ L L N L LP F L L VL+LG N++T A F V+L+EL + N
Sbjct: 65 NLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNK 123
Query: 62 VNGTVPTFIGRL---KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
+ +P I RL + L N+L S+P ++ ++L H L GN
Sbjct: 124 LT-ELPRGIERLTHLTHLALDQNQL-KSIPHGAFDRLSSLTHAYLFGN 169
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 50/227 (22%), Positives = 84/227 (37%), Gaps = 60/227 (26%)
Query: 690 IGNGGFGATYKA--EISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRHP------NL 740
+G G FG + + G VA+K + V R+ + +EI+ L L
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC--EAARSEIQVLEHLNTTDPNSTFRC 79
Query: 741 VTLIGY-----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
V ++ + H + +++ L G + +FI++ + K+A I +++ +
Sbjct: 80 VQMLEWFEHHGH-----ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLS-------------------DFGLARLLGPS 836
LH ++ H D+KP NIL DFG A
Sbjct: 134 LHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD--D 188
Query: 837 ETHATTGVAGTFGYV------APEYAMTCRVSDKADVYSYGVVLLEL 877
E H+T V APE + S DV+S G +L+E
Sbjct: 189 EHHST--------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 27/182 (14%), Positives = 66/182 (36%), Gaps = 31/182 (17%)
Query: 418 NVSNNRI----AGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV--------SLVA 465
N+ N + + +L + + ++ L+ GN + + EL S+ +
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA---SKNCAELAKFLASIPASVTS 200
Query: 466 LNLSWNLMHDQIPTTLGQM-----KGLKYLSLAGNNLTGS----IPSSLGQLQLLEVLDL 516
L+LS NL+ + L + + L+L N L G + L+ L+ + L
Sbjct: 201 LDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260
Query: 517 SSNSLSGLIPDD-------LENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL 569
+ + + + N++ + ++ N ++ ++N+ + +L
Sbjct: 261 DYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSL 320
Query: 570 SG 571
Sbjct: 321 LN 322
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 47/333 (14%), Positives = 95/333 (28%), Gaps = 99/333 (29%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHL---------KSLRVLNLGFNRITGEIPASFSDFV--- 50
+ LDL N L S+ LNL N + + +
Sbjct: 23 GVTSLDLSLNNLY----SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78
Query: 51 --NLEELNLAGNLVNGTVPTFIG--------RLKRVYLSFNRLVGSVPSKIGE----KCT 96
N+ LNL+GN ++ + + + L +N S+ +
Sbjct: 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138
Query: 97 NLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSL 156
++ L+L GN L ++S +L + N+ L++ N+L
Sbjct: 139 SITSLNLRGNDL------------GIKSSDELIQILA-------AIPANVNSLNLRGNNL 179
Query: 157 SGSIPVDLG-----NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGI 211
+ +L + + L LS + +
Sbjct: 180 ASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAE-----------------------L 216
Query: 212 PEAVSSLPN-LRILWAPRATLEGNFPSNWGA---------CDNLEMLNLGHNFFSG---- 257
SS+PN + L L N +L+ + L ++
Sbjct: 217 AYIFSSIPNHVVSLN-----LCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKE 271
Query: 258 --KNLG-VLGPCKNLLFLDLSSNQLTGELAREL 287
K LG + ++ +D + ++ + +
Sbjct: 272 QCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 31/169 (18%)
Query: 430 AEIGRMCKSLKFLDASGNQIVGPIPRGVGELV--------SLVALNLSWNLMHDQIPTTL 481
E + + LD S N + EL+ S+ +LNLS N + + L
Sbjct: 15 EEFTSIPHGVTSLDLSLNNL---YSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDEL 71
Query: 482 GQM-----KGLKYLSLAGNNLTGSIPSSLGQL-----QLLEVLDLSSNSLSG----LIPD 527
Q+ + L+L+GN L+ L + + VLDL N S
Sbjct: 72 VQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131
Query: 528 DLENL-RNLTVLLLNNNKLSGK----IPSGLANV-STLSAFNVSFNNLS 570
NL ++T L L N L K + LA + + +++ N+ NNL+
Sbjct: 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 34/216 (15%), Positives = 68/216 (31%), Gaps = 44/216 (20%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHL--------KSLRVLNLGFNRITGEIPASFSDF----- 49
+ VLDL N S S+ LNL N + +
Sbjct: 110 TITVLDLGWN---DFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166
Query: 50 VNLEELNLAGNLVNGTVPTFIGR--------LKRVYLSFNRL----VGSVPSKIGEKCTN 97
N+ LNL GN + + + + + LS N L + +
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNH 226
Query: 98 LEHLDLSGNYL----VGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGML-------QNL 146
+ L+L N L + + + ++++ L ++++ + L Q +
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286
Query: 147 EVLDVSRNSLSGSIPVDLGN-----CSKLAILVLSN 177
++D + + S + + N K + L N
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 36/109 (33%), Positives = 48/109 (44%), Gaps = 12/109 (11%)
Query: 5 EVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN--- 60
L+LE N L LP F L L L+L N+I F L L L N
Sbjct: 31 TRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89
Query: 61 -LVNGTVPTF--IGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106
L NG F + +LK + L N+L SVP I ++ T+L+ + L N
Sbjct: 90 SLPNG---VFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 25/91 (27%), Positives = 36/91 (39%), Gaps = 11/91 (12%)
Query: 477 IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
IP++ L L N L +L L L LS N + L + L LT
Sbjct: 26 IPSSA------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 537 VLLLNNNKLSGKIPSG----LANVSTLSAFN 563
+L L+ NKL +P+G L + L+
Sbjct: 80 ILYLHENKLQ-SLPNGVFDKLTQLKELALDT 109
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 23/92 (25%), Positives = 35/92 (38%), Gaps = 22/92 (23%)
Query: 29 RVLNLGFNRITGEIPASFSDFVNLEELNLAGN------------LVNGTVPTFIGRLKRV 76
L L N++ F L +L+L+ N L L +
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTK---------LTIL 81
Query: 77 YLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL 108
YL N+L S+P+ + +K T L+ L L N L
Sbjct: 82 YLHENKL-QSLPNGVFDKLTQLKELALDTNQL 112
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 25/91 (27%), Positives = 37/91 (40%), Gaps = 9/91 (9%)
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS----SLGQLQLLEVLDLSSNSL 521
L L N + ++ L LSL+ N + S+P L +L +L L N L
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLT---ILYLHENKL 88
Query: 522 SGLIPDDLENLRNLTVLLLNNNKLSGKIPSG 552
L + L L L L+ N+L +P G
Sbjct: 89 QSLPNGVFDKLTQLKELALDTNQLK-SVPDG 118
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 16/59 (27%), Positives = 22/59 (37%), Gaps = 11/59 (18%)
Query: 485 KGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543
+GL + SL P L L+ N+L+ L P L+ L L L N
Sbjct: 18 RGLTWASLPTA-----FPVDT------TELVLTGNNLTALPPGLLDALPALRTAHLGAN 65
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 Length = 264 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 26/189 (13%), Positives = 50/189 (26%), Gaps = 47/189 (24%)
Query: 690 IGNGGFGA-TYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
G A ++ ++ +K G +Q A + L P ++
Sbjct: 27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVP-CAAVLDVVT 85
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDW----RVLHKIALD-----------IARAL 793
+L+ +PG +L + + + R LH + I RA
Sbjct: 86 EAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERAR 145
Query: 794 AYLHDQCV------------------------------PRVLHRDVKPSNILLDDDFNAY 823
+ V V H D NI++++ +
Sbjct: 146 TRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSG 205
Query: 824 LSDFGLARL 832
D G +
Sbjct: 206 FIDCGRLGV 214
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 23/114 (20%), Positives = 42/114 (36%), Gaps = 15/114 (13%)
Query: 727 AEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIA 786
E + L ++ + + ++ +Y+ G ++ I+ A
Sbjct: 388 REARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYK-------- 439
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840
I + LH V+H D+ SN + D D Y+ DFGL ++ E A
Sbjct: 440 --IGEIVGKLHKN---DVIHNDLTTSNFIFDKD--LYIIDFGLGKISNLDEDKA 486
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 963 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.86 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.84 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.8 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.76 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.73 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.67 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.34 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.19 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.08 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.67 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.56 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.46 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.33 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.3 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.29 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.74 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.71 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.66 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.55 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.4 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.02 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.01 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.01 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.98 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.85 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.85 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.81 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.76 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.73 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.71 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.3 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.37 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.84 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=587.84 Aligned_cols=574 Identities=29% Similarity=0.413 Sum_probs=384.1
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCc--cccCcccccceeccccccccCCCcc----cccccc
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPA--SFSDFVNLEELNLAGNLVNGTVPTF----IGRLKR 75 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~L~~ 75 (963)
+.|+.++++.+.+. ..|..|..+++|++|+|++|.+.+.+|. .|+++++|++|+|++|.+.+.+|.. +.+|++
T Consensus 77 ~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 155 (768)
T 3rgz_A 77 TGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155 (768)
T ss_dssp TTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSE
T ss_pred CcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCE
Confidence 34556666666554 2445666777777777777777666666 6677777777777777666555543 345667
Q ss_pred eeeccccccccCCccc--cccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccC
Q 046851 76 VYLSFNRLVGSVPSKI--GEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSR 153 (963)
Q Consensus 76 L~L~~n~l~~~~p~~~--~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 153 (963)
|+|++|++++..|... +.++++|++|+|++|++++..+. ..+++|++|+|++|++++.+|. +.++++|++|+|++
T Consensus 156 L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~ 232 (768)
T 3rgz_A 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISG 232 (768)
T ss_dssp EECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCS
T ss_pred EECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcC
Confidence 7777777664444331 34566666666666666644332 5666666666666666655554 66666666666666
Q ss_pred CccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCC-CCCceEecCCcccc
Q 046851 154 NSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSL-PNLRILWAPRATLE 232 (963)
Q Consensus 154 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l-~~L~~L~l~~n~l~ 232 (963)
|.+++.+|..+.++++|++|++++|.++...... ....+..++++.|.+.+.+|..+..+ ++|+.|++++|+++
T Consensus 233 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-----~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~ 307 (768)
T 3rgz_A 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-----PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307 (768)
T ss_dssp SCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC-----CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEE
T ss_pred CcCCCcccHHHhcCCCCCEEECCCCcccCccCcc-----ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCC
Confidence 6666666666666666666666666554211111 23444555556666666666555553 66666666666666
Q ss_pred cCCCccccccccCceeecCccccc-CcCccccCCCCCCcEEeccCcccccccCCCC-CCC-ceeEEEeccCcCccCCCC-
Q 046851 233 GNFPSNWGACDNLEMLNLGHNFFS-GKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVP-CMTMFDVSGNALSGSIPT- 308 (963)
Q Consensus 233 ~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~-~L~~L~l~~N~l~~~~~~- 308 (963)
+..|..|..+++|++|+|++|+++ .++...|..+++|++|++++|++++..+..+ .++ +|+.|++++|++.+..+.
T Consensus 308 ~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~ 387 (768)
T 3rgz_A 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387 (768)
T ss_dssp ECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTT
T ss_pred CccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChh
Confidence 666666666666666666666665 3444445566666666666666654444333 233 455555555555543222
Q ss_pred CCC--CCCCCcccccccccccCCC-CchhhhhhhcccccCCCCCccccc----cchhhhhccccCcccccCCCCCCCccc
Q 046851 309 FSN--MVCPPVPYLSRNLFESYNP-STAYLSLFAKKSQAGTPLPLRGRD----GFLAIFHNFGGNNFSGSLPSMPVAPER 381 (963)
Q Consensus 309 ~~~--l~~l~~l~l~~n~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (963)
+.. +.+|+.|++++|.+....| ....+..+.......+.+....-. .......++.+|.+.+..|....
T Consensus 388 ~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~---- 463 (768)
T 3rgz_A 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM---- 463 (768)
T ss_dssp TTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG----
T ss_pred hhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHc----
Confidence 222 4445555555555542221 121111111111111111000000 00011235666777665553211
Q ss_pred CCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCC
Q 046851 382 LGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELV 461 (963)
Q Consensus 382 l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~ 461 (963)
....++.+++++|+++|.+|..+ +.++.|+ +|++++|++++.+|.++..+ ++|++|+|++|++++.+|..+..++
T Consensus 464 -~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~--~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~ 538 (768)
T 3rgz_A 464 -YVKTLETLILDFNDLTGEIPSGL-SNCTNLN--WISLSNNRLTGEIPKWIGRL-ENLAILKLSNNSFSGNIPAELGDCR 538 (768)
T ss_dssp -GCTTCCEEECCSSCCCSCCCGGG-GGCTTCC--EEECCSSCCCSCCCGGGGGC-TTCCEEECCSSCCEEECCGGGGGCT
T ss_pred -CCCCceEEEecCCcccCcCCHHH-hcCCCCC--EEEccCCccCCcCChHHhcC-CCCCEEECCCCcccCcCCHHHcCCC
Confidence 23457789999999999998875 7788888 89999999999999998876 8899999999999999999999999
Q ss_pred CCCEEeccCCcCCCccchhh------------------------------------------------------------
Q 046851 462 SLVALNLSWNLMHDQIPTTL------------------------------------------------------------ 481 (963)
Q Consensus 462 ~L~~L~ls~N~i~~~~~~~~------------------------------------------------------------ 481 (963)
+|+.|++++|.+++.+|..+
T Consensus 539 ~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 618 (768)
T 3rgz_A 539 SLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618 (768)
T ss_dssp TCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSC
T ss_pred CCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccc
Confidence 99999999999887776543
Q ss_pred ----------ccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCC
Q 046851 482 ----------GQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPS 551 (963)
Q Consensus 482 ----------~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 551 (963)
+.+++|+.|||++|+++|.+|..++++++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|.
T Consensus 619 ~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~ 698 (768)
T 3rgz_A 619 VYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698 (768)
T ss_dssp EEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCG
T ss_pred eecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCCh
Confidence 3357899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCceEeeccccCccCCCCCCC--cccccccCCCCCCCC
Q 046851 552 GLANVSTLSAFNVSFNNLSGPLPSSKN--LMKCSSVLGNPYLRP 593 (963)
Q Consensus 552 ~l~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~~~~~~np~~~~ 593 (963)
.+..+++|++|++++|+++|++|+... .+...++.|||..|.
T Consensus 699 ~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp GGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred HHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcC
Confidence 999999999999999999999998654 344567889998884
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=560.66 Aligned_cols=572 Identities=28% Similarity=0.369 Sum_probs=471.6
Q ss_pred CCceEEEccCCccccc---CCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCc--ccc---cc
Q 046851 2 GNLEVLDLEGNLLNGI---LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPT--FIG---RL 73 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~---~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~---~L 73 (963)
+.|+.|||+++.+.+. +|.++.++++|+.++++.|.+. ..|..|+++++|++|+|++|.+++.+|. .++ +|
T Consensus 50 ~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L 128 (768)
T 3rgz_A 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128 (768)
T ss_dssp TEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTC
T ss_pred CcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCC
Confidence 4689999999999987 8889999999999999999987 5778999999999999999999988877 554 79
Q ss_pred cceeeccccccccCCccccccCCCCCeEeCCCCccccCcCcc---ccCcccccEEEcccCcccccCcccccCCCCCCEEE
Q 046851 74 KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRS---LGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLD 150 (963)
Q Consensus 74 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 150 (963)
++|+|++|.+.+.+|..++.++++|++|+|++|++++..+.. +.++++|++|++++|++++..+ +..+++|++|+
T Consensus 129 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~ 206 (768)
T 3rgz_A 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLD 206 (768)
T ss_dssp CEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEE
T ss_pred CEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEE
Confidence 999999999998888888778999999999999999888877 8999999999999999997655 48899999999
Q ss_pred ccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcc
Q 046851 151 VSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT 230 (963)
Q Consensus 151 L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~ 230 (963)
|++|.+++.+|. ++++++|++|++++|.++...... ......+..++++.|.+.+.+|.. .+++|+.|++++|+
T Consensus 207 Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~---l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~ 280 (768)
T 3rgz_A 207 VSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRA---ISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENK 280 (768)
T ss_dssp CCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHH---TTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSE
T ss_pred CcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHH---HhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCc
Confidence 999999987777 999999999999999887433222 233566788899999999988876 89999999999999
Q ss_pred cccCCCcccccc-ccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCC--CCCCCceeEEEeccCcCccCCC
Q 046851 231 LEGNFPSNWGAC-DNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAR--ELPVPCMTMFDVSGNALSGSIP 307 (963)
Q Consensus 231 l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~~L~~L~l~~N~l~~~~~ 307 (963)
+++.+|..+... ++|++|+|++|++++..+..|+.+++|++|++++|++++..+. ...+++|+.|++++|++.+..|
T Consensus 281 l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p 360 (768)
T 3rgz_A 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360 (768)
T ss_dssp EEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCC
T ss_pred cCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCcccc
Confidence 999999998875 9999999999999999889999999999999999999866554 3478999999999999997655
Q ss_pred C-CCCCC-CCCcccccccccccCCCCc-hh--hhhhhcccccCCCCCcc----ccccchhhhhccccCcccccCCCCCCC
Q 046851 308 T-FSNMV-CPPVPYLSRNLFESYNPST-AY--LSLFAKKSQAGTPLPLR----GRDGFLAIFHNFGGNNFSGSLPSMPVA 378 (963)
Q Consensus 308 ~-~~~l~-~l~~l~l~~n~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (963)
. +..+. +|+.|++++|.+....+.. .. ...+.......+.+... ..........++.+|.+.+..|....
T Consensus 361 ~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~- 439 (768)
T 3rgz_A 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG- 439 (768)
T ss_dssp TTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG-
T ss_pred HHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHh-
Confidence 4 77776 8999999999987533221 11 11111111111111100 00000112235677777765553211
Q ss_pred cccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccc
Q 046851 379 PERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVG 458 (963)
Q Consensus 379 ~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~ 458 (963)
....++.+.+.+|.++|.+|..+ +.++.|+ .|++++|+++|.+|..+..+ ++|++|+|++|++++.+|.+++
T Consensus 440 ----~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~--~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~ 511 (768)
T 3rgz_A 440 ----SLSKLRDLKLWLNMLEGEIPQEL-MYVKTLE--TLILDFNDLTGEIPSGLSNC-TNLNWISLSNNRLTGEIPKWIG 511 (768)
T ss_dssp ----GCTTCCEEECCSSCCCSCCCGGG-GGCTTCC--EEECCSSCCCSCCCGGGGGC-TTCCEEECCSSCCCSCCCGGGG
T ss_pred ----cCCCCCEEECCCCcccCcCCHHH-cCCCCce--EEEecCCcccCcCCHHHhcC-CCCCEEEccCCccCCcCChHHh
Confidence 22457788999999999888765 6677777 88999999998899888776 8899999999999999999999
Q ss_pred cCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccc--------------------------------
Q 046851 459 ELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLG-------------------------------- 506 (963)
Q Consensus 459 ~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-------------------------------- 506 (963)
.+++|+.|++++|.+++.+|..++.+++|++|++++|+++|.+|..+.
T Consensus 512 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (768)
T 3rgz_A 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAG 591 (768)
T ss_dssp GCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSE
T ss_pred cCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccc
Confidence 999999999999999989999999999999999999999887776543
Q ss_pred --------------------------------------cCCccceecccccccCCCCChhhhccccCCeEEeccccCCCc
Q 046851 507 --------------------------------------QLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGK 548 (963)
Q Consensus 507 --------------------------------------~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 548 (963)
.+++|+.|||++|+++|.+|..++.+++|+.|+|++|+++|.
T Consensus 592 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ 671 (768)
T 3rgz_A 592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671 (768)
T ss_dssp EEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred cccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCC
Confidence 356789999999999999999999999999999999999999
Q ss_pred CCCCccccccCceEeeccccCccCCCCCCCccc---ccccCCCCCC
Q 046851 549 IPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMK---CSSVLGNPYL 591 (963)
Q Consensus 549 ~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~---~~~~~~np~~ 591 (963)
+|..++.+++|+.|+|++|+++|.+|.....+. -..+.+|+..
T Consensus 672 ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred CChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 999999999999999999999999998654332 2234455543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=533.27 Aligned_cols=569 Identities=20% Similarity=0.138 Sum_probs=454.8
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCccc---ccccceee
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFI---GRLKRVYL 78 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~L~~L~L 78 (963)
.++++|+|++|.++++.+..|.++++|++|+|++|++++..|.+|.++++|++|+|++|.+++..+..+ .+|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 468889999999888877788888999999999998888888888889999999999998885555444 46888899
Q ss_pred ccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCccccc--CCCCCCEEEccCCcc
Q 046851 79 SFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELG--MLQNLEVLDVSRNSL 156 (963)
Q Consensus 79 ~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~N~l 156 (963)
++|+++ .++...|.++++|++|+|++|++++..+..|.++++|+.|++++|++++..+..+. .+++|++|++++|.+
T Consensus 105 ~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 105 MSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 999888 77766677888999999999988888888888888999999999988877776654 457889999999988
Q ss_pred ccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCC--CceEecCCcccccC
Q 046851 157 SGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPN--LRILWAPRATLEGN 234 (963)
Q Consensus 157 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~--L~~L~l~~n~l~~~ 234 (963)
++..|..+..+.+|+.|+++++.+...........-....+..++++.|.+.+..|..|.+++. |+.|++++|++++.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 8888888888888888888877655322221111111245677788889999999999998865 99999999999998
Q ss_pred CCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccc---------cC-CCCCCCceeEEEeccCcCcc
Q 046851 235 FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGE---------LA-RELPVPCMTMFDVSGNALSG 304 (963)
Q Consensus 235 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---------~~-~~~~~~~L~~L~l~~N~l~~ 304 (963)
.+..|..+++|++|++++|+++++.+..|..+++|+.|++++|...+. .. ....+++|+.|++++|++.+
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 899999999999999999999999999999999999999998765431 11 22367899999999999999
Q ss_pred CCCC-CCCCCCCCccccccccccc--CCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCccc
Q 046851 305 SIPT-FSNMVCPPVPYLSRNLFES--YNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPER 381 (963)
Q Consensus 305 ~~~~-~~~l~~l~~l~l~~n~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (963)
..+. +..+.+|+.+++++|.+.. ++... +... . .......++.+|.+.+..|....
T Consensus 344 ~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~-f~~~-~---------------~~~L~~L~L~~n~l~~~~~~~~~---- 402 (680)
T 1ziw_A 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNET-FVSL-A---------------HSPLHILNLTKNKISKIESDAFS---- 402 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTCBSCCCEECTTT-TGGG-T---------------TSCCCEEECTTSCCCEECTTTTT----
T ss_pred CChhHhccccCCcEEECCCCchhhhhcchhh-hccc-c---------------cCcCceEECCCCCCCeEChhhhh----
Confidence 8765 8899999999999987432 11100 0000 0 00011234566777665443221
Q ss_pred CCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCC--CCCcccccc
Q 046851 382 LGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIV--GPIPRGVGE 459 (963)
Q Consensus 382 l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~--~~~p~~~~~ 459 (963)
....++.+++++|.+.+.+|...|..++.|+ +|++++|++++..+..+.. +++|+.|++++|.++ +.+|..+..
T Consensus 403 -~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~--~L~Ls~n~l~~~~~~~~~~-~~~L~~L~l~~n~l~~~~~~p~~~~~ 478 (680)
T 1ziw_A 403 -WLGHLEVLDLGLNEIGQELTGQEWRGLENIF--EIYLSYNKYLQLTRNSFAL-VPSLQRLMLRRVALKNVDSSPSPFQP 478 (680)
T ss_dssp -TCTTCCEEECCSSCCEEECCSGGGTTCTTCC--EEECCSCSEEECCTTTTTT-CTTCCEEECTTSCCBCTTCSSCTTTT
T ss_pred -CCCCCCEEeCCCCcCccccCcccccCccccc--EEecCCCCcceeChhhhhc-CcccccchhccccccccccCCccccc
Confidence 2346788999999999999998899999988 8999999998555555554 589999999999987 578999999
Q ss_pred CCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCC--------cccccCCccceecccccccCCCCChhhhc
Q 046851 460 LVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIP--------SSLGQLQLLEVLDLSSNSLSGLIPDDLEN 531 (963)
Q Consensus 460 l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--------~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 531 (963)
+++|+.|++++|.+++..+..|..+++|++|+|++|++++..+ ..|..+++|+.|+|++|+|+...+..|..
T Consensus 479 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 558 (680)
T 1ziw_A 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccc
Confidence 9999999999999998888889999999999999999985422 23789999999999999999655567999
Q ss_pred cccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCCCCC----CcccccccCCCCCCCCCCC
Q 046851 532 LRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSK----NLMKCSSVLGNPYLRPCRA 596 (963)
Q Consensus 532 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~----~~~~~~~~~~np~~~~c~~ 596 (963)
+++|+.|+|++|+|++..+..|..+++|+.|++++|++++..|... .......+.+|||.|+|+.
T Consensus 559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 9999999999999996666678899999999999999998666532 2333456679999999974
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=519.63 Aligned_cols=507 Identities=22% Similarity=0.187 Sum_probs=353.0
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCccc-ccCCccccCcccccceeccccccccCCCcccc---ccccee
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRIT-GEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVY 77 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~ 77 (963)
+++++|||++|.|+++.+..|.++++|++|+|++|... .+.|.+|.++++|++|+|++|.+++..|..+. +|++|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 57899999999999999999999999999999999544 44588999999999999999999988787765 688999
Q ss_pred eccccccccCCc-cccccCCCCCeEeCCCCccccCcC-ccccCcccccEEEcccCcccccCcccccCC--CCCCEEEccC
Q 046851 78 LSFNRLVGSVPS-KIGEKCTNLEHLDLSGNYLVGGIP-RSLGNCFQVRSLLLFSNMLEETIPAELGML--QNLEVLDVSR 153 (963)
Q Consensus 78 L~~n~l~~~~p~-~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~ 153 (963)
|++|.+++.+|. ..+.++++|++|+|++|++++..+ ..|+++++|+.|+|++|.+++..+..|..+ ++|+.|+|+.
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~ 183 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECC
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCC
Confidence 999999865554 456789999999999999987654 579999999999999999998888888887 8999999999
Q ss_pred CccccCCCcCccCCCC------CceEeecCcCCcccccccccCCcccCCCccc---------CCCCCccccCCcccccCC
Q 046851 154 NSLSGSIPVDLGNCSK------LAILVLSNLFDTYEDVRYSRGQSLVDQPSFM---------NDDFNFFEGGIPEAVSSL 218 (963)
Q Consensus 154 N~l~~~~p~~~~~l~~------L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~---------~~~~n~~~~~~~~~l~~l 218 (963)
|.+.+..|..+..+.+ |+.|++++|.++......+...........+ ....+.+.......|.++
T Consensus 184 n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l 263 (844)
T 3j0a_A 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263 (844)
T ss_dssp SBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT
T ss_pred CccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc
Confidence 9999888887777766 9999999886654332221111000111111 122344444455566665
Q ss_pred --CCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCceeEE
Q 046851 219 --PNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMF 295 (963)
Q Consensus 219 --~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L 295 (963)
++|+.|++++|.+.+..+..|..+++|+.|+|++|+++.+.+..|..+++|++|+|++|++++..+..+ .+++|+.|
T Consensus 264 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 343 (844)
T 3j0a_A 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343 (844)
T ss_dssp TTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEE
T ss_pred ccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEE
Confidence 688999999999888888888899999999999999998888888889999999999999887766555 68889999
Q ss_pred EeccCcCccCCCC-CCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCC
Q 046851 296 DVSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPS 374 (963)
Q Consensus 296 ~l~~N~l~~~~~~-~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (963)
++++|++.+.++. +..+.+|+.|++++|.+..++.
T Consensus 344 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~-------------------------------------------- 379 (844)
T 3j0a_A 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-------------------------------------------- 379 (844)
T ss_dssp ECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS--------------------------------------------
T ss_pred ECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC--------------------------------------------
Confidence 9999988877664 7888888888888887664321
Q ss_pred CCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCC-
Q 046851 375 MPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI- 453 (963)
Q Consensus 375 ~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~- 453 (963)
++.++ .|++++|+++ .+|.. ..+++.|++++|++++..
T Consensus 380 ----------------------------------~~~L~--~L~l~~N~l~-~l~~~----~~~l~~L~ls~N~l~~l~~ 418 (844)
T 3j0a_A 380 ----------------------------------IPSIP--DIFLSGNKLV-TLPKI----NLTANLIHLSENRLENLDI 418 (844)
T ss_dssp ----------------------------------CCSCS--EEEEESCCCC-CCCCC----CTTCCEEECCSCCCCSSTT
T ss_pred ----------------------------------CCCcc--hhccCCCCcc-ccccc----ccccceeecccCccccCch
Confidence 11122 4455555554 44432 134555666666655321
Q ss_pred ccccccCCCCCEEeccCCcCCCccch-hhccCcccceecccccccc-----ccCCcccccCCccceecccccccCCCCCh
Q 046851 454 PRGVGELVSLVALNLSWNLMHDQIPT-TLGQMKGLKYLSLAGNNLT-----GSIPSSLGQLQLLEVLDLSSNSLSGLIPD 527 (963)
Q Consensus 454 p~~~~~l~~L~~L~ls~N~i~~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 527 (963)
+..+..+++|+.|++++|.+++..+. .+..+++|+.|+|++|.++ +..+..|..+++|+.|+|++|+|++..|.
T Consensus 419 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 498 (844)
T 3j0a_A 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498 (844)
T ss_dssp HHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTT
T ss_pred hhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChh
Confidence 11234555666666666665433222 2344555666666666654 22334455556666666666666655555
Q ss_pred hhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCCCCCCcccccccCCCCCCCCCC
Q 046851 528 DLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCR 595 (963)
Q Consensus 528 ~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~np~~~~c~ 595 (963)
.+..+++|+.|+|++|+|++..|..+. ++|+.|++++|++++..|+.........+.||||.|+|.
T Consensus 499 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 499 VFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp SSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred HccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 555666666666666666543333333 556666666666666555554444444445566666664
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=501.95 Aligned_cols=509 Identities=18% Similarity=0.139 Sum_probs=335.0
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceee
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYL 78 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L 78 (963)
.++++|+|++|.|+++.|.+|.++++|++|+|++|++.++.|++|.++++|++|+|++|.+++..|..++ +|++|++
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 4689999999999999999999999999999999999999999999999999999999999988786664 6999999
Q ss_pred ccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCC--EEEccCCcc
Q 046851 79 SFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLE--VLDVSRNSL 156 (963)
Q Consensus 79 ~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~N~l 156 (963)
++|+++ .++...+.++++|++|+|++|++++.....+.++++|+.|++++|++++..+..|..+++|+ .|++++|.+
T Consensus 113 ~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 113 IQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp TTSCCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred cccCcc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 999999 66666677899999999999999975556666699999999999999988899999999999 999999999
Q ss_pred ccCCCcCccCCCCCceEeecCcCCcccccccccCCcc--cCCCcccCCCCCccccCCcccccCCC--CCceEecCCcccc
Q 046851 157 SGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSL--VDQPSFMNDDFNFFEGGIPEAVSSLP--NLRILWAPRATLE 232 (963)
Q Consensus 157 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~--~~~~~~~~~~~n~~~~~~~~~l~~l~--~L~~L~l~~n~l~ 232 (963)
++..|..+.. .+|+.|++++|............... .......+..... ..+..+.++. +|+.|++++|.++
T Consensus 192 ~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~---i~~~~~~~l~~~~L~~L~l~~n~l~ 267 (606)
T 3t6q_A 192 AGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED---ISPAVFEGLCEMSVESINLQKHYFF 267 (606)
T ss_dssp CEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCC---CCGGGGGGGGGSEEEEEECTTCCCS
T ss_pred CccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccc---cChhHhchhhcCceeEEEeecCccC
Confidence 9777766654 68999999876521111100000000 0000111111122 2234444443 7889999999999
Q ss_pred cCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCccCCCC--C
Q 046851 233 GNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPT--F 309 (963)
Q Consensus 233 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~~~--~ 309 (963)
+..+..|..+++|++|++++|+++.++. .+..+++|++|++++|++++..+..+ .+++|+.|++++|.+.+..+. +
T Consensus 268 ~~~~~~~~~l~~L~~L~l~~n~l~~lp~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 346 (606)
T 3t6q_A 268 NISSNTFHCFSGLQELDLTATHLSELPS-GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346 (606)
T ss_dssp SCCTTTTTTCTTCSEEECTTSCCSCCCS-SCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTT
T ss_pred ccCHHHhccccCCCEEeccCCccCCCCh-hhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhh
Confidence 8888889999999999999999997764 57888999999999999988766444 688999999999998865443 8
Q ss_pred CCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEE
Q 046851 310 SNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYA 389 (963)
Q Consensus 310 ~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 389 (963)
..+.+|+.|++++|.+........ ..-....++.
T Consensus 347 ~~l~~L~~L~l~~n~l~~~~~~~~----------------------------------------------~~~~l~~L~~ 380 (606)
T 3t6q_A 347 ENLENLRELDLSHDDIETSDCCNL----------------------------------------------QLRNLSHLQS 380 (606)
T ss_dssp TTCTTCCEEECCSSCCCEEEESTT----------------------------------------------TTTTCTTCCE
T ss_pred hccCcCCEEECCCCccccccCcch----------------------------------------------hcccCCCCCE
Confidence 888999999999887765320000 0000112333
Q ss_pred EEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEecc
Q 046851 390 IVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLS 469 (963)
Q Consensus 390 l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls 469 (963)
+++++|.+.+..|.. |+.++.|+ .|++++|++++..|...+..+++|++|++++|.+++..|..+..+++|++|+++
T Consensus 381 L~l~~n~l~~~~~~~-~~~l~~L~--~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 457 (606)
T 3t6q_A 381 LNLSYNEPLSLKTEA-FKECPQLE--LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457 (606)
T ss_dssp EECCSCSCEEECTTT-TTTCTTCS--EEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECT
T ss_pred EECCCCcCCcCCHHH-hcCCccCC--eEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECC
Confidence 444444444333322 23344444 444455544443333322223445555555555544444444444555555555
Q ss_pred CCcCCCc---cchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCC
Q 046851 470 WNLMHDQ---IPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 470 ~N~i~~~---~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 546 (963)
+|.+++. .+..+..+++|++|++++|++++..|..|..+++|+.|+|++|++++..|..+..+++| .|++++|+++
T Consensus 458 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~ 536 (606)
T 3t6q_A 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536 (606)
T ss_dssp TCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCC
T ss_pred CCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCccc
Confidence 5544331 12334444455555555555544444444445555555555555544444444444444 4555555554
Q ss_pred CcCCCCccccccCceEeecc
Q 046851 547 GKIPSGLANVSTLSAFNVSF 566 (963)
Q Consensus 547 ~~~p~~l~~l~~L~~l~l~~ 566 (963)
+..|..+..+++|+.|++++
T Consensus 537 ~~~~~~~~~l~~L~~L~l~~ 556 (606)
T 3t6q_A 537 IILPSLLPILSQQRTINLRQ 556 (606)
T ss_dssp CCCGGGHHHHHTSSEEECTT
T ss_pred ccCHhhcccCCCCCEEeCCC
Confidence 44444444444454444443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=450.08 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=217.5
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46888999999999999999864 478899999987766677889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 756 IYNYLPGGNLENFIQQRS-----------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
||||+++|+|.++++... ...++|.++..|+.|||+||+|||++ +|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 34699999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcc-cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHH
Q 046851 825 SDFGLARLLGPSETHA-TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGC 902 (963)
Q Consensus 825 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 902 (963)
+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~~~ 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVIE 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH
Confidence 9999998765443332 234569999999999999999999999999999999999 899997432 122222
Q ss_pred HHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 903 MLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.. ..+. ....|..++.++.+++.+||+.||++||||+||.+.|+++..
T Consensus 242 ~i-~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 242 CI-TQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HH-HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22 2221 123355667789999999999999999999999999988754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=490.35 Aligned_cols=485 Identities=18% Similarity=0.162 Sum_probs=281.1
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceee
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYL 78 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L 78 (963)
.++++|+|++|.++++.+..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|.+++..|..++ +|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 3566777777777766666677777777777777777766666777777777777777777665565543 5666777
Q ss_pred ccccccccCCccccccCCCCCeEeCCCCcccc-CcCccccCcccccEEEcccCcccccCcccccCCCCCC----EEEccC
Q 046851 79 SFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVG-GIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLE----VLDVSR 153 (963)
Q Consensus 79 ~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~ 153 (963)
++|+++ .++...+.++++|++|+|++|++++ .+|..|+++++|+.|++++|++++..+..|..+++|+ +|++++
T Consensus 112 ~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 112 VETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp TTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred cCCccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 777776 5554445567777777777777664 3466777777777777777777766666666555443 677777
Q ss_pred CccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCce----------
Q 046851 154 NSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRI---------- 223 (963)
Q Consensus 154 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~---------- 223 (963)
|.+++..+..+... +|+.|++++|.++. +..|..+..+++|+.
T Consensus 191 n~l~~~~~~~~~~~-~L~~L~L~~n~~~~--------------------------~~~~~~~~~l~~L~~l~l~~~~~~~ 243 (606)
T 3vq2_A 191 NPIDFIQDQAFQGI-KLHELTLRGNFNSS--------------------------NIMKTCLQNLAGLHVHRLILGEFKD 243 (606)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCH--------------------------HHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred CCcceeCcccccCc-eeeeeeccCCccch--------------------------hHHHHHhcccccccccccccccccc
Confidence 77764444444443 67777776654431 122333334444433
Q ss_pred ----------------------Eec-CCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccc
Q 046851 224 ----------------------LWA-PRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 224 ----------------------L~l-~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 280 (963)
+++ ..|.+.+..|. +..+++|+.|++++|.+..++ .+..+++|+.|++++|++.
T Consensus 244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--~l~~~~~L~~L~l~~n~l~ 320 (606)
T 3vq2_A 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQLK 320 (606)
T ss_dssp SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--CCCTTCCCSEEEEESCCCS
T ss_pred CCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh--hccccccCCEEEcccccCc
Confidence 333 45555555555 667777777777777776665 5666777777777777774
Q ss_pred cccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhh
Q 046851 281 GELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIF 360 (963)
Q Consensus 281 ~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (963)
.. +.. .+++|+.|++++|+..+.. .+..+.+|+.+++++|.+....+
T Consensus 321 ~l-p~~-~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~~~~------------------------------ 367 (606)
T 3vq2_A 321 QF-PTL-DLPFLKSLTLTMNKGSISF-KKVALPSLSYLDLSRNALSFSGC------------------------------ 367 (606)
T ss_dssp SC-CCC-CCSSCCEEEEESCSSCEEC-CCCCCTTCCEEECCSSCEEEEEE------------------------------
T ss_pred cc-ccC-CCCccceeeccCCcCccch-hhccCCCCCEEECcCCccCCCcc------------------------------
Confidence 33 333 6677777777777555433 45566666666666665543210
Q ss_pred hccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCcc
Q 046851 361 HNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLK 440 (963)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~ 440 (963)
+|. .|+.++.|+ .|++++|.++ .+|..+..+ ++|+
T Consensus 368 ----------------------------------------~~~-~~~~~~~L~--~L~L~~n~l~-~~~~~~~~l-~~L~ 402 (606)
T 3vq2_A 368 ----------------------------------------CSY-SDLGTNSLR--HLDLSFNGAI-IMSANFMGL-EELQ 402 (606)
T ss_dssp ----------------------------------------CCH-HHHCCSCCC--EEECCSCSEE-EECCCCTTC-TTCC
T ss_pred ----------------------------------------hhh-hhccCCccc--EeECCCCccc-cchhhccCC-CCCC
Confidence 111 123333444 4555555554 344333332 4555
Q ss_pred EEECcCCcCCCCCc-cccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccc-cCCcccccCCccceecccc
Q 046851 441 FLDASGNQIVGPIP-RGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTG-SIPSSLGQLQLLEVLDLSS 518 (963)
Q Consensus 441 ~L~ls~n~l~~~~p-~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~ls~ 518 (963)
.|++++|++.+..| ..+..+++|+.|++++|.+++..|..+..+++|++|++++|++++ .+|..|+.+++|+.|+|++
T Consensus 403 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 482 (606)
T 3vq2_A 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482 (606)
T ss_dssp EEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred eeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCC
Confidence 55555555554444 345555555555555555555555555555555555555555554 2455555555555555555
Q ss_pred cccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCCCCCCc----ccccccCCCCCCCCC
Q 046851 519 NSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL----MKCSSVLGNPYLRPC 594 (963)
Q Consensus 519 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~----~~~~~~~~np~~~~c 594 (963)
|++++..|..+..+++|++|+|++|++++..|..+..+++|++|++++|+++. +|..... .....+.+|||.|+|
T Consensus 483 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred CcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCC
Confidence 55555555555555555555555555554445555555555555555555552 3332111 112234466777777
Q ss_pred CC
Q 046851 595 RA 596 (963)
Q Consensus 595 ~~ 596 (963)
..
T Consensus 562 ~~ 563 (606)
T 3vq2_A 562 EH 563 (606)
T ss_dssp TT
T ss_pred cc
Confidence 53
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=450.59 Aligned_cols=258 Identities=23% Similarity=0.369 Sum_probs=211.3
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.+|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35778889999999999999875 478999999987776777889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 756 IYNYLPGGNLENFIQQRS-------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
||||+++|+|.++++... ...++|.++..|+.|||+||+|||++ +|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999997643 24589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhH
Q 046851 823 YLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAW 900 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 900 (963)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~ 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTEA 269 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHHH
Confidence 9999999987654332 23345679999999999999999999999999999999999 899997432 1222
Q ss_pred HHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 901 GCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
+... ..+ .+...|..++.++.+++.+||+.||++||||+||+++|+.+.+
T Consensus 270 ~~~i-~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 270 IDCI-TQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHH-HHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHH-HcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 2222 122 1123355667789999999999999999999999999998754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=486.99 Aligned_cols=519 Identities=22% Similarity=0.210 Sum_probs=388.9
Q ss_pred CCCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCccc---cccccee
Q 046851 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFI---GRLKRVY 77 (963)
Q Consensus 1 l~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~L~~L~ 77 (963)
+++|++|+|++|.++++.|.+|..+++|++|+|++|+++.+.+.+|.++++|++|+|++|.+++..|..+ .+|++|+
T Consensus 48 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 127 (680)
T 1ziw_A 48 YSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127 (680)
T ss_dssp GTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEE
T ss_pred CCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEE
Confidence 3689999999999999999999999999999999999997777789999999999999999987776665 4799999
Q ss_pred eccccccccCCccccccCCCCCeEeCCCCccccCcCcccc--CcccccEEEcccCcccccCcccccCCC-----------
Q 046851 78 LSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG--NCFQVRSLLLFSNMLEETIPAELGMLQ----------- 144 (963)
Q Consensus 78 L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~----------- 144 (963)
|++|.++ .++...+.++++|++|+|++|++++..+..+. .+++|+.|++++|++++..+..|..++
T Consensus 128 Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~ 206 (680)
T 1ziw_A 128 LSHNGLS-STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206 (680)
T ss_dssp CCSSCCS-CCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCC
T ss_pred CCCCccc-ccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccc
Confidence 9999998 55555566899999999999999977777654 558999999999999988888777654
Q ss_pred ----------------CCCEEEccCCccccCCCcCccCCCC--CceEeecCcCCcccccccccCCcccCCCcccCCCCCc
Q 046851 145 ----------------NLEVLDVSRNSLSGSIPVDLGNCSK--LAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNF 206 (963)
Q Consensus 145 ----------------~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~ 206 (963)
+|+.|++++|.+++..|..|.+++. |+.|++++|.++......+ .....+..++++.|.
T Consensus 207 l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~---~~l~~L~~L~L~~n~ 283 (680)
T 1ziw_A 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF---AWLPQLEYFFLEYNN 283 (680)
T ss_dssp CHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTT---TTCTTCCEEECCSCC
T ss_pred cChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccc---cCcccccEeeCCCCc
Confidence 5666667777777666677766654 7777777766554332211 223445555666666
Q ss_pred cccCCcccccCCCCCceEecCCccccc-----CCC----ccccccccCceeecCcccccCcCccccCCCCCCcEEeccCc
Q 046851 207 FEGGIPEAVSSLPNLRILWAPRATLEG-----NFP----SNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSN 277 (963)
Q Consensus 207 ~~~~~~~~l~~l~~L~~L~l~~n~l~~-----~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 277 (963)
+.+..|..|.++++|+.|++++|...+ .+| ..|..+++|++|++++|+++++++..|..+++|++|++++|
T Consensus 284 l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 363 (680)
T 1ziw_A 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363 (680)
T ss_dssp BSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTC
T ss_pred cCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCC
Confidence 666666666666666666666553332 112 25566666666666666666666666666666666666666
Q ss_pred ccccc--cCCCC---CCCceeEEEeccCcCccCCCC-CCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCcc
Q 046851 278 QLTGE--LAREL---PVPCMTMFDVSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLR 351 (963)
Q Consensus 278 ~l~~~--~~~~~---~~~~L~~L~l~~N~l~~~~~~-~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (963)
.+... ....+ ..+.|+.|++++|++.+..+. +..+.+|+.|++++|.+..
T Consensus 364 ~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------------------ 419 (680)
T 1ziw_A 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ------------------------ 419 (680)
T ss_dssp BSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEE------------------------
T ss_pred chhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCcc------------------------
Confidence 54321 11111 224566666666666665443 6666666666666665542
Q ss_pred ccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeee--ecCc
Q 046851 352 GRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIA--GQLP 429 (963)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~--~~~p 429 (963)
.+|...+ -+...++.+++++|++.+..| ..|..++.|+ .|++++|.+. +.+|
T Consensus 420 -------------------~~~~~~~----~~l~~L~~L~Ls~n~l~~~~~-~~~~~~~~L~--~L~l~~n~l~~~~~~p 473 (680)
T 1ziw_A 420 -------------------ELTGQEW----RGLENIFEIYLSYNKYLQLTR-NSFALVPSLQ--RLMLRRVALKNVDSSP 473 (680)
T ss_dssp -------------------ECCSGGG----TTCTTCCEEECCSCSEEECCT-TTTTTCTTCC--EEECTTSCCBCTTCSS
T ss_pred -------------------ccCcccc----cCcccccEEecCCCCcceeCh-hhhhcCcccc--cchhccccccccccCC
Confidence 2221000 112346778999999886555 4557888888 8999999987 4678
Q ss_pred hhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccc--------hhhccCcccceeccccccccccC
Q 046851 430 AEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIP--------TTLGQMKGLKYLSLAGNNLTGSI 501 (963)
Q Consensus 430 ~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~--------~~~~~l~~L~~L~l~~N~l~~~~ 501 (963)
..+..+ ++|+.|++++|++++..+..+..+++|++|++++|.+++..+ ..+..+++|++|+|++|+++...
T Consensus 474 ~~~~~l-~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 552 (680)
T 1ziw_A 474 SPFQPL-RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552 (680)
T ss_dssp CTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCC
T ss_pred cccccC-CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCC
Confidence 777765 889999999999997777789999999999999999975422 24788999999999999999444
Q ss_pred CcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCcc-ccccCceEeeccccCccCCC
Q 046851 502 PSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLA-NVSTLSAFNVSFNNLSGPLP 574 (963)
Q Consensus 502 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~l~l~~N~l~~~~p 574 (963)
+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|++..|..+. .+++|+.+++++|++.+..+
T Consensus 553 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred HHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 45799999999999999999977777789999999999999999976666676 78999999999999987544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=443.72 Aligned_cols=256 Identities=28% Similarity=0.380 Sum_probs=214.2
Q ss_pred CCCCccccccCCCccEEEEEEC------CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++++.+.||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4677889999999999999863 46889999997543 3345789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc
Q 046851 756 IYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN 821 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 821 (963)
||||+++|+|.+++..+. ...++|.++.+|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999997542 24589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhh
Q 046851 822 AYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 822 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 899 (963)
+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--------~~~ 255 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQD 255 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--------HHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------HHH
Confidence 99999999987643332 23345679999999999999999999999999999999998 889987432 122
Q ss_pred HHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.... ...+ .....|..++..+.+++.+||+.||++||||+||+++|+.+.
T Consensus 256 ~~~~-i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 256 VVEM-IRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHH-HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHH-HHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2222 2222 122345667788999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=433.64 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=208.2
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.++||+|+||+||+|++.+ .||||+++... .+..++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 478889999999999999998763 59999986543 3456789999999999999999999999865 568999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC-C
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE-T 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-~ 838 (963)
+++|+|.++++... ..++|.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+...... .
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999998643 4699999999999999999999999 99999999999999999999999999998765332 2
Q ss_pred cccccccccccccCcccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 839 HATTGVAGTFGYVAPEYAMT---CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ...+......+.. .
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------~~~~~~~~~~~~~----~ 256 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------RDQIIFMVGRGYA----S 256 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHTTCC----C
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCC----C
Confidence 23445689999999999964 4589999999999999999999999974321 1122222222211 1
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
+ .....+..++..+.+++.+||+.||++||||+||+++|+.++.+
T Consensus 257 p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 257 P-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp C-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred C-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 1 11223445677899999999999999999999999999988653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=482.02 Aligned_cols=484 Identities=22% Similarity=0.221 Sum_probs=403.0
Q ss_pred CCCceEEEccCCcc-cccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcc-----ccccc
Q 046851 1 MGNLEVLDLEGNLL-NGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTF-----IGRLK 74 (963)
Q Consensus 1 l~~l~~L~ls~n~i-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-----~~~L~ 74 (963)
+.+|++|+|++|.+ ..+.|.+|.++++|++|+|++|++++..|++|.++++|++|+|++|.+++.+|.. +.+|+
T Consensus 47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~ 126 (844)
T 3j0a_A 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126 (844)
T ss_dssp CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCC
Confidence 47899999999954 4455889999999999999999999999999999999999999999999766543 45799
Q ss_pred ceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCc--ccccEEEcccCcccccCcccccCCCC------C
Q 046851 75 RVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNC--FQVRSLLLFSNMLEETIPAELGMLQN------L 146 (963)
Q Consensus 75 ~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~------L 146 (963)
+|+|++|.+++..+...|.++++|++|+|++|.+++..+..|..+ ++|+.|++++|.+.+..+..+..+++ |
T Consensus 127 ~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L 206 (844)
T 3j0a_A 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206 (844)
T ss_dssp EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCB
T ss_pred EEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCce
Confidence 999999999855555677899999999999999998899999988 89999999999999888877777665 9
Q ss_pred CEEEccCCccccCCCcCccCC---CCCceEeecCcCCc---------ccccccccCCcccCCCcccCCCCCccccCCccc
Q 046851 147 EVLDVSRNSLSGSIPVDLGNC---SKLAILVLSNLFDT---------YEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEA 214 (963)
Q Consensus 147 ~~L~L~~N~l~~~~p~~~~~l---~~L~~L~l~~n~~~---------~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~ 214 (963)
+.|+|++|.+++..+..+... .+++.|.++++... ..+...+... ....+..++++.|.+.+..+..
T Consensus 207 ~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l-~~~~L~~L~Ls~n~l~~~~~~~ 285 (844)
T 3j0a_A 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL-ARSSVRHLDLSHGFVFSLNSRV 285 (844)
T ss_dssp SEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT-TTSCCCEEECTTCCCCEECSCC
T ss_pred eEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc-ccCCccEEECCCCcccccChhh
Confidence 999999999988888776643 66778877633221 1111111111 1245677888889999999999
Q ss_pred ccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCcee
Q 046851 215 VSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMT 293 (963)
Q Consensus 215 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~ 293 (963)
|..+++|+.|++++|++.+..+..|.++++|++|+|++|+++.+.+..|..+++|+.|++++|+++..++..+ .+++|+
T Consensus 286 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 365 (844)
T 3j0a_A 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365 (844)
T ss_dssp SSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCC
T ss_pred hhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999998887766 689999
Q ss_pred EEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCC
Q 046851 294 MFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLP 373 (963)
Q Consensus 294 ~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (963)
.|++++|.+.+... +.+|+.+++++|.+..++..
T Consensus 366 ~L~Ls~N~l~~i~~----~~~L~~L~l~~N~l~~l~~~------------------------------------------ 399 (844)
T 3j0a_A 366 TLDLRDNALTTIHF----IPSIPDIFLSGNKLVTLPKI------------------------------------------ 399 (844)
T ss_dssp EEEEETCCSCCCSS----CCSCSEEEEESCCCCCCCCC------------------------------------------
T ss_pred EEECCCCCCCcccC----CCCcchhccCCCCccccccc------------------------------------------
Confidence 99999999986443 77889999999877654211
Q ss_pred CCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCch-hHhhccCCccEEECcCCcCCCC
Q 046851 374 SMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPA-EIGRMCKSLKFLDASGNQIVGP 452 (963)
Q Consensus 374 ~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~-~~~~~~~~L~~L~ls~n~l~~~ 452 (963)
...++ .|++++|++++ ++. .....+++|++|+|++|++++.
T Consensus 400 -----------------------------------~~~l~--~L~ls~N~l~~-l~~~~~~~~l~~L~~L~Ls~N~l~~~ 441 (844)
T 3j0a_A 400 -----------------------------------NLTAN--LIHLSENRLEN-LDILYFLLRVPHLQILILNQNRFSSC 441 (844)
T ss_dssp -----------------------------------CTTCC--EEECCSCCCCS-STTHHHHTTCTTCCEEEEESCCCCCC
T ss_pred -----------------------------------ccccc--eeecccCcccc-CchhhhhhcCCccceeeCCCCccccc
Confidence 01122 67888888874 332 2222348899999999999854
Q ss_pred Ccc-ccccCCCCCEEeccCCcCC-----CccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCC
Q 046851 453 IPR-GVGELVSLVALNLSWNLMH-----DQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIP 526 (963)
Q Consensus 453 ~p~-~~~~l~~L~~L~ls~N~i~-----~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 526 (963)
.+. .+..+++|+.|++++|.++ +..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..|
T Consensus 442 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 521 (844)
T 3j0a_A 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSH 521 (844)
T ss_dssp CSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCC
T ss_pred ccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccCh
Confidence 443 3567899999999999997 4445678999999999999999998888889999999999999999998766
Q ss_pred hhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCC
Q 046851 527 DDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLP 574 (963)
Q Consensus 527 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p 574 (963)
..+. ++|+.|+|++|+|++..|..+ .+|+.|++++|++.+..+
T Consensus 522 ~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 522 NDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECE 564 (844)
T ss_dssp CCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSS
T ss_pred hhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccc
Confidence 6655 899999999999998888765 478999999999987544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=433.82 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=207.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|++++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999764 69999999997553 3345789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++||+|.+++..+....+++.++..|+.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999877666789999999999999999999999 99999999999999999999999999998764221
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+......... ..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~-~~------- 243 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--------SMKNLVLKIISGS-FP------- 243 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHTC-CC-------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcCC-CC-------
Confidence 2234467999999999999999999999999999999999999999743 2223333332221 11
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+.++.+|+.+||+.||++|||++|++++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1233456688999999999999999999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=466.83 Aligned_cols=529 Identities=19% Similarity=0.140 Sum_probs=420.9
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeeccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSFN 81 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~n 81 (963)
+.++.++..++ .+|..+. ..+++|+|++|+|+++.|..|.++++|++|+|++|.+++..|..|. +|++|+|++|
T Consensus 15 ~~~~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 15 KTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEECCCCCcc-cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 57889999998 4566654 3799999999999999899999999999999999999988787664 6999999999
Q ss_pred cccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCC
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIP 161 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 161 (963)
+++ .++...|.++++|++|+|++|+|++..+..|+++++|++|++++|++++.....+..+++|++|+|++|.+++..|
T Consensus 92 ~l~-~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 92 PLI-FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp CCS-EECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred ccc-ccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence 999 5555566789999999999999997778999999999999999999998665566669999999999999998888
Q ss_pred cCccCCCCCc--eEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccc-----ccC
Q 046851 162 VDLGNCSKLA--ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL-----EGN 234 (963)
Q Consensus 162 ~~~~~l~~L~--~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l-----~~~ 234 (963)
..|+.+++|+ .|++++|.++......+... .+..++++.|. .++..+..+.++....+....+ ...
T Consensus 171 ~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~----~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i 243 (606)
T 3t6q_A 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSA----VFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243 (606)
T ss_dssp HHHHTTTTCCSEEEECTTCCCCEECTTTTTTC----EEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCC
T ss_pred hhhhhhcccceeEEecCCCccCccChhHhhhc----cccccccCCch---hHHHHhhhccccchhheechhhcccccccc
Confidence 8899999999 88888865553322221110 11122222221 1222222232222222111111 112
Q ss_pred CCccccccc--cCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCC-CCCC
Q 046851 235 FPSNWGACD--NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIP-TFSN 311 (963)
Q Consensus 235 ~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~~~~ 311 (963)
.+..|.++. +|+.|++++|+++.+++..|+.+++|++|++++|+++..+.....+++|+.|++++|++.+.++ .+..
T Consensus 244 ~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 323 (606)
T 3t6q_A 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASN 323 (606)
T ss_dssp CGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGG
T ss_pred ChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhc
Confidence 233344443 7999999999999999999999999999999999999777766688999999999999998755 5889
Q ss_pred CCCCCccccccccccc-CCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEE
Q 046851 312 MVCPPVPYLSRNLFES-YNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAI 390 (963)
Q Consensus 312 l~~l~~l~l~~n~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 390 (963)
+.+|+.|++++|.+.. +++.. .-....++.+
T Consensus 324 l~~L~~L~l~~n~~~~~~~~~~------------------------------------------------~~~l~~L~~L 355 (606)
T 3t6q_A 324 FPSLTHLSIKGNTKRLELGTGC------------------------------------------------LENLENLREL 355 (606)
T ss_dssp CTTCSEEECCSCSSCCBCCSST------------------------------------------------TTTCTTCCEE
T ss_pred cCcCCEEECCCCCcccccchhh------------------------------------------------hhccCcCCEE
Confidence 9999999999987652 11110 0012346778
Q ss_pred EcCCCcccCCCC-cccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccc-cccCCCCCEEec
Q 046851 391 VAGDNKLSGSFP-GNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRG-VGELVSLVALNL 468 (963)
Q Consensus 391 ~~~~n~~~~~~p-~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l 468 (963)
++++|.+.+..+ ...|+.++.|+ .|++++|++.+..|..+..+ ++|++|++++|++++..|.. +..+++|+.|++
T Consensus 356 ~l~~n~l~~~~~~~~~~~~l~~L~--~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 432 (606)
T 3t6q_A 356 DLSHDDIETSDCCNLQLRNLSHLQ--SLNLSYNEPLSLKTEAFKEC-PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432 (606)
T ss_dssp ECCSSCCCEEEESTTTTTTCTTCC--EEECCSCSCEEECTTTTTTC-TTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred ECCCCccccccCcchhcccCCCCC--EEECCCCcCCcCCHHHhcCC-ccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence 999999987651 23457788888 89999999997777777665 88999999999999776554 899999999999
Q ss_pred cCCcCCCccchhhccCcccceecccccccccc---CCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccC
Q 046851 469 SWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGS---IPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545 (963)
Q Consensus 469 s~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 545 (963)
++|.+++..|..++.+++|++|++++|++++. .+..+..+++|+.|++++|++++..|..+..+++|+.|+|++|++
T Consensus 433 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512 (606)
T ss_dssp TTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCcc
Confidence 99999988899999999999999999999862 346799999999999999999988899999999999999999999
Q ss_pred CCcCCCCccccccCceEeeccccCccCCCCCCC---cccccccCCCCCCCCCCC
Q 046851 546 SGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKN---LMKCSSVLGNPYLRPCRA 596 (963)
Q Consensus 546 ~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~---~~~~~~~~~np~~~~c~~ 596 (963)
++..|..+..+++| .|++++|++++.+|.... ......+.+|||.|+|..
T Consensus 513 ~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 513 TSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred CcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 99999999999999 999999999987776432 233456779999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=427.90 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=212.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
..|+..+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46899999999999999999775 69999999998766666677899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
+||+|.+++.. ..+++.++..|+.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.+.... ..
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 99999999975 3499999999999999999999999 99999999999999999999999999998775433 23
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+......... .. ..
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-~~-------~~ 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDNL-PP-------RL 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSS-CC-------CC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCC-CC-------CC
Confidence 445789999999999999999999999999999999999999997431 122222221111 10 11
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......+.++.+++.+||+.||++|||++|++++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1223456788999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=418.69 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=210.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999764 69999999997542 344678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||++||+|.+++.+. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999875 3599999999999999999999999 99999999999999999999999999999875433
Q ss_pred -CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 -THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+......... .
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-~------ 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKLE-Y------ 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-C------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-C------
Confidence 233456789999999999999999999999999999999999999997432 222222222211 1
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 952 (963)
..+...+.++.+++.+||+.||++|||++|+.
T Consensus 252 ----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12334556789999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=434.73 Aligned_cols=264 Identities=24% Similarity=0.356 Sum_probs=217.5
Q ss_pred HHHcCCCCCccccccCCCccEEEEEECC------CcEEEEEEeecccc-hhHHHHHHHHHHHhccCC-CCeeEEEEeeeC
Q 046851 678 VQATGNFNASNCIGNGGFGATYKAEISP------GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRH-PNLVTLIGYHAS 749 (963)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~ 749 (963)
+...++|++.+.||+|+||+||+|.+.. ++.||||++..... ...+.|.+|++++.++.| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3445789999999999999999997642 36899999976543 345679999999999965 899999999866
Q ss_pred -CCeEEEEEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCe
Q 046851 750 -ETEMFLIYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNI 814 (963)
Q Consensus 750 -~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 814 (963)
.+..++|||||++|+|.++++... ...+++.++..|+.|||+||+|||++ +||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence 457899999999999999997643 24589999999999999999999999 999999999999
Q ss_pred EECCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 046851 815 LLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYG 892 (963)
Q Consensus 815 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~ 892 (963)
|+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-- 294 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-- 294 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--
Confidence 9999999999999999876544333 3445679999999999999999999999999999999998 89999743221
Q ss_pred CCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
+.+......+ .+...|..++.++.+++.+||+.||++||||+||+++|+++.++
T Consensus 295 ------~~~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 295 ------EEFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp ------HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1222222222 12234455677899999999999999999999999999986543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=424.46 Aligned_cols=250 Identities=23% Similarity=0.283 Sum_probs=206.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+.|++.++||+|+||+||+|.+. +|+.||||+++.... ..+|+.++++++|||||++++++.+.+..|+||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46888899999999999999765 699999999976433 257999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeecccccccCCCCCc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~~ 839 (963)
+||+|.+++++.+ .+++.++..|+.||+.||+|||++ +|+||||||+|||++.+| .+||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999998753 599999999999999999999999 999999999999999988 6999999999887543221
Q ss_pred ----ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 840 ----ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 840 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .. ..........
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~---~~~i~~~~~~----- 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-----PL---CLKIASEPPP----- 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-----CC---HHHHHHSCCG-----
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----HH---HHHHHcCCCC-----
Confidence 223467999999999999999999999999999999999999999754322 11 1111111110
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
....+...+..+.+++.+||+.||++|||+.|++++|.+
T Consensus 275 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 275 ---IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ---GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 011234556788999999999999999999999998865
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=422.41 Aligned_cols=270 Identities=23% Similarity=0.298 Sum_probs=204.4
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC----eEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET----EMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 757 (963)
.+|.+.++||+|+||+||+|++. |+.||||++...... ...++.|+..+.+++|||||+++|+|.+.+ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 35788899999999999999985 899999998754322 223355667778899999999999987643 689999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ-----CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
||+++|+|.++++.. .++|.++.+++.|+++||+|||++ ..++|+||||||+|||++.++.+||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999863 489999999999999999999976 246899999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccCccccccC------CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC------Ccch
Q 046851 833 LGPSETH---ATTGVAGTFGYVAPEYAMTC------RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN------GFNI 897 (963)
Q Consensus 833 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~------~~~~ 897 (963)
....... .....+||+.|||||++.+. .++.++|||||||++|||+||++|+......... ....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6543322 22346799999999999764 3677999999999999999999887643321100 0011
Q ss_pred hhHHHHHHhcCcccceeccccCCC-CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 898 VAWGCMLLRQGRAKEFFTAGLWDA-GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
............ .++..... .+.+++..+.+++.+||+.||++||||.||++.|+++..
T Consensus 238 ~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111111111 11111111 123566789999999999999999999999999998754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=463.56 Aligned_cols=496 Identities=18% Similarity=0.120 Sum_probs=389.5
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeeccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSFN 81 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~n 81 (963)
++++.++++++.+ |..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..+. +|++|+|++|
T Consensus 14 ~~~~c~~~~l~~i-p~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLSKV-PDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCSSC-CTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcccC-CCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 5789999999954 55544 7899999999999988888999999999999999999977776654 6888999999
Q ss_pred cccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccc-cCcccccCCCCCCEEEccCCccccCC
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEE-TIPAELGMLQNLEVLDVSRNSLSGSI 160 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (963)
+++ .+++..|.++++|++|+|++|++++..+..|+++++|++|++++|++++ .+|..|.++++|++|+|++|.+++..
T Consensus 91 ~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~ 169 (606)
T 3vq2_A 91 PIQ-SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169 (606)
T ss_dssp CCC-CCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred ccc-ccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence 998 6655556689999999999999987777889999999999999999886 45888999999999999999998888
Q ss_pred CcCccCCCCCc----eEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccc-cCC
Q 046851 161 PVDLGNCSKLA----ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLE-GNF 235 (963)
Q Consensus 161 p~~~~~l~~L~----~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~-~~~ 235 (963)
|..++.+++|+ .|++++ |.+.+..+..+... +|+.|++++|.+. +..
T Consensus 170 ~~~~~~l~~L~~~l~~L~l~~---------------------------n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~ 221 (606)
T 3vq2_A 170 VNDLQFLRENPQVNLSLDMSL---------------------------NPIDFIQDQAFQGI-KLHELTLRGNFNSSNIM 221 (606)
T ss_dssp TTTTHHHHHCTTCCCEEECTT---------------------------CCCCEECTTTTTTC-EEEEEEEESCCSCHHHH
T ss_pred hhhhhhhhccccccceeeccC---------------------------CCcceeCcccccCc-eeeeeeccCCccchhHH
Confidence 88888777765 688877 55554555555554 8999999999886 356
Q ss_pred CccccccccCceeecCcccccC------cCccccCCCC--CCcEEec-cCcccccccCCCCCCCceeEEEeccCcCccCC
Q 046851 236 PSNWGACDNLEMLNLGHNFFSG------KNLGVLGPCK--NLLFLDL-SSNQLTGELARELPVPCMTMFDVSGNALSGSI 306 (963)
Q Consensus 236 ~~~~~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~--~L~~L~L-~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~ 306 (963)
+..+.+++.|+.+++..+.+.. +....+..+. +++.+++ ..|.+.+..+....+++|+.|++++|.+...+
T Consensus 222 ~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~ 301 (606)
T 3vq2_A 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE 301 (606)
T ss_dssp HHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCC
T ss_pred HHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhh
Confidence 7778888888888875554332 2222333332 3445555 56666666666446677777777777776544
Q ss_pred CCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcce
Q 046851 307 PTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQT 386 (963)
Q Consensus 307 ~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 386 (963)
.+..+.+|+.+++++|.+..++. . ....
T Consensus 302 -~l~~~~~L~~L~l~~n~l~~lp~-~--------------------------------------------------~l~~ 329 (606)
T 3vq2_A 302 -DVPKHFKWQSLSIIRCQLKQFPT-L--------------------------------------------------DLPF 329 (606)
T ss_dssp -CCCTTCCCSEEEEESCCCSSCCC-C--------------------------------------------------CCSS
T ss_pred -hccccccCCEEEcccccCccccc-C--------------------------------------------------CCCc
Confidence 67777777777777776643320 0 1223
Q ss_pred EEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeec--CchhHhhccCCccEEECcCCcCCCCCccccccCCCCC
Q 046851 387 VYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQ--LPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLV 464 (963)
Q Consensus 387 ~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~--~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~ 464 (963)
++.+.+++|...+.++ ++.++.|+ .|++++|.+++. +|..+..+ ++|++|++++|.++ .+|..+..+++|+
T Consensus 330 L~~L~l~~n~~~~~~~---~~~l~~L~--~L~ls~n~l~~~~~~~~~~~~~-~~L~~L~L~~n~l~-~~~~~~~~l~~L~ 402 (606)
T 3vq2_A 330 LKSLTLTMNKGSISFK---KVALPSLS--YLDLSRNALSFSGCCSYSDLGT-NSLRHLDLSFNGAI-IMSANFMGLEELQ 402 (606)
T ss_dssp CCEEEEESCSSCEECC---CCCCTTCC--EEECCSSCEEEEEECCHHHHCC-SCCCEEECCSCSEE-EECCCCTTCTTCC
T ss_pred cceeeccCCcCccchh---hccCCCCC--EEECcCCccCCCcchhhhhccC-CcccEeECCCCccc-cchhhccCCCCCC
Confidence 4456666665554442 35667777 899999999865 37777665 88999999999999 5778999999999
Q ss_pred EEeccCCcCCCccc-hhhccCcccceeccccccccccCCcccccCCccceecccccccCC-CCChhhhccccCCeEEecc
Q 046851 465 ALNLSWNLMHDQIP-TTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSG-LIPDDLENLRNLTVLLLNN 542 (963)
Q Consensus 465 ~L~ls~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~l~~ 542 (963)
.|++++|.+.+..| ..+..+++|++|++++|++++..|..+..+++|+.|++++|++++ .+|..+..+++|+.|+|++
T Consensus 403 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 482 (606)
T 3vq2_A 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482 (606)
T ss_dssp EEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred eeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCC
Confidence 99999999988777 689999999999999999998899999999999999999999997 4788899999999999999
Q ss_pred ccCCCcCCCCccccccCceEeeccccCccCCCCCCCc---ccccccCCCCCC
Q 046851 543 NKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL---MKCSSVLGNPYL 591 (963)
Q Consensus 543 N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~---~~~~~~~~np~~ 591 (963)
|++++..|..+..+++|++|++++|++++..|..... .....+.+|...
T Consensus 483 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 9999888999999999999999999999977764432 222334456543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=410.32 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=199.3
Q ss_pred CCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC----CCeEEEEE
Q 046851 685 NASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS----ETEMFLIY 757 (963)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 757 (963)
++.+.||+|+||+||+|.+. +++.||||++.... ....++|.+|++++++++|||||+++++|.+ .+.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66778999999999999765 68999999997543 3345779999999999999999999999864 35689999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecccCCCCeEEC-CCCcEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR--VLHRDVKPSNILLD-DDFNAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~ 834 (963)
||++||+|.+++.+. ..+++.++..|+.||++||+|||++ + |+||||||+|||++ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999875 4589999999999999999999999 6 99999999999998 48999999999998643
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ..... .....+.....
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~-~~i~~~~~~~~- 250 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIY-RRVTSGVKPAS- 250 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHH-HHHTTTCCCGG-
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHH-HHHHcCCCCCC-
Confidence 2 23345689999999999875 699999999999999999999999963321 11111 22222211111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+...+.++.+++.+||+.||++|||++|++++
T Consensus 251 -------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 -------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112234578899999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=429.19 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=212.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+.+|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46999999999999999999775 69999999998766666677899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
+||+|.+++... .+++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+.... ..
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 999999999753 489999999999999999999999 99999999999999999999999999998775433 23
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+......... ... .
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-~~~-------~ 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIRDNL-PPR-------L 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCC-------C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCC-CCC-------C
Confidence 445789999999999999999999999999999999999999997431 122222221111 110 1
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......+.++.+|+.+||+.||++|||++|++++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1223445688999999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=404.80 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=194.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+++.+|++++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999764 69999999997543 233567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+ +|+|.+++.++ ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 67999999874 4599999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.....+||+.|||||++.+..+ +.++||||+||++|||++|+.||... +.......... +..
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------~~~~~~~~i~~-~~~------ 229 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------SIPVLFKNISN-GVY------ 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-TCC------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHc-CCC------
Confidence 2345689999999999998876 57999999999999999999999743 22222222221 111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+.++.+++.+||+.||++|||++|++++
T Consensus 230 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 ----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1233445678899999999999999999999874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=451.21 Aligned_cols=491 Identities=18% Similarity=0.164 Sum_probs=382.4
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceee
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYL 78 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L 78 (963)
.++++|+|++|.++++.+.+|.++++|++|+|++|++++..+.+|.++++|++|+|++|.+++..|..+. +|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 4689999999999998888999999999999999999988889999999999999999999877766654 7899999
Q ss_pred ccccccccCCccccccCCCCCeEeCCCCcccc-CcCccccCcccccEEEcccCcccccCcccccCCCCC----CEEEccC
Q 046851 79 SFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVG-GIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNL----EVLDVSR 153 (963)
Q Consensus 79 ~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~ 153 (963)
++|+++ .++...+.++++|++|+|++|++++ .+|..|+++++|+.|++++|++++..+..|..+++| +.|++++
T Consensus 108 ~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp TTSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred cccccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 999998 7777667789999999999999986 368999999999999999999998888888888888 8999999
Q ss_pred CccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCC------CCCccccCCcccccCCCC--CceEe
Q 046851 154 NSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMND------DFNFFEGGIPEAVSSLPN--LRILW 225 (963)
Q Consensus 154 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~------~~n~~~~~~~~~l~~l~~--L~~L~ 225 (963)
|.+++..|..+..+ +|+.|++++|.......... ......+....+ ..+.+.......+.++++ ++.++
T Consensus 187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~--~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~ 263 (570)
T 2z63_A 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTC--IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263 (570)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHH--HHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEE
T ss_pred CCceecCHHHhccC-cceeEecccccccccchhhh--hcCccccceeeeccccccCchhhhhcchhhhccccccchhhhh
Confidence 99998888878766 89999998875432211100 000000000000 001111222233333333 45566
Q ss_pred cCCc-ccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCcc
Q 046851 226 APRA-TLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSG 304 (963)
Q Consensus 226 l~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~ 304 (963)
++.+ .+.+..+..|..+++|++|++++|.++.++. .+..+ +|+.|++++|++...+. ..++.|+.|++++|.+.+
T Consensus 264 l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~-~~~~~-~L~~L~l~~n~~~~l~~--~~l~~L~~L~l~~n~~~~ 339 (570)
T 2z63_A 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD-FSYNF-GWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGN 339 (570)
T ss_dssp EEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCB-CCSCC-CCSEEEEESCBCSSCCB--CBCSSCCEEEEESCBSCC
T ss_pred hhcchhhhhhchhhhcCcCcccEEEecCccchhhhh-hhccC-CccEEeeccCcccccCc--ccccccCEEeCcCCcccc
Confidence 6666 6677778888888888888888888887654 45566 88888888888875443 356788888888888776
Q ss_pred CCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCc
Q 046851 305 SIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK 384 (963)
Q Consensus 305 ~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 384 (963)
..+. ..+++|+.+++++|.+.....
T Consensus 340 ~~~~-~~~~~L~~L~l~~n~l~~~~~------------------------------------------------------ 364 (570)
T 2z63_A 340 AFSE-VDLPSLEFLDLSRNGLSFKGC------------------------------------------------------ 364 (570)
T ss_dssp BCCC-CBCTTCCEEECCSSCCBEEEE------------------------------------------------------
T ss_pred cccc-ccCCCCCEEeCcCCccCcccc------------------------------------------------------
Confidence 6555 566677777777765543210
Q ss_pred ceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCc-cccccCCCC
Q 046851 385 QTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIP-RGVGELVSL 463 (963)
Q Consensus 385 ~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p-~~~~~l~~L 463 (963)
.|. .|..++.|+ .|++++|.++ .+|..+.. +++|++|++++|.+.+..| ..+..+++|
T Consensus 365 ----------------~~~-~~~~~~~L~--~L~l~~n~l~-~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 423 (570)
T 2z63_A 365 ----------------CSQ-SDFGTTSLK--YLDLSFNGVI-TMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423 (570)
T ss_dssp ----------------EEH-HHHTCSCCC--EEECCSCSEE-EEEEEEET-CTTCCEEECTTSEEESCTTSCTTTTCTTC
T ss_pred ----------------ccc-cccccCccC--EEECCCCccc-cccccccc-cCCCCEEEccCCccccccchhhhhcCCCC
Confidence 011 124455566 7889999988 45555444 4889999999999986655 468899999
Q ss_pred CEEeccCCcCCCccchhhccCcccceecccccccc-ccCCcccccCCccceecccccccCCCCChhhhccccCCeEEecc
Q 046851 464 VALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLT-GSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNN 542 (963)
Q Consensus 464 ~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 542 (963)
+.|++++|.+.+..|..+..+++|++|++++|+++ +.+|..+..+++|+.|++++|++++..|..+..+++|++|++++
T Consensus 424 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 503 (570)
T 2z63_A 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503 (570)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence 99999999998888999999999999999999997 57899999999999999999999988888999999999999999
Q ss_pred ccCCCcCCCCccccccCceEeeccccCccCCCCC
Q 046851 543 NKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576 (963)
Q Consensus 543 N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~ 576 (963)
|++++..|..+..+++|+.|++++|++++..|..
T Consensus 504 n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 9999777788999999999999999999877753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=411.86 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=200.1
Q ss_pred CCCCCccccccCCCccEEEEEEC----CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|++.+.||+|+||+||+|+.. +++.||||++..... ....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999762 478999999965432 233568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||++||+|.+++.+. ..+++.++..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999875 3599999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+.........
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~------- 242 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILKAK------- 242 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-------
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHcCC-------
Confidence 32 23345689999999999999999999999999999999999999997432 222222222211
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM-----KQVVR 953 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 953 (963)
...|...+.++.+++.+||+.||++|||+ +|+++
T Consensus 243 ----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 ----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11234456688999999999999999985 56664
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=450.01 Aligned_cols=436 Identities=19% Similarity=0.245 Sum_probs=311.9
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCccc------c------cCCccccCcccccceeccccccccCCCcc
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRIT------G------EIPASFSDFVNLEELNLAGNLVNGTVPTF 69 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~------~------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 69 (963)
+.|+.|+|++|++++.+|.+|+.|++|++|+|++|.+. + .+|... +..|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 36788888888888888888888888999998888762 1 223222 55666 788888777766655
Q ss_pred ccc----ccceeec--------------------cccccccCCccccccCCCCCeEeCCCCccccC--------------
Q 046851 70 IGR----LKRVYLS--------------------FNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG-------------- 111 (963)
Q Consensus 70 ~~~----L~~L~L~--------------------~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~-------------- 111 (963)
+.. +..+++. +|++++ +|..+. ++++|++|+|++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~-~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~ 235 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVM-RLTKLRQFYMGNSPFVAENICEAWENENSEYA 235 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGG-GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred HHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHh-cccCCCEEECcCCccccccccccccccccchh
Confidence 541 1122222 566664 666543 577777777777777754
Q ss_pred ---cCcccc--CcccccEEEcccCcccccCcccccCCCCCCEEEccCCc-ccc-CCCcCccCC------CCCceEeecCc
Q 046851 112 ---IPRSLG--NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNS-LSG-SIPVDLGNC------SKLAILVLSNL 178 (963)
Q Consensus 112 ---~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~l~~n 178 (963)
+|..++ ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..+.++ ++|+.|++++
T Consensus 236 ~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~- 314 (636)
T 4eco_A 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY- 314 (636)
T ss_dssp HHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCS-
T ss_pred cccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCC-
Confidence 677766 77777777777777776777777777777777777776 665 566666655 6777777766
Q ss_pred CCcccccccccCCcccCCCcccCCCCCccccCCcc--cccCCCCCceEecCCcccccCCCccccccccCceeecCccccc
Q 046851 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE--AVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFS 256 (963)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~--~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 256 (963)
|.+. .+|. .+..+++|+.|++++|++++.+| .|..+++|++|+|++|+++
T Consensus 315 --------------------------n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~ 366 (636)
T 4eco_A 315 --------------------------NNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT 366 (636)
T ss_dssp --------------------------SCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE
T ss_pred --------------------------CcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc
Confidence 4444 4566 67777777777777777776666 6777777777777777777
Q ss_pred CcCccccCCCCC-CcEEeccCcccccccCCCCC--CCceeEEEeccCcCccCCCC-CCCCCCCCcccccccccccCCCCc
Q 046851 257 GKNLGVLGPCKN-LLFLDLSSNQLTGELARELP--VPCMTMFDVSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNPST 332 (963)
Q Consensus 257 ~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~--~~~L~~L~l~~N~l~~~~~~-~~~l~~l~~l~l~~n~~~~~~~~~ 332 (963)
.++. .|..+++ |++|++++|+++.++..... +++|+.|++++|++.+..|. +...
T Consensus 367 ~lp~-~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~-------------------- 425 (636)
T 4eco_A 367 EIPA-NFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL-------------------- 425 (636)
T ss_dssp ECCT-TSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTT--------------------
T ss_pred cccH-hhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCCCcchhhhccc--------------------
Confidence 5543 3666666 77777777777744332222 33677777777776654442 1100
Q ss_pred hhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCc
Q 046851 333 AYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRL 412 (963)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l 412 (963)
..+.+...
T Consensus 426 ------------------------------------------------------------------------~~~~~~~~ 433 (636)
T 4eco_A 426 ------------------------------------------------------------------------DPTPFKGI 433 (636)
T ss_dssp ------------------------------------------------------------------------CSSCCCCC
T ss_pred ------------------------------------------------------------------------ccccccCC
Confidence 00111111
Q ss_pred ceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCcccccc-C-------CCCCEEeccCCcCCCccchhhc--
Q 046851 413 DSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGE-L-------VSLVALNLSWNLMHDQIPTTLG-- 482 (963)
Q Consensus 413 ~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~-l-------~~L~~L~ls~N~i~~~~~~~~~-- 482 (963)
.+..|++++|+++ .+|..++..+++|++|+|++|+++ .+|..+.. . ++|+.|+|++|.++ .+|..+.
T Consensus 434 ~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~ 510 (636)
T 4eco_A 434 NVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRAT 510 (636)
T ss_dssp CEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTT
T ss_pred CCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhc
Confidence 2337888888888 788888876688999999999998 66654433 2 28999999999997 6777776
Q ss_pred cCcccceeccccccccccCCcccccCCccceecc------cccccCCCCChhhhccccCCeEEeccccCCCcCCCCcccc
Q 046851 483 QMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL------SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANV 556 (963)
Q Consensus 483 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l------s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 556 (963)
.+++|+.|+|++|++++ +|..+.++++|+.|+| ++|++.+.+|..+..+++|+.|+|++|+++ .+|..+.
T Consensus 511 ~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~-- 586 (636)
T 4eco_A 511 TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT-- 586 (636)
T ss_dssp TCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--
T ss_pred cCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--
Confidence 89999999999999995 8999999999999999 568888899999999999999999999995 8898876
Q ss_pred ccCceEeeccccCcc
Q 046851 557 STLSAFNVSFNNLSG 571 (963)
Q Consensus 557 ~~L~~l~l~~N~l~~ 571 (963)
++|+.|++++|++..
T Consensus 587 ~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 587 PNISVLDIKDNPNIS 601 (636)
T ss_dssp TTCCEEECCSCTTCE
T ss_pred CcCCEEECcCCCCcc
Confidence 899999999998874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=440.01 Aligned_cols=502 Identities=19% Similarity=0.165 Sum_probs=364.3
Q ss_pred ceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeecc
Q 046851 4 LEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSF 80 (963)
Q Consensus 4 l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~ 80 (963)
.+.++.++.+++. +|..+. +++++|+|++|++++..+.+|.++++|++|+|++|.+++..+..+. +|++|+|++
T Consensus 9 ~~~~~c~~~~l~~-ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 85 (570)
T 2z63_A 9 NITYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (570)
T ss_dssp TTEEECCSSCCSS-CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEeCCCCccc-cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence 3467888888884 455543 5799999999999988888999999999999999999866665543 677788888
Q ss_pred ccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCccccc-CcccccCCCCCCEEEccCCccccC
Q 046851 81 NRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET-IPAELGMLQNLEVLDVSRNSLSGS 159 (963)
Q Consensus 81 n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~ 159 (963)
|+++ .++...|.++++|++|++++|++++..+..|+++++|++|++++|.+++. +|..|.++++|++|++++|.+++.
T Consensus 86 n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~ 164 (570)
T 2z63_A 86 NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (570)
T ss_dssp CCCC-EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE
T ss_pred CcCC-ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcccee
Confidence 8877 66666666788888888888887765555678888888888888877753 577788888888888888888766
Q ss_pred CCcCccCCCCC----ceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccccc-C
Q 046851 160 IPVDLGNCSKL----AILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEG-N 234 (963)
Q Consensus 160 ~p~~~~~l~~L----~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~-~ 234 (963)
.+..++.+++| +.|++++ |.+.+..+..+..+ +|+.|++++|.... .
T Consensus 165 ~~~~~~~l~~L~~~~~~L~l~~---------------------------n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~ 216 (570)
T 2z63_A 165 YCTDLRVLHQMPLLNLSLDLSL---------------------------NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNV 216 (570)
T ss_dssp CGGGGHHHHTCTTCCCEEECTT---------------------------CCCCEECTTTTTTC-EEEEEEEESCCSCTTH
T ss_pred cHHHccchhccchhhhhcccCC---------------------------CCceecCHHHhccC-cceeEecccccccccc
Confidence 67777777777 6677766 55555556666655 68888887764321 1
Q ss_pred CCccccccccCceeecCccc------ccCcCccccCCCCC--CcEEeccCc-ccccccCCCC-CCCceeEEEeccCcCcc
Q 046851 235 FPSNWGACDNLEMLNLGHNF------FSGKNLGVLGPCKN--LLFLDLSSN-QLTGELAREL-PVPCMTMFDVSGNALSG 304 (963)
Q Consensus 235 ~~~~~~~l~~L~~L~Ls~N~------l~~~~~~~~~~l~~--L~~L~L~~N-~l~~~~~~~~-~~~~L~~L~l~~N~l~~ 304 (963)
.+..+.+++.++.+.+..+. +..+....|..+++ ++.+++++| .+.+..+..+ .+++|+.|++++|.+..
T Consensus 217 ~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~ 296 (570)
T 2z63_A 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296 (570)
T ss_dssp HHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS
T ss_pred hhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh
Confidence 22333444444443332221 12222233333322 344555554 4444433333 35556666666666665
Q ss_pred CCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCc
Q 046851 305 SIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK 384 (963)
Q Consensus 305 ~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 384 (963)
.+..+..+ +|+.+++++|.+..++.. ..
T Consensus 297 l~~~~~~~-~L~~L~l~~n~~~~l~~~---------------------------------------------------~l 324 (570)
T 2z63_A 297 VKDFSYNF-GWQHLELVNCKFGQFPTL---------------------------------------------------KL 324 (570)
T ss_dssp CCBCCSCC-CCSEEEEESCBCSSCCBC---------------------------------------------------BC
T ss_pred hhhhhccC-CccEEeeccCcccccCcc---------------------------------------------------cc
Confidence 55555555 666666666555433210 01
Q ss_pred ceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecC--chhHhhccCCccEEECcCCcCCCCCccccccCCC
Q 046851 385 QTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQL--PAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVS 462 (963)
Q Consensus 385 ~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~--p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~ 462 (963)
..++.+.+.+|.+.+.+|. ..++.|+ .|++++|.+++.. |..+..+ ++|++|++++|.+++ +|..+..+++
T Consensus 325 ~~L~~L~l~~n~~~~~~~~---~~~~~L~--~L~l~~n~l~~~~~~~~~~~~~-~~L~~L~l~~n~l~~-~~~~~~~l~~ 397 (570)
T 2z63_A 325 KSLKRLTFTSNKGGNAFSE---VDLPSLE--FLDLSRNGLSFKGCCSQSDFGT-TSLKYLDLSFNGVIT-MSSNFLGLEQ 397 (570)
T ss_dssp SSCCEEEEESCBSCCBCCC---CBCTTCC--EEECCSSCCBEEEEEEHHHHTC-SCCCEEECCSCSEEE-EEEEEETCTT
T ss_pred cccCEEeCcCCcccccccc---ccCCCCC--EEeCcCCccCcccccccccccc-CccCEEECCCCcccc-ccccccccCC
Confidence 1234566666666666665 4566666 8999999998543 6666665 889999999999994 5555999999
Q ss_pred CCEEeccCCcCCCccc-hhhccCcccceeccccccccccCCcccccCCccceecccccccC-CCCChhhhccccCCeEEe
Q 046851 463 LVALNLSWNLMHDQIP-TTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLS-GLIPDDLENLRNLTVLLL 540 (963)
Q Consensus 463 L~~L~ls~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~l 540 (963)
|+.|++++|.+.+..| ..+..+++|++|++++|++++..|..+..+++|+.|++++|+++ +.+|..+..+++|+.|++
T Consensus 398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l 477 (570)
T 2z63_A 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477 (570)
T ss_dssp CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEEC
Confidence 9999999999987665 57899999999999999999889999999999999999999998 568899999999999999
Q ss_pred ccccCCCcCCCCccccccCceEeeccccCccCCCCCCCc---ccccccCCCCCCCCCCC
Q 046851 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL---MKCSSVLGNPYLRPCRA 596 (963)
Q Consensus 541 ~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~---~~~~~~~~np~~~~c~~ 596 (963)
++|++++..|..+..+++|++|++++|++++.+|..... .....+.+|||.|+|..
T Consensus 478 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 999999888999999999999999999999977764332 33456779999999964
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=448.17 Aligned_cols=438 Identities=17% Similarity=0.179 Sum_probs=328.0
Q ss_pred CceEEEccCCcccccCCCccccCCCCcEEEc-cCCcccccCCccccCc----c-----cccceec-------ccccccc-
Q 046851 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNL-GFNRITGEIPASFSDF----V-----NLEELNL-------AGNLVNG- 64 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L-~~n~l~~~~~~~~~~l----~-----~L~~L~L-------s~N~l~~- 64 (963)
.|+.|+|++|++.+.+|.+|+.|++|++|+| ++|.+.+..+-.-... . .++.... ....+++
T Consensus 324 ~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l 403 (876)
T 4ecn_A 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403 (876)
T ss_dssp CEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred CEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHH
Confidence 5677777777777777777777777777777 7777765533111100 0 0000000 0000000
Q ss_pred ----------CCC---cccccccceeecc--ccccccCCccccccCCCCCeEeCCCCcccc-----------------Cc
Q 046851 65 ----------TVP---TFIGRLKRVYLSF--NRLVGSVPSKIGEKCTNLEHLDLSGNYLVG-----------------GI 112 (963)
Q Consensus 65 ----------~~~---~~~~~L~~L~L~~--n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~-----------------~~ 112 (963)
..+ ...-.++.+.+.. |++++ +|..+. ++++|++|+|++|+|++ .+
T Consensus 404 ~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~-~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQ-RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGG-GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHh-cCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 000 0011344555544 89995 998755 79999999999999997 38
Q ss_pred Ccccc--CcccccEEEcccCcccccCcccccCCCCCCEEEccCCc-ccc-CCCcCccCCC-------CCceEeecCcCCc
Q 046851 113 PRSLG--NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNS-LSG-SIPVDLGNCS-------KLAILVLSNLFDT 181 (963)
Q Consensus 113 ~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~l~~n~~~ 181 (963)
|..++ ++++|+.|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..+.+++ +|+.|++++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~---- 557 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY---- 557 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCS----
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeC----
Confidence 99887 99999999999999999999999999999999999998 887 7887666665 999999998
Q ss_pred ccccccccCCcccCCCcccCCCCCccccCCcc--cccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcC
Q 046851 182 YEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE--AVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKN 259 (963)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~--~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 259 (963)
|.+. .+|. .+.++++|+.|++++|+++ .+| .|..+++|+.|+|++|+++.++
T Consensus 558 -----------------------N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp 611 (876)
T 4ecn_A 558 -----------------------NNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIP 611 (876)
T ss_dssp -----------------------SCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCC
T ss_pred -----------------------CcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccch
Confidence 5565 6777 8999999999999999999 677 8999999999999999999665
Q ss_pred ccccCCCCC-CcEEeccCcccccccCCCCCC--CceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhh
Q 046851 260 LGVLGPCKN-LLFLDLSSNQLTGELARELPV--PCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLS 336 (963)
Q Consensus 260 ~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~--~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~ 336 (963)
..+..+++ |+.|+|++|+++..+...... +.|+.|++++|++.+.++.+..-
T Consensus 612 -~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~------------------------ 666 (876)
T 4ecn_A 612 -EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS------------------------ 666 (876)
T ss_dssp -TTSCEECTTCCEEECCSSCCCSCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSC------------------------
T ss_pred -HHHhhccccCCEEECcCCCCCcCchhhhccccCCCCEEECcCCcCCCccccchhh------------------------
Confidence 45788998 999999999999555333333 45999999999998766542200
Q ss_pred hhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEE
Q 046851 337 LFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLM 416 (963)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~ 416 (963)
++.+....+..
T Consensus 667 ---------------------------------------------------------------------l~~~~~~~L~~ 677 (876)
T 4ecn_A 667 ---------------------------------------------------------------------MDDYKGINAST 677 (876)
T ss_dssp ---------------------------------------------------------------------TTTCCCCCEEE
T ss_pred ---------------------------------------------------------------------hccccCCCcCE
Confidence 00011112236
Q ss_pred EEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccC--------CCCCEEeccCCcCCCccchhhc--cCcc
Q 046851 417 VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGEL--------VSLVALNLSWNLMHDQIPTTLG--QMKG 486 (963)
Q Consensus 417 L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l--------~~L~~L~ls~N~i~~~~~~~~~--~l~~ 486 (963)
|++++|.++ .+|..++..+++|+.|+|++|+|+ .+|..+... ++|+.|+|++|.++ .+|..+. .+++
T Consensus 678 L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~ 754 (876)
T 4ecn_A 678 VTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPY 754 (876)
T ss_dssp EECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTT
T ss_pred EEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCC
Confidence 777888877 778777766677888888888888 666654432 37888888888886 6677776 7888
Q ss_pred cceeccccccccccCCcccccCCccceecccc------cccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCc
Q 046851 487 LKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSS------NSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLS 560 (963)
Q Consensus 487 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~------N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~ 560 (963)
|+.|+|++|++++ +|..+.++++|+.|+|++ |++.+.+|..+..+++|+.|+|++|+| +.+|..+. ++|+
T Consensus 755 L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~ 830 (876)
T 4ecn_A 755 LSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLY 830 (876)
T ss_dssp CCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSC
T ss_pred cCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCC
Confidence 8888888888885 788888888888888865 778888888888899999999999999 48888765 6889
Q ss_pred eEeeccccCccCC
Q 046851 561 AFNVSFNNLSGPL 573 (963)
Q Consensus 561 ~l~l~~N~l~~~~ 573 (963)
.|+|++|++...-
T Consensus 831 ~LdLs~N~l~~i~ 843 (876)
T 4ecn_A 831 ILDIADNPNISID 843 (876)
T ss_dssp EEECCSCTTCEEE
T ss_pred EEECCCCCCCccC
Confidence 9999999887533
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=436.06 Aligned_cols=480 Identities=19% Similarity=0.192 Sum_probs=319.9
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeeccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSFN 81 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~n 81 (963)
.+.|.+++.++.+ |..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..+. +|++|+|++|
T Consensus 8 ~~c~~~~~~l~~i-p~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 84 (549)
T 2z81_A 8 GVCDGRSRSFTSI-PSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84 (549)
T ss_dssp SEEECTTSCCSSC-CSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred ceEECCCCccccc-cccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence 4578899999854 55543 7899999999999988899999999999999999999866665543 5777777777
Q ss_pred cccccCCccccccCCCCCeEeCCCCccccC-cCccccCcccccEEEcccCc-ccccCcccccCCCCCCEEEccCCccccC
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGG-IPRSLGNCFQVRSLLLFSNM-LEETIPAELGMLQNLEVLDVSRNSLSGS 159 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 159 (963)
+++ .++...+.++++|++|+|++|++++. .|..|+++++|++|++++|+ +..+.+..|.++++|++|++++|.+++.
T Consensus 85 ~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 163 (549)
T 2z81_A 85 HLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163 (549)
T ss_dssp CCC-SCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred ccC-ccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc
Confidence 777 56665556677777777777777652 45667777777777777776 4444445677777777777777777766
Q ss_pred CCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcc-cccCCCCCceEecCCcccccCC--C
Q 046851 160 IPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE-AVSSLPNLRILWAPRATLEGNF--P 236 (963)
Q Consensus 160 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~-~l~~l~~L~~L~l~~n~l~~~~--~ 236 (963)
.|..+.++++|+.|++++|.++ .+|. .+..+++|+.|++++|++++.. +
T Consensus 164 ~~~~l~~l~~L~~L~l~~n~~~----------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 215 (549)
T 2z81_A 164 QSQSLKSIRDIHHLTLHLSESA----------------------------FLLEIFADILSSVRYLELRDTNLARFQFSP 215 (549)
T ss_dssp CTTTTTTCSEEEEEEEECSBST----------------------------THHHHHHHSTTTBSEEEEESCBCTTCCCCC
T ss_pred ChhhhhccccCceEecccCccc----------------------------ccchhhHhhcccccEEEccCCccccccccc
Confidence 7777777777777777663322 1222 2345666777777777666531 1
Q ss_pred -ccccccccCceeecCcccccCcCc----cccCCCCCCcEEeccCcccccccCC-------CCCCCceeEEEeccCcCcc
Q 046851 237 -SNWGACDNLEMLNLGHNFFSGKNL----GVLGPCKNLLFLDLSSNQLTGELAR-------ELPVPCMTMFDVSGNALSG 304 (963)
Q Consensus 237 -~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~~~L~~L~l~~N~l~~ 304 (963)
.....+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+.... ...+.+++.|+++++.+..
T Consensus 216 ~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~ 295 (549)
T 2z81_A 216 LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295 (549)
T ss_dssp CSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSC
T ss_pred cchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccch
Confidence 122345566666666666654322 2234456666666666666543211 1123445555555544331
Q ss_pred CCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCc
Q 046851 305 SIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK 384 (963)
Q Consensus 305 ~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 384 (963)
.... ..+. ..+ . ..
T Consensus 296 ~~~~-~~l~--------------------------------------------~~~------~---------------~~ 309 (549)
T 2z81_A 296 FYLF-YDLS--------------------------------------------TVY------S---------------LL 309 (549)
T ss_dssp GGGS-CCCC--------------------------------------------HHH------H---------------HS
T ss_pred hhhc-ccch--------------------------------------------hhh------h---------------hc
Confidence 1100 0000 000 0 00
Q ss_pred ceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhH--hhccCCccEEECcCCcCCCCCc--cccccC
Q 046851 385 QTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEI--GRMCKSLKFLDASGNQIVGPIP--RGVGEL 460 (963)
Q Consensus 385 ~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~--~~~~~~L~~L~ls~n~l~~~~p--~~~~~l 460 (963)
..+..+.+++|.+. .+|.++|..++.|+ +|++++|++++.+|... ...+++|++|++++|++++..+ ..+..+
T Consensus 310 ~~L~~L~l~~n~l~-~ip~~~~~~l~~L~--~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 386 (549)
T 2z81_A 310 EKVKRITVENSKVF-LVPCSFSQHLKSLE--FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386 (549)
T ss_dssp TTCCEEEEESSCCC-CCCHHHHHHCTTCC--EEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred ccceEEEeccCccc-cCCHHHHhcCcccc--EEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence 12345666777764 67777777777777 78888888887665432 2234778888888888874322 457788
Q ss_pred CCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEe
Q 046851 461 VSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540 (963)
Q Consensus 461 ~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 540 (963)
++|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+. ++|+.|++++|+|++.+ ..+++|++|+|
T Consensus 387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~L 458 (549)
T 2z81_A 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYI 458 (549)
T ss_dssp TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEEC
Confidence 88888888888885 57777888888888888888887 5555442 57888888888888642 46788888888
Q ss_pred ccccCCCcCCCCccccccCceEeeccccCccCCCCCCCc---ccccccCCCCCCCCCC
Q 046851 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL---MKCSSVLGNPYLRPCR 595 (963)
Q Consensus 541 ~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~---~~~~~~~~np~~~~c~ 595 (963)
++|+|+ .+|. ...+++|++|++++|++++.+|..... .....+.+|||.|+|.
T Consensus 459 s~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 459 SRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 888888 6776 467888888888888888877653322 2234556888888885
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=399.04 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=189.5
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC---------
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET--------- 751 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------- 751 (963)
+|++.+.||+|+||+||+|... +|+.||||++..... ...+++.+|++++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5899999999999999999765 699999999975543 34567899999999999999999999986433
Q ss_pred ---eEEEEEeccCCCChHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeec
Q 046851 752 ---EMFLIYNYLPGGNLENFIQQRST-RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 752 ---~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 827 (963)
..|+||||+++|+|.+++..+.. ...++..+..|+.|+++||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 36999999999999999986542 2356777899999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-----------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcc
Q 046851 828 GLARLLGPSETH-----------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFN 896 (963)
Q Consensus 828 gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~ 896 (963)
|+|+........ ...+.+||+.|||||++.+..|+.++||||+||++|||++ ||.... .
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-------~ 232 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-------E 232 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-------H
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-------H
Confidence 999877543221 2234679999999999999999999999999999999997 664211 1
Q ss_pred hhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 897 IVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... ........... .........+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 RVRTL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 11112111111 12233456789999999999999999999873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=435.65 Aligned_cols=433 Identities=18% Similarity=0.198 Sum_probs=337.4
Q ss_pred CCCcEEEccCCcccccCCccccCcccccceec-cccccccCCCcccccc---------cceee----------ccccccc
Q 046851 26 KSLRVLNLGFNRITGEIPASFSDFVNLEELNL-AGNLVNGTVPTFIGRL---------KRVYL----------SFNRLVG 85 (963)
Q Consensus 26 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L-s~N~l~~~~~~~~~~L---------~~L~L----------~~n~l~~ 85 (963)
.+++.|+|++|.+.+.+|.+|+++++|++|+| ++|.+++..|-....+ +.+.. ....+.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57999999999999999999999999999999 9998887644221111 00000 0000000
Q ss_pred cC----------CccccccCCCCCeEeCCC--CccccCcCccccCcccccEEEcccCcccc-----------------cC
Q 046851 86 SV----------PSKIGEKCTNLEHLDLSG--NYLVGGIPRSLGNCFQVRSLLLFSNMLEE-----------------TI 136 (963)
Q Consensus 86 ~~----------p~~~~~~l~~L~~L~Ls~--N~i~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~ 136 (963)
.+ +.........++.+.++. |++++ +|..|+++++|+.|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 00 000001223455555554 99997 89999999999999999999998 37
Q ss_pred ccccc--CCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCc-ccc-CCc
Q 046851 137 PAELG--MLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNF-FEG-GIP 212 (963)
Q Consensus 137 ~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~-~~~-~~~ 212 (963)
|..++ ++++|++|+|++|.+.+.+|..|.++++|+.|+|++ |. +++ .+|
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~---------------------------N~~lsg~~iP 534 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC---------------------------NRGISAAQLK 534 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTT---------------------------CTTSCHHHHH
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcC---------------------------CCCcccccch
Confidence 88877 999999999999999999999999999999999998 54 555 566
Q ss_pred ccccCC-------CCCceEecCCcccccCCCc--cccccccCceeecCcccccCcCccccCCCCCCcEEeccCccccccc
Q 046851 213 EAVSSL-------PNLRILWAPRATLEGNFPS--NWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGEL 283 (963)
Q Consensus 213 ~~l~~l-------~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 283 (963)
..+..+ ++|+.|++++|+++ .+|. .|.++++|+.|+|++|+++.++ .|+.+++|+.|+|++|+++..+
T Consensus 535 ~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~lp--~~~~L~~L~~L~Ls~N~l~~lp 611 (876)
T 4ecn_A 535 ADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLE--AFGTNVKLTDLKLDYNQIEEIP 611 (876)
T ss_dssp HHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCBCC--CCCTTSEESEEECCSSCCSCCC
T ss_pred HHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcccch--hhcCCCcceEEECcCCccccch
Confidence 666555 49999999999999 7888 8999999999999999999776 8999999999999999999665
Q ss_pred CCCCCCCc-eeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhc
Q 046851 284 ARELPVPC-MTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHN 362 (963)
Q Consensus 284 ~~~~~~~~-L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (963)
.....+++ |+.|++++|++...+..+..+.
T Consensus 612 ~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~------------------------------------------------- 642 (876)
T 4ecn_A 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKS------------------------------------------------- 642 (876)
T ss_dssp TTSCEECTTCCEEECCSSCCCSCCSCCCTTC-------------------------------------------------
T ss_pred HHHhhccccCCEEECcCCCCCcCchhhhccc-------------------------------------------------
Confidence 56667888 9999999999884332222110
Q ss_pred cccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchh---Hhh-ccCC
Q 046851 363 FGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAE---IGR-MCKS 438 (963)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~---~~~-~~~~ 438 (963)
...+. .|++++|+++|.+|.. +.. .+.+
T Consensus 643 ---------------------~~~L~---------------------------~L~Ls~N~l~g~ip~l~~~l~~~~~~~ 674 (876)
T 4ecn_A 643 ---------------------VYVMG---------------------------SVDFSYNKIGSEGRNISCSMDDYKGIN 674 (876)
T ss_dssp ---------------------SSCEE---------------------------EEECCSSCTTTTSSSCSSCTTTCCCCC
T ss_pred ---------------------cCCCC---------------------------EEECcCCcCCCccccchhhhccccCCC
Confidence 01122 4555555555444321 111 1247
Q ss_pred ccEEECcCCcCCCCCcccc-ccCCCCCEEeccCCcCCCccchhhcc--------CcccceeccccccccccCCcccc--c
Q 046851 439 LKFLDASGNQIVGPIPRGV-GELVSLVALNLSWNLMHDQIPTTLGQ--------MKGLKYLSLAGNNLTGSIPSSLG--Q 507 (963)
Q Consensus 439 L~~L~ls~n~l~~~~p~~~-~~l~~L~~L~ls~N~i~~~~~~~~~~--------l~~L~~L~l~~N~l~~~~p~~~~--~ 507 (963)
|+.|+|++|+++ .+|..+ ..+++|+.|+|++|.|+ .+|..+.. +++|+.|+|++|+|+ .+|..+. .
T Consensus 675 L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~ 751 (876)
T 4ecn_A 675 ASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATT 751 (876)
T ss_dssp EEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTT
T ss_pred cCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhcc
Confidence 999999999999 677665 48999999999999997 55554433 349999999999999 8999987 9
Q ss_pred CCccceecccccccCCCCChhhhccccCCeEEecc------ccCCCcCCCCccccccCceEeeccccCccCCCCCCC-cc
Q 046851 508 LQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNN------NKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKN-LM 580 (963)
Q Consensus 508 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~------N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~-~~ 580 (963)
+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..+..+++|+.|++++|++ +.+|.... ..
T Consensus 752 l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L 829 (876)
T 4ecn_A 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQL 829 (876)
T ss_dssp CTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCSSS
T ss_pred CCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhcCCC
Confidence 9999999999999997 798999999999999976 888889999999999999999999999 77887533 23
Q ss_pred cccccCCCCCC
Q 046851 581 KCSSVLGNPYL 591 (963)
Q Consensus 581 ~~~~~~~np~~ 591 (963)
....+.+||+.
T Consensus 830 ~~LdLs~N~l~ 840 (876)
T 4ecn_A 830 YILDIADNPNI 840 (876)
T ss_dssp CEEECCSCTTC
T ss_pred CEEECCCCCCC
Confidence 33455678874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=431.20 Aligned_cols=517 Identities=19% Similarity=0.161 Sum_probs=345.4
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceee
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYL 78 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L 78 (963)
.++++|||++|+|+++.+.+|.++++|++|+|++|+|+++.+++|.++++|++|+|++|+|++..+..|. +|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 3688999999999988888899999999999999999988888899999999999999998866665554 6888899
Q ss_pred ccccccccCCccccccCCCCCeEeCCCCccccC-cCccccCcccccEEEcccCcccccCcccccCCCCC----CEEEccC
Q 046851 79 SFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG-IPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNL----EVLDVSR 153 (963)
Q Consensus 79 ~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~ 153 (963)
++|+++ .+|...|.++++|++|+|++|+|++. .|..++.+++|+.|+|++|++++..+..|..+.++ ..++++.
T Consensus 132 s~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 132 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp TTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred CCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence 999988 78887788889999999999988753 57788888999999999999988888877766554 4688888
Q ss_pred CccccCCCcCccCCCCCceEeecCcCCccccccc-ccCCccc---CCCcccCCCCCccccCCcccccCCCCCceEecCCc
Q 046851 154 NSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRY-SRGQSLV---DQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRA 229 (963)
Q Consensus 154 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~-~~~~~~~---~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n 229 (963)
|.+....+.. .....++.+++.+|......... +...... ............+.......+..+..+..+.+..+
T Consensus 211 n~l~~i~~~~-~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 211 NPMNFIQPGA-FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp CCCCEECTTT-TTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred CcccccCccc-ccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 8888544443 34455677777776544321110 0000000 00000011112333444556666666766665544
Q ss_pred cccc---CCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCC
Q 046851 230 TLEG---NFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSI 306 (963)
Q Consensus 230 ~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~ 306 (963)
.... .....+..+.+++.+++.+|.+..+.. +....+|+.|++++|.+...... .+..|+.+++++|.+...+
T Consensus 290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~~~~~~~~~~--~l~~L~~l~l~~n~~~~~~ 365 (635)
T 4g8a_A 290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTL--KLKSLKRLTFTSNKGGNAF 365 (635)
T ss_dssp CCCSCEEECTTTTGGGTTCSEEEEESCEEEECGG--GGSCCCCSEEEEESCEESSCCCC--BCTTCCEEEEESCCSCCBC
T ss_pred hhcccccchhhhhhhhcccccccccccccccccc--cccchhhhhhhcccccccCcCcc--cchhhhhcccccccCCCCc
Confidence 3322 345567777889999999988877653 45567899999999988765443 4567888999999877544
Q ss_pred CCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcce
Q 046851 307 PTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQT 386 (963)
Q Consensus 307 ~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 386 (963)
....+.+|+.+++++|.+......... ......
T Consensus 366 -~~~~l~~L~~L~ls~n~l~~~~~~~~~----------------------------------------------~~~~~~ 398 (635)
T 4g8a_A 366 -SEVDLPSLEFLDLSRNGLSFKGCCSQS----------------------------------------------DFGTIS 398 (635)
T ss_dssp -CCCBCTTCCEEECCSSCCBEEEECCHH----------------------------------------------HHSCSC
T ss_pred -ccccccccccchhhccccccccccccc----------------------------------------------hhhhhh
Confidence 455678899999998876542211100 000112
Q ss_pred EEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEE
Q 046851 387 VYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVAL 466 (963)
Q Consensus 387 ~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L 466 (963)
+..++...+...+..+ . |..+..++ .++++.+......+...+..+++++.++++.|.+.+..+..+..++.|+.|
T Consensus 399 L~~L~~~~~~~~~~~~-~-~~~l~~L~--~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L 474 (635)
T 4g8a_A 399 LKYLDLSFNGVITMSS-N-FLGLEQLE--HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 474 (635)
T ss_dssp CCEEECCSCSEEEECS-C-CTTCTTCC--EEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred hhhhhccccccccccc-c-cccccccc--chhhhhccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 2334444444433221 1 23444444 566666666655555544445666777777777766666666666677777
Q ss_pred eccCCcCC-CccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccC
Q 046851 467 NLSWNLMH-DQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545 (963)
Q Consensus 467 ~ls~N~i~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 545 (963)
++++|.+. +..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|
T Consensus 475 ~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l 554 (635)
T 4g8a_A 475 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 554 (635)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCC
T ss_pred hhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcC
Confidence 77766532 34566666667777777777777666666666777777777777777666666666667777777777777
Q ss_pred CCcCCCCcccc-ccCceEeeccccCccCCCCCCCcccccccCCCCCCCCCCC
Q 046851 546 SGKIPSGLANV-STLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCRA 596 (963)
Q Consensus 546 ~~~~p~~l~~l-~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~np~~~~c~~ 596 (963)
++..|..+..+ ++|++|+++ +|||.|+|..
T Consensus 555 ~~~~~~~l~~l~~~L~~L~L~---------------------~Np~~C~C~~ 585 (635)
T 4g8a_A 555 MTSKKQELQHFPSSLAFLNLT---------------------QNDFACTCEH 585 (635)
T ss_dssp CBCCSSCTTCCCTTCCEEECT---------------------TCCBCCSGGG
T ss_pred CCCCHHHHHhhhCcCCEEEee---------------------CCCCcccCCc
Confidence 66666666666 456666665 5688899964
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=428.34 Aligned_cols=462 Identities=18% Similarity=0.115 Sum_probs=372.1
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCccc---ccccceee
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFI---GRLKRVYL 78 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~L~~L~L 78 (963)
.+|++|+|++|.++++.|.+|.++++|++|+|++|++++..|++|.++++|++|+|++|.+++..|..+ .+|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 479999999999999999999999999999999999999999999999999999999999997777655 47999999
Q ss_pred ccccccc-cCCccccccCCCCCeEeCCCCcc-ccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCcc
Q 046851 79 SFNRLVG-SVPSKIGEKCTNLEHLDLSGNYL-VGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSL 156 (963)
Q Consensus 79 ~~n~l~~-~~p~~~~~~l~~L~~L~Ls~N~i-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 156 (963)
++|.+++ .+| ..+.++++|++|++++|++ ....+..|.++++|+.|++++|++++..|..+..+++|+.|+++.|.+
T Consensus 106 s~n~l~~~~~~-~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 106 MGNPYQTLGVT-SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp TTCCCSSSCSS-CSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred CCCcccccchh-hhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcc
Confidence 9999984 233 3566899999999999994 444457899999999999999999999999999999999999999999
Q ss_pred ccCCCcC-ccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCC
Q 046851 157 SGSIPVD-LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF 235 (963)
Q Consensus 157 ~~~~p~~-~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 235 (963)
. .+|.. +..+++|+.|++++|.++..+. ........+++|+.|++++|.+.+..
T Consensus 185 ~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~------------------------~~~~~~~~~~~L~~L~l~~n~l~~~~ 239 (549)
T 2z81_A 185 A-FLLEIFADILSSVRYLELRDTNLARFQF------------------------SPLPVDEVSSPMKKLAFRGSVLTDES 239 (549)
T ss_dssp T-THHHHHHHSTTTBSEEEEESCBCTTCCC------------------------CCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred c-ccchhhHhhcccccEEEccCCccccccc------------------------cccchhhhhhcccceeccccccchhH
Confidence 8 44444 4679999999999965542110 01123345789999999999988654
Q ss_pred C----ccccccccCceeecCcccccCcCc------cccCCCCCCcEEeccCcccccccCCC------CCCCceeEEEecc
Q 046851 236 P----SNWGACDNLEMLNLGHNFFSGKNL------GVLGPCKNLLFLDLSSNQLTGELARE------LPVPCMTMFDVSG 299 (963)
Q Consensus 236 ~----~~~~~l~~L~~L~Ls~N~l~~~~~------~~~~~l~~L~~L~L~~N~l~~~~~~~------~~~~~L~~L~l~~ 299 (963)
+ ..+..+++|+.|++++|.+.++.. ..+..+++|+.|+++++.+....... ...++|+.|++++
T Consensus 240 ~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~ 319 (549)
T 2z81_A 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319 (549)
T ss_dssp HHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEES
T ss_pred HHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEecc
Confidence 3 344677899999999999877532 34577889999999999886532111 0246799999999
Q ss_pred CcCccCCCCC-CCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCC
Q 046851 300 NALSGSIPTF-SNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVA 378 (963)
Q Consensus 300 N~l~~~~~~~-~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (963)
|++...+..+ ..+.+|+.|++++|.+.
T Consensus 320 n~l~~ip~~~~~~l~~L~~L~Ls~N~l~---------------------------------------------------- 347 (549)
T 2z81_A 320 SKVFLVPCSFSQHLKSLEFLDLSENLMV---------------------------------------------------- 347 (549)
T ss_dssp SCCCCCCHHHHHHCTTCCEEECCSSCCC----------------------------------------------------
T ss_pred CccccCCHHHHhcCccccEEEccCCccc----------------------------------------------------
Confidence 9987555443 35666666666666554
Q ss_pred cccCCcceEEEEEcCCCcccCCCCc--ccccccCCcceEEEEccCCeeeecCch--hHhhccCCccEEECcCCcCCCCCc
Q 046851 379 PERLGKQTVYAIVAGDNKLSGSFPG--NMFGICNRLDSLMVNVSNNRIAGQLPA--EIGRMCKSLKFLDASGNQIVGPIP 454 (963)
Q Consensus 379 ~~~l~~~~~~~l~~~~n~~~~~~p~--~~~~~~~~l~~~~L~l~~n~l~~~~p~--~~~~~~~~L~~L~ls~n~l~~~~p 454 (963)
+.+|. ..++.++.|+ .|++++|+++ .+|. .....+++|++|++++|+++ .+|
T Consensus 348 --------------------~~~~~~~~~~~~l~~L~--~L~Ls~N~l~-~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp 403 (549)
T 2z81_A 348 --------------------EEYLKNSACKGAWPSLQ--TLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMP 403 (549)
T ss_dssp --------------------HHHHHHHTCTTSSTTCC--EEECTTSCCC-CHHHHHHHGGGCTTCCEEECTTCCCC-CCC
T ss_pred --------------------cccccchhhhhccccCc--EEEccCCccc-ccccchhhhhcCCCCCEEECCCCCCc-cCC
Confidence 32221 1234555666 8999999998 4442 33444589999999999999 789
Q ss_pred cccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhcccc
Q 046851 455 RGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRN 534 (963)
Q Consensus 455 ~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 534 (963)
..+..+++|++|++++|.+++ +|..+ .++|++|+|++|++++. + ..+++|++|+|++|+|+ .+|. ...+++
T Consensus 404 ~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~-~---~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~ 474 (549)
T 2z81_A 404 DSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSF-S---LFLPRLQELYISRNKLK-TLPD-ASLFPV 474 (549)
T ss_dssp SCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCC-C---CCCTTCCEEECCSSCCS-SCCC-GGGCTT
T ss_pred hhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhh-c---ccCChhcEEECCCCccC-cCCC-cccCcc
Confidence 999999999999999999964 45443 36899999999999953 3 57899999999999999 5675 568999
Q ss_pred CCeEEeccccCCCcCCCCccccccCceEeeccccCccCCC
Q 046851 535 LTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLP 574 (963)
Q Consensus 535 L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p 574 (963)
|+.|+|++|++++..|..+..+++|+.|++++|++.+..|
T Consensus 475 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9999999999998888889999999999999999998666
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=438.79 Aligned_cols=452 Identities=17% Similarity=0.208 Sum_probs=284.9
Q ss_pred CCCcEEEccCCcccccCCccccCcccccceeccccccc------c------CCCcc-cccccceeeccccccccCCcccc
Q 046851 26 KSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVN------G------TVPTF-IGRLKRVYLSFNRLVGSVPSKIG 92 (963)
Q Consensus 26 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~------~------~~~~~-~~~L~~L~L~~n~l~~~~p~~~~ 92 (963)
.+++.|+|++|.+++.+|.+|+++++|++|+|++|.+. + .+|.. +..|+ +++++|.+.+.+|..+.
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~-l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR-MHYQKTFVDYDPREDFS 159 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHH-THHHHHHTCCCGGGGSC
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHH-hhHHHhhhccCchhhHH
Confidence 57999999999999999999999999999999999762 2 22222 23466 88888988877777766
Q ss_pred ccCCCCCeEeCCCCccccCcCccccCcccccEEEcc--cCcccccCcccccCCCCCCEEEccCCccccC-----------
Q 046851 93 EKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLF--SNMLEETIPAELGMLQNLEVLDVSRNSLSGS----------- 159 (963)
Q Consensus 93 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----------- 159 (963)
..+..+..+++....+.. .....++.+.+. .|++++ +|.+|+++++|++|+|++|.+++.
T Consensus 160 ~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~ 232 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS 232 (636)
T ss_dssp HHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTS
T ss_pred HHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccccc
Confidence 444444444544322220 011111222221 244444 444444444444444444444432
Q ss_pred ------CCcCcc--CCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcc-
Q 046851 160 ------IPVDLG--NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT- 230 (963)
Q Consensus 160 ------~p~~~~--~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~- 230 (963)
+|..++ ++++|++|++++ |.+.+.+|..+.++++|+.|++++|+
T Consensus 233 ~~~~~~ip~~l~~~~l~~L~~L~L~~---------------------------n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 233 EYAQQYKTEDLKWDNLKDLTDVEVYN---------------------------CPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp HHHHHHTTSCCCGGGCTTCCEEEEEC---------------------------CTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred chhcccCchhhhhcccCCCCEEEecC---------------------------CcCCccChHHHhcCCCCCEEECcCCCC
Confidence 444444 455555555444 33444444445555555555555554
Q ss_pred ccc-CCCcccccc------ccCceeecCcccccCcCc-cccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcC
Q 046851 231 LEG-NFPSNWGAC------DNLEMLNLGHNFFSGKNL-GVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNAL 302 (963)
Q Consensus 231 l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l 302 (963)
+++ .+|..++.+ ++|++|+|++|+++.++. ..|+.+++|++|++++|++++..+....+++|+.|++++|++
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~l 365 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI 365 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSEE
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCcc
Confidence 444 444444443 555555555555553332 144555555555555555553333222344555555555555
Q ss_pred ccCCCCCCCCCC-CCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCccc
Q 046851 303 SGSIPTFSNMVC-PPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPER 381 (963)
Q Consensus 303 ~~~~~~~~~l~~-l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (963)
...+..+..+.+ |+.|++++|.+..++.
T Consensus 366 ~~lp~~l~~l~~~L~~L~Ls~N~l~~lp~--------------------------------------------------- 394 (636)
T 4eco_A 366 TEIPANFCGFTEQVENLSFAHNKLKYIPN--------------------------------------------------- 394 (636)
T ss_dssp EECCTTSEEECTTCCEEECCSSCCSSCCS---------------------------------------------------
T ss_pred ccccHhhhhhcccCcEEEccCCcCcccch---------------------------------------------------
Confidence 544444555544 5555555444432211
Q ss_pred CCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHh-------hccCCccEEECcCCcCCCCCc
Q 046851 382 LGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIG-------RMCKSLKFLDASGNQIVGPIP 454 (963)
Q Consensus 382 l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~-------~~~~~L~~L~ls~n~l~~~~p 454 (963)
. |+......+..|++++|.+++.+|..+. .. ++|++|+|++|+++ .+|
T Consensus 395 ----------------------~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~-~~L~~L~Ls~N~l~-~lp 449 (636)
T 4eco_A 395 ----------------------I-FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG-INVSSINLSNNQIS-KFP 449 (636)
T ss_dssp ----------------------C-CCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCC-CCEEEEECCSSCCC-SCC
T ss_pred ----------------------h-hhhcccCccCEEECcCCcCCCcchhhhcccccccccC-CCCCEEECcCCccC-cCC
Confidence 0 0111111122566666666655555554 33 68999999999999 566
Q ss_pred cc-cccCCCCCEEeccCCcCCCccch-hhccC-------cccceeccccccccccCCcccc--cCCccceecccccccCC
Q 046851 455 RG-VGELVSLVALNLSWNLMHDQIPT-TLGQM-------KGLKYLSLAGNNLTGSIPSSLG--QLQLLEVLDLSSNSLSG 523 (963)
Q Consensus 455 ~~-~~~l~~L~~L~ls~N~i~~~~~~-~~~~l-------~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~ls~N~l~~ 523 (963)
.. +..+++|+.|+|++|.++ .+|. .+..+ ++|++|+|++|+++ .+|..+. .+++|+.|+|++|+|++
T Consensus 450 ~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ 527 (636)
T 4eco_A 450 KELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK 527 (636)
T ss_dssp THHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred HHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC
Confidence 55 556999999999999997 4554 34333 39999999999999 8998887 99999999999999997
Q ss_pred CCChhhhccccCCeEEe------ccccCCCcCCCCccccccCceEeeccccCccCCCCCCC-cccccccCCCCCCC
Q 046851 524 LIPDDLENLRNLTVLLL------NNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKN-LMKCSSVLGNPYLR 592 (963)
Q Consensus 524 ~~p~~~~~l~~L~~L~l------~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~-~~~~~~~~~np~~~ 592 (963)
+|..+..+++|+.|+| ++|++.+.+|..+..+++|++|++++|++ +.+|.... ......+.+||+.|
T Consensus 528 -ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 528 -FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNIS 601 (636)
T ss_dssp -CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCE
T ss_pred -cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcc
Confidence 7999999999999999 56888889999999999999999999999 67777533 33334566888865
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=426.15 Aligned_cols=446 Identities=20% Similarity=0.195 Sum_probs=297.1
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeeccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSFN 81 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~n 81 (963)
++||+++|+++. +|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..++ +|++|+|++|
T Consensus 3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 689999999995 566555 8999999999999988888999999999999999999977676654 6888888888
Q ss_pred cccccCCccccccCCCCCeEeCCCCcccc-CcCccccCcccccEEEcccCcccccCcccccCCCCC--CEEEccCCcc--
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVG-GIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNL--EVLDVSRNSL-- 156 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~l-- 156 (963)
+++ .+|.. .+++|++|+|++|+|++ ..|..|+++++|++|++++|++++ ..+..+++| ++|+|++|.+
T Consensus 80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~ 152 (520)
T 2z7x_B 80 KLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG 152 (520)
T ss_dssp CCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred cee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence 888 77776 57888888888888876 357888888888888888888875 456677777 8888888888
Q ss_pred ccCCCcCccCCCC-CceEeecCcCCcccccccccCCcccCCCcccCCCCCccccC-CcccccCCCCCceEecCCcc----
Q 046851 157 SGSIPVDLGNCSK-LAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGG-IPEAVSSLPNLRILWAPRAT---- 230 (963)
Q Consensus 157 ~~~~p~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~-~~~~l~~l~~L~~L~l~~n~---- 230 (963)
.+..|..+..+.. ...+++++ |.+.+. .+..+..+++|+.|++++|.
T Consensus 153 ~~~~~~~l~~l~~~~l~l~l~~---------------------------n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 205 (520)
T 2z7x_B 153 EKEDPEGLQDFNTESLHIVFPT---------------------------NKEFHFILDVSVKTVANLELSNIKCVLEDNK 205 (520)
T ss_dssp SSCCTTTTTTCCEEEEEEECCS---------------------------SSCCCCCCCCCCTTCSEEEECCEEECCSTTT
T ss_pred cccccccccccccceEEEEecc---------------------------Ccchhhhhhhhhhcccceeeccccccccccc
Confidence 6677777766653 22233333 333332 33456677778888877776
Q ss_pred ---cccCCCccccccccCceeecCcccccCcCccccC---CCCCCcEEeccCcccccccCCC------CCCCceeEEEec
Q 046851 231 ---LEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLG---PCKNLLFLDLSSNQLTGELARE------LPVPCMTMFDVS 298 (963)
Q Consensus 231 ---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~------~~~~~L~~L~l~ 298 (963)
+.+.++ .+..+++|+.|++++|.+++.....+. .+++|++|++++|++++..+.. ..++.|+.++++
T Consensus 206 ~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~ 284 (520)
T 2z7x_B 206 CSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284 (520)
T ss_dssp THHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEE
T ss_pred cceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEecccc
Confidence 555444 677777777777777776543211110 1347777777777777444333 346677777777
Q ss_pred cCcCccCCC-CCCCC---CCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCC
Q 046851 299 GNALSGSIP-TFSNM---VCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPS 374 (963)
Q Consensus 299 ~N~l~~~~~-~~~~l---~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (963)
+|.+ ..+. .+..+ .+++.|++++|.+.
T Consensus 285 ~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~------------------------------------------------ 315 (520)
T 2z7x_B 285 SDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMV------------------------------------------------ 315 (520)
T ss_dssp ECCC-CSCTHHHHHHHHTCCCSEEEEESSCCC------------------------------------------------
T ss_pred ccce-ecchhhhhcccccCceeEEEcCCCccc------------------------------------------------
Confidence 7766 2221 11111 12333333333221
Q ss_pred CCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCC--C
Q 046851 375 MPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVG--P 452 (963)
Q Consensus 375 ~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~--~ 452 (963)
+.. ++..++.|+ +|++++|++++.+|..+..+ ++|++|++++|++++ .
T Consensus 316 ------------------------~~~---~~~~l~~L~--~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~l~~ 365 (520)
T 2z7x_B 316 ------------------------HML---CPSKISPFL--HLDFSNNLLTDTVFENCGHL-TELETLILQMNQLKELSK 365 (520)
T ss_dssp ------------------------CCC---CCSSCCCCC--EEECCSSCCCTTTTTTCCCC-SSCCEEECCSSCCCBHHH
T ss_pred ------------------------ccc---chhhCCccc--EEEeECCccChhhhhhhccC-CCCCEEEccCCccCcccc
Confidence 110 012333444 66667777765566665544 667777777777764 3
Q ss_pred CccccccCCCCCEEeccCCcCCCccch-hhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhc
Q 046851 453 IPRGVGELVSLVALNLSWNLMHDQIPT-TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLEN 531 (963)
Q Consensus 453 ~p~~~~~l~~L~~L~ls~N~i~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 531 (963)
+|..+..+++|+.|++++|.+++.+|. .+..+++|++|++++|++++.+|..+. ++|+.|++++|+|+ .+|..+..
T Consensus 366 ~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~ 442 (520)
T 2z7x_B 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVK 442 (520)
T ss_dssp HHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGG
T ss_pred chHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhc
Confidence 445667777777777777777653444 366667777777777777666655543 56777777777776 55666667
Q ss_pred cccCCeEEeccccCCCcCCCC-ccccccCceEeeccccCcc
Q 046851 532 LRNLTVLLLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 532 l~~L~~L~l~~N~l~~~~p~~-l~~l~~L~~l~l~~N~l~~ 571 (963)
+++|++|+|++|+|+ .+|.. +..+++|++|++++|++++
T Consensus 443 l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 443 LEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 482 (520)
T ss_dssp CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcc
Confidence 777777777777777 45554 6667777777776665543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=395.47 Aligned_cols=292 Identities=38% Similarity=0.680 Sum_probs=255.4
Q ss_pred CCCChHHHHHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeee
Q 046851 670 VPLSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHA 748 (963)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~ 748 (963)
..+++.++..+.++|++.+.||+|+||.||+|...+|+.||||++...... ....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 347889999999999999999999999999999888999999998755332 2346899999999999999999999999
Q ss_pred CCCeEEEEEeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEee
Q 046851 749 SETEMFLIYNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD 826 (963)
Q Consensus 749 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 826 (963)
..+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++.++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998754 33589999999999999999999999778999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 827 FGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 827 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
||++...............||+.|+|||++.+..++.++||||+|+++|||++|+.||+.............+|......
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998876555555556679999999999998889999999999999999999999997544444455667777777777
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
........+.......+...+..+.+++.+||+.||++|||++||+++|++...+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 7777778888887788888999999999999999999999999999999875543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=394.60 Aligned_cols=262 Identities=22% Similarity=0.341 Sum_probs=201.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC------CCe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS------ETE 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 752 (963)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+++.+|++++++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999764 79999999996543 2345678899999999999999999998753 467
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.|+||||++ |+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999996 6899999763 4699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC---CcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 833 LGPSE---THATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 833 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
+.... .......+||+.|||||++.+. .++.++||||+||++|||++|++||...... .....+.......
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-----~~l~~I~~~~g~p 282 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-----HQLQLIMMVLGTP 282 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHHHHCCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhcCCC
Confidence 64322 2234457899999999998875 5689999999999999999999999743211 1111111111000
Q ss_pred cccc-----------eeccc-cCCCCC-----hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 RAKE-----------FFTAG-LWDAGP-----HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 ~~~~-----------~~~~~-~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... .+... .....+ .....++.+|+.+||..||++|||++|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000 000001 1234578899999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=393.23 Aligned_cols=200 Identities=27% Similarity=0.417 Sum_probs=172.3
Q ss_pred HHHcCCCCCccccccCCCccEEEEEEC----CCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCe
Q 046851 678 VQATGNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETE 752 (963)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (963)
....+.|++.+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+++++.+ +||||+++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999653 47889999886543 345678999999988 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC-CcEEEeeccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD-FNAYLSDFGLAR 831 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~ 831 (963)
.++||||+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999999985 389999999999999999999999 99999999999999876 799999999998
Q ss_pred ccCCCCC---------------------------cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCC
Q 046851 832 LLGPSET---------------------------HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKA 883 (963)
Q Consensus 832 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p 883 (963)
....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543221 112345799999999999876 589999999999999999999999
Q ss_pred CCCC
Q 046851 884 LDPS 887 (963)
Q Consensus 884 ~~~~ 887 (963)
|...
T Consensus 247 f~~~ 250 (361)
T 4f9c_A 247 FYKA 250 (361)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 9644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=388.56 Aligned_cols=283 Identities=36% Similarity=0.620 Sum_probs=245.0
Q ss_pred CChHHHHHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC
Q 046851 672 LSFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET 751 (963)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (963)
+.+.++..++++|++.+.||+|+||.||+|.+.+|+.||||++........+.+.+|++++++++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44555666788999999999999999999998889999999988776667788999999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 829 (963)
..++||||+++|+|.+++.... ...+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997543 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC-CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 830 ARLLGPSE-THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 830 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....+. .......|.......+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNG 263 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhccccc
Confidence 98754322 22233456899999999999999999999999999999999999999865443 2345566666666666
Q ss_pred cccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 909 RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.....+++......+...+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 677777777777778889999999999999999999999999999998753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=407.34 Aligned_cols=457 Identities=19% Similarity=0.150 Sum_probs=348.5
Q ss_pred cceeccccccccCCCc-ccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCc
Q 046851 53 EELNLAGNLVNGTVPT-FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNM 131 (963)
Q Consensus 53 ~~L~Ls~N~l~~~~~~-~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~ 131 (963)
++|++++|.++ .+|. ...+|++|+|++|+++ .++...|.++++|++|+|++|+|++..|+.|+++++|++|+|++|+
T Consensus 3 ~~l~ls~n~l~-~ip~~~~~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLSQKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp CEEECTTSCCS-SCCCSCCTTCSEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred ceEecCCCCcc-cccccccccccEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 46889999998 4554 4457899999999988 6666666788999999999999987778889999999999999999
Q ss_pred ccccCcccccCCCCCCEEEccCCcccc-CCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccC
Q 046851 132 LEETIPAELGMLQNLEVLDVSRNSLSG-SIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGG 210 (963)
Q Consensus 132 l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~ 210 (963)
+++ +|.. .+++|++|+|++|.+++ .+|..|+++++|+.|++++|.++ +
T Consensus 81 l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~---------------------------~- 129 (520)
T 2z7x_B 81 LVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE---------------------------K- 129 (520)
T ss_dssp CCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCC---------------------------G-
T ss_pred eee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccc---------------------------h-
Confidence 885 4444 78899999999999886 36788889999999999885443 2
Q ss_pred CcccccCCCCC--ceEecCCccc--ccCCCccccccc-cCceeecCcccccC-cCccccCCCCCCcEEeccCcc------
Q 046851 211 IPEAVSSLPNL--RILWAPRATL--EGNFPSNWGACD-NLEMLNLGHNFFSG-KNLGVLGPCKNLLFLDLSSNQ------ 278 (963)
Q Consensus 211 ~~~~l~~l~~L--~~L~l~~n~l--~~~~~~~~~~l~-~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~------ 278 (963)
..+..+++| +.|++++|.+ .+..|..+..+. +...+++++|++.+ ++...+..+++|+.|++++|.
T Consensus 130 --~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 207 (520)
T 2z7x_B 130 --SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207 (520)
T ss_dssp --GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTH
T ss_pred --hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccc
Confidence 345566666 8889988888 777777777765 34467788887654 455677788888888888887
Q ss_pred -cccccCCCCCCCceeEEEeccCcCccCCCC----CCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCcccc
Q 046851 279 -LTGELARELPVPCMTMFDVSGNALSGSIPT----FSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGR 353 (963)
Q Consensus 279 -l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~----~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (963)
+.+..+....+++|+.|++++|.+.+.... .....+|+.+++++|.+..
T Consensus 208 ~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~-------------------------- 261 (520)
T 2z7x_B 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQG-------------------------- 261 (520)
T ss_dssp HHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEES--------------------------
T ss_pred eeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccC--------------------------
Confidence 666666555778888888888877652111 0112367777777776652
Q ss_pred ccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCc-ccccccCCcceEEEEccCCeeeecCchhH
Q 046851 354 DGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPG-NMFGICNRLDSLMVNVSNNRIAGQLPAEI 432 (963)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~-~~~~~~~~l~~~~L~l~~n~l~~~~p~~~ 432 (963)
.+|...+....-....+..+.+..|.+ .+|. +++..+....+..|++++|.+.+ ++.
T Consensus 262 -----------------~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~-~~~-- 319 (520)
T 2z7x_B 262 -----------------QLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVH-MLC-- 319 (520)
T ss_dssp -----------------CCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCC-CCC--
T ss_pred -----------------ccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccc-ccc--
Confidence 222211111112345688888999998 7774 44333333334489999999873 331
Q ss_pred hhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCC--ccchhhccCcccceeccccccccccCCc-ccccCC
Q 046851 433 GRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHD--QIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQ 509 (963)
Q Consensus 433 ~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~ 509 (963)
...+++|++|++++|++++.+|..+..+++|++|++++|.+++ .+|..++.+++|++|++++|++++.+|. .+..++
T Consensus 320 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~ 399 (520)
T 2z7x_B 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399 (520)
T ss_dssp CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCT
T ss_pred hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCc
Confidence 1345889999999999998899999999999999999999986 5678899999999999999999975665 488899
Q ss_pred ccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCCCC-CC---ccccccc
Q 046851 510 LLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS-KN---LMKCSSV 585 (963)
Q Consensus 510 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~-~~---~~~~~~~ 585 (963)
+|+.|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|++|++++|++++ +|.. .. ......+
T Consensus 400 ~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l 475 (520)
T 2z7x_B 400 SLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWL 475 (520)
T ss_dssp TCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEEC
T ss_pred cCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEEC
Confidence 999999999999877776654 79999999999999 899988899999999999999995 5553 22 2333456
Q ss_pred CCCCCCCCCCC
Q 046851 586 LGNPYLRPCRA 596 (963)
Q Consensus 586 ~~np~~~~c~~ 596 (963)
.+|||.|+|..
T Consensus 476 ~~N~~~c~c~~ 486 (520)
T 2z7x_B 476 HTNPWDCSCPR 486 (520)
T ss_dssp CSSCBCCCHHH
T ss_pred cCCCCcccCCc
Confidence 79999999953
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=400.92 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=202.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHH---HHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQF---HAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|++.++||+|+||+||+|+.. +|+.||||++..... .....+ +.++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 36999999999999999999765 699999999975421 222223 44567778889999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999875 4599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.. .....+||+.|||||++.+ ..|+.++|+||+||++|||++|++||...... .............
T Consensus 344 ~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~~----- 410 (689)
T 3v5w_A 344 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTMA----- 410 (689)
T ss_dssp SC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHCC-----
T ss_pred CC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCCC-----
Confidence 33 2345689999999999974 57999999999999999999999999743221 1112111111111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
...+...+.++.+|+.+||+.||++|++ ++||.+|
T Consensus 411 ------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1223445668899999999999999998 6777653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=403.04 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=211.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+++++.++|||||++++++.+.+..++||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999765 69999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC--CcEEEeecccccccCCCCC
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD--FNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgla~~~~~~~~ 838 (963)
+||+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 237 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred CCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999997543 4589999999999999999999999 99999999999999854 899999999999875443
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+......... .. +...
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~~~-~~--~~~~- 378 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCD-WN--MDDS- 378 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTC-CC--CCSG-
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHhCC-CC--CCcc-
Confidence 23345899999999999999999999999999999999999999974321 22222222111 10 1111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+.++.+|+.+||+.||++|||+.|++++
T Consensus 379 ---~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 ---AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112345678899999999999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=404.14 Aligned_cols=450 Identities=20% Similarity=0.211 Sum_probs=217.8
Q ss_pred ceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeecc
Q 046851 4 LEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSF 80 (963)
Q Consensus 4 l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~ 80 (963)
.+++|+++|++++ +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+. +|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 3567777777775 444433 6777777777777766667777777777777777777744444332 345555555
Q ss_pred ccccccCCccccccCCCCCeEeCCCCccccC-cCccccCcccccEEEcccCcccccCcccccCCCCC--CEEEccCCcc-
Q 046851 81 NRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG-IPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNL--EVLDVSRNSL- 156 (963)
Q Consensus 81 n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~l- 156 (963)
|+++ .+|.. .+++|++|+|++|+|++. .|..|+++++|+.|++++|++++. .+..+++| ++|+|++|.+
T Consensus 110 N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~ 182 (562)
T 3a79_B 110 NRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH 182 (562)
T ss_dssp SCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred CcCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence 5554 44444 345555555555555432 234455555555555555554432 22223333 5555555554
Q ss_pred -ccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCC
Q 046851 157 -SGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF 235 (963)
Q Consensus 157 -~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 235 (963)
++..|..+..+.. + .| .++++.|.+.+..
T Consensus 183 ~~~~~~~~l~~l~~-~------------------------------------------------~l-~l~l~~n~~~~~~ 212 (562)
T 3a79_B 183 IKGGETESLQIPNT-T------------------------------------------------VL-HLVFHPNSLFSVQ 212 (562)
T ss_dssp CCSSSCCEEEECCE-E------------------------------------------------EE-EEEECSSSCCCCC
T ss_pred ccccCcccccccCc-c------------------------------------------------eE-EEEecCccchhhh
Confidence 4444444433321 1 11 2244444444322
Q ss_pred C-ccccccccCceeecCccc-----ccCcCccccCCCCCCcEEeccCcccccccC----CCCCCCceeEEEeccCcCccC
Q 046851 236 P-SNWGACDNLEMLNLGHNF-----FSGKNLGVLGPCKNLLFLDLSSNQLTGELA----RELPVPCMTMFDVSGNALSGS 305 (963)
Q Consensus 236 ~-~~~~~l~~L~~L~Ls~N~-----l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~~~L~~L~l~~N~l~~~ 305 (963)
+ ..+..+++|+.|++++|+ +... ...|..+++|+.|+++++.+.+... .....++|+.|++++|.+.|.
T Consensus 213 ~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 291 (562)
T 3a79_B 213 VNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITER 291 (562)
T ss_dssp CEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSC
T ss_pred hhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeecc
Confidence 2 223445555555555553 1111 1234445555555555555443211 111233566666666666644
Q ss_pred CCC-C-----CCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCc
Q 046851 306 IPT-F-----SNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAP 379 (963)
Q Consensus 306 ~~~-~-----~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (963)
.|. + ..+..|+.++++.+.+
T Consensus 292 ip~~~~~~~~~~L~~L~~~~~~~~~~------------------------------------------------------ 317 (562)
T 3a79_B 292 IDREEFTYSETALKSLMIEHVKNQVF------------------------------------------------------ 317 (562)
T ss_dssp CCCCCCCCCSCSCCEEEEEEEEECCC------------------------------------------------------
T ss_pred ccchhhhcccccchheehhhccccee------------------------------------------------------
Confidence 332 2 2222222222222222
Q ss_pred ccCCcceEEEEEcCCCcccCCCC-cccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccc
Q 046851 380 ERLGKQTVYAIVAGDNKLSGSFP-GNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVG 458 (963)
Q Consensus 380 ~~l~~~~~~~l~~~~n~~~~~~p-~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~ 458 (963)
.+| .+++..+....+..|++++|.+.. ++ +...+++|++|++++|++++.+|..+.
T Consensus 318 --------------------~~p~~~~~~~~~~~~L~~L~l~~n~~~~-~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~ 374 (562)
T 3a79_B 318 --------------------LFSKEALYSVFAEMNIKMLSISDTPFIH-MV--CPPSPSSFTFLNFTQNVFTDSVFQGCS 374 (562)
T ss_dssp --------------------SSCHHHHHHHHHTCCCSEEEEESSCCCC-CC--CCSSCCCCCEEECCSSCCCTTTTTTCC
T ss_pred --------------------ecChhhhhhhhccCcceEEEccCCCccc-cc--CccCCCCceEEECCCCccccchhhhhc
Confidence 122 111111111112245555555431 11 001234555666666655555555555
Q ss_pred cCCCCCEEeccCCcCCC--ccchhhccCcccceeccccccccccCCc-ccccCCccceecccccccCCCCChhhhccccC
Q 046851 459 ELVSLVALNLSWNLMHD--QIPTTLGQMKGLKYLSLAGNNLTGSIPS-SLGQLQLLEVLDLSSNSLSGLIPDDLENLRNL 535 (963)
Q Consensus 459 ~l~~L~~L~ls~N~i~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 535 (963)
.+++|+.|++++|.+++ ..|..+..+++|++|++++|++++.+|. .+..+++|+.|++++|++++.+|..+. ++|
T Consensus 375 ~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L 452 (562)
T 3a79_B 375 TLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKV 452 (562)
T ss_dssp SCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTC
T ss_pred ccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcC
Confidence 55566666666665543 2234455555566666666665542333 345555566666666655544333322 455
Q ss_pred CeEEeccccCCCcCCCCccccccCceEeeccccCccCCCCC-CCc---ccccccCCCCCCCCCC
Q 046851 536 TVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS-KNL---MKCSSVLGNPYLRPCR 595 (963)
Q Consensus 536 ~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~-~~~---~~~~~~~~np~~~~c~ 595 (963)
+.|+|++|+|+ .+|..+..+++|++|++++|++++ +|.. ... ..-..+.+|||.|+|.
T Consensus 453 ~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 55666666555 555555555556666666665553 3332 111 1112334566666663
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=370.11 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=215.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|.+.+.||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 47899999999999999999775 68999999987766667788999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+++... ...+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999874 34589999999999999999999999 99999999999999999999999999998765332211
Q ss_pred -------------cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCC-cchhhHHHHHHh
Q 046851 841 -------------TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG-FNIVAWGCMLLR 906 (963)
Q Consensus 841 -------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 906 (963)
.....||+.|+|||++.+..++.++||||||+++|||++|..|+.......... ...... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----~~ 241 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----LD 241 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----HH
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----cc
Confidence 124579999999999999999999999999999999999999987544331111 111111 00
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
. ..+..++..+.+++.+||+.||++|||+.++++.|+++++
T Consensus 242 ~-------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 242 R-------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp H-------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 1123344578899999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.07 Aligned_cols=283 Identities=31% Similarity=0.539 Sum_probs=230.6
Q ss_pred CCCCChHHHHHHcCCCCCc------cccccCCCccEEEEEECCCcEEEEEEeeccc----chhHHHHHHHHHHHhccCCC
Q 046851 669 GVPLSFESVVQATGNFNAS------NCIGNGGFGATYKAEISPGVLVAIKRLAVGR----FQGVQQFHAEIKTLGRLRHP 738 (963)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~ 738 (963)
...+++.++..++++|... +.||+|+||.||+|... ++.||||++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3458899999999998877 89999999999999874 8899999986432 23457889999999999999
Q ss_pred CeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 739 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
||+++++++.+.+..++||||+++++|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 99999999999999999999999999999997543 45689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcc
Q 046851 818 DDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFN 896 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~ 896 (963)
.++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... ..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~ 242 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP----QL 242 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS----SB
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch----HH
Confidence 999999999999987654322 22334579999999998875 4788999999999999999999999754332 11
Q ss_pred hhhHHHHHHhc-CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 897 IVAWGCMLLRQ-GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 897 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
...+....... ......++... ...+...+..+.+++.+||+.||++|||+++|+++|+++.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 22222222211 11222333322 345667788999999999999999999999999999998764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=403.95 Aligned_cols=439 Identities=20% Similarity=0.169 Sum_probs=329.2
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccc
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFN 81 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n 81 (963)
+++++|+|++|.|+++.+.+|.++++|++|+|++|++++..|++|.++++|++|+|++|.++......+.+|++|+|++|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~l~~L~~L~Ls~N 131 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFN 131 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSCCCTTCSEEECCSS
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCccccccCCEEECCCC
Confidence 57999999999999998899999999999999999999999999999999999999999999555556678999999999
Q ss_pred cccccCCc-cccccCCCCCeEeCCCCccccCcCccccCcccc--cEEEcccCcc--cccCcccccCCC--CCCEEEccCC
Q 046851 82 RLVGSVPS-KIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQV--RSLLLFSNML--EETIPAELGMLQ--NLEVLDVSRN 154 (963)
Q Consensus 82 ~l~~~~p~-~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~--~L~~L~L~~N 154 (963)
+++ .+|. ..|.++++|++|+|++|+|++ ..|.++++| +.|++++|++ ++..|..|..+. .| .+++++|
T Consensus 132 ~l~-~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n 206 (562)
T 3a79_B 132 DFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPN 206 (562)
T ss_dssp CCS-BCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSS
T ss_pred Ccc-ccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCc
Confidence 998 6553 556789999999999999985 456666666 9999999999 888888888775 34 6688999
Q ss_pred ccccCCCc-CccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccccc
Q 046851 155 SLSGSIPV-DLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEG 233 (963)
Q Consensus 155 ~l~~~~p~-~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~ 233 (963)
.+.+.++. .+.++++|+.|++++|.... ..+.+ ....+..+++|+.|++.++.+.+
T Consensus 207 ~~~~~~~~~~~~~l~~L~~L~l~~n~~~~----------------------~~l~~-~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 207 SLFSVQVNMSVNALGHLQLSNIKLNDENC----------------------QRLMT-FLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp SCCCCCCEEEESSEEEEEEEEEECCSTTH----------------------HHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred cchhhhhhhcccccceEEEeccccccccc----------------------chHHH-HHHHHhccCcceEEEecCCcCcH
Confidence 98765554 46788999999998753211 11111 23457788888888888777654
Q ss_pred CCCcc---ccccccCceeecCcccccC-cCcccc----CCCCCCcEEeccCcccccccCCCC----CCCceeEEEeccCc
Q 046851 234 NFPSN---WGACDNLEMLNLGHNFFSG-KNLGVL----GPCKNLLFLDLSSNQLTGELAREL----PVPCMTMFDVSGNA 301 (963)
Q Consensus 234 ~~~~~---~~~l~~L~~L~Ls~N~l~~-~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~----~~~~L~~L~l~~N~ 301 (963)
..... .....+|++|++++|++++ ++...| ..+++|+.++++.|.+ ..+.... ....|+.|++++|.
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~~~~~~L~~L~l~~n~ 342 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSKEALYSVFAEMNIKMLSISDTP 342 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCHHHHHHHHHTCCCSEEEEESSC
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecChhhhhhhhccCcceEEEccCCC
Confidence 21111 1123478888888888874 443332 4555555555555554 1111110 12446677777766
Q ss_pred CccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCccc
Q 046851 302 LSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPER 381 (963)
Q Consensus 302 l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (963)
+.....
T Consensus 343 ~~~~~~-------------------------------------------------------------------------- 348 (562)
T 3a79_B 343 FIHMVC-------------------------------------------------------------------------- 348 (562)
T ss_dssp CCCCCC--------------------------------------------------------------------------
T ss_pred cccccC--------------------------------------------------------------------------
Confidence 542110
Q ss_pred CCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCC--CCcccccc
Q 046851 382 LGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVG--PIPRGVGE 459 (963)
Q Consensus 382 l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~--~~p~~~~~ 459 (963)
++.++.++ +|++++|++++.+|..+..+ ++|++|++++|++++ .+|..+..
T Consensus 349 ------------------------~~~l~~L~--~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~ 401 (562)
T 3a79_B 349 ------------------------PPSPSSFT--FLNFTQNVFTDSVFQGCSTL-KRLQTLILQRNGLKNFFKVALMTKN 401 (562)
T ss_dssp ------------------------CSSCCCCC--EEECCSSCCCTTTTTTCCSC-SSCCEEECCSSCCCBTTHHHHTTTT
T ss_pred ------------------------ccCCCCce--EEECCCCccccchhhhhccc-CCCCEEECCCCCcCCcccchhhhcC
Confidence 01223333 67777777776677666654 789999999999985 23466888
Q ss_pred CCCCCEEeccCCcCCCccc-hhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeE
Q 046851 460 LVSLVALNLSWNLMHDQIP-TTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVL 538 (963)
Q Consensus 460 l~~L~~L~ls~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 538 (963)
+++|+.|++++|.+++.+| ..+..+++|++|++++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|
T Consensus 402 l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L 478 (562)
T 3a79_B 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQEL 478 (562)
T ss_dssp CTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEE
T ss_pred CCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEE
Confidence 9999999999999977444 4588889999999999999877776654 78999999999998 677777799999999
Q ss_pred EeccccCCCcCCCC-ccccccCceEeeccccCccCCC
Q 046851 539 LLNNNKLSGKIPSG-LANVSTLSAFNVSFNNLSGPLP 574 (963)
Q Consensus 539 ~l~~N~l~~~~p~~-l~~l~~L~~l~l~~N~l~~~~p 574 (963)
+|++|+|+ .+|.. +..+++|+.|++++|++.+..|
T Consensus 479 ~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 479 NVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp ECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred ECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 99999999 67766 8889999999999999987444
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=375.18 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=213.9
Q ss_pred CCCCCccccccCCCccEEEEEEC--------CCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCC
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS--------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASET 751 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (963)
++|++.+.||+|+||.||+|.+. ++..||||++..... ...+++.+|+++++++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 57999999999999999999752 356799999976533 3457899999999999 8999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 752 EMFLIYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
..++||||+++|+|.+++.... ...+++.++..++.|+++||+|||++ +|+||||||+||+++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 9999999999999999998753 23579999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCc
Q 046851 818 DDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGF 895 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~ 895 (963)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----- 312 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----- 312 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 999999999999987654332 22334467889999999999999999999999999999999 99998743211
Q ss_pred chhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 896 NIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
+... ....+ .....+..++.++.+++.+||+.||++||++.|+++.|+++.
T Consensus 313 ---~~~~-~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 313 ---ELFK-LLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ---GHHH-HHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHH-HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 11111 112234456678999999999999999999999999999864
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=381.07 Aligned_cols=381 Identities=19% Similarity=0.167 Sum_probs=254.6
Q ss_pred eeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccC-cCccccCcccccEEEcccCccc
Q 046851 55 LNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG-IPRSLGNCFQVRSLLLFSNMLE 133 (963)
Q Consensus 55 L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~L~~n~l~ 133 (963)
++.+++.++ .+|....+|++|+|++|+++ .++...|.++++|++|+|++|.+.+. .+..|.++++|++|+|++|+++
T Consensus 15 ~~c~~~~l~-~lp~l~~~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~ 92 (455)
T 3v47_A 15 AICINRGLH-QVPELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL 92 (455)
T ss_dssp EECCSSCCS-SCCCCCTTCCEEECCSSCCC-EECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTC
T ss_pred cCcCCCCcc-cCCCCCCccCEEEecCCccC-cCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccC
Confidence 444444444 33333334555555555554 44344445667777777777766533 3556677777777777777776
Q ss_pred ccCcccccCCCCCCEEEccCCccccCCCcC--ccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCC
Q 046851 134 ETIPAELGMLQNLEVLDVSRNSLSGSIPVD--LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGI 211 (963)
Q Consensus 134 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~ 211 (963)
+..|..|.++++|++|+|++|.+++..|.. |.++++|++|++++ |.+.+..
T Consensus 93 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~---------------------------n~l~~~~ 145 (455)
T 3v47_A 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD---------------------------NNIKKIQ 145 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCS---------------------------SBCCSCC
T ss_pred ccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCC---------------------------CccCccC
Confidence 666666777777777777777776533333 66667777776666 4444444
Q ss_pred ccc-ccCCCCCceEecCCcccccCCCcccccc--ccCceeecCcccccCcCcccc--------CCCCCCcEEeccCcccc
Q 046851 212 PEA-VSSLPNLRILWAPRATLEGNFPSNWGAC--DNLEMLNLGHNFFSGKNLGVL--------GPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 212 ~~~-l~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~--------~~l~~L~~L~L~~N~l~ 280 (963)
|.. +.++++|+.|++++|.+.+..+..+..+ .+|+.|++++|.+..+++..+ ..+++|+.|++++|+++
T Consensus 146 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 225 (455)
T 3v47_A 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225 (455)
T ss_dssp CCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCC
T ss_pred cccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCccc
Confidence 544 6667777777777777777666666665 567777777777777665432 24567777777777776
Q ss_pred cccCCCC----CCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccc
Q 046851 281 GELAREL----PVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGF 356 (963)
Q Consensus 281 ~~~~~~~----~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (963)
+..+..+ ..++|+.|++++|.+.+.......
T Consensus 226 ~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~--------------------------------------------- 260 (455)
T 3v47_A 226 ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN--------------------------------------------- 260 (455)
T ss_dssp HHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCS---------------------------------------------
T ss_pred ccchhhhhccccccceeeEeeccccccccccchhh---------------------------------------------
Confidence 6544333 236677777777765532211100
Q ss_pred hhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhcc
Q 046851 357 LAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMC 436 (963)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~ 436 (963)
+.+..+. .+.. . ..
T Consensus 261 ----------------------------------------~~~~~~~-----------------------~~~~-~--~~ 274 (455)
T 3v47_A 261 ----------------------------------------FKDPDNF-----------------------TFKG-L--EA 274 (455)
T ss_dssp ----------------------------------------SCCCCTT-----------------------TTGG-G--TT
T ss_pred ----------------------------------------hccCccc-----------------------cccc-c--cc
Confidence 0000000 0000 0 02
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|++|++++|.+++..|..+..+++|+.|++++|.+++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 56888888888888777888888888888888888888777888888888888888888888777788888888888888
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCCC
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPS 575 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~ 575 (963)
++|++++..|..+..+++|++|+|++|++++..+..+..+++|++|++++|++++..|.
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 88888877788888888888888888888865556678888888888888888887774
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=361.14 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=216.9
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.+.||+|+||.||+|...+++.||||++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 47889999999999999999998899999999976543 34678999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999997643 4589999999999999999999999 999999999999999999999999999987654433344
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .+........ ...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~----------~~~ 226 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTG----------FRL 226 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT----------CCC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcC----------ccC
Confidence 45567889999999999999999999999999999999 8999864321 1222111111 111
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
..+...+..+.+++.+||+.||++||+++|++++|+++..+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 22334456789999999999999999999999999998654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=379.15 Aligned_cols=241 Identities=22% Similarity=0.166 Sum_probs=111.7
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccc
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFN 81 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n 81 (963)
..|++|++++|.+ +.+|.+|+++++|++|++++|++.+..|..++++.+|+.+++++|.. .++++|++++|
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~--------~~l~~L~l~~~ 81 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD--------RQAHELELNNL 81 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH--------HTCSEEECTTS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc--------cCCCEEEecCC
Confidence 4678888888888 57788888888888888888888888888888888774444444422 23455555555
Q ss_pred cccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCC
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIP 161 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 161 (963)
+++ .+|.. .++|++|++++|++++ +|.. +++|+.|++++|++++. +.. .++|++|++++|.+++ +|
T Consensus 82 ~l~-~lp~~----~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp 147 (454)
T 1jl5_A 82 GLS-SLPEL----PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP 147 (454)
T ss_dssp CCS-CCCSC----CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC
T ss_pred ccc-cCCCC----cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc
Confidence 555 44431 2455555555555553 3332 24555555555555532 111 1455555555555553 44
Q ss_pred cCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccc
Q 046851 162 VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGA 241 (963)
Q Consensus 162 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 241 (963)
.|+++++|++|++++|.++ + +|.. ..+|+.|++++|++++ +| .+.+
T Consensus 148 -~~~~l~~L~~L~l~~N~l~---------------------------~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~ 193 (454)
T 1jl5_A 148 -ELQNSSFLKIIDVDNNSLK---------------------------K-LPDL---PPSLEFIAAGNNQLEE-LP-ELQN 193 (454)
T ss_dssp -CCTTCTTCCEEECCSSCCS---------------------------C-CCCC---CTTCCEEECCSSCCSS-CC-CCTT
T ss_pred -ccCCCCCCCEEECCCCcCc---------------------------c-cCCC---cccccEEECcCCcCCc-Cc-cccC
Confidence 3555555555555553222 1 1111 1245555555555543 22 3455
Q ss_pred cccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCcc
Q 046851 242 CDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSG 304 (963)
Q Consensus 242 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~ 304 (963)
+++|++|++++|++++++.. .++|++|++++|+++..+ ....+++|+.|++++|++.+
T Consensus 194 l~~L~~L~l~~N~l~~l~~~----~~~L~~L~l~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 194 LPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNILEELP-ELQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp CTTCCEEECCSSCCSSCCCC----CTTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS
T ss_pred CCCCCEEECCCCcCCcCCCC----cCcccEEECcCCcCCccc-ccCCCCCCCEEECCCCcCCc
Confidence 55555555555555443321 134555555555554322 23344555555555555544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=358.72 Aligned_cols=258 Identities=24% Similarity=0.418 Sum_probs=217.5
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++|++.+.||+|+||.||+|+..++..||||++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 357999999999999999999999888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.... ..+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999998753 4589999999999999999999999 99999999999999999999999999998776554444
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ........ .+. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~-~~~---------~ 223 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVLKVS-QGH---------R 223 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHH-TTC---------C
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHHHHH-cCC---------C
Confidence 455567788999999999889999999999999999999 9999864321 11111111 111 1
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
...+...+..+.+++.+||+.||++|||+.|++++|++++..
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 112333456789999999999999999999999999998763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=363.24 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=210.0
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.++|++.+.||+|+||.||+|.+ .+|+.||||++.... ....+++.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999977 579999999997543 344567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++.++..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 999999999999875 3589999999999999999999999 99999999999999999999999999998765332
Q ss_pred CcccccccccccccCccccccCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVS-DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
......||+.|+|||++.+..+. .++||||+||++|||++|+.||.... ............ .
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-~------ 231 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRGK-Y------ 231 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-C------
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C------
Confidence 33456799999999999988765 78999999999999999999997432 222222222211 1
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+.++.+++.+||+.||++|||++|++++
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1233455678899999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=359.51 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=212.5
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35899999999999999999975 56899999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++|+|.+++... .+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999864 489999999999999999999999 999999999999999999999999999987654332
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ............. .
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~~~--------~ 235 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTP--------E 235 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCSC--------C
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCC--------C
Confidence 33446799999999999999999999999999999999999999964321 1111111111110 1
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234456678999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=385.83 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=216.7
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 35788999999999999999999889999999997654 34678999999999999999999999986 56789999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.++++......+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999999865545689999999999999999999999 99999999999999999999999999998765433223
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ..+........ ..
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~~~----------~~ 403 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERG----------YR 403 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHHT----------CC
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcC----------CC
Confidence 334456789999999999999999999999999999999 999986432 11222221111 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
...+..++.++.+++.+||+.||++|||+++|++.|+++..+
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 223445677899999999999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=360.89 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=205.8
Q ss_pred HcCCCCCccccccCCCccEEEEEECCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
..++|++.+.||+|+||+||+|... |+.||||++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 3468999999999999999999875 8899999987553 234567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPR--VLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
||+++|+|.+++.... ...+++..+..++.|+++||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999998643 12389999999999999999999999 8 9999999999999999999999999997643
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
.. ........||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .+.........
T Consensus 191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~------ 255 (309)
T 3p86_A 191 ST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFKC------ 255 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHHSC------
T ss_pred cc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcC------
Confidence 32 2223445799999999999999999999999999999999999999974321 11111111111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.....+...+..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 256 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 256 ---KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1112334556689999999999999999999999999988643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=366.35 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=211.0
Q ss_pred CCCCCccccccCCCccEEEEEEC----CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46889999999999999999874 35569999997653 34456799999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999997643 4589999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 837 ETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 837 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .+........
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~------ 270 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEEG------ 270 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTT------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcC------
Confidence 222 2233456788999999999999999999999999999999 9999864321 1122111111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122344566789999999999999999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.40 Aligned_cols=262 Identities=22% Similarity=0.306 Sum_probs=218.6
Q ss_pred CCCChHHHHHHcCC----------CCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCC
Q 046851 670 VPLSFESVVQATGN----------FNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHP 738 (963)
Q Consensus 670 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 738 (963)
.+++++++..+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888888764 677789999999999999876 7999999999877666678899999999999999
Q ss_pred CeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC
Q 046851 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD 818 (963)
Q Consensus 739 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 818 (963)
||+++++++...+..++||||+++++|.+++.. ..+++.++..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 999999999999999999999999999999875 3589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchh
Q 046851 819 DFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIV 898 (963)
Q Consensus 819 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~ 898 (963)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--------~ 247 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--------V 247 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------H
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence 99999999999987654322 23456799999999999999999999999999999999999999974321 1
Q ss_pred hHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 899 AWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....... ...... .......+..+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~-~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAMKRLR-DSPPPK-------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHH-HSSCCC-------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHh-cCCCCC-------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1121111 111111 01122345678999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=386.09 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=219.0
Q ss_pred CCCCCccccccCCCccEEEEEECC-CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.+|++.+.||+|+||.||+|.+.. +..||||++.... ...++|.+|++++++++||||+++++++...+..++||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 468889999999999999998874 8899999997543 34678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+++.......+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999999999876666799999999999999999999999 99999999999999999999999999998765444333
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... +.. .... ....
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~-~~~~---------~~~~ 437 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVY-ELLE---------KDYR 437 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHH-HHHH---------TTCC
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHH-HHHH---------cCCC
Confidence 444567789999999999899999999999999999999 88888643211 111 1111 1122
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
...+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 233455677899999999999999999999999999987554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.65 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=212.6
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++|++.+.||+|+||.||+|.+.++..||||++...... .+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3578999999999999999999998889999999765433 467899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.... ..+++.++..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999997643 3589999999999999999999999 99999999999999999999999999998765443333
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... ........ .+ ..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~-~~---------~~ 239 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIA-QG---------LR 239 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHH-TT---------CC
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHHh-cc---------cC
Confidence 444567889999999999999999999999999999998 9999874321 11111111 11 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
...+...+..+.+++.+||+.||++|||++|++++|+++.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 1223344568899999999999999999999999998864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=372.53 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=201.1
Q ss_pred CCCCCccccccCCCccEEEEEEC----CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|... ++..||||+++... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 47999999999999999999764 57789999997653 33456799999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.++++.. ...+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999999864 34689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 837 ETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 837 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+..... ..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i-~~------ 265 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAV-DE------ 265 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHH-HT------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-Hc------
Confidence 221 1222345778999999999999999999999999999998 9999864321 1111111 11
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
......+..++..+.+++.+||+.||++||++.+|++.|+++.
T Consensus 266 ---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 266 ---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ---TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1122234456678999999999999999999999999998763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=376.84 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=212.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|.+.+.||+|+||.||+|.+. +++.||||++..... ...+++.+|++++++++||||+++++++...+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 47889999999999999999886 789999999875432 3345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 194 VQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999998653 3589999999999999999999999 9999999999999999999999999999865432221
Q ss_pred cc-ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 840 AT-TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 840 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.. ....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+ .......+
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~-~~~~~~~~--------- 331 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQ-TREFVEKG--------- 331 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HH-HHHHHHTT---------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcC---------
Confidence 11 12235778999999998899999999999999999998 8988864321 11 11111111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.....+..++..+.+++.+||+.||++|||++++++.|++++.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1222344566789999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=355.54 Aligned_cols=261 Identities=24% Similarity=0.414 Sum_probs=209.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+++.+|+..+++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357999999999999999999764 68999999986432 23456789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++.... .+++.++..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999998753 589999999999999999999999 9999999999999999999999999999877554
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.........||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ........... .... ..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~-~~~~-~~ 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQDS-VPNV-TT 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSSC-CCCH-HH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhcc-CCCc-ch
Confidence 44444556799999999999999999999999999999999999999974321 11111111111 1110 01
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhccCC
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-TMKQVVRRLKQLQP 960 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~l~~ 960 (963)
..+...+..+.+++.+|++.||++|| +++++.+.|+++..
T Consensus 235 ----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 235 ----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11233456889999999999999999 99999999988654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=362.08 Aligned_cols=271 Identities=28% Similarity=0.428 Sum_probs=210.8
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC----eEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET----EMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 756 (963)
.++|++.+.||+|+||+||+|++. ++.||||++...... ...+..|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357999999999999999999887 899999999755432 345577999999999999999999987643 47999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCceecccCCCCeEECCCCcEEEeeccc
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ-------CVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 829 (963)
|||+++|+|.++++.. .+++.++..++.|+++||+|||+. ..++|+||||||+||+++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999999763 489999999999999999999976 234899999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccccccCccccccC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCc--------
Q 046851 830 ARLLGPSETH-ATTGVAGTFGYVAPEYAMTC-----RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGF-------- 895 (963)
Q Consensus 830 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~-------- 895 (963)
++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9876543322 23346799999999999873 455688999999999999999999986544321111
Q ss_pred chhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 896 NIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
....+........ ....+... ......+.++.+++.+||+.||++|||+.||++.|++++.
T Consensus 258 ~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 258 SLEDMQEVVVHKK-KRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CHHHHHHHHTTSC-CCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhhhhhhhhccc-CCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111111 11000000 0123456779999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=359.25 Aligned_cols=266 Identities=26% Similarity=0.417 Sum_probs=211.4
Q ss_pred CCCCCccccccCCCccEEEEEE-----CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-----SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 754 (963)
++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5799999999999999999974 3689999999987766667889999999999999999999999854 35689
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999998753 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC-------CCCCcchhhHHHHHH
Q 046851 835 PSET--HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS-------YGNGFNIVAWGCMLL 905 (963)
Q Consensus 835 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~ 905 (963)
.... .......++..|+|||.+.+..++.++||||+|+++|||++|..|+...... ..............
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 244 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL- 244 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH-
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH-
Confidence 4322 1223345778899999999999999999999999999999999988643211 00000000011111
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
+........+..++.++.+++.+||+.||++|||++|+++.|++++.
T Consensus 245 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 245 --------LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11122223355667789999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=377.38 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=211.1
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC-eEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET-EMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 47889999999999999999887 8899999997654 4478999999999999999999999987654 799999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+++.......+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 999999999987655689999999999999999999999 9999999999999999999999999999864322
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... +.... ...+ ..
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~-i~~~---------~~ 404 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPR-VEKG---------YK 404 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--------THHHH-HHTT---------CC
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH-HHcC---------CC
Confidence 122357889999999999999999999999999999998 99998743221 11111 1111 12
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
...+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 23345667789999999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=380.70 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=209.2
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|++++++++||||+++++++.+ +..++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 4688899999999999999999888899999997654 335789999999999999999999999876 67899999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+|+|.+++.......+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 99999999865556689999999999999999999999 999999999999999999999999999987654433333
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+..... ..+ ...
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i-~~~---------~~~ 400 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV-ERG---------YRM 400 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHH-HTT---------CCC
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-HcC---------CCC
Confidence 44567889999999999999999999999999999999 8999864321 1222111 111 122
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
..+..++..+.+++.+||+.||++|||++++++.|+++..
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 2344567789999999999999999999999999998754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=376.33 Aligned_cols=384 Identities=18% Similarity=0.149 Sum_probs=292.4
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLV 84 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~ 84 (963)
+.++.++++++.+ |. + .++|++|+|++|++++..|..|.++++|++|+|++|.+.+
T Consensus 13 ~~~~c~~~~l~~l-p~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~-------------------- 68 (455)
T 3v47_A 13 YNAICINRGLHQV-PE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL-------------------- 68 (455)
T ss_dssp TEEECCSSCCSSC-CC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTC--------------------
T ss_pred cccCcCCCCcccC-CC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccc--------------------
Confidence 3577778888744 44 2 2778888888888888778888888888888888887752
Q ss_pred ccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCccc--ccCCCCCCEEEccCCccccCCCc
Q 046851 85 GSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAE--LGMLQNLEVLDVSRNSLSGSIPV 162 (963)
Q Consensus 85 ~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~p~ 162 (963)
.++...|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+.. |..+++|++|+|++|.+++..|.
T Consensus 69 -~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 147 (455)
T 3v47_A 69 -VIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147 (455)
T ss_dssp -EECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC
T ss_pred -eECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcc
Confidence 455555666777888888888877777777888888888888888777644433 77788888888888888766666
Q ss_pred C-ccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCC--CCCceEecCCcccccCCCccc
Q 046851 163 D-LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSL--PNLRILWAPRATLEGNFPSNW 239 (963)
Q Consensus 163 ~-~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l--~~L~~L~l~~n~l~~~~~~~~ 239 (963)
. +.++++|+.|++++ |.+.+..+..+..+ .+|+.|++++|.+.+..+..+
T Consensus 148 ~~~~~l~~L~~L~L~~---------------------------n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~ 200 (455)
T 3v47_A 148 SFFLNMRRFHVLDLTF---------------------------NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200 (455)
T ss_dssp GGGGGCTTCCEEECTT---------------------------CCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCT
T ss_pred cccCCCCcccEEeCCC---------------------------CcccccChhhhhccccccccccccccCcccccchhhc
Confidence 5 77788888888777 44555556666555 677888888888876554433
Q ss_pred --------cccccCceeecCcccccCcCccccCCC---CCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCC
Q 046851 240 --------GACDNLEMLNLGHNFFSGKNLGVLGPC---KNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPT 308 (963)
Q Consensus 240 --------~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~ 308 (963)
..+++|++|++++|++++..+..+..+ ++|+.|++++|.+.+.... .+.+......
T Consensus 201 ~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~-------------~~~~~~~~~~ 267 (455)
T 3v47_A 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG-------------HTNFKDPDNF 267 (455)
T ss_dssp THHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTT-------------CCSSCCCCTT
T ss_pred cccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccc-------------hhhhccCccc
Confidence 356789999999998887666555433 7899999999987653222 2222211110
Q ss_pred -CCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceE
Q 046851 309 -FSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTV 387 (963)
Q Consensus 309 -~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 387 (963)
+..
T Consensus 268 ~~~~---------------------------------------------------------------------------- 271 (455)
T 3v47_A 268 TFKG---------------------------------------------------------------------------- 271 (455)
T ss_dssp TTGG----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 000
Q ss_pred EEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEe
Q 046851 388 YAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALN 467 (963)
Q Consensus 388 ~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ 467 (963)
.....++ .|++++|.+++.+|..+..+ ++|++|++++|++++..|..|..+++|+.|+
T Consensus 272 -------------------~~~~~L~--~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 329 (455)
T 3v47_A 272 -------------------LEASGVK--TCDLSKSKIFALLKSVFSHF-TDLEQLTLAQNEINKIDDNAFWGLTHLLKLN 329 (455)
T ss_dssp -------------------GTTSCCC--EEECCSSCCCEECTTTTTTC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred -------------------ccccCce--EEEecCccccccchhhcccC-CCCCEEECCCCcccccChhHhcCcccCCEEE
Confidence 0011222 67888888887677766665 8899999999999988888999999999999
Q ss_pred ccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCC
Q 046851 468 LSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547 (963)
Q Consensus 468 ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 547 (963)
+++|.+++..|..|+.+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|+.|++++|++++
T Consensus 330 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 409 (455)
T 3v47_A 330 LSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 409 (455)
T ss_dssp CCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCccc
Confidence 99999988889999999999999999999998889999999999999999999998766778999999999999999997
Q ss_pred cCCC
Q 046851 548 KIPS 551 (963)
Q Consensus 548 ~~p~ 551 (963)
..|.
T Consensus 410 ~~~~ 413 (455)
T 3v47_A 410 SCPR 413 (455)
T ss_dssp CTTT
T ss_pred CCCc
Confidence 7763
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=386.10 Aligned_cols=506 Identities=17% Similarity=0.122 Sum_probs=389.8
Q ss_pred EEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeecccc
Q 046851 6 VLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSFNR 82 (963)
Q Consensus 6 ~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~n~ 82 (963)
+.+-++.+++ .+|..+- +++++|+|++|+|+++.+.+|.++++|++|+|++|+|++..+.+|. +|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 4456667787 4455442 4799999999999988889999999999999999999977776654 79999999999
Q ss_pred ccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCccccc-CcccccCCCCCCEEEccCCccccCCC
Q 046851 83 LVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET-IPAELGMLQNLEVLDVSRNSLSGSIP 161 (963)
Q Consensus 83 l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p 161 (963)
++ .+|...|.++++|++|+|++|+|++..+..|+++++|++|+|++|+++.. .|..+..+++|++|+|++|++++..+
T Consensus 112 l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 190 (635)
T 4g8a_A 112 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 190 (635)
T ss_dssp CC-EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred CC-CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence 99 89999999999999999999999988788899999999999999999864 57889999999999999999998888
Q ss_pred cCccCCCCCc----eEeecCcCCcccccccccCCcccCCCcccCCCCCccc-cCCcccccCCCCCceEecCCc------c
Q 046851 162 VDLGNCSKLA----ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFE-GGIPEAVSSLPNLRILWAPRA------T 230 (963)
Q Consensus 162 ~~~~~l~~L~----~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~-~~~~~~l~~l~~L~~L~l~~n------~ 230 (963)
..|..+.+++ .++++.|.++............ ..+++..|... ...+..+..+..++...+..+ .
T Consensus 191 ~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~----~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~ 266 (635)
T 4g8a_A 191 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL----HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 266 (635)
T ss_dssp GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEE----EEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCC
T ss_pred ccccchhhhhhhhhhhhcccCcccccCcccccchhh----hhhhhhcccccccccchhhcCCcccccccccccccccccc
Confidence 8888776655 5777887776554433322211 12222223322 223456777888877766433 2
Q ss_pred cccCCCccccccccCceeecCcccccCc---CccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCC
Q 046851 231 LEGNFPSNWGACDNLEMLNLGHNFFSGK---NLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIP 307 (963)
Q Consensus 231 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~ 307 (963)
+.......+..+..+..+++..+..... ....+..+.+++.+++.+|.+..... ......++.|++++|.+.+...
T Consensus 267 l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~~~~~~~~~ 345 (635)
T 4g8a_A 267 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKD-FSYNFGWQHLELVNCKFGQFPT 345 (635)
T ss_dssp CSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGG-GGSCCCCSEEEEESCEESSCCC
T ss_pred cccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccc-cccchhhhhhhcccccccCcCc
Confidence 3334555667777787777776654432 23455667899999999999876443 3345679999999999886654
Q ss_pred CCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceE
Q 046851 308 TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTV 387 (963)
Q Consensus 308 ~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 387 (963)
. .+..++.+++..|........ .....+
T Consensus 346 ~--~l~~L~~l~l~~n~~~~~~~~--------------------------------------------------~~l~~L 373 (635)
T 4g8a_A 346 L--KLKSLKRLTFTSNKGGNAFSE--------------------------------------------------VDLPSL 373 (635)
T ss_dssp C--BCTTCCEEEEESCCSCCBCCC--------------------------------------------------CBCTTC
T ss_pred c--cchhhhhcccccccCCCCccc--------------------------------------------------cccccc
Confidence 3 455677777776654322110 011234
Q ss_pred EEEEcCCCcccCC--CCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCc-cccccCCCCC
Q 046851 388 YAIVAGDNKLSGS--FPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIP-RGVGELVSLV 464 (963)
Q Consensus 388 ~~l~~~~n~~~~~--~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p-~~~~~l~~L~ 464 (963)
..+++++|.+... .|... ..+..++ .++++.|.+. .++..+..+ ++|+.+++++|+.....+ ..+..+++++
T Consensus 374 ~~L~ls~n~l~~~~~~~~~~-~~~~~L~--~L~~~~~~~~-~~~~~~~~l-~~L~~l~l~~~~~~~~~~~~~~~~l~~l~ 448 (635)
T 4g8a_A 374 EFLDLSRNGLSFKGCCSQSD-FGTISLK--YLDLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLI 448 (635)
T ss_dssp CEEECCSSCCBEEEECCHHH-HSCSCCC--EEECCSCSEE-EECSCCTTC-TTCCEEECTTSEEESTTSSCTTTTCTTCC
T ss_pred ccchhhccccccccccccch-hhhhhhh--hhhccccccc-ccccccccc-ccccchhhhhccccccccccccccccccc
Confidence 5677788877543 34333 3344455 8899999987 455555554 889999999998875544 4578899999
Q ss_pred EEeccCCcCCCccchhhccCcccceecccccccc-ccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccc
Q 046851 465 ALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLT-GSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543 (963)
Q Consensus 465 ~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 543 (963)
.+++++|.+.+..+..+..+++|+.|++++|.+. +..|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 449 ~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N 528 (635)
T 4g8a_A 449 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 528 (635)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCC
Confidence 9999999999889999999999999999999854 457889999999999999999999988999999999999999999
Q ss_pred cCCCcCCCCccccccCceEeeccccCccCCCCCC
Q 046851 544 KLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSK 577 (963)
Q Consensus 544 ~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~ 577 (963)
+|++..|..|..+++|++|++++|+|++..|+..
T Consensus 529 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 562 (635)
T 4g8a_A 529 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 562 (635)
T ss_dssp CCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCT
T ss_pred cCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHH
Confidence 9998778889999999999999999999777654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=355.75 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=208.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 47999999999999999999775 68999999997542 334567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 999999999999864 3589999999999999999999999 9999999999999999999999999999864322
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~--------- 221 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE--------- 221 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---------
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC---------
Confidence 223345679999999999999999999999999999999999999997432 112222222111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+...+.++.+++.+||+.||++|| +++|++++
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112334566889999999999999999 89999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=357.48 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=219.3
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
..++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 3467999999999999999999876 48899999987543 345788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++++|.+++.......+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999886667799999999999999999999999 999999999999999999999999999988765554
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ...... .. .
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--------~~~~~~-~~---------~ 228 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELL-EK---------D 228 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHH-HT---------T
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH-hc---------c
Confidence 55555667889999999999999999999999999999999 88888643221 111111 11 1
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.....+...+..+.+++.+|++.||++|||+.|+++.|+++.
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 122233455678999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=372.80 Aligned_cols=271 Identities=24% Similarity=0.363 Sum_probs=218.2
Q ss_pred CCChHHHHHHcCCCCCccccccCCCccEEEEEE------CCCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeE
Q 046851 671 PLSFESVVQATGNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVT 742 (963)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~ 742 (963)
++...+.....++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345555556678999999999999999999964 2468999999976433 3456789999999999 7999999
Q ss_pred EEEeeeCCC-eEEEEEeccCCCChHHHHhhhcC-----------------------------------------------
Q 046851 743 LIGYHASET-EMFLIYNYLPGGNLENFIQQRST----------------------------------------------- 774 (963)
Q Consensus 743 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------- 774 (963)
+++++.+.+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999987754 48999999999999999986532
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 775 -----------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 775 -----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1288999999999999999999999 99999999999999999999999999998764332
Q ss_pred C-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 838 T-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 838 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
. .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...... .........+.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~~~------ 313 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGT------ 313 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--------HHHHHHHHHTC------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--------HHHHHHHHcCC------
Confidence 2 23344578899999999999999999999999999999998 99998743221 11111122211
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
....+...+.++.+++.+||+.||++|||++|++++|+++.++
T Consensus 314 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 ---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1122334556789999999999999999999999999987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=364.36 Aligned_cols=261 Identities=26% Similarity=0.423 Sum_probs=214.9
Q ss_pred HcCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (963)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3468999999999999999999774 348899999976533 345678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccC
Q 046851 753 MFLIYNYLPGGNLENFIQQRS----------------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVK 810 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 810 (963)
.++||||+++|+|.+++.... ...+++.++..++.|+++||+|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 999999999999999998743 15689999999999999999999999 99999999
Q ss_pred CCCeEECCCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 046851 811 PSNILLDDDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSF 888 (963)
Q Consensus 811 ~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~ 888 (963)
|+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987643322 22334568899999999999999999999999999999999 999986432
Q ss_pred CCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 889 SSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
. .+... ....+.. ...+...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 282 ~--------~~~~~-~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 282 H--------EEVIY-YVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp H--------HHHHH-HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred h--------HHHHH-HHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 1 12221 1222211 122345567899999999999999999999999999997654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.72 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=214.6
Q ss_pred cCCCCCccccccCCCccEEEEEEC--------CCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS--------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASE 750 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (963)
.++|.+.+.||+|+||.||+|... .+..||||++..... ...+++.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357999999999999999999752 246799999976533 3457789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
+..++||||+++|+|.+++.... ...+++.++..++.|+++||+|||+. +|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999998754 24589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q 046851 817 DDDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNG 894 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~ 894 (963)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~------ 298 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 298 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------
Confidence 9999999999999987654332 22334567889999999999999999999999999999999 999986332
Q ss_pred cchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
..+.... ...+. ....+...+.++.+++.+||+.||++|||++||+++|+++.+
T Consensus 299 --~~~~~~~-~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 299 --VEELFKL-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp --HHHHHHH-HHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHH-HHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122222 12211 112234456789999999999999999999999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=351.59 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=215.5
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 47889999999999999999998899999999976543 34678999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+++|.+++.... ..+++..+..++.|+++|++|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999998653 4589999999999999999999999 999999999999999999999999999987654333333
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... ........ .+ ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~-~~---------~~~ 224 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDIS-TG---------FRL 224 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH-TT---------CCC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHh-cC---------CcC
Confidence 44567889999999999899999999999999999999 8989864321 11221111 11 111
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
..+...+..+.+++.+||+.||++||++++++++|+++...
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 12334456789999999999999999999999999988654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.19 Aligned_cols=262 Identities=23% Similarity=0.375 Sum_probs=203.0
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhc--cCCCCeeEEEEeeeC----CCeEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGR--LRHPNLVTLIGYHAS----ETEMF 754 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~ 754 (963)
.++|++.+.||+|+||+||+|... |+.||||++.... ...+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 357999999999999999999884 8999999986543 3445556666555 789999999998643 35689
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecccCCCCeEECCCCcEEEee
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH--------DQCVPRVLHRDVKPSNILLDDDFNAYLSD 826 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~kl~D 826 (963)
+||||+++|+|.++++. ..+++..+..++.|+++||+||| +. +|+||||||+||+++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999964 35899999999999999999999 77 999999999999999999999999
Q ss_pred cccccccCCCCCcc---cccccccccccCccccccC------CCCcchhhHHHHHHHHHHHcC----------CCCCCCC
Q 046851 827 FGLARLLGPSETHA---TTGVAGTFGYVAPEYAMTC------RVSDKADVYSYGVVLLELLSD----------KKALDPS 887 (963)
Q Consensus 827 fgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg----------~~p~~~~ 887 (963)
||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997765433222 2334799999999999876 445789999999999999999 7777544
Q ss_pred CCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 888 FSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
... .................... .. ...+...+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus 237 ~~~---~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 237 VPN---DPSFEDMRKVVCVDQQRPNI-PN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp SCS---SCCHHHHHHHHTTSCCCCCC-CG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC---CcchhhhhHHHhccCCCCCC-Ch---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 332 11112221111111111111 00 0112346788999999999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=367.45 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=210.6
Q ss_pred CCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|++.+.||+|+||.||+|.+. +++.||||++... ......++.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 57999999999999999999853 4678999998654 3344567899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC---cEEEee
Q 046851 755 LIYNYLPGGNLENFIQQRST-----RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF---NAYLSD 826 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 826 (963)
+||||+++|+|.+++..... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999987542 4589999999999999999999999 999999999999999555 599999
Q ss_pred cccccccCCCC-CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 827 FGLARLLGPSE-THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 827 fgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||..... .+.....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~~~i 299 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEFV 299 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 99997653222 122233467899999999999999999999999999999998 8999864321 1222222
Q ss_pred HhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 905 LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.... ....+...+..+.+++.+||+.||++||++.+|+++|+.+.
T Consensus 300 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 300 TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2111 11223445668899999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=362.53 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=203.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+..|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 47999999999999999999876 588999999976532 2234578899998887 799999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 132 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999999875 3599999999999999999999999 9999999999999999999999999999863322
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...............+.........
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 278 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 278 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-------
T ss_pred -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-------
Confidence 233455689999999999999999999999999999999999999997443221111112222222222211
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
...+...+.++.+++.+||+.||++||++
T Consensus 279 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 ---IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 12234456688999999999999999996
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.94 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=198.8
Q ss_pred cCCCCCccccccCCCccEEEEEECC----CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3579999999999999999997642 5679999886543 334567899999999999999999999985 457889
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++++|.+++... ...+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999864 34589999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
..........+++.|+|||++.+..++.++||||+|+++|||++ |..||...... +...... .+.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--------~~~~~i~-~~~----- 234 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIE-NGE----- 234 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHH-TTC-----
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--------HHHHHHH-cCC-----
Confidence 44333444567889999999999999999999999999999997 88998743221 1111111 111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
....+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11223455678999999999999999999999999998863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=356.67 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=205.3
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5899999999999999999986 578999999987542 222457899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+ +|+|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 67999999775 3599999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||........ ...+..
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------------~~~i~~ 222 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------------------FKKVNS 222 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------------------BCCCCS
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------------------HHHHHc
Confidence 2334579999999999988775 6899999999999999999999975432200 000000
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+...+..+.+++.+||+.||++|||++|++++
T Consensus 223 -~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 -CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0112234456688999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=356.75 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=214.0
Q ss_pred cCCCCCccccccCCCccEEEEEE------CCCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
.++|.+.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45799999999999999999975 345889999997543 34457889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCC
Q 046851 754 FLIYNYLPGGNLENFIQQRST----------------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKP 811 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 811 (963)
++||||+++|+|.+++..... ..+++.++..++.|+++||+|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999987532 3478999999999999999999999 999999999
Q ss_pred CCeEECCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 046851 812 SNILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFS 889 (963)
Q Consensus 812 ~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~ 889 (963)
+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543322 2233457889999999999889999999999999999999 9999874322
Q ss_pred CCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 890 SYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
. . .......+. ....+...+..+.+++.+||+.||++||++.|++++|+++.
T Consensus 259 ~--------~-~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 E--------R-LFNLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp G--------G-HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--------H-HHHHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1 111111111 11233455678999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.16 Aligned_cols=268 Identities=19% Similarity=0.242 Sum_probs=214.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC--eEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET--EMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 47999999999999999999776 58999999997543 344677889999999999999999999987654 789999
Q ss_pred eccCCCChHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE----CCCCcEEEeecccccc
Q 046851 758 NYLPGGNLENFIQQRST-RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL----DDDFNAYLSDFGLARL 832 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla~~ 832 (963)
||+++++|.+++..... ..+++.++..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999987543 3489999999999999999999999 99999999999999 7888899999999987
Q ss_pred cCCCCCcccccccccccccCccccc--------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAM--------TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||...... ....+.+...
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~ 239 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMYKI 239 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG----GGCHHHHHHH
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc----chhHHHHHHH
Confidence 65433 223457999999999986 567889999999999999999999999754322 1122222222
Q ss_pred HhcCccc---ce---------eccc--cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 905 LRQGRAK---EF---------FTAG--LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 905 ~~~~~~~---~~---------~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
....... .. .... .....+......+.+++.+||+.||++|||++|++++..+-
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2221100 00 0001 11133466788899999999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=345.29 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=210.5
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|.+. |+.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 47999999999999999999987 8999999997653 34456799999999999999999999999876 7889999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR--VLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||+++|+|.+++.......+++.++..++.|+++||+|||++ + ++||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 999999999999886655799999999999999999999999 8 9999999999999999999999999876432
Q ss_pred CCCcccccccccccccCccccccCCCCc---chhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSD---KADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.....||+.|+|||.+.+..++. ++||||+|+++|||++|+.||..... ..........+
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~---- 227 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVALEG---- 227 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHHHHSC----
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHHHhcC----
Confidence 22346899999999998765444 79999999999999999999974321 12222222221
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.....+...+..+.+++.+||+.||++|||++|+++.|++++.
T Consensus 228 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 -----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1122334556789999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=352.99 Aligned_cols=268 Identities=25% Similarity=0.383 Sum_probs=207.3
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||+||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 368999999999999999999998899999999865432 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++ ++.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9975 8988887643 4589999999999999999999999 999999999999999999999999999987653322
Q ss_pred cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc-----
Q 046851 839 HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE----- 912 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 912 (963)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+...........
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-----DQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-----THHHHHHHHHCCCCTTTSGGGT
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHCCCChHHhhhhh
Confidence 2334568999999999876 56899999999999999999999999754322 11111111111110000
Q ss_pred -----------eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhccC
Q 046851 913 -----------FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQLQ 959 (963)
Q Consensus 913 -----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l~ 959 (963)
..+.............++.+++.+||+.||++|||++|++++ ++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 000000000112234578899999999999999999999984 44443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=353.99 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=203.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46999999999999999999875 58999999997653 23456688999999888 899999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999999875 3589999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.........................
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 235 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 235 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence 2 23445689999999999999999999999999999999999999997432221111111122222221111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
...+...+..+.+++.+||+.||++||++
T Consensus 236 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ---IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11233456688999999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=358.30 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=203.0
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 755 (963)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|.+++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999775 58999999997542 23456778999999988 69999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999875 3599999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.........
T Consensus 177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~------- 240 (353)
T 3txo_A 177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDE------- 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-------
T ss_pred C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC-------
Confidence 2 2334456899999999999998899999999999999999999999974321 22222222211
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM------KQVVR 953 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~ 953 (963)
...+......+.+++.+|++.||++||++ .|+++
T Consensus 241 ----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11233455678899999999999999998 66665
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=356.89 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=208.0
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch------hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ------GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
.+.|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 357999999999999999999775 6899999999765332 357889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC----cEEEeeccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF----NAYLSDFGL 829 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl 829 (963)
++||||+++|+|.+++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999763 4589999999999999999999999 999999999999998877 799999999
Q ss_pred ccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
+....... ......||+.|+|||++.+..++.++||||+||++|||++|..||..... .+.........
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~i~~~~- 234 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITAVS- 234 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTC-
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcC-
Confidence 98765432 23446799999999999999999999999999999999999999974321 12222211111
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. -++.... ...+..+.+++.+||..||++|||+.|++++
T Consensus 235 ~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 Y--DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp C--CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C--CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0111111 1234578899999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=357.84 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=203.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCc----EEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGV----LVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|++.+.||+|+||+||+|.+. +|+ +||+|.+.... ....+++.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 47999999999999999999764 344 36888775432 345578999999999999999999999998754 789
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
|+||+++|+|.+++.... ..+++..+..|+.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999998753 4589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... . .......+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~-~~~~~~~~----- 235 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------E-ISSILEKG----- 235 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------G-HHHHHHTT-----
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--------H-HHHHHHcC-----
Confidence 3322 2334457889999999999999999999999999999999 99999743221 1 11111111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.....+..++..+.+++.+||+.||++||++.|++++|+++.
T Consensus 236 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 236 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 112234456678999999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.97 Aligned_cols=253 Identities=29% Similarity=0.447 Sum_probs=197.9
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccc----hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF----QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|.+. |+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57999999999999999999886 89999999865432 23567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC--------CCcEEEeeccc
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD--------DFNAYLSDFGL 829 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Dfgl 829 (963)
||+++++|.+++.. ..+++..+..++.|+++|++|||++...+|+||||||+||+++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999964 45899999999999999999999991112999999999999986 77899999999
Q ss_pred ccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
+....... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ...........
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~- 230 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--------LAVAYGVAMNK- 230 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHTSC-
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHhhhcCC-
Confidence 98654332 2245689999999999999999999999999999999999999974321 11111111111
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.....+...+..+.+++.+||+.||++|||+.|++++|+++
T Consensus 231 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 --------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11223345567899999999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.08 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=213.6
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++|++.+.||+|+||.||+|...++..||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 35799999999999999999999888899999987543 345788999999999999999999999874 4689999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.......+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 999999999765444689999999999999999999999 99999999999999999999999999998776544334
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .+....... + ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~-~---------~~ 228 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLER-G---------YR 228 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHT-T---------CC
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHHhc-c---------cC
Confidence 444567889999999998889999999999999999999 8889864321 122211111 1 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
...+...+..+.+++.+|++.||++|||+.++++.|+++.
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1223345678999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=353.97 Aligned_cols=258 Identities=19% Similarity=0.230 Sum_probs=209.2
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5799999999999999999976 5789999999875433 24678999999999 899999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc-----EEEeecccccccC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN-----AYLSDFGLARLLG 834 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgla~~~~ 834 (963)
+ +++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.+.
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9 89999999865 35699999999999999999999999 9999999999999999887 9999999998765
Q ss_pred CCCCc------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 835 PSETH------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 835 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~~~ 236 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-----TLKERYQKIGDTK 236 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-----SHHHHHHHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-----cHHHHHHHHHhhh
Confidence 43321 124567999999999999999999999999999999999999999854222 1222211111110
Q ss_pred cccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 909 RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.... .... ....+ ++.+++..||+.||.+||++.++.+.|+++
T Consensus 237 -~~~~-~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 237 -RATP-IEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp -HHSC-HHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -ccCC-HHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000 0000 11133 899999999999999999999999999865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=358.85 Aligned_cols=260 Identities=21% Similarity=0.366 Sum_probs=197.5
Q ss_pred HHcCCCCCccccccCCCccEEEEEECCC----cEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEISPG----VLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (963)
...++|++.+.||+|+||.||+|..... ..||||++... .....+++.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3456899999999999999999976533 27999998754 33456789999999999999999999999987665
Q ss_pred E------EEEEeccCCCChHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 753 M------FLIYNYLPGGNLENFIQQRST----RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 753 ~------~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
. ++||||+++|+|.+++..... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 999999999999999975431 2589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhH
Q 046851 823 YLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAW 900 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 900 (963)
||+|||+++........ ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... +.
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~ 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--------EI 248 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--------HH
Confidence 99999999876543322 2233456789999999999999999999999999999999 89998743221 11
Q ss_pred HHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 901 GCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
........ ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 249 ~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 249 YNYLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111 11223445678999999999999999999999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=346.46 Aligned_cols=252 Identities=28% Similarity=0.523 Sum_probs=206.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchh-------HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQG-------VQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
++|++.+.||+|+||.||+|... +++.||||++....... .+++.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 58999999999999999999774 78999999986543221 267899999999999999999999997765
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecccCCCCeEECCCCc-----EEEee
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR--VLHRDVKPSNILLDDDFN-----AYLSD 826 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~D 826 (963)
++||||+++|+|.+++... ...+++..+..++.|+++|++|||++ + |+||||||+||+++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999999998764 34689999999999999999999999 8 999999999999988776 99999
Q ss_pred cccccccCCCCCcccccccccccccCccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 827 FGLARLLGPSETHATTGVAGTFGYVAPEYAM--TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 827 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
||+++.... ......||+.|+|||++. ...++.++||||+|+++|||++|+.||...... ...+....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~ 242 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINMI 242 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC------HHHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc------HHHHHHHH
Confidence 999975432 234467999999999984 456788999999999999999999999744222 12222222
Q ss_pred HhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 905 LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.... .....+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 243 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 2221 11223445567899999999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=382.77 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=215.1
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++|++.+.||+|+||.||+|.+.++..||||++.... ...++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 34688999999999999999999988899999997654 335789999999999999999999999876 6789999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+++.......+++.++..|+.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999865556689999999999999999999999 99999999999999999999999999998765332222
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+..... ..+ .+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i-~~~---------~~ 482 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV-ERG---------YR 482 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHH-HTT---------CC
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-HcC---------CC
Confidence 334457789999999999999999999999999999999 8999864321 1222111 111 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
...+..++..+.+++.+||+.||++|||+++|++.|+++..
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 22344566789999999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=353.90 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=214.7
Q ss_pred cCCCCCccccccCCCccEEEEEE------CCCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (963)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35799999999999999999975 3478999999975543 3457789999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 753 MFLIYNYLPGGNLENFIQQRST----------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
.++||||+++|+|.+++..... ..+++.++..++.|+++||+|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999987542 2489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q 046851 817 DDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNG 894 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~ 894 (963)
+.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence 99999999999999876544332 2334567889999999999999999999999999999999 99998744221
Q ss_pred cchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.......... .....+...+..+.+++.+||+.||++|||+.|++++|+++..
T Consensus 255 ----~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 255 ----SKFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp ----HHHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hHHHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1111111111 1112233456789999999999999999999999999988643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=354.12 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=206.9
Q ss_pred HHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeE
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEM 753 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (963)
...++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34568999999999999999999875 68999999997643 23456778899998877 899999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999874 3589999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.........
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~----- 234 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN----- 234 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC-----
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC-----
Confidence 3222 234456899999999999999999999999999999999999999974321 12222221111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMK-QVVR 953 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 953 (963)
...+...+.++.+++.+||+.||++||++. |+.+
T Consensus 235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 112334556789999999999999999997 6653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.41 Aligned_cols=245 Identities=26% Similarity=0.372 Sum_probs=207.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 47999999999999999999775 69999999997542 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999874 4589999999999999999999999 999999999999999999999999999987542
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~--------- 219 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE--------- 219 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC---------
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC---------
Confidence 2334679999999999999999999999999999999999999997432 122222222211
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+.....++.+++.+|++.||++|| +++|++++
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 112334456789999999999999999 88888754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=346.48 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=207.0
Q ss_pred cCCCCCccccccCCCccEEEEEECC----CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ....+++.+|++++++++||||+++++++.+. ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 3579999999999999999997542 3469999987653 34567899999999999999999999998754 5689
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++++|.+++.... ..+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999998653 4589999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
..........+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .... ......
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~---~~~~~~------ 231 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIG---VLEKGD------ 231 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHH---HHHHTC------
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHH---HHhcCC------
Confidence 44444444567889999999999999999999999999999998 99998643221 1111 111111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
....+...+..+.+++.+||+.||++||++.|++++|+++.+
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 ----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 111233455679999999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=359.63 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=212.0
Q ss_pred HcCCCCCccccccCCCccEEEEEE------CCCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCC
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASET 751 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (963)
..++|++.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346899999999999999999976 246789999997543 23446789999999999 8999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccC
Q 046851 752 EMFLIYNYLPGGNLENFIQQRST---------------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVK 810 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 810 (963)
..++||||+++|+|.+++..... ..+++.++..++.|+++||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999986532 2378999999999999999999999 99999999
Q ss_pred CCCeEECCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 046851 811 PSNILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSF 888 (963)
Q Consensus 811 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~ 888 (963)
|+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876433322 2334567889999999999999999999999999999998 999987442
Q ss_pred CCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 889 SSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
.. .........+ .....+...+..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 280 ~~--------~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VD--------ANFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CS--------HHHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cH--------HHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 21 1111122221 11222344567899999999999999999999999999987553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=360.26 Aligned_cols=246 Identities=21% Similarity=0.164 Sum_probs=177.4
Q ss_pred CCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCccccccc---ceeeccccccccCCcccccc
Q 046851 18 LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLK---RVYLSFNRLVGSVPSKIGEK 94 (963)
Q Consensus 18 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~---~L~L~~n~l~~~~p~~~~~~ 94 (963)
-|+.+ ..++|++|++++|.+ +.+|.+|+++++|++|++++|.+.+.+|..+++++ .+++.+|..
T Consensus 4 ~p~~~-~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~----------- 70 (454)
T 1jl5_A 4 NPRNV-SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD----------- 70 (454)
T ss_dssp --------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------
T ss_pred ccccc-ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------
Confidence 34545 458999999999999 59999999999999999999999999998887654 446655542
Q ss_pred CCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEe
Q 046851 95 CTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILV 174 (963)
Q Consensus 95 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 174 (963)
.++++|++++|++++ +|.. .++|+.|++++|++++ +|.. +++|++|++++|.+++ +|.. .++|++|+
T Consensus 71 -~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~ 137 (454)
T 1jl5_A 71 -RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLG 137 (454)
T ss_dssp -HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEE
T ss_pred -cCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEE
Confidence 468999999999985 4542 4789999999999997 5543 4899999999999984 3332 27899999
Q ss_pred ecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCccc
Q 046851 175 LSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNF 254 (963)
Q Consensus 175 l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 254 (963)
+++ |.+.+ +| .+.++++|+.|++++|++++ +|..+ .+|++|++++|+
T Consensus 138 L~~---------------------------n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~ 184 (454)
T 1jl5_A 138 VSN---------------------------NQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQ 184 (454)
T ss_dssp CCS---------------------------SCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSC
T ss_pred CcC---------------------------CCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCc
Confidence 998 55554 56 59999999999999999986 45433 599999999999
Q ss_pred ccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccC
Q 046851 255 FSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESY 328 (963)
Q Consensus 255 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~ 328 (963)
++.++ .|+.+++|+.|++++|++++.+.. .++|+.|++++|++... |.+..+.+|+.|++++|.+..+
T Consensus 185 l~~l~--~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~n~l~~l-p~~~~l~~L~~L~l~~N~l~~l 252 (454)
T 1jl5_A 185 LEELP--ELQNLPFLTAIYADNNSLKKLPDL---PLSLESIVAGNNILEEL-PELQNLPFLTTIYADNNLLKTL 252 (454)
T ss_dssp CSSCC--CCTTCTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCSSC
T ss_pred CCcCc--cccCCCCCCEEECCCCcCCcCCCC---cCcccEEECcCCcCCcc-cccCCCCCCCEEECCCCcCCcc
Confidence 99976 589999999999999999874432 25899999999999954 4699999999999999887654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=357.53 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=204.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 58999999999999999999776 789999999865433 2346688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC-C
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE-T 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-~ 838 (963)
+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+.... .
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999764 4589999999999999999999999 99999999999999999999999999998654322 2
Q ss_pred cccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||...... ......+ ....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~----~~~~--------- 225 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDW----KEKK--------- 225 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT---SHHHHHH----HTTC---------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHH----hccc---------
Confidence 22345679999999999988765 77899999999999999999999744322 1111111 1110
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
............+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0001112345678899999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=354.40 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=206.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 47999999999999999999765 58899999986543 234577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999999863 4599999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcccccccccccccCcccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 838 THATTGVAGTFGYVAPEYAMT---CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ............
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~~~~~~~------- 235 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----SSKEIVHTFETT------- 235 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----CHHHHHHHHHHC-------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhhc-------
Confidence 23345689999999999974 45889999999999999999999999743222 112222211111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-MKQVVR 953 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 953 (963)
....+...+..+.+++.+||+.||++||+ ++++.+
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11233445678999999999999999998 666654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=355.84 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=212.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC--------CCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS--------PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASE 750 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (963)
.++|++.+.||+|+||.||+|... ++..||||++.... ....+++.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 358999999999999999999763 46789999997553 34457789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRST--------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
+..++||||+++|+|.+++..... ..+++.++..++.|+++||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999986532 3489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCC
Q 046851 817 DDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNG 894 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~ 894 (963)
+.++.+||+|||++......... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------ 264 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 264 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC------
Confidence 99999999999999876543322 2233457889999999998889999999999999999999 999986431
Q ss_pred cchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
..+...... .+. ....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 265 --~~~~~~~~~-~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 265 --VEELFKLLK-EGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp --HHHHHHHHH-HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHh-cCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112221111 111 11223445668999999999999999999999999998864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=365.57 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=210.4
Q ss_pred HHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC
Q 046851 676 SVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET 751 (963)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (963)
++....++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999876 588999999865321 22345789999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
..++||||++||+|.++++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999753 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccccCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCR----VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
.............+||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ..........
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~ 288 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNH 288 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHHHHHhc
Confidence 77654444445678999999999998765 77899999999999999999999974321 1222222111
Q ss_pred CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046851 908 GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLST--RPTMKQVVRR 954 (963)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 954 (963)
... .........+.++.+++.+|+..+|++ ||+++||+++
T Consensus 289 ~~~-------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 289 KNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHH-------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccc-------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 100 000111234567889999999999998 9999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=351.67 Aligned_cols=252 Identities=20% Similarity=0.268 Sum_probs=207.9
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.++|++.+.||+|+||.||+|... +|+.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 358999999999999999999765 58899999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC--CCcEEEeecccccccCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD--DFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~ 837 (963)
+++|+|.+++... ...+++.++..++.|+++|++|||++ +|+||||||+||+++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999764 34689999999999999999999999 9999999999999997 7899999999998775433
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .+......... .. ++..
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~-~~--~~~~ 225 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAE-YT--FDEE 225 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTC-CC--CCHH
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHcCC-CC--CChh
Confidence 23345789999999999998889999999999999999999999974321 22222222211 00 0000
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ....+.++.+++.+|++.||++|||+.|++++
T Consensus 226 ~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 A----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 01235678899999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=366.05 Aligned_cols=263 Identities=19% Similarity=0.260 Sum_probs=212.1
Q ss_pred hHHHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeC
Q 046851 674 FESVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749 (963)
Q Consensus 674 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 749 (963)
+.++....++|++.++||+|+||+||+|+.. +++.||||++..... .....+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444455678999999999999999999876 478999999975322 222347899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccc
Q 046851 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829 (963)
Q Consensus 750 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 829 (963)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999999864 34599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
++.............+||+.|+|||++. +..++.++||||+||++|||++|+.||..... .+.....
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------~~~~~~i 293 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKI 293 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--------hHHHHhh
Confidence 9877655554555578999999999997 45689999999999999999999999974321 1222122
Q ss_pred HhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046851 905 LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLST--RPTMKQVVRR 954 (963)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 954 (963)
........ ........+.++.+++.+|+..+|++ ||+++|++++
T Consensus 294 ~~~~~~~~------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHKERFQ------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHHHHCC------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhcccccc------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11100000 00111234567889999999888888 9999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.85 Aligned_cols=267 Identities=26% Similarity=0.386 Sum_probs=215.6
Q ss_pred CCCCCccccccCCCccEEEEEE-----CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeee--CCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-----SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA--SETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 754 (963)
++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4799999999999999999984 368899999998776666778999999999999999999999876 456789
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++++|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999998743 3589999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC------CCCcchhhHHHHHHh
Q 046851 835 PSETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSY------GNGFNIVAWGCMLLR 906 (963)
Q Consensus 835 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~ 906 (963)
..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ...........
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 254 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL---- 254 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH----
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH----
Confidence 43322 2234568889999999999889999999999999999999999986432110 00000001111
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
..+........+...+..+.+++.+||+.||++|||+.|++++|+++..+
T Consensus 255 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 255 -----ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp -----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred -----HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 11122222334556677899999999999999999999999999987553
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=360.91 Aligned_cols=253 Identities=24% Similarity=0.294 Sum_probs=206.9
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45799999999999999999966 4789999999976542 34567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC---CCCcEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD---DDFNAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~ 834 (963)
||+++|+|.+++..+ ..+++.++..++.|+++|++|||++ +|+||||||+||+++ .++.+||+|||++....
T Consensus 90 E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999874 4599999999999999999999999 999999999999998 56789999999998765
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ....... ..+... .
T Consensus 165 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i-~~~~~~-~- 232 (444)
T 3soa_A 165 GEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQI-KAGAYD-F- 232 (444)
T ss_dssp TTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHH-HHTCCC-C-
T ss_pred CCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHH-HhCCCC-C-
Confidence 432 233456799999999999999999999999999999999999999964321 1222221 111110 0
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .......+..+.+++.+||+.||++|||+.|++++
T Consensus 233 ~----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 P----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp C----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 11112345678899999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.65 Aligned_cols=261 Identities=17% Similarity=0.222 Sum_probs=210.6
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|++.+.++ +|++++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35799999999999999999975 5799999998865432 24578899999999 79999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc-----EEEeeccccccc
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN-----AYLSDFGLARLL 833 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgla~~~ 833 (963)
|+ +++|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999998653 4589999999999999999999999 9999999999999987776 999999999876
Q ss_pred CCCCC------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 834 GPSET------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 834 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEKKQS 239 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHHHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc--ccHHHHHHHHhhccC
Confidence 54332 1234567999999999999999999999999999999999999999754322 011111111111111
Q ss_pred CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 908 GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
..... . ....+..+.+++.+||+.||++||++++|++.|+++.
T Consensus 240 ~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 240 TPLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp SCHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccHHH-----H----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 11000 0 1134568899999999999999999999999998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.67 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=202.5
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47899999999999999999888899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++ +|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 976 9999997643 4589999999999999999999999 999999999999999999999999999987653222
Q ss_pred ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc---cc---
Q 046851 840 ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA---KE--- 912 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--- 912 (963)
......||+.|+|||++.+. .++.++||||+|+++|||++|+.||...... .....+......... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-----DQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHHCCCChhhchhhhc
Confidence 22334689999999999764 5899999999999999999999999743211 111111111110000 00
Q ss_pred --eecccc-------CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 --FFTAGL-------WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 --~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..++.. ........+.++.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001100 001112345678899999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.50 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=207.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch------hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ------GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
+.|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46999999999999999999775 6899999999754322 3578999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC----cEEEeecccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF----NAYLSDFGLA 830 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla 830 (963)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999763 4589999999999999999999999 999999999999999887 7999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .+......... .
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~-~ 234 (326)
T 2y0a_A 166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVN-Y 234 (326)
T ss_dssp EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHTC-C
T ss_pred eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHHhcC-C
Confidence 8765332 23345799999999999999999999999999999999999999964321 11111111111 0
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. +.... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 235 -~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 -E-FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -C-CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -C-cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00000 11234578899999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=358.02 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=213.4
Q ss_pred HHHcCCCCCccccccCCCccEEEEEECC------CcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC
Q 046851 678 VQATGNFNASNCIGNGGFGATYKAEISP------GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS 749 (963)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 749 (963)
....++|++.+.||+|+||.||+|.... +..||+|++..... ...+.+.+|+++++++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345789999999999999999997642 24799999976533 3457789999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 750 ETEMFLIYNYLPGGNLENFIQQRS------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 750 ~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 999999999999999999997643 24579999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCc
Q 046851 818 DDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGF 895 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~ 895 (963)
.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----- 273 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN----- 273 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-----
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-----
Confidence 9999999999999866433222 2334567889999999999999999999999999999998 88898643221
Q ss_pred chhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 896 NIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.........+ .....+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 274 ---~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 274 ---SKFYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp ---HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1111111111 111223344568899999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=350.47 Aligned_cols=245 Identities=20% Similarity=0.292 Sum_probs=207.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 47999999999999999999875 68999999997543 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999998753 589999999999999999999999 9999999999999999999999999999876432
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+........ .
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~-~-------- 254 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSG-K-------- 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-C--------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcC-C--------
Confidence 234579999999999999999999999999999999999999997432 12222222211 1
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
...+...+..+.+++.+||+.||++||+ ++|++++
T Consensus 255 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1123345668899999999999999998 8888764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=358.98 Aligned_cols=267 Identities=18% Similarity=0.247 Sum_probs=207.0
Q ss_pred cCCCCCccccccC--CCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 681 TGNFNASNCIGNG--GFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.++|++.+.||+| +||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4579999999999 99999999876 69999999997653 2345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++|+|.+++.......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999886556799999999999999999999999 999999999999999999999999999865422
Q ss_pred CC------CcccccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 836 SE------THATTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 836 ~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
.. ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .............
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~ 256 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKLNGTVPC 256 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST----THHHHC-------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCCCCc
Confidence 11 111223478999999999987 67899999999999999999999999754322 0011000000000
Q ss_pred ----------------------Ccccceec---------cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 ----------------------GRAKEFFT---------AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ----------------------~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......+. .......+......+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000000 000001223345678999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=356.75 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=206.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-----hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-----QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
+.|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 47999999999999999999765 689999999864321 235788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc---EEEeecccc
Q 046851 756 IYNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN---AYLSDFGLA 830 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla 830 (963)
||||+++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886543 34589999999999999999999999 9999999999999987654 999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ +..
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~~-~~~ 249 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGIIK-GKY 249 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHHH-TCC
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHHc-CCC
Confidence 8775432 223445799999999999999999999999999999999999999974311 11111111 111
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ..+... ...+..+.+++.+||+.||++|||+.|++++
T Consensus 250 ~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000000 1234678899999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=353.48 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=207.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999765 68999999997543 234567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC---cEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF---NAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~~ 834 (963)
||+++|+|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999764 4589999999999999999999999 999999999999998654 59999999998765
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ .+... .
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~-~~~~~-~- 249 (362)
T 2bdw_A 183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIK-AGAYD-Y- 249 (362)
T ss_dssp TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HTCCC-C-
T ss_pred CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-hCCCC-C-
Confidence 332 23346799999999999999999999999999999999999999974321 12221111 11110 0
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .......+.++.+++.+||+.||++||++.|++++
T Consensus 250 ~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 P----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp C----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred C----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00112345678999999999999999999999865
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=346.37 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=202.8
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-CeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-TEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|+.. |+.||||++.... ..+.+.+|++++++++||||+++++++... +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 47999999999999999999886 8999999987543 457889999999999999999999987554 5789999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++++|.+++.......+++..+..++.|+++|++|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 999999999876544588999999999999999999999 99999999999999999999999999997654321
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... +.... ...+ ..
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~-~~~~---------~~ 232 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPR-VEKG---------YK 232 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GHHHH-HTTT---------CC
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH-HhcC---------CC
Confidence 22357889999999999999999999999999999998 99998643211 11111 1111 11
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
...+...+..+.+++.+||+.||++||++.|+++.|++++.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 22334556789999999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.12 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=207.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 755 (963)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+..|.+++..+ +||+|+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999876 47899999997542 23456788999999988 79999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||++||+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999998753 489999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.........
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~------- 237 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN------- 237 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-------
T ss_pred C-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC-------
Confidence 2 223445689999999999999999999999999999999999999997432 122222222211
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
...+...+.++.+++.+||+.||++||+ ++|++++
T Consensus 238 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1123345678899999999999999995 4676654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=354.79 Aligned_cols=267 Identities=26% Similarity=0.398 Sum_probs=211.3
Q ss_pred CCCccccccCCCccEEEEEEC-----CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeEEE
Q 046851 684 FNASNCIGNGGFGATYKAEIS-----PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEMFL 755 (963)
Q Consensus 684 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 755 (963)
|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999998653 588999999976533 445778999999999999999999999976 467899
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++|+|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999764 389999999999999999999999 999999999999999999999999999988754
Q ss_pred CCCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... ......+++.|+|||++.+..++.++||||+|+++|||++|+.||....... .....+.............
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF---LELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---hhhhcccccchhHHHHHHH
Confidence 4322 2334567889999999999899999999999999999999999986432110 0000000000000111122
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
++.......+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2222333345566778999999999999999999999999998864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.04 Aligned_cols=253 Identities=24% Similarity=0.278 Sum_probs=197.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.++|++.+.||+|+||.||+|... +|+.||||++...... .+.+.+|+..+++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 458999999999999999999776 7899999999754432 35678999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc--EEEeecccccccCCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN--AYLSDFGLARLLGPSE 837 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~~~~~~ 837 (963)
+++|+|.+++.... .+++.++..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999997643 489999999999999999999999 9999999999999987765 999999999754322
Q ss_pred CcccccccccccccCccccccCCCCcc-hhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDK-ADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.......||+.|+|||++.+..++.+ +||||+||++|||++|+.||...... ..............
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~~~~~~~-------- 238 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----RDYRKTIQRILSVK-------- 238 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C----CCHHHHHHHHHTTC--------
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhcCC--------
Confidence 22334579999999999988887665 89999999999999999999754322 12222222222111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+..+.+++.+||+.||++|||+.|++++
T Consensus 239 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 -YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1111112345678899999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=351.26 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=206.1
Q ss_pred CCCCCccccccCCCccEEEEEECC-C-------cEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP-G-------VLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
++|++.+.||+|+||.||+|.... + ..||+|++........+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 478999999999999999996542 3 57999999877667778899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc--------EEEe
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN--------AYLS 825 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~ 825 (963)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999998753 3489999999999999999999999 9999999999999998887 9999
Q ss_pred ecccccccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 826 DFGLARLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 826 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
|||++...... ....|++.|+|||++.+ ..++.++||||+|+++|||++|+.|+...... .......
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~~~~~ 231 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRKLQFY 231 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHH
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HHHHHHh
Confidence 99998754321 23457889999999987 67899999999999999999976555422111 1111111
Q ss_pred HhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCCC
Q 046851 905 LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPAS 962 (963)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~~ 962 (963)
.... ..+...+.++.+++.+||+.||++|||+.|++++|+++....
T Consensus 232 ~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 232 EDRH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HTTC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred hccC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111 111122346789999999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=353.64 Aligned_cols=264 Identities=23% Similarity=0.373 Sum_probs=210.4
Q ss_pred CCCCCccccccCCCccEEEEEE-----CCCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC--CeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-----SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE--TEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 753 (963)
..|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3588999999999999999984 368999999987543 33457889999999999999999999999876 678
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999997653 4589999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCC--cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC------CCCCcchhhHHHHHH
Q 046851 834 GPSET--HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS------YGNGFNIVAWGCMLL 905 (963)
Q Consensus 834 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~ 905 (963)
..... .......||..|+|||++.+..++.++||||+|+++|||++|+.|+...... ...............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 54432 2233456888999999999999999999999999999999999886432110 000000111111111
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
. .......+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 257 ~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 257 K---------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp H---------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred h---------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1 1112223445667899999999999999999999999999876
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=355.54 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=209.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+.|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 57999999999999999999765 68999999998766556678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC--CCcEEEeecccccccCCCCC
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD--DFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~ 838 (963)
++|+|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++........
T Consensus 131 ~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 131 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999999999754 34589999999999999999999999 9999999999999974 56799999999987654332
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+......... .. ++
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~~~-~~--~~--- 270 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCD-WE--FD--- 270 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCC-CC--CC---
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-CC--CC---
Confidence 233479999999999999999999999999999999999999997432 112222221111 00 11
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.......+.++.+++.+||+.||++|||+.|++++
T Consensus 271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11122345678999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=349.76 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=200.3
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46889999999999999999887 789999998643 345788999999999999999999999874 4789999999
Q ss_pred CCChHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc-EEEeecccccccCCCCCc
Q 046851 762 GGNLENFIQQRST-RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN-AYLSDFGLARLLGPSETH 839 (963)
Q Consensus 762 ~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgla~~~~~~~~~ 839 (963)
+|+|.+++..... ..+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986432 24789999999999999999999932129999999999999998886 799999999765322
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......... .+..
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~-~~~~--------- 222 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWAVH-NGTR--------- 222 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHHHH-TTCC---------
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHHHh-cCCC---------
Confidence 22346899999999999999999999999999999999999999743221 111111111 1111
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
...+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11223445678999999999999999999999999988653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=361.01 Aligned_cols=262 Identities=20% Similarity=0.225 Sum_probs=210.0
Q ss_pred hHHHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeC
Q 046851 674 FESVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749 (963)
Q Consensus 674 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 749 (963)
+++.....++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444445678999999999999999999875 699999999975322 223457889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccc
Q 046851 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829 (963)
Q Consensus 750 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 829 (963)
.+..++||||+++|+|.+++.+.+ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999998653 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccc-------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHH
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAM-------TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGC 902 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 902 (963)
++.............+||+.|+|||++. +..++.++||||+||++|||++|+.||..... .+...
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~ 280 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AETYG 280 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 9887654444445568999999999997 35688999999999999999999999974321 11111
Q ss_pred HHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 046851 903 MLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTR---PTMKQVVRR 954 (963)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~ 954 (963)
.......... ....+...+.++.+++.+||. +|++| |+++|++++
T Consensus 281 ~i~~~~~~~~------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHYKEHLS------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTHHHHCC------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhcccCcC------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1111100000 001122345688999999999 99998 589998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=354.47 Aligned_cols=265 Identities=20% Similarity=0.328 Sum_probs=215.4
Q ss_pred HHHHHHcCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEee
Q 046851 675 ESVVQATGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYH 747 (963)
Q Consensus 675 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 747 (963)
++.....++|++.+.||+|+||.||+|.+. +++.||||++..... ....++.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 334445678999999999999999999654 378899999975432 3456789999999999999999999999
Q ss_pred eCCCeEEEEEeccCCCChHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC
Q 046851 748 ASETEMFLIYNYLPGGNLENFIQQRS--------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD 819 (963)
Q Consensus 748 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 819 (963)
.+.+..++||||+++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 99999999999999999999997643 14578999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcch
Q 046851 820 FNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNI 897 (963)
Q Consensus 820 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~ 897 (963)
+.+||+|||++......... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... .
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~ 246 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------N 246 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------H
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC--------H
Confidence 99999999999865433222 2233457889999999999999999999999999999999 788886331 1
Q ss_pred hhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 898 VAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
........ .+.. ...+...+..+.+++.+||+.||++|||+.|++++|+++..
T Consensus 247 ~~~~~~~~-~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 EQVLRFVM-EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHH-TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHH-cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 12221111 1111 12234456788999999999999999999999999988643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=354.27 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=204.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcE----EEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVL----VAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 47899999999999999999764 3443 7888775432 233356788999999999999999999986 456899
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999997642 3588999999999999999999999 999999999999999999999999999988754
Q ss_pred CCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... ......|++.|+|||++.+..++.++||||+|+++|||++ |+.||...... ... .....+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~-~~~~~~----- 233 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--------EVP-DLLEKG----- 233 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--------HHH-HHHHTT-----
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--------HHH-HHHHcC-----
Confidence 4322 2344567889999999999999999999999999999999 99999743221 111 111111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.....+..++..+.+++.+||+.||++||++.|++++|+++.
T Consensus 234 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 234 ----ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223334456789999999999999999999999998865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=340.64 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=204.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47899999999999999999775 689999999975432 334678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++ ++.+++... ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9976 677766553 34699999999999999999999999 99999999999999999999999999998765332
Q ss_pred cccccccccccccCccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc---cee
Q 046851 839 HATTGVAGTFGYVAPEYAMTCR-VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK---EFF 914 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 914 (963)
.......||+.|+|||++.+.. ++.++||||+|+++|||++|+.|+...... ......+.......... ...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH----HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHHhCCCChhhhhhhc
Confidence 2234457899999999998765 799999999999999999999887533211 11111111111100000 000
Q ss_pred ------------ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 ------------TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...............+.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000111122355678899999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=348.02 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=197.3
Q ss_pred CCCCCccccccCCCccEEEEEE----CCCcEEEEEEeeccc----chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI----SPGVLVAIKRLAVGR----FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|++++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5799999999999999999987 478999999997542 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999874 3589999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ...........
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~----- 237 (327)
T 3a62_A 172 IHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILKCK----- 237 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC-----
T ss_pred ccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCC-----
Confidence 3222 223445799999999999999999999999999999999999999974321 12222222111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+...+..+.+++.+||+.||++|| ++.|++++
T Consensus 238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 112334556889999999999999999 77788764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=351.07 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=203.8
Q ss_pred CCCCCccccccCCCccEEEEEECC-----CcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP-----GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.+|+..+.||+|+||.||+|.... +..||||++..... .....+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467788999999999999997642 34699999875433 345678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++|+|.+++... ...+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999864 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 836 SETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 836 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+..... ..+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~-~~~---- 266 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAI-NDG---- 266 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHH-HTT----
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHH-HCC----
Confidence 3221 2223346789999999999999999999999999999999 9999863321 1111111 111
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.....+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus 267 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 267 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223455678999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=346.44 Aligned_cols=264 Identities=22% Similarity=0.366 Sum_probs=192.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 458999999999999999999765 689999999975433 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 759 YLPGGNLENFIQQRS----TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
|++ |+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999997653 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc---c
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR---A 910 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 910 (963)
.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+........ .
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-----EQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCTTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCChhHh
Confidence 3322 22345789999999999864 6899999999999999999999999743221 11111111110000 0
Q ss_pred cce-----ecccc------------CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEF-----FTAGL------------WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~-----~~~~~------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... ..... ....+.....++.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 00000 000111235578999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.76 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=198.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--------------------------hHHHHHHHHHHHhc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--------------------------GVQQFHAEIKTLGR 734 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~ 734 (963)
++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 58999999999999999999764 6899999998654311 13568899999999
Q ss_pred cCCCCeeEEEEeeeC--CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCC
Q 046851 735 LRHPNLVTLIGYHAS--ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPS 812 (963)
Q Consensus 735 l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 812 (963)
++||||+++++++.+ .+..++||||+++++|.+++. ...+++.++..++.|+++||+|||++ +|+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 999999999999876 578999999999999988654 34689999999999999999999999 9999999999
Q ss_pred CeEECCCCcEEEeecccccccCCCCCcccccccccccccCccccccCC---CCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 046851 813 NILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR---VSDKADVYSYGVVLLELLSDKKALDPSFS 889 (963)
Q Consensus 813 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~p~~~~~~ 889 (963)
||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~- 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER- 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-
Confidence 99999999999999999987654322 233457999999999998765 3678999999999999999999997431
Q ss_pred CCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 890 SYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...... .... .......+.++.+++.+||+.||++|||+.|++++
T Consensus 245 -------~~~~~~~~~~-~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 -------IMCLHSKIKS-QALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -------HHHHHHHHHH-CCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -------HHHHHHHHhc-ccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1122111111 1110 01112345678999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=355.27 Aligned_cols=251 Identities=19% Similarity=0.334 Sum_probs=200.1
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCC--CCeeEEEEeeeCCCeEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRH--PNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 756 (963)
.++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++.+++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35799999999999999999988889999999987543 3345778999999999986 9999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
||+ .+++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 88 ~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 578999999874 4689999999999999999999999 999999999999997 678999999999876543
Q ss_pred CCc-ccccccccccccCcccccc-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 837 ETH-ATTGVAGTFGYVAPEYAMT-----------CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 837 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~ 233 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHAI 233 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHH
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHHHHHHH
Confidence 322 2335679999999999865 6788999999999999999999999964321 11111111
Q ss_pred HhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. +.......+......+.+++.+||+.||++|||+.|++++
T Consensus 234 ~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 I---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp H---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred h---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 1112222333445678899999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.32 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=209.5
Q ss_pred CCCCCcc-ccccCCCccEEEEEEC---CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASN-CIGNGGFGATYKAEIS---PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|.+.+ .||+|+||.||+|... ++..||||++.... ....+++.+|++++++++||||+++++++. .+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence 3566666 8999999999999753 57889999997643 345678899999999999999999999994 5678999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999753 34589999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCcc--cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 837 ETHA--TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 837 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... +.... ...+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~-i~~~----- 229 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAF-IEQG----- 229 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHH-HHTT-----
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHH-HhcC-----
Confidence 3322 223456889999999998889999999999999999998 99998743221 11111 1111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.....+...+..+.+++.+||+.||++||++.+++++|+++.
T Consensus 230 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 230 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112234456678999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=348.32 Aligned_cols=269 Identities=22% Similarity=0.330 Sum_probs=203.6
Q ss_pred HHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhcc--CCCCeeEEEEeeeCC----C
Q 046851 678 VQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL--RHPNLVTLIGYHASE----T 751 (963)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~ 751 (963)
....++|++.+.||+|+||.||+|... |+.||||++.... ...+..|.+++... +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334568999999999999999999887 8999999986443 23445555555554 899999999998776 7
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecccCCCCeEECCCCcEEEee
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC-----VPRVLHRDVKPSNILLDDDFNAYLSD 826 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~D 826 (963)
..++||||+++|+|.++++.. .+++.++..++.|++.||+|||+++ .++|+||||||+||+++.++.+||+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 899999999999999999763 4899999999999999999999762 34899999999999999999999999
Q ss_pred cccccccCCCCCcc---cccccccccccCccccccCCCCcc------hhhHHHHHHHHHHHcCC----------CCCCCC
Q 046851 827 FGLARLLGPSETHA---TTGVAGTFGYVAPEYAMTCRVSDK------ADVYSYGVVLLELLSDK----------KALDPS 887 (963)
Q Consensus 827 fgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~il~elltg~----------~p~~~~ 887 (963)
||+++......... .....||+.|+|||++.+.....+ +|||||||++|||++|+ .||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998765433221 234579999999999988766655 99999999999999994 444432
Q ss_pred CCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 888 FSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
... ... ................+... ..+..++.++.+++.+||+.||++|||+.||+++|+++..
T Consensus 266 ~~~---~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 266 VPS---DPS-YEDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SCS---SCC-HHHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCC---CCc-hhhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 221 111 11111111111111111000 0123677889999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=353.92 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=199.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC--------
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET-------- 751 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 751 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 47899999999999999999876 799999999975443 34578999999999999999999999875433
Q ss_pred -------------------------------------------------eEEEEEeccCCCChHHHHhhhcC-CCCCHHH
Q 046851 752 -------------------------------------------------EMFLIYNYLPGGNLENFIQQRST-RAVDWRV 781 (963)
Q Consensus 752 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~ 781 (963)
..++||||+++|+|.+++..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 37999999999999999987542 3356778
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC-----------cccccccccccc
Q 046851 782 LHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET-----------HATTGVAGTFGY 850 (963)
Q Consensus 782 ~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~y 850 (963)
+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 899999999999999999 999999999999999999999999999987754421 223345799999
Q ss_pred cCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHH
Q 046851 851 VAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEV 930 (963)
Q Consensus 851 ~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 930 (963)
+|||++.+..++.++||||+|+++|||++|..|+.. ..... ......... .........+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~-~~~~~~~~~---------~~~~~~~~~~ 302 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRII-TDVRNLKFP---------LLFTQKYPQE 302 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHH-HHHHTTCCC---------HHHHHHCHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHH-HHhhccCCC---------cccccCChhH
Confidence 999999999999999999999999999998765421 01111 111111111 0112334567
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 046851 931 LHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 931 ~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+++.+||+.||++|||++|++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.04 Aligned_cols=261 Identities=24% Similarity=0.337 Sum_probs=209.2
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeee----CCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA----SETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|++++++++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 5799999999999999999976 579999999997766666788999999999999999999999986 34578999
Q ss_pred EeccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 757 YNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
|||+++|+|.+++... ....+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 9999999999999764 245689999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCc--------ccccccccccccCccccccCC---CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 835 PSETH--------ATTGVAGTFGYVAPEYAMTCR---VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 835 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
..... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ..... .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~----~ 258 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVA----L 258 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHH----H
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhh----H
Confidence 21111 112235799999999987654 688999999999999999999998632111 00010 1
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
.... ......+...+..+.+++.+||+.||++|||+.+++++|+++++.
T Consensus 259 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 259 AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 1111 111112234456899999999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=361.00 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=207.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999876 799999999975432 33567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999763 4589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ........ .+..
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~-~~~~------ 233 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKIC-DGIF------ 233 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHH-TTCC------
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHh-cCCc------
Confidence 2334579999999999998765 6899999999999999999999974321 11221111 1111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+......+.+++.+||+.||++|||++|++++
T Consensus 234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1233345678999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=345.63 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=201.6
Q ss_pred HcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc-----hhHHHHHHHHHHHhcc---CCCCeeEEEEeeeCC
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF-----QGVQQFHAEIKTLGRL---RHPNLVTLIGYHASE 750 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 750 (963)
..++|++.+.||+|+||+||+|.. .+|+.||||++..... .....+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 456899999999999999999976 4689999999874331 1124566777776666 499999999998765
Q ss_pred C-----eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEe
Q 046851 751 T-----EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825 (963)
Q Consensus 751 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 825 (963)
. ..++||||++ ++|.+++.......+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5799999997 5999999887666699999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 826 DFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 826 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+....
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~ 235 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQLGKIFDLI 235 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-----HHHHHHHHHH
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHh
Confidence 999998764332 234457899999999999999999999999999999999999999743221 1111111111
Q ss_pred hcCccccee------ccccCC--C-----CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 906 RQGRAKEFF------TAGLWD--A-----GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 906 ~~~~~~~~~------~~~~~~--~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.......+. ...... . ........+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 110000000 000000 0 012345678899999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.00 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=199.9
Q ss_pred HcCCCCCccccccCCCccEEEEEECCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
..++|++.+.||+|+||.||+|... ..||||++.... ....+.+.+|++++++++||||+++++++. ....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 3468999999999999999999865 359999987543 344577999999999999999999999764 55689999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999754 35689999999999999999999999 99999999999999999999999999998654322
Q ss_pred -CcccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 838 -THATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 838 -~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
........||+.|+|||.+. +..++.++||||+|+++|||++|+.||...... .........+.....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--------DQIIEMVGRGSLSPD 246 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--------HHHHHHHHHTSCCCC
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcccccCcc
Confidence 22234457899999999987 567888999999999999999999999743211 112222222211111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.......++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 247 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 -----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111233456789999999999999999999999999998864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=352.98 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=200.2
Q ss_pred CccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCCCC
Q 046851 686 ASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGN 764 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 764 (963)
..+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3568999999999999764 689999999987766667889999999999999999999999999999999999999999
Q ss_pred hHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE--CCCCcEEEeecccccccCCCCCcccc
Q 046851 765 LENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL--DDDFNAYLSDFGLARLLGPSETHATT 842 (963)
Q Consensus 765 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgla~~~~~~~~~~~~ 842 (963)
|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+++....... ..
T Consensus 173 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 173 LFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp EHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 999987643 3589999999999999999999999 99999999999999 6778999999999987754332 23
Q ss_pred cccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCC
Q 046851 843 GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922 (963)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (963)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... . +... .
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~-~--~~~~----~ 311 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRW-D--LEDE----E 311 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCC-C--SCSG----G
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccC-C--CChh----h
Confidence 34699999999999998999999999999999999999999974321 122222222110 0 0000 1
Q ss_pred ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 923 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+.++.+++.+||+.||++|||+.|++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12345678999999999999999999999873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=356.25 Aligned_cols=266 Identities=18% Similarity=0.276 Sum_probs=206.9
Q ss_pred cCCCCCccccccCCCccEEEEEECC------CcEEEEEEeecccchhH-----------HHHHHHHHHHhccCCCCeeEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISP------GVLVAIKRLAVGRFQGV-----------QQFHAEIKTLGRLRHPNLVTL 743 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 743 (963)
.++|++.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999998764 47899999876542111 123456667788899999999
Q ss_pred EEeeeCC----CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC--
Q 046851 744 IGYHASE----TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD-- 817 (963)
Q Consensus 744 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-- 817 (963)
++++... ...++||||+ +++|.+++... ...+++.++..|+.|++.||+|||++ +|+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 9998664 4589999999 99999999874 35699999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCc------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 046851 818 DDFNAYLSDFGLARLLGPSETH------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSY 891 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~ 891 (963)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 8899999999999876432211 123456999999999999999999999999999999999999999743221
Q ss_pred CCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 892 GNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
............. ....+++..+. ....+.++.+++..||+.+|++||++.++++.|+++.
T Consensus 268 ---~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 268 ---PKYVRDSKIRYRE-NIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp ---HHHHHHHHHHHHH-CHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHhhh-hHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 1222222222211 22233332221 1234568899999999999999999999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=351.89 Aligned_cols=270 Identities=23% Similarity=0.361 Sum_probs=217.0
Q ss_pred CCChHHHHHHcCCCCCccccccCCCccEEEEEE------CCCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeE
Q 046851 671 PLSFESVVQATGNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVT 742 (963)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~ 742 (963)
++...+.....++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|++++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 344445555567899999999999999999974 3468999999976543 3456789999999999 6999999
Q ss_pred EEEeeeCCC-eEEEEEeccCCCChHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 046851 743 LIGYHASET-EMFLIYNYLPGGNLENFIQQRST--------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHR 807 (963)
Q Consensus 743 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 807 (963)
+++++...+ ..++||||+++|+|.+++..... ..+++.++..++.|+++|++|||++ +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999987654 58999999999999999987542 1278999999999999999999999 99999
Q ss_pred ccCCCCeEECCCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCC
Q 046851 808 DVKPSNILLDDDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALD 885 (963)
Q Consensus 808 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~ 885 (963)
||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||+|+++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654332 22334567889999999999999999999999999999998 999986
Q ss_pred CCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 886 PSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
..... .........+. ....+...+..+.+++.+||+.||++|||+.|++++|+++.+
T Consensus 253 ~~~~~--------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 253 GVKID--------EEFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp TCCCS--------HHHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchh--------HHHHHHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 43221 11111111111 111233445678999999999999999999999999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=345.98 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=202.6
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc---cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG---RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4799999999999999999976 47899999998753 2334567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 758 NYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 758 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||+++++|.+++... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999753 245689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......... .......
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~--- 257 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKI-EQCDYPP--- 257 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHH-HTTCSCC---
T ss_pred CC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHh-hcccCCC---
Confidence 32 222345689999999999999999999999999999999999999864321 122222221 1111111
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
......+.++.+++.+||+.||++|||+.+|++.|+++++.
T Consensus 258 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 258 -----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp -----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11233456789999999999999999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=350.02 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=191.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.+.|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 457999999999999999999876 57899999987543 346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEEEeecccccccCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~ 836 (963)
+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 130 VTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999764 4589999999999999999999999 9999999999999975 889999999999875432
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ .....
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~-~~~~~----- 269 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRIL-NCEYY----- 269 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHH-TTCCC-----
T ss_pred c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHH-hCCCc-----
Confidence 2 223457899999999999999999999999999999999999999643221 11111111 11110
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+..+.+++.+||+.||++|||+.|++++
T Consensus 270 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 -FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123445678999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.45 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=196.2
Q ss_pred CCCCccccccCCCccEEEEEEC--CC--cEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeee-CCCeEEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS--PG--VLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHA-SETEMFLI 756 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv 756 (963)
.|++.+.||+|+||.||+|.+. ++ ..||||.+.... ....+++.+|+.++++++||||+++++++. ..+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999763 22 468999886533 345678999999999999999999999865 45678999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++... ...+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999764 34588999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCc---ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 837 ETH---ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 837 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
... ......+++.|+|||++.+..++.++||||||+++|||++ |.+||...... ..... ...+.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----~~~~~----~~~~~--- 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVY----LLQGR--- 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----CHHHH----HHTTC---
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----HHHHH----HHcCC---
Confidence 221 2233467889999999999999999999999999999999 56666533211 11111 11111
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
....+..++..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112234456789999999999999999999999999988643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.47 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=201.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcE----EEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVL----VAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
++|++.+.||+|+||.||+|.+. +++. ||+|.+... .....+++.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57999999999999999999764 4443 577776533 3345678999999999999999999999998764 889
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
|+||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999998753 4589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
... .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ... .....+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~-~~~~~~----- 235 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EIS-SILEKG----- 235 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHH-HHHHTT-----
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHH-HHHHcC-----
Confidence 322 22233456889999999999999999999999999999999 99999744222 111 111111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 236 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 236 ----ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112234445668999999999999999999999999998865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.13 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=208.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC----------
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS---------- 749 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 749 (963)
.++|++.+.||+|+||.||+|... +|+.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 357999999999999999999876 79999999997654 346789999999999999999998754
Q ss_pred ------CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEE
Q 046851 750 ------ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAY 823 (963)
Q Consensus 750 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 823 (963)
....++||||+++++|.+++.......+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 44579999999999999999876666799999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 824 LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
|+|||++....... ......|++.|+|||++.+..++.++||||||+++|||++|..|+... ..+..
T Consensus 163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~~~- 229 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKFFT- 229 (284)
T ss_dssp ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHHHH-
T ss_pred ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHHHH-
Confidence 99999998765432 223456899999999999999999999999999999999999876411 11111
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
...... .+...+..+.+++.+||+.||++|||+.|++++|+.++..
T Consensus 230 ~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DLRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hhhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111111 1223345688999999999999999999999999987754
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=358.91 Aligned_cols=364 Identities=21% Similarity=0.169 Sum_probs=207.3
Q ss_pred ccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccc
Q 046851 14 LNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGE 93 (963)
Q Consensus 14 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~ 93 (963)
+....+..+..+++|++|++++|.+++. | .|..+++|++|+|++|++++....
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~~~------------------------- 82 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLDLS------------------------- 82 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCCCT-------------------------
T ss_pred cCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEccc-------------------------
Confidence 3334455677788888888888888854 4 577888888888888877743222
Q ss_pred cCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceE
Q 046851 94 KCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAIL 173 (963)
Q Consensus 94 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 173 (963)
.+++|++|+|++|+|++. + ++++++|++|++++|+++++ + +..+++|++|++++|++++. .++++++|+.|
T Consensus 83 ~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L 153 (457)
T 3bz5_A 83 QNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTEL 153 (457)
T ss_dssp TCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEE
Confidence 344444444444444432 1 44444444444444444432 1 44444444455544444431 14444444444
Q ss_pred eecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcc
Q 046851 174 VLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHN 253 (963)
Q Consensus 174 ~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N 253 (963)
++++| ...+.+ .+..+++|+.|++++|++++. | +..+++|+.|++++|
T Consensus 154 ~l~~n---------------------------~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N 201 (457)
T 3bz5_A 154 DCHLN---------------------------KKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTN 201 (457)
T ss_dssp ECTTC---------------------------SCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSS
T ss_pred ECCCC---------------------------Cccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCC
Confidence 44442 111111 234445555555555555542 2 445555555555555
Q ss_pred cccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCch
Q 046851 254 FFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTA 333 (963)
Q Consensus 254 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~ 333 (963)
+++.++ ++.+++|+.|++++|++++.+ ...+++|+.|++++|++.+.+ ...+.+|+.++++.|.++
T Consensus 202 ~l~~~~---l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~--~~~l~~L~~L~l~~n~L~------- 267 (457)
T 3bz5_A 202 NITKLD---LNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELD--VSTLSKLTTLHCIQTDLL------- 267 (457)
T ss_dssp CCSCCC---CTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEEECTTCCCS-------
T ss_pred cCCeec---cccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcC--HHHCCCCCEEeccCCCCC-------
Confidence 555542 445555555555555555532 334455555555555555433 223333443333332221
Q ss_pred hhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcc
Q 046851 334 YLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLD 413 (963)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~ 413 (963)
T Consensus 268 -------------------------------------------------------------------------------- 267 (457)
T 3bz5_A 268 -------------------------------------------------------------------------------- 267 (457)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccc
Q 046851 414 SLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLA 493 (963)
Q Consensus 414 ~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~ 493 (963)
.|++++|.+.|.+|. ..+++|+.|++++|...+.+|. ..++|+.|++++| ++|++|+++
T Consensus 268 --~L~l~~n~~~~~~~~---~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~ 326 (457)
T 3bz5_A 268 --EIDLTHNTQLIYFQA---EGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLN 326 (457)
T ss_dssp --CCCCTTCTTCCEEEC---TTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECT
T ss_pred --EEECCCCccCCcccc---cccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECC
Confidence 234445544445542 1236688888888877666663 3445666665554 578888888
Q ss_pred cccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCC
Q 046851 494 GNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPL 573 (963)
Q Consensus 494 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~ 573 (963)
+|++++ ++ ++++++|+.|++++|+|++ ++.|..|++++|.++|. ..+..|..+++++|+++|.+
T Consensus 327 ~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~i 390 (457)
T 3bz5_A 327 NTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAV 390 (457)
T ss_dssp TCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEEC
T ss_pred CCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEc
Confidence 888885 43 7788888888888888875 24566677888888765 35667778888888888888
Q ss_pred CCC
Q 046851 574 PSS 576 (963)
Q Consensus 574 p~~ 576 (963)
|..
T Consensus 391 p~~ 393 (457)
T 3bz5_A 391 SPD 393 (457)
T ss_dssp CTT
T ss_pred Chh
Confidence 764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.48 Aligned_cols=269 Identities=25% Similarity=0.388 Sum_probs=199.8
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHH--HHHHhccCCCCeeEEEEeee-----CCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAE--IKTLGRLRHPNLVTLIGYHA-----SETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~-----~~~~~~ 754 (963)
++|++.+.||+|+||.||+|+.. ++.||||++..... ..+..| +..+..++||||+++++++. .....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 58999999999999999999874 89999999875432 334444 44455689999999998542 334678
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceecccCCCCeEECCCCcEEEeecc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC------VPRVLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
+||||+++|+|.+++.... .++..+..++.|+++||+|||+.+ .++|+||||||+||+++.++.+||+|||
T Consensus 89 lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 9999999999999997643 589999999999999999999873 3489999999999999999999999999
Q ss_pred cccccCCCC-------CcccccccccccccCcccccc-------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q 046851 829 LARLLGPSE-------THATTGVAGTFGYVAPEYAMT-------CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG 894 (963)
Q Consensus 829 la~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~ 894 (963)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 998765322 122234579999999999987 355678999999999999999988876544322111
Q ss_pred cchh---------hHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 895 FNIV---------AWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 895 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.... ...............+... .......+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1111 0011111111111111100 0112346778999999999999999999999999998864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.96 Aligned_cols=259 Identities=23% Similarity=0.289 Sum_probs=202.1
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
-++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999765 689999999875432 2346789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++... ..+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999875 3589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.........|++.|+|||++.+..++.++||||||+++|||++|+.||..... .............
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~~----- 253 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQAIPR----- 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSCCCC-----
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccCCCC-----
Confidence 43344456789999999999999999999999999999999999999974321 1111222111100
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhccCC
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-TMKQVVRRLKQLQP 960 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~l~~ 960 (963)
....+...+..+.+++.+||+.||++|| +++++++.|++..+
T Consensus 254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0011233455788999999999999999 99999999987543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.31 Aligned_cols=265 Identities=22% Similarity=0.377 Sum_probs=202.7
Q ss_pred HHHHHHcCCCCCccccccCCCccEEEEEEC----CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeee
Q 046851 675 ESVVQATGNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748 (963)
Q Consensus 675 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 748 (963)
+++....++|.+.+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334445568999999999999999999654 34589999987543 334577899999999999999999999987
Q ss_pred CCC-----eEEEEEeccCCCChHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC
Q 046851 749 SET-----EMFLIYNYLPGGNLENFIQQR----STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD 819 (963)
Q Consensus 749 ~~~-----~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 819 (963)
+.+ ..++||||+++|+|.+++... ....+++.++..++.|+++||+|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 754 359999999999999999542 235689999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcch
Q 046851 820 FNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNI 897 (963)
Q Consensus 820 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~ 897 (963)
+.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------- 256 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------- 256 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-------
Confidence 99999999999876543322 2233457889999999999999999999999999999999 88888643221
Q ss_pred hhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 898 VAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.......... ....+...+..+.+++.+||+.||++|||+.+++++|+++..
T Consensus 257 -~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 257 -EMYDYLLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp -GHHHHHHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111 112233456689999999999999999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.27 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=197.5
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC----e
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET----E 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 752 (963)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35899999999999999999976 5789999999976532 33467899999999999999999999986543 3
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999998753 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 833 LGPSET--HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 833 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~ 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDPI 237 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCCCC
Confidence 654322 223345789999999999999999999999999999999999999974321 2222222222211
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHh
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV-RRLK 956 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl-~~L~ 956 (963)
... . .....+.++.+++.+||+.||++||++.+++ +.+.
T Consensus 238 ~~~---~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 238 PPS---A----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CHH---H----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred Ccc---c----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 100 0 0122456788999999999999999766655 4443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=376.34 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=204.0
Q ss_pred CCCCcc-ccccCCCccEEEEEEC---CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 683 NFNASN-CIGNGGFGATYKAEIS---PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 683 ~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+++.+|++++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999764 46789999997653 3456789999999999999999999999976 5699999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ...+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999764 35689999999999999999999999 99999999999999999999999999998765433
Q ss_pred Ccc--cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 838 THA--TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 838 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... +... ....+
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~-~i~~~------ 555 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMA-FIEQG------ 555 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHH-HHHTT------
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHH-HHHcC------
Confidence 222 222345689999999999999999999999999999998 99999743221 1111 11122
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.+...+..++.++.+++.+||+.||++||++.+|++.|+.+
T Consensus 556 ---~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 556 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 12233455677899999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.52 Aligned_cols=245 Identities=26% Similarity=0.311 Sum_probs=195.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.++||+|+||+||+|... +|+.||||++..... ....++..|+..+.+. +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 47999999999999999999876 799999998865322 2334455666666555 8999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+ +++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 669999988764 4699999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .+ .....+.... .
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~--~~~~~~~~~~----~ 272 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GW--QQLRQGYLPP----E 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HH--HHHTTTCCCH----H
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HH--HHHhccCCCc----c
Confidence 2334569999999999886 78999999999999999999977664211 11 1111111110 0
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+...+.++.+++.+||+.||++|||++|++++
T Consensus 273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 112345678999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=336.70 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=204.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
.++|++.+.||+|+||.||+|... ++..||||++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 357999999999999999999765 577999999865432 2346789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999875 3489999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
......|++.|+|||.+.+..++.++||||+|+++|||++|+.||.... ...........
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~--------- 222 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRV--------- 222 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHT---------
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhC---------
Confidence 2234578999999999999999999999999999999999999997432 11111111111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
....+...+..+.+++.+||+.||++|||+.|++++-
T Consensus 223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1112334556788999999999999999999999763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=365.02 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=210.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 46899999999999999999775 69999999997542 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||++||+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 999999999999876656699999999999999999999999 99999999999999999999999999998765332
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ....
T Consensus 341 --~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----~~~~~i~~~-i~~~--------- 404 (576)
T 2acx_A 341 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERL-VKEV--------- 404 (576)
T ss_dssp --CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----CCHHHHHHH-HHHC---------
T ss_pred --cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----hhHHHHHHH-hhcc---------
Confidence 233458999999999999989999999999999999999999999754322 111111111 1111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
....+...+.++.+++.+||+.||++|| +++||+++
T Consensus 405 -~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 -PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1112334556889999999999999999 78888764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=338.90 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=207.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 347999999999999999999765 4779999999877666778899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE---CCCCcEEEeecccccccCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~~ 836 (963)
+++++|.+++... ..+++.++..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999999874 3489999999999999999999999 99999999999999 78899999999999876543
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
. ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||..... .+..... ..+... . ..
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~~-~-~~ 228 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKI-REGTFT-F-PE 228 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HHCCCC-C-CH
T ss_pred c--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHH-HhCCCC-C-Cc
Confidence 3 23345799999999998764 89999999999999999999999974321 1111111 111110 0 00
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.. ....+..+.+++.+|++.||++|||+.|++++
T Consensus 229 ~~----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 KD----WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hh----hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01235678999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=357.15 Aligned_cols=250 Identities=19% Similarity=0.331 Sum_probs=199.9
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeeccc--chhHHHHHHHHHHHhccC--CCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLR--HPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 757 (963)
..|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3599999999999999999988889999999987543 344578899999999996 599999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
| +.+++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 5678999999874 3589999999999999999999999 999999999999996 5799999999998765433
Q ss_pred Cc-ccccccccccccCcccccc-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 838 TH-ATTGVAGTFGYVAPEYAMT-----------CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 838 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~~~~ 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHAII 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHH
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHHHHHh
Confidence 22 2345679999999999875 3688899999999999999999999964321 111121111
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .......+...+..+.+++.+||+.||++|||+.|++++
T Consensus 282 ~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 D---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp C---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C---------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 111112233335678899999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=349.86 Aligned_cols=246 Identities=26% Similarity=0.315 Sum_probs=195.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHH-HhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKT-LGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+..|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 47999999999999999999776 588999999976542 233456677776 5778999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999874 3589999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.........
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-------- 255 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKP-------- 255 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHSC--------
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcc--------
Confidence 223445689999999999999999999999999999999999999997432 122222222211
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 952 (963)
...+...+..+.+++.+||+.||++||++.+.+
T Consensus 256 ---~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 256 ---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ---CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ---cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 012234456789999999999999999986433
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.35 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=206.4
Q ss_pred cCCCCCcc-ccccCCCccEEEEEEC---CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 681 TGNFNASN-CIGNGGFGATYKAEIS---PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 681 ~~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
.++|++.+ .||+|+||.||+|.+. +++.||||++..... ...+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34688887 9999999999999542 468899999875432 3357799999999999999999999999 556789
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999999874 4589999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcc--cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 835 PSETHA--TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 835 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
...... .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .+.. .....+.
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~-~~~~~~~-- 237 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVT-AMLEKGE-- 237 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHH-HHHHTTC--
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHH-HHHHcCC--
Confidence 443322 222346789999999998889999999999999999999 9999874321 1111 1111111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
....+...+..+.+++.+||+.||++||++.++++.|+++-
T Consensus 238 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 238 -------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11233455678999999999999999999999999998763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.29 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=211.4
Q ss_pred ChHHHHHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhc--cCCCCeeEEEEeeeCC
Q 046851 673 SFESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGR--LRHPNLVTLIGYHASE 750 (963)
Q Consensus 673 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 750 (963)
.........++|++.+.||+|+||.||+|... |+.||||++... ..+.+.+|++++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 33334455678999999999999999999885 899999998643 23567788888877 7899999999999876
Q ss_pred C----eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecccCCCCeEECC
Q 046851 751 T----EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH--------DQCVPRVLHRDVKPSNILLDD 818 (963)
Q Consensus 751 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlk~~Nill~~ 818 (963)
. ..++||||+++|+|.+++... .+++.++..++.|++.|++||| +. +|+||||||+||+++.
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 5 789999999999999999763 4899999999999999999999 77 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCc---ccccccccccccCccccccCC------CCcchhhHHHHHHHHHHHcC---------
Q 046851 819 DFNAYLSDFGLARLLGPSETH---ATTGVAGTFGYVAPEYAMTCR------VSDKADVYSYGVVLLELLSD--------- 880 (963)
Q Consensus 819 ~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg--------- 880 (963)
++.+||+|||++......... ......||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876544322 234457999999999998753 33689999999999999999
Q ss_pred -CCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 881 -KKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 881 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
+.||...... ......+........ ....+.... ....++..+.+++.+||+.||++|||+.||+++|+++.
T Consensus 263 ~~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 263 YQLPYYDLVPS---DPSVEEMRKVVCEQK-LRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCTTTTTSCS---SCCHHHHHHHHTTSC-CCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCccccCcC---cccHHHHHHHHHHHH-hCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 5666543222 111222222211111 111111000 12356778999999999999999999999999999875
Q ss_pred C
Q 046851 960 P 960 (963)
Q Consensus 960 ~ 960 (963)
.
T Consensus 336 ~ 336 (342)
T 1b6c_B 336 Q 336 (342)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=362.15 Aligned_cols=248 Identities=23% Similarity=0.274 Sum_probs=197.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc---cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG---RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 57999999999999999999764 6899999999754 2233466788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
||+++|+|.+++... ..+++..+..++.|+++||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999999874 358999999999999999999998 8 9999999999999999999999999999864332
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...........
T Consensus 303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~-------- 365 (446)
T 4ejn_A 303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEE-------- 365 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC--------
T ss_pred C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCC--------
Confidence 2 233456899999999999999999999999999999999999999964321 12222222111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 366 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 ---IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 112334456789999999999999999 99999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=341.99 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=204.1
Q ss_pred CCCCCccccccCCCccEEEEEECC----CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEee-eCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYH-ASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 755 (963)
..|++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++++++||||+++++++ ...+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468889999999999999997642 2368999886543 34457889999999999999999999985 45667899
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++|+|.+++... ...+++.++..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999764 35589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC---cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 836 SET---HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 836 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
... .......+|+.|+|||.+.+..++.++||||+|+++|||++|+.|+...... .. ...... .+.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~---~~~~~~-~~~--- 249 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FD---ITVYLL-QGR--- 249 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT----TT---HHHHHH-TTC---
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH----HH---HHHHHh-cCC---
Confidence 321 2233456788999999999999999999999999999999955444322211 11 111111 111
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 250 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 250 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111233445679999999999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=348.52 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=204.0
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc--------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF--------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (963)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45799999999999999999975 4689999999976432 12345778999999999999999999999999
Q ss_pred eEEEEEeccCCC-ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 752 EMFLIYNYLPGG-NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 752 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
..++||||+.+| +|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 999999864 4599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
........ .....||+.|+|||++.+..+ +.++||||+|+++|||++|+.||......
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------- 236 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------- 236 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------
T ss_pred eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------
Confidence 87654332 234579999999999998776 78999999999999999999999632111
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... ...+...+.++.+++.+||+.||++|||++|++++
T Consensus 237 ----~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01122345678999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=353.22 Aligned_cols=265 Identities=18% Similarity=0.234 Sum_probs=202.6
Q ss_pred CCCCCccccccCCCccEEEEEEC----CCcEEEEEEeecccchh-----------HHHHHHHHHHHhccCCCCeeEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGRFQG-----------VQQFHAEIKTLGRLRHPNLVTLIGY 746 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~ 746 (963)
++|++.+.||+|+||.||+|... ++..||||++....... ...+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999875 57889999987553211 1236678889999999999999999
Q ss_pred eeC----CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC--
Q 046851 747 HAS----ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-- 820 (963)
Q Consensus 747 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-- 820 (963)
+.. ....++||||+ +++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 877 77899999999 999999998754 689999999999999999999999 999999999999999887
Q ss_pred cEEEeecccccccCCCCC------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q 046851 821 NAYLSDFGLARLLGPSET------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG 894 (963)
Q Consensus 821 ~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~ 894 (963)
.+||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---- 266 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD---- 266 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC----
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc----
Confidence 999999999987643221 1224457999999999999999999999999999999999999999632211
Q ss_pred cchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.............. ....+.... .....+.++.+++.+||+.||++||++++|++.|+++..
T Consensus 267 ~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVAVQTAKTNLLDE-LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHHHT-TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHHHHHHHHhhccc-ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111111 111111000 011345689999999999999999999999999998653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=354.51 Aligned_cols=269 Identities=19% Similarity=0.240 Sum_probs=213.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC--eEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET--EMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 757 (963)
++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 47999999999999999999776 58999999997543 334577889999999999999999999987654 789999
Q ss_pred eccCCCChHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE----CCCCcEEEeecccccc
Q 046851 758 NYLPGGNLENFIQQRST-RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL----DDDFNAYLSDFGLARL 832 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla~~ 832 (963)
||+++|+|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999986542 3389999999999999999999999 99999999999999 7788899999999987
Q ss_pred cCCCCCcccccccccccccCcccccc--------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMT--------CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...+.+...
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~----~~~~~~~~~ 239 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RNKEVMYKI 239 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT----TCHHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc----chHHHHHHH
Confidence 65332 2334579999999999875 456789999999999999999999997543321 112222222
Q ss_pred HhcCcccce------------ecc--ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 905 LRQGRAKEF------------FTA--GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 905 ~~~~~~~~~------------~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
......... ... ......+......+.+++.+||+.||++||++.|+++.++++.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 222111000 000 1111234667888999999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=337.56 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=186.5
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4799999999999999999976 4799999999865432 23477899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++... ...+++.++..++.|+++|++|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999864 34689999999999999999999999 99999999999999999999999999998765332
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... .. .. .....
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~----~~-----~~~~~ 228 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--------TL----NK-----VVLAD 228 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCSSC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------HH----HH-----Hhhcc
Confidence 2 2234578999999999999889999999999999999999999997543220 00 00 00000
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+.++.+++.+||+.||++|||+++++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 01233445678999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=347.04 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=213.4
Q ss_pred CCCCCccccccCCCccEEEEEE-----CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC--eEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-----SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET--EMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~ 754 (963)
++|++.+.||+|+||.||+|.+ .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4689999999999999999984 368999999998776666788999999999999999999999986644 679
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++++|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999998753 4589999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcc--cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC-------CCCCcchhhHHHHHH
Q 046851 835 PSETHA--TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSS-------YGNGFNIVAWGCMLL 905 (963)
Q Consensus 835 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~ 905 (963)
...... .....++..|+|||.+.+..++.++||||+|+++|||++|+.|+...... ..............
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 275 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL- 275 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH-
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH-
Confidence 443221 22345778899999999888999999999999999999999887632110 00000000011111
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
+........+...+.++.+++.+||+.||++|||+.|+++.|++++.
T Consensus 276 --------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 276 --------LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111222344566789999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.45 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=207.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999765 58999999987543 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc---EEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN---AYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla~~~~ 834 (963)
||+++++|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999998875 3589999999999999999999999 9999999999999986655 9999999998765
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ........ .+...
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~-~~~~~--- 225 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIK-AGAYD--- 225 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HTCCC---
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHHH-hcccc---
Confidence 332 23346799999999999999999999999999999999999999964321 11111111 11110
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+..+.+++.+|++.||++|||+.|++++
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011112345678899999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=351.64 Aligned_cols=270 Identities=21% Similarity=0.279 Sum_probs=210.9
Q ss_pred CCChHHHHHHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccC-----CCCeeEEE
Q 046851 671 PLSFESVVQATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-----HPNLVTLI 744 (963)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~ 744 (963)
.+++.+.....++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+..|+++++.+. ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 455555556678999999999999999999977 468999999986432 33456788999999886 99999999
Q ss_pred EeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC------
Q 046851 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD------ 818 (963)
Q Consensus 745 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~------ 818 (963)
+++...+..++||||+ +++|.+++.......+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 9999999999999999 88999999887666799999999999999999999999 9999999999999975
Q ss_pred -------------------CCcEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc
Q 046851 819 -------------------DFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 879 (963)
Q Consensus 819 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 879 (963)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||+||++|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999865332 234578999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCcchhhHHHHHHh-----------cCcccceecc-ccCCCCC--------------------hhHH
Q 046851 880 DKKALDPSFSSYGNGFNIVAWGCMLLR-----------QGRAKEFFTA-GLWDAGP--------------------HDDL 927 (963)
Q Consensus 880 g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-~~~~~~~--------------------~~~~ 927 (963)
|+.||...... .....+..... .......++. ......+ ....
T Consensus 255 g~~pf~~~~~~-----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 255 GSLLFRTHEHM-----EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp SSCSCCCSSHH-----HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred CCCCCCCCcHH-----HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 99999743211 11111111100 0000011100 0000000 0112
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 928 VEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 928 ~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+.+++.+||+.||++|||++|++++
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 567899999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=342.80 Aligned_cols=257 Identities=29% Similarity=0.433 Sum_probs=206.4
Q ss_pred CCCCccccccCCCccEEEEEEC-C---CcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE-EEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-P---GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM-FLI 756 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 756 (963)
.|+..+.||+|+||.||+|.+. + +..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666789999999999999753 2 2379999986543 34457889999999999999999999999776655 999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+.+|+|.+++... ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999764 35689999999999999999999999 9999999999999999999999999999865432
Q ss_pred C---CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 837 E---THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 837 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
. ........+++.|+|||.+.+..++.++||||+|+++|||++|+.|+...... ...... .....
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-------~~~~~~-~~~~~---- 245 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-------FDLTHF-LAQGR---- 245 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-------GGHHHH-HHTTC----
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-------HHHHHH-hhcCC----
Confidence 2 12233456789999999999999999999999999999999976665432211 111111 11111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
....+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 112233455689999999999999999999999999998643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=347.18 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=206.3
Q ss_pred cCCCCCccccccCCCccEEEEEE------CCCcEEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
.++|++.+.||+|+||.||+|.+ .++..||||++... ......++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35899999999999999999974 34778999999644 334456789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEEEe
Q 046851 754 FLIYNYLPGGNLENFIQQRST-----RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAYLS 825 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 825 (963)
++||||+++|+|.+++..... ..+++.++..++.|+++||+|||++ +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999987542 3589999999999999999999999 9999999999999994 4469999
Q ss_pred ecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHH
Q 046851 826 DFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 826 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
|||++........ .......|++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEF 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHHH
Confidence 9999976543222 22233567899999999999999999999999999999998 8888864321 111111
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
..... ....+...+..+.+++.+||+.||++||++.+++++|+.+.
T Consensus 258 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 258 VTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11111 11223345668899999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=347.93 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=205.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEE--EEEEeecc-cchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLV--AIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|... +|..+ |||++... .....+++.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 47999999999999999999664 46644 99988643 233456789999999999 899999999999999999999
Q ss_pred EeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 757 YNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
|||+++|+|.+++.... ...+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997643 24689999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHH
Q 046851 823 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWG 901 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 901 (963)
||+|||+++..... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY 251 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HHHH
Confidence 99999999743221 12223356889999999998889999999999999999998 9999864321 1111
Q ss_pred HHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 902 CMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
... ..+ .....+...+..+.+++.+||+.||++|||++|++++|+++.
T Consensus 252 ~~~-~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 252 EKL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHG-GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh-hcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 111 112233455678999999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=350.35 Aligned_cols=261 Identities=24% Similarity=0.282 Sum_probs=204.3
Q ss_pred HHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-----chhHHHHHHHHHHHhccCCCCeeEEEEeeeC
Q 046851 676 SVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-----FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749 (963)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 749 (963)
++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556678999999999999999999764 68899999986542 3456789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHhhhc--------------------------------------CCCCCHHHHHHHHHHHHH
Q 046851 750 ETEMFLIYNYLPGGNLENFIQQRS--------------------------------------TRAVDWRVLHKIALDIAR 791 (963)
Q Consensus 750 ~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~~~~~~~~~i~~~i~~ 791 (963)
.+..++||||+++|+|.+++.... ...+++..+..++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999985211 112356778899999999
Q ss_pred HHHHHHhCCCCCceecccCCCCeEECCCC--cEEEeecccccccCCC---CCcccccccccccccCcccccc--CCCCcc
Q 046851 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDF--NAYLSDFGLARLLGPS---ETHATTGVAGTFGYVAPEYAMT--CRVSDK 864 (963)
Q Consensus 792 ~l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgla~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 864 (963)
||+|||+. +|+||||||+||+++.++ .+||+|||++..+... .........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 8999999999865432 2222345679999999999975 678899
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCC
Q 046851 865 ADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLST 944 (963)
Q Consensus 865 ~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 944 (963)
+||||||+++|||++|+.||..... .+............ ........+..+.+++.+||+.||++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999999974321 22222222221100 00011224567899999999999999
Q ss_pred CCCHHHHHHH
Q 046851 945 RPTMKQVVRR 954 (963)
Q Consensus 945 RPs~~evl~~ 954 (963)
||++.|++++
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.93 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=203.6
Q ss_pred HcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEee-eCCCeEEEEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH-ASETEMFLIY 757 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 757 (963)
..++|++.+.||+|+||.||+|.. .+++.||||++...... +++.+|+++++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 446899999999999999999976 57899999987654332 4578899999999988766665554 6678889999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE---CCCCcEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~ 834 (963)
||+ +++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 889999998543 4599999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCC------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 835 PSET------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 835 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
.... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........ ..............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKKMST 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHHHHS
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh--hhhhhhhhcccccc
Confidence 4332 123356799999999999999999999999999999999999999975433211 11111111111111
Q ss_pred cccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 909 RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
... .. ....+..+.+++.+||+.||++|||++++++.|+++.
T Consensus 238 ~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 238 PIE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp CHH-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhh-----hh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 000 00 1123467899999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.96 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=200.7
Q ss_pred CCCCCc-cccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNAS-NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+.|++. +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467774 78999999999999754 6899999999876656678899999999885 79999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc---EEEeecccccccCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN---AYLSDFGLARLLGP 835 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla~~~~~ 835 (963)
|+++|+|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999875 3589999999999999999999999 9999999999999998776 99999999976542
Q ss_pred CCC------cccccccccccccCcccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCC---cch---h
Q 046851 836 SET------HATTGVAGTFGYVAPEYAMT-----CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG---FNI---V 898 (963)
Q Consensus 836 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~---~~~---~ 898 (963)
... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.......... ... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 11223469999999999875 457889999999999999999999998654321110 000 0
Q ss_pred hHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 899 AWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+... .... . ....+..+.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~i~~~~~~-~~~~-~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYE-FPDK-D----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCC-CCHH-H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcc-cCch-h----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111111111110 0000 0 01235678999999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.05 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=202.9
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
..|+..+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3588899999999999999976 579999999997543 233467899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||++ |++.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 58988886543 4689999999999999999999999 9999999999999999999999999999865422
Q ss_pred CcccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 838 THATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ............ ...
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~-~~~-- 272 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE-SPA-- 272 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCC--
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcC-CCC--
Confidence 3357999999999985 5678899999999999999999999986431 112222222211 111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
..+...+..+.+++.+||+.||++|||+++++++-
T Consensus 273 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 273 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11223456788999999999999999999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=350.40 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=207.7
Q ss_pred CCCCCccccccCCCccEEEEEE----CCCcEEEEEEeeccc----chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCe
Q 046851 682 GNFNASNCIGNGGFGATYKAEI----SPGVLVAIKRLAVGR----FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETE 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (963)
++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++.++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 368999999986532 22345677899999999 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||+++|+|.+++.... .+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999998753 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~-- 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSE-- 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCC--
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----chHHHHHHHHhccC--
Confidence 65444444455679999999999986 34788999999999999999999999744322 11222222222111
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRRL 955 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 955 (963)
...+...+..+.+++.+||+.||++|| +++|++++.
T Consensus 283 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 122344566788999999999999999 999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.55 Aligned_cols=251 Identities=27% Similarity=0.356 Sum_probs=199.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 47999999999999999999764 689999999876543 3467889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE---CCCCcEEEeecccccccC
Q 046851 760 LPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 760 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~ 834 (963)
+++|+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998653 245699999999999999999999999 99999999999999 456789999999998654
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
... ......||+.|+|||++. ..++.++||||+|+++|||++|+.||..... ..............
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~~--- 244 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQKATYKEPNY--- 244 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCC---
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhhhccCCccc---
Confidence 332 233457899999999986 4688999999999999999999999974321 11111111111000
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.......+..+.+++.+||+.||++|||+.|++++
T Consensus 245 -----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 245 -----AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -----CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -----ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011234578899999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.92 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=207.1
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEee-eCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH-ASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... +++.+|+++++.++|++++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999976 57999999998755433 4688999999999988766555544 66778899999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC---CCCcEEEeecccccccCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD---DDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~~ 835 (963)
|+ +++|.+++... ...+++.++..++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||++.....
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 88999999754 34699999999999999999999999 999999999999994 888999999999987654
Q ss_pred CCCc------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 836 SETH------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 836 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......+........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT--KRQKYERISEKKMSTP 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--SSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh--hhhhhhhhcccccCCc
Confidence 4321 2345679999999999999999999999999999999999999998543221 1111111111111110
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.. .. ....+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 239 ~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 239 IE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HH-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hH-----HH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 00 00 1223467899999999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.75 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=182.2
Q ss_pred ccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEeccCCCC
Q 046851 687 SNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYNYLPGGN 764 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 764 (963)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999775 6899999998643 3456788999999997 9999999999999999999999999999
Q ss_pred hHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC---cEEEeecccccccCCCCCccc
Q 046851 765 LENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF---NAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 765 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~~~~~~~~~ 841 (963)
|.+++... ..+++.++..++.|+++|++|||++ +|+||||||+||+++.++ .+||+|||+++...... ...
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~ 166 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPL 166 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccc
Confidence 99999874 4699999999999999999999999 999999999999998765 89999999998764332 223
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
....||+.|+|||++.+..++.++||||+|+++|||++|+.||........ .....+.... ...+... .. ..
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~-i~~~~~~--~~----~~ 238 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKK-IKKGDFS--FE----GE 238 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHH-HTTTCCC--CC----SH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHH-HHcCCCC--CC----cc
Confidence 345689999999999999999999999999999999999999975433211 1111222211 1221110 00 00
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+.++.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 012345678999999999999999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=374.01 Aligned_cols=247 Identities=27% Similarity=0.380 Sum_probs=201.2
Q ss_pred cccccCCCccEEEEEEC---CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS---PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999976433 346789999999999999999999999975 458899999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc--c
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH--A 840 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~ 840 (963)
|+|.+++... ..+++.++..|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........ .
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999763 4589999999999999999999999 9999999999999999999999999999877544322 2
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +.. .....+ ..
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~-~~i~~~---------~~ 590 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVT-AMLEKG---------ER 590 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHH-HHHHTT---------CC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH-HHHHcC---------CC
Confidence 233456789999999999999999999999999999998 99999743221 111 122222 12
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
...+..++.++.+++.+||+.||++||++++|++.|+++
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223445677899999999999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=341.20 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=207.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch------hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ------GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 47999999999999999999775 6899999999754321 3578999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC----cEEEeecccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF----NAYLSDFGLA 830 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla 830 (963)
+||||+++++|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999763 4589999999999999999999999 999999999999999888 7999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .+......... .
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~-~ 235 (321)
T 2a2a_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITSVS-Y 235 (321)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTC-C
T ss_pred eecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcc-c
Confidence 8765432 23345799999999999999999999999999999999999999964321 12222211111 0
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 236 --~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 --DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001100 11234578899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=358.92 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=209.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|.+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 47889999999999999999875 699999999975432 33567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 758 NYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||++||+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.+|.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999997644 44699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..............
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~~~~~~~~~i~~~~------- 409 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRVLEQA------- 409 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----CCHHHHHHHHHHCC-------
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----hhHHHHHHHHhhcc-------
Confidence 322 234458999999999999999999999999999999999999999754321 11122222222111
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM-----KQVVR 953 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 953 (963)
...+...+..+.+++.+||+.||++||++ +++.+
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 12234456788999999999999999975 55654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=354.05 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=193.5
Q ss_pred CCCCCc-cccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhc-cCCCCeeEEEEeeeC----CCeEE
Q 046851 682 GNFNAS-NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGR-LRHPNLVTLIGYHAS----ETEMF 754 (963)
Q Consensus 682 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~ 754 (963)
++|.+. +.||+|+||+||+|... +|+.||||++... ..+.+|++++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 356665 68999999999999765 6899999998632 456788888644 579999999998764 56789
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEEEeeccccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAYLSDFGLAR 831 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~ 831 (963)
+||||+++|+|.+++.......+++.++..|+.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999876556799999999999999999999999 9999999999999997 7899999999998
Q ss_pred ccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .....+...
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~----~~i~~~~~~ 285 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMK----TRIRMGQYE 285 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHH----HHHHHTCCC
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHH----HHHHcCccc
Confidence 754322 233457899999999999999999999999999999999999999755332111 1111 111111110
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. . .......+.++.+++.+||+.||++|||+.|++++
T Consensus 286 -~-~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 -F-P----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -C-C----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -C-C----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0 01112345678999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.19 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=208.6
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeee--CCCeEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHA--SETEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 755 (963)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357999999999999999999775 68999999997543 334567899999999999999999999874 4678999
Q ss_pred EEeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceecccCCCCeEECCCCcEEEeecc
Q 046851 756 IYNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPR-----VLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997643 34589999999999999999999999 7 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
++........ ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ..... ....+
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~-~i~~~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAG-KIREG 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH-HHHHT
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHH-HHhhc
Confidence 9987643322 22334689999999999998999999999999999999999999874321 11111 11222
Q ss_pred cccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 909 RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.. ...+...+.++.+++.+||+.||++||++.|+++++..-++
T Consensus 232 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 232 KF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 11 12233456689999999999999999999999998765443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.70 Aligned_cols=250 Identities=15% Similarity=0.157 Sum_probs=203.0
Q ss_pred HcCCCCCccccccCCCccEEEE------EECCCcEEEEEEeecccchhHHHHHHHHHHHhccC---CCCeeEEEEeeeCC
Q 046851 680 ATGNFNASNCIGNGGFGATYKA------EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR---HPNLVTLIGYHASE 750 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 750 (963)
..++|.+.+.||+|+||+||+| ...+++.||||++.... ..++..|++.+.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 3467999999999999999999 34568999999987543 346677777777776 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---------
Q 046851 751 TEMFLIYNYLPGGNLENFIQQR---STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD--------- 818 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--------- 818 (963)
+..++||||+++|+|.+++... ....+++.++..|+.|+++||+|||++ +|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999753 245699999999999999999999999 9999999999999998
Q ss_pred --CCcEEEeecccccccCC-CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCc
Q 046851 819 --DFNAYLSDFGLARLLGP-SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGF 895 (963)
Q Consensus 819 --~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~ 895 (963)
++.+||+|||+|+.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----- 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG----- 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence 89999999999976532 2233345567999999999999999999999999999999999999998643221
Q ss_pred chhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHhcc
Q 046851 896 NIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTR-PTMKQVVRRLKQL 958 (963)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~l 958 (963)
.......... . .....+.+++..|++.+|.+| |+++++.+.|+++
T Consensus 292 ---------------~~~~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 292 ---------------ECKPEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------EEEECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------ceeechhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0001111111 1 234567789999999999999 5788888888764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=346.48 Aligned_cols=255 Identities=21% Similarity=0.311 Sum_probs=191.7
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEee--------eCC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYH--------ASE 750 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~--------~~~ 750 (963)
..+|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++.++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 347999999999999999999864 68999999997776666778999999999996 99999999998 344
Q ss_pred CeEEEEEeccCCCChHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecccCCCCeEECCCCcEEEeec
Q 046851 751 TEMFLIYNYLPGGNLENFIQQR-STRAVDWRVLHKIALDIARALAYLHDQCVPR--VLHRDVKPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df 827 (963)
...++||||++ |+|.+++... ....+++.++..++.|++.||+|||++ + |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 56899999996 6999998753 245699999999999999999999999 8 999999999999999999999999
Q ss_pred ccccccCCCCCc-----------ccccccccccccCcccc---ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 046851 828 GLARLLGPSETH-----------ATTGVAGTFGYVAPEYA---MTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN 893 (963)
Q Consensus 828 gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~ 893 (963)
|++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 999876543221 11134689999999998 5667889999999999999999999999643211
Q ss_pred CcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 894 GFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
. ..........+......+.+++.+||+.||++|||+.|++++|+++.+
T Consensus 260 -----~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 -----R-------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----H-------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 001111111122233457899999999999999999999999988654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=351.20 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=193.1
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCC--CeE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASE--TEM 753 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~ 753 (963)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.++.++. ||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4568999999999999999999764 6899999998543 3344567889999999997 99999999998754 478
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999997 599999976 3589999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCC--------------------CcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 046851 834 GPSE--------------------THATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYG 892 (963)
Q Consensus 834 ~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~ 892 (963)
.... .......+||+.|+|||++.+ ..++.++||||+||++|||++|++||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--- 236 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST--- 236 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 3211 112234579999999999987 6789999999999999999999999974321
Q ss_pred CCcchhhHHHHHHhcCccc--cee----------------------ccccCC------------CCChhHHHHHHHHHHH
Q 046851 893 NGFNIVAWGCMLLRQGRAK--EFF----------------------TAGLWD------------AGPHDDLVEVLHLAVV 936 (963)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~--~~~----------------------~~~~~~------------~~~~~~~~~l~~l~~~ 936 (963)
.............. +.+ ...... ........++.+++.+
T Consensus 237 -----~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 237 -----MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp -----HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred -----HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 11111111000000 000 000000 0011335578899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 046851 937 CTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 937 cl~~dP~~RPs~~evl~~ 954 (963)
||+.||++|||++|++++
T Consensus 312 ~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKH 329 (388)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred hhccCcccCCCHHHHhCC
Confidence 999999999999999887
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.52 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=200.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999875 589999998865433 234668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++++|.+++... ..+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999988753 4589999999999999999999999 999999999999999999999999999987653322
Q ss_pred cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH-----------h
Q 046851 839 HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL-----------R 906 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~ 906 (963)
......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+.... .
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV-----DQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCHHHHHHHH
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhcccccccccccc
Confidence 2234578999999999986 56899999999999999999999999744221 1111111110 0
Q ss_pred cCccc---ceeccccCCC---CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 QGRAK---EFFTAGLWDA---GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~~~---~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... ...++..... .....+..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000000000 002345578899999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.24 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=202.7
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||.||+|... +|+.||||++...... ..+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 357999999999999999999775 6899999999765432 35688888887 79999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC----CcEEEeecccccccC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD----FNAYLSDFGLARLLG 834 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~~~ 834 (963)
|+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||++..+ +.+||+|||++....
T Consensus 97 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999764 4589999999999999999999999 99999999999998543 359999999998764
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+..... ..+...
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i-~~~~~~--- 241 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-----TPEEILARI-GSGKFS--- 241 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-----CHHHHHHHH-HHCCCC---
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-----CHHHHHHHH-ccCCcc---
Confidence 4322 234457899999999999888889999999999999999999999743211 122222222 222111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+..+.+++.+||+.||++||++.|++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111223455688999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=336.35 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=205.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57999999999999999999775 689999999875433 3457789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC-
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET- 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 838 (963)
+++++|.+++... ..+++.++..++.|+++||+|||++ +++||||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999998753 4589999999999999999999999 999999999999999999999999999986543221
Q ss_pred cccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||...... ......+ .....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-----~~~~~------- 226 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDW-----KEKKT------- 226 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHHHHH-----HTTCT-------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHh-----hhccc-------
Confidence 22344578999999999987665 67899999999999999999999754321 1111111 11100
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........+..+.+++.+||+.||++|||++|++++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001112345678899999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=349.76 Aligned_cols=261 Identities=18% Similarity=0.245 Sum_probs=206.6
Q ss_pred CCCCCccccccCCCccEEEEEECC---------CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeE----------
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP---------GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVT---------- 742 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 742 (963)
++|++.+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 589999999999999999997763 789999998754 35788999999999999887
Q ss_pred -----EEEeeeC-CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 743 -----LIGYHAS-ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 743 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
+++++.. ....++||||+ +++|.+++.......+++.++..++.|+++||+|||++ +|+||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 5666655 77899999999 99999999876456799999999999999999999999 99999999999999
Q ss_pred CCCC--cEEEeecccccccCCCCCc------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 046851 817 DDDF--NAYLSDFGLARLLGPSETH------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSF 888 (963)
Q Consensus 817 ~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~ 888 (963)
+.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999876532211 2234579999999999999999999999999999999999999997543
Q ss_pred CCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 889 SSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.. .......... .... ...+.+... .....+..+.+++.+||+.||++||+++++++.|+++.
T Consensus 273 ~~---~~~~~~~~~~-~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 273 PN---TEDIMKQKQK-FVDK-PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TC---HHHHHHHHHH-HHHS-CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cC---HHHHHHHHHh-ccCC-hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 21 1111111111 1111 112211110 01123568899999999999999999999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.39 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=201.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (963)
.++|++.+.||+|+||.||+|... +++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 357999999999999999999776 79999999987542 33456788999999999 899999999999999999999
Q ss_pred EeccCCCChHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC---------------
Q 046851 757 YNYLPGGNLENFIQQRS--TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD--------------- 819 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--------------- 819 (963)
|||+++++|.+++.... ...+++.++..++.|+++||+|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997653 25689999999999999999999999 99999999999999844
Q ss_pred ----CcEEEeecccccccCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q 046851 820 ----FNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG 894 (963)
Q Consensus 820 ----~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~ 894 (963)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||+|+++|||++|.+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 479999999998764322 23589999999999876 56689999999999999999987764221
Q ss_pred cchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+ .....+.. ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus 236 ----~~--~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ----QW--HEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----HH--HHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----HH--HHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11 11112211 12233455688999999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=330.10 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=198.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++.++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57999999999999999999876 79999999986543 234567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++... ..+++.++..++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999875 3489999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||..... ...... ...+.
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~-~~~~~------- 227 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLFKK-IRGGV------- 227 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHHCC-------
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHH-hhcCc-------
Confidence 2234468999999999988765 5789999999999999999999964311 111111 11111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+|++.||++|||+.|++++
T Consensus 228 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 ---FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01223345678899999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=333.90 Aligned_cols=248 Identities=22% Similarity=0.305 Sum_probs=207.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 57999999999999999999776 58899999987543 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++... ..+++.++..++.|+++|++|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999998764 3589999999999999999999999 99999999999999999999999999998764322
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... .+...... ...
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~-~~~-------- 231 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIK-KNE-------- 231 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-TTC--------
T ss_pred -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-hcc--------
Confidence 223345789999999999998899999999999999999999999974321 11111111 111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+......+.+++.+||+.||++|||++|++++
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223445678899999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.48 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=201.2
Q ss_pred CCCCCccccccCCCccEEEEEEC--CCc--EEEEEEeecc---cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS--PGV--LVAIKRLAVG---RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|++.+.||+|+||.||+|.+. +++ .||||++... .....+++.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 47999999999999999999753 233 6899988654 2345678899999999999999999999998765 88
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++++|.+++.... ..+++.++..++.|+++|++|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999998753 4589999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 835 PSETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 835 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
..... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+..........
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~-- 242 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEGE-- 242 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSCC--
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHccCC--
Confidence 44322 2233457889999999998889999999999999999999 9999874321 222222222111
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
....+...+..+.+++.+||+.||++|||+.++++.|+++++.
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1112334567899999999999999999999999999988764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.18 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=206.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999775 57899999986542 223467899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++.... .+++.++..++.|+++|++|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999998753 589999999999999999999999 9999999999999999999999999999765422
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ......... ..
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~-~~-------- 228 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIVN-VD-------- 228 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHT-TC--------
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHhc-cc--------
Confidence 22345789999999999999999999999999999999999999974321 111111111 10
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+|++.||++||+++|++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 --LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11233445678899999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=340.84 Aligned_cols=263 Identities=23% Similarity=0.360 Sum_probs=189.1
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3468999999999999999999754 68999999886543 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 758 NYLPGGNLENFIQQR------STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 758 e~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
||+++++|.+++... ....+++..+..++.|+++|++|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999999752 234589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 832 LLGPSET----HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 832 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
....... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~ 241 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--------KVLMLTLQ 241 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHHHHHT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--------hHHHHHhc
Confidence 7653321 12234578999999999876 56889999999999999999999999754221 11111111
Q ss_pred cCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.. .................+..+.+++.+||+.||++||++.|++++
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 ND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11 111000000011122345678899999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.53 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=208.6
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.+.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 347999999999999999999764 68999999997553 3446789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999975 3589999999999999999999999 99999999999999999999999999998765332
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ....... .....
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~-------- 236 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLI-PKNNP-------- 236 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHH-HHSCC--------
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHHh-hcCCC--------
Confidence 223445789999999999999999999999999999999999999864321 1111111 11111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRL 955 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 955 (963)
...+...+..+.+++.+||+.||++|||+.|++++.
T Consensus 237 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 237 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 112233456789999999999999999999998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=335.12 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=204.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|.+.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 47999999999999999999775 68999999998665545567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE---CCCCcEEEeecccccccCCCC
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~~~ 837 (963)
++++|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 89 SGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999997643 589999999999999999999999 99999999999999 78899999999998764322
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ........ .+...
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~-~~~~~------ 225 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIK-EGYYE------ 225 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH-HCCCC------
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-cCCCC------
Confidence 22334689999999999999999999999999999999999999974321 11111111 11110
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+..+.+++.+|++.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111223445688999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.59 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=203.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46899999999999999999876 689999999875432 13678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC----cEEEeecccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF----NAYLSDFGLA 830 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla 830 (963)
+||||+++++|.+++... ..+++.++..++.|+++||+|||++ +++||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999764 3589999999999999999999999 999999999999999877 8999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
....... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||..... .+...... ....
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~ 228 (283)
T 3bhy_A 160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTNIS-AVNY 228 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-TTCC
T ss_pred eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHHhH-hccc
Confidence 8764332 22345689999999999999999999999999999999999999974321 11111111 1100
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .+... ....+..+.+++.+||+.||++||++.|++++
T Consensus 229 ~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 D--FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C--CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred C--Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 00000 11234578899999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=344.87 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=204.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|... +|..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 47999999999999999999776 68999999987653 33457789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.... .+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 99999999998753 4899999999999999999999832 8999999999999999999999999999765321
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH--------------
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL-------------- 905 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 905 (963)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ..........
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK-----ELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH-----HHHHHHC-----------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhcccccccCCCCCCCcccC
Confidence 223457899999999999999999999999999999999999999753221 0000000000
Q ss_pred ------------hcCcccce----eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 906 ------------RQGRAKEF----FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 906 ------------~~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......+. .............+..+.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000 00000011112345678999999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=354.42 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=195.9
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC------C
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE------T 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 751 (963)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999654 6899999999754 334457789999999999999999999998654 4
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
..++||||+++ ++.+.+.. .+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999976 57777643 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH-------
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML------- 904 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 904 (963)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+....
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-------~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-------DQWNKVIEQLGTPC 283 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCSCC
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHhcCCCC
Confidence 76432 2334467999999999999999999999999999999999999999743211 1111110
Q ss_pred --------------HhcCc------ccceeccccCCCC---ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 --------------LRQGR------AKEFFTAGLWDAG---PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 --------------~~~~~------~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... ....+........ ......++.+|+.+||+.||++|||++|++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000000 01125678999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.35 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=207.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 57999999999999999999775 57899999987542 234567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 121 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 121 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999998764 3589999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ..+......... .
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~-~------- 258 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKNE-Y------- 258 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTC-C-------
T ss_pred -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcCC-C-------
Confidence 22334578999999999999899999999999999999999999997432 111111111111 0
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+......+.+++.+||+.||++||+++|++++
T Consensus 259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223345678899999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=344.75 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=210.0
Q ss_pred CChHHHHHHcCCCCCc-cccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccC-CCCeeEEEEe
Q 046851 672 LSFESVVQATGNFNAS-NCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLR-HPNLVTLIGY 746 (963)
Q Consensus 672 ~~~~~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~ 746 (963)
..+.......+.|.+. +.||+|+||.||+|... +|+.||||++..... .....+.+|+.++.++. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4445555666778887 89999999999999765 689999999875432 34678899999999995 6999999999
Q ss_pred eeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEE
Q 046851 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAY 823 (963)
Q Consensus 747 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~k 823 (963)
+...+..++||||+++|+|.+++.......+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999998765556799999999999999999999999 9999999999999998 78999
Q ss_pred EeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 824 LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
|+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~ 244 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QETYLN 244 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHHH
Confidence 99999998764332 22345799999999999999999999999999999999999999964321 111111
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... . ..........+..+.+++.+||+.||++|||++|++++
T Consensus 245 i~~~~-~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVN-V------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTC-C------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhcc-c------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11111 0 01111223455678899999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.88 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=201.8
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
+|.....||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455566899999999999976 4688999999987666666889999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-CCcEEEeecccccccCCCCCc
Q 046851 762 GGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-DFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 762 ~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++|.+++.... ...+++..+..++.|+++||+|||++ +++||||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 999999998753 23467899999999999999999999 9999999999999987 89999999999987643322
Q ss_pred ccccccccccccCccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 840 ATTGVAGTFGYVAPEYAMTCR--VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......|++.|+|||++.+.. ++.++||||||+++|||++|+.||...... .......... .
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~----------~ 242 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVGMF----------K 242 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHHHH----------C
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhccc----------c
Confidence 223457899999999997643 789999999999999999999998632111 1111111010 0
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+...+.++.+++.+||+.||++||++.|++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112234456688999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.47 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=195.0
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch--hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
..++|++.+.||+|+||+||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3468999999999999999999754 7899999999754332 245678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC-----CCCcEEEeeccccc
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD-----DDFNAYLSDFGLAR 831 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Dfgla~ 831 (963)
|||+++ +|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||+++
T Consensus 112 ~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999975 999999874 3589999999999999999999999 999999999999994 55569999999998
Q ss_pred ccCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc-Cc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ-GR 909 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 909 (963)
....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... +........ +.
T Consensus 186 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~ 256 (329)
T 3gbz_A 186 AFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--------DQLFKIFEVLGL 256 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHHHCC
T ss_pred ccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--------HHHHHHHHHhCC
Confidence 7653322 23345689999999999875 4899999999999999999999999743211 111111110 00
Q ss_pred -----ccce------ec--cccCCC-----CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 -----AKEF------FT--AGLWDA-----GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 -----~~~~------~~--~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... .. +..... .+.....++.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 00 000000 011134678899999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.17 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=203.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc----chhHHHHHHHHHHHhccCCCCeeEEEEee--eCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR----FQGVQQFHAEIKTLGRLRHPNLVTLIGYH--ASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~ 753 (963)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999764 68899999997543 23457889999999999999999999998 445688
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||++++ +.+++.......+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999875 88888876667799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CcccccccccccccCccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 834 GPSE-THATTGVAGTFGYVAPEYAMTCR--VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 834 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
.... ........|++.|+|||++.+.. ++.++||||+|+++|||++|+.||.... ......... .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~-~~~~ 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIG-KGSY 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHH-HCCC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHh-cCCC
Confidence 5322 22234457899999999998654 3779999999999999999999997431 122222211 1111
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+..+.+++.+||+.||++|||++|++++
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1233455678899999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.03 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=199.8
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC----CCeEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS----ETEMFL 755 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 755 (963)
.|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4788889999999999999764 68899999987543 3445778999999999999999999998754 456899
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecccCCCCeEEC-CCCcEEEeecccccc
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR--VLHRDVKPSNILLD-DDFNAYLSDFGLARL 832 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgla~~ 832 (963)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999874 3589999999999999999999999 8 99999999999998 789999999999976
Q ss_pred cCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
.... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||..... ....... ...+....
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~-~~~~~~~~ 249 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRR-VTSGVKPA 249 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHH-HTTTCCCG
T ss_pred cccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHH-HhccCCcc
Confidence 5432 2234568999999998875 589999999999999999999999974321 1122111 11111111
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .+...+..+.+++.+||+.||++|||++|++++
T Consensus 250 ~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 S--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c--------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 112233578999999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.59 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=207.3
Q ss_pred HHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--------hhHHHHHHHHHHHhcc-CCCCeeEEEE
Q 046851 676 SVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--------QGVQQFHAEIKTLGRL-RHPNLVTLIG 745 (963)
Q Consensus 676 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~ 745 (963)
......++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34445578999999999999999999875 799999999875431 1245678999999999 7999999999
Q ss_pred eeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEe
Q 046851 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825 (963)
Q Consensus 746 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 825 (963)
++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999999864 3589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccCcccccc------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhh
Q 046851 826 DFGLARLLGPSETHATTGVAGTFGYVAPEYAMT------CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 826 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~ 899 (963)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~~ 312 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------IL 312 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------HH
Confidence 999998765432 2334679999999999864 3578899999999999999999999964311 11
Q ss_pred HHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...... .+... ...+ . ....+..+.+++.+||+.||++|||+.|++++
T Consensus 313 ~~~~i~-~~~~~-~~~~-~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 MLRMIM-EGQYQ-FSSP-E----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHH-HTCCC-CCHH-H----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHH-hCCCC-CCCc-c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 11110 0000 0 01234578899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=341.75 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=200.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 47999999999999999999775 589999999865433 234567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|++++++.++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 105 FVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp CCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 99999998887653 4589999999999999999999999 99999999999999999999999999998664332
Q ss_pred cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHH----------HHHhc
Q 046851 839 HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGC----------MLLRQ 907 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~~~ 907 (963)
.......|++.|+|||++.+. .++.++||||+|+++|||++|+.||...... ........ .....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI----DQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhhhHhhh
Confidence 223345689999999999875 7889999999999999999999999744221 00110000 00000
Q ss_pred -CcccceeccccCCCC-----ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 -GRAKEFFTAGLWDAG-----PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 -~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........+...... ....+..+.+++.+||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000011111111111 11345689999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=353.60 Aligned_cols=194 Identities=25% Similarity=0.425 Sum_probs=155.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeC-----CCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS-----ETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 752 (963)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 358999999999999999999665 6899999998653 23445788999999999999999999999843 367
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.|+||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 46999999763 4699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--------------------------cccccccccccccCcccc-ccCCCCcchhhHHHHHHHHHHHcC
Q 046851 833 LGPSET--------------------------HATTGVAGTFGYVAPEYA-MTCRVSDKADVYSYGVVLLELLSD 880 (963)
Q Consensus 833 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg 880 (963)
...... ......+||+.|+|||++ .+..++.++||||+||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 643221 123445789999999986 456799999999999999999994
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=344.16 Aligned_cols=262 Identities=21% Similarity=0.326 Sum_probs=196.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchh-HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47899999999999999999775 68999999986543221 12456799999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++ +|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 82 LDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 974 999999865 34689999999999999999999999 99999999999999999999999999998654322 2
Q ss_pred ccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc---ccceec
Q 046851 840 ATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR---AKEFFT 915 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 915 (963)
......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+........ ......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-----EQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHhchhhhc
Confidence 2334568999999999886 56899999999999999999999999744211 11111111111100 000000
Q ss_pred c---------ccCC----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 916 A---------GLWD----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 916 ~---------~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .... ........++.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0000 0012234678899999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=335.01 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=202.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.+.|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 458999999999999999999876 5899999999877666778899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++++|.+++.... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 99999999987643 4589999999999999999999999 9999999999999999999999999987643211 11
Q ss_pred ccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 840 ATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
......|++.|+|||++. +..++.++||||+|+++|||++|+.||..... ........... ...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~-~~~-- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSD-PPT-- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSC-CCC--
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhccC-Ccc--
Confidence 122346899999999983 66788999999999999999999999874321 11222221111 111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+..+.+++.+||+.||++|||+.+++++
T Consensus 242 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 -----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11223445678999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=346.22 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=198.2
Q ss_pred HHHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC-------
Q 046851 678 VQATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS------- 749 (963)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 749 (963)
....++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999976 5799999999865432 23479999999999999999998843
Q ss_pred -------------------------------CCeEEEEEeccCCCChHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHH
Q 046851 750 -------------------------------ETEMFLIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAYL 796 (963)
Q Consensus 750 -------------------------------~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~L 796 (963)
....++||||+++ +|.+.+.. .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3348899999985 88888764 2356799999999999999999999
Q ss_pred HhCCCCCceecccCCCCeEEC-CCCcEEEeecccccccCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHH
Q 046851 797 HDQCVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVL 874 (963)
Q Consensus 797 H~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il 874 (963)
|+. +|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 999999999999997 68899999999998765433 23345789999999998875 489999999999999
Q ss_pred HHHHcCCCCCCCCCCCCCCCcchhhHHHHHH--------h-cC-----cccceeccccCCCCChhHHHHHHHHHHHcccC
Q 046851 875 LELLSDKKALDPSFSSYGNGFNIVAWGCMLL--------R-QG-----RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVD 940 (963)
Q Consensus 875 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~-~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 940 (963)
|||++|+.||...... ..+...+.... . .. ..............+...+..+.+++.+||+.
T Consensus 233 ~ell~g~~pf~~~~~~----~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 233 GELILGKPLFSGETSI----DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999743211 01111111000 0 00 00000000111112334566789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 046851 941 SLSTRPTMKQVVRR 954 (963)
Q Consensus 941 dP~~RPs~~evl~~ 954 (963)
||++|||+.|++++
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=353.59 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=204.8
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357999999999999999999775 78999999986432 234678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC---CCCcEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD---DDFNAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~ 834 (963)
||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||++....
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999775 3589999999999999999999999 999999999999995 55679999999998765
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... .+......... ...
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~-~~~-- 241 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGK-YAF-- 241 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC-CCS--
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CCC--
Confidence 432 2334579999999999876 589999999999999999999999974321 22222222111 110
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+ .......+..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp C----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00112345678899999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=341.85 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=199.0
Q ss_pred HHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchh-----HHHHHHHHHHHhccCCCCeeEEEEeeeCCCe
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQG-----VQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (963)
...++|++.+.||+|+||.||+|... +|+.||||++....... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34568999999999999999999775 58999999987543221 2467899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||+++ +|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999986 8999987643 4588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc-C--
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ-G-- 908 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-- 908 (963)
..... .......||+.|+|||++.+. .++.++||||+||++|||++|.+||..... .+........ +
T Consensus 162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--------~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--------LDQLTRIFETLGTP 232 (346)
T ss_dssp TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCCC
T ss_pred ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHHcCCC
Confidence 64332 223345789999999999764 588999999999999999999999864321 1111111110 0
Q ss_pred ccc---------ceeccccCCCCC-----hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 RAK---------EFFTAGLWDAGP-----HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 ~~~---------~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... +.+........+ ...+.++.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000000000111 2335689999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=349.82 Aligned_cols=199 Identities=24% Similarity=0.398 Sum_probs=168.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-----Ce
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-----TE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 752 (963)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 458999999999999999999765 5889999999653 334457889999999999999999999998765 57
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||++ |+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999996 599999976 34599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---------------------ccccccccccccCcccc-ccCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046851 833 LGPSETH---------------------ATTGVAGTFGYVAPEYA-MTCRVSDKADVYSYGVVLLELLSDKKALD 885 (963)
Q Consensus 833 ~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~p~~ 885 (963)
....... .....+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6533211 23456899999999986 55679999999999999999998766654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=369.33 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=207.1
Q ss_pred HcCCCCCccccccCCCccEEEEEEC----CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
..++|++.+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 3467889999999999999999774 25679999887543 3345778999999999999999999999854 5689
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999998643 4589999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
...........+|+.|+|||++.+..++.++||||||+++|||++ |..||..... .+.........
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~~i~~~~----- 609 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGE----- 609 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHHTC-----
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHcCC-----
Confidence 544444444567889999999999999999999999999999997 8889874321 12222221111
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
....+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 610 -----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11234455678999999999999999999999999998763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=343.58 Aligned_cols=259 Identities=20% Similarity=0.336 Sum_probs=207.5
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchh-----------------HHHHHHHHHHHhccCCCCeeEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQG-----------------VQQFHAEIKTLGRLRHPNLVTL 743 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 743 (963)
.++|++.+.||+|+||.||+|.. +|+.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35899999999999999999988 79999999997543221 2788999999999999999999
Q ss_pred EEeeeCCCeEEEEEeccCCCChHHH------HhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEE
Q 046851 744 IGYHASETEMFLIYNYLPGGNLENF------IQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 744 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill 816 (963)
++++.+.+..++||||+++|+|.++ +.......+++..+..++.|+++|++|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999999 665445679999999999999999999999 8 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCcccccccccccccCccccccC-CCCc-chhhHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q 046851 817 DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC-RVSD-KADVYSYGVVLLELLSDKKALDPSFSSYGNG 894 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~il~elltg~~p~~~~~~~~~~~ 894 (963)
+.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999876433 33446789999999999887 5666 899999999999999999999744321
Q ss_pred cchhhHHHHHHhcCcccceeccc---------cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 895 FNIVAWGCMLLRQGRAKEFFTAG---------LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+.... ...+......+.. .........+..+.+++.+||+.||++|||++|++++
T Consensus 259 ---~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ---VELFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---HHHHHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111 1111111000000 0000113456688999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=355.03 Aligned_cols=241 Identities=16% Similarity=0.192 Sum_probs=190.4
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc---cchhHHHHHHHH---HHHhccCCCCeeEEE-------Ee
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG---RFQGVQQFHAEI---KTLGRLRHPNLVTLI-------GY 746 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 746 (963)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45799999999999999999975 56999999999743 334567889999 555566899999988 55
Q ss_pred eeCCC-----------------eEEEEEeccCCCChHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 046851 747 HASET-----------------EMFLIYNYLPGGNLENFIQQRST-----RAVDWRVLHKIALDIARALAYLHDQCVPRV 804 (963)
Q Consensus 747 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 804 (963)
+.+.+ ..++||||+ +|+|.+++..... ..+++..+..|+.|+++||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 6799999986432 1233588889999999999999999 99
Q ss_pred eecccCCCCeEECCCCcEEEeecccccccCCCCCcccccccccccccCccccccC-----------CCCcchhhHHHHHH
Q 046851 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC-----------RVSDKADVYSYGVV 873 (963)
Q Consensus 805 vH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~i 873 (963)
+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 3344567 999999999887 89999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 874 LLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 874 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
+|||++|+.||........ ...... .....+.++.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~-----------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG-----------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC-----------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc-----------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999974432210 000000 01233467889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=339.85 Aligned_cols=257 Identities=19% Similarity=0.288 Sum_probs=202.1
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeC--CCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHAS--ETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|.. .+++.||||++.... .+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5799999999999999999965 578999999986433 467899999999997 9999999999987 67789999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeecccccccCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGLARLLGPS 836 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~ 836 (963)
||+++++|.+++.. +++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999854 88999999999999999999999 999999999999999777 8999999999876543
Q ss_pred CCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH--------HHhc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM--------LLRQ 907 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~ 907 (963)
.. .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ...+...... ....
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHHHHHCHHHHHHHHHH
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch---HHHHHHHHHhcCCchhhhHHHH
Confidence 32 234578999999999987 67899999999999999999999999643221 0001110000 0000
Q ss_pred Cc--------------ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 GR--------------AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ~~--------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.. .....+.......+...+.++.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 000011111111223356789999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.18 Aligned_cols=260 Identities=24% Similarity=0.395 Sum_probs=202.8
Q ss_pred ChHHHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC-
Q 046851 673 SFESVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS- 749 (963)
Q Consensus 673 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 749 (963)
++.++....++|++.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34444556789999999999999999999874 689999999875433 346789999999999 79999999999866
Q ss_pred -----CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEE
Q 046851 750 -----ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYL 824 (963)
Q Consensus 750 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 824 (963)
.+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 56889999999999999999876556799999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhh
Q 046851 825 SDFGLARLLGPSETHATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~ 899 (963)
+|||++....... .......|++.|+|||++. +..++.++||||||+++|||++|+.||..... ..
T Consensus 171 ~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~ 241 (326)
T 2x7f_A 171 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------MR 241 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HH
T ss_pred eeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HH
Confidence 9999998764322 1223457899999999987 56788999999999999999999999863321 11
Q ss_pred HHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 900 WGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......... ... ..+...+..+.+++.+||+.||++||++++++++
T Consensus 242 ~~~~~~~~~-~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 ALFLIPRNP-APR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHHSC-CCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhcCc-ccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111 111 1122345678999999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.48 Aligned_cols=253 Identities=13% Similarity=0.077 Sum_probs=183.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhcc--CCCCeeEEEE-------eee
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRL--RHPNLVTLIG-------YHA 748 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~~-------~~~ 748 (963)
.+|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.++..+ +||||++++. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999865 789999999987543 3345677885444444 6999888653 332
Q ss_pred CC-----------------CeEEEEEeccCCCChHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCce
Q 046851 749 SE-----------------TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVL------HKIALDIARALAYLHDQCVPRVL 805 (963)
Q Consensus 749 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~iv 805 (963)
.. ...++||||++ |+|.+++..... .+.+..+ ..++.|+++||+|||++ +|+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 21 34899999998 799999987532 3455555 77889999999999999 999
Q ss_pred ecccCCCCeEECCCCcEEEeecccccccCCCCCcccccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCC
Q 046851 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKA 883 (963)
Q Consensus 806 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p 883 (963)
||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876422 113456799999999987 6799999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 884 LDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
|............ ....................+..+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSWK----------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCCC----------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccchh----------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9866433111100 00000011111111122345678999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=350.11 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=206.7
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCC-CCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRH-PNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.++||+|+||.||+|.. .+++.||||++...... .++..|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35899999999999999999976 56899999988654432 457889999999986 566667777778889999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE---CCCCcEEEeecccccccCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~ 835 (963)
|+ +++|.+++.... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 889999998543 4699999999999999999999999 99999999999999 5889999999999987754
Q ss_pred CCCc------ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 836 SETH------ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 836 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~~~-~ 232 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEK-K 232 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----SHHHHHHHHHHH-H
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----hHHHHHHHHhhc-c
Confidence 3322 223567999999999999999999999999999999999999999754322 111111111110 0
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
....++ .+ ....+.++.+++..||+.+|++||++.+|++.|+++
T Consensus 233 ~~~~~~-~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 233 VATSIE-AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHSCHH-HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccHH-HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000000 00 012346789999999999999999999999999876
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=345.90 Aligned_cols=214 Identities=26% Similarity=0.292 Sum_probs=143.0
Q ss_pred ccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEe
Q 046851 23 FHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLD 102 (963)
Q Consensus 23 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~ 102 (963)
..+++|+.|++++|.++. +| .+..+++|++|+|++|.++ .+|. +..+++|++|+
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~----------------------~~~~--~~~l~~L~~L~ 96 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLT----------------------DITP--LKNLTKLVDIL 96 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC----------------------CCGG--GTTCTTCCEEE
T ss_pred hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccC----------------------Cchh--hhccccCCEEE
Confidence 356789999999998883 44 4788888888888888887 3333 34566777777
Q ss_pred CCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcc
Q 046851 103 LSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTY 182 (963)
Q Consensus 103 Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~ 182 (963)
+++|++++..+ +.++++|++|++++|++++..+ +.++++|++|++++|.+++ ++ .+.++++|+.|+++++
T Consensus 97 l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~~~---- 166 (466)
T 1o6v_A 97 MNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFGNQ---- 166 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEEES----
T ss_pred CCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecCCc----
Confidence 77777664433 6677777777777777665432 6677777777777777763 33 3667777777776531
Q ss_pred cccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccc
Q 046851 183 EDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGV 262 (963)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 262 (963)
+.+. ..+..+++|+.|++++|.+.+. ..+..+++|++|++++|+++++.+
T Consensus 167 ------------------------~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-- 216 (466)
T 1o6v_A 167 ------------------------VTDL--KPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-- 216 (466)
T ss_dssp ------------------------CCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred ------------------------ccCc--hhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--
Confidence 1111 1266777777777777777643 346777778888888887777654
Q ss_pred cCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCc
Q 046851 263 LGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALS 303 (963)
Q Consensus 263 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~ 303 (963)
++.+++|+.|++++|++++. +....+++|+.|++++|++.
T Consensus 217 ~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~ 256 (466)
T 1o6v_A 217 LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQIS 256 (466)
T ss_dssp GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC
T ss_pred ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccc
Confidence 56677788888888877754 22334566666666666654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=365.21 Aligned_cols=248 Identities=22% Similarity=0.285 Sum_probs=208.1
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 755 (963)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+..|.+++..+ +||+|+++++++.+.+..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 468999999999999999999765 58899999997542 23456778899999987 69999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 420 V~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999998753 599999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.........
T Consensus 495 ~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~------- 558 (674)
T 3pfq_A 495 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHN------- 558 (674)
T ss_dssp T-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSSC-------
T ss_pred C-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCC-------
Confidence 2 2234557899999999999999999999999999999999999999974321 22222222211
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM-----KQVVR 953 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 953 (963)
...+...+.++.+++.+||+.||++||++ +||.+
T Consensus 559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 12344556789999999999999999997 66664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=341.80 Aligned_cols=255 Identities=22% Similarity=0.375 Sum_probs=196.3
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC------C
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE------T 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 751 (963)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35799999999999999999976 46999999998543 223456789999999999999999999998765 3
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 7899999976 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh-cCc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR-QGR 909 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 909 (963)
..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+....... .+.
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--------LDQLKEIMKVTGT 244 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCC
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcCC
Confidence 75432 234578999999999987 6789999999999999999999999974321 111111110 000
Q ss_pred cc-c------------ee------ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AK-E------------FF------TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~-~------------~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.. + ++ ...............+.+++.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 0 00 0000011122345678999999999999999999999885
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=345.29 Aligned_cols=346 Identities=26% Similarity=0.316 Sum_probs=275.3
Q ss_pred CcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEc
Q 046851 48 DFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLL 127 (963)
Q Consensus 48 ~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 127 (963)
.+++|+.|++++|.+. .+|. +..+++|++|+|++|.+++..+ +.++++|++|++
T Consensus 44 ~l~~l~~L~l~~~~i~----------------------~l~~--~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l 97 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK----------------------SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM 97 (466)
T ss_dssp HHHTCCEEECCSSCCC----------------------CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HhccccEEecCCCCCc----------------------cCcc--hhhhcCCCEEECCCCccCCchh--hhccccCCEEEC
Confidence 4566777777766665 5654 4568999999999999986544 999999999999
Q ss_pred ccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCcc
Q 046851 128 FSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFF 207 (963)
Q Consensus 128 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~ 207 (963)
++|++++..+ +.++++|++|+|++|.+++..+ +.++++|+.|++++|.+
T Consensus 98 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l--------------------------- 146 (466)
T 1o6v_A 98 NNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--------------------------- 146 (466)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEE---------------------------
T ss_pred CCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCcc---------------------------
Confidence 9999997655 9999999999999999985533 89999999999998443
Q ss_pred ccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC
Q 046851 208 EGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL 287 (963)
Q Consensus 208 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 287 (963)
.+ + ..+..+++|+.|+++ |.+.+. ..+..+++|++|++++|+++.++ .+..+++|++|++++|++++..+ ..
T Consensus 147 ~~-~-~~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~-~~ 218 (466)
T 1o6v_A 147 SD-I-SALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDISSNKVSDIS--VLAKLTNLESLIATNNQISDITP-LG 218 (466)
T ss_dssp CC-C-GGGTTCTTCSEEEEE-ESCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCSEEECCSSCCCCCGG-GG
T ss_pred CC-C-hhhccCCcccEeecC-CcccCc--hhhccCCCCCEEECcCCcCCCCh--hhccCCCCCEEEecCCccccccc-cc
Confidence 33 2 248889999999996 555543 34889999999999999998874 47889999999999999987665 44
Q ss_pred CCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCc
Q 046851 288 PVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNN 367 (963)
Q Consensus 288 ~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (963)
.+++|+.|++++|++.+. +.+
T Consensus 219 ~l~~L~~L~l~~n~l~~~-~~l---------------------------------------------------------- 239 (466)
T 1o6v_A 219 ILTNLDELSLNGNQLKDI-GTL---------------------------------------------------------- 239 (466)
T ss_dssp GCTTCCEEECCSSCCCCC-GGG----------------------------------------------------------
T ss_pred ccCCCCEEECCCCCcccc-hhh----------------------------------------------------------
Confidence 578899999999887632 112
Q ss_pred ccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCC
Q 046851 368 FSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGN 447 (963)
Q Consensus 368 ~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n 447 (963)
..+..|+ .|++++|.+++. ++ +.. +++|++|++++|
T Consensus 240 ---------------------------------------~~l~~L~--~L~l~~n~l~~~-~~-~~~-l~~L~~L~l~~n 275 (466)
T 1o6v_A 240 ---------------------------------------ASLTNLT--DLDLANNQISNL-AP-LSG-LTKLTELKLGAN 275 (466)
T ss_dssp ---------------------------------------GGCTTCS--EEECCSSCCCCC-GG-GTT-CTTCSEEECCSS
T ss_pred ---------------------------------------hcCCCCC--EEECCCCccccc-hh-hhc-CCCCCEEECCCC
Confidence 2233333 667777777633 33 333 478999999999
Q ss_pred cCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCCh
Q 046851 448 QIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPD 527 (963)
Q Consensus 448 ~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 527 (963)
.+++. +. +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..| +..+++|+.|++++|++++. .
T Consensus 276 ~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 347 (466)
T 1o6v_A 276 QISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--S 347 (466)
T ss_dssp CCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--G
T ss_pred ccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--h
Confidence 99854 43 8889999999999999976544 7889999999999999986554 78899999999999999865 5
Q ss_pred hhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCcc
Q 046851 528 DLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 528 ~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~ 571 (963)
.+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 348 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 348 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp GGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred hhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 78899999999999999997766 8889999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=352.06 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=194.4
Q ss_pred HHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--------hhHHHHHHHHHHHhccCCCCeeEEEEeeeC
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--------QGVQQFHAEIKTLGRLRHPNLVTLIGYHAS 749 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 749 (963)
...++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34578999999999999999999765 689999999875421 122357899999999999999999999865
Q ss_pred CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC---cEEEee
Q 046851 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF---NAYLSD 826 (963)
Q Consensus 750 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 826 (963)
+..++||||+++|+|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 4589999999999999988753 4689999999999999999999999 999999999999997544 599999
Q ss_pred cccccccCCCCCcccccccccccccCcccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 827 FGLARLLGPSETHATTGVAGTFGYVAPEYAMT---CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 827 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~~~---- 355 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKD---- 355 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CCHHH----
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HHHHH----
Confidence 9999876432 22344679999999999863 56788999999999999999999999744222 11111
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+..... +.. ....+..+.+++.+||+.||++|||++|++++
T Consensus 356 ~i~~~~~~~~--~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 QITSGKYNFI--PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTCCCCC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCC--chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111111100 000 11235678999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=347.69 Aligned_cols=266 Identities=22% Similarity=0.294 Sum_probs=205.4
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccC--------CCCeeEEEEeee---
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR--------HPNLVTLIGYHA--- 748 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 748 (963)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36899999999999999999975 468899999987542 34567889999999985 788999999987
Q ss_pred -CCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-------
Q 046851 749 -SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF------- 820 (963)
Q Consensus 749 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~------- 820 (963)
.....++||||+ ++++.+++.......+++.++..++.|+++||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 566889999999 667877777655567999999999999999999999964 899999999999999875
Q ss_pred ------------------------------------------cEEEeecccccccCCCCCcccccccccccccCcccccc
Q 046851 821 ------------------------------------------NAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858 (963)
Q Consensus 821 ------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 858 (963)
.+||+|||++...... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999876432 234578999999999999
Q ss_pred CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC-CcchhhHHHHHHhc---------Ccccceecccc----------
Q 046851 859 CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN-GFNIVAWGCMLLRQ---------GRAKEFFTAGL---------- 918 (963)
Q Consensus 859 ~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~~~---------- 918 (963)
..++.++|||||||++|||++|+.||......... .......+...... .....++....
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999999755432110 00111111111000 00000010000
Q ss_pred ---------CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 ---------WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+......+.+++.+||+.||++|||++|++++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012345667889999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=334.67 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=189.2
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 35799999999999999999977 4789999999975432 22234455566688889999999999999999999999
Q ss_pred eccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 758 NYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 758 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||+++ +|.+++... ....+++..+..++.|++.|++|||+++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99975 998887652 3456999999999999999999999853 899999999999999999999999999987643
Q ss_pred CCCcccccccccccccCcccc----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 836 SETHATTGVAGTFGYVAPEYA----MTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
... .....||+.|+|||++ .+..++.++||||+|+++|||++|+.||...... ............
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-- 231 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-------FQQLKQVVEEPS-- 231 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-------HHHHHHHHHSCC--
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-------HHHHHHHhccCC--
Confidence 322 2334689999999996 5667889999999999999999999999742211 111222222211
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11112234567899999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=344.12 Aligned_cols=269 Identities=23% Similarity=0.313 Sum_probs=201.2
Q ss_pred hHHHHHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccc-----------hhHHHHHHHHHHHhccCCCCeeE
Q 046851 674 FESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF-----------QGVQQFHAEIKTLGRLRHPNLVT 742 (963)
Q Consensus 674 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~ 742 (963)
.+++....++|++.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 5677788899999999999999999999888899999999854322 12377899999999999999999
Q ss_pred EEEeee-----CCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 743 LIGYHA-----SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 743 l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
+++++. .....++||||++ |+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA 168 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence 999883 3447899999997 5999988754 34689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcc
Q 046851 818 DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFN 896 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~ 896 (963)
.++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~ 241 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-----N 241 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----H
T ss_pred CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-----H
Confidence 99999999999997543322 2334578999999999887 67899999999999999999999999743211 1
Q ss_pred hhhHHHHHHhcCcc-----------cceecccc-------CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 897 IVAWGCMLLRQGRA-----------KEFFTAGL-------WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 897 ~~~~~~~~~~~~~~-----------~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+......... ...+.... ...........+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11111100000000 00000000 001112335678899999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.84 Aligned_cols=263 Identities=21% Similarity=0.294 Sum_probs=200.8
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeC--------C
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--------E 750 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 750 (963)
++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999987 4789999999865432 224577899999999999999999999876 4
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
+..++||||+++ ++.+.+.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 568999999975 8888886543 4589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC---CcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 831 RLLGPSE---THATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 831 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
+...... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~ 246 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQLCG 246 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhC
Confidence 8765322 222344578999999999976 45799999999999999999999999754221 11111111111
Q ss_pred cCcc---cce-----ecc---ccCCCCCh-h------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 QGRA---KEF-----FTA---GLWDAGPH-D------DLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~~---~~~-----~~~---~~~~~~~~-~------~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... ... .+. ........ . ....+.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1000 000 000 00000000 0 13457899999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=330.92 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=202.9
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
..++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3468999999999999999999776 58999999987643 34678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999999754 35689999999999999999999999 99999999999999999999999999998764332
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ........ .......
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~~~----- 245 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIFMIP-TNPPPTF----- 245 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH-HSCCCCC-----
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHh-cCCCccc-----
Confidence 223345789999999999998999999999999999999999999974321 11111111 1111111
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1123345688999999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=355.87 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=206.6
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 47999999999999999999775 78999999986542 345678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE---CCCCcEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL---DDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~ 834 (963)
||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 106 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 106 EVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999764 4589999999999999999999999 99999999999999 567899999999998775
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
.... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... .+....... +....
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~-~~~~~-- 246 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKVEK-GKYTF-- 246 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCCCC--
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHc-CCCCC--
Confidence 4332 234579999999999876 689999999999999999999999974321 122222221 11110
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .......+..+.+++.+||+.||++|||+.|++++
T Consensus 247 ~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 E----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp C----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 00112345678999999999999999999999864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=341.26 Aligned_cols=355 Identities=18% Similarity=0.127 Sum_probs=215.1
Q ss_pred CCCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecc
Q 046851 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSF 80 (963)
Q Consensus 1 l~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~ 80 (963)
+.+|++|++++|.++++ | .+..+++|++|+|++|++++. + |..+++|++|++++|.+++.....+.+|++|++++
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~ 115 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDT 115 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECCS
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCceeecCCCCcCCEEECCC
Confidence 36899999999999976 4 699999999999999999964 4 89999999999999999854333344566666666
Q ss_pred ccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCC
Q 046851 81 NRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSI 160 (963)
Q Consensus 81 n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (963)
|+++ .+| +..+++|++|++++|++++. .++++++|+.|++++|+..+.+ .+..+++|++|++++|++++ +
T Consensus 116 N~l~-~l~---~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l 185 (457)
T 3bz5_A 116 NKLT-KLD---VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-L 185 (457)
T ss_dssp SCCS-CCC---CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-C
T ss_pred CcCC-eec---CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-e
Confidence 6666 444 34566666666666666642 2556666666666666433232 35566666666666666663 3
Q ss_pred CcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcccc
Q 046851 161 PVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWG 240 (963)
Q Consensus 161 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 240 (963)
| +..+++|+.|++++|.++ +. .+..+++|+.|++++|++++ +| +.
T Consensus 186 ~--l~~l~~L~~L~l~~N~l~---------------------------~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~ 230 (457)
T 3bz5_A 186 D--VSQNKLLNRLNCDTNNIT---------------------------KL---DLNQNIQLTFLDCSSNKLTE-ID--VT 230 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCS---------------------------CC---CCTTCTTCSEEECCSSCCSC-CC--CT
T ss_pred c--cccCCCCCEEECcCCcCC---------------------------ee---ccccCCCCCEEECcCCcccc-cC--cc
Confidence 3 555556666665553222 21 14445555555555555554 22 45
Q ss_pred ccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcccc
Q 046851 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYL 320 (963)
Q Consensus 241 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l 320 (963)
.+++|++|++++|++++++. +.+++|+.|++++|++ +.|++++|.+.+..| +..+.
T Consensus 231 ~l~~L~~L~l~~N~l~~~~~---~~l~~L~~L~l~~n~L-------------~~L~l~~n~~~~~~~-~~~l~------- 286 (457)
T 3bz5_A 231 PLTQLTYFDCSVNPLTELDV---STLSKLTTLHCIQTDL-------------LEIDLTHNTQLIYFQ-AEGCR------- 286 (457)
T ss_dssp TCTTCSEEECCSSCCSCCCC---TTCTTCCEEECTTCCC-------------SCCCCTTCTTCCEEE-CTTCT-------
T ss_pred ccCCCCEEEeeCCcCCCcCH---HHCCCCCEEeccCCCC-------------CEEECCCCccCCccc-ccccc-------
Confidence 55555555555555555442 3344555555554432 234444444433322 12222
Q ss_pred cccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCC
Q 046851 321 SRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGS 400 (963)
Q Consensus 321 ~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~ 400 (963)
T Consensus 287 -------------------------------------------------------------------------------- 286 (457)
T 3bz5_A 287 -------------------------------------------------------------------------------- 286 (457)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchh
Q 046851 401 FPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTT 480 (963)
Q Consensus 401 ~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~ 480 (963)
.|+ .|++++|.+.+.+|.. ..+|+.|++++| ++|+.|++++|++++. +
T Consensus 287 ----------~L~--~L~Ls~n~~l~~l~~~----~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~-- 334 (457)
T 3bz5_A 287 ----------KIK--ELDVTHNTQLYLLDCQ----AAGITELDLSQN-------------PKLVYLYLNNTELTEL-D-- 334 (457)
T ss_dssp ----------TCC--CCCCTTCTTCCEEECT----TCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--
T ss_pred ----------cCC--EEECCCCcccceeccC----CCcceEechhhc-------------ccCCEEECCCCccccc-c--
Confidence 333 4445555544444431 133444444444 5677777777777653 2
Q ss_pred hccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCcc
Q 046851 481 LGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLA 554 (963)
Q Consensus 481 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 554 (963)
++.+++|+.|++++|++++ ++.|+.|++++|+++|. ..+..|+.+++++|+++|.+|..+.
T Consensus 335 l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 335 VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence 6667777777777777763 24566667777777754 3456677777777777777776543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=353.55 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=200.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
+.|++.+.||+|+||+||+|... ++..||||++.... ......+.+|+++++.++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46999999999999999999775 68999999987543 2335678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEEEeecccccccCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAYLSDFGLARLLGP 835 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~ 835 (963)
|+++|+|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++. ++.+||+|||++.....
T Consensus 117 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999999775 3589999999999999999999999 9999999999999976 45599999999987653
Q ss_pred CCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 836 SETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.. ......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... .+....... +... ++
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~-~~~~--~~ 257 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVEK-GKYT--FD 257 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-TCCC--CC
T ss_pred Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCCC--CC
Confidence 32 234457999999999986 4689999999999999999999999974321 222222221 1111 01
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+ ...+..+.+++.+||+.||++|||+.|++++
T Consensus 258 ~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111 1335678899999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=327.20 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=205.8
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---------chhHHHHHHHHHHHhccC-CCCeeEEEEeeeC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---------FQGVQQFHAEIKTLGRLR-HPNLVTLIGYHAS 749 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 749 (963)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999775 68999999987543 122456789999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccc
Q 046851 750 ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGL 829 (963)
Q Consensus 750 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 829 (963)
.+..++||||+++++|.+++... ..+++.++..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999874 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccccc------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 830 ARLLGPSETHATTGVAGTFGYVAPEYAM------TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 830 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
+....... ......|++.|+|||++. ...++.++||||+|+++|||++|+.||.... .......
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~ 240 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRM 240 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHHHH
Confidence 98765432 233457899999999985 4567889999999999999999999986431 1112222
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... .. .........+..+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~-~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 241 IMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhcCC-cc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11111 10 0011113456689999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=346.85 Aligned_cols=198 Identities=26% Similarity=0.345 Sum_probs=173.7
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhcc------CCCCeeEEEEeeeCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL------RHPNLVTLIGYHASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 753 (963)
..+|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++..+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357999999999999999999665 58999999987543 3345677788887776 577999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc--EEEeeccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN--AYLSDFGLAR 831 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~ 831 (963)
++||||+. ++|.+++.......+++..+..++.|+++||+|||++ +|+||||||+|||++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 5999999887666799999999999999999999999 9999999999999999987 9999999997
Q ss_pred ccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPS 887 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 887 (963)
..... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 65322 23457899999999999999999999999999999999999999744
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=352.05 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=202.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-------------hhHHHHHHHHHHHhccCCCCeeEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-------------QGVQQFHAEIKTLGRLRHPNLVTLIGY 746 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 746 (963)
.++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999999999999775 588999999875432 234678999999999999999999999
Q ss_pred eeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC---cEE
Q 046851 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF---NAY 823 (963)
Q Consensus 747 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k 823 (963)
+.+....++||||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999999775 3589999999999999999999999 999999999999999776 699
Q ss_pred EeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 824 LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 824 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
|+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... .+....
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~ 258 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND--------QDIIKK 258 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 99999998765432 2344579999999999874 689999999999999999999999974321 222222
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... +... ++...+ ...+..+.+++.+||+.||++|||++|++++
T Consensus 259 i~~-~~~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEK-GKYY--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHH-CCCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHc-CCCC--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 221 1110 000000 1234678999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.46 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=203.7
Q ss_pred HcCCCCCccccccCCCccEEEEEE--CCCcEEEEEEeecccch--hHHHHHHHHHHHhcc---CCCCeeEEEEeee----
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI--SPGVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRL---RHPNLVTLIGYHA---- 748 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 748 (963)
+.++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456899999999999999999987 46889999998654321 123456777776666 8999999999986
Q ss_pred -CCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeec
Q 046851 749 -SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDF 827 (963)
Q Consensus 749 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 827 (963)
.....++||||++ |+|.+++.......+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 5677899999997 5999999887666699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 828 GLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 828 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
|++...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+......
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~ 237 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGL 237 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCC
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcCC
Confidence 999865422 2334457899999999999999999999999999999999999999744221 111111111100
Q ss_pred Ccccce----------ec---cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 GRAKEF----------FT---AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ~~~~~~----------~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+ +. ...........+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00 000011123346678899999999999999999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=338.06 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=192.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC------e
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET------E 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 752 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 58999999999999999999764 68999999987532 334567889999999999999999999987654 7
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 8999999975 88888853 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH--------
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML-------- 904 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 904 (963)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+....
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-------DQWNKVIEQLGTPCP 247 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHC-CCCCCH
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCCCH
Confidence 5432 2233457899999999999999999999999999999999999999744211 1111000
Q ss_pred -------------HhcCc------ccceeccccCCCC---ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 -------------LRQGR------AKEFFTAGLWDAG---PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 -------------~~~~~------~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... ....+........ .......+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000 0000000000000 11236688999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=344.76 Aligned_cols=266 Identities=22% Similarity=0.315 Sum_probs=184.5
Q ss_pred CCCC-ccccccCCCccEEEEEEC---CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEee--eCCCeEEEE
Q 046851 683 NFNA-SNCIGNGGFGATYKAEIS---PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYH--ASETEMFLI 756 (963)
Q Consensus 683 ~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~lv 756 (963)
.|++ +++||+|+||.||+|.+. +++.||||++...... ..+.+|++++++++||||+++++++ ......++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4555 558999999999999865 5789999999754332 5678999999999999999999998 457789999
Q ss_pred EeccCCCChHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE----CCCCcEEEe
Q 046851 757 YNYLPGGNLENFIQQRS-------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL----DDDFNAYLS 825 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~ 825 (963)
|||+++ +|.+++.... ...+++..+..|+.|++.||+|||++ +|+||||||+||++ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999965 8888886432 22489999999999999999999999 99999999999999 678899999
Q ss_pred ecccccccCCCCC--cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCc-chhhHH
Q 046851 826 DFGLARLLGPSET--HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGF-NIVAWG 901 (963)
Q Consensus 826 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~-~~~~~~ 901 (963)
|||+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||........... ...+..
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987653221 223446799999999999874 589999999999999999999999975543211100 001111
Q ss_pred HHHHh---cCccccee---------------ccccCCC---------CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 902 CMLLR---QGRAKEFF---------------TAGLWDA---------GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 902 ~~~~~---~~~~~~~~---------------~~~~~~~---------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..... ......+- ....... ........+.+|+.+||+.||++|||++|++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11110 00000000 0000000 000113467899999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.56 Aligned_cols=253 Identities=19% Similarity=0.328 Sum_probs=199.4
Q ss_pred HHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeeccc--chhHHHHHHHHHHHhccC--CCCeeEEEEeeeCCCeEE
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLR--HPNLVTLIGYHASETEMF 754 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 754 (963)
...++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++.+++ ||||+++++++...+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3446799999999999999999988889999999987543 344578899999999997 599999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||| +.+++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||++++ +.+||+|||++....
T Consensus 105 lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 9999 5578999999874 4589999999999999999999999 9999999999999964 899999999998765
Q ss_pred CCCCc-ccccccccccccCcccccc-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHH
Q 046851 835 PSETH-ATTGVAGTFGYVAPEYAMT-----------CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGC 902 (963)
Q Consensus 835 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 902 (963)
..... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~~ 250 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH 250 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HHHHH
Confidence 43222 2234578999999999875 46888999999999999999999999643211 11111
Q ss_pred HHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 903 MLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... .......+...+..+.+++.+||+.||++||+++|++++
T Consensus 251 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 AIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111 111112233335678999999999999999999999875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=348.32 Aligned_cols=319 Identities=22% Similarity=0.199 Sum_probs=215.7
Q ss_pred ceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCC
Q 046851 75 RVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRN 154 (963)
Q Consensus 75 ~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 154 (963)
.++.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|.++++.|.+|.++++|++|+|++|
T Consensus 15 ~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp EEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 3444455555 6666553 46677777777777666677777777777777777777666777777777777777777
Q ss_pred ccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccC
Q 046851 155 SLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN 234 (963)
Q Consensus 155 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~ 234 (963)
.++...+..|.++++|+.|++++ |.+.+..+..|..+++|+.|++++|.+.+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~---------------------------n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 143 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISE---------------------------NKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTT---------------------------SCCCEECTTTTTTCTTCCEEEECCTTCCEE
T ss_pred cCCccCcccccCCCCCCEEECCC---------------------------CccccCChhHccccccCCEEECCCCcccee
Confidence 77755555566777777777766 444445556667777777777777777777
Q ss_pred CCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCccCCCCCCCCC
Q 046851 235 FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPTFSNMV 313 (963)
Q Consensus 235 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~~~~~~l~ 313 (963)
.+..|.++++|++|+|++|+++.+++..|..+++|+.|++++|.+.+..+..+ .+++|+.|++++|.+.
T Consensus 144 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~---------- 213 (477)
T 2id5_A 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL---------- 213 (477)
T ss_dssp CTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC----------
T ss_pred ChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc----------
Confidence 77777777777777777777777777777777777777777777765544333 3445555555544332
Q ss_pred CCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcC
Q 046851 314 CPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAG 393 (963)
Q Consensus 314 ~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 393 (963)
T Consensus 214 -------------------------------------------------------------------------------- 213 (477)
T 2id5_A 214 -------------------------------------------------------------------------------- 213 (477)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcC
Q 046851 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLM 473 (963)
Q Consensus 394 ~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i 473 (963)
+.+|...+.. .+|++|++++|++++..+..+..+++|+.|+|++|.+
T Consensus 214 --------------------------------~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 260 (477)
T 2id5_A 214 --------------------------------DTMTPNCLYG-LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI 260 (477)
T ss_dssp --------------------------------CEECTTTTTT-CCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCC
T ss_pred --------------------------------cccCcccccC-ccccEEECcCCcccccCHHHhcCccccCeeECCCCcC
Confidence 2222222222 3577777777777743335667777777777777777
Q ss_pred CCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCC
Q 046851 474 HDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547 (963)
Q Consensus 474 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 547 (963)
++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++.+
T Consensus 261 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 261 STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred CccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 66666667777777777777777776667777777777777777777776655666777777777777777763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.37 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=194.6
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC------eEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET------EMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 755 (963)
.+|++.+.||+|+||.||+|....+..||+|++..... ...+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 47999999999999999999988777899998864432 2246999999999999999999985432 3789
Q ss_pred EEeccCCCChHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC-CCCcEEEeecccccc
Q 046851 756 IYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARL 832 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~ 832 (963)
||||+++ ++.+.+.. .....+++..+..++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||+++.
T Consensus 116 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999987 44444332 1245689999999999999999999999 999999999999999 799999999999987
Q ss_pred cCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc--
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR-- 909 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 909 (963)
...... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+....+. .....
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~l~~i~~~-~g~p~~~ 264 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI----DQLVEIIKV-LGTPSRE 264 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHH-HCCCCHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHH-hCCCCHH
Confidence 643332 3345789999999999765 5899999999999999999999999743211 011111110 00000
Q ss_pred -----ccceecccc---C-----CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 -----AKEFFTAGL---W-----DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 -----~~~~~~~~~---~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.....+... . ...+...+.++.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000 0 01122345689999999999999999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=331.16 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=196.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeee------------
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA------------ 748 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~------------ 748 (963)
++|++.+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57999999999999999999876 48999999998776667788999999999999999999999873
Q ss_pred --CCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC-CCCcEEEe
Q 046851 749 --SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD-DDFNAYLS 825 (963)
Q Consensus 749 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~ 825 (963)
+....++||||++ |+|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+||+++ .++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 599999974 4589999999999999999999999 999999999999997 56799999
Q ss_pred ecccccccCCCCC--cccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHH
Q 046851 826 DFGLARLLGPSET--HATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGC 902 (963)
Q Consensus 826 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 902 (963)
|||+++....... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... +...
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~~~~ 235 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--------EQMQ 235 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--------HHHH
Confidence 9999987643221 12233457899999998875 67899999999999999999999999744221 1111
Q ss_pred HHHhcCc-------------ccceeccccC-CC-----CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 903 MLLRQGR-------------AKEFFTAGLW-DA-----GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 903 ~~~~~~~-------------~~~~~~~~~~-~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....... ....+..... .. .....+.++.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1111100 0000000000 00 012345678999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=345.96 Aligned_cols=259 Identities=27% Similarity=0.365 Sum_probs=195.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC------CCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS------ETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~ 754 (963)
.+|++.+.||+|+||.||+|.+. +|+.||||++.... ..+.+|++++++++||||+++++++.. ....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36899999999999999999875 58999999986543 223579999999999999999998743 22367
Q ss_pred EEEeccCCCChHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC-CcEEEeeccccc
Q 046851 755 LIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD-FNAYLSDFGLAR 831 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~ 831 (963)
+||||+++ ++.+.+.. .....+++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999976 77776653 2346699999999999999999999999 99999999999999965 568999999998
Q ss_pred ccCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH------
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML------ 904 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 904 (963)
....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+...++..
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~----~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCSCCHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHH
Confidence 7643322 2345789999999999765 7899999999999999999999999743211 1111111110
Q ss_pred -Hh--cCcccceeccccCC-----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 -LR--QGRAKEFFTAGLWD-----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 -~~--~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+. .....++..+.... ..+...+.++.+|+.+||+.||++||++.|++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 00011110000000 0122345688999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=332.93 Aligned_cols=264 Identities=20% Similarity=0.326 Sum_probs=207.1
Q ss_pred CCCCCccccccCCCccEEEEEE--CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCC------CeeEEEEeeeCCCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI--SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHP------NLVTLIGYHASETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~~ 753 (963)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++++..++|+ +++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5899999999999999999976 368899999986542 3356788899998888655 599999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---------------
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD--------------- 818 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--------------- 818 (963)
++||||+ +++|.+++.......+++.++..++.|+++||+|||++ +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 88999999887666789999999999999999999999 9999999999999987
Q ss_pred ----CCcEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q 046851 819 ----DFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG 894 (963)
Q Consensus 819 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~ 894 (963)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 240 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK---- 240 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH----
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH----
Confidence 668999999999865322 23457899999999999999999999999999999999999999743221
Q ss_pred cchhhHHHHHHhc--------Ccccceecc----------------------ccCCCCChhHHHHHHHHHHHcccCCCCC
Q 046851 895 FNIVAWGCMLLRQ--------GRAKEFFTA----------------------GLWDAGPHDDLVEVLHLAVVCTVDSLST 944 (963)
Q Consensus 895 ~~~~~~~~~~~~~--------~~~~~~~~~----------------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 944 (963)
.....+...... ......+.. ......+...+.++.+++.+||+.||++
T Consensus 241 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 241 -EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp -HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 111111111100 000000000 0001123345778999999999999999
Q ss_pred CCCHHHHHHH--HhccC
Q 046851 945 RPTMKQVVRR--LKQLQ 959 (963)
Q Consensus 945 RPs~~evl~~--L~~l~ 959 (963)
|||++|++++ +++++
T Consensus 320 Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 320 RITLREALKHPFFDLLK 336 (339)
T ss_dssp SCCHHHHTTSGGGGGGG
T ss_pred ccCHHHHhcCHHHHHHh
Confidence 9999999865 44443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.54 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=202.0
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-----CeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-----TEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 753 (963)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999765 68899999987543 33447789999999999999999999998654 468
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||+++ +|.+++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 106 ~iv~e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 999999975 999999753 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--ccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 834 GPSETH--ATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 834 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+.........
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGSPSQ 253 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-----GHHHHHHHHHCSCCH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHHHhCCCCH
Confidence 533222 1244579999999998764 45899999999999999999999999744221 111111111000000
Q ss_pred c-----------ceecccc-CCC-----CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 K-----------EFFTAGL-WDA-----GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~-----------~~~~~~~-~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ....... ... .......++.+++.+||+.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 000 012234678899999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.18 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=198.1
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc--------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF--------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (963)
.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 357999999999999999999765 588999999865321 22345789999999999999999999987665
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc---EEEeecc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN---AYLSDFG 828 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 828 (963)
.++||||+++++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 89999999999999999763 4689999999999999999999999 9999999999999987664 9999999
Q ss_pred cccccCCCCCcccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHH
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL 905 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 905 (963)
++...... .......||+.|+|||++. +..++.++||||+|+++|||++|+.||...... ...... .
T Consensus 163 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~----~ 232 (322)
T 2ycf_A 163 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKDQ----I 232 (322)
T ss_dssp TCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCHHHH----H
T ss_pred cceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHHHHH----H
Confidence 99876432 2223456899999999974 467889999999999999999999999744322 111111 1
Q ss_pred hcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+.... .+.. ....+..+.+++.+||+.||++||++.|++++
T Consensus 233 ~~~~~~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 TSGKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCcccc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1111100 0000 11235678999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.01 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=200.0
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCC-----CeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE-----TEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 753 (963)
.++|++.+.||+|+||.||+|... +|+.||||++.... .....++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999875 68999999986443 33456788999999999999999999987653 678
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++||||++ ++|.+++.. ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 599999976 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc---------ccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 834 GPSETH---------ATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 834 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
...... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~ 237 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-----HQLLLIFG 237 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHH
Confidence 532211 1223578999999998765 67899999999999999999999999744211 00000000
Q ss_pred HHhcCc----c--------cceeccc-cCC-----CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 904 LLRQGR----A--------KEFFTAG-LWD-----AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 904 ~~~~~~----~--------~~~~~~~-~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...... . .+.+... ... ......+.++.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0 0000000 000 0012345678899999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.23 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=183.5
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCC------C
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASE------T 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 751 (963)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999975 46899999998653 233457788999999999999999999998654 5
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
..++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 6799999875 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc-
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR- 909 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 909 (963)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+........
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTPGA 251 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCH
Confidence 65422 234578999999999987 67899999999999999999999999743211 11111111100000
Q ss_pred ----------ccceecccc-CCCC-----ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 ----------AKEFFTAGL-WDAG-----PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ----------~~~~~~~~~-~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...++.... .... .......+.+|+.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000 0000 01234578899999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=321.91 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=204.4
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 458999999999999999999875 68999999986543 235678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC---CcEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD---FNAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~~~ 834 (963)
||+++++|.+++.... .+++.++..++.|+++|++|||++ +++||||||+||+++.+ +.+||+|||++....
T Consensus 101 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999987643 589999999999999999999999 99999999999999764 469999999998765
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
.... .....|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||.... ..+....... +....
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~-~~~~~-- 241 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVET-GKYAF-- 241 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH-CCCCC--
T ss_pred CCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHc-CCCCC--
Confidence 4322 223468999999999876 48899999999999999999999997432 1122222211 11110
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
+.. .....+.++.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DLP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CSG----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cch----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000 012335678999999999999999999999973
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.12 Aligned_cols=259 Identities=22% Similarity=0.353 Sum_probs=202.0
Q ss_pred HHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 679 QATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 679 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
...++|++.+.||+|+||.||+|.... .||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345689999999999999999998863 499999875432 2345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++... ...+++.++..++.|+++|++|||++ +++||||||+||+++ ++.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999999764 34689999999999999999999999 999999999999998 679999999998765322
Q ss_pred C----CcccccccccccccCcccccc---------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 837 E----THATTGVAGTFGYVAPEYAMT---------CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 837 ~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
. ........|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~ 254 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--------EAIIWQ 254 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------HHHHHH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 1 122233468999999999874 4578899999999999999999999974321 111111
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
. ..+..... .+...+.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 255 ~-~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 255 M-GTGMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp H-HTTCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred h-ccCCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1 11111111 1112345688999999999999999999999999987653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=333.93 Aligned_cols=269 Identities=22% Similarity=0.317 Sum_probs=192.4
Q ss_pred HHHHHHcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe-
Q 046851 675 ESVVQATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE- 752 (963)
Q Consensus 675 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 752 (963)
++.....++|++.+.||+|+||.||+|... +|+.||||++..... ...++.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677789999999999999999999875 689999998865432 23456778888899999999999999855332
Q ss_pred ------EEEEEeccCCCChHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceecccCCCCeEECC-CCc
Q 046851 753 ------MFLIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAYLH--DQCVPRVLHRDVKPSNILLDD-DFN 821 (963)
Q Consensus 753 ------~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~dlk~~Nill~~-~~~ 821 (963)
.++||||+++ ++.+.+.. .....+++..+..++.|++.|+.||| +. +|+||||||+||+++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999986 66555543 23456899999999999999999999 88 9999999999999996 899
Q ss_pred EEEeecccccccCCCCCcccccccccccccCccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhH
Q 046851 822 AYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR-VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAW 900 (963)
Q Consensus 822 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~ 900 (963)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ......
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~~ 244 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA----GQLHEI 244 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH----HHHHHH
Confidence 9999999998765433 233457899999999987654 899999999999999999999999754221 011111
Q ss_pred HHHH-----------HhcCcccceec------cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 901 GCML-----------LRQGRAKEFFT------AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 901 ~~~~-----------~~~~~~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... ..........+ ...........+..+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1100 00000000000 000111223356789999999999999999999999875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=343.53 Aligned_cols=346 Identities=22% Similarity=0.157 Sum_probs=274.7
Q ss_pred cceeccccccccCCCc-ccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCc
Q 046851 53 EELNLAGNLVNGTVPT-FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNM 131 (963)
Q Consensus 53 ~~L~Ls~N~l~~~~~~-~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~ 131 (963)
+.++.+++.++ .+|. ...+++.|+|++|+++ .++...|.++++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 14 ~~v~c~~~~l~-~ip~~~~~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TEEECCSCCCS-SCCSCCCTTCSEEECCSSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CEEEeCCCCcC-cCCCCCCCCCcEEECCCCccc-eECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 45666666666 3343 3346777777777777 6766677789999999999999998889999999999999999999
Q ss_pred ccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCC
Q 046851 132 LEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGI 211 (963)
Q Consensus 132 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~ 211 (963)
++++.+..|.++++|++|+|++|.+++..+..|.++++|+.|++++ |.+.+..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~---------------------------n~l~~~~ 144 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD---------------------------NDLVYIS 144 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECC---------------------------TTCCEEC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCC---------------------------CccceeC
Confidence 9988888899999999999999999988889999999999999998 5566667
Q ss_pred cccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCC-CCCCC
Q 046851 212 PEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAR-ELPVP 290 (963)
Q Consensus 212 ~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~ 290 (963)
+..|.++++|+.|++++|++++..+..|..+++|+.|+|++|.+..+++..|..+++|+.|++++|.+.+..+. .+...
T Consensus 145 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~ 224 (477)
T 2id5_A 145 HRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224 (477)
T ss_dssp TTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTC
T ss_pred hhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCc
Confidence 78899999999999999999988778899999999999999999999999999999999999999987654432 22333
Q ss_pred ceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccc
Q 046851 291 CMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSG 370 (963)
Q Consensus 291 ~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (963)
+|+.|+++
T Consensus 225 ~L~~L~l~------------------------------------------------------------------------ 232 (477)
T 2id5_A 225 NLTSLSIT------------------------------------------------------------------------ 232 (477)
T ss_dssp CCSEEEEE------------------------------------------------------------------------
T ss_pred cccEEECc------------------------------------------------------------------------
Confidence 44444444
Q ss_pred cCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCC
Q 046851 371 SLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIV 450 (963)
Q Consensus 371 ~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~ 450 (963)
+|+++ .+|...+..+++|+.|+|++|.++
T Consensus 233 --------------------------------------------------~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~ 261 (477)
T 2id5_A 233 --------------------------------------------------HCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261 (477)
T ss_dssp --------------------------------------------------SSCCC-SCCHHHHTTCTTCCEEECCSSCCC
T ss_pred --------------------------------------------------CCccc-ccCHHHhcCccccCeeECCCCcCC
Confidence 44444 455444444578899999999988
Q ss_pred CCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhh
Q 046851 451 GPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLE 530 (963)
Q Consensus 451 ~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 530 (963)
+..+..|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.++.. ....+
T Consensus 262 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~-c~~~~ 340 (477)
T 2id5_A 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD-CRLLW 340 (477)
T ss_dssp EECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS-GGGHH
T ss_pred ccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc-cchHh
Confidence 77777788889999999999999888888898999999999999999866666788889999999999998743 22222
Q ss_pred ccccCCeEEeccccCCCcCCC
Q 046851 531 NLRNLTVLLLNNNKLSGKIPS 551 (963)
Q Consensus 531 ~l~~L~~L~l~~N~l~~~~p~ 551 (963)
-...+..+.+.++......|.
T Consensus 341 ~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 341 VFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp HHTTTTSSCCTTCCCBEEESG
T ss_pred HHhhhhccccCccCceeCCch
Confidence 223344455555555433443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.71 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=195.4
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC----------
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS---------- 749 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 749 (963)
.++|++.+.||+|+||.||+|... +|+.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 357999999999999999999864 7899999998643 3445778999999999999999999998754
Q ss_pred ---CCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEee
Q 046851 750 ---ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD 826 (963)
Q Consensus 750 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 826 (963)
.+..++||||+++|+|.+++.... ..+++.++..++.|+++|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 457899999999999999998643 4578899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCC-------------CcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 046851 827 FGLARLLGPSE-------------THATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYG 892 (963)
Q Consensus 827 fgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~ 892 (963)
||++....... ........|++.|+|||++.+. .++.++||||+|+++|||++ ||....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---- 232 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---- 232 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----
Confidence 99998764321 1122345689999999999865 68999999999999999998 443211
Q ss_pred CCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........ ..... .......+...+..+.+++.+||+.||++|||+.|++++
T Consensus 233 ---~~~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ---ERVNILKK-LRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---HHHHHHHH-HHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---hHHHHHHh-ccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111111 11110 111122344556678999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=333.87 Aligned_cols=253 Identities=24% Similarity=0.276 Sum_probs=175.7
Q ss_pred cCCCCCcc-ccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC----CCeEE
Q 046851 681 TGNFNASN-CIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS----ETEMF 754 (963)
Q Consensus 681 ~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 754 (963)
.++|.+.+ .||+|+||.||+|... +|+.||||++.... ....+....++.+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45788855 6999999999999776 68999999986532 122223334566789999999999865 45589
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEEEeeccccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAYLSDFGLAR 831 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~ 831 (963)
+||||+++|+|.+++.......+++.++..++.|+++||+|||++ +|+||||||+||+++. ++.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999987666799999999999999999999999 9999999999999986 4559999999998
Q ss_pred ccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......... ..........
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~--- 248 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-----PGMKRRIRLG--- 248 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-----hhHHHhhhcc---
Confidence 65432 223456899999999998888999999999999999999999999754332100 0000000000
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
............+..+.+++.+||+.||++|||++|++++
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001111123456688999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=329.15 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=180.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHH-HHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIK-TLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57999999999999999999875 689999999976532 33345556665 6778899999999999999999999999
Q ss_pred ccCCCChHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 759 YLPGGNLENFIQQ---RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 759 ~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
|+++ +|.+++.. .....+++..+..++.|+++|+.|||+.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9986 88888763 22456899999999999999999999853 899999999999999999999999999987643
Q ss_pred CCCcccccccccccccCcccc----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 836 SETHATTGVAGTFGYVAPEYA----MTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
.. ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .. .. ..
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~----~~--~~ 243 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QL----TQ--VV 243 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CC--CC
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HH----HH--Hh
Confidence 32 22234689999999998 456789999999999999999999999974322100 00 00 00
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+..........+..+.+++.+||+.||++||++.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000111111123456689999999999999999999999763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.42 Aligned_cols=201 Identities=24% Similarity=0.337 Sum_probs=172.8
Q ss_pred HcCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccC-CC-----CeeEEEEeeeCCCe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HP-----NLVTLIGYHASETE 752 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 752 (963)
..++|++.+.||+|+||.||+|... +++.||||++.... ....++..|++++..++ |+ +++++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999765 68899999987432 33466778888888875 54 49999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC--CCCcEEEeecccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD--DDFNAYLSDFGLA 830 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla 830 (963)
.++||||+++ +|.+++.......+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999999965 999999887656799999999999999999999952 12999999999999995 4778999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPS 887 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~ 887 (963)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876432 23457899999999999999999999999999999999999999744
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=337.12 Aligned_cols=263 Identities=19% Similarity=0.292 Sum_probs=201.7
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccC-----------CCCeeEEEEeeeC
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-----------HPNLVTLIGYHAS 749 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 749 (963)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5799999999999999999976 468999999987533 33466788999988886 8999999999875
Q ss_pred CC----eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC------CC
Q 046851 750 ET----EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD------DD 819 (963)
Q Consensus 750 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~------~~ 819 (963)
.+ ..++||||+ +++|.+++.......+++..+..++.|++.||+|||+++ +|+||||||+||+++ ..
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 43 789999999 889999998866667999999999999999999999953 899999999999994 44
Q ss_pred CcEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhh
Q 046851 820 FNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVA 899 (963)
Q Consensus 820 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~ 899 (963)
+.+||+|||++...... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......... .. ..
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~-~~ 248 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT-KD-DD 248 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----------CH-HH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC-Ch-HH
Confidence 58999999999876432 23347899999999999999999999999999999999999999855322100 00 11
Q ss_pred HHHHHHh-cCcccc-----------eecc-------------------ccCCCCChhHHHHHHHHHHHcccCCCCCCCCH
Q 046851 900 WGCMLLR-QGRAKE-----------FFTA-------------------GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTM 948 (963)
Q Consensus 900 ~~~~~~~-~~~~~~-----------~~~~-------------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 948 (963)
....... .+.... +++. ......+...+.++.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111000 000000 0000 00112456678899999999999999999999
Q ss_pred HHHHHH
Q 046851 949 KQVVRR 954 (963)
Q Consensus 949 ~evl~~ 954 (963)
+|++++
T Consensus 329 ~ell~h 334 (373)
T 1q8y_A 329 GGLVNH 334 (373)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=341.16 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=189.2
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 455568899999999987777779999999986543 35678899999886 89999999999999999999999996
Q ss_pred CCChHHHHhhhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC-------------CcEE
Q 046851 762 GGNLENFIQQRSTRA-----VDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD-------------FNAY 823 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~-----~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~k 823 (963)
|+|.+++....... .++..+..++.|++.||+|||++ +|+||||||+||+++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 59999998653211 12334678999999999999999 99999999999999754 4899
Q ss_pred EeecccccccCCCCCc---ccccccccccccCcccccc-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 046851 824 LSDFGLARLLGPSETH---ATTGVAGTFGYVAPEYAMT-------CRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYG 892 (963)
Q Consensus 824 l~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~ 892 (963)
|+|||+++........ ......||+.|+|||++.+ ..++.++||||+||++|||++ |+.||......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-- 246 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-- 246 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--
Confidence 9999999887543322 2234579999999999976 678899999999999999999 89998643211
Q ss_pred CCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ......... .+......+...+.++.+++.+||+.||++|||+.||+++
T Consensus 247 ----~----~~i~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ----E----SNIIRGIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ----H----HHHHHTCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----H----HHHhcCCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0 111111100 0111112244567889999999999999999999999863
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=330.67 Aligned_cols=309 Identities=21% Similarity=0.233 Sum_probs=216.6
Q ss_pred ccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEE
Q 046851 71 GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLD 150 (963)
Q Consensus 71 ~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 150 (963)
.+++.|++++|.++ .+|..+|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 45566666666666 77777777777777788877777766666777777777777777777776667777777777777
Q ss_pred ccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcc
Q 046851 151 VSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT 230 (963)
Q Consensus 151 L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~ 230 (963)
|++|.++...+..|.++++|+.|+ +++|.
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~---------------------------------------------------L~~n~ 152 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLS---------------------------------------------------MSNNN 152 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEE---------------------------------------------------CCSSC
T ss_pred CCCCccCcCCHHHhcCCCCCcEEE---------------------------------------------------CCCCc
Confidence 777777633333344555555554 44555
Q ss_pred cccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCC
Q 046851 231 LEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFS 310 (963)
Q Consensus 231 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~ 310 (963)
+++..+..|..+++|++|++++|+++.++ +..+++|+.|++++|.+++... .+.|+.|++++|.+.
T Consensus 153 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~----~~~L~~L~l~~n~l~------- 218 (390)
T 3o6n_A 153 LERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAI----PIAVEELDASHNSIN------- 218 (390)
T ss_dssp CCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEEC----CSSCSEEECCSSCCC-------
T ss_pred cCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccccCC----CCcceEEECCCCeee-------
Confidence 55455555666666666666666666553 3345666667776666653211 123344444444332
Q ss_pred CCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEE
Q 046851 311 NMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAI 390 (963)
Q Consensus 311 ~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 390 (963)
T Consensus 219 -------------------------------------------------------------------------------- 218 (390)
T 3o6n_A 219 -------------------------------------------------------------------------------- 218 (390)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccC
Q 046851 391 VAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSW 470 (963)
Q Consensus 391 ~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~ 470 (963)
.+|... .++|+.|++++|.+++. ..+..+++|+.|++++
T Consensus 219 ------------------------------------~~~~~~---~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~ 257 (390)
T 3o6n_A 219 ------------------------------------VVRGPV---NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSY 257 (390)
T ss_dssp ------------------------------------EEECCC---CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred ------------------------------------eccccc---cccccEEECCCCCCccc--HHHcCCCCccEEECCC
Confidence 111111 15688888888888742 5788888999999999
Q ss_pred CcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCC
Q 046851 471 NLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP 550 (963)
Q Consensus 471 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 550 (963)
|.+++..|..|..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|
T Consensus 258 n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~-~~~ 334 (390)
T 3o6n_A 258 NELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK 334 (390)
T ss_dssp SCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCC
T ss_pred CcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccc-eeC
Confidence 9988888888888999999999999998 56777788899999999999998 56777888899999999999998 444
Q ss_pred CCccccccCceEeeccccCcc
Q 046851 551 SGLANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 551 ~~l~~l~~L~~l~l~~N~l~~ 571 (963)
+..+++|+.|++++|++.+
T Consensus 335 --~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 335 --LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp --CCTTCCCSEEECCSSCEEH
T ss_pred --chhhccCCEEEcCCCCccc
Confidence 6778899999999998875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=334.36 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=196.6
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE----
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM---- 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 753 (963)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+++.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 358999999999999999999765 68999999997543 23356788999999999999999999999876654
Q ss_pred --EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 754 --FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 754 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
++||||++ ++|.+++. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 58888874 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc-Cc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ-GR 909 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 909 (963)
..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||..... .+........ +.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~ 260 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVTGV 260 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCC
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCC
Confidence 65422 334578999999999987 6789999999999999999999999974321 1111111110 00
Q ss_pred c-ccee---------------ccccCC---CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 A-KEFF---------------TAGLWD---AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~-~~~~---------------~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .+.. ...... .........+.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 0000 000000 0012335678999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=328.17 Aligned_cols=260 Identities=20% Similarity=0.307 Sum_probs=202.5
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CC-cEEEEEEeecccchhHHHHHHHHHHHhccCCCC------eeEEEEeeeCCCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PG-VLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPN------LVTLIGYHASETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 752 (963)
.++|++.+.||+|+||.||+|... ++ +.||||++.... ...+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 358999999999999999999764 34 789999987532 33467788999999987655 9999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE----------------
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL---------------- 816 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---------------- 816 (963)
.++||||+ ++++.+++.......+++.++..++.|+++||+|||++ +|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 66888888776656799999999999999999999999 99999999999999
Q ss_pred ---CCCCcEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 046851 817 ---DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN 893 (963)
Q Consensus 817 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~ 893 (963)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--- 245 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR--- 245 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 56789999999999864322 23457899999999999999999999999999999999999999743221
Q ss_pred CcchhhHHHHHHhc--------Ccccc-eeccc---------------------cCCCCChhHHHHHHHHHHHcccCCCC
Q 046851 894 GFNIVAWGCMLLRQ--------GRAKE-FFTAG---------------------LWDAGPHDDLVEVLHLAVVCTVDSLS 943 (963)
Q Consensus 894 ~~~~~~~~~~~~~~--------~~~~~-~~~~~---------------------~~~~~~~~~~~~l~~l~~~cl~~dP~ 943 (963)
.....+...... ..... +.... ............+.+++.+||+.||+
T Consensus 246 --~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 246 --EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp --HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred --HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 111111111100 00000 00000 00112234466899999999999999
Q ss_pred CCCCHHHHHHH
Q 046851 944 TRPTMKQVVRR 954 (963)
Q Consensus 944 ~RPs~~evl~~ 954 (963)
+|||++|++++
T Consensus 324 ~Rpt~~e~l~h 334 (355)
T 2eu9_A 324 QRITLAEALLH 334 (355)
T ss_dssp TSCCHHHHTTS
T ss_pred hCcCHHHHhcC
Confidence 99999999854
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.20 Aligned_cols=242 Identities=25% Similarity=0.380 Sum_probs=200.7
Q ss_pred HcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccch------hHHHHHHHHHHHhccC--CCCeeEEEEeeeCC
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQ------GVQQFHAEIKTLGRLR--HPNLVTLIGYHASE 750 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 750 (963)
..++|++.+.||+|+||.||+|.. .+|+.||||++...... ..+++.+|+.++++++ |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 346899999999999999999975 46899999999765322 2245678999999996 59999999999999
Q ss_pred CeEEEEEeccCC-CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC-CCCcEEEeecc
Q 046851 751 TEMFLIYNYLPG-GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD-DDFNAYLSDFG 828 (963)
Q Consensus 751 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg 828 (963)
+..++||||+.+ ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 999999999976 8999999874 4589999999999999999999999 999999999999999 78899999999
Q ss_pred cccccCCCCCcccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ....
T Consensus 196 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------------~~~~ 258 (320)
T 3a99_A 196 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRG 258 (320)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHC
T ss_pred cccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------------hhcc
Confidence 99876532 2234568999999999987765 6789999999999999999999863210 0111
Q ss_pred CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 908 GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ...+...+.++.+++.+||+.||++|||++|++++
T Consensus 259 ~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 Q-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 01122345678899999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=328.62 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=193.7
Q ss_pred HHHcCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccch------hHHHHHHHHHHHhcc----CCCCeeEEEEe
Q 046851 678 VQATGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQ------GVQQFHAEIKTLGRL----RHPNLVTLIGY 746 (963)
Q Consensus 678 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~ 746 (963)
....++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999976 46889999999754332 223456789999888 89999999999
Q ss_pred eeCCCeEEEEEec-cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC-CCCcEEE
Q 046851 747 HASETEMFLIYNY-LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD-DDFNAYL 824 (963)
Q Consensus 747 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl 824 (963)
+...+..++|||| +.+++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 78999999998743 589999999999999999999999 999999999999999 8899999
Q ss_pred eecccccccCCCCCcccccccccccccCccccccCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHH
Q 046851 825 SDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS-DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 825 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
+|||++....... .....|++.|+|||++.+..+. .++||||+|+++|||++|+.||.... .
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~---- 244 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------E---- 244 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------H----
Confidence 9999998765332 2345689999999999877664 48999999999999999999986321 0
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... .. ...+......+.+++.+||+.||++|||++|++++
T Consensus 245 ~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ILE-AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHH-TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred Hhh-hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 11233445678999999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=328.51 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=196.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe------
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE------ 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 752 (963)
++|.+.+.||+|+||.||+|... +|+.||||++.... ....+++.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57999999999999999999764 68999999986543 2335678999999999999999999999877653
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||++ ++|.+++.. .+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 599999997 588887743 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc-Cc-
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ-GR- 909 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~- 909 (963)
.... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||..... .+........ +.
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVTGVP 243 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--------HHHHHHHHHHHCBC
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCC
Confidence 5322 234578999999999887 6789999999999999999999999974321 1111111110 00
Q ss_pred -------------------ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 -------------------AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 -------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....... .........+..+.+++.+|++.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRK-DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSC-CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCc-cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 0111223456789999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=346.51 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=199.8
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeC------CCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS------ETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 752 (963)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999976 46899999998754 33445778999999999999999999998765 677
Q ss_pred EEEEEeccCCCChHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCc---EEEeecc
Q 046851 753 MFLIYNYLPGGNLENFIQQRS-TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFN---AYLSDFG 828 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 828 (963)
.++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998743 23588999999999999999999999 9999999999999997765 9999999
Q ss_pred cccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
++....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ..|........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-------~~~~~~i~~~~ 240 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-------VQWHGKVREKS 240 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-------HHSSTTCC---
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-------hhhhhhhhccc
Confidence 998765432 233457999999999999999999999999999999999999999754211 11110000000
Q ss_pred cccce----------ecc--ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHH
Q 046851 909 RAKEF----------FTA--GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQV 951 (963)
Q Consensus 909 ~~~~~----------~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 951 (963)
..... +.. ..........+..+.+++.+||+.||++|||++|+
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000 000 01112344578899999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=323.85 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=182.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccch-h-HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQ-G-VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||.||+|... +|+.||||++...... . .+.+.++..+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 47899999999999999999875 6899999999765332 2 2334555567888899999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
|+ ++.+..+... ....+++..+..++.|+++||+|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 99 5455555543 34568999999999999999999998 6 89999999999999999999999999997664322
Q ss_pred CcccccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 838 THATTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
......|++.|+|||++. +..++.++||||||+++|||++|+.||..... ............. ..
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~-~~ 249 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVLTKVLQEEP-PL 249 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHHHHSCC-CC
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHHHHHhccCC-CC
Confidence 223346899999999994 45688899999999999999999999974321 1222222222211 10
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ......+..+.+++.+||+.||.+||+++|++++
T Consensus 250 ~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 L-------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred C-------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 1112345678999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=334.58 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=188.9
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.+|...++||+|+||+||.....+|+.||||++...... .+.+|+++++++ +||||+++++++.+....++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 468889999999999977666667999999998654332 356799999999 7999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-----CCcEEEeecccccccCC
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-----DFNAYLSDFGLARLLGP 835 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~~~~~ 835 (963)
+ |+|.+++.... ....+.++..++.|+++||+|||++ +|+||||||+||+++. ...+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6 59999998654 2345556778999999999999999 9999999999999953 23588999999987653
Q ss_pred CCC--cccccccccccccCccccc---cCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 836 SET--HATTGVAGTFGYVAPEYAM---TCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 836 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
... .......||+.|+|||++. +..++.++||||+||++|||++ |..||...... ..........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~~~~~~~ 246 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANILLGACS 246 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHHHTTCCC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHHHhccCC
Confidence 321 2334567999999999997 4567889999999999999999 88888533211 1111111110
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. .. ...+......+.+++.+||+.||++|||++||+++
T Consensus 247 ~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 L-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp C-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 00 11123445668899999999999999999999853
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=342.63 Aligned_cols=128 Identities=23% Similarity=0.310 Sum_probs=110.2
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|+.+++|+.|+|++|+++ .+|..+..+++|+.|+|
T Consensus 232 ~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L 308 (597)
T 3oja_B 232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 308 (597)
T ss_dssp SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC-EEECSSSCCTTCCEEEC
T ss_pred CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC-CCCcccccCCCCcEEEC
Confidence 468888888888884 467888999999999999998888889999999999999999998 46777788899999999
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCcc
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~ 571 (963)
++|.++ .+|..+..+++|+.|+|++|+|++ +| +..+++|+.|++++|++++
T Consensus 309 s~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~-~~--~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEH
T ss_pred CCCCCC-ccCcccccCCCCCEEECCCCCCCC-cC--hhhcCCCCEEEeeCCCCCC
Confidence 999998 568888889999999999999984 44 6778899999999999876
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=308.35 Aligned_cols=229 Identities=14% Similarity=0.092 Sum_probs=185.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+..+.+++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999775 489999999976533 33477899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||++|++|.++++.. ....++.+|+.|+++||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999642 45667899999999999999999 99999999999999999999998543
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
|++ .++.++||||||+++|||++|+.||........... ........
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------~~~~~~~~ 221 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------AERDTAGQ 221 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------CCBCTTSC
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------HHHHhccC
Confidence 333 267899999999999999999999985533210000 00000000
Q ss_pred cC--CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 918 LW--DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 918 ~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
.. .......+..+.+++.+||+.||++| |+.|+++.|+++.+
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00 00112345678999999999999999 99999999998654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=308.10 Aligned_cols=227 Identities=22% Similarity=0.286 Sum_probs=180.2
Q ss_pred CCCCCc-cccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHH-hccCCCCeeEEEEeeeC----CCeEE
Q 046851 682 GNFNAS-NCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTL-GRLRHPNLVTLIGYHAS----ETEMF 754 (963)
Q Consensus 682 ~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 754 (963)
++|.+. +.||+|+||.||+|.. .+++.||||++... ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 467776 7899999999999976 46899999998642 4567888887 55689999999999876 67789
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEEEeeccccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAYLSDFGLAR 831 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~ 831 (963)
+||||+++|+|.+++.......+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999999987666799999999999999999999999 9999999999999998 7889999999987
Q ss_pred ccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
... +..++.++||||+|+++|||++|+.||......... .....
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~~~~~ 212 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PGMKT 212 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CCSCC
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------HHHHH
Confidence 542 123567899999999999999999999744322000 00000
Q ss_pred ceeccccCCCCC----hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGP----HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...... ...+ ...+..+.+++.+||+.||++|||+.|++++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0111 2345688999999999999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=346.77 Aligned_cols=237 Identities=24% Similarity=0.312 Sum_probs=192.4
Q ss_pred CCCCCccccccCCCccEEEEEEC--CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe-----E
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS--PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETE-----M 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 753 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999875 58999999886443 3445678999999999999999999999976554 7
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
|+||||+++++|.+++.. .+++.++..|+.|+++||+|||++ +|+||||||+||+++.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999998754 589999999999999999999999 99999999999999986 9999999999876
Q ss_pred CCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+....... ..
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~~-- 285 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------LP-- 285 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------CC--
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------cc--
Confidence 432 3457999999999988754 889999999999999999988876322110 00
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHhc
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-MKQVVRRLKQ 957 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L~~ 957 (963)
...........+.+++.+||+.||++||+ ++++.+.|..
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001123457889999999999999995 5566665554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=318.22 Aligned_cols=249 Identities=24% Similarity=0.210 Sum_probs=192.1
Q ss_pred CCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCC
Q 046851 210 GIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV 289 (963)
Q Consensus 210 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 289 (963)
..|..|.++++|+.|++++|+++...+..|..+++|++|++++|+++.+++..|..+++|++|++++|++++.. ...+
T Consensus 108 ~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l 185 (390)
T 3o6n_A 108 LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLI 185 (390)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGC
T ss_pred CCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccc
Confidence 33444555566666666666666555555678888888888888888888888888888888888888877532 1123
Q ss_pred CceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCccc
Q 046851 290 PCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFS 369 (963)
Q Consensus 290 ~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (963)
+.|+.|++++|.
T Consensus 186 ~~L~~L~l~~n~-------------------------------------------------------------------- 197 (390)
T 3o6n_A 186 PSLFHANVSYNL-------------------------------------------------------------------- 197 (390)
T ss_dssp TTCSEEECCSSC--------------------------------------------------------------------
T ss_pred cccceeeccccc--------------------------------------------------------------------
Confidence 444444444443
Q ss_pred ccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcC
Q 046851 370 GSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQI 449 (963)
Q Consensus 370 ~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l 449 (963)
+++ ++ ..++|++|++++|.+
T Consensus 198 ------------------------------------------------------l~~-~~-----~~~~L~~L~l~~n~l 217 (390)
T 3o6n_A 198 ------------------------------------------------------LST-LA-----IPIAVEELDASHNSI 217 (390)
T ss_dssp ------------------------------------------------------CSE-EE-----CCSSCSEEECCSSCC
T ss_pred ------------------------------------------------------ccc-cC-----CCCcceEEECCCCee
Confidence 321 11 125699999999999
Q ss_pred CCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhh
Q 046851 450 VGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDL 529 (963)
Q Consensus 450 ~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 529 (963)
+ .+|..+ .++|+.|++++|.+++. ..+..+++|++|++++|++++..|..|..+++|+.|+|++|++++ +|..+
T Consensus 218 ~-~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~ 291 (390)
T 3o6n_A 218 N-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYG 291 (390)
T ss_dssp C-EEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSS
T ss_pred e-eccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCccc
Confidence 8 445433 57999999999999754 678999999999999999998889999999999999999999985 57777
Q ss_pred hccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCCCCCCcccccccCCCCCCCCCC
Q 046851 530 ENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPYLRPCR 595 (963)
Q Consensus 530 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~np~~~~c~ 595 (963)
..+++|++|+|++|+++ .+|..+..+++|+.|++++|+++..............+.+|||.|+|.
T Consensus 292 ~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~~~~ 356 (390)
T 3o6n_A 292 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSL 356 (390)
T ss_dssp SCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHHH
T ss_pred CCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccchhH
Confidence 88999999999999999 788889999999999999999987544444445556778999999884
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=328.55 Aligned_cols=241 Identities=18% Similarity=0.201 Sum_probs=181.0
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc---hhHHHHHHHHHHHhccCC-CCe----------------
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRH-PNL---------------- 740 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------------- 740 (963)
.+|...+.||+|+||.||+|.+ .+|+.||||++..... ...+.+.+|+.+++.++| ++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4578889999999999999975 4799999999874332 235778999999999987 211
Q ss_pred -----eEEEEeeeC-----CCeEEEEEeccCCCChHHHHhh-----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 046851 741 -----VTLIGYHAS-----ETEMFLIYNYLPGGNLENFIQQ-----RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805 (963)
Q Consensus 741 -----v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 805 (963)
..+..++.. ....+++|+++ +++|.++++. .....+++..+..++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111111111 22467777776 6799999852 2234477889999999999999999999 999
Q ss_pred ecccCCCCeEECCCCcEEEeecccccccCCCCCcccccccccccccCcccc----------ccCCCCcchhhHHHHHHHH
Q 046851 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYA----------MTCRVSDKADVYSYGVVLL 875 (963)
Q Consensus 806 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slG~il~ 875 (963)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865422 344567 999999999 5556888999999999999
Q ss_pred HHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 876 ELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 876 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
||++|+.||........ ....+.. ....+..+.+++.+||+.||++||++.+++++
T Consensus 309 elltg~~Pf~~~~~~~~-----------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG-----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGSC-----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhhh-----------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999975432210 0000110 01234678999999999999999998877653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=328.80 Aligned_cols=310 Identities=21% Similarity=0.155 Sum_probs=214.5
Q ss_pred ccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEE
Q 046851 71 GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLD 150 (963)
Q Consensus 71 ~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 150 (963)
.+++.|++++|.++ .+|..+|..+++|++|+|++|.|++..+..|+++++|+.|+|++|.+++..|..|+++++|++|+
T Consensus 51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 35566666666666 77777777777888888888887766667777777777777777777777777777777777777
Q ss_pred ccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcc
Q 046851 151 VSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT 230 (963)
Q Consensus 151 L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~ 230 (963)
|++|.+++..+..|+++++|+.|++++ |.+.+..|..|..+++|+.|++++|.
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~---------------------------N~l~~~~~~~~~~l~~L~~L~L~~N~ 182 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSN---------------------------NNLERIEDDTFQATTSLQNLQLSSNR 182 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCS---------------------------SCCCBCCTTTTTTCTTCCEEECTTSC
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeC---------------------------CcCCCCChhhhhcCCcCcEEECcCCC
Confidence 777777744444456666666666655 33444444445555555555555555
Q ss_pred cccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCC
Q 046851 231 LEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFS 310 (963)
Q Consensus 231 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~ 310 (963)
+++. .+..+++|+.|++++|.++.++ ..++|+.|++++|.++..+... .+.|+
T Consensus 183 l~~~---~~~~l~~L~~L~l~~n~l~~l~-----~~~~L~~L~ls~n~l~~~~~~~--~~~L~----------------- 235 (597)
T 3oja_B 183 LTHV---DLSLIPSLFHANVSYNLLSTLA-----IPIAVEELDASHNSINVVRGPV--NVELT----------------- 235 (597)
T ss_dssp CSBC---CGGGCTTCSEEECCSSCCSEEE-----CCTTCSEEECCSSCCCEEECSC--CSCCC-----------------
T ss_pred CCCc---ChhhhhhhhhhhcccCcccccc-----CCchhheeeccCCccccccccc--CCCCC-----------------
Confidence 4432 1333444444444444444321 1233444444444443221111 01122
Q ss_pred CCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEE
Q 046851 311 NMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAI 390 (963)
Q Consensus 311 ~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 390 (963)
T Consensus 236 -------------------------------------------------------------------------------- 235 (597)
T 3oja_B 236 -------------------------------------------------------------------------------- 235 (597)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccC
Q 046851 391 VAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSW 470 (963)
Q Consensus 391 ~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~ 470 (963)
.|++++|.+++ +..+..+ ++|+.|+|++|.+++..|..|..+++|+.|+|++
T Consensus 236 -------------------------~L~L~~n~l~~--~~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 287 (597)
T 3oja_B 236 -------------------------ILKLQHNNLTD--TAWLLNY-PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287 (597)
T ss_dssp -------------------------EEECCSSCCCC--CGGGGGC-TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTT
T ss_pred -------------------------EEECCCCCCCC--ChhhccC-CCCCEEECCCCccCCCCHHHhcCccCCCEEECCC
Confidence 55666666653 2444444 7899999999999988899999999999999999
Q ss_pred CcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCc
Q 046851 471 NLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGK 548 (963)
Q Consensus 471 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 548 (963)
|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++. | +..+++|+.|+|++|++++.
T Consensus 288 N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 288 NRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp SCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 99965 6777888999999999999999 7888999999999999999999865 3 67789999999999999854
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-32 Score=302.33 Aligned_cols=126 Identities=26% Similarity=0.376 Sum_probs=72.4
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|++|++++|++++ ++. +..+++|++|++++|.+++. ..+..+++|++|++++|++++ + ..+..+++|+.|++
T Consensus 221 ~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L 294 (347)
T 4fmz_A 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFL 294 (347)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEEC
Confidence 445556666666552 222 55566666666666666432 345556666666666666653 3 34556666666666
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCc
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~ 570 (963)
++|++++..|..+..+++|++|++++|++++..| +..+++|+.|++++|+|+
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 6666665555566666666666666666664333 566666666666666654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-32 Score=301.76 Aligned_cols=122 Identities=28% Similarity=0.393 Sum_probs=100.9
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
.|++++|.++ .++. +. .+++|++|++++|.+++ + +.+..+++|+.|++++|.+++. ..+..+++|++|++++|
T Consensus 225 ~L~l~~n~l~-~~~~-~~-~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n 297 (347)
T 4fmz_A 225 SLKIGNNKIT-DLSP-LA-NLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNN 297 (347)
T ss_dssp EEECCSSCCC-CCGG-GT-TCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred EEEccCCccC-CCcc-hh-cCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCC
Confidence 4555555555 3333 33 34789999999999984 4 5789999999999999999764 46889999999999999
Q ss_pred cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCC
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 546 (963)
++++..|..++.+++|+.|++++|++++..| +..+++|++|++++|+|+
T Consensus 298 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 9998888999999999999999999997655 889999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=317.75 Aligned_cols=242 Identities=16% Similarity=0.153 Sum_probs=185.7
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeeccc--------chhHHHHHHHHHHHhccC---------CCCeeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGR--------FQGVQQFHAEIKTLGRLR---------HPNLVTLI 744 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l~ 744 (963)
++|++.+.||+|+||+||+|.. +|+.||||++.... ....+.+.+|++++++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5799999999999999999988 58999999997653 223477889999988885 88888877
Q ss_pred Eeee------------------------------CCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 046851 745 GYHA------------------------------SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALA 794 (963)
Q Consensus 745 ~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~ 794 (963)
+++. ..+..++||||+++|++.+.+.+ ..+++.++..++.|++.||+
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence 7642 26789999999999977666643 45899999999999999999
Q ss_pred HHH-hCCCCCceecccCCCCeEECCCC--------------------cEEEeecccccccCCCCCcccccccccccccCc
Q 046851 795 YLH-DQCVPRVLHRDVKPSNILLDDDF--------------------NAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853 (963)
Q Consensus 795 ~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP 853 (963)
||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+||
T Consensus 176 ~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 89 999999999999999887 8999999999876432 24799999999
Q ss_pred cccccCCCCcchhhHHHHHH-HHHHHcCCCCCCCCCCCCCCCcchhhHHH-HHHhcCcccceeccccCCCCChhHHHHHH
Q 046851 854 EYAMTCRVSDKADVYSYGVV-LLELLSDKKALDPSFSSYGNGFNIVAWGC-MLLRQGRAKEFFTAGLWDAGPHDDLVEVL 931 (963)
Q Consensus 854 E~~~~~~~~~~~Dv~slG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 931 (963)
|++.+.. +.++||||+|++ .+++++|..||... ....... ........ ............+.++.
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHHHhhhhhhcc----CcccchhhhhhcCHHHH
Confidence 9998766 889999998777 77889998887410 0001111 11111111 01111112235678899
Q ss_pred HHHHHcccCCCCCCCCHHHHH-HH
Q 046851 932 HLAVVCTVDSLSTRPTMKQVV-RR 954 (963)
Q Consensus 932 ~l~~~cl~~dP~~RPs~~evl-~~ 954 (963)
+++.+||+.| |++|++ ++
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999976 999988 53
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-31 Score=296.19 Aligned_cols=131 Identities=22% Similarity=0.234 Sum_probs=99.6
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|++|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|++|+|++|+++ .+|..+..+++|+.|++
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 45777788888887666677888888888888888887777777888888888888888888 77877888888888888
Q ss_pred cccccCCCCChhhhc------cccCCeEEeccccCC--CcCCCCccccccCceEeecccc
Q 046851 517 SSNSLSGLIPDDLEN------LRNLTVLLLNNNKLS--GKIPSGLANVSTLSAFNVSFNN 568 (963)
Q Consensus 517 s~N~l~~~~p~~~~~------l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~l~l~~N~ 568 (963)
++|+|++..+..+.. ..+|+.|++++|++. +..|..+..+++|+.+++++|+
T Consensus 272 ~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 272 HTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 888888665555544 356888888888886 5566778888888888888774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=288.79 Aligned_cols=131 Identities=24% Similarity=0.266 Sum_probs=89.3
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|++|++++|++++..|..+..+++|+.|++++|.+++..+..+..+++|++|+|++|+++ .+|..+..+++|++|++
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 34667777777776656666777777777777777776666666777777777777777777 67777777777777777
Q ss_pred cccccCCCCChhhhc------cccCCeEEeccccCCC--cCCCCccccccCceEeecccc
Q 046851 517 SSNSLSGLIPDDLEN------LRNLTVLLLNNNKLSG--KIPSGLANVSTLSAFNVSFNN 568 (963)
Q Consensus 517 s~N~l~~~~p~~~~~------l~~L~~L~l~~N~l~~--~~p~~l~~l~~L~~l~l~~N~ 568 (963)
++|+|++..+..+.. .+.|+.|++++|++.. ..|..|..+.+++.+++++|+
T Consensus 271 ~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 777777655555533 3667778888887752 445667777778888887774
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=286.68 Aligned_cols=288 Identities=22% Similarity=0.230 Sum_probs=169.3
Q ss_pred cccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEc
Q 046851 72 RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDV 151 (963)
Q Consensus 72 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 151 (963)
+++.+++++|.++ .+|..++ ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|.+|.++++|++|+|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 3444555555554 6666654 46777777777777666677777777777777777777777777777777777777
Q ss_pred cCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccc
Q 046851 152 SRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL 231 (963)
Q Consensus 152 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l 231 (963)
++|.++ .+|..+. ++|++|++++ |.+.+..+..|.++++|+.|++++|.+
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~---------------------------n~i~~~~~~~~~~l~~L~~L~l~~n~l 159 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHD---------------------------NRIRKVPKGVFSGLRNMNCIEMGGNPL 159 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCS---------------------------SCCCCCCSGGGSSCSSCCEEECCSCCC
T ss_pred CCCcCC-ccCcccc--ccCCEEECCC---------------------------CccCccCHhHhCCCccCCEEECCCCcc
Confidence 777777 4444433 5555555555 333333334455555555555555555
Q ss_pred cc--CCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCC
Q 046851 232 EG--NFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTF 309 (963)
Q Consensus 232 ~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~ 309 (963)
+. ..+..|..+ +|++|++++|+++.++...+ ++|++|++++|++++..+
T Consensus 160 ~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~------------------------- 210 (332)
T 2ft3_A 160 ENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQAIEL------------------------- 210 (332)
T ss_dssp BGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSC---SSCSCCBCCSSCCCCCCT-------------------------
T ss_pred ccCCCCcccccCC-ccCEEECcCCCCCccCcccc---CCCCEEECCCCcCCccCH-------------------------
Confidence 32 344444444 55555555555555443322 344444444444432111
Q ss_pred CCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEE
Q 046851 310 SNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYA 389 (963)
Q Consensus 310 ~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 389 (963)
T Consensus 211 -------------------------------------------------------------------------------- 210 (332)
T 2ft3_A 211 -------------------------------------------------------------------------------- 210 (332)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEecc
Q 046851 390 IVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLS 469 (963)
Q Consensus 390 l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls 469 (963)
..+.. +++|++|++++|++++..+..+..+++|+.|+++
T Consensus 211 ----------------------------------------~~l~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 249 (332)
T 2ft3_A 211 ----------------------------------------EDLLR-YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLD 249 (332)
T ss_dssp ----------------------------------------TSSTT-CTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECC
T ss_pred ----------------------------------------HHhcC-CCCCCEEECCCCcCCcCChhHhhCCCCCCEEECC
Confidence 11111 1446666666666665555566666666666666
Q ss_pred CCcCCCccchhhccCcccceeccccccccccCCccccc------CCccceecccccccC--CCCChhhhccccCCeEEec
Q 046851 470 WNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQ------LQLLEVLDLSSNSLS--GLIPDDLENLRNLTVLLLN 541 (963)
Q Consensus 470 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------l~~L~~L~ls~N~l~--~~~p~~~~~l~~L~~L~l~ 541 (963)
+|.++ .+|..+..+++|+.|++++|++++..+..|.. .+.|+.|++++|.+. +..|..+..+++|+.|+++
T Consensus 250 ~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~ 328 (332)
T 2ft3_A 250 NNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328 (332)
T ss_dssp SSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC-
T ss_pred CCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhcc
Confidence 66664 55556666666666666666666444444443 356778888888876 5666777888888888888
Q ss_pred ccc
Q 046851 542 NNK 544 (963)
Q Consensus 542 ~N~ 544 (963)
+|+
T Consensus 329 ~n~ 331 (332)
T 2ft3_A 329 NYK 331 (332)
T ss_dssp ---
T ss_pred ccc
Confidence 774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=283.98 Aligned_cols=289 Identities=20% Similarity=0.208 Sum_probs=165.3
Q ss_pred cccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEc
Q 046851 72 RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDV 151 (963)
Q Consensus 72 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 151 (963)
+++.++++++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|.+|.++++|++|+|
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 3444455555554 6665543 46777777777777666667777777777777777777666777777777777777
Q ss_pred cCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccc
Q 046851 152 SRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL 231 (963)
Q Consensus 152 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l 231 (963)
++|.++ .+|..+. ++|+.|++++ |.+.+..+..+.++++|+.|++++|.+
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~---------------------------n~l~~~~~~~~~~l~~L~~L~l~~n~l 157 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHE---------------------------NEITKVRKSVFNGLNQMIVVELGTNPL 157 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCS---------------------------SCCCBBCHHHHTTCTTCCEEECCSSCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCC---------------------------CcccccCHhHhcCCccccEEECCCCcC
Confidence 777776 4444332 4555555554 333333344455555555555555554
Q ss_pred cc--CCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCC
Q 046851 232 EG--NFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTF 309 (963)
Q Consensus 232 ~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~ 309 (963)
.. ..+..|..+++|++|++++|+++.++...+ ++|++|++++|++++.
T Consensus 158 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~---~~L~~L~l~~n~l~~~--------------------------- 207 (330)
T 1xku_A 158 KSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKV--------------------------- 207 (330)
T ss_dssp CGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC---TTCSEEECTTSCCCEE---------------------------
T ss_pred CccCcChhhccCCCCcCEEECCCCccccCCcccc---ccCCEEECCCCcCCcc---------------------------
Confidence 32 344444455555555555555544433221 3444444444443321
Q ss_pred CCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEE
Q 046851 310 SNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYA 389 (963)
Q Consensus 310 ~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 389 (963)
T Consensus 208 -------------------------------------------------------------------------------- 207 (330)
T 1xku_A 208 -------------------------------------------------------------------------------- 207 (330)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEecc
Q 046851 390 IVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLS 469 (963)
Q Consensus 390 l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls 469 (963)
.|..+..+ ++|++|++++|.+++..+..+..+++|+.|+++
T Consensus 208 --------------------------------------~~~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 248 (330)
T 1xku_A 208 --------------------------------------DAASLKGL-NNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248 (330)
T ss_dssp --------------------------------------CTGGGTTC-TTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred --------------------------------------CHHHhcCC-CCCCEEECCCCcCceeChhhccCCCCCCEEECC
Confidence 12222222 456666666666665555556666666666666
Q ss_pred CCcCCCccchhhccCcccceeccccccccccCCccccc------CCccceecccccccCC--CCChhhhccccCCeEEec
Q 046851 470 WNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQ------LQLLEVLDLSSNSLSG--LIPDDLENLRNLTVLLLN 541 (963)
Q Consensus 470 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~l~ 541 (963)
+|.++ .+|..+..+++|++|++++|+|++..+..|.. .+.|+.|++++|.+.. ..|..+..+.+|+.++|+
T Consensus 249 ~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~ 327 (330)
T 1xku_A 249 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG 327 (330)
T ss_dssp SSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC-
T ss_pred CCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEec
Confidence 66664 45556666666666666666666444444432 3667788888887753 456677778888888888
Q ss_pred ccc
Q 046851 542 NNK 544 (963)
Q Consensus 542 ~N~ 544 (963)
+|+
T Consensus 328 ~N~ 330 (330)
T 1xku_A 328 NYK 330 (330)
T ss_dssp ---
T ss_pred ccC
Confidence 875
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-34 Score=330.83 Aligned_cols=156 Identities=22% Similarity=0.166 Sum_probs=97.4
Q ss_pred CCceEEEccCCcccccCCCc-cccCCCCcEEEccCCcccc----cCCccccCcccccceeccccccccCCCcccccccce
Q 046851 2 GNLEVLDLEGNLLNGILPDS-GFHLKSLRVLNLGFNRITG----EIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRV 76 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L 76 (963)
.++++|||++|+++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|.+++.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~----------- 71 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV----------- 71 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHH-----------
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChH-----------
Confidence 46788888888887554433 6778888888888888873 3456677778888888888877632
Q ss_pred eeccccccccCCccccccCC----CCCeEeCCCCcccc----CcCccccCcccccEEEcccCcccccCccccc-----CC
Q 046851 77 YLSFNRLVGSVPSKIGEKCT----NLEHLDLSGNYLVG----GIPRSLGNCFQVRSLLLFSNMLEETIPAELG-----ML 143 (963)
Q Consensus 77 ~L~~n~l~~~~p~~~~~~l~----~L~~L~Ls~N~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l 143 (963)
.+..++..++ +|++|+|++|+|+. .++..+..+++|+.|+|++|.+++..+..+. ..
T Consensus 72 ----------~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 141 (461)
T 1z7x_W 72 ----------GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141 (461)
T ss_dssp ----------HHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred ----------HHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence 2222333333 57777777777763 3466666777777777777766643333222 24
Q ss_pred CCCCEEEccCCccccCC----CcCccCCCCCceEeecCc
Q 046851 144 QNLEVLDVSRNSLSGSI----PVDLGNCSKLAILVLSNL 178 (963)
Q Consensus 144 ~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~l~~n 178 (963)
++|++|+|++|.+++.. +..+..+++|+.|++++|
T Consensus 142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n 180 (461)
T 1z7x_W 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSS
T ss_pred CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCC
Confidence 56777777777766422 333444455555555543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=291.18 Aligned_cols=128 Identities=28% Similarity=0.421 Sum_probs=94.1
Q ss_pred CccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceeccc
Q 046851 438 SLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLS 517 (963)
Q Consensus 438 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls 517 (963)
+|++|++++|++++.+|..+..++ |+.|++++|.+++..|..+..+++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 566666666666666666666665 67777777776666666677777777777777777754444 6777888888888
Q ss_pred ccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeecccc
Q 046851 518 SNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNN 568 (963)
Q Consensus 518 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~ 568 (963)
+|+|++.+|..+..+++|+.|+|++|+++|.+|.. ..+++|+.+++++|+
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 88888777888888888888888888888777775 778888888888776
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=288.59 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=139.3
Q ss_pred CCCcEEEccCCcccc--cCCccccCcccccceeccc-cccccCCCcccc---cccceeeccccccccCCccccccCCCCC
Q 046851 26 KSLRVLNLGFNRITG--EIPASFSDFVNLEELNLAG-NLVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLE 99 (963)
Q Consensus 26 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~---~L~~L~L~~n~l~~~~p~~~~~~l~~L~ 99 (963)
.++++|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..+. +|++|+|++|++++.+|..+ .++++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL-SQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGG-GGCTTCC
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHH-hCCCCCC
Confidence 356666666666665 5566666666666666663 555544443332 34444444444443444433 3466666
Q ss_pred eEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCC-CCCEEEccCCccccCCCcCccCCCCCceEeecCc
Q 046851 100 HLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQ-NLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178 (963)
Q Consensus 100 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n 178 (963)
+|+|++|+|++.+|..|.++++|++|+|++|++++.+|..+..++ +|++|+|++|.+++.+|..+..++ |+.|++++
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~- 206 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSR- 206 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCS-
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcC-
Confidence 666666666666666666666666666666666655666666665 666666666666655666665554 66665555
Q ss_pred CCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCc
Q 046851 179 FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGK 258 (963)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 258 (963)
|.+.+..|..+..+++|+.|++++|++++..+. +..+++|++|+|++|++++.
T Consensus 207 --------------------------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~ 259 (313)
T 1ogq_A 207 --------------------------NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGT 259 (313)
T ss_dssp --------------------------SEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEEC
T ss_pred --------------------------CcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCc
Confidence 444444555555555555555555555544333 45555555555555555544
Q ss_pred CccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCc
Q 046851 259 NLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNA 301 (963)
Q Consensus 259 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~ 301 (963)
.+..|..+++|++|+|++|++++.++....+++|+.+++++|+
T Consensus 260 ~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred CChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCC
Confidence 4555555555555555555555544444444455555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-33 Score=323.56 Aligned_cols=154 Identities=23% Similarity=0.119 Sum_probs=96.8
Q ss_pred EEEccCCeeeec----CchhHhhccCCccEEECcCCcCCCCCccccccC-----CCCCEEeccCCcCCCc----cchhhc
Q 046851 416 MVNVSNNRIAGQ----LPAEIGRMCKSLKFLDASGNQIVGPIPRGVGEL-----VSLVALNLSWNLMHDQ----IPTTLG 482 (963)
Q Consensus 416 ~L~l~~n~l~~~----~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l-----~~L~~L~ls~N~i~~~----~~~~~~ 482 (963)
.|++++|++++. ++..+... ++|++|++++|.+++..+..+... ++|+.|++++|.+++. ++..+.
T Consensus 260 ~L~L~~n~l~~~~~~~l~~~l~~~-~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~ 338 (461)
T 1z7x_W 260 TLWIWECGITAKGCGDLCRVLRAK-ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA 338 (461)
T ss_dssp EEECTTSCCCHHHHHHHHHHHHHC-TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHH
T ss_pred EEECcCCCCCHHHHHHHHHHHhhC-CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHh
Confidence 566666666532 45554443 678888888887764444444332 5788888888887654 455666
Q ss_pred cCcccceeccccccccccCCccccc-----CCccceecccccccCC----CCChhhhccccCCeEEeccccCCCcCCCCc
Q 046851 483 QMKGLKYLSLAGNNLTGSIPSSLGQ-----LQLLEVLDLSSNSLSG----LIPDDLENLRNLTVLLLNNNKLSGKIPSGL 553 (963)
Q Consensus 483 ~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l 553 (963)
.+++|++|++++|++++..+..+.. .++|+.|++++|++++ .+|..+..+++|++|++++|++++.-...+
T Consensus 339 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l 418 (461)
T 1z7x_W 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 418 (461)
T ss_dssp HCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHH
T ss_pred hCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHH
Confidence 6778888888888777554444443 5678888888887774 556677777788888888887764311111
Q ss_pred c-----ccccCceEeeccccCc
Q 046851 554 A-----NVSTLSAFNVSFNNLS 570 (963)
Q Consensus 554 ~-----~l~~L~~l~l~~N~l~ 570 (963)
. ...+|+.|.+.++.+.
T Consensus 419 ~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 419 VESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp HHHHTSTTCCCCEEECTTCCCC
T ss_pred HHHhccCCcchhheeecccccC
Confidence 1 1234666666555444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=309.97 Aligned_cols=427 Identities=12% Similarity=0.065 Sum_probs=299.5
Q ss_pred cCCCccccCCCCcEEEccCCccc---ccCCcccc------------CcccccceeccccccccCCCccc----cc-ccce
Q 046851 17 ILPDSGFHLKSLRVLNLGFNRIT---GEIPASFS------------DFVNLEELNLAGNLVNGTVPTFI----GR-LKRV 76 (963)
Q Consensus 17 ~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~------------~l~~L~~L~Ls~N~l~~~~~~~~----~~-L~~L 76 (963)
..+..+..+++|++|+|+++... +.+|..+. .+++|++|+|++|.+++..+..+ ++ |++|
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L 143 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence 33445678899999999885431 23332222 78999999999998876655443 34 9999
Q ss_pred eecccc-ccccCCccccccCCCCCeEeCCCCccccC----cCccccCcccccEEEcccCccc----ccCcccccCCCCCC
Q 046851 77 YLSFNR-LVGSVPSKIGEKCTNLEHLDLSGNYLVGG----IPRSLGNCFQVRSLLLFSNMLE----ETIPAELGMLQNLE 147 (963)
Q Consensus 77 ~L~~n~-l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~ 147 (963)
+|++|. ++...-..+..++++|++|+|++|.+++. ++..+.++++|+.|++++|.++ +.++..+.++++|+
T Consensus 144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~ 223 (592)
T 3ogk_B 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223 (592)
T ss_dssp EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence 999987 32111223334789999999999998765 4445678899999999999997 33455667889999
Q ss_pred EEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecC
Q 046851 148 VLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAP 227 (963)
Q Consensus 148 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~ 227 (963)
+|+|++|.+.+ +|..+.++++|+.|++++..... -....+..+..+++|+.|.++
T Consensus 224 ~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~------------------------~~~~~~~~l~~~~~L~~L~l~ 278 (592)
T 3ogk_B 224 SVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDI------------------------GMPEKYMNLVFPRKLCRLGLS 278 (592)
T ss_dssp EEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCT------------------------TCTTSSSCCCCCTTCCEEEET
T ss_pred EEeccCccHHH-HHHHHhhhhHHHhhccccccccc------------------------chHHHHHHhhccccccccCcc
Confidence 99999999984 77889999999999997521110 012344567788899999998
Q ss_pred CcccccCCCccccccccCceeecCcccccCcCc-cccCCCCCCcEEeccCcccccccC-CCC-CCCceeEEEecc-----
Q 046851 228 RATLEGNFPSNWGACDNLEMLNLGHNFFSGKNL-GVLGPCKNLLFLDLSSNQLTGELA-REL-PVPCMTMFDVSG----- 299 (963)
Q Consensus 228 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~-~~~-~~~~L~~L~l~~----- 299 (963)
++.. ..+|..+..+++|++|+|++|.++.... ..+..+++|+.|+++ |.+..... ... .+++|+.|++++
T Consensus 279 ~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~ 356 (592)
T 3ogk_B 279 YMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQ 356 (592)
T ss_dssp TCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSS
T ss_pred ccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCcccc
Confidence 8643 3567778889999999999999765443 446788999999998 55543222 221 467788888873
Q ss_pred ------CcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCC
Q 046851 300 ------NALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLP 373 (963)
Q Consensus 300 ------N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (963)
|.+++.
T Consensus 357 ~~~~~~~~~~~~-------------------------------------------------------------------- 368 (592)
T 3ogk_B 357 GMEDEEGLVSQR-------------------------------------------------------------------- 368 (592)
T ss_dssp TTSSTTCCCCHH--------------------------------------------------------------------
T ss_pred ccccccCccCHH--------------------------------------------------------------------
Confidence 222100
Q ss_pred CCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECc----CCcC
Q 046851 374 SMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDAS----GNQI 449 (963)
Q Consensus 374 ~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls----~n~l 449 (963)
-...++..++.|+ .|+++.|.+++..+..+...+++|+.|+++ .|.+
T Consensus 369 ---------------------------~~~~l~~~~~~L~--~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l 419 (592)
T 3ogk_B 369 ---------------------------GLIALAQGCQELE--YMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERI 419 (592)
T ss_dssp ---------------------------HHHHHHHHCTTCS--EEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCC
T ss_pred ---------------------------HHHHHHhhCccCe--EEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccc
Confidence 0001123355566 667788888877777777766889999996 6778
Q ss_pred CCC-----CccccccCCCCCEEeccCCc--CCCccchhhcc-Ccccceeccccccccc-cCCcccccCCccceecccccc
Q 046851 450 VGP-----IPRGVGELVSLVALNLSWNL--MHDQIPTTLGQ-MKGLKYLSLAGNNLTG-SIPSSLGQLQLLEVLDLSSNS 520 (963)
Q Consensus 450 ~~~-----~p~~~~~l~~L~~L~ls~N~--i~~~~~~~~~~-l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~ls~N~ 520 (963)
++. ++..+..+++|+.|++++|. +++..+..+.. +++|++|++++|++++ .++..+..+++|+.|+|++|.
T Consensus 420 ~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~ 499 (592)
T 3ogk_B 420 TDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCC 499 (592)
T ss_dssp SSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCC
T ss_pred cCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCC
Confidence 753 33446778999999997543 66555555544 7889999999999875 345556778999999999999
Q ss_pred cCCC-CChhhhccccCCeEEeccccCCCcCCCCc-cccccCceEeeccc
Q 046851 521 LSGL-IPDDLENLRNLTVLLLNNNKLSGKIPSGL-ANVSTLSAFNVSFN 567 (963)
Q Consensus 521 l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~l~l~~N 567 (963)
+++. ++..+..+++|++|+|++|++++.-...+ ..++.+....+..+
T Consensus 500 l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 500 FSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp CBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 8644 23445678999999999999885433333 34566665555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=269.48 Aligned_cols=202 Identities=18% Similarity=0.123 Sum_probs=111.4
Q ss_pred cccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccC
Q 046851 51 NLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN 130 (963)
Q Consensus 51 ~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n 130 (963)
.....++++|.++..+.....+|++|++++|+++ .+|...+.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 32 ~~~~c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (353)
T 2z80_A 32 RNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110 (353)
T ss_dssp TTSEEECCSTTCSSCCTTCCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCeEeeCCCCCcccccccccccCcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCC
Confidence 3334555555555222222234555555555555 555555556667777777777766655666666667777777777
Q ss_pred cccccCcccccCCCCCCEEEccCCccccCCC-cCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCcccc
Q 046851 131 MLEETIPAELGMLQNLEVLDVSRNSLSGSIP-VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEG 209 (963)
Q Consensus 131 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~ 209 (963)
++++..+..|.++++|++|+|++|+++...+ ..+.++++|+.|++++
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~-------------------------------- 158 (353)
T 2z80_A 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN-------------------------------- 158 (353)
T ss_dssp CCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEE--------------------------------
T ss_pred cCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCC--------------------------------
Confidence 6665555556666677777777766663222 2455566666666554
Q ss_pred CCcccccCCCCCceEecCCc-ccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-
Q 046851 210 GIPEAVSSLPNLRILWAPRA-TLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL- 287 (963)
Q Consensus 210 ~~~~~l~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~- 287 (963)
| .+....+..|.++++|++|++++|+++.+.+..|..+++|++|++++|+++..+....
T Consensus 159 -------------------n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 219 (353)
T 2z80_A 159 -------------------MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219 (353)
T ss_dssp -------------------SSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHH
T ss_pred -------------------CccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhh
Confidence 3 2333334444555555555555555555545555555555555555555543333222
Q ss_pred CCCceeEEEeccCcCcc
Q 046851 288 PVPCMTMFDVSGNALSG 304 (963)
Q Consensus 288 ~~~~L~~L~l~~N~l~~ 304 (963)
.+++|+.|++++|++.+
T Consensus 220 ~~~~L~~L~L~~n~l~~ 236 (353)
T 2z80_A 220 VTSSVECLELRDTDLDT 236 (353)
T ss_dssp HTTTEEEEEEESCBCTT
T ss_pred hcccccEEECCCCcccc
Confidence 24555555555555543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=264.65 Aligned_cols=102 Identities=17% Similarity=0.205 Sum_probs=62.8
Q ss_pred cCchhHhhccCCccEEECcCCcCCCCCcccccc---CCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCc
Q 046851 427 QLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGE---LVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS 503 (963)
Q Consensus 427 ~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~---l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 503 (963)
.+|..+...+++|++|++++|.+++..+..+.. .+.++.++++ .+.+++|.+. .+|.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~-------------------~~~l~~~~l~-~l~~ 271 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR-------------------NVKITDESLF-QVMK 271 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEE-------------------SCBCCHHHHH-HHHH
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccc-------------------cccccCcchh-hhHH
Confidence 444444444467777888888777544333221 2223333333 2333344444 5677
Q ss_pred ccccCCccceecccccccCCCCChh-hhccccCCeEEeccccCCCcC
Q 046851 504 SLGQLQLLEVLDLSSNSLSGLIPDD-LENLRNLTVLLLNNNKLSGKI 549 (963)
Q Consensus 504 ~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~ 549 (963)
.+..+++|+.|++++|+|+. +|.. +..+++|++|+|++|++++..
T Consensus 272 ~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 272 LLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp HHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred HHhcccCCCEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 78888888888888888884 4554 578888888888888887543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-27 Score=256.98 Aligned_cols=175 Identities=25% Similarity=0.206 Sum_probs=92.6
Q ss_pred ceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccC--cCccccCcccccEEEcccCc
Q 046851 54 ELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG--IPRSLGNCFQVRSLLLFSNM 131 (963)
Q Consensus 54 ~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~--~~~~~~~l~~L~~L~L~~n~ 131 (963)
.++++++.++..+.....+|++|+|++|+++ .+|..+|.++++|++|+|++|+++.. .+..+.++++|+.|+|++|.
T Consensus 11 ~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~ 89 (306)
T 2z66_A 11 EIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89 (306)
T ss_dssp EEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCS
T ss_pred EEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCc
Confidence 4555555554222222234555555555555 56666666666666666666666522 24455556666666666666
Q ss_pred ccccCcccccCCCCCCEEEccCCccccCCC-cCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccC
Q 046851 132 LEETIPAELGMLQNLEVLDVSRNSLSGSIP-VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGG 210 (963)
Q Consensus 132 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~ 210 (963)
++. ++..+..+++|++|++++|.+++..+ ..+..++
T Consensus 90 i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~------------------------------------------ 126 (306)
T 2z66_A 90 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR------------------------------------------ 126 (306)
T ss_dssp EEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCT------------------------------------------
T ss_pred ccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhcc------------------------------------------
Confidence 653 34445666666666666666653322 2344444
Q ss_pred CcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccC-cCccccCCCCCCcEEeccCccccc
Q 046851 211 IPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSG-KNLGVLGPCKNLLFLDLSSNQLTG 281 (963)
Q Consensus 211 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~ 281 (963)
+|+.|++++|.+.+..+..|..+++|++|++++|++++ ..+..|..+++|++|++++|++++
T Consensus 127 ---------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 189 (306)
T 2z66_A 127 ---------NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 189 (306)
T ss_dssp ---------TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred ---------CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCC
Confidence 44455555555544445555555555555555555544 334455555555555555555543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-27 Score=269.90 Aligned_cols=245 Identities=23% Similarity=0.212 Sum_probs=156.9
Q ss_pred CceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeec
Q 046851 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLS 79 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~ 79 (963)
+...++.+++.++. +|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|.+++..+..+. +|++|+|+
T Consensus 55 ~~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 35678899999984 565554 6899999999999999999999999999999999999855554443 46666666
Q ss_pred cccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEccc-CcccccCcccccCCCCCCEEEccCCcccc
Q 046851 80 FNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFS-NMLEETIPAELGMLQNLEVLDVSRNSLSG 158 (963)
Q Consensus 80 ~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 158 (963)
+|+++ .+|...|..+++|++|+|++|+|+...+..|.++++|+.|++++ |.+..+.+..|.++++|++|+|++|.+++
T Consensus 132 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp SSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 66666 55555555666666666666666655555666666666666665 34444444456666666666666666653
Q ss_pred CCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcc
Q 046851 159 SIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSN 238 (963)
Q Consensus 159 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 238 (963)
+| .+..+++|+.|+|++ |.+.+..|..|.++++|+.|++++|++++..+..
T Consensus 211 -~~-~~~~l~~L~~L~Ls~---------------------------N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 261 (452)
T 3zyi_A 211 -MP-NLTPLVGLEELEMSG---------------------------NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261 (452)
T ss_dssp -CC-CCTTCTTCCEEECTT---------------------------SCCSEECGGGGTTCTTCCEEECTTSCCCEECTTT
T ss_pred -cc-cccccccccEEECcC---------------------------CcCcccCcccccCccCCCEEEeCCCcCceECHHH
Confidence 22 355555555555555 3444444555555555555555555555555555
Q ss_pred ccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccc
Q 046851 239 WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 239 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 280 (963)
|.++++|+.|+|++|+++.+++..|..+++|+.|+|++|++.
T Consensus 262 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 262 FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred hcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 555555555555555555555555555555555555555554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-27 Score=268.29 Aligned_cols=247 Identities=21% Similarity=0.152 Sum_probs=155.9
Q ss_pred CceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccc
Q 046851 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNR 82 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~ 82 (963)
....++.++++++ .+|..+. +++++|+|++|+|+.+.+..|.++++|++|+|++|.+++
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------------------ 102 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT------------------ 102 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE------------------
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc------------------
Confidence 3567889999998 4565554 789999999999998888999999999999999999983
Q ss_pred ccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCC-ccccCCC
Q 046851 83 LVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRN-SLSGSIP 161 (963)
Q Consensus 83 l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p 161 (963)
++...|.++++|++|+|++|+|+...++.|.++++|+.|+|++|+++.+.+..|.++++|++|+|++| .+....+
T Consensus 103 ----i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~ 178 (440)
T 3zyj_A 103 ----IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE 178 (440)
T ss_dssp ----ECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred ----cChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCc
Confidence 34444445555555555555555444445555555555555555555555555555555555555552 3333333
Q ss_pred cCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccc
Q 046851 162 VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGA 241 (963)
Q Consensus 162 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 241 (963)
..|.++++|+.|++++|.++ .+| .+..+++|+.|+|++|++++..+..|.+
T Consensus 179 ~~~~~l~~L~~L~L~~n~l~----------------------------~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 229 (440)
T 3zyj_A 179 GAFEGLSNLRYLNLAMCNLR----------------------------EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQG 229 (440)
T ss_dssp TTTTTCSSCCEEECTTSCCS----------------------------SCC-CCTTCSSCCEEECTTSCCCEECTTTTTT
T ss_pred chhhcccccCeecCCCCcCc----------------------------ccc-ccCCCcccCEEECCCCccCccChhhhcc
Confidence 34555555555555553322 111 2455566666666666666655666666
Q ss_pred cccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCc
Q 046851 242 CDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALS 303 (963)
Q Consensus 242 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~ 303 (963)
+++|+.|+|++|+++.+++..|..+++|+.|+|++|+|++.++..+ .+++|+.|++++|++.
T Consensus 230 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 6666666666666666666666666666666666666665555444 4566666666666655
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=254.31 Aligned_cols=249 Identities=22% Similarity=0.231 Sum_probs=159.0
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLV 84 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~ 84 (963)
+.++.++++++.+ |..+. ++|++|+|++|+++.+.+..|.++++|++|+|++|.++...
T Consensus 10 ~~l~c~~~~l~~i-p~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~------------------ 68 (306)
T 2z66_A 10 TEIRCNSKGLTSV-PTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG------------------ 68 (306)
T ss_dssp TEEECCSSCCSSC-CSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE------------------
T ss_pred CEEEcCCCCcccC-CCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc------------------
Confidence 5688888888844 54443 68999999999998666667889999999999999886221
Q ss_pred ccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCc-ccccCCCCCCEEEccCCccccCCCcC
Q 046851 85 GSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIP-AELGMLQNLEVLDVSRNSLSGSIPVD 163 (963)
Q Consensus 85 ~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~ 163 (963)
.+|..++ .+++|++|+|++|+++ .++..+.++++|+.|++++|++++..+ ..+..+++|++|++++|.+.+..+..
T Consensus 69 -~~~~~~~-~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 145 (306)
T 2z66_A 69 -CCSQSDF-GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145 (306)
T ss_dssp -EEEHHHH-SCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTT
T ss_pred -Ccccccc-cccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhh
Confidence 1122222 3555666666666555 344455556666666666666554433 45556666666666666665555555
Q ss_pred ccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCcccc-CCcccccCCCCCceEecCCcccccCCCcccccc
Q 046851 164 LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEG-GIPEAVSSLPNLRILWAPRATLEGNFPSNWGAC 242 (963)
Q Consensus 164 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~-~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 242 (963)
+.++++|+.|++++ |.+.+ .+|..+..+++|+.|++++|++++..|..|..+
T Consensus 146 ~~~l~~L~~L~l~~---------------------------n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 198 (306)
T 2z66_A 146 FNGLSSLEVLKMAG---------------------------NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198 (306)
T ss_dssp TTTCTTCCEEECTT---------------------------CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred cccCcCCCEEECCC---------------------------CccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCC
Confidence 66666666666655 33332 345556666666666666666666666667777
Q ss_pred ccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CC-CceeEEEeccCcCcc
Q 046851 243 DNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PV-PCMTMFDVSGNALSG 304 (963)
Q Consensus 243 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~-~~L~~L~l~~N~l~~ 304 (963)
++|++|+|++|+++++++..|..+++|+.|++++|++++..+..+ .+ ++|+.|++++|++.+
T Consensus 199 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 199 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp TTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred CCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 777777777777777666666667777777777777766555444 34 366666666666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=263.55 Aligned_cols=256 Identities=20% Similarity=0.163 Sum_probs=222.6
Q ss_pred CCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCC
Q 046851 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106 (963)
Q Consensus 27 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N 106 (963)
..+.++.+++.++ .+|..+. ++++.|+|++|+++ .++...|.++++|++|+|++|
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~----------------------~~~~~~~~~l~~L~~L~Ls~n 98 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ----------------------IIKVNSFKHLRHLEILQLSRN 98 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCC----------------------EECTTTTSSCSSCCEEECCSS
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCC----------------------eeCHHHhhCCCCCCEEECCCC
Confidence 4678999999999 6666553 67788888888776 666666778999999999999
Q ss_pred ccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccc
Q 046851 107 YLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVR 186 (963)
Q Consensus 107 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~ 186 (963)
+|++..+..|.++++|++|+|++|+++.+.+..|..+++|++|+|++|.++...+..|.++++|+.|++++|
T Consensus 99 ~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~-------- 170 (440)
T 3zyj_A 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL-------- 170 (440)
T ss_dssp CCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC--------
T ss_pred cCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCC--------
Confidence 999888899999999999999999999888889999999999999999999777788999999999999873
Q ss_pred cccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCC
Q 046851 187 YSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPC 266 (963)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 266 (963)
+.+....+..|.++++|+.|++++|+++.. | .+..+++|++|+|++|+++.+.+..|..+
T Consensus 171 ------------------~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 230 (440)
T 3zyj_A 171 ------------------KRLSYISEGAFEGLSNLRYLNLAMCNLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGL 230 (440)
T ss_dssp ------------------TTCCEECTTTTTTCSSCCEEECTTSCCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTC
T ss_pred ------------------CCcceeCcchhhcccccCeecCCCCcCccc-c-ccCCCcccCEEECCCCccCccChhhhccC
Confidence 333334456789999999999999999854 4 58899999999999999999999999999
Q ss_pred CCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCccCCCC-CCCCCCCCcccccccccccCCCCchhhh
Q 046851 267 KNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNPSTAYLS 336 (963)
Q Consensus 267 ~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~~~-~~~l~~l~~l~l~~n~~~~~~~~~~~~~ 336 (963)
++|+.|+|++|+|++..+..+ .+++|+.|++++|++++.++. +..+.+|+.++|++|+|.+.. .+.|+.
T Consensus 231 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC-~l~~l~ 301 (440)
T 3zyj_A 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC-DILWLS 301 (440)
T ss_dssp TTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS-TTHHHH
T ss_pred ccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC-CchHHH
Confidence 999999999999999888766 689999999999999988776 788999999999999998853 344443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=253.00 Aligned_cols=251 Identities=23% Similarity=0.179 Sum_probs=193.0
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLV 84 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~ 84 (963)
++++.++++++.+ |..+ .++|++|+|++|++++..+..|.++++|++|+|++|.++
T Consensus 14 ~~~~c~~~~l~~i-p~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~--------------------- 69 (285)
T 1ozn_A 14 VTTSCPQQGLQAV-PVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA--------------------- 69 (285)
T ss_dssp CEEECCSSCCSSC-CTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC---------------------
T ss_pred eEEEcCcCCcccC-CcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccc---------------------
Confidence 5788888888844 5433 468888888888888777778888888888888888877
Q ss_pred ccCCccccccCCCCCeEeCCCCc-cccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcC
Q 046851 85 GSVPSKIGEKCTNLEHLDLSGNY-LVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD 163 (963)
Q Consensus 85 ~~~p~~~~~~l~~L~~L~Ls~N~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 163 (963)
.++...|..+++|++|+|++|+ ++...+..|.++++|++|++++|++++..+..|.++++|++|+|++|.+++..+..
T Consensus 70 -~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 148 (285)
T 1ozn_A 70 -RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148 (285)
T ss_dssp -EECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred -eeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhH
Confidence 4434445567788888888886 77666778888888888888888888777777888888888888888888666666
Q ss_pred ccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccc
Q 046851 164 LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACD 243 (963)
Q Consensus 164 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 243 (963)
|.++++|+.|++++ |.+.+..+..+..+++|+.|++++|.+++..|..|..++
T Consensus 149 ~~~l~~L~~L~l~~---------------------------n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 201 (285)
T 1ozn_A 149 FRDLGNLTHLFLHG---------------------------NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201 (285)
T ss_dssp TTTCTTCCEEECCS---------------------------SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred hccCCCccEEECCC---------------------------CcccccCHHHhcCccccCEEECCCCcccccCHhHccCcc
Confidence 88888888888877 444444556678888889999999999888888899999
Q ss_pred cCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCC
Q 046851 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIP 307 (963)
Q Consensus 244 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~ 307 (963)
+|++|++++|+++++++..|..+++|+.|++++|++............++.+..+.+.+....|
T Consensus 202 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p 265 (285)
T 1ozn_A 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265 (285)
T ss_dssp TCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred cccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence 9999999999999988888899999999999999987654433222345555566666665444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=265.12 Aligned_cols=249 Identities=19% Similarity=0.148 Sum_probs=152.6
Q ss_pred CCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCC
Q 046851 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106 (963)
Q Consensus 27 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N 106 (963)
....++.+++.++ .+|..+. ++|++|+|++|.+++. +...|.++++|++|+|++|
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~----------------------~~~~~~~l~~L~~L~Ls~n 109 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMI----------------------QADTFRHLHHLEVLQLGRN 109 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEE----------------------CTTTTTTCTTCCEEECCSS
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceE----------------------CHHHcCCCCCCCEEECCCC
Confidence 4678999999998 5666553 6788888888888743 3334445556666666666
Q ss_pred ccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccc
Q 046851 107 YLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVR 186 (963)
Q Consensus 107 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~ 186 (963)
+|++..+..|.++++|++|+|++|+++.+.+..|.++++|++|+|++|+++...+..|.++++|+.|++++|
T Consensus 110 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~-------- 181 (452)
T 3zyi_A 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL-------- 181 (452)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC--------
T ss_pred ccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC--------
Confidence 665555555666666666666666666555555566666666666666665444445566666666666541
Q ss_pred cccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCC
Q 046851 187 YSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPC 266 (963)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 266 (963)
+.+....+..|.++++|+.|++++|++++. ..+..+++|++|+|++|+++++.+..|..+
T Consensus 182 ------------------~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 241 (452)
T 3zyi_A 182 ------------------KKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGL 241 (452)
T ss_dssp ------------------TTCCEECTTTTTTCTTCCEEECTTSCCSSC--CCCTTCTTCCEEECTTSCCSEECGGGGTTC
T ss_pred ------------------CCccccChhhccCCCCCCEEECCCCccccc--ccccccccccEEECcCCcCcccCcccccCc
Confidence 122222333455666666666666666543 235566666666666666666666666666
Q ss_pred CCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCccCCCC-CCCCCCCCcccccccccccC
Q 046851 267 KNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPT-FSNMVCPPVPYLSRNLFESY 328 (963)
Q Consensus 267 ~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~~~-~~~l~~l~~l~l~~n~~~~~ 328 (963)
++|+.|+|++|++++..+..+ .+++|+.|++++|++++.++. +..+.+|+.++|++|++.+.
T Consensus 242 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred cCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 666666666666666555444 456666666666666655544 55666677777777777664
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=262.33 Aligned_cols=168 Identities=21% Similarity=0.160 Sum_probs=102.1
Q ss_pred ceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCC
Q 046851 75 RVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRN 154 (963)
Q Consensus 75 ~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 154 (963)
.++++.+.+. .++..++..+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+ |..+++|++|+|++|
T Consensus 14 i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 14 IEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred Eeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 3455555555 6666677677788888888888887767788888888888888888876544 778888888888888
Q ss_pred ccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccC
Q 046851 155 SLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN 234 (963)
Q Consensus 155 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~ 234 (963)
.+++.. ..++|+.|++++|.++ +..+. .+++|+.|++++|++++.
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~---------------------------~~~~~---~~~~L~~L~l~~N~l~~~ 135 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNIS---------------------------RVSCS---RGQGKKNIYLANNKITML 135 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCS---------------------------EEEEC---CCSSCEEEECCSSCCCSG
T ss_pred cccccc-----CCCCcCEEECCCCccC---------------------------CcCcc---ccCCCCEEECCCCCCCCc
Confidence 877322 2356666666653332 21111 134455555555555554
Q ss_pred CCccccccccCceeecCcccccCcCcccc-CCCCCCcEEeccCcccc
Q 046851 235 FPSNWGACDNLEMLNLGHNFFSGKNLGVL-GPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 235 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~ 280 (963)
.+..|..+++|++|+|++|+++.+++..+ ..+++|++|+|++|+++
T Consensus 136 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 182 (317)
T 3o53_A 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (317)
T ss_dssp GGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred cchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence 44455555555555555555555444333 23455555555555544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-26 Score=268.51 Aligned_cols=108 Identities=30% Similarity=0.325 Sum_probs=63.5
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|+.|++++|.++ .+|.. +++|+.|++++|.|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|
T Consensus 201 ~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~L 268 (622)
T 3g06_A 201 SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSV 268 (622)
T ss_dssp TTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEEC
T ss_pred chhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeC
Confidence 34566666666665 34432 3556666666666643 33 33456666666666666 4554 4456666666
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccc
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVS 557 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 557 (963)
++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..++
T Consensus 269 s~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 269 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 666666 4566666666666666666666665555544443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=249.28 Aligned_cols=152 Identities=26% Similarity=0.248 Sum_probs=79.6
Q ss_pred cceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccC
Q 046851 74 KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSR 153 (963)
Q Consensus 74 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 153 (963)
+.++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++++.+.+|.++++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCCC---CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 34555555555 5555432 3555666666655544445555555555555555555554455555555555555555
Q ss_pred Cc-cccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccc
Q 046851 154 NS-LSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLE 232 (963)
Q Consensus 154 N~-l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~ 232 (963)
|. +....|. .+..+++|+.|++++|+++
T Consensus 90 n~~l~~~~~~---------------------------------------------------~~~~l~~L~~L~l~~n~l~ 118 (285)
T 1ozn_A 90 NAQLRSVDPA---------------------------------------------------TFHGLGRLHTLHLDRCGLQ 118 (285)
T ss_dssp CTTCCCCCTT---------------------------------------------------TTTTCTTCCEEECTTSCCC
T ss_pred CCCccccCHH---------------------------------------------------HhcCCcCCCEEECCCCcCC
Confidence 54 4432233 3344444444444444444
Q ss_pred cCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccc
Q 046851 233 GNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 233 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 280 (963)
+..+..|..+++|++|++++|+++.+++..|+.+++|++|++++|+++
T Consensus 119 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 166 (285)
T 1ozn_A 119 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166 (285)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc
Confidence 444455555555555555555555555555555555555555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-28 Score=292.77 Aligned_cols=449 Identities=16% Similarity=0.109 Sum_probs=303.0
Q ss_pred CCCceEEEccCCccc---ccCCCccc------------cCCCCcEEEccCCcccccCCccccCc--ccccceeccccc-c
Q 046851 1 MGNLEVLDLEGNLLN---GILPDSGF------------HLKSLRVLNLGFNRITGEIPASFSDF--VNLEELNLAGNL-V 62 (963)
Q Consensus 1 l~~l~~L~ls~n~i~---~~~~~~~~------------~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~-l 62 (963)
+++|++|+|++|... +..|..++ .+++|++|+|++|.++...+..+... .+|++|+|++|. +
T Consensus 72 ~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~ 151 (592)
T 3ogk_B 72 FPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGF 151 (592)
T ss_dssp CTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEE
T ss_pred CCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCc
Confidence 467999999986431 23443333 78999999999999987766777664 459999999986 3
Q ss_pred ccC-CC---cccccccceeeccccccccCC---ccccccCCCCCeEeCCCCccc----cCcCccccCcccccEEEcccCc
Q 046851 63 NGT-VP---TFIGRLKRVYLSFNRLVGSVP---SKIGEKCTNLEHLDLSGNYLV----GGIPRSLGNCFQVRSLLLFSNM 131 (963)
Q Consensus 63 ~~~-~~---~~~~~L~~L~L~~n~l~~~~p---~~~~~~l~~L~~L~Ls~N~i~----~~~~~~~~~l~~L~~L~L~~n~ 131 (963)
+.. ++ ..+++|++|+|++|.+++.-. ..+...+++|++|+|++|.++ +.++..+.++++|+.|++++|.
T Consensus 152 ~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~ 231 (592)
T 3ogk_B 152 TTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE 231 (592)
T ss_dssp EHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCB
T ss_pred CHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCcc
Confidence 211 11 234689999999999874321 124457899999999999997 3445567788999999999999
Q ss_pred ccccCcccccCCCCCCEEEccCCccc---cCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccc
Q 046851 132 LEETIPAELGMLQNLEVLDVSRNSLS---GSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFE 208 (963)
Q Consensus 132 l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~ 208 (963)
+.+ ++..+.++++|++|+++.+... ...+..+..+++|+.|+++++ ..
T Consensus 232 ~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~----------------------------~~ 282 (592)
T 3ogk_B 232 ILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM----------------------------GP 282 (592)
T ss_dssp GGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC----------------------------CT
T ss_pred HHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcccc----------------------------ch
Confidence 986 6788999999999999864432 344567888999999999752 12
Q ss_pred cCCcccccCCCCCceEecCCcccccCCC-ccccccccCceeecCcccccCc-CccccCCCCCCcEEecc-----------
Q 046851 209 GGIPEAVSSLPNLRILWAPRATLEGNFP-SNWGACDNLEMLNLGHNFFSGK-NLGVLGPCKNLLFLDLS----------- 275 (963)
Q Consensus 209 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~----------- 275 (963)
..+|..+..+++|+.|++++|.+++... ..+..+++|++|+++ |.+... ....+..+++|++|+++
T Consensus 283 ~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~ 361 (592)
T 3ogk_B 283 NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDE 361 (592)
T ss_dssp TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSST
T ss_pred hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccc
Confidence 3467778889999999999999765433 346789999999999 444433 33344668999999999
Q ss_pred CcccccccCCC--CCCCceeEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCcccc
Q 046851 276 SNQLTGELARE--LPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGR 353 (963)
Q Consensus 276 ~N~l~~~~~~~--~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (963)
.|.++...... ..+++|+.|+++.|.+++....
T Consensus 362 ~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~--------------------------------------------- 396 (592)
T 3ogk_B 362 EGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE--------------------------------------------- 396 (592)
T ss_dssp TCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHH---------------------------------------------
T ss_pred cCccCHHHHHHHHhhCccCeEEEeecCCccHHHHH---------------------------------------------
Confidence 46776543222 2478899999988777632111
Q ss_pred ccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEcc----CCeeeec--
Q 046851 354 DGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVS----NNRIAGQ-- 427 (963)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~----~n~l~~~-- 427 (963)
.+...++.|+ .|+++ .|.+++.
T Consensus 397 --------------------------------------------------~l~~~~~~L~--~L~l~~~~~~n~l~~~p~ 424 (592)
T 3ogk_B 397 --------------------------------------------------SIGTYLKNLC--DFRLVLLDREERITDLPL 424 (592)
T ss_dssp --------------------------------------------------HHHHHCCSCC--EEEEEECSCCSCCSSCCC
T ss_pred --------------------------------------------------HHHhhCCCCc--EEEEeecCCCccccCchH
Confidence 0001122333 44443 4455531
Q ss_pred ---CchhHhhccCCccEEECcCCc--CCCCCcccccc-CCCCCEEeccCCcCCC-ccchhhccCcccceecccccccccc
Q 046851 428 ---LPAEIGRMCKSLKFLDASGNQ--IVGPIPRGVGE-LVSLVALNLSWNLMHD-QIPTTLGQMKGLKYLSLAGNNLTGS 500 (963)
Q Consensus 428 ---~p~~~~~~~~~L~~L~ls~n~--l~~~~p~~~~~-l~~L~~L~ls~N~i~~-~~~~~~~~l~~L~~L~l~~N~l~~~ 500 (963)
++..+. .+++|++|++++|. +++..+..+.. +++|+.|++++|.+++ .++..+..+++|++|+|++|.+++.
T Consensus 425 ~~~~~~~~~-~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 425 DNGVRSLLI-GCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp HHHHHHHHH-HCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred HHHHHHHHH-hCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence 233333 35889999997544 66555555543 7889999999999875 3455667889999999999998744
Q ss_pred -CCcccccCCccceecccccccCCCCChhh-hccccCCeEEeccccCCCcCCC-CccccccCceEeeccccCccCCCCCC
Q 046851 501 -IPSSLGQLQLLEVLDLSSNSLSGLIPDDL-ENLRNLTVLLLNNNKLSGKIPS-GLANVSTLSAFNVSFNNLSGPLPSSK 577 (963)
Q Consensus 501 -~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~L~~l~l~~N~l~~~~p~~~ 577 (963)
++..+..+++|+.|+|++|+++......+ ..++.+....+..++-....|. .-........+.. ++.+.|+.|+.+
T Consensus 504 ~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~g~~~~~p 582 (592)
T 3ogk_B 504 AIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHILA-YYSLAGQRTDCP 582 (592)
T ss_dssp HHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC---------------CCCEEEE-EECTTCSCSCCC
T ss_pred HHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCccccccccccCCcCCcchhheEe-eeecCCCccCCC
Confidence 34445678999999999999886533333 4567776666665533211111 1112233444433 466778776654
Q ss_pred C
Q 046851 578 N 578 (963)
Q Consensus 578 ~ 578 (963)
.
T Consensus 583 ~ 583 (592)
T 3ogk_B 583 T 583 (592)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=252.03 Aligned_cols=225 Identities=21% Similarity=0.270 Sum_probs=126.9
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccc
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFN 81 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n 81 (963)
.++++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..|.++++|++|+|++|.++
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~------------------ 140 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR------------------ 140 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC------------------
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc------------------
Confidence 45666666666666 44555666666666666666666 66666666666666666666665
Q ss_pred cccccCCccccccCCCCCeEeCCCCccccCcCcccc---------CcccccEEEcccCcccccCcccccCCCCCCEEEcc
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG---------NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVS 152 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~---------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 152 (963)
.+|..+. .+++|++|+|++|++.+.+|..+. ++++|+.|+|++|+++ .+|..+.++++|++|+|+
T Consensus 141 ----~lp~~l~-~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~ 214 (328)
T 4fcg_A 141 ----ALPASIA-SLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR 214 (328)
T ss_dssp ----CCCGGGG-GCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEE
T ss_pred ----cCcHHHh-cCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEcc
Confidence 3443322 344555555555444444444433 2555555555555555 344455555555555555
Q ss_pred CCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccc
Q 046851 153 RNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLE 232 (963)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~ 232 (963)
+|.++ .+|..+.++++|+.|++++ |.+.+.+|..+..+++|+.|++++|++.
T Consensus 215 ~N~l~-~l~~~l~~l~~L~~L~Ls~---------------------------n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 266 (328)
T 4fcg_A 215 NSPLS-ALGPAIHHLPKLEELDLRG---------------------------CTALRNYPPIFGGRAPLKRLILKDCSNL 266 (328)
T ss_dssp SSCCC-CCCGGGGGCTTCCEEECTT---------------------------CTTCCBCCCCTTCCCCCCEEECTTCTTC
T ss_pred CCCCC-cCchhhccCCCCCEEECcC---------------------------CcchhhhHHHhcCCCCCCEEECCCCCch
Confidence 55555 2444455555555555554 3444445555555555555555555555
Q ss_pred cCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccc
Q 046851 233 GNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 233 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 280 (963)
+.+|..+..+++|++|+|++|.+.+..|..++.+++|+.+++..|.+.
T Consensus 267 ~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 555555555666666666665555555555555666666665555443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-28 Score=282.88 Aligned_cols=184 Identities=22% Similarity=0.151 Sum_probs=130.9
Q ss_pred cccCCCccEEEE-EECCCcEEEEEEeeccc----------chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEEE
Q 046851 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGR----------FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 690 ig~G~~g~Vy~~-~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 757 (963)
.+.|+.|.+..+ +...|+.||||++.... ....++|.+|+++++++ .|+||+++++++.+++..|+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 556666666555 33348889999996542 23356799999999999 6999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||++|++|.+++... ..++.. +|+.||++||+|+|++ |||||||||+|||++++|.+||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999999874 346554 5889999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCC
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKA 883 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 883 (963)
....+.+||++|||||++.+. +..++|+||+|++.+++.++..+
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 233456799999999999864 56789999999998887766544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-26 Score=248.56 Aligned_cols=132 Identities=20% Similarity=0.211 Sum_probs=86.5
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|++|++++|+++ .+|..+..+++|+.|++++|.+++ +|..++.+++|++|+|++|.+.+.+|..++.+++|+.|+|
T Consensus 183 ~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp TTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 45666666666666 566666666666666666666643 4445666666666666666666666666666666666666
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCc
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~ 570 (963)
++|++.+.+|..+..+++|++|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 666666666666666666666666666666666666666666666666655554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-27 Score=258.06 Aligned_cols=250 Identities=20% Similarity=0.097 Sum_probs=180.4
Q ss_pred cccCcccccceeccccccccCCCccc-ccccceeecccccc-ccCCcccc------ccCCCCCeEeCCCCccccCcCccc
Q 046851 45 SFSDFVNLEELNLAGNLVNGTVPTFI-GRLKRVYLSFNRLV-GSVPSKIG------EKCTNLEHLDLSGNYLVGGIPRSL 116 (963)
Q Consensus 45 ~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~L~~L~L~~n~l~-~~~p~~~~------~~l~~L~~L~Ls~N~i~~~~~~~~ 116 (963)
.++..++|++|++++|.+ .+|..+ ..|+.|+|++|+++ ..+|..++ .++++|++|+|++|++++..|..+
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHHHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHHHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 456677788888888877 555543 34778888888874 34555443 147788888888888887777765
Q ss_pred --cCcccccEEEcccCcccccCcccccCC-----CCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCccccccccc
Q 046851 117 --GNCFQVRSLLLFSNMLEETIPAELGML-----QNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSR 189 (963)
Q Consensus 117 --~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 189 (963)
..+++|+.|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+++++|+.|++++|.
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~---------- 184 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP---------- 184 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCT----------
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCC----------
Confidence 7888888888888888866 6777766 788888888888887777888888888888888743
Q ss_pred CCcccCCCcccCCCCCccccC--Ccccc--cCCCCCceEecCCccccc---CCCccccccccCceeecCcccccCcCc-c
Q 046851 190 GQSLVDQPSFMNDDFNFFEGG--IPEAV--SSLPNLRILWAPRATLEG---NFPSNWGACDNLEMLNLGHNFFSGKNL-G 261 (963)
Q Consensus 190 ~~~~~~~~~~~~~~~n~~~~~--~~~~l--~~l~~L~~L~l~~n~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~ 261 (963)
+.+. .+..+ ..+++|+.|++++|++++ .....+..+++|++|+|++|++++.++ .
T Consensus 185 -----------------l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 247 (312)
T 1wwl_A 185 -----------------ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247 (312)
T ss_dssp -----------------TCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCS
T ss_pred -----------------cCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchh
Confidence 2222 22233 677888888888888773 222334567788888888888887653 5
Q ss_pred ccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCccccccccccc
Q 046851 262 VLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFES 327 (963)
Q Consensus 262 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~ 327 (963)
.+..+++|++|+|++|+|+.++.... ++|+.||+++|++++.+ .+..+.+|+.+++++|++..
T Consensus 248 ~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~~~p-~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 248 SCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDRNP-SPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCSSCCCSCC-CTTTSCEEEEEECTTCTTTC
T ss_pred hhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCCCCCCCCh-hHhhCCCCCEEeccCCCCCC
Confidence 56667888888888888875444333 77888888888888774 47888888888888887764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=262.60 Aligned_cols=140 Identities=29% Similarity=0.347 Sum_probs=115.6
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
.|++++|.|+ .+| ..+++|+.|++++|.|+ .+|.. +++|+.|++++|.++ .+|.. +++|+.|+|++|
T Consensus 165 ~L~L~~N~l~-~l~----~~~~~L~~L~Ls~N~l~-~l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N 231 (622)
T 3g06_A 165 KLWAYNNQLT-SLP----MLPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGN 231 (622)
T ss_dssp EEECCSSCCS-CCC----CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSS
T ss_pred EEECCCCCCC-CCc----ccCCCCcEEECCCCCCC-CCCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCC
Confidence 4566666666 455 23477999999999999 46653 478999999999996 45543 588999999999
Q ss_pred cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCCC
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPS 575 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~ 575 (963)
+|+ .+| ..+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++++..|.
T Consensus 232 ~L~-~lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 232 RLT-SLP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CCS-CCC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred ccC-cCC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 999 577 456899999999999994 565 6789999999999999 8899999999999999999999987665
Q ss_pred CC
Q 046851 576 SK 577 (963)
Q Consensus 576 ~~ 577 (963)
..
T Consensus 303 ~l 304 (622)
T 3g06_A 303 AL 304 (622)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-27 Score=259.81 Aligned_cols=126 Identities=20% Similarity=0.172 Sum_probs=81.3
Q ss_pred CCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeec
Q 046851 97 NLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS 176 (963)
Q Consensus 97 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 176 (963)
+++.++++.+.+.......+..+++|+.|+|++|++++..+..|.++++|++|+|++|.+++..+ +..+++|++|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~-- 86 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLD-- 86 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEE--
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEE--
Confidence 34556777777765555666677778888888888877777777788888888888887764332 44455555554
Q ss_pred CcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCccccc
Q 046851 177 NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFS 256 (963)
Q Consensus 177 ~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 256 (963)
+++|++++. ...++|++|++++|+++
T Consensus 87 -------------------------------------------------Ls~n~l~~l-----~~~~~L~~L~l~~n~l~ 112 (317)
T 3o53_A 87 -------------------------------------------------LNNNYVQEL-----LVGPSIETLHAANNNIS 112 (317)
T ss_dssp -------------------------------------------------CCSSEEEEE-----EECTTCCEEECCSSCCS
T ss_pred -------------------------------------------------CcCCccccc-----cCCCCcCEEECCCCccC
Confidence 444554432 12356777777777777
Q ss_pred CcCccccCCCCCCcEEeccCccccccc
Q 046851 257 GKNLGVLGPCKNLLFLDLSSNQLTGEL 283 (963)
Q Consensus 257 ~~~~~~~~~l~~L~~L~L~~N~l~~~~ 283 (963)
.++... +++|+.|++++|++++..
T Consensus 113 ~~~~~~---~~~L~~L~l~~N~l~~~~ 136 (317)
T 3o53_A 113 RVSCSR---GQGKKNIYLANNKITMLR 136 (317)
T ss_dssp EEEECC---CSSCEEEECCSSCCCSGG
T ss_pred CcCccc---cCCCCEEECCCCCCCCcc
Confidence 665543 456777777777766433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-27 Score=254.40 Aligned_cols=250 Identities=20% Similarity=0.161 Sum_probs=211.1
Q ss_pred cccCCCCcEEEccCCcccccCCccccCcccccceeccccccc-cCCCcc----------cccccceeeccccccccCCcc
Q 046851 22 GFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVN-GTVPTF----------IGRLKRVYLSFNRLVGSVPSK 90 (963)
Q Consensus 22 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~----------~~~L~~L~L~~n~l~~~~p~~ 90 (963)
+...++|++|++++|.+ .+|..+... |+.|+|++|.++ ..+|.. +.+|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45678899999999999 677766654 999999999994 345542 558999999999999889998
Q ss_pred cc-ccCCCCCeEeCCCCccccCcCccccCc-----ccccEEEcccCcccccCcccccCCCCCCEEEccCCccccC--CCc
Q 046851 91 IG-EKCTNLEHLDLSGNYLVGGIPRSLGNC-----FQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGS--IPV 162 (963)
Q Consensus 91 ~~-~~l~~L~~L~Ls~N~i~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~ 162 (963)
+| ..+++|++|+|++|+|++. |..+..+ ++|++|+|++|++++..+..|.++++|++|+|++|++.+. .|.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 75 7899999999999999976 8888888 9999999999999998889999999999999999998754 233
Q ss_pred Cc--cCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCC-ccc
Q 046851 163 DL--GNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFP-SNW 239 (963)
Q Consensus 163 ~~--~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~ 239 (963)
.+ .++++|+.|++++|.++..+ ......+..+++|+.|++++|++++..| ..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 249 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPS------------------------GVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHH------------------------HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCC
T ss_pred HHHhccCCCCCEEECCCCcCcchH------------------------HHHHHHHhcCCCCCEEECCCCcCCcccchhhh
Confidence 33 89999999999995544111 1223455788999999999999998775 567
Q ss_pred cccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCcc
Q 046851 240 GACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSG 304 (963)
Q Consensus 240 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~ 304 (963)
..+++|++|+|++|+|+.++...+ ++|++|+|++|+|++.+ ....+++|+.|++++|++++
T Consensus 250 ~~l~~L~~L~Ls~N~l~~ip~~~~---~~L~~L~Ls~N~l~~~p-~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 250 DWPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSYNRLDRNP-SPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCCTTCCEEECTTSCCSSCCSSCC---SEEEEEECCSSCCCSCC-CTTTSCEEEEEECTTCTTTC
T ss_pred hhcCCCCEEECCCCccChhhhhcc---CCceEEECCCCCCCCCh-hHhhCCCCCEEeccCCCCCC
Confidence 778999999999999998876554 89999999999999884 46689999999999999985
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-27 Score=270.32 Aligned_cols=81 Identities=25% Similarity=0.251 Sum_probs=60.1
Q ss_pred CCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEE
Q 046851 217 SLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFD 296 (963)
Q Consensus 217 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~ 296 (963)
..++|+.|+|++|.+++..|..|..+++|++|+|++|.++++++ |..+++|++|+|++|.|++.++. +.|+.|+
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~ 105 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG----PSIETLH 105 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC----TTCCEEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC----CCcCEEE
Confidence 34478888888888887777788888888888888888877665 77788888888888887765432 5666666
Q ss_pred eccCcCc
Q 046851 297 VSGNALS 303 (963)
Q Consensus 297 l~~N~l~ 303 (963)
+++|.+.
T Consensus 106 L~~N~l~ 112 (487)
T 3oja_A 106 AANNNIS 112 (487)
T ss_dssp CCSSCCC
T ss_pred CcCCcCC
Confidence 6666655
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-27 Score=285.92 Aligned_cols=450 Identities=17% Similarity=0.114 Sum_probs=283.6
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccc---cCC------------ccccCcccccceeccccccccCCCcc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITG---EIP------------ASFSDFVNLEELNLAGNLVNGTVPTF 69 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~---~~~------------~~~~~l~~L~~L~Ls~N~l~~~~~~~ 69 (963)
+.++++.+... .....+..+++|++|+|++|.... ..| ..+..+++|++|+|++|.+++..+..
T Consensus 46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~ 124 (594)
T 2p1m_B 46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL 124 (594)
T ss_dssp CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence 35566554332 223346778999999999875321 111 12346789999999999887655433
Q ss_pred ----cccccceeeccc-cccccCCccccccCCCCCeEeCCCCccccCcCccc----cCcccccEEEcccCc--ccc-cCc
Q 046851 70 ----IGRLKRVYLSFN-RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSL----GNCFQVRSLLLFSNM--LEE-TIP 137 (963)
Q Consensus 70 ----~~~L~~L~L~~n-~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~----~~l~~L~~L~L~~n~--l~~-~~~ 137 (963)
+++|++|+|++| .++......++.++++|++|+|++|.+++..+..+ ..+++|+.|++++|. +.. .++
T Consensus 125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~ 204 (594)
T 2p1m_B 125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE 204 (594)
T ss_dssp HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHH
T ss_pred HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHH
Confidence 458999999998 55533234455578999999999999876544444 366799999999987 321 122
Q ss_pred ccccCCCCCCEEEccCC-ccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCccccc
Q 046851 138 AELGMLQNLEVLDVSRN-SLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVS 216 (963)
Q Consensus 138 ~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~ 216 (963)
..+.++++|++|+|++| .+. .++..+.++++|+.|+++.+... .+.+.+.+ ++..+.
T Consensus 205 ~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~--------------------~~~~~~~~-l~~~l~ 262 (594)
T 2p1m_B 205 RLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAE--------------------VRPDVYSG-LSVALS 262 (594)
T ss_dssp HHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCC--------------------CCHHHHHH-HHHHHH
T ss_pred HHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCc--------------------cchhhHHH-HHHHHh
Confidence 22345699999999998 445 47777888999999998753211 11234443 345778
Q ss_pred CCCCCceE-ecCCcccccCCCccccccccCceeecCcccccCcCc-cccCCCCCCcEEeccCcccccccCCCC--CCCce
Q 046851 217 SLPNLRIL-WAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNL-GVLGPCKNLLFLDLSSNQLTGELAREL--PVPCM 292 (963)
Q Consensus 217 ~l~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~--~~~~L 292 (963)
++++|+.| .+..... ..++..+..+++|++|+|++|.++.... ..+..+++|+.|++++| ++......+ .+++|
T Consensus 263 ~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L 340 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDL 340 (594)
T ss_dssp TCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTC
T ss_pred cCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCC
Confidence 88999888 4443332 2344445578899999999998765332 23567889999999888 442221111 36778
Q ss_pred eEEEeccCcCccCCCCCCCCCCCCcccccccccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccC
Q 046851 293 TMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSL 372 (963)
Q Consensus 293 ~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (963)
+.|+++++.-.|. ...+
T Consensus 341 ~~L~L~~~~~~g~--------------~~~~------------------------------------------------- 357 (594)
T 2p1m_B 341 RELRVFPSEPFVM--------------EPNV------------------------------------------------- 357 (594)
T ss_dssp CEEEEECSCTTCS--------------SCSS-------------------------------------------------
T ss_pred CEEEEecCccccc--------------ccCC-------------------------------------------------
Confidence 8887765431100 0000
Q ss_pred CCCCCCcccCCcceEEEEEcCCCcccCCCCcccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECc--C----
Q 046851 373 PSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDAS--G---- 446 (963)
Q Consensus 373 ~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls--~---- 446 (963)
.+++.....+...+..|+ .|+++.|.+++..+..+...+++|+.|+++ +
T Consensus 358 -----------------------~l~~~~l~~l~~~~~~L~--~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~ 412 (594)
T 2p1m_B 358 -----------------------ALTEQGLVSVSMGCPKLE--SVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAP 412 (594)
T ss_dssp -----------------------CCCHHHHHHHHHHCTTCC--EEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCC
T ss_pred -----------------------CCCHHHHHHHHHhchhHH--HHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCc
Confidence 000000001112244555 556677777766666666556788888888 4
Q ss_pred CcCCCC-----CccccccCCCCCEEeccCCcCCCccchhhcc-CcccceeccccccccccCCccc-ccCCccceeccccc
Q 046851 447 NQIVGP-----IPRGVGELVSLVALNLSWNLMHDQIPTTLGQ-MKGLKYLSLAGNNLTGSIPSSL-GQLQLLEVLDLSSN 519 (963)
Q Consensus 447 n~l~~~-----~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~ls~N 519 (963)
|.+++. ++..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|
T Consensus 413 ~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n 491 (594)
T 2p1m_B 413 DYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDC 491 (594)
T ss_dssp CTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESC
T ss_pred ccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCC
Confidence 556521 122256678888888877 666555555555 7888888888888875544444 56788888888888
Q ss_pred ccCCCCCh-hhhccccCCeEEeccccCCCcCCCCc-cccccCceEeecccc
Q 046851 520 SLSGLIPD-DLENLRNLTVLLLNNNKLSGKIPSGL-ANVSTLSAFNVSFNN 568 (963)
Q Consensus 520 ~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~l~l~~N~ 568 (963)
.+++.... .+..+++|+.|++++|+++......+ ..+++|+...+..+.
T Consensus 492 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 492 PFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp SCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred CCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 88543332 33457888888888888853333333 445666655555443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=230.87 Aligned_cols=217 Identities=19% Similarity=0.143 Sum_probs=132.3
Q ss_pred CCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeec
Q 046851 97 NLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLS 176 (963)
Q Consensus 97 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 176 (963)
+|++|+|++|+|++..+..|.++++|+.|++++|+++++.+.+|.++++|++|+|++|.+++..+..|.++++|+.|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555554444455555555555555555555555555555555555555555554444555555555555555
Q ss_pred CcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccC-CCccccccccCceeecCcccc
Q 046851 177 NLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN-FPSNWGACDNLEMLNLGHNFF 255 (963)
Q Consensus 177 ~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l 255 (963)
+ |.+.+..+..+..+++|+.|++++|.+++. +|..|..+++|++|+|++|++
T Consensus 109 ~---------------------------n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 109 E---------------------------TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp T---------------------------SCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred C---------------------------CCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCC
Confidence 4 333333334455666666666666666553 366666666677777777776
Q ss_pred cCcCccccCCCCCCc----EEeccCcccccccCCCCCCCceeEEEeccCcCccCCCC-CCCCCCCCcccccccccccCCC
Q 046851 256 SGKNLGVLGPCKNLL----FLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPT-FSNMVCPPVPYLSRNLFESYNP 330 (963)
Q Consensus 256 ~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~-~~~l~~l~~l~l~~n~~~~~~~ 330 (963)
+.+++..|..+++|+ .|++++|++++.++..+...+|+.|++++|++++.++. +..+.+|+.+++++|++.+..+
T Consensus 162 ~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred CcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 666666665555555 67777777776666666656677777777777766655 5667777777777777777666
Q ss_pred Cchhhhhhhc
Q 046851 331 STAYLSLFAK 340 (963)
Q Consensus 331 ~~~~~~~~~~ 340 (963)
...++..+..
T Consensus 242 ~l~~l~~~~~ 251 (276)
T 2z62_A 242 RIDYLSRWLN 251 (276)
T ss_dssp TTHHHHHHHH
T ss_pred chHHHHHHHH
Confidence 6666655443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=258.41 Aligned_cols=232 Identities=19% Similarity=0.166 Sum_probs=152.2
Q ss_pred CCcEEEccCCcccccCCccccCcccccceeccccccccCCC-cccccccceeeccccccccCCccccccCCCCCeEeCCC
Q 046851 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSG 105 (963)
Q Consensus 27 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~ 105 (963)
+|++|+|++|.+++..|..|..+++|++|+|++|.+++.+| ..+.+|++|+|++|.++ .+|. .++|++|+|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~-~l~~-----~~~L~~L~L~~ 108 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAAN 108 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEECTTCTTCCEEECCSSEEE-EEEE-----CTTCCEEECCS
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcccccCCCCCEEEecCCcCC-CCCC-----CCCcCEEECcC
Confidence 66666666666666556666666666666666666654433 22345666666666666 4442 25677777777
Q ss_pred CccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCcc-CCCCCceEeecCcCCcccc
Q 046851 106 NYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLG-NCSKLAILVLSNLFDTYED 184 (963)
Q Consensus 106 N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~n~~~~~~ 184 (963)
|.|++..+.. +++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..|..+. .+++|+.|+|++|.++
T Consensus 109 N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~--- 182 (487)
T 3oja_A 109 NNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY--- 182 (487)
T ss_dssp SCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC---
T ss_pred CcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc---
Confidence 7776544433 35677777777777766666677777777777777777766666654 6777777777764333
Q ss_pred cccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccC
Q 046851 185 VRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLG 264 (963)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 264 (963)
+. ..+..+++|+.|+|++|.+++..+ .|..+++|+.|+|++|.+++++. .+.
T Consensus 183 ------------------------~~--~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~-~l~ 234 (487)
T 3oja_A 183 ------------------------DV--KGQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEK-ALR 234 (487)
T ss_dssp ------------------------EE--ECCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECT-TCC
T ss_pred ------------------------cc--cccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccch-hhc
Confidence 22 122347778888888888876444 47788888888888888887654 467
Q ss_pred CCCCCcEEeccCcccc-ccc-CCCCCCCceeEEEec
Q 046851 265 PCKNLLFLDLSSNQLT-GEL-ARELPVPCMTMFDVS 298 (963)
Q Consensus 265 ~l~~L~~L~L~~N~l~-~~~-~~~~~~~~L~~L~l~ 298 (963)
.+++|+.|++++|++. +.. .....++.|+.++++
T Consensus 235 ~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred cCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 7888888888888887 222 223356677777775
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=228.39 Aligned_cols=223 Identities=20% Similarity=0.178 Sum_probs=133.5
Q ss_pred EEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccc
Q 046851 6 VLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVG 85 (963)
Q Consensus 6 ~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~ 85 (963)
.++.++.+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.++
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---------------------- 65 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ---------------------- 65 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC----------------------
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC----------------------
Confidence 3455555555 3344332 45777777777777666666777777777777777665
Q ss_pred cCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccC-CCcCc
Q 046851 86 SVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGS-IPVDL 164 (963)
Q Consensus 86 ~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~ 164 (963)
.++...|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..+.++++|++|+|++|.+++. +|..+
T Consensus 66 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~ 145 (276)
T 2z62_A 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145 (276)
T ss_dssp EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGG
T ss_pred ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhh
Confidence 44444455666777777777777666666677777777777777777665555666677777777777776642 35566
Q ss_pred cCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCc----eEecCCcccccCCCcccc
Q 046851 165 GNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLR----ILWAPRATLEGNFPSNWG 240 (963)
Q Consensus 165 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~----~L~l~~n~l~~~~~~~~~ 240 (963)
.++++|+.|++++ |.+.+..+..+..+++|+ .|++++|.+++..+..+.
T Consensus 146 ~~l~~L~~L~Ls~---------------------------N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~ 198 (276)
T 2z62_A 146 SNLTNLEHLDLSS---------------------------NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198 (276)
T ss_dssp GGCTTCCEEECCS---------------------------SCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC
T ss_pred ccCCCCCEEECCC---------------------------CCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC
Confidence 6666666666655 333333333444444444 555666665544444333
Q ss_pred ccccCceeecCcccccCcCccccCCCCCCcEEeccCccccc
Q 046851 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG 281 (963)
Q Consensus 241 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 281 (963)
. .+|++|+|++|+++.+++..|..+++|+.|++++|++++
T Consensus 199 ~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 199 E-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp S-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred C-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 3 256666666666666655555556666666666665553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.4e-27 Score=279.16 Aligned_cols=151 Identities=17% Similarity=0.156 Sum_probs=114.8
Q ss_pred cCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccc-cCCCCCEEecc--C----CcCCCc-----cchhhccCccc
Q 046851 420 SNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVG-ELVSLVALNLS--W----NLMHDQ-----IPTTLGQMKGL 487 (963)
Q Consensus 420 ~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~ls--~----N~i~~~-----~~~~~~~l~~L 487 (963)
+.+.+++.....+...+++|+.|+++.|.+++..+..+. .+++|+.|+++ + |.+++. ++..+..+++|
T Consensus 355 ~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L 434 (594)
T 2p1m_B 355 PNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDL 434 (594)
T ss_dssp CSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTC
T ss_pred cCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCc
Confidence 445666544455555568999999999999866666665 58999999999 4 566522 22336778999
Q ss_pred ceeccccccccccCCccccc-CCccceecccccccCCCCChhh-hccccCCeEEeccccCCCcCCC-CccccccCceEee
Q 046851 488 KYLSLAGNNLTGSIPSSLGQ-LQLLEVLDLSSNSLSGLIPDDL-ENLRNLTVLLLNNNKLSGKIPS-GLANVSTLSAFNV 564 (963)
Q Consensus 488 ~~L~l~~N~l~~~~p~~~~~-l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~L~~l~l 564 (963)
+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+. ....+++|+.|++
T Consensus 435 ~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l 513 (594)
T 2p1m_B 435 RRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWM 513 (594)
T ss_dssp CEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEE
T ss_pred cEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEee
Confidence 9999988 777666666665 8999999999999976544444 6789999999999999754443 4456899999999
Q ss_pred ccccCcc
Q 046851 565 SFNNLSG 571 (963)
Q Consensus 565 ~~N~l~~ 571 (963)
++|+++.
T Consensus 514 ~~~~~~~ 520 (594)
T 2p1m_B 514 SSCSVSF 520 (594)
T ss_dssp ESSCCBH
T ss_pred eCCCCCH
Confidence 9998853
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-23 Score=220.95 Aligned_cols=201 Identities=22% Similarity=0.235 Sum_probs=105.9
Q ss_pred cccceeccccccccCCCc-ccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEccc
Q 046851 51 NLEELNLAGNLVNGTVPT-FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFS 129 (963)
Q Consensus 51 ~L~~L~Ls~N~l~~~~~~-~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~ 129 (963)
++++++++++.++. +|. ...++++|+|++|+++ .++...|.++++|++|+|++|+|+...+..|.++++|++|+|++
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCCTTCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCCEEEccCCCCCc-cCCCCCCCCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 34455555555552 222 2223444455555544 45554455566666666666666544444555566666666666
Q ss_pred CcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCcccc
Q 046851 130 NMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEG 209 (963)
Q Consensus 130 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~ 209 (963)
|++++..+..|.++++|++|+|++|.+++..+..|.++++|+.|++++ |.+.+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~---------------------------n~l~~ 147 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGY---------------------------NELQS 147 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS---------------------------SCCCC
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCC---------------------------CcCCc
Confidence 666655555556666666666666666554444555555555555554 23333
Q ss_pred CCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccc
Q 046851 210 GIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 210 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 280 (963)
..+..|..+++|+.|++++|++++..+..|..+++|++|+|++|+++.+++..|..+++|+.|+|++|++.
T Consensus 148 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 148 LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 33334445555555555555555444444555555555555555555555555555555555555555544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=225.22 Aligned_cols=129 Identities=33% Similarity=0.346 Sum_probs=109.1
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|++|++++|+|+ .+|..+..+++|++|++++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 56888888888888 67888888888999999999988777788888999999999999998666667888999999999
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccc
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFN 567 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N 567 (963)
++|+|++..+..+..+++|+.|+|++|+|+ .+|..+..+++|+.+++++|
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~N 205 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCC
Confidence 999998665566788999999999999998 78888888888888887644
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-25 Score=258.43 Aligned_cols=185 Identities=18% Similarity=0.224 Sum_probs=146.0
Q ss_pred CCccccccCCCccEEEEEECCCcEEEEEEeecccc--------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 685 NASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
...+.||+|+||.||+|... +..+|+|+...... ...+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 44678999999999999555 78899998654321 1235689999999999999999655555566677999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+||+++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999875 468999999999999999 9999999999999999 9999999999987543
Q ss_pred CCcc------cccccccccccCcccccc--CCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046851 837 ETHA------TTGVAGTFGYVAPEYAMT--CRVSDKADVYSYGVVLLELLSDKKALD 885 (963)
Q Consensus 837 ~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~ 885 (963)
.... .....||+.|||||++.. ..|+...|+||..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2221 235679999999999987 567788999999999888888776653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.8e-23 Score=218.30 Aligned_cols=204 Identities=22% Similarity=0.223 Sum_probs=156.4
Q ss_pred CceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccc
Q 046851 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNR 82 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~ 82 (963)
+++.+++++++++. +|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------- 74 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ------------------- 74 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-------------------
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-------------------
Confidence 35667777777763 344333 46777777777777665566777777777777766665
Q ss_pred ccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCc
Q 046851 83 LVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV 162 (963)
Q Consensus 83 l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 162 (963)
.+|..+|..+++|++|+|++|++++..+..|.++++|+.|+|++|+++...+..|..+++|++|+|++|.+++..+.
T Consensus 75 ---~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 151 (270)
T 2o6q_A 75 ---TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKG 151 (270)
T ss_dssp ---CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred ---eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHh
Confidence 67777777788888888888888876677788888888888888888877777788888888888888888866666
Q ss_pred CccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcccccc
Q 046851 163 DLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGAC 242 (963)
Q Consensus 163 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 242 (963)
.|..+++|+.|++++ |.+.+..+..|..+++|+.|++++|++++..+..|..+
T Consensus 152 ~~~~l~~L~~L~L~~---------------------------n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 204 (270)
T 2o6q_A 152 VFDKLTSLKELRLYN---------------------------NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204 (270)
T ss_dssp TTTTCTTCCEEECCS---------------------------SCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred HccCCcccceeEecC---------------------------CcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccc
Confidence 688888888888887 45555566678888899999999999987777778889
Q ss_pred ccCceeecCcccccCc
Q 046851 243 DNLEMLNLGHNFFSGK 258 (963)
Q Consensus 243 ~~L~~L~Ls~N~l~~~ 258 (963)
++|+.|+|++|.+...
T Consensus 205 ~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 205 EKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTCCEEECCSSCBCCS
T ss_pred cCCCEEEecCCCeeCC
Confidence 9999999999987643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-23 Score=221.71 Aligned_cols=203 Identities=24% Similarity=0.173 Sum_probs=126.4
Q ss_pred ccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEE
Q 046851 46 FSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSL 125 (963)
Q Consensus 46 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 125 (963)
++++++|+++++++|.++ .+|..++ +++++|+|++|+|++..+..|.++++|+.|
T Consensus 6 ~~~l~~l~~l~~~~~~l~----------------------~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L 60 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT----------------------ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60 (290)
T ss_dssp EECSTTCCEEECTTSCCS----------------------SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEE
T ss_pred ccccCCccEEECCCCCCC----------------------cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEE
Confidence 556666777777766666 4554443 355566666666655555556666666666
Q ss_pred EcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCC
Q 046851 126 LLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFN 205 (963)
Q Consensus 126 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n 205 (963)
+|++|+|+++.+ ...+++|++|+|++|+++ .+|..+..+++|+.|++++ |
T Consensus 61 ~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~---------------------------N 110 (290)
T 1p9a_G 61 NLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF---------------------------N 110 (290)
T ss_dssp ECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS---------------------------S
T ss_pred ECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCC---------------------------C
Confidence 666666654322 255666666666666666 4555566666666666655 3
Q ss_pred ccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCC
Q 046851 206 FFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAR 285 (963)
Q Consensus 206 ~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 285 (963)
.+++..+..|.++++|+.|++++|++++..+..|..+++|+.|+|++|+|+.++...|..+++|+.|+|++|+|+.++..
T Consensus 111 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~ 190 (290)
T 1p9a_G 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKG 190 (290)
T ss_dssp CCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred cCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChh
Confidence 34444445566666666666666666666666666777777777777777777776777777777777777777765555
Q ss_pred CCCCCceeEEEeccCcCc
Q 046851 286 ELPVPCMTMFDVSGNALS 303 (963)
Q Consensus 286 ~~~~~~L~~L~l~~N~l~ 303 (963)
.+....|+.+++++|++.
T Consensus 191 ~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 191 FFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TTTTCCCSEEECCSCCBC
T ss_pred hcccccCCeEEeCCCCcc
Confidence 555556666666666654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.8e-23 Score=219.52 Aligned_cols=221 Identities=20% Similarity=0.169 Sum_probs=128.0
Q ss_pred CCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCC
Q 046851 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106 (963)
Q Consensus 27 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N 106 (963)
++..+++..+.+... ..+..+++|+.|++++|.++ .++. +..+++|++|+|++|
T Consensus 20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~----------------------~~~~--l~~l~~L~~L~l~~n 73 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK----------------------SVQG--IQYLPNVRYLALGGN 73 (272)
T ss_dssp HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC----------------------CCTT--GGGCTTCCEEECTTS
T ss_pred HHHHHHhcCcccccc--cccccccceeeeeeCCCCcc----------------------cccc--cccCCCCcEEECCCC
Confidence 444555555555432 23445566666666666554 2221 123445555555555
Q ss_pred ccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccc
Q 046851 107 YLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVR 186 (963)
Q Consensus 107 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~ 186 (963)
++++. ..+.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|+.|++++
T Consensus 74 ~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~--------- 142 (272)
T 3rfs_A 74 KLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAH--------- 142 (272)
T ss_dssp CCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS---------
T ss_pred CCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCC---------
Confidence 55431 2445555555555555555544444455555555555555555544444455555555555554
Q ss_pred cccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCC
Q 046851 187 YSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPC 266 (963)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 266 (963)
|.+.+..+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+++++++..|..+
T Consensus 143 ------------------n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 204 (272)
T 3rfs_A 143 ------------------NQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 204 (272)
T ss_dssp ------------------SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred ------------------CccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCC
Confidence 33333444455666666666666677666666666777777777777777777777777777
Q ss_pred CCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCC
Q 046851 267 KNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPT 308 (963)
Q Consensus 267 ~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~ 308 (963)
++|+.|++++|++.+. ++.|+.|+++.|.+.|..|.
T Consensus 205 ~~L~~L~l~~N~~~~~------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 205 TSLQYIWLHDNPWDCT------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp TTCCEEECCSSCBCCC------TTTTHHHHHHHHHTGGGBBC
T ss_pred cCCCEEEccCCCcccc------CcHHHHHHHHHHhCCCcccC
Confidence 7777777777776532 44567777777777776554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=211.03 Aligned_cols=203 Identities=17% Similarity=0.155 Sum_probs=149.5
Q ss_pred CCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCc-cccCcCccccCcccccEEEccc-CcccccCcccccC
Q 046851 65 TVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNY-LVGGIPRSLGNCFQVRSLLLFS-NMLEETIPAELGM 142 (963)
Q Consensus 65 ~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~-i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~ 142 (963)
.+|....+|++|++++|+++ .+|...|.++++|++|++++|+ ++...+..|.++++|+.|++++ |+++++.+.+|.+
T Consensus 25 ~ip~~~~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~ 103 (239)
T 2xwt_C 25 RIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103 (239)
T ss_dssp SCCCCCTTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEEC
T ss_pred ccCCCCCcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCC
Confidence 44443335777777777777 7777777778888888888886 7766667888888888888887 8888777778888
Q ss_pred CCCCCEEEccCCccccCCCcCccCCCCCc---eEeecCcCCcccccccccCCcccCCCcccCCCCC-ccccCCcccccCC
Q 046851 143 LQNLEVLDVSRNSLSGSIPVDLGNCSKLA---ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFN-FFEGGIPEAVSSL 218 (963)
Q Consensus 143 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n-~~~~~~~~~l~~l 218 (963)
+++|++|++++|++++ +|. |..+++|+ .|++++ | .+.+..+..|.++
T Consensus 104 l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~---------------------------N~~l~~i~~~~~~~l 154 (239)
T 2xwt_C 104 LPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITD---------------------------NPYMTSIPVNAFQGL 154 (239)
T ss_dssp CTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEES---------------------------CTTCCEECTTTTTTT
T ss_pred CCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCC---------------------------CcchhhcCcccccch
Confidence 8888888888888884 555 77777777 888776 4 4444555667777
Q ss_pred CCCc-eEecCCcccccCCCccccccccCceeecCccc-ccCcCccccCCC-CCCcEEeccCcccccccCCCCCCCceeEE
Q 046851 219 PNLR-ILWAPRATLEGNFPSNWGACDNLEMLNLGHNF-FSGKNLGVLGPC-KNLLFLDLSSNQLTGELARELPVPCMTMF 295 (963)
Q Consensus 219 ~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~L~~L 295 (963)
++|+ .|++++|+++...+..|.. ++|++|+|++|+ ++.+++..|..+ ++|+.|++++|++++.+.. .++.|+.|
T Consensus 155 ~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L 231 (239)
T 2xwt_C 155 CNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKEL 231 (239)
T ss_dssp BSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEE
T ss_pred hcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCcee
Confidence 8888 8888888777554445554 778888888884 877777777777 7888888888887765544 56667777
Q ss_pred EeccC
Q 046851 296 DVSGN 300 (963)
Q Consensus 296 ~l~~N 300 (963)
+++++
T Consensus 232 ~l~~~ 236 (239)
T 2xwt_C 232 IARNT 236 (239)
T ss_dssp ECTTC
T ss_pred eccCc
Confidence 77665
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-22 Score=213.33 Aligned_cols=221 Identities=19% Similarity=0.197 Sum_probs=153.2
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLV 84 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~ 84 (963)
..++++++.+.+. .....+++|+.|++++|.++. . ..+..+++|++|+|++|.+++
T Consensus 22 ~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-------------------- 77 (272)
T 3rfs_A 22 IKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-------------------- 77 (272)
T ss_dssp HHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC--------------------
T ss_pred HHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC--------------------
Confidence 3455666666644 346688999999999999883 3 358889999999999998872
Q ss_pred ccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCc
Q 046851 85 GSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDL 164 (963)
Q Consensus 85 ~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 164 (963)
++ .+..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..+
T Consensus 78 --~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 153 (272)
T 3rfs_A 78 --IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVF 153 (272)
T ss_dssp --CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred --ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHh
Confidence 21 22346666666666666665555566666666666666666666666666666777777777777665555556
Q ss_pred cCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcccccccc
Q 046851 165 GNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDN 244 (963)
Q Consensus 165 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 244 (963)
.++++|+.|++++ |.+.+..+..+..+++|+.|++++|++++..+..|..+++
T Consensus 154 ~~l~~L~~L~l~~---------------------------n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 206 (272)
T 3rfs_A 154 DKLTNLTELDLSY---------------------------NQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 206 (272)
T ss_dssp TTCTTCCEEECCS---------------------------SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred ccCccCCEEECCC---------------------------CCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcC
Confidence 6677777776666 4444455556667777777777777777766666777778
Q ss_pred CceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC
Q 046851 245 LEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL 287 (963)
Q Consensus 245 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 287 (963)
|++|+|++|.+. +.+++|+.|+++.|.+++..+...
T Consensus 207 L~~L~l~~N~~~-------~~~~~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 207 LQYIWLHDNPWD-------CTCPGIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp CCEEECCSSCBC-------CCTTTTHHHHHHHHHTGGGBBCTT
T ss_pred CCEEEccCCCcc-------ccCcHHHHHHHHHHhCCCcccCcc
Confidence 888888887665 335677788888888877666544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-23 Score=230.77 Aligned_cols=90 Identities=18% Similarity=0.187 Sum_probs=52.7
Q ss_pred CCccEEECcCCcCCCC----CccccccC-CCCCEEeccCCcCCCccc----hhhccCcccceeccccccccc-------c
Q 046851 437 KSLKFLDASGNQIVGP----IPRGVGEL-VSLVALNLSWNLMHDQIP----TTLGQMKGLKYLSLAGNNLTG-------S 500 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~----~p~~~~~l-~~L~~L~ls~N~i~~~~~----~~~~~l~~L~~L~l~~N~l~~-------~ 500 (963)
++|++|+|++|.|++. ++..+... ++|+.|+|++|.+++..+ ..+..+++|+.|+|++|.+.+ .
T Consensus 196 ~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~ 275 (362)
T 3goz_A 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKA 275 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHH
T ss_pred CCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHH
Confidence 3677777777777642 34444443 467777777777765433 233455667777777776432 2
Q ss_pred CCcccccCCccceecccccccCCCCC
Q 046851 501 IPSSLGQLQLLEVLDLSSNSLSGLIP 526 (963)
Q Consensus 501 ~p~~~~~l~~L~~L~ls~N~l~~~~p 526 (963)
++..+..+++|+.||+++|++....+
T Consensus 276 l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 276 LGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHhccCCceEEEecCCCcCCCcch
Confidence 23345556666666666666664433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.6e-22 Score=206.60 Aligned_cols=197 Identities=15% Similarity=0.143 Sum_probs=150.2
Q ss_pred CCcEEEccCCcccccCCccccCcccccceeccccc-cccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCC
Q 046851 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL-VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSG 105 (963)
Q Consensus 27 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~ 105 (963)
+|++|+|++|+++++.+..|.++++|++|++++|. ++ .++...|.++++|++|+|++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~----------------------~i~~~~f~~l~~L~~L~l~~ 89 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ----------------------QLESHSFYNLSKVTHIEIRN 89 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC----------------------EECTTTEESCTTCCEEEEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc----------------------eeCHhHcCCCcCCcEEECCC
Confidence 67788888888876666677777777777777775 65 66666666777888888887
Q ss_pred -CccccCcCccccCcccccEEEcccCcccccCcccccCCCCCC---EEEccCC-ccccCCCcCccCCCCCc-eEeecCcC
Q 046851 106 -NYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLE---VLDVSRN-SLSGSIPVDLGNCSKLA-ILVLSNLF 179 (963)
Q Consensus 106 -N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~l~~n~ 179 (963)
|+|++..+..|.++++|+.|++++|++++ +|. |..+++|+ +|++++| .+++..+..|.++++|+ .|++++|
T Consensus 90 ~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n- 166 (239)
T 2xwt_C 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN- 166 (239)
T ss_dssp ETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSC-
T ss_pred CCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCC-
Confidence 78876666777888888888888888775 444 77777777 8888888 78766666788888888 8888773
Q ss_pred CcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcc-cccCCCcccccc-ccCceeecCcccccC
Q 046851 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT-LEGNFPSNWGAC-DNLEMLNLGHNFFSG 257 (963)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~ 257 (963)
.+....+..+.. ++|+.|++++|+ +++..+..|..+ ++|++|++++|+++.
T Consensus 167 --------------------------~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~ 219 (239)
T 2xwt_C 167 --------------------------GFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219 (239)
T ss_dssp --------------------------CCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC
T ss_pred --------------------------CCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc
Confidence 333223334444 789999999995 888878889999 999999999999999
Q ss_pred cCccccCCCCCCcEEeccCcc
Q 046851 258 KNLGVLGPCKNLLFLDLSSNQ 278 (963)
Q Consensus 258 ~~~~~~~~l~~L~~L~L~~N~ 278 (963)
++.. .+++|+.|+++++.
T Consensus 220 l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 220 LPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp CCCT---TCTTCSEEECTTC-
T ss_pred CChh---HhccCceeeccCcc
Confidence 8876 46788999998763
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5.2e-21 Score=201.74 Aligned_cols=178 Identities=22% Similarity=0.183 Sum_probs=128.1
Q ss_pred cceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccC
Q 046851 74 KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSR 153 (963)
Q Consensus 74 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 153 (963)
++++++++.++ .+|..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..+..|.++++|++|+|++
T Consensus 17 ~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 17 KEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp TEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred eEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 44455555555 6666554 4677777777777766667777777777777777777777777777777777777777
Q ss_pred CccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccccc
Q 046851 154 NSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEG 233 (963)
Q Consensus 154 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~ 233 (963)
|.+++..+..|..+++|+.|++++ |.+.+..+..|..+++|+.|+|++|++++
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~---------------------------N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 145 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGG---------------------------NQLKSLPSGVFDRLTKLKELRLNTNQLQS 145 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCS---------------------------SCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CcccccChhHhcccCCCCEEEcCC---------------------------CcCCCcChhHhccCCcccEEECcCCcCCc
Confidence 777766666677777777777766 44444455556777777777777777776
Q ss_pred CCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccc
Q 046851 234 NFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGE 282 (963)
Q Consensus 234 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 282 (963)
..+..|..+++|++|+|++|+++.+++..|..+++|+.|+|++|++++.
T Consensus 146 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 146 IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 6666777788888888888888888777777788888888888887654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-22 Score=227.09 Aligned_cols=252 Identities=16% Similarity=0.123 Sum_probs=149.5
Q ss_pred EEEccCCcccccCCCccccCCCCcEEEccCCcccccCC----ccccCcc-cccceeccccccccCCCccc--------cc
Q 046851 6 VLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIP----ASFSDFV-NLEELNLAGNLVNGTVPTFI--------GR 72 (963)
Q Consensus 6 ~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~~~~~--------~~ 72 (963)
.++|++|++++.+|..+...++|++|+|++|+++...+ .+|.+++ +|++|+|++|.+++..+..+ .+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46889999998888777777779999999999997666 7788888 89999999999986655443 45
Q ss_pred ccceeeccccccccCCccccc---cC-CCCCeEeCCCCccccCcCccccC-----cccccEEEcccCcccccC----ccc
Q 046851 73 LKRVYLSFNRLVGSVPSKIGE---KC-TNLEHLDLSGNYLVGGIPRSLGN-----CFQVRSLLLFSNMLEETI----PAE 139 (963)
Q Consensus 73 L~~L~L~~n~l~~~~p~~~~~---~l-~~L~~L~Ls~N~i~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~----~~~ 139 (963)
|++|+|++|++++..+..++. .+ ++|++|+|++|+|++..+..+.. .++|++|+|++|++++.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 777777777776433333222 22 67777777777776554444332 246777777777776433 233
Q ss_pred ccCCC-CCCEEEccCCccccCCCcCcc----CC-CCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcc
Q 046851 140 LGMLQ-NLEVLDVSRNSLSGSIPVDLG----NC-SKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPE 213 (963)
Q Consensus 140 ~~~l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~ 213 (963)
+..++ +|++|+|++|++++..+..+. .+ ++|+.|+|++|.++..+. ..++.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~-----------------------~~l~~ 218 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSY-----------------------AELAY 218 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH-----------------------HHHHH
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHH-----------------------HHHHH
Confidence 34444 677777777777655443332 23 466666666543331110 01333
Q ss_pred cccCC-CCCceEecCCcccccCCC----ccccccccCceeecCcccccCcCc-------cccCCCCCCcEEeccCcccc
Q 046851 214 AVSSL-PNLRILWAPRATLEGNFP----SNWGACDNLEMLNLGHNFFSGKNL-------GVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 214 ~l~~l-~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~-------~~~~~l~~L~~L~L~~N~l~ 280 (963)
.+..+ ++|+.|++++|.+++..+ ..+..+++|++|+|++|.+..+.. ..+..+++|+.||+++|++.
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~ 297 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence 44442 355555555555554322 223344555555555555433322 23444455555555555554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.7e-22 Score=216.91 Aligned_cols=226 Identities=17% Similarity=0.125 Sum_probs=115.4
Q ss_pred CCCcEEEccCCcccccCCc---cccCcccccceeccccccccCCCccc-----ccccceeeccccccccCC---cccccc
Q 046851 26 KSLRVLNLGFNRITGEIPA---SFSDFVNLEELNLAGNLVNGTVPTFI-----GRLKRVYLSFNRLVGSVP---SKIGEK 94 (963)
Q Consensus 26 ~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~L~~L~L~~n~l~~~~p---~~~~~~ 94 (963)
..++.|.+.++.+...... .+..+++|++|+|++|.+++..|..+ .+|++|+|++|++++..+ ...+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4578888888877622111 12345679999999998886655443 245555555555543222 111113
Q ss_pred CCCCCeEeCCCCccccCcCccccCcccccEEEcccCccccc--C--cccccCCCCCCEEEccCCccccCCCcCccCCCCC
Q 046851 95 CTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET--I--PAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKL 170 (963)
Q Consensus 95 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 170 (963)
+++|++|+|++|+|++..+..|+++++|++|+|++|++.+. . +..+..+++|++|+|++|+++ .++..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~------- 215 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGV------- 215 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHH-------
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHH-------
Confidence 45555555555555544445555555555555555554321 0 112234455555555555544 11110
Q ss_pred ceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcccccc---ccCce
Q 046851 171 AILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGAC---DNLEM 247 (963)
Q Consensus 171 ~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~ 247 (963)
....+..+++|++|+|++|++++..|..+..+ ++|++
T Consensus 216 ----------------------------------------~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~ 255 (310)
T 4glp_A 216 ----------------------------------------CAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNS 255 (310)
T ss_dssp ----------------------------------------HHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCC
T ss_pred ----------------------------------------HHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCE
Confidence 00013445555555555555555545444444 45666
Q ss_pred eecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCc
Q 046851 248 LNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALS 303 (963)
Q Consensus 248 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~ 303 (963)
|+|++|+|+.++...+ ++|++|+|++|+|++.+. ...+++|+.|++++|+++
T Consensus 256 L~Ls~N~l~~lp~~~~---~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 256 LNLSFAGLEQVPKGLP---AKLRVLDLSSNRLNRAPQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp EECCSSCCCSCCSCCC---SCCSCEECCSCCCCSCCC-TTSCCCCSCEECSSTTTS
T ss_pred EECCCCCCCchhhhhc---CCCCEEECCCCcCCCCch-hhhCCCccEEECcCCCCC
Confidence 6666666665544332 456666666666654422 234555666666666554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.8e-21 Score=213.43 Aligned_cols=241 Identities=15% Similarity=0.145 Sum_probs=192.1
Q ss_pred cceeccccccccCCCccc-ccccceeeccccccccCCccccccCCCCCeEeCCCCccccCc-CccccCcccccE-EEccc
Q 046851 53 EELNLAGNLVNGTVPTFI-GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGI-PRSLGNCFQVRS-LLLFS 129 (963)
Q Consensus 53 ~~L~Ls~N~l~~~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~-L~L~~ 129 (963)
++++.++++++ .+|..+ .++++|+|++|+|+ .+|...|.++++|++|+|++|+|.+.+ +++|.++++|+. +.++.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp TEEEEESTTCC-SCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 45666777776 444433 46777888888887 899999999999999999999986554 468899998775 66678
Q ss_pred CcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCcccc
Q 046851 130 NMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEG 209 (963)
Q Consensus 130 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~ 209 (963)
|+++.+.+.+|.++++|++|++++|+++...+..+....++..|++.++ +.+..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~--------------------------~~i~~ 143 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN--------------------------INIHT 143 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC--------------------------TTCCE
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc--------------------------ccccc
Confidence 9999988999999999999999999999777777888888888988652 34444
Q ss_pred CCcccccCCC-CCceEecCCcccccCCCccccccccCceeecC-cccccCcCccccCCCCCCcEEeccCcccccccCCCC
Q 046851 210 GIPEAVSSLP-NLRILWAPRATLEGNFPSNWGACDNLEMLNLG-HNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL 287 (963)
Q Consensus 210 ~~~~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 287 (963)
..+..|..+. .++.|++++|+|+.+.+..| ...+|+.|+++ +|+++.++.++|..+++|+.|+|++|+|+.++...
T Consensus 144 l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~- 221 (350)
T 4ay9_X 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG- 221 (350)
T ss_dssp ECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS-
T ss_pred ccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh-
Confidence 5556677765 68899999999997655555 45789999997 58899999999999999999999999999877654
Q ss_pred CCCceeEEEeccCcCccCCCCCCCCCCCCcccccccc
Q 046851 288 PVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNL 324 (963)
Q Consensus 288 ~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~ 324 (963)
+..|+.|.+.++.-....|.+..+.+|+.++++++.
T Consensus 222 -~~~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 222 -LENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPS 257 (350)
T ss_dssp -CTTCCEEECTTCTTCCCCCCTTTCCSCCEEECSCHH
T ss_pred -hccchHhhhccCCCcCcCCCchhCcChhhCcCCCCc
Confidence 456777776666555566778889999999987654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=213.89 Aligned_cols=207 Identities=18% Similarity=0.094 Sum_probs=165.0
Q ss_pred CCCCCeEeCCCCccccCcCccc--cCcccccEEEcccCcccccCc----ccccCCCCCCEEEccCCccccCCCcCccCCC
Q 046851 95 CTNLEHLDLSGNYLVGGIPRSL--GNCFQVRSLLLFSNMLEETIP----AELGMLQNLEVLDVSRNSLSGSIPVDLGNCS 168 (963)
Q Consensus 95 l~~L~~L~Ls~N~i~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 168 (963)
+++|++|+|++|++++..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|.+.+..+..|++++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 4679999999999888888887 888899999999999886444 4456788999999999999888888899999
Q ss_pred CCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCC--c-cccccccC
Q 046851 169 KLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFP--S-NWGACDNL 245 (963)
Q Consensus 169 ~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~--~-~~~~l~~L 245 (963)
+|++|++++|.+..... -..+..+..+++|++|++++|+++.... . .+..+++|
T Consensus 170 ~L~~L~Ls~N~l~~~~~-----------------------~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L 226 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERG-----------------------LMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQP 226 (310)
T ss_dssp TCCEEECCSCTTCHHHH-----------------------HHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCC
T ss_pred CCCEEECCCCCCccchh-----------------------hhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCC
Confidence 99999999854331100 0112334678999999999999973211 1 35788999
Q ss_pred ceeecCcccccCcCccccCCC---CCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcccccc
Q 046851 246 EMLNLGHNFFSGKNLGVLGPC---KNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSR 322 (963)
Q Consensus 246 ~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~ 322 (963)
++|+|++|++++..+..+..+ ++|++|+|++|+|+.++.... ++|+.||+++|++++. +.+..+++|+.|++++
T Consensus 227 ~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~ 303 (310)
T 4glp_A 227 HSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDG 303 (310)
T ss_dssp SSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSS
T ss_pred CEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcC
Confidence 999999999999866666665 799999999999996654442 7999999999999986 3478899999999999
Q ss_pred ccccc
Q 046851 323 NLFES 327 (963)
Q Consensus 323 n~~~~ 327 (963)
|++..
T Consensus 304 N~l~~ 308 (310)
T 4glp_A 304 NPFLV 308 (310)
T ss_dssp TTTSC
T ss_pred CCCCC
Confidence 99864
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=4.7e-21 Score=208.45 Aligned_cols=195 Identities=24% Similarity=0.294 Sum_probs=117.6
Q ss_pred ccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEe
Q 046851 23 FHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLD 102 (963)
Q Consensus 23 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~ 102 (963)
..+++|++|++++|.++. ++ .+..+++|++|+|++|.++ .++. +..+++|++|+
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~----------------------~~~~--~~~l~~L~~L~ 91 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQIT----------------------DLAP--LKNLTKITELE 91 (308)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC----------------------CCGG--GTTCCSCCEEE
T ss_pred HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCC----------------------CChh--HccCCCCCEEE
Confidence 345555666666655552 22 3555555555555555554 4444 44567777777
Q ss_pred CCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcc
Q 046851 103 LSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTY 182 (963)
Q Consensus 103 Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~ 182 (963)
|++|++++. ..+..+++|+.|++++|++++. + .+..+++|++|+|++|.+++..+ +..+++|+.|++++|.+
T Consensus 92 L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l-- 163 (308)
T 1h6u_A 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV-- 163 (308)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC--
T ss_pred ccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcC--
Confidence 777776642 2566677777777777777653 2 26677777777777777764332 66666666666666332
Q ss_pred cccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccc
Q 046851 183 EDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGV 262 (963)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 262 (963)
.+..+ +..+++|+.|++++|++++..+ +..+++|++|+|++|+++++++
T Consensus 164 -------------------------~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-- 212 (308)
T 1h6u_A 164 -------------------------SDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212 (308)
T ss_dssp -------------------------CCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--
T ss_pred -------------------------CCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--
Confidence 22222 5566666666666666664332 6666677777777777766653
Q ss_pred cCCCCCCcEEeccCcccccc
Q 046851 263 LGPCKNLLFLDLSSNQLTGE 282 (963)
Q Consensus 263 ~~~l~~L~~L~L~~N~l~~~ 282 (963)
+..+++|+.|++++|++++.
T Consensus 213 l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 213 LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp GTTCTTCCEEEEEEEEEECC
T ss_pred ccCCCCCCEEEccCCeeecC
Confidence 56666777777777766543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-23 Score=232.98 Aligned_cols=92 Identities=23% Similarity=0.262 Sum_probs=40.5
Q ss_pred ccccCCCCCEEeccCCcCC----CccchhhccCcccceecccccccccc----CCccc--ccCCccceecccccccCC--
Q 046851 456 GVGELVSLVALNLSWNLMH----DQIPTTLGQMKGLKYLSLAGNNLTGS----IPSSL--GQLQLLEVLDLSSNSLSG-- 523 (963)
Q Consensus 456 ~~~~l~~L~~L~ls~N~i~----~~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~--~~l~~L~~L~ls~N~l~~-- 523 (963)
.+..+++|+.|+|++|.++ +.+|..+..+++|++|+|++|++++. ++..+ +.+++|+.|+|++|.|++
T Consensus 211 ~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g 290 (386)
T 2ca6_A 211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290 (386)
T ss_dssp TGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHH
T ss_pred HhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHH
Confidence 3334444444444444442 23333444444444444444444422 23333 224555555555555543
Q ss_pred --CCChhh-hccccCCeEEeccccCCC
Q 046851 524 --LIPDDL-ENLRNLTVLLLNNNKLSG 547 (963)
Q Consensus 524 --~~p~~~-~~l~~L~~L~l~~N~l~~ 547 (963)
.+|..+ .++++|++|+|++|++++
T Consensus 291 ~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 291 VRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 234444 334555555555555553
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=7.8e-21 Score=206.68 Aligned_cols=196 Identities=24% Similarity=0.272 Sum_probs=149.1
Q ss_pred CCceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccc
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFN 81 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n 81 (963)
.+|++|++++|.++.+ + .+..+++|++|+|++|++++..+ |..+++|++|+|++|.++
T Consensus 41 ~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~------------------ 98 (308)
T 1h6u_A 41 DGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK------------------ 98 (308)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS------------------
T ss_pred CCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC------------------
Confidence 5799999999999965 4 68999999999999999995544 999999999999999987
Q ss_pred cccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCC
Q 046851 82 RLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIP 161 (963)
Q Consensus 82 ~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 161 (963)
.++ .+..+++|++|+|++|++++. + .+..+++|+.|++++|++++..+ +..+++|++|+|++|.+++..+
T Consensus 99 ----~~~--~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~ 168 (308)
T 1h6u_A 99 ----NVS--AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP 168 (308)
T ss_dssp ----CCG--GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG
T ss_pred ----Cch--hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh
Confidence 232 134567777777777777643 3 27777777777777777775433 7777778888888887774333
Q ss_pred cCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccc
Q 046851 162 VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGA 241 (963)
Q Consensus 162 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 241 (963)
+.++++|+.|++++|.+ .+..+ +..+++|+.|++++|++++.. .+..
T Consensus 169 --l~~l~~L~~L~l~~n~l---------------------------~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~ 215 (308)
T 1h6u_A 169 --LANLSKLTTLKADDNKI---------------------------SDISP--LASLPNLIEVHLKNNQISDVS--PLAN 215 (308)
T ss_dssp --GTTCTTCCEEECCSSCC---------------------------CCCGG--GGGCTTCCEEECTTSCCCBCG--GGTT
T ss_pred --hcCCCCCCEEECCCCcc---------------------------CcChh--hcCCCCCCEEEccCCccCccc--cccC
Confidence 77777888887777433 32222 677888888888888888654 3888
Q ss_pred cccCceeecCcccccCcCccc
Q 046851 242 CDNLEMLNLGHNFFSGKNLGV 262 (963)
Q Consensus 242 l~~L~~L~Ls~N~l~~~~~~~ 262 (963)
+++|+.|+|++|+++..+...
T Consensus 216 l~~L~~L~l~~N~i~~~~~~~ 236 (308)
T 1h6u_A 216 TSNLFIVTLTNQTITNQPVFY 236 (308)
T ss_dssp CTTCCEEEEEEEEEECCCEEC
T ss_pred CCCCCEEEccCCeeecCCeee
Confidence 999999999999998766543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.6e-22 Score=210.96 Aligned_cols=153 Identities=14% Similarity=0.105 Sum_probs=121.7
Q ss_pred HHHHHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccc------------------hhHHHHHHHHHHHhccC
Q 046851 675 ESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF------------------QGVQQFHAEIKTLGRLR 736 (963)
Q Consensus 675 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 736 (963)
..+......|.+.+.||+|+||.||+|...+|+.||||++..... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455567788899999999999999887799999999864322 13456899999999998
Q ss_pred CCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 737 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
|+++. +++.. +..++||||++||+|.+ +.. .+...++.|+++|++|||+. +|+||||||+||++
T Consensus 163 ~~~v~---~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 163 GLAVP---KVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp TSSSC---CEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred CCCcC---eEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 54444 44333 45699999999999988 421 23457999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCcccccccccccccCcccccc
Q 046851 817 DDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 858 (963)
+ ++.+||+|||+|+. +..|+|||++.+
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9 99999999999863 345788998753
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=6.1e-23 Score=231.59 Aligned_cols=253 Identities=19% Similarity=0.181 Sum_probs=136.5
Q ss_pred cCCCccccCCCCcEEEccCCcccccC----CccccCcccccceeccccccc---cCCCcccccccceeeccccccccCCc
Q 046851 17 ILPDSGFHLKSLRVLNLGFNRITGEI----PASFSDFVNLEELNLAGNLVN---GTVPTFIGRLKRVYLSFNRLVGSVPS 89 (963)
Q Consensus 17 ~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~---~~~~~~~~~L~~L~L~~n~l~~~~p~ 89 (963)
.++..+..+++|++|+|++|+++... +..|..+++|++|+|++|.+. +.+|..+. .+..
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~--------------~l~~ 88 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR--------------LLLQ 88 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH--------------HHHH
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHH--------------HHHH
Confidence 44556777888999999999888553 344778888888888886443 23332220 0000
Q ss_pred cccccCCCCCeEeCCCCcccc----CcCccccCcccccEEEcccCcccccCccc----ccCC---------CCCCEEEcc
Q 046851 90 KIGEKCTNLEHLDLSGNYLVG----GIPRSLGNCFQVRSLLLFSNMLEETIPAE----LGML---------QNLEVLDVS 152 (963)
Q Consensus 90 ~~~~~l~~L~~L~Ls~N~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----~~~l---------~~L~~L~L~ 152 (963)
.+..+++|++|+|++|+|++ .++..+..+++|+.|+|++|.++...+.. +..+ ++|++|+|+
T Consensus 89 -~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~ 167 (386)
T 2ca6_A 89 -ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167 (386)
T ss_dssp -HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECC
T ss_pred -HHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECC
Confidence 02345555666666665554 24445555556666666666554322222 2222 566666666
Q ss_pred CCccc-cCCC---cCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCC
Q 046851 153 RNSLS-GSIP---VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPR 228 (963)
Q Consensus 153 ~N~l~-~~~p---~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~ 228 (963)
+|+++ ..++ ..+..+++|+.|++++|.++..+.. ...+..+..+++|+.|+|++
T Consensus 168 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~----------------------~l~~~~l~~~~~L~~L~Ls~ 225 (386)
T 2ca6_A 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE----------------------HLLLEGLAYCQELKVLDLQD 225 (386)
T ss_dssp SSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHH----------------------HHHHTTGGGCTTCCEEECCS
T ss_pred CCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHH----------------------HHHHHHhhcCCCccEEECcC
Confidence 66654 2222 2444555666666665443311110 01223455566666666666
Q ss_pred cccc----cCCCccccccccCceeecCcccccCc----Ccccc--CCCCCCcEEeccCccccc----ccCCCC--CCCce
Q 046851 229 ATLE----GNFPSNWGACDNLEMLNLGHNFFSGK----NLGVL--GPCKNLLFLDLSSNQLTG----ELAREL--PVPCM 292 (963)
Q Consensus 229 n~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~--~~~~L 292 (963)
|.++ ..+|..+..+++|++|+|++|+++.. .+..+ +.+++|+.|+|++|+++. ..+..+ .+++|
T Consensus 226 n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L 305 (386)
T 2ca6_A 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305 (386)
T ss_dssp SCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTC
T ss_pred CCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCc
Confidence 6664 34455556666666666666666554 12233 225666666666666665 122222 24666
Q ss_pred eEEEeccCcCccCC
Q 046851 293 TMFDVSGNALSGSI 306 (963)
Q Consensus 293 ~~L~l~~N~l~~~~ 306 (963)
+.|++++|++.+..
T Consensus 306 ~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 306 LFLELNGNRFSEED 319 (386)
T ss_dssp CEEECTTSBSCTTS
T ss_pred eEEEccCCcCCcch
Confidence 66666666666544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.5e-20 Score=196.46 Aligned_cols=181 Identities=19% Similarity=0.147 Sum_probs=151.5
Q ss_pred ccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEccc
Q 046851 50 VNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFS 129 (963)
Q Consensus 50 ~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~ 129 (963)
.+.++++++++.++..+.....+++.|+|++|+++ .++...|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 14 ~~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 14 EGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GGGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CCCeEEecCCCCccccCCCCCCCCCEEEccCCCcC-ccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 34566677777666333333346777777777777 66666677899999999999999988888899999999999999
Q ss_pred CcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCcccc
Q 046851 130 NMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEG 209 (963)
Q Consensus 130 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~ 209 (963)
|++++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++ |.+.+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~---------------------------N~l~~ 145 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT---------------------------NQLQS 145 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS---------------------------SCCCC
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcC---------------------------CcCCc
Confidence 999988888899999999999999999977777789999999999988 56666
Q ss_pred CCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCc
Q 046851 210 GIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGK 258 (963)
Q Consensus 210 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 258 (963)
..+..|..+++|+.|++++|++++..+..|..+++|++|+|++|.+...
T Consensus 146 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 146 IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 6677899999999999999999988888999999999999999999765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=4.4e-22 Score=220.18 Aligned_cols=249 Identities=17% Similarity=0.201 Sum_probs=165.6
Q ss_pred CcEEEccCCcccccCCccccCc--ccccceeccccccccCCCccc--ccccceeecccccccc-CCccccccCCCCCeEe
Q 046851 28 LRVLNLGFNRITGEIPASFSDF--VNLEELNLAGNLVNGTVPTFI--GRLKRVYLSFNRLVGS-VPSKIGEKCTNLEHLD 102 (963)
Q Consensus 28 L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~--~~L~~L~L~~n~l~~~-~p~~~~~~l~~L~~L~ 102 (963)
++.|++++|.+. +..+..+ ++++.|++++|.+.+..+..+ .+|++|++++|.+++. +|. .+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~-~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHG-ILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHH-HHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHH-HHhhCCCCCEEe
Confidence 445555555444 2334444 455555555555554433322 2455555555555433 433 345678888888
Q ss_pred CCCCccccCcCccccCcccccEEEcccC-ccccc-CcccccCCCCCCEEEccCC-ccccC-CCcCccCCC-CCceEeecC
Q 046851 103 LSGNYLVGGIPRSLGNCFQVRSLLLFSN-MLEET-IPAELGMLQNLEVLDVSRN-SLSGS-IPVDLGNCS-KLAILVLSN 177 (963)
Q Consensus 103 Ls~N~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~l~~ 177 (963)
|++|++++..+..++.+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. ++..+..++ +|+.|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 8888887777778888888888888888 67642 5666778888888888888 77743 466677888 888888887
Q ss_pred cCCcccccccccCCcccCCCcccCCCCCccc-cCCcccccCCCCCceEecCCcc-cccCCCccccccccCceeecCccc-
Q 046851 178 LFDTYEDVRYSRGQSLVDQPSFMNDDFNFFE-GGIPEAVSSLPNLRILWAPRAT-LEGNFPSNWGACDNLEMLNLGHNF- 254 (963)
Q Consensus 178 n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~-~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~- 254 (963)
|.+ .++ +.++..+..+++|+.|++++|. +++..+..+..+++|++|++++|.
T Consensus 205 ~~~-------------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~ 259 (336)
T 2ast_B 205 YRK-------------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 259 (336)
T ss_dssp CGG-------------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTT
T ss_pred Ccc-------------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCC
Confidence 421 122 2345667778888999998888 666777788888899999998885
Q ss_pred ccCcCccccCCCCCCcEEeccCcccccccCCCCCC-CceeEEEeccCcCccCCCC
Q 046851 255 FSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPV-PCMTMFDVSGNALSGSIPT 308 (963)
Q Consensus 255 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~l~~N~l~~~~~~ 308 (963)
+.......+..+++|+.|++++| ++..... .+ ..+..|++++|++++..+.
T Consensus 260 ~~~~~~~~l~~~~~L~~L~l~~~-i~~~~~~--~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 260 IIPETLLELGEIPTLKTLQVFGI-VPDGTLQ--LLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp CCGGGGGGGGGCTTCCEEECTTS-SCTTCHH--HHHHHSTTSEESCCCSCCTTCS
T ss_pred CCHHHHHHHhcCCCCCEEeccCc-cCHHHHH--HHHhhCcceEEecccCccccCC
Confidence 33333346778889999999888 4321111 12 2366667888888887665
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-20 Score=207.07 Aligned_cols=243 Identities=14% Similarity=0.054 Sum_probs=132.5
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLV 84 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~ 84 (963)
++++.++++++. +|..+ .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.
T Consensus 12 ~~v~C~~~~Lt~-iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~------------------- 69 (350)
T 4ay9_X 12 RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV------------------- 69 (350)
T ss_dssp TEEEEESTTCCS-CCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCE-------------------
T ss_pred CEEEecCCCCCc-cCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCc-------------------
Confidence 467888888884 45554 36788999999999877777899999999999998887643
Q ss_pred ccCCccccccCCCCCe-EeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccC-CccccCCCc
Q 046851 85 GSVPSKIGEKCTNLEH-LDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSR-NSLSGSIPV 162 (963)
Q Consensus 85 ~~~p~~~~~~l~~L~~-L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~ 162 (963)
+|...|.++++|.+ +.++.|+|+...++.|.++++|++|++++|+++...+..+....++..|++.+ |.+....+.
T Consensus 70 --i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~ 147 (350)
T 4ay9_X 70 --IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN 147 (350)
T ss_dssp --ECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTT
T ss_pred --cChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccccc
Confidence 33334444444332 33334444444444444444444444444444444443444444444444433 334333333
Q ss_pred CccCCC-CCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCC-cccccCCCcccc
Q 046851 163 DLGNCS-KLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPR-ATLEGNFPSNWG 240 (963)
Q Consensus 163 ~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~-n~l~~~~~~~~~ 240 (963)
.|..+. .++.|++++|.+ +. ++.......+|+.|++++ |.++.+.+..|.
T Consensus 148 ~f~~~~~~l~~L~L~~N~i---------------------------~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~ 199 (350)
T 4ay9_X 148 SFVGLSFESVILWLNKNGI---------------------------QE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199 (350)
T ss_dssp SSTTSBSSCEEEECCSSCC---------------------------CE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTT
T ss_pred chhhcchhhhhhccccccc---------------------------cC-CChhhccccchhHHhhccCCcccCCCHHHhc
Confidence 333332 344444444222 21 112222334555666553 445544445667
Q ss_pred ccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcC
Q 046851 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNAL 302 (963)
Q Consensus 241 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l 302 (963)
++++|++|+|++|+|+.++...|.++++|+.+++ +.++ ..|....+++|+.++++++..
T Consensus 200 ~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 200 GASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPTLEKLVALMEASLTYPSH 258 (350)
T ss_dssp TEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCCCTTTCCSCCEEECSCHHH
T ss_pred cCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCCCchhCcChhhCcCCCCcc
Confidence 7777777777777777777665544443333332 2233 233444567777777766543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.6e-21 Score=213.91 Aligned_cols=133 Identities=20% Similarity=0.247 Sum_probs=59.3
Q ss_pred CccEEECcCC-cCCCC-CccccccCC-CCCEEeccCC--cCC-CccchhhccCcccceecccccc-ccccCCcccccCCc
Q 046851 438 SLKFLDASGN-QIVGP-IPRGVGELV-SLVALNLSWN--LMH-DQIPTTLGQMKGLKYLSLAGNN-LTGSIPSSLGQLQL 510 (963)
Q Consensus 438 ~L~~L~ls~n-~l~~~-~p~~~~~l~-~L~~L~ls~N--~i~-~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~ 510 (963)
+|++|++++| .+++. ++..+..++ +|+.|++++| .++ +.+|..+..+++|++|++++|. +++..+..+..+++
T Consensus 169 ~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~ 248 (336)
T 2ast_B 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 248 (336)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred CCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCC
Confidence 3444444444 44321 233344444 4444444444 232 2233444444555555555555 34344444555555
Q ss_pred cceecccccccCCCCCh---hhhccccCCeEEeccccCCCcCCCCccccc-cCceEeeccccCccCCCCC
Q 046851 511 LEVLDLSSNSLSGLIPD---DLENLRNLTVLLLNNNKLSGKIPSGLANVS-TLSAFNVSFNNLSGPLPSS 576 (963)
Q Consensus 511 L~~L~ls~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~-~L~~l~l~~N~l~~~~p~~ 576 (963)
|+.|++++|. +..+. .+..+++|+.|++++| ++ ...+..+. .+..|++++|++++..|..
T Consensus 249 L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 249 LQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp CCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred CCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCc
Confidence 5555555553 11122 3445555555555555 22 12233332 2455555556665555543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-20 Score=218.62 Aligned_cols=125 Identities=26% Similarity=0.414 Sum_probs=87.1
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
.|++++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. |. ++|+.|+|++|
T Consensus 124 ~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N 190 (571)
T 3cvr_A 124 HLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTN 190 (571)
T ss_dssp EEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSS
T ss_pred EEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCC
Confidence 45555555553 555 23667778888887774 555 46677888888888765 555 54 77888888888
Q ss_pred cccccCCcccccCCcc-------ceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCcccccc
Q 046851 496 NLTGSIPSSLGQLQLL-------EVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVST 558 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L-------~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~ 558 (963)
+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++.
T Consensus 191 ~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 191 LLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred CCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 887 6666 554 56 88888888887 46777777888888888888888777777666544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=9.1e-20 Score=187.64 Aligned_cols=148 Identities=22% Similarity=0.336 Sum_probs=133.2
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
.+++++++++ .+|..+. ++|+.|++++|+|++..+..|..+++|+.|+|++|.|++..|..|..+++|++|+|++|
T Consensus 15 ~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred EEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 6788899988 7887665 67999999999999777778999999999999999998888999999999999999999
Q ss_pred cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccc
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFN 567 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N 567 (963)
+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|++++|
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 162 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence 999555566889999999999999999888899999999999999999999777778999999999998865
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.1e-20 Score=187.62 Aligned_cols=151 Identities=22% Similarity=0.278 Sum_probs=134.9
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCc-cccccCCCCCEEeccCCcCCCccchhhccCcccceecccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIP-RGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAG 494 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p-~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~ 494 (963)
.+++++|.++ .+|..+. ..+++|+|++|+|++..| ..|..+++|+.|+|++|.|++..+..|..+++|++|+|++
T Consensus 15 ~l~~s~n~l~-~iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 6889999998 7888665 458999999999996644 4588999999999999999888888999999999999999
Q ss_pred ccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCc
Q 046851 495 NNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570 (963)
Q Consensus 495 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~ 570 (963)
|++++..+..|..+++|++|+|++|+|++..|..+..+++|++|+|++|+|++..|..|..+++|+.|++++|+|.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 9999777778999999999999999999888899999999999999999999877999999999999998877554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.6e-19 Score=181.84 Aligned_cols=148 Identities=22% Similarity=0.230 Sum_probs=100.5
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLV 84 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~ 84 (963)
+.++.+++.++.+ |..+ .++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--------------------- 65 (208)
T 2o6s_A 10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ--------------------- 65 (208)
T ss_dssp TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC---------------------
T ss_pred CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC---------------------
Confidence 4567777777744 3333 357778888888777666666777777777777777776
Q ss_pred ccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCc
Q 046851 85 GSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDL 164 (963)
Q Consensus 85 ~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 164 (963)
.+|...|..+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|.+++..+..+
T Consensus 66 -~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 144 (208)
T 2o6s_A 66 -SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVF 144 (208)
T ss_dssp -CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred -ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHh
Confidence 5555555566777777777777765555566777777777777777776666666777777777777777765555556
Q ss_pred cCCCCCceEeecC
Q 046851 165 GNCSKLAILVLSN 177 (963)
Q Consensus 165 ~~l~~L~~L~l~~ 177 (963)
..+++|+.|++++
T Consensus 145 ~~l~~L~~L~l~~ 157 (208)
T 2o6s_A 145 DRLTSLQYIWLHD 157 (208)
T ss_dssp TTCTTCCEEECCS
T ss_pred ccCCCccEEEecC
Confidence 6666666666665
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.4e-19 Score=180.54 Aligned_cols=123 Identities=20% Similarity=0.136 Sum_probs=66.3
Q ss_pred ceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCccc
Q 046851 54 ELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLE 133 (963)
Q Consensus 54 ~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~ 133 (963)
.++++++.++........+|++|++++|+++ .++...|..+++|++|+|++|+|++..+..|.++++|++|+|++|+++
T Consensus 11 ~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 89 (208)
T 2o6s_A 11 TVECYSQGRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ 89 (208)
T ss_dssp EEECCSSCCSSCCSCCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EEEecCCCccCCCCCCCCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCC
Confidence 3444444444222222234444444444444 555555555666666666666666544455566666666666666666
Q ss_pred ccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecC
Q 046851 134 ETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177 (963)
Q Consensus 134 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 177 (963)
+..+..|.++++|++|+|++|.+++..+..|.++++|+.|++++
T Consensus 90 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 133 (208)
T 2o6s_A 90 SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQ 133 (208)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCC
Confidence 55555556666666666666666544444455555555555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.5e-20 Score=204.33 Aligned_cols=176 Identities=23% Similarity=0.297 Sum_probs=141.0
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccc-cCCCCCEEeccCCcCCCccchhhccCcccceecccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVG-ELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAG 494 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~ 494 (963)
.+++++++++ .+|..+. +.++.|+|++|+|++..+..+. .+++|+.|+|++|.|++..+..|..+++|++|+|++
T Consensus 22 ~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 6788888887 7887654 5588999999999976666776 899999999999999877778899999999999999
Q ss_pred ccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCC-c---cccccCceEeeccccCc
Q 046851 495 NNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-L---ANVSTLSAFNVSFNNLS 570 (963)
Q Consensus 495 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-l---~~l~~L~~l~l~~N~l~ 570 (963)
|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|.. + ..+++|+.|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 9998766778889999999999999999877888999999999999999998 45544 3 56899999999999998
Q ss_pred cCCCCCCCcc-----cccccCCCCCCCCCCC
Q 046851 571 GPLPSSKNLM-----KCSSVLGNPYLRPCRA 596 (963)
Q Consensus 571 ~~~p~~~~~~-----~~~~~~~np~~~~c~~ 596 (963)
+..+...... ....+.+|||.|+|+.
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 6333221111 2245679999999964
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.1e-19 Score=181.43 Aligned_cols=151 Identities=26% Similarity=0.277 Sum_probs=134.6
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
.++.++++++ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|.|++..+..|..+++|+.|+|++|
T Consensus 23 ~v~c~~~~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 23 TVDCRSKRHA-SVPAGIP---TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp EEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EeEccCCCcC-ccCCCCC---CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 5888888887 8887664 77999999999999888899999999999999999997777777899999999999999
Q ss_pred cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCcc
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~ 571 (963)
+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|++.+
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 999666677899999999999999999 678899999999999999999996666779999999999998776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=203.23 Aligned_cols=94 Identities=24% Similarity=0.338 Sum_probs=46.4
Q ss_pred cccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccC
Q 046851 51 NLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN 130 (963)
Q Consensus 51 ~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n 130 (963)
+|+.|+|++|.+++..+..+.+|+.|+|++|+++ .+| . .+++|++|+|++|+|++ +|. |.+ +|+.|+|++|
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~~~L~~L~Ls~N~l~-~ip-~---~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N 130 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLPPQITVLEITQNALI-SLP-E---LPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNN 130 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCCTTCSEEECCSSCCS-CCC-C---CCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSS
T ss_pred CccEEEeCCCCCCccCHhHcCCCCEEECcCCCCc-ccc-c---ccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCC
Confidence 5555555555555322223334555555555555 455 1 23455555555555553 333 333 5555555555
Q ss_pred cccccCcccccCCCCCCEEEccCCccc
Q 046851 131 MLEETIPAELGMLQNLEVLDVSRNSLS 157 (963)
Q Consensus 131 ~l~~~~~~~~~~l~~L~~L~L~~N~l~ 157 (963)
+|++ +|. .+++|+.|+|++|.|+
T Consensus 131 ~l~~-lp~---~l~~L~~L~Ls~N~l~ 153 (571)
T 3cvr_A 131 QLTM-LPE---LPALLEYINADNNQLT 153 (571)
T ss_dssp CCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred cCCC-CCC---cCccccEEeCCCCccC
Confidence 5554 222 3455555555555555
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=187.96 Aligned_cols=188 Identities=25% Similarity=0.232 Sum_probs=107.8
Q ss_pred ccceeccccccccCCC-cccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccC
Q 046851 52 LEELNLAGNLVNGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN 130 (963)
Q Consensus 52 L~~L~Ls~N~l~~~~~-~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n 130 (963)
+..+.+..+.+++..+ ..+.+|+.|++++|.++ .++. +..+++|++|+|++|++++..+ +.++++|+.|++++|
T Consensus 26 ~~~~~l~~~~~~~~~~~~~l~~L~~L~l~~~~i~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHHTTCSCTTSEECHHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHHhcCCCcccccchhhcCcccEEEccCCCcc-cChh--HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence 3334444444442211 22334555555555554 4443 3456777777777777764433 666777777777777
Q ss_pred cccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccC
Q 046851 131 MLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGG 210 (963)
Q Consensus 131 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~ 210 (963)
++++. ..+..+++|++|+|++|++++. ..+..+++|+.|++++|.++ +.
T Consensus 101 ~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~---------------------------~~ 149 (291)
T 1h6t_A 101 KVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT---------------------------DI 149 (291)
T ss_dssp CCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCC---------------------------CC
T ss_pred cCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCC---------------------------cc
Confidence 76642 2366677777777777776632 34666666666666653322 22
Q ss_pred CcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCccccc
Q 046851 211 IPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG 281 (963)
Q Consensus 211 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 281 (963)
..+..+++|+.|++++|++++..+ +..+++|++|+|++|++++++ .+..+++|+.|++++|+++.
T Consensus 150 --~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~--~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 150 --TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEEEEEEC
T ss_pred --hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCCh--hhccCCCCCEEECcCCcccC
Confidence 345556666666666666664433 666666666666666666653 25666666666666666654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=6e-19 Score=196.50 Aligned_cols=175 Identities=23% Similarity=0.151 Sum_probs=102.1
Q ss_pred ceeeccccccccCCccccccCCCCCeEeCCCCccccCcCcccc-CcccccEEEcccCcccccCcccccCCCCCCEEEccC
Q 046851 75 RVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLG-NCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSR 153 (963)
Q Consensus 75 ~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 153 (963)
.+++++|+++ .+|..++ +.++.|+|++|+|++..+..|. ++++|+.|+|++|+|+++.+.+|.++++|++|+|++
T Consensus 22 ~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 4444444444 5665543 2466666666666655555565 666666666666666666666666666666666666
Q ss_pred CccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccccc
Q 046851 154 NSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEG 233 (963)
Q Consensus 154 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~ 233 (963)
|+|+...+..|.++++|+.|+|++ |.+.+..+..|.++++|+.|+|++|+++.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~---------------------------N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 150 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYN---------------------------NHIVVVDRNAFEDMAQLQKLYLSQNQISR 150 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCS---------------------------SCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred CcCCcCCHHHhCCCcCCCEEECCC---------------------------CcccEECHHHhCCcccCCEEECCCCcCCe
Confidence 666654444555555555555555 33333344455555555555555555554
Q ss_pred CCCccc---cccccCceeecCcccccCcCccccCCCCC--CcEEeccCcccc
Q 046851 234 NFPSNW---GACDNLEMLNLGHNFFSGKNLGVLGPCKN--LLFLDLSSNQLT 280 (963)
Q Consensus 234 ~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~ 280 (963)
..+..| ..+++|+.|+|++|+|+.++...|..+++ |+.|+|++|++.
T Consensus 151 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 433333 44666666677777666666666665555 356666666665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=5.4e-19 Score=190.34 Aligned_cols=179 Identities=22% Similarity=0.234 Sum_probs=127.2
Q ss_pred cccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeE
Q 046851 22 GFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHL 101 (963)
Q Consensus 22 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L 101 (963)
+..+++|++|++++|.++.. + .+..+++|++|+|++|+++ .++. +..+++|++|
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~----------------------~~~~--l~~l~~L~~L 95 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLT----------------------DIKP--LANLKNLGWL 95 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCC----------------------CCGG--GTTCTTCCEE
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccC----------------------CCcc--cccCCCCCEE
Confidence 34556666666666666532 2 3555666666666666555 4444 4567888888
Q ss_pred eCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCc
Q 046851 102 DLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDT 181 (963)
Q Consensus 102 ~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~ 181 (963)
+|++|++++ + ..+..+++|+.|++++|++++. ..+..+++|++|+|++|++++. ..+..+++|+.|++++|
T Consensus 96 ~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N--- 166 (291)
T 1h6t_A 96 FLDENKVKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN--- 166 (291)
T ss_dssp ECCSSCCCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS---
T ss_pred ECCCCcCCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCC---
Confidence 888888874 3 3377888888888888888754 4577888888888888888754 56788888888888873
Q ss_pred ccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCcc
Q 046851 182 YEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLG 261 (963)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 261 (963)
.+.+..+ +..+++|+.|++++|.+++. ..+..+++|+.|++++|++...+..
T Consensus 167 ------------------------~l~~~~~--l~~l~~L~~L~L~~N~i~~l--~~l~~l~~L~~L~l~~n~i~~~~~~ 218 (291)
T 1h6t_A 167 ------------------------QISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN 218 (291)
T ss_dssp ------------------------CCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEEEEEEEEECCCEE
T ss_pred ------------------------ccccchh--hcCCCccCEEECCCCcCCCC--hhhccCCCCCEEECcCCcccCCccc
Confidence 3433333 77888899999999988864 3488899999999999999886654
Q ss_pred cc
Q 046851 262 VL 263 (963)
Q Consensus 262 ~~ 263 (963)
.+
T Consensus 219 ~~ 220 (291)
T 1h6t_A 219 HQ 220 (291)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=205.06 Aligned_cols=193 Identities=24% Similarity=0.233 Sum_probs=94.6
Q ss_pred CCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCC
Q 046851 26 KSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSG 105 (963)
Q Consensus 26 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~ 105 (963)
..+..+.+..+.+....+ +..+++|+.|++++|.+. .+|. +..+++|+.|+|++
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~----------------------~l~~--l~~l~~L~~L~Ls~ 74 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK----------------------SVQG--IQYLPNVTKLFLNG 74 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC----------------------CCTT--GGGCTTCCEEECTT
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC----------------------CChH--HccCCCCCEEEeeC
Confidence 345555566666553332 456666666666666665 2221 12344444444444
Q ss_pred CccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCccccc
Q 046851 106 NYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDV 185 (963)
Q Consensus 106 N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~ 185 (963)
|+|++..+ +..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+.+ + ..+..+++|+.|+|++|.++
T Consensus 75 N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~---- 144 (605)
T 1m9s_A 75 NKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT---- 144 (605)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCC----
T ss_pred CCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccC----
Confidence 44443222 44444444444444444421 134444444444444444442 1 23444444444444442221
Q ss_pred ccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCC
Q 046851 186 RYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGP 265 (963)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 265 (963)
+. ..+..+++|+.|+|++|.+.+..| +..+++|+.|+|++|+|++++ .+..
T Consensus 145 -----------------------~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~--~l~~ 195 (605)
T 1m9s_A 145 -----------------------DI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR--ALAG 195 (605)
T ss_dssp -----------------------CC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG--GGTT
T ss_pred -----------------------Cc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCCh--HHcc
Confidence 11 234455555555555555554433 555666666666666666552 3555
Q ss_pred CCCCcEEeccCccccccc
Q 046851 266 CKNLLFLDLSSNQLTGEL 283 (963)
Q Consensus 266 l~~L~~L~L~~N~l~~~~ 283 (963)
+++|+.|+|++|++.+.+
T Consensus 196 l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 196 LKNLDVLELFSQECLNKP 213 (605)
T ss_dssp CTTCSEEECCSEEEECCC
T ss_pred CCCCCEEEccCCcCcCCc
Confidence 666666666666665443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=7.5e-18 Score=173.26 Aligned_cols=153 Identities=18% Similarity=0.214 Sum_probs=104.9
Q ss_pred cceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccC
Q 046851 74 KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSR 153 (963)
Q Consensus 74 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 153 (963)
+.+++++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|+.|+|++|+|+++.|.+|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 45666666666 6666554 4666677777766655555666666666666666666665566666666666666666
Q ss_pred CccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccccc
Q 046851 154 NSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEG 233 (963)
Q Consensus 154 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~ 233 (963)
|.|+... +..|.++++|+.|+|++|++++
T Consensus 90 N~l~~l~---------------------------------------------------~~~f~~l~~L~~L~L~~N~l~~ 118 (220)
T 2v9t_B 90 NKITELP---------------------------------------------------KSLFEGLFSLQLLLLNANKINC 118 (220)
T ss_dssp SCCCCCC---------------------------------------------------TTTTTTCTTCCEEECCSSCCCC
T ss_pred CcCCccC---------------------------------------------------HhHccCCCCCCEEECCCCCCCE
Confidence 6665322 2334556666666666677776
Q ss_pred CCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCccccc
Q 046851 234 NFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG 281 (963)
Q Consensus 234 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 281 (963)
..+..|..+++|++|+|++|+|+.+++..|..+++|+.|+|++|++..
T Consensus 119 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 119 LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred eCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 777778888888888888888888888888888888888888888764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=9.4e-18 Score=172.53 Aligned_cols=123 Identities=20% Similarity=0.191 Sum_probs=61.2
Q ss_pred ceeccccccccCCCccc-ccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcc
Q 046851 54 ELNLAGNLVNGTVPTFI-GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNML 132 (963)
Q Consensus 54 ~L~Ls~N~l~~~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l 132 (963)
.+++++|.++. +|..+ ..+++|+|++|++++..|...|..+++|++|+|++|+|++..+..|.++++|++|+|++|++
T Consensus 15 ~l~~s~n~l~~-iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l 93 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93 (220)
T ss_dssp EEECCSSCCSS-CCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EeEeCCCCccc-CccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCcc
Confidence 45555555542 22222 23444444444444222344445555555555555555554445555555555555555555
Q ss_pred cccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecC
Q 046851 133 EETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177 (963)
Q Consensus 133 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 177 (963)
++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 94 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 138 (220)
T 2v70_A 94 ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYD 138 (220)
T ss_dssp CCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTT
T ss_pred CccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCC
Confidence 555555555555555555555555544444444444444444433
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.7e-20 Score=216.35 Aligned_cols=122 Identities=20% Similarity=0.284 Sum_probs=101.5
Q ss_pred CccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceeccc
Q 046851 438 SLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLS 517 (963)
Q Consensus 438 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls 517 (963)
.|+.|+|++|+|++ +|. ++.+++|+.|+|++|.|+ .+|..++.+++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 48889999999984 676 888999999999999996 678889999999999999999984 67 78899999999999
Q ss_pred ccccCCCC-ChhhhccccCCeEEeccccCCCcCCCC---ccccccCceEee
Q 046851 518 SNSLSGLI-PDDLENLRNLTVLLLNNNKLSGKIPSG---LANVSTLSAFNV 564 (963)
Q Consensus 518 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~---l~~l~~L~~l~l 564 (963)
+|+|++.. |..+..+++|+.|+|++|+|++..|.. +..+++|+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99998776 888999999999999999998554422 233788888864
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.73 E-value=9.5e-18 Score=197.92 Aligned_cols=194 Identities=18% Similarity=0.176 Sum_probs=163.6
Q ss_pred cccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEc
Q 046851 72 RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDV 151 (963)
Q Consensus 72 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 151 (963)
.+..+.+..+.+.+.++ ...+++|+.|+|++|.|+. ++ .|..+++|+.|+|++|++++..+ +..+++|+.|+|
T Consensus 22 ~l~~l~l~~~~i~~~~~---~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHTTCSCTTSEEC---HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHhccCCCcccccc---hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 34555666666653332 2468999999999999984 44 69999999999999999997655 999999999999
Q ss_pred cCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccc
Q 046851 152 SRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL 231 (963)
Q Consensus 152 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l 231 (963)
++|.+++ +| .+..+++|+.|+|++|.++ +. ..+..+++|+.|+|++|.+
T Consensus 95 s~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~---------------------------~l--~~l~~l~~L~~L~Ls~N~l 143 (605)
T 1m9s_A 95 DENKIKD-LS-SLKDLKKLKSLSLEHNGIS---------------------------DI--NGLVHLPQLESLYLGNNKI 143 (605)
T ss_dssp CSSCCCC-CT-TSTTCTTCCEEECTTSCCC---------------------------CC--GGGGGCTTCSEEECCSSCC
T ss_pred cCCCCCC-Ch-hhccCCCCCEEEecCCCCC---------------------------CC--ccccCCCccCEEECCCCcc
Confidence 9999984 44 7999999999999985443 31 4588999999999999999
Q ss_pred ccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCC
Q 046851 232 EGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPT 308 (963)
Q Consensus 232 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~ 308 (963)
++. ..+..+++|+.|+|++|+|+.+++ +..+++|+.|+|++|+|++. +....+++|+.|+|++|++.+.+..
T Consensus 144 ~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 144 TDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp CCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred CCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCCccc
Confidence 975 679999999999999999999877 89999999999999999976 4556789999999999999976543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1e-19 Score=213.55 Aligned_cols=201 Identities=22% Similarity=0.154 Sum_probs=131.7
Q ss_pred ccCCCCcEEEccCCcccccCCccccCcccccceeccccc-------------cccCCCcccc---ccccee-eccccccc
Q 046851 23 FHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL-------------VNGTVPTFIG---RLKRVY-LSFNRLVG 85 (963)
Q Consensus 23 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-------------l~~~~~~~~~---~L~~L~-L~~n~l~~ 85 (963)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..++ +|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56788889999999988 778888899999999987775 2222332222 344444 3333322
Q ss_pred cCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCcc
Q 046851 86 SVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLG 165 (963)
Q Consensus 86 ~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 165 (963)
+|..+.+++|.|+...+ ..|+.|+|++|+|++ +|. |..+++|+.|+|++|.|+ .+|..|+
T Consensus 424 -----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 424 -----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp -----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred -----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 22233334444442111 136667777777765 344 677777777777777777 6666777
Q ss_pred CCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCC-Ccccccccc
Q 046851 166 NCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNF-PSNWGACDN 244 (963)
Q Consensus 166 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~ 244 (963)
++++|+.|+|++ |.+++ +| .+..+++|+.|+|++|++++.. |..|..+++
T Consensus 484 ~l~~L~~L~Ls~---------------------------N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~ 534 (567)
T 1dce_A 484 ALRCLEVLQASD---------------------------NALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534 (567)
T ss_dssp GCTTCCEEECCS---------------------------SCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTT
T ss_pred cCCCCCEEECCC---------------------------CCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCC
Confidence 777777777776 33433 44 6777788888888888887766 788888888
Q ss_pred CceeecCcccccCcCccc---cCCCCCCcEEec
Q 046851 245 LEMLNLGHNFFSGKNLGV---LGPCKNLLFLDL 274 (963)
Q Consensus 245 L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~L 274 (963)
|+.|+|++|.++++++.. +..+++|+.|++
T Consensus 535 L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 535 LVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 888888888888776532 334778888864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.4e-17 Score=168.06 Aligned_cols=156 Identities=24% Similarity=0.216 Sum_probs=113.4
Q ss_pred cccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEc
Q 046851 72 RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDV 151 (963)
Q Consensus 72 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 151 (963)
+-+.++.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|+.|+|++|+|+.+.+..|.++++|++|+|
T Consensus 20 s~~~v~c~~~~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 20 SGTTVDCRSKRHA-SVPAGIP---TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp ETTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred eCCEeEccCCCcC-ccCCCCC---CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 4566777777777 7777654 67778888888887766777777777777777777777666666777777777777
Q ss_pred cCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccc
Q 046851 152 SRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL 231 (963)
Q Consensus 152 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l 231 (963)
++|+|++..+..| ..+++|+.|++++|++
T Consensus 96 s~N~l~~l~~~~~---------------------------------------------------~~l~~L~~L~Ls~N~l 124 (229)
T 3e6j_A 96 GTNQLTVLPSAVF---------------------------------------------------DRLVHLKELFMCCNKL 124 (229)
T ss_dssp CSSCCCCCCTTTT---------------------------------------------------TTCTTCCEEECCSSCC
T ss_pred CCCcCCccChhHh---------------------------------------------------CcchhhCeEeccCCcc
Confidence 7777764444334 4455555555555666
Q ss_pred ccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCccccccc
Q 046851 232 EGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGEL 283 (963)
Q Consensus 232 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 283 (963)
+ .+|..+..+++|++|+|++|+|+.+++..|..+++|+.|+|++|++.+..
T Consensus 125 ~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 125 T-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp C-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred c-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 5 45667778888888888888888888888888888888888888887543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.5e-18 Score=180.38 Aligned_cols=137 Identities=18% Similarity=0.227 Sum_probs=107.5
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcE--EEEEEeecccch------------------------hHHHHHHHHHHHhcc
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVL--VAIKRLAVGRFQ------------------------GVQQFHAEIKTLGRL 735 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 735 (963)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++.+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 67989 999987543111 113678999999999
Q ss_pred CCCCe--eEEEEeeeCCCeEEEEEeccCC-C----ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceec
Q 046851 736 RHPNL--VTLIGYHASETEMFLIYNYLPG-G----NLENFIQQRSTRAVDWRVLHKIALDIARALAYLH-DQCVPRVLHR 807 (963)
Q Consensus 736 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~ 807 (963)
.|+++ +.++++ +..++||||+.+ | +|.++... .++.++..++.|++.|+.||| +. +|+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 87753 444443 356899999942 3 77776432 234567889999999999999 88 99999
Q ss_pred ccCCCCeEECCCCcEEEeeccccccc
Q 046851 808 DVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 808 dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=166.93 Aligned_cols=154 Identities=18% Similarity=0.238 Sum_probs=132.3
Q ss_pred cccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcc
Q 046851 407 GICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKG 486 (963)
Q Consensus 407 ~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~ 486 (963)
+.+..++ .|++++|.++ .+| .+..+ ++|++|++++|.++ .+..+..+++|++|++++|.+++..+..++.+++
T Consensus 41 ~~l~~L~--~L~l~~n~i~-~l~-~l~~l-~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 113 (197)
T 4ezg_A 41 AQMNSLT--YITLANINVT-DLT-GIEYA-HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113 (197)
T ss_dssp HHHHTCC--EEEEESSCCS-CCT-TGGGC-TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTT
T ss_pred hhcCCcc--EEeccCCCcc-ChH-HHhcC-CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCC
Confidence 4455666 8899999998 777 55554 88999999999887 3458899999999999999998878899999999
Q ss_pred cceeccccccccccCCcccccCCccceecccccc-cCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeec
Q 046851 487 LKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNS-LSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVS 565 (963)
Q Consensus 487 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~ 565 (963)
|++|++++|++++..|..++.+++|++|++++|+ ++ .+| .+..+++|+.|++++|+++ .++ .+..+++|++|+++
T Consensus 114 L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~-~~~-~l~~l~~L~~L~l~ 189 (197)
T 4ezg_A 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVH-DYR-GIEDFPKLNQLYAF 189 (197)
T ss_dssp CCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCC-CCT-TGGGCSSCCEEEEC
T ss_pred CCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCc-ChH-HhccCCCCCEEEee
Confidence 9999999999998788999999999999999998 76 555 6899999999999999999 455 78999999999999
Q ss_pred cccCcc
Q 046851 566 FNNLSG 571 (963)
Q Consensus 566 ~N~l~~ 571 (963)
+|++.+
T Consensus 190 ~N~i~~ 195 (197)
T 4ezg_A 190 SQTIGG 195 (197)
T ss_dssp BC----
T ss_pred CcccCC
Confidence 999864
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=182.23 Aligned_cols=286 Identities=14% Similarity=0.098 Sum_probs=200.7
Q ss_pred cCCCCcEEEccCCcccccCCccccC-cccccceeccccccc--cCCCcccccccceeeccccccccCCcccccc------
Q 046851 24 HLKSLRVLNLGFNRITGEIPASFSD-FVNLEELNLAGNLVN--GTVPTFIGRLKRVYLSFNRLVGSVPSKIGEK------ 94 (963)
Q Consensus 24 ~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~--~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~------ 94 (963)
.+.+++.|.++++ +.......+.. +++|+.|||++|++. ......+..+..+.+..| .+|...|.+
T Consensus 23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~----~I~~~aF~~~~~~~~ 97 (329)
T 3sb4_A 23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMAN----FVPAYAFSNVVNGVT 97 (329)
T ss_dssp HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTT----EECTTTTEEEETTEE
T ss_pred hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccccccccccccccc----ccCHHHhcccccccc
Confidence 3677899999864 22122223444 788999999999988 333344444455555555 567888888
Q ss_pred --CCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCcc----ccCCCcCccCCC
Q 046851 95 --CTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSL----SGSIPVDLGNCS 168 (963)
Q Consensus 95 --l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l----~~~~p~~~~~l~ 168 (963)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++.+|.++.+.+.+|.+..++..+.+..+.. .......|.++.
T Consensus 98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 99999999999 88878888999999999999999999988999999988888887766432 323455677777
Q ss_pred CCc-eEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccc-cCCCCCceEecCCcccccCCCccccccccCc
Q 046851 169 KLA-ILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAV-SSLPNLRILWAPRATLEGNFPSNWGACDNLE 246 (963)
Q Consensus 169 ~L~-~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 246 (963)
.|+ .+.+.... . .....+...........+....+ +.......+ ..+++|+.+++++|+++.+...+|.++++|+
T Consensus 177 ~L~~~i~~~~~~-~-l~~~~~~~~~~~~~~~~l~~~~~-l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~ 253 (329)
T 3sb4_A 177 PLETTIQVGAMG-K-LEDEIMKAGLQPRDINFLTIEGK-LDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLL 253 (329)
T ss_dssp CCEEEEEECTTC-C-HHHHHHHTTCCGGGCSEEEEEEC-CCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCC
T ss_pred ccceeEEecCCC-c-HHHHHhhcccCccccceEEEeee-ecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCC
Confidence 777 44443210 0 00000000000000000000000 000001111 1378999999999999999999999999999
Q ss_pred eeecCcccccCcCccccCCCCCCc-EEeccCcccccccCCCC-CCCceeEEEeccCcCccCCCC-CCCCCCCCcccc
Q 046851 247 MLNLGHNFFSGKNLGVLGPCKNLL-FLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPT-FSNMVCPPVPYL 320 (963)
Q Consensus 247 ~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~~~-~~~l~~l~~l~l 320 (963)
.|+|.+| ++.++..+|.++++|+ .+++.+ .++.+....+ ++++|+.+++++|.+....+. |..+.+|+.++.
T Consensus 254 ~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 254 KIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 9999998 9999999999999999 999988 7887777776 789999999999999987664 888888887653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-17 Score=173.42 Aligned_cols=169 Identities=21% Similarity=0.244 Sum_probs=115.1
Q ss_pred cccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEc
Q 046851 72 RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDV 151 (963)
Q Consensus 72 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 151 (963)
++..+++++|.++ .++ .+..+++|++|++++|+|+ .++ .+..+++|+.|+|++|++++..+ +.++++|++|+|
T Consensus 20 ~l~~l~l~~~~i~-~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 20 NAVKQNLGKQSVT-DLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHTCSCTT-SEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHhcCCCcc-ccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 3444555555555 554 2346778888888888877 344 67778888888888888876544 778888888888
Q ss_pred cCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCccc
Q 046851 152 SRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATL 231 (963)
Q Consensus 152 ~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l 231 (963)
++|++++ +|.. .. ++|+.|++++|.++ +. ..+..+++|+.|++++|++
T Consensus 93 ~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~---------------------------~~--~~l~~l~~L~~L~Ls~N~i 140 (263)
T 1xeu_A 93 NRNRLKN-LNGI-PS-ACLSRLFLDNNELR---------------------------DT--DSLIHLKNLEILSIRNNKL 140 (263)
T ss_dssp CSSCCSC-CTTC-CC-SSCCEEECCSSCCS---------------------------BS--GGGTTCTTCCEEECTTSCC
T ss_pred CCCccCC-cCcc-cc-CcccEEEccCCccC---------------------------CC--hhhcCcccccEEECCCCcC
Confidence 8888874 3332 22 77777777764333 21 2466777777777777777
Q ss_pred ccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCccccccc
Q 046851 232 EGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGEL 283 (963)
Q Consensus 232 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 283 (963)
++. ..+..+++|+.|+|++|+++++ ..+..+++|+.|++++|+++..+
T Consensus 141 ~~~--~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 141 KSI--VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp CBC--GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred CCC--hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence 754 2577777777777777777776 55677777777777777776543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.2e-17 Score=164.75 Aligned_cols=153 Identities=14% Similarity=0.166 Sum_probs=108.2
Q ss_pred ccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCce
Q 046851 93 EKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAI 172 (963)
Q Consensus 93 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 172 (963)
..+++|++|++++|+|+ .++ .+..+++|+.|++++|.++. +..+..+++|++|++++|.+++..+..++.+++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34667777777777777 444 57777777777777776653 246777788888888888887666777777777777
Q ss_pred EeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcc-cccCCCccccccccCceeecC
Q 046851 173 LVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT-LEGNFPSNWGACDNLEMLNLG 251 (963)
Q Consensus 173 L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls 251 (963)
|++++ |.+.+..+..+..+++|+.|++++|. ++ .++ .+..+++|++|+++
T Consensus 117 L~Ls~---------------------------n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 117 LDISH---------------------------SAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQ 167 (197)
T ss_dssp EECCS---------------------------SBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECT
T ss_pred EEecC---------------------------CccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECC
Confidence 77776 44444556667777778888888777 44 333 57778888888888
Q ss_pred cccccCcCccccCCCCCCcEEeccCcccc
Q 046851 252 HNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 252 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 280 (963)
+|++++++ .+..+++|+.|++++|+|.
T Consensus 168 ~n~i~~~~--~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 168 FDGVHDYR--GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp TBCCCCCT--TGGGCSSCCEEEECBC---
T ss_pred CCCCcChH--HhccCCCCCEEEeeCcccC
Confidence 88887765 5677788888888888775
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-17 Score=165.62 Aligned_cols=131 Identities=23% Similarity=0.290 Sum_probs=109.9
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCcc-ccccCCCCCEEeccCCcCCCccchhhccCcccceecccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPR-GVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAG 494 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~ 494 (963)
.+++++|+++ .+|..++ .+|++|++++|+|++..+. .+..+++|+.|+|++|.|++..|..|..+++|++|+|++
T Consensus 12 ~l~~s~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEcCCCCcC-cCccCCC---CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 6788888886 7887664 4689999999999855554 488889999999999999888888888899999999999
Q ss_pred ccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCC
Q 046851 495 NNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP 550 (963)
Q Consensus 495 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 550 (963)
|+|++..+..|..+++|++|+|++|+|++..|..+..+++|++|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99987777778888999999999999988888888888999999999999886544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=177.31 Aligned_cols=44 Identities=9% Similarity=0.118 Sum_probs=24.2
Q ss_pred ccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCc
Q 046851 215 VSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNL 260 (963)
Q Consensus 215 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 260 (963)
+..+++|+.|++++|++++. ..+..+++|+.|++++|.+...+.
T Consensus 146 l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~~ 189 (263)
T 1xeu_A 146 LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPV 189 (263)
T ss_dssp GGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCCE
T ss_pred HccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCcc
Confidence 44455555555555555543 445556666666666666655543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=5e-17 Score=178.57 Aligned_cols=235 Identities=12% Similarity=0.036 Sum_probs=136.5
Q ss_pred CCCceEEEccCCccc--ccCCCccccCCCCcEEEccCCcccccCCccccC--------cccccceeccccccccCCCccc
Q 046851 1 MGNLEVLDLEGNLLN--GILPDSGFHLKSLRVLNLGFNRITGEIPASFSD--------FVNLEELNLAGNLVNGTVPTFI 70 (963)
Q Consensus 1 l~~l~~L~ls~n~i~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~~~~~ 70 (963)
+++|++|||++|+|. ...+..+ +.++.+.+..|. +...+|.+ +++|+.|+|.+ .++.....+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 468999999999998 3332222 224555555553 33455666 77777777776 5653333333
Q ss_pred c---cccceeeccccccccCCccccccCCCCCeEeCCCCcc----ccCcCccccCccccc-EEEc---------------
Q 046851 71 G---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL----VGGIPRSLGNCFQVR-SLLL--------------- 127 (963)
Q Consensus 71 ~---~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i----~~~~~~~~~~l~~L~-~L~L--------------- 127 (963)
. +|+.+++++|.+. .++...|..+.++..+.+..+.. ......+|.++.+|+ .+.+
T Consensus 121 ~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~ 199 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGL 199 (329)
T ss_dssp TTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTC
T ss_pred hcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhccc
Confidence 2 3555555555555 55566665555555555544221 122334444444444 2222
Q ss_pred ----------ccCcccccCcccc-cCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCC
Q 046851 128 ----------FSNMLEETIPAEL-GMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQ 196 (963)
Q Consensus 128 ----------~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~ 196 (963)
.++-.. .....+ ..+++|+.|+|++|+++.+.+..|.++++|+.+++++|
T Consensus 200 ~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n------------------ 260 (329)
T 3sb4_A 200 QPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN------------------ 260 (329)
T ss_dssp CGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT------------------
T ss_pred CccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc------------------
Confidence 221110 000111 12567777777777777555566777777777777652
Q ss_pred CcccCCCCCccccCCcccccCCCCCc-eEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEe
Q 046851 197 PSFMNDDFNFFEGGIPEAVSSLPNLR-ILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLD 273 (963)
Q Consensus 197 ~~~~~~~~n~~~~~~~~~l~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 273 (963)
+....+.+|.++++|+ .+.+++ +++.+.+.+|.+|++|+.|++++|.++.++..+|.++++|+.++
T Consensus 261 ----------i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 261 ----------LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp ----------CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred ----------cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 3334456677777777 777766 66666667777777777777777777777777777777777765
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=5.8e-17 Score=162.77 Aligned_cols=131 Identities=23% Similarity=0.330 Sum_probs=119.6
Q ss_pred ccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccch-hhccCcccceeccccccccccCCcccccCCccceeccc
Q 046851 439 LKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPT-TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLS 517 (963)
Q Consensus 439 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls 517 (963)
-+.+++++|+++ .+|..+.. +|+.|++++|.|++..+. .|+.+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 10 ~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 378999999998 78887654 999999999999776664 48999999999999999998889999999999999999
Q ss_pred ccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccC
Q 046851 518 SNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGP 572 (963)
Q Consensus 518 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~ 572 (963)
+|+|++..+..+..+++|++|+|++|+|++..|..+..+++|++|++++|+|++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 9999988888899999999999999999988899999999999999998877764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-16 Score=159.26 Aligned_cols=124 Identities=24% Similarity=0.370 Sum_probs=79.0
Q ss_pred cEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceeccccc
Q 046851 440 KFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSN 519 (963)
Q Consensus 440 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N 519 (963)
+.+++++|+++ .+|..+. ++|+.|++++|.|+ .+|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45566666665 4554443 35666666666664 45566666666666666666666555556666777777777777
Q ss_pred ccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccc
Q 046851 520 SLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFN 567 (963)
Q Consensus 520 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N 567 (963)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 136 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCC
Confidence 776665666777777777777777777444445666777777766544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.7e-17 Score=199.20 Aligned_cols=126 Identities=20% Similarity=0.309 Sum_probs=49.3
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCc-cceec
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQL-LEVLD 515 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~ 515 (963)
++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+
T Consensus 270 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~ 347 (727)
T 4b8c_D 270 SNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFY 347 (727)
T ss_dssp TTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHH
T ss_pred CCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHh
Confidence 44555555555555 45555555555555555555553 44555555555555555555555555555443321 22355
Q ss_pred ccccccCCCCChhhhccccCCeEEeccc--------cCCCcCCCCccccccCceEeeccccCc
Q 046851 516 LSSNSLSGLIPDDLENLRNLTVLLLNNN--------KLSGKIPSGLANVSTLSAFNVSFNNLS 570 (963)
Q Consensus 516 ls~N~l~~~~p~~~~~l~~L~~L~l~~N--------~l~~~~p~~l~~l~~L~~l~l~~N~l~ 570 (963)
|++|.+++.+|. .|+.|++++| .|.+..+..+..+.++....+++|-+.
T Consensus 348 l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 348 LRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp HHHCCCCCCCCC------C-----------------------------------------CCC
T ss_pred hccCcccCcCcc------ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 566666555543 2333444444 223233333444455555555555544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-17 Score=200.68 Aligned_cols=222 Identities=23% Similarity=0.217 Sum_probs=74.6
Q ss_pred CCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCC
Q 046851 26 KSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSG 105 (963)
Q Consensus 26 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~ 105 (963)
+.++.|+|.+|.+.. .+. ..|+.++|+.|.|. .++++.|++. ++...|..+++|+.|+|++
T Consensus 173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~-----------~~~~~~n~~~--~~~~~~~~l~~L~~L~Ls~ 233 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSID-----------EDDDIENRMV--MPKDSKYDDQLWHALDLSN 233 (727)
T ss_dssp --------------------------------------------------------------------CCCCCCEEECTT
T ss_pred CccceEEeeCCCCCc-chh-----hHhhcCccCccccc-----------Ccccccccee--cChhhhccCCCCcEEECCC
Confidence 557777777777773 222 23555566666554 2333444443 3333344455555555555
Q ss_pred CccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCccccc
Q 046851 106 NYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDV 185 (963)
Q Consensus 106 N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~ 185 (963)
|+|. .+|..+.++++|+.|+|++|+|+ .+|..|.++++|++|+|++|.|+ .+|..|+++++|+.|+|++
T Consensus 234 n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~-------- 302 (727)
T 4b8c_D 234 LQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFD-------- 302 (727)
T ss_dssp SCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCS--------
T ss_pred CCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCC--------
Confidence 5555 44444445555555555555555 44555555555555555555555 4455555555555555555
Q ss_pred ccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcccccccc-CceeecCcccccCcCccccC
Q 046851 186 RYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDN-LEMLNLGHNFFSGKNLGVLG 264 (963)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~ 264 (963)
|.+. .+|..|..+++|+.|+|++|.+++..|..+..+.. +..|+|++|.++...+.
T Consensus 303 -------------------N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~--- 359 (727)
T 4b8c_D 303 -------------------NMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH--- 359 (727)
T ss_dssp -------------------SCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC---
T ss_pred -------------------CCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc---
Confidence 2222 34444555556666666666655555555543321 22355666665544332
Q ss_pred CCCCCcEEeccCc--------ccccccCCCC-CCCceeEEEeccCcCc
Q 046851 265 PCKNLLFLDLSSN--------QLTGELAREL-PVPCMTMFDVSGNALS 303 (963)
Q Consensus 265 ~l~~L~~L~L~~N--------~l~~~~~~~~-~~~~L~~L~l~~N~l~ 303 (963)
.|+.|++++| .+.+.....+ .+..+....+++|-+.
T Consensus 360 ---~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 360 ---ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ---C-----------------------------------------CCC
T ss_pred ---ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 3444555554 2221111111 2344455666777665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.5e-15 Score=168.45 Aligned_cols=263 Identities=16% Similarity=0.143 Sum_probs=121.4
Q ss_pred ceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccc
Q 046851 4 LEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRL 83 (963)
Q Consensus 4 l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l 83 (963)
++.+.+. +.++.+...+|.+. +|+.+.+..+ ++.+...+|.+ .+|+.+.+.+ .+.
T Consensus 115 l~~i~ip-~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~-------------------- 169 (401)
T 4fdw_A 115 YNEIILP-NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLE-------------------- 169 (401)
T ss_dssp CSEEECC-TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCC--------------------
T ss_pred ccEEEEC-CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-Ccc--------------------
Confidence 3334443 23444445555543 4555555544 44455555555 2455555543 333
Q ss_pred cccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcC
Q 046851 84 VGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVD 163 (963)
Q Consensus 84 ~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 163 (963)
.++...|.++++|+.++|++|+++.+...+|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+
T Consensus 170 --~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~a 244 (401)
T 4fdw_A 170 --QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEA 244 (401)
T ss_dssp --EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTT
T ss_pred --EehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccccc
Confidence 44444444445555555554444433333443 344555554422 44444444555555555555433 33233334
Q ss_pred ccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccc-----cCCCcc
Q 046851 164 LGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLE-----GNFPSN 238 (963)
Q Consensus 164 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~-----~~~~~~ 238 (963)
|.+ .+|+.+.+.+ .+......+|.++++|+.+.+.+|.+. .+...+
T Consensus 245 F~~-~~L~~i~lp~----------------------------~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~a 295 (401)
T 4fdw_A 245 FRE-SGITTVKLPN----------------------------GVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYC 295 (401)
T ss_dssp TTT-CCCSEEEEET----------------------------TCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTT
T ss_pred ccc-CCccEEEeCC----------------------------CccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHH
Confidence 444 4444444432 222223344445555555555444332 234445
Q ss_pred ccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CCCceeEEEeccCcCccCCCC-CCCCC-CC
Q 046851 239 WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNALSGSIPT-FSNMV-CP 315 (963)
Q Consensus 239 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~L~~L~l~~N~l~~~~~~-~~~l~-~l 315 (963)
|.++++|+.++|. +.++.+...+|.++++|+.++|..| ++.+....+ .+ +|+.+++++|.+....+. |..+. .+
T Consensus 296 F~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l 372 (401)
T 4fdw_A 296 LEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDI 372 (401)
T ss_dssp TTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTC
T ss_pred hhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCc
Confidence 5555555555555 2355555555555555555555333 444444333 23 555555555554443332 33332 45
Q ss_pred CcccccccccccC
Q 046851 316 PVPYLSRNLFESY 328 (963)
Q Consensus 316 ~~l~l~~n~~~~~ 328 (963)
..+++..+.++.+
T Consensus 373 ~~l~vp~~~~~~y 385 (401)
T 4fdw_A 373 TVIRVPAESVEKY 385 (401)
T ss_dssp CEEEECGGGHHHH
T ss_pred cEEEeCHHHHHHh
Confidence 5566665555443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.1e-15 Score=167.70 Aligned_cols=246 Identities=11% Similarity=0.088 Sum_probs=176.9
Q ss_pred CceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccc
Q 046851 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNR 82 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~ 82 (963)
+|+.+++..+ ++.+...+|.+. +|+.+.+.. .++.+...+|.++++|+.++|++|.++
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~------------------- 193 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT------------------- 193 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-------------------
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-------------------
Confidence 5888999876 887888999884 799999986 788788899999999999999998887
Q ss_pred ccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCc
Q 046851 83 LVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV 162 (963)
Q Consensus 83 l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 162 (963)
.++...|. ..+|+.+.|..+ ++.+...+|.++++|+.+.+.+| ++.+...+|.+ .+|+.++| .+.++.+...
T Consensus 194 ---~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~ 265 (401)
T 4fdw_A 194 ---KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASR 265 (401)
T ss_dssp ---EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTT
T ss_pred ---EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChh
Confidence 56666665 466777777643 55566667777777777777654 55566666766 67777777 3445545566
Q ss_pred CccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcccccc
Q 046851 163 DLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGAC 242 (963)
Q Consensus 163 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 242 (963)
+|.++++|+.+.+.+|.+.. +........+|.++++|+.+.+. ++++.+...+|.++
T Consensus 266 aF~~c~~L~~l~l~~~~~~~----------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c 322 (401)
T 4fdw_A 266 AFYYCPELAEVTTYGSTFND----------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGN 322 (401)
T ss_dssp TTTTCTTCCEEEEESSCCCC----------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTC
T ss_pred HhhCCCCCCEEEeCCccccC----------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCC
Confidence 67777777777776543320 12223445677778888888887 44776777778888
Q ss_pred ccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-CC-CceeEEEeccCcCc
Q 046851 243 DNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PV-PCMTMFDVSGNALS 303 (963)
Q Consensus 243 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~-~~L~~L~l~~N~l~ 303 (963)
.+|+.++|..| ++.+...+|.++ +|+.+++++|.+.......+ ++ ..+..|.+..+.+.
T Consensus 323 ~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 323 RKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 88888888554 777778888888 88888888887776665555 34 35777888777654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.1e-16 Score=153.06 Aligned_cols=132 Identities=22% Similarity=0.204 Sum_probs=109.7
Q ss_pred CCccEEECcCCcCC-CCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceec
Q 046851 437 KSLKFLDASGNQIV-GPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLD 515 (963)
Q Consensus 437 ~~L~~L~ls~n~l~-~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 515 (963)
++|++|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 66889999999887 67888888888999999999988765 7788888999999999999866787777889999999
Q ss_pred ccccccCCCCC-hhhhccccCCeEEeccccCCCcCCC----CccccccCceEeeccccCcc
Q 046851 516 LSSNSLSGLIP-DDLENLRNLTVLLLNNNKLSGKIPS----GLANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 516 ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~L~~l~l~~N~l~~ 571 (963)
+++|+|++..+ ..+..+++|+.|++++|+++ .+|. .+..+++|++|++++|.+..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG-TSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc-chHHHHHHHHHhCccCcEecCCCCChhh
Confidence 99999886422 67888889999999999998 4454 78888999999999888764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=8.2e-16 Score=154.30 Aligned_cols=127 Identities=26% Similarity=0.339 Sum_probs=117.1
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
.+++++|+++ .+|..++ ++|++|+|++|+|+ .+|..|..+++|+.|+|++|.|++..+..|..+++|++|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 6889999998 8887654 67999999999999 78899999999999999999999888889999999999999999
Q ss_pred cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCC
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 547 (963)
+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 9998778889999999999999999997766679999999999999999974
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=150.34 Aligned_cols=129 Identities=20% Similarity=0.263 Sum_probs=66.9
Q ss_pred cEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceeccccc
Q 046851 440 KFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSN 519 (963)
Q Consensus 440 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N 519 (963)
+.+++++|+++ .+|..+. ++|+.|++++|.+++..+..|+.+++|++|++++|++++..+..|..+++|+.|++++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 44555555554 3443322 35555555555554444444555555555555555555333344455555555555555
Q ss_pred ccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCcc
Q 046851 520 SLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 520 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~ 571 (963)
+|++..+..+..+++|++|++++|++++..+..+..+++|++|++++|++.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 5554444445555555555555555553333334555555555555555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.3e-16 Score=150.31 Aligned_cols=128 Identities=21% Similarity=0.186 Sum_probs=106.3
Q ss_pred CCccEEECcCCcCC-CCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceec
Q 046851 437 KSLKFLDASGNQIV-GPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLD 515 (963)
Q Consensus 437 ~~L~~L~ls~n~l~-~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 515 (963)
++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..++.+++|++|++++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56889999999988 67888888889999999999998765 7788889999999999999866888888889999999
Q ss_pred ccccccCCC-CChhhhccccCCeEEeccccCCCcCC---CCccccccCceEeecc
Q 046851 516 LSSNSLSGL-IPDDLENLRNLTVLLLNNNKLSGKIP---SGLANVSTLSAFNVSF 566 (963)
Q Consensus 516 ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p---~~l~~l~~L~~l~l~~ 566 (963)
+++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999998863 23778888999999999999984433 3688889999888763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=148.66 Aligned_cols=134 Identities=29% Similarity=0.291 Sum_probs=81.3
Q ss_pred CCCcEEEccCCccc-ccCCccccCcccccceeccccccccCCC--cccccccceeeccccccccCCccccccCCCCCeEe
Q 046851 26 KSLRVLNLGFNRIT-GEIPASFSDFVNLEELNLAGNLVNGTVP--TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLD 102 (963)
Q Consensus 26 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~ 102 (963)
++|++|+|++|+++ +.+|..|..+++|++|+|++|.+++. . ..+.+|++|+|++|+++ ..+...+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIF-GGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCC-SCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCc-hHHHHHHhhCCCCCEEe
Confidence 55666666666665 45555566666666666666665532 1 11223444444555544 32333444577777777
Q ss_pred CCCCccccCc-CccccCcccccEEEcccCcccccCc---ccccCCCCCCEEEccCCccccCCCc
Q 046851 103 LSGNYLVGGI-PRSLGNCFQVRSLLLFSNMLEETIP---AELGMLQNLEVLDVSRNSLSGSIPV 162 (963)
Q Consensus 103 Ls~N~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~ 162 (963)
|++|+|++.. +..+..+++|+.|++++|.+++..+ ..|..+++|++|++++|.+. ..|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 7777777432 2667777777777777777775544 46777777777777777776 3443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.7e-14 Score=160.98 Aligned_cols=87 Identities=13% Similarity=0.032 Sum_probs=41.6
Q ss_pred cCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCcc
Q 046851 86 SVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLG 165 (963)
Q Consensus 86 ~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 165 (963)
.++...|.++++|+.+.+..+ ++.....+|.++..+........ ..+...+|.++++|+.+++..+... .....|.
T Consensus 107 ~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~ 182 (394)
T 4fs7_A 107 MIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFS 182 (394)
T ss_dssp EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTT
T ss_pred EccchhhcccccchhhcccCc-eeeecceeeecccccccccCccc--cccchhhhcccCCCcEEecCCccce-ecccccc
Confidence 455555555566665555433 33344455555543332222222 2233445555666666665544322 3444455
Q ss_pred CCCCCceEeec
Q 046851 166 NCSKLAILVLS 176 (963)
Q Consensus 166 ~l~~L~~L~l~ 176 (963)
++.+|+.+.+.
T Consensus 183 ~c~~L~~i~l~ 193 (394)
T 4fs7_A 183 GCGKLKSIKLP 193 (394)
T ss_dssp TCTTCCBCCCC
T ss_pred CCCCceEEEcC
Confidence 55555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.9e-15 Score=148.36 Aligned_cols=131 Identities=21% Similarity=0.263 Sum_probs=115.5
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN 495 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N 495 (963)
.+++++|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|.+++..+..|..+++|++|+|++|
T Consensus 11 ~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 11 EIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 6888899888 7886554 67999999999999766677899999999999999998877778899999999999999
Q ss_pred cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCC
Q 046851 496 NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP 550 (963)
Q Consensus 496 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 550 (963)
++++..+..|..+++|+.|++++|+|++..+..+..+++|++|+|++|++++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9997667778999999999999999997766667889999999999999986544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.2e-14 Score=161.71 Aligned_cols=334 Identities=12% Similarity=0.104 Sum_probs=189.0
Q ss_pred ccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCc
Q 046851 83 LVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV 162 (963)
Q Consensus 83 l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 162 (963)
++ +|+...|.++.+|+.+.|.. .++.+...+|.++++|+.+.+.++ ++.+...+|.++++|+.+.+..+ +......
T Consensus 59 Vt-sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 59 VV-SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EE-EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred Ee-EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 44 67777787788888888864 366566777888888888888654 55566677777777777766544 3334555
Q ss_pred CccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcccccc
Q 046851 163 DLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGAC 242 (963)
Q Consensus 163 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 242 (963)
+|.++..+....... .......+|.++++|+.+.+..+ +..+....|.++
T Consensus 135 aF~~~~~~~~~~~~~-----------------------------~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c 184 (394)
T 4fs7_A 135 AFKGCDFKEITIPEG-----------------------------VTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGC 184 (394)
T ss_dssp TTTTCCCSEEECCTT-----------------------------CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred eeecccccccccCcc-----------------------------ccccchhhhcccCCCcEEecCCc-cceeccccccCC
Confidence 666654433322211 12223456777788888887654 344566777888
Q ss_pred ccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCcccccc
Q 046851 243 DNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSR 322 (963)
Q Consensus 243 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~ 322 (963)
.+|+.+++..| ++.+...+|.++..|+.+.+..+... .....+....|+.+.+..+.-
T Consensus 185 ~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i~~~~~~~~~l~~i~ip~~~~-------------------- 242 (394)
T 4fs7_A 185 GKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-LGDFALSKTGVKNIIIPDSFT-------------------- 242 (394)
T ss_dssp TTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-ECTTTTTTCCCCEEEECTTCC--------------------
T ss_pred CCceEEEcCCC-ceEeCchhhccccccceeecCCCceE-eehhhcccCCCceEEECCCce--------------------
Confidence 88888888765 67777778888888887777665432 122222233344443322111
Q ss_pred cccccCCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCC
Q 046851 323 NLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFP 402 (963)
Q Consensus 323 n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p 402 (963)
.+.
T Consensus 243 -----------------------------------------------------------------------------~i~ 245 (394)
T 4fs7_A 243 -----------------------------------------------------------------------------ELG 245 (394)
T ss_dssp -----------------------------------------------------------------------------EEC
T ss_pred -----------------------------------------------------------------------------ecc
Confidence 112
Q ss_pred cccccccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhc
Q 046851 403 GNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLG 482 (963)
Q Consensus 403 ~~~~~~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~ 482 (963)
...|..+..++ .+.+..+.. .++...+..+..++.+.+..+.+. ...+..+.+|+.+.+..+ ++.+....|.
T Consensus 246 ~~~f~~~~~l~--~~~~~~~~~--~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~ 317 (394)
T 4fs7_A 246 KSVFYGCTDLE--SISIQNNKL--RIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFE 317 (394)
T ss_dssp SSTTTTCSSCC--EEEECCTTC--EECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTT
T ss_pred cccccccccce--eEEcCCCcc--eeeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhc
Confidence 22333333333 222222221 233333333455555555444322 234555666666666544 4344455566
Q ss_pred cCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCce
Q 046851 483 QMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSA 561 (963)
Q Consensus 483 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 561 (963)
++++|+.++|.++ ++..-..+|.++.+|+.+++..| ++.+....|.++++|+.+++..+ ++ .+...|.++++|+.
T Consensus 318 ~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 318 SCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred CCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 6666666666543 44344556666666666666655 54444556666667777666544 33 33445666666554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2e-16 Score=172.50 Aligned_cols=139 Identities=13% Similarity=0.136 Sum_probs=103.6
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccch--------------hH--------HHHHHHHHHHhccCCC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQ--------------GV--------QQFHAEIKTLGRLRHP 738 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~--------~~~~~E~~~l~~l~h~ 738 (963)
..-|.+.++||+|++|.||+|...+|+.||||+++..... .. -...+|...+.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 3448999999999999999999889999999987532110 00 1124577777777554
Q ss_pred Ce--eEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 739 NL--VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 739 ni--v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
++ ...+++. ..++||||++|+++.++.. ......++.|++.++.|||+. |||||||||.|||+
T Consensus 174 gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl 238 (397)
T 4gyi_A 174 GFPVPEPIAQS----RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILI 238 (397)
T ss_dssp TCSCCCEEEEE----TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred CCCCCeeeecc----CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence 43 2233322 2379999999988865432 123457889999999999999 99999999999999
Q ss_pred CCCC----------cEEEeecccccccC
Q 046851 817 DDDF----------NAYLSDFGLARLLG 834 (963)
Q Consensus 817 ~~~~----------~~kl~Dfgla~~~~ 834 (963)
++++ .+.|+||+.+....
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred eCCCCcccccccccceEEEEeCCcccCC
Confidence 8876 38999999887543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.55 E-value=5.5e-15 Score=141.75 Aligned_cols=128 Identities=22% Similarity=0.222 Sum_probs=74.0
Q ss_pred CCCCcEEEccCCccc-ccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeC
Q 046851 25 LKSLRVLNLGFNRIT-GEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDL 103 (963)
Q Consensus 25 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L 103 (963)
.++|++|++++|.++ +.+|..|..+++|++|++++|.+++ + ..+..+++|++|+|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~--~~~~~l~~L~~L~L 71 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS----------------------I--ANLPKLNKLKKLEL 71 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCC----------------------C--TTCCCCTTCCEEEC
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCC----------------------c--hhhhcCCCCCEEEC
Confidence 356777777777776 5666666777777777777776662 2 12234555555555
Q ss_pred CCCccccCcCccccCcccccEEEcccCccccc-CcccccCCCCCCEEEccCCccccCCC---cCccCCCCCceEeec
Q 046851 104 SGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET-IPAELGMLQNLEVLDVSRNSLSGSIP---VDLGNCSKLAILVLS 176 (963)
Q Consensus 104 s~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l~ 176 (963)
++|+|++.+|..+.++++|+.|++++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 72 s~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 55555544555555555555555555555542 22455566666666666666654333 345556666666554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=5.1e-15 Score=146.38 Aligned_cols=129 Identities=22% Similarity=0.178 Sum_probs=101.0
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
.+|+.|++++|+++ .+|......++|+.|++++|.|++. ..++.+++|++|+|++|+|++..+..|..+++|++|++
T Consensus 19 ~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 56888888888888 4554333334888888888888654 57888888888888888888544455588888999999
Q ss_pred cccccCCCCCh--hhhccccCCeEEeccccCCCcCCCC----ccccccCceEeeccccCc
Q 046851 517 SSNSLSGLIPD--DLENLRNLTVLLLNNNKLSGKIPSG----LANVSTLSAFNVSFNNLS 570 (963)
Q Consensus 517 s~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~----l~~l~~L~~l~l~~N~l~ 570 (963)
++|+|+ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|+.|++++|.+.
T Consensus 96 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 96 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 999886 4565 7888888999999999988 66764 888888999988888765
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=3.1e-16 Score=158.50 Aligned_cols=147 Identities=23% Similarity=0.315 Sum_probs=106.7
Q ss_pred EEEccCCeeeecCch------hHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccce
Q 046851 416 MVNVSNNRIAGQLPA------EIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKY 489 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~------~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~ 489 (963)
.++++.+.++|.+|. .+..+ ++|++|++++|++++ +| .+..+++|+.|++++|.++ .+|..+..+++|++
T Consensus 22 ~l~l~~~~l~~~~~~l~~l~~~~~~l-~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~ 97 (198)
T 1ds9_A 22 ATEAEKVELHGMIPPIEKMDATLSTL-KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEE 97 (198)
T ss_dssp CTTCSEEECCBCCTTCCCCHHHHHHT-TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSE
T ss_pred CcchheeEeccccCcHhhhhHHHhcC-CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCE
Confidence 344555555555554 66655 778888888888874 66 7788888888888888885 56777777788888
Q ss_pred eccccccccccCCcccccCCccceecccccccCCCCC-hhhhccccCCeEEeccccCCCcCCCC----------cccccc
Q 046851 490 LSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIP-DDLENLRNLTVLLLNNNKLSGKIPSG----------LANVST 558 (963)
Q Consensus 490 L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~----------l~~l~~ 558 (963)
|++++|++++ +| .+..+++|+.|++++|+|++..+ ..+..+++|++|++++|++++.+|.. +..+++
T Consensus 98 L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~ 175 (198)
T 1ds9_A 98 LWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPN 175 (198)
T ss_dssp EEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSS
T ss_pred EECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCC
Confidence 8888888874 55 57778888888888888874322 36778888888888888887665553 677788
Q ss_pred CceEeeccccCc
Q 046851 559 LSAFNVSFNNLS 570 (963)
Q Consensus 559 L~~l~l~~N~l~ 570 (963)
|+.|+ +|+++
T Consensus 176 L~~Ld--~~~i~ 185 (198)
T 1ds9_A 176 LKKLD--GMPVD 185 (198)
T ss_dssp CSEEC--CGGGT
T ss_pred cEEEC--CcccC
Confidence 88775 56554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=2.4e-14 Score=141.54 Aligned_cols=133 Identities=16% Similarity=0.095 Sum_probs=70.0
Q ss_pred CccccCCCCcEEEccCCcccccCCccccCcc-cccceeccccccccCCCcccccccceeeccccccccCCccccccCCCC
Q 046851 20 DSGFHLKSLRVLNLGFNRITGEIPASFSDFV-NLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNL 98 (963)
Q Consensus 20 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L 98 (963)
..+..+.+|++|+|++|+++. ++. +..+. +|++|+|++|.+++. . .+..+++|
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~----------------------~l~~l~~L 66 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--D----------------------GFPLLRRL 66 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--C----------------------CCCCCSSC
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--c----------------------ccccCCCC
Confidence 446677888888888888883 344 44444 888888888877632 1 12234444
Q ss_pred CeEeCCCCccccCcCccccCcccccEEEcccCcccccCcc--cccCCCCCCEEEccCCccccCCCcC----ccCCCCCce
Q 046851 99 EHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPA--ELGMLQNLEVLDVSRNSLSGSIPVD----LGNCSKLAI 172 (963)
Q Consensus 99 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~ 172 (963)
++|+|++|+|++..+..|.++++|+.|+|++|+|+. +|. .+..+++|++|++++|+++ ..|.. +..+++|+.
T Consensus 67 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~ 144 (176)
T 1a9n_A 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV 144 (176)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSE
T ss_pred CEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccce
Confidence 444444444443322333444444444444444432 222 4445555555555555554 23332 445555555
Q ss_pred EeecCcCC
Q 046851 173 LVLSNLFD 180 (963)
Q Consensus 173 L~l~~n~~ 180 (963)
|++++|.+
T Consensus 145 Ld~~~n~~ 152 (176)
T 1a9n_A 145 LDFQKVKL 152 (176)
T ss_dssp ETTEECCH
T ss_pred eCCCcCCH
Confidence 55554433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=1.4e-13 Score=134.89 Aligned_cols=106 Identities=26% Similarity=0.351 Sum_probs=84.1
Q ss_pred ccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccc
Q 046851 439 LKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSS 518 (963)
Q Consensus 439 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~ 518 (963)
.+.+++++|+++ .+|..+. ++|+.|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 567888888887 5776653 6788888888888777788888888888888888888865566678888888888888
Q ss_pred cccCCCCChhhhccccCCeEEeccccCCC
Q 046851 519 NSLSGLIPDDLENLRNLTVLLLNNNKLSG 547 (963)
Q Consensus 519 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 547 (963)
|+|++..+..+..+++|+.|+|++|++++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 88887666668888888888888888874
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.6e-13 Score=134.94 Aligned_cols=104 Identities=24% Similarity=0.368 Sum_probs=76.2
Q ss_pred cEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceeccccc
Q 046851 440 KFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSN 519 (963)
Q Consensus 440 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N 519 (963)
+.+++++|+++ .+|..+. ++|+.|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56777777776 5666554 67777777777777766777777777777777777777544445677788888888888
Q ss_pred ccCCCCChhhhccccCCeEEeccccCC
Q 046851 520 SLSGLIPDDLENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 520 ~l~~~~p~~~~~l~~L~~L~l~~N~l~ 546 (963)
+|++..+..+..+++|+.|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 887655555777888888888888877
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.2e-15 Score=152.12 Aligned_cols=143 Identities=20% Similarity=0.224 Sum_probs=88.3
Q ss_pred CCCcEEEccCCcccccCCc------cccCcccccceeccccccccCCCccc---ccccceeeccccccccCCccccccCC
Q 046851 26 KSLRVLNLGFNRITGEIPA------SFSDFVNLEELNLAGNLVNGTVPTFI---GRLKRVYLSFNRLVGSVPSKIGEKCT 96 (963)
Q Consensus 26 ~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~L~~L~L~~n~l~~~~p~~~~~~l~ 96 (963)
..++.++++.+.+.+..|. .|..+++|++|+|++|.+++ +| .+ .+|+.|++++|+++ .+|..+ ..++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~-~~~~ 93 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD-AVAD 93 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH-HHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh-hcCC
Confidence 3444444444444444433 45555555555555555543 33 22 24555555555555 666533 3467
Q ss_pred CCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCc-ccccCCCCCCEEEccCCccccCCCcC----------cc
Q 046851 97 NLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIP-AELGMLQNLEVLDVSRNSLSGSIPVD----------LG 165 (963)
Q Consensus 97 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~ 165 (963)
+|++|+|++|+|++ +| .+.++++|+.|++++|+++...+ ..+..+++|++|++++|.+.+..|.. +.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 77888888887774 44 57777788888888888775433 46778888888888888887655543 77
Q ss_pred CCCCCceEe
Q 046851 166 NCSKLAILV 174 (963)
Q Consensus 166 ~l~~L~~L~ 174 (963)
.+++|+.|+
T Consensus 172 ~l~~L~~Ld 180 (198)
T 1ds9_A 172 RLPNLKKLD 180 (198)
T ss_dssp HCSSCSEEC
T ss_pred hCCCcEEEC
Confidence 788888776
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=3.9e-13 Score=131.69 Aligned_cols=108 Identities=26% Similarity=0.289 Sum_probs=95.5
Q ss_pred CCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEec
Q 046851 462 SLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLN 541 (963)
Q Consensus 462 ~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 541 (963)
..+.+++++|.++ .+|..+ .++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 4678999999995 467665 3899999999999998778999999999999999999998777778999999999999
Q ss_pred cccCCCcCCCCccccccCceEeeccccCccC
Q 046851 542 NNKLSGKIPSGLANVSTLSAFNVSFNNLSGP 572 (963)
Q Consensus 542 ~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~ 572 (963)
+|+|++..+..|..+++|++|++++|++++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 9999966666799999999999998877653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=7.6e-13 Score=130.06 Aligned_cols=106 Identities=23% Similarity=0.257 Sum_probs=92.7
Q ss_pred CCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEecc
Q 046851 463 LVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNN 542 (963)
Q Consensus 463 L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 542 (963)
-+.+++++|.+ +.+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 14 ~~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 47899999999 56777664 8999999999999987789999999999999999999977666679999999999999
Q ss_pred ccCCCcCCCCccccccCceEeeccccCcc
Q 046851 543 NKLSGKIPSGLANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 543 N~l~~~~p~~l~~l~~L~~l~l~~N~l~~ 571 (963)
|+|++..+..|..+++|++|++++|+|..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 99995555569999999999999876653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.8e-11 Score=135.06 Aligned_cols=85 Identities=11% Similarity=0.163 Sum_probs=34.5
Q ss_pred ccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccC
Q 046851 456 GVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNL 535 (963)
Q Consensus 456 ~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 535 (963)
.|.++.+|+.+++..+ ++.+....|.++.+|+.+.+..+ ++..-..+|.++++|+.+++.+|.... ..+....+|
T Consensus 306 aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L 380 (394)
T 4gt6_A 306 VFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGL 380 (394)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC
T ss_pred eecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCC
Confidence 4444455555555432 33333444555555555555433 332233445555555555555544321 234444555
Q ss_pred CeEEeccccC
Q 046851 536 TVLLLNNNKL 545 (963)
Q Consensus 536 ~~L~l~~N~l 545 (963)
+.+.+..|.+
T Consensus 381 ~~i~i~~~~~ 390 (394)
T 4gt6_A 381 QNLPVAPGSI 390 (394)
T ss_dssp ----------
T ss_pred CEEEeCCCCE
Confidence 5555544433
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.34 E-value=5.6e-11 Score=133.70 Aligned_cols=136 Identities=11% Similarity=0.152 Sum_probs=97.9
Q ss_pred cCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccc
Q 046851 427 QLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLG 506 (963)
Q Consensus 427 ~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 506 (963)
.+....+..+..|+.+.+..+... .....|.++++|+.+.+. +.++.+....|.++.+|+.++|..+ ++..-..+|.
T Consensus 255 ~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~ 331 (394)
T 4gt6_A 255 RIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFA 331 (394)
T ss_dssp EECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred EcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhh
Confidence 344455556678888888776655 566678889999999996 4565666778999999999999865 6645567899
Q ss_pred cCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccC
Q 046851 507 QLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL 569 (963)
Q Consensus 507 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l 569 (963)
++.+|+.+.+..+ ++.+....|.++++|+.+++.+|.... ..+..+.+|+.+.+..|.+
T Consensus 332 ~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 332 GCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 9999999999755 665666889999999999999987642 3567778888888776654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=9.3e-12 Score=137.65 Aligned_cols=103 Identities=20% Similarity=0.221 Sum_probs=66.2
Q ss_pred EEECcCC-cCCCCCccccccCCCCCEEeccC-CcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccc
Q 046851 441 FLDASGN-QIVGPIPRGVGELVSLVALNLSW-NLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSS 518 (963)
Q Consensus 441 ~L~ls~n-~l~~~~p~~~~~l~~L~~L~ls~-N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~ 518 (963)
.++++++ +|+ .+|. +..+++|+.|+|++ |.|++..+..|+.+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3466665 666 4565 66666667777764 666655556666667777777777777666666666677777777777
Q ss_pred cccCCCCChhhhccccCCeEEeccccCC
Q 046851 519 NSLSGLIPDDLENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 519 N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 546 (963)
|+|++..+..+..++ |+.|+|++|+|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777654444444444 677777777665
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-13 Score=150.66 Aligned_cols=70 Identities=14% Similarity=0.071 Sum_probs=37.3
Q ss_pred cccccCCCCCceEecCCcccccC----CCccccccccCceeecCcccccCcCccccCCC---C--CCcEEe--ccCcccc
Q 046851 212 PEAVSSLPNLRILWAPRATLEGN----FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPC---K--NLLFLD--LSSNQLT 280 (963)
Q Consensus 212 ~~~l~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~--~L~~L~--L~~N~l~ 280 (963)
+..+...++|+.|+|++|.|+.. +...+...++|++|+|++|.|+......+..+ . .|+.+. +..|.+.
T Consensus 204 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 204 AAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 34455556666666666666542 22333445777777777777766544433322 1 166676 6666665
Q ss_pred c
Q 046851 281 G 281 (963)
Q Consensus 281 ~ 281 (963)
.
T Consensus 284 ~ 284 (372)
T 3un9_A 284 E 284 (372)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-11 Score=128.39 Aligned_cols=147 Identities=14% Similarity=0.041 Sum_probs=115.4
Q ss_pred HHHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEE
Q 046851 677 VVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 677 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 755 (963)
+...-+.|++....+.|+.+.||++... |..+++|+...........+.+|+++++.+. +..+.++++++...+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3344467888888999999999999765 7889999887533233346888999998885 6778889999988889999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC----------------------------------- 800 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 800 (963)
||||++|.++.+.+. +......++.+++++++.||+..
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999887631 11233478899999999999810
Q ss_pred ---------------------CCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 801 ---------------------VPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 801 ---------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
.+.++|||+++.||++++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1369999999999999876667799998775
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.1e-13 Score=151.24 Aligned_cols=156 Identities=20% Similarity=0.173 Sum_probs=72.7
Q ss_pred CCceEEEccCCcccccCCCccccC-----CCCcEEEccCCcccccCCccc-cCcccccceeccccccccCCCccc-----
Q 046851 2 GNLEVLDLEGNLLNGILPDSGFHL-----KSLRVLNLGFNRITGEIPASF-SDFVNLEELNLAGNLVNGTVPTFI----- 70 (963)
Q Consensus 2 ~~l~~L~ls~n~i~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~----- 70 (963)
.++++|+|++|.|+......+..+ ++|++|+|++|.++......+ ..+++|++|+|++|.+++.....+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 345666666666654333333322 466666666666653222222 234556666666666553322221
Q ss_pred ---ccccceeecccccccc----CCccccccCCCCCeEeCCCCccccC----cCccccCcccccEEEcccCccccc----
Q 046851 71 ---GRLKRVYLSFNRLVGS----VPSKIGEKCTNLEHLDLSGNYLVGG----IPRSLGNCFQVRSLLLFSNMLEET---- 135 (963)
Q Consensus 71 ---~~L~~L~L~~n~l~~~----~p~~~~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~---- 135 (963)
.+|++|+|++|.++.. ++..+ ..+++|++|+|++|+|++. +...+...++|+.|+|++|.|+..
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L-~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGL-AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHH-HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHH-hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 2355555555555421 11111 2344555555555555421 133344444555555555555432
Q ss_pred CcccccCCCCCCEEEccCCcccc
Q 046851 136 IPAELGMLQNLEVLDVSRNSLSG 158 (963)
Q Consensus 136 ~~~~~~~l~~L~~L~L~~N~l~~ 158 (963)
++.++...++|++|+|++|.|++
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHHhCCCCCEEeccCCCCCH
Confidence 12233334555555555555543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.19 E-value=2e-11 Score=135.03 Aligned_cols=105 Identities=21% Similarity=0.171 Sum_probs=91.2
Q ss_pred CEEeccCC-cCCCccchhhccCcccceecccc-ccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEec
Q 046851 464 VALNLSWN-LMHDQIPTTLGQMKGLKYLSLAG-NNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLN 541 (963)
Q Consensus 464 ~~L~ls~N-~i~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 541 (963)
..++++++ .++ .+|. +..+++|++|+|++ |+|++..+..|+.+++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35788988 886 4777 99999999999996 99997777899999999999999999999888899999999999999
Q ss_pred cccCCCcCCCCccccccCceEeeccccCcc
Q 046851 542 NNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571 (963)
Q Consensus 542 ~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~ 571 (963)
+|+|++..+..+..++ |+.|++++|+|..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9999955455555555 9999999988764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.08 E-value=6.3e-09 Score=116.30 Aligned_cols=210 Identities=11% Similarity=0.001 Sum_probs=111.6
Q ss_pred ccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCe
Q 046851 21 SGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEH 100 (963)
Q Consensus 21 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~ 100 (963)
++....+|+.+.+.. .++.+...+|.++.+|+.++|.++ ++ .|+...|.++ +|+.
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~----------------------~Ig~~aF~~c-~l~~ 95 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VT----------------------SIGDGAFADT-KLQS 95 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CC----------------------EECTTTTTTC-CCCE
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ce----------------------EechhhhcCC-CCce
Confidence 456677899999875 577788889999999999999754 55 3444444433 3444
Q ss_pred EeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCC
Q 046851 101 LDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180 (963)
Q Consensus 101 L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~ 180 (963)
+.+..+ ++.+...+|.+. +|+.+.+.++ ++.+...+|.+. +|+.+.+..+ ++......|.++.+++...+..+..
T Consensus 96 i~~~~~-l~~I~~~aF~~~-~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~ 170 (379)
T 4h09_A 96 YTGMER-VKKFGDYVFQGT-DLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNK 170 (379)
T ss_dssp EEECTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCS
T ss_pred EECCce-eeEeccceeccC-CcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccc
Confidence 444322 332333344432 4555555433 222333344332 3444444332 2223344455555555555543211
Q ss_pred cccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCc
Q 046851 181 TYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNL 260 (963)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 260 (963)
......... ..........+.....+....+.... .......+..+.+|+.+.+..+ +..+..
T Consensus 171 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~ 233 (379)
T 4h09_A 171 NYVAENYVL---------------YNKNKTILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGD 233 (379)
T ss_dssp SEEEETTEE---------------EETTSSEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECT
T ss_pred eeeccccee---------------cccccceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEcc
Confidence 111000000 00011122334445555555544332 2245566777788888888654 667777
Q ss_pred cccCCCCCCcEEeccCc
Q 046851 261 GVLGPCKNLLFLDLSSN 277 (963)
Q Consensus 261 ~~~~~l~~L~~L~L~~N 277 (963)
.+|..+.+|+.+.+..+
T Consensus 234 ~~f~~~~~L~~i~lp~~ 250 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN 250 (379)
T ss_dssp TTTTTCSSCCEEEECTT
T ss_pred ccccCCccceEEEcCCC
Confidence 88888888888887654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.3e-08 Score=113.60 Aligned_cols=176 Identities=9% Similarity=0.040 Sum_probs=115.9
Q ss_pred ccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCccccc
Q 046851 44 ASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVR 123 (963)
Q Consensus 44 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 123 (963)
.++....+|+.+.+.+. + + +|+...|.++.+|+.++|..+ ++.+...+|.++ +|+
T Consensus 40 ~~~~~~~~i~~v~ip~~-v---------------------t-~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~ 94 (379)
T 4h09_A 40 PWYKDRDRISEVRVNSG-I---------------------T-SIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQ 94 (379)
T ss_dssp TTGGGGGGCSEEEECTT-E---------------------E-EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCC
T ss_pred cccccccCCEEEEeCCC-c---------------------c-ChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCc
Confidence 45666677777777532 3 3 889999999999999999765 776778899998 688
Q ss_pred EEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCC
Q 046851 124 SLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDD 203 (963)
Q Consensus 124 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (963)
.+.+..+ ++.+...+|... +|+.+++..+-.. .....|.+. +|+.+.+..+
T Consensus 95 ~i~~~~~-l~~I~~~aF~~~-~L~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~------------------------- 145 (379)
T 4h09_A 95 SYTGMER-VKKFGDYVFQGT-DLDDFEFPGATTE-IGNYIFYNS-SVKRIVIPKS------------------------- 145 (379)
T ss_dssp EEEECTT-CCEECTTTTTTC-CCSEEECCTTCCE-ECTTTTTTC-CCCEEEECTT-------------------------
T ss_pred eEECCce-eeEeccceeccC-CcccccCCCcccc-ccccccccc-eeeeeeccce-------------------------
Confidence 8888654 665677788764 8999999876433 455566665 5776666532
Q ss_pred CCccccCCcccccCCCCCceEecCCccccc------------CCCccccccccCceeecCcccccCcCccccCCCCCCcE
Q 046851 204 FNFFEGGIPEAVSSLPNLRILWAPRATLEG------------NFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLF 271 (963)
Q Consensus 204 ~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 271 (963)
+......+|....+++...+..+.... .....+.....+..+.+..+ ...+....|....+|+.
T Consensus 146 ---v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~f~~~~~l~~ 221 (379)
T 4h09_A 146 ---VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPST-VKTVTAYGFSYGKNLKK 221 (379)
T ss_dssp ---CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTT-CCEECTTTTTTCSSCSE
T ss_pred ---eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccc-eeEEeecccccccccce
Confidence 222334456666666666655433211 12223445556666665543 34455677788888888
Q ss_pred EeccCc
Q 046851 272 LDLSSN 277 (963)
Q Consensus 272 L~L~~N 277 (963)
+.+..+
T Consensus 222 i~~~~~ 227 (379)
T 4h09_A 222 ITITSG 227 (379)
T ss_dssp EECCTT
T ss_pred eeeccc
Confidence 888654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=1.4e-10 Score=122.50 Aligned_cols=138 Identities=15% Similarity=0.149 Sum_probs=101.8
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCC--eeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPN--LVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 759 (963)
..+.+....+.|..+.||++...+|..+++|+.... ....+..|+++++.+.+.+ +.++++++...+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345544444466679999998777888999987643 2245778999988886444 55688888888889999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC--------------------------------------- 800 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 800 (963)
++|.++. ... .+ ...++.++++.+..||+..
T Consensus 97 i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9998884 211 11 2356778888888888751
Q ss_pred ----------------CCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 801 ----------------VPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 801 ----------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.+.++|||++|.||++++++.+.|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=3e-09 Score=117.90 Aligned_cols=142 Identities=15% Similarity=0.226 Sum_probs=107.2
Q ss_pred CccccccCCCccEEEEEECCCcEEEEEEee--cccc-hhHHHHHHHHHHHhccC--CCCeeEEEEeeeCC---CeEEEEE
Q 046851 686 ASNCIGNGGFGATYKAEISPGVLVAIKRLA--VGRF-QGVQQFHAEIKTLGRLR--HPNLVTLIGYHASE---TEMFLIY 757 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 757 (963)
..+.++.|.++.||+.... +..+++|+.. .... .....+.+|+++++.+. +..++++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4567899999999999876 4678888775 3321 22356788999999887 45578888888766 4589999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC------------------------------------- 800 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 800 (963)
||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998774311 123678888899999999999999731
Q ss_pred ------------------CCCceecccCCCCeEECCCCc--EEEeecccccc
Q 046851 801 ------------------VPRVLHRDVKPSNILLDDDFN--AYLSDFGLARL 832 (963)
Q Consensus 801 ------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~ 832 (963)
.+.++|||+++.||++++++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999998753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.6e-09 Score=117.10 Aligned_cols=186 Identities=17% Similarity=0.215 Sum_probs=123.7
Q ss_pred ccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCC--eeEEEEeeeCCC---eEEEEEecc
Q 046851 687 SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPN--LVTLIGYHASET---EMFLIYNYL 760 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 760 (963)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++.+....+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999873 56889976433 33567889999998873 332 445555544333 347899999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ----------------------------------------- 799 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------------- 799 (963)
+|.++.+.... .++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888754321 267778888888898888888862
Q ss_pred --------------CCCCceecccCCCCeEECC--CCcEEEeecccccccCCCCCccccc-------------ccccccc
Q 046851 800 --------------CVPRVLHRDVKPSNILLDD--DFNAYLSDFGLARLLGPSETHATTG-------------VAGTFGY 850 (963)
Q Consensus 800 --------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~-------------~~gt~~y 850 (963)
..+.++|+|+++.||++++ ++.+.|+||+.+..-.+........ .....++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1246899999999999998 4568899999987643221110000 0000111
Q ss_pred cC-ccccccCCCCcchhhHHHHHHHHHHHcCCCCC
Q 046851 851 VA-PEYAMTCRVSDKADVYSYGVVLLELLSDKKAL 884 (963)
Q Consensus 851 ~a-PE~~~~~~~~~~~Dv~slG~il~elltg~~p~ 884 (963)
.. |+..... ....+.|++|.++|++.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 12 2222111 12368999999999999998665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.67 E-value=7.6e-09 Score=113.52 Aligned_cols=180 Identities=15% Similarity=0.111 Sum_probs=120.8
Q ss_pred CceEEEccCCcccc-c-------CCCccccCCCCcEEEccCCccc---------ccCCccccCcccccceeccccc-ccc
Q 046851 3 NLEVLDLEGNLLNG-I-------LPDSGFHLKSLRVLNLGFNRIT---------GEIPASFSDFVNLEELNLAGNL-VNG 64 (963)
Q Consensus 3 ~l~~L~ls~n~i~~-~-------~~~~~~~l~~L~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~Ls~N~-l~~ 64 (963)
.++.|.+-.....+ . +..++..+++|+.|.+..+... +.+...+..+|+|+.|+|++|. +.
T Consensus 108 ~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~- 186 (362)
T 2ra8_A 108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS- 186 (362)
T ss_dssp GCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-
T ss_pred hcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-
Confidence 46677777655431 1 1234567899999999765331 1233556778999999999883 32
Q ss_pred CCCcccccccceeeccccccccCCcccc-ccCCCCCeEeCCC--CccccC-----cCccc--cCcccccEEEcccCcccc
Q 046851 65 TVPTFIGRLKRVYLSFNRLVGSVPSKIG-EKCTNLEHLDLSG--NYLVGG-----IPRSL--GNCFQVRSLLLFSNMLEE 134 (963)
Q Consensus 65 ~~~~~~~~L~~L~L~~n~l~~~~p~~~~-~~l~~L~~L~Ls~--N~i~~~-----~~~~~--~~l~~L~~L~L~~n~l~~ 134 (963)
..+....+|+.|+|..|.+.......+. ..+++|++|+|+. |...+. +...+ ..+++|+.|+|.+|.+..
T Consensus 187 l~~~~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~ 266 (362)
T 2ra8_A 187 IGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQN 266 (362)
T ss_dssp CCSCBCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHH
T ss_pred eccccCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCch
Confidence 2222356899999999988643333333 2689999999863 221111 11122 357899999999999875
Q ss_pred cCccccc---CCCCCCEEEccCCccccC----CCcCccCCCCCceEeecCcCCccc
Q 046851 135 TIPAELG---MLQNLEVLDVSRNSLSGS----IPVDLGNCSKLAILVLSNLFDTYE 183 (963)
Q Consensus 135 ~~~~~~~---~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~ 183 (963)
..+..+. .+++|++|+|+.|.+.+. ++..+.++++|+.|++++|.++..
T Consensus 267 ~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 267 VVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp HHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 4444443 578999999999999863 344556789999999998776643
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.56 E-value=9e-09 Score=112.91 Aligned_cols=182 Identities=20% Similarity=0.187 Sum_probs=99.9
Q ss_pred cCCCCCeEeCCCCccc---------cCcCccccCcccccEEEcccCc-ccccCcccccCCCCCCEEEccCCccccCCCcC
Q 046851 94 KCTNLEHLDLSGNYLV---------GGIPRSLGNCFQVRSLLLFSNM-LEETIPAELGMLQNLEVLDVSRNSLSGSIPVD 163 (963)
Q Consensus 94 ~l~~L~~L~Ls~N~i~---------~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 163 (963)
.+++|+.|.+..+... +.+...+..+++|+.|.|++|. +. ++. +. +++|+.|+|..|.+.......
T Consensus 137 ~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~ 212 (362)
T 2ra8_A 137 KFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVED 212 (362)
T ss_dssp HHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHH
T ss_pred hcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHH
Confidence 4566777766554321 1123344556777777777663 22 222 33 677777777777765433333
Q ss_pred cc--CCCCCceEeecCc--CCcccccccccCCcccCCCcccCCCCCccccCCcccc--cCCCCCceEecCCcccccCCCc
Q 046851 164 LG--NCSKLAILVLSNL--FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAV--SSLPNLRILWAPRATLEGNFPS 237 (963)
Q Consensus 164 ~~--~l~~L~~L~l~~n--~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l--~~l~~L~~L~l~~n~l~~~~~~ 237 (963)
+. .+++|+.|+|+.+ .... + ..+. .+...+ ..+++|+.|+|.+|.+....+.
T Consensus 213 l~~~~lp~L~~L~L~~~~~~~~~-~--------------------~~~~-~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~ 270 (362)
T 2ra8_A 213 ILGSDLPNLEKLVLYVGVEDYGF-D--------------------GDMN-VFRPLFSKDRFPNLKWLGIVDAEEQNVVVE 270 (362)
T ss_dssp HHHSBCTTCCEEEEECBCGGGTC-C--------------------SCGG-GTGGGSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred HHHccCCCCcEEEEecccccccc-c--------------------hhHH-HHHHHHhcCCCCCcCEEeCCCCCCchHHHH
Confidence 33 5777777777521 0000 0 0000 011122 2468888888888887643322
Q ss_pred ccc---ccccCceeecCcccccCcCcc----ccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCc
Q 046851 238 NWG---ACDNLEMLNLGHNFFSGKNLG----VLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNA 301 (963)
Q Consensus 238 ~~~---~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~ 301 (963)
.+. .+++|++|+|+.|.+++.... .+..+++|+.|+|++|.|+......+.-.-...+++++++
T Consensus 271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHCCSEEECCSBC
T ss_pred HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHcCCEEEecCCc
Confidence 232 467888888888888764322 2234678888888888877543322210002346676665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-08 Score=104.78 Aligned_cols=80 Identities=24% Similarity=0.342 Sum_probs=47.5
Q ss_pred ccCcccceeccccccccc--cCCcccccCCccceecccccccCCCCChhhhccc--cCCeEEeccccCCCcCCC------
Q 046851 482 GQMKGLKYLSLAGNNLTG--SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLR--NLTVLLLNNNKLSGKIPS------ 551 (963)
Q Consensus 482 ~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~------ 551 (963)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|++++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 345566666666666664 3345555666666666666666643 3344444 677777777777655552
Q ss_pred -CccccccCceEe
Q 046851 552 -GLANVSTLSAFN 563 (963)
Q Consensus 552 -~l~~l~~L~~l~ 563 (963)
.+..+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 255666666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.33 E-value=9.6e-08 Score=94.42 Aligned_cols=111 Identities=17% Similarity=0.153 Sum_probs=70.6
Q ss_pred cCCccEEECcCC-cCCCC----CccccccCCCCCEEeccCCcCCCc----cchhhccCcccceecccccccccc----CC
Q 046851 436 CKSLKFLDASGN-QIVGP----IPRGVGELVSLVALNLSWNLMHDQ----IPTTLGQMKGLKYLSLAGNNLTGS----IP 502 (963)
Q Consensus 436 ~~~L~~L~ls~n-~l~~~----~p~~~~~l~~L~~L~ls~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p 502 (963)
.++|++|+|++| .|... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 367888888888 77632 344556667888888888888542 233444556777777777777632 34
Q ss_pred cccccCCccceecc--cccccCCCC----ChhhhccccCCeEEeccccCC
Q 046851 503 SSLGQLQLLEVLDL--SSNSLSGLI----PDDLENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 503 ~~~~~l~~L~~L~l--s~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~ 546 (963)
..+...+.|++|+| ++|.|+... ...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 45556667777777 667775331 233444466777777777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.30 E-value=6.5e-08 Score=95.66 Aligned_cols=118 Identities=21% Similarity=0.228 Sum_probs=92.6
Q ss_pred CccccccCCCCCEEeccCC-cCCCc----cchhhccCcccceecccccccccc----CCcccccCCccceecccccccCC
Q 046851 453 IPRGVGELVSLVALNLSWN-LMHDQ----IPTTLGQMKGLKYLSLAGNNLTGS----IPSSLGQLQLLEVLDLSSNSLSG 523 (963)
Q Consensus 453 ~p~~~~~l~~L~~L~ls~N-~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~ 523 (963)
+...+...+.|++|+|++| .|+.. +...+...++|++|+|++|+|... +...+...+.|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4456677899999999999 98643 345566678999999999999742 34456667899999999999985
Q ss_pred C----CChhhhccccCCeEEe--ccccCCCc----CCCCccccccCceEeeccccCc
Q 046851 524 L----IPDDLENLRNLTVLLL--NNNKLSGK----IPSGLANVSTLSAFNVSFNNLS 570 (963)
Q Consensus 524 ~----~p~~~~~l~~L~~L~l--~~N~l~~~----~p~~l~~l~~L~~l~l~~N~l~ 570 (963)
. +...+...++|++|+| ++|.|+.. +...+...++|++|++++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3 2456677789999999 88999843 3345566689999999999875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.29 E-value=1.7e-07 Score=97.20 Aligned_cols=80 Identities=30% Similarity=0.358 Sum_probs=54.0
Q ss_pred ccCCCCCEEeccCCcCCC--ccchhhccCcccceeccccccccccCCcccccCC--ccceecccccccCCCCC-------
Q 046851 458 GELVSLVALNLSWNLMHD--QIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQ--LLEVLDLSSNSLSGLIP------- 526 (963)
Q Consensus 458 ~~l~~L~~L~ls~N~i~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p------- 526 (963)
.++++|+.|+|++|.|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456677777777777765 3446666777777777777777743 3344444 78888888888876554
Q ss_pred hhhhccccCCeEE
Q 046851 527 DDLENLRNLTVLL 539 (963)
Q Consensus 527 ~~~~~l~~L~~L~ 539 (963)
..+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 2366778888776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=4.2e-06 Score=89.93 Aligned_cols=136 Identities=21% Similarity=0.214 Sum_probs=95.0
Q ss_pred ccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCC---CeeEEEEeee-CCCeEEEEEeccCC
Q 046851 687 SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHP---NLVTLIGYHA-SETEMFLIYNYLPG 762 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 762 (963)
.+.++.|....||+. |..+++|+... ......+.+|++++..+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899998 56788887432 23356789999999998642 3566666663 45567899999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ------------------------------------------- 799 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------- 799 (963)
.++.+..-. .++..+...++.++++.++.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888763211 134444555555555555555532
Q ss_pred --------------CCCCceecccCCCCeEECC---CCc-EEEeecccccc
Q 046851 800 --------------CVPRVLHRDVKPSNILLDD---DFN-AYLSDFGLARL 832 (963)
Q Consensus 800 --------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgla~~ 832 (963)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2336799999999999998 455 58999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=3.4e-06 Score=89.10 Aligned_cols=136 Identities=18% Similarity=0.135 Sum_probs=98.6
Q ss_pred cccccCCCc-cEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEeccCCCC
Q 046851 688 NCIGNGGFG-ATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYNYLPGGN 764 (963)
Q Consensus 688 ~~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 764 (963)
+.+..|..| .||+.... ++..+++|+-... ....+.+|+..++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345566666 58998665 4667899976543 3456788999888774 3347788889888899999999999988
Q ss_pred hHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 046851 765 LENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ--------------------------------------------- 799 (963)
Q Consensus 765 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------- 799 (963)
+.+..... ......++.++++.+..||+.
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87765431 122344566666667766631
Q ss_pred ----------CCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 800 ----------CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 800 ----------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 122479999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=3.2e-06 Score=93.30 Aligned_cols=80 Identities=6% Similarity=0.030 Sum_probs=55.2
Q ss_pred cccc-ccCCCccEEEEEEC-------CCcEEEEEEeeccc---chhHHHHHHHHHHHhccC-C--CCeeEEEEeeeCC--
Q 046851 687 SNCI-GNGGFGATYKAEIS-------PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLR-H--PNLVTLIGYHASE-- 750 (963)
Q Consensus 687 ~~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 750 (963)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+++++.+. + ..+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998664 26788999765432 101245677888888774 2 3567788877654
Q ss_pred -CeEEEEEeccCCCChH
Q 046851 751 -TEMFLIYNYLPGGNLE 766 (963)
Q Consensus 751 -~~~~lv~e~~~~gsL~ 766 (963)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00013 Score=79.76 Aligned_cols=140 Identities=19% Similarity=0.287 Sum_probs=79.9
Q ss_pred cccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccC--CCCeeEEEE------eeeCCCeEEEEEec
Q 046851 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR--HPNLVTLIG------YHASETEMFLIYNY 759 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~ 759 (963)
+.|+.|..+.||+....+| .+++|+..... .++..|++++..+. .-.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999988755 58999886521 23344555544442 112333332 11235678999999
Q ss_pred cCCCChH--------------HHHhhhcC----C--------CCCHHHH-------------------------------
Q 046851 760 LPGGNLE--------------NFIQQRST----R--------AVDWRVL------------------------------- 782 (963)
Q Consensus 760 ~~~gsL~--------------~~l~~~~~----~--------~~~~~~~------------------------------- 782 (963)
++|.++. ..+|.... . ...|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11222111 0 1123211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 783 HKIALDIARALAYLHD----------QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 783 ~~i~~~i~~~l~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
..+...+.+++++|++ ...+.++|||+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111224446667763 0234899999999999998888999999997753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.74 E-value=8.2e-05 Score=79.07 Aligned_cols=79 Identities=18% Similarity=0.159 Sum_probs=59.1
Q ss_pred CCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-C--CCeeEEEEeeeCCCeEEEEEec
Q 046851 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-H--PNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+....+.+|.|..+.||+.+..+|+.|+||+...........|..|++.++.+. . --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 456677899999999999999999999999876554444456889999888874 2 2345555553 23789999
Q ss_pred cCCCCh
Q 046851 760 LPGGNL 765 (963)
Q Consensus 760 ~~~gsL 765 (963)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=5.8e-05 Score=84.43 Aligned_cols=75 Identities=13% Similarity=0.061 Sum_probs=48.9
Q ss_pred ccccccCCCccEEEEEEC-CCcEEEEEEeecccc-------hhHHHHHHHHHHHhccCC--C-CeeEEEEeeeCCCeEEE
Q 046851 687 SNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-------QGVQQFHAEIKTLGRLRH--P-NLVTLIGYHASETEMFL 755 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 755 (963)
.+.+|.|..+.||++... +++.|+||....... ....++..|+++++.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 457999999999999654 468899997643211 123456778888887632 3 344566543 334589
Q ss_pred EEeccCCC
Q 046851 756 IYNYLPGG 763 (963)
Q Consensus 756 v~e~~~~g 763 (963)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.71 E-value=2.2e-05 Score=88.47 Aligned_cols=80 Identities=11% Similarity=0.029 Sum_probs=49.7
Q ss_pred CCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcccccccccccccCccccccC---CCCcchhhHHHHHHHHHH
Q 046851 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC---RVSDKADVYSYGVVLLEL 877 (963)
Q Consensus 801 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~el 877 (963)
.+.++|||+++.||+++.++ ++++||+.+..-.+.......-..-...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34999999999999999876 99999998875322111100000011346666655421 112235666888888888
Q ss_pred HcCC
Q 046851 878 LSDK 881 (963)
Q Consensus 878 ltg~ 881 (963)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00016 Score=77.17 Aligned_cols=138 Identities=18% Similarity=0.186 Sum_probs=93.4
Q ss_pred CccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccC---CCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 686 ASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR---HPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 686 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
..+.|+.|....+|+.+.. +..+++|+.... ....+..|++.++.+. ...++++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3467899999999999864 678899987643 3567888999888874 35678888888878889999999998
Q ss_pred CChH--------H---HHhhhcC-C-------------------CCCHHHHH---HHH----------------HHHHHH
Q 046851 763 GNLE--------N---FIQQRST-R-------------------AVDWRVLH---KIA----------------LDIARA 792 (963)
Q Consensus 763 gsL~--------~---~l~~~~~-~-------------------~~~~~~~~---~i~----------------~~i~~~ 792 (963)
..+. + .++.... . .-+|.+.. ++. .++.+.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 1232211 0 12454321 111 111111
Q ss_pred -HHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecc
Q 046851 793 -LAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 793 -l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
...|.. ...|.++|+|+.+.||+++.++ +.|.||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123322 2357999999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.66 E-value=9.2e-06 Score=77.94 Aligned_cols=83 Identities=18% Similarity=0.133 Sum_probs=44.6
Q ss_pred CccEEECcCCcCCCCCccccccCCCCCEEeccCCc-CCCccchhhccC----cccceecccccc-ccccCCcccccCCcc
Q 046851 438 SLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNL-MHDQIPTTLGQM----KGLKYLSLAGNN-LTGSIPSSLGQLQLL 511 (963)
Q Consensus 438 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~-i~~~~~~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L 511 (963)
.|+.||++++.|+..--..+..+++|+.|+|++|. |+...-..++.+ ++|++|+|++|. ||..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 46777777776664444445666666666666664 543333334443 245666666553 443323334455555
Q ss_pred ceecccccc
Q 046851 512 EVLDLSSNS 520 (963)
Q Consensus 512 ~~L~ls~N~ 520 (963)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 555555553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.55 E-value=2.3e-05 Score=75.19 Aligned_cols=84 Identities=14% Similarity=0.143 Sum_probs=61.1
Q ss_pred CCCCEEeccCCcCCCccchhhccCcccceecccccc-ccccCCcccccC----Cccceecccccc-cCCCCChhhhcccc
Q 046851 461 VSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNN-LTGSIPSSLGQL----QLLEVLDLSSNS-LSGLIPDDLENLRN 534 (963)
Q Consensus 461 ~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~ls~N~-l~~~~p~~~~~l~~ 534 (963)
..|+.||++++.|+...-..+..+++|+.|+|++|. |+..--..++.+ ++|++|+|++|. ||..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468888888888876666667788888888888885 664444445554 368888888874 76443345677888
Q ss_pred CCeEEecccc
Q 046851 535 LTVLLLNNNK 544 (963)
Q Consensus 535 L~~L~l~~N~ 544 (963)
|++|+|++++
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888888875
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00015 Score=66.36 Aligned_cols=62 Identities=24% Similarity=0.433 Sum_probs=44.8
Q ss_pred ceecccccccC-CCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCCCCCCcccccccCCCCC
Q 046851 512 EVLDLSSNSLS-GLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPY 590 (963)
Q Consensus 512 ~~L~ls~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~np~ 590 (963)
..++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|+ +|||
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~---------------------~NP~ 67 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLG---------------------ANPW 67 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECC---------------------SSCC
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEec---------------------CCCe
Confidence 36778888886 24454432 368889999999985445667888888888766 4588
Q ss_pred CCCCCC
Q 046851 591 LRPCRA 596 (963)
Q Consensus 591 ~~~c~~ 596 (963)
.|+|..
T Consensus 68 ~CdC~l 73 (130)
T 3rfe_A 68 RCDCRL 73 (130)
T ss_dssp BCSGGG
T ss_pred eccCcc
Confidence 899964
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0021 Score=69.64 Aligned_cols=141 Identities=13% Similarity=0.098 Sum_probs=74.6
Q ss_pred cccccCCCcc-EEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCC--CCeeEEEEeeeCCCeEEEEEeccCCCC
Q 046851 688 NCIGNGGFGA-TYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRH--PNLVTLIGYHASETEMFLIYNYLPGGN 764 (963)
Q Consensus 688 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 764 (963)
+.++.|+... +|+....+|..+++|....... ..+..|++++..+.. -.+.+++.+....+ +++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4465565544 6777654467787876543321 223456666655532 23556666654443 68999998777
Q ss_pred hHHHHhhhc---------------------C---CCCCHHHHH-------H-H------------HHHHHHHHHHHHh--
Q 046851 765 LENFIQQRS---------------------T---RAVDWRVLH-------K-I------------ALDIARALAYLHD-- 798 (963)
Q Consensus 765 L~~~l~~~~---------------------~---~~~~~~~~~-------~-i------------~~~i~~~l~~LH~-- 798 (963)
+.+++.... . ..++..... . + ...+.+.++.+..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 765443210 0 112211100 0 0 0111222233311
Q ss_pred -CCCCCceecccCCCCeEECCC----CcEEEeeccccccc
Q 046851 799 -QCVPRVLHRDVKPSNILLDDD----FNAYLSDFGLARLL 833 (963)
Q Consensus 799 -~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~~ 833 (963)
...+.++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124589999999999999875 68999999988754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00014 Score=71.07 Aligned_cols=63 Identities=16% Similarity=0.245 Sum_probs=28.2
Q ss_pred CCCCCeEeCCCC-cccc----CcCccccCcccccEEEcccCccccc----CcccccCCCCCCEEEccCCccc
Q 046851 95 CTNLEHLDLSGN-YLVG----GIPRSLGNCFQVRSLLLFSNMLEET----IPAELGMLQNLEVLDVSRNSLS 157 (963)
Q Consensus 95 l~~L~~L~Ls~N-~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 157 (963)
-+.|++|+|++| +|.. .+.+++..-+.|+.|+|++|+|... +..++..-+.|++|+|++|.|.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 355666666664 5542 1233333334445555555544422 1222333344444444444443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00086 Score=71.59 Aligned_cols=138 Identities=10% Similarity=0.083 Sum_probs=75.5
Q ss_pred ccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCe-eEEEEeeeCCCeEEEEEecc-CCCC
Q 046851 687 SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNL-VTLIGYHASETEMFLIYNYL-PGGN 764 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 764 (963)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+...++ .++++++. +.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 677999999999999 458888776432111 122567777776642222 45555543 3347899999 6654
Q ss_pred hHHH------------------HhhhcC---CCCC-HHHHHHHHH--------------HHHHHHH----HHHh-CCCCC
Q 046851 765 LENF------------------IQQRST---RAVD-WRVLHKIAL--------------DIARALA----YLHD-QCVPR 803 (963)
Q Consensus 765 L~~~------------------l~~~~~---~~~~-~~~~~~i~~--------------~i~~~l~----~LH~-~~~~~ 803 (963)
+... +|.... ...+ +.....+.. .+.+.+. .+.. ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4321 011100 0011 111111111 0111111 1111 12346
Q ss_pred ceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 804 ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
++|+|+.+.||+ ..++.+.++||+.+..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56667899999988653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00012 Score=71.59 Aligned_cols=43 Identities=16% Similarity=0.158 Sum_probs=18.2
Q ss_pred cccCCCCCCEEEccCCccccCC----CcCccCCCCCceEeecCcCCc
Q 046851 139 ELGMLQNLEVLDVSRNSLSGSI----PVDLGNCSKLAILVLSNLFDT 181 (963)
Q Consensus 139 ~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~l~~n~~~ 181 (963)
++..-+.|+.|+|++|.|.+.. ...+...+.|+.|+|++|.|+
T Consensus 65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3444444444444444443221 122334444444444444444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0012 Score=71.36 Aligned_cols=158 Identities=14% Similarity=0.156 Sum_probs=88.9
Q ss_pred CChHHHHHHcCCCCC-----ccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCC--eeEEE
Q 046851 672 LSFESVVQATGNFNA-----SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPN--LVTLI 744 (963)
Q Consensus 672 ~~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 744 (963)
++.+++...-..|.+ .+.|+.|....+|+....+| .+++|+...... ...+..|+.++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence 556666666666665 23566788889999988766 688998765211 134456777666653212 23333
Q ss_pred Ee------eeCCCeEEEEEeccCCCChHH--------------HHhhhc----CCC---C---CHHHHHH----------
Q 046851 745 GY------HASETEMFLIYNYLPGGNLEN--------------FIQQRS----TRA---V---DWRVLHK---------- 784 (963)
Q Consensus 745 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~----~~~---~---~~~~~~~---------- 784 (963)
.. ....+..+++|+|++|..+.. .++... ... . .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112356789999999865311 112211 000 1 1222110
Q ss_pred --HHHHHHHHHHHHHhC----CCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 785 --IALDIARALAYLHDQ----CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 785 --i~~~i~~~l~~LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
+...+.+.++++++. ..++++|+|+.+.||++++++.+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455666532 234899999999999999876668999987753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0071 Score=65.23 Aligned_cols=157 Identities=15% Similarity=0.180 Sum_probs=89.0
Q ss_pred CChHHHHHHcCCCCC-----ccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCC--eeEEE
Q 046851 672 LSFESVVQATGNFNA-----SNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPN--LVTLI 744 (963)
Q Consensus 672 ~~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 744 (963)
.+.+++...-..|.+ ...++ |....||+....+|+.+++|....... ....+..|+.++..+.... +++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence 455555554444432 23466 888899998877787899998863321 2355667877777764212 34444
Q ss_pred Ee-----eeCCCeEEEEEeccCCCChH-----H------H---Hhhhc-------CCCCCHHHH----HHH---------
Q 046851 745 GY-----HASETEMFLIYNYLPGGNLE-----N------F---IQQRS-------TRAVDWRVL----HKI--------- 785 (963)
Q Consensus 745 ~~-----~~~~~~~~lv~e~~~~gsL~-----~------~---l~~~~-------~~~~~~~~~----~~i--------- 785 (963)
.. ....+..+++|||++|.++. . . ++... ....++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 33 11245668899999885432 1 1 11110 011222211 011
Q ss_pred ------HHHHHHHHHHHHhC----CCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 786 ------ALDIARALAYLHDQ----CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 786 ------~~~i~~~l~~LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
...+.+.++.+.+. ..+.++|||+++.||+++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 234789999999999999 5 899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0025 Score=69.81 Aligned_cols=140 Identities=17% Similarity=0.212 Sum_probs=84.2
Q ss_pred cccccCCCccEEEEEEC--------CCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEe
Q 046851 688 NCIGNGGFGATYKAEIS--------PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 758 (963)
+.+..|-...+|+.... ++..|++|+.... ........+|+++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888899999764 2578999986332 233455678999888774 3223566777654 38999
Q ss_pred ccCCCChHH--------------HH---hhhc---CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 046851 759 YLPGGNLEN--------------FI---QQRS---TRAVD--WRVLHKIALDIAR-------------------ALAYLH 797 (963)
Q Consensus 759 ~~~~gsL~~--------------~l---~~~~---~~~~~--~~~~~~i~~~i~~-------------------~l~~LH 797 (963)
|++|.++.. .+ +... ..... +.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865431 11 1111 11122 4555555544322 233332
Q ss_pred ----hC-CCCCceecccCCCCeEECCC----CcEEEeecccccc
Q 046851 798 ----DQ-CVPRVLHRDVKPSNILLDDD----FNAYLSDFGLARL 832 (963)
Q Consensus 798 ----~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~ 832 (963)
.. ....++|+|+.+.||+++++ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 23489999999999999876 7899999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0015 Score=73.26 Aligned_cols=71 Identities=15% Similarity=0.098 Sum_probs=48.6
Q ss_pred cccccCCCccEEEEEECC--------CcEEEEEEeecccchhHHHHHHHHHHHhccCCCC-eeEEEEeeeCCCeEEEEEe
Q 046851 688 NCIGNGGFGATYKAEISP--------GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPN-LVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 758 (963)
+.|+.|....||+....+ +..|++|+...... ...+..|+.++..+...+ ..++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 567888889999998753 57899998743211 144557888888775323 3567776653 38999
Q ss_pred ccCCCC
Q 046851 759 YLPGGN 764 (963)
Q Consensus 759 ~~~~gs 764 (963)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998644
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0095 Score=58.36 Aligned_cols=101 Identities=15% Similarity=0.135 Sum_probs=67.3
Q ss_pred ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccccc
Q 046851 764 NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG 843 (963)
Q Consensus 764 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 843 (963)
||.+.+..+ +.++++++++.++.|.+++|.-.-... .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence 899999886 467999999999999999987763210 111233457899999999998764 1110
Q ss_pred ccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCC
Q 046851 844 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK 882 (963)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~ 882 (963)
.....+.|||... ...+.+.=|||+|+++|.-+-=..
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1122456788764 345688999999999999876443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0032 Score=70.97 Aligned_cols=74 Identities=15% Similarity=0.036 Sum_probs=47.7
Q ss_pred ccccccCCCccEEEEEECC-CcEEEEEEeecccchhHHHHHHHHHHHhccCCCCe-eEEEEeeeCCCeEEEEEeccCCCC
Q 046851 687 SNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNL-VTLIGYHASETEMFLIYNYLPGGN 764 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 764 (963)
.+.|+.|....+|+....+ +..|++|+......... ...+|+.++..+...++ .++++++.. ..||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3568888899999998875 47888997743321111 12578888888864444 567777632 25999998754
Q ss_pred h
Q 046851 765 L 765 (963)
Q Consensus 765 L 765 (963)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0015 Score=59.58 Aligned_cols=55 Identities=16% Similarity=0.182 Sum_probs=34.6
Q ss_pred ceeccccccc-cCCCccc-ccccceeeccccccccCCccccccCCCCCeEeCCCCccc
Q 046851 54 ELNLAGNLVN-GTVPTFI-GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLV 109 (963)
Q Consensus 54 ~L~Ls~N~l~-~~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~ 109 (963)
.++.+++.++ ..+|..+ .+|++|+|++|+|+ .+|..+|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 5666666665 2334333 35666666666666 777777777777777777777654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0034 Score=69.14 Aligned_cols=139 Identities=14% Similarity=0.148 Sum_probs=75.5
Q ss_pred cccccCCCccEEEEEECC---------CcEEEEEEeecccchhHHHHHHHHHHHhccCCCC-eeEEEEeeeCCCeEEEEE
Q 046851 688 NCIGNGGFGATYKAEISP---------GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPN-LVTLIGYHASETEMFLIY 757 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 757 (963)
+.++.|....+|+....+ +..|++|+....... ......|+++++.+...+ +.++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 457788888999998764 268888877543221 112356777777764223 445665542 26899
Q ss_pred eccCCCChH-------H-------H---Hhhhc--C---CCCC-----HHHHHHHHH--------------------HHH
Q 046851 758 NYLPGGNLE-------N-------F---IQQRS--T---RAVD-----WRVLHKIAL--------------------DIA 790 (963)
Q Consensus 758 e~~~~gsL~-------~-------~---l~~~~--~---~~~~-----~~~~~~i~~--------------------~i~ 790 (963)
||++|.++. + . +|... . ..++ +.....+.. .+.
T Consensus 114 e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (369)
T 3c5i_A 114 EWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKESD 193 (369)
T ss_dssp ECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHHHH
T ss_pred EEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHHHH
Confidence 999875431 1 1 11100 0 0111 111111111 112
Q ss_pred HHHHHHHh-------CCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 791 RALAYLHD-------QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 791 ~~l~~LH~-------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
...+++.. ...+.++|+|+.+.||++++++ +.++||+.+..
T Consensus 194 ~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 194 KFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp HHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred HHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 22334432 1134799999999999998765 89999987753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.05 E-value=0.015 Score=63.04 Aligned_cols=33 Identities=21% Similarity=0.386 Sum_probs=28.9
Q ss_pred CCCceecccCCCCeEECCCCcEEEeeccccccc
Q 046851 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833 (963)
Q Consensus 801 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 833 (963)
.+.++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 348999999999999998889999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.98 E-value=0.045 Score=60.73 Aligned_cols=139 Identities=12% Similarity=0.097 Sum_probs=83.0
Q ss_pred cccccCCCccEEEEEECC--------CcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEe
Q 046851 688 NCIGNGGFGATYKAEISP--------GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 758 (963)
+.+..|-...+|+....+ +..|++|+....... .-...+|+++++.+. +.-..++++.+. -+.|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456778888999998763 578999986543221 112356888777774 222445555443 278999
Q ss_pred ccCCCChHH--------------HH---hhh-----------cCCCCCHHHHHHHHHHH-------------------HH
Q 046851 759 YLPGGNLEN--------------FI---QQR-----------STRAVDWRVLHKIALDI-------------------AR 791 (963)
Q Consensus 759 ~~~~gsL~~--------------~l---~~~-----------~~~~~~~~~~~~i~~~i-------------------~~ 791 (963)
|++|.++.. .+ |.. ...+.-|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865321 11 110 01111244444443322 22
Q ss_pred HHHHHHh---------------------CCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 792 ALAYLHD---------------------QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 792 ~l~~LH~---------------------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 11347899999999999 7888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.37 E-value=0.59 Score=51.56 Aligned_cols=30 Identities=30% Similarity=0.438 Sum_probs=25.4
Q ss_pred CceecccCCCCeEE------CCCCcEEEeecccccc
Q 046851 803 RVLHRDVKPSNILL------DDDFNAYLSDFGLARL 832 (963)
Q Consensus 803 ~ivH~dlk~~Nill------~~~~~~kl~Dfgla~~ 832 (963)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4566799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.84 E-value=2.9 Score=40.93 Aligned_cols=115 Identities=14% Similarity=0.212 Sum_probs=80.3
Q ss_pred CCCCeeEEEEeeeCCCeEEEEEeccCCC-ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCe
Q 046851 736 RHPNLVTLIGYHASETEMFLIYNYLPGG-NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNI 814 (963)
Q Consensus 736 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 814 (963)
.||++++. .+-.+++.+.+.|+.-+.+ +... ++ ..+..++++++.+|+....++++. +|=-+.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 58888865 4556667777777665432 3333 32 277899999999999988766644 6778999999
Q ss_pred EECCCCcEEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 046851 815 LLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALD 885 (963)
Q Consensus 815 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~ 885 (963)
+++.++.+++.-.|+.... +|. ..+...=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999877764332 111 11222334467788899999988876
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 963 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.003 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-11 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 9e-65
Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 22/282 (7%)
Query: 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLV 741
G IG+G FG YK + V V + + Q +Q F E+ L + RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
+GY + ++ ++ + G +L + + T+ + L IA A+ + YLH +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP-SETHATTGVAGTFGYVAPEYAMT-- 858
++HRD+K +NI L +D + DFGLA + S +H ++G+ ++APE
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 859 -CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917
S ++DVY++G+VL EL++ + N ++ +G
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYS--------NINNRDQIIFMVGRGYLSPDL--- 231
Query: 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
+ + L C RP Q++ ++ L
Sbjct: 232 --SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 7e-63
Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 22/274 (8%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
+G G FG + + VA+K L G F AE + +L+H LV
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L ++ +++I Y+ G+L +F++ S + L +A IA +A++ ++
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY- 130
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
+HRD++ +NIL+ D + ++DFGLARL+ +E A G + APE +
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 863 DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922
K+DV+S+G++L E+++ + P + + G ++R
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRMVR---------------- 231
Query: 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956
P + E+ L +C + RPT + L+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-60
Identities = 65/277 (23%), Positives = 119/277 (42%), Gaps = 22/277 (7%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
IG+G FG + VAIK + G + F E + + +L HP LV
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L G + + L++ ++ G L ++++ + L + LD+ +AYL + CV
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEACV- 122
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
+HRD+ N L+ ++ +SDFG+ R + + ++TG + +PE R S
Sbjct: 123 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 863 DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922
K+DV+S+GV++ E+ S+ K + S ++ G L +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRLYK---------------- 223
Query: 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
P V + C + RP +++R+L ++
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-60
Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 22/276 (7%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
+ +G G FG + VAIK + G +F E K + L H LV
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L G + +F+I Y+ G L N++++ R + L ++ D+ A+ YL +
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQF- 121
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
LHRD+ N L++D +SDFGL+R + E ++ G + PE M + S
Sbjct: 122 --LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 863 DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922
K+D++++GV++ E+ S K F+ E GL
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFT-----------------NSETAEHIAQGLRLYR 222
Query: 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
PH +V + C + RPT K ++ + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 2e-58
Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 39/306 (12%)
Query: 671 PLSFESVVQATGNFNAS---------NCIGNGGFGATYKAEI----SPGVLVAIKRLAVG 717
P +FE +A F IG G FG + + VAIK L G
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 718 RF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRA 776
+ + F +E +G+ HPN++ L G T + +I ++ G+L++F++Q +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 124
Query: 777 VDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836
L + IA + YL D +HRD+ NIL++ + +SDFGL+R L
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 837 ETHATT----GVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYG 892
+ T G + APE + + +DV+SYG+V+ E++S + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---RPYWDMT 238
Query: 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952
N P D + L + C + RP Q+V
Sbjct: 239 N--------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 953 RRLKQL 958
L ++
Sbjct: 285 NTLDKM 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 3e-58
Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 26/292 (8%)
Query: 689 CIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY-- 746
IG G FG ++ + G VA+K + R + AEI LRH N++ I
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 747 --HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV--- 801
+ + T+++L+ +Y G+L +++ + + V + K+AL A LA+LH + V
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 802 --PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH---ATTGVAGTFGYVAPEYA 856
P + HRD+K NIL+ + ++D GLA + A GT Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 857 MTC------RVSDKADVYSYGVVLLELLSDKK--ALDPSFSSYGNGFNIVAWGCMLLRQG 908
+AD+Y+ G+V E+ + + +R+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 909 RAKEFFTAGLWDAGPHDDLVEVLH-LAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
++ + + + + V+ + C + + R T ++ + L QL
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 7e-58
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 22/276 (7%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
+ +G G FG + + VAIK L G + F E + + +LRH LV
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L + E ++++ Y+ G+L +F++ + + + L +A IA +AY+
Sbjct: 77 LYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY- 134
Query: 803 RVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVS 862
+HRD++ +NIL+ ++ ++DFGLARL+ +E A G + APE A+ R +
Sbjct: 135 --VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 863 DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922
K+DV+S+G++L EL + + P + G
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMV-----------------NREVLDQVERGYRMPC 235
Query: 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
P + + L C RPT + + L+
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (498), Expect = 5e-57
Identities = 64/277 (23%), Positives = 120/277 (43%), Gaps = 22/277 (7%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLV 741
+ + +G G +G Y+ + VA+K L + V++F E + ++HPNLV
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
L+G E ++I ++ GNL +++++ + + V VL +A I+ A+ YL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--- 133
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
+HRD+ N L+ ++ ++DFGL+RL+ A G + APE +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 862 SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921
S K+DV+++GV+L E+ + + P + E
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYELLEKDYRME 236
Query: 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
P +V L C + S RP+ ++ + + +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-56
Identities = 53/207 (25%), Positives = 104/207 (50%), Gaps = 9/207 (4%)
Query: 683 NFNASNCIGNGGFGATYKAEISP-GVLVAIKRLAVGRFQGV-QQFHAEIKTLGRLRHPNL 740
+F + +G G G +K P G+++A K + + + Q E++ L P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
V G S+ E+ + ++ GG+L+ +++ + ++L K+++ + + L YL ++
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH 124
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
+++HRDVKPSNIL++ L DFG++ L S GT Y++PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTH 179
Query: 861 VSDKADVYSYGVVLLELLSDKKALDPS 887
S ++D++S G+ L+E+ + + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPP 206
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-56
Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 28/278 (10%)
Query: 683 NFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVT 742
IG G FG + G VA+K + Q F AE + +LRH NLV
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 743 LIGYHASE-TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
L+G E ++++ Y+ G+L ++++ R + L K +LD+ A+ YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
+HRD+ N+L+ +D A +SDFGL + ++ + APE +
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKF 177
Query: 862 SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921
S K+DV+S+G++L E+ S + P + + +G +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYKMDA-------- 221
Query: 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
P V + C + RP+ Q+ +L+ ++
Sbjct: 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 28/275 (10%)
Query: 690 IGNGGFGATYKAEI---SPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVTLIG 745
+G G FG+ + + VAIK L G + ++ E + + +L +P +V LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ L+ GG L F+ + + + ++ ++ + YL ++ +
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFV 131
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH--ATTGVAGTFGYVAPEYAMTCRVSD 863
HRD+ N+LL + A +SDFGL++ LG +++ A + + APE + S
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 864 KADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGP 923
++DV+SYGV + E LS + + G ++A+ + QG+ E P
Sbjct: 192 RSDVWSYGVTMWEALSYGQ---KPYKKM-KGPEVMAF----IEQGKRMEC---------P 234
Query: 924 HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
+ E+ L C + RP V +R++
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (485), Expect = 5e-55
Identities = 69/306 (22%), Positives = 121/306 (39%), Gaps = 50/306 (16%)
Query: 683 NFNASNCIGNGGFGATYKAE------ISPGVLVAIKRLAVGRFQGVQ-QFHAEIKTLGRL 735
N IG G FG ++A P +VA+K L +Q F E +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAV------------------ 777
+PN+V L+G A M L++ Y+ G+L F++ S V
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 778 ----DWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833
IA +A +AYL ++ + +HRD+ N L+ ++ ++DFGL+R +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 834 GPSE-THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYG 892
++ A A ++ PE R + ++DV++YGVVL E+ S +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--- 247
Query: 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952
+R G P + +E+ +L +C + RP+ +
Sbjct: 248 -----HEEVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 953 RRLKQL 958
R L+++
Sbjct: 294 RILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-54
Identities = 69/294 (23%), Positives = 115/294 (39%), Gaps = 44/294 (14%)
Query: 690 IGNGGFGATYKAEI------SPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRL-RHPNLV 741
+G G FG +A + VA+K L + +E+K L L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQR----------------STRAVDWRVLHKI 785
L+G +I Y G+L NF++++ A+D L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-V 844
+ +A+ +A+L + +HRD+ NILL + DFGLAR + + G
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 845 AGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904
++APE C + ++DV+SYG+ L EL S + P + ++ G +
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267
Query: 905 LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
L P E+ + C RPT KQ+V+ +++
Sbjct: 268 LS----------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-54
Identities = 62/307 (20%), Positives = 114/307 (37%), Gaps = 50/307 (16%)
Query: 683 NFNASNCIGNGGFGATYKA------EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRL 735
N +G+G FG A + + VA+K L + +E+K + +L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 736 -RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTR------------------- 775
H N+V L+G ++LI+ Y G+L N+++ + +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 776 --AVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL 833
+ + L A +A+ + +L + +HRD+ N+L+ + DFGLAR +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 834 GPSETHAT-TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYG 892
+ ++APE + K+DV+SYG++L E+ S P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 893 NGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVV 952
N + ++ G + + P E+ + C RP+ +
Sbjct: 275 NFYKLIQNGFKMDQ----------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 953 RRLK-QL 958
L QL
Sbjct: 319 SFLGCQL 325
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-54
Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 30/283 (10%)
Query: 685 NASNCIGNGGFGATYKAEI----SPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPN 739
+ + IG G FG Y + + A+K L G V QF E + HPN
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 740 LVTLIGYHA-SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
+++L+G SE ++ Y+ G+L NFI+ + + L L +A+ +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGM---KF 145
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE---THATTGVAGTFGYVAPEY 855
+ +HRD+ N +LD+ F ++DFGLAR + E H TG ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 856 AMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915
T + + K+DV+S+GV+L EL++ P N LL+ R +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-------DVNTFDITVYLLQGRRLLQ--- 255
Query: 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
P + + + C RP+ ++V R+ +
Sbjct: 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 69/284 (24%), Positives = 113/284 (39%), Gaps = 29/284 (10%)
Query: 683 NFNASNCIGNGGFGATYKAEISPG-----VLVAIKRLAVGRFQG-VQQFHAEIKTLGRLR 736
IG G FG YK + V VAIK L G + F E +G+
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYL 796
H N++ L G + M +I Y+ G L+ F++++ L + IA + YL
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYL 126
Query: 797 HDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLL--GPSETHATTGVAGTFGYVAPE 854
+ HRD+ NIL++ + +SDFGL+R+L P T+ T+G + APE
Sbjct: 127 ANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 855 YAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914
+ + +DV+S+G+V+ E+++ + S +
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----------------NHEVMKAI 226
Query: 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
G P D + L + C + RP +V L +L
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 2e-53
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G+G FG YKA+ VL A K + + ++ + EI L HPN+V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E ++++ + GG ++ + + R + + + AL YLHD +++HRD
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRD 135
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD----- 863
+K NIL D + L+DFG++ + + GT ++APE M D
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPYDY 194
Query: 864 KADVYSYGVVLLELLS 879
KADV+S G+ L+E+
Sbjct: 195 KADVWSLGITLIEMAE 210
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-53
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 30/275 (10%)
Query: 690 IGNGGFGATYKAEI---SPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHPNLVTLI 744
+G+G FG K VA+K L + AE + +L +P +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 745 GYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRV 804
G +E+ L+ G L ++QQ R V + + ++ ++ + YL +
Sbjct: 75 GICEAES-WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 805 LHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH--ATTGVAGTFGYVAPEYAMTCRVS 862
+HRD+ N+LL A +SDFGL++ L E + A T + APE + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 863 DKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAG 922
K+DV+S+GV++ E S + + G + A +L +G
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQ---KPYRGM-KGSEVTA----MLEKGERMGC--------- 231
Query: 923 PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957
P E+ L +C + RP V RL+
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-53
Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 28/280 (10%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPN 739
++ IG G +G K S G ++ K L G Q +E+ L L+HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 740 LVTLIGYHASETE--MFLIYNYLPGGNLENFIQQ--RSTRAVDWRVLHKIALDIARALAY 795
+V T ++++ Y GG+L + I + + + +D + ++ + AL
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 796 LHDQ--CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853
H + VLHRD+KP+N+ LD N L DFGLAR+L + A GT Y++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183
Query: 854 EYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913
E ++K+D++S G +L EL + P F+ F+ +R+G+ +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM----PPFT----AFSQKEL-AGKIREGKFRRI 234
Query: 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953
P+ E+ + RP++++++
Sbjct: 235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 64/286 (22%), Positives = 108/286 (37%), Gaps = 30/286 (10%)
Query: 683 NFNASNCIGNGGFGATYKAEISP----GVLVAIKRL---AVGRFQGVQQFHAEIKTLGRL 735
+ +G+G FG + E V VA+K L + + + + F E+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
H NL+ L G M ++ P G+L + +++ L + A+ +A + Y
Sbjct: 69 DHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGY 126
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH--ATTGVAGTFGYVAP 853
L + +HRD+ N+LL + DFGL R L ++ H F + AP
Sbjct: 127 LESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 854 EYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913
E T S +D + +GV L E+ + + + I G L R
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------- 236
Query: 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959
P D ++ ++ V C RPT + L + Q
Sbjct: 237 ---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-52
Identities = 61/272 (22%), Positives = 107/272 (39%), Gaps = 31/272 (11%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGY 746
IG G F YK V VA L + Q+F E + L L+HPN+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 747 HASETE----MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
S + + L+ + G L+ ++++ + + +VL I + L +LH + P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-P 133
Query: 803 RVLHRDVKPSNILLDD-DFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
++HRD+K NI + + + D GLA L V GT ++APE +
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM-YEEKY 189
Query: 862 SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921
+ DVY++G+ +LE+ + + Y N + + F
Sbjct: 190 DESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASF-------- 234
Query: 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953
+ EV + C + R ++K ++
Sbjct: 235 -DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 1e-51
Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 34/277 (12%)
Query: 684 FNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG---VQQFHAEIKTLGRLRHPN 739
F+ IG+G FGA Y A + +VAIK+++ Q Q E++ L +LRHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+ G + E +L+ Y G + + + + + + + LAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
++HRDVK NILL + L DFG A ++ P+ + GT ++APE +
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAM 186
Query: 860 ---RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916
+ K DV+S G+ +EL K L + ++ ++I L+ G E
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQNESPALQSGHWSE---- 241
Query: 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953
+ C RPT + +++
Sbjct: 242 ------------YFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-51
Identities = 72/295 (24%), Positives = 123/295 (41%), Gaps = 41/295 (13%)
Query: 683 NFNASNCIGNGGFGATYKAEISPG---VLVAIKRL-AVGRFQGVQQFHAEIKTLGRL-RH 737
+ + IG G FG KA I + AIKR+ + F E++ L +L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQR--------------STRAVDWRVLH 783
PN++ L+G ++L Y P GNL +F+++ + + + L
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 784 KIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG 843
A D+AR + YL + +HRD+ NIL+ +++ A ++DFGL+R G T
Sbjct: 131 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 185
Query: 844 VAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCM 903
++A E + +DV+SYGV+L E++S + G
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---TPY----CGMTCAELYEK 238
Query: 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
L + R ++ P + EV L C + RP+ Q++ L ++
Sbjct: 239 LPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-51
Identities = 68/275 (24%), Positives = 112/275 (40%), Gaps = 27/275 (9%)
Query: 689 CIGNGGFGATYKAEI----SPGVLVAIKRLAVGRFQGV-QQFHAEIKTLGRLRHPNLVTL 743
CIG G FG ++ +P + VAIK V ++F E T+ + HP++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 744 IGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
IG +E +++I G L +F+Q R +D L A ++ ALAYL + R
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESK---R 128
Query: 804 VLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSD 863
+HRD+ N+L+ + L DFGL+R + S + + ++APE R +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 864 KADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGP 923
+DV+ +GV + E+L + I G P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLPM---------P 231
Query: 924 HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
+ + L C S RP ++ +L +
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-51
Identities = 64/276 (23%), Positives = 103/276 (37%), Gaps = 25/276 (9%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPN 739
+++ +G G +G A VA+K + + R + EI L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+V G+ +L Y GG L + I+ + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP-SETHATTGVAGTFGYVAPEYAMT 858
+ HRD+KP N+LLD+ N +SDFGLA + + + GT YVAPE
Sbjct: 123 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 859 CRVSD-KADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917
DV+S G+VL +L+ + D S C + K+ +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----------CQEYSDWKEKKTYLNP 228
Query: 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953
L L V++ S R T+ + +
Sbjct: 229 WKKIDS-----APLALLHKILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-50
Identities = 53/193 (27%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
IG G G Y A +++ G VAI+++ + + + EI + ++PN+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
E++++ YL GG+L + + + D + + + +AL +LH +V+HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 809 VKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 868
+K NILL D + L+DFG + P ++ +T V GT ++APE K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200
Query: 869 SYGVVLLELLSDK 881
S G++ +E++ +
Sbjct: 201 SLGIMAIEMIEGE 213
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 9e-50
Identities = 63/282 (22%), Positives = 124/282 (43%), Gaps = 29/282 (10%)
Query: 684 FNASNCIGNGGFGATYKAEISP-----GVLVAIKRL-AVGRFQGVQQFHAEIKTLGRLRH 737
F +G+G FG YK P + VAIK L + ++ E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
P++ L+G + + LI +P G L +++++ + + L + IA+ + YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLE 128
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA-TTGVAGTFGYVAPEYA 856
D+ R++HRD+ N+L+ + ++DFGLA+LLG E G ++A E
Sbjct: 129 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 857 MTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916
+ + ++DV+SYGV + EL++ + +G +L + R +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGS---KPY----DGIPASEISSILEKGERLPQ---- 234
Query: 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
P ++V + V C + +RP ++++ ++
Sbjct: 235 ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 4e-49
Identities = 68/277 (24%), Positives = 107/277 (38%), Gaps = 35/277 (12%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHP 738
+F +G G FG Y A ++A+K L + Q E++ LRHP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
N++ L GY T ++LI Y P G + +Q+ D + ++A AL+Y H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS 124
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+ RV+HRD+KP N+LL ++DFG + S + GT Y+ PE
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEG 178
Query: 859 CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918
+K D++S GV+ E L G +E +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLV---------------------GKPPFEANTYQETYKRIS 217
Query: 919 WDAGPHDDLV--EVLHLAVVCTVDSLSTRPTMKQVVR 953
D V L + S RP +++V+
Sbjct: 218 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (436), Expect = 9e-48
Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 9/193 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G G FG ++ E + G A K + + EI+T+ LRHP LV L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+ EM +IY ++ GG L + + + + + + L ++H+ +H D
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149
Query: 809 VKPSNILLDDDFNAY--LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
+KP NI+ + L DFGL L P ++ T GT + APE A V D
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTD 207
Query: 867 VYSYGVVLLELLS 879
++S GV+ LLS
Sbjct: 208 MWSVGVLSYILLS 220
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-46
Identities = 67/294 (22%), Positives = 122/294 (41%), Gaps = 45/294 (15%)
Query: 690 IGNGGFGATYKAE--------ISPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRL-RHPN 739
+G G FG AE + VA+K L + + +E++ + + +H N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQR--------------STRAVDWRVLHKI 785
++ L+G + +++I Y GNL ++Q R + + L
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 786 ALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATT-GV 844
A +AR + YL + +HRD+ N+L+ +D ++DFGLAR + + + T
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 845 AGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904
++APE + ++DV+S+GV+L E+ + + P V L
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEELFKL 249
Query: 905 LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
L++G + P + E+ + C S RPT KQ+V L ++
Sbjct: 250 LKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 10/202 (4%)
Query: 683 NFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHP 738
+F +G G F A E++ AIK L V E + RL HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
V L + +++ +Y G L +I++ + D +I AL YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP-SETHATTGVAGTFGYVAPEYAM 857
+ + +HRD+KP NILL++D + ++DFG A++L P S+ GT YV+PE
Sbjct: 127 KGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 858 TCRVSDKADVYSYGVVLLELLS 879
+D+++ G ++ +L++
Sbjct: 184 EKSACKSSDLWALGCIIYQLVA 205
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 8e-46
Identities = 63/297 (21%), Positives = 113/297 (38%), Gaps = 43/297 (14%)
Query: 690 IGNGGFGATYKA------EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHPNLVT 742
+G G FG +A + + VA+K L G + +E+K L + H V
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 743 LIGYHASETE--MFLIYNYLPGGNLENFIQQR--------------STRAVDWRVLHKIA 786
+ ++ + +I + GNL +++ + + L +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 787 LDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA-TTGVA 845
+A+ + +L + + +HRD+ NILL + + DFGLAR + +
Sbjct: 141 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 846 GTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLL 905
++APE + ++DV+S+GV+L E+ S + P G I C L
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRL 250
Query: 906 RQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPAS 962
++G P E+ + C S RPT ++V L L A+
Sbjct: 251 KEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 55/295 (18%), Positives = 117/295 (39%), Gaps = 37/295 (12%)
Query: 683 NFNASNCIGNGGFGATYKAE------ISPGVLVAIKRL-AVGRFQGVQQFHAEIKTLGRL 735
S +G G FG Y+ P VAIK + + +F E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQR--------STRAVDWRVLHKIAL 787
++V L+G + +I + G+L+++++ + ++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 788 DIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTG-VAG 846
+IA +AYL+ + +HRD+ N ++ +DF + DFG+ R + ++ + G
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 847 TFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906
+++PE + +DV+S+GVVL E+ + + S+ +
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVM 249
Query: 907 QGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ-LQP 960
+G + P + + L +C + RP+ +++ +K+ ++P
Sbjct: 250 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (416), Expect = 4e-45
Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 9/193 (4%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G+G FG ++ E + G + K + EI + +L HP L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
+ EM LI +L GG L + I + + + L ++H+ ++H D
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEH---SIVHLD 152
Query: 809 VKPSNILLD--DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
+KP NI+ + + + DFGLA L P E T T + APE V D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTD 210
Query: 867 VYSYGVVLLELLS 879
+++ GV+ LLS
Sbjct: 211 MWAIGVLGYVLLS 223
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 2e-43
Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 6/200 (3%)
Query: 684 FNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQ-FHAEIKTLGRLRHPNLV 741
++ + +G G F AE LVAIK +A +G + EI L +++HPN+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
L + S ++LI + GG L + I ++ R ++ + A+ YLHD +
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
+ LD+D +SDFGL+++ P + GT GYVAPE
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLAQKPY 186
Query: 862 SDKADVYSYGVVLLELLSDK 881
S D +S GV+ LL
Sbjct: 187 SKAVDCWSIGVIAYILLCGY 206
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 4e-43
Identities = 60/287 (20%), Positives = 99/287 (34%), Gaps = 27/287 (9%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNL 740
+ IG+G FG Y I+ G VAIK V Q H E K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
+ I + +E + ++ L G +LE+ S R + + +A + + Y+H +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK- 122
Query: 801 VPRVLHRDVKPSNIL---LDDDFNAYLSDFGLARLLGPSETHA------TTGVAGTFGYV 851
+HRDVKP N L Y+ DFGLA+ + TH + GT Y
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 852 APEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911
+ + S + D+ S G VL+ ++ R K
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--------TKRQKYERISEKK 232
Query: 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
+ G + L+ C +P + + + L
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 153 bits (388), Expect = 3e-42
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---------QGVQQFHAEIKTL 732
N+ +G G + A+K + V + + E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 733 GRLR-HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIAR 791
++ HPN++ L + + T FL+++ + G L +++ ++ + + KI +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLE 121
Query: 792 ALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYV 851
+ LH ++HRD+KP NILLDDD N L+DFG + L P E V GT Y+
Sbjct: 122 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYL 176
Query: 852 APEYAMTCRV------SDKADVYSYGVVLLELLSDK 881
APE + D++S GV++ LL+
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-42
Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 10/193 (5%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHA 748
+G G FG ++ E S K + V + EI L RH N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRD 808
S E+ +I+ ++ G ++ I + ++ R + + AL +LH + H D
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH---NIGHFD 127
Query: 809 VKPSNILLDDDFNAY--LSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
++P NI+ ++ + +FG AR L P + Y APE VS D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTATD 185
Query: 867 VYSYGVVLLELLS 879
++S G ++ LLS
Sbjct: 186 MWSLGTLVYVLLS 198
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (394), Expect = 4e-42
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAE---IKTLGRL 735
+F+ IG GGFG Y G + A+K L R QG E + +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 736 RHPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAY 795
P +V + + ++ I + + GG+L + Q + A +I L +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEH 122
Query: 796 LHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEY 855
+H++ V ++RD+KP+NILLD+ + +SD GLA + HA+ GT GY+APE
Sbjct: 123 MHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 176
Query: 856 AMTCRVSD-KADVYSYGVVLLELLSDK 881
D AD +S G +L +LL
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (385), Expect = 8e-42
Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 31/290 (10%)
Query: 681 TGNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG---VQQFHAEIKTLGRLR 736
+ + +G GG + A + VA+K L + +F E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 737 HPNLVTLIGYHASETE----MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARA 792
HP +V + +ET +++ Y+ G L + + + + ++ D +A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQA 123
Query: 793 LAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA--TTGVAGTFGY 850
L + H + +HRDVKP+NI++ + DFG+AR + S T V GT Y
Sbjct: 124 LNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 851 VAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910
++PE A V ++DVYS G VL E+L+ + P F+ G + V+ + + R
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGE----PPFT----GDSPVS---VAYQHVRE 229
Query: 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-TMKQVVRRLKQLQ 959
+ + DL V+ + R T ++ L ++
Sbjct: 230 DPIPPSARHEGLS-ADLDAVVLK---ALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-41
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 11/204 (5%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGR-LRH 737
+F +G G FG + AE AIK L V+ E + L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
P L + ++ +F + YL GG+L IQ D A +I L +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH 120
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
+ +++RD+K NILLD D + ++DFG+ + + T GT Y+APE +
Sbjct: 121 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILL 176
Query: 858 TCRVSDKADVYSYGVVLLELLSDK 881
+ + D +S+GV+L E+L +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (383), Expect = 3e-41
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHP 738
+F +G G FG + G A+K L V R + V+ + E L + HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
++ + G ++F+I +Y+ GG L + +++ V A ++ AL YLH
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLHS 122
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+ + ++RD+KP NILLD + + ++DFG A+ + + GT Y+APE T
Sbjct: 123 KDI---IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVST 175
Query: 859 CRVSDKADVYSYGVVLLELLSDKK 882
+ D +S+G+++ E+L+
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-40
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 681 TGNFNASNCIGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG-VQQFHAEIKTLGRLRHP 738
+ + IG G +G A + V VAIK+++ Q Q+ EIK L R RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 739 NLVTLIGYHASET----EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALA 794
N++ + + T + + +L G +L ++ + + + I R L
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLK 123
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT--TGVAGTFGYVA 852
Y+H VLHRD+KPSN+LL+ + + DFGLAR+ P H T T Y A
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 853 PEYAMTCRVSD-KADVYSYGVVLLELLSDK 881
PE + + D++S G +L E+LS++
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-40
Identities = 70/282 (24%), Positives = 113/282 (40%), Gaps = 22/282 (7%)
Query: 688 NCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG-----VQQFHAEIKTLGRLRHPNLV 741
+ +G G F YKA + +VAIK++ +G + EIK L L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 742 TLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
L+ ++ + L+++++ + + L + L YLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
LHRD+KP+N+LLD++ L+DFGLA+ G S A T T Y APE R+
Sbjct: 122 ---LHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 862 SD-KADVYSYGVVLLELL---------SDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911
D+++ G +L ELL SD L F + G L
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953
+ F ++L L + + R T Q ++
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-40
Identities = 63/282 (22%), Positives = 110/282 (39%), Gaps = 17/282 (6%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPN 739
NF IG G +G YKA G +VA+K++ + EI L L HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 740 LVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+V L+ +E +++L++ +L +L+ F+ + + ++ + + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 800 CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTC 859
V LHRD+KP N+L++ + L+DFGLAR G T V +
Sbjct: 122 RV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 860 RVSDKADVYSYGVVLLELL---------SDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910
S D++S G + E++ S+ L F + G +V G + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 911 K-EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQV 951
+ + + L + R + K
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 8e-40
Identities = 50/289 (17%), Positives = 97/289 (33%), Gaps = 29/289 (10%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNL 740
++ IG G FG ++ + VAIK R Q E +T L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 741 VTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
+ + Y E ++ L G +LE+ + R + + A + + +H++
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK- 120
Query: 801 VPRVLHRDVKPSNILLDDDFN-----AYLSDFGLARLLGPSETHA------TTGVAGTFG 849
+++RD+KP N L+ + Y+ DFG+ + T ++GT
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 850 YVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909
Y++ + S + D+ + G V + L G R G
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ--------GLKAATNKQKYERIGE 230
Query: 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958
K+ AG ++ + +H + P + ++
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSKV 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 9e-40
Identities = 59/273 (21%), Positives = 104/273 (38%), Gaps = 30/273 (10%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGY- 746
+G G G + A+K L Q + E++ R + P++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 747 ---HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR 803
+A + ++ L GG L + IQ R +A R +I I A+ YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---N 131
Query: 804 VLHRDVKPSNILLDDDFN---AYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
+ HRDVKP N+L L+DFG A+ + T T YVAPE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEK 189
Query: 861 VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920
D++S GV++ LL P F + +A + + R ++
Sbjct: 190 YDKSCDMWSLGVIMYILLCGY----PPF----YSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953
+ +++ ++ + R T+ + +
Sbjct: 242 SEVSEEVKMLIRN---LLKTEPTQRMTITEFMN 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (360), Expect = 2e-38
Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 19/279 (6%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIG 745
IG G +G YKA+ + G A+K++ + + EI L L+H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
++ + L++ +L + ++ L + +AY HD+ RVL
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
HRD+KP N+L++ + ++DFGLAR G T + + + + S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 866 DVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR------AKEFFTAGLW 919
D++S G + E+++ L P S I + K ++
Sbjct: 183 DIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 920 DAGPHDDLVEVLHLAVVCTVDSL-----STRPTMKQVVR 953
+ P + ++ L + + + + + R T KQ +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 8e-38
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLV 741
++ + IGNG FG Y+A+ G LVAIK++ Q + + E++ + +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 742 TLIGYHASETE------MFLIYNYLPGGNLENFIQ-QRSTRAVDWRVLHKIALDIARALA 794
L + S E + L+ +Y+P R+ + + + + R+LA
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 795 YLHDQCVPRVLHRDVKPSNILLDDDFNAY-LSDFGLARLLGPSETHATTGVAGTFGYVAP 853
Y+H + HRD+KP N+LLD D L DFG A+ L E + + + +
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPE 192
Query: 854 EYAMTCRVSDKADVYSYGVVLLELLS 879
+ DV+S G VL ELL
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLL 218
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRFQG------VQQFHAEIKTLGRLRHPNLVT 742
+G+G F K E S G+ A K + R + + E+ L ++HPN++T
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 743 LIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVP 802
L + ++T++ LI + GG L +F+ ++ ++ + I + YLH
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ-- 133
Query: 803 RVLHRDVKPSNILLDDD----FNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+ H D+KP NI+L D + DFGLA + + GT +VAPE
Sbjct: 134 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNY 190
Query: 859 CRVSDKADVYSYGVVLLELLS 879
+ +AD++S GV+ LLS
Sbjct: 191 EPLGLEADMWSIGVITYILLS 211
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 4e-37
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 690 IGNGGFGATYKAE--ISPGVLVAIKRLAV-----GRFQGVQQFHAEIKTLGRLRHPNLVT 742
IG G +G +KA + G VA+KR+ V G + A ++ L HPN+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 743 LIGYHAS-----ETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
L ET++ L++ ++ ++ + V + + + R L +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
V +HRD+KP NIL+ L+DFGLAR+ + V T Y APE +
Sbjct: 134 SHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYRAPEVLL 188
Query: 858 TCRVSDKADVYSYGVVLLELLSDK 881
+ D++S G + E+ K
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 10/201 (4%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHP 738
+F+ +G G FG + G A+K L V E + L RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 739 NLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
L L + + + Y GG L + + +I AL YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS 123
Query: 799 QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
+ V++RD+K N++LD D + ++DFGL + GT Y+APE
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED 179
Query: 859 CRVSDKADVYSYGVVLLELLS 879
D + GVV+ E++
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMC 200
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-36
Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 8/212 (3%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGY 746
IG G +G +KA+ +VA+KR+ + EI L L+H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLH 806
S+ ++ L++ + + F +D ++ + + L + H + V LH
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNV---LH 124
Query: 807 RDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 866
RD+KP N+L++ + L++FGLAR G + V + S D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 867 VYSYGVVLLELLSDKKALDPSFSSYGNGFNIV 898
++S G + EL + + L P I
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-36
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRL------AVGRFQGVQQFHAEIKTLGRLR--HPNL 740
+G+GGFG+ Y +S + VAIK + G + E+ L ++ +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 741 VTLIGYHASETEMFLIYNYL-PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ 799
+ L+ + LI P +L +FI +R A+ + + A+ + H+
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC 129
Query: 800 CVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMT 858
VLHRD+K NIL+D + L DFG LL + T GT Y PE+
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 183
Query: 859 CRVSDK-ADVYSYGVVLLELLSDK 881
R + A V+S G++L +++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 8e-35
Identities = 44/196 (22%), Positives = 84/196 (42%), Gaps = 13/196 (6%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL---AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG 745
+G G FG + G A+K L V + + ++ E + L + P LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 746 YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVL 805
+ ++++ Y+ GG + + +++ A I YLH ++
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLI 163
Query: 806 HRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKA 865
+RD+KP N+L+D ++DFG A+ T + GT +APE ++ +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 866 DVYSYGVVLLELLSDK 881
D ++ GV++ E+ +
Sbjct: 220 DWWALGVLIYEMAAGY 235
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-34
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 20/215 (9%)
Query: 682 GNFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQG--VQQFHAEIKTLGRLRHP 738
+ IG G FG +KA G VA+K++ + + EIK L L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 739 NLVTLIG--------YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIA 790
N+V LI Y+ + ++L++++ + + ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLL 127
Query: 791 RALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET---HATTGVAGT 847
L Y+H ++LHRD+K +N+L+ D L+DFGLAR ++ + T T
Sbjct: 128 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 848 FGYVAPEYAMTCR-VSDKADVYSYGVVLLELLSDK 881
Y PE + R D++ G ++ E+ +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 5e-33
Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 19/222 (8%)
Query: 683 NFNASNCIGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNL 740
++ +G G + ++A I+ V +K L + ++ EIK L LR PN+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNI 92
Query: 741 VTLIGYHASETE--MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD 798
+TL L++ ++ + + Q + + +I +AL Y H
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIRFYMYEILKALDYCHS 147
Query: 799 QCVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAM 857
+ HRDVKP N+++D + L D+GLA P + + + + PE +
Sbjct: 148 MGIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLV 202
Query: 858 TCRVSD-KADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIV 898
++ D D++S G +L ++ K+ +Y I
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 683 NFNASNCIGNGGFGATYKAE----ISPGVLVAIKRL----AVGRFQGVQQFHAEIKTLGR 734
NF +G G +G + G L A+K L V + + + E + L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 735 LRH-PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARAL 793
+R P LVTL +ET++ LI +Y+ GG L + QR + +I AL
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLAL 142
Query: 794 AYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAP 853
+LH +++RD+K NILLD + + L+DFGL++ ET GT Y+AP
Sbjct: 143 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 854 EYAMTCRVSD--KADVYSYGVVLLELLSDK 881
+ D +S GV++ ELL+
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 43/201 (21%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGY 746
+G+G +GA A + G VAIK+L ++ + E++ L +RH N++ L+
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 747 HASE------TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
+ T+ +L+ ++ + ++ + + + + + L Y+H
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
+ HRD+KP N+ +++D + DFGLAR + T V + R
Sbjct: 142 II---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILNWMR 195
Query: 861 VSDKADVYSYGVVLLELLSDK 881
+ D++S G ++ E+++ K
Sbjct: 196 YTQTVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 46/201 (22%), Positives = 86/201 (42%), Gaps = 19/201 (9%)
Query: 690 IGNGGFGATYKA-EISPGVLVAIKRL--AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY 746
IG+G G A + VAIK+L ++ + E+ + + H N+++L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 747 HASE------TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQC 800
+ +++L+ + + + D + + + + +LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSAG 139
Query: 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCR 860
+ +HRD+KPSNI++ D + DFGLAR G S T T Y APE +
Sbjct: 140 I---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMG 194
Query: 861 VSDKADVYSYGVVLLELLSDK 881
+ D++S G ++ E++ K
Sbjct: 195 YKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-28
Identities = 47/200 (23%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRL--AVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGY 746
+G+G +G+ A G+ VA+K+L ++ + E++ L ++H N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 747 -----HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCV 801
E + +L G +L N ++ + + + + I R L Y+H +
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADI 142
Query: 802 PRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRV 861
HRD+KPSN+ +++D + DFGLAR ++ T VA +
Sbjct: 143 I---HRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 862 SDKADVYSYGVVLLELLSDK 881
+ D++S G ++ ELL+ +
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 2e-26
Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 21/234 (8%)
Query: 690 IGNGGFGATYKAE-ISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIG--- 745
+G G F + A+ + VA+K + G + EIK L R+ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 746 -----------YHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALA 794
+ ++ + G NL I++ R + + +I+ + L
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 795 YLHDQCVPRVLHRDVKPSNILLD-DDFNAYLSDFGLARLLGPSETHATTG-VAGTFGYVA 852
Y+H +C ++H D+KP N+L++ D L +A L T Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 853 PEYAMTCRVSDKADVYSYGVVLLELLSDKKALDP-SFSSYGNGFNIVAWGCMLL 905
PE + AD++S ++ EL++ +P SY + +A LL
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.5 bits (221), Expect = 5e-21
Identities = 26/157 (16%), Positives = 48/157 (30%), Gaps = 19/157 (12%)
Query: 688 NCIGNGGFGATYKAEISPGVLVAIKRLAVG----------RFQGVQQFHAEIKTLGRLRH 737
+G G A + +K VG R G F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 738 PNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLH 797
L L G + +Y + L I + V ++ I +A +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 798 DQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834
+ ++H D+ N+L+ + ++ DF + +G
Sbjct: 121 HRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.2 bits (225), Expect = 5e-20
Identities = 42/177 (23%), Positives = 71/177 (40%), Gaps = 12/177 (6%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+ NL+ L L GN L I + L +L L+L N+I+ P S L EL L N
Sbjct: 218 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 273
Query: 61 LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCF 120
++ P + L + NL +L L N + P + +
Sbjct: 274 QISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 121 QVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+++ L +N + + + L L N+ L N +S P L N +++ L L++
Sbjct: 330 KLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.7 bits (221), Expect = 1e-19
Identities = 62/358 (17%), Positives = 123/358 (34%), Gaps = 51/358 (14%)
Query: 243 DNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELA-------------RELPV 289
D + L K++ + NL ++ S+NQLT
Sbjct: 44 DQVTTLQADRL--GIKSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIA 101
Query: 290 PCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLP 349
+ +++ + P + N E + + + +S + +
Sbjct: 102 DITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSF 161
Query: 350 LRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGIC 409
+ + S + + +++A +N++S P GI
Sbjct: 162 GNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP---LGIL 218
Query: 410 NRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLS 469
LD L +++ N++ + +L LD + NQI P + L L L L
Sbjct: 219 TNLDEL--SLNGNQLKD--IGTLAS-LTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271
Query: 470 WNLMHDQIP--------------------TTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQ 509
N + + P + + +K L YL+L NN++ P + L
Sbjct: 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 510 LLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFN 567
L+ L ++N +S L NL N+ L +N++S P LAN++ ++ ++
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 76.2 bits (186), Expect = 3e-15
Identities = 54/383 (14%), Positives = 116/383 (30%), Gaps = 38/383 (9%)
Query: 101 LDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSI 160
L + + ++ + QV +L ++ + L NL ++ S N L+
Sbjct: 27 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT 82
Query: 161 PVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAV----- 215
P L N +KL ++++N + +
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140
Query: 216 -SSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLF--- 271
+++ ++ L + + +F + L L N L
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200
Query: 272 -LDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNP 330
L ++NQ++ + + ++GN L I T +++ L+ N + P
Sbjct: 201 SLIATNNQISDITPLGIL-TNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP 258
Query: 331 STAYLSLFAKKSQAGTPLPLRGRD--GFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVY 388
+ L T L L + N + + + +
Sbjct: 259 LSGLTKL--------TELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 389 AIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQ 448
+ N +S P +L L +NN+++ + + ++ +L A NQ
Sbjct: 311 YLTLYFNNISDISP---VSSLTKLQRL--FFANNKVSD--VSSLAN-LTNINWLSAGHNQ 362
Query: 449 IVGPIPRGVGELVSLVALNLSWN 471
I P + L + L L+
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.6 bits (143), Expect = 6e-10
Identities = 51/350 (14%), Positives = 95/350 (27%), Gaps = 58/350 (16%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF-HLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAG 59
+ + L + + I G +L +L +N N++T P + L ++ +
Sbjct: 43 LDQVTTLQADRLGIKSI---DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 60 N---------------LVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLS 104
N + L+ + + I + L
Sbjct: 98 NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157
Query: 105 GNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDL 164
+ L + + + + L L NLE L + N +S P+ +
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI 217
Query: 165 GNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRIL 224
L + L D + L + N P +S L L L
Sbjct: 218 LTNLDELSLNGNQLKDIGTLASLTNLTDL-------DLANNQISNLAP--LSGLTKLTEL 268
Query: 225 WAPRATLEGNFP--------------------SNWGACDNLEMLNLGHNFFSGKNLGVLG 264
+ P S NL L L N S + +
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVS 326
Query: 265 PCKNLLFLDLSSNQLTG--ELARELPVPCMTMFDVSGNALSGSIPTFSNM 312
L L ++N+++ LA + + N +S P +N+
Sbjct: 327 SLTKLQRLFFANNKVSDVSSLAN---LTNINWLSAGHNQISDLTP-LANL 372
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.6 bits (143), Expect = 7e-10
Identities = 28/128 (21%), Positives = 44/128 (34%), Gaps = 28/128 (21%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGF--------------------HLKSLRVLNLGFNRITG 40
+ L L L N ++ I P +G +LK+L L L FN I+
Sbjct: 262 LTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD 321
Query: 41 EIPASFSDFVNLEELNLAGNLVNGTVPTFIG--RLKRVYLSFNRLVGSVPSKIGEKCTNL 98
P S L+ L A N V+ V + + + N++ P T +
Sbjct: 322 ISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTPL---ANLTRI 375
Query: 99 EHLDLSGN 106
L L+
Sbjct: 376 TQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 5e-07
Identities = 38/132 (28%), Positives = 51/132 (38%), Gaps = 26/132 (19%)
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLI 525
L + N + D P + + L LSL GN L +L L L LDL++N +S L
Sbjct: 202 LIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 526 PDDLENLRNLTVLLLNNNKLSGKIPSGLANVST--------------------LSAFNVS 565
P L L LT L L N++S P T L+ +
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 315
Query: 566 FNNLSGPLPSSK 577
FNN+S P S
Sbjct: 316 FNNISDISPVSS 327
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 1e-05
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 6/79 (7%)
Query: 490 LSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKI 549
L N+T ++ + L + L + + D +E L NLT + +NN+L+
Sbjct: 27 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT 82
Query: 550 PSGLANVSTLSAFNVSFNN 568
P L N++ L ++ N
Sbjct: 83 P--LKNLTKLVDILMNNNQ 99
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 2e-19
Identities = 48/285 (16%), Positives = 90/285 (31%), Gaps = 38/285 (13%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+ +LDL+ N + I +LK+L L L N+I+ P +F+ V LE L L+ N +
Sbjct: 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 63 NGTVPTFIGRLKRVYLSFNRLVGSVPSKIGE-KCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
L+ + + N + S + L + G + +
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
Query: 122 VRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDT 181
+ + + + TIP G+ +L L + N ++ L + LA L LS +
Sbjct: 152 LSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 182 YEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGA 241
D + + N+ P
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVK----------------------------VPGGLAD 240
Query: 242 CDNLEMLNLGHNFFSG------KNLGVLGPCKNLLFLDLSSNQLT 280
++++ L +N S G + + L SN +
Sbjct: 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 1e-16
Identities = 50/281 (17%), Positives = 87/281 (30%), Gaps = 12/281 (4%)
Query: 73 LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNML 132
L+ V S L VP + + LDL N + N + +L+L +N +
Sbjct: 12 LRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 133 EETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQS 192
+ P L LE L +S+N L +L +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 193 LVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGH 252
+V+ + G A + L + + P G +L L+L
Sbjct: 128 VVELGTNPLKSS----GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDG 180
Query: 253 NFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP-VPCMTMFDVSGNALSGSIPTFSN 311
N + + L NL L LS N ++ L P + ++ N L ++
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD 240
Query: 312 MVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRG 352
V YL N + + + K + + + L
Sbjct: 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 59.7 bits (143), Expect = 5e-10
Identities = 26/145 (17%), Positives = 44/145 (30%), Gaps = 2/145 (1%)
Query: 471 NLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLE 530
+L +++P L L L N +T L+ L L L +N +S + P
Sbjct: 19 DLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 76
Query: 531 NLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSSVLGNPY 590
L L L L+ N+L + L + + + N M + NP
Sbjct: 77 PLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 136
Query: 591 LRPCRAFTLTEPSQDLHGPPSNGNR 615
+ + L
Sbjct: 137 KSSGIENGAFQGMKKLSYIRIADTN 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.2 bits (134), Expect = 6e-09
Identities = 39/186 (20%), Positives = 74/186 (39%), Gaps = 7/186 (3%)
Query: 400 SFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGE 459
F +L+ L + S N++ +LP ++ + + L+ + ++ + G+ +
Sbjct: 69 KISPGAFAPLVKLERLYL--SKNQL-KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125
Query: 460 LVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSN 519
++ + L + MK L Y+ +A N+T +IP L L L L N
Sbjct: 126 MIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 181
Query: 520 SLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL 579
++ + L+ L NL L L+ N +S LAN L +++ N L +
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241
Query: 580 MKCSSV 585
V
Sbjct: 242 KYIQVV 247
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.4 bits (132), Expect = 1e-08
Identities = 27/131 (20%), Positives = 48/131 (36%), Gaps = 2/131 (1%)
Query: 453 IPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLE 512
+P+ + L+L N + + +K L L L N ++ P + L LE
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 513 VLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGP 572
L LS N L L + L+ L V K+ + +GL + + +
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 573 LPSSKNLMKCS 583
+ + + K S
Sbjct: 143 NGAFQGMKKLS 153
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.0 bits (123), Expect = 1e-07
Identities = 57/310 (18%), Positives = 108/310 (34%), Gaps = 42/310 (13%)
Query: 268 NLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIP-TFSNMVCPPVPYLSRNLFE 326
+L + S L ++ ++LP P + D+ N ++ F N+ L N
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 327 SYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQT 386
+P FA + L + N MP + L
Sbjct: 69 KISPGA-----FAPLVK-------------LERLY-LSKNQLKELPEKMPKTLQELRV-- 107
Query: 387 VYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASG 446
++F N++ + + + + +G M K L ++ +
Sbjct: 108 -------HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM-KKLSYIRIAD 159
Query: 447 NQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLG 506
I IP+G+ SL L+L N + +L + L L L+ N+++ SL
Sbjct: 160 TNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 216
Query: 507 QLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG------KIPSGLANVSTLS 560
L L L++N L +P L + + + V+ L+NN +S P ++ S
Sbjct: 217 NTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 275
Query: 561 AFNVSFNNLS 570
++ N +
Sbjct: 276 GVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.0 bits (110), Expect = 6e-06
Identities = 30/158 (18%), Positives = 55/158 (34%), Gaps = 15/158 (9%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
M L + + + I SL L+L N+IT AS NL +L L+ N
Sbjct: 149 MKKLSYIRIADTNITTIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 61 LVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL------VGG 111
++ + L+ ++L+ N+LV ++ + L N +
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVPGGL--ADHKYIQVVYLHNNNISAIGSNDFC 263
Query: 112 IPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVL 149
P + LFSN + + + + + V
Sbjct: 264 PPGYNTKKASYSGVSLFSNPV-QYWEIQPSTFRCVYVR 300
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 6e-13
Identities = 26/81 (32%), Positives = 35/81 (43%), Gaps = 1/81 (1%)
Query: 470 WNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDL 529
+G K L L L N + G++P L QL+ L L++S N+L G IP
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QG 287
Query: 530 ENLRNLTVLLLNNNKLSGKIP 550
NL+ V NNK P
Sbjct: 288 GNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.8 bits (151), Expect = 5e-11
Identities = 40/178 (22%), Positives = 62/178 (34%), Gaps = 11/178 (6%)
Query: 408 ICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALN 467
I + + + + NRI+G +P G K + S N++ G IP L
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204
Query: 468 LSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPD 527
L D N +G + L LDL +N + G +P
Sbjct: 205 SRNMLEGDASVLFGSDKN--TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ 262
Query: 528 DLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNL--SGPLPSSKNLMKCS 583
L L+ L L ++ N L G+IP N+ + N PLP+ C+
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPA------CT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 61.7 bits (148), Expect = 1e-10
Identities = 52/275 (18%), Positives = 94/275 (34%), Gaps = 15/275 (5%)
Query: 15 NGILPDSGFHLKSLRVLNLGFNRITG--EIPASFSDFVNLEELNLAGN----LVNGTVPT 68
G+L D+ + L+L + IP+S ++ L L + G
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 69 FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLF 128
+ +L +Y++ V + L LD S N L G +P S+ + + +
Sbjct: 99 KLTQLHYLYITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157
Query: 129 SNMLEETIPAELGMLQNLEV-LDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRY 187
N + IP G L + +SRN L+G IP N + + + N+ + V +
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLF 217
Query: 188 SRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEM 247
++ N + +LR + G P L
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLR-----NNRIYGTLPQGLTQLKFLHS 272
Query: 248 LNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQ-LTG 281
LN+ N G+ + G + ++N+ L G
Sbjct: 273 LNVSFNNLCGE-IPQGGNLQRFDVSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 6e-10
Identities = 51/266 (19%), Positives = 90/266 (33%), Gaps = 9/266 (3%)
Query: 47 SDFVNLEELNLAGNLVNG--TVPTFIGRLKRV---YLSFNRLVGSVPSKIGEKCTNLEHL 101
+ + L+L+G + +P+ + L + Y+ + K T L +L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 102 DLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIP 161
++ + G IP L + +L N L T+P + L NL + N +SG+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 162 VDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNL 221
G+ SKL ++ + + + + D G +
Sbjct: 167 DSYGSFSKLFT----SMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 222 RILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG 281
G NL L+L +N G L K L L++S N L G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 282 ELARELPVPCMTMFDVSGNALSGSIP 307
E+ + + + + N P
Sbjct: 283 EIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.0 bits (141), Expect = 9e-10
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 533 RNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNL--MKCSSVLGNPY 590
+NL L L NN++ G +P GL + L + NVSFNNL G +P NL S+ N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 591 L 591
L
Sbjct: 304 L 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.6 bits (140), Expect = 1e-09
Identities = 22/58 (37%), Positives = 27/58 (46%), Gaps = 1/58 (1%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
NL LDL N + G LP LK L LN+ FN + GEIP + + A N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 58/261 (22%), Positives = 91/261 (34%), Gaps = 11/261 (4%)
Query: 68 TFIGRLKRVYLSFNRLVG--SVPSKIGEKCTNLEHLDLSGNY-LVGGIPRSLGNCFQVRS 124
T R+ + LS L +PS + L L + G LVG IP ++ Q+
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 125 LLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVL-SNLFDTYE 183
L + + IP L ++ L LD S N+LSG++P + + L + N
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 184 DVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACD 243
Y L + + ++ S D
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE-----GDASVLFGSD 220
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-PVPCMTMFDVSGNAL 302
+LG +G KNL LDL +N++ G L + L + + +VS N L
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 303 SGSIPTFSNMVCPPVPYLSRN 323
G IP N+ V + N
Sbjct: 281 CGEIPQGGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 2/167 (1%)
Query: 12 NLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEE-LNLAGNLVNGTVPTFI 70
N L+G LP S L +L + NRI+G IP S+ F L + ++ N + G +P
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF 194
Query: 71 GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN 130
L ++ +R + + + + +G + L L +N
Sbjct: 195 ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254
Query: 131 MLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177
+ T+P L L+ L L+VS N+L G IP GN + + +N
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.4 bits (98), Expect = 2e-04
Identities = 56/315 (17%), Positives = 94/315 (29%), Gaps = 60/315 (19%)
Query: 145 NLEVLDVSRNSLSG--SIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMND 202
+ LD+S +L IP L N L L + + + + + + + Q ++
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK--LTQLHYLYI 108
Query: 203 DFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGV 262
G IP+ +S + L L L G P + + NL + N SG
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
Query: 263 LGPCKNLLF-LDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLS 321
G L + +S N+LTG++ + D+S N L G
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228
Query: 322 RNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPER 381
+++ LS + N G+LP
Sbjct: 229 AKNSLAFDLGKVGLSKNL-------------------NGLDLRNNRIYGTLPQ------- 262
Query: 382 LGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKF 441
L SL NVS N + G++P G +
Sbjct: 263 -----------------------GLTQLKFLHSL--NVSFNNLCGEIPQ--GGNLQRFDV 295
Query: 442 LDASGNQIV--GPIP 454
+ N+ + P+P
Sbjct: 296 SAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.6 bits (88), Expect = 0.003
Identities = 11/43 (25%), Positives = 18/43 (41%), Gaps = 1/43 (2%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIP 43
+ L L++ N L G +P G +L+ V N+ P
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSP 308
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (157), Expect = 5e-12
Identities = 54/282 (19%), Positives = 79/282 (28%), Gaps = 33/282 (11%)
Query: 26 KSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYL---SFNR 82
+ + + L NRI+ ASF NL L L N++ L + S N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 83 LVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGM 142
+ SV L L L L P ++ L L N L+
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 143 LQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMND 202
L NL L + N +S L L+L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL--------------------------- 184
Query: 203 DFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGV 262
N P A L L L+ L L+ L L N + +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRA 243
Query: 263 LGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSG 304
L SS+++ L + L + ++ N L G
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLPQRL--AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (147), Expect = 1e-10
Identities = 41/180 (22%), Positives = 64/180 (35%), Gaps = 4/180 (2%)
Query: 397 LSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRG 456
S F RL +L ++ +L + R +L++L N +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLD---RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 457 VGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516
+L +L L L N + + L L L N + P + L L L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSS 576
+N+LS L + L LR L L LN+N + + L F S + + LP
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR 267
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (141), Expect = 5e-10
Identities = 47/280 (16%), Positives = 82/280 (29%), Gaps = 12/280 (4%)
Query: 270 LFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIP-TFSNMVCPPVPYLSRNLFESY 328
+ L + +P + GN +S +F + +L N+
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 329 NPSTAYLSLFAKKSQAGTPLPLRG-RDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTV 387
+ + ++ LR + G +
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 388 YAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGN 447
+ DN L F L L ++ NRI+ +P R SL L N
Sbjct: 132 QYLYLQDNALQALPDD-TFRDLGNLTHLFLH--GNRISS-VPERAFRGLHSLDRLLLHQN 187
Query: 448 QIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQ 507
++ P +L L+ L L N + L ++ L+YL L N +
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPL 246
Query: 508 LQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547
L+ SS+ + +P + L + L N L G
Sbjct: 247 WAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (140), Expect = 9e-10
Identities = 50/256 (19%), Positives = 74/256 (28%), Gaps = 26/256 (10%)
Query: 74 KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLE 133
L +VP I + + L GN + S C + L L SN+L
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69
Query: 134 ETIPAELGMLQNLEVLDVSRNSLSGSI-PVDLGNCSKLAILVLSNLFDTYEDV-RYSRGQ 191
A L LE LD+S N+ S+ P +L L L +
Sbjct: 70 RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129
Query: 192 SLVDQPSFMND--------------------DFNFFEGGIPEAVSSLPNLRILWAPRATL 231
+L N N A L +L L + +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 232 EGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC 291
P + L L L N S L P + L +L L+ N +
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249
Query: 292 MTMFDVSGNALSGSIP 307
+ F S + + S+P
Sbjct: 250 LQKFRGSSSEVPCSLP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (138), Expect = 1e-09
Identities = 49/222 (22%), Positives = 79/222 (35%), Gaps = 6/222 (2%)
Query: 394 DNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI 453
N++S P F C L L ++ + A + + + Q+
Sbjct: 41 GNRISH-VPAASFRACRNLTILWLHSNVLAR--IDAAAFTGLALLEQLDLSDNAQLRSVD 97
Query: 454 PRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEV 513
P L L L+L + + P + L+YL L N L + L L
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157
Query: 514 LDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPL 573
L L N +S + L +L LLL+ N+++ P ++ L + NNLS
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 574 PSSKNLMKCSSVL---GNPYLRPCRAFTLTEPSQDLHGPPSN 612
+ ++ L NP++ CRA L Q G S
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSE 259
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 37/184 (20%), Positives = 62/184 (33%), Gaps = 30/184 (16%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+G L L L+ L + P L +L+ L L N + +F D NL L L GN
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 61 LVNGTVPTFIGRLK---RVYLSFNRLVGSVPSKI-----------------------GEK 94
++ L R+ L NR+ P
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 95 CTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRN 154
L++L L+ N V R+ ++ S+ + ++P L ++ ++ N
Sbjct: 224 LRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAAN 279
Query: 155 SLSG 158
L G
Sbjct: 280 DLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 43/280 (15%), Positives = 69/280 (24%), Gaps = 29/280 (10%)
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALS 303
+ + L N S C+NL L L SN L A + +
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD--- 89
Query: 304 GSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNF 363
V P + L + L + L +
Sbjct: 90 ---NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ----------YLYL 136
Query: 364 GGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNR 423
N L + N++S G L SL + +
Sbjct: 137 QDNALQALPDDTFRDLGNL-----THLFLHGNRISSVPERAFRG----LHSLDRLLLHQN 187
Query: 424 IAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQ 483
+ R L L N + + L +L L L+ N
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPL 246
Query: 484 MKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSG 523
L+ + + + S+P L L L++N L G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.2 bits (154), Expect = 3e-11
Identities = 50/483 (10%), Positives = 111/483 (22%), Gaps = 44/483 (9%)
Query: 73 LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL----VGGIPRSLGNCFQVRSLLLF 128
++ + + L + +++ + + L L I +L + L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 129 SNMLEETIPAELG-----MLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYE 183
SN L + + ++ L + L+G+ L + + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR------TLPTLQEL 117
Query: 184 DVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACD 243
+ + Q + + + L
Sbjct: 118 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 177
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALS 303
N ++ G + L + ++ +++ +
Sbjct: 178 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 237
Query: 304 GSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNF 363
+ + + SR +
Sbjct: 238 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 297
Query: 364 GGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNR 423
G P + A S + + N +
Sbjct: 298 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL--QISNNRLEDA 355
Query: 424 IAGQLPAEIGRMCKSLKFLDASGNQI----VGPIPRGVGELVSLVALNLSWNLMHDQIPT 479
+L +G+ L+ L + + + + SL L+LS N + D
Sbjct: 356 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415
Query: 480 TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLR----NL 535
L + S+ LLE L L S + D L+ L +L
Sbjct: 416 QLVE-------SVRQPGC------------LLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
Query: 536 TVL 538
V+
Sbjct: 457 RVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (132), Expect = 2e-08
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 487 LKYLSLAGNNLTGS-IPSSLGQLQLLEVLDLSSNSLSG----LIPDDLENLRNLTVLLLN 541
++ L + L+ + L LQ +V+ L L+ I L L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 542 NNKLSGKIPSGLANVSTLSAFNVSFNNLSG 571
+N+L + + + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 3e-08
Identities = 19/93 (20%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 473 MHDQIPTTLGQMKGLKYLSLAGNNLTG----SIPSSLGQLQLLEVLDLSSNSLSGLIPDD 528
+ + L+ L LA +++ S+ ++L L LDLS+N L
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 529 L-----ENLRNLTVLLLNNNKLSGKIPSGLANV 556
L + L L+L + S ++ L +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 7e-08
Identities = 16/110 (14%), Positives = 35/110 (31%), Gaps = 22/110 (20%)
Query: 3 NLEVLDLEGNLLNGI-LPDSGFHLKSLRVLNLGFNRITGE----IPASFSDFVNLEELNL 57
+++ LD++ L+ + L+ +V+ L +T I ++ L ELNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 58 AGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNY 107
N + + + + ++ L L
Sbjct: 63 RSNELGDVGVHCVLQG-----------------LQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 18/91 (19%), Positives = 30/91 (32%), Gaps = 10/91 (10%)
Query: 97 NLEHLDLSGNYLV-GGIPRSLGNCFQVRSLLLFSNMLEE----TIPAELGMLQNLEVLDV 151
+++ LD+ L L Q + + L L E I + L + L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 152 SRNSLSGSIPVDLG-----NCSKLAILVLSN 177
N L + K+ L L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 4e-07
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 1 MGNLEVLDLEGNLLNGI----LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFV-----N 51
L VL L ++ L + SLR L+L N + + V
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 52 LEELNLAGNLVNGTVPTFIGRLKR 75
LE+L L + + + L++
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 5e-07
Identities = 12/85 (14%), Positives = 28/85 (32%), Gaps = 7/85 (8%)
Query: 50 VNLEELNLAGNLVNGT----VPTFIGRLKRVYLSFNRLVGSVPSKIGE---KCTNLEHLD 102
++++ L++ ++ + + + + V L L + I L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 103 LSGNYLVGGIPRSLGNCFQVRSLLL 127
L N L + Q S +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 14/92 (15%), Positives = 28/92 (30%), Gaps = 10/92 (10%)
Query: 438 SLKFLDASGNQIV-GPIPRGVGELVSLVALNLSWNLMHDQ----IPTTLGQMKGLKYLSL 492
++ LD ++ + L + L + + I + L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 493 AGNNLTGSIPSSLGQL-----QLLEVLDLSSN 519
N L + Q ++ L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 15/77 (19%), Positives = 23/77 (29%), Gaps = 9/77 (11%)
Query: 509 QLLEVLDLSSNSLSGL----IPDDLENLRNLTVLLLNNNKLSGKIPSGLA-----NVSTL 559
+L VL L+ +S + L +L L L+NN L L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 560 SAFNVSFNNLSGPLPSS 576
+ S +
Sbjct: 429 EQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 10/70 (14%), Positives = 23/70 (32%), Gaps = 6/70 (8%)
Query: 244 NLEMLNLGHNFFSGKNLGVLGPC-KNLLFLDLSSNQLTGELARELP-----VPCMTMFDV 297
+++ L++ S L P + + L LT +++ P + ++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 298 SGNALSGSIP 307
N L
Sbjct: 63 RSNELGDVGV 72
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 10/69 (14%), Positives = 23/69 (33%), Gaps = 9/69 (13%)
Query: 1 MGNLEVLDLEGNLLNGI----LPDSGFHLKSLRVLNLGFNRITGEIPASFSDFV-----N 51
+ +V+ L+ L + + +L LNL N + +
Sbjct: 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 85
Query: 52 LEELNLAGN 60
+++L+L
Sbjct: 86 IQKLSLQNC 94
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (148), Expect = 1e-10
Identities = 41/267 (15%), Positives = 82/267 (30%), Gaps = 13/267 (4%)
Query: 55 LNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYL-VGGIP 113
L+L G ++ V + + R P ++H+DLS + + V +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 64
Query: 114 RSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAIL 173
L C ++++L L L + I L NL L++S S S + L
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-LQTLLSSCSRL 123
Query: 174 VLSNLFDTYEDVRYSRGQSLVDQPSFMNDDF-------NFFEGGIPEAVSSLPNLRILWA 226
NL ++ ++ + + + +
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 227 PRATLEGNFPSNWGACDNLEMLNLGH-NFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAR 285
L+ + + + L+ L+L + L LG L L + G L
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 286 ELPVPCMTMFDVSGNALSG-SIPTFSN 311
+ ++ + + + PT N
Sbjct: 244 LK--EALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 6e-09
Identities = 24/130 (18%), Positives = 46/130 (35%), Gaps = 3/130 (2%)
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSG-L 524
L+L+ +H + L +G+ + + + ++ + +DLS++ +
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRV-QHMDLSNSVIEVST 62
Query: 525 IPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKNLMKCSS 584
+ L L L L +LS I + LA S L N+S + L CS
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 585 VLGNPYLRPC 594
+
Sbjct: 123 LDELNLSWCF 132
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 33/274 (12%), Positives = 82/274 (29%), Gaps = 27/274 (9%)
Query: 244 NLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPC--MTMFDVSGNA 301
+ +F P + + +DLS++ + + C + + G
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 302 LSGSIP-TFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIF 360
LS I T + NL + S FA ++ + L +
Sbjct: 83 LSDPIVNTLAKN---------SNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 361 HNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVS 420
+ + S + L + + + + + +++S
Sbjct: 134 FTEKHVQVAVAHVSETITQLNL----------SGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 421 NNRIAGQLPAEIGRMCKSLKFLDASG-NQIVGPIPRGVGELVSLVALNLSWNLMHDQIPT 479
++ + + L+ L S I+ +GE+ +L L + + +
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 480 TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEV 513
+ L +L + ++ T ++G + E+
Sbjct: 244 LK---EALPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.001
Identities = 16/76 (21%), Positives = 28/76 (36%), Gaps = 1/76 (1%)
Query: 23 FHLKSLRVLNL-GFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFN 81
F L L+ L+L I E + L+ L + G + +GT+ L + ++ +
Sbjct: 197 FQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCS 256
Query: 82 RLVGSVPSKIGEKCTN 97
IG K
Sbjct: 257 HFTTIARPTIGNKKNQ 272
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.8 bits (143), Expect = 5e-10
Identities = 22/93 (23%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 467 NLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIP 526
N ++I + L+ L+++ N L +P+ + LE L S N L+ +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAEVP- 320
Query: 527 DDLENLRNLTVLLLNNNKLSGKIPSGLANVSTL 559
E +NL L + N L + P +V L
Sbjct: 321 ---ELPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.3 bits (139), Expect = 2e-09
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 8/89 (8%)
Query: 32 NLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKI 91
N + EI + +LEELN++ N + +P RL+R+ SFN L +++
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIASFNHL-----AEV 319
Query: 92 GEKCTNLEHLDLSGNYL--VGGIPRSLGN 118
E NL+ L + N L IP S+ +
Sbjct: 320 PELPQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 4e-09
Identities = 21/93 (22%), Positives = 40/93 (43%), Gaps = 10/93 (10%)
Query: 12 NLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG 71
N + + SL LN+ N++ E+PA LE L + N + VP
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQ 324
Query: 72 RLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLS 104
LK++++ +N L + + ++E L ++
Sbjct: 325 NLKQLHVEYNPL-----REFPDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 8e-08
Identities = 52/329 (15%), Positives = 93/329 (28%), Gaps = 31/329 (9%)
Query: 266 CKNLLFLDLSSNQLTGELARELP--VPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRN 323
+ L+L++ L+ LP P + S N+L+ +P + + N
Sbjct: 37 DRQAHELELNNLGLS-----SLPELPPHLESLVASCNSLT-ELPELPQSLK--SLLVDNN 88
Query: 324 LFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLG 383
++ + L + LP FL I + + G
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAG 148
Query: 384 KQTVYAIVAGDN--KLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKF 441
+ + N L+ + N L + + L
Sbjct: 149 NNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 208
Query: 442 LDASGNQIVGPIPRGVGELVSLVALNL--------SWNLMHDQIPTTLGQMKGLKYLSLA 493
+ A N + V N D + L
Sbjct: 209 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYY 268
Query: 494 GNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGL 553
N + I S LE L++S+N L +P L L + N L+ ++P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPELP 323
Query: 554 ANVSTLSAFNVSFNNLSG--PLPSS-KNL 579
N+ L +V +N L +P S ++L
Sbjct: 324 QNLKQL---HVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 20/78 (25%), Positives = 35/78 (44%), Gaps = 10/78 (12%)
Query: 435 MCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAG 494
+ SL+ L+ S N+++ +P L L S+N + ++P LK L +
Sbjct: 282 LPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHL-AEVPELPQN---LKQLHVEY 333
Query: 495 NNLTG--SIPSSLGQLQL 510
N L IP S+ L++
Sbjct: 334 NPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 17/79 (21%), Positives = 33/79 (41%), Gaps = 9/79 (11%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
+LE L++ N L + P L L FN + E+P NL++L++ N
Sbjct: 283 PPSLEELNVSNNKLIEL-PAL---PPRLERLIASFNHLA-EVPELPQ---NLKQLHVEYN 334
Query: 61 LVNGTVPTFIGRLKRVYLS 79
+ P ++ + ++
Sbjct: 335 PLR-EFPDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 8/72 (11%)
Query: 511 LEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
L+L++ LS L P+ +L +L + N L+ ++P + L + V NNL
Sbjct: 40 AHELELNNLGLSSL-PELPPHLESLV---ASCNSLT-ELPELPQS---LKSLLVDNNNLK 91
Query: 571 GPLPSSKNLMKC 582
L
Sbjct: 92 ALSDLPPLLEYL 103
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 49/373 (13%), Positives = 92/373 (24%), Gaps = 64/373 (17%)
Query: 95 CTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRN 154
L+L+ L ++P +LE L S N
Sbjct: 37 DRQAHELELNNLGL-------------------------SSLPELPP---HLESLVASCN 68
Query: 155 SLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVD-QPSFMNDDFNFFEGGIPE 213
SL+ +P + V + ++L D P + +
Sbjct: 69 SLT-ELPELPQSL-------------KSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP 114
Query: 214 AVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLG---VLGPCKNLL 270
+ + L+I+ +L+ N +NL + N L
Sbjct: 115 ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 174
Query: 271 FLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNP 330
+ + + L+ + + P S +
Sbjct: 175 KKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDN 234
Query: 331 STAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAI 390
L + + + N S + S+ P L + +
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEE-----L 289
Query: 391 VAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIV 450
+NKL P RL+ L S N + ++P +LK L N +
Sbjct: 290 NVSNNKLI-ELPALP----PRLERL--IASFNHL-AEVPELPQ----NLKQLHVEYNPLR 337
Query: 451 GPIPRGVGELVSL 463
P + L
Sbjct: 338 E-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 14/58 (24%), Positives = 22/58 (37%), Gaps = 8/58 (13%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN 60
L+L L+ LP+ L L N +T E+P +L+ L + N
Sbjct: 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNN 88
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (129), Expect = 1e-08
Identities = 19/86 (22%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 466 LNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLI 525
L L+ N + + + + NNL +LD+S + L
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 526 PDDLENLRNLTVLLLNNNKLSGKIPS 551
LENL+ L N K K+P+
Sbjct: 218 SYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 7e-06
Identities = 25/207 (12%), Positives = 55/207 (26%), Gaps = 5/207 (2%)
Query: 76 VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEET 135
+++ +PS + N L L + + + + N + E
Sbjct: 13 FLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 136 IPAELGMLQNLEVLDV-SRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLV 194
I A++ + + I + +L + + SL
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 195 DQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNF 254
+ D+ N V ILW + ++ + E+ +N
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 255 FSGKNLGVLGPCKNLLFLDLSSNQLTG 281
V + LD+S ++
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHS 215
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 26/233 (11%), Positives = 58/233 (24%), Gaps = 6/233 (2%)
Query: 272 LDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIP-TFSNMVCPPVPYLSRNLFESYNP 330
+++T E+ +LP L FS +S+N
Sbjct: 13 FLCQESKVT-EIPSDLP-RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70
Query: 331 STAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAI 390
+ + +L A + S + P+ ++ +
Sbjct: 71 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 130
Query: 391 VAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIV 450
+ ++ N ++ + + + N +
Sbjct: 131 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE 190
Query: 451 GPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPS 503
V L++S +H L +K L+ S NL +P+
Sbjct: 191 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 10/39 (25%), Positives = 13/39 (33%)
Query: 140 LGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL 178
+LD+SR + L N KL NL
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 5e-04
Identities = 25/221 (11%), Positives = 56/221 (25%), Gaps = 5/221 (2%)
Query: 256 SGKNLGVL--GPCKNLLFLDLSSNQLTGELARELP-VPCMTMFDVSGNALSGSIPTFSNM 312
+ + +N + L +L + ++S N + I
Sbjct: 16 QESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 75
Query: 313 VCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSL 372
P + + + Q + +
Sbjct: 76 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135
Query: 373 PSMPVAPERLGKQTVYAIVAGDNKLSGSFPG-NMFGICNRLDSLMVNVSNNRIAGQLPAE 431
++ + + + L+ + N +N+S+N +LP +
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195
Query: 432 IGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNL 472
+ LD S +I G+ L L A + +NL
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST-YNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 12/52 (23%), Positives = 20/52 (38%), Gaps = 3/52 (5%)
Query: 524 LIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPS 575
L D +L ++ ++ GL N+ L A + NL LP+
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 10/56 (17%), Positives = 19/56 (33%), Gaps = 3/56 (5%)
Query: 494 GNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKI 549
+ +T IPS L + L L + +L + ++ N + I
Sbjct: 17 ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 8/53 (15%), Positives = 21/53 (39%), Gaps = 3/53 (5%)
Query: 85 GSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIP 137
+P+ + + LD+S + L N ++R+ ++ + +P
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLP 239
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 2e-08
Identities = 26/128 (20%), Positives = 52/128 (40%), Gaps = 10/128 (7%)
Query: 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHD 475
++++++ + + ++ + LD S N++ P + L L L S N + +
Sbjct: 2 VLHLAHKDLTV--LCHLEQL-LLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 476 QIPTTLGQMKGLKYLSLAGNNLTG-SIPSSLGQLQLLEVLDLSSNSLS---GLIPDDLEN 531
+ L+ L L N L + L L +L+L NSL G+ E
Sbjct: 58 VDGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 532 LRNLTVLL 539
L +++ +L
Sbjct: 116 LPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 3e-08
Identities = 24/125 (19%), Positives = 43/125 (34%), Gaps = 7/125 (5%)
Query: 29 RVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVP 88
RVL+L +T + + + L+L+ N + P L+ + +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALEN 57
Query: 89 SKIGEKCTNLEHLDLSGNYLVGG-IPRSLGNCFQVRSLLLFSNML---EETIPAELGMLQ 144
L+ L L N L + L +C ++ L L N L E ML
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 145 NLEVL 149
++ +
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 4e-08
Identities = 32/125 (25%), Positives = 45/125 (36%), Gaps = 7/125 (5%)
Query: 6 VLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGT 65
VL L L + L + L+L NR+ P + + LE L + N +
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 66 VPTFIGRLKR-VYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVG--GIPRSLGNCF-Q 121
+ + L NRL S + C L L+L GN L GI L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 122 VRSLL 126
V S+L
Sbjct: 119 VSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 25/127 (19%), Positives = 50/127 (39%), Gaps = 12/127 (9%)
Query: 440 KFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTG 499
+ L + + + + +L+ + L+LS N + P L ++ L+ L ++
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNAL 55
Query: 500 SIPSSLGQLQLLEVLDLSSNSLSGL-IPDDLENLRNLTVLLLNNNKLSG------KIPSG 552
+ L L+ L L +N L L + L +L L N L ++
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 553 LANVSTL 559
L +VS++
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 9e-07
Identities = 32/107 (29%), Positives = 40/107 (37%), Gaps = 26/107 (24%)
Query: 488 KYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNL------------ 535
+ L LA +LT + L QL L+ LDLS N L L P L LR L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 536 ----------TVLLLNNNKL-SGKIPSGLANVSTLSAFNVSFNNLSG 571
LLL NN+L L + L N+ N+L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 3e-04
Identities = 25/136 (18%), Positives = 40/136 (29%), Gaps = 33/136 (24%)
Query: 148 VLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFF 207
VL ++ L+ + L + L LS+ N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSH---------------------------NRL 32
Query: 208 EGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHN-FFSGKNLGVLGPC 266
P +++L L +L A L+ L L +N + L C
Sbjct: 33 RALPPA-LAALRCLEVLQASDNA--LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSC 89
Query: 267 KNLLFLDLSSNQLTGE 282
L+ L+L N L E
Sbjct: 90 PRLVLLNLQGNSLCQE 105
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 20/74 (27%), Positives = 29/74 (39%), Gaps = 4/74 (5%)
Query: 469 SWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDD 528
S T L + L L N ++ P L L L + L +N +S + P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212
Query: 529 LENLRNLTVLLLNN 542
L N NL ++ L N
Sbjct: 213 LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 19/62 (30%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 116 LGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVL 175
L N ++ +L N + + P L L NL + + N +S P L N S L I+ L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 176 SN 177
+N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 7e-06
Identities = 39/265 (14%), Positives = 77/265 (29%), Gaps = 46/265 (17%)
Query: 14 LNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRL 73
+N I PD L + + G + +T + + +D + L+ G V
Sbjct: 9 INVIFPDPA--LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT---------- 54
Query: 74 KRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLE 133
+ + + NL L+L N + P +
Sbjct: 55 -----TIEGV---------QYLNNLIGLELKDNQITDLAPLKNLTKITEL------ELSG 94
Query: 134 ETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSL 193
+ + + + S + L S L +L + + + L
Sbjct: 95 NPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL-------YLDLNQITNISPL 147
Query: 194 VDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHN 253
+ + +++L L L A + S + NL ++L +N
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNN 205
Query: 254 FFSGKNLGVLGPCKNLLFLDLSSNQ 278
S + L NL + L +NQ
Sbjct: 206 QISD--VSPLANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 22/66 (33%), Positives = 31/66 (46%), Gaps = 4/66 (6%)
Query: 500 SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTL 559
S + L L L L N +S + P L +L NL + L NN++S P LAN S L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 560 SAFNVS 565
++
Sbjct: 220 FIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 14/57 (24%), Positives = 27/57 (47%), Gaps = 4/57 (7%)
Query: 1 MGNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNL 57
+ L L + N ++ I P + L +L ++L N+I+ P ++ NL + L
Sbjct: 172 LSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 10/63 (15%), Positives = 28/63 (44%), Gaps = 4/63 (6%)
Query: 483 QMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNN 542
+ ++ +N+T ++ + L + L ++ + + ++ L NL L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 543 NKL 545
N++
Sbjct: 73 NQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 4/62 (6%)
Query: 460 LVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSN 519
L + + + + + D + T + G+ LS G +T +I + L L L+L N
Sbjct: 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDN 73
Query: 520 SL 521
+
Sbjct: 74 QI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 15/58 (25%), Positives = 24/58 (41%), Gaps = 4/58 (6%)
Query: 435 MCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSL 492
L L A N+I P + L +L+ ++L N + D P L L ++L
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 53.0 bits (125), Expect = 8e-08
Identities = 39/316 (12%), Positives = 80/316 (25%), Gaps = 26/316 (8%)
Query: 235 FPSNWGACDNLEMLNLGHNFFSGKNLGVLGP----CKNLLFLDLSSNQLTGELARELPVP 290
+ D+++ + L N + L K+L + S + E+P
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG-RVKDEIPEA 81
Query: 291 CMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPL 350
+ S+ P F S + +L L +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 351 RGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFGICN 410
LA+ S+ E + L
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 411 RLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSW 470
++ L++ ++ L + P R + L+
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL---------GLND 252
Query: 471 NLMHDQIPTTLGQM------KGLKYLSLAGNNLTGSIPSSL-----GQLQLLEVLDLSSN 519
L+ + + GL+ L L N + +L ++ L L+L+ N
Sbjct: 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 312
Query: 520 SLSGLIPDDLENLRNL 535
S D ++ +R +
Sbjct: 313 RFSEE-DDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.5 bits (116), Expect = 1e-06
Identities = 11/89 (12%), Positives = 34/89 (38%), Gaps = 5/89 (5%)
Query: 485 KGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSG----LIPDDLENLRNLTVLLL 540
K LK ++ + S+ + L + ++ + LS N++ + +++ + ++L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNL 569
++ + L + L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 39/352 (11%), Positives = 78/352 (22%), Gaps = 45/352 (12%)
Query: 134 ETIPAELGMLQNLEVLDVSRNSLSG----SIPVDLGNCSKLAILVLSNLFDTYEDVRYSR 189
+++ A L +++ + +S N++ + ++ + L I S++F
Sbjct: 21 KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGR------- 73
Query: 190 GQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLN 249
+ D+ + +A+ P L +
Sbjct: 74 ----------VKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL------IDFL 117
Query: 250 LGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTF 309
H L G + Q + P + N L
Sbjct: 118 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 177
Query: 310 SNMVCPPVPYLSRNLFESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFS 369
L + + A H
Sbjct: 178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237
Query: 370 GSLPSMPVAPERLGKQTVYAIVAGDNKLSG---SFPGNMFGICNRLDSLMVNVSNNRI-- 424
+ L D LS + + F + + + N I
Sbjct: 238 ALKSWPNLRELGLN----------DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 287
Query: 425 --AGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMH 474
L I L FL+ +GN+ V E+ + + L
Sbjct: 288 DAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGELDE 338
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 3e-05
Identities = 41/319 (12%), Positives = 82/319 (25%), Gaps = 34/319 (10%)
Query: 26 KSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGR-------LKRVYL 78
KSL++ + + A + +++E+ L+GN + ++ L+
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 79 SFNRLVGSVPSKIGEKCTNLEHLDLSGNYLV---GGIPRSLGNCFQVRSLLLFSNMLEET 135
S V +I E L L L + L + E
Sbjct: 67 SDIFTG-RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125
Query: 136 IPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVD 195
+ L ++R ++ N L ++ ++
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185
Query: 196 QPSFMNDD---FNFFEGGIPEAVSSLPNLRILWAPRATLE-------GNFPSNWGACDNL 245
+ EG + L + L + NL
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 246 EMLNLGHNFFSGKNLGVLG------PCKNLLFLDLSSNQLTGELARELP------VPCMT 293
L L S + + L L L N++ + R L +P +
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 294 MFDVSGNALSGSIPTFSNM 312
+++GN S +
Sbjct: 306 FLELNGNRFSEEDDVVDEI 324
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 5e-05
Identities = 18/92 (19%), Positives = 37/92 (40%), Gaps = 8/92 (8%)
Query: 462 SLVALNLSWNLMHDQ----IPTTLGQMKGLKYLSLAGNNLTG----SIPSSLGQLQLLEV 513
S+ +L + + + + L + +K + L+GN + + ++ + LE+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 514 LDLSSNSLSGLIPDDLENLRNLTVLLLNNNKL 545
+ S + + E LR L LL KL
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 16/71 (22%), Positives = 30/71 (42%), Gaps = 8/71 (11%)
Query: 72 RLKRVYLSFNRL----VGSVPSKIGEKCTNLEHLDLSGNYL--VGGIPRSLGNCFQVRSL 125
L+ + L +N + V ++ + I EK +L L+L+GN + + F R
Sbjct: 274 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGR 333
Query: 126 LLFSNM--LEE 134
+ +EE
Sbjct: 334 GELDELDDMEE 344
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.0 bits (123), Expect = 1e-07
Identities = 15/65 (23%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 480 TLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLL 539
+ ++ ++ NLT ++P L + +L LS N L L LT L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 540 LNNNK 544
L+ +
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 43/199 (21%), Positives = 64/199 (32%), Gaps = 28/199 (14%)
Query: 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
+LEV + + L + PD K +L+L N + A+ + L +LNL
Sbjct: 11 SHLEV-NCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 62 VNGTVPTFI-----------------------GRLKRVYLSFNRLVGSVPSKIGEKCTNL 98
+ V + S+P L
Sbjct: 67 LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126
Query: 99 EHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSG 158
+ L L GN L P L ++ L L +N L E L L+NL+ L + NSL
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY- 185
Query: 159 SIPVDLGNCSKLAILVLSN 177
+IP L L
Sbjct: 186 TIPKGFFGSHLLPFAFLHG 204
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 43/207 (20%), Positives = 60/207 (28%), Gaps = 51/207 (24%)
Query: 409 CNRLDSLM-VNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALN 467
+++ S + VN + LP ++ K L S N + + L LN
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 468 LSWNLMHDQI---------------------------------------------PTTLG 482
L + L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 483 QMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNN 542
+ L+ L L GN L P L LE L L++N+L+ L L L NL LLL
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 543 NKLSGKIPSGLANVSTLSAFNVSFNNL 569
N L IP G L + N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 33/186 (17%), Positives = 57/186 (30%), Gaps = 20/186 (10%)
Query: 135 TIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNL---------------- 178
+P +L ++ +L +S N L L ++L L L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 179 --FDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFP 236
+ + + ++ FN A+ L L+ L+ L+ P
Sbjct: 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141
Query: 237 SNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFD 296
LE L+L +N + G+L +NL L L N L +
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAF 201
Query: 297 VSGNAL 302
+ GN
Sbjct: 202 LHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 35/233 (15%), Positives = 51/233 (21%), Gaps = 35/233 (15%)
Query: 266 CKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIP-TFSNMVCPPVPYLSRNL 324
+ L ++ LT L +LP T+ +S N L T L R
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 325 FESYNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGK 384
L L L +
Sbjct: 67 LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR--------------- 111
Query: 385 QTVYAIVAGDNKLSGSFPGNMFGICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDA 444
G L L LP + L+ L
Sbjct: 112 ----------------LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155
Query: 445 SGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNL 497
+ N + + L +L L L N ++ IP L + L GN
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 1e-06
Identities = 24/103 (23%), Positives = 43/103 (41%), Gaps = 5/103 (4%)
Query: 468 LSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPD 527
L+ L+ +Q ++ + L L G + I + L + +D S N + L D
Sbjct: 3 LTAELI-EQAAQYTNAVR-DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--D 57
Query: 528 DLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570
LR L LL+NNN++ + L+ ++ N+L
Sbjct: 58 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 3e-05
Identities = 23/147 (15%), Positives = 46/147 (31%), Gaps = 9/147 (6%)
Query: 9 LEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGN-LVNGTVP 67
L L+ + R L+L +I I + + ++ + N +
Sbjct: 3 LTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 59
Query: 68 TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLL 127
+ RLK + ++ NR+ + +L L L+ N LV + + L
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLD-QALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118
Query: 128 FSNMLEETIPAE----LGMLQNLEVLD 150
+ + + VLD
Sbjct: 119 ILRNPVTNKKHYRLYVIYKVPQVRVLD 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 2e-06
Identities = 28/124 (22%), Positives = 44/124 (35%), Gaps = 7/124 (5%)
Query: 438 SLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNL 497
S + LD G + V LN + M + + L L+L+ N L
Sbjct: 23 SQQALDLKGL----RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRL 77
Query: 498 TG--SIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLAN 555
+ S + + L++L+LS N L D L L L+ N LS
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
Query: 556 VSTL 559
+S +
Sbjct: 138 ISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 4e-04
Identities = 25/120 (20%), Positives = 44/120 (36%), Gaps = 7/120 (5%)
Query: 461 VSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNS 520
S AL+L L D L L+ +++ ++ + L L+LS+N
Sbjct: 22 GSQQALDLK-GLRSDPD---LVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNR 76
Query: 521 LSGL--IPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLPSSKN 578
L L + ++ NL +L L+ N+L + L + N+LS
Sbjct: 77 LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 6e-04
Identities = 33/156 (21%), Positives = 49/156 (31%), Gaps = 32/156 (20%)
Query: 2 GNLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNL 61
G+ + LDL+G + L VLN + + + L LNL+ N
Sbjct: 22 GSQQALDLKGLRSDPDL----VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNR 76
Query: 62 VNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQ 121
+ S I +K NL+ L+LSGN L +
Sbjct: 77 LYRLDD--------------------MSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116
Query: 122 VRSLLLFSNMLEETIPAE-------LGMLQNLEVLD 150
+ L L N L +T + L LD
Sbjct: 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 15/78 (19%), Positives = 37/78 (47%), Gaps = 10/78 (12%)
Query: 476 QIPTTLGQMKGLKYLS------LAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDL 529
+PT + Q+ + L ++T ++ + +L ++ + +++ + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 530 ENLRNLTVLLLNNNKLSG 547
+ L N+T L LN NKL+
Sbjct: 65 QYLPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 31/207 (14%), Positives = 67/207 (32%), Gaps = 22/207 (10%)
Query: 86 SVPSKIGE-----KCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAEL 140
+VP+ I + +L + + ++ + ++ ++ ++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 141 GMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFM 200
L N+ L ++ N L+ P+ L + + D + +SL + + +
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 201 NDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNW-----------GACDNLEMLN 249
+D E++ N + L + L+ L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLY 184
Query: 250 LGHNFFSGKNLGVLGPCKNLLFLDLSS 276
L N S +L L KNL L+L S
Sbjct: 185 LSKNHIS--DLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 9e-05
Identities = 32/195 (16%), Positives = 61/195 (31%), Gaps = 30/195 (15%)
Query: 3 NLEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLV 62
+L+ + + + L S+ + + I N+ +L L GN +
Sbjct: 25 ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKL 80
Query: 63 NGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIP--------- 113
+ LK + F + L+ L L N +
Sbjct: 81 TD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 114 -----------RSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV 162
L ++ +L L N + + +P L L L+ L +S+N +S +
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR- 194
Query: 163 DLGNCSKLAILVLSN 177
L L +L L +
Sbjct: 195 ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 12/49 (24%), Positives = 22/49 (44%), Gaps = 2/49 (4%)
Query: 470 WNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSS 518
L + L+ L L+ N+++ +L L+ L+VL+L S
Sbjct: 163 LEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 15/62 (24%), Positives = 27/62 (43%), Gaps = 8/62 (12%)
Query: 483 QMKGLKYLSLAGNNLTGSIP------SSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLT 536
+ K + L G IP ++L L+ + L LS+N++ + L + NL
Sbjct: 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLR 73
Query: 537 VL 538
+L
Sbjct: 74 IL 75
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 25/186 (13%), Positives = 55/186 (29%), Gaps = 17/186 (9%)
Query: 96 TNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNS 155
L + + ++ + QV +L ++ + L NL ++ S N
Sbjct: 18 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 73
Query: 156 LSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAV 215
L+ P+ + + + L + + + + +
Sbjct: 74 LTDITPLKNLTKLV---------DILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 216 SSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLS 275
+L NL L T+ + + +L L L LD+S
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLN----FSSNQVTDLKPLANLTTLERLDIS 180
Query: 276 SNQLTG 281
SN+++
Sbjct: 181 SNKVSD 186
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 22/71 (30%), Positives = 32/71 (45%), Gaps = 4/71 (5%)
Query: 468 LSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPD 527
L + + L + L+ L+ + N +T P L L LE LD+SSN +S +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDI--S 188
Query: 528 DLENLRNLTVL 538
L L NL L
Sbjct: 189 VLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 14/58 (24%), Positives = 26/58 (44%), Gaps = 4/58 (6%)
Query: 490 LSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSG 547
L N+T ++ + L + L + + D +E L NLT + +NN+L+
Sbjct: 23 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD 76
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 963 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.22 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.59 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.45 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.58 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.23 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.86 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.8 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=422.46 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=206.2
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
.+|++.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++||||++++|+|...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4788999999999999999999889999999997543 345789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+|+|.+++... ...+++..+..|+.|+|+||+|+|++ +|+||||||+||++++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99999998764 35689999999999999999999999 999999999999999999999999999988765554445
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
....||+.|+|||++.+..++.++|||||||++|||+|++.|+.... ...+....... + ....
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~-~---------~~~~ 222 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVVEDIST-G---------FRLY 222 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-------CHHHHHHHHHH-T---------CCCC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHh-c---------CCCC
Confidence 55679999999999999999999999999999999999655554221 11222222211 1 1122
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
.|..++.++.+++.+||+.||++||||+||+++|++++++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 3445567899999999999999999999999999998654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-49 Score=424.06 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=221.6
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
.++|++.+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 357889999999999999999875 58899999987543 3467899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+++|+|.+++.......+++..+..|+.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999877677899999999999999999999999 9999999999999999999999999999987655555
Q ss_pred ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 840 ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+..... .... ...... ...
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~-~~~i~~---------~~~ 234 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQV-YELLEK---------DYR 234 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHH-HHHHHT---------TCC
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHH-HHHHhc---------CCC
Confidence 55566789999999999999999999999999999999998877653321 1111 111211 222
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQPA 961 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~~ 961 (963)
...+...+.++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 334455677899999999999999999999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=419.10 Aligned_cols=255 Identities=26% Similarity=0.431 Sum_probs=215.3
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.+.||+|+||+||+|.+++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4788999999999999999999988999999997543 345789999999999999999999998865 56789999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+|+|.+++.......+++.++.+|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+..........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999988776656699999999999999999999999 999999999999999999999999999998765554555
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
....||+.|+|||++.+..++.++|||||||++|||+||+.|+..... ..+.... ...+ ....
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~-i~~~---------~~~~ 230 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQN-LERG---------YRMV 230 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHH-HHTT---------CCCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHH-HHhc---------CCCC
Confidence 566799999999999999999999999999999999997766553221 1121111 1111 1222
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.+...+.++.+++.+||+.||++||||+||++.|+++
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 3445667899999999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=407.99 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=218.5
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 58999999999999999999999888999999986543 35789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+|++.+++.... ..+++..+.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999987653 4589999999999999999999999 999999999999999999999999999987765555555
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.... ...+ .+.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~-i~~~---------~~~ 220 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEH-IAQG---------LRL 220 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHH-HHTT---------CCC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHH-HHhC---------CCC
Confidence 56779999999999999999999999999999999998 788886432 1222222 2222 122
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
..|...+.++.+++.+||+.||++|||++|++++|.+|
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 23445667899999999999999999999999999765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-49 Score=421.01 Aligned_cols=267 Identities=27% Similarity=0.441 Sum_probs=207.1
Q ss_pred CCChHHHHHHc---------CCCCCccccccCCCccEEEEEECC-C---cEEEEEEeeccc-chhHHHHHHHHHHHhccC
Q 046851 671 PLSFESVVQAT---------GNFNASNCIGNGGFGATYKAEISP-G---VLVAIKRLAVGR-FQGVQQFHAEIKTLGRLR 736 (963)
Q Consensus 671 ~~~~~~~~~~~---------~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~ 736 (963)
+++++++..++ ++|++.+.||+|+||+||+|.+.. | ..||||++.... ....++|.+|++++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 34555555554 346677899999999999998752 2 368999886543 344578999999999999
Q ss_pred CCCeeEEEEeeeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEE
Q 046851 737 HPNLVTLIGYHASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 816 (963)
Q Consensus 737 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 816 (963)
|||||+++|++.+.+..++||||+++|+|.+++... ...+++.++..|+.|||+||+|||++ +|+||||||+|||+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 999999999999999999999999999999998864 34589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCc----ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 046851 817 DDDFNAYLSDFGLARLLGPSETH----ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSY 891 (963)
Q Consensus 817 ~~~~~~kl~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~ 891 (963)
+.++.+||+|||+|+........ ...+..||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-- 239 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-- 239 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999876543322 2223468999999999999999999999999999999998 8999864321
Q ss_pred CCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 892 GNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.+...... . ..+...+..++..+.+++.+||+.||++||||+||++.|+++.
T Consensus 240 ------~~~~~~i~-~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 240 ------QDVINAIE-Q---------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp ------HHHHHHHH-T---------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------HHHHHHHH-c---------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 12222111 1 1222345566778999999999999999999999999998863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=412.80 Aligned_cols=260 Identities=25% Similarity=0.416 Sum_probs=207.1
Q ss_pred cCCCCCccccccCCCccEEEEEECCCcEEEEEEeecc--cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVG--RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++||||++++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 358999999999999999999875 35999998654 34456789999999999999999999998765 56899999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++|+|.+++.... ..+++.++..|+.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999997643 4599999999999999999999999 999999999999999999999999999987654322
Q ss_pred -cccccccccccccCcccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 839 -HATTGVAGTFGYVAPEYAMT---CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 839 -~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||..... ...+......+.....
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~p~- 230 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRGYLSPD- 230 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHHTSCCCC-
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCCCCc-
Confidence 23445689999999999864 3578999999999999999999999974321 1112222222211100
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
....+..++.++.+++.+||+.||++||||+||+++|+.++.
T Consensus 231 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 ----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111234456789999999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=407.13 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=212.8
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999976 469999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+++.+. .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence 999999988753 489999999999999999999999 99999999999999999999999999998875433 23
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWD 920 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (963)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+........... ..
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~~--------~~ 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTP--------EL 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSC--------CC
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCC--------CC
Confidence 345679999999999999999999999999999999999999996332 11222222222211 11
Q ss_pred CCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 921 AGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 921 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234456788999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=401.63 Aligned_cols=246 Identities=28% Similarity=0.408 Sum_probs=208.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 36999999999999999999775 68999999987542 234577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++.... .+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999998753 599999999999999999999999 9999999999999999999999999999865432
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+......+ ..
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~-~~-------- 220 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISR-VE-------- 220 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHT-TC--------
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHc-CC--------
Confidence 2334679999999999999999999999999999999999999996432 1222222211 11
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+.++.+++.+||+.||++|||++|++++
T Consensus 221 --~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11233456688999999999999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=409.73 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=205.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||+||+|... +|+.||||++..... +..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 47999999999999999999775 699999999976543 3346789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC-C
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE-T 838 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-~ 838 (963)
+++|+|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+...... .
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999753 4599999999999999999999999 99999999999999999999999999998764332 2
Q ss_pred cccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||...... ...+ ........
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~-~~~~~~~~-------- 224 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEY-SDWKEKKT-------- 224 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT------SHHH-HHHHTTCT--------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH------HHHH-HHHhcCCC--------
Confidence 23445689999999999988776 57899999999999999999999744221 1111 11111110
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........+.++.+++.+||+.||++|||++|++++
T Consensus 225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011122345678899999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=408.01 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=197.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC--CCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--ETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 756 (963)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999764 68999999987653 2345678999999999999999999998864 4568999
Q ss_pred EeccCCCChHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 757 YNYLPGGNLENFIQQR--STRAVDWRVLHKIALDIARALAYLHDQC--VPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
|||+++|+|.+++.+. ....+++.+++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999753 2467999999999999999999999871 11499999999999999999999999999988
Q ss_pred cCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccc
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKE 912 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (963)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||.... ..+.... ...+...
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~-i~~~~~~- 232 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGK-IREGKFR- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH-HHHTCCC-
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHH-HHcCCCC-
Confidence 754332 2345689999999999999999999999999999999999999996431 1222222 2222111
Q ss_pred eeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 913 FFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 913 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+.++.+++.+||+.||++|||++|++++
T Consensus 233 --------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1233456689999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=406.35 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=209.6
Q ss_pred CCCCCccc-cccCCCccEEEEEEC---CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNC-IGNGGFGATYKAEIS---PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~-ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|.+.+. ||+|+||+||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 35666674 999999999999764 35679999997543 3446789999999999999999999999875 468999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++... ...+++.++..++.|+|+||+|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999998654 34689999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 837 ETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 837 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+... ....+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~-~i~~~----- 228 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMA-FIEQG----- 228 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHH-HHHTT-----
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHHH-HHHcC-----
Confidence 332 2234568999999999999999999999999999999998 8999974321 11111 22222
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.+...+..++.++.+++.+||+.||++||||.+|++.|+.+
T Consensus 229 ----~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 229 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12233456677899999999999999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=407.26 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=208.7
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLP 761 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 761 (963)
++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4799999999999999999999988899999997543 345789999999999999999999999865 56889999999
Q ss_pred CCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCccc
Q 046851 762 GGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHAT 841 (963)
Q Consensus 762 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 841 (963)
+|++.+++.......++|.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999999876666799999999999999999999999 999999999999999999999999999987765554455
Q ss_pred ccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccCCC
Q 046851 842 TGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDA 921 (963)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (963)
....||+.|+|||++.+..++.++||||||+++|||++|+.|+..... ..+........ ....
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~~----------~~~~ 234 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERG----------YRMP 234 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTT----------CCCC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhc----------CCCC
Confidence 556799999999999999999999999999999999998777653321 12222222211 1122
Q ss_pred CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 922 GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 922 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.+..+++++.+++.+||+.||++||+|++|++.|++.-
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 34456678999999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=406.25 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=205.7
Q ss_pred CCCCCccccccCCCccEEEEEECCC-----cEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPG-----VLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
..|+..++||+|+||+||+|.++.+ ..||||++..... ....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999977532 4799999865433 334678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
||||+++|++.+++... ...+++.++..++.|+++|++|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999988764 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SET--HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..+.... .
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~~~~~-i-------- 226 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKA-I-------- 226 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHH-H--------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHHHHHH-H--------
Confidence 322 223345689999999999999999999999999999999998777653221 1122211 1
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
....+...+..++.++.+++.+||+.||++||||.||++.|+++.
T Consensus 227 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 227 -NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp -HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 122233445566778999999999999999999999999998763
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=404.69 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=210.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
+.|++.+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999765 68999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+++.+.. ..+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-ccc
Confidence 9999999987643 4599999999999999999999999 9999999999999999999999999999765321 122
Q ss_pred cccccccccccCccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 841 TTGVAGTFGYVAPEYAM-----TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.....||+.|+|||++. +..++.++||||+||++|||++|+.||...... +......... ..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--------~~~~~i~~~~-~~---- 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--------RVLLKIAKSE-PP---- 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHHHHHHSC-CC----
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCC-CC----
Confidence 33567999999999984 456789999999999999999999999743221 1122222211 11
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
....+...+.++.+++.+||+.||++|||++|++++
T Consensus 234 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 ---TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112234456789999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=401.26 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=201.3
Q ss_pred cccccCCCccEEEEEEC---CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEeccCC
Q 046851 688 NCIGNGGFGATYKAEIS---PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYLPG 762 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 762 (963)
++||+|+||+||+|.++ .++.||||+++... ....++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999764 35689999986532 3345689999999999999999999999965 457899999999
Q ss_pred CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc--
Q 046851 763 GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA-- 840 (963)
Q Consensus 763 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-- 840 (963)
|+|.++++.. ..+++.++..|+.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999999864 4599999999999999999999999 99999999999999999999999999998775443322
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.. .....+ .+
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~-~~i~~~---------~~ 228 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVT-AMLEKG---------ER 228 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHH-HHHHTT---------CC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHH-HHHHcC---------CC
Confidence 234578999999999999999999999999999999998 899987431 11211 122222 12
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQ 957 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 957 (963)
...+..++.++.+++.+||+.||++||||++|++.|+.
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 23345567789999999999999999999999988875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=398.47 Aligned_cols=251 Identities=26% Similarity=0.425 Sum_probs=202.6
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC-CCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS-ETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|+++ |+.||||+++... ..++|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 36888999999999999999986 8899999996543 34789999999999999999999999855 46689999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
++|+|.+++..+....+++..+++|+.||++||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 999999999876555689999999999999999999999 9999999999999999999999999999865432
Q ss_pred cccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccccC
Q 046851 841 TTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLW 919 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (963)
.....+++.|+|||++.+..++.++||||||+++|||+| |++||..... .....++ .. ..+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~~~i----~~---------~~~ 218 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRV----EK---------GYK 218 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHH----TT---------TCC
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHH----Hc---------CCC
Confidence 223457899999999999999999999999999999998 5766653211 1122221 11 122
Q ss_pred CCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 920 DAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 920 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
...+...+.++.+++.+||+.||++||||.|++++|++++.
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 23445566789999999999999999999999999998763
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=399.70 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=206.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999774 69999999997542 234577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999999875 3599999999999999999999999 99999999999999999999999999998875433
Q ss_pred -CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 838 -THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 838 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+...... ....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~-~~~~------ 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKII-KLEY------ 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-TTCC------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHH-cCCC------
Confidence 223445689999999999999999999999999999999999999997432 112222221 1111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVR 953 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 953 (963)
..+...+.++.+++.+||+.||++|||++|+.+
T Consensus 228 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 123345667899999999999999999998643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=410.98 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=208.8
Q ss_pred CCCCCccccccCCCccEEEEEECC------CcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP------GVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (963)
++|++.++||+|+||+||+|++.. ...||||++.... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 579999999999999999997642 2369999886543 33446789999999998 899999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCC
Q 046851 754 FLIYNYLPGGNLENFIQQRST---------------------RAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPS 812 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 812 (963)
++||||+++|+|.++++.+.. ..+++.++..++.|+++||+|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999976432 3589999999999999999999999 9999999999
Q ss_pred CeEECCCCcEEEeecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 046851 813 NILLDDDFNAYLSDFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSS 890 (963)
Q Consensus 813 Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~ 890 (963)
||+++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876543332 2334578999999999999999999999999999999998 89998743221
Q ss_pred CCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 046851 891 YGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLK 956 (963)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 956 (963)
+........+ .....+..++.++.+|+.+||+.||++||||+||+++|.
T Consensus 274 --------~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 --------ANFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --------HHHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --------HHHHHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1111222222 222345566778999999999999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=390.83 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=198.5
Q ss_pred CCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC----CCeEEEEE
Q 046851 685 NASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS----ETEMFLIY 757 (963)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 757 (963)
++.+.||+|+||+||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56778999999999999765 68899999987543 3345678999999999999999999999854 45689999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecccCCCCeEEC-CCCcEEEeecccccccC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPR--VLHRDVKPSNILLD-DDFNAYLSDFGLARLLG 834 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~ 834 (963)
||+++|+|.+++.+. ..+++.++..++.|+++||+|||++ + |+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999875 3589999999999999999999998 6 99999999999996 58899999999998643
Q ss_pred CCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccccee
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFF 914 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (963)
.. ......||+.|||||++.+ .++.++||||+||++|||++|+.||..... ..... .....+.....
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~-~~i~~~~~~~~- 233 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIY-RRVTSGVKPAS- 233 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHH-HHHTTTCCCGG-
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHH-HHHHcCCCCcc-
Confidence 22 2345689999999999876 599999999999999999999999963321 11111 12222211111
Q ss_pred ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 915 TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 915 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+.....++.+++.+||+.||++|||++|++++
T Consensus 234 -------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 -------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 112234568899999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=408.45 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=206.0
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||+||+|... +|+.||+|+++... ....+++.+|++++++++|||||+++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457999999999999999999764 68999999997653 3345678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
|+++|+|.+++.+.. .+++.++..++.|+++||.|||+ + +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 999999999998753 49999999999999999999997 6 8999999999999999999999999999876422
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh-----------
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR----------- 906 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 906 (963)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-----LELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH-----HHHHC----------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHHHhcCCcccCCcccc
Confidence 2335689999999999999999999999999999999999999997543210 0000000000
Q ss_pred -----------cCcc----cceec---cccCCCCC-hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 -----------QGRA----KEFFT---AGLWDAGP-HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 -----------~~~~----~~~~~---~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... .+..+ .......+ ...+.++.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000 00000 00000011 1234578899999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-46 Score=397.99 Aligned_cols=251 Identities=26% Similarity=0.351 Sum_probs=193.0
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
+.|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56999999999999999999775 689999999975543 2345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC---CCCcEEEeecccccccCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD---DDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~~~ 836 (963)
++||+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||++. +++.+||+|||+|+.....
T Consensus 89 ~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 89 VSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred cCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999763 4599999999999999999999999 999999999999995 5789999999999876433
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
. .....+||+.|||||++.+..++.++||||+||++|||++|+.||..... .+......... .
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~-~------ 226 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILKAE-Y------ 226 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHTTC-C------
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHhccC-C------
Confidence 2 23346799999999999999999999999999999999999999974321 12222222111 1
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..........+.++.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111223455688999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=394.92 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=199.3
Q ss_pred CCCCCccccccCCCccEEEEEECC----CcEEEEEEeecccc-hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||.||+|.+.. +..||||++..... ...+.|.+|++++++++||||++++|++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 479999999999999999997642 45789998865433 345679999999999999999999999964 678999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|++.+++... ...+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 86 ~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999988764 34689999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.........||+.|+|||++.+..++.++|||||||++|||++ |.+||...... +.... ...+.
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~-i~~~~------ 226 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGR-IENGE------ 226 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHH-HHTTC------
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHH-HHcCC------
Confidence 5555555678999999999999999999999999999999998 78888643221 11111 12221
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
....+...+..+.+++.+||+.||++|||+.||+++|+++.
T Consensus 227 ---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11234456678999999999999999999999999998763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-46 Score=401.57 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=213.2
Q ss_pred HcCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccch-hHHHHHHHHHHHhccCCCCeeEEEEeeeCCCe
Q 046851 680 ATGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETE 752 (963)
Q Consensus 680 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (963)
+.++|++.+.||+|+||+||+|++. +++.||||++...... ..++|.+|++++++++||||++++++|...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4568999999999999999999764 3578999999765433 35679999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccC
Q 046851 753 MFLIYNYLPGGNLENFIQQRS----------------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVK 810 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 810 (963)
.++||||+++|+|.+++.... ...+++.++..|+.|++.||+|||++ +|+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 999999999999999997532 23488999999999999999999999 99999999
Q ss_pred CCCeEECCCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCC
Q 046851 811 PSNILLDDDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK-ALDPSF 888 (963)
Q Consensus 811 ~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~-p~~~~~ 888 (963)
|+|||++.++.+||+|||+|+....... .......|++.|+|||.+.+..++.++|||||||++|||++|.. ||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999987644332 22344678999999999999999999999999999999999964 554321
Q ss_pred CCCCCCcchhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 889 SSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
..+.... ...+.. ...+..++.++.+|+.+||+.||++||||.||+++|++|.
T Consensus 248 --------~~e~~~~-v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 --------HEEVIYY-VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp --------HHHHHHH-HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------HHHHHHH-HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1222222 222221 2234456678999999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-45 Score=402.61 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=211.4
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47999999999999999999764 69999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC--CCCcEEEeecccccccCCCCC
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD--DDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~~~ 838 (963)
+||+|.+++.... ..+++.++..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+......
T Consensus 106 ~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 106 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 9999999996543 4599999999999999999999999 999999999999996 46789999999998875433
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
......||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+......... .. .+
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~-~~--~~--- 245 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCD-WN--MD--- 245 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC-CC--SC---
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-CC--CC---
Confidence 2334579999999999999999999999999999999999999996431 222222222211 00 00
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.......+.++.+++.+||+.||++|||++|++++
T Consensus 246 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 -DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112345678999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-45 Score=395.50 Aligned_cols=245 Identities=26% Similarity=0.374 Sum_probs=202.9
Q ss_pred CCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 683 NFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
.|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 589999999999999999976 4689999999975532 334678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+++|++..++... ..+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 99999998776553 4699999999999999999999999 999999999999999999999999999986532
Q ss_pred cccccccccccccCcccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceec
Q 046851 839 HATTGVAGTFGYVAPEYAMT---CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFT 915 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (963)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.... ..+......... ...
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~-~~~--- 233 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNE-SPA--- 233 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSC-CCC---
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC-CCC---
Confidence 234579999999999864 458899999999999999999999996331 112222222221 111
Q ss_pred cccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 916 AGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 916 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..+...+..+.+++.+||+.||++|||++|++++
T Consensus 234 -----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 -----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -----CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1122345678999999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-45 Score=400.12 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=211.7
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||.||+|.. .+|+.||||++......+.+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4799999999999999999976 479999999998776666678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC--CCCcEEEeecccccccCCCCC
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD--DDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~~~ 838 (963)
+||+|.+++... ...+++.++..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.......
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 999999988654 34589999999999999999999999 999999999999998 678999999999998764432
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..+......... .. .
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~-~~------~ 247 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCD-WE------F 247 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCC-CC------C
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-CC------C
Confidence 334579999999999999999999999999999999999999997432 122222222211 10 1
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........+.++.+|+.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223455678999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=390.55 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=207.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc------hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF------QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
+.|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999874 699999999865422 23578999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC----cEEEeecccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF----NAYLSDFGLA 830 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla 830 (963)
+||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||+|
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999998753 599999999999999999999999 999999999999998776 4999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+......... .
T Consensus 165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~-~ 233 (293)
T d1jksa_ 165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVN-Y 233 (293)
T ss_dssp EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTC-C
T ss_pred hhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcC-C
Confidence 8765332 33445799999999999999999999999999999999999999974321 22222221111 0
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ... ..+...+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~--~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 E--FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C--CCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C--CCc----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000 0112345678899999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=396.94 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=204.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCc----EEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGV----LVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFL 755 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (963)
.+|++.++||+|+||+||+|.+. +|+ +||||++... ..+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 36999999999999999999765 343 6899988643 334567899999999999999999999999875 5678
Q ss_pred EEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCC
Q 046851 756 IYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGP 835 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 835 (963)
++||+.+|+|.+++... ...+++..+.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 88999999999998765 45699999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 836 SETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 836 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.... ......||+.|+|||++.+..++.++|||||||++|||+| |++||+..... +.. .....+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--------~~~-~~i~~~----- 229 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EIS-SILEKG----- 229 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------GHH-HHHHHT-----
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--------HHH-HHHHcC-----
Confidence 4333 2334568999999999999999999999999999999998 67777633211 111 112221
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.+...+..++.++.+++.+||+.||++|||+.|++++|+.+
T Consensus 230 ----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 22234456677899999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=398.36 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=201.6
Q ss_pred cCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC-CC
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS-ET 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 751 (963)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|...+.++ +|+||+.+++++.. ..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357999999999999999999753 346899999875433 3456778888888777 68999999998765 45
Q ss_pred eEEEEEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 752 EMFLIYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
..++||||+++|+|.++++... ...+++.++..++.||++||+|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 6899999999999999997643 23588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCCCCCCCCc
Q 046851 818 DDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK-ALDPSFSSYGNGF 895 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~-p~~~~~~~~~~~~ 895 (963)
.++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||.. ||......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~----- 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----- 243 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999987654333 23445679999999999999999999999999999999999754 56432111
Q ss_pred chhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 896 NIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
+........+. ....+...+.++.+++.+||+.||++||||+||+++|+++.+
T Consensus 244 ---~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 ---EEFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ---HHHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 12222222221 122344556789999999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=391.48 Aligned_cols=248 Identities=23% Similarity=0.273 Sum_probs=209.8
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4699999999999999999976 479999999997542 234577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||++||+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++++|.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999998753 589999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
......+||+.|+|||++.+..++.++||||+||++|||++|++||.... ..+.........
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~~~--------- 221 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE--------- 221 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---------
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhcCC---------
Confidence 23445689999999999999999999999999999999999999997432 122222222211
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
...|...+.++.+++.+||+.||++||+ +.|++++
T Consensus 222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1123445667889999999999999995 7888764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=385.62 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=201.9
Q ss_pred CCCCCccccccCCCccEEEEEECC----CcEEEEEEeecc---cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP----GVLVAIKRLAVG---RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|++.+.||+|+||.||+|++.. +..||||++... ..+..++|.+|++++++++||||++++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 469999999999999999997542 247899988654 234457899999999999999999999999764 678
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||+++|++.+++..+. ..+++..+..++.|+|+||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999987754 3599999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCc--ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 835 PSETH--ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 835 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
..... ......|+..|+|||++.+..++.++||||||+++|||+| |+.||... +..+......+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~~--- 231 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEG--- 231 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSC---
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHHHHHhCC---
Confidence 44332 2234567889999999999999999999999999999998 89998633 2223333333332
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.....+...+..+.+++.+||+.||++||||.||.+.|++.|
T Consensus 232 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 232 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 112233455678999999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=389.67 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=205.9
Q ss_pred ccccccCCCccEEEEEECCC----cEEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeC-CCeEEEEEecc
Q 046851 687 SNCIGNGGFGATYKAEISPG----VLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS-ETEMFLIYNYL 760 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 760 (963)
.++||+|+||+||+|.+.++ ..||||++... .....++|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987532 36899998643 44556789999999999999999999999765 56899999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC--
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET-- 838 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-- 838 (963)
++|+|.+++... ....++..+.+++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999998864 34578899999999999999999999 999999999999999999999999999987654322
Q ss_pred -cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 839 -HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 839 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .++..... .+.
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-------~~~~~~i~-~g~-------- 251 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDITVYLL-QGR-------- 251 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHH-TTC--------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-------HHHHHHHH-cCC--------
Confidence 2233457899999999999999999999999999999999998887643222 11122211 121
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
+...+..++..+.+++.+||+.||++||+|.||+++|+++..
T Consensus 252 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112234456789999999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-44 Score=386.45 Aligned_cols=245 Identities=26% Similarity=0.371 Sum_probs=207.9
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 36999999999999999999874 69999999997542 344678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||++||++..++... ..+++..+..++.|++.|++|||++ +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999999874 4588999999999999999999999 9999999999999999999999999999876432
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+.........
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~--------- 217 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE--------- 217 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC---------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHcCC---------
Confidence 334689999999999999999999999999999999999999997432 122222222211
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+...+.++.+++.+|++.||.+|| |++|++++
T Consensus 218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 112334456788999999999999996 89999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=389.65 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=208.6
Q ss_pred CCCCCccccccCCCccEEEEEECC--------CcEEEEEEeecccc-hhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCC
Q 046851 682 GNFNASNCIGNGGFGATYKAEISP--------GVLVAIKRLAVGRF-QGVQQFHAEIKTLGRL-RHPNLVTLIGYHASET 751 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (963)
++|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 478999999999999999996532 35799999976543 3457788999999888 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 752 EMFLIYNYLPGGNLENFIQQRS--------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
..++||||+++|+|.+++..+. ...+++.++.+++.|++.||+|||++ +|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999997653 24589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCCCCc
Q 046851 818 DDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS-DKKALDPSFSSYGNGF 895 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~ 895 (963)
.++.+||+|||+++....... .......|++.|+|||.+.+..++.++||||||+++|||++ |.+||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 999999999999987654332 23344678999999999999999999999999999999998 5777653221
Q ss_pred chhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 896 NIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
. .+......+ .....+...+.++.+++.+||+.||++||||.||++.|+++.+
T Consensus 244 --~-~~~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 --E-ELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp --H-HHHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --H-HHHHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1 122222222 2223344556789999999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=392.90 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=205.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCc--EEEEEEeecc-cchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGV--LVAIKRLAVG-RFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.++||+|+||+||+|.+. +|. .||||++... ..+..+.|.+|+++++++ +||||++++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 47889999999999999999775 344 4788887543 334456799999999998 799999999999999999999
Q ss_pred EeccCCCChHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcE
Q 046851 757 YNYLPGGNLENFIQQR--------------STRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 822 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 822 (963)
|||+++|+|.++++.. ....+++.++.+++.|||+|+.|+|++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 245689999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCCCCCCCCcchhhHH
Q 046851 823 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK-ALDPSFSSYGNGFNIVAWG 901 (963)
Q Consensus 823 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~-p~~~~~~~~~~~~~~~~~~ 901 (963)
||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||... +..+..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------~~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELY 236 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--------CHHHHH
Confidence 999999998654222 2233468999999999999999999999999999999999865 45422 112222
Q ss_pred HHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccC
Q 046851 902 CMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 959 (963)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~ 959 (963)
.. ...+ .+...+...+.++.+++.+||+.||++||||+||+++|+++.
T Consensus 237 ~~-i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 237 EK-LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HH-GGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-HHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 1111 122334556778999999999999999999999999998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=385.77 Aligned_cols=270 Identities=23% Similarity=0.301 Sum_probs=202.8
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC----eEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET----EMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 757 (963)
++|.+.+.||+|+||.||+|+++ |+.||||++...... ...++.|+..+.+++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 46778899999999999999975 899999998654322 122344566667889999999999987543 689999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ-----CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
||+++|+|.+++++. .++|.++.+++.|+|.|++|+|+. ..++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999863 489999999999999999999973 134999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccccCccccccCC------CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCc------ch
Q 046851 833 LGPSETH---ATTGVAGTFGYVAPEYAMTCR------VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGF------NI 897 (963)
Q Consensus 833 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~------~~ 897 (963)
....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+........... ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 7543322 234567999999999987643 56789999999999999999988764332211110 11
Q ss_pred hhHHHHHHhcCcccceeccccCCC-CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 898 VAWGCMLLRQGRAKEFFTAGLWDA-GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
............ .++..... .+.+....+.+++.+||+.||++||||.||++.|+++..
T Consensus 238 ~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111222211111 11111111 123456779999999999999999999999999998753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=390.13 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=213.1
Q ss_pred CCCCCccccccCCCccEEEEEE------CCCcEEEEEEeeccc-chhHHHHHHHHHHHhcc-CCCCeeEEEEeeeCCCeE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI------SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRL-RHPNLVTLIGYHASETEM 753 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (963)
++|++.++||+|+||.||+|++ .+++.||||+++... ......|.+|+.+++++ +|||||+++|++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788999999999999999975 246789999997643 34456789999999999 699999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEEC
Q 046851 754 FLIYNYLPGGNLENFIQQRS----------------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLD 817 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 817 (963)
++||||+++|+|.++++... ...+++..+..++.||++|++|||++ +++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999997643 23588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC-cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcc
Q 046851 818 DDFNAYLSDFGLARLLGPSET-HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFN 896 (963)
Q Consensus 818 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~ 896 (963)
.++.+|++|||.++....... .......||+.|+|||++.+..++.++|||||||++|||+|++.|+......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~------ 253 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------ 253 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS------
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999987754433 3344568999999999999999999999999999999999965554433221
Q ss_pred hhhHHHHHHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 897 IVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
.+.+......+ .+...+...+..+.+|+.+||+.||++||||+||+++|+++
T Consensus 254 -~~~~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 254 -DSKFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp -SHHHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11122222222 22233445667899999999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.7e-44 Score=381.26 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=205.6
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc---hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC----e
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF---QGVQQFHAEIKTLGRLRHPNLVTLIGYHASET----E 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 752 (963)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+++.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35799999999999999999976 4799999999975432 33567899999999999999999999986543 4
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.|+||||++|++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.++++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 79999999999999999775 3599999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCC--cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 833 LGPSET--HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 833 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..+...........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVREDPI 232 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCCCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------HHHHHHHHHhcCCC
Confidence 543322 23445679999999999999999999999999999999999999997432 22333333333221
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhccC
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRP-TMKQVVRRLKQLQ 959 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~l~ 959 (963)
.. .......+.++.+++.+||+.||++|| |++++.+.|.+++
T Consensus 233 ~~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CG-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CC-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 10 011223456889999999999999999 8999999998875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-43 Score=375.14 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=207.3
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc---------hhHHHHHHHHHHHhccC-CCCeeEEEEeeeCC
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF---------QGVQQFHAEIKTLGRLR-HPNLVTLIGYHASE 750 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 750 (963)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+++.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999976 4689999999875432 12346889999999997 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
+..|+||||+++|+|.+++..+. .+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999998753 599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccc------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMT------CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML 904 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 904 (963)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... .......
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~i 227 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRMI 227 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHHH
Confidence 8875432 3344679999999999863 3467899999999999999999999974321 1111122
Q ss_pred HhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 905 LRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... .. .........++++.+++.+||+.||++|||++||+++
T Consensus 228 ~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCC-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2111 11 1111223456789999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=387.40 Aligned_cols=259 Identities=20% Similarity=0.335 Sum_probs=213.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC------CCcEEEEEEeecc-cchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS------PGVLVAIKRLAVG-RFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEM 753 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (963)
.++|++.+.||+|+||+||+|.+. +++.||||++... .......|.+|++++++++||||++++|++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 357899999999999999999763 3578999999754 334456789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEe
Q 046851 754 FLIYNYLPGGNLENFIQQRS--------TRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLS 825 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 825 (963)
++||||+++|+|.+++.... ...+++..+.+++.|+|+||.|||++ +|+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999987542 23478999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCc-ccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCCCCCCCcchhhHHHH
Q 046851 826 DFGLARLLGPSETH-ATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDK-KALDPSFSSYGNGFNIVAWGCM 903 (963)
Q Consensus 826 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 903 (963)
|||+|+........ ......||+.|+|||.+.+..++.++||||||+++|||+||+ +||... +..+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------~~~~~~~~ 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNEQVLRF 247 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------CHHHHHHH
Confidence 99999876433322 233456899999999999999999999999999999999996 555422 22233322
Q ss_pred HHhcCcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccCC
Q 046851 904 LLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQP 960 (963)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l~~ 960 (963)
... + .....+..++..+.+++.+||+.+|++||||++|+++|++..+
T Consensus 248 i~~-~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 VME-G---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHT-T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHh-C---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222 1 1122344556789999999999999999999999999998643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-43 Score=386.98 Aligned_cols=245 Identities=20% Similarity=0.287 Sum_probs=208.1
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (963)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 37999999999999999999774 69999999986532 234577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSE 837 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 837 (963)
||+.+|+|.+++.+.. .+++.++..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999998753 599999999999999999999999 9999999999999999999999999999876432
Q ss_pred CcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceeccc
Q 046851 838 THATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAG 917 (963)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (963)
.....||+.|||||++.+..++.++||||+||++|||+||+.||.... ............
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~--------- 254 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK--------- 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhcCC---------
Confidence 234679999999999999999999999999999999999999997431 122222222111
Q ss_pred cCCCCChhHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046851 918 LWDAGPHDDLVEVLHLAVVCTVDSLSTRP-----TMKQVVRR 954 (963)
Q Consensus 918 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 954 (963)
...+...+.++.+++.+||+.||++|+ |++|++++
T Consensus 255 --~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 112334556889999999999999994 89999863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-44 Score=388.22 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=200.4
Q ss_pred CCCCCcc-ccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhcc-CCCCeeEEEEeeeC----CCeEE
Q 046851 682 GNFNASN-CIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRL-RHPNLVTLIGYHAS----ETEMF 754 (963)
Q Consensus 682 ~~~~~~~-~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~ 754 (963)
++|.+.+ .||+|+||+||+|.. .+|+.||||++... ..+.+|+.++.++ +||||+++++++.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4788765 699999999999976 57899999998642 4567899886655 79999999999864 46689
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEEEeeccccc
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAYLSDFGLAR 831 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~ 831 (963)
+||||++||+|.+++..++...+++.++..|+.|++.|++|||++ +|+||||||+|||++. ++.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence 999999999999999876666799999999999999999999999 9999999999999985 5679999999998
Q ss_pred ccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
....... .....||+.|+|||++.+..++.++||||+||++|||+||+.||....... ...........+..
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-----~~~~~~~~i~~~~~- 234 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIRMGQY- 234 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSCSS-
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-----HHHHHHHHHhcCCC-
Confidence 7754332 344579999999999999999999999999999999999999997543220 00000000000000
Q ss_pred ceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 EFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
..........+.++.+++.+||+.||++|||+.|++++
T Consensus 235 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000112345689999999999999999999999884
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-43 Score=387.08 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=201.5
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc---hhHHHH---HHHHHHHhccCCCCeeEEEEeeeCCCeEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF---QGVQQF---HAEIKTLGRLRHPNLVTLIGYHASETEMF 754 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (963)
++|++.+.||+|+||.||+|... +|+.||||++..... .....+ ..|+++++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999775 699999999864322 222233 34577788889999999999999999999
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
+||||++||+|.+++.+. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999875 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce
Q 046851 835 PSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF 913 (963)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (963)
.. ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||...... ........ ....
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~-~~~~----- 224 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRM-TLTM----- 224 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CHHHHHHH-SSSC-----
T ss_pred CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-cccC-----
Confidence 43 2334579999999999974 56899999999999999999999999754322 11111111 0000
Q ss_pred eccccCCCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 914 FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 914 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
....+...+.++.+++.+||+.||++||| ++|++++
T Consensus 225 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11123345567899999999999999999 6888753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=383.01 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=205.2
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc---chhHHHHHHHHHHHh-ccCCCCeeEEEEeeeCCCeEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR---FQGVQQFHAEIKTLG-RLRHPNLVTLIGYHASETEMFLI 756 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 756 (963)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47999999999999999999775 69999999997542 334556677777665 68999999999999999999999
Q ss_pred EeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCC
Q 046851 757 YNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 757 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 836 (963)
|||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999998753 489999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecc
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTA 916 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (963)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+..... ..+.
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i-~~~~------- 219 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSI-RMDN------- 219 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HHCC-------
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHH-HcCC-------
Confidence 3 333446799999999999999999999999999999999999999974321 1222111 1111
Q ss_pred ccCCCCChhHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 046851 917 GLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMK-QVVR 953 (963)
Q Consensus 917 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 953 (963)
...+...+.++.+++.+||+.||++||++. |+++
T Consensus 220 ---~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 112334566789999999999999999995 6754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=379.87 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=206.8
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
++|++.+.||+|+||+||+|... +|+.||||+++.... +...+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 57999999999999999999775 688999999976543 3456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC--CcEEEeecccccccCCCCC
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD--FNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgla~~~~~~~~ 838 (963)
+||+|.+++.... ..+++.++..|+.|+++||+|||++ +|+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999999997643 3589999999999999999999999 99999999999999854 479999999998764432
Q ss_pred cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccceecccc
Q 046851 839 HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGL 918 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (963)
......+|+.|+|||...+..++.++||||+||++|||++|+.||..... .+......... .. ++...
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~-~~--~~~~~ 226 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAE-YT--FDEEA 226 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTC-CC--CCHHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CC--CChhh
Confidence 23345789999999999999999999999999999999999999974321 22222222211 00 01100
Q ss_pred CCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 919 WDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 919 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
. ...+.++.+++.+|++.||++|||++|++++
T Consensus 227 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1234578899999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=378.05 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=205.0
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+++.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999976 5799999999965432 235678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
|+.+ ++.+++.......+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9965 666666665566799999999999999999999999 999999999999999999999999999987754332
Q ss_pred cccccccccccccCccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh-cCccccee--
Q 046851 839 HATTGVAGTFGYVAPEYAMTCR-VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR-QGRAKEFF-- 914 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-- 914 (963)
......||+.|+|||...... ++.++||||+||++|||++|+.||...... +....... .+...+..
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCCCTTTST
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--------HHHHHHHHhcCCCchhhcc
Confidence 334457999999999987665 578999999999999999999999743211 11111110 00000000
Q ss_pred ----ccccCC------CC-----ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 046851 915 ----TAGLWD------AG-----PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQL 958 (963)
Q Consensus 915 ----~~~~~~------~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l 958 (963)
...... .. ......++.+++.+||+.||++|||+.|++++ ++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000000 00 01234678899999999999999999999986 6554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=375.09 Aligned_cols=257 Identities=25% Similarity=0.333 Sum_probs=194.9
Q ss_pred ccccccCCCccEEEEEEC-CCcEEEEEEeecccchh-----HHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEecc
Q 046851 687 SNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQG-----VQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNYL 760 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 760 (963)
.++||+|+||+||+|... +|+.||||++....... .+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999764 69999999986543221 246889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCcc
Q 046851 761 PGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETHA 840 (963)
Q Consensus 761 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 840 (963)
+++++..+... ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 83 ~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A 156 (299)
T ss_dssp SEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred cchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence 88776665543 34589999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred cccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcccce------
Q 046851 841 TTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEF------ 913 (963)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 913 (963)
....+||+.|+|||++.+. .++.++||||+||++|||++|++||...... .....+............
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-----~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----DQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-----HHHHHHHHhcCCCChhhccchhcc
Confidence 3345799999999998754 5799999999999999999999998643211 111111111100000000
Q ss_pred ---eccccCCCCC-----hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 914 ---FTAGLWDAGP-----HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 914 ---~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.........+ .....++.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000111 1234678999999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=373.74 Aligned_cols=240 Identities=25% Similarity=0.371 Sum_probs=198.7
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccc------hhHHHHHHHHHHHhccC--CCCeeEEEEeeeCCCe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRF------QGVQQFHAEIKTLGRLR--HPNLVTLIGYHASETE 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 752 (963)
++|++.+.||+|+||+||+|... +|+.||||++..... ....++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999764 789999999875422 12244678999999986 8999999999999999
Q ss_pred EEEEEeccCC-CChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCC-CcEEEeecccc
Q 046851 753 MFLIYNYLPG-GNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD-FNAYLSDFGLA 830 (963)
Q Consensus 753 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla 830 (963)
.++||||+.+ +++.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.+ +.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 5888888764 4599999999999999999999999 99999999999999854 79999999999
Q ss_pred cccCCCCCcccccccccccccCccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCc
Q 046851 831 RLLGPSETHATTGVAGTFGYVAPEYAMTCRV-SDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGR 909 (963)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (963)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ...+..
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~~- 220 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRGQ- 220 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHCC-
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhcc-
Confidence 875432 2345679999999999987765 567899999999999999999996321 011110
Q ss_pred ccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
...+...+.++.+++.+||+.||++|||++|++++
T Consensus 221 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01122345678999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.2e-42 Score=368.33 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=201.5
Q ss_pred CCCCCccccccCCCccEEEEEECCCcEEEEEEeecccc--hhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF--QGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.++||+|+||+||+|+..+|+.||||++..... ...+++.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57999999999999999999999999999999965432 2357899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCCc
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSETH 839 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 839 (963)
+.++.+..+... ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 988666666554 35699999999999999999999999 999999999999999999999999999988754332
Q ss_pred ccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC---------c
Q 046851 840 ATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG---------R 909 (963)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 909 (963)
......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... ....... ...... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~----~~~~~i~-~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA----DQLMRIF-RILGTPNSKNWPNVTE 230 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHH-HHHCCCCTTTSTTGGG
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH----HHHHHHH-HhhCCCChhhccchhh
Confidence 23345689999999998764 5689999999999999999999999743211 0000000 000000 0
Q ss_pred ccce------eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 910 AKEF------FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 910 ~~~~------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.... ................+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000011122345678899999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=367.43 Aligned_cols=268 Identities=24% Similarity=0.324 Sum_probs=200.2
Q ss_pred cCCCCCccccccCCCccEEEEEEC-C-CcEEEEEEeecccch--hHHHHHHHHHHHhcc---CCCCeeEEEEeee-----
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-P-GVLVAIKRLAVGRFQ--GVQQFHAEIKTLGRL---RHPNLVTLIGYHA----- 748 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~----- 748 (963)
.++|++.+.||+|+||+||+|... + ++.||||+++..... ....+.+|+++++.+ +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999863 4 677999998654322 223456777776665 7999999999884
Q ss_pred CCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecc
Q 046851 749 SETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFG 828 (963)
Q Consensus 749 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 828 (963)
.....+++|||++++++..... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 2356899999998866554433 3456689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcC
Q 046851 829 LARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQG 908 (963)
Q Consensus 829 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (963)
+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......
T Consensus 162 ~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 162 LARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGLP 234 (305)
T ss_dssp SCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCC
T ss_pred hhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhhCCC
Confidence 9876532 23344568999999999999999999999999999999999999999743211 1111111110000
Q ss_pred cccce------eccc-------cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhccC
Q 046851 909 RAKEF------FTAG-------LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQLQ 959 (963)
Q Consensus 909 ~~~~~------~~~~-------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l~ 959 (963)
....+ .... ............+.+|+.+||+.||++|||++|++++ +++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 00000 0000 0001122345678899999999999999999999886 55553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-40 Score=353.17 Aligned_cols=260 Identities=17% Similarity=0.219 Sum_probs=206.3
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCC-CCeeEEEEeeeCCCeEEEEEe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRH-PNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 758 (963)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+|++.+..++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 358999999999999999999765 689999998865432 2456788899998875 899999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC-----CCcEEEeeccccccc
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD-----DFNAYLSDFGLARLL 833 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~~~ 833 (963)
|+ +++|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+|+.+
T Consensus 82 ~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 67999998764 35689999999999999999999999 9999999999999974 578999999999876
Q ss_pred CCCCC------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhc
Q 046851 834 GPSET------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQ 907 (963)
Q Consensus 834 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 907 (963)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.||...... ........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEKKQS 234 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch--hHHHHHHHHHhccCC
Confidence 53322 2234567999999999999999999999999999999999999999744322 010111111111111
Q ss_pred CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 908 GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
....+ + ....++++.+++..|++.+|++||+++.+.+.|+++
T Consensus 235 ~~~~~-----l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 235 TPLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SCHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CChHH-----h----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111 1 122346788999999999999999999998888764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-40 Score=354.94 Aligned_cols=259 Identities=21% Similarity=0.272 Sum_probs=199.5
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCC-eeEEEEeeeCCCeEEEEEec
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPN-LVTLIGYHASETEMFLIYNY 759 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 759 (963)
++|++.+.||+|+||+||+|.+ .+|+.||||++...... +++..|++++++++|++ |+.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4799999999999999999976 46899999988764332 45788999999998766 55555666778889999999
Q ss_pred cCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECC---CCcEEEeecccccccCCC
Q 046851 760 LPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDD---DFNAYLSDFGLARLLGPS 836 (963)
Q Consensus 760 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~ 836 (963)
+ ++++.+.+... ...+++.++..++.|++.||+|||++ +|+||||||+||+++. +..+|++|||+|+.+...
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 55777776553 35699999999999999999999999 9999999999999864 557999999999887543
Q ss_pred CC------cccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 837 ET------HATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 837 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .......+...... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~-~~~~~~~~~~~~~~-~~~ 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-KRQKYERISEKKMS-TPI 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-SCH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH-HHHHHHHhhcccCC-CCh
Confidence 32 22345679999999999999999999999999999999999999997543321 11111111111000 000
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQL 958 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~l 958 (963)
+.. ....+.++.+++..||+.+|++||+++++.+.|+++
T Consensus 238 -----~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 -----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -----HHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -----hHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 001 123456789999999999999999999998888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=364.62 Aligned_cols=263 Identities=25% Similarity=0.316 Sum_probs=196.1
Q ss_pred CCCCccccccCCCccEEEEEEC-CCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCeeEEEEeeeC------CCeEEE
Q 046851 683 NFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS------ETEMFL 755 (963)
Q Consensus 683 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l 755 (963)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|++++++++||||+++++++.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999875 699999999975432 23579999999999999999998843 335789
Q ss_pred EEeccCCCChHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeeccccccc
Q 046851 756 IYNYLPGGNLENFIQQ-RSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGLARLL 833 (963)
Q Consensus 756 v~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~ 833 (963)
||||++++.+..+... .....+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987543333321 2355699999999999999999999999 999999999999999875 8999999999876
Q ss_pred CCCCCcccccccccccccCcccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHH----------
Q 046851 834 GPSETHATTGVAGTFGYVAPEYAMT-CRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGC---------- 902 (963)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 902 (963)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+....+
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~----~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH----HHHHHHHHHHCCCCHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH----HHHHHHHHHhCCChHHhh
Confidence 54332 334579999999998875 46899999999999999999999999743211 00111100
Q ss_pred -HHHhc---CcccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 046851 903 -MLLRQ---GRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQL 958 (963)
Q Consensus 903 -~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l 958 (963)
..... .....................++.+|+.+||+.||++|||+.|++++ ++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00000 00000000000011122345678899999999999999999999975 5544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=359.52 Aligned_cols=253 Identities=26% Similarity=0.336 Sum_probs=206.3
Q ss_pred CCCCCccccccCCCccEEEEEEC----CCcEEEEEEeeccc----chhHHHHHHHHHHHhccCC-CCeeEEEEeeeCCCe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS----PGVLVAIKRLAVGR----FQGVQQFHAEIKTLGRLRH-PNLVTLIGYHASETE 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 752 (963)
++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 46999999999999999999652 48899999986432 2334678899999999976 899999999999999
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.++||||+.+|+|.+++.... .+.+..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999998754 478899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTC--RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA 910 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (963)
+............|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... .....+.......
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~-----~~~~~i~~~~~~~-- 251 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-----NSQAEISRRILKS-- 251 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-----CCHHHHHHHHHHC--
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcccC--
Confidence 765555555567899999999999764 4678999999999999999999999755332 1111111111111
Q ss_pred cceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046851 911 KEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPT-----MKQVVRR 954 (963)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 954 (963)
....+...+.++.+++.+||++||++||| ++|++++
T Consensus 252 --------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11223456678999999999999999994 7888763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-40 Score=357.87 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=195.2
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC--------C
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS--------E 750 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 750 (963)
++|++.+.||+|+||+||+|.. .+|+.||||++.... .....++.+|++++++++|||++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5899999999999999999976 479999999986542 2335678999999999999999999998755 3
Q ss_pred CeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccc
Q 046851 751 TEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLA 830 (963)
Q Consensus 751 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 830 (963)
...++||||+.++.+..+... ...+++.+++.++.|+++||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 468999999988666544433 45689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHh
Q 046851 831 RLLGPSET---HATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLR 906 (963)
Q Consensus 831 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 906 (963)
+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-----~~~~~i~~~~~ 239 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQLCG 239 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-----HHHHHHHHhcC
Confidence 87654322 223345799999999998765 6889999999999999999999999743211 11111111111
Q ss_pred cCc--c-cc--------eeccccCCCCCh-------hHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 907 QGR--A-KE--------FFTAGLWDAGPH-------DDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 907 ~~~--~-~~--------~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... . .. ............ .....+.+|+.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 0 00 000000000011 113356789999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=360.18 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=196.5
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc-chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC----eEE
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR-FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET----EMF 754 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 754 (963)
+.+|++.+.||+|+||+||+|.. .+|+.||||++.... ....+++.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999965 579999999997543 344568899999999999999999999986543 334
Q ss_pred EEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccC
Q 046851 755 LIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLG 834 (963)
Q Consensus 755 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 834 (963)
++++|+.+|+|.+++..+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|....
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 555667799999999753 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--cccccccccccccCccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCccc
Q 046851 835 PSET--HATTGVAGTFGYVAPEYAM-TCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRAK 911 (963)
Q Consensus 835 ~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (963)
.... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||...... ................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGSPSQE 235 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH-----HHHHHHhhhccCCChh
Confidence 4322 2234467999999999985 456788999999999999999999999744221 0000000000000000
Q ss_pred -----------ce-eccccCCCCC-----hhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 912 -----------EF-FTAGLWDAGP-----HDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 912 -----------~~-~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.. .........+ .....++.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000001 1223468899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=348.83 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=205.8
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCCeEEEEEe
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 758 (963)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .....++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4799999999999999999976 478999999986543 2346788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccccCCCCC
Q 046851 759 YLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARLLGPSET 838 (963)
Q Consensus 759 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 838 (963)
++.++++..++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999988887653 4689999999999999999999999 999999999999999999999999999988754332
Q ss_pred cccccccccccccCccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc-------
Q 046851 839 HATTGVAGTFGYVAPEYAMTCR-VSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA------- 910 (963)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 910 (963)
......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||...... ......+.........
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH----HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH----HHHHHHHHhhcCCCChhhhhhhh
Confidence 233346788999999988665 689999999999999999999997533211 1111111111110000
Q ss_pred --cce-----e-ccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 --KEF-----F-TAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 --~~~-----~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
.+. . ...............+.+|+.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 0000111223345678899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=359.48 Aligned_cols=263 Identities=21% Similarity=0.334 Sum_probs=196.7
Q ss_pred cCCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeCCC------
Q 046851 681 TGNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHASET------ 751 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 751 (963)
.++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 358999999999999999999764 69999999997542 234567899999999999999999999987654
Q ss_pred eEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeeccccc
Q 046851 752 EMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLAR 831 (963)
Q Consensus 752 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 831 (963)
.+++||||+ +.++..+.+. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 579999999 5688887764 3599999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHH------
Q 046851 832 LLGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCML------ 904 (963)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 904 (963)
..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.......
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL----DQLKEIMKVTGTPPAE 241 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCHH
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH----HHHHHHHhccCCCcHH
Confidence 76432 2345799999999998764 5688999999999999999999999744211 0000000000
Q ss_pred -HhcC----------cccceeccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhccC
Q 046851 905 -LRQG----------RAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR--LKQLQ 959 (963)
Q Consensus 905 -~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~l~ 959 (963)
.... ....... .............+.+|+.+||+.||++|||++|++++ ++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCC-CCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhhhcchhhhhhhccCCcccc-cchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 0000000 00001122334578899999999999999999999986 55543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.4e-40 Score=359.26 Aligned_cols=260 Identities=20% Similarity=0.296 Sum_probs=198.4
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeC--CCeEEEEE
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHAS--ETEMFLIY 757 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 757 (963)
++|++.++||+|+||+||+|+. .+|+.||||+++... .+++.+|++++++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4799999999999999999976 479999999987543 467889999999995 9999999999864 45689999
Q ss_pred eccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCC-cEEEeecccccccCCC
Q 046851 758 NYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDF-NAYLSDFGLARLLGPS 836 (963)
Q Consensus 758 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~ 836 (963)
||+++++|.++. +.+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997764 3489999999999999999999999 999999999999998655 6999999999876543
Q ss_pred CCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhH-----HHHHHhcC--
Q 046851 837 ETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAW-----GCMLLRQG-- 908 (963)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~-- 908 (963)
. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||................ ........
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 3 23445789999999998865 47899999999999999999999997543221000000000 00000000
Q ss_pred ccc-ce-----------eccccCCCCChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 909 RAK-EF-----------FTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 909 ~~~-~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
... .. ...............++.+|+.+||+.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00 00001111122345678999999999999999999999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-39 Score=352.54 Aligned_cols=263 Identities=21% Similarity=0.260 Sum_probs=190.3
Q ss_pred CCCCCccccccCCCccEEEEEEC-CCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC------CCe
Q 046851 682 GNFNASNCIGNGGFGATYKAEIS-PGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS------ETE 752 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 752 (963)
++|++.++||+|+||+||+|... +|+.||||++.... ....+++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999765 69999999997543 3345678999999999999999999999853 468
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.|+||||+.+ ++.+.+. ..+++.+++.++.|++.|++|||++ ||+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 8999999976 4555543 3489999999999999999999999 999999999999999999999999999887
Q ss_pred cCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCC----------C----cchh
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGN----------G----FNIV 898 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~----------~----~~~~ 898 (963)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......... . ....
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 6432 2334457899999999999999999999999999999999999999643211000 0 0000
Q ss_pred hHHHHHHhcCc------ccceeccccCCC---CChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 899 AWGCMLLRQGR------AKEFFTAGLWDA---GPHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 899 ~~~~~~~~~~~------~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
........... ....+....... .......++.+|+.+|++.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 000011111111 112346678999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=351.86 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=195.4
Q ss_pred cCCCCCccccccCCCccEEEEEE-CCCcEEEEEEeeccc--chhHHHHHHHHHHHhccCCCCeeEEEEeeeC-----CCe
Q 046851 681 TGNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGR--FQGVQQFHAEIKTLGRLRHPNLVTLIGYHAS-----ETE 752 (963)
Q Consensus 681 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 752 (963)
+++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+++.+|++++++++|||++++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45899999999999999999976 479999999997543 3345678999999999999999999998853 334
Q ss_pred EEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 753 MFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 753 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.+++++|+.+|+|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.+..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 5677788889999999965 3599999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCcccccccccccccCccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCCcchhhHHHHHHhcCcc-
Q 046851 833 LGPSETHATTGVAGTFGYVAPEYAMTC-RVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWGCMLLRQGRA- 910 (963)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 910 (963)
.. .......|++.|+|||...+. .++.++||||+||++|||++|+.||...... .....+.........
T Consensus 171 ~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-----~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 171 TD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTPGAE 241 (348)
T ss_dssp CT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCHH
T ss_pred cC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCChH
Confidence 43 334456799999999987765 4688999999999999999999999743211 111111000000000
Q ss_pred ----------cceeccccC-CCC-----ChhHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046851 911 ----------KEFFTAGLW-DAG-----PHDDLVEVLHLAVVCTVDSLSTRPTMKQVVRR 954 (963)
Q Consensus 911 ----------~~~~~~~~~-~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 954 (963)
......... ... ......++.+|+.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000 000 11234568899999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-34 Score=320.87 Aligned_cols=265 Identities=20% Similarity=0.250 Sum_probs=192.1
Q ss_pred CCCCCccccccCCCccEEEEEE-CCCcEEEEEEeecccchhHHHHHHHHHHHhccC-----------CCCeeEEEEeeeC
Q 046851 682 GNFNASNCIGNGGFGATYKAEI-SPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-----------HPNLVTLIGYHAS 749 (963)
Q Consensus 682 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 749 (963)
++|++.++||+|+||+||+|+. .+|+.||||++..... ..+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999976 4799999999976532 2456788888888775 5789999988754
Q ss_pred --CCeEEEEEeccCCC-ChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCc----
Q 046851 750 --ETEMFLIYNYLPGG-NLENFIQQRSTRAVDWRVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFN---- 821 (963)
Q Consensus 750 --~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~---- 821 (963)
....+++|+++..+ +............+++..+..++.|+++|++|||+ . +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 45566666666554 44444444455678999999999999999999998 6 9999999999999986653
Q ss_pred --EEEeecccccccCCCCCcccccccccccccCccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCCCC-c-ch
Q 046851 822 --AYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNG-F-NI 897 (963)
Q Consensus 822 --~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~-~-~~ 897 (963)
++++|||.+..... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||.......... . ..
T Consensus 169 ~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 99999999986532 2344579999999999999999999999999999999999999997543221110 0 00
Q ss_pred hhHHHHH-------HhcC-cccceec---------cc----------cCCCCChhHHHHHHHHHHHcccCCCCCCCCHHH
Q 046851 898 VAWGCML-------LRQG-RAKEFFT---------AG----------LWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQ 950 (963)
Q Consensus 898 ~~~~~~~-------~~~~-~~~~~~~---------~~----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 950 (963)
...+... .... ......+ .. ...........++.+|+.+|++.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1110000 0000 0000000 00 011234556788999999999999999999999
Q ss_pred HHHH
Q 046851 951 VVRR 954 (963)
Q Consensus 951 vl~~ 954 (963)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9986
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=9.8e-27 Score=260.09 Aligned_cols=121 Identities=30% Similarity=0.440 Sum_probs=82.3
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|++|++++|++++ ++ .+..++.++.+++++|.+++ ...+..+++++.|++++|++++ ++ .+..+++|+.|++
T Consensus 263 ~~L~~L~l~~~~l~~-~~-~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISN-IS-PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCC-CC-cccccccccccccccccccc--ccccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEEC
Confidence 567777777777763 32 35666777777777777754 2346667777777777777774 33 2677777777777
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccc
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFN 567 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N 567 (963)
++|+|++ ++ .+.++++|++|++++|+|++..| +..+++|+.|++++|
T Consensus 337 ~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 337 ANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7777774 33 57777777777777777774433 677777777777776
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=2.8e-28 Score=264.33 Aligned_cols=127 Identities=27% Similarity=0.387 Sum_probs=83.5
Q ss_pred ccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecccc
Q 046851 439 LKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSS 518 (963)
Q Consensus 439 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~ 518 (963)
++.+++++|++++..|..+..+..+ .+++++|.+.+..|..+..+++|+.+++++|.+++.+ ..++.+++|+.|+|++
T Consensus 176 ~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~ 253 (313)
T d1ogqa_ 176 FTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRN 253 (313)
T ss_dssp CCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCS
T ss_pred ccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc-cccccccccccccCcc
Confidence 3555555555555555555544333 4666666665666666666666666666666666443 3466667777777777
Q ss_pred cccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeecccc
Q 046851 519 NSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNN 568 (963)
Q Consensus 519 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~ 568 (963)
|+|+|.+|..++++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 254 N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp SCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred CeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 777777777777777777777777777777774 5667777777777776
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=8.9e-28 Score=260.31 Aligned_cols=245 Identities=25% Similarity=0.333 Sum_probs=149.8
Q ss_pred CCcEEEccCCcccc--cCCccccCcccccceeccc-cccccCCCcccc---cccceeeccccccccCCccccccCCCCCe
Q 046851 27 SLRVLNLGFNRITG--EIPASFSDFVNLEELNLAG-NLVNGTVPTFIG---RLKRVYLSFNRLVGSVPSKIGEKCTNLEH 100 (963)
Q Consensus 27 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~---~L~~L~L~~n~l~~~~p~~~~~~l~~L~~ 100 (963)
+++.|+|++|.+.+ .+|..|.++++|++|+|++ |.+++.+|..++ +|++|+|++|++. .++...+..+.+|++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~-~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS-GAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE-EECCGGGGGCTTCCE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccc-ccccccccchhhhcc
Confidence 45666666666554 3555666666666666654 455544444433 3444444444444 344444556677777
Q ss_pred EeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCC-CEEEccCCccccCCCcCccCCCCCceEeecCcC
Q 046851 101 LDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNL-EVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLF 179 (963)
Q Consensus 101 L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 179 (963)
+++++|.+.+.+|..|.++++|+.+++++|.+++.+|..+..+.++ +.+++++|++++..|..+.++..+ .+++++
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~-- 206 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSR-- 206 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCS--
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccc--
Confidence 7777777776777777777777777777777776677777666664 667777777776666666655443 455544
Q ss_pred CcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcC
Q 046851 180 DTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKN 259 (963)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 259 (963)
+.+.+.+|..+..+++|+.+++++|.+.+..+ .+..+++|+.|+|++|++++..
T Consensus 207 -------------------------~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~i 260 (313)
T d1ogqa_ 207 -------------------------NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTL 260 (313)
T ss_dssp -------------------------SEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECC
T ss_pred -------------------------cccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccC
Confidence 55555666666666666666666666654433 4566666666666666666544
Q ss_pred ccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCc
Q 046851 260 LGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNA 301 (963)
Q Consensus 260 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~ 301 (963)
|..|+++++|++|+|++|+|++.+|....+.+|+.+++++|+
T Consensus 261 P~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 261 PQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp CGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred ChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCc
Confidence 555666666666666666666555544445555555555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=3.4e-26 Score=255.62 Aligned_cols=356 Identities=23% Similarity=0.251 Sum_probs=204.5
Q ss_pred EccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccC
Q 046851 8 DLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSV 87 (963)
Q Consensus 8 ~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~ 87 (963)
++..+.+++.+. ...+.+|++|++++|.|+.. +.++.+++|++|+|++|+|+ .+
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~----------------------~l 81 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT----------------------DI 81 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCC----------------------CC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCC----------------------CC
Confidence 455566665443 35778899999999999843 46888999999999999887 34
Q ss_pred CccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCC
Q 046851 88 PSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNC 167 (963)
Q Consensus 88 p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 167 (963)
|. +.++++|++|++++|+|++.. .++++++|+.|++++|.+++..+ ......+..+....|.+....+......
T Consensus 82 ~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 155 (384)
T d2omza2 82 TP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTS 155 (384)
T ss_dssp GG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTT
T ss_pred cc--ccCCccccccccccccccccc--ccccccccccccccccccccccc--cccccccccccccccccccccccccccc
Confidence 32 346777777777777776432 36777777777777777765432 3445667777777777653333222222
Q ss_pred CCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCce
Q 046851 168 SKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEM 247 (963)
Q Consensus 168 ~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 247 (963)
........... ....+.............|... ....+..+++++.
T Consensus 156 ~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~ 201 (384)
T d2omza2 156 LQQLSFGNQVT--------------------------------DLKPLANLTTLERLDISSNKVS--DISVLAKLTNLES 201 (384)
T ss_dssp CSEEEEEESCC--------------------------------CCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSE
T ss_pred ccccccccccc--------------------------------hhhhhccccccccccccccccc--cccccccccccce
Confidence 22222211110 0111222222222233222221 2233444444555
Q ss_pred eecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCccCCCCCCCCCCCCccccccccccc
Q 046851 248 LNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSGSIPTFSNMVCPPVPYLSRNLFES 327 (963)
Q Consensus 248 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~l~~l~~l~l~~n~~~~ 327 (963)
+++++|.++.+.+ +..+++|+.|++++|+++..+ ....++.|+.+++++|++.+..+ +..+.+|+
T Consensus 202 l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~----------- 266 (384)
T d2omza2 202 LIATNNQISDITP--LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAP-LSGLTKLT----------- 266 (384)
T ss_dssp EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCS-----------
T ss_pred eeccCCccCCCCc--ccccCCCCEEECCCCCCCCcc-hhhcccccchhccccCccCCCCc-ccccccCC-----------
Confidence 5555555444432 233444555555555544321 12234445555555554443221 12222222
Q ss_pred CCCCchhhhhhhcccccCCCCCccccccchhhhhccccCcccccCCCCCCCcccCCcceEEEEEcCCCcccCCCCccccc
Q 046851 328 YNPSTAYLSLFAKKSQAGTPLPLRGRDGFLAIFHNFGGNNFSGSLPSMPVAPERLGKQTVYAIVAGDNKLSGSFPGNMFG 407 (963)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~n~~~~~~p~~~~~ 407 (963)
T Consensus 267 -------------------------------------------------------------------------------- 266 (384)
T d2omza2 267 -------------------------------------------------------------------------------- 266 (384)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCcceEEEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCccc
Q 046851 408 ICNRLDSLMVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGL 487 (963)
Q Consensus 408 ~~~~l~~~~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L 487 (963)
.|++++|+++ .+++ +.. ++.++.+++++|++++ ...+..+++++.|++++|++++.. .+..+++|
T Consensus 267 --------~L~l~~~~l~-~~~~-~~~-~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L 331 (384)
T d2omza2 267 --------ELKLGANQIS-NISP-LAG-LTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKL 331 (384)
T ss_dssp --------EEECCSSCCC-CCGG-GTT-CTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTC
T ss_pred --------EeeccCcccC-CCCc-ccc-cccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCC
Confidence 3333333333 2221 111 2557777777777773 234677778888888888886543 37778888
Q ss_pred ceeccccccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccc
Q 046851 488 KYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNN 543 (963)
Q Consensus 488 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 543 (963)
++|++++|+|+ .++ .+.++++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 332 ~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 332 QRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 88888888887 444 57888888888888888886533 778888888888877
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=4e-25 Score=238.30 Aligned_cols=109 Identities=25% Similarity=0.326 Sum_probs=60.9
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|+.|++++|.+++..+..+.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.+|.++++|++|+|
T Consensus 171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249 (305)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence 44556666666655555555556666666666666665555555566666666666666665 45555666666666666
Q ss_pred cccccCCCCChhh------hccccCCeEEeccccCC
Q 046851 517 SSNSLSGLIPDDL------ENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 517 s~N~l~~~~p~~~------~~l~~L~~L~l~~N~l~ 546 (963)
++|+|+......| ..+.+|+.|+|++|+++
T Consensus 250 s~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 6666653322222 23344555555555543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=1.6e-24 Score=233.59 Aligned_cols=262 Identities=20% Similarity=0.217 Sum_probs=198.9
Q ss_pred ceEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccc---cccceeecc
Q 046851 4 LEVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIG---RLKRVYLSF 80 (963)
Q Consensus 4 l~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~L~~L~L~~ 80 (963)
.+.+|=++++++.+ |..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..+. +|++|++++
T Consensus 12 ~~~~~C~~~~L~~l-P~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCCSC-CCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCCcc-CCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 35677777778744 55553 5788888888888866666788888888888888888866665554 577888888
Q ss_pred ccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCccc--ccCcccccCCCCCCEEEccCCcccc
Q 046851 81 NRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLE--ETIPAELGMLQNLEVLDVSRNSLSG 158 (963)
Q Consensus 81 n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~N~l~~ 158 (963)
|+++ .+|...+ ..++.|++++|.+.+..+..+.....+..+....|... ...+..|..+++|+.+++++|.+.
T Consensus 89 n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~- 163 (305)
T d1xkua_ 89 NQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 163 (305)
T ss_dssp SCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CccC-cCccchh---hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-
Confidence 8888 7777654 46788888888888766667777778888888777544 334567788888888888888887
Q ss_pred CCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcc
Q 046851 159 SIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSN 238 (963)
Q Consensus 159 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 238 (963)
.+|..+ .++|+.|++++ |...+..+..|.+++.++.|++++|.+.+..+..
T Consensus 164 ~l~~~~--~~~L~~L~l~~---------------------------n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~ 214 (305)
T d1xkua_ 164 TIPQGL--PPSLTELHLDG---------------------------NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 214 (305)
T ss_dssp SCCSSC--CTTCSEEECTT---------------------------SCCCEECTGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred ccCccc--CCccCEEECCC---------------------------CcCCCCChhHhhcccccccccccccccccccccc
Confidence 455443 57788888877 5555566778888888888888888888888888
Q ss_pred ccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC-------CCCceeEEEeccCcCc
Q 046851 239 WGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL-------PVPCMTMFDVSGNALS 303 (963)
Q Consensus 239 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------~~~~L~~L~l~~N~l~ 303 (963)
|.++++|++|+|++|+|+.++. .|..+++|++|+|++|+|+.+....+ ....|+.|++++|++.
T Consensus 215 ~~~l~~L~~L~L~~N~L~~lp~-~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 215 LANTPHLRELHLNNNKLVKVPG-GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp GGGSTTCCEEECCSSCCSSCCT-TTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccccccceeeeccccccccccc-ccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 8888888888888888888754 67888888888888888887654433 3567888899998876
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.3e-24 Score=228.26 Aligned_cols=247 Identities=22% Similarity=0.159 Sum_probs=180.7
Q ss_pred EEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccc
Q 046851 6 VLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVG 85 (963)
Q Consensus 6 ~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~ 85 (963)
+++.++++++. +|..+. +.+++|+|++|+|+++.+.+|.++++|++|++++|++.
T Consensus 15 ~v~c~~~~L~~-iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~---------------------- 69 (284)
T d1ozna_ 15 TTSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA---------------------- 69 (284)
T ss_dssp EEECCSSCCSS-CCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC----------------------
T ss_pred EEEcCCCCCCc-cCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccc----------------------
Confidence 46777888874 455443 56888999999888777778888888888888888887
Q ss_pred cCCccccccCCCCCeEeCC-CCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCc
Q 046851 86 SVPSKIGEKCTNLEHLDLS-GNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDL 164 (963)
Q Consensus 86 ~~p~~~~~~l~~L~~L~Ls-~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 164 (963)
.++...+.++..+..++.+ .|.++...+..|.++++|+.|++++|.+....+..+...++|+.+++++|.++++.+..|
T Consensus 70 ~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f 149 (284)
T d1ozna_ 70 RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh
Confidence 4555555556666666543 455665556677777777777777777766666667777777777777777776666667
Q ss_pred cCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCcccccccc
Q 046851 165 GNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDN 244 (963)
Q Consensus 165 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 244 (963)
+.+++|+.|++++ |.+.+..+.+|.++++|+.+++++|++.+..|..|.++++
T Consensus 150 ~~~~~L~~L~l~~---------------------------N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~ 202 (284)
T d1ozna_ 150 RDLGNLTHLFLHG---------------------------NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202 (284)
T ss_dssp TTCTTCCEEECCS---------------------------SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred ccccchhhccccc---------------------------CcccccchhhhccccccchhhhhhccccccChhHhhhhhh
Confidence 7777777777776 4555556677788888888888888888888888999999
Q ss_pred CceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCcc
Q 046851 245 LEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALSG 304 (963)
Q Consensus 245 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~~ 304 (963)
|++|++++|++..+++..|+.+++|++|+|++|++.+.-....-...++.+....+.+..
T Consensus 203 L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C 262 (284)
T d1ozna_ 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262 (284)
T ss_dssp CCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBE
T ss_pred cccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEe
Confidence 999999999999988888888999999999999887643322212234555555555554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.1e-23 Score=224.29 Aligned_cols=68 Identities=22% Similarity=0.207 Sum_probs=32.9
Q ss_pred ccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccc
Q 046851 213 EAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLT 280 (963)
Q Consensus 213 ~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 280 (963)
..|.++++|+.|++++|.+....+..+..+.+|+.+++++|+++.+++..|..+++|++|++++|+++
T Consensus 99 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~ 166 (284)
T d1ozna_ 99 ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166 (284)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred hhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccc
Confidence 33444444444444444444444444444555555555555555555555555555555555554443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.1e-23 Score=218.10 Aligned_cols=129 Identities=33% Similarity=0.346 Sum_probs=110.8
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
++|++|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.+++..+..+..+++|+.|++
T Consensus 77 ~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l 155 (266)
T d1p9ag_ 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (266)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccc
Confidence 56888888888887 56777888888889999988888777888888899999999999998666777788999999999
Q ss_pred cccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccc
Q 046851 517 SSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFN 567 (963)
Q Consensus 517 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N 567 (963)
++|+|++..+..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus 156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~N 205 (266)
T d1p9ag_ 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205 (266)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred ccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCC
Confidence 999999877788899999999999999999 88988889999999887744
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.8e-22 Score=210.76 Aligned_cols=195 Identities=24% Similarity=0.178 Sum_probs=128.1
Q ss_pred ceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCC
Q 046851 75 RVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRN 154 (963)
Q Consensus 75 ~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 154 (963)
+.+.++++++ ++|..+. ++|++|+|++|+|++..+++|.++++|++|+|++|+|+.+ + .++.+++|++|+|++|
T Consensus 14 ~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N 87 (266)
T d1p9ag_ 14 EVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHN 87 (266)
T ss_dssp EEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSS
T ss_pred EEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccccc
Confidence 3444455555 5665543 3566666666666655556666666666666666666643 2 3456677777777777
Q ss_pred ccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccC
Q 046851 155 SLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN 234 (963)
Q Consensus 155 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~ 234 (963)
+++ ..+..+.++++|+.|++++ |.+.+..+..+..+.+++.|++++|.+...
T Consensus 88 ~l~-~~~~~~~~l~~L~~L~l~~---------------------------~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l 139 (266)
T d1p9ag_ 88 QLQ-SLPLLGQTLPALTVLDVSF---------------------------NRLTSLPLGALRGLGELQELYLKGNELKTL 139 (266)
T ss_dssp CCS-SCCCCTTTCTTCCEEECCS---------------------------SCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred ccc-ccccccccccccccccccc---------------------------cccceeecccccccccccccccccccccee
Confidence 776 4455666666666666665 334444455566677777777777777766
Q ss_pred CCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEeccCcCc
Q 046851 235 FPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSGNALS 303 (963)
Q Consensus 235 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~N~l~ 303 (963)
.+..+..+++|+.|++++|+++.+++..|..+++|++|+|++|+|+.++...+.++.|+.|+|++|++.
T Consensus 140 ~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence 666677777777777777777777777777777777777777777766555666666777777666654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=9.1e-20 Score=200.16 Aligned_cols=133 Identities=23% Similarity=0.249 Sum_probs=65.5
Q ss_pred CCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCC
Q 046851 27 SLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGN 106 (963)
Q Consensus 27 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N 106 (963)
++++|+|++|.++ .+|+. .++|++|+|++|+|+ .+|..+++|+.|++++|+++ .++.- .+.|++|++++|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~~L~~L~l~~n~l~-~l~~l----p~~L~~L~L~~n 108 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNN 108 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchhhhhhhhhhhcccc-hhhhh----cccccccccccc
Confidence 4566666666665 34543 345666666666665 44555555555555555555 44321 134556666666
Q ss_pred ccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecC
Q 046851 107 YLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177 (963)
Q Consensus 107 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 177 (963)
+|+ .+|. ++.+++|+.|++++|.+.... .....+..+++..+... .+..+..++.++.+.+++
T Consensus 109 ~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~----~~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~ 171 (353)
T d1jl5a_ 109 QLE-KLPE-LQNSSFLKIIDVDNNSLKKLP----DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADN 171 (353)
T ss_dssp CCS-SCCC-CTTCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCS
T ss_pred ccc-cccc-hhhhccceeeccccccccccc----cccccccchhhcccccc--ccccccccccceeccccc
Confidence 555 2332 345555555555555554221 12234444555444433 122334444444444443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=6.3e-22 Score=196.53 Aligned_cols=164 Identities=13% Similarity=0.174 Sum_probs=121.6
Q ss_pred CCccccccCCCccEEEEEECCCcEEEEEEeecccc------------------hhHHHHHHHHHHHhccCCCCeeEEEEe
Q 046851 685 NASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRF------------------QGVQQFHAEIKTLGRLRHPNLVTLIGY 746 (963)
Q Consensus 685 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 746 (963)
.++++||+|+||+||+|...+|+.||||+++.... ........|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999988899999998753211 012334678889999999999988876
Q ss_pred eeCCCeEEEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecccCCCCeEECCCCcEEEee
Q 046851 747 HASETEMFLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNAYLSD 826 (963)
Q Consensus 747 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 826 (963)
.. .+++|||+++..+.+ ++...+..++.|+++|++|||++ +|+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 43 279999998865432 44455678999999999999999 99999999999999976 589999
Q ss_pred cccccccCCCCCcccccccccccccCcc-----ccccCCCCcchhhHHHHHHH
Q 046851 827 FGLARLLGPSETHATTGVAGTFGYVAPE-----YAMTCRVSDKADVYSYGVVL 874 (963)
Q Consensus 827 fgla~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~Dv~slG~il 874 (963)
||.|......... .|.... .+....|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999765422211 111110 01234677889999976443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=7.1e-20 Score=201.05 Aligned_cols=95 Identities=26% Similarity=0.299 Sum_probs=53.6
Q ss_pred cccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccC
Q 046851 51 NLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN 130 (963)
Q Consensus 51 ~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n 130 (963)
+|++|+|++|.++ .+|..+++|++|+|++|+|+ ++|.. +.+|+.|++++|+++ .+++. .+.|++|++++|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n 108 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPELPPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNN 108 (353)
T ss_dssp TCSEEECTTSCCS-CCCSCCTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSS
T ss_pred CCCEEEeCCCCCC-CCCCCCCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---cccccccccccc
Confidence 4667777777776 45555566666666666666 56543 245666666666665 22221 124556666666
Q ss_pred cccccCcccccCCCCCCEEEccCCccc
Q 046851 131 MLEETIPAELGMLQNLEVLDVSRNSLS 157 (963)
Q Consensus 131 ~l~~~~~~~~~~l~~L~~L~L~~N~l~ 157 (963)
.++.. |. +..+++|+.|++++|.+.
T Consensus 109 ~l~~l-p~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 109 QLEKL-PE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CCSSC-CC-CTTCTTCCEEECCSSCCS
T ss_pred ccccc-cc-hhhhccceeecccccccc
Confidence 55532 22 345555666666555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.4e-21 Score=223.05 Aligned_cols=61 Identities=23% Similarity=0.251 Sum_probs=45.8
Q ss_pred CceEEEccCCcccccC-CCccccCCCCcEEEccCCcccc----cCCccccCcccccceeccccccc
Q 046851 3 NLEVLDLEGNLLNGIL-PDSGFHLKSLRVLNLGFNRITG----EIPASFSDFVNLEELNLAGNLVN 63 (963)
Q Consensus 3 ~l~~L~ls~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~ 63 (963)
+|++|||++|+|++.. ...+..++++++|+|++|.|+. .+..++..+++|++|+|++|.|+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence 5788999999888532 3345677888889999888872 33455677888888888888775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.9e-18 Score=177.21 Aligned_cols=217 Identities=14% Similarity=0.110 Sum_probs=149.6
Q ss_pred cceeccccccccCCCcc-cccccceeeccccccccCCccccccCCCCCeEeCCCCccccC-cCccccCcccccEEEccc-
Q 046851 53 EELNLAGNLVNGTVPTF-IGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGG-IPRSLGNCFQVRSLLLFS- 129 (963)
Q Consensus 53 ~~L~Ls~N~l~~~~~~~-~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~L~~- 129 (963)
+.++.+++.++ .+|.. +.++++|+|++|+++ .+|...|.++++|++|+|++|.+... .+..|.++++++.|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCS-SCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCC-CcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 45666666666 44433 346777777777777 88888888899999999999988754 356788899999988754
Q ss_pred CcccccCcccccCCCCCCEEEccCCccccCCCc-CccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccc
Q 046851 130 NMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV-DLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFE 208 (963)
Q Consensus 130 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~ 208 (963)
|.+....+..|.++++|++|++++|.+....+. .+..+..+..+..++ +.+.
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n---------------------------~~l~ 141 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN---------------------------INIH 141 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESC---------------------------TTCC
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccc---------------------------cccc
Confidence 678777888889999999999999988743222 234455555555554 2333
Q ss_pred cCCcccccCCC-CCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCC
Q 046851 209 GGIPEAVSSLP-NLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELAREL 287 (963)
Q Consensus 209 ~~~~~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 287 (963)
...+..|.+++ .++.|++++|+++...+..|.....++.+++++|+++.++...|.++++|++|+|++|+|+.++...+
T Consensus 142 ~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~ 221 (242)
T d1xwdc1 142 TIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL 221 (242)
T ss_dssp EECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSC
T ss_pred cccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHH
Confidence 33345555554 67788888888886655555443334445678888888888888888888888888888886665443
Q ss_pred -CCCceeEEEec
Q 046851 288 -PVPCMTMFDVS 298 (963)
Q Consensus 288 -~~~~L~~L~l~ 298 (963)
.++.|+.+++.
T Consensus 222 ~~l~~L~~l~~~ 233 (242)
T d1xwdc1 222 ENLKKLRARSTY 233 (242)
T ss_dssp TTCCEEESSSEE
T ss_pred cCCcccccCcCC
Confidence 45555555443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.8e-18 Score=177.33 Aligned_cols=220 Identities=14% Similarity=0.071 Sum_probs=138.4
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLV 84 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~ 84 (963)
++++.++++++ .+|+.+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~-------------------- 67 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-------------------- 67 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCC--------------------
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccc--------------------
Confidence 57788888888 4455442 578999999999987777789999999999999888763
Q ss_pred ccCCccccccCCCCCeEeCCC-CccccCcCccccCcccccEEEcccCcccccCcc-cccCCCCCCEEEccCCccccCCCc
Q 046851 85 GSVPSKIGEKCTNLEHLDLSG-NYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPA-ELGMLQNLEVLDVSRNSLSGSIPV 162 (963)
Q Consensus 85 ~~~p~~~~~~l~~L~~L~Ls~-N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~ 162 (963)
.++...|.++++++++.+.. |.+....+..|.++++|+.|++++|+++...+. .+..+..+..+..+++.+....+.
T Consensus 68 -~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~ 146 (242)
T d1xwdc1 68 -VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN 146 (242)
T ss_dssp -EECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTT
T ss_pred -eeeccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccc
Confidence 34444455555555555432 445444555555566666666666555533221 223344444445555555544444
Q ss_pred CccCCC-CCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCc-eEecCCcccccCCCcccc
Q 046851 163 DLGNCS-KLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLR-ILWAPRATLEGNFPSNWG 240 (963)
Q Consensus 163 ~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~-~L~l~~n~l~~~~~~~~~ 240 (963)
.|.+++ .++.|++++|. ++...+..+. .+++. .+.+.+|+++...+..|.
T Consensus 147 ~~~~~~~~l~~L~l~~n~---------------------------l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~ 198 (242)
T d1xwdc1 147 SFVGLSFESVILWLNKNG---------------------------IQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFH 198 (242)
T ss_dssp SSTTSBSSCEEEECCSSC---------------------------CCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTT
T ss_pred ccccccccceeeeccccc---------------------------cccccccccc-chhhhccccccccccccccHHHhc
Confidence 454443 45555555532 2222222222 23333 335667777766666788
Q ss_pred ccccCceeecCcccccCcCccccCCCCCCcEEeccC
Q 046851 241 ACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSS 276 (963)
Q Consensus 241 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 276 (963)
++++|++|+|++|+|+.++...|.++++|+.|++.+
T Consensus 199 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 199 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp TSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred CCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 888999999999999888888888888888777654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.2e-18 Score=172.74 Aligned_cols=175 Identities=19% Similarity=0.182 Sum_probs=140.7
Q ss_pred EEEccCCeeeecCchhHhhccCCccEEECcCCcCCCCC-ccccccCCCCCEEeccCCcCCCccchhhccCcccceecccc
Q 046851 416 MVNVSNNRIAGQLPAEIGRMCKSLKFLDASGNQIVGPI-PRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAG 494 (963)
Q Consensus 416 ~L~l~~n~l~~~~p~~~~~~~~~L~~L~ls~n~l~~~~-p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~ 494 (963)
.++.++++++ .+|+.++ +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+....+..|..+++|++|+|++
T Consensus 12 ~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 5788889888 8888764 67999999999997544 56678999999999999999988899999999999999999
Q ss_pred ccccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEeccccCCCcCCCCccccccCceEeeccccCccCCC
Q 046851 495 NNLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSGLANVSTLSAFNVSFNNLSGPLP 574 (963)
Q Consensus 495 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p 574 (963)
|+|++..|..|.++++|++|+|++|+|+++.|..|..+++|++|+|++|++.+. +....-...++.+.+..|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~-~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN-CHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS-GGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc-cchHHHhhhhhhhcccCCCeEeCCC
Confidence 999977788899999999999999999988788889999999999999999743 2222223446677788888887777
Q ss_pred CCCCcccccccCCCCCCCCCC
Q 046851 575 SSKNLMKCSSVLGNPYLRPCR 595 (963)
Q Consensus 575 ~~~~~~~~~~~~~np~~~~c~ 595 (963)
.......-..+..|-+.|.+.
T Consensus 167 ~~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 167 SKVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp TTTTTSBGGGSCTTTCCCCCC
T ss_pred hhhcCCEeeecCHhhCcCCCC
Confidence 655544445555666766554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=6.9e-18 Score=172.27 Aligned_cols=206 Identities=20% Similarity=0.205 Sum_probs=123.0
Q ss_pred ccccceeccccccccCCC-cccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcc
Q 046851 50 VNLEELNLAGNLVNGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLF 128 (963)
Q Consensus 50 ~~L~~L~Ls~N~l~~~~~-~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~ 128 (963)
.++..++++.+++++.+. ..+.+|+.|++.+|+++ +++ . ++++++|++|++++|+|++..+ +..+++|+.++++
T Consensus 19 ~~~~~~~l~~~~~~d~~~~~~l~~L~~L~l~~~~i~-~l~-~-l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~ 93 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-G-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS 93 (227)
T ss_dssp HHHHHHHTTCSSTTSEECHHHHHTCCEEECTTSCCC-CCT-T-GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred HHHHHHHhCCCCcCCcCCHHHcCCcCEEECCCCCCC-cch-h-HhcCCCCcEeecCCceeecccc--ccccccccccccc
Confidence 334445555555554332 22445555555566555 553 2 3467777777777777764332 6777777777777
Q ss_pred cCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccc
Q 046851 129 SNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFE 208 (963)
Q Consensus 129 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~ 208 (963)
+|.++.+ ..+.++++|+.+++++|...+. ..+...+.++.+.++++.+.
T Consensus 94 ~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~--------------------------- 142 (227)
T d1h6ua2 94 GNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQIT--------------------------- 142 (227)
T ss_dssp SCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCC---------------------------
T ss_pred ccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhc---------------------------
Confidence 7777643 3466777777777777766532 23555666666666553221
Q ss_pred cCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCC
Q 046851 209 GGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELP 288 (963)
Q Consensus 209 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 288 (963)
. ...+...++|+.|++++|.+... ..+.++++|++|+|++|+++++++ |+.+++|++|+|++|+|+++.+ ...
T Consensus 143 ~--~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~-l~~ 215 (227)
T d1h6ua2 143 N--ISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LAN 215 (227)
T ss_dssp C--CGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-GTT
T ss_pred h--hhhhccccccccccccccccccc--hhhcccccceecccCCCccCCChh--hcCCCCCCEEECcCCcCCCCcc-ccc
Confidence 1 12355666777777777766532 236667777777777777766543 5667777777777777765443 335
Q ss_pred CCceeEEEec
Q 046851 289 VPCMTMFDVS 298 (963)
Q Consensus 289 ~~~L~~L~l~ 298 (963)
+++|+.|+++
T Consensus 216 l~~L~~L~ls 225 (227)
T d1h6ua2 216 TSNLFIVTLT 225 (227)
T ss_dssp CTTCCEEEEE
T ss_pred CCCCCEEEee
Confidence 6666666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=5.5e-18 Score=173.01 Aligned_cols=203 Identities=21% Similarity=0.249 Sum_probs=144.5
Q ss_pred EEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccccccc
Q 046851 7 LDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGS 86 (963)
Q Consensus 7 L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~ 86 (963)
++++.+++++.. .+..+.+|++|++.+|+|+.. ..|.++++|++|++++|+++ .
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~----------------------~ 77 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT----------------------D 77 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC----------------------C
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceee----------------------c
Confidence 445555665442 345667777777777777733 24677777777777777665 3
Q ss_pred CCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCcCccC
Q 046851 87 VPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGN 166 (963)
Q Consensus 87 ~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 166 (963)
++. +..+++|+++++++|.++. + ..+.++++|+.+.++++..... ..+...+.++.+.++.+.+... ..+.+
T Consensus 78 ~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~ 149 (227)
T d1h6ua2 78 LAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAG 149 (227)
T ss_dssp CGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGG
T ss_pred ccc--ccccccccccccccccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcc
Confidence 322 3467778888888887763 2 3567778888888888777643 3466777888888888877632 34677
Q ss_pred CCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccCCCccccccccCc
Q 046851 167 CSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLE 246 (963)
Q Consensus 167 l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 246 (963)
.++|+.|++++|.+. . ...+.++++|+.|++++|++++. ..++++++|+
T Consensus 150 ~~~L~~L~l~~n~~~---------------------------~--~~~l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~ 198 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVS---------------------------D--LTPLANLSKLTTLKADDNKISDI--SPLASLPNLI 198 (227)
T ss_dssp CTTCCEEECCSSCCC---------------------------C--CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCC
T ss_pred ccccccccccccccc---------------------------c--chhhcccccceecccCCCccCCC--hhhcCCCCCC
Confidence 788888888774433 1 12477888999999999998753 3488999999
Q ss_pred eeecCcccccCcCccccCCCCCCcEEeccC
Q 046851 247 MLNLGHNFFSGKNLGVLGPCKNLLFLDLSS 276 (963)
Q Consensus 247 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 276 (963)
+|+|++|+++++++ ++++++|+.|++++
T Consensus 199 ~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 199 EVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp EEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred EEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 99999999998864 78999999999973
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=2.1e-20 Score=213.30 Aligned_cols=108 Identities=19% Similarity=0.230 Sum_probs=67.8
Q ss_pred ccccceeccccccccCC----Ccccccccceeeccccccc----cCCccccccCCCCCeEeCCCCccccC----cCcccc
Q 046851 50 VNLEELNLAGNLVNGTV----PTFIGRLKRVYLSFNRLVG----SVPSKIGEKCTNLEHLDLSGNYLVGG----IPRSLG 117 (963)
Q Consensus 50 ~~L~~L~Ls~N~l~~~~----~~~~~~L~~L~L~~n~l~~----~~p~~~~~~l~~L~~L~Ls~N~i~~~----~~~~~~ 117 (963)
++|++||+++|++++.. .+.+.+++.|+|++|+++. .++.. +..+++|++|||++|+|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~-L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~ 80 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA-LRVNPALAELNLRSNELGDVGVHCVLQGLQ 80 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHH-HHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHH-HhcCCCCCEEECcCCcCChHHHHHHHHHHh
Confidence 46888888888887532 2334567778888887762 12222 24567788888888877521 222222
Q ss_pred -CcccccEEEcccCccccc----CcccccCCCCCCEEEccCCcccc
Q 046851 118 -NCFQVRSLLLFSNMLEET----IPAELGMLQNLEVLDVSRNSLSG 158 (963)
Q Consensus 118 -~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~ 158 (963)
...+|++|+|++|++++. ++.++..+++|++|+|++|.++.
T Consensus 81 ~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 81 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred cCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 234677777777777643 34456667777777777777653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=1.3e-17 Score=165.11 Aligned_cols=127 Identities=20% Similarity=0.210 Sum_probs=89.2
Q ss_pred cceeccccccccCCCccc-ccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCc
Q 046851 53 EELNLAGNLVNGTVPTFI-GRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNM 131 (963)
Q Consensus 53 ~~L~Ls~N~l~~~~~~~~-~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~ 131 (963)
++++.+++.++ .+|..+ .++++|+|++|+|++.++...|.++++|++|+|++|+++...++.|..+++|++|+|++|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CEEEEeCCCcC-ccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 45666666666 333332 3566666666666545667777777777777777777777777777777777777777777
Q ss_pred ccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCC
Q 046851 132 LEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFD 180 (963)
Q Consensus 132 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~ 180 (963)
|+.+.+.+|.++++|++|+|++|+|+...+..|..+++|++|+|++|.+
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence 7777777777777777777777777766666677777777777766443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=4e-17 Score=163.95 Aligned_cols=115 Identities=25% Similarity=0.263 Sum_probs=55.8
Q ss_pred ceeccccccccCCCc-ccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcc
Q 046851 54 ELNLAGNLVNGTVPT-FIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNML 132 (963)
Q Consensus 54 ~L~Ls~N~l~~~~~~-~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l 132 (963)
..++..+.+++.++. .+.+|++|++++|.++ .++. ++.+++|++|+|++|+|++.. .++.+++|+.|++++|++
T Consensus 28 ~~~l~~~~~~~~~~~~~L~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHHTTCSCTTSEECHHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHHhCcCccCCccCHHHhcCccEEECcCCCCC-Cchh--HhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 334444444433332 2334455555555554 3332 234556666666666655322 245555566666655555
Q ss_pred cccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecC
Q 046851 133 EETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSN 177 (963)
Q Consensus 133 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 177 (963)
+++ + .+.++++|+.|++++|.+.. + ..+..+++++.+++++
T Consensus 103 ~~l-~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~ 143 (210)
T d1h6ta2 103 KDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGN 143 (210)
T ss_dssp CCG-G-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCS
T ss_pred ccc-c-cccccccccccccccccccc-c-cccccccccccccccc
Confidence 532 2 35555556666665555542 1 2344445555555444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=4e-17 Score=162.52 Aligned_cols=63 Identities=27% Similarity=0.294 Sum_probs=31.2
Q ss_pred ccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCccccc
Q 046851 215 VSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTG 281 (963)
Q Consensus 215 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 281 (963)
+.++++|+.|++++|++.. ...+..+++|++|++++|++++++ .|+++++|++|++++|++++
T Consensus 124 ~~~l~~L~~L~l~~n~l~~--~~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 124 LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp GTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred cchhhhhHHhhhhhhhhcc--cccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence 3444455555555554432 123445555555555555555443 24555555555555555544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=7.9e-17 Score=161.79 Aligned_cols=184 Identities=18% Similarity=0.175 Sum_probs=142.2
Q ss_pred ccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccCcccccCcccccCCCCCCEEEcc
Q 046851 73 LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVS 152 (963)
Q Consensus 73 L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 152 (963)
.....+..+.+++.++.. .+.+|++|++++|+|+.. + .+..+++|++|+|++|+|+++. .+..+++|++|+++
T Consensus 26 ~i~~~l~~~~~~~~~~~~---~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLD 98 (210)
T ss_dssp HHHHHTTCSCTTSEECHH---HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred HHHHHhCcCccCCccCHH---HhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccc
Confidence 334566777776555442 467899999999999843 3 4888999999999999998653 36889999999999
Q ss_pred CCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccc
Q 046851 153 RNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLE 232 (963)
Q Consensus 153 ~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~ 232 (963)
+|++++ +| .+.++++|+.|++++|.+. . ...+.+++.|+.++++.|.++
T Consensus 99 ~n~i~~-l~-~l~~l~~L~~L~l~~~~~~---------------------------~--~~~l~~l~~l~~l~~~~n~l~ 147 (210)
T d1h6ta2 99 ENKVKD-LS-SLKDLKKLKSLSLEHNGIS---------------------------D--INGLVHLPQLESLYLGNNKIT 147 (210)
T ss_dssp SSCCCC-GG-GGTTCTTCCEEECTTSCCC---------------------------C--CGGGGGCTTCCEEECCSSCCC
T ss_pred cccccc-cc-ccccccccccccccccccc---------------------------c--ccccccccccccccccccccc
Confidence 999984 44 5888999999999874332 1 245778888999999998887
Q ss_pred cCCCccccccccCceeecCcccccCcCccccCCCCCCcEEeccCcccccccCCCCCCCceeEEEecc
Q 046851 233 GNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFLDLSSNQLTGELARELPVPCMTMFDVSG 299 (963)
Q Consensus 233 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~ 299 (963)
+ +..+..+++|+.+++++|+++++++ ++++++|+.|+|++|+|+++. ....+++|+.|++++
T Consensus 148 ~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 148 D--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp C--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEE
T ss_pred c--ccccccccccccccccccccccccc--ccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEccC
Confidence 4 4457788889999999999887753 788889999999999887643 445677888888764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=2.6e-16 Score=156.55 Aligned_cols=183 Identities=24% Similarity=0.215 Sum_probs=120.2
Q ss_pred CcccccceeccccccccCCC-cccccccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEE
Q 046851 48 DFVNLEELNLAGNLVNGTVP-TFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLL 126 (963)
Q Consensus 48 ~l~~L~~L~Ls~N~l~~~~~-~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 126 (963)
++.++..+.++.+.+++.+. ..+.++++|++++|.++ .++. ++.+++|++|+|++|+|++..+ ++++++|+.|+
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~~~~l~~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 90 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEECHHHHTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHHhCCCCCCCccCHHHhcCCCEEECCCCCCC-Cccc--cccCCCcCcCccccccccCccc--ccCCccccccc
Confidence 34455566677777765443 23556777777777777 5542 3457777777777777774332 77777777777
Q ss_pred cccCcccccCcccccCCCCCCEEEccCCccccCCCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCc
Q 046851 127 LFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNF 206 (963)
Q Consensus 127 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~ 206 (963)
+++|.+.... .+.++++|+.|++++|.+... ..+..+++|+.|++++|.+.
T Consensus 91 l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~------------------------- 141 (199)
T d2omxa2 91 MNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS------------------------- 141 (199)
T ss_dssp CCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-------------------------
T ss_pred cccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-------------------------
Confidence 7777776432 367777777777777777632 34667777777777764332
Q ss_pred cccCCcccccCCCCCceEecCCcccccCCCccccccccCceeecCcccccCcCccccCCCCCCcEE
Q 046851 207 FEGGIPEAVSSLPNLRILWAPRATLEGNFPSNWGACDNLEMLNLGHNFFSGKNLGVLGPCKNLLFL 272 (963)
Q Consensus 207 ~~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 272 (963)
. .+.+..+++|+.|++.+|++++. ..+.++++|++|++++|++++++ .++.+++|+.|
T Consensus 142 --~--~~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~L 199 (199)
T d2omxa2 142 --D--ISALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSDIS--VLAKLTNLESL 199 (199)
T ss_dssp --C--CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCSEE
T ss_pred --c--cccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCCCc--cccCCCCCCcC
Confidence 1 13466777777777777777643 24677777777777777777764 35667777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=2.2e-14 Score=129.63 Aligned_cols=102 Identities=24% Similarity=0.352 Sum_probs=73.7
Q ss_pred cEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceeccccc
Q 046851 440 KFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLSSN 519 (963)
Q Consensus 440 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N 519 (963)
+.|+|++|+|+ .++ .+..+++|++|++++|.|+ .+|..++.+++|+.|++++|+|+ .+| .++.+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 46777788877 454 4777777888888888775 45666777778888888888877 454 4777778888888888
Q ss_pred ccCCCCC-hhhhccccCCeEEeccccCC
Q 046851 520 SLSGLIP-DDLENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 520 ~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 546 (963)
+|+.... ..+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 8774422 45677777888888888776
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=8.3e-15 Score=139.46 Aligned_cols=123 Identities=24% Similarity=0.200 Sum_probs=97.4
Q ss_pred CCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceecc
Q 046851 437 KSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDL 516 (963)
Q Consensus 437 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 516 (963)
..+++|+|++|+|+ .++..+..+++|+.|++++|.|+. + +.+..+++|++|++++|+++...+..+..+++|+.|++
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 45888999999998 567777788899999999999864 3 35788889999999999998544555677899999999
Q ss_pred cccccCCCCC-hhhhccccCCeEEeccccCCCcCCC----CccccccCceEe
Q 046851 517 SSNSLSGLIP-DDLENLRNLTVLLLNNNKLSGKIPS----GLANVSTLSAFN 563 (963)
Q Consensus 517 s~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~L~~l~ 563 (963)
++|+|+.... ..+..+++|++|++++|+++ ..|. .+..+|+|++||
T Consensus 95 ~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 95 TNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 9999874321 35778889999999999987 5564 467788888876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.5e-14 Score=137.71 Aligned_cols=129 Identities=16% Similarity=0.093 Sum_probs=81.6
Q ss_pred ccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCe
Q 046851 21 SGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEH 100 (963)
Q Consensus 21 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~ 100 (963)
.|.+...|++|+|++|+|+ .++..+..+++|+.|+|++|.|+ +++. +..+++|++
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~----------------------~l~~--~~~l~~L~~ 67 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR----------------------KLDG--FPLLRRLKT 67 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC----------------------EECC--CCCCSSCCE
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC----------------------ccCC--cccCcchhh
Confidence 4667778888999999888 44666778888888888888887 2321 234555666
Q ss_pred EeCCCCccccCcCccccCcccccEEEcccCcccccCc-ccccCCCCCCEEEccCCccccCCCc----CccCCCCCceEee
Q 046851 101 LDLSGNYLVGGIPRSLGNCFQVRSLLLFSNMLEETIP-AELGMLQNLEVLDVSRNSLSGSIPV----DLGNCSKLAILVL 175 (963)
Q Consensus 101 L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~l 175 (963)
|++++|+|+...+..+..+++|+.|++++|+|+.... ..+..+++|++|++++|+++ ..|. .+..+++|+.||-
T Consensus 68 L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp EECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred hhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCC
Confidence 6666666554444444555566666666665553321 34666667777777777665 3332 3566677776653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=8.4e-14 Score=125.70 Aligned_cols=102 Identities=25% Similarity=0.259 Sum_probs=59.1
Q ss_pred eEEEccCCcccccCCCccccCCCCcEEEccCCcccccCCccccCcccccceeccccccccCCCcccccccceeecccccc
Q 046851 5 EVLDLEGNLLNGILPDSGFHLKSLRVLNLGFNRITGEIPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLV 84 (963)
Q Consensus 5 ~~L~ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~ 84 (963)
|+|||++|+|+.+ + .+.++++|++|++++|+|+ .+|..|..+++|++|++++|+|+
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~--------------------- 56 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--------------------- 56 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC---------------------
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc---------------------
Confidence 4677777777633 2 3666777777777777776 45556666777777777666665
Q ss_pred ccCCccccccCCCCCeEeCCCCccccCc-CccccCcccccEEEcccCccc
Q 046851 85 GSVPSKIGEKCTNLEHLDLSGNYLVGGI-PRSLGNCFQVRSLLLFSNMLE 133 (963)
Q Consensus 85 ~~~p~~~~~~l~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~L~~n~l~ 133 (963)
.+|. +..+++|++|++++|+|+... ...+..+++|+.|++++|.++
T Consensus 57 -~l~~--~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 57 -NVDG--VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp -CCGG--GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred -ccCc--cccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 3332 234556666666666665322 133444455555555555444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.3e-14 Score=152.60 Aligned_cols=180 Identities=21% Similarity=0.205 Sum_probs=121.9
Q ss_pred ccceeeccccccccCCccccccCCCCCeEeCCCCccccCcCccccCcccccEEEcccC-ccccc-CcccccCCCCCCEEE
Q 046851 73 LKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVGGIPRSLGNCFQVRSLLLFSN-MLEET-IPAELGMLQNLEVLD 150 (963)
Q Consensus 73 L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~ 150 (963)
|++|++++|.++......++.++++|++|+|+++.+++..+..++.+++|+.|+++++ .++.. +...+.++++|++|+
T Consensus 48 L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ 127 (284)
T d2astb2 48 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELN 127 (284)
T ss_dssp CCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEE
T ss_pred CCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccc
Confidence 3444444444433334455677888999999998887777778888888999999885 56532 122345688899999
Q ss_pred ccCC-ccccC-CCcCccC-CCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccc-cCCcccccCCCCCceEec
Q 046851 151 VSRN-SLSGS-IPVDLGN-CSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFE-GGIPEAVSSLPNLRILWA 226 (963)
Q Consensus 151 L~~N-~l~~~-~p~~~~~-l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~-~~~~~~l~~l~~L~~L~l 226 (963)
++++ .+++. +...+.. .++|+.|+++++... +. ..+...+.++++|+.|++
T Consensus 128 ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~-------------------------i~~~~l~~l~~~~~~L~~L~L 182 (284)
T d2astb2 128 LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN-------------------------LQKSDLSTLVRRCPNLVHLDL 182 (284)
T ss_dssp CCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG-------------------------SCHHHHHHHHHHCTTCSEEEC
T ss_pred cccccccccccchhhhcccccccchhhhcccccc-------------------------ccccccccccccccccccccc
Confidence 9886 34421 1122333 467888888763211 11 112233456788999999
Q ss_pred CCc-ccccCCCccccccccCceeecCcc-cccCcCccccCCCCCCcEEeccCc
Q 046851 227 PRA-TLEGNFPSNWGACDNLEMLNLGHN-FFSGKNLGVLGPCKNLLFLDLSSN 277 (963)
Q Consensus 227 ~~n-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N 277 (963)
++| .+++.....+..+++|++|+|+++ .+++.....++++++|+.|+++++
T Consensus 183 ~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 886 467667777888899999999984 677766667788899999999887
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=6e-15 Score=160.52 Aligned_cols=249 Identities=18% Similarity=0.161 Sum_probs=133.4
Q ss_pred CCccccCCCCcEEEccCCcccc----cCCccccCcccccceeccccccccC---CCcccccccceeeccccccccCCccc
Q 046851 19 PDSGFHLKSLRVLNLGFNRITG----EIPASFSDFVNLEELNLAGNLVNGT---VPTFIGRLKRVYLSFNRLVGSVPSKI 91 (963)
Q Consensus 19 ~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~L~~L~L~~n~l~~~~p~~~ 91 (963)
...+.+...|++|+|++|.|.. .+...+...++|+.|+++++..... .+..+. .+...
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~--------------~l~~~- 88 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR--------------LLLQA- 88 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH--------------HHHHH-
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHH--------------HHHHH-
Confidence 3445667889999999998863 3344567788999999988755411 111110 11111
Q ss_pred cccCCCCCeEeCCCCccccC----cCccccCcccccEEEcccCcccccCcc-------------cccCCCCCCEEEccCC
Q 046851 92 GEKCTNLEHLDLSGNYLVGG----IPRSLGNCFQVRSLLLFSNMLEETIPA-------------ELGMLQNLEVLDVSRN 154 (963)
Q Consensus 92 ~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~L~L~~N 154 (963)
+..+++|++|+|++|.+... +...+...++|+.|++++|.++..... .....+.|+.|++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 11234455555555554422 222333444555555555544311000 1123455666666666
Q ss_pred ccccC----CCcCccCCCCCceEeecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcc
Q 046851 155 SLSGS----IPVDLGNCSKLAILVLSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRAT 230 (963)
Q Consensus 155 ~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~ 230 (963)
.+... +...+...+.|+.|++++|.++..+... .+...+...++|+.|++++|.
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~----------------------~l~~~l~~~~~L~~L~Ls~N~ 226 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH----------------------LLLEGLAYCQELKVLDLQDNT 226 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHH----------------------HHHTTGGGCTTCCEEECCSSC
T ss_pred cccccccccccchhhhhhhhccccccccccccccccc----------------------chhhhhcchhhhccccccccc
Confidence 65421 1222445566666666665544322110 122345566677777777776
Q ss_pred cccC----CCccccccccCceeecCcccccCcCcccc----C--CCCCCcEEeccCcccccccCCCC------CCCceeE
Q 046851 231 LEGN----FPSNWGACDNLEMLNLGHNFFSGKNLGVL----G--PCKNLLFLDLSSNQLTGELAREL------PVPCMTM 294 (963)
Q Consensus 231 l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~--~l~~L~~L~L~~N~l~~~~~~~~------~~~~L~~ 294 (963)
++.. +...+..+++|++|+|++|.|++.....+ . ..+.|++|++++|+|+......+ ..+.|+.
T Consensus 227 i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~ 306 (344)
T d2ca6a1 227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306 (344)
T ss_dssp CHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE
T ss_pred ccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCE
Confidence 6432 23445566777777777777765433222 1 23567788888887764322111 2456788
Q ss_pred EEeccCcCcc
Q 046851 295 FDVSGNALSG 304 (963)
Q Consensus 295 L~l~~N~l~~ 304 (963)
|++++|++..
T Consensus 307 L~l~~N~~~~ 316 (344)
T d2ca6a1 307 LELNGNRFSE 316 (344)
T ss_dssp EECTTSBSCT
T ss_pred EECCCCcCCC
Confidence 8888888764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=6.8e-15 Score=160.06 Aligned_cols=246 Identities=17% Similarity=0.140 Sum_probs=125.5
Q ss_pred CCccccCcccccceeccccccccCCCcccccccceeeccccccccCCccccccCCCCCeEeCCCCcccc----------C
Q 046851 42 IPASFSDFVNLEELNLAGNLVNGTVPTFIGRLKRVYLSFNRLVGSVPSKIGEKCTNLEHLDLSGNYLVG----------G 111 (963)
Q Consensus 42 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~Ls~N~i~~----------~ 111 (963)
+..++.....|++|+|++|.+....... +... +...++|+.|+++++.+.. .
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~-----------------l~~~-l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~ 84 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARW-----------------LSEN-IASKKDLEIAEFSDIFTGRVKDEIPEALRL 84 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHH-----------------HHHT-TTTCTTCCEEECCSCCTTSCGGGSHHHHHH
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHH-----------------HHHH-HHhCCCCCEEECCCCcccccccccchHHHH
Confidence 3445555666777777666664221111 1111 1234555555555543321 1
Q ss_pred cCccccCcccccEEEcccCccccc----CcccccCCCCCCEEEccCCccccCCCc-------------CccCCCCCceEe
Q 046851 112 IPRSLGNCFQVRSLLLFSNMLEET----IPAELGMLQNLEVLDVSRNSLSGSIPV-------------DLGNCSKLAILV 174 (963)
Q Consensus 112 ~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~-------------~~~~l~~L~~L~ 174 (963)
+...+..+++|+.|+|++|.++.. +...+...++|++|++++|.+...... .....+.|+.+.
T Consensus 85 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~ 164 (344)
T d2ca6a1 85 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 164 (344)
T ss_dssp HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred HHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceee
Confidence 122344556677777777766543 223344556677777776665421110 012455666666
Q ss_pred ecCcCCcccccccccCCcccCCCcccCCCCCccccCCcccccCCCCCceEecCCcccccC-----CCccccccccCceee
Q 046851 175 LSNLFDTYEDVRYSRGQSLVDQPSFMNDDFNFFEGGIPEAVSSLPNLRILWAPRATLEGN-----FPSNWGACDNLEMLN 249 (963)
Q Consensus 175 l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~L~ 249 (963)
+++|.++..+.. .+...+...+.|+.|++++|++... +...+..+++|+.|+
T Consensus 165 l~~n~i~~~~~~-----------------------~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~ 221 (344)
T d2ca6a1 165 CGRNRLENGSMK-----------------------EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD 221 (344)
T ss_dssp CCSSCCTGGGHH-----------------------HHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEE
T ss_pred cccccccccccc-----------------------cccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccc
Confidence 666554432221 1233445566667777777666431 233455566677777
Q ss_pred cCcccccCcC----ccccCCCCCCcEEeccCcccccccCCCC-------CCCceeEEEeccCcCccC-----CCCC-CCC
Q 046851 250 LGHNFFSGKN----LGVLGPCKNLLFLDLSSNQLTGELAREL-------PVPCMTMFDVSGNALSGS-----IPTF-SNM 312 (963)
Q Consensus 250 Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------~~~~L~~L~l~~N~l~~~-----~~~~-~~l 312 (963)
|++|.++... ...+..+++|++|+|++|.|++.....+ ..+.|+.||+++|.+... ...+ .+.
T Consensus 222 Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~ 301 (344)
T d2ca6a1 222 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301 (344)
T ss_dssp CCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHC
T ss_pred cccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccC
Confidence 7777664421 1334556667777777776654322111 234566777777766531 1111 133
Q ss_pred CCCCcccccccccccC
Q 046851 313 VCPPVPYLSRNLFESY 328 (963)
Q Consensus 313 ~~l~~l~l~~n~~~~~ 328 (963)
..|+.++|++|+|...
T Consensus 302 ~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 302 PDLLFLELNGNRFSEE 317 (344)
T ss_dssp TTCCEEECTTSBSCTT
T ss_pred CCCCEEECCCCcCCCc
Confidence 4566667777766543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=6e-14 Score=147.50 Aligned_cols=62 Identities=23% Similarity=0.240 Sum_probs=30.0
Q ss_pred ccCCCCCEEeccCCc-CCCccchhhccCcccceeccccc-cccccCCcccccCCccceeccccc
Q 046851 458 GELVSLVALNLSWNL-MHDQIPTTLGQMKGLKYLSLAGN-NLTGSIPSSLGQLQLLEVLDLSSN 519 (963)
Q Consensus 458 ~~l~~L~~L~ls~N~-i~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~ls~N 519 (963)
.++++|++|++++|. +++.....+..+++|++|+|++| .+++.....++++++|+.|+++++
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 344555555555532 44344444455555555555552 344333334445555555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=3.5e-14 Score=140.12 Aligned_cols=131 Identities=26% Similarity=0.344 Sum_probs=94.3
Q ss_pred cCchhHhhccCCccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccc
Q 046851 427 QLPAEIGRMCKSLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLG 506 (963)
Q Consensus 427 ~~p~~~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 506 (963)
.+|..+..+ ++|++|+|++|+|+ .++ .+..+++|+.|++++|.|+ .+|..+..+++|++|++++|+++ .++ .+.
T Consensus 39 ~l~~sl~~L-~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~ 112 (198)
T d1m9la_ 39 KMDATLSTL-KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIE 112 (198)
T ss_dssp CCHHHHHHT-TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHH
T ss_pred hhhhHHhcc-cccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccc
Confidence 455666665 77888888888887 454 5788888888888888885 45555566677888888888887 343 477
Q ss_pred cCCccceecccccccCCCCC-hhhhccccCCeEEeccccCCCcCCCC----------ccccccCceEe
Q 046851 507 QLQLLEVLDLSSNSLSGLIP-DDLENLRNLTVLLLNNNKLSGKIPSG----------LANVSTLSAFN 563 (963)
Q Consensus 507 ~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~----------l~~l~~L~~l~ 563 (963)
.+++|+.|++++|+|+.... ..+..+++|+.|+|++|++....+.. +..+|+|+.||
T Consensus 113 ~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 78888888888888874321 35778888888888888876443332 45677777765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=2e-12 Score=121.84 Aligned_cols=106 Identities=19% Similarity=0.140 Sum_probs=56.0
Q ss_pred ccEEECcCCcCCCCCccccccCCCCCEEeccCC-cCCCccchhhccCcccceeccccccccccCCcccccCCccceeccc
Q 046851 439 LKFLDASGNQIVGPIPRGVGELVSLVALNLSWN-LMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLDLS 517 (963)
Q Consensus 439 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N-~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls 517 (963)
.+.++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|++..|..|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 345566666665 45555555566666666444 3544444555555555555555555554445555555555555555
Q ss_pred ccccCCCCChhhhccccCCeEEeccccCC
Q 046851 518 SNSLSGLIPDDLENLRNLTVLLLNNNKLS 546 (963)
Q Consensus 518 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 546 (963)
+|+|+.. |.......+|+.|+|++|++.
T Consensus 89 ~N~l~~l-~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESL-SWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCC-CSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCccc-ChhhhccccccccccCCCccc
Confidence 5555532 322222234555555555553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.27 E-value=1.1e-13 Score=136.40 Aligned_cols=130 Identities=28% Similarity=0.314 Sum_probs=109.2
Q ss_pred CccEEECcCC--cCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceeccccccccccCCcccccCCccceec
Q 046851 438 SLKFLDASGN--QIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGSIPSSLGQLQLLEVLD 515 (963)
Q Consensus 438 ~L~~L~ls~n--~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 515 (963)
.++.++++++ .++ .++..+..+++|+.|+|++|.|+. ++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence 3566666655 354 677889999999999999999965 44 5899999999999999998 7887777778999999
Q ss_pred ccccccCCCCChhhhccccCCeEEeccccCCCcCC--CCccccccCceEeeccccCccCCC
Q 046851 516 LSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIP--SGLANVSTLSAFNVSFNNLSGPLP 574 (963)
Q Consensus 516 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~L~~l~l~~N~l~~~~p 574 (963)
+++|+|+.. ..+..+++|+.|++++|+++ .++ ..+..+++|+.|++++|++....+
T Consensus 100 l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 100 ISYNQIASL--SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp CSEEECCCH--HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccc--ccccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcc
Confidence 999999953 46889999999999999998 444 468899999999999999876433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=1.1e-11 Score=116.68 Aligned_cols=107 Identities=20% Similarity=0.118 Sum_probs=66.4
Q ss_pred CCCEEeccCCcCCCccchhhccCcccceeccccc-cccccCCcccccCCccceecccccccCCCCChhhhccccCCeEEe
Q 046851 462 SLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGN-NLTGSIPSSLGQLQLLEVLDLSSNSLSGLIPDDLENLRNLTVLLL 540 (963)
Q Consensus 462 ~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 540 (963)
..+.++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+.+.|..|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3455666666663 34555666666677776554 366444455666677777777777776555566666677777777
Q ss_pred ccccCCCcCCCCccccccCceEeeccccCc
Q 046851 541 NNNKLSGKIPSGLANVSTLSAFNVSFNNLS 570 (963)
Q Consensus 541 ~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~ 570 (963)
++|+|+ .+|.......+|+.|+|++|+|.
T Consensus 88 s~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cCCCCc-ccChhhhccccccccccCCCccc
Confidence 777776 45544444445666777776664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=2.5e-09 Score=100.94 Aligned_cols=125 Identities=22% Similarity=0.161 Sum_probs=82.4
Q ss_pred CccEEECcCCcCCCCCccccccCCCCCEEeccCCcCCCccchhhccCcccceecccccccccc--CCcccccCCccceec
Q 046851 438 SLKFLDASGNQIVGPIPRGVGELVSLVALNLSWNLMHDQIPTTLGQMKGLKYLSLAGNNLTGS--IPSSLGQLQLLEVLD 515 (963)
Q Consensus 438 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~ 515 (963)
+.+.|+++++... ..+..+..+..++..+|.+ ..++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3566677665533 1244444555555555544 34455556788899999999998842 234567789999999
Q ss_pred ccccccCCCCChhhhccccCCeEEeccccCCCcCCCC-------ccccccCceEeeccccC
Q 046851 516 LSSNSLSGLIPDDLENLRNLTVLLLNNNKLSGKIPSG-------LANVSTLSAFNVSFNNL 569 (963)
Q Consensus 516 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------l~~l~~L~~l~l~~N~l 569 (963)
|++|+|+...+-......+|+.|++++|+++...... +..+|+|+.|| ++.+
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 9999998543334445567899999999997544422 55688888765 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.45 E-value=5.8e-09 Score=98.31 Aligned_cols=84 Identities=26% Similarity=0.109 Sum_probs=50.7
Q ss_pred ccccCCCCCeEeCCCCccccCc--CccccCcccccEEEcccCcccccCcccccCCCCCCEEEccCCccccCCCc------
Q 046851 91 IGEKCTNLEHLDLSGNYLVGGI--PRSLGNCFQVRSLLLFSNMLEETIPAELGMLQNLEVLDVSRNSLSGSIPV------ 162 (963)
Q Consensus 91 ~~~~l~~L~~L~Ls~N~i~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~------ 162 (963)
++..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|++......
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 4445666777777777766432 34455666777777777777654443444445677777777777643332
Q ss_pred -CccCCCCCceEe
Q 046851 163 -DLGNCSKLAILV 174 (963)
Q Consensus 163 -~~~~l~~L~~L~ 174 (963)
.+..+++|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 145677777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=3.6e-07 Score=93.55 Aligned_cols=150 Identities=13% Similarity=0.037 Sum_probs=103.9
Q ss_pred HHHHHHcCCCCCccccccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeE
Q 046851 675 ESVVQATGNFNASNCIGNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEM 753 (963)
Q Consensus 675 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 753 (963)
+++...-+.|+..+..+.++.+.||+...+ +..++||+...........+.+|+..+..+. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 455666677877776655556789998755 6678889876554444456778888877664 43467778888888889
Q ss_pred EEEEeccCCCChHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 046851 754 FLIYNYLPGGNLENFIQQRSTRAVDWRVLHKIALDIARALAYLHDQ---------------------------------- 799 (963)
Q Consensus 754 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------------------------------- 799 (963)
++||++++|.++.+..... .....++.++++.++.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998876543211 11223445555555555521
Q ss_pred ----------------------CCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 800 ----------------------CVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 800 ----------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
..+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112479999999999999877777999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=2.1e-05 Score=79.47 Aligned_cols=141 Identities=16% Similarity=0.159 Sum_probs=85.6
Q ss_pred ccccCCC-ccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccC--CCCeeEEEEeeeCCCeEEEEEeccCCCCh
Q 046851 689 CIGNGGF-GATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR--HPNLVTLIGYHASETEMFLIYNYLPGGNL 765 (963)
Q Consensus 689 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL 765 (963)
.+..|.. +.||+...+++..+++|....... ..+..|+..++.+. .-.+.+++++..+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 578999988888899997665433 34566777776663 33367788888888889999999988654
Q ss_pred HHH--------------Hhh---hc--CCCC--CHHHHHH-----H---------------HHHHHHHHHHHHhC----C
Q 046851 766 ENF--------------IQQ---RS--TRAV--DWRVLHK-----I---------------ALDIARALAYLHDQ----C 800 (963)
Q Consensus 766 ~~~--------------l~~---~~--~~~~--~~~~~~~-----i---------------~~~i~~~l~~LH~~----~ 800 (963)
.+. +.+ .. .... .+..... + .......+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 321 110 00 0000 0000000 0 00011122333222 1
Q ss_pred CCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 801 VPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 801 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
.+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 23589999999999999887778999987753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.58 E-value=1.8e-05 Score=74.10 Aligned_cols=107 Identities=14% Similarity=0.103 Sum_probs=56.1
Q ss_pred CCccEEECcCC-cCCCC----CccccccCCCCCEEeccCCcCCCc----cchhhccCcccceecccccccccc----CCc
Q 046851 437 KSLKFLDASGN-QIVGP----IPRGVGELVSLVALNLSWNLMHDQ----IPTTLGQMKGLKYLSLAGNNLTGS----IPS 503 (963)
Q Consensus 437 ~~L~~L~ls~n-~l~~~----~p~~~~~l~~L~~L~ls~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~ 503 (963)
++|++|+|+++ .++.. +-..+...+.|+.|+|++|.++.. +...+...+.|++|+|++|.++.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 56777777763 45421 223445556677777777776422 223334455666666666666522 122
Q ss_pred ccccCCccceecccccccCCC-------CChhhhccccCCeEEeccc
Q 046851 504 SLGQLQLLEVLDLSSNSLSGL-------IPDDLENLRNLTVLLLNNN 543 (963)
Q Consensus 504 ~~~~l~~L~~L~ls~N~l~~~-------~p~~~~~l~~L~~L~l~~N 543 (963)
.+...+.|++|++++|++... +...+...++|+.|+++.+
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 334445566666666655422 1122333455555555444
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.37 E-value=2.6e-05 Score=72.96 Aligned_cols=64 Identities=16% Similarity=0.224 Sum_probs=31.9
Q ss_pred cCCCCCeEeCCCC-ccccC----cCccccCcccccEEEcccCcccc----cCcccccCCCCCCEEEccCCccc
Q 046851 94 KCTNLEHLDLSGN-YLVGG----IPRSLGNCFQVRSLLLFSNMLEE----TIPAELGMLQNLEVLDVSRNSLS 157 (963)
Q Consensus 94 ~l~~L~~L~Ls~N-~i~~~----~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~ 157 (963)
+.++|++|+|+++ .|+.. +..++...+.|+.|+|++|.+.. .+...+...+.|++|+|++|.|+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 4567777777763 35421 22234444555555555555542 12223334455555555555554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.23 E-value=0.00025 Score=76.18 Aligned_cols=76 Identities=13% Similarity=0.049 Sum_probs=48.6
Q ss_pred ccccccCCCccEEEEEECC-CcEEEEEEeecc-------cchhHHHHHHHHHHHhccC-C--CCeeEEEEeeeCCCeEEE
Q 046851 687 SNCIGNGGFGATYKAEISP-GVLVAIKRLAVG-------RFQGVQQFHAEIKTLGRLR-H--PNLVTLIGYHASETEMFL 755 (963)
Q Consensus 687 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 755 (963)
.+.||.|....||+....+ |+.|+||.-... .+....+...|++.++.+. + ..+++++.+.. +..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence 3468999999999997654 678999854321 1122345567888877663 2 34666666543 34578
Q ss_pred EEeccCCCC
Q 046851 756 IYNYLPGGN 764 (963)
Q Consensus 756 v~e~~~~gs 764 (963)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.86 E-value=0.00015 Score=67.53 Aligned_cols=109 Identities=19% Similarity=0.161 Sum_probs=59.8
Q ss_pred cCCccEEECcC-CcCCCC----CccccccCCCCCEEeccCCcCCCc----cchhhccCcccceecccccccccc----CC
Q 046851 436 CKSLKFLDASG-NQIVGP----IPRGVGELVSLVALNLSWNLMHDQ----IPTTLGQMKGLKYLSLAGNNLTGS----IP 502 (963)
Q Consensus 436 ~~~L~~L~ls~-n~l~~~----~p~~~~~l~~L~~L~ls~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p 502 (963)
.++|++|+|++ +.++.. +-..+...+.|++|++++|.++.. +-..+...++++.+++++|.++.. +.
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 36677888876 456421 233345667777778877777532 223344556677777777766522 22
Q ss_pred cccccCCcccee--cccccccCCC----CChhhhccccCCeEEecccc
Q 046851 503 SSLGQLQLLEVL--DLSSNSLSGL----IPDDLENLRNLTVLLLNNNK 544 (963)
Q Consensus 503 ~~~~~l~~L~~L--~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~ 544 (963)
..+...+.|+.+ ++++|.+... +...+...++|+.|+++.|.
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 344555666653 3345555421 22334455666666665544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.68 E-value=0.00014 Score=67.69 Aligned_cols=64 Identities=17% Similarity=0.218 Sum_probs=30.1
Q ss_pred cCCCCCeEeCCC-CccccC----cCccccCcccccEEEcccCccccc----CcccccCCCCCCEEEccCCccc
Q 046851 94 KCTNLEHLDLSG-NYLVGG----IPRSLGNCFQVRSLLLFSNMLEET----IPAELGMLQNLEVLDVSRNSLS 157 (963)
Q Consensus 94 ~l~~L~~L~Ls~-N~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 157 (963)
+.++|++|+|++ +.|+.. +..++...++|++|+|++|.++.. +...+...++|+.|++++|.+.
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 456777777776 345421 222333444555555555554421 1223333444555555544443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.48 E-value=0.003 Score=65.50 Aligned_cols=135 Identities=16% Similarity=0.156 Sum_probs=77.8
Q ss_pred CccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCCCCe--eEEEE-----eeeCCCeEEEEEeccCCCChH-
Q 046851 695 FGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRHPNL--VTLIG-----YHASETEMFLIYNYLPGGNLE- 766 (963)
Q Consensus 695 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~- 766 (963)
--.||+++..+|++|++|+...+. ...+++..|...+..+...++ +..+. .+...+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 457999999999999999876543 234667788888777742222 11111 123356778999999864321
Q ss_pred ----H------HH---hhh----c---CCCCCH-------------------HHHHHHHHHHHHHHHHHHh----CCCCC
Q 046851 767 ----N------FI---QQR----S---TRAVDW-------------------RVLHKIALDIARALAYLHD----QCVPR 803 (963)
Q Consensus 767 ----~------~l---~~~----~---~~~~~~-------------------~~~~~i~~~i~~~l~~LH~----~~~~~ 803 (963)
. .+ +.. . ....++ .....+...+.+.++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 11 110 0 011111 1111122222333333332 22458
Q ss_pred ceecccCCCCeEECCCCcEEEeecccccc
Q 046851 804 VLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 804 ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
+||+|+.+.||+++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.09 E-value=0.0068 Score=64.62 Aligned_cols=72 Identities=17% Similarity=0.122 Sum_probs=49.0
Q ss_pred cccccCCCccEEEEEECC--------CcEEEEEEeecccchhHHHHHHHHHHHhccC-CCCeeEEEEeeeCCCeEEEEEe
Q 046851 688 NCIGNGGFGATYKAEISP--------GVLVAIKRLAVGRFQGVQQFHAEIKTLGRLR-HPNLVTLIGYHASETEMFLIYN 758 (963)
Q Consensus 688 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 758 (963)
+.|+.|-.-.+|+....+ ...|.+++.. .. .......+|..+++.+. +.-..++++++.+ +.|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 567878888999998754 3567777654 22 22334567888888875 4334577887754 68999
Q ss_pred ccCCCCh
Q 046851 759 YLPGGNL 765 (963)
Q Consensus 759 ~~~~gsL 765 (963)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.80 E-value=0.014 Score=59.95 Aligned_cols=158 Identities=13% Similarity=0.072 Sum_probs=83.9
Q ss_pred CChHHHHHHcCCCCCcccc-----ccCCCccEEEEEECCCcEEEEEEeecccchhHHHHHHHHHHHhccCC-----CCee
Q 046851 672 LSFESVVQATGNFNASNCI-----GNGGFGATYKAEISPGVLVAIKRLAVGRFQGVQQFHAEIKTLGRLRH-----PNLV 741 (963)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~i-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv 741 (963)
++.+++.....+|.+++.. ..|.--+.|+.+..+|+ +++|++...... +.+..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH--HHHHHHHHHHHhhhhccccccccc
Confidence 5667888888889876544 35556778999888665 889988653222 334455666655532 2221
Q ss_pred EEEE---eeeCCCeEEEEEeccCCCChHH-----------H---Hhhhc-------CCCCCH------------------
Q 046851 742 TLIG---YHASETEMFLIYNYLPGGNLEN-----------F---IQQRS-------TRAVDW------------------ 779 (963)
Q Consensus 742 ~l~~---~~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~-------~~~~~~------------------ 779 (963)
...+ +.......+.++.++.+..... . ++... ......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1100 1122345666777776542211 1 11000 000000
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCceecccCCCCeEECCCCcEEEeecccccc
Q 046851 780 RVLHKIALDIARALAYLHD-QCVPRVLHRDVKPSNILLDDDFNAYLSDFGLARL 832 (963)
Q Consensus 780 ~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 832 (963)
......+......+...+. ....|+||+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111122222222222222 1244899999999999999988778999998753
|